Citrus Sinensis ID: 012715

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------46
Protein Sequence
MLAPKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccEEEEEEEccccEEEEEEccccccHHHHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEccccccccccccccccccccEEEEccccccccHHHcccccccccccccHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccEEHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccHHcccccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEEHHHEEEEccccHHHHccccccccEEEEEEEEEccccccHHHHHcccccccccHHHHHHEHHHHHcccccccccHHHHHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHccccHHccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mlapkaspsplvavspsqhmlavpqnenhhpyhltlipgIGIAVTAVAVILLMVLIILIRRksrgledpenldktslkpfppprslrkfqegpspmfqkfsyketkkatdnfstiigqggfgtvykaqfsdgslIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANgslkdhlhspgrtplswQTRIQIAIDVANALEYLhfycdpplchrdikssnilldeNFVAKLADFGlahaskdgsicfepvntdirgtpgymdpeyvVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLaelvdprikdsfdmEQLRTIVTIVRWCtqregqarpSIKQVLRILyessdpmhsgfvqavedeeyeetdgrprtsqrkahrsdptfysgdgrylasssstsrsycsrsfllengspqsppnllsl
Flexible Loop (DISEMBL)
mlapkaspsplVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRrksrgledpenldktslkpfppprslrkfqegpspmfQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHaskdgsicfePVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLaelvdprikdsfdmeqLRTIVTIVrwctqregqarpsIKQVLRILYESSDPMHSGFVqavedeeyeetdgrprtsqrkahrsdptfysgdgrylasssSTSRSYCSRSfllengspqsppnllsl
Low Complexity Region (SEG)
MlapkaspsplvavspsQHMLAVPQNENHHPYHLTLIPGigiavtavavillmvliiliRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEllarlhhrhlvalrGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGRYLAsssstsrsycsrsFLLENGSPQSPPNLLSL
Disordered region (IsUnstruct)
****************************HHPYHLTLIPGIGIAVTAVAVILLMVLIILIRR***********************************************TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE******************************************************************************
Disordered Region (DISOPRED)
*************************************PGIGIAVTAVAVILLMVLIILI***************************************KFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAV*R***********FCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE******************************************************************************
Disordered Region (DISEMBL)
**************SPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVE*********************DPTFYSGDGR*************SRSFLLEN************
Disordered Region (DISPRO)
********************************HLTLIPGIGIAVTAVAVILLMVLIILIRRKSR*******************************MFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES*****************************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLAPKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	458	2.2.26 [Sep-21-2011]
Q9FX99	663	Probable receptor-like pr	no	no	0.960	0.663	0.618	1e-162
C0LGD7	953	Probable LRR receptor-lik	no	no	0.711	0.342	0.428	4e-68
Q9SA72	849	Probable receptor-like pr	no	no	0.735	0.396	0.405	1e-65
Q9C821	509	Proline-rich receptor-lik	no	no	0.803	0.722	0.359	6e-64
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.606	0.408	0.429	7e-64
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.810	0.522	0.344	1e-63
Q9LK03	717	Proline-rich receptor-lik	no	no	0.615	0.393	0.416	3e-63
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.858	0.766	0.347	9e-63
Q9SFT7	414	Serine/threonine-protein	no	no	0.609	0.673	0.446	1e-62
Q9LFV3	436	Probable leucine-rich rep	no	no	0.593	0.623	0.409	2e-62

>sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1

 Score =  570 bits (1469), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 285/461 (61%), Positives = 356/461 (77%), Gaps = 21/461 (4%)

Query: 3   APKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRK 62
           +P+ SPS +  +SPS     +  + + +PYHLT++P IGI VTAVA+ +L+VL+ILIRRK
Sbjct: 219 SPEPSPSTVGGISPSNSDSQMTTSRSTNPYHLTMVPTIGIVVTAVALTMLVVLVILIRRK 278

Query: 63  SRGLEDPENLDKTSLKPFPPPRSLRKFQEG-PSPMFQKFSYKETKKATDNFSTIIGQGGF 121
           +R L++ E+LD+ S K  P    + K  E   S  F+KFSYKE   AT++F+T+IGQGGF
Sbjct: 279 NRELDESESLDRKSTKSVPSSLPVFKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQGGF 338

Query: 122 GTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 181
           GTVYKA+F+DG + AVK+M+K+SEQ E DFCREI LLA+LHHR+LVAL+GFCI K+ERFL
Sbjct: 339 GTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFL 398

Query: 182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 241
           +Y+YM NGSLKDHLH+ G+ P SW TR++IAIDVANALEYLHFYCDPPLCHRDIKSSNIL
Sbjct: 399 VYDYMKNGSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 458

Query: 242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGV 301
           LDENFVAKL+DFGLAH+S+DGS+CFEPVNTDIRGTPGY+DPEYVVTQELTEKSDVYSYGV
Sbjct: 459 LDENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGV 518

Query: 302 VLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD---MEQLRTIVTIVR 358
           VLLE++T RRAV +G+NLVE +Q  + ++S+  ELVDPRIKDS +    +QL  +VT+VR
Sbjct: 519 VLLELITGRRAVDEGRNLVEMSQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVTVVR 578

Query: 359 WCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPT 418
            CT++EG++RPSIKQVLR+L ES DP+HS F +AVE+E     D R R++ R        
Sbjct: 579 LCTEKEGRSRPSIKQVLRLLCESCDPVHSAFAKAVEEE--IGWDSRKRSNLR-------- 628

Query: 419 FYSGDGRYLA-SSSSTSRSYCSRSFLLENGSPQSPPNLLSL 458
              GD R    SSS+TSRS+ SRS       P SP N  S 
Sbjct: 629 IQRGDSRIFGPSSSTTSRSHYSRSL------PHSPINGFSF 663

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2

 Score =  259 bits (661), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 153/357 (42%), Positives = 218/357 (61%), Gaps = 31/357 (8%)

Query: 37  IPGIGIAVTAVAVILLMVL-IILIRRKSRG---LEDPENLDKTSLKPFPPPRSLRKFQEG 92
           + GI +   A AV L  ++ +I++R++ RG   +   +   K SLK            EG
Sbjct: 561 VAGIVLGSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLK-----------IEG 609

Query: 93  PSPMFQKFSYKETKKATDNF--STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGD 150
                + F+Y E   ATDNF  ST IGQGG+G VYK     G+++A+KR  + S Q E +
Sbjct: 610 ----VKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKE 665

Query: 151 FCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 210
           F  EIELL+RLHHR+LV+L GFC E+ E+ L+YEYM NG+L+D++    + PL +  R++
Sbjct: 666 FLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLR 725

Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS----KDGSICF 266
           IA+  A  + YLH   +PP+ HRDIK+SNILLD  F AK+ADFGL+  +     +G I  
Sbjct: 726 IALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEG-ISP 784

Query: 267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 326
           + V+T ++GTPGY+DPEY +T +LT+KSDVYS GVVLLE+ T  + +  GKN+V    + 
Sbjct: 785 QHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIA 844

Query: 327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR---ILYE 380
             S S L+  VD R+    D E L    T+   C + E  ARPS+ +V+R   I++E
Sbjct: 845 YESGSILST-VDKRMSSVPD-ECLEKFATLALRCCREETDARPSMAEVVRELEIIWE 899

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  251 bits (640), Expect = 1e-65,   Method: Compositional matrix adjust.
 Identities = 145/358 (40%), Positives = 204/358 (56%), Gaps = 21/358 (5%)

Query: 39  GIGIAVTAVAVIL-LMVLIILIRRKSRGLEDPEN----------LDKTSLKPFPPPRSLR 87
           G GIA+    V L ++V+ +  +R+S+  E   N          ++ ++        SLR
Sbjct: 436 GAGIAIIIFFVFLGILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNSTANAKATGGSLR 495

Query: 88  KFQEGPSPMFQKFSYKETKKATDNF--STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE 145
                 S M +KF+  E + AT NF     IG GGFG VY+ +  DG+LIA+KR    S+
Sbjct: 496 LNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQ 555

Query: 146 QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
           Q   +F  EI +L+RL HRHLV+L GFC E  E  L+YEYMANG+L+ HL      PLSW
Sbjct: 556 QGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSW 615

Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 265
           + R++  I  A  L YLH   +  + HRD+K++NILLDENFVAK++DFGL+ A    S+ 
Sbjct: 616 KQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGP--SMD 673

Query: 266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-----QDGKNLV 320
              V+T ++G+ GY+DPEY   Q+LTEKSDVYS+GVVL E V AR  +     +D  NL 
Sbjct: 674 HTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLA 733

Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           E A +    +  L  ++D  ++ ++  E L     I   C   EG+ RP + +VL  L
Sbjct: 734 EWA-LSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSL 790

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1

 Score =  245 bits (625), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 145/403 (35%), Positives = 230/403 (57%), Gaps = 35/403 (8%)

Query: 4   PKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPG-----------IGIAVTAVAVILL 52
           P  +P    + +PSQ  +  P +    P   T I G            G+ + A  V+L 
Sbjct: 18  PSTTPDTATSPAPSQPSIIGPSSLAPFPETTTNIDGGSRNVALTGLITGVVLGATFVLLG 77

Query: 53  MVLIILI------RRKSRGLEDPE-NLDKTSLKPFPPPRSLRKFQEGPSPMFQK-FSYKE 104
           + + +        + K +  ED E ++++ SL P     +L+++    S + Q  F+Y++
Sbjct: 78  VCIFVCFYKRKKRKLKKKKKEDIEASINRDSLDPKDDSNNLQQWSS--SEIGQNLFTYED 135

Query: 105 TKKATDNFST--IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH 162
             KAT NFS   ++GQGGFG V++    DG+L+A+K++   S Q E +F  EI+ ++R+H
Sbjct: 136 LSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEIQTISRVH 195

Query: 163 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
           HRHLV+L G+CI   +R L+YE++ N +L+ HLH   R  + W  R++IA+  A  L YL
Sbjct: 196 HRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALGAAKGLAYL 255

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
           H  C+P   HRD+K++NIL+D+++ AKLADFGLA +S D       V+T I GT GY+ P
Sbjct: 256 HEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDT---HVSTRIMGTFGYLAP 312

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQ------DGKNLVESAQVCMA---SESRL 333
           EY  + +LTEKSDV+S GVVLLE++T RR V       D  ++V+ A+  M    ++   
Sbjct: 313 EYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQALNDGNF 372

Query: 334 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
             LVDPR+++ FD+ ++  +V       +   + RP + Q++R
Sbjct: 373 DGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVR 415

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  244 bits (624), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 124/289 (42%), Positives = 181/289 (62%), Gaps = 11/289 (3%)

Query: 100 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL 157
           FSY E  + T  FS   ++G+GGFG VYK   SDG  +AVK++     Q E +F  E+E+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386

Query: 158 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
           ++R+HHRHLV L G+CI ++ R L+Y+Y+ N +L  HLH+PGR  ++W+TR+++A   A 
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAAR 446

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
            + YLH  C P + HRDIKSSNILLD +F A +ADFGLA  +++  +    V+T + GT 
Sbjct: 447 GIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTH-VSTRVMGTF 505

Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-----NLVESAQVCMAS--- 329
           GYM PEY  + +L+EK+DVYSYGV+LLE++T R+ V   +     +LVE A+  +     
Sbjct: 506 GYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIE 565

Query: 330 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                ELVDPR+  +F   ++  +V     C +     RP + QV+R L
Sbjct: 566 NEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  244 bits (622), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 154/447 (34%), Positives = 224/447 (50%), Gaps = 76/447 (17%)

Query: 2   LAPKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPG------IGIAVTAVAVILLMVL 55
           L PK++ +     SPS+    VP + N  P       G       G A+   AVI LM +
Sbjct: 196 LPPKSTAAGGPLTSPSR---GVPSSGNSVPPPANSGGGYQGKTMAGFAIAGFAVIALMAV 252

Query: 56  IILIRRKSRGLEDPENLDKTSLKPFPPPRSLR-------------KFQEGPSPMFQK--- 99
           + L+RRK +      N+D  S   + PP +               K   GP     +   
Sbjct: 253 VFLVRRKKK-----RNIDAYSDSQYLPPSNFSIKSDGFLYGQNPTKGYSGPGGYNSQQQS 307

Query: 100 ---------------------------------FSYKETKKATDNFS--TIIGQGGFGTV 124
                                            F+Y+E    T+ FS   I+G+GGFG V
Sbjct: 308 NSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCV 367

Query: 125 YKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE 184
           YK + +DG L+AVK++   S Q + +F  E+E+++R+HHRHLV+L G+CI   ER L+YE
Sbjct: 368 YKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYE 427

Query: 185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE 244
           Y+ N +L+ HLH  GR  L W  R++IAI  A  L YLH  C P + HRDIKS+NILLD+
Sbjct: 428 YVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDD 487

Query: 245 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL 304
            F A++ADFGLA  +         V+T + GT GY+ PEY  + +LT++SDV+S+GVVLL
Sbjct: 488 EFEAQVADFGLAKLNDSTQTH---VSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLL 544

Query: 305 EIVTARRAVQDGKNLVESAQVCMA--------SESRLAELVDPRIKDSFDMEQLRTIVTI 356
           E++T R+ V   + L E + V  A             +ELVD R++  +   ++  ++  
Sbjct: 545 ELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIET 604

Query: 357 VRWCTQREGQARPSIKQVLRILYESSD 383
              C +  G  RP + QV+R L    D
Sbjct: 605 AAACVRHSGPKRPRMVQVVRALDSEGD 631

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  243 bits (619), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 123/295 (41%), Positives = 185/295 (62%), Gaps = 13/295 (4%)

Query: 100 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL 157
           F+Y+E  +AT+ FS   ++GQGGFG V+K    +G  +AVK++ + S Q E +F  E+ +
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401

Query: 158 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
           ++R+HHRHLVAL G+CI   +R L+YE++ N +L+ HLH  GR  + W +R++IA+  A 
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAK 461

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
            L YLH  C+P + HRDIK+SNIL+D  F AK+ADFGLA  + D +     V+T + GT 
Sbjct: 462 GLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTH---VSTRVMGTF 518

Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR-----AVQDGKNLVESAQVCMASESR 332
           GY+ PEY  + +LTEKSDV+S+GVVLLE++T RR      V    +LV+ A+  +   S 
Sbjct: 519 GYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSE 578

Query: 333 LAE---LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 384
           L     +VD ++ + +D E++  +V     C +     RP + QV R+L  +  P
Sbjct: 579 LGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISP 633

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  241 bits (615), Expect = 9e-63,   Method: Compositional matrix adjust.
 Identities = 155/446 (34%), Positives = 235/446 (52%), Gaps = 53/446 (11%)

Query: 4   PKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKS 63
           P ASPS     +P+      P      P    L  G  + ++    + ++ LI  + +K 
Sbjct: 93  PPASPSGQEPTTPTM----TPGFSLSPPSPSRLSTGAVVGISIGGGVFVLTLIFFLCKKK 148

Query: 64  RGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFS--TIIGQGGF 121
           R  +D         K  P P  L       +     F+Y E  +AT+ FS   ++G+GGF
Sbjct: 149 RPRDD---------KALPAPIGLVLGIHQST-----FTYGELARATNKFSEANLLGEGGF 194

Query: 122 GTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 181
           G VYK   ++G+ +AVK++   S Q E +F  E+ +++++HHR+LV+L G+CI   +R L
Sbjct: 195 GFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLL 254

Query: 182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 241
           +YE++ N +L+ HLH  GR  + W  R++IA+  +  L YLH  C+P + HRDIK++NIL
Sbjct: 255 VYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANIL 314

Query: 242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGV 301
           +D  F AK+ADFGLA  + D +     V+T + GT GY+ PEY  + +LTEKSDVYS+GV
Sbjct: 315 IDFKFEAKVADFGLAKIALDTNTH---VSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGV 371

Query: 302 VLLEIVTARRAVQDGKN------LVESAQ---VCMASESRLAELVDPRIKDSFDMEQLRT 352
           VLLE++T RR V D  N      LV+ A+   V    ES    L D ++ + +D E++  
Sbjct: 372 VLLELITGRRPV-DANNVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEYDREEMAR 430

Query: 353 IVTIVRWCTQREGQARPSIKQVLRI---------LYESSDPMHSGFV------QAVEDEE 397
           +V     C +   + RP + QV+R+         L +   P HS  V      +AV  + 
Sbjct: 431 MVACAAACVRYTARRRPRMDQVVRVLEGNISPSDLNQGITPGHSNTVSVRLDARAVRVKP 490

Query: 398 YEETDGRPRTSQRKAHRSDPTFYSGD 423
           + E D R    +R A R     Y GD
Sbjct: 491 HGEMDSRWGRFKRTAQR-----YGGD 511

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1

 Score =  240 bits (613), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 130/291 (44%), Positives = 179/291 (61%), Gaps = 12/291 (4%)

Query: 98  QKFSYKETKKATDNF--STIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCRE 154
           Q FS++E   AT NF    +IG+GGFG VYK +    G ++AVK++D+   Q   +F  E
Sbjct: 65  QTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVE 124

Query: 155 IELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH--SPGRTPLSWQTRIQIA 212
           + +L+ LHH+HLV L G+C +  +R L+YEYM+ GSL+DHL   +P + PL W TRI+IA
Sbjct: 125 VLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIA 184

Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 272
           +  A  LEYLH   +PP+ +RD+K++NILLD  F AKL+DFGLA     G    + V++ 
Sbjct: 185 LGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDK--QHVSSR 242

Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-----QDGKNLVESAQVCM 327
           + GT GY  PEY  T +LT KSDVYS+GVVLLE++T RR +     +D +NLV  AQ   
Sbjct: 243 VMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVF 302

Query: 328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
              SR  EL DP ++  F  + L   V +   C Q E   RP +  V+  L
Sbjct: 303 KEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFV3|Y5157_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 OS=Arabidopsis thaliana GN=At5g15730 PE=2 SV=1

 Score =  240 bits (612), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 115/281 (40%), Positives = 184/281 (65%), Gaps = 9/281 (3%)

Query: 99  KFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELL 158
           +++YK+ +KAT NF+T++GQG FG VYKA   +G L A K     S Q + +F  E+ LL
Sbjct: 103 RYNYKDIQKATQNFTTVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDREFQTEVSLL 162

Query: 159 ARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH-SPGRTPLSWQTRIQIAIDVAN 217
            RLHHR+LV L G+C++K  R L+YE+M+NGSL++ L+   G   L+W+ R+QIA+D+++
Sbjct: 163 GRLHHRNLVNLTGYCVDKSHRMLIYEFMSNGSLENLLYGGEGMQVLNWEERLQIALDISH 222

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
            +EYLH    PP+ HRD+KS+NILLD +  AK+ADFGL+       +  + + + ++GT 
Sbjct: 223 GIEYLHEGAVPPVIHRDLKSANILLDHSMRAKVADFGLSK-----EMVLDRMTSGLKGTH 277

Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 337
           GYMDP Y+ T + T KSD+YS+GV++LE++T   A+   +NL+E   +   S   + E++
Sbjct: 278 GYMDPTYISTNKYTMKSDIYSFGVIILELIT---AIHPQQNLMEYINLASMSPDGIDEIL 334

Query: 338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           D ++  +  +E++R +  I   C  +  + RPSI +V + +
Sbjct: 335 DQKLVGNASIEEVRLLAKIANRCVHKTPRKRPSIGEVTQFI 375

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	458
147801125	673	hypothetical protein VITISV_029977 [Viti	0.986	0.671	0.825	0.0
359475361	734	PREDICTED: probable receptor-like protei	0.986	0.615	0.825	0.0
297741261	619	unnamed protein product [Vitis vinifera]	0.943	0.697	0.804	0.0
356519713	670	PREDICTED: probable receptor-like protei	0.997	0.682	0.730	0.0
356499747	670	PREDICTED: probable receptor-like protei	0.973	0.665	0.751	0.0
449445884	680	PREDICTED: probable receptor-like protei	0.993	0.669	0.740	0.0
357475327	671	Senescence-induced receptor-like serine/	0.993	0.678	0.728	0.0
297834848	663	kinase family protein [Arabidopsis lyrat	0.943	0.651	0.684	1e-170
18402188	663	protein kinase family protein [Arabidops	0.943	0.651	0.675	1e-164
75309871	663	RecName: Full=Probable receptor-like pro	0.960	0.663	0.618	1e-160

>gi|147801125|emb|CAN68826.1| hypothetical protein VITISV_029977 [Vitis vinifera]

 Score =  735 bits (1897), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/453 (82%), Positives = 413/453 (91%), Gaps = 1/453 (0%)

Query: 7   SPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGL 66
           SPSPLVA SPSQ +  V ++ENHHPYHLTLIPG+GIAVTAVAVI+L+VLIILIR+K+R L
Sbjct: 221 SPSPLVAASPSQVVSTVTRDENHHPYHLTLIPGVGIAVTAVAVIMLVVLIILIRKKNREL 280

Query: 67  EDPENLDKTSLKPFPPP-RSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVY 125
           E+ EN  KTS K FPPP R +RK QEG S MFQK+SYKETKKAT+NF+TI+GQGGFGTVY
Sbjct: 281 ENFENTGKTSSKDFPPPPRPIRKLQEGSSSMFQKYSYKETKKATNNFNTIVGQGGFGTVY 340

Query: 126 KAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 185
           KAQF DGS+ AVKRM+K+SEQ E +FC+EIELLARLHHRHLVALRGFCIEK  RFLMYEY
Sbjct: 341 KAQFRDGSVAAVKRMNKVSEQGEDEFCQEIELLARLHHRHLVALRGFCIEKHNRFLMYEY 400

Query: 186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 245
           M NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN
Sbjct: 401 MENGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 460

Query: 246 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
           FVAK+ADFGLAHASKDGSICFEPVNTD+RGTPGYMDPEYV+T+ELTEKSDVYSYGVVLLE
Sbjct: 461 FVAKVADFGLAHASKDGSICFEPVNTDVRGTPGYMDPEYVITRELTEKSDVYSYGVVLLE 520

Query: 306 IVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREG 365
           +VTARRA+QD KNLVE +Q+ MASESRLAELVDP I DSFD +QL+T+VTIVRWCTQRE 
Sbjct: 521 LVTARRAIQDNKNLVEWSQIFMASESRLAELVDPSIGDSFDFDQLQTVVTIVRWCTQREA 580

Query: 366 QARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGR 425
           +ARPSIKQVLR+LYESSDPMH+GFVQAVEDEEYEET+ R RTS+ K +R D  F+SGDGR
Sbjct: 581 RARPSIKQVLRLLYESSDPMHNGFVQAVEDEEYEETEERGRTSKGKMNRGDGIFHSGDGR 640

Query: 426 YLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL 458
            LASSSSTSRSYCSRSFLLENGSPQSP  +LS+
Sbjct: 641 CLASSSSTSRSYCSRSFLLENGSPQSPSGILSV 673

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475361|ref|XP_002282345.2| PREDICTED: probable receptor-like protein kinase At1g49730-like [Vitis vinifera]

 Score =  733 bits (1893), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/453 (82%), Positives = 412/453 (90%), Gaps = 1/453 (0%)

Query: 7   SPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGL 66
           SPSPLVA SPSQ +  V ++ENHHPYHLTLIPG+GIAVTAVAVI+L+VLIILIR+K+R L
Sbjct: 282 SPSPLVAASPSQVVSTVTRDENHHPYHLTLIPGVGIAVTAVAVIMLVVLIILIRKKNREL 341

Query: 67  EDPENLDKTSLKPFPPP-RSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVY 125
           E+ EN  KTS K FPPP R +RK QEG S MFQK+SYKETKKAT+NF+TI+GQGGFGTVY
Sbjct: 342 ENFENTGKTSSKDFPPPPRPIRKLQEGSSSMFQKYSYKETKKATNNFNTIVGQGGFGTVY 401

Query: 126 KAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 185
           KAQF DGS+ AVKRM+K+SEQ E +FC+EIELLARLHHRHLVALRGFCIEK  RFLMYEY
Sbjct: 402 KAQFRDGSVAAVKRMNKVSEQGEDEFCQEIELLARLHHRHLVALRGFCIEKHNRFLMYEY 461

Query: 186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 245
           M NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN
Sbjct: 462 MENGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 521

Query: 246 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
           FVAK+ADFGLAHASKDGSICFEPVNTD+RGTPGYMDPEYV+TQELTEKSDVYSYGVVLLE
Sbjct: 522 FVAKVADFGLAHASKDGSICFEPVNTDVRGTPGYMDPEYVITQELTEKSDVYSYGVVLLE 581

Query: 306 IVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREG 365
           +VTARRA+QD KNLVE +Q+ MASESRLAELVDP I DSFD +QL+T+VTIVRWCTQ E 
Sbjct: 582 LVTARRAIQDNKNLVEWSQIFMASESRLAELVDPSIGDSFDFDQLQTVVTIVRWCTQGEA 641

Query: 366 QARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGR 425
           +ARPSIKQVLR+LYESSDPMH+GFVQAVEDEEYEET+ R RTS+ K +R D  F+SGDGR
Sbjct: 642 RARPSIKQVLRLLYESSDPMHNGFVQAVEDEEYEETEERGRTSKGKMNRGDGIFHSGDGR 701

Query: 426 YLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL 458
            LASSSSTSRSYCSRSFLLENGSPQSP  +LS+
Sbjct: 702 CLASSSSTSRSYCSRSFLLENGSPQSPSGILSV 734

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297741261|emb|CBI32392.3| unnamed protein product [Vitis vinifera]

 Score =  721 bits (1860), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/450 (80%), Positives = 396/450 (88%), Gaps = 18/450 (4%)

Query: 7   SPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGL 66
           SPSPLVA SPSQ +  V ++ENHHPYHLTLIPG+GIAVTAVAVI+L+VLIILIR+K+R L
Sbjct: 147 SPSPLVAASPSQVVSTVTRDENHHPYHLTLIPGVGIAVTAVAVIMLVVLIILIRKKNREL 206

Query: 67  EDPENLDKTSLKPFPPP-RSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVY 125
           E+ EN  KTS K FPPP R +RK QEG S MFQK+SYKETKKAT+NF+TI+GQGGFGTVY
Sbjct: 207 ENFENTGKTSSKDFPPPPRPIRKLQEGSSSMFQKYSYKETKKATNNFNTIVGQGGFGTVY 266

Query: 126 KAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 185
           KAQF DGS+ AVKRM+K+SEQ E +FC+EIELLARLHHRHLVALRGFCIEK  RFLMYEY
Sbjct: 267 KAQFRDGSVAAVKRMNKVSEQGEDEFCQEIELLARLHHRHLVALRGFCIEKHNRFLMYEY 326

Query: 186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 245
           M NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN
Sbjct: 327 MENGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 386

Query: 246 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
           FVAK+ADFGLAHASKDGSICFEPVNTD+RGTPGYMDPEYV+TQELTEKSDVYSYGVVLLE
Sbjct: 387 FVAKVADFGLAHASKDGSICFEPVNTDVRGTPGYMDPEYVITQELTEKSDVYSYGVVLLE 446

Query: 306 IVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREG 365
           +VTARRA+QD KNLVE +Q+ MASESRLAELVDP I DSFD +QL+T+VTIVRWCTQ E 
Sbjct: 447 LVTARRAIQDNKNLVEWSQIFMASESRLAELVDPSIGDSFDFDQLQTVVTIVRWCTQGEA 506

Query: 366 QARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGR 425
           +ARPSIKQVLR+LYESSDPMH+GFVQAVEDEE                  D  F+SGDGR
Sbjct: 507 RARPSIKQVLRLLYESSDPMHNGFVQAVEDEE-----------------GDGIFHSGDGR 549

Query: 426 YLASSSSTSRSYCSRSFLLENGSPQSPPNL 455
            LASSSSTSRSYCSRSFLLENGSPQSP  +
Sbjct: 550 CLASSSSTSRSYCSRSFLLENGSPQSPSGI 579

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356519713|ref|XP_003528514.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max]

 Score =  689 bits (1778), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/468 (73%), Positives = 403/468 (86%), Gaps = 11/468 (2%)

Query: 1   MLAPKASPS----------PLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVI 50
           ++ P++SPS          PLVA  PSQ +L+ P   NHH YHLTL+PGI IAVTAVAVI
Sbjct: 204 LIPPESSPSFPAPKASPSPPLVADGPSQPLLSAPLKGNHHSYHLTLVPGIAIAVTAVAVI 263

Query: 51  LLMVLIILIRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATD 110
            L+VLI+LIR+KSR L++P+N  K+  K  PP  +  KFQEG S MF+KFSY+E KKAT+
Sbjct: 264 TLIVLIVLIRQKSRELDEPDNFGKSCSKTLPPCATW-KFQEGSSSMFRKFSYREIKKATE 322

Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALR 170
           +FST+IGQGGFGTVYKAQFSDG +IAVKRM++ISEQ E +FCREIELLARLHHRHLVAL+
Sbjct: 323 DFSTVIGQGGFGTVYKAQFSDGLVIAVKRMNRISEQGEDEFCREIELLARLHHRHLVALK 382

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           GFCI+KRERFL+YEYM NGSLKDHLHSPG+TPLSW+TRIQIAIDVANALEYLHFYCDPPL
Sbjct: 383 GFCIKKRERFLLYEYMGNGSLKDHLHSPGKTPLSWRTRIQIAIDVANALEYLHFYCDPPL 442

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           CHRDIKSSN LLDENFVAK+ADFGLA ASKDGS+CFEPVNT+IRGTPGYMDPEYVVTQEL
Sbjct: 443 CHRDIKSSNTLLDENFVAKIADFGLAQASKDGSVCFEPVNTEIRGTPGYMDPEYVVTQEL 502

Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 350
           TEKSD+YS+GV+LLEIVT RRA+Q  KNLVE AQ  M S++RL ELVDP +++SFD++QL
Sbjct: 503 TEKSDIYSFGVLLLEIVTGRRAIQGNKNLVEWAQPYMESDTRLLELVDPNVRESFDLDQL 562

Query: 351 RTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQR 410
           +T+++IV WCTQREG+ARPSIKQVLR+LYE+S+PMHS F+QAVEDEE + +  R R S+ 
Sbjct: 563 QTVISIVAWCTQREGRARPSIKQVLRLLYETSEPMHSEFLQAVEDEECQGSQHRGRRSKG 622

Query: 411 KAHRSDPTFYSGDGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL 458
           K  R++   +SGDGRYLASSSSTSRSYCSR+FLLE+GSPQSPPN+ SL
Sbjct: 623 KMLRNEALSHSGDGRYLASSSSTSRSYCSRTFLLESGSPQSPPNIFSL 670

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356499747|ref|XP_003518698.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Glycine max]

 Score =  688 bits (1775), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/447 (75%), Positives = 393/447 (87%), Gaps = 1/447 (0%)

Query: 12  VAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGLEDPEN 71
           VA  PS  +L+ P   NHH YHLTL+PGI IAVTAVAVI L+VLI+LIR+KSR L++P+N
Sbjct: 225 VADGPSHPLLSAPLKGNHHSYHLTLVPGIAIAVTAVAVITLIVLIVLIRQKSRELDEPDN 284

Query: 72  LDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD 131
             K+  K  PP  +  KFQEG S MF+KFSY+E KKAT++FST+IGQGGFGTVYKAQFSD
Sbjct: 285 FGKSCSKTLPPCATW-KFQEGSSSMFRKFSYREIKKATNDFSTVIGQGGFGTVYKAQFSD 343

Query: 132 GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 191
           G ++AVKRM++ISEQ E +FCREIELLARLHHRHLVALRGFCI+K ERFLMYEYM NGSL
Sbjct: 344 GLIVAVKRMNRISEQGEDEFCREIELLARLHHRHLVALRGFCIKKCERFLMYEYMGNGSL 403

Query: 192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 251
           KDHLHSPG+TPLSW+TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN LLDENFVAK+A
Sbjct: 404 KDHLHSPGKTPLSWRTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNTLLDENFVAKIA 463

Query: 252 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
           DFGLA ASKDGS+CFEPVNT+IRGTPGYMDPEY+VTQELTEKSD+YS+GV+LLEIVT RR
Sbjct: 464 DFGLAQASKDGSVCFEPVNTEIRGTPGYMDPEYIVTQELTEKSDIYSFGVLLLEIVTGRR 523

Query: 312 AVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSI 371
           A+QD KNLVE AQ  M S++RL ELVDP +++SFD++QL+T+++IV WCTQREG+ARPSI
Sbjct: 524 AIQDNKNLVEWAQPYMESDTRLLELVDPNVRESFDLDQLQTVISIVVWCTQREGRARPSI 583

Query: 372 KQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGRYLASSS 431
           KQVLR+LYE+S+PMHS F+QAVEDEE + +  R R S+ K  R++  F+SGDGRYLASSS
Sbjct: 584 KQVLRLLYETSEPMHSEFLQAVEDEEGQGSQHRGRRSKGKMLRNEALFHSGDGRYLASSS 643

Query: 432 STSRSYCSRSFLLENGSPQSPPNLLSL 458
           STSRSYCSR+FLLE+GSPQSPPN+ SL
Sbjct: 644 STSRSYCSRTFLLESGSPQSPPNMFSL 670

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449445884|ref|XP_004140702.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Cucumis sativus] gi|449486593|ref|XP_004157342.1| PREDICTED: probable receptor-like protein kinase At1g49730-like [Cucumis sativus]

 Score =  680 bits (1754), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/459 (74%), Positives = 395/459 (86%), Gaps = 4/459 (0%)

Query: 1   MLAPKASPSPLVAVSPSQHMLAVP--QNENHHPYHLTLIPGIGIAVTAVAVILLMVLIIL 58
           +  PK SPSP  A SP    L V   ++  HH YHLTL+ GIGIAVT  +V++L+VLI+L
Sbjct: 218 LTTPKISPSPSAAESPGSLTLDVAGDKSHQHHSYHLTLVAGIGIAVTVGSVMMLVVLIVL 277

Query: 59  IRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQ 118
           IRRKSR L+D + +D  S K FP  R ++K+QEGPS MF+KFSYKE KKATD+FST IGQ
Sbjct: 278 IRRKSRELKDSDKMDANSSKSFPS-RPIKKYQEGPS-MFKKFSYKEIKKATDSFSTTIGQ 335

Query: 119 GGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE 178
           GG+GTVYKAQF+D  ++AVKRM+K+SEQ E +F REIELLARLHHRHLVALRGFC+EK E
Sbjct: 336 GGYGTVYKAQFTDDVVVAVKRMNKVSEQGEDEFGREIELLARLHHRHLVALRGFCVEKHE 395

Query: 179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS 238
           RFL+YE+MANGSLKDHLH+PGRTPLSW+TRIQIAIDVANALEYLH+YCDPPLCHRDIKSS
Sbjct: 396 RFLLYEFMANGSLKDHLHAPGRTPLSWRTRIQIAIDVANALEYLHYYCDPPLCHRDIKSS 455

Query: 239 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYS 298
           NILLDENFVAK+ADFGLAHASK GS+ FEPVNTDIRGTPGYMDPEYV+TQELTEKSD+YS
Sbjct: 456 NILLDENFVAKVADFGLAHASKGGSVFFEPVNTDIRGTPGYMDPEYVITQELTEKSDIYS 515

Query: 299 YGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVR 358
           YGV+LLEIVT RRA+QDGKNLVE +   M S+SR++ELVDP IK  F+++QL TIV+IVR
Sbjct: 516 YGVLLLEIVTGRRAIQDGKNLVEWSLGYMISDSRISELVDPSIKGCFNLDQLHTIVSIVR 575

Query: 359 WCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPT 418
           WCT+ EG+ARPSIKQVLR+LYESSDPMH G ++AV+DEEY  T+GR   S+RK H+SD  
Sbjct: 576 WCTEGEGRARPSIKQVLRLLYESSDPMHQGLMEAVDDEEYGGTEGRQSMSKRKMHKSDVI 635

Query: 419 FYSGDGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLS 457
           F+SGDGRYLASSSSTSRSYCSRSFLLE GSPQSPPN+ S
Sbjct: 636 FHSGDGRYLASSSSTSRSYCSRSFLLETGSPQSPPNIYS 674

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357475327|ref|XP_003607949.1| Senescence-induced receptor-like serine/threonine-protein kinase [Medicago truncatula] gi|355509004|gb|AES90146.1| Senescence-induced receptor-like serine/threonine-protein kinase [Medicago truncatula]

 Score =  667 bits (1722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/457 (72%), Positives = 388/457 (84%), Gaps = 2/457 (0%)

Query: 3   APKASPSPLVAV-SPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRR 61
           AP+ SPSP VA  SPSQ +L +P    HH YHL L+P I IAVTAVA ++ +VL+ILIR+
Sbjct: 216 APEVSPSPPVAADSPSQLLLGLPTKGKHHSYHLALVPCIAIAVTAVAFVMFIVLMILIRQ 275

Query: 62  KSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGF 121
           KSR L +P N  K S K  P   +  KFQEG S MF+KF++KE KKAT+ FSTIIGQGGF
Sbjct: 276 KSRELNEPHNFGKPSSKTVPS-MAKWKFQEGSSSMFRKFNFKEIKKATEGFSTIIGQGGF 334

Query: 122 GTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 181
           GTVYKA FSDG + AVKRMD++SEQ E DFCREIELLARLHHRHLV LRGFCI+K+ERFL
Sbjct: 335 GTVYKAHFSDGQVAAVKRMDRVSEQGEDDFCREIELLARLHHRHLVTLRGFCIKKQERFL 394

Query: 182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 241
           +YEYM NGSLKDHLHSPG+TPLSW+TRIQIAIDVANALEYLHFYCDPPL HRDIK+SN L
Sbjct: 395 LYEYMGNGSLKDHLHSPGKTPLSWRTRIQIAIDVANALEYLHFYCDPPLFHRDIKASNTL 454

Query: 242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGV 301
           LDENFVAK+ADFGLA ASKDGSICFEPVNT+I GTPGYMDPEY+VTQELTEKSD+YSYGV
Sbjct: 455 LDENFVAKIADFGLAQASKDGSICFEPVNTEIWGTPGYMDPEYIVTQELTEKSDIYSYGV 514

Query: 302 VLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCT 361
           +LLEIVT RRA+QD KNLVE A+  M SE+RL ELVDP +++SFD++QL+T+++IV WCT
Sbjct: 515 LLLEIVTGRRAIQDNKNLVEWAKPYMESETRLLELVDPNVRESFDLDQLQTVISIVGWCT 574

Query: 362 QREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYS 421
           QREG+ARPSIKQVLR+LYE+S+PMH+ F+QAVEDEE +  + R R S+ K  R++  F+S
Sbjct: 575 QREGRARPSIKQVLRLLYETSEPMHTEFLQAVEDEESQGNEQRGRRSKGKMLRNEGNFHS 634

Query: 422 GDGRYLASSSSTSRSYCSRSFLLENGSPQSPPNLLSL 458
           GDGRYLASSSSTSRSYCSRSFLLENGS QS PN+ S+
Sbjct: 635 GDGRYLASSSSTSRSYCSRSFLLENGSAQSSPNVFSV 671

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297834848|ref|XP_002885306.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297331146|gb|EFH61565.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  605 bits (1560), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 310/453 (68%), Positives = 364/453 (80%), Gaps = 21/453 (4%)

Query: 11  LVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGLEDPE 70
           ++A SPS   L +   ++HH YHLT++P IGIAV+AVA+++L+ LI+LI+RK R L+D +
Sbjct: 227 VLADSPSSDNLVLSPLKSHHRYHLTMVPTIGIAVSAVALVMLVFLIVLIQRKKRELDDSK 286

Query: 71  ----NLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYK 126
               NL +TS  P P PRS+    EG S  F+KFSYKE +KAT++F+T+IG+GGFGTVYK
Sbjct: 287 GMDCNLKRTS--PSPHPRSM--IHEGDSSGFRKFSYKEIRKATEDFNTVIGRGGFGTVYK 342

Query: 127 AQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 186
           A+FS+G + AVKRM+K SEQ E +FCREIELLARLHHRHLVAL+GFC +K ERFL+YEYM
Sbjct: 343 AEFSNGLVAAVKRMNKSSEQAEDEFCREIELLARLHHRHLVALKGFCNKKNERFLVYEYM 402

Query: 187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 246
            NGSLKDHLHS  + PLSW+TR++IAIDVANALEYLHFYCDPPLCHRDIKS NILLDENF
Sbjct: 403 ENGSLKDHLHSTEKPPLSWETRMKIAIDVANALEYLHFYCDPPLCHRDIKSGNILLDENF 462

Query: 247 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
           VAKLADFGLAHAS+DGSICFEPVNTDIRGTPGY+DPEYVVTQELTEKSDVYSYGVVLLEI
Sbjct: 463 VAKLADFGLAHASRDGSICFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLLEI 522

Query: 307 VTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQ 366
           +T +RAV +G+NLVE  Q  + SESR  +LVDPRIKD  D EQL T+V +VRWCT++EG 
Sbjct: 523 ITGKRAVDEGRNLVELCQPLLVSESRRIDLVDPRIKDCIDGEQLETLVAVVRWCTEKEGV 582

Query: 367 ARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGRY 426
           ARPSIKQVLR+LYES DP+H G   AV     EE  GR       + R D  F SGD R 
Sbjct: 583 ARPSIKQVLRLLYESCDPLHLGLAMAV-----EENKGR-------SLRGDSGFQSGDIRG 630

Query: 427 LA-SSSSTSRSYCSRSFLLENGSPQSPPNLLSL 458
           LA SSS+TSRS+CSRSFLLE GSP SPPN LS 
Sbjct: 631 LASSSSTTSRSHCSRSFLLETGSPHSPPNGLSF 663

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18402188|ref|NP_566630.1| protein kinase family protein [Arabidopsis thaliana] gi|11994452|dbj|BAB02454.1| unnamed protein product [Arabidopsis thaliana] gi|53828541|gb|AAU94380.1| At3g19300 [Arabidopsis thaliana] gi|55733747|gb|AAV59270.1| At3g19300 [Arabidopsis thaliana] gi|332642700|gb|AEE76221.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  583 bits (1502), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 306/453 (67%), Positives = 365/453 (80%), Gaps = 21/453 (4%)

Query: 11  LVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGLEDPE 70
           ++A SPS   L +   ++HHPYHLT++P IGIAVT  A+++++VLI+LI+RK R L+D +
Sbjct: 227 VLADSPSSDNLVLSPLKSHHPYHLTMVPTIGIAVTVFALVMVVVLIVLIQRKKRELDDSK 286

Query: 71  ----NLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYK 126
               NL +TS  P P PRS+    EG S  F+KFSYKE +KAT++F+ +IG+GGFGTVYK
Sbjct: 287 SIACNLTRTS--PSPRPRSM--IHEGNSFGFRKFSYKEIRKATEDFNAVIGRGGFGTVYK 342

Query: 127 AQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 186
           A+FS+G + AVK+M+K SEQ E +FCREIELLARLHHRHLVAL+GFC +K ERFL+YEYM
Sbjct: 343 AEFSNGLVAAVKKMNKSSEQAEDEFCREIELLARLHHRHLVALKGFCNKKNERFLVYEYM 402

Query: 187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 246
            NGSLKDHLHS  ++PLSW++R++IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE+F
Sbjct: 403 ENGSLKDHLHSTEKSPLSWESRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEHF 462

Query: 247 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
           VAKLADFGLAHAS+DGSICFEPVNTDIRGTPGY+DPEYVVT ELTEKSDVYSYGVVLLEI
Sbjct: 463 VAKLADFGLAHASRDGSICFEPVNTDIRGTPGYVDPEYVVTHELTEKSDVYSYGVVLLEI 522

Query: 307 VTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQ 366
           +T +RAV +G+NLVE +Q  + SESR  +LVDPRIKD  D EQL T+V +VRWCT++EG 
Sbjct: 523 ITGKRAVDEGRNLVELSQPLLVSESRRIDLVDPRIKDCIDGEQLETVVAVVRWCTEKEGV 582

Query: 367 ARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGRY 426
           ARPSIKQVLR+LYES DP+H G   AV     EE  GR       + R D  F SGD R 
Sbjct: 583 ARPSIKQVLRLLYESCDPLHLGLAMAV-----EENKGR-------SLRGDSGFQSGDIRG 630

Query: 427 LA-SSSSTSRSYCSRSFLLENGSPQSPPNLLSL 458
           LA SSS+TSRS+CSRSFLLE GSP SPPN LS 
Sbjct: 631 LASSSSTTSRSHCSRSFLLETGSPHSPPNGLSF 663

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|75309871|sp|Q9FX99.1|Y1497_ARATH RecName: Full=Probable receptor-like protein kinase At1g49730; Flags: Precursor gi|10120430|gb|AAG13055.1|AC011807_14 Unknown protein [Arabidopsis thaliana]

 Score =  570 bits (1469), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 285/461 (61%), Positives = 356/461 (77%), Gaps = 21/461 (4%)

Query: 3   APKASPSPLVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRK 62
           +P+ SPS +  +SPS     +  + + +PYHLT++P IGI VTAVA+ +L+VL+ILIRRK
Sbjct: 219 SPEPSPSTVGGISPSNSDSQMTTSRSTNPYHLTMVPTIGIVVTAVALTMLVVLVILIRRK 278

Query: 63  SRGLEDPENLDKTSLKPFPPPRSLRKFQEG-PSPMFQKFSYKETKKATDNFSTIIGQGGF 121
           +R L++ E+LD+ S K  P    + K  E   S  F+KFSYKE   AT++F+T+IGQGGF
Sbjct: 279 NRELDESESLDRKSTKSVPSSLPVFKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQGGF 338

Query: 122 GTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 181
           GTVYKA+F+DG + AVK+M+K+SEQ E DFCREI LLA+LHHR+LVAL+GFCI K+ERFL
Sbjct: 339 GTVYKAEFNDGLIAAVKKMNKVSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFL 398

Query: 182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 241
           +Y+YM NGSLKDHLH+ G+ P SW TR++IAIDVANALEYLHFYCDPPLCHRDIKSSNIL
Sbjct: 399 VYDYMKNGSLKDHLHAIGKPPPSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 458

Query: 242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGV 301
           LDENFVAKL+DFGLAH+S+DGS+CFEPVNTDIRGTPGY+DPEYVVTQELTEKSDVYSYGV
Sbjct: 459 LDENFVAKLSDFGLAHSSRDGSVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGV 518

Query: 302 VLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD---MEQLRTIVTIVR 358
           VLLE++T RRAV +G+NLVE +Q  + ++S+  ELVDPRIKDS +    +QL  +VT+VR
Sbjct: 519 VLLELITGRRAVDEGRNLVEMSQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVTVVR 578

Query: 359 WCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPT 418
            CT++EG++RPSIKQVLR+L ES DP+HS F +AVE+E     D R R++ R        
Sbjct: 579 LCTEKEGRSRPSIKQVLRLLCESCDPVHSAFAKAVEEE--IGWDSRKRSNLR-------- 628

Query: 419 FYSGDGRYLA-SSSSTSRSYCSRSFLLENGSPQSPPNLLSL 458
              GD R    SSS+TSRS+ SRS       P SP N  S 
Sbjct: 629 IQRGDSRIFGPSSSTTSRSHYSRSL------PHSPINGFSF 663

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	458
TAIR|locus:2090634	663	AT3G19300 [Arabidopsis thalian	0.910	0.628	0.603	3.8e-133
TAIR|locus:2012191	693	AT1G49730 [Arabidopsis thalian	0.847	0.559	0.6	9.2e-123
TAIR|locus:2172149	440	CRLK1 "calcium/calmodulin-regu	0.596	0.620	0.421	1.1e-55
TAIR|locus:2181017	951	AT5G01950 [Arabidopsis thalian	0.604	0.291	0.411	9.4e-55
TAIR|locus:2019863	971	AT1G79620 [Arabidopsis thalian	0.679	0.320	0.387	1.1e-54
TAIR|locus:2099009	400	AT3G58690 [Arabidopsis thalian	0.631	0.722	0.396	7e-54
TAIR|locus:2157042	953	AT5G49760 [Arabidopsis thalian	0.644	0.309	0.415	2.5e-53
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.611	0.394	0.420	4.2e-53
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.646	0.453	0.391	5.4e-53
TAIR|locus:2200552	730	WAKL1 "wall associated kinase-	0.670	0.420	0.384	6.3e-53

TAIR|locus:2090634 AT3G19300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1305 (464.4 bits), Expect = 3.8e-133, P = 3.8e-133
 Identities = 262/434 (60%), Positives = 311/434 (71%)

Query:    27 ENHHPYHLTLIPGXXXXXXXXXXXXXXXXXXXXRRKSRGLEDPENL--DKTSLKPFPPPR 84
             ++HHPYHLT++P                     +RK R L+D +++  + T   P P PR
Sbjct:   243 KSHHPYHLTMVPTIGIAVTVFALVMVVVLIVLIQRKKRELDDSKSIACNLTRTSPSPRPR 302

Query:    85 SLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS 144
             S+    EG S  F+KFSYKE +KAT++F+ +IG+GGFGTVYKA+FS+G + AVK+M+K S
Sbjct:   303 SM--IHEGNSFGFRKFSYKEIRKATEDFNAVIGRGGFGTVYKAEFSNGLVAAVKKMNKSS 360

Query:   145 EQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLS 204
             EQ E +FCREIE              GFC +K ERFL+YEYM NGSLKDHLHS  ++PLS
Sbjct:   361 EQAEDEFCREIELLARLHHRHLVALKGFCNKKNERFLVYEYMENGSLKDHLHSTEKSPLS 420

Query:   205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 264
             W++R++IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE+FVAKLADFGLAHAS+DGSI
Sbjct:   421 WESRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEHFVAKLADFGLAHASRDGSI 480

Query:   265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ 324
             CFEPVNTDIRGTPGY+DPEYVVT ELTEKSDVYSYGVVLLEI+T +RAV +G+NLVE +Q
Sbjct:   481 CFEPVNTDIRGTPGYVDPEYVVTHELTEKSDVYSYGVVLLEIITGKRAVDEGRNLVELSQ 540

Query:   325 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 384
               + SESR  +LVDPRIKD  D EQL T+V +VRWCT++EG ARPSIKQVLR+LYES DP
Sbjct:   541 PLLVSESRRIDLVDPRIKDCIDGEQLETVVAVVRWCTEKEGVARPSIKQVLRLLYESCDP 600

Query:   385 MHSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFYSGDGRYLAXXXXXXXXXX-XXXFL 443
             +H G   AVE     E  GR       + R D  F SGD R LA              FL
Sbjct:   601 LHLGLAMAVE-----ENKGR-------SLRGDSGFQSGDIRGLASSSSTTSRSHCSRSFL 648

Query:   444 LENGSPQSPPNLLS 457
             LE GSP SPPN LS
Sbjct:   649 LETGSPHSPPNGLS 662

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2012191 AT1G49730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1207 (429.9 bits), Expect = 9.2e-123, P = 9.2e-123
 Identities = 237/395 (60%), Positives = 293/395 (74%)

Query:    30 HPYHLTLIPGXXXXXXXXXXXXXXXXXXXXRRKSRGLEDPENLDKTSLKPFPPPRSLRKF 89
             +PYHLT++P                     RRK+R L++ E+LD+ S K  P    + K 
Sbjct:   276 NPYHLTMVPTIGIVVTAVALTMLVVLVILIRRKNRELDESESLDRKSTKSVPSSLPVFKI 335

Query:    90 QEGPSPM-FQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVE 148
              E  S   F+KFSYKE   AT++F+T+IGQGGFGTVYKA+F+DG + AVK+M+K+SEQ E
Sbjct:   336 HEDDSSSAFRKFSYKEMTNATNDFNTVIGQGGFGTVYKAEFNDGLIAAVKKMNKVSEQAE 395

Query:   149 GDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 208
              DFCREI               GFCI K+ERFL+Y+YM NGSLKDHLH+ G+ P SW TR
Sbjct:   396 QDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLHAIGKPPPSWGTR 455

Query:   209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
             ++IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL+DFGLAH+S+DGS+CFEP
Sbjct:   456 MKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLSDFGLAHSSRDGSVCFEP 515

Query:   269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA 328
             VNTDIRGTPGY+DPEYVVTQELTEKSDVYSYGVVLLE++T RRAV +G+NLVE +Q  + 
Sbjct:   516 VNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLLELITGRRAVDEGRNLVEMSQRFLL 575

Query:   329 SESRLAELVDPRIKDSFDM---EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 385
             ++S+  ELVDPRIKDS +    +QL  +VT+VR CT++EG++RPSIKQVLR+L ES DP+
Sbjct:   576 AKSKHLELVDPRIKDSINDAGGKQLDAVVTVVRLCTEKEGRSRPSIKQVLRLLCESCDPV 635

Query:   386 HSGFVQAVEDEEYEETDGRPRTSQRKAHRSDPTFY 420
             HS F +AVE+E     D R R++ R   R D   +
Sbjct:   636 HSAFAKAVEEEI--GWDSRKRSNLR-IQRGDSRIF 667

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2172149 CRLK1 "calcium/calmodulin-regulated receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 574 (207.1 bits), Expect = 1.1e-55, P = 1.1e-55
 Identities = 119/282 (42%), Positives = 174/282 (61%)

Query:    99 KFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXX 158
             ++SY++ +KAT NF+T+IGQG FG VYKAQ S G ++AVK +   S+Q E +F  E+   
Sbjct:   102 EYSYRDLQKATCNFTTLIGQGAFGPVYKAQMSTGEIVAVKVLATDSKQGEKEFQTEVMLL 161

Query:   159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                         G+C EK +  L+Y YM+ GSL  HL+S    PLSW  R+ IA+DVA  
Sbjct:   162 GRLHHRNLVNLIGYCAEKGQHMLIYVYMSKGSLASHLYSEKHEPLSWDLRVYIALDVARG 221

Query:   219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
             LEYLH    PP+ HRDIKSSNILLD++  A++ADFGL   S++  +     N  IRGT G
Sbjct:   222 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL---SREEMVDKHAAN--IRGTFG 276

Query:   279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--EL 336
             Y+DPEY+ T+  T+KSDVY +GV+L E++  R   Q    LVE A   M +E ++   E+
Sbjct:   277 YLDPEYISTRTFTKKSDVYGFGVLLFELIAGRNPQQGLMELVELA--AMNAEEKVGWEEI 334

Query:   337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             VD R+   +D++++  +      C  R  + RP+++ ++++L
Sbjct:   335 VDSRLDGRYDLQEVNEVAAFAYKCISRAPRKRPNMRDIVQVL 376

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0009409 "response to cold" evidence=IEP

TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)]

 Score = 572 (206.4 bits), Expect = 9.4e-55, P = 9.4e-55
 Identities = 117/284 (41%), Positives = 177/284 (62%)

Query:   100 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEX 157
             FS+KE  +ATD+FS  T++G+GG+G VY+   SD ++ A+KR D+ S Q E +F  EIE 
Sbjct:   614 FSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEGSLQGEKEFLNEIEL 673

Query:   158 XXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
                          G+C E+ E+ L+YE+M+NG+L+D L + G+  LS+  RI++A+  A 
Sbjct:   674 LSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGKESLSFGMRIRVALGAAK 733

Query:   218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS---KDGSICFEPVNTDIR 274
              + YLH   +PP+ HRDIK+SNILLD NF AK+ADFGL+  +   +D     + V+T +R
Sbjct:   734 GILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLEDEEDVPKHVSTVVR 793

Query:   275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 334
             GTPGY+DPEY +T +LT+KSDVYS GVV LE++T   A+  GKN+V   +        + 
Sbjct:   794 GTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGKNIVREVKTA-EQRDMMV 852

Query:   335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
              L+D R+ + + ME +     +   C+    + RP + +V++ L
Sbjct:   853 SLIDKRM-EPWSMESVEKFAALALRCSHDSPEMRPGMAEVVKEL 895

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)]

 Score = 572 (206.4 bits), Expect = 1.1e-54, P = 1.1e-54
 Identities = 127/328 (38%), Positives = 187/328 (57%)

Query:    78 KPFPPPRSLRKFQEGPSPMFQK---FSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDG 132
             +PF    S  K   G +P  +    FSY+E KK T+NFS    +G GG+G VYK    DG
Sbjct:   602 RPFVSWASSGK-DSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDG 660

Query:   133 SLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLK 192
              ++A+KR  + S Q   +F  EIE              GFC E+ E+ L+YEYM+NGSLK
Sbjct:   661 HMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLK 720

Query:   193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD 252
             D L       L W+ R+++A+  A  L YLH   DPP+ HRD+KS+NILLDEN  AK+AD
Sbjct:   721 DSLTGRSGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVAD 780

Query:   253 FGLAHASKDGSICFEP-VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
             FGL+    D   C +  V+T ++GT GY+DPEY  TQ+LTEKSDVYS+GVV++E++TA++
Sbjct:   781 FGLSKLVSD---CTKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQ 837

Query:   312 AVQDGKNLVESAQVCMASESR----LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQA 367
              ++ GK +V   ++ M         L + +D  ++D   + +L   + +   C       
Sbjct:   838 PIEKGKYIVREIKLVMNKSDDDFYGLRDKMDRSLRDVGTLPELGRYMELALKCVDETADE 897

Query:   368 RPSIKQVLR---ILYESSDPMHSGFVQA 392
             RP++ +V++   I+ ++S    S    A
Sbjct:   898 RPTMSEVVKEIEIIIQNSGASSSSSASA 925

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)]

 Score = 557 (201.1 bits), Expect = 7.0e-54, P = 7.0e-54
 Identities = 121/305 (39%), Positives = 176/305 (57%)

Query:    87 RKFQEGPSPMFQKFSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS 144
             +K Q+      Q F++K+   AT  FS   ++G GGFG VY+   +DG  +A+K MD   
Sbjct:    62 QKVQDVTENGLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHAG 121

Query:   145 EQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRT--- 201
             +Q E +F  E+E              G+C +   + L+YE+MANG L++HL+ P R+   
Sbjct:   122 KQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGSV 181

Query:   202 P--LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 259
             P  L W+TR++IA++ A  LEYLH    PP+ HRD KSSNILLD NF AK++DFGLA   
Sbjct:   182 PPRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVG 241

Query:   260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR------RAV 313
              D +     V+T + GT GY+ PEY +T  LT KSDVYSYGVVLLE++T R      RA 
Sbjct:   242 SDKA--GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRAT 299

Query:   314 QDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQ 373
              +G  LV  A   +A   ++ +++DP ++  +  +++  +  I   C Q E   RP +  
Sbjct:   300 GEGV-LVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMAD 358

Query:   374 VLRIL 378
             V++ L
Sbjct:   359 VVQSL 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)]

 Score = 559 (201.8 bits), Expect = 2.5e-53, P = 2.5e-53
 Identities = 127/306 (41%), Positives = 177/306 (57%)

Query:    79 PFPPPRSLRKFQEGPSPMFQK-FSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDGSLI 135
             PF    + +   + P  M  K F+++E KK TDNFS    +G GG+G VY+    +G LI
Sbjct:   597 PFAKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLI 656

Query:   136 AVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHL 195
             A+KR  + S Q   +F  EIE              GFC ++ E+ L+YEY++NGSLKD L
Sbjct:   657 AIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSL 716

Query:   196 HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 255
                    L W  R++IA+     L YLH   DPP+ HRDIKS+NILLDEN  AK+ADFGL
Sbjct:   717 SGKSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGL 776

Query:   256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD 315
             +    D       V T ++GT GY+DPEY +T +LTEKSDVY +GVVLLE++T R  ++ 
Sbjct:   777 SKLVGDPEKTH--VTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIER 834

Query:   316 GKNLVESAQVCMASESR----LAELVDPRI-KDSFDMEQLRTIVTIVRWCTQREGQARPS 370
             GK +V   +  M ++SR    L EL+D  I   S +++     V +   C + EG  RPS
Sbjct:   835 GKYVVREVKTKM-NKSRSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPS 893

Query:   371 IKQVLR 376
             + +V++
Sbjct:   894 MGEVVK 899

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0044242 "cellular lipid catabolic process" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 530 (191.6 bits), Expect = 4.2e-53, Sum P(2) = 4.2e-53
 Identities = 124/295 (42%), Positives = 176/295 (59%)

Query:   100 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEX 157
             F+Y+E    T+ FS   I+G+GGFG VYK + +DG L+AVK++   S Q + +F  E+E 
Sbjct:   341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query:   158 XXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
                          G+CI   ER L+YEY+ N +L+ HLH  GR  L W  R++IAI  A 
Sbjct:   401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAK 460

Query:   218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
              L YLH  C P + HRDIKS+NILLD+ F A++ADFGLA  + D +     V+T + GT 
Sbjct:   461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLN-DSTQTH--VSTRVMGTF 517

Query:   278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD----GK-NLVESAQVCM--ASE 330
             GY+ PEY  + +LT++SDV+S+GVVLLE++T R+ V      G+ +LVE A+  +  A E
Sbjct:   518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIE 577

Query:   331 SR-LAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 383
             +   +ELVD R++  + + E  R I T    C +  G  RP + QV+R L    D
Sbjct:   578 TGDFSELVDRRLEKHYVENEVFRMIETAAA-CVRHSGPKRPRMVQVVRALDSEGD 631

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 528 (190.9 bits), Expect = 5.4e-53, Sum P(2) = 5.4e-53
 Identities = 125/319 (39%), Positives = 181/319 (56%)

Query:    73 DKTSLKPFPPPRSLRKFQEGPSPMFQK--FSYKETKKATDNFS--TIIGQGGFGTVYKAQ 128
             D + L   PPP        G    F K  F+Y+E  +AT+ FS   ++GQGGFG V+K  
Sbjct:   245 DYSDLPVLPPP------SPGLVLGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGI 298

Query:   129 FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMAN 188
                G  +AVK++   S Q E +F  E+E              G+C+   +R L+YE++ N
Sbjct:   299 LPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPN 358

Query:   189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA 248
              +L+ HLH  GR  + W TR++IA+  A  L YLH  C+P + HRDIK+SNIL+D  F A
Sbjct:   359 NNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEA 418

Query:   249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             K+ADFGLA  + D +     V+T + GT GY+ PEY  + +LTEKSDV+S+GVVLLE++T
Sbjct:   419 KVADFGLAKIASDTNT---HVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELIT 475

Query:   309 ARRAVQDGKN------LVESAQVCM--ASESRLAE-LVDPRIKDSFDMEQLRTIVTIVRW 359
              RR V D  N      LV+ A+  +  ASE    E L D ++ + +D E++  +V     
Sbjct:   476 GRRPV-DANNVYVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAA 534

Query:   360 CTQREGQARPSIKQVLRIL 378
             C +   + RP + Q++R L
Sbjct:   535 CVRHSARRRPRMSQIVRAL 553

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 6.3e-53, P = 6.3e-53
 Identities = 123/320 (38%), Positives = 183/320 (57%)

Query:    90 QEGPSPMFQKFSYKETKKATDNFST--IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQV 147
             ++G   M + FS KE +KATDNFS   ++GQGG GTVYK    DGS++AVKR   + E  
Sbjct:   407 KDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDK 466

Query:   148 EGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQ 206
               +F  EI               G C+E     L+YEY+ NG L   LH       ++W+
Sbjct:   467 MEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWE 526

Query:   207 TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 266
              R++IAI++A AL Y+H     P+ HRDIK++NILLDE + AK++DFG    S+  ++  
Sbjct:   527 VRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFG---TSRSVTLDQ 583

Query:   267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-----QDGKNLVE 321
               + T + GT GYMDPEY ++ + T KSDVYS+GVVL+E++T  + +     ++G+ L  
Sbjct:   584 THLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLAT 643

Query:   322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE- 380
                  M  E+R+ +++D RIKD   +EQ+  +  + R C  R+G+ RP++K+V   L   
Sbjct:   644 HFLEAM-KENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERI 702

Query:   381 SSDPMHSGFVQAVEDEEYEE 400
              S P         EDEE ++
Sbjct:   703 RSSPEDLDVRTENEDEEEDQ 722

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	458
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-57
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-52
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-36
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-30
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-30
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-27
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	9e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-26
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-26
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-26
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-25
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-25
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-23
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-20
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-17
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	8e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-13
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-07
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-04
COG2334	331	COG2334, COG2334, Putative homoserine kinase type	3e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.001
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  187 bits (476), Expect = 6e-57
 Identities = 86/267 (32%), Positives = 124/267 (46%), Gaps = 56/267 (20%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFC 173
           +G+GGFGTVY A+    G  +A+K + K  S  +  +  REIE+L +L+H ++V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
            ++   +L+ EY   GSLKD L       LS    ++I + +   LEYLH      + HR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLHSN---GIIHR 116

Query: 234 DIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-YVVTQELT 291
           D+K  NILLD  N   KLADFGL+                I GTP YM PE  +     +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL----KTIVGTPAYMAPEVLLGKGYYS 172

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 351
           EKSD++S GV+L E+                                P +KD        
Sbjct: 173 EKSDIWSLGVILYEL--------------------------------PELKD-------- 192

Query: 352 TIVTIVRWCTQREGQARPSIKQVLRIL 378
               ++R   Q++ + RPS K++L  L
Sbjct: 193 ----LIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  176 bits (449), Expect = 2e-52
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 18/206 (8%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGS-----LIAVKRM--DKISEQVEGDFCREIELLARLHHR 164
               +G+G FG VYK             +AVK +  D   +Q+E +F RE  ++ +L H 
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE-EFLREARIMRKLDHP 61

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           ++V L G C E+    ++ EYM  G L D+L       LS    +  A+ +A  +EYL  
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDP 282
                  HRD+ + N L+ EN V K++DFGL+    D    ++       IR    +M P
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIR----WMAP 173

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E +   + T KSDV+S+GV+L EI T
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  175 bits (447), Expect = 6e-52
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 60/292 (20%)

Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVAL 169
            +G+G FG VYK +          +AVK + +  SE+   DF +E  ++ +L H ++V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHL-------HSPGRTPLSWQTRIQIAIDVANALEYL 222
            G C E+   +L+ EYM  G L D+L        SP ++ LS +  +  AI +A  +EYL
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMD 281
                    HRD+ + N L+ E+ V K++DFGL   S+D               P  +M 
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPIRWMA 175

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT-------------ARRAVQDGKNLVESAQVCMA 328
           PE +     T KSDV+S+GV+L EI T                 ++ G            
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG------------ 223

Query: 329 SESRLA--ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
              RL   E     + +            ++  C Q + + RP+  +++  L
Sbjct: 224 --YRLPKPEYCPDELYE------------LMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  171 bits (437), Expect = 1e-50
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGS-----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRH 165
               +G+G FG VYK +           +AVK + +  SEQ   +F RE  ++ +L H +
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           +V L G C E+   +++ EYM  G L  +L    R  LS    +  A+ +A  +EYL   
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYLE-- 119

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG---YMDP 282
                 HRD+ + N L+ EN V K++DFGL+    D            RG      +M P
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY------YRKRGGKLPIRWMAP 172

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E +   + T KSDV+S+GV+L EI T
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  169 bits (431), Expect = 1e-49
 Identities = 86/265 (32%), Positives = 124/265 (46%), Gaps = 19/265 (7%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRG 171
            +G G FGTVYKA+    G ++AVK + K     + +    REI +L RL H ++V L  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
              +K   +L+ EY   G L D+L      PLS     +IA+ +   LEYLH      + 
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-YVVTQEL 290
           HRD+K  NILLDEN V K+ADFGLA      S       T   GTP YM PE  +     
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSS----SSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 350
             K DV+S GV+L E++T +        L +   +       L          S + + L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236

Query: 351 RTIVTIVRWCTQREGQARPSIKQVL 375
                 ++ C  ++   RP+ +++L
Sbjct: 237 ------IKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  167 bits (426), Expect = 5e-49
 Identities = 80/268 (29%), Positives = 125/268 (46%), Gaps = 29/268 (10%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRG 171
            +G+G FG VY A+    G L+A+K + K  I +  E    REI++L +L H ++V L  
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE-RILREIKILKKLKHPNIVRLYD 64

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
              ++ + +L+ EY   G L D L   GR     + R      + +ALEYLH      + 
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED-EAR-FYLRQILSALEYLHSKG---IV 119

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K  NILLDE+   KLADFGLA     G      V     GTP YM PE ++ +   
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV-----GTPEYMAPEVLLGKGYG 174

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA---SESRLAELVDPRIKDSFDME 348
           +  D++S GV+L E++T +        L+E  +               + P  KD     
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD----- 229

Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLR 376
                  ++R    ++ + R + ++ L+
Sbjct: 230 -------LIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  166 bits (423), Expect = 2e-48
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 112 FSTIIGQGGFGTVYKA-----QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRH 165
               +G+G FG VYK           + +AVK + +  SE+   +F  E  ++ +L H +
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           +V L G C +    +++ EYM  G L D L   G   L+ +  +Q+A+ +A  +EYL   
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKGMEYLE-- 119

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLA--HASKD----GSICFEPVNTDIRGTPGY 279
                 HRD+ + N L+ EN V K++DFGL+      D          P+         +
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK--------W 170

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           M PE +   + T KSDV+S+GV+L EI T
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  150 bits (380), Expect = 3e-42
 Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 18/205 (8%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+G FG+VY A   D G L+AVK ++      E++E    REI +L+ L H ++V   
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-LEREIRILSSLQHPNIVRYY 65

Query: 171 GFCIEKRERFL---MYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFYC 226
           G   ++ +  L   + EY++ GSL   L   G+ P   +  I+     +   L YLH   
Sbjct: 66  GSERDEEKNTLNIFL-EYVSGGSLSSLLKKFGKLP---EPVIRKYTRQILEGLAYLH--- 118

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRDIK +NIL+D + V KLADFG   A + G I        +RGTP +M PE + 
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGC--AKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 287 TQELTEKSDVYSYGVVLLEIVTARR 311
            +E    +D++S G  ++E+ T + 
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  136 bits (346), Expect = 2e-37
 Identities = 64/196 (32%), Positives = 102/196 (52%), Gaps = 14/196 (7%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           IG+GGFG VYKA+    G  +A+K +   S++ +     EI++L +  H ++V   G  +
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 175 EKRERFLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQ-IAIDVANALEYLHFYCDPPLCH 232
           +K E +++ E+ + GSLKD L  +      S    I  +  ++   LEYLH      + H
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ---IAYVCKELLKGLEYLHSN---GIIH 121

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RDIK++NILL  +   KL DFGL+    D       V     GTP +M PE +  +    
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-----GTPYWMAPEVINGKPYDY 176

Query: 293 KSDVYSYGVVLLEIVT 308
           K+D++S G+  +E+  
Sbjct: 177 KADIWSLGITAIELAE 192

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  137 bits (345), Expect = 3e-36
 Identities = 89/333 (26%), Positives = 138/333 (41%), Gaps = 16/333 (4%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARL-HHRHLVALRG 171
           +G+G FG VY A+  D  L+A+K + K      +    F REI++LA L H  ++V L  
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           F  ++   +L+ EY+  GSL+D L   GR  PLS    + I   + +ALEYLH      +
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122

Query: 231 CHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDPEYV-- 285
            HRDIK  NILLD +  V KL DFGLA    D           +   GTPGYM PE +  
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 286 -VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 344
                 +  SD++S G+ L E++T     +  KN   ++Q            +   +  S
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242

Query: 345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGR 404
                 +    +++    ++ + R S    L     +   +    +  +   +       
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRL 302

Query: 405 PRTSQRKAHRSDPTFYSGDGRYLASSSSTSRSY 437
                 +A  S     +  G  L    S     
Sbjct: 303 SLPPSLEALISSLNSLAISGSDLKLDDSNFSKE 335

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  131 bits (332), Expect = 2e-35
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 48/279 (17%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G FG VY  +  SDG L  +K +D   +SE+   D   E+++L +L+H +++     
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 173 CIEKRERFLMYEYMANGSLKDHLHS--PGRTPLS----WQTRIQIAIDVANALEYLHFYC 226
             EK +  ++ EY   G L   +        P          +Q+ +    AL+YLH   
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLH--- 120

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYV 285
              + HRDIK  NI L  N + KL DFG++   S    +      T + GTP Y+ PE  
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA----KTVV-GTPYYLSPELC 175

Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD------- 338
             +    KSD++S G VL E+ T +   + G+N              L EL         
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFE-GEN--------------LLELALKILKGQY 220

Query: 339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 377
           P I   +  E    +  +V    Q++ + RPSI Q+L+ 
Sbjct: 221 PPIPSQYSSE----LRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 7e-35
 Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 20/204 (9%)

Query: 112 FSTIIGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVA 168
              +IG+G FG VYK      G  +A+K++   KI E+      +EI+LL  L H ++V 
Sbjct: 4   LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN---ALEYLHFY 225
             G        +++ EY  NGSL+  +   G  P S      +A+ V      L YLH  
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPES-----LVAVYVYQVLQGLAYLH-- 116

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEY 284
            +  + HRDIK++NIL  ++ V KLADFG+A   +         V     GTP +M PE 
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-----GTPYWMAPEV 170

Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           +     +  SD++S G  ++E++T
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLT 194

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  125 bits (316), Expect = 3e-33
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 33/272 (12%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
               IG+G FG V    +  G  +AVK +   S   +  F  E  ++  L H +LV L G
Sbjct: 10  LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLG 67

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             ++    +++ EYMA GSL D+L S GR  ++   ++  A+DV   +EYL    +    
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQEL 290
           HRD+ + N+L+ E+ VAK++DFGLA  +            D    P  +  PE +  ++ 
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEAS--------QGQDSGKLPVKWTAPEALREKKF 176

Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 350
           + KSDV+S+G++L EI +  R       L +               V P ++  + ME  
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------------VVPHVEKGYRMEAP 221

Query: 351 RT----IVTIVRWCTQREGQARPSIKQVLRIL 378
                 +  +++ C + +   RP+ KQ+   L
Sbjct: 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  121 bits (306), Expect = 1e-31
 Identities = 86/294 (29%), Positives = 133/294 (45%), Gaps = 55/294 (18%)

Query: 116 IGQGGFGTVYKAQFS------DGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
           +G+G FG V+  +        D  L+AVK + +  S     DF RE ELL    H ++V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGR------------TPLSWQTRIQIAIDVA 216
             G C E     +++EYM +G L   L S G               L+    +QIA+ +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 217 NALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD- 272
           + + YL   HF       HRD+ + N L+  + V K+ DFG+   S+D         TD 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGM---SRD------VYTTDY 177

Query: 273 --IRGTP----GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 326
             + G       +M PE ++ ++ T +SDV+S+GVVL EI T  +    G +  E  +  
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC- 236

Query: 327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
             ++ RL  L  PR   S        +  I+  C +R+ Q R +IK +   L +
Sbjct: 237 -ITQGRL--LQRPRTCPSE-------VYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  121 bits (305), Expect = 1e-31
 Identities = 61/193 (31%), Positives = 96/193 (49%), Gaps = 7/193 (3%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V++  + +   +A+K +       + DF +E++ L RL H+HL++L   C  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
               +++ E M  GSL   L SP    L   + I +A  VA  + YL    +    HRD+
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            + NIL+ E+ V K+ADFGLA   K+            + T     PE       + KSD
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA----PEAASHGTFSTKSD 186

Query: 296 VYSYGVVLLEIVT 308
           V+S+G++L E+ T
Sbjct: 187 VWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (299), Expect = 1e-30
 Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 9/194 (4%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V+   ++  + +AVK +   +   E  F +E +++ +L H  LV L   C E
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L S     L     + +A  +A  + YL         HRD+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSIC-FEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NIL+ EN V K+ADFGLA   +D      E     I+ T     PE       T KS
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA----PEAANYGRFTIKS 185

Query: 295 DVYSYGVVLLEIVT 308
           DV+S+G++L EIVT
Sbjct: 186 DVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  118 bits (298), Expect = 2e-30
 Identities = 88/287 (30%), Positives = 132/287 (45%), Gaps = 53/287 (18%)

Query: 116 IGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 169
           +G+G FG V+ A+        D  L+AVK + + SE    DF RE ELL  L H+H+V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRT-------------PLSWQTRIQIAIDVA 216
            G C E R   +++EYM +G L   L S G                L+    + IA  +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 217 NALEY---LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKD----GSICFE 267
           + + Y   LHF       HRD+ + N L+ +  V K+ DFG++    S D    G     
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 327
           P+         +M PE ++ ++ T +SD++S+GVVL EI T  +  Q    L  +  +  
Sbjct: 187 PIR--------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK--QPWYQLSNTEAIEC 236

Query: 328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
            ++ R  EL  PR            +  I++ C QRE Q R  IK +
Sbjct: 237 ITQGR--ELERPRTCPP-------EVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  114 bits (287), Expect = 8e-29
 Identities = 73/220 (33%), Positives = 106/220 (48%), Gaps = 36/220 (16%)

Query: 116 IGQGGFGTVYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
           IGQG FG V++A+      +   +++AVK + ++ S  ++ DF RE  L+A   H ++V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLH--------------------SPGRTPLSWQTR 208
           L G C   +   L++EYMA G L + L                          PLS   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICF 266
           + IA  VA  + YL    +    HRD+ + N L+ EN V K+ADFGL+    S D     
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
           E     IR    +M PE +     T +SDV++YGVVL EI
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  110 bits (276), Expect = 2e-27
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 23/210 (10%)

Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRH 165
           F   +G+G FG V   ++     + G  +AVK ++    EQ   DF REIE+L  L H +
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 166 LVALRGFCIEKRER--FLMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEY 221
           +V  +G C +   R   L+ EY+ +GSL+D+L  H      ++ +  +  +  +   ++Y
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDY 124

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPG 278
           L         HRD+ + NIL++   + K++DFGLA      KD     EP  + I     
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF---- 177

Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +  PE + T + +  SDV+S+GV L E+ T
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  109 bits (275), Expect = 4e-27
 Identities = 65/228 (28%), Positives = 115/228 (50%), Gaps = 34/228 (14%)

Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKISE-QVEGDFCREIE 156
           E   +   F   +G+G FG VYK +          + +A+K + + +E +V+ +F +E E
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 157 LLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL--HSP------------GRTP 202
           L++ L H ++V L G C +++   +++EY+A+G L + L  +SP             ++ 
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 203 LSWQTRIQIAIDVANALEYL--HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 260
           L     + IAI +A  +EYL  H +      HRD+ + N L+ E    K++DFGL+    
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 261 DGSICFEPVNT--DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
                     +   +R    +M PE ++  + T +SD++S+GVVL EI
Sbjct: 176 SADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  108 bits (272), Expect = 5e-27
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 24/265 (9%)

Query: 115 IIGQGGFG--TVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+G FG  T+Y+    D SL+  K ++  ++SE+   D   EI +L+ L H +++A  
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              ++     +  EY   G+L D +          +  +     + +A+ Y+H      +
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGI 122

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            HRDIK+ NI L +  + KL DFG++          E V     GTP YM PE     + 
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV----VGTPYYMSPELCQGVKY 178

Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 350
             KSD+++ G VL E++T +R   D  N +      +             +   +  E  
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTP-------VVSVYSSE-- 228

Query: 351 RTIVTIVRWCTQREGQARPSIKQVL 375
             ++++V    Q++ + RP+  +VL
Sbjct: 229 --LISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (273), Expect = 5e-27
 Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRM------DKISEQVEGDFCREIELLARLHHRHLVA 168
           IG G FG VY A     G L+AVK +       K  +++      E+++L  L H +LV 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA----DEMKVLELLKHPNLVK 63

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G  + + + ++  EY + G+L++ L   GR       R    + +   L YLH     
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIR-VYTLQLLEGLAYLH---SH 118

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRDIK +NI LD N V KL DFG A   K+ +    E V + + GTP YM PE +  
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYMAPEVITG 177

Query: 288 QELTEK---SDVYSYGVVLLEIVTARR 311
            +       +D++S G V+LE+ T +R
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  108 bits (271), Expect = 8e-27
 Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 30/268 (11%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G FG V+K  + +D  + A+K++D  K++ +   +   E  +LA+L   +++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLS----WQTRIQIAIDVANALEYLHFYCDP 228
            ++K +  ++ EY  NG L   L      PL     W+  IQI +     L +LH     
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLH---SK 120

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + HRDIKS N+ LD     K+ D G+A    D +      NT I GTP Y+ PE    +
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF---ANT-IVGTPYYLSPELCEDK 176

Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
              EKSDV++ GVVL E  T +    D  N  + A +      ++   V P +   +  +
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPF-DANN--QGALI-----LKIIRGVFPPVSQMYSQQ 228

Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLR 376
               +  ++  C  ++ + RP   Q+LR
Sbjct: 229 ----LAQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (271), Expect = 9e-27
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 15/203 (7%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG G    VY A    +   +A+KR  ++K    V+ +  +E++ +++ +H ++V     
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTS 67

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPP 229
            +   E +L+  Y++ GSL D + S    P        IA    +V   LEYLH      
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKS--SYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
             HRDIK+ NILL E+   K+ADFG++ +  DG      V     GTP +M PE V+ Q 
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQV 181

Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
                K+D++S+G+  +E+ T  
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 13/197 (6%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           IG+G FG VYK      + +AVK  R     +     F +E E+L +  H ++V L G C
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC-H 232
           ++K+  +++ E +  GSL   L       L+ +  +Q+++D A  +EYL        C H
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN----CIH 116

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELT 291
           RD+ + N L+ EN V K++DFG++   + G      V+  ++  P  +  PE +     T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGG---IYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 292 EKSDVYSYGVVLLEIVT 308
            +SDV+SYG++L E  +
Sbjct: 174 SESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V++  +++ + +AVK +   +   + DF  E +++ +L H  L+ L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL--HFYCDPPLCHR 233
           +   +++ E M  GSL ++L       L     I +A  VA+ + YL    Y      HR
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY-----IHR 127

Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           D+ + N+L+ EN + K+ADFGLA   K+    +E      +    +  PE  +    + K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDI--YEA-REGAKFPIKWTAPEAALYNRFSIK 184

Query: 294 SDVYSYGVVLLEIVTARR 311
           SDV+S+G++L EIVT  R
Sbjct: 185 SDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  107 bits (268), Expect = 2e-26
 Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 37/266 (13%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           IIG+G FG V + +++ G  +AVK +   ++ Q    F  E  ++ +LHH++LV L G  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           +      +M E M+ G+L + L + GR  +S    +Q ++DVA  +EYL       L HR
Sbjct: 69  LHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124

Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELTE 292
           D+ + NIL+ E+ VAK++DFGLA            +  D    P  +  PE +  ++ + 
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV--------GSMGVDNSKLPVKWTAPEALKHKKFSS 176

Query: 293 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR- 351
           KSDV+SYGV+L E+ +  RA     +L E               V   ++  + ME    
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKE---------------VKECVEKGYRMEPPEG 221

Query: 352 ---TIVTIVRWCTQREGQARPSIKQV 374
               +  ++  C + E + RPS  ++
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  108 bits (270), Expect = 2e-26
 Identities = 87/295 (29%), Positives = 137/295 (46%), Gaps = 58/295 (19%)

Query: 116 IGQGGFGTVYKAQ------FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 169
           +G+G FG V+ A+        D  L+AVK +   +     DF RE ELL  L H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHL--HSP------------GRTPLSWQTRIQIAIDV 215
            G C +     +++EYM +G L   L  H P             +  L     + IA  +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 216 ANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKD----GSICF 266
           A+ + YL   HF       HRD+ + N L+  N + K+ DFG++    S D    G    
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 326
            P+         +M PE ++ ++ T +SDV+S+GV+L EI T  +  Q    L  +  + 
Sbjct: 187 LPIR--------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGK--QPWFQLSNTEVIE 236

Query: 327 MASESRLAELVDPRI--KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 379
             ++ R+ E   PR+  K+ +D         I+  C QRE Q R +IK++ +IL+
Sbjct: 237 CITQGRVLE--RPRVCPKEVYD---------IMLGCWQREPQQRLNIKEIYKILH 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  106 bits (267), Expect = 2e-26
 Identities = 72/272 (26%), Positives = 128/272 (47%), Gaps = 40/272 (14%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           +G+G +G+VYK +  SD    A+K +D   +S++   D   EI +LA ++H ++++ +  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 173 CIEKRERFLMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            ++  +  ++ EY   G L   +      R  +  Q   +I I +   L+ LH   +  +
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKI 124

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            HRD+KS+NILL  N + K+ D G++   K          T I GTP YM PE    +  
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKKNM-----AKTQI-GTPHYMAPEVWKGRPY 178

Query: 291 TEKSDVYSYGVVLLEIVTAR-----RAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 345
           + KSD++S G +L E+ T       R++QD +  V+  +              P I   +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY-------------PPIPPIY 225

Query: 346 --DMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
             D++        +R   Q + + RP+  ++L
Sbjct: 226 SQDLQN------FIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  106 bits (267), Expect = 2e-26
 Identities = 72/272 (26%), Positives = 127/272 (46%), Gaps = 29/272 (10%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVAL 169
               IG G FG V+   + +   +A+K  R   +SE+   DF  E +++ +L H  LV L
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQL 64

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            G C E+    L++E+M +G L D+L +  R   S +T + + +DV   + YL       
Sbjct: 65  YGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN--- 120

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP---GYMDPEYVV 286
           + HRD+ + N L+ EN V K++DFG+           +   T   GT     +  PE   
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTR------FVLDDQYTSSTGTKFPVKWSSPEVFS 174

Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
             + + KSDV+S+GV++ E+ +  +   + ++  E  +   A       L  PR+     
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----RLYKPRLAS--- 227

Query: 347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
               +++  +++ C +   + RPS   +L  L
Sbjct: 228 ----QSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 4e-26
 Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 31/269 (11%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V+  ++     +A+K + + +   E DF  E +++ +L H +LV L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 176 KRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
           +R  F++ EYMANG L ++L    G+  L  +  + +  DV  A+EYL         HRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 235 IKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           + + N L+ E+ V K++DFGLA +   D     +     ++  P    PE       + K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAP----PEVFDYSRFSSK 181

Query: 294 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR-- 351
           SDV+S+GV++ E+ +  +   +             S S + E     +   + + + +  
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERF-----------SNSEVVE----SVSAGYRLYRPKLA 226

Query: 352 --TIVTIVRWCTQREGQARPSIKQVLRIL 378
              + TI+  C   + + RP+ K++L  L
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (267), Expect = 5e-26
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 31/209 (14%)

Query: 110 DNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA 168
            N    IG+G  G VYKA   + G  +A+K+M ++ +Q +     EI ++    H ++V 
Sbjct: 22  KNLE-KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQIAI---DVANALEYLH- 223
                +   E +++ EYM  GSL D +  +  R         QIA    +V   LEYLH 
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP-----QIAYVCREVLQGLEYLHS 134

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPG 278
                   HRDIKS NILL ++   KLADFG A       SK  S+          GTP 
Sbjct: 135 QNV----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---------GTPY 181

Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
           +M PE +  ++   K D++S G++ +E+ 
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  105 bits (264), Expect = 1e-25
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 28/219 (12%)

Query: 112 FSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARL-HHRHL 166
           F  IIG+G F TV  A+        A+K +DK   I E+       E E+L RL  H  +
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64

Query: 167 VALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           + L  +  +  E  + + EY  NG L  ++   G   L  +     A ++  ALEYLH  
Sbjct: 65  IKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLH-- 119

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLA---------HASKDGSICFEPVNTDIR-- 274
               + HRD+K  NILLD++   K+ DFG A          ++K  +   +      R  
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178

Query: 275 -----GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                GT  Y+ PE +  +   + SD+++ G ++ +++T
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  104 bits (262), Expect = 1e-25
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 16/202 (7%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 170
           +IG+G FG V   Q  D   + A+K M+K   + +    +   E  +L  L+H  LV L 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 171 GFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            +  +  E  +L+ + +  G L+ HL    +     Q +  I  ++  ALEYLH      
Sbjct: 67  -YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-QVKFWIC-EIVLALEYLH---SKG 120

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRDIK  NILLDE     + DF +A      ++      T   GTPGYM PE +  Q 
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----TTSTSGTPGYMAPEVLCRQG 175

Query: 290 LTEKSDVYSYGVVLLEIVTARR 311
            +   D +S GV   E +  +R
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  104 bits (261), Expect = 2e-25
 Identities = 79/267 (29%), Positives = 136/267 (50%), Gaps = 37/267 (13%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGF 172
            IG+G FG V    +  G+ +AVK  + D  ++     F  E  ++ +L H +LV L G 
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGV 67

Query: 173 CIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
            +E K   +++ EYMA GSL D+L S GR+ L     ++ ++DV  A+EYL         
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+ + N+L+ E+ VAK++DFGL   +K+ S   +     ++ T     PE +  ++ +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTA----PEALREKKFS 177

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ-- 349
            KSDV+S+G++L EI +  R        V   ++       L ++V PR++  + M+   
Sbjct: 178 TKSDVWSFGILLWEIYSFGR--------VPYPRI------PLKDVV-PRVEKGYKMDAPD 222

Query: 350 --LRTIVTIVRWCTQREGQARPSIKQV 374
                +  +++ C   +   RPS  Q+
Sbjct: 223 GCPPVVYDVMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  105 bits (262), Expect = 2e-25
 Identities = 87/290 (30%), Positives = 134/290 (46%), Gaps = 53/290 (18%)

Query: 116 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 169
           +G+G FG V+ A+        D  L+AVK +   S+    DF RE ELL  L H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHL--HSP-------GRTP--LSWQTRIQIAIDVANA 218
            G C+E     +++EYM +G L   L  H P       G  P  L+    + IA  +A  
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 219 LEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 275
           + YL   HF       HRD+ + N L+ EN + K+ DFG++          +  +TD   
Sbjct: 133 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSR---------DVYSTDYYR 177

Query: 276 TPG-------YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA 328
             G       +M PE ++ ++ T +SDV+S GVVL EI T  +  Q    L  +  +   
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK--QPWYQLSNNEVIECI 235

Query: 329 SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           ++ R+  L  PR          + +  ++  C QRE   R +IK++  +L
Sbjct: 236 TQGRV--LQRPRTCP-------KEVYDLMLGCWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  103 bits (260), Expect = 3e-25
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 21/198 (10%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
            +G+G +G+VYKA     G ++A+K   +++  +++     +EI +L +    ++V   G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII----KEISILKQCDSPYIVKYYG 65

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDP 228
              +  + +++ EY   GS+ D +    +T L+ +   +IA         LEYLH     
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSDIMKITNKT-LTEE---EIAAILYQTLKGLEYLH---SN 118

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
              HRDIK+ NILL+E   AKLADFG++    D        NT I GTP +M PE +   
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---MAKRNTVI-GTPFWMAPEVIQEI 174

Query: 289 ELTEKSDVYSYGVVLLEI 306
               K+D++S G+  +E+
Sbjct: 175 GYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  104 bits (260), Expect = 4e-25
 Identities = 71/221 (32%), Positives = 100/221 (45%), Gaps = 50/221 (22%)

Query: 116 IGQGGFGTVYKAQFS----DGSLIAVK---RMDKISEQVEGDFCREIELLARLHHRHLVA 168
           +G G FG VY+  +     D   + V      +  SEQ E DF  E  ++++ +H+++V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLH----SPGR-TPLSWQTRIQIAIDVANALEYL- 222
           L G   E+  RF++ E MA G LK  L      P R + L+ +  +  A DVA   +YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 223 --HFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
             HF       HRDI + N LL       VAK+ADFG+A               DI    
Sbjct: 134 ENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMAR--------------DIYRAS 173

Query: 278 GY------------MDPEYVVTQELTEKSDVYSYGVVLLEI 306
            Y            M PE  +    T K+DV+S+GV+L EI
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  103 bits (258), Expect = 5e-25
 Identities = 82/275 (29%), Positives = 128/275 (46%), Gaps = 33/275 (12%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRM-----DKISEQVE-GDFCREIELLARLHHRHLVA 168
           ++G+G +GTVY    + G LIAVK++     + ++ + E      E++LL  L H ++V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP---LSWQTRIQIAIDVANALEYLHFY 225
             G C++     +  E++  GS+   L+  G  P       T+ QI   VA    YLH  
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHNN 121

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFG----LAHASKDGSICFEPVNTDIRGTPGYMD 281
           C   + HRDIK +N++L  N + KL DFG    LA     G+     +   + GTP +M 
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT--HSNMLKSMHGTPYWMA 176

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 341
           PE +       KSD++S G  + E+ T +  +     L  +A   + +   L     PR+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMFYIGAHRGLM----PRL 230

Query: 342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
            DSF        +  V  C  R+   RPS  Q+LR
Sbjct: 231 PDSFS----AAAIDFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  103 bits (259), Expect = 7e-25
 Identities = 75/222 (33%), Positives = 111/222 (50%), Gaps = 39/222 (17%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSL---IAVKRM-DKISEQVEGDFCREIELLARL-HHRHL 166
           F  +IG+G FG V KA+     L    A+KRM +  S+    DF  E+E+L +L HH ++
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHL---------------HSPGRTPLSWQTRIQI 211
           + L G C  +   +L  EY  +G+L D L               +S   T LS Q  +  
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-LSSQQLLHF 129

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A DVA  ++YL         HRD+ + NIL+ EN+VAK+ADFGL+   +           
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE----------V 176

Query: 272 DIRGTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVT 308
            ++ T G +   ++  + L     T  SDV+SYGV+L EIV+
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 1e-24
 Identities = 65/200 (32%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G+G FG V   +    G L A+K + K   I  +       E  +L+R++H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 172 FCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
           +  +  E+   ++ EY   G L  HL   GR       R   A ++  ALEYLH      
Sbjct: 60  YAFQTEEKLYLVL-EYAPGGELFSHLSKEGRFSEER-ARFYAA-EIVLALEYLH---SLG 113

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           + +RD+K  NILLD +   KL DFGLA   S +GS           GTP Y+ PE ++ +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-----GTPEYLAPEVLLGK 168

Query: 289 ELTEKSDVYSYGVVLLEIVT 308
              +  D +S GV+L E++T
Sbjct: 169 GYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  101 bits (254), Expect = 2e-24
 Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 45/281 (16%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVAL-- 169
            IG+G FGTV K +  SDG ++  K +D   ++E+ +     E+ +L  L H ++V    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 170 RGFCIEKRERFLMYEYMANGSL--------KDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           R      +  +++ EY   G L        K+  +        W+   Q+ +    AL  
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF--IWRILTQLLL----ALYE 120

Query: 222 LHF--YCDPPLCHRDIKSSNILLDENFVAKLADFGLA----HASKDGSICFEPVNTDIRG 275
            H        + HRD+K +NI LD N   KL DFGLA    H S               G
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV--------G 172

Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 335
           TP YM PE +      EKSD++S G ++ E+          +N ++ A        ++ E
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT-ARNQLQLAS-------KIKE 224

Query: 336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
               RI   +   +L  ++         +   RPS +++L+
Sbjct: 225 GKFRRIPYRYS-SELNEVIKS---MLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  100 bits (251), Expect = 4e-24
 Identities = 60/198 (30%), Positives = 106/198 (53%), Gaps = 16/198 (8%)

Query: 116 IGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G G +G VY+  +   SL +AVK + + + +VE +F +E  ++  + H +LV L G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 231
            +   +++ E+M  G+L D+L    R  ++    + +A  +++A+EYL   +F       
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF------I 126

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP-VNTDIRGTPGYMDPEYVVTQEL 290
           HRD+ + N L+ EN + K+ADFGL+      +          I+ T     PE +   + 
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKF 182

Query: 291 TEKSDVYSYGVVLLEIVT 308
           + KSDV+++GV+L EI T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  105 bits (263), Expect = 4e-24
 Identities = 76/280 (27%), Positives = 137/280 (48%), Gaps = 26/280 (9%)

Query: 115 IIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           +I +G  G  YK +     +   VK ++ ++         EI  + +L H ++V L G C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLC 752

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
             ++  +L++EY+   +L + L +     LSW+ R +IAI +A AL +LH  C P +   
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           ++    I++D      L        S  G +C    +T    +  Y+ PE   T+++TEK
Sbjct: 808 NLSPEKIIIDGKDEPHLR------LSLPGLLC---TDTKCFISSAYVAPETRETKDITEK 858

Query: 294 SDVYSYGVVLLEIVTARRA--VQDGKN--LVESAQVCMASESRLAELVDPRIKD--SFDM 347
           SD+Y +G++L+E++T +     + G +  +VE A+ C  S+  L   +DP I+   S + 
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY-SDCHLDMWIDPSIRGDVSVNQ 917

Query: 348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 387
            ++  ++ +   CT  +  ARP    VL+ L  +S    S
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957

Length = 968

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  100 bits (251), Expect = 4e-24
 Identities = 68/201 (33%), Positives = 108/201 (53%), Gaps = 12/201 (5%)

Query: 115 IIGQGGFGTVYKAQF--SDGSLI--AVKRMDKIS--EQVEGDFCREIELLARLHHRHLVA 168
           +IG+G FG VY      SDG  I  AVK +++I+  E+VE  F +E  ++    H ++++
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVLS 60

Query: 169 LRGFCIEKR-ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
           L G C+       ++  YM +G L++ + S    P + +  I   + VA  +EYL     
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYL---AS 116

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
               HRD+ + N +LDE+F  K+ADFGLA    D        +T  +    +M  E + T
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 288 QELTEKSDVYSYGVVLLEIVT 308
           Q+ T KSDV+S+GV+L E++T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 24/201 (11%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G FG VYKA       ++A+K +D  +  +++E D  +EI+ L++    ++    G 
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE-DIQQEIQFLSQCRSPYITKYYGS 67

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
            ++  + +++ EY   GS  D L  PG   L       I  +V   LEYLH   +    H
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLD-LLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIH 121

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-----GTPGYMDPEYVVT 287
           RDIK++NILL E    KLADFG++     G +     +T  +     GTP +M PE +  
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVS-----GQL----TSTMSKRNTFVGTPFWMAPEVIKQ 172

Query: 288 QELTEKSDVYSYGVVLLEIVT 308
               EK+D++S G+  +E+  
Sbjct: 173 SGYDEKADIWSLGITAIELAK 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 32/272 (11%)

Query: 114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDF----CREIELLARLHHRHLVA 168
            ++GQG  G VYK +    G + A+K   KI    + +F     RE++ L      ++V 
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALK---KIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP---LSWQTRIQIAIDVANALEYLHFY 225
             G   ++ E  ++ EYM  GSL D L   G+ P   L+      IA  +   L+YLH  
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHT- 117

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEY 284
               + HRDIK SN+L++     K+ADFG++         C   V     GT  YM PE 
Sbjct: 118 -KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPER 171

Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 344
           +  +  +  +D++S G+ LLE    +              +    +     L        
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE 231

Query: 345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
           F     R  ++    C Q++ + RPS  ++L+
Sbjct: 232 F-----RDFISA---CLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 98.9 bits (246), Expect = 4e-23
 Identities = 81/292 (27%), Positives = 133/292 (45%), Gaps = 58/292 (19%)

Query: 112 FSTIIGQGGFGTVYKAQFS-DGSLI--AVKRMDKI-SEQVEGDFCREIELLARL-HHRHL 166
           F  +IG+G FG V +A    DG  +  A+K + +  SE    DF  E+E+L +L HH ++
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHL---------------HSPGRTPLSWQTRIQI 211
           + L G C  +   ++  EY   G+L D L               H    T L+ Q  +Q 
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST-LTSQQLLQF 124

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A DVA  ++YL    +    HRD+ + N+L+ EN  +K+ADFGL+   +           
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE----------V 171

Query: 272 DIRGTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 326
            ++ T G +   ++  + L     T KSDV+S+GV+L EIV+           +     C
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS-----------LGGTPYC 220

Query: 327 MASESRLAELVDPRIKDSFDMEQLRT----IVTIVRWCTQREGQARPSIKQV 374
             + + L E    ++   + ME+ R     +  ++R C +     RP   Q+
Sbjct: 221 GMTCAELYE----KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 97.6 bits (243), Expect = 4e-23
 Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 10/197 (5%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V+   ++  + +A+K + + S   E  F  E  L+ +L H  LV L    + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA-VVT 71

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM NGSL D L +P    L+    I +A  +A  + ++         HRD+
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +++NIL+ E    K+ADFGLA   +D      E     I+ T     PE +     T KS
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFTIKS 184

Query: 295 DVYSYGVVLLEIVTARR 311
           DV+S+G++L EIVT  R
Sbjct: 185 DVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.6 bits (243), Expect = 6e-23
 Identities = 71/208 (34%), Positives = 105/208 (50%), Gaps = 24/208 (11%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMD------KISEQVEGDFCREIELLARLHHRHLV 167
           ++GQG FG VY     D G  +AVK++       +  ++V    C EI+LL  L H  +V
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC-EIQLLKNLQHERIV 67

Query: 168 ALRGFCIEKRERFLMY-EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
              G C+   E   ++ EYM  GS+KD L + G   L+     +    +   +EYLH   
Sbjct: 68  QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH--- 121

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-GSICFEPVNTDIR---GTPGYMDP 282
              + HRDIK +NIL D     KL DFG   ASK   +IC     T ++   GTP +M P
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFG---ASKRLQTICSS--GTGMKSVTGTPYWMSP 176

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           E +  +    K+DV+S G  ++E++T +
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.0 bits (245), Expect = 6e-23
 Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 71/238 (29%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEG---DFCREIELLARLHHRHLVALR 170
            IG+G +G VYKA+    G L+A+K++   +E+ EG      REI+LL +L H ++V L+
Sbjct: 6   QIGEGTYGQVYKARNKKTGELVALKKIRMENEK-EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 171 GFCIEKRER--FLMYEYMANGSLKDH-----LHSPGRTPLSWQTRIQIAID--------V 215
                K +   ++++EYM      DH     L SP          ++            +
Sbjct: 65  EIVTSKGKGSIYMVFEYM------DHDLTGLLDSPE---------VKFTESQIKCYMKQL 109

Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 275
              L+YLH      + HRDIK SNIL++ + V KLADFGLA         +   N     
Sbjct: 110 LEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRN----- 154

Query: 276 TPGYMDPEY---VVT-----QEL-------TEKSDVYSYGVVLLEIVTARRAVQDGKN 318
                  +Y   V+T      EL         + D++S G +L E+    + +  G  
Sbjct: 155 -----SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGST 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 97.1 bits (242), Expect = 7e-23
 Identities = 80/273 (29%), Positives = 119/273 (43%), Gaps = 38/273 (13%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC-----REIELLARLHHRHLVAL 169
           +G G FG+VY+     DG   AVK +    +   G        +EI LL++L H ++V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP---LSWQTRIQIAIDVANALEYLHFYC 226
            G   E+   ++  E +  GSL   L   G  P   +   TR QI +     LEYLH   
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILL----GLEYLH--- 119

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYV 285
           D    HRDIK +NIL+D N V KLADFG+A    +             +G+P +M PE +
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA------KSFKGSPYWMAPEVI 173

Query: 286 V-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD-PRIKD 343
                    +D++S G  +LE+ T +           S    +A+  ++    + P I D
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPW--------SQLEGVAAVFKIGRSKELPPIPD 225

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
               E    I      C QR+   RP+  ++L 
Sbjct: 226 HLSDEAKDFI----LKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 39/272 (14%)

Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG G FG VY A+      ++A+K+M    K S +   D  +E+  L +L H + +  +G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 172 FCIEKRERFLMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             + +   +L+ EY   GS  D L  H   + PL       I       L YLH +    
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE--- 135

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ- 288
             HRDIK+ NILL E    KLADFG A      S+   P N+ + GTP +M PE ++   
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSA------SLV-SPANSFV-GTPYWMAPEVILAMD 187

Query: 289 --ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV--DPRIKDS 344
             +   K DV+S G+  +E+   +  + +           M + S L  +   D     S
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFN-----------MNAMSALYHIAQNDSPTLSS 236

Query: 345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
            D          V  C Q+  Q RPS +++L+
Sbjct: 237 NDWSD--YFRNFVDSCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           +G G  G V K      G ++AVK +  +I+E ++    RE+++L + +  ++V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
               +  +  EYM  GSL D +    +  +  +   +IA+ V   L YLH      + HR
Sbjct: 69  YNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIHR 125

Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           D+K SNIL++     KL DFG++     G +      T + GT  YM PE +   + + K
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFV-GTSSYMAPERIQGNDYSVK 179

Query: 294 SDVYSYGVVLLEIVTAR 310
           SD++S G+ L+E+ T R
Sbjct: 180 SDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 74/283 (26%), Positives = 127/283 (44%), Gaps = 48/283 (16%)

Query: 114 TIIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
            +IG G FG V + +          +A+K +    S++   DF  E  ++ +  H +++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQIAIDVANALEYL--HFY 225
           L G   + R   ++ EYM NGSL   L  + G+   +    + +   +A+ ++YL    Y
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD------IRGTPGY 279
                 HRD+ + NIL++ N V K++DFGL+   +D     E   T       IR T   
Sbjct: 128 V-----HRDLAARNILVNSNLVCKVSDFGLSRRLED----SEATYTTKGGKIPIRWTA-- 176

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASES--RLAEL 336
             PE +  ++ T  SDV+S+G+V+ E+++   R   D  N      V  A E   RL   
Sbjct: 177 --PEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAVEDGYRLPPP 230

Query: 337 VD-PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           +D P             +  ++  C Q++   RP+  Q++  L
Sbjct: 231 MDCP-----------SALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 18/207 (8%)

Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL 166
           F   +G+G FG+V   ++     + G ++AVK++   + +   DF REIE+L  L H ++
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 167 VALRGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           V  +G C    +R   L+ EY+  GSL+D+L    R  L  +  +  A  +   +EYL  
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYLG- 125

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYA 179

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 38/217 (17%)

Query: 116 IGQGGFGTVYK---AQFSDGSL---IAVKRM---DKISEQVEGDFCREIELLARLHHRHL 166
           +GQG FG VY+        G     +A+K +     + E++E  F  E  ++   +  H+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE--FLNEASVMKEFNCHHV 71

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHL--------HSPGRTPLSWQTRIQIAIDVANA 218
           V L G     +   ++ E MA G LK +L        ++PG  P + Q  IQ+A ++A+ 
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-------HASKDGSICFEPVNT 271
           + YL         HRD+ + N ++ E+   K+ DFG+        +  K G     PV  
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVR- 186

Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                  +M PE +     T KSDV+S+GVVL E+ T
Sbjct: 187 -------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 57/195 (29%), Positives = 101/195 (51%), Gaps = 12/195 (6%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V   ++     +A+K M K     E +F  E +++ +L H  LV L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +R  +++ EYM+NG L ++L   G+     Q  +++  DV   + YL         HRD+
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE---SKQFIHRDL 126

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPEYVVTQELTEK 293
            + N L+D+    K++DFGL+    D       V +   +R +P    PE ++  + + K
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP----PEVLLYSKFSSK 181

Query: 294 SDVYSYGVVLLEIVT 308
           SDV+++GV++ E+ +
Sbjct: 182 SDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 13/201 (6%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
           I +G +G V+ A+  S G + A+K   + D I +        E ++L++    ++V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
               K+  +L+ EY+  G L   L + G        RI IA ++  ALEYLH      + 
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-ARIYIA-EIVLALEYLHSN---GII 115

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPGYMDPEYVVT 287
           HRD+K  NIL+D N   KL DFGL+             +      I GTP Y+ PE ++ 
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 288 QELTEKSDVYSYGVVLLEIVT 308
           Q  ++  D +S G +L E + 
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 95.1 bits (236), Expect = 4e-22
 Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 20/264 (7%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V+   +++ + +AVK +   +  V+  F  E  L+  L H  LV L     +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYMA GSL D L S     +     I  +  +A  + Y+         HRD+
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +++N+L+ E+ + K+ADFGLA   +D      E     I+ T     PE +     T KS
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFTIKS 185

Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+G++L EIVT  +    G     S    M++  R   +  PR+++  D      + 
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGM----SNSDVMSALQRGYRM--PRMENCPD-----ELY 234

Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
            I++ C + + + RP+   +  +L
Sbjct: 235 DIMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 94.4 bits (235), Expect = 7e-22
 Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 40/277 (14%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKR------MDKISEQVEGDFCREIELLARLHHRHLVA 168
           IG+G F  VYKA    DG ++A+K+      MD  + Q   D  +EI+LL +L H +++ 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLKQLDHPNVIK 66

Query: 169 LRGFCIEKRERFLMYEYMANGSLK---DHLHSPGRT---PLSWQTRIQIAIDVANALEYL 222
                IE  E  ++ E    G L     H     R       W+  +Q+     +ALE++
Sbjct: 67  YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHM 122

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMD 281
           H      + HRDIK +N+ +    V KL D GL    S   +     V     GTP YM 
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-----GTPYYMS 174

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-QDGKNLVESAQVCMASESRLAELVDPR 340
           PE +       KSD++S G +L E+   +     D  NL    +     +        P 
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD------YPPL 228

Query: 341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 377
             D +  E+LR +V+    C   + + RP I  VL++
Sbjct: 229 PADHYS-EELRDLVSR---CINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 93.7 bits (234), Expect = 2e-21
 Identities = 66/213 (30%), Positives = 94/213 (44%), Gaps = 39/213 (18%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
            +G+G +G VYKA+    G ++A+K  R+D   E +     REI LL  L H ++V L  
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH--FYCDPP 229
               +R+ +L++EY     LK +L      PLS      I   +   L Y H        
Sbjct: 66  VIHTERKLYLVFEYCDM-DLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHRIL--- 120

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ- 288
             HRD+K  NIL++ + V KLADFGLA A         P+ T           E VVT  
Sbjct: 121 --HRDLKPQNILINRDGVLKLADFGLARA------FGIPLRT--------YTHE-VVTLW 163

Query: 289 ----ELTEKSDVYSYGV-------VLLEIVTAR 310
               E+   S  YS  V       +  E++T +
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 71/205 (34%), Positives = 95/205 (46%), Gaps = 26/205 (12%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISE--QVEGDFCREIELLARLHHRHLVAL- 169
           +G GGFG V   +  S     A+K + K  I E  Q E  F  E E+L   +H  +V L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
           R F  +K    LM EY   G L   L   G     +  R  IA  V  A EYLH   +  
Sbjct: 60  RTFKDKKYIYMLM-EYCLGGELWTILRDRGLFD-EYTARFYIAC-VVLAFEYLH---NRG 113

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDG----SICFEPVNTDIRGTPGYMDPEYV 285
           + +RD+K  N+LLD N   KL DFG A   K G    + C         GTP Y+ PE +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---------GTPEYVAPEII 164

Query: 286 VTQELTEKSDVYSYGVVLLEIVTAR 310
           + +      D +S G++L E++T R
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 67/200 (33%), Positives = 100/200 (50%), Gaps = 24/200 (12%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVE-GDFCREIELLARLHHRHLVALRGFC 173
           IG G +G VYKA+  + G L+A+K + K+    +     +EI +L    H ++VA  G  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPL 230
           + + + +++ EY   GSL+D      R PLS     QIA    +    L YLH   +   
Sbjct: 70  LRRDKLWIVMEYCGGGSLQDIYQV-TRGPLSEL---QIAYVCRETLKGLAYLH---ETGK 122

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            HRDIK +NILL E+   KLADFG++ A    +I      + I GTP +M PE  V    
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVS-AQLTATI--AKRKSFI-GTPYWMAPE--VAAVE 176

Query: 291 -----TEKSDVYSYGVVLLE 305
                  K D+++ G+  +E
Sbjct: 177 RKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 14/200 (7%)

Query: 116 IGQGGFGTVYKAQF--SDGSLI--AVK--RMDKISEQVEGDFCREIELLARLHHRHLVAL 169
           +G G FG V + ++  S G +I  AVK  + DK+S+ ++ DF +E  ++  L H +L+ L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIRL 61

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            G  +      ++ E    GSL D L           T    A+ +AN + YL       
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQ 288
             HRD+ + NILL  +   K+ DFGL  A       +  V  +    P  +  PE + T+
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--VMEEHLKVPFAWCAPESLRTR 175

Query: 289 ELTEKSDVYSYGVVLLEIVT 308
             +  SDV+ +GV L E+ T
Sbjct: 176 TFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 9e-21
 Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 53/229 (23%)

Query: 102 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC---REIEL 157
           YK  K+        +G G FG+VY A+    G L+A+K+M K     E   C   RE++ 
Sbjct: 1   YKVIKQ--------LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--CMNLREVKS 50

Query: 158 LARL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 216
           L +L  H ++V L+    E  E + ++EYM  G+L   +      P S      I   + 
Sbjct: 51  LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQIL 109

Query: 217 NALEYLH---FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 273
             L ++H   F+      HRD+K  N+L+    V K+ADFGLA               +I
Sbjct: 110 QGLAHIHKHGFF------HRDLKPENLLVSGPEVVKIADFGLAR--------------EI 149

Query: 274 RGTPGYMDPEYVVTQ-----ELTEKSDVYS-------YGVVLLEIVTAR 310
           R  P Y D  YV T+     E+  +S  YS        G ++ E+ T R
Sbjct: 150 RSRPPYTD--YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 74/277 (26%), Positives = 134/277 (48%), Gaps = 20/277 (7%)

Query: 116 IGQGGFGTV----YKAQFSD-GSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL 169
           +G+G FG V    Y       G ++AVK + +   +Q    + +EI +L  L+H ++V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 170 RGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
           +G C E+  +   L+ EY+  GSL+D+L    +  L+    +  A  +   + YLH    
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH---S 125

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
               HRD+ + N+LLD + + K+ DFGLA A  +G   +  V  D      +   E +  
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSPVFWYAVECLKE 184

Query: 288 QELTEKSDVYSYGVVLLEIVTARRAVQDGK----NLVESAQVCMASESRLAELVDPRIKD 343
            + +  SDV+S+GV L E++T   + Q        ++   Q  M +  RL EL++  ++ 
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM-TVVRLIELLERGMRL 243

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
                  + +  +++ C + E + RP+ + ++ IL E
Sbjct: 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 17/227 (7%)

Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIE 156
           +  K+       ++G G FGTVYK  +  +G  +    A+K + ++ S +   +   E  
Sbjct: 2   RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61

Query: 157 LLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 216
           ++A + H H+V L G C+  + + L+ + M  G L D++ +  +  +  Q  +   + +A
Sbjct: 62  VMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIA 119

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIR 274
             + YL    +  L HRD+ + N+L+      K+ DFGLA      +     E     I+
Sbjct: 120 KGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176

Query: 275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
               +M  E ++ +  T KSDV+SYGV + E++T      +G   VE
Sbjct: 177 ----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKI------SEQVEGDFCREIELLARLHHRHLV 167
            +G G F + Y+A+    G+L+AVK++  +       E+V     +EI L+ARL+H H++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
            + G   E     L  E+MA GS+   L   G         I     +   L YLH   +
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH---E 121

Query: 228 PPLCHRDIKSSNILLDEN-FVAKLADFGLA---HASKDGSICFEPVNTDIRGTPGYMDPE 283
             + HRD+K +N+L+D      ++ADFG A    A   G+  F+     + GT  +M PE
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ---GQLLGTIAFMAPE 178

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTAR 310
            +  ++     DV+S G V++E+ TA+
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 24/212 (11%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCR----------EIELLARLHH 163
           +IG+G +G VY A   + G ++AVK+++  +        R          EIE L  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 164 RHLVALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
            ++V   GF  E  E +L    EY+  GS+   L + GR     Q        V   L Y
Sbjct: 68  LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEGLAY 123

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 281
           LH      + HRD+K+ N+L+D + + K++DFG++  S D     +  N  ++G+  +M 
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ--NMSMQGSVFWMA 178

Query: 282 PEYVVTQE--LTEKSDVYSYGVVLLEIVTARR 311
           PE + +     + K D++S G V+LE+   RR
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 84/289 (29%), Positives = 134/289 (46%), Gaps = 58/289 (20%)

Query: 115 IIGQGGFGTVYKAQFSDGSL---IAVKRMDK-ISEQVEGDFCREIELLARL-HHRHLVAL 169
           +IG+G FG V KA+     L    A+KRM +  S+    DF  E+E+L +L HH +++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHL---------------HSPGRTPLSWQTRIQIAID 214
            G C  +   +L  EY  +G+L D L               +S   T LS Q  +  A D
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-LSSQQLLHFAAD 120

Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           VA  ++YL         HRD+ + NIL+ EN+VAK+ADFGL+   +            ++
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE----------VYVK 167

Query: 275 GTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS 329
            T G +   ++  + L     T  SDV+SYGV+L EIV+           +     C  +
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----------LGGTPYCGMT 216

Query: 330 ESRLAELVDPRIKDSFDMEQLRT----IVTIVRWCTQREGQARPSIKQV 374
            + L E    ++   + +E+       +  ++R C + +   RPS  Q+
Sbjct: 217 CAELYE----KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 10/204 (4%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V+   ++  + +AVK +   +   E  F  E +++ +L H  LV L    + 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYA-VVS 71

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  VA  + Y+         HRD+
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 128

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +S+NIL+ +  V K+ADFGLA   +D      +     I+ T     PE  +    T KS
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKS 184

Query: 295 DVYSYGVVLLEIVTARRAVQDGKN 318
           DV+S+G++L E+VT  R    G N
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMN 208

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 20/200 (10%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G G FG VYKAQ  + G   A K +   SE+   DF  EI++L+   H ++V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 231
            + + +++ E+   G+L   +    R  L   T  QI      +  AL +LH      + 
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELER-GL---TEPQIRYVCRQMLEALNFLH---SHKVI 125

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K+ NILL  +   KLADFG++  +K      +  +T I GTP +M PE V  +   
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKST---LQKRDTFI-GTPYWMAPEVVACETFK 181

Query: 292 E-----KSDVYSYGVVLLEI 306
           +     K+D++S G+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 70/228 (30%), Positives = 109/228 (47%), Gaps = 13/228 (5%)

Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH 163
           E  + +      +G G FG V+ A ++  + +AVK M   S  VE  F  E  ++  L H
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 60

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
             LV L    + K   +++ E+MA GSL D L S   +       I  +  +A  + ++ 
Sbjct: 61  DKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDP 282
                   HRD++++NIL+  + V K+ADFGLA   +D      E     I+ T     P
Sbjct: 120 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----P 172

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 330
           E +     T KSDV+S+G++L+EIVT  R    G   + + +V  A E
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG---MSNPEVIRALE 217

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 89.1 bits (221), Expect = 6e-20
 Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 28/213 (13%)

Query: 114 TIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHL 166
           T +G+G FG V+ A+          +L+ VK + K  ++ ++ +F RE+++  +L H+++
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHL-------HSPGRTPLSWQTRIQIAIDVANAL 219
           V L G C E    +++ EY   G LK  L             PLS + ++ +   +A  +
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD--GSICFEPVNT--DIRG 275
           ++L    +    HRD+ + N L+      K++   L   SKD   S  ++  N    +R 
Sbjct: 131 DHLS---NARFVHRDLAARNCLVSSQREVKVSLLSL---SKDVYNSEYYKLRNALIPLR- 183

Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
              ++ PE V   + + KSDV+S+GV++ E+ T
Sbjct: 184 ---WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.6 bits (219), Expect = 7e-20
 Identities = 70/207 (33%), Positives = 103/207 (49%), Gaps = 20/207 (9%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMD------KISEQVEGDFCREIELLARLHHRHLV 167
           ++GQG FG VY    +D G  +AVK++       + S++V    C EI+LL  L H  +V
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC-EIQLLKNLLHERIV 67

Query: 168 ALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
              G   +  ER L    E+M  GS+KD L S G   L+     +    +   + YLH  
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH-- 123

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-GSICFEPVN-TDIRGTPGYMDPE 283
               + HRDIK +NIL D     KL DFG   ASK   +IC        + GTP +M PE
Sbjct: 124 -SNMIVHRDIKGANILRDSVGNVKLGDFG---ASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTAR 310
            +  +    K+D++S G  ++E++T +
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.0 bits (221), Expect = 7e-20
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 27/216 (12%)

Query: 115 IIGQGGFGTVYKAQFSD------GSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRHL 166
            +G+G FG V KA+          S +AVK + D  +E+   D   E+E++  +  H+++
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQIA 212
           + L G C ++   +++ EY A+G+L+D L +              P    L+ +  +  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 272
             VA  +E+L         HRD+ + N+L+ E+ V K+ADFGLA       I +    T+
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH--IDYYRKTTN 193

Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 88.7 bits (220), Expect = 8e-20
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 37/218 (16%)

Query: 115 IIGQGGFGTVYKAQFS--DGSL--IAVKRM--DKISEQVEGDFCREIELLARLHHRHLVA 168
           I+G+G FG+V + Q S  DGS   +AVK M  D  +     +F  E   +    H +++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 169 LRGFCIEKRER------FLMYEYMANGSLKDHLHS------PGRTPLSWQTRIQIAIDVA 216
           L G C E           ++  +M +G L   L        P + PL  QT ++  +D+A
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDIA 123

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKD----GSICFEPVN 270
             +EYL    +    HRD+ + N +L E+    +ADFGL+    S D    G I   PV 
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                   ++  E +  +  T KSDV+++GV + EI T
Sbjct: 181 --------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 10/197 (5%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +++ +L H  LV L    + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 71

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 128

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +++NIL+ EN V K+ADFGLA   +D      +     I+ T     PE  +    T KS
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKS 184

Query: 295 DVYSYGVVLLEIVTARR 311
           DV+S+G++L E+ T  R
Sbjct: 185 DVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 24/207 (11%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDK--ISE--QVEGDFCREIELLARLH 162
           D+F  I  +G G FG V   +    G   A+K + K  I +  QVE     E  +L  + 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIR 59

Query: 163 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
           H  LV L G   +    +L+ EY+  G L  HL   GR P     R   A  V  ALEYL
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP-VARFYAA-QVVLALEYL 117

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--SICFEPVNTDIRGTPGYM 280
           H   D  + +RD+K  N+LLD +   K+ DFG A   K    ++C         GTP Y+
Sbjct: 118 H-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC---------GTPEYL 165

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIV 307
            PE ++++   +  D ++ G+++ E++
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 78/268 (29%), Positives = 125/268 (46%), Gaps = 31/268 (11%)

Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVE---GDFCREIELLARLHHRHLVALRG 171
           IG G FG VY A  S    ++AVK+M    +Q      D  +E++ L +L H + +  +G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             +++   +L+ EY   GS  D L    + PL       I       L YLH +    + 
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---MI 143

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRDIK+ NILL E    KLADFG A  S        P N+ + GTP +M PE ++  +  
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKS-------SPANSFV-GTPYWMAPEVILAMDEG 195

Query: 292 E---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
           +   K DV+S G+  +E+   +  + +           M++   +A+   P ++ +   +
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNDSPTLQSNEWTD 247

Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLR 376
             R  V    +C Q+  Q RP+  ++LR
Sbjct: 248 SFRGFVD---YCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 14/215 (6%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRG 171
           +G+GGFG V   Q    G + A K++DK      + E     E ++L ++  R +V+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 172 FCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           +  E ++   L+   M  G LK H+++ G         I  A  +   LE+LH      +
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            +RD+K  N+LLD++   +++D GLA   K G            GTPGYM PE +  +  
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA-----GTPGYMAPEVLQGEVY 171

Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
               D ++ G  L E++  R   +  K  VE  ++
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 26/206 (12%)

Query: 110 DNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA 168
           DNF   IG+G  G V  A   S G  +AVK+MD   +Q       E+ ++    H ++V 
Sbjct: 22  DNF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI---QIA---IDVANALEYL 222
           +    +   E +++ E++  G+L D         +   TR+   QIA   + V  AL +L
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLAVLKALSFL 131

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMD 281
           H      + HRDIKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M 
Sbjct: 132 H---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMA 183

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIV 307
           PE +       + D++S G++++E+V
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 25/267 (9%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRG 171
            IG+G FG +Y A+  SD     +K +D  K+  + +    +E+ LLA++ H ++V    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
              E    F++ EY   G L   ++       S    +   + ++  L+++H   D  + 
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKIL 123

Query: 232 HRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRDIKS NI L +N  VAKL DFG+A    D     E   T + GTP Y+ PE    +  
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM---ELAYTCV-GTPYYLSPEICQNRPY 179

Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA-QVCMASESRLAELVDPRIKDSFDMEQ 349
             K+D++S G VL E+ T +   + G NL +   ++C       A  + P    S D+  
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFE-GNNLHQLVLKICQG---YFAP-ISPNF--SRDLRS 232

Query: 350 LRTIVTIVRWCTQREGQARPSIKQVLR 376
           L      +    +   + RPSI  +L+
Sbjct: 233 L------ISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 24/205 (11%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGF 172
           +G+G +G V K +    G ++A+K+  +    E V+    RE+++L +L H ++V L+  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTP------LSWQTRIQIAIDVANALEYLHFYC 226
              K   +L++EY+    L+    SPG  P        WQ           A+ Y H + 
Sbjct: 69  FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHSH- 119

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRDIK  NIL+ E+ V KL DFG A A +          TD   T  Y  PE +V
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARP---ASPLTDYVATRWYRAPELLV 174

Query: 287 TQELTEKS-DVYSYGVVLLEIVTAR 310
                 K  DV++ G ++ E++   
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 78/292 (26%), Positives = 133/292 (45%), Gaps = 47/292 (16%)

Query: 116 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHL 166
           +GQG FG VY+    D       + +AVK +++   + E++E  F  E  ++      H+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 71

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
           V L G   + +   ++ E MA+G LK +L S        PGR P + Q  IQ+A ++A+ 
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 272
           + YL+        HRD+ + N ++  +F  K+ DFG+          + G     PV   
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186

Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
                 +M PE +     T  SD++S+GVVL EI +          L E     +++E  
Sbjct: 187 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQV 230

Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 384
           L  ++D    D  D    R +  ++R C Q   + RP+  +++ +L +   P
Sbjct: 231 LKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 47/224 (20%)

Query: 115 IIGQGGFGTVYKAQFSD-------GSLIAVKRMDK---ISEQVEGDFCREIELLARLHHR 164
            +G G FG VY+   +D          +AVK + K     E+ E  F +E  L++  +H 
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE--FLKEAHLMSNFNHP 59

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLH-----SPGRTPLSWQTRIQIAIDVANAL 219
           ++V L G C+    ++++ E M  G L  +L        G   L+ +  + I +DVA   
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 220 EYL---HFYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLA-------HASKDGSI 264
            YL   HF       HRD+ + N L+ E     + V K+ DFGLA       +  K+G  
Sbjct: 120 VYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
              PV         +M PE ++  + T +SDV+S+GV++ EI+T
Sbjct: 174 LL-PVR--------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 86.6 bits (214), Expect = 5e-19
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 47/288 (16%)

Query: 116 IGQGGFGTVY----KAQFSDG--SLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHL 166
           +GQG FG VY    K    D   + +A+K +++   + E++E  F  E  ++   +  H+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFNCHHV 71

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
           V L G   + +   ++ E M  G LK +L S        P + P S +  IQ+A ++A+ 
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 272
           + YL+        HRD+ + N ++ E+F  K+ DFG+          + G     PV   
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186

Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
                 +M PE +     T  SDV+S+GVVL EI T          L E     M++E  
Sbjct: 187 ------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQPYQGMSNEQV 230

Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
           L  +++  + D  D      +  ++R C Q   + RPS  +++  + E
Sbjct: 231 LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.1 bits (213), Expect = 6e-19
 Identities = 68/267 (25%), Positives = 125/267 (46%), Gaps = 27/267 (10%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V+  ++     +A+K +++     E DF  E +++ +L H  LV L G C +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           ++  +++ E+M NG L ++L    +  LS    + +  DV   +EYL         HRD+
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDL 126

Query: 236 KSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + N L+    V K++DFG+  +   D           ++ +P    PE     + + KS
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSP----PEVFNFSKYSSKS 182

Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESA---QVCMASESRLAELVDPRIKDSFDMEQLR 351
           DV+S+GV++ E+ T      +GK   E     +V +   SR   L  P++          
Sbjct: 183 DVWSFGVLMWEVFT------EGKMPFEKKSNYEV-VEMISRGFRLYRPKLAS-------M 228

Query: 352 TIVTIVRWCTQREGQARPSIKQVLRIL 378
           T+  ++  C   + + RP+  ++LR +
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.9 bits (212), Expect = 6e-19
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 10/202 (4%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +++ +L H  LV L    + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYA-VVS 71

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ E+M  GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 72  EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDL 128

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +++NIL+ +N V K+ADFGLA   +D      +     I+ T     PE  +    T KS
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTIKS 184

Query: 295 DVYSYGVVLLEIVTARRAVQDG 316
           DV+S+G++L E+VT  R    G
Sbjct: 185 DVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 64/222 (28%), Positives = 107/222 (48%), Gaps = 34/222 (15%)

Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRH 165
           F   +G+  FG +YK            L+A+K +  I+  Q  G+F +E  L+A LHH +
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHL--HSPG-------------RTPLSWQTRIQ 210
           +V L G   +++   +++EY+  G L + L   SP              ++ L     + 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 211 IAIDVANALEYL--HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICF 266
           IAI +A  +EYL  HF+      H+D+ + NIL+ E    K++D GL+    S D    +
Sbjct: 129 IAIQIAAGMEYLSSHFF-----VHKDLAARNILIGEQLHVKISDLGLSREIYSAD----Y 179

Query: 267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             V         +M PE ++  + +  SD++S+GVVL EI +
Sbjct: 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 14/197 (7%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G G FG VYKA+  + G+L A K ++  SE+   D+  EIE+LA  +H ++V L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              + ++M E+   G++   +    R      T  QI +     LE L +     + HRD
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE-- 292
           +K+ N+LL  +   KLADFG+   S       +  ++ I GTP +M PE V+ + + +  
Sbjct: 136 LKAGNVLLTLDGDIKLADFGV---SAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191

Query: 293 ---KSDVYSYGVVLLEI 306
              K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 27/208 (12%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 172
           +IG+G +G VYKA+    G L+A+K MD I ++ E +   E  +L +  +H ++    G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGA 71

Query: 173 CIEKRER-------FLMYEYMANGSLKD---HLHSPGRTPLSWQTRIQIAIDVANALEYL 222
            I+K           +M E    GS+ D    L   G+  L  +    I  +    L YL
Sbjct: 72  FIKKNPPGNDDQLWLVM-ELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYL 129

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
           H   +  + HRDIK  NILL +N   KL DFG++ A  D ++     NT I GTP +M P
Sbjct: 130 H---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS-AQLDSTL--GRRNTFI-GTPYWMAP 182

Query: 283 EYVVTQELTE-----KSDVYSYGVVLLE 305
           E +   E  +     +SDV+S G+  +E
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 40/223 (17%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALRG 171
           IG+G +G VYKA+    G ++A+K++ K+  + EG      REI+LL  L+H +++ L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLHFYCDPPL 230
               K + +L++E+M +  L   L    +  L  ++ I+     +   L + H +    +
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-- 288
            HRD+K  N+L++   V KLADFGLA +                G+P      YVVT+  
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF---------------GSPVRPYTHYVVTRWY 164

Query: 289 ---EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
              EL       +   D++S G +  E+++ RR +  GK+ ++
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPLFPGKSEID 206

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 27/208 (12%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVALRGF 172
            +G+G  G+V K +  +  +I   +      +  ++    RE+E+       ++V   G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 173 CIEKRE---RFLMYEYMANGSL----KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
            +++        M EY   GSL    K      GR     +   +IA  V   L YLH  
Sbjct: 68  FLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRI--GEKVLGKIAESVLKGLSYLH-- 122

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT---DIRGTPGYMDP 282
               + HRDIK SNILL      KL DFG++          E VN+      GT  YM P
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG---------ELVNSLAGTFTGTSFYMAP 172

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           E +  +  +  SDV+S G+ LLE+   R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 19/212 (8%)

Query: 115 IIGQGGFGTVYKAQFSDGS------LIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA 168
           ++G+G FG V+  +            I V++M K       +   E ++L  L H +++ 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN---ECQVLKLLSHPNIIE 63

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                +E +   ++ EY   G+L +++     + L   T +   + +  AL ++H     
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TK 120

Query: 229 PLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRD+K+ NILLD++  V K+ DFG++      S  +  V     GTP Y+ PE    
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-----GTPCYISPELCEG 175

Query: 288 QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL 319
           +   +KSD+++ G VL E+ + +RA  +  NL
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAF-EAANL 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 19/209 (9%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGD---------FCREIELLARLHHR 164
           +IG G FG+VY     S G L+AVK+++  S                 REI LL  L H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLH 223
           ++V   G  ++     +  EY+  GS+   L++ G      +T ++  +  +   L YLH
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---ETLVRNFVRQILKGLNYLH 123

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE--PVNTDIRGTPGYMD 281
              +  + HRDIK +NIL+D     K++DFG++   +  S+  +       ++G+  +M 
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           PE V     T K+D++S G +++E++T +
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.4 bits (208), Expect = 3e-18
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 34/274 (12%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMD------KISEQVEGDFCREIELLARLHHRHLV 167
           ++GQG FG VY     D G  +A K++       + S++V    C EI+LL  L H  +V
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC-EIQLLKNLQHERIV 67

Query: 168 ALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
              G   ++ E+ L    EYM  GS+KD L + G   L+     +    +   + YLH  
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH-- 123

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-GSICFEPVNT-DIRGTPGYMDPE 283
               + HRDIK +NIL D     KL DFG   ASK   +IC        + GTP +M PE
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFG---ASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-ELVDPRIK 342
            +  +    K+DV+S G  ++E++T +    + +         MA+  ++A +  +P++ 
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--------AMAAIFKIATQPTNPQLP 231

Query: 343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
            S   E  R  +     C   E + RPS +++LR
Sbjct: 232 -SHISEHARDFLG----CIFVEARHRPSAEELLR 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 65/197 (32%), Positives = 104/197 (52%), Gaps = 14/197 (7%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G G FG VYKAQ  + G L A K +D  SE+   D+  EI++LA   H ++V L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            +   +++ E+ A G++ D +      PL   T  QI +     LE L++  +  + HRD
Sbjct: 73  YENNLWILIEFCAGGAV-DAVMLELERPL---TEPQIRVVCKQTLEALNYLHENKIIHRD 128

Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE-- 292
           +K+ NIL   +   KLADFG+   S   +   +  ++ I GTP +M PE V+ +   +  
Sbjct: 129 LKAGNILFTLDGDIKLADFGV---SAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184

Query: 293 ---KSDVYSYGVVLLEI 306
              K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 67/285 (23%), Positives = 126/285 (44%), Gaps = 33/285 (11%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQ--VEGDFCREIELLARLHHRHLVALRG 171
           ++G+G +G V K +  + G ++A+K+  +  +   V+    REI +L +L H +LV L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
               K+  +L++E++ +  L D    P    L      +    +   +E+ H +    + 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NII 122

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRDIK  NIL+ ++ V KL DFG A   +  G +      TD   T  Y  PE +V    
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-----TDYVATRWYRAPELLVGDTK 177

Query: 291 TEKS-DVYSYGVVLLEIVTAR-------------RAVQDGKNLVESAQVCMASESRLAEL 336
             ++ D+++ G ++ E++T                 ++   NL+   Q         A +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 337 VDPRIKDSFDMEQL-----RTIVTIVRWCTQREGQARPSIKQVLR 376
             P +K+   +E+        ++ + + C + +   RPS  Q+L 
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 84.2 bits (208), Expect = 5e-18
 Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 31/218 (14%)

Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 165
           +G+G FG V +A+              +AVK + D  +++   D   E+EL+  +  H++
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS---PG-----------RTPLSWQTRIQI 211
           ++ L G C ++   +++ EY A G+L++ L +   PG              LS++  +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 212 AIDVANALEYLHFYCDPPLC-HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 270
           A  VA  +EYL    +   C HRD+ + N+L+ E+ V K+ADFGLA    D  I +    
Sbjct: 140 AYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD--IDYYKKT 193

Query: 271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           ++ R    +M PE +  +  T +SDV+S+G+++ EI T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 66/234 (28%), Positives = 105/234 (44%), Gaps = 43/234 (18%)

Query: 111 NFSTIIGQGGFGTVY------------KAQFSDGS-----LIAVK--RMDKISEQVEGDF 151
           NF   +G+G FG V+            KA   + +     L+AVK  R D      E DF
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE-DF 66

Query: 152 CREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH---------SPGRTP 202
            +E+++L+RL   ++  L G C       ++ EYM NG L   L          +     
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 262
           LS+ T + +A  +A+ + YL         HRD+ + N L+ +N+  K+ADFG++      
Sbjct: 127 LSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183

Query: 263 SICFEPVNTDIRGTP----GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARR 311
                     ++G       +M  E V+  + T KSDV+++GV L EI+T  R 
Sbjct: 184 DYY------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 83.7 bits (207), Expect = 6e-18
 Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 41/286 (14%)

Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSL-IAVKRMDKISEQVEGD-FCREIELLARL-HH 163
           F   +G G FG V +A       SD  + +AVK +   +   E +    E+++++ L +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
            ++V L G C       ++ EY   G L + L     + L+ +  +  +  VA  + +L 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 224 FY-CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP----G 278
              C     HRD+ + N+LL    + K+ DFGLA    + S      N  ++G       
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDS------NYVVKGNARLPVK 208

Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 338
           +M PE +     T +SDV+SYG++L EI +          L  +    M  +S+  +L  
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS----------LGSNPYPGMPVDSKFYKL-- 256

Query: 339 PRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
             IK+ + M Q       I  I++ C   +   RP+ KQ+++++ +
Sbjct: 257 --IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 38/272 (13%)

Query: 116 IGQGGFG-TVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G FG  +      DG    +K ++  K+S +   +  +E+ +L+ + H ++V  +  
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 173 CIEKRERFLMYEYMANGSLKDHLHS------PGRTPLSWQTRIQIAIDVANALEYLHFYC 226
             E    +++ +Y   G L   +++      P    L W   +QI +    AL+++H   
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICL----ALKHVH--- 118

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           D  + HRDIKS NI L ++   KL DFG+A          E   T I GTP Y+ PE   
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS---TVELARTCI-GTPYYLSPEICE 174

Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASESRLAELVDPRIKDS 344
            +    KSD+++ G VL E+ T + A + G  KNLV   ++   S   ++         S
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV--LKIIRGSYPPVS------SHYS 226

Query: 345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
           +D+  L      V    +R  + RPS+  +L 
Sbjct: 227 YDLRNL------VSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 29/217 (13%)

Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E++  +  H++
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS---PG-----------RTPLSWQTRIQI 211
           ++ L G C +    +++ EY + G+L+++L +   PG              ++++  +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              VA  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN--IDYYKKTT 197

Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 40/265 (15%)

Query: 124 VYKAQFSDGSLIAVK--RMDKISEQVEGDFC-REIELLARLHHRHLVALRGFCIEKRERF 180
           +YK  F +   + ++  +      +V  D    EI+ L R+   +++ + GF I+  +  
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 181 ----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 236
               L+ EY   G L++ L       LS++T++ +AID    L  L+ Y + P  ++++ 
Sbjct: 95  PRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 237 SSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV--VTQELTEKS 294
           S + L+ EN+  K+   GL          F+ VN  +     Y   + +  +  E T K 
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPP--FKNVNFMV-----YFSYKMLNDIFSEYTIKD 203

Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS----FDMEQL 350
           D+YS GVVL EI T       GK   E+            E+ D  I  +      ++  
Sbjct: 204 DIYSLGVVLWEIFT-------GKIPFENLTT--------KEIYDLIINKNNSLKLPLDCP 248

Query: 351 RTIVTIVRWCTQREGQARPSIKQVL 375
             I  IV  CT  +   RP+IK++L
Sbjct: 249 LEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 21/205 (10%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 172
           ++G G +G VYK +    G L A+K MD ++E  E +   EI +L +  HHR++    G 
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 173 CIEKR------ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
            I+K       + +L+ E+   GS+ D + +     L       I  ++   L +LH + 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRDIK  N+LL EN   KL DFG++ A  D ++     NT I GTP +M PE + 
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRR--NTFI-GTPYWMAPEVIA 194

Query: 287 TQELTE-----KSDVYSYGVVLLEI 306
             E  +     +SD++S G+  +E+
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 22/208 (10%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRM------DKISEQVEGDFCREIELLARLHHRHLV 167
           ++G+G FG VY    +D G  +AVK++       + S++V    C EI+LL  L H  +V
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC-EIQLLKNLRHDRIV 67

Query: 168 ALRGFCI---EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
              G C+   E+++  +  EYM  GS+KD L + G   L+     +    +   + YLH 
Sbjct: 68  QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH- 123

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-GSICFEPVN-TDIRGTPGYMDP 282
                + HRDIK +NIL D     KL DFG   ASK   +IC        + GTP +M P
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFG---ASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           E +  +    K+DV+S    ++E++T +
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 76/299 (25%), Positives = 130/299 (43%), Gaps = 63/299 (21%)

Query: 114 TIIGQGGFGTVYKAQ------FSDGSLIAVKRMDKISEQVE-GDFCREIELLARLHHRHL 166
             +G+G FG V KA        +  + +AVK + + +   E  D   E  LL +++H H+
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLH----------------------SPGRTPLS 204
           + L G C +     L+ EY   GSL+  L                       +P    L+
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 264
               I  A  ++  ++YL    +  L HRD+ + N+L+ E    K++DFGL   S+D   
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL---SRD--- 176

Query: 265 CFEPVNTDIRGTPG-----YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL 319
            +E  ++ ++ + G     +M  E +     T +SDV+S+GV+L EIVT          L
Sbjct: 177 VYEE-DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------L 225

Query: 320 VESAQVCMASESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQV 374
             +    +A E RL  L    +K  + ME+       +  ++  C ++E   RP+   +
Sbjct: 226 GGNPYPGIAPE-RLFNL----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 65/249 (26%), Positives = 116/249 (46%), Gaps = 27/249 (10%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKR-MDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           IG+G FG V+  +  +D + +AVK   + +   ++  F +E  +L +  H ++V L G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
            +K+  +++ E +  G     L + G   L  +  IQ+  + A  +EYL         HR
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHR 118

Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELTE 292
           D+ + N L+ E  V K++DFG++   +DG          ++  P  +  PE +     + 
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDG---VYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 293 KSDVYSYGVVLLEIVT-------------ARRAVQDGKNLVESAQVCMASESRLAELV-- 337
           +SDV+S+G++L E  +              R A++ G  L    ++C  +  RL E    
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL-PCPELCPDAVYRLMERCWE 234

Query: 338 -DPRIKDSF 345
            DP  + SF
Sbjct: 235 YDPGQRPSF 243

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 54/164 (32%), Positives = 77/164 (46%), Gaps = 35/164 (21%)

Query: 116 IGQGGFGTVYKAQ---FSDGSLIAVKRMDKISEQVEG---DFCREIELLARLHHRHLVAL 169
           IG+G +G VYKA+     DG   A+K+     EQ  G     CREI LL  L H ++V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 170 RGFCIEKRER--FLMYEYMANGSL----KDHLHS-----PGRT--PLSWQTRIQIAIDVA 216
               +E  ++  +L+++Y A   L    K H  +     P      L WQ        + 
Sbjct: 68  VEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------IL 118

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLA 256
           N + YLH      + HRD+K +NIL+     E  V K+ D GLA
Sbjct: 119 NGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 76/226 (33%), Positives = 106/226 (46%), Gaps = 34/226 (15%)

Query: 106 KKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAVK--RMDKISEQVEGDFCREIELLAR 160
           K+  D F  I  IG+G +G VYKA+  D G L+A+K  R+D   E       REI++L +
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 161 LHHRHLVALR----------GFCIEKRERFLMYEYMANGSLKDH----LHSPGRTPLSWQ 206
           L+HR++V L+           F  +K   +L++EYM      DH    L   G    S  
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSED 116

Query: 207 TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSIC 265
                   +   L Y H        HRDIK SNILL+     KLADFGLA   + + S  
Sbjct: 117 HIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 266 FEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTAR 310
           +   N  I  T  Y  PE ++ +E      DV+S G +L E+ T +
Sbjct: 174 Y--TNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 26/264 (9%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G FG VYK        ++A+K +D  +  +++E D  +EI +L++    ++    G 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYITRYYGS 70

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
            ++  + +++ EY+  GS  D L  PG  PL       I  ++   L+YLH        H
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLL-KPG--PLEETYIATILREILKGLDYLH---SERKIH 124

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RDIK++N+LL E    KLADFG+A    D  I     NT + GTP +M PE +       
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFV-GTPFWMAPEVIKQSAYDF 180

Query: 293 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 352
           K+D++S G+  +E+        D   +            R+  L+      + + +  + 
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPM------------RVLFLIPKNSPPTLEGQYSKP 228

Query: 353 IVTIVRWCTQREGQARPSIKQVLR 376
               V  C  ++ + RP+ K++L+
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
            IG+G +G VY+A+ +  G ++A+K  RMD   + +     REI LL  L H ++V L+ 
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 172 FCIEKR--ERFLMYEYMAN--GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             + K     FL+ EY      SL D++ +P       Q +  + + +   L+YLH    
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSES---QVKC-LMLQLLRGLQYLHENF- 128

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----YMDP 282
             + HRD+K SN+LL +    K+ADFGLA         +      +  TP      Y  P
Sbjct: 129 --IIHRDLKVSNLLLTDKGCLKIADFGLART-------YGLPAKPM--TPKVVTLWYRAP 177

Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVT 308
           E ++     T   D+++ G +L E++ 
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 13/201 (6%)

Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVAL 169
           +G+G FG V   ++     + G  +AVK +   S      D  +EIE+L  L+H ++V  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 170 RGFCIEKRERF--LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
           +G C E       L+ E++ +GSLK++L    +  ++ + +++ A+ +   ++YL     
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLG---S 127

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
               HRD+ + N+L++     K+ DFGL  A +     +  V  D+     +  PE ++ 
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYTVKDDLDSPVFWYAPECLIQ 186

Query: 288 QELTEKSDVYSYGVVLLEIVT 308
            +    SDV+S+GV L E++T
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 29/273 (10%)

Query: 115 IIGQGGFGTVYKAQFS----DGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL 169
           +IG G FG V++            +A+K +    +E+   DF  E  ++ +  H +++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            G   + +   ++ EYM NG+L  +L        S+Q  + +   +A  ++YL    D  
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDMN 127

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKD---GSICFEPVNTDIRGTPGYMDPEYVV 286
             HRD+ + NIL++ N   K++DFGL+   +D   G+         IR T     PE + 
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA----PEAIA 183

Query: 287 TQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 345
            ++ T  SDV+S+G+V+ E+++   R   D  N        M + +    L  P      
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAINDGFRLPAP------ 232

Query: 346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            M+    +  ++  C Q++   RP    ++ +L
Sbjct: 233 -MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 21/215 (9%)

Query: 111 NFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRH 165
           NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI LL  L+H +
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           +V L      + + +L++E++ +  LK  + +   +PLS      I   +   L+ L F 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDA---SPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-PVNTDIRG--TPGYMDP 282
               + HRD+K  N+L++     KLADFGLA A       F  PV T      T  Y  P
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARA-------FGVPVRTYTHEVVTLWYRAP 169

Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.1 bits (202), Expect = 3e-17
 Identities = 79/290 (27%), Positives = 137/290 (47%), Gaps = 34/290 (11%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG G FG VY A+      ++A+K+M    K S +   D  +E++ L R+ H + +  +G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             + +   +L+ EY   GS  D L    + PL     ++IA     AL+ L +     + 
Sbjct: 93  CYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQ---EVEIAAITHGALQGLAYLHSHNMI 147

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRDIK+ NILL E    KLADFG A  +        P N+ + GTP +M PE ++  +  
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIA-------SPANSFV-GTPYWMAPEVILAMDEG 199

Query: 292 E---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
           +   K DV+S G+  +E+   +  + +           M++   +A+   P ++ +   +
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPTLQSNEWSD 251

Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLR---ILYESSDPMHSGFVQAVED 395
             R  V     C Q+  Q RP+ +++L+   +L E  + +    +Q  +D
Sbjct: 252 YFRNFVDS---CLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKD 298

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD-FCREIELLARLHH-RHLVALRGF 172
           IG G  G VYK +F   G ++AVK+M +   + E      +++++ + H   ++V   G+
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPP 229
            I   + F+  E M+  +  D L    + P+      ++ + +  AL YL   H      
Sbjct: 83  FITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH-----G 135

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNILLD +   KL DFG++     G +      T   G   YM PE +   +
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGIS-----GRLVDSKAKTRSAGCAAYMAPERIDPPD 190

Query: 290 LTEK----SDVYSYGVVLLEIVTAR 310
              K    +DV+S G+ L+E+ T +
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 18/201 (8%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALR 170
           I +G FG+VY A+  S G   A+K + K       QV         ++ +    ++  L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
                K   +L+ EY+  G     + + G  P  W    Q   +V   +E LH      +
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEVVLGVEDLH---QRGI 118

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            HRDIK  N+L+D+    KL DFGL   S++G       N    GTP Y+ PE ++    
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGL---SRNGLE-----NKKFVGTPDYLAPETILGVGD 170

Query: 291 TEKSDVYSYGVVLLEIVTARR 311
            + SD +S G V+ E +    
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 15/195 (7%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC-REIELLARLHHRHLVALRGFC 173
           IGQG  GTVY A   + G  +A+K+M+ + +Q + +    EI ++    H ++V      
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           +   E +++ EY+A GSL D +     T +       +  +   ALE+LH      + HR
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139

Query: 234 DIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           DIKS NILL  +   KL DFG  A  + + S       + + GTP +M PE V  +    
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 293 KSDVYSYGVVLLEIV 307
           K D++S G++ +E+V
Sbjct: 195 KVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.5 bits (198), Expect = 5e-17
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 21/205 (10%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 172
           ++G G +G VYK +    G L A+K MD   ++ E +  +EI +L +  HHR++    G 
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 173 CIEKR------ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
            I+K       + +L+ E+   GS+ D + +     L  +    I  ++   L +LH + 
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRDIK  N+LL EN   KL DFG++ A  D ++     NT I GTP +M PE + 
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRR--NTFI-GTPYWMAPEVIA 184

Query: 287 TQELTE-----KSDVYSYGVVLLEI 306
             E  +     KSD++S G+  +E+
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 29/217 (13%)

Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 165
           +G+G FG V  A+         +    +AVK + D  +++   D   E+E++  +  H++
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
           ++ L G C +    +++ EY + G+L+++L +   PG        + P   L+++  +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA    +  I +    T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHN--IDYYKKTT 194

Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 18/203 (8%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFC-REIELLARLHHRHLVA 168
           ++G+G FG V  A+      L AVK + K      + VE     + +  LA   H  L  
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60

Query: 169 LRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
           L   C + ++R F + EY+  G L  H+   GR     + R   A ++   L++LH   +
Sbjct: 61  LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-RARF-YAAEIVLGLQFLH---E 114

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
             + +RD+K  N+LLD     K+ADFG+    K+G I      +   GTP Y+ PE +  
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKIADFGM---CKEG-ILGGVTTSTFCGTPDYIAPEILSY 170

Query: 288 QELTEKSDVYSYGVVLLEIVTAR 310
           Q      D ++ GV+L E++  +
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 79.7 bits (196), Expect = 8e-17
 Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 10/193 (5%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKR-MDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           ++G+G FG V+K    D + +AVK   + + ++++  F  E  +L +  H ++V L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
            +++  +++ E +  G     L    +  L  +  ++ A+D A  + YL         HR
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELTE 292
           D+ + N L+ EN V K++DFG++    DG       ++ ++  P  +  PE +     + 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYS----SSGLKQIPIKWTAPEALNYGRYSS 173

Query: 293 KSDVYSYGVVLLE 305
           +SDV+SYG++L E
Sbjct: 174 ESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 20/198 (10%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG G FG VY A+   +  ++A+K+M    K S +   D  +E+  L +L H + +  RG
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             + +   +L+ EY   GS  D L    + PL     ++IA     AL+ L +     + 
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQ---EVEIAAVTHGALQGLAYLHSHNMI 137

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K+ NILL E  + KL DFG A      SI   P N  + GTP +M PE ++  +  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSA------SI-MAPANXFV-GTPYWMAPEVILAMDEG 189

Query: 292 E---KSDVYSYGVVLLEI 306
           +   K DV+S G+  +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 68/244 (27%), Positives = 110/244 (45%), Gaps = 27/244 (11%)

Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRM---DKISEQVEGDFCREIELLARLHH 163
           D+   I  +G G FG V+  +        A+K M   + I  + E     E  +L  + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 164 RHLVALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
             ++ L  F  E  +RFL  + EY+  G L  +L + GR   S  T +  A ++  ALEY
Sbjct: 61  PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEY 116

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--SICFEPVNTDIRGTPGY 279
           LH      + +RD+K  NILLD+    KL DFG A   +D   ++C         GTP Y
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---------GTPEY 164

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 339
           + PE + ++   +  D ++ G+++ E++       D  N     +  +A +      +D 
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLEFPRHLDL 223

Query: 340 RIKD 343
             KD
Sbjct: 224 YAKD 227

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 14/194 (7%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G FG V+K        ++A+K +D  +  +++E D  +EI +L++    ++    G 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYGS 70

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
            ++  + +++ EY+  GS  D L  PG  PL       I  ++   L+YLH        H
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLE-PG--PLDETQIATILREILKGLDYLH---SEKKIH 124

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RDIK++N+LL E+   KLADFG+A    D  I          GTP +M PE +       
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQI----KRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 293 KSDVYSYGVVLLEI 306
           K+D++S G+  +E+
Sbjct: 181 KADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 44/287 (15%)

Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRM---DKISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG+G F  VY+A    DG  +A+K++   D +  +   D  +EI+LL +L+H +++    
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANALEYLH 223
             IE  E  ++ E    G L   +          P +T   W+  +Q+     +ALE++H
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKT--VWKYFVQLC----SALEHMH 123

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMD 281
                 + HRDIK +N+ +    V KL D GL    +SK  +         + GTP YM 
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA------HSLVGTPYYMS 174

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQ-DGKNLVESAQVCMASESRLAELVDPR 340
           PE +       KSD++S G +L E+   +     D  NL     +C     ++ +   P 
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLC----KKIEQCDYPP 227

Query: 341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS 387
           +      E+LR +V +   C   + + RP I  V    Y+ +  MH+
Sbjct: 228 LPSDHYSEELRQLVNM---CINPDPEKRPDITYV----YDVAKRMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 29/217 (13%)

Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIELLARL-HHRH 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E++  +  H++
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 211
           ++ L G C +    +++ EY + G+L+++L           ++P + P   LS++  +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I +    T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 200

Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 115 IIGQGGFGTVYKAQFS----DGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL 169
           +IG G FG V + +          +A+K +    +E+   DF  E  ++ +  H +++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA---IDVANALEYLHFYC 226
            G   + R   ++ E+M NG+L   L    R      T IQ+      +A  ++YL    
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL----RQNDGQFTVIQLVGMLRGIAAGMKYL---S 123

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD-------IRGTPGY 279
           +    HRD+ + NIL++ N V K++DFGL+   +D +   +P  T        IR T   
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSSLGGKIPIRWTA-- 179

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             PE +  ++ T  SDV+SYG+V+ E+++
Sbjct: 180 --PEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 84/318 (26%), Positives = 130/318 (40%), Gaps = 56/318 (17%)

Query: 79  PFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI-----IGQGGFGTVYKAQF-SDG 132
           P PPP S        S      +      A  + S +     IG G  GTVYK      G
Sbjct: 46  PLPPPSS------SSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTG 99

Query: 133 SLIAVKRM-----DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA 187
            L A+K +     D +  Q+    CREIE+L  ++H ++V          E  ++ E+M 
Sbjct: 100 RLYALKVIYGNHEDTVRRQI----CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155

Query: 188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV 247
            GSL+   H      L+      +A  + + + YLH      + HRDIK SN+L++    
Sbjct: 156 GGSLEGT-HIADEQFLA-----DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKN 206

Query: 248 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE------KSDVYSYGV 301
            K+ADFG+   S+  +   +P N+ + GT  YM PE + T +L          D++S GV
Sbjct: 207 VKIADFGV---SRILAQTMDPCNSSV-GTIAYMSPERINT-DLNHGAYDGYAGDIWSLGV 261

Query: 302 VLLEIVTARRAVQDGKNLVESA---QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVR 358
            +LE    R     G+    ++    +CM+             +              + 
Sbjct: 262 SILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH------------FIS 309

Query: 359 WCTQREGQARPSIKQVLR 376
            C QRE   R S  Q+L+
Sbjct: 310 CCLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.4 bits (201), Expect = 3e-16
 Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 21/192 (10%)

Query: 135 IAVKRMDKISEQVE-GDFCREIELLARLHHRHLVAL--RGFCIEKRERFLMYEYMANGSL 191
           I + R D   E+ +   F RE  L ARL+H ++VAL   G        F ++EY+   +L
Sbjct: 8   IKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTL 66

Query: 192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVA 248
           ++ L + G   L      ++ + V +AL   H   +  + HRD+K  NI++        A
Sbjct: 67  REVLAADG--ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 249 KLADFGL------AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVV 302
           K+ DFG+         +   ++      T++ GTP Y  PE +  + +T  SD+Y++G++
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRT---TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 303 LLEIVTARRAVQ 314
            LE +T +R VQ
Sbjct: 179 FLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 58/194 (29%), Positives = 100/194 (51%), Gaps = 14/194 (7%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G FG V+K        ++A+K +D  +  +++E D  +EI +L++    ++    G 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYGS 70

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
            ++  + +++ EY+  GS  D L +         T ++   ++   L+YLH        H
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLH---SEKKIH 124

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RDIK++N+LL E    KLADFG+A    D  I     NT + GTP +M PE +       
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFV-GTPFWMAPEVIQQSAYDS 180

Query: 293 KSDVYSYGVVLLEI 306
           K+D++S G+  +E+
Sbjct: 181 KADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 78.0 bits (192), Expect = 4e-16
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALR 170
           +G+GGFG V   Q  + G L A K+++K      +  EG    E  +LA++H R +V+L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSLA 59

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHS-----PGRTPLSWQTRIQIAIDVANALEYLHFY 225
                K +  L+   M  G L+ H+++     PG               + + LE+LH  
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG---FPEPRACFYTAQIISGLEHLH-- 114

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + +RD+K  N+LLD +   +++D GLA   KDG    +       GTPG+M PE +
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG----QSKTKGYAGTPGFMAPELL 169

Query: 286 VTQELTEKSDVYSYGVVLLEIVTAR 310
             +E     D ++ GV L E++ AR
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 28/208 (13%)

Query: 115 IIGQGGFGTV----YKAQFSDGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL 169
           +IG G FG V     K        +A+K +    +E+   DF  E  ++ +  H +++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA---IDVANALEYLHFYC 226
            G   + +   ++ EYM NGSL   L    R      T IQ+      +A+ ++YL    
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYL---S 123

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD------IRGTPGYM 280
           D    HRD+ + NIL++ N V K++DFGL+   +D     E   T       IR T    
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP---EAAYTTRGGKIPIRWTA--- 177

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            PE +  ++ T  SDV+SYG+V+ E+++
Sbjct: 178 -PEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 19/198 (9%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALRG 171
           +G G +G VYKA+    G L AVK    I  +   DF    +EI ++    H ++VA  G
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVK---IIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             + + + ++  EY   GSL+D  H  G  PLS    +QIA      L+ L +       
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTG--PLS---ELQIAYVCRETLQGLAYLHSKGKM 128

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE-- 289
           HRDIK +NILL +N   KLADFG+A A    +I          GTP +M PE    ++  
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA-AKITATIA---KRKSFIGTPYWMAPEVAAVEKNG 184

Query: 290 -LTEKSDVYSYGVVLLEI 306
              +  D+++ G+  +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 77.2 bits (191), Expect = 8e-16
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 25/154 (16%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEG-DFC--REIELLARLHHRHLVAL 169
           +G+G +  VYKA     G ++A+K++   +  E  +G +F   REI+LL  L H +++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 170 RGFCIEKRERFLMYEYMANGSL------KDHLHSPGRTP-LSWQTRIQIAIDVANALEYL 222
                 K    L++E+M    L      K  + +P         T           LEYL
Sbjct: 68  LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT--------LRGLEYL 118

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
           H      + HRD+K +N+L+  + V KLADFGLA
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLA 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 76.9 bits (190), Expect = 9e-16
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 20/198 (10%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRM------DKISEQVEGDFCREIELLARLHHRHLVA 168
           IG+G  G V+KA+    G  +A+K++        I  Q      REI+ L    H ++V 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA----LREIKALQACQHPYVVK 63

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L           L+ EYM    L + L    R PL           +   + Y+H     
Sbjct: 64  LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMH---AN 118

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-T 287
            + HRD+K +N+L+  + V K+ADFGLA    +       + +    T  Y  PE +   
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE---PRLYSHQVATRWYRAPELLYGA 175

Query: 288 QELTEKSDVYSYGVVLLE 305
           ++     D+++ G +  E
Sbjct: 176 RKYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 77.4 bits (191), Expect = 9e-16
 Identities = 66/211 (31%), Positives = 97/211 (45%), Gaps = 33/211 (15%)

Query: 111 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---IS-EQVEGDFC--REIELLARLHH 163
               ++G+G FG V  A++   G L A+K + K   I+ ++VE   C  R  E      H
Sbjct: 2   RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERH 61

Query: 164 RHLVALRG-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEY 221
             LV L   F  E    F+M EY A G L  H+H+   +    + R    A  V   L+Y
Sbjct: 62  PFLVNLFACFQTEDHVCFVM-EYAAGGDLMMHIHTDVFS----EPRAVFYAACVVLGLQY 116

Query: 222 LHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLA-----HASKDGSICFEPVNTDIRG 275
           LH   +  + +RD+K  N+LLD E FV K+ADFGL         +  + C         G
Sbjct: 117 LH---ENKIVYRDLKLDNLLLDTEGFV-KIADFGLCKEGMGFGDRTSTFC---------G 163

Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
           TP ++ PE +     T   D +  GV++ E+
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 68/232 (29%), Positives = 96/232 (41%), Gaps = 46/232 (19%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFCREIELLARLH 162
           D+F  I  IG+G FG V+  +  D G + A+K + K       Q+      E ++LA   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQI-AHVRAERDILADAD 59

Query: 163 HRHLVALRGFCIEKRERFLMY--EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
              +V L  +   + E  L    EYM  G L + L      P     R  IA  V  AL+
Sbjct: 60  SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVL-ALD 115

Query: 221 YLH--FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA---HASKDG---------SICF 266
            +H   +      HRDIK  NIL+D +   KLADFGL    + +KD           +  
Sbjct: 116 SVHKLGFI-----HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 267 EPVNTDIR-------------GTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
           + V    R             GTP Y+ PE +       + D +S GV+L E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 69/231 (29%), Positives = 105/231 (45%), Gaps = 29/231 (12%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
           ++G+G FG     Q  +     A+K  R+ K S  VE D  +E  LLA++ H ++VA + 
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVE-DSRKEAVLLAKMKHPNIVAFKE 65

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHS------PGRTPLSWQTRIQIAIDVANALEYLHFY 225
                   +++ EY   G L   +        P  T L W  ++ + +      +++H  
Sbjct: 66  SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV------QHIH-- 117

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEY 284
            +  + HRDIKS NI L +N   KL DFG A   +  G+     V     GTP Y+ PE 
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-----GTPYYVPPEI 171

Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASESRL 333
                   KSD++S G +L E+ T +   Q    KNL+   +VC  S   L
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI--LKVCQGSYKPL 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 14/200 (7%)

Query: 110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA 168
           DNF  I G+G  G V  A   S G L+AVK+MD   +Q       E+ ++    H ++V 
Sbjct: 23  DNFIKI-GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           +    +   E +++ E++  G+L D +     T ++ +    + + V  AL  LH     
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLH---AQ 135

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRDIKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M PE +  
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMAPELISR 190

Query: 288 QELTEKSDVYSYGVVLLEIV 307
                + D++S G++++E+V
Sbjct: 191 LPYGPEVDIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 67/278 (24%), Positives = 125/278 (44%), Gaps = 41/278 (14%)

Query: 116 IGQGGFGTVYKAQFSDG--SLIAVKRMD----------KISEQVEGDFCREIELL-ARLH 162
           +G G FG VYK +  +   +L+A+K ++          +  ++  GD   E+ ++  +L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 163 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS----PGRTPLS--WQTRIQIAIDVA 216
           H ++V      +E    +++ + +    L +H +S      R      W   +Q+ +   
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
            AL YLH   +  + HRD+  +NI+L E+    + DFGLA   +      E   T + GT
Sbjct: 125 -ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-----ESKLTSVVGT 176

Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 336
             Y  PE V  +   EK+DV+++G +L ++ T +        L  + ++  A       +
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA-------V 229

Query: 337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
            +P + +    E +  ++T    C   + +ARP I QV
Sbjct: 230 YEP-LPEGMYSEDVTDVIT---SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 70/273 (25%), Positives = 124/273 (45%), Gaps = 42/273 (15%)

Query: 134 LIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL 191
           L+AVK  R D  ++    DF +E+++L+RL   +++ L G C+++    ++ EYM NG L
Sbjct: 48  LVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106

Query: 192 KDHLHS-----------PGRTP------LSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              L S               P      +S+ + + +A+ +A+ ++YL         HRD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163

Query: 235 IKSSNILLDENFVAKLADFGLA---HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           + + N L+ EN   K+ADFG++   +A     I    V   IR    +M  E ++  + T
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAV-LPIR----WMAWECILMGKFT 218

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDG----KNLVESAQVCMASESRLAELVDPRIKDSFDM 347
             SDV+++GV L EI+   +    G    + ++E+A      + R   L  P        
Sbjct: 219 TASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCP---- 274

Query: 348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
              + +  ++  C  R+ + RPS   +   L E
Sbjct: 275 ---QGLYELMLQCWSRDCRERPSFSDIHAFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 33/216 (15%)

Query: 115 IIGQGGFGTVYKAQF--SDGSL--IAVK--RMDKISEQVEGDFCREIELLARLHHRHLVA 168
           ++G+G FG+V +AQ    DGS   +AVK  + D  S     +F RE   +    H +++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 169 LRGFCIEKRER------FLMYEYMANGSLKDHLHSP--GRTP--LSWQTRIQIAIDVANA 218
           L G  +  R +       ++  +M +G L   L     G  P  L  QT ++  ID+A+ 
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA------SKDGSICFEPVNTD 272
           +EYL         HRD+ + N +L+EN    +ADFGL+         + G     PV   
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK-- 180

Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                 ++  E +     T  SDV+++GV + EI+T
Sbjct: 181 ------WLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 70/269 (26%), Positives = 117/269 (43%), Gaps = 18/269 (6%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFC 173
           +G G  G+V K +      +  K++  I     V     RE++++      ++V+  G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           + +    +  E+M  GSL       G  P+  +   +IA+ V   L YL  Y    + HR
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYL--YNVHRIMHR 128

Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           DIK SNIL++     KL DFG++     G +     +T + GT  YM PE +   + T K
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFV-GTSTYMSPERIQGGKYTVK 182

Query: 294 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD---PRIKDSFDMEQL 350
           SDV+S G+ ++E+   +          +     M     L ++V    PR+  S   E L
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242

Query: 351 RTIVTIVRWCTQREGQARPSIKQVLRILY 379
           R  V     C  ++   RP+ +Q+  +  
Sbjct: 243 RDFVDA---CLLKDPTERPTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 41/281 (14%)

Query: 112 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMD---------KISEQVEGDFCREIELLARL 161
           F  ++G+G +G V   +  +DG    +K+++         K +EQ       E +LL++L
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ-------EAQLLSQL 56

Query: 162 HHRHLVALR-GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
            H ++VA R  +  E    +++  +   G L   L       L     ++  + +A AL+
Sbjct: 57  KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 280
           YLH   +  + HRD+K+ N+ L    + K+ D G+A   ++       + + + GTP YM
Sbjct: 117 YLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC----DMASTLIGTPYYM 169

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVTARRA--VQDGKNLVESAQVCMASESRLAELVD 338
            PE    +    KSDV++ G  + E+ T + A   +D  +LV           R+ E   
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV----------YRIIEGKL 219

Query: 339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 379
           P +   +  E    +  ++     +  + RPS+K +LR  Y
Sbjct: 220 PPMPKDYSPE----LGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 74/265 (27%), Positives = 130/265 (49%), Gaps = 25/265 (9%)

Query: 104 ETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH 162
           + ++  D+F  I G+G  G V  A +   G  +AVK+MD   +Q       E+ ++   H
Sbjct: 19  DPREYLDSFIKI-GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77

Query: 163 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
           H ++V +    +   E +++ E++  G+L D +     T ++ +    + + V  AL YL
Sbjct: 78  HENVVDMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYL 134

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMD 281
           H   +  + HRDIKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M 
Sbjct: 135 H---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-----VPKRKSLVGTPYWMA 186

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 341
           PE +       + D++S G++++E++       DG+    +     A   R+ + + PR+
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMI-------DGEPPYFNEPPLQAMR-RIRDNLPPRV 238

Query: 342 KDSFDMEQ-LRTI--VTIVRWCTQR 363
           KDS  +   LR    + +VR  +QR
Sbjct: 239 KDSHKVSSVLRGFLDLMLVREPSQR 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 19/198 (9%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALRG 171
           IG G +G VYKA+  + G L A+K    I  +   DF    +EI ++    H ++VA  G
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIK---VIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             + + + ++  E+   GSL+D  H  G  PLS     QIA      L+ L++       
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTG--PLS---ESQIAYVSRETLQGLYYLHSKGKM 128

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE-- 289
           HRDIK +NILL +N   KLADFG++ A    +I          GTP +M PE    +   
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS-AQITATIA---KRKSFIGTPYWMAPEVAAVERKG 184

Query: 290 -LTEKSDVYSYGVVLLEI 306
              +  D+++ G+  +E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 39/223 (17%)

Query: 116 IGQGGFGTVY--------------KAQFSDG-SLIAVKRM-DKISEQVEGDFCREIELLA 159
           +G+G FG V+                +F     L+AVK +   +++    DF +EI++++
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 160 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL----------HSPGRTPLSWQTRI 209
           RL + +++ L G C+      ++ EYM NG L   L          H+     +S    +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 210 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 269
            +A+ +A+ ++YL         HRD+ + N L+  ++  K+ADFG++     G       
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY----- 184

Query: 270 NTDIRGTP----GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
              I+G       +M  E ++  + T  SDV+++GV L E+ T
Sbjct: 185 -YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 36/216 (16%)

Query: 116 IGQGGFGTVYKAQFS-DGSL--IAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVA 168
           +G+G FG+V + Q + D S+  +AVK M KI+     ++E DF  E   +    H +++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEME-DFLSEAVCMKEFDHPNVMR 64

Query: 169 LRGFCIEKRER------FLMYEYMANGSLKDHL--HSPGRTP--LSWQTRIQIAIDVANA 218
           L G C++  E        ++  +M +G L   L     G  P  L  Q  ++   D+A+ 
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA------SKDGSICFEPVNTD 272
           +EYL         HRD+ + N +L+EN    +ADFGL+         + G I   PV   
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK-- 179

Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                 ++  E +  +  T KSDV+S+GV + EI T
Sbjct: 180 ------WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 75/306 (24%), Positives = 126/306 (41%), Gaps = 58/306 (18%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVE-GDFCREIELLARLHH-RHLVALRG- 171
           IG+G FGTV K      G+++AVKR+    ++ E      +++++ R     ++V   G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 172 --------FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEY 221
                    C+E     LM   +       +       P      I  +IA+    AL Y
Sbjct: 72  LFREGDCWICME-----LMDISLDKFYKYVYEVLKSVIP----EEILGKIAVATVKALNY 122

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR----GTP 277
           L    +  + HRD+K SNILLD N   KL DFG         I  + V++  +    G  
Sbjct: 123 LK--EELKIIHRDVKPSNILLDRNGNIKLCDFG---------ISGQLVDSIAKTRDAGCR 171

Query: 278 GYMDPEYVVTQELTE---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 334
            YM PE +          +SDV+S G+ L E+ T +       ++ +          +L 
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD----------QLT 221

Query: 335 ELVD---PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI----LYESSDPMHS 387
           ++V    P + +S + E   + V  +  C  ++   RP  K++L       YE  +   +
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVA 281

Query: 388 GFVQAV 393
            +VQ +
Sbjct: 282 AYVQRI 287

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 77.2 bits (190), Expect = 4e-15
 Identities = 83/282 (29%), Positives = 124/282 (43%), Gaps = 42/282 (14%)

Query: 113 STIIGQGGFGTV-YKAQFSDGSLIAVKRMDKISEQVEGDFCR---EIELLARLHHRHLVA 168
           S ++G G  GTV    + SDG   AVK +D +    E D  R   E+  L       +V 
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVK 95

Query: 169 LRGFCIEKRER--------FLMYEYMANGSLKDHLHSPGRT--PLSWQTRIQIAIDVANA 218
                 +K  R         L+ +Y   G L+  + S  +T           + I V  A
Sbjct: 96  CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-----AHASKDGSICFEPVNTDI 273
           + ++H      + HRDIKS+NILL  N + KL DFG      A  S D       V    
Sbjct: 156 VHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD-------VGRTF 205

Query: 274 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
            GTP Y+ PE    +  ++K+D++S GV+L E++T +R   DG+N+ E           L
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMH------KTL 258

Query: 334 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
           A   DP +  S   E ++ IVT +      + + RPS  ++L
Sbjct: 259 AGRYDP-LPPSISPE-MQEIVTAL---LSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 31/270 (11%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHH---RHLVA 168
           +IG+G +G VY+      G ++A+K   +D   + V  D  RE+ LL++L      ++  
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQPPNITK 66

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G  ++    +++ EY   GS++  L   G  P++ +    I  +V  AL+Y+H     
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRT-LMKAG--PIAEKYISVIIREVLVALKYIH---KV 120

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT- 287
            + HRDIK++NIL+      KL DFG+A      S       +   GTP +M PE V+T 
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS----KRSTFVGTPYWMAPE-VITE 175

Query: 288 -QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +    K+D++S G+ + E+ T      D    V++ +  M     + +   PR++D+  
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSD----VDAFRAMML----IPKSKPPRLEDNGY 227

Query: 347 MEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
            + LR  V     C   E + R S +++L+
Sbjct: 228 SKLLREFVAA---CLDEEPKERLSAEELLK 254

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 15/209 (7%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG-----DFCREIELLARLHHRHLVA 168
           ++G G FGTVYK  +  +G  + +    KI  +  G     +F  E  ++A + H HLV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L G C+    + L+ + M +G L D++H   +  +  Q  +   + +A  + YL    + 
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 128

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVT 287
            L HRD+ + N+L+      K+ DFGLA   +      +  N D    P  +M  E +  
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE---KEYNADGGKMPIKWMALECIHY 185

Query: 288 QELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           ++ T +SDV+SYGV + E++T      DG
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 16/217 (7%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+GGFG V   Q  + G + A K+++K      + E     E ++L +++ R +V+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL- 65

Query: 171 GFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            +  E ++   L+   M  G LK H++  G         +  A ++   LE LH      
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QER 122

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           + +RD+K  NILLD++   +++D GLA H  +  +I          GT GYM PE V  +
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI------KGRVGTVGYMAPEVVKNE 176

Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
             T   D ++ G +L E++  +   Q  K  ++  +V
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 7/146 (4%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G +G VYKA+    G ++A+K  R++   E V     REI LL  L+H ++V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              + + +L++E++ +  LK ++ S   T L           +   + Y H +    + H
Sbjct: 67  VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLH 122

Query: 233 RDIKSSNILLDENFVAKLADFGLAHA 258
           RD+K  N+L+D     KLADFGLA A
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 34/217 (15%)

Query: 113 STIIGQGGFGTVYKAQFSDGSL-----IAVKRM-DKISEQVEGDFCREIELLARLHHRHL 166
           S ++ +G FG ++     D        + VK + D  SE       +E  LL  L H+++
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 167 VALRGFCIEKRER-FLMYEYMANGSLKDHL----HSPGRTPLSWQTR--IQIAIDVANAL 219
           + +   CIE  E  F++Y YM  G+LK  L          P +  T+  + +AI +A  +
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNT 271
            YLH      + H+DI + N ++DE    K+ D  L+        H   D        N 
Sbjct: 131 SYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE------NR 181

Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            ++    +M  E +V +E +  SDV+S+GV+L E++T
Sbjct: 182 PVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 40/228 (17%)

Query: 112 FSTIIGQGGFGTVY-----------KAQFS------DGSLIAVK--RMDKISEQVEGDFC 152
           F   +G+G FG V+              FS         L+AVK  R D  ++    DF 
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFL 67

Query: 153 REIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL--HSPGRTP-------L 203
           +EI++++RL   +++ L   CI      ++ EYM NG L   L  H P           +
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 263
           S+ T I +A  +A+ ++YL         HRD+ + N L+ +N+  K+ADFG++     G 
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Query: 264 ---ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
              I    V   IR    +M  E ++  + T  SDV+++GV L EI+T
Sbjct: 185 YYRIQGRAV-LPIR----WMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 32/208 (15%)

Query: 116 IGQGGFGTVYKA--QFSDGSLI--AVKRMDKISEQV-EGDFCREIELLARLHHRHLVALR 170
           +G G FG+V K       G  +  AVK + +      + +F RE  ++A+L H  +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 171 GFCIEKRERFLMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYC 226
           G C  K E  ++   +A  G L  +L      P+S     ++A  VA  + YL   HF  
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVS--DLKELAHQVAMGMAYLESKHF-- 116

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG------YM 280
                HRD+ + N+LL     AK++DFG++ A   GS          R T        + 
Sbjct: 117 ----VHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-------DYYRATTAGRWPLKWY 165

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            PE +   + + KSDV+SYGV L E  +
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 17/202 (8%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
           ++G G FGTV+K  +  +G  I    A+K + D+   Q   +    +  +  L H ++V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L G C     + L+ +    GSL DH+    R  L  Q  +   + +A  + YL  +   
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHR-- 129

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            + HR++ + NILL  + + ++ADFG+A      D    +    T I+    +M  E ++
Sbjct: 130 -MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMALESIL 184

Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
               T +SDV+SYGV + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 12/214 (5%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGD---FCREIELLARLHHRHLVALRG 171
           +G+GGFG V   Q  + G + A K++DK   + +        E E+L +++   +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
               K    L+   M  G LK H+++ G   L  +  I  +  +   + +LH      + 
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           +RD+K  N+LLD+    +L+D GLA   KDG    + + T   GT GYM PE +  +  +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDG----KTI-TQRAGTNGYMAPEILKEEPYS 172

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
              D ++ G  + E+V  R   +D K  V   ++
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 20/217 (9%)

Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDK----ISEQVEGDFCREIELLARLHHRHLVAL 169
           ++G+G FG V+ A+        A+K + K    + + VE     +  L     H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 170 RGFCI--EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             +C    K   F + EY+  G L  H+ S  +  L   T    A ++   L++LH    
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLH---S 114

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
             + +RD+K  NILLD +   K+ADFG+   +  G    +       GTP Y+ PE ++ 
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLG 170

Query: 288 QELTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVES 322
           Q+     D +S+GV+L E++  +      D + L +S
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 13/194 (6%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           IGQG  GTV+ A   + G  +A+K+++   +  +     EI ++  L + ++V      +
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E F++ EY+A GSL D +        +     QIA      L+ L F     + HRD
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHANQVIHRD 140

Query: 235 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           IKS N+LL  +   KL DFG  A  + + S       + + GTP +M PE V  +    K
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 294 SDVYSYGVVLLEIV 307
            D++S G++ +E+V
Sbjct: 196 VDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G +G VYK +    G ++A+K  R++   E V     REI LL  L H ++V L+  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 173 CIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
            +++   +L++E+++   LK +L S P    +  +        +   + + H      + 
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVL 123

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-PVN--TDIRGTPGYMDPEYVV-T 287
           HRD+K  N+L+D   V KLADFGLA A       F  PV   T    T  Y  PE ++ +
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARA-------FGIPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 288 QELTEKSDVYSYGVVLLEIVTAR 310
              +   D++S G +  E+ T +
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 13/194 (6%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           IG+G  G V  A +   G  +AVK MD   +Q       E+ ++    H+++V +    +
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E +++ E++  G+L D +    +T L+ +    +   V  AL YLH      + HRD
Sbjct: 89  VGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRD 142

Query: 235 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           IKS +ILL  +   KL+DFG  A  SKD      P    + GTP +M PE +       +
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKD-----VPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 294 SDVYSYGVVLLEIV 307
            D++S G++++E+V
Sbjct: 198 VDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 82/257 (31%), Positives = 117/257 (45%), Gaps = 59/257 (22%)

Query: 101 SYKETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGD-F----CRE 154
            Y+   K        +G+G FG VYKA Q   G ++A+K   KI    E D F     RE
Sbjct: 9   DYEILGK--------LGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALRE 57

Query: 155 IELLARLHHRHLVALRGFCIEK-----RERFLMY---EYMANGSLKDHLHSPGRTPLSWQ 206
           I++L +L H ++V L    +E+     R+R  +Y    YM +  L   L +P    L   
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKL--- 112

Query: 207 TRIQIAIDVANALE---YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 263
           T  QI   +   LE   YLH   +  + HRDIK++NIL+D   + K+ADFGLA    DG 
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR-PYDGP 168

Query: 264 ICFEPVNTDIRGTPGYMDPEY---VVTQ-----EL-------TEKSDVYSYGVVLLEIVT 308
               P      G  G    +Y   VVT+     EL       T   D++  G V  E+ T
Sbjct: 169 P---PNPK---GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222

Query: 309 ARRAVQDGKNLVESAQV 325
            RR +  GK+ ++   +
Sbjct: 223 -RRPILQGKSDIDQLHL 238

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 101 SYKETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLA 159
           S  + KK    F  I GQG  GTVY A   + G  +A+K+M+   +  +     EI ++ 
Sbjct: 13  SVGDPKKKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 160 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
              + ++V      +   E +++ EY+A GSL D +        +     QIA      L
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECL 125

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPG 278
           + L F     + HRDIKS NILL  +   KL DFG  A  + + S       + + GTP 
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPY 180

Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
           +M PE V  +    K D++S G++ +E+V
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 101 SYKETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLA 159
           S  + KK    F  I GQG  GTVY A   + G  +A+++M+   +  +     EI ++ 
Sbjct: 14  SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 160 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
              + ++V      +   E +++ EY+A GSL D +        +     QIA      L
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECL 126

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPG 278
           + L F     + HRDIKS NILL  +   KL DFG  A  + + S       + + GTP 
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPY 181

Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
           +M PE V  +    K D++S G++ +E++
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 66/244 (27%), Positives = 115/244 (47%), Gaps = 20/244 (8%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+GGFG V   Q  + G + A K+++K      + E     E ++L +++ R +V+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 65

Query: 171 GFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            +  E ++   L+   M  G LK H+++ G      +  +  A ++   LE LH      
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RER 122

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + +RD+K  NILLD+    +++D GLA    +G    E +   + GT GYM PE V  + 
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----ETIRGRV-GTVGYMAPEVVKNER 177

Query: 290 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 349
            T   D +  G ++ E++  +   +  K  V+  +V    E R+ E  D         E 
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----ERRVKE--DQEEYSEKFSEA 231

Query: 350 LRTI 353
            R+I
Sbjct: 232 ARSI 235

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 17/210 (8%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G +GTV+KA+  +   ++A+KR  +D   E V     REI LL  L H+++V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
               ++  L++EY  +  LK +  S        +        +   L + H +    + H
Sbjct: 68  LHSDKKLTLVFEY-CDQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NVLH 122

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICF--EPVNTDIRGTPGYMDPEYVVTQEL 290
           RD+K  N+L+++N   KLADFGLA A      C+  E V      T  Y  P+ +   +L
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV------TLWYRPPDVLFGAKL 176

Query: 291 TEKS-DVYSYGVVLLEIVTARRAVQDGKNL 319
              S D++S G +  E+  A R +  G ++
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDV 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 36/275 (13%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRM---DKISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG+G F  VY+A    D   +A+K++   + +  +   D  +EI+LL +L+H +++    
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANALEYLH 223
             IE  E  ++ E    G L   +          P RT   W+  +Q+     +A+E++H
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT--VWKYFVQLC----SAVEHMH 123

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRDIK +N+ +    V KL D GL       +         + GTP YM PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPE 176

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAV-QDGKNLVESAQVCMASESRLAELVDPRIK 342
            +       KSD++S G +L E+   +     D  NL    Q       ++ +   P + 
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ-------KIEQCDYPPLP 229

Query: 343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 377
                E+LR +V++   C   +   RP I  V +I
Sbjct: 230 TEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 14/216 (6%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+GGFG V   Q  + G + A KR++K      + E     E ++L +++ + +V L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL- 65

Query: 171 GFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            +  E ++   L+   M  G LK H+++ G      +  +  A ++   LE LH      
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---REN 122

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
             +RD+K  NILLD+    +++D GLA    +G      V     GT GYM PE +  Q 
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTVGYMAPEVLNNQR 177

Query: 290 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
            T   D +  G ++ E++  +   +  K  V+  +V
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 16/216 (7%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRH 165
           D+F  I  +G G  G V+K       LI  +++   +I   +     RE+++L   +  +
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           +V   G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 121

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 122 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 174

Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAV--QDGKNL 319
                + +SD++S G+ L+E+   R  +   D K L
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.8 bits (177), Expect = 9e-14
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 51/230 (22%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 169
            IG G +G V  A     G  +A+K++  + + +         REI+LL  L H +++ L
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI--DAKRILREIKLLRHLRHENIIGL 64

Query: 170 RG-FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLH 223
                    E F    ++ E M    L   + SP   PL+    IQ     +   L+YLH
Sbjct: 65  LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLTDD-HIQYFLYQILRGLKYLH 120

Query: 224 FYCDPPLC---HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 280
                      HRD+K SNIL++ N   K+ DFGLA            V+ D     G++
Sbjct: 121 S------ANVIHRDLKPSNILVNSNCDLKICDFGLARG----------VDPDED-EKGFL 163

Query: 281 DPEYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKN 318
             EYVVT+     EL       T+  D++S G +  E++T R+ +  G++
Sbjct: 164 T-EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRD 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.0 bits (174), Expect = 9e-14
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 14/202 (6%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           ++G+G +G VY A+  S    IA+K + +   +       EI L + L HR++V   G  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 174 IEKRERFLMYEYMANGSLKDHLHSP-GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
            E     +  E +  GSL   L S  G    + QT I     +   L+YLH   D  + H
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVH 131

Query: 233 RDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           RDIK  N+L++  + V K++DFG    SK  +    P      GT  YM PE V+ +   
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFG---TSKRLA-GINPCTETFTGTLQYMAPE-VIDKGPR 186

Query: 292 ---EKSDVYSYGVVLLEIVTAR 310
                +D++S G  ++E+ T +
Sbjct: 187 GYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 19/199 (9%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG- 171
           I+G G  GTVYKA       ++AVK +   I+ +++     E+E+L +    +++   G 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           F +E R   +  E+M  GSL  +     + P     RI +A  V   L YL       + 
Sbjct: 68  FFVENRIS-ICTEFMDGGSLDVY----RKIPEHVLGRIAVA--VVKGLTYL---WSLKIL 117

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K SN+L++     KL DFG++      +     +     GT  YM PE +  ++  
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVS------TQLVNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 292 EKSDVYSYGVVLLEIVTAR 310
             SDV+S G+  +E+   R
Sbjct: 172 IHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 14/205 (6%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRH 165
           D+F  +  +G G  G V K       LI  +++    I   +     RE+++L   +  +
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           +V   G      E  +  E+M  GSL   L   GR P +   +I IA  V   L YL   
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLREK 118

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 119 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 170

Query: 286 VTQELTEKSDVYSYGVVLLEIVTAR 310
                T +SD++S G+ L+E+   R
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 17/199 (8%)

Query: 115 IIGQGGFGTVYKAQF----SDGSLIAVKRMDKISEQVEGD-FCREIELLARLHHRHLVAL 169
            IG+G FG VY+  +    ++   +AVK     +     + F +E  ++ +  H H+V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            G   E     +M E    G L+ +L    +  L   + I  +  ++ AL YL       
Sbjct: 73  IGVITENPVWIVM-ELAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLE---SKR 127

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT-P-GYMDPEYVVT 287
             HRDI + N+L+      KL DFGL+   +D     E      +G  P  +M PE +  
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-----ESYYKASKGKLPIKWMAPESINF 182

Query: 288 QELTEKSDVYSYGVVLLEI 306
           +  T  SDV+ +GV + EI
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 24/203 (11%)

Query: 115 IIGQGGFGTVYKAQFSDGS-LIAVKRMDK----ISEQVEGDFCREIE---LLARLHHRHL 166
           ++G+G FG V  A+    +   A+K + K      + VE   C  +E   L     H  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVE---CTMVERRVLALAWEHPFL 58

Query: 167 VALRGFCI--EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
             L  FC    K   F + EY+  G L  H+ S GR   + + R   A ++   L++LH 
Sbjct: 59  THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARF-YAAEIICGLQFLH- 113

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                + +RD+K  N+LLD++   K+ADFG+   + +G    E   +   GTP Y+ PE 
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYIAPEI 167

Query: 285 VVTQELTEKSDVYSYGVVLLEIV 307
           +  Q+  E  D +S+GV+L E++
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 14/216 (6%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+GGFG V   Q  + G + A K+++K      + E     E  +L +++ R +V+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65

Query: 171 GFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            +  E ++   L+   M  G LK H+++ G      Q  I  A ++   LE L       
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RER 122

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + +RD+K  NILLD+    +++D GLA    +G    E V   + GT GYM PE +  ++
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----ETVRGRV-GTVGYMAPEVINNEK 177

Query: 290 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
            T   D +  G ++ E++  +   +  K  V+  +V
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 26/204 (12%)

Query: 114 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREI----ELLARLHHRHLVA 168
           T +GQGG+G V+ A+  D G ++A+KRM K S   + +  R +    ++L       LV 
Sbjct: 7   TQVGQGGYGQVFLAKKKDTGEIVALKRMKK-SLLFKLNEVRHVLTERDILTTTKSEWLVK 65

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA--IDVANALEYLHFYC 226
           L     +    +L  EY+  G  +  L++ G        R  +A   +  +AL  L +  
Sbjct: 66  LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGY-- 122

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMDPEY 284
                HRD+K  N L+D +   KL DFGL+    +   S+          G+P YM PE 
Sbjct: 123 ----IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV---------GSPDYMAPEV 169

Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           +  +      D +S G +L E + 
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 45/213 (21%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALR 170
           IG+G F  V KAQ    G   A+K M K     EQV     REI+ L RL  H +++ L 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64

Query: 171 GFCIEKRERFL----------MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
               +++   L          +YE +     K       + PL  +        +  +L+
Sbjct: 65  EVLFDRKTGRLALVFELMDMNLYELI-----KGR-----KRPLPEKRVKSYMYQLLKSLD 114

Query: 221 YLH----FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
           ++H    F       HRDIK  NIL+ ++ + KLADFG         I  +P  T+   T
Sbjct: 115 HMHRNGIF-------HRDIKPENILIKDD-ILKLADFGSCR-----GIYSKPPYTEYIST 161

Query: 277 PGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVT 308
             Y  PE ++T      K D+++ G V  EI++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 16/216 (7%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRH 165
           D+F  I  +G G  G V K Q     LI  +++   +I   +     RE+++L   +  +
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           +V   G      E  +  E+M  GSL   L    R P     ++ IA  V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLRE- 121

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 122 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 174

Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAV--QDGKNL 319
                + +SD++S G+ L+E+   R  +   D K L
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 20/159 (12%)

Query: 113 STIIGQGGFGTVYKAQF-SDGSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVAL 169
              IGQG FG V+KA+      ++A+K+  M+   E       REI++L  L H ++V L
Sbjct: 17  LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 76

Query: 170 RGFCIEK-----RER---FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANAL 219
              C  K     R +   +L++E+  +  L   L +     T    +  +++ +   N L
Sbjct: 77  IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLL---NGL 132

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
            Y+H      + HRD+K++NIL+ ++ + KLADFGLA A
Sbjct: 133 YYIHR---NKILHRDMKAANILITKDGILKLADFGLARA 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 40/208 (19%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVA-L 169
           +G G FG V  A+    G   A+K + K      +QV+    +E  +L  L H  +V  +
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ-HVAQEKSILMELSHPFIVNMM 84

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN--------ALEY 221
             F  E R  FL+ E++  G L  HL   GR P           DVA         A EY
Sbjct: 85  CSFQDENRVYFLL-EFVVGGELFTHLRKAGRFP----------NDVAKFYHAELVLAFEY 133

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--SICFEPVNTDIRGTPGY 279
           LH   D  + +RD+K  N+LLD     K+ DFG A    D   ++C         GTP Y
Sbjct: 134 LH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC---------GTPEY 181

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIV 307
           + PE + ++   +  D ++ GV+L E +
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 15/224 (6%)

Query: 109 TDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK-ISEQVEGDFCREIE--LLARLHHR 164
             NF  ++G+G FG V  A+      L A+K + K +  Q +   C  +E  +LA     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 165 HLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
             +     C +  +R + + EY+  G L  H+   G+        +  A +++  L +LH
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLH 118

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + +RD+K  N++LD     K+ADFG+        +          GTP Y+ PE
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT----TRTFCGTPDYIAPE 171

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 327
            +  Q   +  D ++YGV+L E++  +    DG++  E  Q  M
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 29/207 (14%)

Query: 115 IIGQGGFGTVY---KAQFSD-GSLIAVKRMDKISEQVEGDFCR---EIELLARLHHRHLV 167
           ++GQG FG V+   K    D G L A+K + K + +V  D  R   E ++LA ++H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEVNHPFIV 61

Query: 168 ALR-GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
            L   F  E +  +L+ +++  G L   L S          +  +A ++A AL++LH   
Sbjct: 62  KLHYAFQTEGK-LYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELALALDHLH--- 115

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMD 281
              + +RD+K  NILLDE    KL DFGL+     H  K  S C         GT  YM 
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---------GTVEYMA 166

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE V  +  T+ +D +S+GV++ E++T
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 20/202 (9%)

Query: 114 TIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLV 167
            +IG+G FG V  A+  +DG   AVK + K +     EQ      R + LL  + H  LV
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLV 59

Query: 168 ALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFY 225
            L  +  +  ++ + + +Y+  G L  HL      P   + R +  A ++A+AL YLH  
Sbjct: 60  GLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFP---EPRARFYAAEIASALGYLH-- 113

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + +RD+K  NILLD      L DFGL    K+G I      +   GTP Y+ PE +
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLC---KEG-IEHSKTTSTFCGTPEYLAPEVL 168

Query: 286 VTQELTEKSDVYSYGVVLLEIV 307
             Q      D +  G VL E++
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G +G V+K +  + G ++A+K+  +  +   ++    REI +L +L H +LV L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 173 CIEKRERFLMYEYMANGSLKDH--LHSPGRTP--LSWQTRIQIAIDVANALEYLHFY-CD 227
              KR+  L++EY       DH  L+   + P  +      +I      A+ + H + C 
Sbjct: 69  FRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC- 121

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV- 286
               HRD+K  NIL+ +    KL DFG A         +    TD   T  Y  PE +V 
Sbjct: 122 ---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDYVATRWYRAPELLVG 174

Query: 287 -TQELTEKSDVYSYGVVLLEIVT 308
            TQ      DV++ G V  E++T
Sbjct: 175 DTQYGP-PVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 72/294 (24%), Positives = 123/294 (41%), Gaps = 46/294 (15%)

Query: 117 GQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCR---EIELLARLHHRHLVALRGFC 173
                  + K +    +L+AVK+++ +    + D      EI    +L H +++      
Sbjct: 11  EDLMIVHLAKHK-PTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 174 IEKRERFLMYEYMANGSLKDHL--HSPGRTPLSWQTRI-QIAIDVANALEYLHFYCDPPL 230
           I   E +++   MA GS +D L  H P   P   +  I  I  DV NAL+Y+H       
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIH---SKGF 122

Query: 231 CHRDIKSSNILLDENFVAKLADFG-----LAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
            HR +K+S+ILL  +    L+        + H  +   +   P +  ++  P ++ PE V
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS-SVKNLP-WLSPE-V 179

Query: 286 VTQEL---TEKSDVYSYGVVLLEI---VTARRAVQDGKNLVESAQVCM----------AS 329
           + Q L    EKSD+YS G+   E+       + +   + L+E  +  +            
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239

Query: 330 ESRLAE----LVDPRIKDSFDMEQLRTIVT----IVRWCTQREGQARPSIKQVL 375
           E  +++       P  +DS D    RT        V  C QR+ ++RPS  Q+L
Sbjct: 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.0 bits (166), Expect = 1e-12
 Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 26/223 (11%)

Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDK----ISEQVEGDFCREIELLARLHHRHLVAL 169
           ++G+G FG V  A+    G   AVK + K    I + VE     +  L     +  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
                 K   F + E++  G L  H+   GR  L   T    A ++   L++LH      
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLH---SKG 116

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-----GTPGYMDPEY 284
           + +RD+K  N++LD +   K+ADFG+         C E V  D R     GTP Y+ PE 
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGM---------CKENVFGDNRASTFCGTPDYIAPEI 167

Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQ--DGKNLVESAQV 325
           +   + T   D +S+GV+L E++  +      D   L ES +V
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 38/277 (13%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDF--------CREIELLARLHHRHLV 167
           +G+G FGTVY     D   +A +R+  + E   G+          +E +LL++L H  +V
Sbjct: 8   LGKGSFGTVYLV--KDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRT--PLSWQTRIQIAIDVANALEYLHFY 225
                 +E+    ++ EY     L   L     T   LS     +  I +   + Y+H  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAH---ASKDGSICFEPVNTDIRGTPGYMDP 282
               + HRD+K+ NI L  N + K+ DFG++     S D       + T   GTP YM P
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD-------LATTFTGTPYYMSP 174

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 342
           E +  Q    KSD++S G +L E+     A + G+N        ++   R+ E   P + 
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFE-GQNF-------LSVVLRIVEGPTPSLP 226

Query: 343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 379
           +++     R + +I++    ++   RPS  ++LR  +
Sbjct: 227 ETYS----RQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 24/276 (8%)

Query: 116 IGQGGFGTVYKAQFSDGSLIA---VKRMDKISEQVEGD-FCREIELLARLHHRHLVALRG 171
           IG G FG V   +   G   A   VK +   +   E   F +E++    L+H +++   G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQ--IAIDVANALEYLHFYCDP 228
            CIE     L+ E+   G LK++L S  G      Q  +   +A +VA+ L +LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHAS--KDGSICFEPVNTDIRGT-PGYMDP--E 283
              H D+   N  L  +   K+ D+GLA     +D  I  +     +R   P  ++   +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 342
            ++ ++ T+KS+++S GV + E+ T A +   D  +     QV    + +L        K
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP-------K 232

Query: 343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
              D++       ++++C       RP+ ++V  +L
Sbjct: 233 PQLDLKYSDRWYEVMQFCWLDPET-RPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 44/156 (28%), Positives = 84/156 (53%), Gaps = 16/156 (10%)

Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDF----CREIELLARLH 162
           D +  +  I +G +G VY+A+    G ++A+K++ K+ ++ EG F     REI +L +L 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEG-FPITSLREINILLKLQ 62

Query: 163 HRHLVALRGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
           H ++V ++   +       +++ EY+ +  LK  L    + P        + + + + + 
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVKCLMLQLLSGVA 120

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
           +LH   D  + HRD+K+SN+LL+   + K+ DFGLA
Sbjct: 121 HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLA 153

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 19/203 (9%)

Query: 116 IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G +G VYKA+       IA+K  R+++  E V     REI LL  + H ++V L+  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L++EY+ +  LK H+ S   +P   +    I   +   L  + +     + H
Sbjct: 70  VHSEKRLYLVFEYL-DLDLKKHMDS---SPDFAKNPRLIKTYLYQILRGIAYCHSHRVLH 125

Query: 233 RDIKSSNILLDENFVA-KLADFGLAHASKDGSICFE-PVNTDIRG--TPGYMDPEYVV-T 287
           RD+K  N+L+D    A KLADFGLA A       F  PV T      T  Y  PE ++ +
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARA-------FGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 288 QELTEKSDVYSYGVVLLEIVTAR 310
           +  +   D++S G +  E+V  +
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 24/203 (11%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK----ISEQVEGDFC-REIELLARLHHRHLVA 168
           ++G+G FG V  A+    G L AVK + K      + VE     + I  LAR +H  L  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60

Query: 169 LRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFYC 226
           L   C +  +R F + E++  G L  H+    R     + R +  A ++ +AL +LH   
Sbjct: 61  LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEITSALMFLH--- 113

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           D  + +RD+K  N+LLD     KLADFG+    K+G I      +   GTP Y+ PE  +
Sbjct: 114 DKGIIYRDLKLDNVLLDHEGHCKLADFGMC---KEG-IFNGKTTSTFCGTPDYIAPE--I 167

Query: 287 TQELTEKSDV--YSYGVVLLEIV 307
            QE+     V  ++ GV+L E++
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 107 KATD-NFSTIIGQGGFGTVYKAQFSDGS-LIAVKRMDKISEQVEGD---FCREIELLARL 161
           KA D +   +IG+G FG V   +      + A+K + K       D   F  E +++A  
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 162 HHRHLVALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
           +   +V L      + +++L  + EYM  G L + L S    P  W  R   A +V  AL
Sbjct: 101 NSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKW-ARFYTA-EVVLAL 155

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSI-CFEPVNTDIRGTP 277
           + +H        HRD+K  N+LLD++   KLADFG       +G + C   V     GTP
Sbjct: 156 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-----GTP 207

Query: 278 GYMDPEYVVTQ----ELTEKSDVYSYGVVLLEIV 307
            Y+ PE + +Q        + D +S GV L E++
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 70/202 (34%), Positives = 97/202 (48%), Gaps = 22/202 (10%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVA 168
           +IG+G FG V  A+  SDGS  AVK + K +     EQ      R + LL  L H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60

Query: 169 LRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
           L  +  +  E+ + + +Y+  G L  HL    R  L  + R   A +VA+A+ YLH    
Sbjct: 61  LH-YSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARF-YAAEVASAIGYLH---S 114

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--GTPGYMDPEYV 285
             + +RD+K  NILLD      L DFGL    K+G    EP  T     GTP Y+ PE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLC---KEG---VEPEETTSTFCGTPEYLAPEVL 168

Query: 286 VTQELTEKSDVYSYGVVLLEIV 307
             +      D +  G VL E++
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 16/200 (8%)

Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALRG 171
           +G+G + TV+K +     +L+A+K +    E  EG  C   RE+ LL  L H ++V L  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
               +R   L++EY+ +  LK +L + G        +I     +   L Y H      + 
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCH---KRKIL 125

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQEL 290
           HRD+K  N+L++E    KLADFGLA A    S+  +  + ++  T  Y  P+ ++ + E 
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAK---SVPTKTYSNEVV-TLWYRPPDVLLGSTEY 181

Query: 291 TEKSDVYSYGVVLLEIVTAR 310
           +   D++  G +L E+ T R
Sbjct: 182 STPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 31/163 (19%)

Query: 113 STIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEG---DFCREIELLARL---HHRH 165
              IG+G +GTVYKA+  + G  +A+K++ ++    EG      REI LL +L    H +
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 166 LVALRGFCIEKR-ER----FLMYEYMAN--GSLKDHLHSPGRTP-----LSWQTRIQIAI 213
           +V L   C   R +R     L++E++     +       PG  P     L  Q       
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ------- 115

Query: 214 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
            +   +++LH +    + HRD+K  NIL+  +   K+ADFGLA
Sbjct: 116 -LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 31/206 (15%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH---------- 165
           IG+G FG VY+ +  D   I    M  +S++       + E+   +  R+          
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYA--MKVLSKKE---IVAKKEVAHTIGERNILVRTLLDES 55

Query: 166 --LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
             +V L+       + +L+ +YM+ G L  HL   GR     + +  IA ++  ALE+LH
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-RAKFYIA-ELVLALEHLH 113

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMD 281
            Y    + +RD+K  NILLD      L DFGL+ A  + + +      NT   GT  Y+ 
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-----TNT-FCGTTEYLA 164

Query: 282 PEYVVTQE-LTEKSDVYSYGVVLLEI 306
           PE ++ ++  T+  D +S GV++ E+
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.9 bits (158), Expect = 9e-12
 Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 30/274 (10%)

Query: 116 IGQGGFGTVYKA----QFSDGSL----IAVKRMDKISEQVEGDFCREIELLARLHHRHLV 167
           +GQG F  ++K         G L    + +K +DK        F     ++++L H+HLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQTRIQIAIDVANALEYLHFYC 226
              G C+   E  ++ EY+  GSL  +L        +SW  ++++A  +A AL +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG-SICFEPVNTDIRGTPGYMDPEYV 285
           D  L H ++ + N+LL      K  +      S  G SI   P    +   P ++ PE +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-WVPPECI 176

Query: 286 V-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 344
              Q L+  +D +S+G  L EI +         + ++S +     E R  +L  P+  + 
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFS---GGDKPLSALDSQKKLQFYEDRH-QLPAPKWTE- 231

Query: 345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                   +  ++  C   E   RPS + ++R L
Sbjct: 232 --------LANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 9e-12
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 25/203 (12%)

Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG+G FG V + +  D   I A+K + K   +S         E  +LA+++   +V L+ 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 172 FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           F  +  E+ +L+  ++  G L  HL   GR  LS + R   A ++  ALE LH +    +
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFYTA-ELLCALENLHKF---NV 114

Query: 231 CHRDIKSSNILLDENFVAKLADFGL-----AHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
            +RD+K  NILLD      L DFGL         K  + C         GTP Y+ PE +
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---------GTPEYLAPELL 165

Query: 286 VTQELTEKSDVYSYGVVLLEIVT 308
           +    T+  D ++ GV+L E++T
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 63/249 (25%), Positives = 108/249 (43%), Gaps = 40/249 (16%)

Query: 115 IIGQGGFGTVYKAQFSD---GSLIAVKRMDK-ISEQ--VEGDFCREIELLARLHHRHLVA 168
           +IG+GG G VY A   D      +A+K++ + +SE   ++  F RE ++ A L H  +V 
Sbjct: 9   LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 169 LRGFCIEKRERFLMYEYMANGSLK---------DHLHSPGRTPLSWQTRIQIAIDVANAL 219
           +   C +    +    Y+   +LK         + L        S    + I   +   +
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK------------DGSICFE 267
           EY+H      + HRD+K  NILL       + D+G A   K            + +IC+ 
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 268 --PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA----RRAVQDGKNLVE 321
              +   I GTP YM PE ++    +E +D+Y+ GV+L +++T     RR  + G+ +  
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR--KKGRKISY 241

Query: 322 SAQVCMASE 330
              +    E
Sbjct: 242 RDVILSPIE 250

Length = 932

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 18/201 (8%)

Query: 116 IGQGGFGTVYK--AQFSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALR 170
           +G+G + TVYK  ++ +D +L+A+K +    E  EG  C   RE+ LL  L H ++V L 
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
                ++   L++EY+ +  LK +L   G +      ++     +   L Y H      +
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL-FLFQLLRGLNYCH---RRKV 125

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQE 289
            HRD+K  N+L++E    KLADFGLA A    SI  +  + ++  T  Y  P+ ++ + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAK---SIPTKTYSNEVV-TLWYRPPDILLGSTD 181

Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
            + + D++  G +  E+ T R
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 49/195 (25%), Positives = 95/195 (48%), Gaps = 11/195 (5%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVALRG 171
           ++G+G +G V K +  +   ++A+K+    + +E+V+    RE+++L  L   ++V L+ 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
               + + +L++EY+    L+     P   P       ++   +   ++ +H+     + 
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKNDIV 122

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRDIK  N+L+  N V KL DFG A    +GS       T+   T  Y  PE ++     
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGS---NANYTEYVATRWYRSPELLLGAPYG 179

Query: 292 EKSDVYSYGVVLLEI 306
           +  D++S G +L E+
Sbjct: 180 KAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 24/207 (11%)

Query: 111 NFSTIIGQGGFGTVYKAQFSDGS--LIAVKRMDK-ISEQVEGDFCREIE--LLARLHHRH 165
           NF  ++G+G FG V  A+   G+  L A+K + K +  Q +   C  +E  +LA      
Sbjct: 3   NFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 166 -LVALRG-FCIEKRERFLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEY 221
            L  L   F    R  F+M EY+  G L  H+   G  + P +    +  A ++A  L +
Sbjct: 62  FLTQLHSCFQTMDRLYFVM-EYVNGGDLMYHIQQVGKFKEPHA----VFYAAEIAIGLFF 116

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT-DIRGTPGYM 280
           LH      + +RD+K  N++LD     K+ADFG+    K+    F    T    GTP Y+
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMC---KEN--IFGGKTTRTFCGTPDYI 168

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIV 307
            PE +  Q   +  D +++GV+L E++
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 24/173 (13%)

Query: 99  KFSYKETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRM--DKISEQVEGDF---- 151
            FS  E           +G+G +G V KA  +  G ++A+K++   +IS  V  D     
Sbjct: 3   SFSISERYIQKGAH---LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVG 59

Query: 152 --------CREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPL 203
                    RE++++  + H +++ L    +E     L+ + MA   LK  +    +  L
Sbjct: 60  MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRL 116

Query: 204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
           +      I + + N L  LH +      HRD+  +NI ++   + K+ADFGLA
Sbjct: 117 TESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLA 166

Length = 335

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 24/205 (11%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG---DFCREIELLARLHHRHLVALRG 171
           +G+G + TVYK +  + G ++A+K +   +E  EG      REI L+  L H ++V L  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHD 65

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
               + +  L++EYM +  LK ++ + G R  L   T       +   + + H   +  +
Sbjct: 66  VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-PVNT---DIRGTPGYMDPEYVV 286
            HRD+K  N+L+++    KLADFGLA A       F  PVNT   ++  T  Y  P+ ++
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARA-------FGIPVNTFSNEVV-TLWYRAPDVLL 173

Query: 287 TQELTEKS-DVYSYGVVLLEIVTAR 310
                  S D++S G ++ E++T R
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 35/280 (12%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLAR-LHHR 164
           D+   I  +G+G +G V K +    G+++AVKR+   ++ Q +     ++++  R +   
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKD---HLHSPGRT-PLSWQTRIQIAIDVANALE 220
           + V   G    + + ++  E M + SL      ++  G T P     +I  A+ +  ALE
Sbjct: 61  YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKI--AVSIVKALE 117

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 280
           YLH      + HRD+K SN+L++ N   KL DFG++     G +      T   G   YM
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKTIDAGCKPYM 170

Query: 281 DPEYV----VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES-AQVCMASESRLAE 335
            PE +      +    KSDV+S G+ ++E+ T R      K   +   QV      +L  
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA 230

Query: 336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
                  + F  E        V  C ++  + RP+  ++L
Sbjct: 231 -------EKFSPE----FQDFVNKCLKKNYKERPNYPELL 259

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 21/198 (10%)

Query: 116 IGQGGFGTVYKA--QFSDGSLIAVKR-MDKISEQVEGDFC-REIELLARLHHRHLVALRG 171
           +G G FG V  A  Q + G  +A+K+ M   S  V      RE++LL  L H ++++L  
Sbjct: 18  VGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76

Query: 172 FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
             I   E  + + E +    L   L S    PL  Q        +   L+Y+H      +
Sbjct: 77  IFISPLEDIYFVTELLGT-DLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH---SAGV 129

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QE 289
            HRD+K SNIL++EN   K+ DFGLA          +P  T    T  Y  PE ++T Q+
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQ-------DPQMTGYVSTRYYRAPEIMLTWQK 182

Query: 290 LTEKSDVYSYGVVLLEIV 307
              + D++S G +  E++
Sbjct: 183 YDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 40/113 (35%), Positives = 58/113 (51%), Gaps = 11/113 (9%)

Query: 199 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
            + PL+ +  I  +  VA  +E+L         HRD+ + NILL EN V K+ DFGLA  
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR- 221

Query: 259 SKDGSICFEP---VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                I  +P      D R    +M PE +  +  T +SDV+S+GV+L EI +
Sbjct: 222 ----DIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 34/221 (15%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSDG-SLIAVKRMDK----ISEQVEGDFCREIELLARLH 162
           ++F TI  I  G +G VY  +  +     A+K+++K    +  Q++  F  E ++L    
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59

Query: 163 HRHLVALRGFC-IEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
           +  +V++  FC  E +    M  EY+  G     L + G  P+    R+  A  V  ALE
Sbjct: 60  NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFAETVL-ALE 115

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------------HASKDGSICF 266
           YLH Y    + HRD+K  N+L+      KL DFGL+              H  KD     
Sbjct: 116 YLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR--- 169

Query: 267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
           E ++  + GTP Y+ PE ++ Q   +  D ++ G++L E +
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 54/228 (23%), Positives = 101/228 (44%), Gaps = 30/228 (13%)

Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRM-DKISEQVEGDFCREIE 156
           E   +T  F   +G+  FG VYK              +A+K + DK    +  +F  E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 157 LLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL--HSPG------------RTP 202
           + +RL H ++V L G   +++   +++ Y ++  L + L   SP             ++ 
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SK 260
           L     + I   +A  +E+L  +    + H+D+ + N+L+ +    K++D GL     + 
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           D           IR    +M PE ++  + +  SD++SYGVVL E+ +
Sbjct: 178 DYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 64/199 (32%), Positives = 90/199 (45%), Gaps = 16/199 (8%)

Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVA 168
           +IG+G FG V  A+   DG   AVK + K       EQ      R + LL  + H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L        + + + +++  G L  HL    R+    + R   A ++A+AL YLH     
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAA-EIASALGYLH---SI 115

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + +RD+K  NILLD      L DFGL    K+G I      T   GTP Y+ PE +  Q
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLC---KEG-IAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 289 ELTEKSDVYSYGVVLLEIV 307
                 D +  G VL E++
Sbjct: 172 PYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)

Query: 101 SYKETKKATD------NFSTIIGQGGFGTVYKAQFSDGSL--IAVKRMDKI----SEQVE 148
           S KE K+         NF   +G G FG V  A + +     +A+KR +K      +QV+
Sbjct: 17  STKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76

Query: 149 GDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 208
             F  E ++L  ++H   V L G   ++   +L+ E++  G     L    R P      
Sbjct: 77  HVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND--VG 133

Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICF 266
              A  +    EYL       + +RD+K  N+LLD++   K+ DFG A    ++  ++C 
Sbjct: 134 CFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC- 189

Query: 267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                   GTP Y+ PE ++     + +D ++ G+ + EI+
Sbjct: 190 --------GTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 36/214 (16%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 169
            IG+G +G V  A     G  +A+K++     Q    FC    REI++L R  H +++ +
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFKHENIIGI 68

Query: 170 ------RGFCIEKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQTRIQIAI-DVANALEY 221
                   F     + +++ E M     +  L+   +T  LS    IQ  +  +   L+Y
Sbjct: 69  LDIIRPPSFE-SFNDVYIVQELM-----ETDLYKLIKTQHLSND-HIQYFLYQILRGLKY 121

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTP 277
           +H      + HRD+K SN+LL+ N   K+ DFGLA              E V      T 
Sbjct: 122 IH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-----ATR 173

Query: 278 GYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            Y  PE ++  +   K+ D++S G +L E+++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 15/214 (7%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRG 171
            IG G +G V  A     G  +A+K++    +   +     RE+++L    H +++A+R 
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71

Query: 172 FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
                   F    ++ + M +  L   +HS    PL+ +        +   L+Y+H    
Sbjct: 72  ILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSAN- 127

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
             + HRD+K SN+L++E+   ++ DFG+A          +   T+   T  Y  PE +++
Sbjct: 128 --VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185

Query: 288 -QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
             E T   D++S G +  E++  RR +  GKN V
Sbjct: 186 LPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV 218

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 27/224 (12%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E  ++A + + H+  
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSP-----GRTPLSWQTRIQIAIDVANALEYLH 223
           L G C+    + L+ + M  G L D++         +  L+W       + +A  + YL 
Sbjct: 74  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 126

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMD 281
              +  L HRD+ + N+L+      K+ DFGLA    + +     E     I+    +M 
Sbjct: 127 ---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK----WMA 179

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
            E ++ +  T +SDV+SYGV + E++T      DG    E + +
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 115 IIGQGGFGTVYKAQFS-DGSLI----AVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
           ++G G FGTVYK  +  DG  +    A+K + +  S +   +   E  ++A +   ++  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    + 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLE---EV 128

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVT 287
            L HRD+ + N+L+      K+ DFGLA       I     + D    P  +M  E ++ 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLL---DIDETEYHADGGKVPIKWMALESILH 185

Query: 288 QELTEKSDVYSYGVVLLEIVT 308
           +  T +SDV+SYGV + E++T
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+G FG V    + + G   A+K + K   I++        E  +L    H  L AL+
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 171 -GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             F    R  F+M EY   G L  HL S  R     + R   A ++ +AL YLH  CD  
Sbjct: 62  YSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALGYLH-SCD-- 115

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + +RD+K  N++LD++   K+ DFGL    K+G I          GTP Y+ PE +   +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLC---KEG-ISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
                D +  GVV+ E++  R
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 62/204 (30%), Positives = 92/204 (45%), Gaps = 26/204 (12%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIE-LLARLHHRHLVAL 169
           +IG+G FG V  A+  ++    AVK + K   + ++ E     E   LL  + H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 170 RGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             F  +  ++ + + +Y+  G L  HL    R  L  + R   A ++A+AL YLH     
Sbjct: 62  H-FSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPE 283
            + +RD+K  NILLD      L DFGL      H     + C         GTP Y+ PE
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC---------GTPEYLAPE 166

Query: 284 YVVTQELTEKSDVYSYGVVLLEIV 307
            +  Q      D +  G VL E++
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 20/202 (9%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVK--RMDKISEQVEGDFCREIELLARLH---HRHLVAL 169
           IG G +GTVYKA+    G  +A+K  R+    + +     RE+ LL RL    H ++V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 170 RGFCIEKR-----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
              C   R     +  L++E++ +  L+ +L       L  +T   +       L++LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
            C   + HRD+K  NIL+      KLADFGLA       +   PV      T  Y  PE 
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVVV----TLWYRAPEV 178

Query: 285 VVTQELTEKSDVYSYGVVLLEI 306
           ++        D++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 62.8 bits (152), Expect = 2e-10
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 28/182 (15%)

Query: 137 VKRMDKISEQVEGDFCREIELLARLHHRHLVALR--------GFCIEKRERFLMYEYMAN 188
           VK   + + Q+E     EI  L RL+H +++ +          + I ++  F +Y +M +
Sbjct: 200 VKAGSRAAIQLEN----EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 189 GSL--KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 246
            +   KD        PL  QTR  I   +  A+EY+H   D  L HRDIK  NI L+ + 
Sbjct: 256 EAFDWKD-------RPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDG 304

Query: 247 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
              L DFG A   +      E  +    GT     PE +      E +D++S G++LL++
Sbjct: 305 KIVLGDFGTAMPFEKER---EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Query: 307 VT 308
           ++
Sbjct: 362 LS 363

Length = 501

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 54/195 (27%), Positives = 81/195 (41%), Gaps = 47/195 (24%)

Query: 200 RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 259
           ++PL+ +  I  +  VA  +E+L         HRD+ + NILL EN V K+ DFGLA   
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-- 222

Query: 260 KDGSICFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                       DI   P Y            M PE +  +  T +SDV+S+GV+L EI 
Sbjct: 223 ------------DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270

Query: 308 TARRAVQDGKNLVESAQVCM----ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQR 363
           +   +   G  + E  + C      +  R  E   P I              I+  C Q 
Sbjct: 271 SLGASPYPGVQINE--EFCQRLKDGTRMRAPENATPEIY------------RIMLACWQG 316

Query: 364 EGQARPSIKQVLRIL 378
           + + RP+   ++ IL
Sbjct: 317 DPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)

Query: 115 IIGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQVEGD---FCREIELLARLHHRHLVALR 170
           +IG+G FG V   +      + A+K + K       D   F  E +++A  +   +V L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHS---PGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
               + R  +++ EYM  G L + + +   P +    +   + +A+D  +++ ++H    
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSI-CFEPVNTDIRGTPGYMDPEYV 285
                RD+K  N+LLD++   KLADFG     +K+G + C   V     GTP Y+ PE +
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVL 215

Query: 286 VTQ----ELTEKSDVYSYGVVLLEIVTA 309
            +Q        + D +S GV L E++  
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 31/193 (16%)

Query: 190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAK 249
             KD   +    PL     ++ +  VA  +++L         HRD+ + N+LL +  VAK
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAK 252

Query: 250 LADFGLAHASKDGSICFEPVNTDIRGTP----GYMDPEYVVTQELTEKSDVYSYGVVLLE 305
           + DFGLA    + S      N  ++G       +M PE +     T +SDV+SYG++L E
Sbjct: 253 ICDFGLARDIMNDS------NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 306

Query: 306 IVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCT 361
           I +       GK+        +   S+  ++    +K  + M +       I +I++ C 
Sbjct: 307 IFSL------GKSPYPG----ILVNSKFYKM----VKRGYQMSRPDFAPPEIYSIMKMCW 352

Query: 362 QREGQARPSIKQV 374
             E   RP+  Q+
Sbjct: 353 NLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)

Query: 109 TDNFSTI--IGQGGFGTVYK-AQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHR 164
           TD +  I  IG+G +G VYK     DGSL AVK +D IS+ V+ +   E  +L  L +H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHP 79

Query: 165 HLVALRGFCIEKR-----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ---IAIDVA 216
           ++V   G   +       + +L+ E    GS+ + +    +  L    R+    I+  + 
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYILY 135

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
            AL  L    +  + HRD+K +NILL      KL DFG++       +     NT + GT
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSV-GT 191

Query: 277 PGYMDPEYVVTQELTEKS-----DVYSYGVVLLEI 306
           P +M PE +  ++  + S     DV+S G+  +E+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 68/257 (26%), Positives = 110/257 (42%), Gaps = 55/257 (21%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL---- 169
           IIG+GGFG VY  + +D G + A+K +DK   +++       E LA L+ R +++L    
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-----ETLA-LNERIMLSLVSTG 54

Query: 170 ---------RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
                      F    +  F++ + M  G L  HL   G    S       A ++   LE
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLE 111

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTD 272
           ++H   +  + +RD+K +NILLDE+   +++D GLA        HAS             
Sbjct: 112 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------------ 156

Query: 273 IRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
             GT GYM PE +      + S D +S G +L +++      +  K   +          
Sbjct: 157 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEI----D 208

Query: 332 RLAELVDPRIKDSFDME 348
           R+   +   + DSF  E
Sbjct: 209 RMTLTMAVELPDSFSPE 225

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 116 IGQGGFGTVYK--AQFSDGSLIAVKRMDKISEQVEGDFC---REIELLARLHHRHLVALR 170
           +G+G + TV+K  ++ ++ +L+A+K +    E  EG  C   RE+ LL  L H ++V L 
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
                 +   L++EY+ +  LK ++   G   +S          +   L Y H      +
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNI-MSMHNVKIFLYQILRGLAYCH---RRKV 125

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQE 289
            HRD+K  N+L++E    KLADFGLA A    S+  +  + ++  T  Y  P+ ++ + E
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAK---SVPTKTYSNEVV-TLWYRPPDVLLGSSE 181

Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
            + + D++  G +  E+ + R
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 69/250 (27%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVE----GDFCREIELLARLH 162
           D+F +I  IG+G FG V   Q  D G + A+K++ K SE +E         E ++LA   
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEAD 59

Query: 163 HRHLVALRGFCIEKRERFLMYEYMANGSL------KDHLHSPGRTPLSWQTRIQI----- 211
           +  +V L     ++   +L+ EY+  G +      KD            +TR  I     
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-------ETRFYIAETIL 112

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL---------------- 255
           AID  + L Y+H         RDIK  N+LLD     KL+DFGL                
Sbjct: 113 AIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163

Query: 256 AHASKDGSICFEPVNTDIR------------------GTPGYMDPEYVVTQELTEKSDVY 297
           +HA     + F       +                  GTP Y+ PE  +     ++ D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 298 SYGVVLLEIV 307
           S GV++ E++
Sbjct: 224 SLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 72/235 (30%), Positives = 106/235 (45%), Gaps = 20/235 (8%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+G FG V    + + G   A+K + K   I++        E  +L    H  L AL+
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 171 -GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             F    R  F+M EY   G L  HL S  R     + R   A ++ +ALEYLH      
Sbjct: 62  YAFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYLH---SRD 115

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + +RDIK  N++LD++   K+ DFGL    K+G I          GTP Y+ PE +   +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLC---KEG-ISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + M  E R    + P  K
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--LILM-EEIRFPRTLSPEAK 223

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 21/159 (13%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR-HLVALR 170
            IG+G +G VYKA+  + G L+A+K  R++   E +     REI LL  L    ++V L 
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66

Query: 171 GFCIEKRER-------FLMYEYMANGSLKDHLHSPGR---TPLSWQTRIQIAIDVANALE 220
              +E  E        +L++EY+ +  LK  + S GR    PL  +T       +   + 
Sbjct: 67  -LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 221 YLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHA 258
           + H +    + HRD+K  N+L+D +  + K+AD GL  A
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 49/195 (25%), Positives = 96/195 (49%), Gaps = 12/195 (6%)

Query: 116 IGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRG 171
           +G G FG V K  +        +A+K +   +E+ V  +  RE E++ +L + ++V + G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
            C  + E  ++   MA+G   +   S  +  ++    +++   V+  ++YL         
Sbjct: 63  VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRD+ + N+LL     AK++DFGL+ A   D S  +    +  +    +  PE +  ++ 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKARSAGKWPLKWYAPECINFRKF 175

Query: 291 TEKSDVYSYGVVLLE 305
           + +SDV+SYG+ + E
Sbjct: 176 SSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 17/214 (7%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+G FG V    + + G   A+K + K   I++        E  +L    H  L +L+
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 171 -GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             F  + R  F+M EY+  G L  HL S  R     +TR   A ++ +AL+YLH      
Sbjct: 62  YSFQTKDRLCFVM-EYVNGGELFFHL-SRERVFSEDRTRFYGA-EIVSALDYLH---SGK 115

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + +RD+K  N++LD++   K+ DFGL    K+G      + T   GTP Y+ PE +   +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLC---KEGITDAATMKT-FCGTPEYLAPEVLEDND 171

Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVE 321
                D +  GVV+ E++  R     QD + L E
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 48/228 (21%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDF-----CREIELLARLHHRHLVAL 169
           IG+G +G V  A+ S+    +A+K   KI+   +         REI+LL  L H +++A+
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIK---KIANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69

Query: 170 RGFCI-EKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           +       RE F    ++YE M +  L   + S     LS          +   L+Y+H 
Sbjct: 70  KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH- 125

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                + HRD+K SN+LL+ N   K+ DFGLA  + +                 +M  EY
Sbjct: 126 --SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--------------KGDFM-TEY 168

Query: 285 VVTQ------------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
           VVT+            E T   DV+S G +  E++  R+ +  GK+ V
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG-RKPLFPGKDYV 215

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 63/254 (24%), Positives = 106/254 (41%), Gaps = 36/254 (14%)

Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHL 166
           +  +++G+G FG V    + + G + A+K M K   ++++    F  E ++L+  +   +
Sbjct: 4   DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI 63

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAID-------VANAL 219
             L+    +K   +L+ EY   G L           LS   R +   D       +A  +
Sbjct: 64  PQLQYAFQDKDNLYLVMEYQPGGDL-----------LSLLNRYEDQFDEDMAQFYLAELV 112

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSI-CFEPVNTDIRGTP 277
             +H        HRDIK  N+L+D     KLADFG A   + +  +    PV     GTP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-----GTP 167

Query: 278 GYMDPEYVVTQELTEKS------DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            Y+ PE + T     K       D +S GV+  E++  R    +G    ++    M  + 
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQR 226

Query: 332 RLAELVDPRIKDSF 345
            L    DP++   F
Sbjct: 227 FLKFPEDPKVSSDF 240

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 24/215 (11%)

Query: 107 KATD-NFSTIIGQGGFGTV----YKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL 161
           KA D +   +IG+G FG V    +K+     ++  + + + I       F  E +++A  
Sbjct: 41  KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100

Query: 162 HHRHLVALRGFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
           +   +V L  FC  + +++L  + EYM  G L + L S    P  W  +   A +V  AL
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKW-AKFYTA-EVVLAL 155

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-GTPG 278
           + +H      L HRD+K  N+LLD++   KLADFG      +  +    V  D   GTP 
Sbjct: 156 DAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM----VRCDTAVGTPD 208

Query: 279 YMDPEYVVTQ----ELTEKSDVYSYGVVLLEIVTA 309
           Y+ PE + +Q        + D +S GV L E++  
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 18/200 (9%)

Query: 115 IIGQGGFGTVYKAQFSDGSLI-AVKRMDKIS----EQVEGDFC-REIELLARLHHRHLVA 168
           ++G+G FG V  A+      + A+K + K      + V+     + I  LA   H  L A
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60

Query: 169 LRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
           L   C + ++R F + EY+  G L   +    +     ++R   A +V  AL +LH +  
Sbjct: 61  LHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP-RSRF-YAAEVTLALMFLHRH-- 115

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
             + +RD+K  NILLD     KLADFG+    K+G I      T   GTP Y+ PE +  
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMC---KEG-ILNGVTTTTFCGTPDYIAPEILQE 170

Query: 288 QELTEKSDVYSYGVVLLEIV 307
            E     D ++ GV++ E++
Sbjct: 171 LEYGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 112 FSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCR-EIELLARLHHRHLVAL 169
            +T++G+      + A + SD     V +   ++++ +  + R E+  LA   H  +V  
Sbjct: 71  LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKH 130

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR------IQIAIDVANALEYLH 223
                   +  L+ EY + G L   +    +  L +Q         QI +    AL+ +H
Sbjct: 131 FDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL----ALDEVH 186

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRD+KS+NI L    + KL DFG +    D S+  + V +   GTP Y+ PE
Sbjct: 187 SRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD-SVSLD-VASSFCGTPYYLAPE 241

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARR 311
               +  ++K+D++S GV+L E++T  R
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 59/229 (25%), Positives = 93/229 (40%), Gaps = 45/229 (19%)

Query: 115 IIGQGGFGTVYKAQ----FSDGSLIAVKRMDKI-------------SEQVEGDFCREIEL 157
           ++G G +G V+  +       G L A+K + K              +E+   +  R    
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 158 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
           L  LH+        F  + +   ++ +Y+  G L  HL+       S + R+ IA ++  
Sbjct: 67  LVTLHY-------AFQTDTKLHLIL-DYVNGGELFTHLYQREHFTES-EVRVYIA-EIVL 116

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----I 273
           AL++LH      + +RDIK  NILLD      L DFGL   SK+    F     +     
Sbjct: 117 ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGL---SKE----FLAEEEERAYSF 166

Query: 274 RGTPGYMDPEYVVTQELTEKS--DVYSYGVVLLEIVTARR--AVQDGKN 318
            GT  YM PE +           D +S GV+  E++T      V   +N
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 31/230 (13%)

Query: 111 NFSTIIGQGGFGTVYKAQFSDG-SLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVA 168
           NF  ++G+G FG V  A+      L A+K + K +  Q +   C  +E       + ++A
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVE-------KRVLA 55

Query: 169 LRG---------FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
           L G          C +  +R + + EY+  G L   +   GR        +  A ++A  
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIG 113

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-GTP 277
           L +LH      + +RD+K  N++LD     K+ADFG+   +      ++ V T    GTP
Sbjct: 114 LFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-----MWDGVTTKTFCGTP 165

Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 327
            Y+ PE +  Q   +  D +++GV+L E++ A +A  +G++  E  Q  M
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 21/236 (8%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 170
           ++G+G FG V    + + G   A+K + K   +++        E  +L    H  L AL+
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 171 -GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             F    R  F+M EY   G L  HL S  R     + R   A ++ +AL+YLH   +  
Sbjct: 62  YSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALDYLH--SEKN 116

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHAS-KDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           + +RD+K  N++LD++   K+ DFGL     KDG+           GTP Y+ PE +   
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-----KTFCGTPEYLAPEVLEDN 171

Query: 289 ELTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
           +     D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEIRFPRTLSPEAK 224

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 54/180 (30%), Positives = 82/180 (45%), Gaps = 17/180 (9%)

Query: 200 RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-A 258
           +  L+ +  I  +  VA  +E+L         HRD+ + NILL EN V K+ DFGLA   
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229

Query: 259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            KD     +    D R    +M PE +  +  T +SDV+S+GV+L EI +   +   G  
Sbjct: 230 YKDPDYVRK---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286

Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           + E  + C     RL E    R  D    E  +T++     C   E   RP+  +++  L
Sbjct: 287 IDE--EFC----RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 18/217 (8%)

Query: 116 IGQGGFGTVYKAQF---SDGSLIAVKRMDKI-SEQVEGDFC-REIELLARLH-HRHLVAL 169
           +GQG +G V  A+    S+   +A+K++  + S+++      RE++LL     H+++  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 170 RGFCIEKRERF---LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFY 225
               I     F    +YE +    L   + S    PL+     Q  I  +   L+Y+H  
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIRS--GQPLT-DAHFQSFIYQILCGLKYIH-- 122

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K  N+L++ +   K+ DFGLA    +         T+   T  Y  PE +
Sbjct: 123 -SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181

Query: 286 VT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           ++ Q  T+  DV+S G +L E++  R+ V  GK+ V+
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVD 217

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 68/261 (26%), Positives = 111/261 (42%), Gaps = 51/261 (19%)

Query: 135 IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDH 194
           + +K +D     +   F     L++++ H HL  + G C+   E  ++ E++ +G L   
Sbjct: 47  VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106

Query: 195 LH-SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF 253
           L    GR P++W  +I +A  +A+AL YL    D  L H ++ + NIL        LA  
Sbjct: 107 LRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNIL--------LARL 153

Query: 254 GLAHASK------DGSICFEPVNTDIR--GTPGYMDPEYVVT-QELTEKSDVYSYGVVLL 304
           GLA  +       D  + F  ++ + R    P ++ PE V     L+  +D +S+G  LL
Sbjct: 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLL 212

Query: 305 EIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR-------TIVTIV 357
           EI                   C   E  L E   P  K+ F  ++ R        + T++
Sbjct: 213 EI-------------------CFDGEVPLKERT-PSEKERFYEKKHRLPEPSCKELATLI 252

Query: 358 RWCTQREGQARPSIKQVLRIL 378
             C   E   RPS + +LR L
Sbjct: 253 SQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 14/196 (7%)

Query: 116 IGQGGFGTVYKAQFS---DGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALR 170
           +G G FGTV K  +        +AVK  + D     ++ +  RE  ++ +L + ++V + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G C E     L+ E    G L   L       ++ +   ++   V+  ++YL    +   
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLE---ETNF 116

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD+ + N+LL     AK++DFGL+ A   D +  +    T  +    +  PE +   +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADEN--YYKAKTHGKWPVKWYAPECMNYYK 174

Query: 290 LTEKSDVYSYGVVLLE 305
            + KSDV+S+GV++ E
Sbjct: 175 FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 116 IGQGGFGTVYKAQ--FSDGSLIAVKRMDKISEQVEG---DFCREIELLARLH---HRHLV 167
           IG+G +G V+KA+   + G  +A+KR+ ++    EG      RE+ +L  L    H ++V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 168 ALRGFCIEKR-----ERFLMYEYMANG--SLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
            L   C   R     +  L++E++     +  D +  PG      +T   +   +   L+
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLD 124

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 280
           +LH +    + HRD+K  NIL+  +   KLADFGLA         F+   T +  T  Y 
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWYR 176

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
            PE ++        D++S G +  E+   +
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 25/208 (12%)

Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG-F 172
           +G+G +G+VYK      G  +A+K +  ++ E        E+++L +    ++V   G F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 173 CIEKRERFLMYEYMANGSLKDHLH----SPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
            IE      M EYM  GSL D L+    +    P     RI  A  V   L++L    + 
Sbjct: 69  FIEGAVYMCM-EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKE--EH 122

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV--- 285
            + HRD+K +N+L++ N   KL DFG++     G++      T+I G   YM PE +   
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNI-GCQSYMAPERIKSG 176

Query: 286 -VTQELTE--KSDVYSYGVVLLEIVTAR 310
              Q  T   +SDV+S G+ +LE+   R
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 35/159 (22%)

Query: 116 IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFC---REIELLARLHHRHLVAL 169
           +G+G + TVYK +    G L+A+K  R+    E  EG      RE  LL  L H ++V L
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRL----EHEEGAPFTAIREASLLKDLKHANIVTL 68

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA----------L 219
                 K+   L++EY+ +  LK ++   G             + + N           L
Sbjct: 69  HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGG-----------GLSMHNVRLFLFQLLRGL 116

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
            Y H      + HRD+K  N+L+ E    KLADFGLA A
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARA 152

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.0 bits (136), Expect = 1e-08
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 37/214 (17%)

Query: 116 IGQGGFGTVYKAQFSD---GSLIAVKRM-DKISEQVEGD--FCREIELLARL-HHRHLVA 168
           +G+G +G V+KA   D     ++A+K++ D      +    F REI  L  L  H ++V 
Sbjct: 15  LGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVK 71

Query: 169 LRGF--CIEKRERFLMYEYMAN--------GSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
           L         ++ +L++EYM            L+D +H           +  I   +  A
Sbjct: 72  LLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-VH-----------KRYIMYQLLKA 119

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-PVNTDIRGTP 277
           L+Y+H      + HRD+K SNILL+ +   KLADFGLA +  +     E PV TD   T 
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 278 GYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTAR 310
            Y  PE ++ +   T+  D++S G +L E++  +
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 20/151 (13%)

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+ + NILL    + K+ DFGLA   ++ S     V  + R    +M PE +     T
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSNYV--VKGNARLPVKWMAPESIFNCVYT 294

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 351
            +SDV+SYG++L EI +          L  S    M  +S+  ++    IK+ + M    
Sbjct: 295 FESDVWSYGILLWEIFS----------LGSSPYPGMPVDSKFYKM----IKEGYRMLSPE 340

Query: 352 ----TIVTIVRWCTQREGQARPSIKQVLRIL 378
                +  I++ C   +   RP+ KQ+++++
Sbjct: 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 15/152 (9%)

Query: 162 HHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
           +H  LV L   C +   R F + EY+  G L  H+    + P     R   A +++ AL 
Sbjct: 54  NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYSA-EISLALN 110

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--GTPG 278
           YLH   +  + +RD+K  N+LLD     KL D+G+    K+G     P +T     GTP 
Sbjct: 111 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEG---LRPGDTTSTFCGTPN 161

Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           Y+ PE +  ++     D ++ GV++ E++  R
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 46/148 (31%), Positives = 73/148 (49%), Gaps = 15/148 (10%)

Query: 166 LVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           LV L   C +   R FL+ EY+  G L  H+    + P     R   A ++  AL +LH 
Sbjct: 58  LVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP-EEHARF-YAAEICIALNFLH- 113

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--GTPGYMDP 282
             +  + +RD+K  N+LLD +   KL D+G+    K+G     P +T     GTP Y+ P
Sbjct: 114 --ERGIIYRDLKLDNVLLDADGHIKLTDYGMC---KEG---LGPGDTTSTFCGTPNYIAP 165

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           E +  +E     D ++ GV++ E++  R
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 53/218 (24%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL---- 169
           IIG+GGFG VY  + +D G + A+K +DK   ++     ++ E LA L+ R +++L    
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM-----KQGETLA-LNERIMLSLVSTG 54

Query: 170 ---------RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
                      F    +  F++ + M  G L  HL   G    S +     A ++   LE
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFIL-DLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLE 111

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTD 272
           ++H   +  + +RD+K +NILLDE+   +++D GLA        HAS             
Sbjct: 112 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------------ 156

Query: 273 IRGTPGYMDPEYVVTQELT---EKSDVYSYGVVLLEIV 307
             GT GYM PE  V Q+ T     +D +S G +L +++
Sbjct: 157 --GTHGYMAPE--VLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 34/211 (16%)

Query: 116 IGQGGFGTVYKA---QFSDGSLIA-------VKRMDKISEQVEGDFCREIELLARLHHRH 165
           +GQG F  +YK      SD  ++        V ++     +    F     L+++L H+H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHF 224
           LV L G C+ + E  ++ EY+  G L   LH       L W  ++ +A  +A+AL YL  
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE- 118

Query: 225 YCDPPLCHRDIKSSNILL-----DENFV--AKLADFGLAHASKDGSICFEPVNTDIRGTP 277
             D  L H ++   NIL+     +E +V   KL+D G+           E +       P
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-------P 169

Query: 278 GYMDPEYV--VTQELTEKSDVYSYGVVLLEI 306
            ++ PE +      LT  +D +S+G  LLEI
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 38/213 (17%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG+G +G V+K     +GS  AVK +D    I E++E ++     L A   H ++V   G
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI---LKALSDHPNVVKFYG 82

Query: 172 FCIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ---IAIDVANALEYLH 223
              +K  +     +L+ E    GS+ D +    +  L    R++   IA  +  AL  L 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLV----KGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-----GTPG 278
                   HRD+K +NILL      KL DFG++          +  +T +R     GTP 
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA---------QLTSTRLRRNTSVGTPF 189

Query: 279 YMDPEYVVTQE-----LTEKSDVYSYGVVLLEI 306
           +M PE +  ++        + DV+S G+  +E+
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 24/185 (12%)

Query: 149 GDFCREIELLARLHHRHLVAL-------RGFCIEKRE-RFLMYEYMANGSLKDHLHSPGR 200
               REI++L  + HR ++ L          C+   + +  ++ Y+              
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-----------DRS 179

Query: 201 TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 260
            PL  +  I I   +  AL YLH      + HRD+K+ NI LDE   A L DFG   A K
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGA--ACK 234

Query: 261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
             +    P      GT     PE +       K+D++S G+VL E+      +   +   
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294

Query: 321 ESAQV 325
            S+Q+
Sbjct: 295 SSSQL 299

Length = 392

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 14/208 (6%)

Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFC--REIELLARLHHRHLVALRGF 172
           +G+G + TVYK +   +G L+A+K + ++ E+    F   RE  LL  L H ++V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K    L++EY+     +     PG   L  +        +   L Y+H      + H
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIH---QRYILH 126

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELT 291
           RD+K  N+L+ +    KLADFGLA A    S  +    ++   T  Y  P+ ++ + E +
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTY----SNEVVTLWYRPPDVLLGSTEYS 182

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNL 319
              D++  G + +E++    A    K++
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDI 210

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 29/210 (13%)

Query: 116 IGQGGFGTVYKAQFSDG---SLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG G FG V   + + G   + + VK +    S Q +  F  E +    L H +L+   G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRT------PLSWQTRIQIAIDVANALEYLHFY 225
            C E     L+ E+   G LK +L S  +       P + Q   ++A ++A  L +LH  
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ---RMACEIALGLLHLH-- 117

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS--KDGSICFEPVNTDIRGTPGYMDPE 283
                 H D+   N LL  +   K+ D+GL+H    +D  +  + +   +R    ++ PE
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPE 172

Query: 284 YV-------VTQELTEKSDVYSYGVVLLEI 306
            V       +  + T++S+V+S GV + E+
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 12/209 (5%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           +G+G + TVYK     +G L+A+K +  K  E V     RE  LL  L H ++V L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
             K     ++EYM     +  +  PG     +  R+     +   L Y+H      + HR
Sbjct: 73  HTKETLTFVFEYMHTDLAQYMIQHPGGLH-PYNVRL-FMFQLLRGLAYIH---GQHILHR 127

Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELTE 292
           D+K  N+L+      KLADFGLA A    SI  +  ++++  T  Y  P+ ++   + + 
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAK---SIPSQTYSSEVV-TLWYRPPDVLLGATDYSS 183

Query: 293 KSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
             D++  G + +E++  + A     ++ E
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.8 bits (126), Expect = 1e-07
 Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 30/214 (14%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEG-----DFCREIELLARLHHRHLVALR 170
           +G+G +G VYKA+  DG        D   +Q+EG       CREI LL  L H ++++L+
Sbjct: 9   VGRGTYGHVYKAKRKDGK----DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64

Query: 171 GFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY-----LH 223
              +   +R  +L+++Y  +     H+    R   + +  +Q+   +  +L Y     +H
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 224 FYCDPPLCHRDIKSSNILL----DENFVAKLADFGLA---HASKDGSICFEPVNTDIRGT 276
           +     + HRD+K +NIL+     E    K+AD G A   ++        +PV      T
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----T 178

Query: 277 PGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTA 309
             Y  PE ++  +  T+  D+++ G +  E++T+
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 50/175 (28%), Positives = 77/175 (44%), Gaps = 21/175 (12%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK-------ISEQVEGDFCREIELLARLHHRHLV 167
           I +G FG VY  +  ++  L AVK + K       +  QV+     E + LA      +V
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQA----ERDALALSKSPFIV 67

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
            L          +L+ EY+  G +K  LH  G      +  ++   +VA AL+YLH +  
Sbjct: 68  HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRH-- 123

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
             + HRD+K  N+L+      KL DFGL+  + +  +       DI  TP    P
Sbjct: 124 -GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM----MDILTTPSMAKP 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 26/212 (12%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEG-----DFCREIELLARLHHRHLVALR 170
           +G+G +G VYKA+  DG        +   +Q+EG       CREI LL  L H +++AL+
Sbjct: 9   VGRGTYGHVYKAKRKDGK----DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64

Query: 171 GFCIEKRER--FLMYEYMANG---SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
              +   +R  +L+++Y  +     +K H  S          R  +   +   L+ +H+ 
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 226 CDPPLCHRDIKSSNILL----DENFVAKLADFGLA---HASKDGSICFEPVNTDIRGTPG 278
               + HRD+K +NIL+     E    K+AD G A   ++        +PV      T  
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV----TFW 180

Query: 279 YMDPEYVV-TQELTEKSDVYSYGVVLLEIVTA 309
           Y  PE ++  +  T+  D+++ G +  E++T+
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 44/201 (21%), Positives = 87/201 (43%), Gaps = 16/201 (7%)

Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVAL 169
           I+G G FG + +      S     +A+  +    S++    F  E   L +  H ++V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            G         ++ EYM+NG+L   L       L     + +   +A+ ++YL    +  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYL---SEMG 127

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG--YMDPEYVVT 287
             H+ + +  +L++ + V K++ F      K      E + T + G     +  PE +  
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK-----SEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 288 QELTEKSDVYSYGVVLLEIVT 308
              +  SDV+S+G+V+ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 51/151 (33%), Positives = 67/151 (44%), Gaps = 19/151 (12%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCR---EIELLARLHHRHLVALRG 171
           +G+G  G V+  +    G L A+K +DK          R   E E+LA L H  L  L  
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 172 -FCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLH----FY 225
            F  E     +M +Y   G L   L   PG+  LS +     A +V  ALEYLH     Y
Sbjct: 69  SFQTETYLCLVM-DYCPGGELFRLLQRQPGKC-LSEEVARFYAAEVLLALEYLHLLGIVY 126

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
                  RD+K  NILL E+    L+DF L+
Sbjct: 127 -------RDLKPENILLHESGHIMLSDFDLS 150

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 29/234 (12%)

Query: 115 IIGQGGFGTVYKAQFSDG-SLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 170
           +IG+G FG V   +  +   + A+K ++K   +       F  E ++L    ++ +  L 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHS-----PGRTPLSWQTRIQIAIDVANALEYLHFY 225
               ++   +L+ +Y   G L   L       P      +   + IAID  + L Y+H  
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH-- 125

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFG-LAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  RDIK  NIL+D N   +LADFG      +DG++     ++   GTP Y+ PE 
Sbjct: 126 -------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----QSSVAVGTPDYISPEI 174

Query: 285 VVTQE-----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +   E        + D +S GV + E++         ++LVE+    M  + R 
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERF 227

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 27/207 (13%)

Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVKRMDK---ISEQVEGDFCR-EIELLARLHHRHL 166
           ++G+GG+G V++ +   G+    + A+K + K   +  Q +    + E  +L  + H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPG----RTPLSWQTRIQIAIDVANALEYL 222
           V L        + +L+ EY++ G L  HL   G     T   + + I +A      LE+L
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEHL 116

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS-KDGSICFEPVNTDIRGTPGYMD 281
           H      + +RD+K  NILLD     KL DFGL   S  +G+     V     GT  YM 
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-----VTHTFCGTIEYMA 168

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE ++     +  D +S G ++ +++T
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLT 195

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 59/241 (24%), Positives = 91/241 (37%), Gaps = 54/241 (22%)

Query: 116 IGQGGFGTVYKAQFSDGS-LIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG G FG V   +  D + L A+K + K   +          E ++LA   +  +V L  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
              +K   + + +Y+  G +   L   G        R  IA ++  A+E +H        
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-ARFYIA-ELTCAIESVH---KMGFI 123

Query: 232 HRDIKSSNILLDENFVAKLADFGLA----------------HASKDGSICFEPVNT---- 271
           HRDIK  NIL+D +   KL DFGL                 H  +D     EP       
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS---MEPSEEWSEI 180

Query: 272 ----------------------DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
                                  + GTP Y+ PE ++    T+  D +S GV+L E++  
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240

Query: 310 R 310
           +
Sbjct: 241 Q 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 20/164 (12%)

Query: 151 FCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 210
           F     ++ ++ H+H+V L G C+   E  ++ E++  G L   +H      L+   + +
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFK 109

Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-------AKLADFGLAHASKDGS 263
           +A  +A+AL YL    D  L H ++ + NILL    +        KL+D G+        
Sbjct: 110 VAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ 166

Query: 264 ICFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEI 306
            C E +         ++ PE V  ++ L+  +D +S+G  L EI
Sbjct: 167 ECVERIP--------WIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 31/189 (16%)

Query: 110 DNFST--IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGD---FCREIELLARLHH 163
           D+F    +IG+G FG V   +  + G + A+K ++K       +   F  E ++L     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSL-------KDHLHSPGRTPLSWQTRIQIAIDVA 216
           R +  L     ++   +L+ +Y   G L       +D L  P      +   + +AID  
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL--PEDMARFYLAEMVLAIDSV 118

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG-LAHASKDGSICFEPVNTDIR- 274
           + L Y+H         RDIK  N+LLD+N   +LADFG       DG+     V +++  
Sbjct: 119 HQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-----VQSNVAV 164

Query: 275 GTPGYMDPE 283
           GTP Y+ PE
Sbjct: 165 GTPDYISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 40/227 (17%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEG--DFCREIELLARLHHRHLVALRG 171
           +IG+G +G V  A     G  +A+K+++ + E V       REI+LL  L H  +V ++ 
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 172 FCI-----EKRERFLMYEYM---------ANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
             +     E ++ ++++E M         AN  L         TP   Q  +     +  
Sbjct: 67  IMLPPSRREFKDIYVVFELMESDLHQVIKANDDL---------TPEHHQFFL---YQLLR 114

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS--KDGSICFEPVNTDIRG 275
           AL+Y+H      + HRD+K  NIL + +   K+ DFGLA  +     +  F    TD   
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW---TDYVA 168

Query: 276 TPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
           T  Y  PE   +   + T   D++S G +  E++T  + +  GKN+V
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 214

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 21/134 (15%)

Query: 183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 242
           Y+   +  +K+ L   G   L+    +     VA  +E+L         HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270

Query: 243 DENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            +  + K+ DFGLA        + SK  +  F PV         +M PE +     T  S
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGST--FLPVK--------WMAPESIFDNLYTTLS 320

Query: 295 DVYSYGVVLLEIVT 308
           DV+SYG++L EI +
Sbjct: 321 DVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 48.9 bits (117), Expect = 7e-07
 Identities = 48/187 (25%), Positives = 71/187 (37%), Gaps = 24/187 (12%)

Query: 189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA 248
            SL D L   GR PL+ +   +I       L  L         HR  KS NILL  + + 
Sbjct: 1   VSLADILEVRGR-PLNEE---EIWAVCLQCLGALRE------LHRQAKSGNILLTWDGLL 50

Query: 249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           KL          DGS+ F+      R  P +M PE +  Q  TEK+D+YS G+ L E + 
Sbjct: 51  KL----------DGSVAFKTPEQS-RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL- 98

Query: 309 ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR 368
                 +     E + +     + +         +   +   R+    +R C  R  Q R
Sbjct: 99  DYELPYN--EERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRR 156

Query: 369 PSIKQVL 375
            +    L
Sbjct: 157 EAANHYL 163

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.8 bits (121), Expect = 8e-07
 Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 21/114 (18%)

Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA------ 256
           LS+   +  +  VAN +E+L         HRD+ + N+L+ E  + K+ DFGLA      
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 257 --HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             + SK  +  F P+         +M PE +     T  SDV+S+G++L EI T
Sbjct: 293 SNYISKGST--FLPLK--------WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 15/151 (9%)

Query: 163 HRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           H  LV L   C +   R F + E+++ G L  H+    + P     R   A +++ AL +
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLP-EEHARFYSA-EISLALNF 111

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--GTPGY 279
           LH   +  + +RD+K  N+LLD     KL D+G+    K+G     P +T     GTP Y
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC---KEG---IRPGDTTSTFCGTPNY 162

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           + PE +  ++     D ++ GV++ E++  R
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 21/159 (13%)

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLH 223
           ++V L  + + +   FL+ ++   G L  H+      P   +  ++  A ++  AL+ LH
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP---EECVKRWAAEMVVALDALH 102

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
              +  +C RD+  +NILLD+    +L  F      +D S   E V         Y  PE
Sbjct: 103 R--EGIVC-RDLNPNNILLDDRGHIQLTYFSRWSEVED-SCDGEAVEN------MYCAPE 152

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 322
                E TE  D +S G +L E++T       GK LVE 
Sbjct: 153 VGGISEETEACDWWSLGAILFELLT-------GKTLVEC 184

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 54/241 (22%)

Query: 110 DNFST--IIGQGGFGTVYKAQFSD-GSLIAVK---RMDKISEQVEGDFCREIELLARLHH 163
           D+F +  +IG+G FG V   Q  D G + A+K   + D + ++       E ++L     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSL------KDHLHSPGRTPLSWQTRIQIAIDVAN 217
             +V +     +KR  +L+ E++  G +      KD L S   T   +     +AID  +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTL-SEEATQF-YIAETVLAIDAIH 118

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL------AHASK---------DG 262
            L ++H         RDIK  N+LLD     KL+DFGL      AH ++           
Sbjct: 119 QLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169

Query: 263 SICFEPVNTDIR----------------GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
              F+ +N+  +                GTP Y+ PE  +     +  D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 307 V 307
           +
Sbjct: 230 L 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 40/228 (17%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVK---RMDKISEQVEGDFCREIELLARLHHRHLVALR 170
           +IG+G FG V   Q  D G + A+K   + D + ++  G    E ++L       +V + 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
               +K   +L+ E++  G +   L     T    +T+  IA  V  A++ +H       
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVL-AIDSIH---QLGF 122

Query: 231 CHRDIKSSNILLDENFVAKLADFGL------AHASK---------DGSICFEPVNTDIR- 274
            HRDIK  N+LLD     KL+DFGL      AH ++              F+ +N+  + 
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 275 ---------------GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                          GTP Y+ PE  +     +  D +S GV++ E++
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 35/243 (14%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLI-AVKRMDK---ISEQVEGDFCREIELLARLHH 163
           D+F  I  IG+G FG V   +      I A+K ++K   +       F  E  +L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSL-------KDHLHSPGRTPLSWQTRIQIAIDVA 216
           + +  L     ++   +L+ +Y   G L       +D L  P      +   + +AI   
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRL--PEDMARFYIAEMVLAIHSI 118

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG-LAHASKDGSICFEPVNTDIRG 275
           + L Y+H         RDIK  N+LLD N   +LADFG     ++DG++     ++   G
Sbjct: 119 HQLHYVH---------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV----QSSVAVG 165

Query: 276 TPGYMDPEYVVTQE-----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 330
           TP Y+ PE +   E        + D +S GV + E++         ++LVE+    M  E
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHE 224

Query: 331 SRL 333
            R 
Sbjct: 225 ERF 227

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 24/205 (11%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVE---GDFCREIELLARLHHRHLV-ALR 170
           +G G +G V  A  +  G  +A+K++ +  +        + RE+ LL  + H +++  L 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81

Query: 171 GFC-IEKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQTRIQIAI-DVANALEYLHFYCD 227
            F      E F    Y+    +   L++  +   LS    IQ  +  +   L+Y+H    
Sbjct: 82  VFTPASSLEDFQDV-YLVTHLMGADLNNIVKCQKLS-DDHIQFLVYQILRGLKYIH---S 136

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
             + HRD+K SNI ++E+   K+ DFGLA H   +         T    T  Y  PE ++
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--------MTGYVATRWYRAPEIML 188

Query: 287 T-QELTEKSDVYSYGVVLLEIVTAR 310
                 +  D++S G ++ E++T +
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)

Query: 115 IIGQGGFGTVY---KAQFSD-GSLIAVKRMDK---ISEQVEGDFCR-EIELLARLHHRHL 166
           ++G G +G V+   K    D G L A+K + K   + +    +  R E ++L  +     
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 167 VALRGFCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHF 224
           +    +  +   +  L+ +Y+  G L  HL    R     +  +QI   ++  ALE+LH 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLH- 122

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                + +RDIK  NILLD N    L DFGL   SK+             GT  YM P+ 
Sbjct: 123 --KLGIIYRDIKLENILLDSNGHVVLTDFGL---SKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 285 VVTQELTEKS--DVYSYGVVLLEIVTA 309
           V   +       D +S GV++ E++T 
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 50/218 (22%)

Query: 115 IIGQGGFGTVYKAQFSDGS-LIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGF- 172
           IIG G FG VY+A   D S  +A+K++ +  +       RE+ ++  L+H +++ L+ + 
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN----RELLIMKNLNHINIIFLKDYY 128

Query: 173 ---CIEKRER--FL----------MYEYMANGSLKDHLHSPGRTPL------SWQTRIQI 211
              C +K E+  FL          +++YM + +  +H       PL      S+Q     
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH-----ALPLFLVKLYSYQ----- 178

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVN 270
              +  AL Y+H      +CHRD+K  N+L+D N    KL DFG A     G      + 
Sbjct: 179 ---LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232

Query: 271 TDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           +       Y  PE ++     T   D++S G ++ E++
Sbjct: 233 SRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 64/243 (26%), Positives = 99/243 (40%), Gaps = 54/243 (22%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFCREIELLARLHHRHLVALR 170
           +G G FG V  A+  D  +L A+K + K    +  QV      E ++LA   +  +V L 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQV-AHVKAERDILAEADNEWVVRLY 67

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
               +K   + + +Y+  G +   L   G  P     R  IA ++  A+E +H       
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL-ARFYIA-ELTCAVESVH---KMGF 122

Query: 231 CHRDIKSSNILLDENFVAKLADFGL------AHASK--------------------DGSI 264
            HRDIK  NIL+D +   KL DFGL       H SK                    D + 
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 265 C-----FEPVNT------------DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
           C      +P+               + GTP Y+ PE ++    T+  D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 308 TAR 310
             +
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.2 bits (113), Expect = 8e-06
 Identities = 38/155 (24%), Positives = 59/155 (38%), Gaps = 28/155 (18%)

Query: 162 HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
            + + + L       +   L+ +Y+ +G L D L   G+  LS     +I   +  AL  
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALND 124

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFV-AKLADFGLAHASKDGSICFEPVNTDIRGTPG-- 278
           LH +    + H DIK  N+L D       L D+GL                 I GTP   
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------------IIGTPSCY 166

Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                Y  PE +         D ++ GV+  E++T
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201

Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 48.2 bits (114), Expect = 8e-06
 Identities = 53/244 (21%), Positives = 98/244 (40%), Gaps = 51/244 (20%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDK-----------ISEQVEGDFCREIELLARLHHR 164
           IG G FG V+        L+  KR  +           + E+ +     E+ ++  L H+
Sbjct: 21  IGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 165 HLVAL--RGFCIEKRERFLMYEYMANGSLKDHLHSPGRT--PLSWQTRIQIAIDVANALE 220
           ++V    R      ++ +++ E+   G L  ++    +    +     + I   + +AL 
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 221 YLHFYCDPP----LCHRDIKSSNILLDENF-----------------VAKLADFGLAHAS 259
           Y H   D P    + HRD+K  NI L                     +AK+ DFGL+   
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-- 190

Query: 260 KDGSICFEPVNTDIRGTPGYMDPEYVV--TQELTEKSDVYSYGVVLLEIVTARRAVQDGK 317
              +I  E +     GTP Y  PE ++  T+   +KSD+++ G ++ E+ + +       
Sbjct: 191 ---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247

Query: 318 NLVE 321
           N  +
Sbjct: 248 NFSQ 251

Length = 1021

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 36/211 (17%)

Query: 116 IGQGGFGTV-YKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGF 172
           +G G +GTV        G+ +A+K++ +   SE       RE+ LL  + H +++ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 173 CI--EKRERF----LMYEYMAN--GSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLH 223
                  +RF    L+  +M    G L  H        LS + RIQ  +  +   L+Y+H
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKH------EKLS-EDRIQFLVYQMLKGLKYIH 135

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG---TPGYM 280
                 + HRD+K  N+ ++E+   K+ DFGLA  +          ++++ G   T  Y 
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQT----------DSEMTGYVVTRWYR 182

Query: 281 DPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            PE ++     T+  D++S G ++ E++T +
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 25/160 (15%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGD----FCREIELLARLH 162
           ++F T+  IG+G FG V   Q  D G + A+K + K SE  + D       E ++LA   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLK-SEMFKKDQLAHVKAERDVLAESD 59

Query: 163 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQ------TRIQIAIDVA 216
              +V+L     + +  +L+ E++  G L   L       + +       TR  +A +  
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA-ECV 111

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
            A+E +H        HRDIK  NIL+D     KL+DFGL+
Sbjct: 112 LAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 48/203 (23%), Positives = 90/203 (44%), Gaps = 16/203 (7%)

Query: 114 TIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQV--EGDFCREIELLARLHHRHLVALR 170
           + +G G +G+V  A     G  +AVK++ +  + +       RE+ LL  + H +++ L 
Sbjct: 23  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 171 G-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYCDP 228
             F   +        Y+    +   L++  +        +Q  I  +   L+Y+H     
Sbjct: 83  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 139

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT- 287
            + HRD+K SN+ ++E+   K+ DFGLA  + D         T    T  Y  PE ++  
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNW 192

Query: 288 QELTEKSDVYSYGVVLLEIVTAR 310
               +  D++S G ++ E++T R
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 32/153 (20%), Positives = 52/153 (33%), Gaps = 28/153 (18%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLV-ALR 170
           ++  G    VY     D   +      KI+   E    RE E+            V  + 
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYVL-----KINPSREKGADREREVAILQLLARKGLPVPKVL 59

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRT--PLSWQTRIQIAIDVANALEYLH---FY 225
                    +L+ E++            G T   +S + +  IA  +A  L  LH     
Sbjct: 60  ASGESDGWSYLLMEWI-----------EGETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
               LCH D+   NIL+D+  +  + D+  A  
Sbjct: 109 V---LCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 8/107 (7%)

Query: 201 TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK 260
            PL     + I   +   L YLH      + HRD+K+ NI +++     + D G A    
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP- 207

Query: 261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                  P    + GT     PE +   +   K+D++S G+VL E++
Sbjct: 208 ----VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 114 TIIGQGGFGTVYKA-QFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALR 170
             +G G +G+V  A     G  +A+K++ +   SE       RE+ LL  + H +++ L 
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 171 GFCIEKRERFLMYE-YMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYCDP 228
                        + Y+    ++  L      PLS + ++Q  +  +   L+Y+H     
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLS-EDKVQYLVYQMLCGLKYIH---SA 136

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRD+K  N+ ++E+   K+ DFGLA HA  +         T    T  Y  PE ++ 
Sbjct: 137 GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--------MTGYVVTRWYRAPEVILN 188

Query: 288 -QELTEKSDVYSYGVVLLEIVTAR 310
                +  D++S G ++ E++T +
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 48/219 (21%)

Query: 115 IIGQGGFGTVY---KAQFSD-GSLIAVKRMDKI-------------SEQVEGDFCREIEL 157
           ++G G +G V+   K    D G L A+K + K              +E+   +  R+   
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 158 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW-QTRIQIAIDVA 216
           L  LH+        F  E +   L+ +Y++ G +  HL+   R   S  + R     ++ 
Sbjct: 67  LVTLHY-------AFQTEAKLH-LILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSG-EII 115

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA------HASKDGSICFEPVN 270
            ALE+LH      + +RDIK  NILLD      L DFGL+         +  S C     
Sbjct: 116 LALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC----- 167

Query: 271 TDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVT 308
               GT  YM PE +  +    K+ D +S G+++ E++T
Sbjct: 168 ----GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 53/226 (23%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G G  G V+ A  SD    +AVK++     Q      REI+++ RL H ++V       
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ--IAIDVANALE------------ 220
                  +YE +              T L+    +Q  +  D+AN LE            
Sbjct: 67  -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119

Query: 221 ---------YLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLA-----HASKDGSIC 265
                    Y+H      + HRD+K +N+ ++ E+ V K+ DFGLA     H S  G + 
Sbjct: 120 MYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 266 FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
              V      T  Y  P  +++    T+  D+++ G +  E++T +
Sbjct: 177 EGLV------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 25/172 (14%)

Query: 154 EIELLARLHHRHLVALRG-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           E  +L  ++H  ++ L+G F   K    ++  Y  +  L  +L +     +     I+ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDILAIERS 190

Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 272
             V  A++YLH   +  + HRDIK+ NI ++      L DFG A        CF PV+ +
Sbjct: 191 --VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA--------CF-PVDIN 236

Query: 273 IR------GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV--QDG 316
                   GT     PE +         D++S G+VL E+ T   ++  +DG
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Length = 391

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 48/206 (23%), Positives = 93/206 (45%), Gaps = 22/206 (10%)

Query: 116 IGQGGFGTVYKAQFSDGSLIA---VKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG G FG V  ++    + +A   VK +    S + + +F ++ +    L H +++   G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPP 229
            C+E     L++EY   G LK +L        + Q  +  ++A ++A  + ++H +    
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMDPEYV-- 285
             H D+   N  L  +   K+ D+G+  +   +D     +     +R    ++ PE V  
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPELVGE 175

Query: 286 -----VTQELTEKSDVYSYGVVLLEI 306
                +T E T+ S+V++ GV L E+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 13/96 (13%)

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF---EPVNTDIRG 275
           L+YLH      + HRDIK  N+L++ N V K+ DFGLA   +         E V      
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV------ 166

Query: 276 TPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTAR 310
           T  Y  PE ++ ++  T   D++S G +  E++  R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 60/242 (24%), Positives = 95/242 (39%), Gaps = 52/242 (21%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRM---DKISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G G FG V  A   D  +L A+K +   D ++         E ++LA   +  +V L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
              +K   + + +Y+  G +   L      P     R  IA ++  A+E +H        
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP-EVLARFYIA-ELTLAIESVH---KMGFI 123

Query: 232 HRDIKSSNILLDENFVAKLADFGL------AHASK----------------------DGS 263
           HRDIK  NIL+D +   KL DFGL       H SK                         
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183

Query: 264 ICFEPVNT---------------DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            C + + T                + GTP Y+ PE ++ +  T+  D +S GV+L E++ 
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV 243

Query: 309 AR 310
            +
Sbjct: 244 GQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 24/108 (22%), Positives = 36/108 (33%), Gaps = 12/108 (11%)

Query: 152 CREI-ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 210
             E+  +L RLH    +ALRGF  E+       E+                      R  
Sbjct: 124 LEELGRMLGRLH----LALRGFPFERPNALRRLEWDILEPRALLRL---DLVEPEDLRAA 176

Query: 211 IAIDVANALEYL--HF-YCDPPLCHRDIKSSNILLD-ENFVAKLADFG 254
           +   +   L  L  H       + H D+   N+L D +  V+   DF 
Sbjct: 177 LLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFD 224

Length = 331

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 5/78 (6%)

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +     C   + T    T  Y  PE ++   
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----CTNFMMTPYVVTRYYRAPEVILGMG 198

Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 199 YKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 41.2 bits (96), Expect = 9e-04
 Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 5/78 (6%)

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVV----TRYYRAPEVILGMG 201

Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E++
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 51/216 (23%), Positives = 98/216 (45%), Gaps = 21/216 (9%)

Query: 114 TIIGQG--GFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCR----EIELLARLHHRHL 166
           T+IG+G     TV  A++   G  + V+R++   E    +       E+ +    +H ++
Sbjct: 4   TVIGRGFEDLMTVNLARYKPTGEYVTVRRIN--LEACTNEMVTFLQGELHVSKLFNHPNI 61

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
           V  R   I   E +++  +MA GS KD + +     +S      I   V  AL+Y+H   
Sbjct: 62  VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM- 120

Query: 227 DPPLCHRDIKSSNILLDEN---FVAKL-ADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
                HR +K+S+IL+  +   +++ L ++  + +  +   +  +     ++  P ++ P
Sbjct: 121 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSP 177

Query: 283 EYVVTQELT---EKSDVYSYGVVLLEIVTARRAVQD 315
           E V+ Q L     KSD+YS G+   E+       +D
Sbjct: 178 E-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 5/79 (6%)

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K SNI++  +   K+ DFGLA  +    +      T    T  Y  PE ++     
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-----TPYVVTRYYRAPEVILGMGYK 195

Query: 292 EKSDVYSYGVVLLEIVTAR 310
           E  D++S G ++ E++   
Sbjct: 196 ENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 32/110 (29%), Positives = 49/110 (44%), Gaps = 17/110 (15%)

Query: 202 PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 261
           PL       +A  + +A++Y+H      + HRDIK+ N+L++      L DFG A     
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAA----- 307

Query: 262 GSICF------EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
              CF       P +  I GT     PE +     T   D++S G+V+ E
Sbjct: 308 ---CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 40.1 bits (93), Expect = 0.002
 Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 16/198 (8%)

Query: 116 IGQGGFGTVYKAQFSDGSL---IAVKRMDK-ISEQVEGDFC-REIELLARLHHRHLVALR 170
           IG G  G V  A   D  L   +A+K++ +    Q       RE+ L+  ++H+++++L 
Sbjct: 25  IGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 171 G-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             F  +K        Y+    +  +L    +  L  +    +   +   +++LH      
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 139

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVV----TRYYRAPEVILGMG 194

Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 195 YKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 17/46 (36%), Positives = 26/46 (56%), Gaps = 3/46 (6%)

Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
           I  D+   LEY+H +    + H DIK  NI++D N    + D+G+A
Sbjct: 131 IMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	458
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
PRK10345	210	hypothetical protein; Provisional	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
smart00090	237	RIO RIO-like kinase.	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.55
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
KOG1243	690	consensus Protein kinase [General function predict	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.31
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.31
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.17
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.02
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.97
PRK09902	216	hypothetical protein; Provisional	98.94
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.87
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.85
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.81
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.6
COG4248	637	Uncharacterized protein with protein kinase and he	98.58
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.49
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.47
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.41
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.4
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.32
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.29
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.28
PLN02876	822	acyl-CoA dehydrogenase	98.19
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.15
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.14
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.08
PRK10593	297	hypothetical protein; Provisional	98.01
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.94
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.92
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.92
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.7
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.65
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.49
PRK05231	319	homoserine kinase; Provisional	97.39
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.39
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.18
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.14
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.13
PLN02236	344	choline kinase	97.07
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.06
PLN02756	418	S-methyl-5-thioribose kinase	96.89
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.79
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.76
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.75
PRK12396	409	5-methylribose kinase; Reviewed	96.7
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.49
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.49
COG2334	331	Putative homoserine kinase type II (protein kinase	96.46
KOG2270	520	consensus Serine/threonine protein kinase involved	96.04
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.84
PRK11768	325	serine/threonine protein kinase; Provisional	95.83
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.74
PRK06148	1013	hypothetical protein; Provisional	95.68
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.63
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	95.62
PTZ00384	383	choline kinase; Provisional	95.57
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.44

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-57  Score=446.70  Aligned_cols=279  Identities=49%  Similarity=0.849  Sum_probs=243.7

Q ss_pred             cccccCHHHHHHHhhccc--ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeee
Q 012715           96 MFQKFSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC  173 (458)
Q Consensus        96 ~~~~~~~~~~~~~~~~~~--~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  173 (458)
                      ....|++.++.+||++|+  ++||+|+||.||+|.+.+|..||||++.....+...+|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999998  699999999999999999999999988754433145699999999999999999999999


Q ss_pred             eccC-ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          174 IEKR-ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       174 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                      .+.+ +.+||||||++|+|.++|+.....+++|..+++||.++|+||+|||+.+.+.|||||||++|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9999 499999999999999999875543799999999999999999999998888999999999999999999999999


Q ss_pred             cccccccCC-CCcccccccccc-cCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCC-----CcchHHHHHH
Q 012715          253 FGLAHASKD-GSICFEPVNTDI-RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD-----GKNLVESAQV  325 (458)
Q Consensus       253 fGla~~~~~-~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~-----~~~~~~~~~~  325 (458)
                      ||+|+.... ...     .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+...     ...+.+|...
T Consensus       221 FGLa~~~~~~~~~-----~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  221 FGLAKLGPEGDTS-----VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             ccCcccCCccccc-----eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            999976554 221     1111 799999999999999999999999999999999999988763     2346777755


Q ss_pred             HHhhccccccccCCcCC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          326 CMASESRLAELVDPRIK-DSFDM-EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       326 ~~~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+.. ..+.+++|+.+. ..++. +++..+..++.+|++.+|.+||+|.||++.|..
T Consensus       296 ~~~~-~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  296 LLEE-GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HHHC-cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            4444 389999999987 66664 788999999999999999999999999999844

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-51  Score=382.15  Aligned_cols=250  Identities=29%  Similarity=0.453  Sum_probs=212.3

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEec-ccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc-eeeeeeecCCC
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE-RFLMYEYMANG  189 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~~g  189 (458)
                      ...||+|..|+|||++++ +++.+|+|.+. ..+....+++.+|+++++.++|||||.++|.|..... ..|+||||++|
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG  163 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG  163 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence            457999999999999987 68999999984 3456667889999999999999999999999999984 99999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|++++...+  .+++...-+|+.++++||.|||+  +++||||||||+|||++..|++||||||.++...+.      .
T Consensus       164 SLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS------~  233 (364)
T KOG0581|consen  164 SLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS------I  233 (364)
T ss_pred             CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh------h
Confidence            9999998754  48999999999999999999993  389999999999999999999999999999876543      3


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCC----cchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG----KNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      ...++||..|||||.+.+..|+.++||||||+.++|+++|+.|+...    .+..+....+....       .|.+... 
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-------pP~lP~~-  305 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-------PPRLPEG-  305 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-------CCCCCcc-
Confidence            45688999999999999999999999999999999999999999753    23333333322211       1333333 


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                        ....++.+++..||++||.+||+++|+++|.|...
T Consensus       306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             --cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence              23356999999999999999999999999998654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-51  Score=397.80  Aligned_cols=252  Identities=33%  Similarity=0.530  Sum_probs=209.5

Q ss_pred             cceeeeecceEEEEEEEcCCCEEEEEEecccch--hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC-ceeeeeeecCCC
Q 012715          113 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKR-ERFLMYEYMANG  189 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g  189 (458)
                      .+.||+|+||+||+|.+.....||||++.....  ...+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            446999999999999995444499999975332  22568999999999999999999999999988 799999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEeccCCCCCeeeCCCC-cEEEeecccccccCCCCcccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP-LCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|.++++......+++..+++|+.|||+||.|||   +.+ |||||||++|||++.++ ++||+|||+++......    
T Consensus       126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~----  198 (362)
T KOG0192|consen  126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK----  198 (362)
T ss_pred             cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc----
Confidence            9999998744457999999999999999999999   777 99999999999999997 99999999998765432    


Q ss_pred             cccccccCCCccccccccc--cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVV--TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||.+... .+.........          .+...
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~----------~Rp~~  267 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGG----------LRPPI  267 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcC----------CCCCC
Confidence            1234478999999999999  66999999999999999999999999987666 33333222111          12222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      +..+...+..++.+||..||..||++.+++..|....
T Consensus       268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence            2235577999999999999999999999999987543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-51  Score=396.65  Aligned_cols=260  Identities=27%  Similarity=0.441  Sum_probs=216.3

Q ss_pred             HHHHHhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       104 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ++.+....+.+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|...+.+||||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            3444455677889999999999999987779999998754 334568999999999999999999999999988999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      |||+.|+|.+||+...+..+...+.+.++.|||+||+||+   ++++|||||.++||||++++.+||+|||||+...++.
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            9999999999999866677999999999999999999999   9999999999999999999999999999999655543


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ..   ......-+..|.|||++....++.|||||||||+||||+|-.....++....+....+ ..+.++          
T Consensus       358 Y~---~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyRl----------  423 (468)
T KOG0197|consen  358 YT---ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYRL----------  423 (468)
T ss_pred             ee---ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCcC----------
Confidence            22   2333445789999999999999999999999999999999554444444444444332 223232          


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..+..|+..+.++|..||..+|++|||++.+...+...
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            33445668899999999999999999999988877543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-49  Score=369.87  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=205.2

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.||+|+||+||+|+++ ++..||||.+...  .....+.+..|+.+|+.++|||||.|++++..++..|||||||.|
T Consensus        14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g   93 (429)
T KOG0595|consen   14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG   93 (429)
T ss_pred             ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence            4557999999999999886 5899999998754  556677889999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC------CcEEEeecccccccCCC
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN------FVAKLADFGLAHASKDG  262 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~------~~~kl~DfGla~~~~~~  262 (458)
                      |+|.+||+..+  .+++.++..++.|||.||++||   +++||||||||+||||+..      -.+||+|||+|+....+
T Consensus        94 GDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   94 GDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            99999999865  4999999999999999999999   9999999999999999764      46999999999988765


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      .     .....+|++-|||||++...+|+.|+|+||+|++||++++|+.||... ...+......... ......     
T Consensus       169 ~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~-t~~eL~~~~~k~~-~~~~~~-----  236 (429)
T KOG0595|consen  169 S-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE-TPKELLLYIKKGN-EIVPVL-----  236 (429)
T ss_pred             h-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc-CHHHHHHHHhccc-cccCch-----
Confidence            4     345688999999999999999999999999999999999999999643 3333333222211 111111     


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                         +......+.+++...++.++.+|-+..+-..+..-..
T Consensus       237 ---~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  237 ---PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             ---hhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence               1111123456777788888888888887776654433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.4e-50  Score=408.36  Aligned_cols=263  Identities=31%  Similarity=0.482  Sum_probs=217.0

Q ss_pred             HHHHHHhhcccceeeeecceEEEEEEEc------CCCEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeec
Q 012715          103 KETKKATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIE  175 (458)
Q Consensus       103 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~  175 (458)
                      .++......|.+.||+|.||.||+|+..      +...||||.+++.... ...+|.+|+++|..++|||||+|+|+|.+
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            3444455567788999999999999753      3468999999876554 77899999999999999999999999999


Q ss_pred             cCceeeeeeecCCCCHHHHhcCCC--------C----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC
Q 012715          176 KRERFLMYEYMANGSLKDHLHSPG--------R----TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD  243 (458)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~--------~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~  243 (458)
                      ++..+||+|||..|||.+||...+        +    .+|+..+.+.||.|||.||+||-   ++.++||||..+|+||.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence            999999999999999999996421        2    23899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHH
Q 012715          244 ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVES  322 (458)
Q Consensus       244 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~  322 (458)
                      ++..|||+||||++.....+..  .......-+.+||+||.+..++|+.+||||||||+|||+++ |+.|+.+..+- +.
T Consensus       638 e~l~VKIsDfGLsRdiYssDYY--k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-EV  714 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYY--KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-EV  714 (774)
T ss_pred             cceEEEecccccchhhhhhhhh--cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-HH
Confidence            9999999999999976654432  22334456789999999999999999999999999999998 77787654332 32


Q ss_pred             HHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          323 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       323 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ...+..          ..+ -..+..++.+++++|..||+.+|++||+++||-..|....
T Consensus       715 Ie~i~~----------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  715 IECIRA----------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHHc----------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            222111          112 2455667788999999999999999999999999886543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-49  Score=384.33  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=217.4

Q ss_pred             hhcccceeeeecceEEEEEEE-cCCCEEEEEEecc---cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +|...+.||+|||+.||.++. ..|..||+|++.+   ......+...+|+++.+.|+|||||+++++|.+.++.|||.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            344567899999999999987 7899999999865   234455678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      +|.+|+|..+++.  +.++++.++..+..||+.||.|||   +++|+|||||..|+|++++.++||+|||||....... 
T Consensus        99 LC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   99 LCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             ecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            9999999999984  457999999999999999999999   9999999999999999999999999999998776432 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         ......+||+.|+|||++.....+..+||||+||+||-|+.|++||+. .++.+....+...+..++..        
T Consensus       173 ---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y~~P~~--------  240 (592)
T KOG0575|consen  173 ---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEYSMPSH--------  240 (592)
T ss_pred             ---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCcccccc--------
Confidence               134568999999999999999999999999999999999999999964 34445455444444443331        


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .    ..+..++|..+|+.||.+|||+++|+.|-++...
T Consensus       241 l----s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  241 L----SAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             c----CHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence            1    2457789999999999999999999999988543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-50  Score=373.66  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=210.0

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccch-------hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCce
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-------QVEGDFCREIELLARLHHRHLVALRGFCIEKRER  179 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  179 (458)
                      ..+-.++.||+|+||.|-+|..+ +|+.||||.+++...       .......+|+++|++|+|||||++++++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            34445678999999999999654 799999999864211       1122356999999999999999999999999999


Q ss_pred             eeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC---CcEEEeecccc
Q 012715          180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN---FVAKLADFGLA  256 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla  256 (458)
                      ||||||++||+|.+++-..+  .+.+..-.-+++|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+|
T Consensus       252 YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             EEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999997644  3677777889999999999999   9999999999999999765   78999999999


Q ss_pred             cccCCCCcccccccccccCCCccccccccccCCC---CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc
Q 012715          257 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL---TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL  333 (458)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  333 (458)
                      +..+.+.     .+...+||+.|.|||++.+..+   ..++|+||+||+||-+++|.+||.+..........+......+
T Consensus       327 K~~g~~s-----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f  401 (475)
T KOG0615|consen  327 KVSGEGS-----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF  401 (475)
T ss_pred             hccccce-----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence            9887654     4567899999999999987643   3478999999999999999999986544332333333222222


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          334 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       334 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      ..    ...    .+..++..++|.+||..||++|||+.|+|+|.|....+.
T Consensus       402 ~p----~~w----~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  402 GP----LQW----DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             cC----hhh----hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            11    111    233467889999999999999999999999999876554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8e-49  Score=353.60  Aligned_cols=258  Identities=24%  Similarity=0.336  Sum_probs=209.4

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .++|+|+||.||||+.+ +|+.||||++....  ....+-.++|+++|++++|+|+|.|+.+|..+...+||+|||+..-
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTv   87 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTV   87 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHH
Confidence            47999999999999987 59999999996533  3334567899999999999999999999999999999999998854


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |.++-+-  ...++...+.+++.|++.|+.|+|   ++++|||||||+||||+.+|.+||||||+|+......    ...
T Consensus        88 L~eLe~~--p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg----d~Y  158 (396)
T KOG0593|consen   88 LHELERY--PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG----DNY  158 (396)
T ss_pred             HHHHHhc--cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc----chh
Confidence            4444332  235889999999999999999999   9999999999999999999999999999999876332    245


Q ss_pred             ccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-------------ccccc
Q 012715          271 TDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-------------RLAEL  336 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~  336 (458)
                      +..+.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+.|.+..++.+...+....+.             .+..+
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            77889999999999987 78999999999999999999999999877777666554333221             11111


Q ss_pred             cCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          337 VDPRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       337 ~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .-|.....-+     +.....+.+++..|++.||.+|++.+|++.|.++
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF  287 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF  287 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence            1122111111     1223468999999999999999999999999887

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-48  Score=348.84  Aligned_cols=253  Identities=28%  Similarity=0.438  Sum_probs=205.6

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEec--ccchhhHhHHHHHHHHHHhcCCCCeeeeee-eeeccCc-eeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRG-FCIEKRE-RFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv~e  184 (458)
                      +...++||+|.||+|||+.. .+|..||.|.+.  ..+....++...|+.+|++|+|||||++++ -+.+.+. ++||||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            33456899999999999964 589999999886  344556678999999999999999999998 4445554 899999


Q ss_pred             ecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          185 YMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       185 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      ||.+|+|...++.  ..++.+++..+++++.|++.||.++|+.. +.  |+||||||.||+|+.+|.+||+||||++.+.
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            9999999999863  33556999999999999999999999421 44  9999999999999999999999999999887


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ....    .....+||+.||+||.+.+.+|+.|+||||+||++|||+.-+.||.+. ++.+....+...+  .     +.
T Consensus       180 s~~t----fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd--~-----~~  247 (375)
T KOG0591|consen  180 SKTT----FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGD--Y-----PP  247 (375)
T ss_pred             chhH----HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCC--C-----CC
Confidence            6542    456789999999999999999999999999999999999999999754 6666555543321  1     11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      +.   +.-....+.+++..|+..||+.||+...++..+
T Consensus       248 ~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  248 LP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             Cc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            11   123346688999999999999999854444433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-48  Score=368.51  Aligned_cols=263  Identities=23%  Similarity=0.370  Sum_probs=217.1

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhH-hHHHHHHHHHHhcC-CCCeeeeeeeeeccC-ceeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVE-GDFCREIELLARLH-HRHLVALRGFCIEKR-ERFLMYE  184 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~e  184 (458)
                      .|...++||.|.||+||+|+-. +|..||||++++.-.... -.-++|++.|++|+ ||||+++.+++.+.+ .+|+|||
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE   90 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE   90 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence            3455678999999999999754 689999999975443322 23568999999998 999999999999988 9999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      ||+. +|+++++.+ ...|++..+..|+.||++||+|+|   .+|+.|||+||+|||+..+..+||+||||||.....  
T Consensus        91 ~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--  163 (538)
T KOG0661|consen   91 FMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK--  163 (538)
T ss_pred             hhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC--
Confidence            9965 999999887 678999999999999999999999   999999999999999999999999999999977653  


Q ss_pred             ccccccccccCCCccccccccc-cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc----------
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL----------  333 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  333 (458)
                         +..+..+.|.+|+|||++. .+-|+.+.||||+||+++|+.+-++.|.+..+..+...++...+..-          
T Consensus       164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence               3567889999999999886 56799999999999999999999999987777777776654322111          


Q ss_pred             ccccC--------CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          334 AELVD--------PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       334 ~~~~d--------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ...+.        ..+..-++ ....+..+++.+|++.||.+|||+.|+++|.++..
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~  296 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHPFFQV  296 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence            11111        11111112 24567899999999999999999999999998754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=387.05  Aligned_cols=269  Identities=24%  Similarity=0.433  Sum_probs=220.4

Q ss_pred             cccccCHHHHHHHhhcc-----------cceeeeecceEEEEEEEc----CCCEEEEEEeccc-chhhHhHHHHHHHHHH
Q 012715           96 MFQKFSYKETKKATDNF-----------STIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI-SEQVEGDFCREIELLA  159 (458)
Q Consensus        96 ~~~~~~~~~~~~~~~~~-----------~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~  159 (458)
                      ..+.++|++--.|..+|           .++||.|.||.||+|+++    ....||||.++.. .+....+|+.|+.||.
T Consensus       606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG  685 (996)
T KOG0196|consen  606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG  685 (996)
T ss_pred             ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence            34556665554444444           467999999999999986    2457999999853 3455678999999999


Q ss_pred             hcCCCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCC
Q 012715          160 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN  239 (458)
Q Consensus       160 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~N  239 (458)
                      ++.||||++|.|+....+..+||.|||+||+|+.||+.+.++ |++.++..++++||.||.||-   +.+++||||.++|
T Consensus       686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARN  761 (996)
T KOG0196|consen  686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARN  761 (996)
T ss_pred             cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhh
Confidence            999999999999999999999999999999999999987765 999999999999999999999   9999999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcc
Q 012715          240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKN  318 (458)
Q Consensus       240 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~  318 (458)
                      ||++.+..+|++||||+|...++... ........-+.+|.|||.+...+++.++|||||||+|||.++ |.+|+++..+
T Consensus       762 ILVNsnLvCKVsDFGLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  762 ILVNSNLVCKVSDFGLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             eeeccceEEEeccccceeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence            99999999999999999987665411 111222233689999999999999999999999999999876 8899987554


Q ss_pred             hHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      -.-  ...+..+.          +-..+.+++..|.++|..||++|-.+||.+.||+.+|...
T Consensus       841 QdV--IkaIe~gy----------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  841 QDV--IKAIEQGY----------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             HHH--HHHHHhcc----------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence            211  11122222          3333556778999999999999999999999999998653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-47  Score=357.04  Aligned_cols=258  Identities=30%  Similarity=0.475  Sum_probs=206.5

Q ss_pred             ccceeeeecceEEEEEEEcC-CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC--ceeeeeeecCC
Q 012715          112 FSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR--ERFLMYEYMAN  188 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~  188 (458)
                      ..+.||+|+||+||++...+ |...|||.+...+....+.+.+|+.+|.+++|||||+++|......  .+++.|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            45689999999999998764 8999999886553333567899999999999999999999855555  58999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccccCCCCcccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      |+|.+++...+. .+++..+..++.||++||+|||   +++|+||||||+|||++. ++.+||+|||+++...... ...
T Consensus       101 GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~-~~~  175 (313)
T KOG0198|consen  101 GSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG-TKS  175 (313)
T ss_pred             CcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc-ccc
Confidence            999999998776 6999999999999999999999   999999999999999999 7999999999998665311 111


Q ss_pred             cccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      .......||+.|||||++..+ ....++|||||||++.||+||+.||.+.....+....... ....     |.+....+
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~-~~~~-----P~ip~~ls  249 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR-EDSL-----PEIPDSLS  249 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc-cCCC-----CCCCcccC
Confidence            223457899999999999853 3345999999999999999999999763222222211111 1111     23333333


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                          ....+++..|+..||++|||+.++|+|++...+.
T Consensus       250 ----~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  250 ----DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ----HHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                5588999999999999999999999999776543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-47  Score=350.84  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=208.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.++||+|+||+||.++.+ +++.+|+|.+++.   .....+...+|..+|.+++||.||+++..|.+.+.+|||+||+
T Consensus        28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~  107 (357)
T KOG0598|consen   28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL  107 (357)
T ss_pred             eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence            35678999999999999765 5899999998753   2334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      .||.|..+|++.+.  +++..+.-++.+|+.||.|||   +++||||||||+|||+|++|.++|+|||||+..-...   
T Consensus       108 ~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~---  179 (357)
T KOG0598|consen  108 NGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG---  179 (357)
T ss_pred             CCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC---
Confidence            99999999987553  999999999999999999999   9999999999999999999999999999998654332   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc-cccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-SRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~d~~~~~~~  345 (458)
                       ......+||+.|||||++.+..|+..+|.||+|+++|||++|.+||.. .+...+...+.... ...+..        .
T Consensus       180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~~~p~~--------l  249 (357)
T KOG0598|consen  180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLPLPPGY--------L  249 (357)
T ss_pred             -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCCCCCcc--------C
Confidence             134557999999999999999999999999999999999999999964 44444444433322 111111        1


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC----CHHHHHHHhhhC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP----SIKQVLRILYES  381 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP----s~~evl~~l~~~  381 (458)
                      +    ....+++...+..||++|.    ++.+|-+|.++.
T Consensus       250 s----~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~  285 (357)
T KOG0598|consen  250 S----EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFK  285 (357)
T ss_pred             C----HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccc
Confidence            1    4577899999999999995    688888887664

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-46  Score=359.12  Aligned_cols=266  Identities=27%  Similarity=0.384  Sum_probs=212.6

Q ss_pred             ccceeeeecceEEEEEEE-cCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeeeeeec
Q 012715          112 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYM  186 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~  186 (458)
                      -.++||+|.||.||+|+. .+|+.||+|++...  .........+||.||++|+||||++|.+...+.  ..+|||+|||
T Consensus       121 ki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM  200 (560)
T KOG0600|consen  121 KIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM  200 (560)
T ss_pred             HHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence            345799999999999975 57999999998643  345556778999999999999999999998887  6899999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++ +|.-++...+ ..|+..++..+++|++.||+|+|   .++|+|||||.+|||||++|.+||+|||||+++.....  
T Consensus       201 dh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~--  273 (560)
T KOG0600|consen  201 DH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS--  273 (560)
T ss_pred             cc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCC--
Confidence            87 9999887654 35999999999999999999999   99999999999999999999999999999997755432  


Q ss_pred             ccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC--c---
Q 012715          267 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP--R---  340 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~--~---  340 (458)
                       ...+..+-|.+|.|||.+.+ ..|+.++|+||.||||.||++|++.+++..++.+.-.++... +...+-.-+  .   
T Consensus       274 -~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc-GSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  274 -APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC-GSPTEDYWPVSKLPH  351 (560)
T ss_pred             -cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh-CCCChhccccccCCc
Confidence             23567788999999999987 579999999999999999999999998666555544433221 111111111  0   


Q ss_pred             ---CC--CCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          341 ---IK--DSFD-------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       341 ---~~--~~~~-------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                         ++  ..+.       ........+++..+|..||.+|.|+.++|++-++...+.+
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~  409 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP  409 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence               00  0000       0112467889999999999999999999999998665543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-46  Score=351.06  Aligned_cols=268  Identities=22%  Similarity=0.345  Sum_probs=216.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      |++.+.||.|..++||+|+.. .+..||||++.-. .....+.+.+|+..++.++||||++++..|..++.+|+||.||.
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            567789999999999999764 6799999998632 23336789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|++.+.++..-...+++..+..|++++++||.|||   .+|.||||||+.||||+.+|.+||+|||.+..+.+......
T Consensus       108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~  184 (516)
T KOG0582|consen  108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV  184 (516)
T ss_pred             CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence            999999998766667999999999999999999999   99999999999999999999999999998865543332111


Q ss_pred             cccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      ......+||+.|||||+++.  ..|+.|+||||||++..||.+|..||..-..+.-.... +..  ..+...-..+..+.
T Consensus       185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-Lqn--~pp~~~t~~~~~d~  261 (516)
T KOG0582|consen  185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-LQN--DPPTLLTSGLDKDE  261 (516)
T ss_pred             EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcC--CCCCcccccCChHH
Confidence            11166789999999999654  57999999999999999999999999865554333222 211  12111111112222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      +......+.+++..||+.||.+|||+++++++.++...
T Consensus       262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence            22334689999999999999999999999999987653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.3e-46  Score=328.77  Aligned_cols=266  Identities=22%  Similarity=0.300  Sum_probs=216.2

Q ss_pred             cceeeeecceEEEEEEE-cCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          113 STIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      .++||+|.||.||+|+. ++|+.||||+++..  .+.......+|++.|+.++|+||+.+++++...+...||+|||+. 
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-   85 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-   85 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence            45799999999999975 47999999998643  333345688999999999999999999999999999999999975 


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|+..++... ..++..++..++.++++||+|||   .+.|+||||||.|+|++++|.+||+|||+|+.......    .
T Consensus        86 dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~----~  157 (318)
T KOG0659|consen   86 DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR----I  157 (318)
T ss_pred             cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc----c
Confidence            9999998653 56999999999999999999999   99999999999999999999999999999998876543    2


Q ss_pred             cccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc-------cccccccCCc-
Q 012715          270 NTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-------SRLAELVDPR-  340 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~d~~-  340 (458)
                      .+..+-|.+|.|||.+.+ ..|+..+||||.||++.||+.|.+-|.+..++.+...++...+       ..+..+.|.. 
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            334478999999998876 5799999999999999999998877777777766655543322       1122222211 


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCc
Q 012715          341 -------IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS  387 (458)
Q Consensus       341 -------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~  387 (458)
                             ........+.....+++..++..||.+|+++.|+++|.++.+.+.+.
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT  291 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence                   11112223335569999999999999999999999999998866543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=361.86  Aligned_cols=254  Identities=26%  Similarity=0.373  Sum_probs=214.8

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecc---cchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      .|.++||+|+|++|++|+.. .++.||||++.+   ..+...+....|-++|.+| .||.|++|+..|.+...+|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            46789999999999999764 689999999864   2334445677899999999 799999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.++|+..+.  |++.....++.+|+.||+|||   ++|||||||||+|||||.||.+||+|||-|+.+......
T Consensus       156 A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  156 APNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             cCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            999999999998754  999999999999999999999   999999999999999999999999999999876533221


Q ss_pred             -----ccc----ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          266 -----FEP----VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       266 -----~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                           ...    ....++||..|.+||++.....+..+|+|+|||+||+|+.|++||....+. ...+.++..+..+++ 
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqkI~~l~y~fp~-  308 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQKIQALDYEFPE-  308 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHHHHHhcccCCC-
Confidence                 111    124589999999999999999999999999999999999999999866554 444444544444433 


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                             .++    +.+.+++.+.|..||.+|++.+||-+|+++..
T Consensus       309 -------~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  309 -------GFP----EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             -------CCC----HHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence                   333    45778999999999999999999999987754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=365.49  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=219.6

Q ss_pred             ceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      .+||+|+.|.||.+.. .++..||||++........+-+++|+.+|+..+|+|||++++.+..++++|+|||||+||+|.
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence            4699999999999964 478999999998766666778999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccc
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      +.+...   .+++.++..|+.++++||+|||   .++|+|||||.+|||++.+|.+||+|||+|........    ....
T Consensus       359 DvVt~~---~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~----KR~T  428 (550)
T KOG0578|consen  359 DVVTKT---RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS----KRST  428 (550)
T ss_pred             hhhhcc---cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC----cccc
Confidence            999753   3899999999999999999999   99999999999999999999999999999987654432    3456


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT  352 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  352 (458)
                      .+||+.|||||++....|+.|.||||||++++||+-|.+||..+..+.....+......        .++  ........
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P--------~lk--~~~klS~~  498 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP--------KLK--NPEKLSPE  498 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC--------CcC--CccccCHH
Confidence            78999999999999999999999999999999999999999887766555544332221        111  12233367


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCcchhh
Q 012715          353 IVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQ  391 (458)
Q Consensus       353 l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~~~~~  391 (458)
                      |.+|+.+||+.|+.+|+++.|+|+|.+.......+.+..
T Consensus       499 ~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~p  537 (550)
T KOG0578|consen  499 LKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNP  537 (550)
T ss_pred             HHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHH
Confidence            999999999999999999999999998755544444433

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=363.96  Aligned_cols=239  Identities=26%  Similarity=0.470  Sum_probs=203.3

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHHHH
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDH  194 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~  194 (458)
                      -||.|+.|.||+|++ .++.||||+++...+       .+|+-|++|+|+||+.|.|+|.....++||||||..|-|+..
T Consensus       131 WlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  131 WLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            599999999999999 578999998764332       468889999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccccc
Q 012715          195 LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR  274 (458)
Q Consensus       195 l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~  274 (458)
                      |+.  +.+++......|..+||.||.|||   .+.|||||||.-||||+.+..+||+|||.++...+-.     ....+.
T Consensus       203 Lka--~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-----TkMSFa  272 (904)
T KOG4721|consen  203 LKA--GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-----TKMSFA  272 (904)
T ss_pred             Hhc--cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh-----hhhhhh
Confidence            987  446888999999999999999999   9999999999999999999999999999998765543     345688


Q ss_pred             CCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHH
Q 012715          275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV  354 (458)
Q Consensus       275 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~  354 (458)
                      ||..|||||++...+.+.|+||||||||||||+||..||.+-....    +++...       ...+.-..+..+++-|.
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVG-------sNsL~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVG-------SNSLHLPVPSTCPDGFK  341 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEecc-------CCcccccCcccCchHHH
Confidence            9999999999999999999999999999999999999997533221    111111       12223334445667788


Q ss_pred             HHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          355 TIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       355 ~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      -+++.||+..|.+||++++++.||....
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            8999999999999999999999986543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=355.48  Aligned_cols=267  Identities=27%  Similarity=0.423  Sum_probs=215.1

Q ss_pred             HHHHHHhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          103 KETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       103 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.-+..-.|.++||+|-||.|.++....+..||||.++..... ...+|..|+++|.+|+||||++|+|+|..++.+++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            34444445567899999999999999987899999999865433 34789999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      |+|||++|+|.+|+..+....+......+|+.|||.||+||.   +.+++||||.++|||++.++++||+|||+++.+..
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccccccc
Confidence            999999999999998764444566677889999999999999   99999999999999999999999999999997765


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh--CCCccCCCcch--HHHHHHHHhhcccccccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT--ARRAVQDGKNL--VESAQVCMASESRLAELV  337 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  337 (458)
                      +...  ......+-+.+|||+|.+.-++++.++|||+||++|||+++  ...||.+..+.  .+.........++-.-+.
T Consensus       690 g~yy--~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  690 GDYY--RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             CCce--eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence            5532  23344566899999999999999999999999999999865  66787643332  222222222211111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                             .+.-++..+++++.+||+.|-.+||+++++..+|.+.
T Consensus       768 -------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  768 -------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             -------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                   2234457799999999999999999999999988653

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=361.82  Aligned_cols=260  Identities=25%  Similarity=0.408  Sum_probs=210.3

Q ss_pred             HHhhcccceeeeecceEEEEEEEcC--C--CE-EEEEEecc---cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFSD--G--SL-IAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE  178 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  178 (458)
                      .....+.++||+|+||.||+|.+..  +  .. ||||..+.   .......+|++|++++++++|||||+++|++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            3334456789999999999998753  2  23 89998874   345667789999999999999999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      +++|||+|.||+|.++|+..+. .++..++++++.++|.||+|||   ++++|||||.++|+|++.++.+||+||||++.
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            9999999999999999987654 5999999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ...-.    .......-+.+|+|||.+....|+.++|||||||++||+++ |..||.+.... +....+.....+     
T Consensus       312 ~~~~~----~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-~v~~kI~~~~~r-----  381 (474)
T KOG0194|consen  312 GSQYV----MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-EVKAKIVKNGYR-----  381 (474)
T ss_pred             Cccee----eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-HHHHHHHhcCcc-----
Confidence            53111    11112246789999999999999999999999999999999 78888765444 322222222211     


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                           ...+...+..+..++..||..+|++||+|.++.+.+.......
T Consensus       382 -----~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  382 -----MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             -----CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                 1222244567888999999999999999999999987655443

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-45  Score=383.61  Aligned_cols=260  Identities=30%  Similarity=0.496  Sum_probs=210.7

Q ss_pred             HHHHhhcccceeeeecceEEEEEEEcC--CC----EEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC
Q 012715          105 TKKATDNFSTIIGQGGFGTVYKAQFSD--GS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR  177 (458)
Q Consensus       105 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  177 (458)
                      +......+.+.||+|.||.||.|.+.+  |.    .||||.+.+. +.+...+|++|..+|++++|||||+++|+|.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            444555677899999999999998753  43    4999998754 5666789999999999999999999999999999


Q ss_pred             ceeeeeeecCCCCHHHHhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          178 ERFLMYEYMANGSLKDHLHSP-----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                      ..+|++|||++|+|..||++.     ....++..+.+.++.|||+|+.||+   ++++|||||.++|+||++...+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence            999999999999999999864     1345899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhC-CCccCCCcchHHHHHHHHhhcc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      ||||+...+....  .......-..+|||||.+..+.++.|+|||||||+|||++|. ..||.+..+. +...... .++
T Consensus       846 FGlArDiy~~~yy--r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~-~gg  921 (1025)
T KOG1095|consen  846 FGLARDIYDKDYY--RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVL-EGG  921 (1025)
T ss_pred             cchhHhhhhchhe--eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHH-hCC
Confidence            9999955444322  112223456799999999999999999999999999999995 4566543332 3222112 222


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ++          ..+..++..++++|..||+.+|++||++..|++.+...
T Consensus       922 RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  922 RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            22          22334557899999999999999999999999976543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-44  Score=351.40  Aligned_cols=252  Identities=24%  Similarity=0.388  Sum_probs=211.9

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc----ch-hhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI----SE-QVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||+|+.|... +|..||+|.+...    .. ...+.+.+|+.+++.++ ||||++++.++......|+
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            4556778999999999999664 6899999976542    11 33456778999999998 9999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC-CcEEEeecccccccC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASK  260 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~  260 (458)
                      ||||+.||+|.+++...  ..+.+..+..++.|++.|++|||   +++|+||||||+|||++.+ +++||+|||++....
T Consensus        98 vmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             EEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999873  34888999999999999999999   9999999999999999999 999999999998773


Q ss_pred             -CCCcccccccccccCCCccccccccccCC-CC-cccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          261 -DGSICFEPVNTDIRGTPGYMDPEYVVTQE-LT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       261 -~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                       .+.     .....+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||.+ .+.......+......++..+
T Consensus       173 ~~~~-----~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~~~p~~~  246 (370)
T KOG0583|consen  173 GEDG-----LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEFKIPSYL  246 (370)
T ss_pred             CCCC-----cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCccCCCCc
Confidence             222     346678999999999999877 86 789999999999999999999987 333344444343333333332


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      +           ...+..++.+|+..||.+|+++.+++++.|...
T Consensus       247 ~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  247 L-----------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             C-----------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            1           245788999999999999999999999999886

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.2e-44  Score=342.28  Aligned_cols=255  Identities=25%  Similarity=0.354  Sum_probs=204.8

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      ...+.||+|+||+||+|... +|+.||+|.+....   ......+.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            34578999999999999764 78999999886432   223346789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++|+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++.......   
T Consensus        83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---  156 (285)
T cd05631          83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---  156 (285)
T ss_pred             CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---
Confidence            9999998886544456899999999999999999999   9999999999999999999999999999998654332   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......||..|+|||.+.+..++.++|||||||++|||++|+.||...................     .......+ 
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-  228 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED-----QEEYSEKF-  228 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----cccCCccC-
Confidence              1234568999999999999999999999999999999999999997543321111110000000     00111122 


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS  382 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  382 (458)
                         ...+.+++.+||+.||.+||+     ++++++|.|...
T Consensus       229 ---s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         229 ---SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             ---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence               356889999999999999997     899999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-45  Score=357.32  Aligned_cols=266  Identities=26%  Similarity=0.403  Sum_probs=208.6

Q ss_pred             CHHHHHHHhhcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc
Q 012715          101 SYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE  178 (458)
Q Consensus       101 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  178 (458)
                      ..+++......+.+.||+|.||+||+|+|.  ..||||.++..  .....+.|++|+.+|++-+|.||+-+.|||.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            344444444556778999999999999985  36999998643  34466789999999999999999999999988777


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                       .||+.+|+|-+|+.+|+... ..|...+.+.||.||++||.|||   .++|||||||..|||+.++++|||+||||+..
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceee
Confidence             99999999999999998754 45999999999999999999999   99999999999999999999999999999964


Q ss_pred             cCCCCcccccccccccCCCcccccccccc---CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE  335 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  335 (458)
                      -..-..  ........|...|||||++..   .+|+..+||||||+|+|||+||..||. ..+..+.... ...+.-.++
T Consensus       538 k~~w~g--~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifm-VGrG~l~pd  613 (678)
T KOG0193|consen  538 KTRWSG--EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFM-VGRGYLMPD  613 (678)
T ss_pred             eeeecc--ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEE-ecccccCcc
Confidence            321110  011222347788999999974   479999999999999999999999997 3332221110 111111111


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      +.      .....+.+++.+++..||..++++||.+.+|+..|.+...
T Consensus       614 ~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  614 LS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11      1123456789999999999999999999999998876544

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.8e-44  Score=351.34  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=200.5

Q ss_pred             hhcccceeeeecceEEEEEEE------cCCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccC-ce
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKR-ER  179 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~  179 (458)
                      .+.+.++||+|+||.||+|.+      .++..||||.+.... ......+.+|+.++.++ +||||++++++|...+ ..
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL   87 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence            455678999999999999974      235689999986432 23345789999999999 8999999999887654 57


Q ss_pred             eeeeeecCCCCHHHHhcCCC------------------------------------------------------------
Q 012715          180 FLMYEYMANGSLKDHLHSPG------------------------------------------------------------  199 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------  199 (458)
                      ++||||+++|+|.+++....                                                            
T Consensus        88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (338)
T cd05102          88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW  167 (338)
T ss_pred             EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence            89999999999999986421                                                            


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCcc
Q 012715          200 RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGY  279 (458)
Q Consensus       200 ~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y  279 (458)
                      ..++++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........  .......++..|
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~~y  242 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGSARLPLKW  242 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcch--hcccCCCCCccc
Confidence            134888899999999999999999   899999999999999999999999999999865332211  112233467889


Q ss_pred             ccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHH
Q 012715          280 MDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVR  358 (458)
Q Consensus       280 ~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~  358 (458)
                      +|||.+.+..++.++|||||||+||||++ |..||............... ..      ......    .....+.+++.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~------~~~~~~----~~~~~l~~li~  311 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GT------RMRAPE----NATPEIYRIML  311 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CC------CCCCCC----CCCHHHHHHHH
Confidence            99999999999999999999999999997 88898654332222222111 11      011111    22356889999


Q ss_pred             HccccCCCCCCCHHHHHHHhhhC
Q 012715          359 WCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       359 ~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      +||+.||++||++.++++.|...
T Consensus       312 ~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         312 ACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.5e-44  Score=327.57  Aligned_cols=264  Identities=21%  Similarity=0.318  Sum_probs=212.3

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--CceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~  188 (458)
                      +.|++|+||.||+|+.+ +++.||+|+++-..  ....-..++|+.+|.+++|||||.+-.+....  +..|||||||+.
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            47999999999999875 68999999986432  22334578999999999999999998887654  578999999987


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                       +|..++...+ .+|...++..+..|+++|++|||   .+.|+|||||++|+|+++.|.+||+|||||+.++....    
T Consensus       162 -DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k----  232 (419)
T KOG0663|consen  162 -DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK----  232 (419)
T ss_pred             -hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCCcc----
Confidence             9999997654 57999999999999999999999   99999999999999999999999999999998876532    


Q ss_pred             ccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc----ccccccCC----
Q 012715          269 VNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLAELVDP----  339 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~d~----  339 (458)
                      ..+..+-|.+|.|||.+.+ ..|+...|+||+|||+.||+++++.|.+...+.+...++...+.    .++.+...    
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK  312 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence            3566788999999999886 56999999999999999999999999877776665555432221    11111111    


Q ss_pred             ----------cCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          340 ----------RIKDSFDME-QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       340 ----------~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                                .++..|... ..+.-.+++..++..||.+|.|++|.|+|-|+...+.+
T Consensus       313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence                      111111111 12567889999999999999999999999999876553

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=349.59  Aligned_cols=246  Identities=28%  Similarity=0.421  Sum_probs=211.1

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ..+.||+|+||.||||+.+ +.+.||+|.+.+.  .+...+.+.+|+++++.++||||+.++++|....+.|+|.||+.|
T Consensus         6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g   85 (808)
T KOG0597|consen    6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG   85 (808)
T ss_pred             HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence            3467999999999999876 5789999998653  334456799999999999999999999999999999999999987


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                       +|..+|...+  .++++.+..++.++..||.|||   +.+|+|||+||+|||++.+|.+|+||||+|+....+..    
T Consensus        86 -~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~----  155 (808)
T KOG0597|consen   86 -DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS----  155 (808)
T ss_pred             -hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCce----
Confidence             9999998755  4999999999999999999999   99999999999999999999999999999998876543    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ..+...||+-|||||.+.+++|+..+|+||+||++||+++|++||. ...+.+....+.......+            ..
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-a~si~~Lv~~I~~d~v~~p------------~~  222 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-ARSITQLVKSILKDPVKPP------------ST  222 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch-HHHHHHHHHHHhcCCCCCc------------cc
Confidence            4567789999999999999999999999999999999999999996 3344454444433222111            13


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ....+..++...+.+||..|.+-.+++.|.+-
T Consensus       223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~  254 (808)
T KOG0597|consen  223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW  254 (808)
T ss_pred             ccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence            33568899999999999999999999998753

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=340.24  Aligned_cols=256  Identities=28%  Similarity=0.413  Sum_probs=212.3

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecc-cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      +.||+|.||.||+|... .++.||+|.+.- ......+++.+|+.+|.+++++||.+++|.+..+..++++||||.||++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            57999999999999764 689999999863 3344567889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT  271 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  271 (458)
                      .+.|....  .+.+..+.-++++++.||.|||   ..+.+|||||+.|||+..+|.+||+|||++........    ...
T Consensus        99 ~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~----rr~  169 (467)
T KOG0201|consen   99 LDLLKSGN--ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK----RRK  169 (467)
T ss_pred             hhhhccCC--CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh----ccc
Confidence            99997643  3577788889999999999999   99999999999999999999999999999987655432    236


Q ss_pred             cccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       272 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      .++||+.|||||++....|+.|+||||||++.+||++|.+|+.+...+.        .-..++.-..|.+.+.++    +
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr--------vlflIpk~~PP~L~~~~S----~  237 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR--------VLFLIPKSAPPRLDGDFS----P  237 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce--------EEEeccCCCCCccccccC----H
Confidence            7889999999999999999999999999999999999999997654321        111122223344444333    6


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCcchh
Q 012715          352 TIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFV  390 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~~~~  390 (458)
                      .+.+++..||..||+.||++.++++|-+-......+.+.
T Consensus       238 ~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~  276 (467)
T KOG0201|consen  238 PFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSELK  276 (467)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHHH
Confidence            699999999999999999999999997765543333333

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.9e-43  Score=337.65  Aligned_cols=243  Identities=24%  Similarity=0.357  Sum_probs=198.7

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchh---hHhHHHHHHHHHHhcCCCCeeeeeeeeec----cCceeeeeeec
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ---VEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMYEYM  186 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  186 (458)
                      ..||+|++|.||+|.+ +|+.||||.+......   ..+.|.+|+.+|.+++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            3699999999999998 7899999998754322   24678899999999999999999999877    34679999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      ++|+|.+++...  ..+++....+++.+++.||.|||   . .+++||||||+|||++.++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            999999999764  35899999999999999999999   5 488899999999999999999999999988654321  


Q ss_pred             cccccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                           ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||.+.. ..+...........      +.   
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-~~~~~~~i~~~~~~------~~---  242 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYDLIINKNNS------LK---  242 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhcCCC------CC---
Confidence                 23458899999999976  689999999999999999999999997543 22332222221111      11   


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       .+......+.+++.+||+.||++|||++++++.|..
T Consensus       243 -~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        243 -LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             -CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence             112234679999999999999999999999998854

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=333.96  Aligned_cols=257  Identities=29%  Similarity=0.459  Sum_probs=196.0

Q ss_pred             ccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHh--cCCCCeeeeeeeeeccC----ceeeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLAR--LHHRHLVALRGFCIEKR----ERFLMYEY  185 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~  185 (458)
                      +.++||+|.||.||||++ +++.||||++..   +..+.|.+|-+|.+.  ++|+||++++++-..+.    +++||++|
T Consensus       214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             hHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            456899999999999999 569999998853   344568888888776  47999999999876555    88999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhh------cCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF------YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~------~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      .++|+|.+||..+   .++|....+|+..+++||+|||+      +.+++|+|||||++||||.+|+++.|+|||||..+
T Consensus       290 h~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  290 HPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             ccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            9999999999864   59999999999999999999995      34678999999999999999999999999999877


Q ss_pred             CCCCcccccccccccCCCccccccccccC------CCCcccccHhHHHHHHHHHhCCCccCC-C--------------cc
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQD-G--------------KN  318 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg~~p~~~-~--------------~~  318 (458)
                      ..+..  .......+||.+|||||++.+.      ..-.+.||||+|.|||||+++-...+. .              ..
T Consensus       367 ~p~~~--~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  367 EPGKP--QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             cCCCC--CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            64332  1223457899999999999653      223478999999999999997543321 0              11


Q ss_pred             hHHHHHHHHhhccccccccCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          319 LVESAQVCMASESRLAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      -.+..+......     -..|.+++.. ....+..+.+.+..||..|++.|.|+.=+-+++.+..
T Consensus       445 t~e~mq~~VV~k-----K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  445 TLEEMQELVVRK-----KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CHHHHHHHHHhh-----ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            111111111111     1122222211 1145678999999999999999999999888876643

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-43  Score=346.52  Aligned_cols=247  Identities=22%  Similarity=0.334  Sum_probs=202.9

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.||+|+||.||+|... +|+.||+|.+....   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999875 68999999986432   233456789999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......    ..
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----~~  151 (323)
T cd05571          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----AT  151 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----Cc
Confidence            999999764  35899999999999999999999   8999999999999999999999999999987532211    12


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...........        ..+...+    
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~~~~~~--------~~~p~~~----  218 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEE--------IRFPRTL----  218 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-HHHHHHHHcCC--------CCCCCCC----
Confidence            2345699999999999999999999999999999999999999965432 22222222111        1112222    


Q ss_pred             HHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          350 LRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      ...+.+++.+||+.||++||     ++.++++|.|+..
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            24688999999999999999     8999999988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-44  Score=320.31  Aligned_cols=245  Identities=23%  Similarity=0.362  Sum_probs=209.0

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.||.|+||.|.+++.+ +|..+|+|.+++..   ....+...+|-.+|+.+.||.++++.+.|.+.+..||||||++
T Consensus        48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~  127 (355)
T KOG0616|consen   48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVP  127 (355)
T ss_pred             heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccC
Confidence            3568999999999999876 68999999997533   3344567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      ||-|..+|++.+  .+++..+.-+|.||+.||+|||   +.+|++|||||+|||+|.+|.+||+|||+|+.....     
T Consensus       128 GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----  197 (355)
T KOG0616|consen  128 GGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----  197 (355)
T ss_pred             CccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-----
Confidence            999999998755  4999999999999999999999   999999999999999999999999999999877653     


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                        ....+||+.|+|||.+....|..++|-|||||++|||+.|.+||.+... ......+....-.++..+.+        
T Consensus       198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~fP~~fs~--------  266 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVKFPSYFSS--------  266 (355)
T ss_pred             --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCcccCCcccCH--------
Confidence              3457899999999999999999999999999999999999999987666 34555555554444444433        


Q ss_pred             HHHHHHHHHHHHccccCCCCC-----CCHHHHHHHhhhC
Q 012715          348 EQLRTIVTIVRWCTQREGQAR-----PSIKQVLRILYES  381 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~R-----Ps~~evl~~l~~~  381 (458)
                          .+.+++...++.|-.+|     ....+|-.|.|+.
T Consensus       267 ----~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  267 ----DAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             ----HHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence                46679999999999999     3445666666664

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-43  Score=345.52  Aligned_cols=248  Identities=24%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|+.. +|+.||+|.+....   ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   99 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF   99 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence            456779999999999999876 58899999986432   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +.+|+|.+++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......  
T Consensus       100 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263        100 VVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             CCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            99999999997643  4888999999999999999999   8999999999999999999999999999998654322  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                           ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.... +...........        +...+
T Consensus       173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~--------~p~~~  238 (329)
T PTZ00263        173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-RIYEKILAGRLK--------FPNWF  238 (329)
T ss_pred             -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCcC--------CCCCC
Confidence                 2346899999999999999999999999999999999999999754432 222222211111        11112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  382 (458)
                      +    ..+.+++.+||+.||.+||+     ++++++|.|+..
T Consensus       239 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        239 D----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             C----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            2    45789999999999999996     799999988754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-43  Score=329.78  Aligned_cols=272  Identities=26%  Similarity=0.399  Sum_probs=210.0

Q ss_pred             cccCHHHHHHHhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhc--CCCCeeeeeeeeec
Q 012715           98 QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL--HHRHLVALRGFCIE  175 (458)
Q Consensus        98 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~  175 (458)
                      ..+-.+.....+..+.+.||+|.||.||+|+| .|+.||||.+...+   +..+.+|.++.+..  +|+||+.+++.-..
T Consensus       201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             chhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            34455666666777889999999999999999 58999999986443   45688999999875  99999999998765


Q ss_pred             cC----ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEeccCCCCCeeeCCCC
Q 012715          176 KR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH-----FYCDPPLCHRDIKSSNILLDENF  246 (458)
Q Consensus       176 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH-----~~~~~~iiHrDlk~~NIll~~~~  246 (458)
                      ++    .+|||.+|.++|||+|||..   ..++....++++..+|.||+|||     +..++.|.|||||+.||||..+|
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence            54    67999999999999999986   45999999999999999999999     34578899999999999999999


Q ss_pred             cEEEeecccccccCCCCcccccccccccCCCccccccccccC------CCCcccccHhHHHHHHHHHhC----------C
Q 012715          247 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTA----------R  310 (458)
Q Consensus       247 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg----------~  310 (458)
                      .+.|+|+|||..............+..+||.+|||||++...      ..-..+||||||.|+||++.+          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            999999999987665543333445667899999999998643      223469999999999999763          2


Q ss_pred             CccCCC----cchHHHHHHHHhhccccccccCCcCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          311 RAVQDG----KNLVESAQVCMASESRLAELVDPRIKD-SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       311 ~p~~~~----~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .||.+-    .+..++.... .     .+-+.|.+.. -.+.+.+..+.++|+.||..+|..|-|+-.+-+.|.+..
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVV-C-----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVV-C-----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCcccCCCCCCCHHHHhcce-e-----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            455432    1122211110 0     0111222222 124577889999999999999999999998888776543

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.7e-43  Score=340.76  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      ++||+|+||.||+++.. +|..||+|.+...   .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999875 6899999998643   2233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|..++....  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......    .
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----~  151 (323)
T cd05595          81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----T  151 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----c
Confidence            9999987543  5899999999999999999999   89999999999999999999999999999875322211    1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...........        .+...+    
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~~~~--------~~p~~~----  218 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEI--------RFPRTL----  218 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCC--------CCCCCC----
Confidence            23456899999999999999999999999999999999999999754332 22222211111        111222    


Q ss_pred             HHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          350 LRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      ...+.+++.+||+.||.+||     ++.++++|.|+..
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            25688999999999999998     8999999987754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-43  Score=339.48  Aligned_cols=247  Identities=23%  Similarity=0.313  Sum_probs=204.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +|+.||+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            345678999999999999876 68999999985422   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...+  .+++..+..++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++......  
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--  155 (291)
T cd05612          83 VPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--  155 (291)
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence            99999999997643  5899999999999999999999   9999999999999999999999999999997654321  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                           ....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+...........        +...+
T Consensus       156 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~--------~~~~~  221 (291)
T cd05612         156 -----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-FGIYEKILAGKLE--------FPRHL  221 (291)
T ss_pred             -----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCcC--------CCccC
Confidence                 234689999999999999999999999999999999999999975433 2222222221111        11112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES  381 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  381 (458)
                          ...+.+++.+||+.||.+||+     ++++++|.|..
T Consensus       222 ----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         222 ----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             ----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence                245889999999999999995     99999998874

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-42  Score=334.85  Aligned_cols=258  Identities=25%  Similarity=0.432  Sum_probs=198.9

Q ss_pred             hhcccceeeeecceEEEEEEEcC-----------------CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD-----------------GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALR  170 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~  170 (458)
                      .+.+.+.||+|+||.||+|.+.+                 +..||+|.+... .......|.+|++++.+++|+||++++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   85 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL   85 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            34567789999999999997632                 336999988643 233456799999999999999999999


Q ss_pred             eeeeccCceeeeeeecCCCCHHHHhcCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 012715          171 GFCIEKRERFLMYEYMANGSLKDHLHSPG-----------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR  233 (458)
Q Consensus       171 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHr  233 (458)
                      +++.+.+..++||||+++|+|.+++....                 ...+++..+++++.||+.||+|||   +.+|+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~  162 (304)
T cd05096          86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHR  162 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence            99999999999999999999999985421                 124788899999999999999999   8999999


Q ss_pred             cCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh--CCC
Q 012715          234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT--ARR  311 (458)
Q Consensus       234 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~  311 (458)
                      ||||+|||++.++.+||+|||+++........  .......++..|+|||.+.+..++.++||||||+++|||++  +..
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYY--RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCcee--EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999865433211  12223446789999999998899999999999999999987  455


Q ss_pred             ccCCCcchHHHHHH---HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          312 AVQDGKNLVESAQV---CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       312 p~~~~~~~~~~~~~---~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ||...... +....   ...........       ..+..++..+.+++.+||+.||++|||+.+|.+.|.
T Consensus       241 p~~~~~~~-~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDE-QVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHH-HHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            66543221 11111   11100000000       011123357899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-43  Score=348.48  Aligned_cols=247  Identities=26%  Similarity=0.417  Sum_probs=210.5

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.||+|+-|.|-+|++. +|+.+|||.+.+.   .......+.+|+-+|+.+.||||+++++++.++.++|+|.||+
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv   94 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV   94 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence            35668999999999999774 7999999998654   2233345789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++|-|.+++-..+  ++++.++.+++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||+|..-..+.   
T Consensus        95 ~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---  166 (786)
T KOG0588|consen   95 PGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---  166 (786)
T ss_pred             CCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc---
Confidence            9999999998755  4899999999999999999999   8999999999999999999999999999998766655   


Q ss_pred             ccccccccCCCccccccccccCCCC-cccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        .....+|.+.|.|||++.+.+|. .++||||+|||||.|+||+.||.+ .++.........+...++..+        
T Consensus       167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~MPs~I--------  235 (786)
T KOG0588|consen  167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFEMPSNI--------  235 (786)
T ss_pred             --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCcccCCCcC--------
Confidence              33567899999999999999985 789999999999999999999974 455444444333333333222        


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                          ..+..+++.+|+..||+.|.|++||++|+|-
T Consensus       236 ----s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l  266 (786)
T KOG0588|consen  236 ----SSEAQDLLRRMLDVDPSTRITTEEILKHPFL  266 (786)
T ss_pred             ----CHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence                2457789999999999999999999999875

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-43  Score=340.56  Aligned_cols=245  Identities=25%  Similarity=0.349  Sum_probs=201.2

Q ss_pred             eeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      ||+|+||.||+|... +++.||+|.+...   .......+.+|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999875 5889999998642   233445688999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT  271 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  271 (458)
                      .+++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......    ....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~  151 (312)
T cd05585          81 FHHLQREG--RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----DKTN  151 (312)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC----Cccc
Confidence            99997643  4899999999999999999999   9999999999999999999999999999997543221    1223


Q ss_pred             cccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       272 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.. ..+..........        .+...+    ..
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-~~~~~~~~~~~~~--------~~~~~~----~~  218 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYRKILQEPL--------RFPDGF----DR  218 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-HHHHHHHHHcCCC--------CCCCcC----CH
Confidence            4569999999999999999999999999999999999999997543 2233332222111        111122    24


Q ss_pred             HHHHHHHHccccCCCCCC---CHHHHHHHhhhCC
Q 012715          352 TIVTIVRWCTQREGQARP---SIKQVLRILYESS  382 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RP---s~~evl~~l~~~~  382 (458)
                      .+.+++.+||+.||.+||   ++.++++|.|...
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~  252 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ  252 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence            688999999999999997   5799999988754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.2e-42  Score=339.45  Aligned_cols=250  Identities=29%  Similarity=0.371  Sum_probs=195.4

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.||+|+||+||+|.+. +|+.||||.+... .......+.+|+++++.++|+||+++++++.+.+..++||||+++|
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            4568999999999999875 6899999998543 2334567899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+..      ...+..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.......    .
T Consensus       158 ~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~----~  224 (353)
T PLN00034        158 SLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD----P  224 (353)
T ss_pred             cccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc----c
Confidence            987543      2567788899999999999999   89999999999999999999999999999986543211    1


Q ss_pred             cccccCCCcccccccccc-----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          270 NTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      .....||..|+|||.+..     ...+.++|||||||++|||++|+.||..... .++..........    ..+.... 
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~----~~~~~~~-  298 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMCAICMS----QPPEAPA-  298 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHHHHHhcc----CCCCCCC-
Confidence            234568999999998743     2345689999999999999999999963221 1111111100000    0011111 


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                         .....+.+++.+||+.||++||++.|+++|.|....
T Consensus       299 ---~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        299 ---TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ---ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence               223568999999999999999999999999877553

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8e-43  Score=341.68  Aligned_cols=247  Identities=21%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      ++||+|+||.||+++.. +|..||+|.+...   .......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999875 6899999998643   2233457889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......    ..
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----~~  151 (328)
T cd05593          81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----AT  151 (328)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----cc
Confidence            999998754  35899999999999999999999   9999999999999999999999999999987532221    11


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.........        ..+...++   
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~~~~~~~~~--------~~~p~~~~---  219 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMED--------IKFPRTLS---  219 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-HHHHHHhccCC--------ccCCCCCC---
Confidence            2345699999999999999999999999999999999999999965432 22222221111        11122222   


Q ss_pred             HHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          350 LRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                       ..+.+++.+||+.||++||     ++.++++|.|+..
T Consensus       220 -~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         220 -ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             -HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence             4578999999999999997     8999999987753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=335.95  Aligned_cols=266  Identities=21%  Similarity=0.289  Sum_probs=211.0

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccch---hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE---QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ...||+|+||.||+|+-+ +|..+|+|++++...   ...+..+.|-.+|....+++||+|+..|.+.+.+||||||++|
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            368999999999999765 699999999986543   3345678899999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC-------
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-------  261 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~-------  261 (458)
                      |++..+|...+  .|++..+..++.+++.|++-||   +.|+|||||||+|+|||..|.+||+|||||.....       
T Consensus       226 GD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~  300 (550)
T KOG0605|consen  226 GDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY  300 (550)
T ss_pred             ccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence            99999998754  5999999999999999999999   99999999999999999999999999999953211       


Q ss_pred             ---------------CCcc-----c----------------ccccccccCCCccccccccccCCCCcccccHhHHHHHHH
Q 012715          262 ---------------GSIC-----F----------------EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE  305 (458)
Q Consensus       262 ---------------~~~~-----~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~e  305 (458)
                                     ....     .                .......+|||.|||||++.+..|+..+|.||||||+||
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE  380 (550)
T KOG0605|consen  301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE  380 (550)
T ss_pred             cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence                           0000     0                001124679999999999999999999999999999999


Q ss_pred             HHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHhhhCC
Q 012715          306 IVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP---SIKQVLRILYESS  382 (458)
Q Consensus       306 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl~~l~~~~  382 (458)
                      |+.|-+||........+..+... ...+..-.+        .....+..++|.+|+. ||++|.   .++||-+|+|+..
T Consensus       381 mLvGyPPF~s~tp~~T~rkI~nw-r~~l~fP~~--------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  381 MLVGYPPFCSETPQETYRKIVNW-RETLKFPEE--------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHH-hhhccCCCc--------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence            99999999766554444433221 111111111        1112568899999999 999996   5999999998754


Q ss_pred             ------CCCCcchhhcc
Q 012715          383 ------DPMHSGFVQAV  393 (458)
Q Consensus       383 ------~~~~~~~~~~~  393 (458)
                            .....+|+..+
T Consensus       451 v~W~~l~~~~apfvP~v  467 (550)
T KOG0605|consen  451 VDWDHLREMPAPFVPQV  467 (550)
T ss_pred             CCcchhhcCCCCCCCCC
Confidence                  33445666554

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-42  Score=343.47  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             hhcccceeeeecceEEEEEEE------cCCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||.||+|.+      .++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+..+
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~  115 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL  115 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence            345678999999999999964      235689999986432 33345788999999999 8999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCC-------------------------------------------------------------
Q 012715          181 LMYEYMANGSLKDHLHSPG-------------------------------------------------------------  199 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  199 (458)
                      +|||||++|+|.+++....                                                             
T Consensus       116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (375)
T cd05104         116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI  195 (375)
T ss_pred             eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence            9999999999999986421                                                             


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          200 ------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       200 ------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                                  ...+++..+++++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........  
T Consensus       196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--  270 (375)
T cd05104         196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY--  270 (375)
T ss_pred             ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc--
Confidence                        124788999999999999999999   899999999999999999999999999999865433211  


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||.............. .....   ..+   .   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~---~---  340 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-EGYRM---LSP---E---  340 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH-hCccC---CCC---C---
Confidence            11222345678999999999999999999999999999998 7778765433222222211 11100   001   1   


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ..+..+.+++.+||+.||++||++.++++.|+.
T Consensus       341 -~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 -CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence             112468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.5e-42  Score=338.72  Aligned_cols=262  Identities=23%  Similarity=0.311  Sum_probs=204.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +...+.||+|+||.||+++.. +|..||+|.+... .......+.+|++++++++|+||+++++++.+++..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   86 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   86 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence            344568999999999999876 5889999988643 33345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +|+|.+++....  .+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||++.......   
T Consensus        87 ~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  158 (331)
T cd06649          87 GGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  158 (331)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence            999999997643  4889999999999999999999   64 69999999999999999999999999987654321   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc----cccc--------
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SRLA--------  334 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~--------  334 (458)
                         .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..... .+.........    ....        
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-KELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHhcccccccccCCccccCcccc
Confidence               2345689999999999999999999999999999999999999964322 12111110000    0000        


Q ss_pred             --------------------c----ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          335 --------------------E----LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       335 --------------------~----~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                                          +    +................+.+++.+||+.||++||+++++++|.|....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                0    000000000001123568999999999999999999999999987543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=345.56  Aligned_cols=259  Identities=24%  Similarity=0.407  Sum_probs=216.7

Q ss_pred             HHHHHHHhhcccceeeeecceEEEEEEEcC-CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          102 YKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       102 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      .+|+.+....+..+||.|.||.||.|.|+. ...||||.++... ...++|+.|+.+|+.++|||+|+|+|+|.....+|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            344555555667899999999999999974 6789999987544 34678999999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      ||+|||.+|+|.+||++..+..++...++.++.||+.||+||.   .+++|||||.++|+|+.++..+||+||||++...
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            9999999999999999887777888899999999999999999   9999999999999999999999999999999887


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      .+...   ......-...|.|||.+....++.|+|||+|||+|||+.| |..|| .+.++.+.+.. +          ..
T Consensus       417 gDTYT---AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY-PGidlSqVY~L-L----------Ek  481 (1157)
T KOG4278|consen  417 GDTYT---AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYGL-L----------EK  481 (1157)
T ss_pred             CCcee---cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHH-H----------hc
Confidence            65432   1222334678999999999999999999999999999998 44555 45555444332 1          22


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .++-+.+..|+..++++|+.||+..|.+||++.|+.+.++
T Consensus       482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            2233344566688999999999999999999999988764

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-42  Score=328.71  Aligned_cols=250  Identities=38%  Similarity=0.612  Sum_probs=196.1

Q ss_pred             ccceeeeecceEEEEEEEc-----CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFS-----DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.. .....+.|.+|++.+.+++||||++++|+|...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4568999999999999886     2578999999643 333467899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.++|.......+++..+..|+.||+.||+|||   +.+++|+||+++|||++.++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999998764556999999999999999999999   889999999999999999999999999999876322211


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                        ...........|+|||.+....++.++||||||+++|||++ |+.|+.+. +..+..... .......      ... 
T Consensus       160 --~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~-~~~~~~~------~~~-  228 (259)
T PF07714_consen  160 --KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKL-KQGQRLP------IPD-  228 (259)
T ss_dssp             --EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHH-HTTEETT------SBT-
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc-cccccce------ecc-
Confidence              12233457789999999999999999999999999999999 67887654 333333322 1111111      111 


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                         .....+.+++..||..+|.+||++.++++.|
T Consensus       229 ---~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 ---NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               1235688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-42  Score=338.14  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=200.6

Q ss_pred             ceeeeecceEEEEEEE----cCCCEEEEEEecccc----hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          114 TIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.||+|+||.||+++.    .+++.||+|.+....    ......+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            4799999999999975    357899999986422    22334678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...+  .+.+..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (323)
T cd05584          82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-  155 (323)
T ss_pred             CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence            99999999997643  4788899999999999999999   89999999999999999999999999999875432211 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ...........        .+....
T Consensus       156 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-~~~~~~~~~~~--------~~~~~~  223 (323)
T cd05584         156 ---VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKILKGKL--------NLPPYL  223 (323)
T ss_pred             ---cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-HHHHHHHcCCC--------CCCCCC
Confidence               123456899999999999988999999999999999999999999754332 22222221111        111112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                          ...+.+++.+||+.+|++||     +++++++|.|...
T Consensus       224 ----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         224 ----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             ----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence                24588999999999999999     8999999987653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-42  Score=333.28  Aligned_cols=263  Identities=21%  Similarity=0.299  Sum_probs=203.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||.||+|+.. ++..||+|++...  .....+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            445678999999999999886 5789999998643  2233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +++.|..+...  ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.......  
T Consensus        83 ~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  155 (287)
T cd07848          83 EKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--  155 (287)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc--
Confidence            98777665543  235899999999999999999999   89999999999999999999999999999986543221  


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc-------------ccc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-------------SRL  333 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------------~~~  333 (458)
                       .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.................             ...
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence             112345689999999999988999999999999999999999999976543332222111000             000


Q ss_pred             ccccCCcCCCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          334 AELVDPRIKDSF------DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       334 ~~~~d~~~~~~~------~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .....+......      .......+.+++.+||+.||++|||++++++|.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            000001110000      01123568999999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=338.58  Aligned_cols=256  Identities=23%  Similarity=0.307  Sum_probs=206.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +++.||+|.+....   ......+.+|++++..++|+||+++++++.+.+..|+||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            345678999999999999876 58899999986432   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...+  .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        83 ~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----  153 (333)
T cd05600          83 VPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----  153 (333)
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence            99999999997543  5889999999999999999999   89999999999999999999999999999975533    


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......||+.|+|||.+.+..++.++|||||||++|||++|..||...... +...........+.   .+.... .
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~---~~~~~~-~  225 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWENLKYWKETLQ---RPVYDD-P  225 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-HHHHHHHhcccccc---CCCCCc-c
Confidence               123456999999999999999999999999999999999999999654322 22221111111010   111110 0


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .......+.+++.+||..+|.+||+++++++|.|...
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            0122356889999999999999999999999988754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-42  Score=320.29  Aligned_cols=265  Identities=26%  Similarity=0.321  Sum_probs=210.7

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccch--hhHhHHHHHHHHHHhcCCCC-eeeeeeeeeccC------ceeee
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRH-LVALRGFCIEKR------ERFLM  182 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~~~lv  182 (458)
                      .++||+|+||+||+|+.. +|+.||+|++.-..+  .......+|+.+|+.++|+| |+.+++++...+      ..++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            456999999999999765 689999999864332  34456789999999999999 999999999877      78999


Q ss_pred             eeecCCCCHHHHhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          183 YEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||++. +|..++.....  ..++...+..++.||+.||+|||   +++|+||||||.||||+++|.+||+|||+|+...
T Consensus        96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen   96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            999965 99999976543  35777899999999999999999   9999999999999999999999999999999665


Q ss_pred             CCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc----ccccc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SRLAE  335 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~  335 (458)
                      -+..    ..+..++|.+|.|||++.+. .|+...||||+||++.||++++..|.+..+..+...+....+    ..++.
T Consensus       172 ip~~----~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  172 IPMR----TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             CCcc----cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            4332    35677899999999999876 799999999999999999999988887776655554433211    11221


Q ss_pred             cc---CCc--CCCCC---C--HHHH---HHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          336 LV---DPR--IKDSF---D--MEQL---RTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       336 ~~---d~~--~~~~~---~--~~~~---~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      ..   +..  .....   +  ....   ....+++.+|++.+|.+|.|++.+++|.++...+.
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            11   111  00000   0  0111   36789999999999999999999999988765543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-42  Score=342.28  Aligned_cols=248  Identities=21%  Similarity=0.324  Sum_probs=204.1

Q ss_pred             hcccceeeeecceEEEEEEEcC--CCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD--GSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|.+.+  +..||+|.+...   .......+.+|++++..++||||+++++++.+.+..++|||
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E  111 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE  111 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence            4567899999999999997653  368999988542   22334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       112 y~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        112 FVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            999999999997643  4899999999999999999999   999999999999999999999999999999865432  


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                           .....||+.|+|||++.+..++.++|||||||++|||++|..||...... ............        +...
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~~~~--------~p~~  250 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILEGIIY--------FPKF  250 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhcCCCC--------CCCC
Confidence                 12356899999999999988999999999999999999999999754432 222222211111        1112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      .+    ..+.+++.+|++.||++|+     +++++++|.|+..
T Consensus       251 ~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        251 LD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             CC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            22    4578899999999999995     8999999998754

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.2e-42  Score=331.45  Aligned_cols=262  Identities=22%  Similarity=0.302  Sum_probs=198.8

Q ss_pred             hcccceeeeecceEEEEEEEc--CCCEEEEEEecccc--hhhHhHHHHHHHHHHhc---CCCCeeeeeeeeec-----cC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS--DGSLIAVKRMDKIS--EQVEGDFCREIELLARL---HHRHLVALRGFCIE-----KR  177 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  177 (458)
                      +.+.+.||+|+||.||+|+..  +|..||+|.+....  ......+.+|+.+++.+   +||||++++++|..     ..
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            445678999999999999863  46889999886422  22234567788887776   59999999999853     34


Q ss_pred             ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..++||||+. ++|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            6899999996 69999997655556899999999999999999999   8999999999999999999999999999997


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc----ccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SRL  333 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~  333 (458)
                      ......     ......||..|+|||.+.+..++.++|||||||++|||++|+.||....+............    ...
T Consensus       159 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         159 IYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             eccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            654321     22345689999999999988999999999999999999999999976554433222211100    000


Q ss_pred             cc-------ccCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          334 AE-------LVDPRIKD---SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       334 ~~-------~~d~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..       ...+....   .........+.+++.+||+.||++||++.++++|.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            00       00000000   0001122467899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.6e-42  Score=330.94  Aligned_cols=262  Identities=24%  Similarity=0.307  Sum_probs=200.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||.|+||.||+|... ++..||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            445678999999999999875 68899999886432 2234467899999999999999999999999999999999997


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      + +|.+++...+ ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus        87 ~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~---  158 (288)
T cd07871          87 S-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK---  158 (288)
T ss_pred             c-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc---
Confidence            5 9999986543 34789999999999999999999   89999999999999999999999999999975433221   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc----ccc--------
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLA--------  334 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~--------  334 (458)
                       ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..................    ...        
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence             1233568999999998865 56899999999999999999999999654332222111111000    000        


Q ss_pred             -cccCCcCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          335 -ELVDPRIKDSF----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       335 -~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ....+......    .......+.+++.+||+.||.+|||++|+++|.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence             01111110000    00112457899999999999999999999998763

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-42  Score=328.14  Aligned_cols=253  Identities=20%  Similarity=0.347  Sum_probs=201.8

Q ss_pred             HhhcccceeeeecceEEEEEEEc----CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      ..+.+.++||+|+||.||+|.+.    .+..||+|.++... ......|.+|+.++.+++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            34567789999999999999763    35689999987542 33345789999999999999999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+......
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999997643 35899999999999999999999   899999999999999999999999999987654322


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ...   ......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.... +...... ....      ...
T Consensus       161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~~~~~~-~~~~------~~~  229 (266)
T cd05064         161 AIY---TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIKAVE-DGFR------LPA  229 (266)
T ss_pred             chh---cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHH-CCCC------CCC
Confidence            111   1112345678999999999999999999999999999775 99998754332 2222111 1100      111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                          +...+..+.+++..||+.+|.+||+++++++.|.
T Consensus       230 ----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~  263 (266)
T cd05064         230 ----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILS  263 (266)
T ss_pred             ----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence                1223456899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=322.78  Aligned_cols=261  Identities=23%  Similarity=0.337  Sum_probs=203.7

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecc--cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeec-----cCceeeeee
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIE-----KRERFLMYE  184 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e  184 (458)
                      .+.||+|+||.|+.+... +|..||||++.+  ......+...+|+++|+.++|+||+.+.+.+.-     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            356999999999999775 689999999863  334445678899999999999999999998765     357899999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      +| +.+|...++..  ..++...+..+..|+++||.|+|   +.+++||||||+|+|++.+..+||+|||||+.....  
T Consensus       107 lM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~--  178 (359)
T KOG0660|consen  107 LM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF--  178 (359)
T ss_pred             HH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeecccc--
Confidence            99 45999999864  34899999999999999999999   999999999999999999999999999999987543  


Q ss_pred             ccccccccccCCCccccccccc-cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC-----
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD-----  338 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d-----  338 (458)
                      ......+..+.|.+|.|||.+. ...|+.+.||||.||++.||++|++.|.+...+ ...+.+...-+...+..-     
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHHHHHhcCCCCHHHHHHhcc
Confidence            1223457788999999999875 468999999999999999999999888654433 333332221111110000     


Q ss_pred             ----------Cc-CCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 ----------PR-IKDSFD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 ----------~~-~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                |. -+..+.   ...-....+++.+||..||.+|+|++|+|+|++...
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~  315 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP  315 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence                      00 000000   011245789999999999999999999999987643

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-42  Score=329.40  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=205.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      ++..++||+|+||+||++... +++.||+|.+....   ......+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            345678999999999999875 68999999986432   22234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++.......+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence            99999999987654456999999999999999999999   8999999999999999999999999999998654332  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.+.............    +..     ....+
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~----~~~-----~~~~~  224 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR----VKE-----DQEEY  224 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH----hhh-----ccccc
Confidence               122346899999999999889999999999999999999999999754332111111000    000     00111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      +......+.+++.+||+.||++||     +++++++|.|...
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            122335688999999999999999     8999999987743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=324.42  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=215.8

Q ss_pred             HHHHHhhcccceeeeecceEEEEEEE-cCCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCce
Q 012715          104 ETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER  179 (458)
Q Consensus       104 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  179 (458)
                      .-.+..++|.+.||+|.||.|-+|.. ..|+.||||.+++.   +++..-.+.+|+++|+.|+||||+.++.+|..++..
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            34456677888999999999999965 57999999988653   445555688999999999999999999999999999


Q ss_pred             eeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      .|||||..+|.|++|+.+.+  .|++.++..++.||..|+.|+|   .++++|||||.+|||+|.|+++||+||||+..+
T Consensus       129 vivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhh
Confidence            99999999999999998755  4999999999999999999999   999999999999999999999999999999888


Q ss_pred             CCCCcccccccccccCCCccccccccccCCCC-cccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                      .++.     ....++|++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||. +.+....+..+.....+.+    
T Consensus       204 ~~~k-----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD-G~Dhk~lvrQIs~GaYrEP----  273 (668)
T KOG0611|consen  204 ADKK-----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD-GRDHKRLVRQISRGAYREP----  273 (668)
T ss_pred             cccc-----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC-CchHHHHHHHhhcccccCC----
Confidence            7765     34678999999999999999885 78999999999999999999995 5555555554443332221    


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       .        .+....-+|+|||..+|++|-|+.+|..|-|-
T Consensus       274 -~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  274 -E--------TPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             -C--------CCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence             1        11235569999999999999999999999874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.4e-42  Score=331.21  Aligned_cols=265  Identities=23%  Similarity=0.280  Sum_probs=202.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccch-hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||.||+|... +++.||||.+..... .....+.+|+.+++.++|+||+++++++.+.+..++||||+.
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH   86 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence            445678999999999999876 689999999864322 223467889999999999999999999999999999999995


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                       ++|.+++.... ..++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......   
T Consensus        87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---  158 (303)
T cd07869          87 -TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH---  158 (303)
T ss_pred             -cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc---
Confidence             68888886543 34889999999999999999999   99999999999999999999999999999875432211   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc-----ccc-----
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL-----AEL-----  336 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~-----  336 (458)
                       ......||+.|+|||.+.+ ..++.++|||||||++|||++|..||.+..+..+.........+..     ...     
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence             1234568999999998865 4588899999999999999999999976555433332221110000     000     


Q ss_pred             cCCc-CCC--CCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          337 VDPR-IKD--SFDM-------EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       337 ~d~~-~~~--~~~~-------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .++. ...  ....       .....+.+++.+||+.||++|||++|+++|.|+..-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            0000 000  0000       012457899999999999999999999999988643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-42  Score=340.07  Aligned_cols=247  Identities=22%  Similarity=0.344  Sum_probs=201.2

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.||+|+||.||++... +|..||+|.+...   .......+.+|++++..++|+||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999764 6899999998643   2233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      +|..++...  ..+++..+..++.||+.||+|||   + .+|+||||||+|||++.++.+||+|||+++.......    
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~----  151 (325)
T cd05594          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA----  151 (325)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----
Confidence            999998753  35899999999999999999999   6 7999999999999999999999999999875322211    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............        .+...++  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~~~~~~i~~~~~--------~~p~~~~--  220 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI--------RFPRTLS--  220 (325)
T ss_pred             ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-HHHHHHHhcCCC--------CCCCCCC--
Confidence            12335699999999999999999999999999999999999999965432 222222221111        1122222  


Q ss_pred             HHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                        ..+.+++.+||+.||++|+     ++.++++|.|...
T Consensus       221 --~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         221 --PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             --HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence              4588999999999999996     9999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-43  Score=307.72  Aligned_cols=249  Identities=25%  Similarity=0.369  Sum_probs=212.8

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +..+.||+|-||.||.|+.+ ++-.||+|.+.+.   ..+...++.+|+++-+.|+||||+++++++.+....||++||.
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya  104 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA  104 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence            45678999999999999876 5789999998643   2344568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      .+|.|...|.......+++.....++.|+|.||.|+|   .+++|||||||+|+|++.++.+||+|||.+.....+    
T Consensus       105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~----  177 (281)
T KOG0580|consen  105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN----  177 (281)
T ss_pred             CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC----
Confidence            9999999999776777999999999999999999999   999999999999999999999999999998765533    


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        .....+||..|.+||...+..++..+|+|++|++.||++.|.+||.... ..+..+.+...+-.+     |   ...+
T Consensus       178 --kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~~-----p---~~is  246 (281)
T KOG0580|consen  178 --KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLKF-----P---STIS  246 (281)
T ss_pred             --CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccccC-----C---cccC
Confidence              3456789999999999999999999999999999999999999997554 334444333322222     2   1122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                          ....++|.+|+..+|.+|....|+++|.|..
T Consensus       247 ----~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  247 ----GGAADLISRLLVKNPIERLALTEVMDHPWIV  277 (281)
T ss_pred             ----hhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence                4578899999999999999999999998753

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-41  Score=320.12  Aligned_cols=249  Identities=26%  Similarity=0.461  Sum_probs=201.4

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      ..+.+.||+|+||.||++.++++..+|+|.+... .....++.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG   84 (256)
T ss_pred             cEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence            4456789999999999999988889999987643 233467899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.++++.... .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++........   .
T Consensus        85 ~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~---~  157 (256)
T cd05114          85 CLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT---S  157 (256)
T ss_pred             cHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee---c
Confidence            99999975432 4899999999999999999999   899999999999999999999999999998765432211   1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+......... .   ...+..       
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~~i~~~~-~---~~~~~~-------  225 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGF-R---LYRPKL-------  225 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCC-C---CCCCCC-------
Confidence            122345678999999998899999999999999999999 8888864432 22222221111 0   111111       


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      ....+.+++.+||+.+|++||++.++++.|
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            124689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3e-42  Score=343.33  Aligned_cols=256  Identities=26%  Similarity=0.405  Sum_probs=200.7

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||.||+|...      ++..||||++.... ......+.+|+++++.+ +|+||++++++|.+.+..+
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~  118 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL  118 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence            4456789999999999998742      34579999986432 33345688999999999 8999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCC-------------------------------------------------------------
Q 012715          181 LMYEYMANGSLKDHLHSPG-------------------------------------------------------------  199 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  199 (458)
                      +||||+++|+|.+++....                                                             
T Consensus       119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (374)
T cd05106         119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK  198 (374)
T ss_pred             EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence            9999999999999985321                                                             


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccc
Q 012715          200 -------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       200 -------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                             ..++++..+++++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++........  .....
T Consensus       199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~~~~~  273 (374)
T cd05106         199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVKGN  273 (374)
T ss_pred             chhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--eeccC
Confidence                   124788899999999999999999   899999999999999999999999999999765433211  11222


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      ..++..|||||++.+..++.++|||||||++|||++ |+.||............. ...      ..+.....    .+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~-~~~------~~~~~~~~----~~~  342 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV-KRG------YQMSRPDF----APP  342 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH-Hcc------cCccCCCC----CCH
Confidence            345678999999998999999999999999999997 999986543222222211 111      01111111    125


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          352 TIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+.+++.+||+.||++||++.++++.|.+
T Consensus       343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         343 EIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            68899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8e-41  Score=372.19  Aligned_cols=264  Identities=27%  Similarity=0.525  Sum_probs=210.9

Q ss_pred             cCHHHHHHHhhcccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc
Q 012715          100 FSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE  178 (458)
Q Consensus       100 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  178 (458)
                      +++.++..+ ....++||+|+||.||+|.. .+|..||||++......    ...|++++++++||||++++|+|.+.+.
T Consensus       683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            455555443 23356899999999999987 47899999988643322    2356889999999999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      .++||||+++|+|.++++.     ++|..+.+++.|+++||+|||..+.++|+||||||+||+++.++..++. ||....
T Consensus       758 ~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            9999999999999999963     8999999999999999999997777899999999999999999888875 665543


Q ss_pred             cCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCC----cchHHHHHHHHhhccccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG----KNLVESAQVCMASESRLA  334 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~----~~~~~~~~~~~~~~~~~~  334 (458)
                      ...        .....+|..|||||++.+..++.++|||||||++|||+||+.|+...    ....+|..... ......
T Consensus       832 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  902 (968)
T PLN00113        832 LCT--------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY-SDCHLD  902 (968)
T ss_pred             ccc--------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc-Cccchh
Confidence            221        12235789999999999999999999999999999999999998532    23444544332 222344


Q ss_pred             cccCCcCCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          335 ELVDPRIKDS--FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       335 ~~~d~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ..+|+.+...  .+.++..++.+++.+||+.||++||+|+|+++.|.....
T Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            5566665432  345677789999999999999999999999999976543

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-41  Score=334.09  Aligned_cols=263  Identities=24%  Similarity=0.337  Sum_probs=203.6

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.++||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|+||++++++|.+++..++||||+
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   85 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecC
Confidence            4456678999999999999876 5888999987643 3334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      ++|+|.+++...+  .+++..+..++.|++.||.|||   + .+++||||||+|||++.++.+||+|||++......   
T Consensus        86 ~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  157 (333)
T cd06650          86 DGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (333)
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence            9999999997643  4889999999999999999999   5 47999999999999999999999999998754322   


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHh-hccccccc--------
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA-SESRLAEL--------  336 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~--------  336 (458)
                         ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... +....... ........        
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-HHHHHhcCcccCCccccccCcccCC
Confidence               123356899999999999889999999999999999999999998643221 11100000 00000000        


Q ss_pred             -------cCCcC-----------------CCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          337 -------VDPRI-----------------KDSFD-MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       337 -------~d~~~-----------------~~~~~-~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                             ..+..                 ..... ......+.+++.+||+.||++||++.|+++|.|....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                   00000                 00000 0112468899999999999999999999999887543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=321.60  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=206.0

Q ss_pred             HHhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      ...+++.+.||+|+||.||+|.+.++..||+|.+.... ...+++.+|++++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            34466778999999999999998778899999986433 23467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++++|.+++.......+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++........ 
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence            9999999997655456899999999999999999999   899999999999999999999999999999876532211 


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        .......+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ....... .....          ..
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~-~~~~~----------~~  225 (261)
T cd05068         160 --AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-EVLQQVD-QGYRM----------PC  225 (261)
T ss_pred             --ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH-cCCCC----------CC
Confidence              1112223468999999999999999999999999999999 88888643322 2111111 11110          11


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +......+.+++.+|++.+|.+||+++++++.|++
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            11233568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=341.93  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=206.0

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +|.++||+|+||+|+++.++ +++.+|||.+++.   .....+..+.|-.|+.... ||.+++++.++..+++.|+||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            45689999999999999887 5889999999753   3445667888999988885 99999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +.||++..+.+.   ..|++..+.-++..|+.||+|||   +++|||||||.+|||+|.+|.+||+||||++..-...  
T Consensus       451 ~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--  522 (694)
T KOG0694|consen  451 VAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--  522 (694)
T ss_pred             cCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCCCC--
Confidence            999995444442   35999999999999999999999   9999999999999999999999999999998643211  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        ..+..++||+.|||||++.+..|+.++|.|||||+||||+.|..||.+ .+..+....+...+        +....  
T Consensus       523 --~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~--------~~yP~--  589 (694)
T KOG0694|consen  523 --DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDE--------VRYPR--  589 (694)
T ss_pred             --CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC--------CCCCC--
Confidence              245678999999999999999999999999999999999999999963 34444444443322        22222  


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~~~~  382 (458)
                        -...+..+|+++++..+|++|.-+     ++|.+|+++..
T Consensus       590 --~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  590 --FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             --cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence              223568899999999999999854     77888877643

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.1e-42  Score=335.54  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=200.4

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ++||+|+||+||+|..+ +++.||||.+...   .......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 5889999998642   223345678899999877 699999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++....  .+++..+..++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++......    .
T Consensus        81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~----~  151 (320)
T cd05590          81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----K  151 (320)
T ss_pred             chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----C
Confidence            99999987643  4899999999999999999999   9999999999999999999999999999987532211    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+...........        .....   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-~~~~~~i~~~~~~--------~~~~~---  219 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEVV--------YPTWL---  219 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCCCC--------CCCCC---
Confidence            22345689999999999999999999999999999999999999975432 2332222221111        11112   


Q ss_pred             HHHHHHHHHHHccccCCCCCCCH------HHHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSI------KQVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~------~evl~~l~~~~  382 (458)
                       ...+.+++.+||+.||.+||++      +++++|.|+..
T Consensus       220 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         220 -SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             -CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence             2457899999999999999998      88998887643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2e-41  Score=323.92  Aligned_cols=249  Identities=27%  Similarity=0.372  Sum_probs=196.0

Q ss_pred             eeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      ||+|+||.||++... +|+.||+|.+....   ......+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999875 58999999886321   12234566799999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT  271 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  271 (458)
                      .+++.......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.......     ...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~~  152 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----TIT  152 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----eee
Confidence            99987655566899999999999999999999   8999999999999999999999999999987654432     122


Q ss_pred             cccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       272 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||................   ....... ....    ...
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~-~~~~----~~~  224 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT---LEDEVKF-EHQN----FTE  224 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh---hcccccc-cccc----CCH
Confidence            3468999999999998889999999999999999999999996533211111110000   0000000 0011    234


Q ss_pred             HHHHHHHHccccCCCCCCCHHHH----HHHhhh
Q 012715          352 TIVTIVRWCTQREGQARPSIKQV----LRILYE  380 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RPs~~ev----l~~l~~  380 (458)
                      .+.+++..||+.||++||+++|+    +.|.|+
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f  257 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF  257 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence            68899999999999999999554    455444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-41  Score=332.94  Aligned_cols=246  Identities=23%  Similarity=0.332  Sum_probs=200.2

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ++||+|+||.||+|... +++.||+|.+...   .......+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999876 5789999998643   223345677899999876 799999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|..++....  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......    
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~----  151 (321)
T cd05591          81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----  151 (321)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc----
Confidence            99999987543  4899999999999999999999   89999999999999999999999999999875432211    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||..|+|||.+.+..++.++|||||||++|||++|+.||..... .+...........        .....   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~i~~~~~~--------~p~~~---  219 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILHDDVL--------YPVWL---  219 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCC--------CCCCC---
Confidence            22345689999999999999999999999999999999999999975433 2332222221111        11111   


Q ss_pred             HHHHHHHHHHHccccCCCCCC-------CHHHHHHHhhhC
Q 012715          349 QLRTIVTIVRWCTQREGQARP-------SIKQVLRILYES  381 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RP-------s~~evl~~l~~~  381 (458)
                       ...+.+++..||+.||++||       +++++++|.|..
T Consensus       220 -~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~  258 (321)
T cd05591         220 -SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK  258 (321)
T ss_pred             -CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccC
Confidence             24688999999999999999       899999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.1e-42  Score=335.88  Aligned_cols=266  Identities=21%  Similarity=0.332  Sum_probs=198.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC-----ceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  181 (458)
                      +.+.+.||+|+||.||+|... +|..||||++...  .......+.+|++++++++||||+++++++....     ..|+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            345678999999999999865 6899999988642  2233456889999999999999999999886432     4799


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      |||||. ++|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        82 v~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          82 VFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            999995 69999987543  4899999999999999999999   89999999999999999999999999999975432


Q ss_pred             CCcccccccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc-------
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-------  332 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------  332 (458)
                      .... ........||..|+|||.+.+  ..++.++|||||||++|||++|+.||...................       
T Consensus       156 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         156 DTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             ccCc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2110 011234578999999999865  678999999999999999999999996543321111100000000       


Q ss_pred             --------cccccCCcCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          333 --------LAELVDPRIKDSFD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       333 --------~~~~~d~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                              ....+.......+.   ......+.+++.+||+.||++||+++|+++|.|+..
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence                    00000000000000   011245789999999999999999999999988754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-41  Score=325.52  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=200.2

Q ss_pred             eeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      ||+|+||+||++... +|+.||+|.+....   ....+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999765 68899999986432   22235678899999999999999999999999999999999999999


Q ss_pred             HHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          192 KDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       192 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      .+++...  ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........    .
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----~  153 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----K  153 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc----c
Confidence            9887432  2345899999999999999999999   89999999999999999999999999999976544321    1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...............       .....  ..++...
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-------~~~~~--~~~~~~~  224 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR-------ILNDS--VTYPDKF  224 (280)
T ss_pred             ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh-------hcccC--CCCcccC
Confidence            23456899999999999999999999999999999999999999754322111111000       00000  0111223


Q ss_pred             HHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          350 LRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      ...+.+++.+||+.||++||     +++++++|.|+..
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            35688999999999999999     8899999988753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3e-41  Score=319.50  Aligned_cols=253  Identities=25%  Similarity=0.424  Sum_probs=204.8

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK   85 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence            345667899999999999998888899999876433 2356789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.........   
T Consensus        86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~---  159 (261)
T cd05072          86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT---  159 (261)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCcee---
Confidence            99999997655556899999999999999999999   899999999999999999999999999999876543211   


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......++..|+|||.+....++.++|||||||++|||++ |..||...... ...... .....      ......   
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~-~~~~~------~~~~~~---  228 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMSAL-QRGYR------MPRMEN---  228 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHHHHH-HcCCC------CCCCCC---
Confidence            1223346778999999988889999999999999999998 88888643322 111111 11111      111111   


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       .+..+.+++.+||..+|++||+++++++.|..
T Consensus       229 -~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         229 -CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             23568899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-41  Score=349.15  Aligned_cols=253  Identities=23%  Similarity=0.310  Sum_probs=203.5

Q ss_pred             hcccceeeeecceEEEEEEEc-C-CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-D-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||.||+|... + +..||+|.+..........+.+|+.+|+.++||||+++++++...+..||||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            556789999999999999654 3 67888887755444545678889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          188 NGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       188 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +|+|.+++...  ...++++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~-  224 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-  224 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc-
Confidence            99999988542  2346899999999999999999999   89999999999999999999999999999986543221 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                       ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+..........      ++ ...  
T Consensus       225 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~------~~-~~~--  293 (478)
T PTZ00267        225 -LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-REIMQQVLYGKY------DP-FPC--  293 (478)
T ss_pred             -cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC------CC-CCc--
Confidence             1123345699999999999999999999999999999999999999964332 222222221110      00 111  


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                        .....+.+++.+||+.+|++||++.+++.+.+
T Consensus       294 --~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~  325 (478)
T PTZ00267        294 --PVSSGMKALLDPLLSKNPALRPTTQQLLHTEF  325 (478)
T ss_pred             --cCCHHHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence              12246889999999999999999999987643

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.9e-42  Score=334.83  Aligned_cols=247  Identities=21%  Similarity=0.348  Sum_probs=198.8

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ++||+|+||.||+|... ++..||+|.+...   .......+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999875 6889999998643   223345688899999998 699999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...  ..+++..+..++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++......    .
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~  151 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG----D  151 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----C
Confidence            9999998654  35999999999999999999999   9999999999999999999999999999987432211    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc-------chHHHH-HHHHhhccccccccCCc
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-------NLVESA-QVCMASESRLAELVDPR  340 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~-------~~~~~~-~~~~~~~~~~~~~~d~~  340 (458)
                      ......||..|+|||.+.+..++.++|||||||++|||++|+.||....       ...++. .......        ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~  223 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------IR  223 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------CC
Confidence            2234578999999999999999999999999999999999999995211       111111 1111111        11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPS------IKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs------~~evl~~l~~~  381 (458)
                      +...++    ..+.+++.+||+.||.+|++      ++++++|.|..
T Consensus       224 ~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         224 IPRSLS----VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             CCCCCC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            122222    45889999999999999987      78999998874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.2e-41  Score=331.59  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=198.8

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||.||+|... +|..||+|.++...   ......+..|..++..+ +|+||+++++++.+++..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999876 58899999986432   22344567788888765 899999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|..++...  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......    .
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~  151 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----N  151 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----C
Confidence            9999999764  34889999999999999999999   8999999999999999999999999999987432211    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||..|+|||.+.+..++.++|||||||++|||++|+.||..... .+.........        +.+....+  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~~~~~~~~~~--------~~~~~~~~--  220 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRVDT--------PHYPRWIT--  220 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC--------CCCCCCCC--
Confidence            22345689999999999999999999999999999999999999975432 22222221111        11112222  


Q ss_pred             HHHHHHHHHHHccccCCCCCCCH-HHHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSI-KQVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~-~evl~~l~~~~  382 (458)
                        ..+.+++.+||+.||++||++ +++++|.|+..
T Consensus       221 --~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         221 --KESKDILEKLFERDPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             --HHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence              457899999999999999997 57888887644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-41  Score=331.03  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=199.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHH---HhcCCCCeeeeeeeeeccCceeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELL---ARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.||+|+||.||+|... +|+.||||.+....   ....+.+.+|++++   +.++||||+++++++.+++..|+||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            35678999999999999875 68999999986432   22334566776665   4567999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|..++..   ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......
T Consensus        82 E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          82 EYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             cCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999999998864   35899999999999999999999   8999999999999999999999999999987532211


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                          .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+..........        ....
T Consensus       156 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~~--------~~p~  222 (324)
T cd05589         156 ----DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFDSIVNDEV--------RYPR  222 (324)
T ss_pred             ----CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--------CCCC
Confidence                122345789999999999999999999999999999999999999965432 222222221111        1111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      .+    ...+.+++.+||+.||.+||     ++.+++++.|+..
T Consensus       223 ~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         223 FL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             CC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            22    24578999999999999999     6899999887643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-42  Score=320.58  Aligned_cols=257  Identities=24%  Similarity=0.348  Sum_probs=199.5

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC-----ceeeeeeec
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLMYEYM  186 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~  186 (458)
                      .+++|.|+||.||+|.+. +++.||||++-.....    --+|+++|+.+.|||||+|+.++....     ...+|||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            358999999999999875 5799999987543322    127999999999999999999886532     346899999


Q ss_pred             CCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC-CcEEEeecccccccCCCC
Q 012715          187 ANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGS  263 (458)
Q Consensus       187 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~  263 (458)
                      +. +|.++++..  .+..++...+.-+..||++||+|||   +.+|+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            86 999999742  2345788888899999999999999   8999999999999999975 999999999999876654


Q ss_pred             cccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc----------
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----------  332 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------  332 (458)
                           .+....-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.....+...++...+..          
T Consensus       181 -----pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  181 -----PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             -----CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence                 2344567889999999876 579999999999999999999999997655554444433221111          


Q ss_pred             -cccccCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          333 -LAELVDPRIKDS-----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       333 -~~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       ..+...|.++..     +.........+++.++++.+|.+|.++.|++.|.++..
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde  311 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE  311 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence             111122222211     12233467899999999999999999999999987643

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-41  Score=338.93  Aligned_cols=260  Identities=19%  Similarity=0.238  Sum_probs=199.7

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.+.||+|+||.||+|... +++.||+|...      ...+.+|++++++++||||+++++++..+...++|+|++.
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            4556688999999999999875 68899999643      2346799999999999999999999999999999999995


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                       ++|..++...  ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus       167 -~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~---  237 (391)
T PHA03212        167 -TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA---  237 (391)
T ss_pred             -CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc---
Confidence             6899988654  34889999999999999999999   89999999999999999999999999999975332110   


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch------HHHHHHHHhhccccc-------
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL------VESAQVCMASESRLA-------  334 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~------~~~~~~~~~~~~~~~-------  334 (458)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.|+......      ......+....+..+       
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            1223457999999999999999999999999999999999999887533211      111111111000000       


Q ss_pred             -----cc---------cCCcCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          335 -----EL---------VDPRIKDSF--DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       335 -----~~---------~d~~~~~~~--~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                           +.         ..+..+...  ....+..+.+++.+||+.||++|||++|+++|.|+...
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                 00         000000000  01234578899999999999999999999999988553

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3e-41  Score=320.06  Aligned_cols=252  Identities=24%  Similarity=0.394  Sum_probs=204.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|.+. ++..||+|.+... ......+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            456678999999999999875 5889999988643 33356789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.........   
T Consensus        87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~---  160 (263)
T cd05052          87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT---  160 (263)
T ss_pred             CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceee---
Confidence            99999997655556899999999999999999999   899999999999999999999999999999866543211   


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..|+... +..+........       ..+...    .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~-------~~~~~~----~  228 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKG-------YRMERP----E  228 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCC-------CCCCCC----C
Confidence            1122234678999999999999999999999999999998 88887543 333332222111       111111    1


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..+..+.+++.+||+.+|++||++.++++.|..
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            223568999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-41  Score=322.46  Aligned_cols=253  Identities=29%  Similarity=0.429  Sum_probs=209.0

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.++||.|+||.||+|...++..+|+|.+..........+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK   86 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence            34566789999999999999888999999998766555567899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++........    
T Consensus        87 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~----  159 (261)
T cd05148          87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY----  159 (261)
T ss_pred             CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc----
Confidence            99999998765567899999999999999999999   89999999999999999999999999999976544321    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......++..|+|||.+....++.++||||||+++|+|++ |+.||.... ..+....... ...      +    ..+.
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~-~~~------~----~~~~  227 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITA-GYR------M----PCPA  227 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHHh-CCc------C----CCCC
Confidence            1123346778999999988899999999999999999998 788885433 2222222111 100      1    1112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..+..+.+++.+||+.+|.+||++.++++.|..
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            233568899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.7e-41  Score=339.24  Aligned_cols=258  Identities=23%  Similarity=0.296  Sum_probs=199.8

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.||+|+||+||+|... ++..||+|.+...   .......+.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus         4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~   83 (381)
T cd05626           4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (381)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence            45678999999999999775 6889999998643   2333457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc-
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC-  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-  265 (458)
                      ++|+|.+++....  .+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++........ 
T Consensus        84 ~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          84 PGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999999997643  4889999999999999999999   899999999999999999999999999998643110000 


Q ss_pred             ------------------------------------------cccccccccCCCccccccccccCCCCcccccHhHHHHH
Q 012715          266 ------------------------------------------FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL  303 (458)
Q Consensus       266 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l  303 (458)
                                                                .........||+.|+|||.+.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                      00011235799999999999999999999999999999


Q ss_pred             HHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHHhhhC
Q 012715          304 LEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRW--CTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       304 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      |||++|+.||............. .....+.   -+. ...++    ..+.+++.+  |+..++..||++.++++|.|+.
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~-~~~~~~~---~~~-~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~  309 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVI-NWENTLH---IPP-QVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAHPFFS  309 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHH-ccccccC---CCC-CCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcCcccC
Confidence            99999999997554332222211 1111000   000 11122    346677766  5566777799999999998875


Q ss_pred             C
Q 012715          382 S  382 (458)
Q Consensus       382 ~  382 (458)
                      .
T Consensus       310 ~  310 (381)
T cd05626         310 E  310 (381)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-41  Score=324.77  Aligned_cols=253  Identities=26%  Similarity=0.474  Sum_probs=202.0

Q ss_pred             cccceeeeecceEEEEEEEcC------CCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.||+|+||.||+|....      ...||+|.+.... ......|.+|++++.+++|+||+++++++.+.+..+++|
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            456789999999999997643      2579999886432 334467899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEE
Q 012715          184 EYMANGSLKDHLHSPGR--------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAK  249 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  249 (458)
                      ||+++|+|.+++.....              ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEE
Confidence            99999999999965321              45888999999999999999999   89999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHh
Q 012715          250 LADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMA  328 (458)
Q Consensus       250 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  328 (458)
                      |+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.......
T Consensus       165 L~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~~~~i~~  241 (283)
T cd05048         165 ISDFGLSRDIYSADYY--RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEVIEMIRS  241 (283)
T ss_pred             ECCCcceeeccccccc--cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHc
Confidence            9999999765332211  11233456889999999998899999999999999999998 9989865332 222221111


Q ss_pred             hccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          329 SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       329 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .  .         ....+...+..+.+++.+||+.||.+||++.+|+++|..
T Consensus       242 ~--~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         242 R--Q---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             C--C---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1  0         011122334679999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.4e-41  Score=322.36  Aligned_cols=255  Identities=29%  Similarity=0.475  Sum_probs=204.2

Q ss_pred             HhhcccceeeeecceEEEEEEEcC------CCEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      .++.+.+.||+|+||.||+|...+      +..||||.+...... ..+.+.+|+++++.++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            345667789999999999997643      478999998754333 4568999999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcE
Q 012715          181 LMYEYMANGSLKDHLHSPG------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA  248 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~  248 (458)
                      +||||+++|+|.+++...+            ...+++..+..++.|++.||+|||   .++++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999997532            235789999999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHH
Q 012715          249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCM  327 (458)
Q Consensus       249 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  327 (458)
                      ||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +......
T Consensus       162 kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~~~~~~  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVIECIT  238 (280)
T ss_pred             EECCcccceecccCcce--ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH
Confidence            99999999754332211  11233446788999999999999999999999999999998 99998654332 2222111


Q ss_pred             hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       328 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                        .+....         .+......+.+++.+||+.||++||++.|+++.|.
T Consensus       239 --~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 --QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             --cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence              111110         11122356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4e-41  Score=318.04  Aligned_cols=249  Identities=25%  Similarity=0.440  Sum_probs=201.2

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|+.++.+++||||+++++++.+.+..++||||+.+|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG   84 (256)
T ss_pred             eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence            45667899999999999988777789999886432 33467999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++..... .+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++........   .
T Consensus        85 ~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~---~  157 (256)
T cd05113          85 CLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT---S  157 (256)
T ss_pred             cHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee---e
Confidence            99999976433 5899999999999999999999   999999999999999999999999999998765433211   1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... +......... .      +.....    
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~~-~------~~~~~~----  225 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVSQGL-R------LYRPHL----  225 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHhcCC-C------CCCCCC----
Confidence            122345678999999988889999999999999999999 88888643322 2222111110 0      000111    


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      ....+.+++.+||+.+|.+||++.++++.+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            235789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.2e-41  Score=331.78  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=196.3

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||.||+|... +++.||+|.+....   ......+..|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 57899999886422   22334566777777755 799999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......    .
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----~  151 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----G  151 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----C
Confidence            99999997643  4899999999999999999999   8999999999999999999999999999997543222    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.........        +.+...+   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~--------~~~~~~~---  219 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILNDR--------PHFPRWI---  219 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC--------CCCCCCC---
Confidence            23345689999999999999999999999999999999999999975432 22222221111        1111122   


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHH-HHHHHhhhC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIK-QVLRILYES  381 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~-evl~~l~~~  381 (458)
                       ...+.+++.+||+.||.+||++. ++++|.+..
T Consensus       220 -~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~  252 (316)
T cd05592         220 -SKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFR  252 (316)
T ss_pred             -CHHHHHHHHHHccCCHHHcCCChHHHHcCcccC
Confidence             24578899999999999999864 777776653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=337.17  Aligned_cols=257  Identities=21%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.||+|+||+||+|+.. +|+.||||.+....   ......+.+|++++..++|+||+++++++.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL   83 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence            45678999999999999875 68999999986432   233456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++|+|.+++...+  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++..........
T Consensus        84 ~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          84 PGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            9999999997643  4899999999999999999999   8999999999999999999999999999987543211000


Q ss_pred             --c--------------------------------cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCc
Q 012715          267 --E--------------------------------PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRA  312 (458)
Q Consensus       267 --~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p  312 (458)
                        .                                .......||+.|+|||++....++.++|||||||++|||++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence              0                                001124699999999999999999999999999999999999999


Q ss_pred             cCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHhhhCC
Q 012715          313 VQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYESS  382 (458)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~l~~~~  382 (458)
                      |...... +...........+.   .+. ...+    ...+.+++.+|+. +|.+|++   +.++++|.|...
T Consensus       239 f~~~~~~-~~~~~i~~~~~~~~---~~~-~~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         239 FCSDNPQ-ETYRKIINWKETLQ---FPD-EVPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             CCCCCHH-HHHHHHHcCCCccC---CCC-CCCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            9755432 22222211111110   010 0011    2457788999986 9999998   999999988754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=335.76  Aligned_cols=250  Identities=25%  Similarity=0.398  Sum_probs=211.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecc--cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc-eeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE-RFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~  185 (458)
                      |...+.+|+|+||.++.++.+ ++..+++|.+.-  ..........+|+.++++++|||||.+.+.+.+++. .+|||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            445678999999999999876 678999998853  333444578899999999999999999999999988 9999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |+||+|.+.+.+..+..++++.+..|+.|++.|+.|||   ++.|+|||||+.|||++.++.+||+|||+|+......  
T Consensus        86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--  160 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--  160 (426)
T ss_pred             cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence            99999999998877778999999999999999999999   9999999999999999999999999999999876653  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        .......||+.||.||.+.+.+|..|+|||||||++|||++-+.+|.. .+.......+....      ++     ..
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~------~~-----Pl  226 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL------YS-----PL  226 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc------CC-----CC
Confidence              134567899999999999999999999999999999999999999964 34434433322211      11     12


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      +.....++..++..|++.+|..||++.++|.++
T Consensus       227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             CccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            223346688999999999999999999999874

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-41  Score=333.58  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=197.4

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||.||+|... +++.||+|.+...   .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999875 5789999998643   223345678899998887 799999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|..++...  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......    .
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----~  151 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----D  151 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----C
Confidence            9999988654  35899999999999999999999   8999999999999999999999999999987532211    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc-------chHHHHH-HHHhhccccccccCCc
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-------NLVESAQ-VCMASESRLAELVDPR  340 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~-------~~~~~~~-~~~~~~~~~~~~~d~~  340 (458)
                      ......||..|+|||.+.+..++.++|||||||++|||++|+.||....       ....+.. ......        ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~~  223 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------IR  223 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------CC
Confidence            1234568999999999999999999999999999999999999995211       1111111 111111        11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPS------IKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs------~~evl~~l~~~  381 (458)
                      +....    ...+.+++.+||+.||++||+      +.++++|.|+.
T Consensus       224 ~p~~~----~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~  266 (329)
T cd05618         224 IPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  266 (329)
T ss_pred             CCCCC----CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            11222    245789999999999999998      68999988764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.1e-41  Score=328.68  Aligned_cols=246  Identities=24%  Similarity=0.356  Sum_probs=194.3

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHH-HHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ++||+|+||.||+|+.. +|..||+|.+....   ......+.+|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 68899999986432   222334555554 67888999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|..++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......    .
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~  151 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE----E  151 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----C
Confidence            9999988653  34888899999999999999999   8999999999999999999999999999987532221    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ............        ..+..    .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~--------~~~~~----~  218 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKP--------LQLPG----G  218 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-HHHHHHHHhcCC--------CCCCC----C
Confidence            2234568999999999999899999999999999999999999997543 222222222111        01111    1


Q ss_pred             HHHHHHHHHHHccccCCCCCCCH----HHHHHHhhhC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSI----KQVLRILYES  381 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~~  381 (458)
                      ....+.+++.+||+.||.+||++    .+++++.+..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~  255 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS  255 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence            22468899999999999999875    4777777653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-41  Score=334.02  Aligned_cols=256  Identities=22%  Similarity=0.308  Sum_probs=204.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||++... +|+.||+|.+....   ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            345678999999999999875 68999999986432   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          83 QPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999997642 35899999999999999999999   999999999999999999999999999999865443211


Q ss_pred             cccccccccCCCccccccccc------cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVV------TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                         ......||+.|+|||.+.      ...++.++|||||||++|||++|+.||......... ....... .....  +
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~i~~~~-~~~~~--~  231 (330)
T cd05601         159 ---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-NNIMNFQ-RFLKF--P  231 (330)
T ss_pred             ---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-HHHHcCC-CccCC--C
Confidence               122346899999999986      456789999999999999999999999765443222 2211111 10000  0


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .     .......+.+++..|++ +|.+||++.++++|.|...
T Consensus       232 ~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         232 E-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             C-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            0     01122458889999997 9999999999999988753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-41  Score=333.96  Aligned_cols=253  Identities=21%  Similarity=0.284  Sum_probs=201.0

Q ss_pred             hcccceeeeecceEEEEEEE----cCCCEEEEEEeccc----chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCcee
Q 012715          110 DNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI----SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  180 (458)
                      +.+.+.||+|+||.||+++.    .++..||+|.+...    .....+.+.+|++++..+ +|+||+++++++...+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            34567899999999999975    25789999998642    122345678899999999 4899999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        82 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          82 LILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999999999999999754  34899999999999999999999   8999999999999999999999999999997643


Q ss_pred             CCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcc--h-HHHHHHHHhhccccccc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKN--L-VESAQVCMASESRLAEL  336 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~--~-~~~~~~~~~~~~~~~~~  336 (458)
                      ....   .......||..|+|||.+.+. .++.++|||||||++|||++|+.||.....  . .........        
T Consensus       157 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------  225 (332)
T cd05614         157 SEEK---ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--------  225 (332)
T ss_pred             ccCC---CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--------
Confidence            3221   112345699999999998765 478899999999999999999999963221  1 111111111        


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      .++.+....    ...+.+++.+||+.||++||     +++++++|.|...
T Consensus       226 ~~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         226 CDPPFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             CCCCCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            112222222    24578999999999999999     8899999988754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.6e-41  Score=334.46  Aligned_cols=257  Identities=22%  Similarity=0.327  Sum_probs=203.7

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .+.+.+.||+|+||.||+++.. ++..||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            4456678999999999999875 5889999998642   22333457889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++|+|.+++...   .++...+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++........
T Consensus       124 y~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         124 YMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             CCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999653   4788889999999999999999   89999999999999999999999999999976543221


Q ss_pred             ccccccccccCCCccccccccccC----CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQ----ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      .   ......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||...... .....+......+   .   
T Consensus       198 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~---~---  267 (370)
T cd05596         198 V---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMDHKNSL---T---  267 (370)
T ss_pred             c---cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-HHHHHHHcCCCcC---C---
Confidence            1   12345699999999998653    4789999999999999999999999754432 2222222111110   0   


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhhCCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESSD  383 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~~  383 (458)
                      ...  .......+.+++.+||+.+|.+  |++++++++|.|....
T Consensus       268 ~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         268 FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            011  0112356889999999999987  9999999999987653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.7e-41  Score=328.21  Aligned_cols=247  Identities=25%  Similarity=0.374  Sum_probs=197.8

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||.||+|+.. +++.||||.+....   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999876 57899999986431   22334567788888765 899999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...  ..+++..+..++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++.......    
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----  151 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA----  151 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC----
Confidence            9999999753  34889999999999999999999   89999999999999999999999999999875322211    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||..|+|||.+.+..++.++|||||||++|||++|+.||..... .+.........        +......+  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~--------~~~~~~~~--  220 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIRMDN--------PCYPRWLT--  220 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCC--------CCCCccCC--
Confidence            12345689999999999999999999999999999999999999965432 22222211111        11111122  


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHH-HHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIK-QVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~-evl~~l~~~~  382 (458)
                        ..+.+++.+||+.||.+||++. ++++|.+...
T Consensus       221 --~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         221 --REAKDILVKLFVREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             --HHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence              4578999999999999999996 8888776543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=336.72  Aligned_cols=258  Identities=22%  Similarity=0.271  Sum_probs=206.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|... +|+.||||.+....   ......+.+|++++..++|+||+++++++.+++..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY   82 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence            345678999999999999876 68999999986432   23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc-
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-  264 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-  264 (458)
                      +++|+|.+++...  ..+++..+..++.|++.||+|||   .++|+||||||+|||++.++.+||+|||++........ 
T Consensus        83 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          83 MPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            9999999999765  35899999999999999999999   89999999999999999999999999999976543320 


Q ss_pred             ------------------------ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchH
Q 012715          265 ------------------------CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV  320 (458)
Q Consensus       265 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~  320 (458)
                                              ..........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                    00011234568999999999999999999999999999999999999997654332


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhhhCC
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS-IKQVLRILYESS  382 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~l~~~~  382 (458)
                      .. .........   ...+... .    ....+.+++.+|+. ||.+||+ ++++++|+|...
T Consensus       238 ~~-~~i~~~~~~---~~~p~~~-~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         238 TY-NKIINWKES---LRFPPDP-P----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HH-HHHhccCCc---ccCCCCC-C----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            22 221110000   0011111 1    23568899999997 9999999 999999987643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.2e-41  Score=329.09  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=200.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCC-CCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|... +++.||||.+...   .....+.+..|.+++..+.| ++|+++++++.+.+..|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            346678999999999999876 5789999998642   22344568889999999976 568889999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          82 YVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            999999999997543  4889999999999999999999   8999999999999999999999999999987432211 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         .......||..|+|||++.+..++.++|||||||++|||+||+.||..... .+.........        ..+...
T Consensus       156 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~--------~~~~~~  223 (324)
T cd05587         156 ---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSIMEHN--------VSYPKS  223 (324)
T ss_pred             ---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCC--------CCCCCC
Confidence               112345689999999999999999999999999999999999999965432 22222222111        111112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhhCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYESS  382 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~~~~  382 (458)
                      .    ...+.+++.+||..||.+|++.     +++++|.+...
T Consensus       224 ~----~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         224 L----SKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             C----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            2    2467899999999999999976     78888876643

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.2e-41  Score=328.97  Aligned_cols=247  Identities=24%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||+||+|... ++..||||.+...   .......+.+|.+++..+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999876 5789999998643   223345678899999888 699999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|..++...+  .+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.......    
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----  151 (318)
T cd05570          81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----  151 (318)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC----
Confidence            99999987643  5899999999999999999999   99999999999999999999999999999875322211    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.... ............        ......    
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-~~~~~~~i~~~~--------~~~~~~----  218 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-EDELFQSILEDE--------VRYPRW----  218 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCC--------CCCCCc----
Confidence            1233468999999999999999999999999999999999999996443 222222222111        111111    


Q ss_pred             HHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSI-----KQVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~~~~  382 (458)
                      ....+.+++.+||+.||.+||++     .+++++.|...
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            22568899999999999999999     99999887643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.4e-41  Score=322.26  Aligned_cols=258  Identities=30%  Similarity=0.480  Sum_probs=206.8

Q ss_pred             hcccceeeeecceEEEEEEEc------CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+.||+|+||.||+|...      ++..+++|.+..........+.+|++++++++|+||+++++++...+..++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF   86 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence            445678999999999999742      35579999887665555677999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEE
Q 012715          184 EYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAK  249 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  249 (458)
                      ||+++++|.+++...+              ...+++..++.++.|++.||+|||   +++++||||||+|||++.++.+|
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~  163 (291)
T cd05094          87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVK  163 (291)
T ss_pred             ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999996532              134899999999999999999999   99999999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHh
Q 012715          250 LADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMA  328 (458)
Q Consensus       250 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~  328 (458)
                      |+|||++........  ........++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +...... 
T Consensus       164 l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~-  239 (291)
T cd05094         164 IGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIECIT-  239 (291)
T ss_pred             ECCCCcccccCCCce--eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHh-
Confidence            999999976543321  112233456789999999999999999999999999999999 88888654332 2221111 


Q ss_pred             hccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          329 SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       329 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                       ......         .....+..+.+++.+||+.+|++||+++++++.|.....+
T Consensus       240 -~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         240 -QGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -CCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence             111111         1112235688999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-42  Score=324.74  Aligned_cols=257  Identities=26%  Similarity=0.358  Sum_probs=200.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccch--------------hhHhHHHHHHHHHHhcCCCCeeeeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--------------QVEGDFCREIELLARLHHRHLVALRGFCI  174 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~  174 (458)
                      |.+...||+|.||.|-+|+.. +++.||||.+.+...              ...+...+|+.+|++|+|+|||+|+.+..
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            445568999999999999865 689999999854211              11247889999999999999999999987


Q ss_pred             cc--CceeeeeeecCCCCHHHHhcCCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 012715          175 EK--RERFLMYEYMANGSLKDHLHSPGRTP-LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA  251 (458)
Q Consensus       175 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  251 (458)
                      +.  +.+|||+|||..|.+...=   ...+ ++..++++++.++..||+|||   .++||||||||+|+||+++|++||+
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             CcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEee
Confidence            64  5889999999988765432   2334 899999999999999999999   9999999999999999999999999


Q ss_pred             ecccccccCCCCcc-cccccccccCCCccccccccccCC----CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHH
Q 012715          252 DFGLAHASKDGSIC-FEPVNTDIRGTPGYMDPEYVVTQE----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC  326 (458)
Q Consensus       252 DfGla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  326 (458)
                      |||.+.....+... .........||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+...+ +....+
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-~l~~KI  331 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-ELFDKI  331 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-HHHHHH
Confidence            99999866332111 111223478999999999987743    356789999999999999999999765443 333322


Q ss_pred             HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       327 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ....-.+     |.     ..+....+.++|.++|..||+.|.+..+|..|+|-..+
T Consensus       332 vn~pL~f-----P~-----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  332 VNDPLEF-----PE-----NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             hcCcccC-----CC-----cccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            2211111     11     11334678899999999999999999999999997653

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-42  Score=332.86  Aligned_cols=249  Identities=28%  Similarity=0.441  Sum_probs=208.1

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.||.|+||.||.|+.. +...||||++.-..   .....+++.|+..|.+++|||++.+-|+|......|||||||- |
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence            35999999999999764 68899999986433   3445678999999999999999999999999999999999995 5


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +-.|++.-. .+++.+..+..|+.+.+.||+|||   +.+.||||||+.|||+++.|.|||+|||.|.....        
T Consensus       111 SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--------  178 (948)
T KOG0577|consen  111 SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--------  178 (948)
T ss_pred             cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc--------
Confidence            877877543 357999999999999999999999   99999999999999999999999999998865433        


Q ss_pred             cccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          270 NTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      ...++||+.|||||++.   .+.|+-++||||||++..||.-.++|+++...+...+.+.....        |.+.   .
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes--------PtLq---s  247 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--------PTLQ---S  247 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC--------CCCC---C
Confidence            34678999999999985   47899999999999999999999999987665554444322211        2222   3


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                      .+....+..|+..||+.-|.+|||.+++++|.+-...+..
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence            4566789999999999999999999999999876554443

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.8e-41  Score=323.80  Aligned_cols=253  Identities=26%  Similarity=0.454  Sum_probs=200.5

Q ss_pred             hcccceeeeecceEEEEEEE-----cCCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ..+.+.||+|+||.||+|.+     .++..||+|.+... .......+.+|++++++++|+||+++++++..++..++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   86 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF   86 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence            45667899999999999975     24678999998643 2334467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcE
Q 012715          184 EYMANGSLKDHLHSPG---------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA  248 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~  248 (458)
                      ||+++++|.+++....               ...+++..++.++.|++.||+|||   +++++||||||+|||+++++.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcE
Confidence            9999999999985321               234788999999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHH
Q 012715          249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCM  327 (458)
Q Consensus       249 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  327 (458)
                      ||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ........
T Consensus       164 kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~~~~~  240 (283)
T cd05090         164 KISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEMVR  240 (283)
T ss_pred             EeccccccccccCCcce--ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH
Confidence            99999999865433211  11233446778999999988889999999999999999998 8888864332 22222111


Q ss_pred             hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       328 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      . ...      ......    ....+.+++.+||+.+|++||++.+++++|.
T Consensus       241 ~-~~~------~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         241 K-RQL------LPCSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             c-CCc------CCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            1 110      011112    2356889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.7e-41  Score=315.43  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=204.8

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecc--cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|++|.||+|... ++..|++|.+..  ........+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE   82 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence            45678999999999999875 689999998753  234455679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +++|.+++.......+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++.......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~---  156 (256)
T cd08529          83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---  156 (256)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence            999999998654556999999999999999999999   89999999999999999999999999999886654321   


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                       ......|+..|+|||++.+..++.++||||||+++|||++|+.||...... ........  ...     +.+.    .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~--~~~-----~~~~----~  223 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-ALILKIIR--GVF-----PPVS----Q  223 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHc--CCC-----CCCc----c
Confidence             123346889999999999999999999999999999999999999654322 22221111  111     1111    1


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      .....+.+++.+||+.+|++||++.+++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~  254 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP  254 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence            2335689999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.2e-41  Score=335.69  Aligned_cols=256  Identities=24%  Similarity=0.331  Sum_probs=200.4

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||.||+|.+.      .+..||||++.... ....+.+.+|+++++++. ||||++++++|.+.+..|
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY  117 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence            3445678999999999999752      23479999986432 333457999999999996 999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCC-------------------------------------------------------------
Q 012715          181 LMYEYMANGSLKDHLHSPG-------------------------------------------------------------  199 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  199 (458)
                      ||||||++|+|.++|....                                                             
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (400)
T cd05105         118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA  197 (400)
T ss_pred             EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence            9999999999999885421                                                             


Q ss_pred             ---------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC
Q 012715          200 ---------------------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF  246 (458)
Q Consensus       200 ---------------------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~  246 (458)
                                                       ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~  274 (400)
T cd05105         198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGK  274 (400)
T ss_pred             hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCC
Confidence                                             124788889999999999999999   89999999999999999999


Q ss_pred             cEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHH
Q 012715          247 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQV  325 (458)
Q Consensus       247 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~  325 (458)
                      .+||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||............
T Consensus       275 ~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~  352 (400)
T cd05105         275 IVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK  352 (400)
T ss_pred             EEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence            9999999999865432211  11223456788999999999899999999999999999997 88888643222111111


Q ss_pred             HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          326 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       326 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ......      ..    .+...+..+.+++.+||+.+|++||++.+|.+.|..
T Consensus       353 -~~~~~~------~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         353 -IKSGYR------MA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             -HhcCCC------CC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence             111111      11    112234568999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.5e-41  Score=334.02  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=197.5

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.||+|+||+||+|... +++.||+|.+....   ......+.+|+.++.+++|+||+++++.+.+....|+||||+
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            45678999999999999775 58899999986432   233456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc-
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC-  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-  265 (458)
                      ++|+|.+++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........ 
T Consensus        84 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          84 PGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            9999999997643  5899999999999999999999   999999999999999999999999999998754321100 


Q ss_pred             ------------------------------cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCC
Q 012715          266 ------------------------------FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD  315 (458)
Q Consensus       266 ------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~  315 (458)
                                                    .........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                          00011235799999999999999999999999999999999999999975


Q ss_pred             CcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHcc--ccCCCCCCCHHHHHHHhhhCC
Q 012715          316 GKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCT--QREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl--~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .... +...........   +..+.. ...+    ..+.+++.+++  ..++..||+++|+++|.|+..
T Consensus       239 ~~~~-~~~~~i~~~~~~---~~~p~~-~~~s----~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~  298 (363)
T cd05628         239 ETPQ-ETYKKVMNWKET---LIFPPE-VPIS----EKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG  298 (363)
T ss_pred             CCHH-HHHHHHHcCcCc---ccCCCc-CCCC----HHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCC
Confidence            4432 222222211111   111110 0122    23555665533  334446799999999988754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.4e-42  Score=333.95  Aligned_cols=246  Identities=26%  Similarity=0.369  Sum_probs=199.2

Q ss_pred             ceeeeecceEEEEEEE----cCCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.||+|+||.||+++.    .+|..||+|.+....  ......+.+|++++++++|+||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999865    357899999986432  2233457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......   
T Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---  153 (318)
T cd05582          82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---  153 (318)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---
Confidence            99999999653  35899999999999999999999   89999999999999999999999999999876543211   


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                       ......||..|+|||.+.+..++.++|||||||++|||++|+.||...... +...........        +...+  
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~i~~~~~~--------~p~~~--  221 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-ETMTMILKAKLG--------MPQFL--  221 (318)
T ss_pred             -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-HHHHHHHcCCCC--------CCCCC--
Confidence             123456899999999999888999999999999999999999999754332 222222211111        11112  


Q ss_pred             HHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES  381 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  381 (458)
                        ...+.+++.+||+.||++||+     +.+++++.|+.
T Consensus       222 --~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~  258 (318)
T cd05582         222 --SPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFS  258 (318)
T ss_pred             --CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcC
Confidence              245789999999999999999     67788777654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.8e-41  Score=322.65  Aligned_cols=254  Identities=24%  Similarity=0.362  Sum_probs=203.5

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      ...+.||+|+||+||++... +++.||+|.+....   ......+.+|+.++++++|+||+.+++.+.+++..++||||+
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence            34568999999999999775 68899999886432   222345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++.......   
T Consensus        83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  156 (285)
T cd05630          83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---  156 (285)
T ss_pred             CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---
Confidence            9999999996555556999999999999999999999   8999999999999999999999999999987654322   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......|+..|+|||.+.+..++.++|||||||++|||++|+.||............ ........    ......+ 
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-~~~~~~~~----~~~~~~~-  228 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-ERLVKEVQ----EEYSEKF-  228 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-Hhhhhhhh----hhcCccC-
Confidence              112346899999999999999999999999999999999999999754322111100 00000000    1111122 


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES  381 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  381 (458)
                         ...+.+++..||+.||++||+     ++|+++|.|..
T Consensus       229 ---~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         229 ---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             ---CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence               245889999999999999999     99999998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.2e-41  Score=329.73  Aligned_cols=247  Identities=26%  Similarity=0.377  Sum_probs=196.7

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHH-HHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||+||+|... +|+.||+|.+....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999875 68999999986432   122234555555 56778999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|..++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......    .
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~----~  151 (323)
T cd05575          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS----K  151 (323)
T ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----C
Confidence            9999999763  35889999999999999999999   8999999999999999999999999999987532221    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+..........        .+....   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~--------~~~~~~---  219 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYDNILNKPL--------RLKPNI---  219 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-HHHHHHHHHcCCC--------CCCCCC---
Confidence            2234568999999999999999999999999999999999999997543 2233222221111        111122   


Q ss_pred             HHHHHHHHHHHccccCCCCCCCH----HHHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSI----KQVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~~~  382 (458)
                       ...+.+++.+||+.||.+||++    .+++++.|...
T Consensus       220 -~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         220 -SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             -CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence             2568899999999999999987    58888877643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.9e-41  Score=320.78  Aligned_cols=255  Identities=25%  Similarity=0.351  Sum_probs=204.5

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      ..+.||+|+||+||+|... +++.||+|.+....   ......+.+|+++++.++|+||+.+.+++.+++..++||||+.
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence            4568999999999999875 68899999886432   2233457889999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +++|.+++...+...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++.......    
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~----  156 (285)
T cd05632          84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE----  156 (285)
T ss_pred             CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence            999999987655556999999999999999999999   9999999999999999999999999999987654322    


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                       ......|+..|+|||.+.+..++.++|+|||||++|||++|..||...............    .... .......+  
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~--  228 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR----VLET-EEVYSAKF--  228 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh----hhcc-ccccCccC--
Confidence             123456899999999999899999999999999999999999999754432221111100    0000 01111122  


Q ss_pred             HHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCCC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESSD  383 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~~  383 (458)
                        ...+.+++..||+.||++||+     +.+++++.|....
T Consensus       229 --~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         229 --SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             --CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence              245789999999999999999     8899998877543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.4e-41  Score=328.52  Aligned_cols=255  Identities=23%  Similarity=0.377  Sum_probs=199.7

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCC----EEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      .+...+.||+|+||.||+|.+. +|.    .||+|.+... .......+.+|+.+++.++|+||++++|+|... ..++|
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v   86 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   86 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence            3445678999999999999864 333    3899998643 334456789999999999999999999999765 57899


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      +||+++|+|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 ~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          87 TQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999997643 34889999999999999999999   899999999999999999999999999999866543


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ....  ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.. ..+...... ......   .   
T Consensus       163 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-~~~~~~~~~-~~~~~~---~---  232 (316)
T cd05108         163 EKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-ASEISSILE-KGERLP---Q---  232 (316)
T ss_pred             Ccce--eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHh-CCCCCC---C---
Confidence            2211  1122334678999999999999999999999999999998 888886432 222222211 111111   0   


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..    .+...+.+++.+||+.+|.+||++.+++..+....
T Consensus       233 ~~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         233 PP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             CC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11    12245889999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.6e-41  Score=315.49  Aligned_cols=248  Identities=24%  Similarity=0.425  Sum_probs=197.1

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      +.||+|+||.||+|.+. +++.||+|.+... .......+.+|++++++++|+||++++++|...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999875 6899999987543 334456799999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT  271 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  271 (458)
                      .+++...+ ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.........  ....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~  154 (252)
T cd05084          81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--STGG  154 (252)
T ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc--ccCC
Confidence            99997543 35899999999999999999999   999999999999999999999999999998764432110  0111


Q ss_pred             cccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 012715          272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL  350 (458)
Q Consensus       272 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  350 (458)
                      ....+..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..... ....          .....+...+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-~~~~~-~~~~----------~~~~~~~~~~  222 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-QTREA-IEQG----------VRLPCPELCP  222 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-HHHHH-HHcC----------CCCCCcccCC
Confidence            1223567999999998899999999999999999998 77777543321 11111 1110          0111122234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          351 RTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       351 ~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ..+.+++.+||+.+|++||++.++++.|.
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            57899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.4e-40  Score=319.86  Aligned_cols=257  Identities=30%  Similarity=0.495  Sum_probs=204.5

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      .+.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|++++++++|+||+++++++...+..++|
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV   85 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            3456678999999999999742      3457999998766656667899999999999999999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 012715          183 YEYMANGSLKDHLHSPG-----------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA  251 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  251 (458)
                      |||+++++|.+++...+           ...+++..++.++.|++.||+|||   +++++||||||+|||+++++.+||+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~  162 (288)
T cd05093          86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIG  162 (288)
T ss_pred             EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEec
Confidence            99999999999996432           134899999999999999999999   8999999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhc
Q 012715          252 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASE  330 (458)
Q Consensus       252 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  330 (458)
                      |||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+........ 
T Consensus       163 dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-~~~~~~i~~~-  238 (288)
T cd05093         163 DFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQG-  238 (288)
T ss_pred             cCCccccccCCcee--ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC-
Confidence            99999765432211  11223446788999999998899999999999999999999 8888754332 2222221111 


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          331 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       331 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       ..     ......+    ...+.+++.+||+.+|.+||+++++++.|....
T Consensus       239 -~~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         239 -RV-----LQRPRTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             -Cc-----CCCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence             11     0111122    246899999999999999999999998886543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-41  Score=317.50  Aligned_cols=253  Identities=25%  Similarity=0.459  Sum_probs=202.5

Q ss_pred             hcccceeeeecceEEEEEEEcC----CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|.+..    ...||||.+... .......|.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            4567799999999999998742    458999988643 33345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++++|.+++..... .+++..+++++.|++.||+|||   +++|+|+||||+|||+++++.+||+|||+++.......
T Consensus        86 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          86 YMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             cCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            9999999999976433 5899999999999999999999   89999999999999999999999999999987642221


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ..  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.... +...... .....     +    
T Consensus       162 ~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~-~~~~~-----~----  228 (266)
T cd05033         162 TY--TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-DVIKAVE-DGYRL-----P----  228 (266)
T ss_pred             ce--eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-HHHHHHH-cCCCC-----C----
Confidence            11  1112345678999999998899999999999999999998 88888654322 1111111 11010     0    


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       .+...+..+.+++.+||+.+|++||++++++++|..
T Consensus       229 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         229 -PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             -CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence             111233568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.4e-41  Score=342.32  Aligned_cols=260  Identities=20%  Similarity=0.327  Sum_probs=194.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--------Ccee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK--------RERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~  180 (458)
                      +.+.++||+|+||.||+|... +++.||||++....    ....+|+.+++.++|+||+++++++...        ...+
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            456688999999999999875 68899999885422    2345799999999999999999876432        2467


Q ss_pred             eeeeecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC-CcEEEeeccccc
Q 012715          181 LMYEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAH  257 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~  257 (458)
                      +||||+++ +|.+++..  .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            89999975 78777642  22346899999999999999999999   8999999999999999865 479999999998


Q ss_pred             ccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc----
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----  332 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----  332 (458)
                      ....+.     ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.................    
T Consensus       220 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        220 NLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             hccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            654332     1234568999999998875 468999999999999999999999997654433322221111000    


Q ss_pred             -------cccccCCc-----CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          333 -------LAELVDPR-----IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       333 -------~~~~~d~~-----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                             ..+..-+.     +...++......+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence                   00000010     111111122356889999999999999999999999998743

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.8e-41  Score=336.12  Aligned_cols=257  Identities=22%  Similarity=0.296  Sum_probs=198.0

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.++||+|+||+||+|+.. +++.||+|.+....   ......+.+|++++++++|+||+++++.+.+++..|+|||||
T Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~   83 (382)
T cd05625           4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI   83 (382)
T ss_pred             EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence            45678999999999999875 68899999986432   233457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc--
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI--  264 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~--  264 (458)
                      ++|+|.+++...+  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++........  
T Consensus        84 ~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          84 PGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            9999999997643  4888999999999999999999   89999999999999999999999999999753210000  


Q ss_pred             -----------------------------------------ccccccccccCCCccccccccccCCCCcccccHhHHHHH
Q 012715          265 -----------------------------------------CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL  303 (458)
Q Consensus       265 -----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l  303 (458)
                                                               ..........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                     000011234699999999999999999999999999999


Q ss_pred             HHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHhhh
Q 012715          304 LEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYE  380 (458)
Q Consensus       304 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~l~~  380 (458)
                      |||++|+.||............ .......   ..+. ....+    ..+.+++.+++ .+|.+|++   +.++++|.|+
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i-~~~~~~~---~~p~-~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f  308 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKV-INWQTSL---HIPP-QAKLS----PEASDLIIKLC-RGPEDRLGKNGADEIKAHPFF  308 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHH-HccCCCc---CCCC-cccCC----HHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCc
Confidence            9999999999755433222211 1111100   0010 11122    34566666655 49999997   9999999876


Q ss_pred             CC
Q 012715          381 SS  382 (458)
Q Consensus       381 ~~  382 (458)
                      ..
T Consensus       309 ~~  310 (382)
T cd05625         309 KT  310 (382)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=314.55  Aligned_cols=249  Identities=29%  Similarity=0.431  Sum_probs=199.9

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      ..+.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             cchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            34567899999999999998777889999876432 23457889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++..... .+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...+....   .
T Consensus        85 ~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~---~  157 (256)
T cd05059          85 CLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT---S  157 (256)
T ss_pred             CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc---c
Confidence            99999975433 5899999999999999999999   899999999999999999999999999999765432211   1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....+. +....... .      .......    .
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~-~------~~~~~~~----~  225 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESVSA-G------YRLYRPK----L  225 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHHHc-C------CcCCCCC----C
Confidence            112234568999999999999999999999999999999 78888644332 22111111 1      1111111    2


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      .+..+.+++.+||..+|++||++.++++.|
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            335799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.8e-41  Score=326.64  Aligned_cols=249  Identities=23%  Similarity=0.337  Sum_probs=199.6

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      ++.+.||+|+||.||+|... ++..||+|.+....   ......+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            45678999999999999876 57899999986432   22334567788888887 589999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...+  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        83 ~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-  156 (323)
T cd05616          83 VNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-  156 (323)
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence            99999999987643  4899999999999999999999   89999999999999999999999999999975432211 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.....        .+... 
T Consensus       157 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~--------~~p~~-  223 (323)
T cd05616         157 ---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHNV--------AYPKS-  223 (323)
T ss_pred             ---ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC--------CCCCc-
Confidence               12345689999999999999999999999999999999999999975433 233222222111        11112 


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhhC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYES  381 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~~~  381 (458)
                         ....+.+++.+|++.+|.+|++.     .++++|.++.
T Consensus       224 ---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~  261 (323)
T cd05616         224 ---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  261 (323)
T ss_pred             ---CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence               22567899999999999999984     7888776653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=331.25  Aligned_cols=257  Identities=22%  Similarity=0.291  Sum_probs=199.3

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.||+|+||+||++... +|+.||||.+....   ......+.+|++++.+++||||+++++++.+.+..|+||||+
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~   83 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL   83 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence            45678999999999999765 68999999885422   233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc--
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI--  264 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~--  264 (458)
                      ++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        84 ~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          84 PGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            999999999754  35889999999999999999999   99999999999999999999999999999963321000  


Q ss_pred             ----------ccc-------------------------------cccccccCCCccccccccccCCCCcccccHhHHHHH
Q 012715          265 ----------CFE-------------------------------PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL  303 (458)
Q Consensus       265 ----------~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l  303 (458)
                                ...                               .......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                      000                               000124699999999999999999999999999999


Q ss_pred             HHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHhhh
Q 012715          304 LEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR---PSIKQVLRILYE  380 (458)
Q Consensus       304 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~evl~~l~~  380 (458)
                      |||++|..||...... +...........+   .-+   ..  ......+.+++.+|+. +|.+|   +++.++++|.|.
T Consensus       239 ~elltG~~Pf~~~~~~-~~~~~i~~~~~~~---~~p---~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~  308 (377)
T cd05629         239 FECLIGWPPFCSENSH-ETYRKIINWRETL---YFP---DD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF  308 (377)
T ss_pred             hhhhcCCCCCCCCCHH-HHHHHHHccCCcc---CCC---CC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence            9999999999754432 2222221111110   001   10  0112457889999997 66665   699999999987


Q ss_pred             CC
Q 012715          381 SS  382 (458)
Q Consensus       381 ~~  382 (458)
                      ..
T Consensus       309 ~~  310 (377)
T cd05629         309 RG  310 (377)
T ss_pred             CC
Confidence            53

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.7e-41  Score=320.99  Aligned_cols=262  Identities=24%  Similarity=0.286  Sum_probs=197.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhc---CCCCeeeeeeeeecc-----Cc
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARL---HHRHLVALRGFCIEK-----RE  178 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~~  178 (458)
                      +...+.||+|+||+||+|... +|+.||+|.+....  ......+.+|+++++.+   +|+||+++++++.+.     ..
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            345678999999999999875 68899999886422  22223566788777766   699999999988653     35


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      .++||||+. ++|.+++.......+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            799999997 48999987655556899999999999999999999   89999999999999999999999999999976


Q ss_pred             cCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc----cccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SRLA  334 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~  334 (458)
                      .....     ......||..|+|||.+.+..++.++|||||||++|||++|++||.................    ..+.
T Consensus       158 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         158 YSCQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccCcc-----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            54322     12345689999999999988999999999999999999999999865443322222111000    0000


Q ss_pred             c-------ccCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          335 E-------LVDPRIKD---SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       335 ~-------~~d~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .       ...+....   .........+.+++.+||+.||++||++.+++.|.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0       00000000   0011223567899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-40  Score=331.44  Aligned_cols=256  Identities=22%  Similarity=0.322  Sum_probs=200.6

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .+.+.+.||+|+||.||+++.. +++.||+|.+...   .......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            4456678999999999999876 5889999988542   22234468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++|+|.+++...   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++........
T Consensus       124 y~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         124 YMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             CCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            99999999999653   4788999999999999999999   89999999999999999999999999999986543221


Q ss_pred             ccccccccccCCCccccccccccC----CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQ----ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      .   ......||+.|+|||.+.+.    .++.++|||||||++|||++|+.||...... ............+      .
T Consensus       198 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~------~  267 (370)
T cd05621         198 V---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-GTYSKIMDHKNSL------N  267 (370)
T ss_pred             e---ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCccc------C
Confidence            1   12345699999999998754    3788999999999999999999999754432 2222222111110      0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhhCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESS  382 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~  382 (458)
                      ...  +......+.+++..|+..++.+  |+++.|+++|.|...
T Consensus       268 ~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~  309 (370)
T cd05621         268 FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN  309 (370)
T ss_pred             CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence            011  1112345778889999755543  899999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.5e-40  Score=313.06  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=205.6

Q ss_pred             HHHHhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          105 TKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       105 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +....+.+.++||+|+||.||+|...+++.||+|.+..... ....+.+|++++++++|+||+++++++ ..+..+++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEE
Confidence            34456677889999999999999988899999998864332 345789999999999999999999986 4567899999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+.+++|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999999997655567999999999999999999999   89999999999999999999999999999976543221


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      .   ......++..|+|||.+....++.++||||||+++|||++ |+.||.+... .+...... ..      .......
T Consensus       158 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~-~~------~~~~~~~  226 (260)
T cd05067         158 T---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQNLE-RG------YRMPRPD  226 (260)
T ss_pred             c---cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHH-cC------CCCCCCC
Confidence            1   1123345778999999998889999999999999999999 8988864432 22222111 11      0111111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                          ..+..+.+++.+||..+|++||+++++++.|.
T Consensus       227 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         227 ----NCPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             ----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence                12356999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-40  Score=317.34  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=199.5

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||.||+|.+.      .+..||+|.+.... .....++.+|+.+++.++|+||+++++++.++...++
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   86 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV   86 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence            3556789999999999999753      24679999885432 2334568999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 012715          182 MYEYMANGSLKDHLHSPG--------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF  253 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  253 (458)
                      ||||+++|+|.+++....        ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~df  163 (277)
T cd05062          87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCC
Confidence            999999999999986422        124678899999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccc
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      |+++.........  ......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ...........  .
T Consensus       164 g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~--~  238 (277)
T cd05062         164 GMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-NEQVLRFVMEG--G  238 (277)
T ss_pred             CCccccCCcceee--cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcC--C
Confidence            9987654332211  1122345788999999998899999999999999999999 677775432 22222211111  1


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ...     .    +...+..+.+++.+||+.+|++||++.|++++|.
T Consensus       239 ~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         239 LLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111     1    1122356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.7e-41  Score=333.98  Aligned_cols=258  Identities=22%  Similarity=0.293  Sum_probs=199.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|+.. +++.||||.+....   ......+.+|++++.+++|+||+++++.+.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            345678999999999999875 58999999986432   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc-
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-  264 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-  264 (458)
                      +++|+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|........ 
T Consensus        83 ~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          83 IPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            99999999997643  4888999999999999999999   89999999999999999999999999999853210000 


Q ss_pred             --------------------------------------ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHH
Q 012715          265 --------------------------------------CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI  306 (458)
Q Consensus       265 --------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el  306 (458)
                                                            ..........||+.|||||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                  000001234799999999999999999999999999999999


Q ss_pred             HhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHhhhCC
Q 012715          307 VTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP---SIKQVLRILYESS  382 (458)
Q Consensus       307 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl~~l~~~~  382 (458)
                      ++|+.||............ ......   ...+ .....+    ..+.+++.+|+ .+|.+|+   ++.++++|.|...
T Consensus       238 l~G~~Pf~~~~~~~~~~~i-~~~~~~---~~~~-~~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         238 LVGQPPFLADTPAETQLKV-INWETT---LHIP-SQAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHH-hccCcc---ccCC-CCCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            9999999765433222211 111100   0001 011122    34667777766 5999999   9999999988754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-40  Score=315.43  Aligned_cols=251  Identities=25%  Similarity=0.416  Sum_probs=201.3

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. .+..+++|||++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~   85 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG   85 (260)
T ss_pred             hhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence            456678999999999999988888999998864332 3457899999999999999999999875 45689999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.........   .
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~---~  159 (260)
T cd05070          86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT---A  159 (260)
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc---c
Confidence            9999997655556899999999999999999999   889999999999999999999999999999765433211   1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+... .+....... ..      .+    ..+..
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~~~~~-~~------~~----~~~~~  227 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVER-GY------RM----PCPQD  227 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHc-CC------CC----CCCCc
Confidence            122345678999999988889999999999999999999 7888864332 222222111 10      01    11122


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ....+.+++.+||..+|.+|||+.++.+.|.+
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         228 CPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            33569999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=340.81  Aligned_cols=257  Identities=28%  Similarity=0.418  Sum_probs=207.0

Q ss_pred             cccceeeeecceEEEEEEEcCC-CEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeee-eec------cCceee
Q 012715          111 NFSTIIGQGGFGTVYKAQFSDG-SLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGF-CIE------KRERFL  181 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~~~l  181 (458)
                      ...+.|.+|||+.||.|+...+ ..||+|++-..++...+...+|+++|++|+ |+|||.+++. ...      .-+.+|
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll  119 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL  119 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence            3456899999999999988765 999999988778888899999999999997 9999999993 222      136789


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      .||||.||+|-++++.+....|++.++++|+.++++|+++||.. ..+|||||||-+||||+.+|..||||||-+...-.
T Consensus       120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~  198 (738)
T KOG1989|consen  120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL  198 (738)
T ss_pred             ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence            99999999999999866555699999999999999999999955 78899999999999999999999999998863211


Q ss_pred             CC-cccc----cccccccCCCcccccccc---ccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc
Q 012715          262 GS-ICFE----PVNTDIRGTPGYMDPEYV---VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL  333 (458)
Q Consensus       262 ~~-~~~~----~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  333 (458)
                      .. ....    ...-...-|+-|+|||.+   .+...++|+|||+|||+||-|+....||.+...+.             
T Consensus       199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-------------  265 (738)
T KOG1989|consen  199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-------------  265 (738)
T ss_pred             CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------------
Confidence            11 0000    000012358999999977   46789999999999999999999999998654321             


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          334 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       334 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                        +++..+.-.-.......|.+||+.||+.||.+||++-|++..+.+...
T Consensus       266 --Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 --ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence              122222222224566889999999999999999999999999877653

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.1e-40  Score=313.08  Aligned_cols=252  Identities=26%  Similarity=0.414  Sum_probs=201.8

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.++||+|+||.||+|.+.++..||+|++.... ...+.+.+|+++++.++|+||+++++++. .+..++||||+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK   84 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence            356778999999999999988777789999986432 23457899999999999999999999874 4568999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.......+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++........   
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~---  158 (262)
T cd05071          85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---  158 (262)
T ss_pred             CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc---
Confidence            99999997654456899999999999999999999   899999999999999999999999999999765443211   


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......++..|+|||...+..++.++||||||+++|||++ |..||...... +....... ..          ......
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~~~~~~~-~~----------~~~~~~  226 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVER-GY----------RMPCPP  226 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HHHHHHhc-CC----------CCCCcc
Confidence            1123346778999999988899999999999999999999 77777543322 21111111 00          011122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +.+..+.+++.+|++.+|++||++.++++.|.+
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            344678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.8e-41  Score=344.25  Aligned_cols=254  Identities=28%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC--------
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR--------  177 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  177 (458)
                      .+.+.+.||+|+||+||+|... +|+.||||.+...  .......+.+|+.++..++|+||+++++.+...+        
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            3556789999999999999764 6899999998542  3344567889999999999999999988765432        


Q ss_pred             ceeeeeeecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 012715          178 ERFLMYEYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL  255 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  255 (458)
                      ..++||||+++|+|.+++...  ....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence            368999999999999999643  2346899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc
Q 012715          256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE  335 (458)
Q Consensus       256 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  335 (458)
                      ++.......  ........||+.|+|||.+.+..++.++|||||||++|||++|+.||... +..+.........     
T Consensus       190 s~~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~-~~~~~~~~~~~~~-----  261 (496)
T PTZ00283        190 SKMYAATVS--DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-NMEEVMHKTLAGR-----  261 (496)
T ss_pred             Ceecccccc--ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCC-----
Confidence            986543211  11223457999999999999999999999999999999999999999643 3333332222111     


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       .++ +..    .....+.+++.+||+.||.+||++.+++++.+
T Consensus       262 -~~~-~~~----~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~  299 (496)
T PTZ00283        262 -YDP-LPP----SISPEMQEIVTALLSSDPKRRPSSSKLLNMPI  299 (496)
T ss_pred             -CCC-CCC----CCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence             011 111    22356889999999999999999999998764

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.3e-41  Score=328.17  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=198.0

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||+||+|... +++.||+|.+....   ......+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999875 57899999986432   23345688999999998 699999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|..++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......    .
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~  151 (327)
T cd05617          81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG----D  151 (327)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----C
Confidence            99999886533  5999999999999999999999   8999999999999999999999999999987532211    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc-----chHHHHHHHHhhccccccccCCcCCC
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-----NLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....     ...+.........       ...+..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~p~  224 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-------PIRIPR  224 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-------CCCCCC
Confidence            1234569999999999999999999999999999999999999995311     1111111111110       011111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPS------IKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs------~~evl~~l~~~~  382 (458)
                      ..+    ..+.+++.+||+.||++|++      ++++++|.|+..
T Consensus       225 ~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         225 FLS----VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             CCC----HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            222    45788999999999999997      579998887643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.7e-41  Score=327.00  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=200.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +++.+.||+|+||+||+|... +|+.||+|.+....   ....+.+..|..++..+. |++|+++++++.+.+..|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            456789999999999999875 68899999986432   233456788999998886 5788889999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++|+|.+++...+  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 y~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          82 YVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            999999999997643  4899999999999999999999   89999999999999999999999999999875432211


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............        ....
T Consensus       157 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~--------~p~~  223 (323)
T cd05615         157 ----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNVS--------YPKS  223 (323)
T ss_pred             ----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC--------CCcc
Confidence                12345689999999999999999999999999999999999999975433 2222222221111        1112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  381 (458)
                      .    ...+.+++.+||+.+|.+|++     .+++++|.++.
T Consensus       224 ~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~  261 (323)
T cd05615         224 L----SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR  261 (323)
T ss_pred             C----CHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence            2    245788999999999999997     46777776654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.3e-40  Score=330.18  Aligned_cols=259  Identities=22%  Similarity=0.298  Sum_probs=198.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC------cee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  180 (458)
                      +...+.||+|+||.||++... +|..||+|.+...  .......+.+|+.+++.++|+||+++++++...+      ..|
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  102 (359)
T cd07876          23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY  102 (359)
T ss_pred             eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence            445678999999999999875 5899999998642  2334557889999999999999999999886543      469


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++ +|.+.+..    .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       103 lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         103 LVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             EEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            99999975 67776643    3788999999999999999999   8999999999999999999999999999997543


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc-------
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL-------  333 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  333 (458)
                      ...     ......||..|+|||.+.+..++.++|||||||++|||++|+.||........+...........       
T Consensus       175 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         175 TNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             cCc-----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            321     22345689999999999999999999999999999999999999976543332222111100000       


Q ss_pred             ----cccc--CCcCC----------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          334 ----AELV--DPRIK----------------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       334 ----~~~~--d~~~~----------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                          ....  .+...                ...+......+.+++.+||+.||++|||+.|+++|.|..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence                0000  00000                000111235688999999999999999999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-42  Score=335.01  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=211.1

Q ss_pred             cceeeeecceEEEEEEEcC-CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          113 STIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      ...||.|+||.||+|..++ +...|.|.+...+....++|+-|++||..+.||+||+|++.|...+.+||+.|||.||-.
T Consensus        37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV  116 (1187)
T KOG0579|consen   37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV  116 (1187)
T ss_pred             HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence            3469999999999998764 455667877777777788999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT  271 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  271 (458)
                      +..+-..+ .+|++.++.-++.|++.||.|||   +++|||||||+.|||++-+|.++|+|||++......    .....
T Consensus       117 DaimlEL~-r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----~qkRD  188 (1187)
T KOG0579|consen  117 DAIMLELG-RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----RQKRD  188 (1187)
T ss_pred             hHHHHHhc-cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH----Hhhhc
Confidence            98886654 46999999999999999999999   999999999999999999999999999998644321    12345


Q ss_pred             cccCCCcccccccccc-----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          272 DIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       272 ~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      .+.||+.|||||+.++     .+|+.++||||||++|.||..+.+|..+-..+.....+..   ...+.++.|       
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTLlqP-------  258 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLLQP-------  258 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcccCc-------
Confidence            6889999999998854     5899999999999999999999998765444433322211   112222222       


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                      ......+.+|+.+||..||..||++.++++|.|..+.+.+
T Consensus       259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             chhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            2344679999999999999999999999999998865544

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.3e-40  Score=327.13  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeecc-Cce
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEK-RER  179 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~  179 (458)
                      .+.+.+.||+|+||.||+|...      +++.||+|++.... ......+.+|++++.++ +|+||++++++|... ...
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            4556789999999999999642      24789999886432 23345688999999999 799999999988654 567


Q ss_pred             eeeeeecCCCCHHHHhcCCC-----------------------------------------------------------C
Q 012715          180 FLMYEYMANGSLKDHLHSPG-----------------------------------------------------------R  200 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------~  200 (458)
                      +++|||+++|+|.+++....                                                           .
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            89999999999999985421                                                           1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccc
Q 012715          201 TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM  280 (458)
Q Consensus       201 ~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~  280 (458)
                      ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........  .......++..|+
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~~~~y~  242 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWM  242 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--hhccCCCCCcccc
Confidence            25899999999999999999999   899999999999999999999999999999865432211  1122345677899


Q ss_pred             cccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHH
Q 012715          281 DPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRW  359 (458)
Q Consensus       281 aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~  359 (458)
                      |||.+.+..++.++|||||||++|||++ |..||............ ......      +    ..+......+.+++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~------~----~~~~~~~~~~~~l~~~  311 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR-LKEGTR------M----RAPEYATPEIYSIMLD  311 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH-HhccCC------C----CCCccCCHHHHHHHHH
Confidence            9999999999999999999999999998 98888643222111111 111100      0    1111223568999999


Q ss_pred             ccccCCCCCCCHHHHHHHhhh
Q 012715          360 CTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       360 cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ||+.+|++||++.|++++|..
T Consensus       312 cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         312 CWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HccCChhhCcCHHHHHHHHHH
Confidence            999999999999999999965

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-40  Score=316.23  Aligned_cols=253  Identities=27%  Similarity=0.402  Sum_probs=200.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|... ++..||+|++..........+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~   90 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG   90 (267)
T ss_pred             cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence            445678999999999999874 6889999998654444455688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......    
T Consensus        91 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~----  161 (267)
T cd06646          91 GSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA----  161 (267)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc----
Confidence            9999998753  35899999999999999999999   89999999999999999999999999999986533211    


Q ss_pred             ccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          269 VNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+............   ..   .....+....  
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~---~~---~~~~~~~~~~--  233 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---SK---SNFQPPKLKD--  233 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee---ec---CCCCCCCCcc--
Confidence            123346889999999874   345788999999999999999999998644322111100   00   0011111111  


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .......+.+++.+||+.+|++||++++++++|+
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            1122357889999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-40  Score=313.23  Aligned_cols=252  Identities=25%  Similarity=0.424  Sum_probs=194.2

Q ss_pred             ceeeeecceEEEEEEEc----CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec-cCceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  187 (458)
                      +.||+|+||.||+|.+.    ++..||+|++... .......+.+|+.+++.++|+||+++++++.. ++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999763    2457999988543 33445678899999999999999999998764 556899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++..... .+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++..........
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            9999999975432 3678888999999999999999   89999999999999999999999999999976543221111


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      .......++..|+|||.+.+..++.++|||||||++|||++|+.|+....+..+......... .      +....    
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~----  225 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-R------LLQPE----  225 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-C------CCCCC----
Confidence            112234567789999999888999999999999999999996555433333333222221110 0      11111    


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..+..+.+++..||+.+|++||++.++++.|..
T Consensus       226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            123568899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-40  Score=325.17  Aligned_cols=265  Identities=22%  Similarity=0.299  Sum_probs=200.5

Q ss_pred             ccceeeee--cceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          112 FSTIIGQG--GFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       112 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.++||+|  +||+||++... +|+.||+|++...  .......+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45689999  78999999775 6899999998643  2333456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc-
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC-  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-  265 (458)
                      ++|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.++++|||.+......... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999997654456899999999999999999999   899999999999999999999999999875433211100 


Q ss_pred             --cccccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC---
Q 012715          266 --FEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD---  338 (458)
Q Consensus       266 --~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d---  338 (458)
                        .........++..|+|||++.+  ..++.++|||||||++|||++|+.||............ .  ........+   
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-~--~~~~~~~~~~~~  235 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-L--NGTVPCLLDTTT  235 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-h--cCCccccccccc
Confidence              0001122356788999999876  46899999999999999999999999653322111111 0  011111000   


Q ss_pred             ----------------CcC-----------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 ----------------PRI-----------------KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 ----------------~~~-----------------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                      ...                 ...........+.+++.+||+.||++|||+++++++.|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                            000                 00011122357889999999999999999999999988743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-40  Score=319.19  Aligned_cols=253  Identities=31%  Similarity=0.476  Sum_probs=202.4

Q ss_pred             hcccceeeeecceEEEEEEEc------CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ..+.+.||+|+||.||++...      ++..+|+|.+..........+.+|+++++.++|+||+++++++.+.+..+++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF   86 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence            345678999999999999642      35689999887766666778999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 012715          184 EYMANGSLKDHLHSPGR-------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL  250 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  250 (458)
                      ||+++|+|.+++.....             ..+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEE
Confidence            99999999999975421             34889999999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhh
Q 012715          251 ADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMAS  329 (458)
Q Consensus       251 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  329 (458)
                      +|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ........
T Consensus       164 ~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~  240 (280)
T cd05092         164 GDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-AIECITQG  240 (280)
T ss_pred             CCCCceeEcCCCcee--ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-HHHHHHcC
Confidence            999999755432211  11223345788999999999999999999999999999998 888886543322 11111111


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          330 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       330 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      . .      .....    ..+..+.+++.+||+.||.+||++.+|++.|.
T Consensus       241 ~-~------~~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         241 R-E------LERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             c-c------CCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            0 0      01111    22356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=305.04  Aligned_cols=255  Identities=23%  Similarity=0.356  Sum_probs=210.3

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEec--ccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|.|+.||++... +|+.+|+|.++  +.+....+++.+|+.+.+.|+||||++|.+...+....|||+|+|+
T Consensus        14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~   93 (355)
T KOG0033|consen   14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT   93 (355)
T ss_pred             hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEeccc
Confidence            34468999999999999654 68999999874  3344467789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~~  264 (458)
                      |++|..-+-..  ..+++..+-..+.||+++|.|+|   .++|+|||+||.|+|+-.   .--+||+|||+|....++. 
T Consensus        94 G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~-  167 (355)
T KOG0033|consen   94 GGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE-  167 (355)
T ss_pred             chHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc-
Confidence            99998766432  34778888899999999999999   999999999999999943   4479999999999887543 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                          ......||+.|||||++...+|+..+|||+.||+||-|+.|.+||.+... ...+..++....++.    +...+.
T Consensus       168 ----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g~yd~~----~~~w~~  238 (355)
T KOG0033|consen  168 ----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAGAYDYP----SPEWDT  238 (355)
T ss_pred             ----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhccccCCC----CcccCc
Confidence                45678899999999999999999999999999999999999999986433 334444444443332    222222


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      ..    ++..+++++||..||.+|.|+.|.|+|.|-....
T Consensus       239 is----~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  239 VT----PEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             CC----HHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            22    4578899999999999999999999999987653

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=325.68  Aligned_cols=254  Identities=25%  Similarity=0.343  Sum_probs=212.9

Q ss_pred             hhcccceeeeecceEEEEEEEcC-CCEEEEEEecccch---hhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISE---QVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .|.+.+.||+|.||.||+++.+. |+.+|+|.+.+...   .....+.+|+.+|+++. |||||.+.+++.+....++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            45566899999999999998774 99999999865333   23468999999999998 999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC----CCcEEEeeccccccc
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE----NFVAKLADFGLAHAS  259 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~----~~~~kl~DfGla~~~  259 (458)
                      |+|.||.|.+.+...   .+++..+..++.|++.+++|||   +.|++||||||+|+|+..    ++.+|++|||++...
T Consensus       116 EL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            999999999999765   2999999999999999999999   899999999999999953    358999999999887


Q ss_pred             CCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      ..+.     .....+||+.|+|||++....|+..+||||+||++|.|++|..||.+.........+ .....        
T Consensus       190 ~~~~-----~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-~~~~~--------  255 (382)
T KOG0032|consen  190 KPGE-----RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-LRGDF--------  255 (382)
T ss_pred             cCCc-----eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-HcCCC--------
Confidence            6532     345678999999999999999999999999999999999999999876654443322 22211        


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .+....-......+.+++..|+..||.+|+++.++|+|+|...
T Consensus       256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~  298 (382)
T KOG0032|consen  256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS  298 (382)
T ss_pred             CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence            1111111223466889999999999999999999999998655

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.6e-41  Score=328.90  Aligned_cols=247  Identities=26%  Similarity=0.348  Sum_probs=195.4

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHH-HHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||+||+|... +|+.||+|.+...   .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999875 6899999998643   2223345556655 46778999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|..++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......    .
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~----~  151 (325)
T cd05604          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS----D  151 (325)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----C
Confidence            9999998753  35899999999999999999999   8999999999999999999999999999987532211    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||..|+|||.+.+..++.++|||||||++|||++|+.||.... ..+.........        ..+....   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~~~~~~~--------~~~~~~~---  219 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEMYDNILHKP--------LVLRPGA---  219 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-HHHHHHHHHcCC--------ccCCCCC---
Confidence            2234569999999999999999999999999999999999999997543 223322222111        0111112   


Q ss_pred             HHHHHHHHHHHccccCCCCCCCH----HHHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSI----KQVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~~~  382 (458)
                       ...+.+++.+|++.+|.+||++    .++++|.|+..
T Consensus       220 -~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         220 -SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             -CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence             2457789999999999999977    47777776643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.7e-40  Score=310.77  Aligned_cols=251  Identities=25%  Similarity=0.425  Sum_probs=201.3

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||+.+|
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~   85 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG   85 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence            45667899999999999998777789999876432 23457889999999999999999999875 45689999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++........   .
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~---~  159 (260)
T cd05069          86 SLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---A  159 (260)
T ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc---c
Confidence            9999997655556899999999999999999999   899999999999999999999999999999765433211   1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+...... ..... ....      +    ..+..
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~-~~~~------~----~~~~~  227 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LEQVE-RGYR------M----PCPQG  227 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHH-cCCC------C----CCCcc
Confidence            122346778999999988899999999999999999999 8888865433222 11111 1100      1    11122


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+..+.+++.+||+.+|++||+++++++.|.+
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            34678999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.9e-40  Score=317.94  Aligned_cols=253  Identities=21%  Similarity=0.359  Sum_probs=200.1

Q ss_pred             hcccceeeeecceEEEEEEEc------CCCEEEEEEecccch-hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|.+.      ++..||+|.+..... .....+.+|+.++..++|+||+++++++.+.+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            455678999999999999763      257899999874332 3345688999999999999999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcE
Q 012715          183 YEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA  248 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~  248 (458)
                      +||+.+++|.+++....              ...+++..+..++.|++.||+|||   +++++||||||+||++++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence            99999999999985211              234788899999999999999999   8999999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHH
Q 012715          249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCM  327 (458)
Q Consensus       249 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  327 (458)
                      ||+|||+++........  .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.. ..+......
T Consensus       164 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~i~  240 (283)
T cd05091         164 KISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVIEMIR  240 (283)
T ss_pred             Eecccccccccccchhe--eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHH
Confidence            99999998865433211  11233446789999999988889999999999999999998 777775432 223222221


Q ss_pred             hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       328 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ...  .     .....    ..+..+.+++..||+.+|.+||++.+|++.|.
T Consensus       241 ~~~--~-----~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         241 NRQ--V-----LPCPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             cCC--c-----CCCCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            111  0     01112    23456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.7e-40  Score=312.97  Aligned_cols=254  Identities=25%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecc---cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +++.||||.+..   ........+.+|+++++.++||||+++++++.+.+..++|+||
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence            345678999999999999875 689999998753   2233345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          186 MANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       186 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      +++|+|.+++...  ....+++..+..++.|++.||+|||   +++++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            9999999988532  2345889999999999999999999   8999999999999999999999999999988654322


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc-hHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-LVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      .    ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .......... ..      .+.  
T Consensus       161 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~------~~~--  227 (267)
T cd08228         161 T----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CD------YPP--  227 (267)
T ss_pred             H----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-CC------CCC--
Confidence            1    12234688899999999988899999999999999999999999865432 2222222111 00      111  


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       .........+.+++.+||..+|++||++.++++.+..
T Consensus       228 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         228 -LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             -CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence             1112233568999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3e-40  Score=316.61  Aligned_cols=264  Identities=27%  Similarity=0.454  Sum_probs=200.1

Q ss_pred             cccceeeeecceEEEEEEE-----cCCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeee
Q 012715          111 NFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLM  182 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  182 (458)
                      .+.+.||+|+||+||++.+     .++..||+|.+.... ......+.+|++++++++|+||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4567899999999988753     357899999886432 23456788999999999999999999998764  357899


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+++|+|.+++...   .+++..+..++.|++.||+|||   +++++||||||+|||+++++.+||+|||+++....+
T Consensus        87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            9999999999999753   4899999999999999999999   899999999999999999999999999999866443


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchH-HHHHHHH--hhccccccccCC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV-ESAQVCM--ASESRLAELVDP  339 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~-~~~~~~~--~~~~~~~~~~d~  339 (458)
                      .... .......++..|+|||.+....++.++||||||+++|||++|..|+....... +......  .....+.+..+.
T Consensus       161 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         161 HEYY-RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             chhh-ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            2111 11122345677999999988889999999999999999999999986432211 1100000  000011111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ......+...+..+.+++..||+.+|++||+++++++.|...
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            111111223346799999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.7e-40  Score=322.49  Aligned_cols=264  Identities=23%  Similarity=0.316  Sum_probs=200.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +...+.||+|+||+||+|... ++..||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||++
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   87 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD   87 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence            445678999999999999875 57899999886432 2233467899999999999999999999999999999999997


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      + +|.+++...+ ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus        88 ~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---  159 (309)
T cd07872          88 K-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK---  159 (309)
T ss_pred             C-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc---
Confidence            5 8988886543 34889999999999999999999   89999999999999999999999999999975433221   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc----ccc------
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL----AEL------  336 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~------  336 (458)
                       ......++..|+|||.+.+ ..++.++|||||||++|||+||+.||....................    ..+      
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             1223457899999998865 5688999999999999999999999975433222111111000000    000      


Q ss_pred             cC---CcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          337 VD---PRIKDS----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       337 ~d---~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .+   +.....    ........+.+++.+||+.||.+|||+.|+++|.|...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  291 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS  291 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence            00   000000    00012245789999999999999999999999998754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.1e-40  Score=328.53  Aligned_cols=258  Identities=23%  Similarity=0.325  Sum_probs=201.3

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ..+.+.+.||+|+||.||+|+.. +++.||+|.+...   .......+.+|+.+++.++||||+++++++.+++..++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            44556789999999999999876 5889999988532   2233445788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++...   .++...+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       123 Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         123 EYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            999999999999753   3788889999999999999999   9999999999999999999999999999998654322


Q ss_pred             cccccccccccCCCccccccccccC----CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQ----ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      ..   ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...... .....+......+. ..+ 
T Consensus       197 ~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~-~~~-  270 (371)
T cd05622         197 MV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKIMNHKNSLT-FPD-  270 (371)
T ss_pred             cc---cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCccc-CCC-
Confidence            11   12345799999999998754    3789999999999999999999999754332 22222221111110 000 


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhhCCC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESSD  383 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~~  383 (458)
                            .......+.+++..|+..++.+  |++++++++|+|....
T Consensus       271 ------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         271 ------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             ------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence                  0112356788999999844433  7899999999987553

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.5e-41  Score=327.41  Aligned_cols=245  Identities=25%  Similarity=0.364  Sum_probs=192.7

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHH-HHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||+||+|+.. +++.||+|.+....   ......+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999876 57889999986422   122234444544 56778999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++....  .+....+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......    .
T Consensus        81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----~  151 (325)
T cd05602          81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----G  151 (325)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----C
Confidence            99999997643  4788888999999999999999   8999999999999999999999999999987542221    1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +..........        .+....   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~--------~~~~~~---  219 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-EMYDNILNKPL--------QLKPNI---  219 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-HHHHHHHhCCc--------CCCCCC---
Confidence            223456999999999999999999999999999999999999999754332 32222221110        111112   


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHH----HHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIK----QVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~----evl~~l~~  380 (458)
                       ...+.+++.+||+.+|.+||++.    +++++++.
T Consensus       220 -~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~  254 (325)
T cd05602         220 -TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF  254 (325)
T ss_pred             -CHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence             24688999999999999999876    56655544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-40  Score=317.65  Aligned_cols=253  Identities=29%  Similarity=0.420  Sum_probs=198.4

Q ss_pred             hcccceeeeecceEEEEEEEcC------CCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|.+.+      +..||+|.+.... ......|.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   87 (277)
T cd05036           8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL   87 (277)
T ss_pred             cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence            3445789999999999998753      5678999876432 33446799999999999999999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC---cEEEeecc
Q 012715          183 YEYMANGSLKDHLHSPGR-----TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFG  254 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfG  254 (458)
                      |||+++++|.+++.....     ..+++..+++++.||+.||+|||   +++++||||||+||+++.++   .+||+|||
T Consensus        88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCc
Confidence            999999999999965421     25899999999999999999999   88999999999999998654   69999999


Q ss_pred             cccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcccc
Q 012715          255 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL  333 (458)
Q Consensus       255 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  333 (458)
                      +++........  ........+..|+|||.+.+..++.++|||||||++|||++ |..||..... ......... ... 
T Consensus       165 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~~~~~~~-~~~-  239 (277)
T cd05036         165 MARDIYRASYY--RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTG-GGR-  239 (277)
T ss_pred             cccccCCccce--ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHc-CCc-
Confidence            99865332211  11122234568999999998999999999999999999997 8888864332 222221111 111 


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          334 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       334 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                               ...+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus       240 ---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         240 ---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                     0111122356889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6e-40  Score=308.49  Aligned_cols=246  Identities=23%  Similarity=0.405  Sum_probs=198.3

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      ++||+|+||.||+|...++..+|+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3699999999999998888999999886533 333457889999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccc
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      +++.... ..+++..++.++.|++.||.|||   .++++||||||+||+++.++.+||+|||++.....+...   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~---~~~~  153 (250)
T cd05085          81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS---SSGL  153 (250)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc---cCCC
Confidence            9986543 35899999999999999999999   899999999999999999999999999998754332211   1112


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      ..++..|+|||++.+..++.++||||||+++||+++ |..||...... ....... ...      ....    +...+.
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~~~~~~~-~~~------~~~~----~~~~~~  221 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQVE-KGY------RMSC----PQKCPD  221 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHH-cCC------CCCC----CCCCCH
Confidence            234678999999998899999999999999999998 88888654322 2111111 110      1111    112235


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          352 TIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      .+.+++.+||+.+|++||++.++++.|
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKEL  248 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHh
Confidence            789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.9e-40  Score=312.32  Aligned_cols=248  Identities=22%  Similarity=0.384  Sum_probs=195.4

Q ss_pred             eeeeecceEEEEEEEc---CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          115 IIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .||+|+||.||+|.+.   ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999764   35579999886443 333467999999999999999999999875 457899999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |.+++.... ..+++..+++++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++.......... ..
T Consensus        81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~  155 (257)
T cd05115          81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-AR  155 (257)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee-cc
Confidence            999997532 35899999999999999999999   89999999999999999999999999999976543322111 11


Q ss_pred             ccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      ....++..|+|||.+....++.++|||||||++|||++ |..||.+.... +...... ....          ...+..+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~-~~~~----------~~~~~~~  223 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-EVMSFIE-QGKR----------LDCPAEC  223 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHH-CCCC----------CCCCCCC
Confidence            22334678999999988889999999999999999996 99998754332 2211111 1110          1112223


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          350 LRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...+.+++.+||+.+|++||++.+|.+.|..
T Consensus       224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         224 PPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            4678899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.9e-40  Score=329.32  Aligned_cols=263  Identities=24%  Similarity=0.331  Sum_probs=200.3

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC-----ceeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLMY  183 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~  183 (458)
                      ..+.||+|+||.||+|... +|+.||||++...  .......+.+|+++++.++|+||+++++++...+     ..|+||
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            4568999999999999864 7899999988643  2234467889999999999999999999998776     789999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+. ++|.+++...  ..+++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++......
T Consensus        84 e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          84 ELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             eccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            9996 5888888653  35899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             cccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc-cccc-------
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-SRLA-------  334 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~-------  334 (458)
                      .   .......++..|+|||.+.+. .++.++|||||||++|||++|+.||................. ....       
T Consensus       158 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         158 S---KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             c---ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            1   122334678999999998774 578999999999999999999999975443322111110000 0000       


Q ss_pred             --------cccCC-cCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          335 --------ELVDP-RIKD--SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       335 --------~~~d~-~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                              ....+ ....  .........+.+++.+||+.||++|||+.|+++|.|....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                    00000 0000  0011123568899999999999999999999999987653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.1e-40  Score=315.15  Aligned_cols=248  Identities=24%  Similarity=0.365  Sum_probs=199.3

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++.+++|+||+++++++...+..++||||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            35578999999999999764 6889999988543 233445789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|..+.      .+++..+..++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||++......      
T Consensus        84 ~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------  148 (279)
T cd06619          84 GSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------  148 (279)
T ss_pred             CChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------
Confidence            9997653      3678889999999999999999   999999999999999999999999999999765432      


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchH------HHHHHHHhhccccccccCCcCC
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV------ESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......      ........ .      ..+.+.
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~  221 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E------DPPVLP  221 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c------CCCCCC
Confidence            1234568999999999999899999999999999999999999986422110      11111000 0      011111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .   ......+.+++.+||+.+|++||++++++++.|....
T Consensus       222 ~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         222 V---GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             C---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            0   1122458899999999999999999999999887554

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.8e-40  Score=326.85  Aligned_cols=263  Identities=20%  Similarity=0.290  Sum_probs=208.8

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-C-----CCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-H-----RHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  181 (458)
                      +|...+.||+|+||.|-+|... +++.||||++++.. ....+-..|+.+|..|+ |     -|+|++++++...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            5556789999999999999654 69999999997643 33456778999999997 4     499999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC--CCcEEEeeccccccc
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE--NFVAKLADFGLAHAS  259 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~~  259 (458)
                      |+|.+. .+|+++|+.+.-.+|+...+..|+.||+.||.+||   +.+|||+||||+||||.+  ...+||+|||.+...
T Consensus       266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999885 59999999888888999999999999999999999   999999999999999965  348999999999876


Q ss_pred             CCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc--------
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES--------  331 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------  331 (458)
                      ....       ....-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.....+...++...+.        
T Consensus       342 ~q~v-------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  342 SQRV-------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             CCcc-------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            5432       1456788999999999999999999999999999999997777655444444333211110        


Q ss_pred             --ccccccCC---------------------------------cCC-C------CCCHHHHHHHHHHHHHccccCCCCCC
Q 012715          332 --RLAELVDP---------------------------------RIK-D------SFDMEQLRTIVTIVRWCTQREGQARP  369 (458)
Q Consensus       332 --~~~~~~d~---------------------------------~~~-~------~~~~~~~~~l~~l~~~cl~~dp~~RP  369 (458)
                        +....++.                                 ... +      ......-..+.+++.+|+..||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence              00000110                                 000 0      00112235789999999999999999


Q ss_pred             CHHHHHHHhhhCCC
Q 012715          370 SIKQVLRILYESSD  383 (458)
Q Consensus       370 s~~evl~~l~~~~~  383 (458)
                      |..|+++|.|....
T Consensus       495 tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  495 TPAQALNHPFLTGT  508 (586)
T ss_pred             CHHHHhcCcccccc
Confidence            99999999988643

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.1e-40  Score=319.28  Aligned_cols=255  Identities=28%  Similarity=0.429  Sum_probs=201.7

Q ss_pred             hcccceeeeecceEEEEEEEcC------CCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  181 (458)
                      +.+.+.||+|+||.||++...+      ...+|+|.+... .......+.+|++++.++ +|+||+++++++..++..++
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   93 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV   93 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence            4456789999999999997642      368999988643 233445688999999999 79999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc
Q 012715          182 MYEYMANGSLKDHLHSP--------------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV  247 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~  247 (458)
                      +|||+++|+|.+++...              ....+++..++.++.|++.||+|||   +++|+||||||+|||+++++.
T Consensus        94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~  170 (293)
T cd05053          94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHV  170 (293)
T ss_pred             EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCe
Confidence            99999999999999642              2346899999999999999999999   899999999999999999999


Q ss_pred             EEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHH
Q 012715          248 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVC  326 (458)
Q Consensus       248 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~  326 (458)
                      +||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+.....
T Consensus       171 ~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~  247 (293)
T cd05053         171 MKIADFGLARDIHHIDYY--RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKLL  247 (293)
T ss_pred             EEeCccccccccccccce--eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-HHHHHHHH
Confidence            999999999865443211  11222345678999999998899999999999999999998 888875432 22222221


Q ss_pred             HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       327 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ... ..      +    ..+......+.+++.+||..+|++|||+.++++.|...
T Consensus       248 ~~~-~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         248 KEG-YR------M----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HcC-Cc------C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            111 00      0    11112235688999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.5e-40  Score=313.31  Aligned_cols=251  Identities=26%  Similarity=0.431  Sum_probs=199.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeecc------Cceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEK------RERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~l  181 (458)
                      +++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++.++ +|+||+++++++...      ...++
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            344568999999999999875 58899999886433 3345788999999999 699999999998753      35789


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+.+|+|.+++.......+++..+..++.|++.||+|||   +++++||||||+||++++++.+||+|||++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~  163 (272)
T cd06637          87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence            999999999999998655556899999999999999999999   88999999999999999999999999999976533


Q ss_pred             CCcccccccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      ..    .......|+..|+|||++.     ...++.++|||||||++|||++|+.||.+...........   .......
T Consensus       164 ~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~  236 (272)
T cd06637         164 TV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPAPRL  236 (272)
T ss_pred             cc----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---cCCCCCC
Confidence            21    1223456889999999886     3458889999999999999999999996544332222110   0000001


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                          ..    ......+.+++.+||..+|.+||++.++++|.|
T Consensus       237 ----~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  271 (272)
T cd06637         237 ----KS----KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF  271 (272)
T ss_pred             ----CC----CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence                11    122356889999999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.2e-40  Score=310.91  Aligned_cols=252  Identities=24%  Similarity=0.335  Sum_probs=193.1

Q ss_pred             eeeeecceEEEEEEEcC---CCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          115 IIGQGGFGTVYKAQFSD---GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .||+|+||.||+|.+.+   +..+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999997653   4579999886433 2334578899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          191 LKDHLHSPG---RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       191 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      |.+++....   ....++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++........  
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~--  156 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY--  156 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence            999996432   224677888899999999999999   899999999999999999999999999999754332211  


Q ss_pred             cccccccCCCccccccccccC-------CCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQ-------ELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      .......++..|+|||.+.+.       .++.++||||||+++|||++ |+.||..............   .......++
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~  233 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR---EQQLKLPKP  233 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---cccCCCCCC
Confidence            112234578899999988642       35789999999999999996 9999865443322111111   111122223


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .+....    ...+.+++..|| .+|++||++++|+..|.
T Consensus       234 ~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         234 RLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            322222    245788999999 68999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4e-40  Score=318.02  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=205.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||.|+||.||+|... ++..||+|.+..........+.+|+.+++.+.|+||+++++++......++||||+++
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~  101 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence            344568999999999999864 6889999998755544556789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++..   ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........    
T Consensus       102 ~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~----  171 (296)
T cd06654         102 GSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----  171 (296)
T ss_pred             CCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc----
Confidence            999999964   24889999999999999999999   89999999999999999999999999999876433221    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......|+..|+|||.+.+..++.++|||||||++|||++|+.||............. ...  ...     +  .....
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~-~~~--~~~-----~--~~~~~  241 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNG--TPE-----L--QNPEK  241 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh-cCC--CCC-----C--CCccc
Confidence            1223468899999999998889999999999999999999999997554332222111 100  000     0  01112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ....+.+++.+||..+|++||++.+++++.|...
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence            2356889999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7e-40  Score=311.65  Aligned_cols=251  Identities=24%  Similarity=0.350  Sum_probs=190.7

Q ss_pred             eeeeecceEEEEEEEcC---CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          115 IIGQGGFGTVYKAQFSD---GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .||+|+||.||+|...+   ...+|+|.+... .......+.+|+++++.++|+||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   357888877543 23344578899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCC---CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          191 LKDHLHSPGR---TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       191 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      |.+++.....   ...++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~-  157 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI-  157 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence            9999975432   23567888999999999999999   8999999999999999999999999999987543322110 


Q ss_pred             cccccccCCCcccccccccc-------CCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-------QELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                       ......++..|+|||++..       ..++.++|||||||++|||++ |..||....+...........   .....++
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~  233 (269)
T cd05042         158 -TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ---DIKLPKP  233 (269)
T ss_pred             -ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc---CccCCCC
Confidence             1123346778999998743       456889999999999999999 677776544332222221111   1112222


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      .+...    ....+.+++..|| .||++||++++|++.|
T Consensus       234 ~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         234 QLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            22222    2355778889998 5999999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-40  Score=334.26  Aligned_cols=259  Identities=22%  Similarity=0.287  Sum_probs=196.1

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      .+.+.||+|+||.||+|... .++.||||...      ...+.+|+++|++++|+||+++++++..++..++|||++. +
T Consensus       172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~  244 (461)
T PHA03211        172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S  244 (461)
T ss_pred             EEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence            34568999999999999876 47899999532      2346789999999999999999999999999999999995 6


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++.... ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus       245 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~--~~~  318 (461)
T PHA03211        245 DLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS--TPF  318 (461)
T ss_pred             CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc--ccc
Confidence            9999886533 35999999999999999999999   89999999999999999999999999999986543211  111


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc------h-HHHHHHHHhhcccccccc-----
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN------L-VESAQVCMASESRLAELV-----  337 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~------~-~~~~~~~~~~~~~~~~~~-----  337 (458)
                      .....||..|+|||++.+..++.++|||||||+||||++|..++.....      . .+....+........+..     
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            2345699999999999999999999999999999999998876543211      1 111111111110000000     


Q ss_pred             --------------CCcCCC-CCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 --------------DPRIKD-SFD--MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 --------------d~~~~~-~~~--~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                    .+.... ...  ......+.+++.+||+.||.+|||+.|+|+|.|+..
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                          000000 000  011135788999999999999999999999988743

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-40  Score=311.08  Aligned_cols=247  Identities=29%  Similarity=0.480  Sum_probs=203.1

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.+.||+|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||++++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKG   85 (256)
T ss_pred             ccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCC
Confidence            45667899999999999987 488999999875544 4567999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++.......+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||+++......      
T Consensus        86 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~------  156 (256)
T cd05039          86 SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ------  156 (256)
T ss_pred             cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc------
Confidence            9999998765556999999999999999999999   9999999999999999999999999999998653321      


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                       ....++..|+|||.+....++.++||||||+++|||++ |..||.... ..+...... ....      ...    +..
T Consensus       157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~-~~~~------~~~----~~~  223 (256)
T cd05039         157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHVE-KGYR------MEA----PEG  223 (256)
T ss_pred             -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHh-cCCC------CCC----ccC
Confidence             12335678999999988889999999999999999997 888886442 222211111 1100      111    112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+..+.+++.+||..+|++||+++++++.|..
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            23568899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-40  Score=312.83  Aligned_cols=255  Identities=32%  Similarity=0.506  Sum_probs=201.5

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhH--hHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVE--GDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|+||+||++... ++..||+|.+........  ....+|+.++++++|+||+++++++.+....++||||++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            46779999999999999886 466899999875443322  234569999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +++|.+++..  ...+++..++.++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||.+.......    
T Consensus        82 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~----  152 (260)
T PF00069_consen   82 GGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN----  152 (260)
T ss_dssp             TEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT----
T ss_pred             cccccccccc--cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc----
Confidence            9999999973  235899999999999999999999   8899999999999999999999999999987541111    


Q ss_pred             cccccccCCCccccccccc-cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      .......++..|+|||.+. +..++.++||||||+++|+|++|..||........................    ..  .
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~  226 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS----QQ--S  226 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT----TS--H
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc----cc--c
Confidence            1234566899999999998 888999999999999999999999999865211111111100000000000    00  0


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ......+.+++..||+.||++||++.+++++.|+
T Consensus       227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  227 REKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             chhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            0011679999999999999999999999998864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1e-39  Score=312.84  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=203.8

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +..+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||+++++++...+..++||||++++
T Consensus         8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~   87 (282)
T cd06643           8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG   87 (282)
T ss_pred             HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence            34567999999999999876 47788999887655555678999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|..++.... .++++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........    .
T Consensus        88 ~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----~  159 (282)
T cd06643          88 AVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----R  159 (282)
T ss_pred             cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc----c
Confidence            9999886432 35899999999999999999999   89999999999999999999999999999875433211    1


Q ss_pred             cccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          270 NTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      .....++..|+|||.+.     +..++.++|||||||++|||++|+.||............ ....  ......      
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~------  230 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSE--PPTLAQ------  230 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH-hhcC--CCCCCC------
Confidence            23346899999999884     345788999999999999999999998654332221111 1110  011111      


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                       +......+.+++.+||+.+|.+||++.+++++.+....
T Consensus       231 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         231 -PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             -ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence             11123568899999999999999999999999886544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.9e-40  Score=311.34  Aligned_cols=247  Identities=23%  Similarity=0.384  Sum_probs=196.0

Q ss_pred             eeeeecceEEEEEEEc---CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          115 IIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      .||+|+||.||+|.++   ++..+|+|.+....  ....+.+.+|+.+++.+.|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   57899999886432  334567899999999999999999999875 45778999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++...  ..+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.......... .
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~  154 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-A  154 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee-e
Confidence            999999753  35899999999999999999999   89999999999999999999999999999986544322111 1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....++..|+|||.+....++.++|||||||++|||++ |+.||..... .+....... ...      +.....    
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~i~~-~~~------~~~~~~----  222 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIES-GER------MECPQR----  222 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHC-CCC------CCCCCC----
Confidence            122334678999999988889999999999999999998 8889864332 222222211 110      111222    


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ....+.+++.+||+.||++||++.+|.+.|..
T Consensus       223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            23568899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-41  Score=301.12  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=205.1

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccc--------hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeee
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--------EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  182 (458)
                      .++||.|..++|-++..+ +|..+|+|++....        ....+.-.+|+.+|+++ .||||+.+.+++..+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            458999999999998665 68899999885321        12234567899999999 599999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      +|.|+.|.|.|+|.+  ...+++....+|+.|+.+|++|||   .++|+||||||+|||++++.++||+|||++.....+
T Consensus       102 Fdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             hhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence            999999999999986  346999999999999999999999   999999999999999999999999999999988776


Q ss_pred             CcccccccccccCCCcccccccccc------CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVT------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      .     .....+||++|+|||.+..      ..|+..+|+||+||+||.|+.|.+||+.-..+.. .+.++.....+.  
T Consensus       177 e-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM-LR~ImeGkyqF~--  248 (411)
T KOG0599|consen  177 E-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM-LRMIMEGKYQFR--  248 (411)
T ss_pred             h-----hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-HHHHHhcccccC--
Confidence            5     3456899999999999854      3688899999999999999999999976443322 222222222111  


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                       .|. .    .+......+++.+||+.||.+|.|++|+|+|.|+.
T Consensus       249 -spe-W----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  249 -SPE-W----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             -Ccc-h----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence             111 1    12234688999999999999999999999999873

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.5e-40  Score=310.02  Aligned_cols=250  Identities=24%  Similarity=0.379  Sum_probs=200.6

Q ss_pred             ceeeeecceEEEEEEEcC--C--CEEEEEEecccch-hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFSD--G--SLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998743  3  3699999876544 556789999999999999999999999988 889999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.......+++..++.++.|++.||+|||   .++++|+||||+||+++.++.+||+|||+++.......... 
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-  155 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV-  155 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccccee-
Confidence            99999997654346899999999999999999999   89999999999999999999999999999987644321111 


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +...........   .       ..+.
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~~---~-------~~~~  224 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-QILKKIDKEGER---L-------ERPE  224 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCCc---C-------CCCc
Confidence            1123457789999999998899999999999999999999 99998644322 222221111100   0       0111


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ..+..+.+++.+||+.+|++||++.++++.|.
T Consensus       225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            22356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=322.21  Aligned_cols=258  Identities=21%  Similarity=0.292  Sum_probs=198.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||++... +++.||+|.+...   .......+.+|+.++..++|+||+++++++.+++..|+||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            345678999999999999875 5899999998642   223345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++.........
T Consensus        83 ~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          83 YVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             CCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            99999999997532 34889999999999999999999   999999999999999999999999999998765432211


Q ss_pred             cccccccccCCCcccccccccc-----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                         ......||+.|+|||++..     ..++.++|||||||++|||++|+.||..... .+............. +  +.
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-~~~~~~i~~~~~~~~-~--~~  231 (331)
T cd05597         159 ---QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKEHFQ-F--PP  231 (331)
T ss_pred             ---cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-HHHHHHHHcCCCccc-C--CC
Confidence               1123468999999999863     4578899999999999999999999975432 222222221111110 0  11


Q ss_pred             CCCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHhhhCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQR--EGQARPSIKQVLRILYESS  382 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~--dp~~RPs~~evl~~l~~~~  382 (458)
                      ....    ....+.+++.+|+..  ++..||+++++++|.|...
T Consensus       232 ~~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         232 DVTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             ccCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            1111    224567788876654  3444889999999998754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=331.81  Aligned_cols=250  Identities=25%  Similarity=0.401  Sum_probs=206.1

Q ss_pred             ccceeeeecceEEEEEEEc--CC--CEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          112 FSTIIGQGGFGTVYKAQFS--DG--SLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.++||+|+||.|++|.|.  +|  ..||||.+...... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||||++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3468999999999999886  34  36899999754433 66789999999999999999999999887 7788999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +.|+|.+.|+......|-......++.|||.||.||.   .+++|||||.++|+|+-..-.+||+||||.+.+..+...+
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            9999999998865667889999999999999999999   9999999999999999998999999999999887765443


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhC-CCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                       .+.....-...|+|||.+....++.++|||+|||++|||+|+ ..||.+ ..-.+..+.+           |..-+-.-
T Consensus       270 -vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g~qIL~~i-----------D~~erLpR  336 (1039)
T KOG0199|consen  270 -VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRGIQILKNI-----------DAGERLPR  336 (1039)
T ss_pred             -EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC-CCHHHHHHhc-----------cccccCCC
Confidence             122333456789999999999999999999999999999995 456653 3333333222           21112223


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      +..|.+.+++++..||..+|++||++..|.+.+
T Consensus       337 Pk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            445668899999999999999999999998544

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-40  Score=315.95  Aligned_cols=261  Identities=22%  Similarity=0.372  Sum_probs=197.5

Q ss_pred             hhcccceeeeecceEEEEEEEcC---------------CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD---------------GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGF  172 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~  172 (458)
                      .+.+.+.||+|+||.||++...+               ...||+|.+... .......|.+|++++++++|+||++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            45566789999999999987532               235899988643 33344579999999999999999999999


Q ss_pred             eeccCceeeeeeecCCCCHHHHhcCCC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 012715          173 CIEKRERFLMYEYMANGSLKDHLHSPG----------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL  242 (458)
Q Consensus       173 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll  242 (458)
                      +...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||   +.+++||||||+||++
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill  162 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLV  162 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEE
Confidence            999999999999999999999986432          123788999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh--CCCccCCCcchH
Q 012715          243 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT--ARRAVQDGKNLV  320 (458)
Q Consensus       243 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~p~~~~~~~~  320 (458)
                      ++++.+||+|||++.........  .......++..|+|||.+.+..++.++|||||||++|||++  +..||..... .
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~  239 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-E  239 (295)
T ss_pred             cCCCcEEecccccccccccCcce--eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-H
Confidence            99999999999999765433211  11223345778999999998899999999999999999998  4556643222 1


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      +..................    ..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYL----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHhhhhccccccC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1111110000000000000    001112357999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.6e-40  Score=313.47  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=197.6

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      ..||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            47999999999999865 57889999887665556678999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccccCCCCcccccc
Q 012715          193 DHLHSPGRTPL--SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       193 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +++.... ..+  ++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.+||+|||++........    .
T Consensus        94 ~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~----~  165 (268)
T cd06624          94 ALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP----C  165 (268)
T ss_pred             HHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC----c
Confidence            9997532 224  78888999999999999999   899999999999999976 77999999999876543221    1


Q ss_pred             cccccCCCccccccccccC--CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          270 NTDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      .....|+..|+|||.+...  .++.++||||||+++|||++|+.||.............. ..     -..+.+..    
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-~~-----~~~~~~~~----  235 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-MF-----KIHPEIPE----  235 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-hh-----ccCCCCCc----
Confidence            2234578999999998654  378899999999999999999999865332211111000 00     00111121    


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .....+.+++.+||+.+|.+||++.+++++.|
T Consensus       236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  267 (268)
T cd06624         236 SLSAEAKNFILRCFEPDPDKRASAHDLLQDPF  267 (268)
T ss_pred             ccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence            22356889999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.9e-40  Score=328.50  Aligned_cols=259  Identities=24%  Similarity=0.365  Sum_probs=201.8

Q ss_pred             HHHhhcccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccC
Q 012715          106 KKATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKR  177 (458)
Q Consensus       106 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  177 (458)
                      ......+.+.||+|+||.||+|++.      .+..||+|++.... ......+.+|+++|.++. |+||++++++|...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3334455679999999999999863      24689999997532 233356889999999997 999999999999999


Q ss_pred             ceeeeeeecCCCCHHHHhcCCC----------------------------------------------------------
Q 012715          178 ERFLMYEYMANGSLKDHLHSPG----------------------------------------------------------  199 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  199 (458)
                      ..++||||+.+|+|.++++...                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999996421                                                          


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 012715          200 --------------------------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL  241 (458)
Q Consensus       200 --------------------------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIl  241 (458)
                                                            ...+++..++.++.|++.||+|||   +++++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence                                                  124678888999999999999999   899999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchH
Q 012715          242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLV  320 (458)
Q Consensus       242 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~  320 (458)
                      +++++.+||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EeCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            999999999999999865332211  11223456889999999998889999999999999999998 888886433222


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..... .....+      +....    .....+.+++.+||..+|.+||++++|++.|..
T Consensus       350 ~~~~~-~~~~~~------~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         350 QFYNA-IKRGYR------MAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             HHHHH-HHcCCC------CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            21111 111111      11111    123568999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-40  Score=310.40  Aligned_cols=252  Identities=27%  Similarity=0.417  Sum_probs=202.1

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc-----hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      ...+.||+|++|.||+|... ++..||+|.+....     ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   84 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME   84 (263)
T ss_pred             cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence            34578999999999999764 68999999875322     1223468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++++|.+++...+  .+++..+..++.|++.||.|||   ..+++||||+|+||++++++.++|+|||+++.......
T Consensus        85 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          85 YMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             ECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            999999999997643  4889999999999999999999   89999999999999999999999999999875533211


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      . ........|+..|+|||.+.+..++.++||||||+++|||++|+.||............... .      ..+.+.. 
T Consensus       160 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~------~~~~~~~-  230 (263)
T cd06625         160 S-GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-P------TNPQLPS-  230 (263)
T ss_pred             c-cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-C------CCCCCCc-
Confidence            0 00112345788999999999988999999999999999999999999765443332221111 0      0111122 


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                         .....+.+++.+||..+|.+||++.+++++.|
T Consensus       231 ---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         231 ---HVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             ---cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence               22356889999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=309.68  Aligned_cols=252  Identities=24%  Similarity=0.393  Sum_probs=198.0

Q ss_pred             ccceeeeecceEEEEEEEcC----CCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc------e
Q 012715          112 FSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE------R  179 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~  179 (458)
                      +.+.||+|+||.||+|.+..    +..||+|++...  .......+.+|++.++.++|+||+++++++.....      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            46789999999999997642    367999998642  23345679999999999999999999999876554      7


Q ss_pred             eeeeeecCCCCHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 012715          180 FLMYEYMANGSLKDHLHSP----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL  255 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  255 (458)
                      ++||||+++|+|..++...    ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccc
Confidence            9999999999999998432    2235899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccc
Q 012715          256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLA  334 (458)
Q Consensus       256 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  334 (458)
                      ++.........  ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..+ .+........  .  
T Consensus       160 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~~~~~~--~--  232 (273)
T cd05035         160 SKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHG--N--  232 (273)
T ss_pred             eeecccccccc--ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcC--C--
Confidence            98654432211  1122335678999999988899999999999999999999 7788754432 2222221111  0  


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       335 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                         .....    ......+.+++.+||+.||.+||++.+++++|..
T Consensus       233 ---~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         233 ---RLKQP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             ---CCCCC----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence               01111    1233578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-41  Score=333.27  Aligned_cols=249  Identities=25%  Similarity=0.429  Sum_probs=207.9

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEec--c--cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc--eeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMD--K--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE--RFLMYE  184 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  184 (458)
                      |..+||+|+|-+||+|.+. +|..||--.++  +  .+....+.|..|+.+|+.|+|+||+++++++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4568999999999999764 57777743332  2  233445789999999999999999999999887654  789999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccccCCCC
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~  263 (458)
                      .+..|+|..|+++.+.  ++...+..|++||++||.|||+. .++|||||||.+||||+. -|.|||+|+|||.......
T Consensus       124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999988654  88899999999999999999976 789999999999999975 6899999999998776543


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc--ccccccCCcC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES--RLAELVDPRI  341 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~d~~~  341 (458)
                            .....|||.|||||.+. ..|...+||||||++++||+|+..||.+..+.++.+.....+..  .+..+-|   
T Consensus       201 ------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d---  270 (632)
T KOG0584|consen  201 ------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD---  270 (632)
T ss_pred             ------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC---
Confidence                  34578999999999776 88999999999999999999999999998888887776543321  1122222   


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                               .++.+||.+|+.. .++|||+.|+|++.++..+
T Consensus       271 ---------Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  271 ---------PEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ---------HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                     3577899999999 9999999999999887765

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.6e-40  Score=327.67  Aligned_cols=259  Identities=20%  Similarity=0.284  Sum_probs=198.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Ccee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  180 (458)
                      +...+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++|+||+++++++...      ...+
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   98 (355)
T cd07874          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY   98 (355)
T ss_pred             eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence            445678999999999999764 5889999998643  233345788999999999999999999988643      3469


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++ +|.+.+..    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        99 lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          99 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             EEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            99999965 77777753    3888999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc---------
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES---------  331 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------  331 (458)
                      ...     ......||..|+|||.+.+..++.++|||||||++|||++|+.||........+.........         
T Consensus       171 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         171 TSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             Ccc-----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            322     223456899999999999999999999999999999999999999754433322221111000         


Q ss_pred             ------------ccccccCCcC--------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          332 ------------RLAELVDPRI--------KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       332 ------------~~~~~~d~~~--------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                  .......+..        ...........+.+++.+||+.||++|||+.|+++|.|..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~  315 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN  315 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence                        0000000000        0001111235688999999999999999999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-39  Score=310.02  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=196.0

Q ss_pred             ccceeeeecceEEEEEEEcC-CC--EEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Ccee
Q 012715          112 FSTIIGQGGFGTVYKAQFSD-GS--LIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERF  180 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  180 (458)
                      +.+.||+|+||.||+|.+.+ +.  .||+|.++..  .....+.+.+|+++++.++|+||++++++|...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            45689999999999998754 32  6899987642  334456789999999999999999999987542      2468


Q ss_pred             eeeeecCCCCHHHHhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 012715          181 LMYEYMANGSLKDHLHS----PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA  256 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla  256 (458)
                      ++|||+.+|+|.+++..    .....+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            99999999999998742    12345899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcccccc
Q 012715          257 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAE  335 (458)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  335 (458)
                      +........  .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+....... ....  
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~-~~~~--  233 (272)
T cd05075         160 KKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDYLRQ-GNRL--  233 (272)
T ss_pred             cccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHc-CCCC--
Confidence            876443211  11122346778999999999999999999999999999999 7788764332 222222111 1110  


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                          ....    ..+..+.+++.+||+.+|++||++.++++.|..
T Consensus       234 ----~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         234 ----KQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             ----CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                0111    223568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=326.97  Aligned_cols=246  Identities=24%  Similarity=0.332  Sum_probs=194.1

Q ss_pred             eeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhc---CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL---HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ||+|+||+||+|+.. +|..||||.+....   ......+..|..++..+   +||||+++++++.+.+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875 58999999986422   12233456677777765   699999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......    .
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----~  151 (330)
T cd05586          81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN----K  151 (330)
T ss_pred             ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----C
Confidence            99999987643  4899999999999999999999   8999999999999999999999999999987543221    1


Q ss_pred             ccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......||..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+...........+.       ...+  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~-------~~~~--  221 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFP-------KNVL--  221 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-HHHHHHHHHcCCCCCC-------CccC--
Confidence            22345699999999998764 48999999999999999999999996543 2222222221111111       0111  


Q ss_pred             HHHHHHHHHHHHccccCCCCCC----CHHHHHHHhhhCC
Q 012715          348 EQLRTIVTIVRWCTQREGQARP----SIKQVLRILYESS  382 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RP----s~~evl~~l~~~~  382 (458)
                        ...+.+++.+||+.||.+||    ++.++++|.|...
T Consensus       222 --~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         222 --SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             --CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence              24578899999999999998    6899999887653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.6e-40  Score=311.87  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=200.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~   90 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG   90 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence            345568999999999999765 6889999988655444455688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++...+  .+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......    .
T Consensus        91 ~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~----~  161 (267)
T cd06645          91 GSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI----A  161 (267)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc----c
Confidence            99999987543  5899999999999999999999   8899999999999999999999999999987553321    1


Q ss_pred             ccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          269 VNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+............. ..  .   ...+..... 
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-~~--~---~~~~~~~~~-  234 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-KS--N---FQPPKLKDK-  234 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-cc--C---CCCCccccc-
Confidence            123456899999999874   4568899999999999999999999986544322221111 00  0   001111110 


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       ......+.+++.+||+.+|++||+++++++|.|
T Consensus       235 -~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         235 -MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -CCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence             011245889999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.5e-40  Score=315.61  Aligned_cols=253  Identities=24%  Similarity=0.384  Sum_probs=196.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCC----EEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .+.+.||+|+||+||+|.+. +|.    .+++|.+.... .....++..|+..++++.|+||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e   88 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ   88 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence            34568999999999999874 344    47788775432 2334578888889999999999999998764 56788999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++|+|.+++.... ..+++..+..++.|++.||+|||   +++++||||||+|||+++++.+||+|||+++.......
T Consensus        89 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          89 LSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             eCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence            999999999997543 35899999999999999999999   89999999999999999999999999999986543321


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      .  .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... ...... .......   ..+..  
T Consensus       165 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~-~~~~~~~---~~~~~--  235 (279)
T cd05111         165 K--YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDL-LEKGERL---AQPQI--  235 (279)
T ss_pred             c--cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH-HHCCCcC---CCCCC--
Confidence            1  11233457789999999998899999999999999999998 8888865432 121111 1111111   11111  


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                           +...+.+++.+||..+|++||++.|+++.|....
T Consensus       236 -----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         236 -----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             -----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                 1245788999999999999999999999886643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.4e-40  Score=315.56  Aligned_cols=253  Identities=30%  Similarity=0.428  Sum_probs=198.1

Q ss_pred             hcccceeeeecceEEEEEEEcC-CC--EEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD-GS--LIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|..++ +.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            3456789999999999998753 33  4788887642 334456789999999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 012715          185 YMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL  250 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  250 (458)
                      |+++|+|.+++....              ...+++..++.++.|++.||+|||   +++++||||||+|||+++++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEE
Confidence            999999999996532              124889999999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhh
Q 012715          251 ADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMAS  329 (458)
Q Consensus       251 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  329 (458)
                      +|||++.......     .......+..|+|||.+.+..++.++|||||||++|||++ |..||..... .+........
T Consensus       161 ~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~~~~~~~~  234 (297)
T cd05089         161 ADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG  234 (297)
T ss_pred             CCcCCCcccccee-----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhcC
Confidence            9999986432110     1111233567999999998899999999999999999998 9899865432 2222211110


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          330 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       330 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                             ..+.....    ....+.+++.+||+.+|.+||++.++++.|....
T Consensus       235 -------~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         235 -------YRMEKPRN----CDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             -------CCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                   11111111    2256889999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.1e-40  Score=310.24  Aligned_cols=238  Identities=22%  Similarity=0.415  Sum_probs=188.8

Q ss_pred             eeeeecceEEEEEEEcC-------------CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          115 IIGQGGFGTVYKAQFSD-------------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .||+|+||.||+|.+.+             ...|++|.+..........|.+|+.++..++||||+++++++..+...++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            68999999999997532             23588998765555555678999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc-------EEEeecc
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-------AKLADFG  254 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~-------~kl~DfG  254 (458)
                      ||||+++|+|..++.... ..+++..+++++.||+.||+|||   +++|+||||||+|||++.++.       +|++|||
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999987543 35899999999999999999999   999999999999999987664       8999999


Q ss_pred             cccccCCCCcccccccccccCCCccccccccc-cCCCCcccccHhHHHHHHHHH-hCCCccCCCcchHHHHHHHHhhccc
Q 012715          255 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV-TARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       255 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      ++......        ....++..|+|||.+. +..++.++|||||||++|||+ +|..|+... ...+... .....  
T Consensus       158 ~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~~-~~~~~--  225 (262)
T cd05077         158 IPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKER-FYEGQ--  225 (262)
T ss_pred             CCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc-chhHHHH-HHhcC--
Confidence            98654321        2345788999999886 467899999999999999998 477776532 2212111 11110  


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                       ...     ..    .....+.+++.+||+.||.+||++.+|++++
T Consensus       226 -~~~-----~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 -CML-----VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -ccC-----CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             000     01    1124688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-40  Score=315.73  Aligned_cols=262  Identities=27%  Similarity=0.450  Sum_probs=198.4

Q ss_pred             cccceeeeecceEEEEEEEc-----CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeec--cCceeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-----DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMY  183 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  183 (458)
                      .+.+.||+|+||.||+|.+.     ++..||+|.+........+.+.+|++++++++|+||+++++++..  ....++||
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            35578999999999999752     578999999876666666789999999999999999999998754  34688999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++.... ..+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++......
T Consensus        87 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          87 EYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            9999999999997543 34899999999999999999999   8999999999999999999999999999998664432


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-------ccccc
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-------RLAEL  336 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~  336 (458)
                      .... ......++..|+|||.+.+..++.++|||||||++|||++|..++.....  .+... .....       .+.+.
T Consensus       163 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         163 EYYK-VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EFMRM-MGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             ccee-ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hhhhh-cccccccccchHHHHHH
Confidence            1110 11122345569999999988999999999999999999998776532211  11000 00000       00000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +...............+.+++.+||+.+|++|||+.++++.|..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            10000001111223568999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-40  Score=309.41  Aligned_cols=252  Identities=27%  Similarity=0.427  Sum_probs=204.3

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.+.||+|+||.||+|.++++..||||.+.... ....++.+|++++++++|+||+++++++......++||||+++
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   85 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK   85 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence            445677899999999999998888899999886433 3346799999999999999999999999998999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.......+++..+..++.+++.||+|||   +++++|+||||+||++++++.+||+|||+++........   
T Consensus        86 ~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~---  159 (261)
T cd05034          86 GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT---  159 (261)
T ss_pred             CCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhh---
Confidence            99999998765556999999999999999999999   899999999999999999999999999998765432211   


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........ ..      .....    .
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~-~~------~~~~~----~  227 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVER-GY------RMPRP----P  227 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc-CC------CCCCC----C
Confidence            1122335678999999998899999999999999999999 88888643322 22221111 00      00011    1


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ..+..+.+++.+|++.+|.+||+++++++.|.
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence            12356899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.7e-40  Score=314.72  Aligned_cols=258  Identities=26%  Similarity=0.382  Sum_probs=204.3

Q ss_pred             HHhhcccceeeeecceEEEEEEEcC-----CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec-cCce
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRER  179 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  179 (458)
                      ...+.+.++||+|+||.||+|.+.+     +..|++|.+... .......+.+|+.++++++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3445567899999999999998765     688999988643 33445678899999999999999999998876 4678


Q ss_pred             eeeeeecCCCCHHHHhcCCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 012715          180 FLMYEYMANGSLKDHLHSPGR------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF  253 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  253 (458)
                      +++++|+++|+|.+++.....      ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            999999999999999965321      45899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccc
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      |+++........  .......++..|+|||.+.+..++.++||||||+++||+++ |+.||..... .+...... ....
T Consensus       162 g~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~-~~~~  237 (280)
T cd05043         162 ALSRDLFPMDYH--CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAYLK-DGYR  237 (280)
T ss_pred             CCcccccCCceE--EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHHHH-cCCC
Confidence            999865433211  11223346778999999998889999999999999999999 9999865432 22222211 1111


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .      ...    ...+..+.+++.+||+.+|++||++.++++.|...
T Consensus       238 ~------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         238 L------AQP----INCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             C------CCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1      111    11235689999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-40  Score=316.30  Aligned_cols=255  Identities=24%  Similarity=0.341  Sum_probs=204.1

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.+.||+|+||+||++... +|..||+|.+... .......+.+|+++++.++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM   85 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence            3455678999999999999875 5889999987543 2344567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++++|.+++...+  .+++..+..++.+++.||.|||+  ..+++||||||+||++++++.++|+|||++.......   
T Consensus        86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          86 DCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            9999999987643  58999999999999999999993  2589999999999999999999999999986543221   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch----------HHHHHHHHhhccccccc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL----------VESAQVCMASESRLAEL  336 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~----------~~~~~~~~~~~~~~~~~  336 (458)
                         .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......          .+........       
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  228 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-------  228 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------
Confidence               12346899999999998889999999999999999999999999743321          1111111100       


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ..+.+.   ....+..+.+++.+||+.||.+||++.|++++++....
T Consensus       229 ~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         229 PPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             cCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            011111   11133568899999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.9e-40  Score=312.47  Aligned_cols=254  Identities=25%  Similarity=0.435  Sum_probs=200.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CC---CEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DG---SLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +...+.||+|+||.||+|.+. ++   ..+|+|.+... .....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (268)
T cd05063           7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE   86 (268)
T ss_pred             ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence            345678999999999999875 33   37999988643 23345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++........
T Consensus        87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          87 YMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            999999999997543 35899999999999999999999   89999999999999999999999999999976543221


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      .. ........+..|+|||.+....++.++|||||||++|||++ |+.||..... .+....... ....          
T Consensus       163 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i~~-~~~~----------  229 (268)
T cd05063         163 GT-YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAIND-GFRL----------  229 (268)
T ss_pred             cc-eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhc-CCCC----------
Confidence            10 01112223567999999998889999999999999999998 9999864432 222222111 1111          


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ....+.+..+.+++.+||+.+|++||++.++++.|.+
T Consensus       230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            1111233568999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.3e-40  Score=317.62  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++.+++|+||+++++++.+++..++||||+++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~   83 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   83 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence            45678999999999999875 5788999987643 333445688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      ++|.+++...  ..+++..+..++.|++.||.|||   + .+++||||||+|||++.++.+||+|||++......     
T Consensus        84 ~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  153 (308)
T cd06615          84 GSLDQVLKKA--GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----  153 (308)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence            9999999764  35889999999999999999999   5 58999999999999999999999999998754332     


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc------------
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE------------  335 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------------  335 (458)
                       ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.... .................            
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCC
Confidence             1234568899999999988889999999999999999999999985432 11211111100000000            


Q ss_pred             --------------c---cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          336 --------------L---VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       336 --------------~---~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                    .   ..+.+..   ......+.+++.+||..+|++||++.+++++.|...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                          0   0000000   012245889999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-39  Score=315.84  Aligned_cols=256  Identities=24%  Similarity=0.379  Sum_probs=202.8

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||.||+|...      .+..||+|.++... ....+.+.+|+++++++ +|+||+++++++...+..+
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  115 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL  115 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence            3456789999999999999642      34579999886543 33345789999999999 7999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+.+|+|.++++......+++.++..++.|++.||+|||   +++++|+||||+|||++.++.+||+|||+++...
T Consensus       116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence            9999999999999997644445899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      .....  .......++..|+|||.+.+..++.++|||||||++|||++ |..||............ .....      .+
T Consensus       193 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~-~~~~~------~~  263 (302)
T cd05055         193 NDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL-IKEGY------RM  263 (302)
T ss_pred             CCCce--eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH-HHcCC------cC
Confidence            33211  01223346788999999999899999999999999999998 88888654332222111 11110      01


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ....    .....+.+++.+||+.+|++||++.++++.|..
T Consensus       264 ~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         264 AQPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             CCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            1111    122568999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.3e-40  Score=326.47  Aligned_cols=259  Identities=19%  Similarity=0.282  Sum_probs=198.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Ccee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  180 (458)
                      +.+.+.||+|+||.||+|... .++.||||++...  .......+.+|+.+++.++|+||+++++++...      ...|
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~  105 (364)
T cd07875          26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  105 (364)
T ss_pred             eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence            445678999999999999765 5889999998642  233345788999999999999999999987543      3579


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++ +|.+++..    .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       106 lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         106 IVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             EEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            99999965 78887753    3788999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc----
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL----  336 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  336 (458)
                      ...     ......||..|+|||.+.+..++.++|||||||++|||++|+.||........+............+.    
T Consensus       178 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         178 TSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             CCC-----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            322     22345689999999999999999999999999999999999999975544333222211100000000    


Q ss_pred             -------c--CCcCC----------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          337 -------V--DPRIK----------------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       337 -------~--d~~~~----------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                             .  .+...                ..........+.+++.+|++.||.+|||+.++++|.|..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~  322 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  322 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                   0  00000                000111224688999999999999999999999998763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.8e-40  Score=310.42  Aligned_cols=254  Identities=25%  Similarity=0.398  Sum_probs=203.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... ++..+|||.+...   .......+.+|+++++.++|+||+++++++.+++..+++|||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            345678999999999999864 7899999987542   233345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          186 MANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       186 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      +++++|.+++..  .....+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999863  22345899999999999999999999   9999999999999999999999999999987654332


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc-hHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-LVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      .    ......|+..|+|||.+.+..++.++||||||+++|||++|..||..... .........       ....+...
T Consensus       161 ~----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~  229 (267)
T cd08229         161 T----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-------QCDYPPLP  229 (267)
T ss_pred             c----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh-------cCCCCCCC
Confidence            1    12234688999999999988899999999999999999999999864322 112111111       11111111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                         .......+.+++.+||+.+|.+|||+.+|++.+.+
T Consensus       230 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         230 ---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             ---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence               11233568899999999999999999999988754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.8e-40  Score=310.17  Aligned_cols=248  Identities=24%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.||.|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+.+++..++||||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            45678999999999999875 6889999987532 333456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.......++...++.++.|++.||.|||   +++++|+||||+||++++++.++|+|||++........    
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~----  155 (255)
T cd08219          83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----  155 (255)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc----
Confidence            99999987654556899999999999999999999   99999999999999999999999999999876543221    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... ...........  ...     .+    +..
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-~~~~~~~~~~~--~~~-----~~----~~~  223 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-WKNLILKVCQG--SYK-----PL----PSH  223 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-HHHHHHHHhcC--CCC-----CC----Ccc
Confidence            1234568899999999998899999999999999999999999997533 22222211111  110     01    112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRI  377 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~  377 (458)
                      ....+.+++.+||+.||++||++.+++..
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            22458899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.2e-40  Score=313.14  Aligned_cols=238  Identities=25%  Similarity=0.419  Sum_probs=187.7

Q ss_pred             eeeeecceEEEEEEEcC-------------------------CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeee
Q 012715          115 IIGQGGFGTVYKAQFSD-------------------------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL  169 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  169 (458)
                      .||+|+||.||+|.+..                         ...||+|.+..........|.+|+.+++.++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997521                         13588998865544445678899999999999999999


Q ss_pred             eeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC---
Q 012715          170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---  246 (458)
Q Consensus       170 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~---  246 (458)
                      +++|.+....++||||+++|+|..++.... ..+++..++.++.|++.||+|||   +++|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence            999999999999999999999999986533 35889999999999999999999   89999999999999997643   


Q ss_pred             ----cEEEeecccccccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHH-hCCCccCCCcchH
Q 012715          247 ----VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIV-TARRAVQDGKNLV  320 (458)
Q Consensus       247 ----~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~-tg~~p~~~~~~~~  320 (458)
                          .+|++|||++......        ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||...... 
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-  228 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-  228 (274)
T ss_pred             CccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-
Confidence                4899999987643221        12347788999998865 56899999999999999995 688888643321 


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      +.... .......        ....    ...+.+++.+||+.+|++||++.++++.|
T Consensus       229 ~~~~~-~~~~~~~--------~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         229 EKERF-YEKKHRL--------PEPS----CKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHH-HHhccCC--------CCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            11111 1111111        1111    13588999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=325.51  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=210.5

Q ss_pred             HHHHhhcccceeeeecceEEEEEEEcC---C--CEEEEEEecc-cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc
Q 012715          105 TKKATDNFSTIIGQGGFGTVYKAQFSD---G--SLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE  178 (458)
Q Consensus       105 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  178 (458)
                      +.+....+.++||.|-||.||+|.+.+   |  -.||||.-+. ......+.|+.|+.+|++++||||++|+|+|.+ ..
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            344455567899999999999997642   3  3588998765 344557789999999999999999999999876 57


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      .|||||.++.|.|..||+.... .++......++.||..+|+|||   +..++||||..+|||+...-.+||+||||++.
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence            8999999999999999987543 5899999999999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ..+.....   .+...-+..|||||.+.-..++.++|||-|||++||+++ |..||++-.+-.            +...+
T Consensus       541 ~ed~~yYk---aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------------VI~~i  605 (974)
T KOG4257|consen  541 LEDDAYYK---ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------------VIGHI  605 (974)
T ss_pred             ccccchhh---ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc------------eEEEe
Confidence            87765431   223445789999999999999999999999999999876 788997533221            11111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ...-+..++..|+..|+.++.+||..+|.+||.+.++...|.+.
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            12223345566778899999999999999999999998887553

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-40  Score=325.26  Aligned_cols=257  Identities=18%  Similarity=0.240  Sum_probs=193.5

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.+.||+|+||.||+|... ++..||+|.....      ....|+.++++++|+||+++++++.+.+..++||||+.
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            4566789999999999999875 4678999964322      23579999999999999999999999999999999995


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                       ++|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......    
T Consensus       141 -~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----  211 (357)
T PHA03209        141 -SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP----  211 (357)
T ss_pred             -CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc----
Confidence             68999886543 35899999999999999999999   8999999999999999999999999999997533221    


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchH--HH-------HHHHHhhccccccccC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV--ES-------AQVCMASESRLAELVD  338 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~--~~-------~~~~~~~~~~~~~~~d  338 (458)
                       ......||..|+|||.+.+..++.++|||||||++|||+++..++.......  ..       ........+..+..+.
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence             1234568999999999999999999999999999999999766654321110  00       0000000000000000


Q ss_pred             --C-------------cCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          339 --P-------------RIKDSFD-------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       339 --~-------------~~~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                        +             ..+..+.       ......+.+++.+||+.||.+|||+.|+++|.|+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~  355 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA  355 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence              0             0000000       01123456799999999999999999999998864

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.2e-40  Score=317.12  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=202.0

Q ss_pred             HhhcccceeeeecceEEEEEEEc--------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccC
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKR  177 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  177 (458)
                      ..+.+.+.||+|+||.||++...        ++..+|+|.+... .......+.+|++++..+ +|+||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            44567789999999999999752        2357999988643 233445788999999999 7999999999999999


Q ss_pred             ceeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC
Q 012715          178 ERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD  243 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~  243 (458)
                      ..++||||+++|+|.+++....              ...+++.++++++.|++.||+|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            9999999999999999997532              134889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHH
Q 012715          244 ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVES  322 (458)
Q Consensus       244 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~  322 (458)
                      .++.+||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||. +.+..+.
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~-~~~~~~~  251 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEEL  251 (307)
T ss_pred             CCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC-cCCHHHH
Confidence            9999999999998765432211  01122234578999999998889999999999999999998 777774 3333333


Q ss_pred             HHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          323 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       323 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....... ..      .    ..+......+.+++.+||..+|.+||++.++++.|...
T Consensus       252 ~~~~~~~-~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         252 FKLLKEG-HR------M----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHHHcC-CC------C----CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            3322111 00      0    11112235788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.7e-40  Score=328.13  Aligned_cols=257  Identities=22%  Similarity=0.336  Sum_probs=199.7

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      ++.+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++..++|+||+++++.+.+.+..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~   83 (360)
T cd05627           4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL   83 (360)
T ss_pred             eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            45678999999999999875 58999999986422   233456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc-
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC-  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-  265 (458)
                      ++|+|.+++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........ 
T Consensus        84 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          84 PGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            9999999997643  4899999999999999999999   999999999999999999999999999998754321100 


Q ss_pred             ------------------------------cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCC
Q 012715          266 ------------------------------FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD  315 (458)
Q Consensus       266 ------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~  315 (458)
                                                    .........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                          00001235699999999999999999999999999999999999999975


Q ss_pred             CcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHhhhCC
Q 012715          316 GKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP---SIKQVLRILYESS  382 (458)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl~~l~~~~  382 (458)
                      .... ............+  .+.+..  ..+    ..+.+++.+|+ .||.+|+   ++.++++|.|+..
T Consensus       239 ~~~~-~~~~~i~~~~~~~--~~p~~~--~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         239 ETPQ-ETYRKVMNWKETL--VFPPEV--PIS----EKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CCHH-HHHHHHHcCCCce--ecCCCC--CCC----HHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence            4432 2222222111100  011110  112    35677777766 4999998   5899999988754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-39  Score=309.34  Aligned_cols=252  Identities=26%  Similarity=0.440  Sum_probs=202.0

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccch---------hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE---------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      .+...||+|+||.||+|... ++..+|+|.+.....         ...+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN   82 (267)
T ss_pred             cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence            35678999999999999764 588999998754221         12356889999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||+++...
T Consensus        83 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          83 IFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            999999999999999764  34889999999999999999999   8999999999999999999999999999998664


Q ss_pred             CCCccc--ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          261 DGSICF--EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       261 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                      ......  ........|+..|+|||.+.+..++.++|||||||++|||++|+.||............        .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~  229 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--------GENAS  229 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH--------hccCC
Confidence            321110  01112345788999999999888999999999999999999999999765433222111        11111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      +.+..    .....+.+++.+||+.||.+||++.+++++.|
T Consensus       230 ~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  266 (267)
T cd06628         230 PEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF  266 (267)
T ss_pred             CcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence            22222    22356889999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=311.30  Aligned_cols=254  Identities=25%  Similarity=0.395  Sum_probs=201.4

Q ss_pred             hhcccceeeeecceEEEEEEEcC------CCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.++..++|+||+++++++......++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   86 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV   86 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence            34556789999999999997642      3689999986432 2334578899999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 012715          182 MYEYMANGSLKDHLHSPG--------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF  253 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  253 (458)
                      ||||+++|+|.+++....        ...+++..++.++.|++.||.|||   +.+++||||||+|||++.++.+||+||
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCc
Confidence            999999999999996422        224788999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccc
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      |+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..+...... .. .
T Consensus       164 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~~~~-~~-~  238 (277)
T cd05032         164 GMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLKFVI-DG-G  238 (277)
T ss_pred             ccchhhccCccc--ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHHHHh-cC-C
Confidence            999765433211  11223446789999999988889999999999999999998 888885433 222222211 11 1


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .     +.....    .+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       239 ~-----~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         239 H-----LDLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             C-----CCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1     111122    2467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-39  Score=310.75  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=208.5

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      ..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+++++.+.|+||+++++++.+++..++||||+++|
T Consensus         8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640           8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            4457999999999999875 58899999886432 344567899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++..   .++++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........    .
T Consensus        88 ~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~  157 (277)
T cd06640          88 SALDLLRA---GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----K  157 (277)
T ss_pred             cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----c
Confidence            99999874   24889999999999999999999   89999999999999999999999999999976543321    1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      .....++..|+|||.+.+..++.++|||||||++|||++|..|+......... ...           ............
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~-----------~~~~~~~~~~~~  225 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-FLI-----------PKNNPPTLTGEF  225 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-hhh-----------hcCCCCCCchhh
Confidence            22345788999999998888999999999999999999999998654322111 100           001112223345


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCcch
Q 012715          350 LRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGF  389 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~~~  389 (458)
                      ...+.+++.+||+.+|++||++.+++++.+......+...
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~  265 (277)
T cd06640         226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSY  265 (277)
T ss_pred             hHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhH
Confidence            5678999999999999999999999999987666554433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.4e-40  Score=315.44  Aligned_cols=260  Identities=26%  Similarity=0.401  Sum_probs=200.0

Q ss_pred             hcccceeeeecceEEEEEEEcC-----------------CCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD-----------------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRG  171 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~  171 (458)
                      +.+.+.||+|+||.||+|...+                 +..||+|.+.... ....+.+.+|++++++++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   86 (296)
T cd05051           7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG   86 (296)
T ss_pred             CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            4566789999999999997642                 2468999886432 344567899999999999999999999


Q ss_pred             eeeccCceeeeeeecCCCCHHHHhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 012715          172 FCIEKRERFLMYEYMANGSLKDHLHSPG---------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL  242 (458)
Q Consensus       172 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll  242 (458)
                      ++..++..++||||+++++|.+++....         ...+++..++.++.|++.||+|||   +.+++||||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili  163 (296)
T cd05051          87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceee
Confidence            9999999999999999999999996533         225899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh--CCCccCCCcchH
Q 012715          243 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT--ARRAVQDGKNLV  320 (458)
Q Consensus       243 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~p~~~~~~~~  320 (458)
                      +.++.++|+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++  |..|+...... 
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-  240 (296)
T ss_pred             cCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence            99999999999999765433211  12233456788999999988889999999999999999998  56666533221 


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      +...........    .........+...+..+.+++.+||+.||.+||++.++++.|.
T Consensus       241 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QVIENAGHFFRD----DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHhcccc----ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            111111100000    0000000111122357999999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.3e-40  Score=308.49  Aligned_cols=246  Identities=29%  Similarity=0.452  Sum_probs=198.6

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeee-ccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI-EKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||++.. .|..||+|.+....  ..+.+.+|+.++++++|+|++++++++. +++..++||||+++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   84 (256)
T ss_pred             CeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence            45667899999999999987 57889999886432  2457899999999999999999999765 45678999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.......+++..++.++.|++.||+|||   .++++||||||+||++++++.+||+|||+++......     
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----  156 (256)
T cd05082          85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----  156 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence            99999998765556899999999999999999999   8999999999999999999999999999987543321     


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                        ....++..|+|||++.+..++.++|||||||++|||++ |+.||... ...+.........       .+..    ..
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~~~-------~~~~----~~  222 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGY-------KMDA----PD  222 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCC-------CCCC----CC
Confidence              22335678999999998899999999999999999998 88887543 2222222211110       0111    11


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..+..+.+++.+||+.+|++||++.++++.|..
T Consensus       223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            233568899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-39  Score=318.03  Aligned_cols=261  Identities=20%  Similarity=0.308  Sum_probs=189.4

Q ss_pred             cceeeeecceEEEEEEEc---CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeec--cCceeeeeeecC
Q 012715          113 STIIGQGGFGTVYKAQFS---DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYEYMA  187 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  187 (458)
                      ..+||+|+||+||+|...   ++..||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            358999999999999864   46789999886432  23457899999999999999999998864  456789999986


Q ss_pred             CCCHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee----CCCCcEEEeecccc
Q 012715          188 NGSLKDHLHSP-------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLA  256 (458)
Q Consensus       188 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DfGla  256 (458)
                       ++|.+++...       ....+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5888887532       1235889999999999999999999   8999999999999999    45679999999999


Q ss_pred             cccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcch--------HHHHHHHH
Q 012715          257 HASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--------VESAQVCM  327 (458)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--------~~~~~~~~  327 (458)
                      +........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......        ........
T Consensus       160 ~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         160 RLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            865432211 112234578999999999876 45899999999999999999999998632210        00000000


Q ss_pred             hhcc-----------ccc---ccc---CCcCCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          328 ASES-----------RLA---ELV---DPRIKDSFD---------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       328 ~~~~-----------~~~---~~~---d~~~~~~~~---------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...+           .+.   ...   .........         ......+.+++.+||+.||.+|||++|+++|.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0000           000   000   000000000         0001357899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.4e-40  Score=315.10  Aligned_cols=254  Identities=25%  Similarity=0.374  Sum_probs=199.4

Q ss_pred             cccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.||+|+||.||+|...      ....+|+|.+.... ......+.+|+++++.++||||+++++.|...+..++|+
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            34568999999999999753      23578898876433 333467899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCC----------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 012715          184 EYMANGSLKDHLHSP----------------------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL  241 (458)
Q Consensus       184 e~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIl  241 (458)
                      ||+.+|+|.+++...                      ....+++..++.++.|++.||+|||   +.+++||||||+|||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEE
Confidence            999999999998532                      1235889999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchH
Q 012715          242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLV  320 (458)
Q Consensus       242 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~  320 (458)
                      +++++.+||+|||+++.........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||... ...
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~  236 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYV--KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-APE  236 (290)
T ss_pred             EcCCCcEEeccccccccccCccchh--cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-CHH
Confidence            9999999999999997653322110  1122345778999999988889999999999999999999 88888543 222


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....... ..      .......    .....+.+++.+||+.+|++||++.++++.|...
T Consensus       237 ~~~~~~~-~~------~~~~~~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         237 RLFNLLK-TG------YRMERPE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             HHHHHHh-CC------CCCCCCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            2222211 10      0111111    2235688999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-39  Score=315.44  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=202.8

Q ss_pred             HHhhcccceeeeecceEEEEEEEc--------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeecc
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEK  176 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  176 (458)
                      ...+.+.+.||+|+||.||+|+..        ++..||+|.+... .......+.+|+.+++.+ +|+||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            334456678999999999999641        2457999988643 234456789999999999 799999999999999


Q ss_pred             CceeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 012715          177 RERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL  242 (458)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll  242 (458)
                      ...++||||+.+|+|.+++....              ...+++..++.++.|++.||+|||   +++++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999997532              235788999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHH
Q 012715          243 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVE  321 (458)
Q Consensus       243 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~  321 (458)
                      +.++.+||+|||+++........  .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.. .+..+
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEE  247 (304)
T ss_pred             cCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHH
Confidence            99999999999999866432211  11223346678999999998889999999999999999998 6677643 33334


Q ss_pred             HHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       322 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ........ ...          ..+......+.+++.+||+.+|.+||++.++++.|...
T Consensus       248 ~~~~~~~~-~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         248 LFKLLKEG-HRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             HHHHHHcC-CcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence            33332211 110          01112335688999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=307.84  Aligned_cols=248  Identities=29%  Similarity=0.453  Sum_probs=202.2

Q ss_pred             ceeeeecceEEEEEEEcC----CCEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFSD----GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||.||+|....    +..||+|.+...... ....+.+|++++..++|+||+++++++.++...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            369999999999998753    789999998754333 357899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          189 GSLKDHLHSPG-------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       189 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ++|.+++....       ...+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997641       246899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ...  ........++..|+|||.+....++.++||||||+++|||++ |..||.... ..+....... .      ....
T Consensus       158 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~-~------~~~~  227 (262)
T cd00192         158 DDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVLEYLRK-G------YRLP  227 (262)
T ss_pred             ccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHc-C------CCCC
Confidence            321  112234557889999999988899999999999999999999 588886542 2222222111 0      0111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                          .+......+.+++.+||+.+|.+||++.+++++|
T Consensus       228 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         228 ----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             ----CCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                1112235788999999999999999999999987

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-39  Score=313.56  Aligned_cols=254  Identities=25%  Similarity=0.360  Sum_probs=206.8

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+.+++.++|+||+++++++.+.+..++|+||+++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  100 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG  100 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence            34557899999999999976 46899999998655545566789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++...   .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........    
T Consensus       101 ~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~----  170 (296)
T cd06655         101 GSLTDVVTET---CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS----  170 (296)
T ss_pred             CcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc----
Confidence            9999998642   4899999999999999999999   89999999999999999999999999999876543221    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.............. ..  ......       ...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~-~~--~~~~~~-------~~~  240 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG--TPELQN-------PEK  240 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cC--CcccCC-------ccc
Confidence            12234688999999999988899999999999999999999999976544332222111 10  111101       111


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ....+.+++.+||..||.+||++.+++++.|....
T Consensus       241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             CCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            22468889999999999999999999999887643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.4e-40  Score=309.25  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=202.9

Q ss_pred             HHhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      ...+.+.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            34456778999999999999988778889999876432 234678999999999999999999999887 7889999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++|+|.+++.......+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++......... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence            9999999997655556899999999999999999999   889999999999999999999999999999765433211 


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        ......++..|+|||.+....++.++|||||||++||+++ |+.||...... ....... ....      ....   
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~-~~~~------~~~~---  225 (260)
T cd05073         159 --AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALE-RGYR------MPRP---  225 (260)
T ss_pred             --cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHh-CCCC------CCCc---
Confidence              1222345678999999998889999999999999999999 88888643322 2211111 1100      0011   


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       ...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       226 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         226 -ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             -ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence             122356889999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1e-39  Score=312.92  Aligned_cols=261  Identities=25%  Similarity=0.324  Sum_probs=199.1

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|++|.||+|... ++..||+|.+...  .......+.+|+.++++++|+||+++++++.+++..++||||+.
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS   82 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence            45578999999999999875 6899999988532  22234568899999999999999999999999999999999997


Q ss_pred             CCCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          188 NGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       188 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                       ++|.+++.... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......   
T Consensus        83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  155 (285)
T cd07861          83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---  155 (285)
T ss_pred             -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence             68998886533 246899999999999999999999   8999999999999999999999999999987543321   


Q ss_pred             ccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc----------c--
Q 012715          267 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----------L--  333 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------~--  333 (458)
                       .......++..|+|||.+.+ ..++.++|||||||++|||+||+.||...................          +  
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             11233457889999998865 457889999999999999999999997554433222211110000          0  


Q ss_pred             -ccccCCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          334 -AELVDPRIKDS---FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       334 -~~~~d~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       ....+......   .......++.+++.+||+.||++|||+.+++++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~  284 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY  284 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence             00000000000   00012356789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.3e-40  Score=335.41  Aligned_cols=259  Identities=21%  Similarity=0.308  Sum_probs=193.6

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCC------CCeeeeeeeeecc-Ccee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHH------RHLVALRGFCIEK-RERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~  180 (458)
                      .+.+.++||+|+||+||+|... .++.||||+++... .....+..|+++++.++|      .+++++++++... ...+
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            3455678999999999999875 57899999986432 223456678888887754      4588898888764 4688


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCC-------------
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENF-------------  246 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~-------------  246 (458)
                      +|||++ +++|.+++...+  .+++..+..++.||+.||+|||   . .+|+||||||+|||++.++             
T Consensus       209 iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             EEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence            999988 779999887643  5899999999999999999999   6 5999999999999998765             


Q ss_pred             ---cEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHH
Q 012715          247 ---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA  323 (458)
Q Consensus       247 ---~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~  323 (458)
                         .+||+|||++.....       ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       283 ~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             CCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence               499999998764322       2234679999999999999999999999999999999999999997544332221


Q ss_pred             HHHHhhcccccc-------------ccCC--cCCCCCC---------------HHHHHHHHHHHHHccccCCCCCCCHHH
Q 012715          324 QVCMASESRLAE-------------LVDP--RIKDSFD---------------MEQLRTIVTIVRWCTQREGQARPSIKQ  373 (458)
Q Consensus       324 ~~~~~~~~~~~~-------------~~d~--~~~~~~~---------------~~~~~~l~~l~~~cl~~dp~~RPs~~e  373 (458)
                      . +....+.++.             +++.  .+....+               ......+.+++.+||+.||++|||++|
T Consensus       356 ~-i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        356 L-MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             H-HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence            1 1111110000             0000  0000000               011245789999999999999999999


Q ss_pred             HHHHhhhCC
Q 012715          374 VLRILYESS  382 (458)
Q Consensus       374 vl~~l~~~~  382 (458)
                      +++|.|...
T Consensus       435 ~L~Hp~~~~  443 (467)
T PTZ00284        435 MTTHPYVLK  443 (467)
T ss_pred             HhcCccccc
Confidence            999998754

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.2e-39  Score=305.76  Aligned_cols=251  Identities=24%  Similarity=0.423  Sum_probs=202.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec-cCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  185 (458)
                      +.+.+.||+|++|.||++... +++.||+|++...  .......+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            456778999999999999865 5789999998542  23344568899999999999999999998764 3467899999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++.......+++.++..++.+++.||+|||   +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-  157 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-  157 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence            99999999997654556899999999999999999999   89999999999999999999999999999976543221 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......+++.|+|||.+.+..++.++||||||++++||++|+.||.... ..........  ..+     +.+.   
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-~~~~~~~~~~--~~~-----~~~~---  223 (257)
T cd08223         158 ---MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-MNSLVYRIIE--GKL-----PPMP---  223 (257)
T ss_pred             ---ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHh--cCC-----CCCc---
Confidence               2234468899999999999999999999999999999999999986433 2222222211  111     1111   


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       ......+.+++.+||+.+|++||++.+++++.|
T Consensus       224 -~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  256 (257)
T cd08223         224 -KDYSPELGELIATMLSKRPEKRPSVKSILRQPY  256 (257)
T ss_pred             -cccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence             223356889999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6e-40  Score=317.85  Aligned_cols=252  Identities=33%  Similarity=0.470  Sum_probs=197.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCC--EEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGS--LIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|.++ ++.  .+|+|.+... .......+.+|++++.++ +|+||+++++++.+++..++|||
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   88 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   88 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence            356678999999999999875 444  4678876542 334456788999999999 89999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 012715          185 YMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL  250 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  250 (458)
                      |+++|+|.+++....              ...+++..++.++.|++.||+|||   +++++||||||+|||++.++.+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEe
Confidence            999999999996432              135789999999999999999999   999999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhh
Q 012715          251 ADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMAS  329 (458)
Q Consensus       251 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  329 (458)
                      +|||+++......     ......++..|+|||.+.+..++.++|||||||++|||+| |..||..... .+...... .
T Consensus       166 ~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~-~  238 (303)
T cd05088         166 ADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLP-Q  238 (303)
T ss_pred             CccccCcccchhh-----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHHHHh-c
Confidence            9999986432110     1112234678999999988889999999999999999998 8888854322 22222111 0


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          330 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       330 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .      .......    .....+.+++.+||+.+|++||++.++++.+...
T Consensus       239 ~------~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         239 G------YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             C------CcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0      0111111    1234688999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=310.89  Aligned_cols=247  Identities=33%  Similarity=0.469  Sum_probs=194.3

Q ss_pred             ceeeeecceEEEEEEEcC-CC--EEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFSD-GS--LIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ++||+|+||.||+|.+.+ +.  .+|+|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998754 43  4688887643 334456788999999999 799999999999999999999999999


Q ss_pred             CCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 012715          189 GSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG  254 (458)
Q Consensus       189 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  254 (458)
                      |+|.+++....              ...+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999996432              124789999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcccc
Q 012715          255 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL  333 (458)
Q Consensus       255 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  333 (458)
                      ++.......     .......+..|+|||++....++.++|||||||++|||++ |..||.... ..+....... ..  
T Consensus       158 l~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~~~-~~--  228 (270)
T cd05047         158 LSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQ-GY--  228 (270)
T ss_pred             Cccccchhh-----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-HHHHHHHHhC-CC--
Confidence            986322110     1112234667999999988899999999999999999997 888885432 2222222111 00  


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          334 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       334 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                          ......    .....+.+++.+||+.+|.+||++.++++.|..
T Consensus       229 ----~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         229 ----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             ----CCCCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence                011111    223568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3e-39  Score=311.21  Aligned_cols=255  Identities=27%  Similarity=0.360  Sum_probs=203.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||.|+||.||+|... ++..||+|.+..........+.+|+++++.++|+||+++++++..++..++||||+++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG   93 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence            345568999999999999876 4889999998766666667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|..++.+.. ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........    
T Consensus        94 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~----  165 (292)
T cd06644          94 GAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ----  165 (292)
T ss_pred             CcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc----
Confidence            99998876533 35899999999999999999999   89999999999999999999999999999875432211    


Q ss_pred             ccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          269 VNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ......++..|+|||.+.     ...++.++|||||||++|||++|+.||......... ......  ......      
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~--~~~~~~------  236 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKS--EPPTLS------  236 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH-HHHhcC--CCccCC------
Confidence            123345788999999885     345788999999999999999999998654322211 111111  001110      


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       .+......+.+++.+||..+|++||++++++++.+...
T Consensus       237 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         237 -QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             -CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence             01122346889999999999999999999999887644

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-39  Score=306.43  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=204.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||.||++... +|+.||+|.+...  ......++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            345678999999999999765 6889999988632  2334457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      .+++|.+++.......+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--  156 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--  156 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--
Confidence            9999999997654456899999999999999999999   89999999999999999999999999999976544321  


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......|+..|+|||.+.+..++.++|||||||+++||++|+.|+...... +.........  .     +....   
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~~~~~~--~-----~~~~~---  223 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-NLVLKIIRGS--Y-----PPVSS---  223 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-HHHHHHhcCC--C-----CCCcc---
Confidence              112345788999999999888999999999999999999999998754332 2222211111  0     11111   


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       .....+.+++.+||+.+|.+||++.+++++.|
T Consensus       224 -~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         224 -HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             -cCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence             22356889999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-39  Score=307.69  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=205.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +++.+.||.|+||+||+|... ++..+|+|.+.... ......+.+|+++++.++|+||+++++.+..++..++|||+++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            345678999999999999865 67899999886432 2345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          188 NGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       188 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +++|.+++..... ..+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++..........
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            9999999975432 45899999999999999999999   9999999999999999999999999999997665433221


Q ss_pred             ccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      ........|+..|+|||.+... .++.++|||||||++|||++|+.||............ ....       .+.+....
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~-~~~~-------~~~~~~~~  231 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT-LQND-------PPSLETGA  231 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH-hcCC-------CCCcCCcc
Confidence            1122344688999999998876 7899999999999999999999999754433222211 1110       11111111


Q ss_pred             C-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          346 D-MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       346 ~-~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      . ......+.+++.+||..||++||+++++++|.|
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~  266 (267)
T cd06610         232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF  266 (267)
T ss_pred             ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence            0 122356889999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-39  Score=306.91  Aligned_cols=253  Identities=29%  Similarity=0.480  Sum_probs=202.3

Q ss_pred             ccceeeeecceEEEEEEEcCCCEEEEEEecccc------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      ..+.||+|+||+||+|...+|..+|+|.+....      ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF   83 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence            456899999999999988889999999875321      12235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc-
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-  264 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~-  264 (458)
                      +++++|.+++...+  .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          84 VPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999997643  4889999999999999999999   88999999999999999999999999999875432111 


Q ss_pred             -ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          265 -CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       265 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                       ..........|+..|+|||.+.+..++.++||||||+++|||++|..||............ ......     .+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~-----~~~~~~  232 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-GAHRGL-----MPRLPD  232 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-hhccCC-----CCCCCC
Confidence             0111223456899999999999988999999999999999999999999754433222111 111111     122222


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .+    ...+.+++.+||+.+|.+||++.+++++.|
T Consensus       233 ~~----~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  264 (265)
T cd06631         233 SF----SAAAIDFVTSCLTRDQHERPSALQLLRHDF  264 (265)
T ss_pred             CC----CHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence            22    356889999999999999999999998765

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-39  Score=307.37  Aligned_cols=255  Identities=27%  Similarity=0.419  Sum_probs=204.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecc---cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +|+.||+|.++.   ........+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            456678999999999999886 789999998753   2223356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          186 MANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       186 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      +++|+|.+++...  ....+++..++.++.+++.||+|||   +.+++||||+|+||+++.++.++|+|||+++......
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            9999999998642  2345899999999999999999999   8999999999999999999999999999987654322


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc-chHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-NLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      .    ......++..|+|||.+.+..++.++|||||||++|||++|+.||.... +..+.......  ...     +...
T Consensus       161 ~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-----~~~~  229 (267)
T cd08224         161 T----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--CDY-----PPLP  229 (267)
T ss_pred             c----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc--CCC-----CCCC
Confidence            1    1223458889999999998889999999999999999999999986433 22222111111  000     0011


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                         .......+.+++.+||..+|++||++.+|++.|...
T Consensus       230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence               112335688999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-40  Score=308.16  Aligned_cols=257  Identities=25%  Similarity=0.321  Sum_probs=211.8

Q ss_pred             ccceeeeecceEEEEEEEcC-CCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          112 FSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.||+|.-|+||++++.+ +..+|+|.+.+..   .........|-+||+.+.||.+..|++.+..++..|+|||||+
T Consensus        81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp  160 (459)
T KOG0610|consen   81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP  160 (459)
T ss_pred             HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence            34579999999999999874 5899999997643   3334567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC------
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD------  261 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~------  261 (458)
                      ||+|..+++.+....+++..+.-++.+++.||+|||   -.|||+|||||+||||.++|.+.|+||.|+.....      
T Consensus       161 GGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~  237 (459)
T KOG0610|consen  161 GGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK  237 (459)
T ss_pred             CccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence            999999999888888999999999999999999999   99999999999999999999999999999852210      


Q ss_pred             -CC---------------ccc------------------------------ccccccccCCCccccccccccCCCCcccc
Q 012715          262 -GS---------------ICF------------------------------EPVNTDIRGTPGYMDPEYVVTQELTEKSD  295 (458)
Q Consensus       262 -~~---------------~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  295 (458)
                       ..               .++                              ......++||-.|.|||++.+...+.++|
T Consensus       238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVD  317 (459)
T KOG0610|consen  238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVD  317 (459)
T ss_pred             cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhh
Confidence             00               000                              01123467999999999999999999999


Q ss_pred             cHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC----H
Q 012715          296 VYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS----I  371 (458)
Q Consensus       296 vws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs----~  371 (458)
                      .|+|||+||||+.|..||.+..+......+. .....+++          .......+.++|++.|..||++|..    +
T Consensus       318 WWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv-~~~l~Fp~----------~~~vs~~akDLIr~LLvKdP~kRlg~~rGA  386 (459)
T KOG0610|consen  318 WWTFGIFLYEMLYGTTPFKGSNNKETLRNIV-GQPLKFPE----------EPEVSSAAKDLIRKLLVKDPSKRLGSKRGA  386 (459)
T ss_pred             HHHHHHHHHHHHhCCCCcCCCCchhhHHHHh-cCCCcCCC----------CCcchhHHHHHHHHHhccChhhhhccccch
Confidence            9999999999999999998766554444332 22212211          1133456889999999999999998    9


Q ss_pred             HHHHHHhhhCC
Q 012715          372 KQVLRILYESS  382 (458)
Q Consensus       372 ~evl~~l~~~~  382 (458)
                      .||-+|.++..
T Consensus       387 ~eIK~HpFF~g  397 (459)
T KOG0610|consen  387 AEIKRHPFFEG  397 (459)
T ss_pred             HHhhcCccccC
Confidence            99999987743

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-39  Score=314.44  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=205.0

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      ..||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            46999999999999875 68899999986555555667899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccc
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      +++...   .+++..+..++.||+.||+|||   +++++||||||+||++++++.+||+|||++.......    .....
T Consensus       108 ~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----~~~~~  177 (292)
T cd06658         108 DIVTHT---RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----PKRKS  177 (292)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc----ccCce
Confidence            998542   4889999999999999999999   8899999999999999999999999999987543221    11233


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT  352 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  352 (458)
                      ..|+..|+|||.+.+..++.++||||||+++|||++|+.||........... ..       ....+.+...  ......
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~-------~~~~~~~~~~--~~~~~~  247 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IR-------DNLPPRVKDS--HKVSSV  247 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HH-------hcCCCccccc--cccCHH
Confidence            4688999999999888899999999999999999999999975443322111 11       1111111111  112246


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          353 IVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       353 l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                      +.+++..||..||.+||++++++++.+......+
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            8889999999999999999999999887655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-39  Score=304.45  Aligned_cols=249  Identities=27%  Similarity=0.395  Sum_probs=196.7

Q ss_pred             ceeeeecceEEEEEEEcC----CCEEEEEEecccch-hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFSD----GSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ++||+|+||.||+|.+..    +..+|+|.+..... .....+.+|+++++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            369999999999997632    26899998864433 34567899999999999999999999875 4568999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++....  .+++..++.++.|++.||+|||   ..+++|+||||+|||++.++.+||+|||+++.......... 
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~-  153 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR-  153 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc-
Confidence            99999997644  5899999999999999999999   88999999999999999999999999999986644332111 


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+....... ....      ...    .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~~~~~-~~~~------~~~----~  221 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLES-GERL------PRP----E  221 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHHc-CCcC------CCC----C
Confidence            1112234568999999998899999999999999999998 8888865433 222222111 1110      111    1


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .....+.+++.+||..+|++||++.++++.|...
T Consensus       222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            2235688999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.7e-39  Score=311.21  Aligned_cols=257  Identities=25%  Similarity=0.435  Sum_probs=198.0

Q ss_pred             hcccceeeeecceEEEEEEEc-----------------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-----------------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRG  171 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~  171 (458)
                      +.+.+.||+|+||.||++...                 ++..||+|.+... .......+.+|+++++.++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            456778999999999998542                 2346899988643 3334567999999999999999999999


Q ss_pred             eeeccCceeeeeeecCCCCHHHHhcCCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 012715          172 FCIEKRERFLMYEYMANGSLKDHLHSPGR---------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL  242 (458)
Q Consensus       172 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll  242 (458)
                      ++...+..++||||+++|+|.+++.....         ..+++.++..++.|++.||+|||   +.+++||||||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili  163 (296)
T cd05095          87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEE
Confidence            99999999999999999999999975321         24778899999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh--CCCccCCCcchH
Q 012715          243 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT--ARRAVQDGKNLV  320 (458)
Q Consensus       243 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~p~~~~~~~~  320 (458)
                      +.++.++|+|||+++........  .......++..|+|||...+..++.++|||||||++|||++  |..||..... .
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-~  240 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-E  240 (296)
T ss_pred             cCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-H
Confidence            99999999999999765432211  11222345678999999888889999999999999999998  6677754322 1


Q ss_pred             HHHHHH---HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          321 ESAQVC---MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       321 ~~~~~~---~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      +.....   .....  .....+     .+..++..+.+++.+||+.||.+||++.+|++.|.
T Consensus       241 ~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIENTGEFFRDQG--RQVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHhhcc--ccccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            211111   00000  000001     01123367899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.7e-40  Score=311.76  Aligned_cols=240  Identities=23%  Similarity=0.385  Sum_probs=190.5

Q ss_pred             ceeeeecceEEEEEEEcC--------CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          114 TIIGQGGFGTVYKAQFSD--------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.||+|+||.||+|....        ...+|+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999997642        234888887655555566789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc--------EEEeeccccc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--------AKLADFGLAH  257 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~--------~kl~DfGla~  257 (458)
                      +++|+|.+++...+. .+++..++.++.||+.||+|||   +++|+||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999976443 5899999999999999999999   999999999999999987665        6999999886


Q ss_pred             ccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      .....        ....++..|+|||++.+ ..++.++|||||||++|||++|..++....+....... ....      
T Consensus       157 ~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~------  221 (258)
T cd05078         157 TVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDR------  221 (258)
T ss_pred             ccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHcc------
Confidence            54322        23457889999999976 45799999999999999999996544333222222111 1111      


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                        ..+...    ....+.+++.+||+.+|++||+++++++.|
T Consensus       222 --~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 --HQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             --ccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              111111    124588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.5e-39  Score=319.08  Aligned_cols=258  Identities=21%  Similarity=0.290  Sum_probs=199.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.++||+|+||.||++... +++.||+|.+.+..   ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            345678999999999999876 47889999985422   22234588899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........ 
T Consensus        83 ~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-  157 (332)
T cd05623          83 YVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-  157 (332)
T ss_pred             cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-
Confidence            99999999997532 24899999999999999999999   89999999999999999999999999999875433221 


Q ss_pred             cccccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          266 FEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                        .......||+.|+|||++.     ...++.++|||||||++|||++|+.||..... .+..........+..   -+.
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~~---~p~  231 (332)
T cd05623         158 --VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKERFQ---FPA  231 (332)
T ss_pred             --ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-HHHHHHHhCCCcccc---CCC
Confidence              1122356999999999986     34688999999999999999999999975433 233332222111110   011


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHHhhhCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQ--ARPSIKQVLRILYESS  382 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~--~RPs~~evl~~l~~~~  382 (458)
                      ....    ....+.+++.+|+..++.  .|++++++++|.|+..
T Consensus       232 ~~~~----~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         232 QVTD----VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             cccc----CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            1111    234577888888755444  4789999999988753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-39  Score=313.99  Aligned_cols=255  Identities=25%  Similarity=0.345  Sum_probs=206.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  100 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence            445678999999999999864 7899999998755545556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++..   ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.++|+|||++........    
T Consensus       101 ~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~----  170 (297)
T cd06656         101 GSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----  170 (297)
T ss_pred             CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc----
Confidence            999999864   24889999999999999999999   89999999999999999999999999999876543221    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......+++.|+|||.+.+..++.++|||||||++|+|++|..||............ .. . .     .+..  .....
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~~-~-~-----~~~~--~~~~~  240 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-AT-N-G-----TPEL--QNPER  240 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-cc-C-C-----CCCC--CCccc
Confidence            122346888999999999988999999999999999999999999654332111110 00 0 0     0000  01112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      ....+.+++.+||+.+|++||++++++++.|.....
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence            235678999999999999999999999998876443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-39  Score=311.74  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=197.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCC----EEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ..+.++||+|+||+||+|.+. +|.    .||+|.+... .......+.+|+.++..++|+||+++++++.. ...+++|
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~   87 (279)
T cd05109           9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT   87 (279)
T ss_pred             eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence            345678999999999999764 444    4899988643 33445678899999999999999999999875 4578999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++.... ..+++..++.++.|++.||+|||   +++++||||||+|||+++++.+||+|||+++......
T Consensus        88 ~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          88 QLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE  163 (279)
T ss_pred             EcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence            9999999999997643 35899999999999999999999   9999999999999999999999999999998664322


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ...  ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..... .......      .. 
T Consensus       164 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~-~~~~~~~------~~-  232 (279)
T cd05109         164 TEY--HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDL-LEKGERL------PQ-  232 (279)
T ss_pred             cee--ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH-HHCCCcC------CC-
Confidence            111  1122335678999999998899999999999999999998 88888643321 11111 1111110      01 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                         +......+.+++..||+.||++||++.++++.|...
T Consensus       233 ---~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         233 ---PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence               112235688999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-39  Score=307.39  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=203.1

Q ss_pred             hcccceeeeecceEEEEEEEcC-CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|...+ +..+++|.+.....  ..++.+|++++++++|+||+++++++.+....|+++||+.+
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            3455689999999999998864 78999998865432  56899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.... ..+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||++........    
T Consensus        83 ~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~----  154 (256)
T cd06612          83 GSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA----  154 (256)
T ss_pred             CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc----
Confidence            99999996533 45899999999999999999999   88999999999999999999999999999886544321    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.............   ..     ..+.+  ..+..
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~-----~~~~~--~~~~~  224 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NK-----PPPTL--SDPEK  224 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cC-----CCCCC--Cchhh
Confidence            1223457889999999998899999999999999999999999987543322211110   00     00000  11112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ....+.+++.+||+.+|++||++++++++.|
T Consensus       225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~  255 (256)
T cd06612         225 WSPEFNDFVKKCLVKDPEERPSAIQLLQHPF  255 (256)
T ss_pred             cCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence            2356899999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-39  Score=311.74  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=200.1

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV   86 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            4456679999999999999653      24589999876432 2334468899999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 012715          182 MYEYMANGSLKDHLHSPG--------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF  253 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  253 (458)
                      ||||+++|+|.+++....        ...+++..+..++.|++.||+|||   +++++||||||+|||+++++.+||+||
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Df  163 (288)
T cd05061          87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDF  163 (288)
T ss_pred             EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcC
Confidence            999999999999996422        234577888999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccc
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      |+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||... ...+.........  
T Consensus       164 g~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~-~~~~~~~~~~~~~--  238 (288)
T cd05061         164 GMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVLKFVMDGG--  238 (288)
T ss_pred             Cccccccccccc--cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCC--
Confidence            999865432211  11222345778999999998899999999999999999999 67777542 2222222211110  


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .     .....    .....+.+++.+||+.+|++||++.++++.+....
T Consensus       239 ~-----~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 Y-----LDQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             C-----CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            0     01111    22357999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-39  Score=311.81  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=202.7

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ...+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||+++
T Consensus         7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06642           7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG   86 (277)
T ss_pred             HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence            34457999999999999765 57899999876432 33446789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++..   ..+++..+..++.|++.||.|||   +++++|+||+|+||++++++.++|+|||++........    
T Consensus        87 ~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----  156 (277)
T cd06642          87 GSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----  156 (277)
T ss_pred             CcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch----
Confidence            999999864   35899999999999999999999   89999999999999999999999999999976543321    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......|+..|+|||.+.+..++.++|||||||++|||++|+.|+.+...... ...       ......+.+.    ..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~-------~~~~~~~~~~----~~  224 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-LFL-------IPKNSPPTLE----GQ  224 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-Hhh-------hhcCCCCCCC----cc
Confidence            12234578899999999998999999999999999999999999864332211 111       0011111121    22


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ....+.+++.+||+.+|.+||++.+++++.+...
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06642         225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR  258 (277)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence            3456889999999999999999999999987644

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-39  Score=309.43  Aligned_cols=256  Identities=25%  Similarity=0.440  Sum_probs=200.9

Q ss_pred             hhcccceeeeecceEEEEEEEcC-C---CEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD-G---SLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.+.||+|+||.||+|.+.. +   ..||||.+... .......|..|+.++++++||||+++++++.+++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            34567899999999999998753 3   36999998643 3444568999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999997643 35899999999999999999999   8999999999999999999999999999987654322


Q ss_pred             ccccc-ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          264 ICFEP-VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       264 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ..... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...... +...... .....        
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~~i~-~~~~~--------  230 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVINAIE-QDYRL--------  230 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHHHHH-cCCcC--------
Confidence            11000 0111112457999999999999999999999999999886 98888654322 2222111 11110        


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                        ....+.+..+.+++.+||+.+|.+||++++++..|..
T Consensus       231 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         231 --PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             --CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence              0111233568899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.7e-39  Score=306.69  Aligned_cols=252  Identities=21%  Similarity=0.358  Sum_probs=191.0

Q ss_pred             eeeeecceEEEEEEEcCC---CEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          115 IIGQGGFGTVYKAQFSDG---SLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999976443   346677665332 3345689999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          191 LKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       191 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |.+++....  ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++........  ..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~--~~  156 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY--IE  156 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchh--hh
Confidence            999997532  234667788899999999999999   89999999999999999999999999999864322111  01


Q ss_pred             ccccccCCCcccccccccc-------CCCCcccccHhHHHHHHHHHhC-CCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          269 VNTDIRGTPGYMDPEYVVT-------QELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ......++..|+|||++..       ..++.++|||||||++|||+++ ..||...... +.......  .......++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~--~~~~~~~~~~  233 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIK--DQQVKLFKPQ  233 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHh--hcccccCCCc
Confidence            1234467889999998753       2457899999999999999975 5566543332 22222111  1122334444


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      +...++    ..+.+++..|| .+|++||++++|++.|.
T Consensus       234 ~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 LELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            444333    45778999999 67999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=326.26  Aligned_cols=247  Identities=27%  Similarity=0.400  Sum_probs=205.7

Q ss_pred             eeeeecceEEEEEEEcC-CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHHH
Q 012715          115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKD  193 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  193 (458)
                      +||+|.||+||.|+..+ ...+|||.+........+-+..|+.+-++|+|.|||+++|.|.+++.+-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999998764 56789999876666666778999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC-CCCcEEEeecccccccCCCCccccccc
Q 012715          194 HLHSPGRTPL--SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       194 ~l~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      +|...-+ ++  ++.+.-.+.+||++||.|||   .+.|+|||||-+||||+ -.|.+||+|||.++....    ..+..
T Consensus       662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg----inP~T  733 (1226)
T KOG4279|consen  662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG----INPCT  733 (1226)
T ss_pred             HHHhccC-CCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc----CCccc
Confidence            9976432 35  77888889999999999999   99999999999999996 489999999999987653    23456


Q ss_pred             ccccCCCccccccccccC--CCCcccccHhHHHHHHHHHhCCCccCCCcchH-HHHHHHHhhccccccccCCcCCCCCCH
Q 012715          271 TDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV-ESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ..+.||..|||||++..+  .|+.++|||||||++.||.||++||.+..+.. .+.+.-+.           ......+.
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy-----------KvHP~iPe  802 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY-----------KVHPPIPE  802 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce-----------ecCCCCcH
Confidence            678899999999999764  68999999999999999999999997654432 22222110           11223344


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +...+...+|.+|+..||.+||+++++|+-.+-
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~DpFl  835 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFL  835 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhccCccc
Confidence            555778899999999999999999999986543

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.4e-39  Score=303.67  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=204.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||.|+||.||.++.. ++..+++|.+...  .......+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            345678999999999999764 6889999987543  3444567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++|+|.+++.......+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++........  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--  156 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--  156 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence            9999999997654456899999999999999999999   88999999999999999999999999999976543321  


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|..||..... .+........  ....         ..
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~~~~~~--~~~~---------~~  222 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVVKIVQG--NYTP---------VV  222 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcC--CCCC---------Cc
Confidence              12345689999999999888899999999999999999999999865332 2222222211  1111         01


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ......+.+++.+||+.+|.+||++++++++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence            122356889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.3e-40  Score=314.40  Aligned_cols=262  Identities=24%  Similarity=0.278  Sum_probs=200.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||.||+|... +|..||+|.+...  .......+.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            345678999999999999875 6899999988532  2223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      . ++|.+++.... ..+++..++.++.||++||.|||   +.+++||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          82 D-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            7 58888876533 34899999999999999999999   89999999999999999999999999999976543221  


Q ss_pred             ccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc--------ccccc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR--------LAELV  337 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~  337 (458)
                        ......++..|+|||.+.+. .++.++|||||||++|||+||+.|+..+.+..+...........        +.+..
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence              12334578899999988764 47899999999999999999999976555543333222111000        00000


Q ss_pred             CC----cCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          338 DP----RIKDSF-----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       338 d~----~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +.    ......     .......+.+++.+||+.||.+|||++++++|.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            00    000000     01123568899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-39  Score=320.77  Aligned_cols=257  Identities=27%  Similarity=0.378  Sum_probs=197.6

Q ss_pred             hhcccceeeeecceEEEEEEE------cCCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeecc-Cce
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEK-RER  179 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~  179 (458)
                      .+.+.+.||+|+||.||+|.+      .+++.||||++.... ......+.+|+.++.++ +|+||++++++|... ...
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL   87 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence            456778999999999999963      346899999986432 23345788999999999 689999999988654 467


Q ss_pred             eeeeeecCCCCHHHHhcCCC------------------------------------------------------------
Q 012715          180 FLMYEYMANGSLKDHLHSPG------------------------------------------------------------  199 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------  199 (458)
                      ++||||+++|+|.+++....                                                            
T Consensus        88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (343)
T cd05103          88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE  167 (343)
T ss_pred             EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence            89999999999999986421                                                            


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccccc
Q 012715          200 -----RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR  274 (458)
Q Consensus       200 -----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~  274 (458)
                           ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++..........  ......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~  242 (343)
T cd05103         168 QEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--RKGDAR  242 (343)
T ss_pred             hhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh--hcCCCC
Confidence                 123688889999999999999999   9999999999999999999999999999997653321110  112234


Q ss_pred             CCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHH
Q 012715          275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTI  353 (458)
Q Consensus       275 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  353 (458)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||............. .....      .......    ...+
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~------~~~~~~~----~~~~  311 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGTR------MRAPDYT----TPEM  311 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH-hccCC------CCCCCCC----CHHH
Confidence            5678999999998999999999999999999997 888886533222221111 11111      0111111    2458


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          354 VTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       354 ~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+++..||+.+|++||++.+++++|...
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            8999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-40  Score=322.16  Aligned_cols=258  Identities=20%  Similarity=0.308  Sum_probs=196.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Ccee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  180 (458)
                      +...+.||+|+||.||+|... ++..||||++....  ......+.+|++++++++|+||+++++++...      ...|
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07878          17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY   96 (343)
T ss_pred             hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence            334568999999999999764 68899999986432  22345678999999999999999999987543      3568


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      ++++++ +++|.+++..   ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          97 LVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            999988 7899988864   34899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC-
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD-  338 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d-  338 (458)
                      ..       .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||.....................+... 
T Consensus       170 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         170 DE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             CC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32       234568999999999876 578999999999999999999999996543322221111100000000000 


Q ss_pred             ----------CcCCCCCCH--------HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 ----------PRIKDSFDM--------EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 ----------~~~~~~~~~--------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                ..+. ..+.        .....+.+++.+|++.||.+|||+.|+++|.|...
T Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         243 ISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             cchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                      0000 0000        01134789999999999999999999999988754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-40  Score=322.45  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=208.8

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEec--ccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      |+..++||+||.+.||++...+.+.||+|++.  ..+.+...-|++|+.+|.+|+ |.+|++|++|-..++.+||||||=
T Consensus       363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G  442 (677)
T KOG0596|consen  363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG  442 (677)
T ss_pred             hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence            34456799999999999998888899999864  456667778999999999996 999999999999999999999965


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                       ..+|..+|++.......| .+..+..|++.++.++|   .+||||.||||.|+|+- .|.+||+|||+|.....+... 
T Consensus       443 -d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs-  515 (677)
T KOG0596|consen  443 -DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS-  515 (677)
T ss_pred             -cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc-
Confidence             569999999876665556 77889999999999999   99999999999999884 569999999999987765543 


Q ss_pred             ccccccccCCCccccccccccCC-----------CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQE-----------LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE  335 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  335 (458)
                       -.....+||+.||+||.+....           .+.++|||||||+||+|+.|+.||..-.+...          ++..
T Consensus       516 -I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a----------Kl~a  584 (677)
T KOG0596|consen  516 -IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA----------KLHA  584 (677)
T ss_pred             -eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH----------HHHh
Confidence             2456788999999999996432           56789999999999999999999975433221          2344


Q ss_pred             ccCCcCCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          336 LVDPRIKDSFDM-EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       336 ~~d~~~~~~~~~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      +.||....+|+. ....++.++++.||..||.+||+..++|+|.+-...+.
T Consensus       585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i  635 (677)
T KOG0596|consen  585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI  635 (677)
T ss_pred             hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence            455544434331 11133899999999999999999999999986554343

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=304.81  Aligned_cols=248  Identities=26%  Similarity=0.417  Sum_probs=198.5

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccch-hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      ++||+|+||.||++...+++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36999999999999887799999998865433 24567999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccc
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      +++.... ..+++..++.++.+++.||+|||   +++++||||||+||+++.++.+||+|||++.........  .....
T Consensus        81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~  154 (251)
T cd05041          81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT--VSDGL  154 (251)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce--ecccc
Confidence            9996543 25889999999999999999999   899999999999999999999999999999765432211  11112


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      ..++..|+|||.+.+..++.++||||||+++|||+| |..||...... ....... ...          ....+...+.
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~~~~~~-~~~----------~~~~~~~~~~  222 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRERIE-SGY----------RMPAPQLCPE  222 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HHHHHHh-cCC----------CCCCCccCCH
Confidence            234667999999988899999999999999999999 77777543321 1111111 100          0011122335


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          352 TIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .+.+++.+||+.+|.+||++.|+++.|.
T Consensus       223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         223 EIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            7999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-39  Score=318.98  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=199.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+++.. +++.||+|.+...   .......+.+|..++..++|+||+++++++.+.+..|+||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            345678999999999999876 5789999988642   222334588899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        83 ~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          83 YVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            99999999997632 35889999999999999999999   999999999999999999999999999999765433211


Q ss_pred             cccccccccCCCcccccccccc-----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                         ......||+.|+|||.+.+     ..++.++|||||||++|||++|+.||...... +..........+..  + +.
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~-p~  231 (331)
T cd05624         159 ---QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHEERFQ--F-PS  231 (331)
T ss_pred             ---eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-HHHHHHHcCCCccc--C-CC
Confidence               1123569999999998875     56889999999999999999999999754332 22222221111110  0 11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~  381 (458)
                      ...    .....+.+++.+|+..++++  |++++++++|.|+.
T Consensus       232 ~~~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~  270 (331)
T cd05624         232 HIT----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE  270 (331)
T ss_pred             ccc----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence            111    12356788999988765544  57899999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-39  Score=346.84  Aligned_cols=257  Identities=21%  Similarity=0.358  Sum_probs=200.6

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLM  182 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  182 (458)
                      ..+.+.+.||+|+||+||+|... ++..||+|.+...  .......|..|+.++.+|+||||+++++++.+.  ..+|||
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            34556789999999999999875 5778999987532  333456789999999999999999999988553  568999


Q ss_pred             eeecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC----CCCeEeccCCCCCeeeCC------------
Q 012715          183 YEYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYC----DPPLCHRDIKSSNILLDE------------  244 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~----~~~iiHrDlk~~NIll~~------------  244 (458)
                      |||+++|+|.++|...  ....+++..++.|+.||+.||+|||...    ..+|+||||||+||||+.            
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            9999999999999642  1235999999999999999999999432    156999999999999964            


Q ss_pred             -----CCcEEEeecccccccCCCCcccccccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCccCCCc
Q 012715          245 -----NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGK  317 (458)
Q Consensus       245 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~  317 (458)
                           .+.+||+|||++.......     ......||+.|+|||++.+  ..++.++|||||||+||||+||+.||....
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccCCCCceEEccCCccccccccc-----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                 3359999999998654332     2234569999999999864  458899999999999999999999997665


Q ss_pred             chHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          318 NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ........... .        +.+..   ......+.+||..||+.+|.+||++.|+|.+.+..
T Consensus       248 ~~~qli~~lk~-~--------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        248 NFSQLISELKR-G--------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             cHHHHHHHHhc-C--------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            54443332211 1        11100   01125688999999999999999999999876654

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-39  Score=303.70  Aligned_cols=249  Identities=27%  Similarity=0.484  Sum_probs=200.2

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      ..+.+.||+|+||.||+|.+.++..+|+|.+.... ....+|.+|++++++++|+|++++++++......++||||++++
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            34667899999999999988778899999886432 23457899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++.... ..+++..+..++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||+++........   .
T Consensus        85 ~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~---~  157 (256)
T cd05112          85 CLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT---S  157 (256)
T ss_pred             cHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc---c
Confidence            9999997543 24889999999999999999999   889999999999999999999999999998765432211   1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....++.+|+|||.+.+..++.++||||||+++|||++ |..||.... ...........    .....+..       
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~----~~~~~~~~-------  225 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-NSEVVETINAG----FRLYKPRL-------  225 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHhCC----CCCCCCCC-------
Confidence            122335678999999998899999999999999999998 888886433 22222221111    01111111       


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      ....+.+++.+||+.+|++||++.+++++|
T Consensus       226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            125689999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-39  Score=326.37  Aligned_cols=267  Identities=21%  Similarity=0.263  Sum_probs=202.6

Q ss_pred             HHHHhhcccceeeeecceEEEEEEEc---CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          105 TKKATDNFSTIIGQGGFGTVYKAQFS---DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       105 ~~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      +....+.+.+.||+|+||.||+|...   .+..||+|.+...     ..+.+|+++|++++|+||+++++++......++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            33445667789999999999999753   3578999987542     235689999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      |||++. ++|.+++..  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       164 v~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        164 VMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             EehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            999995 689998843  345999999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch--HHHHHHHHhhccc----ccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESR----LAE  335 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~----~~~  335 (458)
                      ...  ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ...........+.    +..
T Consensus       238 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        238 HPD--TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             ccc--cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            321  11223457999999999999999999999999999999999999999653321  1111111100000    000


Q ss_pred             -----------ccCCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          336 -----------LVDPRIKDSFD-------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       336 -----------~~d~~~~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                                 ......+..+.       ......+.+++.+||..||++||++.|++.|.|+...+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                       00000000000       01124578899999999999999999999999886543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-39  Score=314.26  Aligned_cols=262  Identities=23%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++||||+.
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~   87 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   87 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence            445678999999999999875 58899999886432 2233467889999999999999999999999999999999997


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                       ++|.+++.... ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++........   
T Consensus        88 -~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---  159 (301)
T cd07873          88 -KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---  159 (301)
T ss_pred             -cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC---
Confidence             59999887543 35889999999999999999999   99999999999999999999999999999875432221   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhh-----ccccccccC---
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS-----ESRLAELVD---  338 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~d---  338 (458)
                       ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +........     ...+...++   
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhcccc
Confidence             1223457889999998865 45788999999999999999999999654332 221111110     000011100   


Q ss_pred             ------CcCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          339 ------PRIKDSF----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       339 ------~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                            +.....+    .......+.+++.+|++.||.+|||++|+++|.|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence                  1111000    011234678999999999999999999999998874

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-39  Score=304.46  Aligned_cols=253  Identities=26%  Similarity=0.397  Sum_probs=204.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||.|+||.||+|... ++..+|+|.+..........+.+|++++++++|+||+++++++.+++..+++|||+.+
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~   84 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG   84 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence            345678999999999999875 5789999998755555567899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.... ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.......    .
T Consensus        85 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----~  156 (262)
T cd06613          85 GSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI----A  156 (262)
T ss_pred             CcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh----h
Confidence            99999987642 35899999999999999999999   8999999999999999999999999999987654321    0


Q ss_pred             ccccccCCCccccccccccC---CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          269 VNTDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      ......++..|+|||.+...   .++.++||||||+++|||++|+.|+.+........... ...     ...+.+  ..
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-~~~-----~~~~~~--~~  228 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-KSN-----FPPPKL--KD  228 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcc-----CCCccc--cc
Confidence            12335688899999998776   88999999999999999999999997544322221111 100     001111  11


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      .......+.+++.+||..+|.+||++.+++.+-
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  261 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP  261 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            223446789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=310.47  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=204.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||.|+||.||+|.+. ++..+|+|.+..........+.+|++++++++|+||+++++++......++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            344567999999999999875 6889999998765555667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.... ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++........    
T Consensus        87 ~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~----  158 (280)
T cd06611          87 GALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ----  158 (280)
T ss_pred             CcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc----
Confidence            99999987543 35899999999999999999999   89999999999999999999999999999875433221    


Q ss_pred             ccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          269 VNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ......++..|+|||.+.     ...++.++||||||+++|||++|+.||......... ......  ..     +.+. 
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~--~~-----~~~~-  229 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-LKILKS--EP-----PTLD-  229 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-HHHhcC--CC-----CCcC-
Confidence            123346889999999875     345778999999999999999999999654332211 111110  00     1110 


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       .+......+.+++..||+.+|.+||++.+++++.|...
T Consensus       230 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         230 -QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             -CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence             01112346889999999999999999999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.3e-39  Score=307.88  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=201.3

Q ss_pred             hhcccceeeeecceEEEEEEEc-C---CCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-D---GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.+.||+|+||.||+|.+. +   +..+|+|.++... ......+.+|+.++.+++||||+++++++.+++..++||
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT   84 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            3456678999999999999764 2   3479999886432 333467899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.++|+|||++.......
T Consensus        85 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          85 EYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999997643 35899999999999999999999   8999999999999999999999999999998664432


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ... .......++..|+|||.+.+..++.++||||||+++||+++ |..||.+.... +...... ....      ... 
T Consensus       161 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~~-~~~~------~~~-  230 (267)
T cd05066         161 EAA-YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAIE-EGYR------LPA-  230 (267)
T ss_pred             cee-eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHHh-CCCc------CCC-
Confidence            111 01122234568999999998899999999999999999886 99998654322 2222111 1111      001 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                         ....+..+.+++.+||+.+|.+||++.++++.|..
T Consensus       231 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         231 ---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             ---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence               11223568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-39  Score=309.84  Aligned_cols=248  Identities=28%  Similarity=0.459  Sum_probs=196.7

Q ss_pred             eeeeecceEEEEEEEcC-------CCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSD-------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .||+|+||.||+|...+       +..+|+|.+.... ......+.+|+++++.++|+||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            68999999999997642       2579999875432 234567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-----cEEEeecccc
Q 012715          187 ANGSLKDHLHSP-----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-----VAKLADFGLA  256 (458)
Q Consensus       187 ~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-----~~kl~DfGla  256 (458)
                      ++++|.+++...     ....+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999642     1234789999999999999999999   89999999999999999877     8999999999


Q ss_pred             cccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcccccc
Q 012715          257 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAE  335 (458)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  335 (458)
                      +........  .......++..|+|||.+.+..++.++|||||||++|||++ |+.||....+. +...... ....   
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~~~~~~-~~~~---  231 (269)
T cd05044         159 RDIYKSDYY--RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVLQHVT-AGGR---  231 (269)
T ss_pred             ccccccccc--ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HHHHHHh-cCCc---
Confidence            765433211  11222345788999999999999999999999999999998 89888654332 2221111 1100   


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                             .......+..+.+++.+||+.+|.+||+++++++.|.
T Consensus       232 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         232 -------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   0111223467889999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.8e-39  Score=310.02  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=201.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++|+||+++++++......++||||+
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   82 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC   82 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence            345678999999999999876 58999999885432  223356789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++++|..++....  .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........  
T Consensus        83 ~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07847          83 DHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--  155 (286)
T ss_pred             CccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence            9988888876532  4899999999999999999999   89999999999999999999999999999986644321  


Q ss_pred             ccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc-------------
Q 012715          267 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-------------  332 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  332 (458)
                        ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+..+..............             
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence              1223457889999999876 567899999999999999999999997554432222111100000             


Q ss_pred             cccccCCcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          333 LAELVDPRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ......+......+.     .....+.+++.+||+.+|++||++.|++.|.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            000111111110110     113568899999999999999999999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.7e-39  Score=313.19  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=199.9

Q ss_pred             hhcccceeeeecceEEEEEEEc--------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCc
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE  178 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  178 (458)
                      .+.+.+.||+|+||.||+|...        .+..+|+|.+... .......+.+|++++.++ +|+||++++++|.+.+.
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP   92 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence            3446679999999999999642        2457999988643 233456788999999999 69999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC
Q 012715          179 RFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE  244 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~  244 (458)
                      .++||||+++|+|.+++....              ...+++.++.+++.|++.||.|||   +++++||||||+|||+++
T Consensus        93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~  169 (314)
T cd05099          93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTE  169 (314)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcC
Confidence            999999999999999996532              235899999999999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHH
Q 012715          245 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESA  323 (458)
Q Consensus       245 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~  323 (458)
                      ++.+||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||.. .+..+..
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~  246 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYY--KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELF  246 (314)
T ss_pred             CCcEEEccccccccccccccc--cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHH
Confidence            999999999999865432211  01112234567999999998899999999999999999999 7777753 3322222


Q ss_pred             HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..... ...      ..    .+......+.+++.+||+.+|++||++.++++.|...
T Consensus       247 ~~~~~-~~~------~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         247 KLLRE-GHR------MD----KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHHHc-CCC------CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            22111 100      01    1112234688999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=314.76  Aligned_cols=258  Identities=22%  Similarity=0.268  Sum_probs=206.0

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccch---hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE---QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.||+|+||.||+|... ++..||+|.+.....   .....+.+|++++..++|+||+++++.+.+.+..++||||+
T Consensus         4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            44578999999999999876 489999998864322   24457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      .+++|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++..........
T Consensus        84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            9999999997655556999999999999999999999   8999999999999999999999999999987543221100


Q ss_pred             c-------------------------cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHH
Q 012715          267 E-------------------------PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE  321 (458)
Q Consensus       267 ~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~  321 (458)
                      .                         .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence            0                         011234688999999999988899999999999999999999999965443322


Q ss_pred             HHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHHhhhCC
Q 012715          322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS----IKQVLRILYESS  382 (458)
Q Consensus       322 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs----~~evl~~l~~~~  382 (458)
                      .... .......        .  ........+.+++.+||..+|++||+    +++++++.|+..
T Consensus       241 ~~~~-~~~~~~~--------~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         241 FSNI-LKKEVTF--------P--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HHHH-hcCCccC--------C--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            2211 1111100        0  01113467999999999999999999    999999877643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-39  Score=312.39  Aligned_cols=257  Identities=23%  Similarity=0.409  Sum_probs=198.9

Q ss_pred             hhcccceeeeecceEEEEEEE-----cCCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Ccee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  180 (458)
                      ++...+.||+|+||.||++.+     .++..||+|.+.... ......+.+|+++++.++|+||+++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            344556899999999999975     257889999986432 33446799999999999999999999998875  5689


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++++|.+++.... ..+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++...
T Consensus        85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            9999999999999996543 35899999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch-------------HHHHHHHH
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-------------VESAQVCM  327 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~-------------~~~~~~~~  327 (458)
                      ...... .......++..|+|||.+.+..++.++|||||||++|||++++.|.......             ........
T Consensus       161 ~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         161 TDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             cCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            332111 1123345677899999998888999999999999999999987654321110             00000000


Q ss_pred             hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       328 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ....      ......    .....+.+++.+||+.+|.+||+++++++.+..
T Consensus       240 ~~~~------~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         240 EEGK------RLPRPP----NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HcCc------cCCCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            0000      000111    223579999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=308.98  Aligned_cols=252  Identities=27%  Similarity=0.412  Sum_probs=205.3

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG   83 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence            34568999999999999875 68899999886432 33446788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++...   .+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||+++.......    
T Consensus        84 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~----  153 (274)
T cd06609          84 GSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS----  153 (274)
T ss_pred             CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc----
Confidence            9999999753   6899999999999999999999   89999999999999999999999999999987654321    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......++..|+|||.+.+..++.++||||||+++|||+||+.||...... .........       ..+.+...   .
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~-------~~~~~~~~---~  222 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVLFLIPKN-------NPPSLEGN---K  222 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-HHHHHhhhc-------CCCCCccc---c
Confidence            123346888999999999888999999999999999999999999644322 111111111       11111111   0


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ....+.+++.+||..+|++||++++++++.|....
T Consensus       223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             cCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            23458899999999999999999999999887654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=290.17  Aligned_cols=261  Identities=24%  Similarity=0.331  Sum_probs=202.6

Q ss_pred             hhcccceeeeecceEEEEEE-EcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC-----ceeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLM  182 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  182 (458)
                      .+.+.+.||+|||+-||.++ ..++..||+|++.-.+.+..+..++|++..++++||||+++++++..+.     ..||+
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll  101 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL  101 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence            45567899999999999996 4578999999998767777888999999999999999999999886544     48999


Q ss_pred             eeecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          183 YEYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      ++|...|+|.+.+...  ++..+++.+.+.|+.+|.+||++||.. ..+++||||||.|||+++.+.++|.|||.+....
T Consensus       102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~  180 (302)
T KOG2345|consen  102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP  180 (302)
T ss_pred             eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence            9999999999999643  344699999999999999999999933 3359999999999999999999999999987543


Q ss_pred             CCCccc-----ccccccccCCCcccccccccc---CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc
Q 012715          261 DGSICF-----EPVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       261 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      -.-...     .........|..|.|||.+.-   ...+.++|||||||+||+|+.|..||...          ...++.
T Consensus       181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----------~~~GgS  250 (302)
T KOG2345|consen  181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI----------YQQGGS  250 (302)
T ss_pred             eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH----------hhcCCe
Confidence            111000     001223456899999998853   45788999999999999999999998521          001111


Q ss_pred             cc-cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          333 LA-ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       333 ~~-~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +. .+..+.+...-+....+.+.+++.+|++.||.+||++.+++.++..
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence            11 1111122111112244679999999999999999999999998753

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.7e-39  Score=304.89  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=202.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||.||++... ++..+|+|.+...  .......+.+|++++++++|+||+++++.+..++..++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            345678999999999999774 6889999988643  2334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccccCCCCcc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~  265 (458)
                      ++++|.+++.......+++..+..++.+++.||+|||   +++++|+||+|+||++++ ++.+||+|||++.......  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--  156 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--  156 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence            9999999998755556899999999999999999999   899999999999999985 4568999999998664432  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..........  ...     .+... 
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~--~~~-----~~~~~-  224 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIMSG--TFA-----PISDR-  224 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-HHHHHHHHhc--CCC-----CCCCC-
Confidence               12234688899999999988899999999999999999999999865432 2222221111  011     11111 


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                         ....+.+++.+||+.+|.+||++.|++++.+
T Consensus       225 ---~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~  255 (256)
T cd08220         225 ---YSPDLRQLILSMLNLDPSKRPQLSQIMAQPI  255 (256)
T ss_pred             ---cCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence               2346889999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.6e-39  Score=304.56  Aligned_cols=237  Identities=27%  Similarity=0.439  Sum_probs=189.0

Q ss_pred             ceeeeecceEEEEEEEcCCC-----------EEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          114 TIIGQGGFGTVYKAQFSDGS-----------LIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            36899999999999886432           5788876543333 5788999999999999999999999988 788999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-------cEEEeeccc
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-------VAKLADFGL  255 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-------~~kl~DfGl  255 (458)
                      |||+++|+|.+++..... .+++..++.++.|++.||+|||   +++|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999976443 5899999999999999999999   89999999999999999887       799999999


Q ss_pred             ccccCCCCcccccccccccCCCccccccccccC--CCCcccccHhHHHHHHHHHhC-CCccCCCcchHHHHHHHHhhccc
Q 012715          256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       256 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      +......        ....++..|+|||.+...  .++.++|||||||++|||++| ..|+.... ..+...... ....
T Consensus       155 a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~-~~~~  224 (259)
T cd05037         155 PITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQ-DQHR  224 (259)
T ss_pred             ccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHh-cCCC
Confidence            8765331        123467789999998876  789999999999999999995 66664432 222211111 0000


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                         ...+         ....+.+++.+||..+|.+||++.++++.|
T Consensus       225 ---~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         225 ---LPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ---CCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence               0000         015688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.7e-39  Score=310.62  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=204.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccch-----hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-----QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .+.+.||+|+||.||+|... +|+.||||.+.....     .....+..|++++++++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            45668999999999999875 689999999864332     233457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+ +|+|.+++.... ..+++..++.++.||++||+|||   ..+++|+||+|+||+++.++.+||+|||+++.......
T Consensus        83 ~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          83 FM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             cc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            99 899999997644 35999999999999999999999   89999999999999999999999999999986644321


Q ss_pred             ccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc----------cc
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----------RL  333 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----------~~  333 (458)
                          ......++..|+|||.+.+ ..++.++|||||||++|||++|..+|....+.............          .+
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         158 ----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             ----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence                1223356788999998854 46789999999999999999997777544433322222111000          00


Q ss_pred             ccccCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          334 AELVDPRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       334 ~~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      ............+     ......+.+++.+||+.+|++||++.|++++.|....+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence            0000000000111     122467889999999999999999999999988766543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.3e-39  Score=311.77  Aligned_cols=255  Identities=23%  Similarity=0.328  Sum_probs=205.4

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      ..||+|+||.||+|... ++..||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            36999999999999875 68999999986544445567889999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccc
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      .++..   ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........    ....
T Consensus       107 ~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----~~~~  176 (297)
T cd06659         107 DIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----KRKS  176 (297)
T ss_pred             HHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc----cccc
Confidence            98864   34899999999999999999999   89999999999999999999999999999875443221    1233


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT  352 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  352 (458)
                      ..|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... .... . ....   .....    .....
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~-~-~~~~---~~~~~----~~~~~  246 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRD-S-PPPK---LKNAH----KISPV  246 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhc-c-CCCC---ccccC----CCCHH
Confidence            568899999999998899999999999999999999999997544332221 1111 0 0000   00011    11245


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCcc
Q 012715          353 IVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSG  388 (458)
Q Consensus       353 l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~~  388 (458)
                      +.+++.+||+.+|.+||++++++++.+......+..
T Consensus       247 l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         247 LRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence            889999999999999999999999988766554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.4e-39  Score=309.31  Aligned_cols=253  Identities=31%  Similarity=0.482  Sum_probs=199.0

Q ss_pred             hcccceeeeecceEEEEEEEc------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|...      ++..||+|.+... ......++.+|+.++++++|+||+++++++.+++..++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL   86 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence            345578999999999999763      4678999988643 233456799999999999999999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 012715          183 YEYMANGSLKDHLHSPG--------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL  242 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll  242 (458)
                      |||+++|+|.+++....                    ...+++..++.++.|++.||+|||   ..+++||||||+||++
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~  163 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLV  163 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEe
Confidence            99999999999996321                    134788899999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHH
Q 012715          243 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVE  321 (458)
Q Consensus       243 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~  321 (458)
                      +.++.++|+|||+++........  ........+..|+|||.+.+..++.++|||||||++|||++ |..||.+.. ..+
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-~~~  240 (288)
T cd05050         164 GENMVVKIADFGLSRNIYSADYY--KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-HEE  240 (288)
T ss_pred             cCCCceEECccccceecccCccc--cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHH
Confidence            99999999999998754332211  11122335678999999998899999999999999999998 777875432 222


Q ss_pred             HHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       322 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .......  ....     ....    ..+..+.+++.+||+.+|.+||++.|+++.|.
T Consensus       241 ~~~~~~~--~~~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 VIYYVRD--GNVL-----SCPD----NCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHhc--CCCC-----CCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            2222111  1110     0111    22356899999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-39  Score=315.69  Aligned_cols=260  Identities=21%  Similarity=0.322  Sum_probs=188.8

Q ss_pred             ceeeeecceEEEEEEEc---CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeec--cCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS---DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  188 (458)
                      .+||+|+||+||+|...   ++..||+|.+....  ....+.+|++++++++|+||+++++++..  +...++||||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            47999999999999865   35789999886432  23457899999999999999999998854  4577999999864


Q ss_pred             CCHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee----CCCCcEEEeeccccc
Q 012715          189 GSLKDHLHSP-------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAH  257 (458)
Q Consensus       189 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DfGla~  257 (458)
                       +|.+++...       ....+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             888877421       1235889999999999999999999   8999999999999999    567799999999998


Q ss_pred             ccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcch---------HHHHHHHH
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL---------VESAQVCM  327 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~---------~~~~~~~~  327 (458)
                      ......... .......||..|+|||.+.+ ..++.++|||||||++|||+||+.||......         ........
T Consensus       161 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         161 LFNSPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             ccCCCcccc-cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            654332111 11234568999999999876 45899999999999999999999998632211         00000000


Q ss_pred             hhc-------------cccccccCCcCCCC------------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          328 ASE-------------SRLAELVDPRIKDS------------FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       328 ~~~-------------~~~~~~~d~~~~~~------------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...             ..............            ........+.+++.+|++.||.+|||+.|+++|.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000             00000000000000            000112357889999999999999999999998763

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.2e-39  Score=314.63  Aligned_cols=261  Identities=26%  Similarity=0.405  Sum_probs=204.3

Q ss_pred             HHHHhhcccceeeeecceEEEEEEEc--------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeee
Q 012715          105 TKKATDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCI  174 (458)
Q Consensus       105 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  174 (458)
                      +....+.+.+.||+|+||.||+|...        .+..||+|.+... .......+.+|++++.++ +|+||++++++|.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            33445677889999999999999642        1236899987643 233456789999999999 7999999999999


Q ss_pred             ccCceeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCe
Q 012715          175 EKRERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI  240 (458)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NI  240 (458)
                      ..+..+++|||+++|+|.+++....              ...+++..++.++.|++.||+|||   .++++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceE
Confidence            9999999999999999999996432              234888999999999999999999   89999999999999


Q ss_pred             eeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcch
Q 012715          241 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNL  319 (458)
Q Consensus       241 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~  319 (458)
                      |++.++.+||+|||+++........  .......++..|+|||.+.+..++.++||||||+++|||++ |..||... +.
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~  242 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PV  242 (334)
T ss_pred             EEcCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-CH
Confidence            9999999999999999865432211  11222334578999999999999999999999999999998 77777543 33


Q ss_pred             HHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          320 VESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .+........ ..      ..    .+......+.+++.+||+.+|.+||++.++++.|....
T Consensus       243 ~~~~~~~~~~-~~------~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 EELFKLLKEG-HR------MD----KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHHHHHcC-CC------CC----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            3333222111 00      01    11122356889999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.1e-39  Score=309.16  Aligned_cols=257  Identities=23%  Similarity=0.310  Sum_probs=202.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +++.+.||+|+||.||++... +|..||+|.+... .......+.+|++++++++|+||+++++++...+..++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            345678999999999999886 6899999988643 33345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          188 NGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       188 ~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +++|..++.... ...+++..+..++.|++.||.|||+  +.+++||||||+||+++.++.+||+|||++.......   
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  157 (286)
T cd06622          83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---  157 (286)
T ss_pred             CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence            999999987531 2358999999999999999999992  2589999999999999999999999999987653321   


Q ss_pred             ccccccccCCCccccccccccC------CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                         .....++..|+|||.+.+.      .++.++|||||||++|||++|+.||...... .........    .....+.
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~----~~~~~~~  229 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFAQLSAI----VDGDPPT  229 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHHHHHHH----hhcCCCC
Confidence               2234578899999988554      3588999999999999999999999654321 111111100    0000111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      +    +......+.+++.+||+.+|++||++++++++.|....
T Consensus       230 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         230 L----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             C----CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            1    12233568899999999999999999999999876443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.9e-39  Score=306.68  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=200.7

Q ss_pred             HhhcccceeeeecceEEEEEEEcC----CCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      ..+.+.+.||+|+||.||+|.+.+    ...||||...... ....+.+.+|+.++++++|+||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            345567899999999999997643    2468999876443 4445679999999999999999999999875 567899


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+++|+|.+++.... ..+++..++.++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999997543 35899999999999999999999   899999999999999999999999999999865443


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ...   ......++..|+|||.+....++.++||||||+++|||++ |..||......... .... .....      ..
T Consensus       161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~-~~~~~------~~  229 (270)
T cd05056         161 SYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIE-NGERL------PM  229 (270)
T ss_pred             cce---ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHH-cCCcC------CC
Confidence            211   1122334568999999988889999999999999999986 99998655432222 1111 11111      11


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..    ..+..+.+++.+|+..+|.+||++.++++.|...
T Consensus       230 ~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         230 PP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11    2235688999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.2e-39  Score=310.64  Aligned_cols=261  Identities=24%  Similarity=0.332  Sum_probs=200.5

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +..+.||.|++|.||+|... +|..||||++....  ......+.+|++++++++|+||+++++++.+.+..++||||+.
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   82 (284)
T ss_pred             eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence            34568999999999999875 68999999886322  2233578899999999999999999999999999999999996


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                       ++|.+++.......+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|||++........   
T Consensus        83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~---  155 (284)
T cd07860          83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---  155 (284)
T ss_pred             -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence             68999987655566899999999999999999999   89999999999999999999999999999875543211   


Q ss_pred             cccccccCCCccccccccccCC-CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC-------
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP-------  339 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~-------  339 (458)
                       ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||..........+........ .....+       
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  233 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP-DEVVWPGVTSLPD  233 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC-ChhhhhhhhHHHH
Confidence             122345688999999887644 6889999999999999999999997654433332221111100 000000       


Q ss_pred             ------cC-CCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          340 ------RI-KDSF---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       340 ------~~-~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                            .. ...+   .......+.+++.+||+.||.+||+++++++|.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                  00 0000   00112457889999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-39  Score=305.01  Aligned_cols=247  Identities=30%  Similarity=0.472  Sum_probs=200.9

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc-----hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      ..+.||+|+||.||+|... ++..|++|.+....     ......+.+|+++++.++|+||+++++++.+....++||||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            4568999999999999876 78999999875432     23456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++....  .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.......  
T Consensus        84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          84 VPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            99999999997643  4889999999999999999999   8999999999999999999999999999987654322  


Q ss_pred             cccccccccCCCccccccccccCC-CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||............  ......     +.+...
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~~~-----~~~~~~  226 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI--GRSKEL-----PPIPDH  226 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH--HhcccC-----CCcCCC
Confidence               123456889999999987766 899999999999999999999999755432222111  110111     111111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                          ....+.+++.+||+.+|.+||++.+++++.+
T Consensus       227 ----~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         227 ----LSDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             ----cCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence                2256788999999999999999999998764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.8e-39  Score=309.06  Aligned_cols=262  Identities=22%  Similarity=0.293  Sum_probs=203.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||.||+|... +|..||+|++....  ......+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            345678999999999999875 68999999986433  334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                       +++|.+++.... ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++........  
T Consensus        82 -~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (286)
T cd07832          82 -PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--  154 (286)
T ss_pred             -CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--
Confidence             999999986543 45999999999999999999999   89999999999999999999999999999986644321  


Q ss_pred             ccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc--------ccc-
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL--------AEL-  336 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~-  336 (458)
                       .......|+..|+|||.+.+. .++.++||||||+++|||++|..+|....+...+... .......        .++ 
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV-FRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH-HHHcCCCChHHHhhccCcc
Confidence             112345689999999988654 4689999999999999999997777544433222221 1110000        000 


Q ss_pred             -----cCCcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          337 -----VDPRIKD----SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       337 -----~d~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                           ..+....    ....+....+.+++.+||+.+|++||+++++++|.|.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence                 0000000    0001123678999999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.3e-39  Score=304.40  Aligned_cols=244  Identities=30%  Similarity=0.496  Sum_probs=197.1

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.+.||+|+||.||+|.. ++..||+|.+....  ....+.+|+.++++++|+|++++++++... ..++||||+.++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~   83 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG   83 (254)
T ss_pred             ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence            45678899999999999975 67889999886432  235788999999999999999999998664 579999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++.......+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......      
T Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------  154 (254)
T cd05083          84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------  154 (254)
T ss_pred             CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC------
Confidence            9999998665556899999999999999999999   8999999999999999999999999999987543221      


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                       .....+..|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+...... ....      +...    ..
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~-~~~~------~~~~----~~  221 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVE-KGYR------MEPP----EG  221 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-HHHHHHHHh-CCCC------CCCC----Cc
Confidence             12234578999999988899999999999999999998 888886433 222222211 1100      1111    12


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .+..+.+++.+||+.+|++||+++++++.|.
T Consensus       222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         222 CPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            2356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.3e-39  Score=304.20  Aligned_cols=251  Identities=26%  Similarity=0.425  Sum_probs=195.9

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc-----hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMY  183 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  183 (458)
                      ..+.||+|+||.||+|... ++..||+|++....     ......+.+|+.++++++|+||+++++++.+.  ...++++
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence            4568999999999999764 58999999875321     22335688999999999999999999988753  5678999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++++|.+++...+  .+++...+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        86 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          86 EYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            9999999999997543  4889999999999999999999   8999999999999999999999999999987553211


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      .. ........++..|+|||.+.+..++.++|||||||++|||++|+.||..............       ....+.+. 
T Consensus       161 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~-  231 (266)
T cd06651         161 MS-GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-------QPTNPQLP-  231 (266)
T ss_pred             cc-CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-------CCCCCCCc-
Confidence            10 0111234588999999999988899999999999999999999999975433322221110       00112222 


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                         ......+.+++ .||..+|++||+++|+++|.+.
T Consensus       232 ---~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~  264 (266)
T cd06651         232 ---SHISEHARDFL-GCIFVEARHRPSAEELLRHPFA  264 (266)
T ss_pred             ---hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence               12224466676 6888999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.2e-39  Score=307.36  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=195.8

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeee-----ccCceeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCI-----EKRERFLMY  183 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~lv~  183 (458)
                      .+.+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.++.++ +|+||+++++++.     .++..++||
T Consensus        21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~   99 (286)
T cd06638          21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL   99 (286)
T ss_pred             eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence            34568999999999999775 57899999876432 2235688999999999 6999999999884     345689999


Q ss_pred             eecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          184 EYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       184 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||+++++|.+++...  ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~  176 (286)
T cd06638         100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  176 (286)
T ss_pred             eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence            999999999987531  2345889999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCcccccccccccCCCcccccccccc-----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      ...    ......|+..|+|||.+..     ..++.++|||||||++|||++|+.|+............   ........
T Consensus       177 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~  249 (286)
T cd06638         177 TRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI---PRNPPPTL  249 (286)
T ss_pred             CCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc---cccCCCcc
Confidence            221    1223468999999998753     45788999999999999999999999765433222111   00011111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .++.       .....+.+++.+||+.+|++||++.|++++++
T Consensus       250 ~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         250 HQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             cCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            1111       11246889999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5e-39  Score=340.31  Aligned_cols=258  Identities=24%  Similarity=0.315  Sum_probs=197.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.++||+|+||.||+|... +|+.||+|++...   .....+.|.+|++++++++||||+++++++.+++..++||||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY   83 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY   83 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence            345678999999999999875 5899999998642   223345799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 012715          186 MANGSLKDHLHSP---------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA  256 (458)
Q Consensus       186 ~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla  256 (458)
                      ++||+|.+++...         ....+++..+++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999998631         1134667888999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCcc------------c--ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHH
Q 012715          257 HASKDGSIC------------F--EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES  322 (458)
Q Consensus       257 ~~~~~~~~~------------~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~  322 (458)
                      +........            .  ........||+.|||||.+.+..++.++|||||||++|||+||+.||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            865211000            0  00112356999999999999999999999999999999999999999653221111


Q ss_pred             HHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhhh
Q 012715          323 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS-IKQVLRILYE  380 (458)
Q Consensus       323 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~l~~  380 (458)
                      ....         ..++... ....+.+..+.+++.+|++.||++||+ ++++++.|..
T Consensus       241 ~~~~---------i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        241 YRDV---------ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hhhh---------ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1100         0011000 000122356889999999999999965 6666665543

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.6e-39  Score=304.97  Aligned_cols=256  Identities=26%  Similarity=0.406  Sum_probs=201.3

Q ss_pred             ccceeeeecceEEEEEEE-cCCCEEEEEEecccc------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKIS------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      ..+.||+|+||.||+|.. .++..||+|.+....      ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            346899999999999976 468999999886322      1234678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGS  263 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~  263 (458)
                      |+++++|.+++...  .++++..+..++.|++.||+|||   +.+++|+||+|+||+++.++ .+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          84 WMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             ccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            99999999999753  35889999999999999999999   89999999999999998765 69999999987664432


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++|..||............ ....   .....+    
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---~~~~~~----  230 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKIA---SATTAP----  230 (268)
T ss_pred             ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-HHHh---ccCCCC----
Confidence            11111223346889999999998888999999999999999999999998643321111111 0000   000111    


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..+......+.+++.+||..+|.+||++.+++++.+.
T Consensus       231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~  267 (268)
T cd06630         231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF  267 (268)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence            1222333568899999999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2e-38  Score=303.11  Aligned_cols=255  Identities=26%  Similarity=0.405  Sum_probs=205.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++.+++|+||+++++++.+++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            345568999999999999764 68899999875432 2334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +++|.+++..   ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++........   
T Consensus        86 ~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~---  156 (277)
T cd06641          86 GGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---  156 (277)
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh---
Confidence            9999999864   24899999999999999999999   89999999999999999999999999999876543221   


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                       ......++..|+|||.+.+..++.++|||||||++|||++|..|+...... ........  ..     .+.+..    
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~--~~-----~~~~~~----  223 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-KVLFLIPK--NN-----PPTLEG----  223 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHHHHHhc--CC-----CCCCCc----
Confidence             122345788999999998888999999999999999999999998643321 11111110  00     111111    


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                      .....+.+++.+||+.+|.+||++.+++++.+......+
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence            223568899999999999999999999999877554433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.2e-39  Score=304.70  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=199.8

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc----------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS----------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      ..+.||.|+||.||+|... +|+.||+|.+....          ....+.+.+|+++++.++|+|++++++++...+..+
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (272)
T cd06629           5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS   84 (272)
T ss_pred             ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence            3468999999999999764 68999999875311          111246788999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++++|.+++...  ..+++..+..++.|++.||.|||   +++++||||+|+||+++.++.++|+|||+++...
T Consensus        85 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          85 IFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             EEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            999999999999999765  35899999999999999999999   8999999999999999999999999999997653


Q ss_pred             CCCcccccccccccCCCccccccccccCC--CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                      ....  ........|+..|+|||.+....  ++.++||||||+++|||++|..||..............   ....    
T Consensus       160 ~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~----  230 (272)
T cd06629         160 DIYD--NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---KRSA----  230 (272)
T ss_pred             cccc--ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---cccC----
Confidence            3211  01123346889999999987654  88999999999999999999999965444322221110   0111    


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      +.+...........+.+++..||..+|.+||++.++++|.|
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (272)
T cd06629         231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF  271 (272)
T ss_pred             CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence            11111111123367889999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-39  Score=307.93  Aligned_cols=262  Identities=24%  Similarity=0.319  Sum_probs=197.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|++|.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++.+++..++||||+.
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD   86 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence            345678999999999999876 68999999986432 2223457789999999999999999999999999999999997


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      + +|.+++..... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.......   
T Consensus        87 ~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---  158 (291)
T cd07844          87 T-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK---  158 (291)
T ss_pred             C-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc---
Confidence            5 99999875433 5899999999999999999999   89999999999999999999999999999875432211   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc-----ccc-----
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL-----AEL-----  336 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~-----  336 (458)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......+............     ...     
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1122346889999998865 5688999999999999999999999965443222222111100000     000     


Q ss_pred             -cC--------CcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          337 -VD--------PRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       337 -~d--------~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ..        ..+.... .......+.+++.+|++.+|++||++.+++++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence             00        0000000 00011467899999999999999999999988753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-38  Score=302.02  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=197.3

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc-----chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLM  182 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  182 (458)
                      ...+.||+|+||.||+|... +|..||+|.+...     .......+.+|++++++++|+||+++++++.+.  ...++|
T Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (265)
T cd06652           5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF   84 (265)
T ss_pred             eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence            34678999999999999875 5899999987521     122345788999999999999999999988764  467899


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+++++|.+++....  .+++...++++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          85 MEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            99999999999997543  4788899999999999999999   899999999999999999999999999998755322


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      .... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..............  .     ...+   
T Consensus       160 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~-----~~~~---  228 (265)
T cd06652         160 CLSG-TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--Q-----PTNP---  228 (265)
T ss_pred             cccc-cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc--C-----CCCC---
Confidence            1110 112234588999999999888899999999999999999999999975433322211110  0     0111   


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ..+......+.+++.+|+. +|++||++++++++.|.
T Consensus       229 -~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         229 -VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             -CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence             1222333567889999984 99999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.9e-39  Score=306.72  Aligned_cols=251  Identities=24%  Similarity=0.424  Sum_probs=198.6

Q ss_pred             ccceeeeecceEEEEEEEc------CCCEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      ..+.||+|+||.||+|+.+      +...|++|.+...... ....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            3467999999999999864      2467999988654433 45679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          185 YMANGSLKDHLHSPGR-------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      |+++|+|.+++.....       ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++|||++.
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccccccc
Confidence            9999999999975431       25899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      .......   .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........  ....  
T Consensus       166 ~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~~~--~~~~--  237 (275)
T cd05046         166 DVYNSEY---YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRLQA--GKLE--  237 (275)
T ss_pred             ccCcccc---cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHHHc--CCcC--
Confidence            5432211   11223356778999999988889999999999999999999 67777543322 22221111  1110  


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                        .....    ..+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       238 --~~~~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         238 --LPVPE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --CCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence              00111    22357899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-38  Score=301.79  Aligned_cols=255  Identities=29%  Similarity=0.453  Sum_probs=203.3

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccch--hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      ...+.||+|+||.||+|... ++..||+|.+.....  .....+.+|+++++.++|+||+++++++.+.+..++|+||++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS   82 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence            44578999999999999865 688999999865433  356789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +++|.+++...  ..+++..+..++.+++.||+|||   +.+++|+||+|+||++++++.+||+|||++...........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          83 GGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            99999999764  24788999999999999999999   89999999999999999999999999999987654332211


Q ss_pred             cccccccCCCccccccccccCC---CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      .......++..|+|||.+.+..   ++.++||||||+++|||++|+.||...............  .     ..+.+...
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~-----~~~~~~~~  230 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--G-----HKPPIPDS  230 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--C-----CCCCCCcc
Confidence            1122356788999999998766   889999999999999999999999754332222211111  1     11111111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .  .....+.+++.+||+.+|.+||++.+++.+.|
T Consensus       231 ~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         231 L--QLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             c--ccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            1  11356789999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-39  Score=310.62  Aligned_cols=260  Identities=24%  Similarity=0.387  Sum_probs=201.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +++.+.||+|+||.||+|..+ +++.||+|++....  ....+.+.+|+++++.++|+||+++++++.+++..++||||+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV   82 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence            345678999999999999886 58999999875432  223456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++++|..+....  ..+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++........  
T Consensus        83 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--  155 (286)
T cd07846          83 DHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  155 (286)
T ss_pred             CccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--
Confidence            999998887653  24899999999999999999999   88999999999999999999999999999876543321  


Q ss_pred             ccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc-----------
Q 012715          267 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-----------  334 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------  334 (458)
                        ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ...+.           
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  232 (286)
T cd07846         156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC-LGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH-hCCCchhhHHHhccch
Confidence              1233457899999998875 45788999999999999999999888654433222221110 00000           


Q ss_pred             ---cccCCcCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          335 ---ELVDPRIKDSF-----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       335 ---~~~d~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                         ....+......     .......+.+++.+||+.+|++||++.+++++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence               00011111000     0112356899999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=303.39  Aligned_cols=253  Identities=27%  Similarity=0.435  Sum_probs=211.6

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      ...+||+|+||.||++.++ .|..+|||.+..  +...+++..|+.+++++..+++|+++|.+.....+|+|||||..|+
T Consensus        37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            3458999999999999765 699999998753  3446789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      +.+.++.+ +++|++.++..++...++||+|||   ...-||||||+.|||++.+|.+||+|||+|..+.+..    ...
T Consensus       115 iSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM----AKR  186 (502)
T KOG0574|consen  115 ISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM----AKR  186 (502)
T ss_pred             HHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH----Hhh
Confidence            99999764 357999999999999999999999   7778999999999999999999999999997665432    134


Q ss_pred             ccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 012715          271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL  350 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  350 (458)
                      ..+.||+.|||||++..-.|..++||||||++..||.-|++|+.+-......+   +.....     .|.++  .+....
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---MIPT~P-----PPTF~--KPE~WS  256 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---MIPTKP-----PPTFK--KPEEWS  256 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---eccCCC-----CCCCC--ChHhhh
Confidence            56789999999999999999999999999999999999999998654432211   111111     11121  234556


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          351 RTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       351 ~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      ..+.++++.||..+|++|-|+-++++|.+..+.+
T Consensus       257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            7899999999999999999999999998776544

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1e-38  Score=305.82  Aligned_cols=251  Identities=26%  Similarity=0.446  Sum_probs=197.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeec------cCceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE------KRERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~l  181 (458)
                      +.+.+.||.|+||.||+|... +++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..      .+..++
T Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   96 (282)
T cd06636          18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL   96 (282)
T ss_pred             hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence            344568999999999999874 68899999875433 2345688999999999 69999999999863      457899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      +|||+.+|+|.+++.......+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.....
T Consensus        97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~  173 (282)
T cd06636          97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence            999999999999997655556888999999999999999999   89999999999999999999999999999875432


Q ss_pred             CCcccccccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      ..    .......|+..|+|||.+.     ...++.++|||||||++|||++|+.||.+..........   ...     
T Consensus       174 ~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~---~~~-----  241 (282)
T cd06636         174 TV----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRN-----  241 (282)
T ss_pred             cc----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH---hhC-----
Confidence            11    1123356889999999876     346788999999999999999999999654432222111   000     


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ..+.+.   .......+.+++.+||+.||.+||++.|++++.|
T Consensus       242 ~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         242 PPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             CCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            011111   1122356899999999999999999999998865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.9e-39  Score=306.84  Aligned_cols=266  Identities=27%  Similarity=0.439  Sum_probs=201.7

Q ss_pred             hcccceeeeecceEEEEEEEc-----CCCEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeec--cCceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-----DGSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIE--KRERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  181 (458)
                      +.+.+.||+|+||.||+|.+.     ++..||||.+...... ....|.+|+++++.++|+||+++++++..  ....++
T Consensus         6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05038           6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL   85 (284)
T ss_pred             chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence            345578999999999999864     3689999998754432 45689999999999999999999999887  567899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++++|.+++..... .+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        86 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          86 IMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             EEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            9999999999999976432 4899999999999999999999   89999999999999999999999999999987653


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHH-HHHH--HhhccccccccC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES-AQVC--MASESRLAELVD  338 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~-~~~~--~~~~~~~~~~~d  338 (458)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ....  ......+.+.+.
T Consensus       162 ~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYY-YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcce-eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            22111 1112234566799999998889999999999999999999999887543211100 0000  000000000011


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .......+..++..+.+++.+||+.+|++||++.++++.|..
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            111111112233679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-38  Score=299.64  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=200.5

Q ss_pred             ccceeeeecceEEEEEEEcC-----CCEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.||.|+||.||++...+     +..||+|.+...... ....+.+|++++..++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45689999999999998753     388999998654332 456899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            99999999997644333899999999999999999999   999999999999999999999999999999876544221


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      .   .....++..|+|||.+.+..++.++||||||++++||++ |..|+.. .............. .      ....  
T Consensus       160 ~---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~-~------~~~~--  226 (258)
T smart00219      160 K---KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGY-R------LPKP--  226 (258)
T ss_pred             c---cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCC-C------CCCC--
Confidence            1   112337789999999988889999999999999999998 6666653 33323322221111 0      0111  


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                        ......+.+++.+|+..+|++|||+.++++.|
T Consensus       227 --~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 --ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              11335689999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.3e-39  Score=304.10  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=204.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.||.|+||.||++... +++.+|+|.+.... ......+.+|++++++++|+||+++++++...+..++++||+++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            34568999999999999876 58999999886543 34456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      ++|.+++.... ..++...+..++.|++.||+|||   + .+++|+||||+||++++++.++|+|||++.......    
T Consensus        84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----  155 (265)
T cd06605          84 GSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----  155 (265)
T ss_pred             CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH----
Confidence            99999997643 46899999999999999999999   7 899999999999999999999999999987553221    


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc----chHHHHHHHHhhccccccccCCcCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK----NLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....    ...+........       ..+.+..
T Consensus       156 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~  226 (265)
T cd06605         156 --AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-------PPPRLPS  226 (265)
T ss_pred             --hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC-------CCCCCCh
Confidence              112568889999999999999999999999999999999999986542    222222221111       0111111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .   .....+.+++..||..+|.+||++.+++.+.|+.
T Consensus       227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             h---hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence            1   1335688999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.9e-38  Score=303.39  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=203.7

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      +.||+|++|.||++... ++..+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            58999999999999864 68899999886554455567889999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccc
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      +++..   ..+++..+..++.|++.||+|||   +++++||||+|+||+++.++.++|+|||++.......    .....
T Consensus       105 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~  174 (285)
T cd06648         105 DIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV----PRRKS  174 (285)
T ss_pred             HHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC----ccccc
Confidence            99976   24899999999999999999999   8999999999999999999999999999887543321    11223


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT  352 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  352 (458)
                      ..|+..|+|||.+.+..++.++|||||||++|||++|+.||...... .........  .     .+....  .......
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~~~~~~~~--~-----~~~~~~--~~~~~~~  244 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDN--L-----PPKLKN--LHKVSPR  244 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHhc--C-----CCCCcc--cccCCHH
Confidence            45889999999998888999999999999999999999998654432 222211111  0     111111  0112256


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          353 IVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       353 l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      +.+++.+||+.+|++||++.+++++.+.....
T Consensus       245 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         245 LRSFLDRMLVRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             HHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence            89999999999999999999999988765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.2e-39  Score=307.87  Aligned_cols=247  Identities=24%  Similarity=0.384  Sum_probs=203.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||++... +++.||+|.+....   ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            345678999999999999875 58999999886422   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++...  ..+++..+..++.|++.||+|||   +.+++|+||+|+|||++.++.+||+|||++......   
T Consensus        83 ~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---  154 (290)
T cd05580          83 VPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---  154 (290)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence            9999999999764  35899999999999999999999   899999999999999999999999999999865443   


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                          .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ..........        ..+....
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~--------~~~~~~~  221 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEGK--------VRFPSFF  221 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC--------ccCCccC
Confidence                22346889999999998888999999999999999999999999754422 2222211111        1111122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES  381 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~  381 (458)
                          ...+.+++.+||..+|.+|+     +++++++|.|+.
T Consensus       222 ----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  258 (290)
T cd05580         222 ----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA  258 (290)
T ss_pred             ----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence                25688999999999999999     899999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-38  Score=307.18  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=201.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +...+.||+|+||+||+|... +|+.||+|.+....   ......+.+|+++++.++|+||++++++|.+.+..++||||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            344568999999999999875 68999999885322   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +. |+|.+++.... ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++......   
T Consensus        97 ~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          97 CL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             hC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            97 57877775432 35899999999999999999999   899999999999999999999999999998754322   


Q ss_pred             cccccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                           ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+............. ..  .     .+.+.
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~-~~--~-----~~~~~  235 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QN--D-----SPTLS  235 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-cC--C-----CCCCC
Confidence                 2345788999999874   4568899999999999999999999987544332221111 00  0     01111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                         .......+.+++.+||+.+|++||++.+++.+.|......
T Consensus       236 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         236 ---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             ---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence               1123457899999999999999999999999998876543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-39  Score=306.71  Aligned_cols=259  Identities=24%  Similarity=0.313  Sum_probs=199.8

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ..+.||.|++|.||+|... +|..||+|++....  ......+.+|+++++.++|+|++++++++.+.+..+++|||++ 
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence            4568999999999999875 79999999886432  2233568899999999999999999999999999999999995 


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.......+++..++.++.|++.||+|||   +++++||||+|+||+++.++.++|+|||+++.......    
T Consensus        82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~----  154 (283)
T cd07835          82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR----  154 (283)
T ss_pred             cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence            69999997655456899999999999999999999   89999999999999999999999999999975432211    


Q ss_pred             ccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc----------cccc
Q 012715          269 VNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL----------AELV  337 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~  337 (458)
                      ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+..+............          .+..
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            12233568899999988654 578899999999999999999999976554433222211100000          0000


Q ss_pred             -------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          338 -------DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       338 -------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                             ..... .........+.+++.+||+.+|++||++++++++.|
T Consensus       235 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  282 (283)
T cd07835         235 PTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY  282 (283)
T ss_pred             hhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence                   00000 000111256889999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-38  Score=306.30  Aligned_cols=255  Identities=25%  Similarity=0.353  Sum_probs=205.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++...+..|+|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  100 (293)
T cd06647          21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG  100 (293)
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence            445678999999999999764 6889999998654444556789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.+.   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........    
T Consensus       101 ~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~----  170 (293)
T cd06647         101 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----  170 (293)
T ss_pred             CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc----
Confidence            9999999753   4789999999999999999999   99999999999999999999999999999875543221    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......|+..|+|||.+....++.++||||||+++|||++|+.||............ .. .. .     +..  .....
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-~~-~~-~-----~~~--~~~~~  240 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-AT-NG-T-----PEL--QNPEK  240 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-hc-CC-C-----CCC--CCccc
Confidence            122346888999999998888999999999999999999999999654332211111 00 00 0     000  01112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      ....+.+++.+||..+|++||++.+++.|.|+....
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            235688999999999999999999999998876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-40  Score=327.84  Aligned_cols=249  Identities=23%  Similarity=0.356  Sum_probs=202.5

Q ss_pred             cceeeeecceEEEEEEEc-C----CCEEEEEEecc-cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          113 STIIGQGGFGTVYKAQFS-D----GSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .++||+|+||+||+|.|- .    ..+||+|.+.. ...+...++++|+-+|.++.|||+++|+|+|.... ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            458999999999999762 2    35799998864 34555678999999999999999999999998776 88999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +.|+|.+|++.+. ..+.....+.|..|||+||.|||   .+.++||||.++||||..-..+||.|||+++........+
T Consensus       780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            9999999998754 35888999999999999999999   9999999999999999999999999999999876655333


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      .  .....-.+.|||-|.+....|+.++|||||||++||++| |..|+++ ....+.-. .+....+          -..
T Consensus       856 ~--~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~d-lle~geR----------Lsq  921 (1177)
T KOG1025|consen  856 S--APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPD-LLEKGER----------LSQ  921 (1177)
T ss_pred             c--ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhH-HHhcccc----------CCC
Confidence            2  233345678999999999999999999999999999998 7777753 33322222 1222222          222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +.-+...++.++.+||..|+..||+++++.....+
T Consensus       922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            33344568899999999999999999999887654

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-38  Score=306.23  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=196.6

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeecc-----Cceeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEK-----RERFLMYE  184 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~e  184 (458)
                      +.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|+|++++++++...     +..++|||
T Consensus        26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e  104 (291)
T cd06639          26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE  104 (291)
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence            4568999999999999874 68899999886432 2245678899999999 799999999998754     35899999


Q ss_pred             ecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          185 YMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       185 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |+++|+|.++++..  ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus       105 y~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~  181 (291)
T cd06639         105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST  181 (291)
T ss_pred             ECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence            99999999988631  2345899999999999999999999   899999999999999999999999999998765432


Q ss_pred             CcccccccccccCCCccccccccccC-----CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQ-----ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ..    ......|+..|+|||.+...     .++.++|||||||++|||++|+.||.............   ......+.
T Consensus       182 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~  254 (291)
T cd06639         182 RL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP---RNPPPTLL  254 (291)
T ss_pred             cc----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh---cCCCCCCC
Confidence            21    11234588999999987643     36889999999999999999999997543322222111   11111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +       ..+....+.+++.+||+.+|++||++.++++|.|.
T Consensus       255 ~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  290 (291)
T cd06639         255 H-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI  290 (291)
T ss_pred             c-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence            1       11223568999999999999999999999998764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-38  Score=303.58  Aligned_cols=258  Identities=24%  Similarity=0.331  Sum_probs=201.8

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~  186 (458)
                      ++.+.||.|++|.||+|... +++.+|+|.+.... ......+.+|++++++++|+||++++++|.+.  +..++||||+
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   83 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC   83 (287)
T ss_pred             EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence            34578999999999999875 58899999886432 23456799999999999999999999998654  4689999999


Q ss_pred             CCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          187 ANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       187 ~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      ++++|.+++..  .....+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.++|+|||++....... 
T Consensus        84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  159 (287)
T cd06621          84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-  159 (287)
T ss_pred             CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence            99999988753  22345889999999999999999999   8999999999999999999999999999987543221 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc----chHHHHHHHHhhccccccccCCc
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK----NLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                           .....++..|+|||.+.+..++.++|||||||++|||++|+.||....    ...+.......  .....+.+. 
T Consensus       160 -----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-  231 (287)
T cd06621         160 -----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--MPNPELKDE-  231 (287)
T ss_pred             -----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc--CCchhhccC-
Confidence                 123457889999999999999999999999999999999999997542    11222221111  011111110 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..  ........+.+++.+||+.+|.+|||+.|++++.|...
T Consensus       232 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~  271 (287)
T cd06621         232 PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA  271 (287)
T ss_pred             CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence            00  01123467899999999999999999999999988743

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.3e-38  Score=303.71  Aligned_cols=261  Identities=23%  Similarity=0.282  Sum_probs=196.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||.||+|... +|..||+|.+.... ......+.+|+++++.++|+||+++.+++.+++..++||||+.
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH   86 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence            344678999999999999765 68899999986432 2223467899999999999999999999999999999999995


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                       ++|.+++.... ..+++..+..++.|++.||+|||   ..+++|+||||+|||++.++.+||+|||+++.......   
T Consensus        87 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---  158 (291)
T cd07870          87 -TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ---  158 (291)
T ss_pred             -CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC---
Confidence             68877775432 34788889999999999999999   88999999999999999999999999999875432211   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-----------ccc-
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-----------RLA-  334 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-----------~~~-  334 (458)
                       ......++..|+|||.+.+ ..++.++|||||||++|||++|..||.......+.........+           .+. 
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence             1223457889999999875 45788999999999999999999999754433222221111000           000 


Q ss_pred             ---cccCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          335 ---ELVDPRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       335 ---~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                         +...........     ......+.+++.+|+..||++|||++|++.|.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~  290 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY  290 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence               000000000000     011356789999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=287.07  Aligned_cols=250  Identities=26%  Similarity=0.435  Sum_probs=204.0

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      ...||.|+.|.|+++++. .|...|||.+.+.. ....+.+++.++++.+.+ +|+||+.+|||..+...++.||.|. .
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence            346999999999999886 58999999987543 344567888898888776 8999999999999999999999884 3


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      .++.+|..- ..++++.-+-++...+..||.||.+  .++|+|||+||+|||+|+.|++|+||||++-.+-+..     .
T Consensus       176 C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-----A  247 (391)
T KOG0983|consen  176 CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-----A  247 (391)
T ss_pred             HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc-----c
Confidence            566666543 3468888888999999999999986  7799999999999999999999999999997665443     4


Q ss_pred             cccccCCCcccccccccc---CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          270 NTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      .+...|.+.|||||.+.-   .+|+.++||||||+.|+||.||+.||.......+....++..+.   ..+++...  |+
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP---P~L~~~~g--FS  322 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP---PLLPGHMG--FS  322 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC---CCCCcccC--cC
Confidence            567789999999999864   47889999999999999999999999876666666555554322   22222221  34


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                          ..+.+++..||+.|+.+||.+.++++|.+-
T Consensus       323 ----p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi  352 (391)
T KOG0983|consen  323 ----PDFQSFVKDCLTKDHRKRPKYNKLLEHPFI  352 (391)
T ss_pred             ----HHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence                458999999999999999999999998754

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-38  Score=303.48  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=199.2

Q ss_pred             eeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      ||+|+||+||+|... +|+.||+|.+....   ......+.+|+++++.++|+||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999765 68999999885422   22344577899999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT  271 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  271 (458)
                      .+++.......+++..+..++.|++.||.|||   ..+++||||+|+||++++++.+||+|||++.......     ...
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~~  152 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----KIK  152 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----ccc
Confidence            99997655556999999999999999999999   8999999999999999999999999999987654321     122


Q ss_pred             cccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       272 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|+.||................   ..  ........+    ..
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~----~~  223 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT---LE--MAVEYPDKF----SP  223 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc---cc--ccccCCccC----CH
Confidence            3457889999999988889999999999999999999999996543311111110000   00  011111122    35


Q ss_pred             HHHHHHHHccccCCCCCC-----CHHHHHHHhhhC
Q 012715          352 TIVTIVRWCTQREGQARP-----SIKQVLRILYES  381 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~  381 (458)
                      .+.+++.+||+.+|.+||     ++.++++|.|..
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~  258 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK  258 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence            688999999999999999     888899988774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.2e-38  Score=305.30  Aligned_cols=261  Identities=21%  Similarity=0.330  Sum_probs=198.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  184 (458)
                      +.+.+.||.|+||.||+|... +++.+|+|.++...  ......+.+|++++.+++|+||+++++++...  +..++|||
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            344568999999999999876 58899999886432  22234577899999999999999999998877  89999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+. ++|.+++..... .+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++........
T Consensus        87 ~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          87 YVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             hcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            997 499998875432 5899999999999999999999   89999999999999999999999999999986654321


Q ss_pred             ccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc-------------
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-------------  330 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------------  330 (458)
                          ......++..|+|||.+.+. .++.++||||||+++|||++|..||.................             
T Consensus       162 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         162 ----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             ----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence                12334578899999988754 468999999999999999999999875443322211110000             


Q ss_pred             -----cccccccCCcCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          331 -----SRLAELVDPRIKDSFDME-QLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       331 -----~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                           ..........+...+... ....+.+++..||+.+|++||++.|++++.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~  292 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY  292 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence                 000000001111111111 2356889999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.9e-38  Score=302.61  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=197.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHH-HHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIEL-LARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|+||.||+|... +|+.||+|++.... ......+..|+.+ ++.++|+||+++++++..++..++||||++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD   83 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence            45678999999999999876 68999999886432 2234456667775 555689999999999999999999999996


Q ss_pred             CCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                       |+|.+++...  ....+++..++.++.|++.||+|||   ++ +++||||||+||+++.++.+||+|||++....... 
T Consensus        84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence             6888887542  2346899999999999999999999   76 99999999999999999999999999987654321 


Q ss_pred             ccccccccccCCCcccccccccc----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVT----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                          ......|+..|+|||.+.+    ..++.++|+|||||++|||++|+.||.......+........       ..+.
T Consensus       159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~  227 (283)
T cd06617         159 ----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-------PSPQ  227 (283)
T ss_pred             ----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-------CCCC
Confidence                1223457889999998864    456889999999999999999999996543322222211110       0111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      +..   ......+.+++.+||..+|.+||++.+++++.|.....
T Consensus       228 ~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         228 LPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             CCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            110   11235688999999999999999999999998776543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.9e-38  Score=309.55  Aligned_cols=264  Identities=21%  Similarity=0.256  Sum_probs=198.6

Q ss_pred             eeeee--cceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          115 IIGQG--GFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       115 ~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      .||+|  +||+||++... +|+.||+|.+...  .....+.+.+|+.+++.++|+||+++++++..++..++||||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  99999999875 7899999998632  2333467889999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc--
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE--  267 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~--  267 (458)
                      +|.+++.......+++..+..++.|++.||+|||   +.+++||||||+|||++.++.++++|||.+...........  
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999998655556899999999999999999999   89999999999999999999999999986543221110000  


Q ss_pred             -cccccccCCCccccccccccC--CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-------------
Q 012715          268 -PVNTDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-------------  331 (458)
Q Consensus       268 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------  331 (458)
                       .......++..|+|||.+.+.  .++.++|||||||++|||++|+.||..................             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence             001112356779999998763  5789999999999999999999999754332222111100000             


Q ss_pred             -------cc--------------ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          332 -------RL--------------AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       332 -------~~--------------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                             ..              ..+.+..+...........+.+++.+||+.||++|||+.|++++.|..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~  312 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK  312 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence                   00              000111111112233456789999999999999999999999998763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.2e-38  Score=299.34  Aligned_cols=249  Identities=25%  Similarity=0.443  Sum_probs=197.8

Q ss_pred             ccceeeeecceEEEEEEEcC--CCEEEEEEeccc----------chhhHhHHHHHHHHHHh-cCCCCeeeeeeeeeccCc
Q 012715          112 FSTIIGQGGFGTVYKAQFSD--GSLIAVKRMDKI----------SEQVEGDFCREIELLAR-LHHRHLVALRGFCIEKRE  178 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~  178 (458)
                      +.+.||+|+||.||+|.+..  +..+|+|.+...          ......++.+|+.++.+ ++|+||+++++++.+++.
T Consensus         4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   83 (269)
T cd08528           4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR   83 (269)
T ss_pred             hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence            45689999999999998764  688999987421          22334567889998876 699999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeeccc
Q 012715          179 RFLMYEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGL  255 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGl  255 (458)
                      .++||||+++++|.+++..  .....+++..++.++.|++.||.|||   . .+++|+||+|+||+++.++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999998743  12345899999999999999999999   5 6899999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc
Q 012715          256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE  335 (458)
Q Consensus       256 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  335 (458)
                      +.......     ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .........  ..  
T Consensus       161 ~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~--~~--  230 (269)
T cd08528         161 AKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATKIVEA--VY--  230 (269)
T ss_pred             eeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHHHhhc--cC--
Confidence            97654432     123456889999999999888999999999999999999999998654322 221111111  10  


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                        .+....    .....+.+++.+||+.||++||++.|+.+++.
T Consensus       231 --~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 --EPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --CcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence              111111    12256889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-38  Score=305.75  Aligned_cols=255  Identities=26%  Similarity=0.390  Sum_probs=197.1

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      .+.||+|+||.||++... +|..||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||+.. 
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence            457999999999999875 58999999886432 234557889999999996 99999999999999999999999864 


Q ss_pred             CHHHHh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          190 SLKDHL---HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       190 sL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +|.++.   .......+++..+..++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||+++......   
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---  162 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---  162 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC---
Confidence            655543   22233468999999999999999999992  3599999999999999999999999999997554322   


Q ss_pred             ccccccccCCCccccccccccC---CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                        ......|+..|+|||.+.+.   .++.++|||||||++|||++|+.||.......+........       ..+.+..
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~  233 (288)
T cd06616         163 --AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-------DPPILSN  233 (288)
T ss_pred             --ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-------CCCcCCC
Confidence              12234588999999998766   68999999999999999999999996544222221111110       0111211


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .........+.+++.+||+.+|++||++++++++.+...
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  272 (288)
T cd06616         234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD  272 (288)
T ss_pred             cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence            111223456899999999999999999999999987743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-38  Score=302.50  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=200.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCC----EEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+.||+|+||.||+|.+. +|.    .+|+|.+.... ......+.+|+.++++++|+||++++++|.. ...++||
T Consensus         9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   87 (279)
T cd05057           9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT   87 (279)
T ss_pred             cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence            455678999999999999864 233    58999876443 3345678999999999999999999999987 7889999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++..... .+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++......
T Consensus        88 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          88 QLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             ecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            99999999999976433 4899999999999999999999   8999999999999999999999999999998664332


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ...  ......++..|+|||.+....++.++||||||+++||+++ |+.||... ...+........ ...   -.+   
T Consensus       164 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~-~~~---~~~---  233 (279)
T cd05057         164 KEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKG-ERL---PQP---  233 (279)
T ss_pred             cce--ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCC-CCC---CCC---
Confidence            111  1112234678999999988899999999999999999998 99988643 222333222211 100   001   


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .    .+...+.+++.+||..+|.+||++.++++.+...
T Consensus       234 ~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         234 P----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             C----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1    1224588999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.4e-38  Score=297.84  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=206.3

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccch-hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ++.+.||+|++|.||+|... ++..|++|++..... .....+.+|++.+.+++|+||+++++++...+..++||||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            45678999999999999876 489999999865433 4456799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      ++|.+++...  ..+++..++.++.|++.||+|||   + .+++|+||+|+||+++.++.++|+|||++........   
T Consensus        84 ~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~---  155 (264)
T cd06623          84 GSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD---  155 (264)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence            9999999764  45899999999999999999999   8 9999999999999999999999999999886543321   


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc--chHHHHHHHHhhccccccccCCcCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK--NLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....  ...+.......       ...+..... 
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-  226 (264)
T cd06623         156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-------GPPPSLPAE-  226 (264)
T ss_pred             -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-------CCCCCCCcc-
Confidence             1123457889999999998899999999999999999999999997654  32222222111       011111111 


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                        .....+.+++..||..+|++||++.+++++.|.
T Consensus       227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~  259 (264)
T cd06623         227 --EFSPEFRDFISACLQKDPKKRPSAAELLQHPFI  259 (264)
T ss_pred             --cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence              033578999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=304.19  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=201.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +++.+.||+|+||.||+|... ++..||+|.+...  .......+.+|++++++++|+||+++++++.+++..++||||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            456678999999999999876 5889999988642  2333467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +++.|..++...  ..+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++........  
T Consensus        83 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~--  155 (288)
T cd07833          83 ERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA--  155 (288)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence            987777666543  34899999999999999999999   89999999999999999999999999999886554321  


Q ss_pred             ccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc----cc--cCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA----EL--VDP  339 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~--~d~  339 (458)
                       .......++..|+|||.+.+. .++.++||||||+++|||++|+.||............... .+.+.    ..  .++
T Consensus       156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (288)
T cd07833         156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC-LGPLPPSHQELFSSNP  233 (288)
T ss_pred             -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCCHHHhhhcccCc
Confidence             122335678899999999887 8899999999999999999999988654332221111100 00000    00  000


Q ss_pred             cCC--------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          340 RIK--------------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       340 ~~~--------------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ...              ..++......+.+++.+||..+|++||++++++++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  287 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY  287 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence            000              0011112467899999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.9e-38  Score=299.20  Aligned_cols=250  Identities=27%  Similarity=0.427  Sum_probs=201.6

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|+||.||+|... +|..+|+|.+...  .....+.+.+|+++++.++|+||+++++.+.+.+..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            45678999999999999876 5889999988542  22334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-cEEEeecccccccCCCCccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~  266 (458)
                      +++|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||++++++ .+||+|||.+........  
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--  157 (257)
T cd08225          83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--  157 (257)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence            999999997655556899999999999999999999   89999999999999999875 579999999876543321  


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ..+.......  .....     ...   
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~--~~~~~-----~~~---  224 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKICQ--GYFAP-----ISP---  224 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhc--ccCCC-----CCC---
Confidence              1123458899999999988889999999999999999999999986432 2222221111  11111     111   


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       .....+.+++.+||..+|++||++.+++++.|
T Consensus       225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~  256 (257)
T cd08225         225 -NFSRDLRSLISQLFKVSPRDRPSITSILKRPF  256 (257)
T ss_pred             -CCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence             12246889999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-38  Score=301.19  Aligned_cols=252  Identities=26%  Similarity=0.375  Sum_probs=205.7

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      +.+.||+|+||.||+|.+. ++..|++|.+..... ....+.+|+++++.++|+|++++++++...+..++|+||+++++
T Consensus        23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~  101 (286)
T cd06614          23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS  101 (286)
T ss_pred             HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence            3457999999999999886 688999999875443 45678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |.+++.... ..+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++........    ..
T Consensus       102 L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~  173 (286)
T cd06614         102 LTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----KR  173 (286)
T ss_pred             HHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh----hh
Confidence            999998654 36999999999999999999999   89999999999999999999999999999865433211    11


Q ss_pred             ccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 012715          271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL  350 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  350 (458)
                      ....++..|++||.+.+..++.++||||||+++|+|++|+.|+..............   .......+       .....
T Consensus       174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~-------~~~~~  243 (286)
T cd06614         174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT---KGIPPLKN-------PEKWS  243 (286)
T ss_pred             ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCCCCcc-------hhhCC
Confidence            234578899999999888899999999999999999999999875544322222111   11111111       11123


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          351 RTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       351 ~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..+.+++.+||+.+|.+||++.+++++.+...
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            56889999999999999999999999887654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-38  Score=300.25  Aligned_cols=246  Identities=26%  Similarity=0.368  Sum_probs=201.4

Q ss_pred             eeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      ||.|+||.||+|... ++..||+|.+....   ....+.+.+|+++++.++|+||+++++++.+++..++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999875 48999999886432   23446799999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT  271 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  271 (458)
                      .+++....  .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......     ...
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----~~~  150 (262)
T cd05572          81 WTILRDRG--LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTW  150 (262)
T ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----ccc
Confidence            99997643  4899999999999999999999   8999999999999999999999999999998665432     112


Q ss_pred             cccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc-hHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 012715          272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-LVESAQVCMASESRLAELVDPRIKDSFDMEQL  350 (458)
Q Consensus       272 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  350 (458)
                      ...++..|++||.+....++.++|+||||+++|||++|..||..... ............          ....++....
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~  220 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN----------GKLEFPNYID  220 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC----------CCCCCCcccC
Confidence            34578899999999888899999999999999999999999975542 222222211100          0111111223


Q ss_pred             HHHHHHHHHccccCCCCCCC-----HHHHHHHhhhC
Q 012715          351 RTIVTIVRWCTQREGQARPS-----IKQVLRILYES  381 (458)
Q Consensus       351 ~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  381 (458)
                      ..+.+++.+||+.+|++||+     ++|+++|.|+.
T Consensus       221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  256 (262)
T cd05572         221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN  256 (262)
T ss_pred             HHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence            57899999999999999999     99999998875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.1e-38  Score=293.23  Aligned_cols=249  Identities=29%  Similarity=0.481  Sum_probs=204.7

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      ..+.||+|++|.||++... ++..+++|++..........+.+|++++++++|+|++++++++...+..++++||+++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            4568999999999999886 688999999876554456789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |.+++.... ..+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.++|+|||++........     .
T Consensus        84 L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----~  154 (253)
T cd05122          84 LKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-----R  154 (253)
T ss_pred             HHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-----c
Confidence            999997643 45899999999999999999999   89999999999999999999999999999876654321     2


Q ss_pred             ccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 012715          271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL  350 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  350 (458)
                      ....++..|+|||.+.+..++.++||||||+++++|++|+.|+..............   ........+       ....
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~-------~~~~  224 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNP-------EKWS  224 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcc-------cccC
Confidence            345688899999999888899999999999999999999999875533222221111   111111111       1113


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          351 RTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       351 ~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ..+.+++.+||+.||++||++.+++++.|
T Consensus       225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         225 DEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            56899999999999999999999998754

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.7e-38  Score=304.26  Aligned_cols=257  Identities=21%  Similarity=0.288  Sum_probs=200.8

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.||+|+||.||++... .++.||+|.+....   ......+.+|+++++.++|+||+++++.+..++..++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            45678999999999999875 57899999886432   223456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc-
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC-  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-  265 (458)
                      ++++|.+++...+  .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++........ 
T Consensus        84 ~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          84 EGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            9999999997643  5899999999999999999999   899999999999999999999999999998742111000 


Q ss_pred             ----------cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc
Q 012715          266 ----------FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE  335 (458)
Q Consensus       266 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  335 (458)
                                .........++..|+|||.+.+..++.++|||||||++|||++|..||.+.. ..+.........     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-~~~~~~~~~~~~-----  232 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDD-----  232 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcc-----
Confidence                      0001122457889999999988889999999999999999999999996433 223222221111     


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHhhhCC
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYESS  382 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~l~~~~  382 (458)
                      ...+.....    ....+.+++.+||+.+|++||+   +.+++++.|...
T Consensus       233 ~~~~~~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         233 IEWPEGDEA----LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             cCCCCcccc----CCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            111111111    2245889999999999999998   677888776644

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=300.75  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=199.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccC------ceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKR------ERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~l  181 (458)
                      +.+.+.||+|+||.||+|... ++..+++|.+..... ....+.+|+++++++ +|+||+++++++.+..      ..++
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l   86 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL   86 (275)
T ss_pred             eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence            445678999999999999875 578999998865433 346789999999999 6999999999997654      4899


Q ss_pred             eeeecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          182 MYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      ||||+++++|.+++....  ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            999999999999986533  346899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCcccccccccccCCCcccccccccc-----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA  334 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  334 (458)
                      .....    ......|+..|+|||.+..     ..++.++|||||||++|||++|+.||.............   .... 
T Consensus       164 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~-  235 (275)
T cd06608         164 DSTLG----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP---RNPP-  235 (275)
T ss_pred             ccchh----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh---ccCC-
Confidence            43221    1233568899999998753     346789999999999999999999997543332222211   0001 


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       335 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                          +.+.  ........+.+++.+||..||++|||+.+++++.|
T Consensus       236 ----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         236 ----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             ----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence                1111  11223467889999999999999999999999765

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.9e-38  Score=297.36  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=202.1

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec--cCceeeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYEY  185 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  185 (458)
                      ++.+.||.|+||.||++... +|..||+|.+...  .....+.+.+|++++++++|+||+++++++..  +...+++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            45568999999999999764 6889999988632  33445678899999999999999999998764  3467999999


Q ss_pred             cCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          186 MANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYC--DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       186 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      +++++|.+++...  ....+++..++.++.|++.||+|||..+  ..+++|+||+|+||++++++.+||+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            9999999998642  2346899999999999999999999554  67899999999999999999999999999987654


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ...    ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ...........  .     .+. 
T Consensus       163 ~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~--~-----~~~-  229 (265)
T cd08217         163 DSS----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIKEG--K-----FRR-  229 (265)
T ss_pred             Ccc----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHHhcC--C-----CCC-
Confidence            331    1233468999999999998889999999999999999999999997543 22222221111  1     111 


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                         .+......+.+++.+|++.+|++||++++|+++.+
T Consensus       230 ---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~  264 (265)
T cd08217         230 ---IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL  264 (265)
T ss_pred             ---CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence               12223357899999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-38  Score=300.44  Aligned_cols=248  Identities=27%  Similarity=0.361  Sum_probs=203.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||.|+||.||+|... ++..||+|.+....   ....+.+.+|++++++++||||+++++++.+++..++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            345678999999999999876 58999999886432   23456899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +.+++|.+++...  .++++..+..++.|+++||.|||   ..+++|+||+|+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          82 LLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            9999999999764  35899999999999999999999   8999999999999999999999999999987654432  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc--hHHHHHHHHhhccccccccCCcCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--LVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....  ..........    .    .+    
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~----~~----  219 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET----A----DV----  219 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----c----cc----
Confidence               12345688899999999988899999999999999999999999975543  1111111100    0    01    


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSI--KQVLRILY  379 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~--~evl~~l~  379 (458)
                      ..+......+.+++.+||+.||.+||++  +|++++.|
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~  257 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY  257 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence            1111223678899999999999999999  88887754

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-37  Score=303.70  Aligned_cols=253  Identities=28%  Similarity=0.441  Sum_probs=201.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +...+.||+|+||.||+|... ++..||+|.+...   .......+.+|++++++++|+|++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            334568999999999999865 6889999988632   223345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +. |+|.+++... ..++++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++......   
T Consensus       107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            97 5888877543 235899999999999999999999   899999999999999999999999999998754322   


Q ss_pred             cccccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                           ....|+..|+|||.+.   ...++.++|||||||++|||++|+.||.............. ...       +.. 
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~-------~~~-  244 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NES-------PTL-  244 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-ccC-------CCC-
Confidence                 2345888999999874   45688999999999999999999999875433322222111 100       000 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                        ........+.+++.+||+.+|.+||++.+++++++.......
T Consensus       245 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         245 --QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             --CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence              011223568899999999999999999999999987665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=301.03  Aligned_cols=251  Identities=25%  Similarity=0.450  Sum_probs=201.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccCceeeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      .+.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++   |+|++++++++.++...++||||
T Consensus         4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~   83 (277)
T cd06917           4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY   83 (277)
T ss_pred             hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence            34568999999999999864 6899999988643 3334567889999999997   99999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++...   .+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06917          84 AEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-  156 (277)
T ss_pred             CCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence            9999999998653   5899999999999999999999   89999999999999999999999999999986654321 


Q ss_pred             cccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ..... .      .....+.+...
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~-~------~~~~~~~~~~~  225 (277)
T cd06917         157 ---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-RAMML-I------PKSKPPRLEDN  225 (277)
T ss_pred             ---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-hhhhc-c------ccCCCCCCCcc
Confidence               1233468899999998865 45689999999999999999999999643321 11110 0      00011111111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                         .....+.+++.+||+.||++||++.+++++.|...
T Consensus       226 ---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         226 ---GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             ---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence               12356889999999999999999999999887644

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.9e-38  Score=307.28  Aligned_cols=251  Identities=25%  Similarity=0.411  Sum_probs=194.9

Q ss_pred             ccceeeeecceEEEEEEEc-CCC----EEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      ..+.||+|+||.||+|.+. +|.    .||+|.+.... ......+.+|+.+++.++|+||++++++|... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            3457999999999999764 444    57888876433 23334688999999999999999999998754 56799999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++.... ..+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++........
T Consensus        90 ~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  165 (303)
T cd05110          90 MPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE  165 (303)
T ss_pred             cCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence            99999999997643 24889999999999999999999   899999999999999999999999999999865432211


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                        .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.. ....... ........   .   .. 
T Consensus       166 --~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-~~~~~~~-~~~~~~~~---~---~~-  234 (303)
T cd05110         166 --YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-TREIPDL-LEKGERLP---Q---PP-  234 (303)
T ss_pred             --cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH-HHCCCCCC---C---CC-
Confidence              11122345778999999998999999999999999999997 888886432 1122111 11111110   0   11 


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                         .+...+.+++..||..+|++||++.++++.+...
T Consensus       235 ---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         235 ---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1224688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.2e-38  Score=303.25  Aligned_cols=246  Identities=25%  Similarity=0.331  Sum_probs=191.5

Q ss_pred             eeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHh---cCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLAR---LHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +||+|+||.||++... +++.+|+|.+....   ......+.+|..++..   .+|+||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 58999999885422   1222334455544444   469999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++...+  .+++..+..++.|++.||+|||   +.+++||||||+|||+++++.++|+|||++.......    
T Consensus        81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----  151 (279)
T cd05633          81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (279)
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence            999999987543  4999999999999999999999   8999999999999999999999999999987543321    


Q ss_pred             cccccccCCCccccccccc-cCCCCcccccHhHHHHHHHHHhCCCccCCCcch-HHHHHHHHhhccccccccCCcCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-VESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        .....|+..|+|||.+. +..++.++|||||||++|||++|..||...... ........       ...+..+..  
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-------~~~~~~~~~--  220 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-------LTVNVELPD--  220 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-------hcCCcCCcc--
Confidence              12346899999999886 456889999999999999999999999643221 11111100       001111222  


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                        .....+.+++.+||+.||++||     +++++++|.|+..
T Consensus       221 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         221 --SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             --ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence              2235688999999999999999     6999999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6e-38  Score=310.43  Aligned_cols=258  Identities=20%  Similarity=0.290  Sum_probs=198.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Ccee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  180 (458)
                      +...+.||+|+||.||+|... +|+.||+|.+...  .......+.+|+.++++++|+||+++++++...      ...|
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   97 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY   97 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence            445578999999999999865 6899999988642  233345678899999999999999999987643      3569


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+. ++|.+.+...    ++...+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++...
T Consensus        98 lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          98 LVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             EEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            9999996 5898888642    888999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc--------
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR--------  332 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------  332 (458)
                      ...     ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........+..........        
T Consensus       170 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         170 TSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             CCC-----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            322     1233457889999999999999999999999999999999999997554332222211100000        


Q ss_pred             ------------------cccccCCcC----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          333 ------------------LAELVDPRI----KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       333 ------------------~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                                        +.+......    ...........+.+++.+||+.||++||++.|++++.|.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence                              000000000    000011234568899999999999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=305.87  Aligned_cols=250  Identities=21%  Similarity=0.339  Sum_probs=210.0

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      |.+.+.||+|.|..|-+|++ -.|..||||.+.+.  +......+++|++.|+.++|||||+|+.+......+|||+|.-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            45667899999999999965 38999999999764  3444567899999999999999999999998899999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC-CCCcEEEeecccccccCCCCcc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      ++|+|++||.++.. .+.+..+.+++.||+.|+.|+|   +..++||||||+||.+- .-|-+||.|||++..+..+.  
T Consensus       100 D~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--  173 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--  173 (864)
T ss_pred             CCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence            99999999987643 5999999999999999999999   88999999999998775 57899999999998776654  


Q ss_pred             cccccccccCCCccccccccccCCCC-cccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         ..+..+|...|-|||++.+..|+ +++||||||||||-|++|+.||+...+-.....           ++|=  +-.
T Consensus       174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm-----------ImDC--KYt  237 (864)
T KOG4717|consen  174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM-----------IMDC--KYT  237 (864)
T ss_pred             ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh-----------hhcc--ccc
Confidence               34567899999999999999997 578999999999999999999987655432221           2221  112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+.....+..++|..||..||.+|-+.++|..+.|-.
T Consensus       238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence            2334446788999999999999999999999988753

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.2e-38  Score=303.45  Aligned_cols=264  Identities=24%  Similarity=0.305  Sum_probs=199.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|++|+||+|... +|+.||+|.+....  ......+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL   83 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence            345678999999999999875 68899999875432  233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccccCCCCcc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~  265 (458)
                      + ++|.+++.......+++..+..++.||+.||+|||   +++++||||+|+||+++. ++.+||+|||++.......  
T Consensus        84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--  157 (294)
T PLN00009         84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--  157 (294)
T ss_pred             c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence            6 58888886655445788889999999999999999   899999999999999985 5679999999997543321  


Q ss_pred             cccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC------
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD------  338 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d------  338 (458)
                        .......++..|+|||.+.+ ..++.++|||||||++|+|+||+.||........................+      
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence              11233457889999998866 457899999999999999999999997654433332221111100000000      


Q ss_pred             ------CcCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          339 ------PRIKDS----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       339 ------~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                            +.....    ........+.+++.+|++.+|++||++.+++++.|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence                  000000    0011224588999999999999999999999987653

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.5e-38  Score=305.52  Aligned_cols=264  Identities=22%  Similarity=0.243  Sum_probs=198.2

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      +.+|.|+++.||++.. +++.||||++...  .......+.+|+++++.++|+||+++++++.+.+..+++|||+++|+|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3445555655666554 6899999998643  344556799999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc---ccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC---FEP  268 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~---~~~  268 (458)
                      .+++.......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+.........   ...
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            99998654456899999999999999999999   899999999999999999999999999988754322110   111


Q ss_pred             ccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-------------cc
Q 012715          269 VNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-------------RL  333 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------~~  333 (458)
                      ......++..|+|||.+..  ..++.++|||||||++|||++|+.||..................             .+
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            1233457889999999876  45889999999999999999999999765443322221110000             00


Q ss_pred             cc----ccCCcCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          334 AE----LVDPRIK----DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       334 ~~----~~d~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..    ..++...    ..........+.+++.+||+.||++||+++++++|.+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence            00    0000000    001112235688999999999999999999999998864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.5e-38  Score=304.05  Aligned_cols=265  Identities=23%  Similarity=0.287  Sum_probs=195.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC--------c
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKR--------E  178 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~  178 (458)
                      +...+.||+|+||.||+|... ++..||||.+....  ......+.+|++++++++||||++++++|...+        .
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            445678999999999999875 68999999885322  222345678999999999999999999987654        3


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      .++||||+. ++|.+++.... ..+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++..
T Consensus        94 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          94 FYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             EEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence            499999996 48888886543 35899999999999999999999   88999999999999999999999999999976


Q ss_pred             cCCCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ................++..|+|||.+.+. .++.++||||||+++|||++|..||............ ....+.....+
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  247 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI-SQLCGSITPEV  247 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhCCCChhh
Confidence            543321111122334578899999988664 4788999999999999999999988654432211111 11001110000


Q ss_pred             CCc-----------CCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          338 DPR-----------IKDSFD---------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       338 d~~-----------~~~~~~---------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+.           ......         ......+.+++.+||..||.+||+++++++|.|+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000           000000         0012456789999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.1e-38  Score=301.32  Aligned_cols=251  Identities=23%  Similarity=0.383  Sum_probs=202.3

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      .+||+|+||.||++... +|..||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            46999999999999875 68999999886544455567899999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccc
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      +++...   .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........    ....
T Consensus       106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~----~~~~  175 (292)
T cd06657         106 DIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP----RRKS  175 (292)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc----cccc
Confidence            988542   4889999999999999999999   88999999999999999999999999999875543211    1223


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT  352 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  352 (458)
                      ..|+..|+|||.+.+..++.++||||||+++|||++|..||...... .........       ..+.+..  .......
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~~~~~~-------~~~~~~~--~~~~~~~  245 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDN-------LPPKLKN--LHKVSPS  245 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhh-------CCcccCC--cccCCHH
Confidence            45889999999998888999999999999999999999998754332 211111110       0111100  0112245


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          353 IVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       353 l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      +.+++.+||+.+|.+||++.+++++.|.....
T Consensus       246 l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         246 LKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             HHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            78899999999999999999999998765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.4e-38  Score=303.28  Aligned_cols=262  Identities=24%  Similarity=0.301  Sum_probs=196.9

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCc-----eee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRE-----RFL  181 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~l  181 (458)
                      ...+.||+|+||.||+|... +|+.||+|.+....  ......+.+|+.+++.++ |+||+++++++...+.     .|+
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l   83 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL   83 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence            44578999999999999875 68999999875432  223356889999999995 6999999999887665     899


Q ss_pred             eeeecCCCCHHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeeccccc
Q 012715          182 MYEYMANGSLKDHLHSPG---RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAH  257 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~  257 (458)
                      ||||+++ +|.+++....   ...+++..++.++.||+.||+|||   .++++||||||+||+++. ++.+||+|||+++
T Consensus        84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            9999985 8988886432   246899999999999999999999   899999999999999998 8999999999987


Q ss_pred             ccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc----
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----  332 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----  332 (458)
                      .......    ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||...................    
T Consensus       160 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         160 AFSIPVK----SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ecCCCcc----ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            5432211    1223356889999998865 457899999999999999999999997655443332221110000    


Q ss_pred             ccccc---C----CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          333 LAELV---D----PRIKD----SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       333 ~~~~~---d----~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .....   +    +....    .........+.+++.+||..||.+||++.+++.|.|.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~  294 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF  294 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence            00000   0    00000    0001123568899999999999999999999998764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.7e-38  Score=310.53  Aligned_cols=268  Identities=21%  Similarity=0.328  Sum_probs=201.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeec----cCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|... +|..||+|++....  ......+.+|+.++++++|+||+++++++..    ....++|
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv   86 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV   86 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence            344578999999999999865 68999999986432  2334567889999999999999999998753    3467999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+. |+|.+++....  .+++..+..++.|++.||+|||   .++++||||||+||+++.++.+||+|||++......
T Consensus        87 ~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          87 MDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             Eehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            99995 69999987543  4899999999999999999999   899999999999999999999999999999765432


Q ss_pred             CcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc----
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV----  337 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  337 (458)
                      ............|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...................++.    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            2211112234568899999998865 56889999999999999999999999654332221111110000000000    


Q ss_pred             --------C-CcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          338 --------D-PRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       338 --------d-~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                              + ........     ......+.+++.+||+.+|.+||++.+++.+.|....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence                    0 00000011     1124678999999999999999999999999987643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8e-38  Score=299.28  Aligned_cols=257  Identities=24%  Similarity=0.292  Sum_probs=194.6

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeecc--Cceeeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEK--RERFLMYEY  185 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~  185 (458)
                      .+.+.||+|+||.||+|... ++..||+|.+.... ........+|+.++.++. |+|++++++++.+.  +..++||||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            35678999999999999865 68999999886432 222334567999999995 99999999999987  889999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +. |+|.+++.... ..+++..+..++.|++.||+|||   ..+++||||+|+||+++. +.+||+|||+++......  
T Consensus        82 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--  153 (282)
T cd07831          82 MD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--  153 (282)
T ss_pred             CC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence            97 58888886533 35899999999999999999999   899999999999999999 999999999998654322  


Q ss_pred             cccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc---------
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE---------  335 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  335 (458)
                         ......++..|+|||.+.. ..++.++|||||||++|||++|..||....... .........+...+         
T Consensus       154 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         154 ---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             ---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCCCCHHHHHhhccc
Confidence               1123457899999997654 557889999999999999999999996543322 11111110000000         


Q ss_pred             -ccCCcCCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          336 -LVDPRIKDS-------FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       336 -~~d~~~~~~-------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       ..+......       ........+.+++.+||+.+|++||++++++++.|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence             000000000       00123467999999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=304.58  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=208.4

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      ++||+||||.||-++.. +|+.+|.|++.+.   ....+...++|-.+|++++.+.||.+-..+..++.+++|+..|.||
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG  270 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG  270 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence            58999999999999775 6999999988642   2334456789999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.-+|.+.+...|++..++.++.+|+.||++||   ..+|++|||||+|||+|+.|+++|+|+|||....++..     
T Consensus       271 DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-----  342 (591)
T KOG0986|consen  271 DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-----  342 (591)
T ss_pred             ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCc-----
Confidence            9999999888888999999999999999999999   99999999999999999999999999999998887753     


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHH---HHHHhhccccccccCCcCCCCCC
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA---QVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      ....+||.+|||||++.+..|+...|.|||||+||||+.|+.||..-..-+.+.   +......        ..+.+.|+
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~--------~ey~~kFS  414 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP--------EEYSDKFS  414 (591)
T ss_pred             cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--------hhcccccC
Confidence            344589999999999999999999999999999999999999997544333321   1111111        11223333


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYES  381 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  381 (458)
                          ++..++.+..|..||.+|..     +.+|-+|+.+.
T Consensus       415 ----~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk  450 (591)
T KOG0986|consen  415 ----EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK  450 (591)
T ss_pred             ----HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence                55778888999999999964     56888887664

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=305.89  Aligned_cols=266  Identities=22%  Similarity=0.339  Sum_probs=196.8

Q ss_pred             hcccceeeeecceEEEEEEEc---CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  181 (458)
                      +.+.+.||+|+||.||+|...   ++..||+|.+....   ......+.+|+.++.+++||||+++++++.+.  +..++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            345678999999999999875   47899999987532   33345678999999999999999999999988  78999


Q ss_pred             eeeecCCCCHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC----CCcEEEeecc
Q 012715          182 MYEYMANGSLKDHLHSP---GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE----NFVAKLADFG  254 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~----~~~~kl~DfG  254 (458)
                      ||||+++ +|.+++...   ....++...+..++.|++.||+|||   +.+++||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 777776432   1236889999999999999999999   899999999999999999    9999999999


Q ss_pred             cccccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchH---------HHHH
Q 012715          255 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV---------ESAQ  324 (458)
Q Consensus       255 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~---------~~~~  324 (458)
                      ++......... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......         ....
T Consensus       158 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99865433211 111234467899999998876 457899999999999999999999986432211         0000


Q ss_pred             HH--Hh-----------hccccccccCCcCCCCCC---H--------HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          325 VC--MA-----------SESRLAELVDPRIKDSFD---M--------EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       325 ~~--~~-----------~~~~~~~~~d~~~~~~~~---~--------~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..  +.           .........+......++   .        .....+.+++.+||+.||++|||+.|+++|.|+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            00  00           000000000000000011   0        122468899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=341.88  Aligned_cols=253  Identities=28%  Similarity=0.393  Sum_probs=203.1

Q ss_pred             ceeeeecceEEEEEEE-cCCCEEEEEEecc--cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          114 TIIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      ..||.|.||.||-|.. ++|...|+|.+.-  ........+.+|+.+|..|+|||+|+++|+-.+.+..+|.||||++|+
T Consensus      1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred             cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence            4799999999999964 5789999997752  334445678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |.+.+....  -+++.....+..|++.|++|||   +.|||||||||.|||++.+|.+|++|||.|.....+........
T Consensus      1321 La~ll~~gr--i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1321 LASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred             HHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence            999997532  2566666778899999999999   99999999999999999999999999999987765532233334


Q ss_pred             ccccCCCccccccccccC---CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          271 TDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ....||+-|||||++.+.   ....++||||+|||+.||+||++||..-.+.........  .+.     .|.+    +.
T Consensus      1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~--~gh-----~Pq~----P~ 1464 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA--AGH-----KPQI----PE 1464 (1509)
T ss_pred             HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh--ccC-----CCCC----ch
Confidence            567899999999999764   356789999999999999999999976544322222111  111     1222    22


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ....+-.+++.+||..||++|+++.|++++-+...
T Consensus      1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            23356778999999999999999999999976644

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-37  Score=302.61  Aligned_cols=267  Identities=24%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  184 (458)
                      ++..+.||+|+||.||+|... +|..||+|.+....  ......+.+|+.++++++|+||+++++++.+.  +..++|||
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME   88 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence            345678999999999999875 58999999885322  22233567899999999999999999998765  46899999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+. ++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++........
T Consensus        89 ~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          89 YCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             cCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence            996 48988886533 45899999999999999999999   89999999999999999999999999999986643321


Q ss_pred             ccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc----cC-
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL----VD-  338 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~d-  338 (458)
                          ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......................    .+ 
T Consensus       164 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         164 ----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             ----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence                1223345788999998865 5678999999999999999999999975443322221111100000000    00 


Q ss_pred             -----CcCCCC----CC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          339 -----PRIKDS----FD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       339 -----~~~~~~----~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                           ..+...    ..   ......+.+++.+||+.||++||+++++++|.|+...+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~  298 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL  298 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence                 000000    00   011356789999999999999999999999998865443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=296.85  Aligned_cols=259  Identities=25%  Similarity=0.311  Sum_probs=197.7

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhc---CCCCeeeeeeeeeccCc-----e
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARL---HHRHLVALRGFCIEKRE-----R  179 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~  179 (458)
                      .+.+.||+|+||.||+|..+ ++..||+|++....  ......+.+|+.++.++   +|+||+++++++.+.+.     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            34568999999999999986 48999999986322  22234566788887776   59999999999988776     8


Q ss_pred             eeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      +++|||+. ++|.+++.......+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        82 ~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          82 TLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             EEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            99999997 48999887654446899999999999999999999   899999999999999999999999999999765


Q ss_pred             CCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc----
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE----  335 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----  335 (458)
                      ....     ......++..|+|||.+.+..++.++|||||||++|||++|..||...... +..............    
T Consensus       158 ~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         158 SFEM-----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             cCCc-----ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcC
Confidence            4332     112345788999999999999999999999999999999998888654332 222222111000000    


Q ss_pred             --------ccCCcCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          336 --------LVDPRIKD---SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       336 --------~~d~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                              ........   .........+.+++.+||+.||.+||+++++++|.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~  286 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY  286 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence                    00000000   011123466789999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.7e-38  Score=299.11  Aligned_cols=262  Identities=24%  Similarity=0.338  Sum_probs=199.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.||.|++|.||+|... +|..||||.+.... ......+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK   82 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence            45678999999999999875 68899999886432 22345677899999999999999999999999999999999985


Q ss_pred             CCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          189 GSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       189 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                       +|.+++.... ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++.......   
T Consensus        83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~---  155 (284)
T cd07836          83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN---  155 (284)
T ss_pred             -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc---
Confidence             8998886543 245899999999999999999999   88999999999999999999999999999975433211   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhh----ccccccccC-CcC
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS----ESRLAELVD-PRI  341 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~d-~~~  341 (458)
                       ......++..|++||.+.+ ..++.++|||||||++|||++|+.||.+..............    ...+..+.+ +.+
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             1223457889999998865 457889999999999999999999987544322221111000    000000000 000


Q ss_pred             CCC-----------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          342 KDS-----------FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       342 ~~~-----------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...           ........+.+++.+|++.||.+||++.+++++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            000           001223568899999999999999999999988653

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-37  Score=293.11  Aligned_cols=251  Identities=28%  Similarity=0.425  Sum_probs=205.0

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeeeeeec
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYM  186 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~  186 (458)
                      ..+.||+|++|.||+|... ++..|++|.+....  ....+.+.+|++++++++|+||+++++.+.+.  +..++|+||+
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   83 (260)
T cd06606           4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV   83 (260)
T ss_pred             eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence            4568999999999999876 68999999886543  24456789999999999999999999999988  8899999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++++|.+++....  .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  157 (260)
T cd06606          84 SGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-  157 (260)
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc-
Confidence            9999999997644  6999999999999999999999   899999999999999999999999999999876544310 


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                       .......++..|+|||.+.+...+.++||||||+++++|++|..||....+..........          .......+
T Consensus       158 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------~~~~~~~~  226 (260)
T cd06606         158 -EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS----------SGEPPEIP  226 (260)
T ss_pred             -ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc----------cCCCcCCC
Confidence             0123456889999999998888999999999999999999999999765422222111110          00011111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ......+.+++.+|+..+|.+||++.+++++.|
T Consensus       227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~  259 (260)
T cd06606         227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF  259 (260)
T ss_pred             cccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence            222467999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=299.95  Aligned_cols=259  Identities=28%  Similarity=0.394  Sum_probs=199.2

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeeeeeec
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEYM  186 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~  186 (458)
                      +.+.||.|+||.||+|... +|..+|+|.+....  ......+.+|++++++++|+|++++++++.+.  +..++||||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            4568999999999999876 58899999987542  33345688999999999999999999999988  8999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++ +|.+++.... ..+++..++.++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++........  
T Consensus        83 ~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~--  155 (287)
T cd07840          83 DH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS--  155 (287)
T ss_pred             cc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence            75 8999887643 36899999999999999999999   88999999999999999999999999999986544321  


Q ss_pred             ccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-----ccccccC--
Q 012715          267 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-----RLAELVD--  338 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~d--  338 (458)
                       .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .......     ......+  
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE-KIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCchhhccccccch
Confidence             11233456888999998765 467899999999999999999999987544322211 1111100     0000000  


Q ss_pred             ------C------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          339 ------P------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       339 ------~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                            +      .+...+...+...+.+++.+||+.+|.+||++++++++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~  286 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY  286 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence                  0      0000000112467899999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=294.10  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=198.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-----chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  181 (458)
                      +.+.+.||+|+||.||+|... ++..||+|.+...     .......+.+|++++++++|+||+++++++.+.  +..++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            345678999999999999865 6899999987421     223345788999999999999999999998764  45789


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      |+||+++++|.+++...+  .+++..+.+++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          84 FVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            999999999999987543  4889999999999999999999   89999999999999999999999999999986532


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      .... ........++..|+|||.+.+..++.++|||||||++|||++|+.||.+........+....   .    ..+.+
T Consensus       159 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~----~~~~~  230 (264)
T cd06653         159 ICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ---P----TKPML  230 (264)
T ss_pred             cccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC---C----CCCCC
Confidence            1110 01122346889999999999888999999999999999999999999765433322221110   0    11111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                          +......+.+++.+||+ ++..||++.++++|++
T Consensus       231 ----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~  263 (264)
T cd06653         231 ----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF  263 (264)
T ss_pred             ----CcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence                22233568899999999 5799999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-38  Score=308.50  Aligned_cols=265  Identities=22%  Similarity=0.322  Sum_probs=197.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC-----ceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  182 (458)
                      +.+.+.||+|+||.||+|... +|..||+|.+... .......+.+|+.++++++|+||+++++++....     ..++|
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   86 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV   86 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence            445678999999999999764 6899999998642 2234456889999999999999999999876543     57999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      +||+. ++|.+++..   ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        87 ~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          87 QELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             ehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            99996 488888864   35899999999999999999999   899999999999999999999999999999765432


Q ss_pred             CcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc----ccccccc
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SRLAELV  337 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~  337 (458)
                      ... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+......+........    ..+..+.
T Consensus       160 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         160 HDH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             ccc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            211 112233568999999998754 5688999999999999999999999965432211111100000    0000000


Q ss_pred             CCc---------CCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 DPR---------IKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 d~~---------~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      +..         ......     ......+.+++.+||+.+|++||++.++++|.|...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~  297 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ  297 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence            000         000000     012356889999999999999999999999987653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-37  Score=295.72  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=194.6

Q ss_pred             ccceeeeecceEEEEEEEc----CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC------ce
Q 012715          112 FSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ER  179 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  179 (458)
                      +.+.||+|+||.||+|.+.    ++..||||.+...  .....+++.+|++++++++||||+++++++...+      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4568999999999999763    3688999988642  2334567899999999999999999999886542      24


Q ss_pred             eeeeeecCCCCHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 012715          180 FLMYEYMANGSLKDHLHSP----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL  255 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  255 (458)
                      +++++|+.+|+|.+++...    ....+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccc
Confidence            7889999999999887421    1224788999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccc
Q 012715          256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLA  334 (458)
Q Consensus       256 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  334 (458)
                      ++........  .......++..|++||.+....++.++|||||||++|||++ |+.||.... ..+....... ...+ 
T Consensus       160 ~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~-~~~~-  234 (273)
T cd05074         160 SKKIYSGDYY--RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-NSEIYNYLIK-GNRL-  234 (273)
T ss_pred             cccccCCcce--ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-HHHHHHHHHc-CCcC-
Confidence            9865433211  01122345678999999998889999999999999999999 777775432 2222221111 1111 


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       335 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                           ..    +......+.+++.+||+.+|++||++.++++.|..
T Consensus       235 -----~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         235 -----KQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             -----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                 00    11223579999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=298.84  Aligned_cols=260  Identities=26%  Similarity=0.412  Sum_probs=198.7

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccch-hhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-QVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||.|+||+||+|... +++.||||++..... .......+|+..+.+++ |+||+++++++.+++..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            35678999999999999886 478999998864322 22234567999999999 999999999999999999999999 


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++.......+++..+..++.|++.+|.|||   +++++|+||+|+||++++++.++|+|||++.......    
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~----  153 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----  153 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence            889999997655456899999999999999999999   8999999999999999999999999999997654322    


Q ss_pred             cccccccCCCccccccccc-cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc----------ccccc
Q 012715          268 PVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----------RLAEL  336 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----------~~~~~  336 (458)
                       ......++..|+|||.+. ...++.++||||||+++|||++|+.||..................          .+...
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             123345788999999875 456789999999999999999999888654332222111110000          00000


Q ss_pred             cCCcCCCCC--C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          337 VDPRIKDSF--D-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       337 ~d~~~~~~~--~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .+..+....  .     ......+.+++.+||+.+|++||+++|++.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~  282 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY  282 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence            000000000  0     011356889999999999999999999998865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.9e-38  Score=296.34  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=199.8

Q ss_pred             eeeecceEEEEEEEc-CCCEEEEEEecccch---hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISE---QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      ||.|+||.||++... +|+.+++|.+.....   .....+.+|++++++++|+||+++++.+..++..|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999886 489999998864332   3456789999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc----c
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF----E  267 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~----~  267 (458)
                      .+++...+  .+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.++|+|||++..........    .
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99997644  5899999999999999999999   8999999999999999999999999999987543321100    0


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      .......++..|+|||.+....++.++||||||+++|||++|..||..... .+.............        ...  
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~--------~~~--  224 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGKIEWP--------EDV--  224 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCcCCC--------ccc--
Confidence            122345578899999999888899999999999999999999999865432 222222221111110        000  


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCH---HHHHHHhhhC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSI---KQVLRILYES  381 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~---~evl~~l~~~  381 (458)
                      .....+.+++.+||+.+|.+||++   .+++++.|+.
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~  261 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK  261 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence            013568899999999999999999   8888877653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-37  Score=320.59  Aligned_cols=269  Identities=20%  Similarity=0.243  Sum_probs=190.7

Q ss_pred             HhhcccceeeeecceEEEEEEEcC--CCEEEEEEe--------------c---ccchhhHhHHHHHHHHHHhcCCCCeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFSD--GSLIAVKRM--------------D---KISEQVEGDFCREIELLARLHHRHLVA  168 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~niv~  168 (458)
                      ..+.+.+.||+|+||+||+|.++.  +..+++|.+              .   .........+.+|+++|++++|+||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            446667899999999999987542  222222211              0   112223456889999999999999999


Q ss_pred             eeeeeeccCceeeeeeecCCCCHHHHhcCCC---CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC
Q 012715          169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPG---RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN  245 (458)
Q Consensus       169 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~  245 (458)
                      +++++.+.+..|+|++++. ++|.+++....   ........+..++.|++.||+|||   +++|+||||||+|||++.+
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence            9999999999999999985 57888775321   112345667889999999999999   8999999999999999999


Q ss_pred             CcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCC-Cc-c-hHHH
Q 012715          246 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD-GK-N-LVES  322 (458)
Q Consensus       246 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~-~~-~-~~~~  322 (458)
                      +.+||+|||+++.......   .......||..|+|||++.+..++.++|||||||++|||++|+.++.. .. . ....
T Consensus       304 ~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999986644321   122345799999999999999999999999999999999999865432 21 1 1111


Q ss_pred             HHHHHhhccccccccCC-----------cC---CCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          323 AQVCMASESRLAELVDP-----------RI---KDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       323 ~~~~~~~~~~~~~~~d~-----------~~---~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ............++.++           .+   .....     ......+.+++.+||+.||++||++.|+++|.|+...
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            11111000000000000           00   00000     0011346778999999999999999999999988654

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=291.75  Aligned_cols=248  Identities=28%  Similarity=0.468  Sum_probs=204.1

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccch--hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|++|.||++... ++..|++|.+.....  .....+.+|++++.+++|+|++++++++.+.+..++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            45678999999999999775 578999999875443  445679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++.........  
T Consensus        83 ~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  155 (254)
T cd06627          83 NGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--  155 (254)
T ss_pred             CCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--
Confidence            99999999764  35899999999999999999999   899999999999999999999999999999866543321  


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..............   ..     .+.+...   
T Consensus       156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~-----~~~~~~~---  222 (254)
T cd06627         156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---DD-----HPPLPEG---  222 (254)
T ss_pred             --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---cC-----CCCCCCC---
Confidence              2334678899999999888889999999999999999999999876543332222111   00     1111111   


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       ....+.+++.+||..+|++||++.+++.+.+
T Consensus       223 -~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  253 (254)
T cd06627         223 -ISPELKDFLMQCFQKDPNLRPTAKQLLKHPW  253 (254)
T ss_pred             -CCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence             2356889999999999999999999998654

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=297.12  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=201.4

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccch--hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ..+.||.|++|.||+|... +|..+++|.+.....  .....+.+|++++++++|+||+++++++.+++..++||||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            3567999999999999875 688999998864322  2456788999999999999999999999999999999999975


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                       +|.+++.... ..+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||.+........    
T Consensus        83 -~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----  153 (283)
T cd05118          83 -DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----  153 (283)
T ss_pred             -CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc----
Confidence             8988887643 46899999999999999999999   89999999999999999999999999999876644321    


Q ss_pred             ccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc----ccccccC-----
Q 012715          269 VNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RLAELVD-----  338 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~d-----  338 (458)
                      ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..................    ......+     
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            12234578899999998876 7899999999999999999999998655443332222111000    0000000     


Q ss_pred             -CcCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          339 -PRIK-------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       339 -~~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       ....       ..........+.+++..||+.||.+||++++++.+.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~  282 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY  282 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence             0000       0011123467899999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.5e-37  Score=290.18  Aligned_cols=250  Identities=29%  Similarity=0.480  Sum_probs=204.6

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||.|+||.||++... ++..||+|++....  ......+.+|+++++.++|+|++++++.+..++..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD   82 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence            34568999999999999875 58899999986433  2455678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          188 NGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       188 ~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|.+++....  ...+++..+..++.+++.||.|||   +.+++|+||+|+||++++++.++|+|||++........ 
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  158 (258)
T cd08215          83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-  158 (258)
T ss_pred             CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCcc-
Confidence            999999997642  356999999999999999999999   88999999999999999999999999999976544321 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.... ...........  ..     +.+..  
T Consensus       159 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~--~~-----~~~~~--  225 (258)
T cd08215         159 ---LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILKG--QY-----PPIPS--  225 (258)
T ss_pred             ---eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhcC--CC-----CCCCC--
Confidence               1233468889999999988889999999999999999999999986443 22222221111  11     11111  


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                        .....+.+++.+||..+|++||++.+++++.+
T Consensus       226 --~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         226 --QYSSELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             --CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence              22356889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-37  Score=299.00  Aligned_cols=253  Identities=25%  Similarity=0.427  Sum_probs=196.9

Q ss_pred             cccceeeeecceEEEEEEEcC-CCEEEEEEecccc-hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|+||.||+|.+.+ +..||||.+.... ......+..|+.++.+.. |+||++++++|.+....++||||+.
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   97 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS   97 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence            456789999999999998864 8999999986432 233455777888777775 9999999999999999999999985


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                       ++|.+++.... ..+++..+..++.|++.||+|||   + .+|+||||+|+||++++++.+||+|||++.......   
T Consensus        98 -~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~---  169 (296)
T cd06618          98 -TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---  169 (296)
T ss_pred             -cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC---
Confidence             57777775433 36899999999999999999999   6 589999999999999999999999999987654322   


Q ss_pred             ccccccccCCCccccccccccCC----CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQE----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                        ......++..|+|||.+.+..    ++.++||||||+++|||++|+.||.......+.........  ...     ..
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~-----~~  240 (296)
T cd06618         170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PPS-----LP  240 (296)
T ss_pred             --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CCC-----CC
Confidence              112335788999999987553    78899999999999999999999965433222222222111  011     11


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..  ......+.+++.+||+.||.+||++++++++.|...
T Consensus       241 ~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         241 PN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             CC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            00  012356899999999999999999999999987654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4e-38  Score=328.44  Aligned_cols=249  Identities=27%  Similarity=0.432  Sum_probs=186.5

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec----------------
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE----------------  175 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------------  175 (458)
                      ++||+||||.|||++.+ ||+.||||++.-. +........+|+.+|++|+|||||+++..+.+                
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            47999999999999987 8999999998633 44555678999999999999999999821110                


Q ss_pred             --------------------------------------------------------------c-----------------
Q 012715          176 --------------------------------------------------------------K-----------------  176 (458)
Q Consensus       176 --------------------------------------------------------------~-----------------  176 (458)
                                                                                    +                 
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                                          0                 


Q ss_pred             ------------------------CceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 012715          177 ------------------------RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH  232 (458)
Q Consensus       177 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiH  232 (458)
                                              ..+||-||||+..+|.+++..+... -.....++++.+|++||+|+|   +.||||
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH---~~giIH  720 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIH---DQGIIH  720 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHH---hCceee
Confidence                                    1147889999998888888654321 146788999999999999999   999999


Q ss_pred             ccCCCCCeeeCCCCcEEEeecccccccC------C-----C---CcccccccccccCCCccccccccccC---CCCcccc
Q 012715          233 RDIKSSNILLDENFVAKLADFGLAHASK------D-----G---SICFEPVNTDIRGTPGYMDPEYVVTQ---ELTEKSD  295 (458)
Q Consensus       233 rDlk~~NIll~~~~~~kl~DfGla~~~~------~-----~---~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~D  295 (458)
                      |||||.||++++++.+||+|||+|....      +     .   ........+..+||.-|+|||.+.+.   .|+.|+|
T Consensus       721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD  800 (1351)
T KOG1035|consen  721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID  800 (1351)
T ss_pred             ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence            9999999999999999999999998621      0     0   00011234567899999999999764   4999999


Q ss_pred             cHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 012715          296 VYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL  375 (458)
Q Consensus       296 vws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl  375 (458)
                      +||+||||+||+.   ||...-+........  ..+.++..      ..+..+....-..+|.++++.||.+|||+.|+|
T Consensus       801 mYSLGIVlFEM~y---PF~TsMERa~iL~~L--R~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  801 MYSLGIVLFEMLY---PFGTSMERASILTNL--RKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             hHHHHHHHHHHhc---cCCchHHHHHHHHhc--ccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence            9999999999985   564432222222111  11222211      122333334456799999999999999999999


Q ss_pred             HH
Q 012715          376 RI  377 (458)
Q Consensus       376 ~~  377 (458)
                      +.
T Consensus       870 ~s  871 (1351)
T KOG1035|consen  870 NS  871 (1351)
T ss_pred             hc
Confidence            85

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-39  Score=285.36  Aligned_cols=270  Identities=25%  Similarity=0.354  Sum_probs=208.2

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEec--ccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--------Cceeee
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGFCIEK--------RERFLM  182 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~lv  182 (458)
                      .+||+|.||.||+|+.+ .|+.||+|++.  ...........+|+++|..|+|+|++.++..|...        ..+|+|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            47999999999999876 47788988753  23334445678999999999999999999988753        347999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |++|+. +|..+|.... ..++..++.+++.++..||.|+|   ...|+|||+|+.|+||+.+|.+||+|||+++.+...
T Consensus       103 f~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~  177 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFSTS  177 (376)
T ss_pred             HHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence            999986 8999887643 35899999999999999999999   999999999999999999999999999999877655


Q ss_pred             CcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc----ccccccc
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SRLAELV  337 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~  337 (458)
                      .....+..+..+.|.+|.+||.+.+ ..|+++.|||..||++.||+||.+-+++..+......+....+    ..++++.
T Consensus       178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d  257 (376)
T KOG0669|consen  178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD  257 (376)
T ss_pred             cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence            4444445667778999999998876 5799999999999999999999988876554333222111100    0111111


Q ss_pred             C----------CcCCCCCC--HHHH------HHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCcc
Q 012715          338 D----------PRIKDSFD--MEQL------RTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSG  388 (458)
Q Consensus       338 d----------~~~~~~~~--~~~~------~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~~  388 (458)
                      .          |-.+..+.  .+.+      ...++++..++..||.+|++++++++|-|+..++.+..
T Consensus       258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqa  326 (376)
T KOG0669|consen  258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQA  326 (376)
T ss_pred             cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchh
Confidence            0          00000000  0111      25778999999999999999999999999999998743

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4e-37  Score=297.58  Aligned_cols=261  Identities=28%  Similarity=0.393  Sum_probs=197.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC---------
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKR---------  177 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  177 (458)
                      +.+.+.||+|+||.||+|... +|+.||+|.+....  ......+.+|++++++++||||+++++++.+..         
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~   88 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK   88 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence            445678999999999999886 58899999986432  233356788999999999999999999987655         


Q ss_pred             -ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 012715          178 -ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA  256 (458)
Q Consensus       178 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla  256 (458)
                       ..++|+||+++ +|.+++... ...+++..+..++.|++.||+|||   +.+|+|+||||+||++++++.+||+|||++
T Consensus        89 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          89 GAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             CcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence             78999999976 787777654 335899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc---
Q 012715          257 HASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR---  332 (458)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---  332 (458)
                      ........   .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...................   
T Consensus       164 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         164 RLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             ccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            86543321   11122346788999998764 457889999999999999999999997554332222211111110   


Q ss_pred             -cccccC--------C------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          333 -LAELVD--------P------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       333 -~~~~~d--------~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       .+++..        +      .....+ ...+..+.+++..||+.+|.+||++++++++.|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  301 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW  301 (302)
T ss_pred             hcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence             000000        0      000000 012357899999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=325.12  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=201.7

Q ss_pred             cccceeeeecceEEEEEEEc----C----CCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCcee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS----D----GSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.||+|.||.|++|...    .    ...||||.++.. .....+.+..|+++|..+ +|+||+.++|+|..++..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            45568999999999999753    1    357999998753 334567899999999999 5999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCC------C--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC
Q 012715          181 LMYEYMANGSLKDHLHSPG------R--------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF  246 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~  246 (458)
                      +|+||+..|+|.++|+...      .        ..++..+.+.++.|||.||+||+   +.+++||||.++|||++.+.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence            9999999999999997644      0        13889999999999999999999   99999999999999999999


Q ss_pred             cEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhC-CCccCCCcchHHHHHH
Q 012715          247 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQV  325 (458)
Q Consensus       247 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg-~~p~~~~~~~~~~~~~  325 (458)
                      .+||+|||+|+.......... ......-...|||||.+....|+.++|||||||+|||++|. ..|+.+-....+... 
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-  533 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-  533 (609)
T ss_pred             EEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-
Confidence            999999999996554432211 11111135679999999999999999999999999999994 556644221223322 


Q ss_pred             HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          326 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       326 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+..+.++          ..+..+..+++++|+.||+.+|++||++.++.+.+..
T Consensus       534 ~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  534 FLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             HHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            22222221          2223334679999999999999999999999998755

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.1e-37  Score=298.04  Aligned_cols=250  Identities=27%  Similarity=0.427  Sum_probs=198.2

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      ..+.||+|+||.||+|... ++..+|+|.+...   .......+.+|+++++.++|+|++++++++...+..++||||+.
T Consensus        19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   98 (308)
T cd06634          19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL   98 (308)
T ss_pred             HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence            3457999999999999875 5789999987532   22334568899999999999999999999999999999999996


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                       |+|.+++.... ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++......     
T Consensus        99 -~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----  168 (308)
T cd06634          99 -GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  168 (308)
T ss_pred             -CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence             68888775433 35899999999999999999999   899999999999999999999999999998754322     


Q ss_pred             cccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         ....++..|+|||.+.   ...++.++|||||||++|||++|..|+.+........... .  ...     +...  
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~--~~~-----~~~~--  235 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-Q--NES-----PALQ--  235 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh-h--cCC-----CCcC--
Confidence               2345788999999874   3567889999999999999999999986543222111111 0  000     1110  


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                       .......+.+++.+||+.+|.+||++.+++++.+......
T Consensus       236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             -cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence             1122356889999999999999999999999998766433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.5e-37  Score=303.78  Aligned_cols=267  Identities=22%  Similarity=0.294  Sum_probs=200.4

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccchhh--------------HhHHHHHHHHHHhcCCCCeeeeeeeeeccC
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQV--------------EGDFCREIELLARLHHRHLVALRGFCIEKR  177 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  177 (458)
                      .+.||.|+||+||+|... +++.||||.+.......              ...+.+|+++++.++|+||+++++++..++
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            457999999999999865 68999999885432211              124779999999999999999999999999


Q ss_pred             ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..++||||+. |+|.+++...  ..+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcccee
Confidence            9999999996 6999998653  34899999999999999999999   8999999999999999999999999999997


Q ss_pred             ccCCCCcc----------cccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHH
Q 012715          258 ASKDGSIC----------FEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC  326 (458)
Q Consensus       258 ~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  326 (458)
                      ........          .........++..|+|||.+.+. .++.++|||||||++|||++|+.||....+........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~  247 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF  247 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            65421100          00111233468889999998764 46899999999999999999999997655433222211


Q ss_pred             Hhhccc----ccccc--------CCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          327 MASESR----LAELV--------DPRIKDS---FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       327 ~~~~~~----~~~~~--------d~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      ......    +....        .......   ........+.+++.+||+.+|++||++++++.+.|....+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence            111000    00000        0000000   00112356889999999999999999999999998876544

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.6e-37  Score=294.69  Aligned_cols=245  Identities=25%  Similarity=0.334  Sum_probs=191.6

Q ss_pred             eeeeecceEEEEEEEc-CCCEEEEEEecccch---hhHhHHHHHHHH---HHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE---QVEGDFCREIEL---LARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +||+|+||.||+|... +++.||+|.+.....   .....+..|..+   ++...|+||+.+++++.+.+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999764 588999998864321   112234445444   444579999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      ||+|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......    
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            99999998753  35999999999999999999999   8999999999999999999999999999987543221    


Q ss_pred             cccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcch--HHHHHHHHhhccccccccCCcCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                        .....|+..|+|||.+.++ .++.++|||||||++|||++|+.||......  ........        ..++.+...
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~  221 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------TMAVELPDS  221 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--------ccCCCCCCc
Confidence              1234689999999998754 6899999999999999999999999754221  11111110        011222222


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      .    ...+.+++.+|+..+|.+||     ++.+++++.|...
T Consensus       222 ~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         222 F----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             C----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence            2    35688999999999999999     9999999887754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-37  Score=290.01  Aligned_cols=245  Identities=22%  Similarity=0.283  Sum_probs=191.3

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccch---hhHhHHHHHHHHHH-hcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE---QVEGDFCREIELLA-RLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||.|+||.||+|... +|+.||+|.+.....   .....+..|..++. ..+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            35899999999999775 588999998864321   22233455555544 45899999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++...+  .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++....       
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------  149 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------  149 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence            99999997643  5889999999999999999999   89999999999999999999999999999875432       


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                       .....++..|+|||.+.+..++.++||||||+++|||++|..||..... ...............    .    .....
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~----~----~~~~~  219 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-DAVFDNILSRRINWP----E----EVKEF  219 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcccCCC----C----ccccc
Confidence             1234578899999999888899999999999999999999999965433 222222111111100    0    11112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCH---HHHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSI---KQVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~---~evl~~l~~  380 (458)
                      ....+.+++.+||+.+|++||++   +|++.|.|.
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence            23568999999999999999955   688887765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.4e-36  Score=295.64  Aligned_cols=249  Identities=30%  Similarity=0.449  Sum_probs=198.9

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.||+|+||+||+|... +|..|++|.+...   .......+.+|+++++.++|+|++++++++.+.+..|+||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            357999999999999864 6889999988632   22334568899999999999999999999999999999999996 


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.... .++++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.....       
T Consensus       105 ~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------  173 (313)
T cd06633         105 GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------  173 (313)
T ss_pred             CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-------
Confidence            58888775433 35899999999999999999999   89999999999999999999999999999864322       


Q ss_pred             ccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          269 VNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                       .....|+..|+|||.+.   ...++.++|||||||++|||++|..|+...............   ......        
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~--------  241 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---DSPTLQ--------  241 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCCCCC--------
Confidence             22346889999999984   456888999999999999999999998765433322222111   111111        


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      .......+.+++.+||+.+|.+||++.+++++.+....+.
T Consensus       242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence            1112245889999999999999999999999988776543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.3e-37  Score=302.37  Aligned_cols=265  Identities=25%  Similarity=0.347  Sum_probs=197.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeecc--Cceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARL-HHRHLVALRGFCIEK--RERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~lv~  183 (458)
                      +.+.+.||+|+||.||+|... +|..+|+|++...  .......+.+|+.++.++ +|+||++++++|...  ...++||
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            345578999999999999875 5889999988532  223345678899999999 999999999998654  3689999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+. ++|..++...   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        89 e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          89 EYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             cccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            9997 5999998753   5889999999999999999999   8999999999999999999999999999998654332


Q ss_pred             cc-cccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc---------
Q 012715          264 IC-FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR---------  332 (458)
Q Consensus       264 ~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------  332 (458)
                      .. .........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...................         
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence            11 0112234568999999998765 567889999999999999999999986543332221111100000         


Q ss_pred             ---cccccC----CcCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          333 ---LAELVD----PRIK--DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       333 ---~~~~~d----~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                         ...+++    ....  ..........+.+++.+||+.+|++||++.+++++.|..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~  299 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA  299 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhh
Confidence               000000    0000  000011235689999999999999999999999986553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.4e-38  Score=285.73  Aligned_cols=272  Identities=22%  Similarity=0.324  Sum_probs=202.8

Q ss_pred             hcccceeeeecceEEEEEEEcC-----CCEEEEEEecccch--hhHhHHHHHHHHHHhcCCCCeeeeeeeeec-cCceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  181 (458)
                      ++....||+|.||.||+|.-.+     ...+|+|+++....  ......++|+.+++.++|+||+.|..++.. +...+|
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            4455689999999999995432     33799999875422  223467899999999999999999999887 778999


Q ss_pred             eeeecCCCCHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC----CcEEEeecc
Q 012715          182 MYEYMANGSLKDHLHSP---GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN----FVAKLADFG  254 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~----~~~kl~DfG  254 (458)
                      ++||.+. +|+..++-+   ....++...+..|+.||+.|+.|||   ++=|+||||||.|||+..+    |.+||+|||
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999987 999988632   2346889999999999999999999   8899999999999999877    899999999


Q ss_pred             cccccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcc------h--HHHHHH
Q 012715          255 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKN------L--VESAQV  325 (458)
Q Consensus       255 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~------~--~~~~~~  325 (458)
                      +++.+.+.-... .....++.|.+|.|||.+.+ ..|+.+.||||.||++.||+|..+.|.+...      .  .+....
T Consensus       182 laR~~~~plkpl-~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  182 LARLFNNPLKPL-ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             HHHHhhcccccc-ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999876543211 12345678999999999987 5799999999999999999998887753211      0  111111


Q ss_pred             HHhhc-----cccccccC-C-----------cCCCCCCHH--------HHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          326 CMASE-----SRLAELVD-P-----------RIKDSFDME--------QLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       326 ~~~~~-----~~~~~~~d-~-----------~~~~~~~~~--------~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ++..-     .+++.+.. |           ......+..        ......+++..+|..||.+|.|+++.+++.++
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            11111     11111110 0           001111000        01236789999999999999999999999999


Q ss_pred             CCCCCC
Q 012715          381 SSDPMH  386 (458)
Q Consensus       381 ~~~~~~  386 (458)
                      ..++.+
T Consensus       341 ~~d~lp  346 (438)
T KOG0666|consen  341 TEDPLP  346 (438)
T ss_pred             ccCCCC
Confidence            988665

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-37  Score=303.66  Aligned_cols=265  Identities=22%  Similarity=0.314  Sum_probs=203.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC-----ceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKR-----ERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  181 (458)
                      +.+.+.||.|+||.||+|... +|..||+|++....  ....+.+.+|+++++.++|+||+++++++....     ..|+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            345678999999999999875 48999999886533  334567899999999999999999999988775     7899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+. ++|.+++....  .+++..++.++.|++.||+|||   +.+++||||||+|||++.++.++|+|||++.....
T Consensus        82 v~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          82 VTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             Eecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            999997 58999987643  6999999999999999999999   89999999999999999999999999999986654


Q ss_pred             CCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc-cc---
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-EL---  336 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~---  336 (458)
                      .... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... +.........+... +.   
T Consensus       156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         156 DEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-DQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHhcCCCChhHhhh
Confidence            3210 0112344678899999999887 8899999999999999999999999654432 21111111110000 00   


Q ss_pred             ---------cCC-cCCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          337 ---------VDP-RIKDSF-----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       337 ---------~d~-~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                               +.. ......     .......+.+++.+||+.+|.+||++++++++.|...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence                     000 000000     0112356889999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.3e-37  Score=290.81  Aligned_cols=238  Identities=19%  Similarity=0.258  Sum_probs=186.5

Q ss_pred             eeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCCCCHHH
Q 012715          116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKD  193 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  193 (458)
                      ||+|+||.||++..+ ++..+|+|.+.......     .|+.....+ +|+||+++++++...+..++||||+++|+|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            599999999999865 68889999875432111     133333323 69999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-cEEEeecccccccCCCCccccccccc
Q 012715          194 HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       194 ~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      ++....  .+++..+..++.|+++||.|||   +.+++||||||+||+++.++ .++|+|||++......        ..
T Consensus        99 ~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--------~~  165 (267)
T PHA03390         99 LLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--------SC  165 (267)
T ss_pred             HHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--------cc
Confidence            997643  6999999999999999999999   89999999999999999988 9999999998765432        22


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchH-HHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV-ESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.||....... ......... ..     ......    ....
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-----~~~~~~----~~~~  235 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK-----KLPFIK----NVSK  235 (267)
T ss_pred             CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc-----cCCccc----ccCH
Confidence            358899999999999899999999999999999999999997432211 111110000 00     001111    2235


Q ss_pred             HHHHHHHHccccCCCCCCC-HHHHHHHhhhC
Q 012715          352 TIVTIVRWCTQREGQARPS-IKQVLRILYES  381 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RPs-~~evl~~l~~~  381 (458)
                      .+.+++.+||+.+|.+||+ ++++++|.|..
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        236 NANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            6889999999999999996 69999988753

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=289.23  Aligned_cols=257  Identities=24%  Similarity=0.355  Sum_probs=204.8

Q ss_pred             HHhhcccceeeeecceEEEEEEEc------CCCEEEEEEecc-cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-Cc
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEK-RE  178 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  178 (458)
                      +....+..++-+|.||.||.|.|.      +.+.|-+|.++. .+.-....++.|.-++..+.|||+..+.+++.+. ..
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            333444567999999999999664      334566777653 3334456788999999999999999999999865 56


Q ss_pred             eeeeeeecCCCCHHHHhc-----C-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          179 RFLMYEYMANGSLKDHLH-----S-PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~-----~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                      ++.+|.++.-|+|..||.     + ...+.++..+...++.|++.||+|||   ++++||.||.++|++||+..++||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEecc
Confidence            789999999999999997     2 22345788899999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      =.|+|..-..+.  .....+...+..||+||.+....|+.++|||||||+||||+| |+.|+.+- +..+..... ..+.
T Consensus       440 saLSRDLFP~DY--hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI-DPfEm~~yl-kdGy  515 (563)
T KOG1024|consen  440 SALSRDLFPGDY--HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI-DPFEMEHYL-KDGY  515 (563)
T ss_pred             chhccccCcccc--cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc-CHHHHHHHH-hccc
Confidence            999997655543  233444556889999999999999999999999999999988 67777543 333433332 2232


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ++          ..+..++.++..+|..||..+|++||+++|+...|.+
T Consensus       516 Rl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  516 RL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            22          2234566889999999999999999999999998865

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-37  Score=302.78  Aligned_cols=255  Identities=23%  Similarity=0.381  Sum_probs=192.7

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC------ceeeee
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERFLMY  183 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~  183 (458)
                      .+.||+|+||.||+|... +|..||||++...  .......+.+|+++++.++|+||+++++++....      ..++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            468999999999999864 6899999988642  2223456889999999999999999999987543      458999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+.. +|..++.    ..+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++..... 
T Consensus       100 e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-  170 (342)
T cd07879         100 PYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-  170 (342)
T ss_pred             ccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence            99964 7877763    24889999999999999999999   899999999999999999999999999998754322 


Q ss_pred             cccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc-----
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV-----  337 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  337 (458)
                            .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....................++.     
T Consensus       171 ------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         171 ------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             ------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence                  123457889999999876 46889999999999999999999999754433222221111000000000     


Q ss_pred             -------C--CcC-CCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 -------D--PRI-KDSFD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 -------d--~~~-~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                             +  +.. +....   ......+.+++.+||+.||.+||++.+++.|.|+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence                   0  000 00000   012245789999999999999999999999877643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8e-37  Score=294.68  Aligned_cols=259  Identities=20%  Similarity=0.239  Sum_probs=182.1

Q ss_pred             hhcccceeeeecceEEEEEEEcC----CCEEEEEEecccchhhH-----------hHHHHHHHHHHhcCCCCeeeeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKISEQVE-----------GDFCREIELLARLHHRHLVALRGFC  173 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~~~  173 (458)
                      .+.+.++||+|+||+||+|.+.+    +..+|+|..........           .....+...+..+.|+|++++++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   92 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG   92 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence            34566789999999999998754    34566665322111110           1122334445566899999999977


Q ss_pred             eccC----ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEE
Q 012715          174 IEKR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAK  249 (458)
Q Consensus       174 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~k  249 (458)
                      ....    ..+++++++. .++.+.+...  ...++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++
T Consensus        93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         93 SFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            6543    3467788774 4677766542  23578888999999999999999   89999999999999999999999


Q ss_pred             EeecccccccCCCCccc---ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHH
Q 012715          250 LADFGLAHASKDGSICF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC  326 (458)
Q Consensus       250 l~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  326 (458)
                      |+|||+++.........   ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            99999998653221111   111233469999999999999999999999999999999999999997553222211111


Q ss_pred             HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       327 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      ..  .....+..+.+..   ...+..+.+++..|+..+|++||++.++++.+
T Consensus       247 ~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        247 KC--DFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HH--HHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00  0001111111100   11236789999999999999999999999875

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-37  Score=302.22  Aligned_cols=260  Identities=23%  Similarity=0.324  Sum_probs=196.7

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-----Cceeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFLM  182 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  182 (458)
                      ...+.||+|+||+||+|... +|..||||.+...  .......+.+|+.+++.++|+||+++++++...     ...++|
T Consensus         8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv   87 (337)
T cd07858           8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV   87 (337)
T ss_pred             eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence            34568999999999999764 6899999988642  223345678899999999999999999988654     357999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+. ++|.+++...+  .+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          88 YELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             EeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            99996 69999987643  5899999999999999999999   899999999999999999999999999999865433


Q ss_pred             CcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-----cc---
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-----RL---  333 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-----~~---  333 (458)
                      ..    ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..... ...........+     ..   
T Consensus       162 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         162 GD----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             cc----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhc
Confidence            21    1233457889999998865 5689999999999999999999999864322 111111110000     00   


Q ss_pred             ------------ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          334 ------------AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       334 ------------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                  ....++.... ........+.+++.+||+.+|++||+++++++|.|...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence                        0000000000 00122356889999999999999999999999987643

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7e-37  Score=288.26  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=201.6

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|+||.||++... ++..+|+|.+...  .......+.+|+++++.++|+||+++++++.+....++||||++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            45678999999999999765 6889999988643  23334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          188 NGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       188 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|.+++...  ....+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++......  
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--  157 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--  157 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence            99999998642  2245899999999999999999999   9999999999999999999999999999998765431  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                          .....++..|++||.+.+..++.++|+||||+++|||++|+.||..... .+......  .....         ..
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~--~~~~~---------~~  221 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLRYKVQ--RGKYP---------PI  221 (256)
T ss_pred             ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh--cCCCC---------CC
Confidence                1234578899999999999999999999999999999999999965432 22211111  11111         11


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      .......+.+++.+|++.+|++||++.++++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             chhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence            123346689999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-37  Score=306.20  Aligned_cols=249  Identities=27%  Similarity=0.403  Sum_probs=205.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+...||+|.|++|.+|+.. ++..||||.+++..  ......+.+|+++|..++|||||+++.+......+|+||||+
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya  137 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA  137 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence            345678999999999999765 69999999987643  233355899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      .+|.+++|+..++.  .....+..++.|+..+++|||   .++|+|||||++||||+.+.++||+|||++..+..+.   
T Consensus       138 ~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~---  209 (596)
T KOG0586|consen  138 SGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL---  209 (596)
T ss_pred             cCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc---
Confidence            99999999987765  555888899999999999999   9999999999999999999999999999998776543   


Q ss_pred             ccccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        .....+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||.+ .++.+.....+....+++..+.       
T Consensus       210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~rIp~~ms-------  279 (596)
T KOG0586|consen  210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYRIPFYMS-------  279 (596)
T ss_pred             --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeecccceee-------
Confidence              3456789999999999998876 4789999999999999999999963 3333322222222222221111       


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                           ....+++++++..+|.+|++++++.++-|-.
T Consensus       280 -----~dce~lLrk~lvl~Pskr~~~dqim~~~W~n  310 (596)
T KOG0586|consen  280 -----CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN  310 (596)
T ss_pred             -----chhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence                 2356799999999999999999999987654

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.7e-37  Score=294.95  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=198.0

Q ss_pred             cccceeeeecceEEEEEEE----cCCCEEEEEEecccc----hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceee
Q 012715          111 NFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.||+|+||.||++..    .+|..||+|.+....    ....+.+.+|++++.++ +|+||+++++++..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            4567899999999999976    368899999986432    22335678899999999 58999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||+|+|||++.++.+||+|||++.....
T Consensus        83 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          83 ILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            99999999999999764  35889999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCcccccccccccCCCccccccccccC--CCCcccccHhHHHHHHHHHhCCCccCCCcc---hHHHHHHHHhhccccccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LVESAQVCMASESRLAEL  336 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~  336 (458)
                      ....   ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.....   ..+.........      
T Consensus       158 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------  228 (290)
T cd05613         158 DEVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------  228 (290)
T ss_pred             cccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC------
Confidence            2211   12234588999999998753  467899999999999999999999863221   122222111111      


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES  381 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~  381 (458)
                        +....    .....+.+++.+||+.+|++||     ++++++++.+..
T Consensus       229 --~~~~~----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  272 (290)
T cd05613         229 --PPYPQ----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ  272 (290)
T ss_pred             --CCCCc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccc
Confidence              11111    1235688999999999999997     889999987654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.1e-37  Score=293.11  Aligned_cols=252  Identities=26%  Similarity=0.353  Sum_probs=203.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|... +|..||+|.+...   .......+.+|++++.+++ |+||+++++++.+++..++|||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            345678999999999999875 6899999988642   2333467889999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++++|.+++...+  .+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          83 YAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            999999999997643  5999999999999999999999   89999999999999999999999999999976543221


Q ss_pred             cc----------------ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHh
Q 012715          265 CF----------------EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA  328 (458)
Q Consensus       265 ~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~  328 (458)
                      ..                ........++..|+|||.+....++.++||||||++++++++|+.||...... ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~  236 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQKILK  236 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh
Confidence            00                01223345788999999998888999999999999999999999999754422 21222111


Q ss_pred             hccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHhh
Q 012715          329 SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSI----KQVLRILY  379 (458)
Q Consensus       329 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~  379 (458)
                      ...            .++......+.+++.+||+.+|.+||++    +++++|.|
T Consensus       237 ~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         237 LEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             cCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence            111            1111223568899999999999999999    99998865

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-37  Score=293.04  Aligned_cols=260  Identities=27%  Similarity=0.349  Sum_probs=200.3

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.||+|+||.||+|... +++.||+|.+....  ......+.+|++++++++|+|++++++++.+.+..++||||+. 
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence            4467999999999999876 48999999987542  3334678899999999999999999999999999999999997 


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.... ..+++..+..++.|++.||+|||   ..+++||||+|+||++++++.+||+|||+++.......    
T Consensus        82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----  153 (282)
T cd07829          82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR----  153 (282)
T ss_pred             cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc----
Confidence            59999997643 35999999999999999999999   88999999999999999999999999999976543321    


Q ss_pred             ccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc----cc---cccc--cC
Q 012715          269 VNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE----SR---LAEL--VD  338 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~---~~~~--~d  338 (458)
                      ......++..|+|||.+.+. .++.++|||||||++|||++|+.||.................    ..   ..++  .+
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            12234467889999998766 889999999999999999999988865443322211110000    00   0000  00


Q ss_pred             CcCC---CC-C---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          339 PRIK---DS-F---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       339 ~~~~---~~-~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ....   .. .   .......+.+++..||+.+|++||++.+++++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0000   00 0   00113569999999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=259.01  Aligned_cols=260  Identities=25%  Similarity=0.333  Sum_probs=206.9

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEec--ccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      ++||+|.||+||+|+.. .++.||+|++.  ..++.......+|+-+|+.++|.|||++++....++..-+|+|||.. +
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d   86 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D   86 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence            47999999999999865 58899999875  33444456788999999999999999999999999999999999964 8


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |..|..+..+ .++...+..++.|+++||.|+|   ++++.||||||.|.||+.+|++|++|||+++.++-.-.+    .
T Consensus        87 lkkyfdslng-~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc----y  158 (292)
T KOG0662|consen   87 LKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC----Y  158 (292)
T ss_pred             HHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe----e
Confidence            9888876543 4889999999999999999999   999999999999999999999999999999987655433    3


Q ss_pred             ccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc--------cccccCCcC
Q 012715          271 TDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR--------LAELVDPRI  341 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~d~~~  341 (458)
                      ...+.|.+|.+|.++.+. -|+...|+||-||++.|+.....|...+.+..+....+...-+.        +..+.|...
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            345679999999999875 58899999999999999999888888887777666554432222        222222222


Q ss_pred             CCCCC----HH-HH----HHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          342 KDSFD----ME-QL----RTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       342 ~~~~~----~~-~~----~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      -..++    .. ..    ..=.+++...+.-+|..|.++++.+++.++..
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence            11121    11 11    23356777777889999999999999998753

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.1e-36  Score=298.88  Aligned_cols=264  Identities=23%  Similarity=0.336  Sum_probs=194.3

Q ss_pred             cccceeeeecceEEEEEEEc-C--CCEEEEEEeccc--chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeecc----Ccee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-D--GSLIAVKRMDKI--SEQVEGDFCREIELLARL-HHRHLVALRGFCIEK----RERF  180 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~~  180 (458)
                      .+.+.||+|+||.||++... +  +..||+|++...  .......+.+|+++++++ +|+||+++++++...    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            45678999999999999875 3  779999988642  222345688999999999 599999999875432    4578


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +++||+. ++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          83 LYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            8889885 6999998653  35899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc----ccc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----LAE  335 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~  335 (458)
                      ..............|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...................    +..
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            332211112234568999999998765 568999999999999999999999986543221111111000000    000


Q ss_pred             ccCC-----------cCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          336 LVDP-----------RIKDSF---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       336 ~~d~-----------~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +.++           .-...+   .......+.+++.+|++.||.+||++.+++++.|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            0000           000000   00113568899999999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-36  Score=295.42  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=195.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC--------c
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKR--------E  178 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~  178 (458)
                      +.+.+.||.|+||.||+|... ++..+|+|++....  ......+.+|+++++.++|+||+++++++.+..        .
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   89 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS   89 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence            445678999999999999875 58899999885322  222346789999999999999999999875543        4


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      .++|+||+.+ +|...+.... ..+++..+..++.|+++||+|||   +.+++|+||||+||++++++.+||+|||+++.
T Consensus        90 ~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          90 VYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             EEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence            6999999965 7887776533 35999999999999999999999   89999999999999999999999999999975


Q ss_pred             cCCCCccc-------ccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc
Q 012715          259 SKDGSICF-------EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE  330 (458)
Q Consensus       259 ~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  330 (458)
                      ........       ....+...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+......... .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~-~~~~~  243 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL-IFKLC  243 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHh
Confidence            54322110       011233467888999998765 4588999999999999999999999865444322221 11111


Q ss_pred             cc-----------cccccCCcCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          331 SR-----------LAELVDPRIKDSFD-------MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       331 ~~-----------~~~~~d~~~~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..           +....+.......+       ......+.+++.+||+.||.+|||+.+++.+.|+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            00           01100000000000       0112568899999999999999999999998753

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=284.55  Aligned_cols=243  Identities=26%  Similarity=0.373  Sum_probs=198.7

Q ss_pred             eeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      ||.|+||.||++... +++.+|+|.+....   ......+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 58999999886432   22345788999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT  271 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  271 (458)
                      .+++....  .+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++........    ...
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~  151 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS----RTN  151 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC----ccc
Confidence            99997643  5899999999999999999999   89999999999999999999999999999876544321    123


Q ss_pred             cccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       272 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      ...++..|++||.+.+...+.++|+||||+++|||++|+.||..... ...........        ..+...    ...
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~--------~~~~~~----~~~  218 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILKDP--------LRFPEF----LSP  218 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhcCC--------CCCCCC----CCH
Confidence            45678899999999888889999999999999999999999964432 22222222111        111111    135


Q ss_pred             HHHHHHHHccccCCCCCCCH---HHHHHHhhh
Q 012715          352 TIVTIVRWCTQREGQARPSI---KQVLRILYE  380 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RPs~---~evl~~l~~  380 (458)
                      .+.+++.+||..||++||++   +++++|.|+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            68899999999999999999   888887653

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-36  Score=287.81  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=195.5

Q ss_pred             hcccceeeeecceEEEEEEEcC-CCEEEEEEeccc-----chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+.||+|+||.||++.... +..+++|.++..     .......+..|+.+++.++||||+++++++.+.+..++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            3456789999999999997653 445556655421     2223345778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          184 EYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       184 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||+++++|.+++..  .....+++..++.++.|++.||.|||   +.+++|+||+|+||++++ +.+||+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999998863  22346899999999999999999999   899999999999999975 5699999999876543


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ...    ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+...... ........  .     ..+. 
T Consensus       158 ~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-~~~~~~~~--~-----~~~~-  224 (260)
T cd08222         158 SCD----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-SVVLRIVE--G-----PTPS-  224 (260)
T ss_pred             Ccc----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHc--C-----CCCC-
Confidence            221    123345788999999998888899999999999999999999998643322 22221111  1     1111 


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                         .+......+.+++.+||+.+|++||++.+++++.|
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         225 ---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             ---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence               12233457889999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-36  Score=299.04  Aligned_cols=258  Identities=22%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC------cee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  180 (458)
                      +...+.||+|+||.||+|... +|..||||++...  .......+.+|++++++++|+||+++++++....      ..+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07880          17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY   96 (343)
T ss_pred             eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence            334578999999999999764 6899999988532  2233456889999999999999999999887653      358


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+ +++|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        97 lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          97 LVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            999999 7799988864   34899999999999999999999   8999999999999999999999999999987553


Q ss_pred             CCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc-c---
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-E---  335 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~---  335 (458)
                      ..       .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ........ +   
T Consensus       170 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~  241 (343)
T cd07880         170 SE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI-MKVTGTPSKEFVQ  241 (343)
T ss_pred             cC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHhcCCCCHHHHH
Confidence            32       123457889999998876 45889999999999999999999999755432222111 11110000 0   


Q ss_pred             ccC-----------CcCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          336 LVD-----------PRIKD----SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       336 ~~d-----------~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .+.           +....    .........+.+++.+|++.||++||++.+++++.|+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~  303 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE  303 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence            000           00000    000112245889999999999999999999999887643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-36  Score=296.79  Aligned_cols=265  Identities=22%  Similarity=0.329  Sum_probs=196.9

Q ss_pred             HHHHHhhcc--cceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--
Q 012715          104 ETKKATDNF--STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--  176 (458)
Q Consensus       104 ~~~~~~~~~--~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  176 (458)
                      ++...+++|  .+.||+|+||.||+|... +|..||+|++....  ....+.+.+|++++.+++|+||+++++++...  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            333344444  468999999999999764 68999999986432  22345688899999999999999999987643  


Q ss_pred             ----CceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          177 ----RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       177 ----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                          ...+++++++ +++|.+++...   .+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEec
Confidence                3467888876 78999888642   4899999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      ||+++.....       .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..................
T Consensus       164 fg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         164 FGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             cccccccccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9998754332       223467889999998866 56889999999999999999999998644332221111110000


Q ss_pred             cccccc---------------CCcCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          332 RLAELV---------------DPRIKDSFD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       332 ~~~~~~---------------d~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ....+.               .......+.   ......+.+++.+|++.||.+||++.++++|.|+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~  305 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  305 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence            000000               000000000   011245789999999999999999999999988754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=281.76  Aligned_cols=267  Identities=23%  Similarity=0.375  Sum_probs=207.2

Q ss_pred             CHHHHHHHhhcccceeeeecceEEEEEE-EcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCc
Q 012715          101 SYKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRE  178 (458)
Q Consensus       101 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  178 (458)
                      .+.+..+-|.+   +||+|+|+.|-.+. +.+|.+||||++.+...-......+|++++.+++ |+||++|++||.++..
T Consensus        74 ~F~d~YkLt~e---~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   74 KFEDMYKLTSE---LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             hHHHHHHhHHH---HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            35666665544   79999999999884 5689999999998877677778999999999996 9999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC---cEEEeeccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFGL  255 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGl  255 (458)
                      +|||||-|.||+|..+|+++  ..|++.++.++.++|+.||.|||   .+||.||||||+|||-....   -+|||||.|
T Consensus       151 FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence            99999999999999999874  45999999999999999999999   99999999999999996543   589999998


Q ss_pred             ccccCCCCcc---cccccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcc---------
Q 012715          256 AHASKDGSIC---FEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKN---------  318 (458)
Q Consensus       256 a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~---------  318 (458)
                      ..........   ..+....-+|+..|||||+..     ...|+.++|.||||||||-|++|.+||.+.-.         
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            8643322211   112234567889999999763     24688999999999999999999999964211         


Q ss_pred             hHHHHHHHHhhccccccccCCcCCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          319 LVESAQVCMASESRLAELVDPRIKDSFDM----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .-...+..+     +..+-+.  +-+|+.    ....+..+++...+..|+.+|.++.++++|+|...
T Consensus       306 ~Cr~CQ~~L-----FesIQEG--kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~  366 (463)
T KOG0607|consen  306 VCRVCQNKL-----FESIQEG--KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR  366 (463)
T ss_pred             ccHHHHHHH-----HHHHhcc--CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence            111111110     0001111  012222    12356778889999999999999999999988654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=283.67  Aligned_cols=250  Identities=23%  Similarity=0.368  Sum_probs=205.6

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .|.++||+|.||+|.+++-+ .|+.+|+|++++.   .......-+.|-++|+..+||.+..|-..+...+.+|+||||.
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya  250 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA  250 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence            35678999999999999876 6999999998752   2333445678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      .||.|.-+|..  ...+++.....+..+|..||.|||   +++|++||||.+|.|+|.+|.+||+|||||+..-.    +
T Consensus       251 nGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~----~  321 (516)
T KOG0690|consen  251 NGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK----Y  321 (516)
T ss_pred             cCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc----c
Confidence            99999999976  345899999999999999999999   99999999999999999999999999999985321    1


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      -.....++||+.|+|||++....|..++|.|.+||++|||++|+.||..... ......++..+-+++..        .+
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLIl~ed~kFPr~--------ls  392 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELILMEDLKFPRT--------LS  392 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHHHhhhccCCcc--------CC
Confidence            2245678999999999999999999999999999999999999999975433 23333333333232222        22


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                          .+...++...|..||.+|.     +++||.+|-++..
T Consensus       393 ----~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  393 ----PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             ----HHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence                3466788999999999995     5888888877653

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=306.35  Aligned_cols=255  Identities=29%  Similarity=0.421  Sum_probs=195.0

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Cceeeeee
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLMYE  184 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  184 (458)
                      .+.||+|+||.||+|+.+ .|+.||||.++.. .....+.+.+|+++|++++|+|||++++.=.+.      ....+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            457999999999999965 7999999988753 334456789999999999999999999875443      35689999


Q ss_pred             ecCCCCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC--CCC--cEEEeeccccccc
Q 012715          185 YMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENF--VAKLADFGLAHAS  259 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~--~~~--~~kl~DfGla~~~  259 (458)
                      ||.||||...|++.. ..+|++.+.+.+..++..||.|||   +++|+||||||.||++-  ++|  .-||+|||.|+..
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999998643 357999999999999999999999   99999999999999993  334  5799999999998


Q ss_pred             CCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcch---HHHHHHHHh-hccccc
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL---VESAQVCMA-SESRLA  334 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~---~~~~~~~~~-~~~~~~  334 (458)
                      .++.     ..+..+||..|.+||.+.. +.|+..+|.|||||++||.+||..||-.....   .+....... ......
T Consensus       175 ~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  175 DDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             CCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            8876     4567889999999999984 88999999999999999999999999643332   112211111 111010


Q ss_pred             cccCCc----C--------CCCCCHHHHHHHHHHHHHccccCCCCCC--CHHHHH
Q 012715          335 ELVDPR----I--------KDSFDMEQLRTIVTIVRWCTQREGQARP--SIKQVL  375 (458)
Q Consensus       335 ~~~d~~----~--------~~~~~~~~~~~l~~l~~~cl~~dp~~RP--s~~evl  375 (458)
                      -..++.    +        ...........+-..+..+|..+|++|.  ...+..
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~F  304 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFF  304 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHH
Confidence            001111    0        1112233445667777778888899998  444433

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-36  Score=298.18  Aligned_cols=264  Identities=21%  Similarity=0.265  Sum_probs=196.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------------
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK------------  176 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------------  176 (458)
                      +.+.+.||.|+||.||+|... +|..||+|.+........+.+.+|++++++++|+||+++++++...            
T Consensus         7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (342)
T cd07854           7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT   86 (342)
T ss_pred             eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence            445678999999999999875 5899999998655555566788999999999999999999876543            


Q ss_pred             --CceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC-CCCcEEEeec
Q 012715          177 --RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADF  253 (458)
Q Consensus       177 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~-~~~~~kl~Df  253 (458)
                        ...++||||+. ++|.+++...   .+++..+..++.||+.||.|||   +.+++||||||+||+++ +++.+||+||
T Consensus        87 ~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          87 ELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             ccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCc
Confidence              35789999997 5999888642   4889999999999999999999   89999999999999997 4668999999


Q ss_pred             ccccccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-  331 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-  331 (458)
                      |+++........ ........++..|+|||.+.. ..++.++|||||||++|||++|+.||.................. 
T Consensus       160 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         160 GLARIVDPHYSH-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             ccceecCCcccc-ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            998754322110 011123457889999997754 56888999999999999999999999755443322211110000 


Q ss_pred             ----------ccccccC-CcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          332 ----------RLAELVD-PRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       332 ----------~~~~~~d-~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                ....... .......+     ......+.+++..||+.||.+||++.++++|.|..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence                      0000000 00000000     01225688999999999999999999999998875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-36  Score=291.07  Aligned_cols=250  Identities=22%  Similarity=0.286  Sum_probs=194.1

Q ss_pred             cccceeeeecceEEEEEEE----cCCCEEEEEEecccc----hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceee
Q 012715          111 NFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.||+|+||.||++..    .++..||||.+....    ......+.+|++++.++ +|+||+++++.+..+...++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            4567899999999999964    257889999886422    22335688999999999 59999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.++|+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          83 ILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            99999999999998753  35889999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCcccccccccccCCCccccccccccCC--CCcccccHhHHHHHHHHHhCCCccCCCcch---HHHHHHHHhhccccccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARRAVQDGKNL---VESAQVCMASESRLAEL  336 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~  336 (458)
                      ....   ......|+..|+|||.+.+..  .+.++||||||+++|||++|..||......   .+........       
T Consensus       158 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------  227 (288)
T cd05583         158 EEEE---RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-------  227 (288)
T ss_pred             cccc---ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-------
Confidence            2211   122345889999999987654  788999999999999999999998643221   1111111111       


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH---HHHhhh
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV---LRILYE  380 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev---l~~l~~  380 (458)
                       .+.....++    ..+.+++.+||+.+|++|||+.++   ++++|.
T Consensus       228 -~~~~~~~~~----~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~  269 (288)
T cd05583         228 -KPPFPKTMS----AEARDFIQKLLEKDPKKRLGANGADEIKNHPFF  269 (288)
T ss_pred             -CCCCCcccC----HHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence             111222222    457889999999999999996655   555443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.6e-36  Score=292.74  Aligned_cols=258  Identities=24%  Similarity=0.341  Sum_probs=195.1

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec-cCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  186 (458)
                      .+.+.||.|+||.||+|... +|..||+|++...  .......+.+|++++..++||||+++++++.. .+..++|+||+
T Consensus        13 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~   92 (328)
T cd07856          13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL   92 (328)
T ss_pred             EEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh
Confidence            34578999999999999765 7899999987532  22334568899999999999999999998865 56789999998


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                       +++|.+++...   ++++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||++......    
T Consensus        93 -~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----  161 (328)
T cd07856          93 -GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----  161 (328)
T ss_pred             -ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence             56999988642   4788888999999999999999   899999999999999999999999999998754321    


Q ss_pred             ccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc------------cc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES------------RL  333 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------------~~  333 (458)
                         .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..................            ..
T Consensus       162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence               123457889999998765 56899999999999999999999998644322111110000000            00


Q ss_pred             cccc-CCcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          334 AELV-DPRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       334 ~~~~-d~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .++. .-......+.     .....+.+++.+||+.+|++||++.+++.+.|...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~  293 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP  293 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence            0000 0000001111     12357899999999999999999999999987644

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-36  Score=298.81  Aligned_cols=257  Identities=22%  Similarity=0.338  Sum_probs=197.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc------eee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE------RFL  181 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l  181 (458)
                      .+.+.||+|+||.||+|... ++..||+|++...  .......+.+|+.++++++|+||+++++++...+.      .++
T Consensus        18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07851          18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL   97 (343)
T ss_pred             EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence            34578999999999999876 5789999987642  22334567889999999999999999998766554      899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      |+||+ +++|.+++..   ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus        98 v~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          98 VTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             EEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            99998 6799999875   35899999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc-ccc--
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-ELV--  337 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~--  337 (458)
                      .       .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .......+... .+.  
T Consensus       171 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         171 E-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL-KRIMNLVGTPDEELLQK  242 (343)
T ss_pred             c-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCCHHHHhh
Confidence            2       223457889999998865 46789999999999999999999999755433222 21111111000 000  


Q ss_pred             ----------C---CcCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 ----------D---PRIKDSFD---MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 ----------d---~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                .   ......+.   ......+.+++.+||+.+|.+|||+.+|++|.|...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~  303 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE  303 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence                      0   00000000   012357899999999999999999999999987653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=282.88  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=199.0

Q ss_pred             eeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      .||.|+||+|+|-.++ .|+..|||++.... .....+++.|.+...+- +.||||+++|.+...+..|+.||.|+ .||
T Consensus        71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~Sl  149 (361)
T KOG1006|consen   71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISL  149 (361)
T ss_pred             HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhH
Confidence            5999999999999876 69999999997543 35567889999877666 68999999999999999999999995 466


Q ss_pred             HHHh---cCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          192 KDHL---HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       192 ~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      +.+-   .......+++.-+-.|+.....||.||.+  ...|||||+||+|||++..|.+||||||++-.+.+.     .
T Consensus       150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-----i  222 (361)
T KOG1006|consen  150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-----I  222 (361)
T ss_pred             HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH-----H
Confidence            6543   22233458888888899999999999986  678999999999999999999999999998655432     2


Q ss_pred             ccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          269 VNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      ..+...|...|||||.+..  ..|+.++||||||++|+|+.||+.|+....+..+........  ..+.+..+.-.    
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g--dpp~l~~~~~~----  296 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG--DPPILLFDKEC----  296 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC--CCCeecCcccc----
Confidence            3455678999999999864  358999999999999999999999998766655544443332  22222222111    


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ......+..++..|+..|-..||++.+++++.+
T Consensus       297 ~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f  329 (361)
T KOG1006|consen  297 VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF  329 (361)
T ss_pred             cccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence            223356899999999999999999999998754

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=275.19  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=198.7

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeec----cCceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE----KRERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~  187 (458)
                      ++||-|-.|.|-.+..+ +|+.+|+|.+...     ....+|+++--.. .|+|||.+++++..    ...+++|||+|+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            58999999999999765 6899999988643     2456888876666 59999999998764    357789999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~~  264 (458)
                      ||.|...+++++...+++.++-.|..||..|+.|||   ..+|.||||||+|+|.+.   |-.+||+|||+|+...... 
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~-  218 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG-  218 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCCc-
Confidence            999999999999889999999999999999999999   999999999999999964   5689999999998765432 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch--HH-HHHHHHhhccccccccCCcC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VE-SAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--~~-~~~~~~~~~~~~~~~~d~~~  341 (458)
                          ....-+-|+.|.|||++...+|+...|+||+||++|-|++|.+||......  .. ....+......++   +++ 
T Consensus       219 ----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP---~pE-  290 (400)
T KOG0604|consen  219 ----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP---EPE-  290 (400)
T ss_pred             ----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC---Chh-
Confidence                223445789999999999999999999999999999999999999743221  11 1111111111110   000 


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                          =....+...++|+.+|..+|.+|.|++++++|.|-..
T Consensus       291 ----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~  327 (400)
T KOG0604|consen  291 ----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ  327 (400)
T ss_pred             ----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence                0123467889999999999999999999999999765

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.6e-35  Score=314.53  Aligned_cols=143  Identities=30%  Similarity=0.417  Sum_probs=127.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|.+. +++.||||.+....   ......+.+|+.++..++|+||+++++++...+..||||||
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy   85 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY   85 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence            345678999999999999876 68999999986432   23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      +.+++|.+++...+  .+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          86 LIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999997543  4888999999999999999999   8899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7e-36  Score=278.93  Aligned_cols=227  Identities=20%  Similarity=0.218  Sum_probs=181.7

Q ss_pred             ecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcC
Q 012715          119 GGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS  197 (458)
Q Consensus       119 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  197 (458)
                      |.||.||++... +++.||+|.+....     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999875 68999999986533     233455556666799999999999999999999999999999999875


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCC
Q 012715          198 PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP  277 (458)
Q Consensus       198 ~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~  277 (458)
                      ..  .+++..+..++.|++.||+|||   +++++||||||+||+++.++.++++|||++.......       ....++.
T Consensus        79 ~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~  146 (237)
T cd05576          79 FL--NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------DGEAVEN  146 (237)
T ss_pred             hc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-------ccCCcCc
Confidence            43  4899999999999999999999   8999999999999999999999999999876544321       2234577


Q ss_pred             ccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHH
Q 012715          278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIV  357 (458)
Q Consensus       278 ~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~  357 (458)
                      .|+|||.+.+..++.++||||+|+++|||++|..++.......             .......+...    ....+.+++
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~~~~~~~----~~~~~~~li  209 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTTLNIPEW----VSEEARSLL  209 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccccccCCccc----CCHHHHHHH
Confidence            8999999988889999999999999999999998764321110             00000111111    225688999


Q ss_pred             HHccccCCCCCCCH-----HHHHHHhh
Q 012715          358 RWCTQREGQARPSI-----KQVLRILY  379 (458)
Q Consensus       358 ~~cl~~dp~~RPs~-----~evl~~l~  379 (458)
                      .+|++.||++||++     +++++|.|
T Consensus       210 ~~~l~~dp~~R~~~~~~~~~~~~~h~~  236 (237)
T cd05576         210 QQLLQFNPTERLGAGVAGVEDIKSHPF  236 (237)
T ss_pred             HHHccCCHHHhcCCCccchHHHHcCCC
Confidence            99999999999996     77877754

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=283.37  Aligned_cols=245  Identities=25%  Similarity=0.363  Sum_probs=199.1

Q ss_pred             HHHHHhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCc
Q 012715          104 ETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE  178 (458)
Q Consensus       104 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  178 (458)
                      .++.+..||..+||+|+||.|.+|..+ +.+.+|||++++.   .....+--+.|-++|... +-|.+++++.++..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            445555788999999999999999765 4678999998752   222233345677777766 46899999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      +|+||||+.||+|.-++++.++  +.+..+.-+|.+||-||-|||   +++||+||||.+|||+|.+|.+||+|||+++.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccc
Confidence            9999999999999999988765  778888999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                      .--+.    ......+||+.|+|||++..++|+.++|.|||||+||||+.|++||. +.+..+..+.+....-       
T Consensus       500 ni~~~----~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd-GeDE~elF~aI~ehnv-------  567 (683)
T KOG0696|consen  500 NIFDG----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQAIMEHNV-------  567 (683)
T ss_pred             cccCC----cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHHccC-------
Confidence            43222    23456899999999999999999999999999999999999999995 4555566555443221       


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPS  370 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs  370 (458)
                           .++.....+...+....+...|.+|..
T Consensus       568 -----syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 -----SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -----cCcccccHHHHHHHHHHhhcCCccccC
Confidence                 222233356778888899999999954

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=290.92  Aligned_cols=249  Identities=25%  Similarity=0.387  Sum_probs=208.1

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      ++||.|.||+||-|.++ +|+.||||.+.+.  ....+.++.+|+.||++++||.||.|.-.|...+..++|||-+.|.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            68999999999999765 7999999998753  34445789999999999999999999999999999999999996644


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCCCCcccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      |.-.|.+ ....|++.....+..||+.||.|||   -++|+|+||||+|||+..   --++||||||+|+..++..    
T Consensus       650 LEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks----  721 (888)
T KOG4236|consen  650 LEMILSS-EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS----  721 (888)
T ss_pred             HHHHHHh-hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh----
Confidence            4444443 3345888888889999999999999   899999999999999964   3489999999999988765    


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                       ....++||+.|+|||++..+.|...-|+||.||++|--++|.-||.++.++.+..+..       .-+..+..+.+.+ 
T Consensus       722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA-------aFMyPp~PW~eis-  792 (888)
T KOG4236|consen  722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA-------AFMYPPNPWSEIS-  792 (888)
T ss_pred             -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc-------ccccCCCchhhcC-
Confidence             3467889999999999999999999999999999999999999999888887765531       1122233333333 


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                         ....++|...|+..-++|-+.++.+.|.|-..
T Consensus       793 ---~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  793 ---PEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             ---HHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence               45778999999999999999999999987543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=280.83  Aligned_cols=272  Identities=19%  Similarity=0.289  Sum_probs=211.9

Q ss_pred             cCHHHHHHHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-C-C----Ceeeeeee
Q 012715          100 FSYKETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-H-R----HLVALRGF  172 (458)
Q Consensus       100 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~  172 (458)
                      |...+.....+....++|+|.||.|-.+... .+..||||+++..... .+..+-|+++|+++. + |    -+|.+.+|
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            4445555556666778999999999999654 4789999998765544 345677999999994 2 2    36788888


Q ss_pred             eeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC--------
Q 012715          173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE--------  244 (458)
Q Consensus       173 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~--------  244 (458)
                      +...++.+||+|.+ |-|++++|..++-.+++...+..|+.|++++++|||   +.+++|-||||+|||+.+        
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEec
Confidence            99999999999988 669999999988889999999999999999999999   999999999999999921        


Q ss_pred             ------------CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCc
Q 012715          245 ------------NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRA  312 (458)
Q Consensus       245 ------------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p  312 (458)
                                  +..+||+|||-|+......       ...+.|..|.|||++.+-.++..+||||+||||.||.||...
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                        2358999999998655432       456789999999999999999999999999999999999999


Q ss_pred             cCCCcchHHHHHHHHhhccccccccCCc----------C--------------CC---------CCCHHHHHHHHHHHHH
Q 012715          313 VQDGKNLVESAQVCMASESRLAELVDPR----------I--------------KD---------SFDMEQLRTIVTIVRW  359 (458)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~----------~--------------~~---------~~~~~~~~~l~~l~~~  359 (458)
                      |+...+....+......++....++...          +              .+         .....+...|.+++++
T Consensus       309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~  388 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR  388 (415)
T ss_pred             cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence            9876655433222111111111111110          0              00         0122344679999999


Q ss_pred             ccccCCCCCCCHHHHHHHhhhCCC
Q 012715          360 CTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       360 cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      +|..||.+|+|+.|++.|.++...
T Consensus       389 mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  389 MLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HHccCccccccHHHHhcCHHhhcC
Confidence            999999999999999999988653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=298.62  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=211.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeec-----cCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE-----KRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv  182 (458)
                      ..|.+.||+|.+|.||+++.. +|+.+|+|++.... ...++...|.++|+.+ .|||++.++|++..     ++.+|||
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            346779999999999999754 78899999876433 3345677899999988 59999999999864     4689999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      ||||.+||..|+++...+..+.|..+..|+..++.||.+||   .+.++|||||-.|||++.++.+||+|||++......
T Consensus       100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST  176 (953)
T ss_pred             eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence            99999999999998766777999999999999999999999   999999999999999999999999999999766543


Q ss_pred             CcccccccccccCCCccccccccccC-----CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQ-----ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      .    .......||+.|||||++...     .|+..+|+||||++..||.-|.+|+.+.......+.+.   .       
T Consensus       177 ~----grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---R-------  242 (953)
T KOG0587|consen  177 V----GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---R-------  242 (953)
T ss_pred             c----ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---C-------
Confidence            2    234567899999999999653     57789999999999999999999998765554433321   1       


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .|..+...+....+++.++|..||..|..+||++.++++|.+....
T Consensus       243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            1222222345667889999999999999999999999999877633

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=311.12  Aligned_cols=255  Identities=24%  Similarity=0.323  Sum_probs=207.0

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ..+.+.++||+|+||.|..++.+ .++.||+|++++.   ......-|..|-++|..-+.+-|++++..|.+.+++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            33445678999999999999886 5899999999763   3344456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      |||+||+|-.++...+  .+++.-+..++..|..||.-||   +.|+|||||||+|||||..|.+||+|||.|-....+.
T Consensus       155 dY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             ecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            9999999999998766  5888889999999999999999   9999999999999999999999999999997765333


Q ss_pred             cccccccccccCCCcccccccccc-----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                      ..   .....+|||.|++||++..     +.|+..+|.||+||++|||+.|..||.. ..+++-+..++.-...+     
T Consensus       230 ~V---~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l-----  300 (1317)
T KOG0612|consen  230 TV---RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESL-----  300 (1317)
T ss_pred             cE---EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhc-----
Confidence            22   2345689999999999952     5789999999999999999999999974 34444444443321111     


Q ss_pred             CcCCCCCC--HHHHHHHHHHHHHccccCCCCCCC---HHHHHHHhhhCC
Q 012715          339 PRIKDSFD--MEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYESS  382 (458)
Q Consensus       339 ~~~~~~~~--~~~~~~l~~l~~~cl~~dp~~RPs---~~evl~~l~~~~  382 (458)
                           .|+  .+......++|++.+ -+|+.|..   ++++-.|+++..
T Consensus       301 -----~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  301 -----SFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             -----CCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence                 111  123356777777655 47888888   999999998865

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=282.19  Aligned_cols=259  Identities=26%  Similarity=0.378  Sum_probs=197.8

Q ss_pred             ccceeeeecceEEEEEE-EcCCCEEEEEEecc---cch----hhHhHHHHHHHHHHhcCCCCeeeeeeeee-ccCceeee
Q 012715          112 FSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISE----QVEGDFCREIELLARLHHRHLVALRGFCI-EKRERFLM  182 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  182 (458)
                      +..+||+|||+.||+|. +...+.||||+-..   ..+    .-.+..++|.+|-+.|.||.||++++++. +.+.+|-|
T Consensus       467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV  546 (775)
T KOG1151|consen  467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV  546 (775)
T ss_pred             HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence            44679999999999994 45678999997531   111    12235788999999999999999999986 55678999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC---CCCcEEEeeccccccc
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHAS  259 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~  259 (458)
                      +|||+|.+|+-||+.+.  .+++.++..|+.||+.||.||.+. +.+|||-||||.|||+-   ..|.+||.||||++..
T Consensus       547 LEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM  623 (775)
T KOG1151|consen  547 LEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM  623 (775)
T ss_pred             eeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence            99999999999998753  589999999999999999999965 78999999999999994   4578999999999987


Q ss_pred             CCCCccc---ccccccccCCCcccccccccc----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc
Q 012715          260 KDGSICF---EPVNTDIRGTPGYMDPEYVVT----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       260 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      .+.....   ........||.+|++||++.-    .+.+.|+||||.||++|..+.|+.||.....-.+..+..-..  .
T Consensus       624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl--k  701 (775)
T KOG1151|consen  624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL--K  701 (775)
T ss_pred             cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh--c
Confidence            6554321   123455689999999999853    357889999999999999999999997654433322211000  0


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..++--|. +.    ....+...+|++||+..-++|.+..++..+.+.
T Consensus       702 AtEVqFP~-KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl  744 (775)
T KOG1151|consen  702 ATEVQFPP-KP----VVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL  744 (775)
T ss_pred             ceeccCCC-CC----ccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence            01111111 11    112457789999999999999999988876543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=304.07  Aligned_cols=266  Identities=26%  Similarity=0.342  Sum_probs=207.9

Q ss_pred             ceeeeecceE-EEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          114 TIIGQGGFGT-VYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       114 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      +++|.|+-|+ ||+|.+ +|+.||||++-...   ..-..+|+..|+.- .|||||++++.-.+....||..|.|. .+|
T Consensus       515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL  589 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL  589 (903)
T ss_pred             HHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence            5799999887 799998 68999999875322   33467999999998 59999999998888889999999995 599


Q ss_pred             HHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---C--CcEEEeecccccccCCCCc
Q 012715          192 KDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---N--FVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       192 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~--~~~kl~DfGla~~~~~~~~  264 (458)
                      .+++...  ..........+.+..|++.||++||   +.+|+||||||.||||+.   +  ..++|+|||+++....+..
T Consensus       590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             HHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            9999763  1111121455788899999999999   899999999999999965   2  5899999999998877665


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhC-CCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA-RRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      .+.. .....||-+|+|||.+....-+.++||+||||++|+.++| ..||.+..  ...+ .++.....+..+..     
T Consensus       667 S~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~-NIl~~~~~L~~L~~-----  737 (903)
T KOG1027|consen  667 SFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQA-NILTGNYTLVHLEP-----  737 (903)
T ss_pred             hhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--Hhhh-hhhcCccceeeecc-----
Confidence            5544 5567899999999999998888999999999999999997 67885432  1111 12222222222111     


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCcchhhccchhhhhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEE  400 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~~~~~~~~~~~~~~  400 (458)
                        ..++  ...++|.+|+..+|..||++.+|+.|+.++....+-.|.+.+.+.-.-+
T Consensus       738 --~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e  790 (903)
T KOG1027|consen  738 --LPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKE  790 (903)
T ss_pred             --CchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhh
Confidence              1111  6789999999999999999999999999999888888888776544333

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=293.18  Aligned_cols=266  Identities=18%  Similarity=0.212  Sum_probs=180.4

Q ss_pred             hcccceeeeecceEEEEEEE-----------------cCCCEEEEEEecccchhhHh--------------HHHHHHHHH
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-----------------SDGSLIAVKRMDKISEQVEG--------------DFCREIELL  158 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E~~~l  158 (458)
                      +.+.++||+|+||.||+|.+                 .+++.||||++........+              .+..|+.++
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            34457999999999999964                 23568999998643322222              244577788


Q ss_pred             HhcCCCCe-----eeeeeeeec--------cCceeeeeeecCCCCHHHHhcCCCC----------------------CCC
Q 012715          159 ARLHHRHL-----VALRGFCIE--------KRERFLMYEYMANGSLKDHLHSPGR----------------------TPL  203 (458)
Q Consensus       159 ~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l  203 (458)
                      .+++|.|+     ++++++|..        .+..+|||||+++|+|.++++....                      ..+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            88876654     677887753        3568999999999999999864211                      134


Q ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCcccccc
Q 012715          204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE  283 (458)
Q Consensus       204 ~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE  283 (458)
                      ++..+..++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++....+...   ......+|+.|+|||
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~---~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF---NPLYGMLDPRYSPPE  380 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc---CccccCCCcceeChh
Confidence            67788999999999999999   889999999999999999999999999999755432210   112234578999999


Q ss_pred             ccccCC--------------------C--CcccccHhHHHHHHHHHhCCC-ccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          284 YVVTQE--------------------L--TEKSDVYSYGVVLLEIVTARR-AVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       284 ~~~~~~--------------------~--~~~~Dvws~Gv~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      .+....                    +  ..+.||||+||+++||++|.. |+.+.................+.......
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            875432                    1  134799999999999999875 55422111111100000000000000000


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREG---QARPSIKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp---~~RPs~~evl~~l~~~  381 (458)
                      ..-...........+++.+++..+|   .+|+|++|+|+|.|+.
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            0000011123567889999998766   6899999999999874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.3e-34  Score=267.84  Aligned_cols=241  Identities=32%  Similarity=0.469  Sum_probs=196.6

Q ss_pred             cceEEEEEEEc-CCCEEEEEEecccchhh-HhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcC
Q 012715          120 GFGTVYKAQFS-DGSLIAVKRMDKISEQV-EGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS  197 (458)
Q Consensus       120 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  197 (458)
                      +||.||+|... +|..+|+|.+....... ...+.+|++.+++++|+||+++++++......++++||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999886 48999999987544433 57899999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCC
Q 012715          198 PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP  277 (458)
Q Consensus       198 ~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~  277 (458)
                      ...  +++..++.++.+++.++.|||   ..+++|+||+|+||++++++.++|+|||++.......     ......++.
T Consensus        81 ~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~  150 (244)
T smart00220       81 RGR--LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFVGTP  150 (244)
T ss_pred             ccC--CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----ccccccCCc
Confidence            432  889999999999999999999   8899999999999999999999999999998665432     223456888


Q ss_pred             ccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHH
Q 012715          278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIV  357 (458)
Q Consensus       278 ~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~  357 (458)
                      .|++||.+....++.++||||||+++|+|++|..||....+................         .........+.+++
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~i  221 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP---------PPEWKISPEAKDLI  221 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------cccccCCHHHHHHH
Confidence            999999998888999999999999999999999998654333333322211111000         00000235688999


Q ss_pred             HHccccCCCCCCCHHHHHHHhh
Q 012715          358 RWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       358 ~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      .+|+..+|++||++.+++++.+
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~~~~  243 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQHPF  243 (244)
T ss_pred             HHHccCCchhccCHHHHhhCCC
Confidence            9999999999999999998654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=289.69  Aligned_cols=240  Identities=25%  Similarity=0.291  Sum_probs=195.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.|...+|.|+|+.|-.+... +++..+||++.+..    .+-.+|+.++... +|+||+++.+.+.++.+.|+|||.+.
T Consensus       324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD  399 (612)
T ss_pred             hccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence            345567999999999999765 68899999987542    2334677777776 69999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee-CCCCcEEEeecccccccCCCCccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL-DENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll-~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ||-|.+.+....   .....+..|+.+|+.++.|||   .+|++||||||+|||+ ++.++++|+|||.++.....    
T Consensus       400 g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----  469 (612)
T KOG0603|consen  400 GGELLRRIRSKP---EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----  469 (612)
T ss_pred             ccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence            998888886532   222677889999999999999   8999999999999999 68999999999999876543    


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                         ...-+-|..|.|||++....|+.++|+||||++||+|++|+.||.....-.+....+.          .+    .++
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~----------~~----~~s  532 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ----------MP----KFS  532 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc----------CC----ccc
Confidence               1223457899999999999999999999999999999999999986554422222111          11    112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ........+++.+||+.||.+||+|.++..|.|.
T Consensus       533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            2233568899999999999999999999999998

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=283.78  Aligned_cols=246  Identities=22%  Similarity=0.331  Sum_probs=207.0

Q ss_pred             eeeeecceEEEEEEEcCCC-EEEEEEecc---cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          115 IIGQGGFGTVYKAQFSDGS-LIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .||.||||.|=++..++.. .+|+|.+++   .+....+....|-++|..++.+.||+++..+.+....|++||-|-||.
T Consensus       427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE  506 (732)
T KOG0614|consen  427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE  506 (732)
T ss_pred             hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence            5999999999999875433 488888764   234445668899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |+..|+..+  .|+..+...++..+.+|++|||   .++||+|||||+|.+++.+|-+||.|||+|+....+.     .+
T Consensus       507 lWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-----KT  576 (732)
T KOG0614|consen  507 LWTILRDRG--SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-----KT  576 (732)
T ss_pred             hhhhhhhcC--CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC-----ce
Confidence            999998765  4888999999999999999999   9999999999999999999999999999999887765     34


Q ss_pred             ccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHH
Q 012715          271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL  350 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  350 (458)
                      ..++||+.|.|||++.+...+.++|.||||+++|||++|.+||.....+..+-.+ +..-.          ...++....
T Consensus       577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I-LkGid----------~i~~Pr~I~  645 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI-LKGID----------KIEFPRRIT  645 (732)
T ss_pred             eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH-Hhhhh----------hhhcccccc
Confidence            5689999999999999999999999999999999999999999865554433322 22111          112333344


Q ss_pred             HHHHHHHHHccccCCCCCCC-----HHHHHHHhhhC
Q 012715          351 RTIVTIVRWCTQREGQARPS-----IKQVLRILYES  381 (458)
Q Consensus       351 ~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~  381 (458)
                      +...+++++.+..+|.+|..     +.+|-+|-|+.
T Consensus       646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence            66788999999999999976     78888888874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.4e-34  Score=294.90  Aligned_cols=262  Identities=22%  Similarity=0.314  Sum_probs=170.9

Q ss_pred             hcccceeeeecceEEEEEEEc-C----CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeee------eeccCc
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-D----GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGF------CIEKRE  178 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~~  178 (458)
                      +.+.+.||+|+||.||+|.+. +    +..||||++......  +.+..|  .+....+.++..++..      +.....
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence            345678999999999999875 4    689999987543211  111111  1122222233222211      245668


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCC------------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCe
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRT------------------PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI  240 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NI  240 (458)
                      .++||||+.+++|.+++......                  ......+..++.|++.||+|||   +++|+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHE
Confidence            89999999999999998753210                  0122345679999999999999   89999999999999


Q ss_pred             eeCC-CCcEEEeecccccccCCCCcccccccccccCCCccccccccccC----------------------CCCcccccH
Q 012715          241 LLDE-NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ----------------------ELTEKSDVY  297 (458)
Q Consensus       241 ll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dvw  297 (458)
                      |++. ++.+||+|||+++....+..   .......+++.|||||.+...                      .+..++|||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9986 68999999999986543321   123446789999999965322                      244567999


Q ss_pred             hHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc---ccccCCc----CCCCCC--HHHHHHHHHHHHHccccCCCCC
Q 012715          298 SYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL---AELVDPR----IKDSFD--MEQLRTIVTIVRWCTQREGQAR  368 (458)
Q Consensus       298 s~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~d~~----~~~~~~--~~~~~~l~~l~~~cl~~dp~~R  368 (458)
                      ||||+||||+++..+...  ...............+   .....+.    +...++  ........+++.+||+.||++|
T Consensus       364 SlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            999999999997655432  2222211111111111   1111111    010000  0011345689999999999999


Q ss_pred             CCHHHHHHHhhhCCC
Q 012715          369 PSIKQVLRILYESSD  383 (458)
Q Consensus       369 Ps~~evl~~l~~~~~  383 (458)
                      ||++++++|.|+...
T Consensus       442 ~ta~e~L~Hpff~~~  456 (566)
T PLN03225        442 ISAKAALAHPYFDRE  456 (566)
T ss_pred             CCHHHHhCCcCcCCC
Confidence            999999999998653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=241.01  Aligned_cols=204  Identities=26%  Similarity=0.410  Sum_probs=168.9

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecc-cchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDK-ISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      ..||+|+||.|-+-++. +|...|+|++.. ...+..+..++|+++..+. .+|.+|.++|........++.||.|+. |
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-S  130 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-S  130 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-h
Confidence            46999999999888764 799999999863 3455566788999988776 589999999999999999999999964 8


Q ss_pred             HHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          191 LKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       191 L~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |..+-.+  ..+..+++.-+-+|+..+.+||.|||+  ...+||||+||+||||+.+|++||||||++-.+.+.-     
T Consensus       131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-----  203 (282)
T KOG0984|consen  131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-----  203 (282)
T ss_pred             HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-----
Confidence            8766542  123458888899999999999999996  6789999999999999999999999999987655432     


Q ss_pred             ccccccCCCcccccccccc----CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHH
Q 012715          269 VNTDIRGTPGYMDPEYVVT----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV  325 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  325 (458)
                      ..+...|...|||||.+..    ..|+.++||||||+++.||.+++.|+.......+....
T Consensus       204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq  264 (282)
T KOG0984|consen  204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ  264 (282)
T ss_pred             HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence            3344568899999998853    47899999999999999999999999876665554443

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-33  Score=276.18  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=196.2

Q ss_pred             ceeeeecceEEEEEE-EcCCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          114 TIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.||-|+||.|.+++ .++...||+|.+.+.+   .........|-+||..-..+-||+|+..|.+++.+|+||||++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            569999999999995 4457789999887543   233345778999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC---------
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK---------  260 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~---------  260 (458)
                      ++..+|-..+  -|.+..+..++.++..|+++.|   ..|+|||||||+|||||.+|.+||.|||||.-+.         
T Consensus       715 DmMSLLIrmg--IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq  789 (1034)
T KOG0608|consen  715 DMMSLLIRMG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  789 (1034)
T ss_pred             cHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence            9999997754  3888888899999999999999   9999999999999999999999999999996321         


Q ss_pred             CCCcc------c-----------------------ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCC
Q 012715          261 DGSIC------F-----------------------EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR  311 (458)
Q Consensus       261 ~~~~~------~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~  311 (458)
                      .++..      .                       .......+||+.|+|||++....|+..+|.||.|||||||+.|+.
T Consensus       790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~  869 (1034)
T KOG0608|consen  790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP  869 (1034)
T ss_pred             CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence            11100      0                       011234679999999999999999999999999999999999999


Q ss_pred             ccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHhhhCC
Q 012715          312 AVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP---SIKQVLRILYESS  382 (458)
Q Consensus       312 p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl~~l~~~~  382 (458)
                      ||-..........+     ..+...++-.....++.++...+.++   |.  +++.|.   -++||-.|.|+..
T Consensus       870 pf~~~tp~~tq~kv-----~nw~~~l~~~~~~~ls~e~~~li~kL---c~--sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  870 PFLADTPGETQYKV-----INWRNFLHIPYQGNLSKEALDLIQKL---CC--SADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             CccCCCCCcceeee-----eehhhccccccccccCHHHHHHHHHH---hc--ChhhhhcccchhhhhcCccccc
Confidence            99755443222111     12334455555566666655444433   43  455554   3566888877653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=254.25  Aligned_cols=259  Identities=22%  Similarity=0.344  Sum_probs=195.1

Q ss_pred             eeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-----Cceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~  186 (458)
                      -||-|+||.||.+... +|+.||.|++...  +-...+.+.+|+++|..++|.|++..++...-.     .+.|+++|.|
T Consensus        60 PIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm  139 (449)
T KOG0664|consen   60 PIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM  139 (449)
T ss_pred             cccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence            5999999999999764 7999999988643  233456799999999999999999998876543     3568899988


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      .. +|...+-+  ...++...+.-+..||++||.|||   +.+|.||||||.|.|++.|..+||||||+++.......  
T Consensus       140 QS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~--  211 (449)
T KOG0664|consen  140 QS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR--  211 (449)
T ss_pred             Hh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhhh--
Confidence            64 88888765  346888888999999999999999   99999999999999999999999999999997654331  


Q ss_pred             ccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHh------------hcccc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA------------SESRL  333 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~------------~~~~~  333 (458)
                       ..++..+-|..|.|||.+++ ..|+.+.||||.||++.||+..+..|+....+.+...+...            .++.-
T Consensus       212 -~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  212 -LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             -hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence             23455667899999999987 47999999999999999999988888755544332222111            01111


Q ss_pred             ccccCCcCCC-----CC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          334 AELVDPRIKD-----SF----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       334 ~~~~d~~~~~-----~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..++....+.     -+    ....-.+...+...++..||.+|.+..+.+.+++...
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence            1111111110     00    0011124556778889999999999999999987644

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=2.4e-32  Score=237.96  Aligned_cols=255  Identities=19%  Similarity=0.299  Sum_probs=195.8

Q ss_pred             cccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeecc--Cceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEK--RERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~  186 (458)
                      ++.+++|+|.|+.||.|.. .+++.++||.++...   .+.+.+|+.+|..|. ||||++|++...+.  ..+.||+||+
T Consensus        41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v  117 (338)
T KOG0668|consen   41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV  117 (338)
T ss_pred             HHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence            3456899999999999964 578899999987543   356889999999997 99999999998765  4678999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccccCCCCcc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~  265 (458)
                      .+.+...+-.     .++...+..+..+++.||.|+|   +.||.|||+||.|++||. .-.++|+|+|||.+...+.. 
T Consensus       118 ~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e-  188 (338)
T KOG0668|consen  118 NNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  188 (338)
T ss_pred             ccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCce-
Confidence            9988777654     3777888999999999999999   999999999999999996 56899999999987765442 


Q ss_pred             cccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhh-c-c-------cccc
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS-E-S-------RLAE  335 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-~-~-------~~~~  335 (458)
                          ..-.+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||..|.+..+....+... + .       ...-
T Consensus       189 ----YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  189 ----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             ----eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence                222345677889998875 568889999999999999999999998766543332221110 0 0       0001


Q ss_pred             ccCCcCCC---CCC------------H-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          336 LVDPRIKD---SFD------------M-EQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       336 ~~d~~~~~---~~~------------~-~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+||.+.+   ..+            . -...+..+++...|..|-.+|+|++|.+.|.++.
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence            12222211   000            0 0125688999999999999999999999998764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.4e-32  Score=264.14  Aligned_cols=271  Identities=23%  Similarity=0.290  Sum_probs=213.1

Q ss_pred             ccCHHHHHHHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC------CCCeeeeee
Q 012715           99 KFSYKETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH------HRHLVALRG  171 (458)
Q Consensus        99 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~  171 (458)
                      .+.+.++....|......|+|-|++|..|... .|..||||++.+. +...+.=+.|+++|++|+      -.|+++|+.
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            34567777777777778999999999999765 4789999999653 334455678999999996      358999999


Q ss_pred             eeeccCceeeeeeecCCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEE
Q 012715          172 FCIEKRERFLMYEYMANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAK  249 (458)
Q Consensus       172 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~k  249 (458)
                      .|...+++|||+|-+. -+|.+.|+..+. ..|....+..++.|+..||..|.   ..+|+|.||||.|||+++ ...+|
T Consensus       502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceee
Confidence            9999999999999885 599999987653 46888999999999999999999   899999999999999987 56899


Q ss_pred             EeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhh
Q 012715          250 LADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS  329 (458)
Q Consensus       250 l~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~  329 (458)
                      |||||.|....++.+      +.+..+..|.|||++.+..|+...|+||.||+||||.||+..|.+..+ .++...++..
T Consensus       578 LCDfGSA~~~~enei------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN-N~MLrl~me~  650 (752)
T KOG0670|consen  578 LCDFGSASFASENEI------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN-NQMLRLFMEL  650 (752)
T ss_pred             eccCccccccccccc------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc-HHHHHHHHHh
Confidence            999999987766543      223445679999999999999999999999999999999999865433 3333333332


Q ss_pred             ccccccc-----------cCCc----------------------CCC------------CCC---HHHHHHHHHHHHHcc
Q 012715          330 ESRLAEL-----------VDPR----------------------IKD------------SFD---MEQLRTIVTIVRWCT  361 (458)
Q Consensus       330 ~~~~~~~-----------~d~~----------------------~~~------------~~~---~~~~~~l~~l~~~cl  361 (458)
                      .+.++.-           +|..                      ++.            .++   ......|.+++..|+
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            2222110           0100                      000            011   234568999999999


Q ss_pred             ccCCCCCCCHHHHHHHhhhC
Q 012715          362 QREGQARPSIKQVLRILYES  381 (458)
Q Consensus       362 ~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..||++|.+..|+|+|++..
T Consensus       731 ~LdP~KRit~nqAL~HpFi~  750 (752)
T KOG0670|consen  731 ILDPEKRITVNQALKHPFIT  750 (752)
T ss_pred             ccChhhcCCHHHHhcCCccc
Confidence            99999999999999998764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.1e-30  Score=237.13  Aligned_cols=211  Identities=39%  Similarity=0.632  Sum_probs=183.6

Q ss_pred             eeeecceEEEEEEEcC-CCEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHHH
Q 012715          116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKD  193 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  193 (458)
                      ||+|++|.||++...+ +..+++|.+...... ....+.+|++.++.++|++++++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998864 899999998754332 34678999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccccCCCCccccccccc
Q 012715          194 HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       194 ~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      ++.... ..+++..+..++.+++.+|+|||   ..+++|+||+|.||+++. ++.++|+|||.+........    ....
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~  152 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LLKT  152 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----hhhc
Confidence            997542 35899999999999999999999   889999999999999999 89999999999986654321    1233


Q ss_pred             ccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHH
Q 012715          273 IRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR  351 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  351 (458)
                      ..+...|++||.+... .++.+.|+|++|+++++|                                            .
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~  188 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------P  188 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------H
Confidence            4578899999998877 888999999999999999                                            2


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          352 TIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       352 ~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      .+.+++..|++.+|.+||++.++++++
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            477899999999999999999999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-32  Score=246.74  Aligned_cols=236  Identities=22%  Similarity=0.369  Sum_probs=188.3

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecC
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .++||+|+|.+|..+++. +.+.+|+|.+++.   ......=...|-.+..+. +||.+|-++.++.....+++|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            468999999999999876 5789999988642   222233345677777776 69999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC-CCCccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK-DGSICF  266 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~-~~~~~~  266 (458)
                      ||+|.-+++...  .++++.+..+..+|..||.|||   ++|||+||||.+|||+|..|.+||.|+|+++..- .++   
T Consensus       335 ggdlmfhmqrqr--klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd---  406 (593)
T KOG0695|consen  335 GGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD---  406 (593)
T ss_pred             Ccceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCCc---
Confidence            999998887643  4999999999999999999999   9999999999999999999999999999998643 332   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCC------CcchHHH-HHHHHhhccccccccCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD------GKNLVES-AQVCMASESRLAELVDP  339 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~------~~~~~~~-~~~~~~~~~~~~~~~d~  339 (458)
                        ....++||+.|+|||.+.+..|...+|.|++||+++||+.|+.||.-      ..+..++ .+.++...-+++.    
T Consensus       407 --~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----  480 (593)
T KOG0695|consen  407 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----  480 (593)
T ss_pred             --ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----
Confidence              35678999999999999999999999999999999999999999951      1222222 3333333222221    


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPS  370 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs  370 (458)
                          ..+    .....+++.-|..||.+|..
T Consensus       481 ----sls----vkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  481 ----SLS----VKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ----eee----hhhHHHHHHhhcCCcHHhcC
Confidence                122    23456788888999999853

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=241.69  Aligned_cols=253  Identities=21%  Similarity=0.286  Sum_probs=194.3

Q ss_pred             eeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Cceeeeeee
Q 012715          115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLMYEY  185 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~  185 (458)
                      .+|.|.- .|..+-.. .++.||+|++...  .....+...+|..++..++|+||++++.++.-.      .+.|+|||+
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~  102 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL  102 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence            4677766 45555332 5889999987532  233445678999999999999999999988643      367999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |. ++|...+..    .++-.++..+..|++.|++|||   +.+|+||||||+||++..+..+||.|||+|+.....   
T Consensus       103 m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---  171 (369)
T KOG0665|consen  103 MD-ANLCQVILM----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---  171 (369)
T ss_pred             hh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcc---
Confidence            96 599988873    3677888999999999999999   999999999999999999999999999999865433   


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc-------------
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-------------  332 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  332 (458)
                        -..+..+.|..|.|||++.+..|...+||||.||++.||++|+..|.+...+.+|.+.....+..             
T Consensus       172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence              13566788999999999999889999999999999999999999998666666665543221110             


Q ss_pred             -------------cccc-cCCcCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          333 -------------LAEL-VDPRIKD--SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       333 -------------~~~~-~d~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                   +.+. -|.....  +.+......+.+++.+||..+|++|.+++++|+|++..
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                         0000 0000000  01112234678899999999999999999999999874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=267.15  Aligned_cols=252  Identities=26%  Similarity=0.378  Sum_probs=203.7

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      ++.+.+|.|.||.|||++.. .++..|||.++-.......-..+|+-+++.++|+||+.++|.+...+..++.||||.+|
T Consensus        18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg   97 (829)
T KOG0576|consen   18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG   97 (829)
T ss_pred             hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence            35568999999999999875 68999999987665566667789999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+.-+..+  ++++.++..+++..++||+|||   +.+-+|||||-.|||+++.|.+|++|||.+-.+...-    ..
T Consensus        98 slQdiy~~Tg--plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati----~K  168 (829)
T KOG0576|consen   98 SLQDIYHVTG--PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI----AK  168 (829)
T ss_pred             cccceeeecc--cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh----hh
Confidence            9999877543  5999999999999999999999   9999999999999999999999999999986543211    13


Q ss_pred             cccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          270 NTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      ...+.||+.|||||+..   .+.|..++|||++|+...|+---+.|..+......... .-......+.+-|+.      
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-mTkS~~qpp~lkDk~------  241 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-MTKSGFQPPTLKDKT------  241 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-hhccCCCCCcccCCc------
Confidence            45678999999999773   56799999999999999999888887765433322211 111222222222222      


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       .....+-++++.|+..+|++||+++.+|.|.+
T Consensus       242 -kws~~fh~fvK~altknpKkRptaeklL~h~f  273 (829)
T KOG0576|consen  242 -KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPF  273 (829)
T ss_pred             -cchHHHHHHHHHHhcCCCccCCChhhheecee
Confidence             33467889999999999999999999887653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.5e-29  Score=233.14  Aligned_cols=197  Identities=35%  Similarity=0.541  Sum_probs=170.9

Q ss_pred             ccceeeeecceEEEEEEEcC-CCEEEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          112 FSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.||.|++|.||++...+ +..+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            45689999999999998865 889999998755443 5678999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++...... +++..+..++.+++.++.|||   ..+++|+||+++||+++.++.++|+|||++........   ..
T Consensus        83 ~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~---~~  155 (225)
T smart00221       83 DLFDYLRKKGGK-LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA---AL  155 (225)
T ss_pred             CHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc---cc
Confidence            999999764321 789999999999999999999   88999999999999999999999999999986654320   01


Q ss_pred             cccccCCCcccccccc-ccCCCCcccccHhHHHHHHHHHhCCCccCC
Q 012715          270 NTDIRGTPGYMDPEYV-VTQELTEKSDVYSYGVVLLEIVTARRAVQD  315 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~  315 (458)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2334578899999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-29  Score=242.64  Aligned_cols=137  Identities=21%  Similarity=0.298  Sum_probs=114.3

Q ss_pred             HHHHH-HhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-----C---CCeeeeeee
Q 012715          103 KETKK-ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-----H---RHLVALRGF  172 (458)
Q Consensus       103 ~~~~~-~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~  172 (458)
                      .+..+ +.|-..++||=|.|++||+|... +.+.||+|+.+.... -.+..+.||++|++++     |   .+||+|+++
T Consensus        72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            34444 56667789999999999999654 678999998865333 3456789999999994     2   479999999


Q ss_pred             eec----cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC
Q 012715          173 CIE----KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD  243 (458)
Q Consensus       173 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~  243 (458)
                      |..    +.+.+||+|++ |.+|..+|....-+.++...+.+|++||+.||.|||.  +.+|||-||||+|||+.
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC  222 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence            875    45889999998 7799999987777789999999999999999999997  55999999999999993

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=253.39  Aligned_cols=191  Identities=27%  Similarity=0.376  Sum_probs=164.4

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccc--------hhhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccCcee
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--------EQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERF  180 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  180 (458)
                      .+.||.|+||.|+.|.++ +...|+||.+.+..        .......-.|+.||..++   |+||++++++|.+++.+|
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            357999999999999886 46789999876422        122234567999999997   999999999999999999


Q ss_pred             eeeeec-CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          181 LMYEYM-ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       181 lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      |+||-. ++.+|.+++....  .+++..+.-|++|++.|+++||   ..+|+|||||-+||.++.+|-+||+|||.+...
T Consensus       646 l~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             EEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhh
Confidence            999965 5679999997643  4899999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCcccccccccccCCCccccccccccCCCC-cccccHhHHHHHHHHHhCCCccC
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQ  314 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tg~~p~~  314 (458)
                      ..+.      ...++||..|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus       721 ksgp------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  721 KSGP------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cCCC------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            6553      3567899999999999998875 56899999999999998888875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-29  Score=222.92  Aligned_cols=248  Identities=20%  Similarity=0.354  Sum_probs=183.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeee-eeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF-CIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e~~  186 (458)
                      +++.+.||+|.||.+-+++++ ..+.+++|.+... .....+|.+|..-=-.| .|.||+.-++. +...+.+++++||+
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a  104 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA  104 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence            455678999999999999886 4678999987543 34457899998876666 48999987764 45567788999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC--CCCcEEEeecccccccCCCCc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~--~~~~~kl~DfGla~~~~~~~~  264 (458)
                      +.|+|.+-+..   .++.+....+++.|++.|+.|+|   +++++|||||.+||||-  +...+||||||+.+..+..- 
T Consensus       105 P~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-  177 (378)
T KOG1345|consen  105 PRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-  177 (378)
T ss_pred             ccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCcee-
Confidence            99999998865   34788888999999999999999   99999999999999993  34589999999987543211 


Q ss_pred             ccccccccccCCCccccccccccC-----CCCcccccHhHHHHHHHHHhCCCccCCC----cchHHHHHHHHhhcccccc
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQ-----ELTEKSDVYSYGVVLLEIVTARRAVQDG----KNLVESAQVCMASESRLAE  335 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~el~tg~~p~~~~----~~~~~~~~~~~~~~~~~~~  335 (458)
                            ....-+..|.+||.....     ...+.+|||.||++++..+||..||+..    ....+|.+........+++
T Consensus       178 ------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  178 ------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             ------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence                  122345679999977432     3567899999999999999999999833    3344444433222222222


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHhhh
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR---PSIKQVLRILYE  380 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~evl~~l~~  380 (458)
                      .+.     .++    ..+..+.++-+..++++|   .+.+.....+|.
T Consensus       252 ~F~-----~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  252 KFN-----PFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             hhc-----ccC----HHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            222     223    346667888889999999   555555555543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=4.3e-29  Score=271.47  Aligned_cols=204  Identities=17%  Similarity=0.232  Sum_probs=143.9

Q ss_pred             hcCC-CCeeeeeeee-------eccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 012715          160 RLHH-RHLVALRGFC-------IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC  231 (458)
Q Consensus       160 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ii  231 (458)
                      .++| +||++++++|       ...+..++++||+ +++|.++|... ...+++..++.++.||+.||+|||   +++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            3445 6888888877       2334677888987 56999999754 345999999999999999999999   99999


Q ss_pred             eccCCCCCeeeCCCC-------------------cEEEeecccccccCCCCc----c--------cccccccccCCCccc
Q 012715          232 HRDIKSSNILLDENF-------------------VAKLADFGLAHASKDGSI----C--------FEPVNTDIRGTPGYM  280 (458)
Q Consensus       232 HrDlk~~NIll~~~~-------------------~~kl~DfGla~~~~~~~~----~--------~~~~~~~~~gt~~y~  280 (458)
                      ||||||+||||+..+                   .+|++|||+++.......    .        .........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999996544                   455555555543211000    0        000011245889999


Q ss_pred             cccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHc
Q 012715          281 DPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWC  360 (458)
Q Consensus       281 aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~c  360 (458)
                      |||++.+..++.++|||||||+||||++|..|+............         ....+..     .........++.+|
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~---------~~~~~~~-----~~~~~~~~~~~~~~  248 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH---------RVLPPQI-----LLNWPKEASFCLWL  248 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH---------hhcChhh-----hhcCHHHHHHHHHh
Confidence            999999999999999999999999999988876432111110000         0011111     01123456788999


Q ss_pred             cccCCCCCCCHHHHHHHhhhCC
Q 012715          361 TQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       361 l~~dp~~RPs~~evl~~l~~~~  382 (458)
                      |+.+|.+||++.|+++|.|...
T Consensus       249 L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        249 LHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             CCCChhhCcChHHHhhchhhhh
Confidence            9999999999999999988643

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=8.5e-29  Score=233.88  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=194.4

Q ss_pred             cceeeeecceEEEEEEEc----CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecC
Q 012715          113 STIIGQGGFGTVYKAQFS----DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .++||+|.|++||++.+.    ..+.||+|.+...+..  ....+|+++|..+. +.||+++.+++..++...+|+||++
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~  118 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE  118 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence            468999999999999653    4678999988654433  45889999999995 8999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccccC------
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASK------  260 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~------  260 (458)
                      .....++...     ++...+..++..++.||+++|   .+|||||||||+|+|.+. -+.-.|.|||||....      
T Consensus       119 H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  119 HDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             ccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhh
Confidence            9999999875     778899999999999999999   999999999999999985 5678899999996110      


Q ss_pred             -----------C--CCc--------------cc-------ccccccccCCCccccccccc-cCCCCcccccHhHHHHHHH
Q 012715          261 -----------D--GSI--------------CF-------EPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLE  305 (458)
Q Consensus       261 -----------~--~~~--------------~~-------~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~e  305 (458)
                                 .  +..              ..       ........||++|.|||++. ....+.++||||.||+++.
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence                       0  000              00       01122356999999999986 4678899999999999999


Q ss_pred             HHhCCCccCCCcc----hHHHHHHH--------Hhhccc--ccc---------c------cC-CcCCC--------CCCH
Q 012715          306 IVTARRAVQDGKN----LVESAQVC--------MASESR--LAE---------L------VD-PRIKD--------SFDM  347 (458)
Q Consensus       306 l~tg~~p~~~~~~----~~~~~~~~--------~~~~~~--~~~---------~------~d-~~~~~--------~~~~  347 (458)
                      +++++.||....+    +.+.+.+.        ....+.  +.+         .      ++ ..+..        ....
T Consensus       271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~  350 (418)
T KOG1167|consen  271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS  350 (418)
T ss_pred             hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence            9999999864322    22222211        001111  000         0      00 00000        0000


Q ss_pred             H-HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          348 E-QLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       348 ~-~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      + .+..+++++.+|+..||.+|.++++.|+|.++.
T Consensus       351 d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  351 DVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             ccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence            1 123689999999999999999999999999876

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.3e-27  Score=212.49  Aligned_cols=167  Identities=28%  Similarity=0.321  Sum_probs=128.3

Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...+ .++++..++.++.|++.||+|||   +.+      ||+|||++.++.+|+  ||+++......     
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence            78999997543 35999999999999999999999   555      999999999999999  99987654321     


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                          ..||+.|||||++.+..++.++|||||||++|||+||+.||..................   .. ++... .....
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~-~~~~~-~~~~~  134 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP---AD-DPRDR-SNLES  134 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc---cC-Ccccc-ccHHH
Confidence                25899999999999999999999999999999999999999755443333322221111   00 00000 01111


Q ss_pred             HHH--HHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          349 QLR--TIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       349 ~~~--~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ...  .+.+++.+||..+|.+||++.+++++++..
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            222  689999999999999999999999999764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-26  Score=224.36  Aligned_cols=262  Identities=24%  Similarity=0.259  Sum_probs=196.6

Q ss_pred             hhcccceeeeecceEEEEEEEcCC--CEEEEEEecccchhhHhHHHHHHHHHHhcCC----CCeeeeeeee-eccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDG--SLIAVKRMDKISEQVEGDFCREIELLARLHH----RHLVALRGFC-IEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  181 (458)
                      .+.+.+.||+|+||.||++...+.  ..+|+|............+..|..++..+..    .++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            345677999999999999987543  4788887654333322368889999999973    6899999988 47778899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC-----CcEEEeecccc
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-----FVAKLADFGLA  256 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~-----~~~kl~DfGla  256 (458)
                      ||+.+ |.+|.++........++..++++|+.|++.+|++||   +.|++||||||.|++++..     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99977 789999886655567999999999999999999999   9999999999999999754     46999999999


Q ss_pred             c--ccCCCCc----ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc
Q 012715          257 H--ASKDGSI----CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE  330 (458)
Q Consensus       257 ~--~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  330 (458)
                      +  .......    ..........||.+|++++++.+...+.+.|+||++.++.|++.|..||.................
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  4322221    111113456799999999999999999999999999999999999999975543322211111111


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          331 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       331 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..   ....     +....+..+.++...+-..+..++|....+...+....
T Consensus       255 ~~---~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  255 KL---LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             hh---cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            00   0000     11112245667777777799999999999999876543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-27  Score=210.01  Aligned_cols=246  Identities=20%  Similarity=0.404  Sum_probs=189.3

Q ss_pred             cccceeeeecceEEEEEEEcCCCEEEEEEec--ccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +|..+|.+...|..|+|+|+ |..+++|.+.  ........+|..|.-.|+.+.||||+.++|.|.....+.++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            45567999999999999996 4455556654  33444456899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEe--ecccccccCCCCccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA--DFGLAHASKDGSICF  266 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~--DfGla~~~~~~~~~~  266 (458)
                      |+|+..|++......+..++.+++.++|+|++|||+. ++-|.---|.+..++||++.+++|+  |--++.  .      
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--q------  342 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q------  342 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--e------
Confidence            9999999987777788899999999999999999965 4445555799999999999988875  221111  1      


Q ss_pred             ccccccccCCCccccccccccCCCC---cccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELT---EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                         .....-.+.||+||.+...+.+   .++|+|||.++||||.|...||.+-.+..--..+.+       +-    ++.
T Consensus       343 ---e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------eg----lrv  408 (448)
T KOG0195|consen  343 ---EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------EG----LRV  408 (448)
T ss_pred             ---ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------cc----ccc
Confidence               1112236789999999876543   578999999999999999999987655422111111       11    122


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..++.....+.+++.-|+..||.+||.+..++-.|+.
T Consensus       409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            2233334668899999999999999999999888753

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.4e-25  Score=218.71  Aligned_cols=173  Identities=18%  Similarity=0.154  Sum_probs=130.1

Q ss_pred             hcccceeeeecceEEEEEEEc--CCCEEEEEEeccc-----chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS--DGSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.+.||+|+||+||+|.+.  ++..||||++...     .......|.+|+++|++++|+|++..+..   .+..|+|
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV   96 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV   96 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence            456678999999999999875  5778899986532     12234568999999999999999853322   2467999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccC-CCCCeeeCCCCcEEEeecccccccCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI-KSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDl-k~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      |||++|++|... ..     ..   ...++.++++||+|||   +++|+|||| ||+|||++.++.+||+|||+|+....
T Consensus        97 mE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         97 RGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             EEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            999999999732 11     11   1467889999999999   899999999 99999999999999999999987654


Q ss_pred             CCcccc----cccccccCCCccccccccccCC------CCcccccH
Q 012715          262 GSICFE----PVNTDIRGTPGYMDPEYVVTQE------LTEKSDVY  297 (458)
Q Consensus       262 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw  297 (458)
                      ......    ...+...+++.|+|||.+....      .+..+|-|
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            321111    1123567889999999986432      23346666

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=8.4e-26  Score=198.68  Aligned_cols=259  Identities=20%  Similarity=0.283  Sum_probs=198.7

Q ss_pred             HHhhcccceeeeecceEEEEEE-EcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC-CCeeeeeeeeeccCceeeeee
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  184 (458)
                      ...+.+.++||.|+||.+|.|. ..+|..||||.-..  .....++..|.++...|+| ..|..+..|..+++.-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3446677899999999999996 45899999996432  2334578899999999985 788888888999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCC
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKD  261 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~  261 (458)
                      .+ |.+|.++++-.. ..++..+++.++-|++.-++|+|   .++++||||||+|+|..-   ...+.++|||||+...+
T Consensus        92 LL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            88 789999886443 34999999999999999999999   999999999999999963   45799999999987654


Q ss_pred             CCcccc---cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          262 GSICFE---PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       262 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                      ......   .......||.+|.+-..+.+...+.+.|+-|+|.+|.++..|..||++-.............+..+.-.+ 
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i-  245 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI-  245 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH-
Confidence            332211   2345578999999999999989999999999999999999999999875543322222111111111111 


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI  377 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~  377 (458)
                      ..+...++    .++.-.+..|-....++-|+..-+.+.
T Consensus       246 e~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrql  280 (341)
T KOG1163|consen  246 EVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQL  280 (341)
T ss_pred             HHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence            11233333    567788999999999999997665543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-25  Score=204.61  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=196.5

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +...++||+|+||..+.|.. -+++.||||.-..  .....++..|....+.|. .++|..++.|..++.+-.||+|.+ 
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            34567999999999999953 4799999995322  223357888999999985 699999999999999999999988 


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-----CCcEEEeecccccccCCC
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDG  262 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-----~~~~kl~DfGla~~~~~~  262 (458)
                      |.+|+|+..-.+ ..|+..++..+|+|++.-++|+|   ++.+|.|||||+|+||..     ...+.|+|||+|+...+.
T Consensus       107 GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  107 GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            789999886544 35999999999999999999999   999999999999999963     346899999999988766


Q ss_pred             Ccccc---cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch--HHHHHHHHhhcccccccc
Q 012715          263 SICFE---PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESRLAELV  337 (458)
Q Consensus       263 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  337 (458)
                      .....   .......||.+||+-..+.+...+.+.|+-|||-++++.+.|..||++....  -+..+.+- ...+...+ 
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG-e~Kr~T~i-  260 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG-ETKRSTPI-  260 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc-cccccCCH-
Confidence            54322   1234567999999999999999999999999999999999999999865432  22222211 11000000 


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       ..+...    .+.++...+...-..+..+-|+.+-+...+.
T Consensus       261 -~~Lc~g----~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~  297 (449)
T KOG1165|consen  261 -EVLCEG----FPEEFATYLRYVRRLDFFETPDYDYLRKLFD  297 (449)
T ss_pred             -HHHHhc----CHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence             011222    2356777777777889999999887765543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=3.1e-23  Score=200.76  Aligned_cols=259  Identities=32%  Similarity=0.470  Sum_probs=197.7

Q ss_pred             cccceeeeecceEEEEEEEcCCCEEEEEEecccchh---hHhHHHHHHHHHHhcCCC-CeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ---VEGDFCREIELLARLHHR-HLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ |++++.+++......+++++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            34568999999999999875  78899988643322   367899999999999988 7999999997777789999999


Q ss_pred             CCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-cEEEeecccccccCCCCc
Q 012715          187 ANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSI  264 (458)
Q Consensus       187 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~  264 (458)
                      .+++|.+++..... ..+.......+..|++.++.|+|   ..+++|||+||+||+++..+ .++++|||+++.......
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            99999977765432 25888999999999999999999   88999999999999999988 799999999985544322


Q ss_pred             ccc--cccccccCCCcccccccccc---CCCCcccccHhHHHHHHHHHhCCCccCCCcc---hHHHHHHHHhhccccccc
Q 012715          265 CFE--PVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LVESAQVCMASESRLAEL  336 (458)
Q Consensus       265 ~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~  336 (458)
                      ...  .......|+..|+|||.+.+   ..++...|+||+|++++++++|..|+.....   ..............   .
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~  234 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---S  234 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---c
Confidence            111  12356779999999999987   5788999999999999999999999765443   22222222211111   0


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI  377 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~  377 (458)
                      ................+.+++..|+..+|..|.+..+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00011111001223568889999999999999999988776

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=4.5e-25  Score=228.81  Aligned_cols=260  Identities=22%  Similarity=0.228  Sum_probs=189.6

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEec----c-cch-hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMD----K-ISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      ..++|.|.+|.|+..... ....++.|...    . ... .....+..|+-+-..++|+|++..+..+.+....+-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            458999999977776432 34444444332    1 111 1112255677777888999999888888777777777999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |++ +|..++...+  .++..++..+++|+..|+.|+|   ..|+.|||||++|++++.+|.+||+|||.+....-+...
T Consensus       403 ~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  403 CPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             ccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            999 9999998642  4888899999999999999999   999999999999999999999999999999866543322


Q ss_pred             cccccccccCCCccccccccccCCCCcc-cccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEK-SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      ........+|+..|+|||.+.+..|.+. .||||.|+++..|++|+.||............ ....   .+.....-...
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-~~~~---~~~~~~~~~~~  552 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-NNYS---DQRNIFEGPNR  552 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-hccc---cccccccChHH
Confidence            2234567889999999999999999874 79999999999999999999643322111100 0000   00000000000


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .....+.+...++.++|+.+|.+|-++++|++.-|...
T Consensus       553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS  590 (601)
T ss_pred             HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence            11233467888999999999999999999999877654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=9.8e-23  Score=182.81  Aligned_cols=138  Identities=20%  Similarity=0.203  Sum_probs=107.4

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchh--h-------HhH-----------------HHHHHHHHHhcCCCCee
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ--V-------EGD-----------------FCREIELLARLHHRHLV  167 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~niv  167 (458)
                      ..||+|+||.||+|...+|+.||||.++.....  .       ...                 ..+|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            479999999999998888999999998643110  0       011                 23499999999887764


Q ss_pred             eeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEeccCCCCCeeeCCCC
Q 012715          168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL-HFYCDPPLCHRDIKSSNILLDENF  246 (458)
Q Consensus       168 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~iiHrDlk~~NIll~~~~  246 (458)
                      ....+.  ....+|||||++++++.......  ..++...+..++.|++.+|.|+ |   ..+|+||||||+|||++ ++
T Consensus        83 ~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          83 CPEPIL--LKSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCcEEE--ecCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            333222  22348999999988776553322  3588999999999999999999 7   78999999999999998 47


Q ss_pred             cEEEeeccccccc
Q 012715          247 VAKLADFGLAHAS  259 (458)
Q Consensus       247 ~~kl~DfGla~~~  259 (458)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=9.5e-23  Score=185.24  Aligned_cols=172  Identities=15%  Similarity=0.147  Sum_probs=131.4

Q ss_pred             HHHHhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhH---hH------HHHHHHHHHhcCCCCeeeeeeeeec
Q 012715          105 TKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVE---GD------FCREIELLARLHHRHLVALRGFCIE  175 (458)
Q Consensus       105 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~h~niv~l~~~~~~  175 (458)
                      +....+...++||.|+||.||.... ++..+|||.+........   ..      +.+|++.+.++.|++|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3445555668999999999999766 577899999864322221   12      6799999999999999999888654


Q ss_pred             c--------CceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc
Q 012715          176 K--------RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV  247 (458)
Q Consensus       176 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~  247 (458)
                      .        +..+|||||++|.+|.++..      ++.    ....+++.+|..+|   ..|++|||+||+||+++.+| 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence            3        35789999999999988742      222    34569999999999   99999999999999999988 


Q ss_pred             EEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHH
Q 012715          248 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV  307 (458)
Q Consensus       248 ~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~  307 (458)
                      ++|+|||...........                ..+.....|..++|+|+||+++.-+.
T Consensus       173 i~liDfg~~~~~~e~~a~----------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK----------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH----------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999987654322110                01334455678999999999987654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=2.8e-22  Score=198.98  Aligned_cols=215  Identities=27%  Similarity=0.414  Sum_probs=161.9

Q ss_pred             HHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-EeccCC
Q 012715          158 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL-CHRDIK  236 (458)
Q Consensus       158 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i-iHrDlk  236 (458)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...+++.-...+.++|+.||+|||   ..+| .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeec
Confidence            35678999999999999999999999999999999999763 446899999999999999999999   4444 999999


Q ss_pred             CCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccC-------CCCcccccHhHHHHHHHHHhC
Q 012715          237 SSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-------ELTEKSDVYSYGVVLLEIVTA  309 (458)
Q Consensus       237 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dvws~Gv~l~el~tg  309 (458)
                      ++|++++....+||+|||+........  .........-..-|.|||.+...       ..+.+.||||||++++|+++.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~--~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETA--EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccc--cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            999999999999999999987654310  00111122234579999998763       146789999999999999999


Q ss_pred             CCccCCCcchH---HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          310 RRAVQDGKNLV---ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       310 ~~p~~~~~~~~---~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      +.||.......   +.......   .....+.|.+....  +....+..++..||..+|.+||+++++-..+.....
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~---~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKK---GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cCccccccccCChHHHHHHHHh---cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            99997533222   22222111   12222333332111  233468999999999999999999999887765443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=3.8e-23  Score=214.82  Aligned_cols=252  Identities=23%  Similarity=0.287  Sum_probs=178.3

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccc-hhhHhHHHHHHHH--HHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-EQVEGDFCREIEL--LARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      ..+.+.||.+.|=+|.+|+.+.|. |+||.+-+.. .-....|.++++-  ...++|||.+.+.-+-......|||-+|.
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv  103 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV  103 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence            345678999999999999987776 8899875433 3334444444433  44558999999988877778889999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc--C-CCC
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS--K-DGS  263 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~--~-~~~  263 (458)
                      .+ +|+|.|..+.  -+...+...|+.|++.||..+|   ..||+|+|||.+||||+.-+-+.|+||.--+..  . ++.
T Consensus       104 kh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  104 KH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             hh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            65 9999997633  3677888899999999999999   999999999999999999989999999765422  1 111


Q ss_pred             cccccccccccCCCccccccccccC----------C-CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHH-HHhhcc
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQ----------E-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV-CMASES  331 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~  331 (458)
                      ..+.-.......-..|+|||.+...          . .+++.||||+||+++||++-..|...-..+..+... ....+.
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence            1111122233344579999988541          1 678899999999999999965444322111111000 000001


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      -+.++-|            ..+..++..|++.||.+|.++++.|+.-..
T Consensus       258 ~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  258 LLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            1111222            246789999999999999999999997433

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.6e-21  Score=175.43  Aligned_cols=139  Identities=22%  Similarity=0.237  Sum_probs=109.8

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchh--------------------------hHhHHHHHHHHHHhcCCCCee
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ--------------------------VEGDFCREIELLARLHHRHLV  167 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~niv  167 (458)
                      ..||+|+||.||+|...+|+.||||.+......                          ....+.+|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            479999999999998878999999998643110                          011245789999999999875


Q ss_pred             eeeeeeeccCceeeeeeecCCCCHHHH-hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCC
Q 012715          168 ALRGFCIEKRERFLMYEYMANGSLKDH-LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDEN  245 (458)
Q Consensus       168 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~  245 (458)
                      ....+...  ..+|||||++|+++... +..   ..++......++.|++.+|.++|   . .||+||||||+|||++ +
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            44443332  34899999998865443 332   24778899999999999999999   7 8999999999999999 8


Q ss_pred             CcEEEeecccccccCC
Q 012715          246 FVAKLADFGLAHASKD  261 (458)
Q Consensus       246 ~~~kl~DfGla~~~~~  261 (458)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.5e-22  Score=198.35  Aligned_cols=233  Identities=23%  Similarity=0.295  Sum_probs=183.0

Q ss_pred             eeeeecceEEEEEE----EcCCCEEEEEEecccchh--hHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecC
Q 012715          115 IIGQGGFGTVYKAQ----FSDGSLIAVKRMDKISEQ--VEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+|+|+||.|++++    .+.|..+|+|.+.+....  .......|-.++..++ |+.++++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999873    235788999987643211  1124567888999997 9999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      ||.|...+....  .++......+...++-+++++|   +.+++|||+|++||+++.+|.+++.|||+++..-+..    
T Consensus        81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----  151 (612)
T ss_pred             cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence            999999887643  4777777888889999999999   9999999999999999999999999999998664433    


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                          ..+||..|||||++.  ....++|.||||++++||+||..||..     +....+...            +...+.
T Consensus       152 ----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~------------~~~~p~  208 (612)
T KOG0603|consen  152 ----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKA------------ELEMPR  208 (612)
T ss_pred             ----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhh------------ccCCch
Confidence                127999999999988  568899999999999999999999976     222222211            112233


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSI-----KQVLRILY  379 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~  379 (458)
                      +......+++..++..+|.+|.-.     .|+.++.+
T Consensus       209 ~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f  245 (612)
T KOG0603|consen  209 ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEF  245 (612)
T ss_pred             hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccch
Confidence            444556778888888999999654     45555543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.2e-20  Score=167.87  Aligned_cols=186  Identities=17%  Similarity=0.125  Sum_probs=137.3

Q ss_pred             cceeeeecceEEEEEEEcCCCEEEEEEecccchh----hHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecC
Q 012715          113 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ----VEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      ...|++|+||+||.+.. .+..++.+.+.....-    ....+.+|+++|++|. |+++.+++++    +..+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            35799999999998765 6788887777543321    1125789999999995 5889999886    45799999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccC-CCCCeeeCCCCcEEEeecccccccCCCCcc-
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI-KSSNILLDENFVAKLADFGLAHASKDGSIC-  265 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDl-k~~NIll~~~~~~kl~DfGla~~~~~~~~~-  265 (458)
                      |.+|...+..         ....++.|++.+|+++|   ..||+|||| ||.|||++.++.++|+|||++......... 
T Consensus        82 G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         82 GAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             CccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            9999765421         11357789999999999   999999999 799999999999999999999855433210 


Q ss_pred             ----ccc----ccccccCCCccccccccccC-CCC-cccccHhHHHHHHHHHhCCCccCC
Q 012715          266 ----FEP----VNTDIRGTPGYMDPEYVVTQ-ELT-EKSDVYSYGVVLLEIVTARRAVQD  315 (458)
Q Consensus       266 ----~~~----~~~~~~gt~~y~aPE~~~~~-~~~-~~~Dvws~Gv~l~el~tg~~p~~~  315 (458)
                          ...    .......++.|++|+...-- ..+ ...+.++-|+-+|.++|++.+...
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                000    01112356777777744321 223 456888999999999999988653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=4.2e-20  Score=172.98  Aligned_cols=228  Identities=21%  Similarity=0.269  Sum_probs=144.6

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecc---cchhhHhHHHHHHHHHHhcCC----------CCeeeeeeeee----
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARLHH----------RHLVALRGFCI----  174 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~----  174 (458)
                      .+.||.|+++.||.+.+. +|+.+|||.+..   ......+++.+|.-....+.+          -.++.-++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            468999999999999886 589999998742   233345566666655544322          12222222211    


Q ss_pred             -----cc---C-----ceeeeeeecCCCCHHHHhcC---C--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCC
Q 012715          175 -----EK---R-----ERFLMYEYMANGSLKDHLHS---P--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK  236 (458)
Q Consensus       175 -----~~---~-----~~~lv~e~~~~gsL~~~l~~---~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk  236 (458)
                           .+   .     ..+++|+-+ .+||.+++..   .  ....+....++.+..|+.+.+++||   ..|++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccc
Confidence                 11   1     236677777 4588887641   1  1122445566778899999999999   9999999999


Q ss_pred             CCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCcccccccccc--------CCCCcccccHhHHHHHHHHHh
Q 012715          237 SSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--------QELTEKSDVYSYGVVLLEIVT  308 (458)
Q Consensus       237 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvws~Gv~l~el~t  308 (458)
                      |+|+|++.+|.++|+||+.....+...       .....+..|.+||....        -.++.+.|.|++|+++|.|++
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~-------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRY-------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEE-------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCcee-------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999999999998776544321       11234578999997644        257889999999999999999


Q ss_pred             CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 012715          309 ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR  368 (458)
Q Consensus       309 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R  368 (458)
                      |..||........               .+..+. .+. +.++.+..+|..+|+.+|.+|
T Consensus       246 ~~lPf~~~~~~~~---------------~~~~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEAD---------------PEWDFS-RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGST---------------SGGGGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCcccc---------------ccccch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999964322100               000122 333 666889999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=6.8e-20  Score=166.04  Aligned_cols=131  Identities=15%  Similarity=0.197  Sum_probs=103.2

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhc-----CCCCeeeeeeeeeccC---c-eeeeee
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-----HHRHLVALRGFCIEKR---E-RFLMYE  184 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lv~e  184 (458)
                      +.||+|+||.||.  +.+....+||++........+.+.+|+.++..+     .||||++++|++.++.   . ..+|+|
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            4799999999996  433333479987654444556799999999999     5799999999998864   3 337899


Q ss_pred             e--cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEeccCCCCCeeeCC----CCcEEEeecc
Q 012715          185 Y--MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL-EYLHFYCDPPLCHRDIKSSNILLDE----NFVAKLADFG  254 (458)
Q Consensus       185 ~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~iiHrDlk~~NIll~~----~~~~kl~DfG  254 (458)
                      |  +.+|+|.+++.+.   .+++.  ..++.+++.++ +|||   +++|+||||||+|||++.    ++.++|+||+
T Consensus        86 ~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         86 FDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             CCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            9  5579999999653   25554  35677888777 9999   999999999999999973    3489999954

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=2.6e-19  Score=168.28  Aligned_cols=198  Identities=23%  Similarity=0.332  Sum_probs=141.2

Q ss_pred             CCCCeeeeeeeeecc---------------------------CceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHH
Q 012715          162 HHRHLVALRGFCIEK---------------------------RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAID  214 (458)
Q Consensus       162 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  214 (458)
                      +|||||+++++|.+.                           ...|+||..++. +|..++-...   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence            499999999887652                           246899998865 9999997543   566677788999


Q ss_pred             HHHHHHHHhhcCCCCeEeccCCCCCeee--CCCC--cEEEeecccccccCCCCc--ccccccccccCCCccccccccccC
Q 012715          215 VANALEYLHFYCDPPLCHRDIKSSNILL--DENF--VAKLADFGLAHASKDGSI--CFEPVNTDIRGTPGYMDPEYVVTQ  288 (458)
Q Consensus       215 ia~gL~~LH~~~~~~iiHrDlk~~NIll--~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~  288 (458)
                      +++|+.|||   .+||.|||+|++|||+  |+|+  .+.|+|||++-.......  .+..-.....|...-||||+....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   9999999999999999  3444  688999998864433211  122222334577889999988643


Q ss_pred             C------CCcccccHhHHHHHHHHHhCCCccCCCcch-HHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHcc
Q 012715          289 E------LTEKSDVYSYGVVLLEIVTARRAVQDGKNL-VESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCT  361 (458)
Q Consensus       289 ~------~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl  361 (458)
                      +      --.|+|.|+.|.+.||+++...||...... .+...        ..+.--|.+.+.    ++.-+.+++...+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--------Yqe~qLPalp~~----vpp~~rqlV~~lL  494 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--------YQESQLPALPSR----VPPVARQLVFDLL  494 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh--------hhhhhCCCCccc----CChHHHHHHHHHh
Confidence            2      135899999999999999999999753221 11111        111111223332    2345778999999


Q ss_pred             ccCCCCCCCHHHHHHHh
Q 012715          362 QREGQARPSIKQVLRIL  378 (458)
Q Consensus       362 ~~dp~~RPs~~evl~~l  378 (458)
                      +.||++|++..-..+.|
T Consensus       495 ~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  495 KRDPSKRVSPNIAANVL  511 (598)
T ss_pred             cCCccccCCccHHHhHH
Confidence            99999999977655543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=4.2e-19  Score=162.57  Aligned_cols=134  Identities=21%  Similarity=0.327  Sum_probs=113.2

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccch--------hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE--------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.||+|++|.||+|.+ +|..+++|.......        .....+.+|++++..++|+|+.....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 678899997543211        1123578899999999999998877777777888999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      ++|++|.+++...     .+ .+..++.+++.+|.++|   ..+++|+|++|+|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998642     12 78899999999999999   99999999999999999 78999999998754

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=5.3e-19  Score=164.06  Aligned_cols=141  Identities=19%  Similarity=0.169  Sum_probs=109.1

Q ss_pred             hcccceeeeecceEEEEEE--EcCCCEEEEEEecccchh------------------------hHhHHHHHHHHHHhcCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQ--FSDGSLIAVKRMDKISEQ------------------------VEGDFCREIELLARLHH  163 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h  163 (458)
                      +.+.+.||+|+||.||+|.  ..+|+.||+|.+......                        ....+.+|++++.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            3456789999999999998  458999999988632110                        11235689999999975


Q ss_pred             C--CeeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEeccCCCCCe
Q 012715          164 R--HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP-LCHRDIKSSNI  240 (458)
Q Consensus       164 ~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-iiHrDlk~~NI  240 (458)
                      .  .+.+++++    ...++||||+++++|.......  ..+.......++.|++.+|++||   ..+ ++||||||+||
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            3  34444443    2358999999998887765322  23566677899999999999999   889 99999999999


Q ss_pred             eeCCCCcEEEeecccccccC
Q 012715          241 LLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       241 ll~~~~~~kl~DfGla~~~~  260 (458)
                      +++ ++.++|+|||++....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999986543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=6.3e-19  Score=159.86  Aligned_cols=130  Identities=22%  Similarity=0.321  Sum_probs=107.0

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccc--------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .||+|+||.||+|.+ +|..|++|......        ......+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 67889999854321        111245778999999999887665555666677789999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      +|++|.+++....         ..++.+++.+|.+||   ..+++|+|++|.||+++ ++.+++.|||++..
T Consensus        80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN---------DELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH---------HHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999885421         078999999999999   99999999999999999 88999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=6.8e-19  Score=186.58  Aligned_cols=238  Identities=20%  Similarity=0.265  Sum_probs=172.8

Q ss_pred             ccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccCceeeeeeecCC
Q 012715          112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.||+|+||+||+|...+|+.||+|.=+...   .-+|.-=.+++.+|+   -+-|..+...+.-.+..+||+||.+.
T Consensus       702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~  778 (974)
T KOG1166|consen  702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY  778 (974)
T ss_pred             EEeeeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence            346799999999999998889999999654322   123333344555555   24455555555667788999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC-------CCCcEEEeecccccc---
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-------ENFVAKLADFGLAHA---  258 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~-------~~~~~kl~DfGla~~---  258 (458)
                      |+|.++++.  ...++|..++.++.|++..+++||   ..+|||+||||+|+||.       +...++|+|||.+..   
T Consensus       779 Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l  853 (974)
T KOG1166|consen  779 GTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL  853 (974)
T ss_pred             ccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence            999999984  456999999999999999999999   99999999999999993       244799999999853   


Q ss_pred             cCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCcc-CCCcchHHHHHHHHhhcccccccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-QDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      +.++.     .....++|-.+-.+|...+..++..+|.|.|.-+++-|+.|+..- .++.                ...+
T Consensus       854 fp~~~-----~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~----------------~~~~  912 (974)
T KOG1166|consen  854 FPDGT-----KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGS----------------SWMV  912 (974)
T ss_pred             cCCCc-----EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCc----------------ceec
Confidence            33331     234567888999999999999999999999999999999986421 1110                0111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      +..++.-...   ..+.+|+..+|..|-..=|...++...+.+.
T Consensus       913 ~~~~~Ry~~~---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~  953 (974)
T KOG1166|consen  913 KTNFPRYWKR---DMWNKFFDLLLNPDCDTLPNLQELRTELEEV  953 (974)
T ss_pred             cccchhhhhH---HHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence            1111111111   2355677777776655567777777776553

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.4e-18  Score=157.40  Aligned_cols=137  Identities=17%  Similarity=0.160  Sum_probs=108.2

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccch----------------------hhHhHHHHHHHHHHhcCCCC--
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE----------------------QVEGDFCREIELLARLHHRH--  165 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n--  165 (458)
                      +.+.+.||+|+||.||+|...+|+.||||.+.....                      .....+..|+.++..+.|.+  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            445678999999999999888899999998643210                      01123678899999998874  


Q ss_pred             eeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC
Q 012715          166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN  245 (458)
Q Consensus       166 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~  245 (458)
                      +...++.    ...++||||++|++|......        .....++.+++.++.++|   ..+++||||||+||+++++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCC
Confidence            4444442    456899999999999776431        245678899999999999   8999999999999999999


Q ss_pred             CcEEEeecccccccCC
Q 012715          246 FVAKLADFGLAHASKD  261 (458)
Q Consensus       246 ~~~kl~DfGla~~~~~  261 (458)
                      +.++|+|||++.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            9999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=7.1e-20  Score=178.72  Aligned_cols=172  Identities=26%  Similarity=0.407  Sum_probs=129.3

Q ss_pred             ceeeeeeecCCCCHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 012715          178 ERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA  256 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla  256 (458)
                      .+|+.|++|...+|.++|.. ......++...+.++.|++.|++|      ++.+|||+||.||++..+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            57899999999999999963 334457888999999999999999      68899999999999999999999999998


Q ss_pred             cccCCCCcc--cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcccc
Q 012715          257 HASKDGSIC--FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRL  333 (458)
Q Consensus       257 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  333 (458)
                      .........  .....+...||.+||+||.+.+..|+.|+||||||++|+||+. -...+..              ...+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------------~~t~  469 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------------IATL  469 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------------HHhh
Confidence            765443311  1123466789999999999999999999999999999999997 2222210              0111


Q ss_pred             ccc----cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 012715          334 AEL----VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV  374 (458)
Q Consensus       334 ~~~----~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~ev  374 (458)
                      .++    ++|....+++     .=..++.+++...|.+||++.+.
T Consensus       470 ~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 TDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence            111    1222222222     23468999999999999954443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.3e-18  Score=179.15  Aligned_cols=131  Identities=21%  Similarity=0.317  Sum_probs=108.4

Q ss_pred             cceeeeecceEEEEEEEcCCCEEEEEE-eccc-c------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          113 STIIGQGGFGTVYKAQFSDGSLIAVKR-MDKI-S------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .+.||+|+||+||+|.+.+. .+++|+ +.+. .      ....+.+.+|++++..++|+|++....++.+....++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            56899999999999987544 344443 2211 1      1123468899999999999999988888888788899999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      |+++++|.+++.          ....++.+++.+|.|||   +.+++||||||+|||+ +++.++|+|||+++.
T Consensus       417 ~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        417 YIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             ecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999885          35678999999999999   8999999999999999 677999999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=5.7e-18  Score=176.55  Aligned_cols=213  Identities=24%  Similarity=0.386  Sum_probs=145.4

Q ss_pred             cceeeeecceEEEEEEEcC-CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          113 STIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      .++|..|+||.||..+++. .+.+|+| +++..-           ++     +||..+-+      ..+.|      |+-
T Consensus        88 IklisngAygavylvrh~~trqrfa~k-iNkq~l-----------il-----Rnilt~a~------npfvv------gDc  138 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----------IL-----RNILTFAG------NPFVV------GDC  138 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhc-ccccch-----------hh-----hccccccC------Cccee------chh
Confidence            4579999999999998863 5678884 332110           11     12222221      22222      555


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC--------CC
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD--------GS  263 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~--------~~  263 (458)
                      ...++..+.  ++..        .+.+++|||   +.+|+|||+||+|.+|+.-|.+|+.|||+++....        +.
T Consensus       139 ~tllk~~g~--lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~  205 (1205)
T KOG0606|consen  139 ATLLKNIGP--LPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH  205 (1205)
T ss_pred             hhhcccCCC--Ccch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence            666655443  2222        278899999   99999999999999999999999999999874321        11


Q ss_pred             ccc---ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          264 ICF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      +..   +-....++||+.|+|||++..+.|...+|.|++|+++||.+-|..||.+.. ..+.+...+.....+++- |..
T Consensus       206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt-peelfg~visd~i~wpE~-dea  283 (1205)
T KOG0606|consen  206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDIEWPEE-DEA  283 (1205)
T ss_pred             hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC-HHHHHhhhhhhhcccccc-CcC
Confidence            100   112234689999999999999999999999999999999999999997543 334444444443333333 222


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARP---SIKQVLRI  377 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---s~~evl~~  377 (458)
                              ...+..+++.+.|+.+|..|-   .+-++-+|
T Consensus       284 --------~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h  315 (1205)
T KOG0606|consen  284 --------LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQH  315 (1205)
T ss_pred             --------CCHHHHHHHHHHHHhChHhhcccchhhhhhhc
Confidence                    224688899999999999995   33444444

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=7e-17  Score=144.87  Aligned_cols=136  Identities=21%  Similarity=0.216  Sum_probs=98.0

Q ss_pred             cceeeeecceEEEEEEEcCCCEEEEEEecccchh--hHhH----------------------HHHHHHHHHhcCCC--Ce
Q 012715          113 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ--VEGD----------------------FCREIELLARLHHR--HL  166 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni  166 (458)
                      .+.||+|+||+||+|...+|+.||||.+......  ....                      ...|.+.+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999998878999999987542211  1111                      13566666666543  24


Q ss_pred             eeeeeeeeccCceeeeeeecCCCCHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCC
Q 012715          167 VALRGFCIEKRERFLMYEYMANGSLKD-HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDE  244 (458)
Q Consensus       167 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~  244 (458)
                      .+.+++    ...++||||++++++.. .+....   .. .....++.+++.++.++|   . .+|+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-
Confidence            444443    24689999999854321 111110   11 567889999999999999   7 9999999999999999 


Q ss_pred             CCcEEEeecccccccC
Q 012715          245 NFVAKLADFGLAHASK  260 (458)
Q Consensus       245 ~~~~kl~DfGla~~~~  260 (458)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.4e-16  Score=136.97  Aligned_cols=133  Identities=22%  Similarity=0.244  Sum_probs=112.7

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC--CCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      +.||+|.++.||++... +..+++|.......  ...+.+|+.++..++|  .++.+++++....+..+++|||+.++.+
T Consensus         4 ~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           4 KLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             eecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            46999999999999984 47899998764333  4578899999999976  5899999988888889999999998777


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      ..+         +......++.+++.+|++||.....+++|+|++|+||+++.++.+++.|||++..
T Consensus        81 ~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            554         4566778899999999999954446899999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=3.1e-16  Score=145.78  Aligned_cols=134  Identities=22%  Similarity=0.250  Sum_probs=105.3

Q ss_pred             ceee-eecceEEEEEEEcCCCEEEEEEecccc-------------hhhHhHHHHHHHHHHhcCCCCe--eeeeeeeeccC
Q 012715          114 TIIG-QGGFGTVYKAQFSDGSLIAVKRMDKIS-------------EQVEGDFCREIELLARLHHRHL--VALRGFCIEKR  177 (458)
Q Consensus       114 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  177 (458)
                      .+|| .||.|+||++.. ++..++||++....             ......+.+|++++.+|+|++|  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4798 899999999987 47789999774311             1223467889999999998775  67777654432


Q ss_pred             c----eeeeeeecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          178 E----RFLMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       178 ~----~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                      .    .++|||+++| .+|.+++...   .++..    .+.+++.+|.+||   ..||+||||||.|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    3599999997 6999988642   34443    3568999999999   99999999999999999989999999


Q ss_pred             cccccc
Q 012715          253 FGLAHA  258 (458)
Q Consensus       253 fGla~~  258 (458)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=3.9e-17  Score=169.80  Aligned_cols=259  Identities=26%  Similarity=0.281  Sum_probs=188.2

Q ss_pred             ccceeeeecceEEEEEEEc--CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeec
Q 012715          112 FSTIIGQGGFGTVYKAQFS--DGSLIAVKRMDKIS--EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-..+. |.|++.+++...+.+..+++++|.
T Consensus        24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s  103 (601)
T KOG0590|consen   24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS  103 (601)
T ss_pred             ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence            4556999999999888653  34567777665432  222334445777777786 999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-cEEEeecccccccCC-CCc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKD-GSI  264 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~-~~~  264 (458)
                      .++++.+.+........+....-.+..|+..++.|+|.  ..++.|||+||+|.+++..+ ..+++|||+|..... ...
T Consensus       104 ~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~  181 (601)
T KOG0590|consen  104 DGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGA  181 (601)
T ss_pred             cccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCCc
Confidence            99999998842222245666777899999999999995  67899999999999999999 999999999987655 221


Q ss_pred             ccccccccccC-CCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          265 CFEPVNTDIRG-TPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       265 ~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                        .......+| ++.|+|||...+. -.....|+||.|+++.-+++|..|+...................    ......
T Consensus       182 --~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~  255 (601)
T KOG0590|consen  182 --ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR----FTQLPW  255 (601)
T ss_pred             --ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc----cccCcc
Confidence              122334567 9999999999884 45678999999999999999999986433222111100000000    001111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ...    .....+++..++..+|..|.+.+++-...|...
T Consensus       256 ~~~----~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSI----SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccC----ChhhhhcccccccCCchhccccccccccccccc
Confidence            111    134667888888899999999999987766544

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=7.5e-16  Score=142.03  Aligned_cols=208  Identities=23%  Similarity=0.359  Sum_probs=144.9

Q ss_pred             HHHHHhcCCCCeeeeeeeeeccC-----ceeeeeeecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 012715          155 IELLARLHHRHLVALRGFCIEKR-----ERFLMYEYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCD  227 (458)
Q Consensus       155 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~  227 (458)
                      +.-|-++-|-|||+++.|+.+..     ...++.|||..|+|..+|++.  ....+......+|+-||..||.|||.+ .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            34455667999999999987654     468899999999999999753  233477778889999999999999966 8


Q ss_pred             CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHH
Q 012715          228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV  307 (458)
Q Consensus       228 ~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~  307 (458)
                      +.|+|+++..+.|++..+|-+|+.----......-............+-++|.+||+-...+.+-++|||+||...+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            99999999999999999998887532111110000000111122345678999999888788888999999999999998


Q ss_pred             hCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          308 TARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       308 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      -+..-..++..-+.....+.   .....+-++.-            ..++..|++..|..||+|++++.|+
T Consensus       277 ilEiq~tnseS~~~~ee~ia---~~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIA---NVIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCcceeehhhhhh---hheeeccCccc------------cCcCcccccCCCCCCcchhhhhcCc
Confidence            88654433322211111100   00111111111            2378889999999999999998875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=9e-15  Score=147.57  Aligned_cols=140  Identities=23%  Similarity=0.237  Sum_probs=100.1

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhh----------------------------------------HhHHHH
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQV----------------------------------------EGDFCR  153 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~  153 (458)
                      +.||.|++|.||+|++.+|+.||||.........                                        +-+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            4699999999999999999999999874321000                                        013556


Q ss_pred             HHHHHHhcC----CCCeeeeeeeee-ccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHH-HHHHHhhcCC
Q 012715          154 EIELLARLH----HRHLVALRGFCI-EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN-ALEYLHFYCD  227 (458)
Q Consensus       154 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~~LH~~~~  227 (458)
                      |+..+.+++    |.+-+.+-..+. .....+|||||++|++|.++...... ..   ...+++..++. .+..+|   .
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH---h
Confidence            666666663    333333333332 24567999999999999887643111 12   23456666666 467888   8


Q ss_pred             CCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       228 ~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      .|++|+|+||.||+++.++.++++|||++....
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.55  E-value=5.7e-15  Score=147.26  Aligned_cols=260  Identities=22%  Similarity=0.198  Sum_probs=188.4

Q ss_pred             CHHHHHHHhhcccceeee--ecceEEEEEEE---cCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcC-CCCeeeeeee
Q 012715          101 SYKETKKATDNFSTIIGQ--GGFGTVYKAQF---SDGSLIAVKRMDKI--SEQVEGDFCREIELLARLH-HRHLVALRGF  172 (458)
Q Consensus       101 ~~~~~~~~~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  172 (458)
                      ...+......+..+.+|.  |.+|.||.+..   .++..+|+|+-+..  .......=.+|+....+++ |+|.++....
T Consensus       107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            334445555566778999  99999999976   36888999974321  1122223346777777774 9999999999


Q ss_pred             eeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEeccCCCCCeeeCCC-Cc
Q 012715          173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN----ALEYLHFYCDPPLCHRDIKSSNILLDEN-FV  247 (458)
Q Consensus       173 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~iiHrDlk~~NIll~~~-~~  247 (458)
                      +..++..++-+|+|. .+|..+.+.... .++...++....+...    ||.++|   ..+++|-|+||.||+...+ ..
T Consensus       187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  187 WEGSGILFIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             cccCCcceeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccce
Confidence            999999999999985 799998876443 3667777888888888    999999   9999999999999999998 89


Q ss_pred             EEEeecccccccCCCCccccccc-ccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHH
Q 012715          248 AKLADFGLAHASKDGSICFEPVN-TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC  326 (458)
Q Consensus       248 ~kl~DfGla~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  326 (458)
                      .+++|||+.....++........ ....|...|++||... ..++..+|+|++|.+..+..++......+... .|.+  
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~--  337 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQ--  337 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-Cccc--
Confidence            99999999998877664332221 2226788999999654 56788999999999999999988776544211 1111  


Q ss_pred             HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       327 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                            +....   +..++......++...+..+++.++..|++.+.+.++-
T Consensus       338 ------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~  380 (524)
T KOG0601|consen  338 ------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALN  380 (524)
T ss_pred             ------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccc
Confidence                  01100   11111111123455588889999999999999987753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.42  E-value=7e-13  Score=116.78  Aligned_cols=126  Identities=21%  Similarity=0.204  Sum_probs=94.5

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCee-eeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLV-ALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      +.|+.|.++.||++.. .+..|++|....... ....+..|+.++..+.+.+++ +++++.  ....++||||++|.++.
T Consensus         4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            3588999999999987 477899998654321 223567899999999765544 455443  33458999999998876


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP-----LCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-----iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      +..       .   ....++.+++++|+.||   ..+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~-------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED-------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc-------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            430       1   11245678999999999   555     59999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=3.8e-13  Score=137.45  Aligned_cols=139  Identities=18%  Similarity=0.216  Sum_probs=91.8

Q ss_pred             ceeeeecceEEEEEEEcC-CCEEEEEEecccch----------------------------------hhH------hHHH
Q 012715          114 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISE----------------------------------QVE------GDFC  152 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----------------------------------~~~------~~~~  152 (458)
                      +-||+|++|.||+|++++ |+.||||.....-.                                  +..      -+|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            469999999999999987 99999998853210                                  001      1244


Q ss_pred             HHHHHHHhcC----CCCeeeeeeeeec-cCceeeeeeecCCCCHHHH--hcCCCCCCCCHHHHHHHHHHHHH-HHHHHhh
Q 012715          153 REIELLARLH----HRHLVALRGFCIE-KRERFLMYEYMANGSLKDH--LHSPGRTPLSWQTRIQIAIDVAN-ALEYLHF  224 (458)
Q Consensus       153 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~~ia~-gL~~LH~  224 (458)
                      +|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.|.++  +...+   .+..   .++...+. -+..+. 
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~---~la~~~v~~~~~Qif-  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMK---LLAERGVEVFFTQVF-  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHH---HHHHHHHHHHHHHHH-
Confidence            5555555553    3444443333333 4567899999999999874  22221   2222   22222222 123334 


Q ss_pred             cCCCCeEeccCCCCCeeeCCCC----cEEEeecccccccCC
Q 012715          225 YCDPPLCHRDIKSSNILLDENF----VAKLADFGLAHASKD  261 (458)
Q Consensus       225 ~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~~~~~  261 (458)
                        ..|++|+|+||.||+++.++    .+++.|||++.....
T Consensus       278 --~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 --RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             --hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence              67999999999999999888    999999999976643

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=4.1e-12  Score=128.19  Aligned_cols=165  Identities=18%  Similarity=0.222  Sum_probs=126.9

Q ss_pred             cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHH
Q 012715          130 SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI  209 (458)
Q Consensus       130 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~  209 (458)
                      .++.+|.|...+...........+-++.|+.++||||++++......+..|||+|.+.  .|..++.+.     ......
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v~  107 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEVC  107 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHHH
Confidence            4688888888766555445567788899999999999999999999999999999985  688888763     345666


Q ss_pred             HHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCC
Q 012715          210 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE  289 (458)
Q Consensus       210 ~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  289 (458)
                      -.+.||+.||.|||.  ..+++|++|.-+.|+|+..|..||++|.++........    ......--..|..|+.+....
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChhhcCccc
Confidence            678999999999985  67899999999999999999999999998764432210    001111122356666543322


Q ss_pred             CCcccccHhHHHHHHHHHhC
Q 012715          290 LTEKSDVYSYGVVLLEIVTA  309 (458)
Q Consensus       290 ~~~~~Dvws~Gv~l~el~tg  309 (458)
                        -..|.|-|||++||++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              457999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=2e-12  Score=129.13  Aligned_cols=242  Identities=19%  Similarity=0.223  Sum_probs=173.2

Q ss_pred             ccceeeeecceEEEEEEEc--CCCEEEEEEecccchhhHh--HHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeec
Q 012715          112 FSTIIGQGGFGTVYKAQFS--DGSLIAVKRMDKISEQVEG--DFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +...||.|.|+.|++...+  ++..|++|.+.+.......  .-..|+.+...+ .|.+++.....+...+..|+--|||
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~  348 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC  348 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence            3457999999999998543  6889999987653332222  234677777777 4899998888777788888999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC-CcEEEeecccccccCCCCcc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++...+..  ...++...++++..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||++..+.-..  
T Consensus       349 ~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~--  421 (524)
T KOG0601|consen  349 EGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS--  421 (524)
T ss_pred             cCcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceec--
Confidence            99998877632  234777888999999999999999   9999999999999999886 889999999986422111  


Q ss_pred             cccccccccCCCccc--cccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          266 FEPVNTDIRGTPGYM--DPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                           ....+.-+++  +++......+..+.|++|||.-+.|.+++..-...+...   ..+        ..-.-+....
T Consensus       422 -----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i--------~~~~~p~~~~  485 (524)
T KOG0601|consen  422 -----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI--------RSGDTPNLPG  485 (524)
T ss_pred             -----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee--------ecccccCCCc
Confidence                 1112333444  555556678889999999999999999987544333221   110        0000011111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                           ....+..+...+...++..||.+.++..+..+.
T Consensus       486 -----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  486 -----LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             -----hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                 114466777888889999999999988876554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.31  E-value=2e-11  Score=112.31  Aligned_cols=142  Identities=23%  Similarity=0.291  Sum_probs=111.1

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccch-hhHhHHHHHHHHHHhcCC--CCeeeeeeeeeccC---ceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE-QVEGDFCREIELLARLHH--RHLVALRGFCIEKR---ERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~  187 (458)
                      +.||.|..+.||++...+|..+++|....... .....+.+|+++++.+++  .++.+++.++....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            35899999999999887778999998754322 234578899999999975  44677888776643   6689999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC-----------------------------------------  226 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----------------------------------------  226 (458)
                      |.++.+.+..   ..++......++.+++++|.+||...                                         
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9988876542   24777788888999999999998421                                         


Q ss_pred             ------------CCCeEeccCCCCCeeeCC--CCcEEEeecccccc
Q 012715          227 ------------DPPLCHRDIKSSNILLDE--NFVAKLADFGLAHA  258 (458)
Q Consensus       227 ------------~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~  258 (458)
                                  ...++|+|+++.||++++  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        245799999999999998  67789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.31  E-value=3.8e-11  Score=107.05  Aligned_cols=136  Identities=15%  Similarity=0.166  Sum_probs=98.7

Q ss_pred             eeeeecceEEEEEEEcC-------CCEEEEEEeccc-------------c---------hhhHhHHH----HHHHHHHhc
Q 012715          115 IIGQGGFGTVYKAQFSD-------GSLIAVKRMDKI-------------S---------EQVEGDFC----REIELLARL  161 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~l  161 (458)
                      .||.|--+.||.|...+       +..+|||..+..             +         ......+.    +|++.|.++
T Consensus         4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl   83 (197)
T cd05146           4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM   83 (197)
T ss_pred             ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            68999999999997543       479999976310             0         01112233    799999999


Q ss_pred             CC--CCeeeeeeeeeccCceeeeeeecCCCCHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEeccCCC
Q 012715          162 HH--RHLVALRGFCIEKRERFLMYEYMANGSLKD-HLHSPGRTPLSWQTRIQIAIDVANALEYL-HFYCDPPLCHRDIKS  237 (458)
Q Consensus       162 ~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~iiHrDlk~  237 (458)
                      ..  -++...+++    ...+|||||+.++.+.. .+..   ..++......+..+++.+|..| |   ..+++|+||++
T Consensus        84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            53  566666654    56789999997654422 2222   1245556678889999999999 8   88999999999


Q ss_pred             CCeeeCCCCcEEEeecccccccCC
Q 012715          238 SNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       238 ~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      .||+++ ++.+.|+|||.+.....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCCC
Confidence            999997 46899999998875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=5.9e-11  Score=101.87  Aligned_cols=141  Identities=25%  Similarity=0.316  Sum_probs=105.8

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEe-ccc-------chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRM-DKI-------SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      .+|-+|+-+.|+++.+ .|+.+.||.- .+.       ..-......+|+++|.+++--.|.--.-++.+...-.|+|||
T Consensus        13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            4688999999999988 6788777742 210       111234578899999999755555444556677777899999


Q ss_pred             cCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC---cEEEeecccccc
Q 012715          186 MAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFGLAHA  258 (458)
Q Consensus       186 ~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGla~~  258 (458)
                      ++| -++.+++...............++..|-+.+.-||   .++|+|+||..+||++..++   .+.++|||++..
T Consensus        92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            976 48888887544433444444788899999999999   99999999999999996544   458999999754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=9e-11  Score=101.27  Aligned_cols=131  Identities=26%  Similarity=0.369  Sum_probs=99.3

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEe-ccc------c-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRM-DKI------S-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~------~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+++|+-+.+|.+.+. |..+.+|.- .+.      + .-....-.+|+.++.+++--.|.--.=+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999774 445666642 211      1 111234678999999997655554444556777888999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      +|..|.+++...         ...++..+-.-+.-||   ..+|+|+||.++||.+..++ +.++||||+...
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999999998753         2456677777888899   99999999999999998765 999999998743

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.17  E-value=1.4e-09  Score=106.91  Aligned_cols=218  Identities=17%  Similarity=0.230  Sum_probs=151.8

Q ss_pred             cceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeec----cCceeeeeeecCC-CCHHH
Q 012715          120 GFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMYEYMAN-GSLKD  193 (458)
Q Consensus       120 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~  193 (458)
                      --.+.||+... ||..|++|++.....+.......-++.++++.|.|+|++..++..    +..+++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34567888654 899999999954444444444566889999999999999998763    3467999999986 67877


Q ss_pred             HhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          194 HLHSP-------------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       194 ~l~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +-...             .+...++..+|.++.|+..||.++|   +.|+.-+-|.+.+||++.+.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            65321             1234678899999999999999999   9999999999999999999999999988876554


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      .+..                  |.+.   --.+-|.=.||.+++.|.||...-.............              
T Consensus       445 ~d~~------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~--------------  489 (655)
T KOG3741|consen  445 EDPT------------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR--------------  489 (655)
T ss_pred             CCCC------------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------------
Confidence            3320                  1111   1245799999999999999965422111111110000              


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                          ........+.+++......++++ -++.+++.+..+
T Consensus       490 ----I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~  524 (655)
T KOG3741|consen  490 ----ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS  524 (655)
T ss_pred             ----hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence                00112234566777777777776 577777776543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=1.8e-09  Score=101.64  Aligned_cols=139  Identities=19%  Similarity=0.152  Sum_probs=101.1

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchh-----------hHhHHHHHHHHHHhcCC--CCeeeeeeeeec-----c
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----------VEGDFCREIELLARLHH--RHLVALRGFCIE-----K  176 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h--~niv~l~~~~~~-----~  176 (458)
                      .+-......|++..+ +|+.|.||+.......           ....+.+|...+.+|..  -.....+++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            444444455777766 6788999976432211           11147899999999853  333445555543     2


Q ss_pred             CceeeeeeecCCC-CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-------CCcE
Q 012715          177 RERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-------NFVA  248 (458)
Q Consensus       177 ~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-------~~~~  248 (458)
                      ...+||+|++++. +|.+++......+.+......++.+++..+.-||   ..||+|+||+++|||++.       ++.+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence            3468999999886 8999986432234566777899999999999999   999999999999999974       5689


Q ss_pred             EEeeccccc
Q 012715          249 KLADFGLAH  257 (458)
Q Consensus       249 kl~DfGla~  257 (458)
                      .++||+.+.
T Consensus       185 ~LIDl~r~~  193 (268)
T PRK15123        185 SVIDLHRAQ  193 (268)
T ss_pred             EEEECCccc
Confidence            999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.02  E-value=2.5e-09  Score=95.00  Aligned_cols=126  Identities=24%  Similarity=0.280  Sum_probs=83.6

Q ss_pred             EEEEEEEcCCCEEEEEEecccc--------------h------------hhHhHHHHHHHHHHhcCCC--Ceeeeeeeee
Q 012715          123 TVYKAQFSDGSLIAVKRMDKIS--------------E------------QVEGDFCREIELLARLHHR--HLVALRGFCI  174 (458)
Q Consensus       123 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  174 (458)
                      .||.|...+|..+|||......              .            .......+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999763200              0            0112367899999999755  566666552 


Q ss_pred             ccCceeeeeeecC--CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 012715          175 EKRERFLMYEYMA--NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY-LHFYCDPPLCHRDIKSSNILLDENFVAKLA  251 (458)
Q Consensus       175 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~-LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  251 (458)
                         ..+|||||++  |..+..+....    ++......++.+++..+.. +|   ..|++|+||.+.||+++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence               4579999998  65554443321    2234556777888885555 57   8899999999999999988 99999


Q ss_pred             ecccccccC
Q 012715          252 DFGLAHASK  260 (458)
Q Consensus       252 DfGla~~~~  260 (458)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999886544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.97  E-value=6.3e-10  Score=117.33  Aligned_cols=243  Identities=19%  Similarity=0.186  Sum_probs=159.6

Q ss_pred             eeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      -+-.|.++.++.+.-. .|...++|.....   .....+....+-.++-.-++|-++....-+.-....+||++|+.+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            4667888888876432 2434444433211   11111222223333333345666655555555678899999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC------CC--
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK------DG--  262 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~------~~--  262 (458)
                      |...|+..+  ..+..-.......+...++|||   ...+.|||++|.|+|+..++..+++|||+.....      +.  
T Consensus       891 ~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg  965 (1205)
T KOG0606|consen  891 LPSKLHNSG--CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG  965 (1205)
T ss_pred             chhhhhcCC--CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence            999998755  3555556667778889999999   7779999999999999999999999998443211      00  


Q ss_pred             C-----------------cc--cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHH
Q 012715          263 S-----------------IC--FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA  323 (458)
Q Consensus       263 ~-----------------~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~  323 (458)
                      .                 ..  .........||+.|.+||...+......+|.|++|++++|.++|..||.....- ...
T Consensus       966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq-~~f 1044 (1205)
T KOG0606|consen  966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ-QIF 1044 (1205)
T ss_pred             ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh-hhh
Confidence            0                 00  001133457899999999999999999999999999999999999999653321 111


Q ss_pred             HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 012715          324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIK  372 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~  372 (458)
                      +.+......         ......+......+++...+..++.+|-.+.
T Consensus      1045 ~ni~~~~~~---------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1045 ENILNRDIP---------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hccccCCCC---------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            111111000         0111122234566788888899999998777

>PRK09902 hypothetical protein; Provisional

Probab=98.94  E-value=1.7e-08  Score=90.26  Aligned_cols=138  Identities=20%  Similarity=0.140  Sum_probs=105.2

Q ss_pred             eeeecceEEEEEEEcCCCEEEEEEeccc-c-----hhhHhHHHHHHHHHHhcCC--CCeeeeeeeeeccC----ceeeee
Q 012715          116 IGQGGFGTVYKAQFSDGSLIAVKRMDKI-S-----EQVEGDFCREIELLARLHH--RHLVALRGFCIEKR----ERFLMY  183 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~-----~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~  183 (458)
                      -|+||-+.|+.-.+ +|..+-+|+-... .     ......|.+|+..|.+|..  -++.+...+.....    .-+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            47799999999887 4557889976421 1     2345689999999999963  33555553222222    357999


Q ss_pred             eecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc--EEEeeccccc
Q 012715          184 EYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--AKLADFGLAH  257 (458)
Q Consensus       184 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~--~kl~DfGla~  257 (458)
                      |-+.| .+|.+++.+....+.+...+..+..+++..++-||   ..|+.|+|+.+.|||++.++.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97764 68999987654445677888899999999999999   999999999999999986666  9999998665

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.87  E-value=1.8e-08  Score=92.29  Aligned_cols=137  Identities=22%  Similarity=0.170  Sum_probs=99.4

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecc----------cc------------hhhHhHHHHHHHHHHhcCCC--C
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDK----------IS------------EQVEGDFCREIELLARLHHR--H  165 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----------~~------------~~~~~~~~~E~~~l~~l~h~--n  165 (458)
                      +.++++||.|--+.||.|...+|..+|||.-+.          ..            ........+|.++|.+|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            445679999999999999998999999994321          00            01123467899999999754  6


Q ss_pred             eeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC
Q 012715          166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN  245 (458)
Q Consensus       166 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~  245 (458)
                      +.+.+++    +...+||||++|--|...-       ++....-.++..|+.-+.-+-   ..|++|+|+..-||+++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence            7776654    5668999999986655432       123333445555555555554   6789999999999999999


Q ss_pred             CcEEEeecccccccC
Q 012715          246 FVAKLADFGLAHASK  260 (458)
Q Consensus       246 ~~~kl~DfGla~~~~  260 (458)
                      |.+.++||--+....
T Consensus       239 g~~~vIDwPQ~v~~~  253 (304)
T COG0478         239 GDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCEEEEeCcccccCC
Confidence            999999998775443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.85  E-value=1.3e-09  Score=110.86  Aligned_cols=160  Identities=19%  Similarity=0.247  Sum_probs=109.8

Q ss_pred             HHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc-----ccccCCCccccccccc
Q 012715          212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN-----TDIRGTPGYMDPEYVV  286 (458)
Q Consensus       212 ~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~-----~~~~gt~~y~aPE~~~  286 (458)
                      +.+++.||.|+|.  +.++||++|.|++|.++.++..||+.|+.+.....+....-...     .-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455699999995  67999999999999999999999999999875544222111111     1122356799999999


Q ss_pred             cCCCCcccccHhHHHHHHHHHhCCCccCCCc-chHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCC
Q 012715          287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGK-NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREG  365 (458)
Q Consensus       287 ~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp  365 (458)
                      ....+.++|+||+||++|-+..|+.+..... .........         ..+..-...++...+.++.+-+.+.+..+.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---------~~~~~~~~~~s~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---------NLLNAGAFGYSNNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---------cccccccccccccCcHHHHHHHHHHhcCCc
Confidence            9888999999999999999995555443222 111111100         000000111223344678888999999999


Q ss_pred             CCCCCHHHHHHHhhhCC
Q 012715          366 QARPSIKQVLRILYESS  382 (458)
Q Consensus       366 ~~RPs~~evl~~l~~~~  382 (458)
                      .-||++.++....++..
T Consensus       254 ~~rp~~~~l~~~~ff~D  270 (700)
T KOG2137|consen  254 AVRPTLDLLLSIPFFSD  270 (700)
T ss_pred             ccCcchhhhhcccccCC
Confidence            99999999988776654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.81  E-value=2.3e-08  Score=101.87  Aligned_cols=144  Identities=22%  Similarity=0.214  Sum_probs=95.5

Q ss_pred             ccc-ceeeeecceEEEEEEEcCCCEEEEEEecccc-----------------------h-----------------hhHh
Q 012715          111 NFS-TIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-----------------------E-----------------QVEG  149 (458)
Q Consensus       111 ~~~-~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------------~-----------------~~~~  149 (458)
                      +|. +-|+.++-|.||+|++++|+.||||.....-                       .                 ..+-
T Consensus       127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El  206 (517)
T COG0661         127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL  206 (517)
T ss_pred             HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence            444 4699999999999999999999999764210                       0                 0011


Q ss_pred             HHHHHHHHHHhcC----CCCeeeeeeeee-ccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHH-HHHHh
Q 012715          150 DFCREIELLARLH----HRHLVALRGFCI-EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA-LEYLH  223 (458)
Q Consensus       150 ~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~~LH  223 (458)
                      ++.+|+.-+.+++    +..-+.+=..+. ..+...|+|||++|..+.+...-.. ..++...   ++..++++ +..+-
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~  282 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLL  282 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHH
Confidence            2556666666663    222233333333 3567799999999998888742211 2355333   33333332 23333


Q ss_pred             hcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       224 ~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                         ..|++|.|.+|.||+++.+|.+.+.|||+.....+
T Consensus       283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               56899999999999999999999999999876544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=5.1e-08  Score=88.69  Aligned_cols=107  Identities=23%  Similarity=0.264  Sum_probs=85.2

Q ss_pred             HhHHHHHHHHHHhcC--CCCeeeeeeeeeccC----ceeeeeeecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 012715          148 EGDFCREIELLARLH--HRHLVALRGFCIEKR----ERFLMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALE  220 (458)
Q Consensus       148 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~  220 (458)
                      .....+|...+..|.  .-...+.+++.....    ..++|+|++++ .+|.+++.....  .+......++.+++..++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            346788999888885  344556667665533    34899999988 489999875332  556677899999999999


Q ss_pred             HHhhcCCCCeEeccCCCCCeeeCCCC---cEEEeeccccccc
Q 012715          221 YLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFGLAHAS  259 (458)
Q Consensus       221 ~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGla~~~  259 (458)
                      -||   ..||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999   99999999999999998876   8999999977643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.60  E-value=8.1e-07  Score=81.91  Aligned_cols=137  Identities=16%  Similarity=0.145  Sum_probs=84.2

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCC--eeeeeeeeeccCceeeeeeecCCCC-H
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH--LVALRGFCIEKRERFLMYEYMANGS-L  191 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-L  191 (458)
                      .||+|..+.||+.   .|..+++|......  ......+|.+++..+..-+  +.+.++++...+...+|||+++|.+ +
T Consensus         8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            6899999999984   24567788765322  2345688999999986433  4677888877778889999999863 2


Q ss_pred             HHHh---------------------cCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhh-cCCCCeEeccCCC
Q 012715          192 KDHL---------------------HSPGRTPLSWQTRI-QIAI----------DVAN-ALEYLHF-YCDPPLCHRDIKS  237 (458)
Q Consensus       192 ~~~l---------------------~~~~~~~l~~~~~~-~i~~----------~ia~-gL~~LH~-~~~~~iiHrDlk~  237 (458)
                      ...+                     +............. .+..          .+.. ...+|.. .....++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            2111                     11100111111100 0000          0001 1122221 1134578999999


Q ss_pred             CCeeeCCCCcEEEeeccccc
Q 012715          238 SNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       238 ~NIll~~~~~~kl~DfGla~  257 (458)
                      .||++++++ +.|+||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.58  E-value=5.5e-07  Score=86.93  Aligned_cols=256  Identities=15%  Similarity=0.179  Sum_probs=149.1

Q ss_pred             cceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeee------eecc-Cceeeeee
Q 012715          113 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF------CIEK-RERFLMYE  184 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~-~~~~lv~e  184 (458)
                      +.-||+|+-+.+|-.-- -+.. +.|+..........   +-+..|... .||-+-.-+.|      .-+. ...-++|.
T Consensus        16 gr~LgqGgea~ly~l~e-~~d~-VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGE-VRDQ-VAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecch-hhch-hheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            45699999999996521 1222 33555433222211   122333333 35533321111      1111 22556777


Q ss_pred             ecCCC-CHHHHhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          185 YMANG-SLKDHLHS----PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       185 ~~~~g-sL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      .+.+. -+.++++-    ..-....|.-.++++..+|.+.+-||   +.|.+-+|++++|+|+++++.+.|.|-.--...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence            77653 23333321    12234789999999999999999999   899999999999999999999999885433222


Q ss_pred             CCCCcccccccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhC-CCccCCCc------c-hH-HHHHH
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTA-RRAVQDGK------N-LV-ESAQV  325 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg-~~p~~~~~------~-~~-~~~~~  325 (458)
                      ..+.     .....+|...|.+||.-.     +..-+...|.|.||+++++|+.| +.||.+-.      + .. ....-
T Consensus       168 ~ng~-----~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         168 ANGT-----LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             cCCc-----eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            2222     234557889999999653     34556789999999999999988 77875311      1 11 11110


Q ss_pred             HHhhccccccccCCcCCCCCCHH-HHHHHHHHHHHcccc--CCCCCCCHHHHHHHhhhCC
Q 012715          326 CMASESRLAELVDPRIKDSFDME-QLRTIVTIVRWCTQR--EGQARPSIKQVLRILYESS  382 (458)
Q Consensus       326 ~~~~~~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~--dp~~RPs~~evl~~l~~~~  382 (458)
                      .+....+-..-..+. ....+.. .+..+..+..+|+..  ++.-||+++-.+..|-...
T Consensus       243 ~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         243 RFAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             eeeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            000000000000000 1112221 124566677788754  3678999999887765543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.49  E-value=1.9e-06  Score=77.53  Aligned_cols=130  Identities=17%  Similarity=0.175  Sum_probs=83.1

Q ss_pred             cceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhH---------HHHHHHHHHhcCC---CCeeeeeeeee-----c
Q 012715          113 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGD---------FCREIELLARLHH---RHLVALRGFCI-----E  175 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~l~~~~~-----~  175 (458)
                      .+++-......|.+-.. +|..+.+|..........+.         ..+++..+.+++.   .....++.+..     .
T Consensus        36 ~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~  114 (229)
T PF06176_consen   36 IKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY  114 (229)
T ss_pred             EEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence            34555555666666655 67888999775433222222         2334444444432   22222222222     1


Q ss_pred             cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccc
Q 012715          176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL  255 (458)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl  255 (458)
                      ....+|+|||++|..|.++..      ++.    .++..+.+++.-||   ..|++|+|..|+|+++++++ +++.||+.
T Consensus       115 ~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~  180 (229)
T PF06176_consen  115 TSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQG  180 (229)
T ss_pred             eeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECcc
Confidence            234578999999988876542      222    34566778899999   99999999999999998654 99999986


Q ss_pred             cc
Q 012715          256 AH  257 (458)
Q Consensus       256 a~  257 (458)
                      .+
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            54

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.47  E-value=6.5e-07  Score=91.11  Aligned_cols=140  Identities=21%  Similarity=0.248  Sum_probs=91.3

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccc-------------------------------hh------hHhHHHHHHH
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-------------------------------EQ------VEGDFCREIE  156 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------------------------~~------~~~~~~~E~~  156 (458)
                      +-||.-+.|.||+|++++|+.||||.-+..-                               ++      .+-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            4699999999999999999999999643200                               00      0113555665


Q ss_pred             HHHhc----CCCCe---eeeeeeeec-cCceeeeeeecCCCCHHHH--hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 012715          157 LLARL----HHRHL---VALRGFCIE-KRERFLMYEYMANGSLKDH--LHSPGRTPLSWQTRIQIAIDVANALEYLHFYC  226 (458)
Q Consensus       157 ~l~~l----~h~ni---v~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~  226 (458)
                      -..++    .|-+.   |.+=.++.+ .....|+||||+|..+.+.  +.+.   .++...+..-+.++..-+-+     
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~qIf-----  318 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQIF-----  318 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHHHH-----
Confidence            44444    35551   122222222 3467999999999877654  3333   35555444444443332222     


Q ss_pred             CCCeEeccCCCCCeeeC----CCCcEEEeecccccccCC
Q 012715          227 DPPLCHRDIKSSNILLD----ENFVAKLADFGLAHASKD  261 (458)
Q Consensus       227 ~~~iiHrDlk~~NIll~----~~~~~kl~DfGla~~~~~  261 (458)
                      ..|++|.|-+|.||+++    .++.+.+.|||+......
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            45799999999999998    367999999999876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.41  E-value=7.8e-08  Score=97.13  Aligned_cols=180  Identities=18%  Similarity=0.129  Sum_probs=128.7

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCC-eeeeeeeeeccCceeeeeeecCCC-CHH
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH-LVALRGFCIEKRERFLMYEYMANG-SLK  192 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL~  192 (458)
                      -+++|+++++||.+-...+....+.+...     ....-++++|.+++||| .+..++-+..+...+++++++.++ +-.
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            47899999999987543444445544322     34557899999999999 677777777777889999999876 221


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccc
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD  272 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  272 (458)
                      .-.. .....+...+...+...-+++++|+|   +-.-+|+|    ||+..+ +..|..||+....+....     ....
T Consensus       324 ~~~~-~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-----~~~t  389 (829)
T KOG0576|consen  324 LEMT-VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-----KPRT  389 (829)
T ss_pred             ccCC-hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc-----cccc
Confidence            1111 01111333344455666778899999   55457888    877765 688999999887665432     2345


Q ss_pred             ccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCcc
Q 012715          273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV  313 (458)
Q Consensus       273 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~  313 (458)
                      ..+|+.|+|||+.....+..+.|+|++|+--.++.-|-+|-
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            67999999999999999999999999998777777766554

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.40  E-value=4.3e-06  Score=78.18  Aligned_cols=134  Identities=17%  Similarity=0.136  Sum_probs=83.1

Q ss_pred             cceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecCCCCHHHHh---
Q 012715          120 GFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGSLKDHL---  195 (458)
Q Consensus       120 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l---  195 (458)
                      .-..||+.... +..+.||......   ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|....   
T Consensus        11 ~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~   86 (244)
T cd05150          11 SGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEEL   86 (244)
T ss_pred             CcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhccc
Confidence            34789999764 4678888765432   345778999998884 444567788777766789999999998776432   


Q ss_pred             ----------------cCCC--CCCCCH--HHHHHHHH--------------------HHHHHHHHHhh----cCCCCeE
Q 012715          196 ----------------HSPG--RTPLSW--QTRIQIAI--------------------DVANALEYLHF----YCDPPLC  231 (458)
Q Consensus       196 ----------------~~~~--~~~l~~--~~~~~i~~--------------------~ia~gL~~LH~----~~~~~ii  231 (458)
                                      +...  ..++..  ........                    .+...+..|-.    .....++
T Consensus        87 ~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  166 (244)
T cd05150          87 EPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVT  166 (244)
T ss_pred             CHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEE
Confidence                            1110  001110  00000000                    01111122210    1135689


Q ss_pred             eccCCCCCeeeCCCCcEEEeeccccc
Q 012715          232 HRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       232 HrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      |+|+.|.|||+++++...|+||+.+.
T Consensus       167 HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         167 HGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCCCCccEEEeCCcEEEEEEccccc
Confidence            99999999999998888999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=5.5e-06  Score=76.47  Aligned_cols=141  Identities=22%  Similarity=0.257  Sum_probs=84.0

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCC--Ceeeeeeeeecc---CceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALRGFCIEK---RERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~~  188 (458)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.++...   ...+++|++++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            468999999999999866 68999986543  3456778899999988533  355666654332   346899999999


Q ss_pred             CCHHH----------------Hh---cCC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHHhh-
Q 012715          189 GSLKD----------------HL---HSP--GRTPLSWQTR---------IQI------------AIDVAN-ALEYLHF-  224 (458)
Q Consensus       189 gsL~~----------------~l---~~~--~~~~l~~~~~---------~~i------------~~~ia~-gL~~LH~-  224 (458)
                      ..+..                .+   +..  ...++.+...         ...            ...+.. .++.++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                11   111  1111111110         000            111222 2333331 


Q ss_pred             ---cCCCCeEeccCCCCCeeeC-CCCcEEEeeccccc
Q 012715          225 ---YCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAH  257 (458)
Q Consensus       225 ---~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGla~  257 (458)
                         .....++|+|+.+.|||++ +++.+.|.||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               1356799999999999999 66666899998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.32  E-value=6.6e-06  Score=74.96  Aligned_cols=137  Identities=22%  Similarity=0.262  Sum_probs=90.9

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhh-------------------Hh----H-HHHHHHHHHhcC--CCCeee
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQV-------------------EG----D-FCREIELLARLH--HRHLVA  168 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~----~-~~~E~~~l~~l~--h~niv~  168 (458)
                      .|+.|--+.||+|.-.++..+|||+........                   ..    . ...|+.-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            466777778999988789999999875311100                   00    0 234677777764  334444


Q ss_pred             eeeeeeccCceeeeeeecCCCC-HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc
Q 012715          169 LRGFCIEKRERFLMYEYMANGS-LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV  247 (458)
Q Consensus       169 l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~  247 (458)
                      -+++.    .-.|||||+.... -.-.|..   .++.......+..++++.+.-|-.  ..+++|+||..=|||+. ++.
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCe
Confidence            44442    4479999996431 1111221   123333567778888888887762  48999999999999999 889


Q ss_pred             EEEeecccccccCC
Q 012715          248 AKLADFGLAHASKD  261 (458)
Q Consensus       248 ~kl~DfGla~~~~~  261 (458)
                      +.|+|||-|.....
T Consensus       205 p~iID~~QaV~~~h  218 (268)
T COG1718         205 PYIIDVSQAVTIDH  218 (268)
T ss_pred             EEEEECccccccCC
Confidence            99999998876543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.29  E-value=3.4e-06  Score=75.29  Aligned_cols=101  Identities=27%  Similarity=0.311  Sum_probs=81.9

Q ss_pred             HHHHHHHHhcCC-CCeeeeeeeeeccCceeeeeeecCCCCHHHH---hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 012715          152 CREIELLARLHH-RHLVALRGFCIEKRERFLMYEYMANGSLKDH---LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD  227 (458)
Q Consensus       152 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~  227 (458)
                      ..|.-+++.+++ +++.+++|+|    ..++|.||...+++...   +..  -..-+|..+.+||.++++.+.+|++...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            358888999976 7999999999    44789999987766421   111  1136899999999999999999996545


Q ss_pred             CCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          228 PPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       228 ~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      ..+.-.|++++|+-++++|.+|+.|...+..
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            6688899999999999999999999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.28  E-value=1.3e-05  Score=71.35  Aligned_cols=134  Identities=25%  Similarity=0.409  Sum_probs=93.7

Q ss_pred             cccccCHHHHHHHhhcccceeeeecc-eEEEEEEEcCCCEEEEEEeccc------------c--h-------hhHhHHHH
Q 012715           96 MFQKFSYKETKKATDNFSTIIGQGGF-GTVYKAQFSDGSLIAVKRMDKI------------S--E-------QVEGDFCR  153 (458)
Q Consensus        96 ~~~~~~~~~~~~~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~------------~--~-------~~~~~~~~  153 (458)
                      ....|+...   +...|.+.||.|.- |.||+++. +|..+|+|.+...            .  .       .-..-|..
T Consensus        28 KL~~F~~h~---~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~  103 (207)
T PF13095_consen   28 KLEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNC  103 (207)
T ss_pred             CcCCcCCCC---CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHH
Confidence            344555522   55667889999999 99999998 6889999984210            0  0       11234788


Q ss_pred             HHHHHHhcC---CCCe--eeeeeeeeccC------------------ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHH
Q 012715          154 EIELLARLH---HRHL--VALRGFCIEKR------------------ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ  210 (458)
Q Consensus       154 E~~~l~~l~---h~ni--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~  210 (458)
                      |.+...+|+   +.++  |+++||..-..                  ...||.||.+...           .++.    +
T Consensus       104 ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~  168 (207)
T PF13095_consen  104 ECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----R  168 (207)
T ss_pred             HHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----h
Confidence            999888885   4566  89999874221                  1357778776532           1222    3


Q ss_pred             HHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccc
Q 012715          211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA  256 (458)
Q Consensus       211 i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla  256 (458)
                      -+.++.+-|..+|   ..||+-+|+++.|..     .-||+|||.+
T Consensus       169 ~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  169 DIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            3456777788899   999999999999986     4589999854

>PLN02876 acyl-CoA dehydrogenase

Probab=98.19  E-value=2.6e-05  Score=85.61  Aligned_cols=77  Identities=17%  Similarity=0.309  Sum_probs=56.1

Q ss_pred             ceeeeecceEEEEEEEcCC---CEEEEEEecccc-hhhHhHHHHHHHHHHhcC-CCCe--eeeeeeeecc---Cceeeee
Q 012715          114 TIIGQGGFGTVYKAQFSDG---SLIAVKRMDKIS-EQVEGDFCREIELLARLH-HRHL--VALRGFCIEK---RERFLMY  183 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~  183 (458)
                      +.++.|.++.+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++++|.+.   +..|+||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            4688999999999877654   367777653211 122346889999999995 6665  7888888764   4678999


Q ss_pred             eecCCCC
Q 012715          184 EYMANGS  190 (458)
Q Consensus       184 e~~~~gs  190 (458)
                      ||++|..
T Consensus       124 E~v~G~~  130 (822)
T PLN02876        124 EYLEGRI  130 (822)
T ss_pred             EecCCcc
Confidence            9998864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.15  E-value=1.3e-05  Score=86.55  Aligned_cols=201  Identities=18%  Similarity=0.205  Sum_probs=140.8

Q ss_pred             HHHHHHHHHhcCCCCeeeeeeeeeccCce----eeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 012715          151 FCREIELLARLHHRHLVALRGFCIEKRER----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC  226 (458)
Q Consensus       151 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~  226 (458)
                      ..-|++.+.++.|+|++.++.|..+....    .+..++|..-++...+...+  ..+..+.+.+..++.+||+|+|   
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h---  303 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLH---  303 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHH---
Confidence            44567778888999999999988765443    34457888888888887644  4778888899999999999999   


Q ss_pred             CCCeEeccCCCC---CeeeCCCCcEEEe--ecccccccCCCCcccccccccccCCCccccccccccCCCCc--ccccHhH
Q 012715          227 DPPLCHRDIKSS---NILLDENFVAKLA--DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE--KSDVYSY  299 (458)
Q Consensus       227 ~~~iiHrDlk~~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dvws~  299 (458)
                      .....|.-|..+   +...+.++...++  ||+..+...+....     ....-+..|.++|......+..  ..|+|++
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-----FSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc-----hhhcCccccccccccccccchhhhhhHHHHH
Confidence            555555555555   5555667777777  88888766544321     2223455688888776655544  4799999


Q ss_pred             HHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          300 GVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       300 Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      |.++..+..|..+.......              ..+++..    +.    ..+.+....|+..++++|+++.+++.+.+
T Consensus       379 gll~~~~~~~~~i~~~~~~~--------------~~~l~~~----~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAVP--------------VSLLDVL----ST----SELLDALPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             HHHHhhhhhcCcccccccch--------------hhhhccc----cc----hhhhhhhhhhcchhhhhccchhhhhhchh
Confidence            99999999886554321111              1111111    00    13567888999999999999999999986


Q ss_pred             hCCC
Q 012715          380 ESSD  383 (458)
Q Consensus       380 ~~~~  383 (458)
                      ....
T Consensus       437 ~~~~  440 (1351)
T KOG1035|consen  437 LRFP  440 (1351)
T ss_pred             cccc
Confidence            6443

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.14  E-value=5.2e-05  Score=68.03  Aligned_cols=130  Identities=25%  Similarity=0.294  Sum_probs=91.9

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccc----------------hhhHhHHHHHHHHHHhcC------CCCeeeeee
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS----------------EQVEGDFCREIELLARLH------HRHLVALRG  171 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~~  171 (458)
                      ..||+|+.-.||.-  .+.....||.+....                .....+..+|+.-...+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            47999999999974  455667788775433                223456777887777666      789999999


Q ss_pred             eeeccCceeeeeeecCC------CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-
Q 012715          172 FCIEKRERFLMYEYMAN------GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-  244 (458)
Q Consensus       172 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-  244 (458)
                      +...+....+|+|.+.+      -+|.+++....   ++. ...+.+.   +-..||-   ...|+.+||+|.||++.. 
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~---~f~~~l~---~~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALD---EFKRYLL---DHHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHH---HHHHHHH---HcCCeecCCCcccEEEEec
Confidence            99999999999998743      46888886432   444 3333333   3345665   778999999999999953 


Q ss_pred             -CC--cEEEee-ccc
Q 012715          245 -NF--VAKLAD-FGL  255 (458)
Q Consensus       245 -~~--~~kl~D-fGl  255 (458)
                       ++  .+.|+| ||-
T Consensus       155 ~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGE  169 (199)
T ss_pred             CCCceEEEEEeCCCC
Confidence             22  466666 453

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.08  E-value=3.7e-05  Score=66.40  Aligned_cols=128  Identities=16%  Similarity=0.213  Sum_probs=87.5

Q ss_pred             cceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeee-eeeeeeccCceeeeeeecCCCCH
Q 012715          113 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA-LRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      .+.||+|++|.||+|.+. |..+|+|.-..  +.....+..|+++|..+.-.++.. ++.|.    ..++.|||..|-.|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L   99 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence            357999999999999994 56888886543  233467889999999998776653 44432    33455999999888


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCC-CCCeeeCCCCcEEEeeccccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK-SSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk-~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      .+.-...     +...    ...+++.---|.   ..||-|+.|. |...+|.+++.+.|+||.-|...
T Consensus       100 ~~~~~~~-----~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112         100 GKLEIGG-----DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhcc-----cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            8765431     2223    233444433444   7789999987 44444444459999999987643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.08  E-value=3.1e-05  Score=71.92  Aligned_cols=72  Identities=15%  Similarity=0.233  Sum_probs=45.2

Q ss_pred             eeeeecce-EEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCC---Ceeeeeeeeecc---CceeeeeeecC
Q 012715          115 IIGQGGFG-TVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR---HLVALRGFCIEK---RERFLMYEYMA  187 (458)
Q Consensus       115 ~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~~  187 (458)
                      .|+.|+.. .||+.    +..+++|....  ......+.+|++++..+...   .+.++++.+...   ...+++|++++
T Consensus         4 ~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           4 PVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            46766666 48875    23567776443  12244788999999888532   344455444332   23488999999


Q ss_pred             CCCHH
Q 012715          188 NGSLK  192 (458)
Q Consensus       188 ~gsL~  192 (458)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            87764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.01  E-value=0.00011  Score=70.89  Aligned_cols=75  Identities=15%  Similarity=0.094  Sum_probs=55.6

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC---CCeeeeeeeeecc---CceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH---RHLVALRGFCIEK---RERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~~~  187 (458)
                      +-||.|..+.||+....++ .+.+|..+.  ......+..|++.|+.|.-   -.+.+++++|.+.   +..+||||+++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~   96 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR   96 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence            4699999999999876555 456665432  1123478899999999953   4678888887653   56899999999


Q ss_pred             CCCH
Q 012715          188 NGSL  191 (458)
Q Consensus       188 ~gsL  191 (458)
                      ++++
T Consensus        97 G~~~  100 (297)
T PRK10593         97 GVSV  100 (297)
T ss_pred             CEec
Confidence            8765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.94  E-value=0.00013  Score=67.71  Aligned_cols=72  Identities=18%  Similarity=0.166  Sum_probs=47.7

Q ss_pred             eeeeecceEEEEEEEcC--CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCC-eeeeeeeeeccCceeeeeeecCCCCH
Q 012715          115 IIGQGGFGTVYKAQFSD--GSLIAVKRMDKISEQVEGDFCREIELLARLHHRH-LVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      .|..|-...+|+....+  +..|++|....... ......+|+.++..+...+ ..++++.+.    ..+||||++|.++
T Consensus         5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            57788888999997654  67888887653221 1223457899999985433 344444332    2489999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.92  E-value=0.00015  Score=72.01  Aligned_cols=75  Identities=15%  Similarity=0.162  Sum_probs=53.9

Q ss_pred             ceeeeecceEEEEEEEcCC-CEEEEEEeccc----c---hhhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccCceeee
Q 012715          114 TIIGQGGFGTVYKAQFSDG-SLIAVKRMDKI----S---EQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.||.|.+..||++...+| +.|+||.-...    .   ....+.+..|.+.|..+.   -.++.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            3689999999999998776 48999974311    1   123456778888888873   2467777776  34567899


Q ss_pred             eeecCCCC
Q 012715          183 YEYMANGS  190 (458)
Q Consensus       183 ~e~~~~gs  190 (458)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.92  E-value=6.9e-05  Score=70.59  Aligned_cols=136  Identities=18%  Similarity=0.202  Sum_probs=78.7

Q ss_pred             eeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCe-eeeeeeeeccCceeeeeeecCCCCHHHH
Q 012715          116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYMANGSLKDH  194 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~  194 (458)
                      +..|-.+.+|+... ++..+++|...........+..+|.++++.+...++ .++++.+.    .++||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            55688889999874 577888886543322211245789999999864333 34444432    3689999998665321


Q ss_pred             -----------------hcCCC--CCCCCHHHH-HHHHHHH---------HHHHHHHhhc-----CCCCeEeccCCCCCe
Q 012715          195 -----------------LHSPG--RTPLSWQTR-IQIAIDV---------ANALEYLHFY-----CDPPLCHRDIKSSNI  240 (458)
Q Consensus       195 -----------------l~~~~--~~~l~~~~~-~~i~~~i---------a~gL~~LH~~-----~~~~iiHrDlk~~NI  240 (458)
                                       |+...  ..+++.... ..+..++         ...+..+-..     ....++|+|+.+.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             12111  112222211 1111111         1112212111     123589999999999


Q ss_pred             eeCCCCcEEEeeccccc
Q 012715          241 LLDENFVAKLADFGLAH  257 (458)
Q Consensus       241 ll~~~~~~kl~DfGla~  257 (458)
                      ++++++ +.|+||..+.
T Consensus       159 l~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEeCCC-CEEEeccccC
Confidence            999877 7899999775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.70  E-value=0.00015  Score=69.73  Aligned_cols=139  Identities=19%  Similarity=0.182  Sum_probs=83.2

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCC--Ceeeeeee------eeccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALRGF------CIEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e~~  186 (458)
                      .|..|....+|+.... +..+++|....   ........|++++..+.+.  .+.+++..      ....+..++|++|+
T Consensus        21 ~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          21 GISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             cccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            4777877899998764 44688887654   2234567788888888533  34444432      12234568999999


Q ss_pred             CCCCHHH----H----------hcCC----CC-----CCCCHHHHH----------HHHHHHHHHHHHHhh----cCCCC
Q 012715          187 ANGSLKD----H----------LHSP----GR-----TPLSWQTRI----------QIAIDVANALEYLHF----YCDPP  229 (458)
Q Consensus       187 ~~gsL~~----~----------l~~~----~~-----~~l~~~~~~----------~i~~~ia~gL~~LH~----~~~~~  229 (458)
                      +|..+..    .          ++..    ..     ....|....          .....+...+.++..    ....+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            9866521    0          1110    00     111222111          011112333444442    12357


Q ss_pred             eEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          230 LCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       230 iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ++|+|+.|.||++++++.+.|.||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999998778999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.65  E-value=0.00044  Score=66.77  Aligned_cols=138  Identities=28%  Similarity=0.306  Sum_probs=82.3

Q ss_pred             eeeeecceEEEEEEEcC-------CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCe-eeeeeeeeccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSD-------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  186 (458)
                      .|..|-...+|+....+       ++.+++|...... ....+..+|.+++..+...++ .++++++..    .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            45667777999987654       4788899865432 223456789999998863333 355555432    3689999


Q ss_pred             CCCCHHHH-----------------hcCCCCC-------CC--CHHHHHHH--------------------------HHH
Q 012715          187 ANGSLKDH-----------------LHSPGRT-------PL--SWQTRIQI--------------------------AID  214 (458)
Q Consensus       187 ~~gsL~~~-----------------l~~~~~~-------~l--~~~~~~~i--------------------------~~~  214 (458)
                      +|..+...                 ++.....       ..  -+.....+                          ...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88766431                 1111100       00  01111111                          111


Q ss_pred             HHHHHHHHhh------cCCCCeEeccCCCCCeeeCCC----CcEEEeeccccc
Q 012715          215 VANALEYLHF------YCDPPLCHRDIKSSNILLDEN----FVAKLADFGLAH  257 (458)
Q Consensus       215 ia~gL~~LH~------~~~~~iiHrDlk~~NIll~~~----~~~kl~DfGla~  257 (458)
                      +..-+.+|..      .....++|+|+.+.||+++++    +.+.++||..|.
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            1222333321      135679999999999999875    889999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.49  E-value=0.00021  Score=67.58  Aligned_cols=136  Identities=15%  Similarity=0.153  Sum_probs=92.9

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEec--cc--------c-------h-----hhHhHHHHHHHHHHhcCC--CC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMD--KI--------S-------E-----QVEGDFCREIELLARLHH--RH  165 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~--------~-------~-----~~~~~~~~E~~~l~~l~h--~n  165 (458)
                      +.+.+.||-|--+.||.+-..+|...++|.-.  ..        .       .     -+.-...+|+..|+.|..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            34567999999999999999899999998421  10        0       0     011134578888888853  34


Q ss_pred             eeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC
Q 012715          166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN  245 (458)
Q Consensus       166 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~  245 (458)
                      +.+.+++    +..++|||++.|-.|...-+-     .+..++..-+.   .-+--|-   .+|+||+|..-=||+++++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm---~~Iv~la---~~GlIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLM---GLIVRLA---NHGLIHGDFNEFNIMVKDD  238 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHHHH---HHHHHHH---HcCceecccchheeEEecC
Confidence            4455444    466899999988777654322     22333333222   2233444   7899999999999999999


Q ss_pred             CcEEEeecccccccC
Q 012715          246 FVAKLADFGLAHASK  260 (458)
Q Consensus       246 ~~~kl~DfGla~~~~  260 (458)
                      +.++++||--+....
T Consensus       239 ~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  239 DKIVVIDFPQMVSTS  253 (465)
T ss_pred             CCEEEeechHhhccC
Confidence            999999998765443

>PRK05231 homoserine kinase; Provisional

Probab=97.39  E-value=0.0015  Score=63.60  Aligned_cols=139  Identities=17%  Similarity=0.223  Sum_probs=76.6

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCC--Ceeeeee------eeeccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALRG------FCIEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~e~~  186 (458)
                      .|+.|....+|+....+| .+++|+.....   ......|+.++..|...  .+.+.+.      +....+..+++++|+
T Consensus        29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         29 GIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             hhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            467787789999877555 67888775212   23344566666666322  2333332      112345678999999


Q ss_pred             CCCCHH-----------HHh---cCCC---------CCCCCH-HHHHHH------------H-HHHHHHHHHHhhc----
Q 012715          187 ANGSLK-----------DHL---HSPG---------RTPLSW-QTRIQI------------A-IDVANALEYLHFY----  225 (458)
Q Consensus       187 ~~gsL~-----------~~l---~~~~---------~~~l~~-~~~~~i------------~-~~ia~gL~~LH~~----  225 (458)
                      +|..+.           ..|   +...         ...+.| .....-            . ..+...++.+...    
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            986431           111   1100         001112 111111            1 1111112222210    


Q ss_pred             CCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       226 ~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      -..+++|+|+.+.||+++++...-|+||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            24589999999999999977666899999764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.39  E-value=0.0016  Score=63.03  Aligned_cols=140  Identities=18%  Similarity=0.198  Sum_probs=81.1

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCC--Ceeeeeeee------eccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR--HLVALRGFC------IEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e~~  186 (458)
                      .++.|....+|+....+| .+++|......  .......|++++..|...  ++.+++...      ...+..+++++|+
T Consensus        29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        29 GIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             ccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            467777789999876545 57788764321  123455677888877432  244444421      1235578999999


Q ss_pred             CCCCHH-----------HH---hcCCCC------C----CCCHHHHH------------HHHHHHHHHHHHHhh----cC
Q 012715          187 ANGSLK-----------DH---LHSPGR------T----PLSWQTRI------------QIAIDVANALEYLHF----YC  226 (458)
Q Consensus       187 ~~gsL~-----------~~---l~~~~~------~----~l~~~~~~------------~i~~~ia~gL~~LH~----~~  226 (458)
                      +|..+.           ..   ++....      .    .-.|....            .....+...++++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            885432           11   111000      0    01111110            001123334555531    22


Q ss_pred             CCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          227 DPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       227 ~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..+++|+|+++.||++++++...|.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            5789999999999999998877899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.18  E-value=0.0045  Score=58.89  Aligned_cols=31  Identities=32%  Similarity=0.481  Sum_probs=25.5

Q ss_pred             CCeEeccCCCCCeeeCCCCc-EEEeecccccc
Q 012715          228 PPLCHRDIKSSNILLDENFV-AKLADFGLAHA  258 (458)
Q Consensus       228 ~~iiHrDlk~~NIll~~~~~-~kl~DfGla~~  258 (458)
                      ..++|+|+++.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997554 56999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.14  E-value=0.0054  Score=59.03  Aligned_cols=121  Identities=23%  Similarity=0.279  Sum_probs=74.3

Q ss_pred             CCEEEEEEec-ccchhhHhHHHHHHHHHHhcCC--CCeeeeeeeeeccC--ceeeeeeecCCCCHHHHhcCCCCCCCCHH
Q 012715          132 GSLIAVKRMD-KISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKR--ERFLMYEYMANGSLKDHLHSPGRTPLSWQ  206 (458)
Q Consensus       132 ~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~  206 (458)
                      ++.+++.+-. ...........+|+.+++.+.-  --+...+++|.++.  ..+.||+|++|..+.+.+....   ..  
T Consensus        48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~---~~--  122 (321)
T COG3173          48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPES---LG--  122 (321)
T ss_pred             CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCccc---ch--
Confidence            6667776221 1222334456788888888853  34456677777766  7799999999854433322100   00  


Q ss_pred             HHHHHH-HHHHHHHHHHh--------------------------------------------------hc-----CCCCe
Q 012715          207 TRIQIA-IDVANALEYLH--------------------------------------------------FY-----CDPPL  230 (458)
Q Consensus       207 ~~~~i~-~~ia~gL~~LH--------------------------------------------------~~-----~~~~i  230 (458)
                        .+++ ..++..|+-||                                                  ..     ....+
T Consensus       123 --~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~l  200 (321)
T COG3173         123 --RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVL  200 (321)
T ss_pred             --HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCcee
Confidence              0111 13333333333                                                  11     13469


Q ss_pred             EeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          231 CHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       231 iHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      +|+|+++.|+++++++-+-|.||+++..-
T Consensus       201 vHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         201 VHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            99999999999999888999999998653

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.13  E-value=0.0031  Score=60.13  Aligned_cols=72  Identities=22%  Similarity=0.294  Sum_probs=48.3

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.|+.|....+|+.. .+++.+.||.-.   ......|..|++-|+.|.   --.+.+++++....+..+||+||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            468889999999987 578889999654   333456889999999884   456778899888888889999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.07  E-value=0.0061  Score=60.01  Aligned_cols=137  Identities=18%  Similarity=0.233  Sum_probs=79.8

Q ss_pred             eeeecceEEEEEEEcC-----CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCee-eeeeeeeccCceeeeeeecCCC
Q 012715          116 IGQGGFGTVYKAQFSD-----GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLV-ALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      |-.|-...+|+..+.+     +..|++|........ .-+-.+|..++..+..-++. ++++++..+    .|++|+++.
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            4457778899987532     367888877543322 22346799999988644443 455554332    589999876


Q ss_pred             CHHHH-----------------hcCCC---CC-CCCHHHHHHHHHHH-----------------HHHHHHH----hh-cC
Q 012715          190 SLKDH-----------------LHSPG---RT-PLSWQTRIQIAIDV-----------------ANALEYL----HF-YC  226 (458)
Q Consensus       190 sL~~~-----------------l~~~~---~~-~l~~~~~~~i~~~i-----------------a~gL~~L----H~-~~  226 (458)
                      +|...                 +|...   .. ..-+..+.++..++                 ...+..|    .. ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            66421                 11111   01 11233333332211                 1111122    11 22


Q ss_pred             CCCeEeccCCCCCeeeCC-CCcEEEeeccccc
Q 012715          227 DPPLCHRDIKSSNILLDE-NFVAKLADFGLAH  257 (458)
Q Consensus       227 ~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~  257 (458)
                      ...++|+|+++.||++++ ++.+.++||..+.
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            447899999999999986 5789999998775

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.06  E-value=0.0073  Score=59.00  Aligned_cols=79  Identities=16%  Similarity=0.152  Sum_probs=50.6

Q ss_pred             eeeeecceEEEEEEEcCC-CEEEEEEecc----c--c-hhhHhHHHHHHHHHHhcC--CC-CeeeeeeeeeccCceeeee
Q 012715          115 IIGQGGFGTVYKAQFSDG-SLIAVKRMDK----I--S-EQVEGDFCREIELLARLH--HR-HLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~----~--~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  183 (458)
                      .||.|....||++...+| +.|+||.-..    .  + .-.......|.+.|....  -| .+.+++.|  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            479999999999987654 5899996421    1  1 222344567888887764  34 44455543  455667999


Q ss_pred             eecCC-CCHHHHh
Q 012715          184 EYMAN-GSLKDHL  195 (458)
Q Consensus       184 e~~~~-gsL~~~l  195 (458)
                      |+++. ..|...|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            99854 3344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.89  E-value=0.017  Score=57.44  Aligned_cols=79  Identities=18%  Similarity=0.181  Sum_probs=52.8

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecc----cch---hhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccCceeeee
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDK----ISE---QVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.||.|....||+... ++..++||.-..    ...   -....-..|++.|+.+.   ..++.+++.+|.  +..+++|
T Consensus        38 ~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence            3689999999999876 455788997531    111   12333445677777664   357888888876  4567889


Q ss_pred             eecCC--CCHHHHh
Q 012715          184 EYMAN--GSLKDHL  195 (458)
Q Consensus       184 e~~~~--gsL~~~l  195 (458)
                      ||+++  ..+.+.+
T Consensus       115 E~L~~~~~ilr~~L  128 (418)
T PLN02756        115 RYLEPPHIILRKGL  128 (418)
T ss_pred             eecCCcceehhhhh
Confidence            99976  3455444

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.79  E-value=0.014  Score=56.50  Aligned_cols=31  Identities=26%  Similarity=0.293  Sum_probs=28.0

Q ss_pred             CCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          227 DPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       227 ~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..+++|+|+.++|||+++++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4579999999999999999999999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.76  E-value=0.013  Score=56.71  Aligned_cols=30  Identities=30%  Similarity=0.459  Sum_probs=25.8

Q ss_pred             CCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          227 DPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       227 ~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            468999999999999987 578899998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.75  E-value=0.00028  Score=78.51  Aligned_cols=159  Identities=13%  Similarity=-0.004  Sum_probs=111.6

Q ss_pred             HHHHHHHHHhcCCCCeeeeeeeee--ccCceeeeeeecCCCCHHHHhcCCCC--CCCCHHHHHHHHHHHHHHHHHHhh--
Q 012715          151 FCREIELLARLHHRHLVALRGFCI--EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHF--  224 (458)
Q Consensus       151 ~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~~LH~--  224 (458)
                      ...|.+.++...|+++.....-..  +..+.+.+++|+.+|.+.+.|.+...  .++...-+.....+......-+|.  
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            445555666678988876654433  23467899999999999999865322  233333333333333444444442  


Q ss_pred             cCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHH
Q 012715          225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL  304 (458)
Q Consensus       225 ~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~  304 (458)
                      ....--+|++||+-|.+|..+..+|++++|+.+......    .......+++.|++|+....-.++.++|+|..|+.+|
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~----sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL----SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchH----hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            223457899999999999999999999999998322211    1233456788899999988889999999999999999


Q ss_pred             HHHhCCCcc
Q 012715          305 EIVTARRAV  313 (458)
Q Consensus       305 el~tg~~p~  313 (458)
                      ++.-|..++
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            998876655

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.70  E-value=0.011  Score=58.54  Aligned_cols=80  Identities=18%  Similarity=0.193  Sum_probs=52.1

Q ss_pred             ceeeeecceEEEEEEEcC-CCEEEEEEecc---cc---hhhHhHHHHHHHHHHhcC--CC-CeeeeeeeeeccCceeeee
Q 012715          114 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDK---IS---EQVEGDFCREIELLARLH--HR-HLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~---~~---~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  183 (458)
                      +.||.|.-.-||++...+ ++.|+||.-..   ..   .-..+....|.+.|+...  -| ++.+++.+  +.+...+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            368999999999998743 67899996421   11   223445667888888774  34 45556554  455667899


Q ss_pred             eecCC-CCHHHHh
Q 012715          184 EYMAN-GSLKDHL  195 (458)
Q Consensus       184 e~~~~-gsL~~~l  195 (458)
                      |+++. ..|.+.|
T Consensus       113 EdL~~~~ilR~~L  125 (409)
T PRK12396        113 EDLSDHTILRTAL  125 (409)
T ss_pred             HhCcccHHHHHHH
Confidence            99854 3344444

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.49  E-value=0.0036  Score=62.84  Aligned_cols=49  Identities=22%  Similarity=0.261  Sum_probs=38.8

Q ss_pred             hHHHHHHHHHHhcCCCCeeeeeeeeeccC-ceeeeeeecCCCCHHHHhcCC
Q 012715          149 GDFCREIELLARLHHRHLVALRGFCIEKR-ERFLMYEYMANGSLKDHLHSP  198 (458)
Q Consensus       149 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~  198 (458)
                      .+....+.+++.+.|+|+...+++..... ...+|+|++ +.||++.+..+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            35667788999999999999999876554 457889998 56999998753

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.49  E-value=0.026  Score=55.26  Aligned_cols=138  Identities=17%  Similarity=0.230  Sum_probs=78.1

Q ss_pred             eeeeecceEEEEEEEcC----CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCe-eeeeeeeeccCceeeeeeecCCC
Q 012715          115 IIGQGGFGTVYKAQFSD----GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      .|..|-...+|+....+    +..|.+|....... ..-+-.+|..+++.+..-++ .++++++.. +   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCC
Confidence            45557777889886543    23788887654332 22345688999999865444 355555532 1   588998776


Q ss_pred             CHHHH-----------------hcCCC---CC-CCCHHHHHHHHHHH----------------------HHHHHHHhh--
Q 012715          190 SLKDH-----------------LHSPG---RT-PLSWQTRIQIAIDV----------------------ANALEYLHF--  224 (458)
Q Consensus       190 sL~~~-----------------l~~~~---~~-~l~~~~~~~i~~~i----------------------a~gL~~LH~--  224 (458)
                      .|..-                 +|...   .. +--|..+.++..++                      ..-+..+..  
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            55210                 11111   01 11233322222221                      111111111  


Q ss_pred             ---cCCCCeEeccCCCCCeeeCC-CCcEEEeeccccc
Q 012715          225 ---YCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAH  257 (458)
Q Consensus       225 ---~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~  257 (458)
                         ....-++|.|+.+.|||+++ ++.++++||..|.
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence               11234799999999999975 5789999999874

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.46  E-value=0.033  Score=54.22  Aligned_cols=138  Identities=21%  Similarity=0.294  Sum_probs=79.5

Q ss_pred             eeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCe------eeeeee----eeccCceeeeeee
Q 012715          116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL------VALRGF----CIEKRERFLMYEY  185 (458)
Q Consensus       116 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni------v~l~~~----~~~~~~~~lv~e~  185 (458)
                      |.+ .-..||+....+|.. ++|.....  ....+...|...|..|.-.+|      ..+=|-    .......+-|++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 556799998877766 77766543  344567778888888842222      222121    1111267789999


Q ss_pred             cCCCCHHH-----Hh----------c----CCC------CCCCCHHH-------------HHHHHHHHHHHHHHHhh---
Q 012715          186 MANGSLKD-----HL----------H----SPG------RTPLSWQT-------------RIQIAIDVANALEYLHF---  224 (458)
Q Consensus       186 ~~~gsL~~-----~l----------~----~~~------~~~l~~~~-------------~~~i~~~ia~gL~~LH~---  224 (458)
                      ++|..+..     .+          +    ...      .....|..             ......++...+..+..   
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99877762     10          1    000      01233330             01122333334443331   


Q ss_pred             -cCCCC---eEeccCCCCCeeeCCCCc-EEEeeccccc
Q 012715          225 -YCDPP---LCHRDIKSSNILLDENFV-AKLADFGLAH  257 (458)
Q Consensus       225 -~~~~~---iiHrDlk~~NIll~~~~~-~kl~DfGla~  257 (458)
                       .-...   +||+|+.+.||+++++.. +.+.|||-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             11223   999999999999998874 8999999664

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.04  E-value=0.083  Score=51.39  Aligned_cols=139  Identities=19%  Similarity=0.201  Sum_probs=90.8

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEeccc-------c------------------hhhHhH-HHHHHHHHHhcCCCCee
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKI-------S------------------EQVEGD-FCREIELLARLHHRHLV  167 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-------~------------------~~~~~~-~~~E~~~l~~l~h~niv  167 (458)
                      -.|..|--+.||.+.-.+|..+|||+.+..       .                  ...... ...|++-|.+|+...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            367788888999999889999999976420       0                  000111 23477777777643332


Q ss_pred             eeeeeeeccCceeeeeeecCCCCHHH--HhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC
Q 012715          168 ALRGFCIEKRERFLMYEYMANGSLKD--HLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN  245 (458)
Q Consensus       168 ~l~~~~~~~~~~~lv~e~~~~gsL~~--~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~  245 (458)
                      .---+.  -....|||+|+.. +=+.  .|+   ...++...+..+-.+++.-|.-|-.  ..++||.||.-=|+|+- +
T Consensus       230 ~PePIl--Lk~hVLVM~FlGr-dgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  230 CPEPIL--LKNHVLVMEFLGR-DGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYH-D  300 (520)
T ss_pred             CCCcee--eecceEeeeeccC-CCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEE-C
Confidence            110000  0234699999953 2211  122   2347777788888888888877764  55899999999999984 5


Q ss_pred             CcEEEeecccccccCC
Q 012715          246 FVAKLADFGLAHASKD  261 (458)
Q Consensus       246 ~~~kl~DfGla~~~~~  261 (458)
                      |.+.|+|.+-+.....
T Consensus       301 G~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHDH  316 (520)
T ss_pred             CEEEEEEccccccCCC
Confidence            6899999998765443

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.84  E-value=0.015  Score=52.85  Aligned_cols=30  Identities=37%  Similarity=0.626  Sum_probs=21.4

Q ss_pred             CCeEeccCCCCCeee-CCCCcEEEeeccccc
Q 012715          228 PPLCHRDIKSSNILL-DENFVAKLADFGLAH  257 (458)
Q Consensus       228 ~~iiHrDlk~~NIll-~~~~~~kl~DfGla~  257 (458)
                      ..++|.||.+.|||+ +.++.++++||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            458899999999999 889999999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.83  E-value=0.17  Score=49.37  Aligned_cols=72  Identities=17%  Similarity=0.151  Sum_probs=44.6

Q ss_pred             eecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC--CCeeeee---e--eeeccCceeeeeeecCCCC
Q 012715          118 QGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH--RHLVALR---G--FCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       118 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~---~--~~~~~~~~~lv~e~~~~gs  190 (458)
                      .+.-..||+....+|..+++|.... ......+...|++++..|..  -.++...   |  +...++..+.++++++|..
T Consensus        35 ~s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         35 NSYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            3455679999887788899997642 22234567778888887742  1222211   1  1222456788999998754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.74  E-value=0.046  Score=49.34  Aligned_cols=137  Identities=15%  Similarity=0.140  Sum_probs=83.5

Q ss_pred             EEEEEecccchh-hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHH
Q 012715          135 IAVKRMDKISEQ-VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI  213 (458)
Q Consensus       135 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~  213 (458)
                      ..+|++....-. ....|..+.+++++++  .|+++..=  .....-++.|+|-...              ... ..++.
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~--------------i~~-~N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK--------------INF-SNFIT  148 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc--------------cch-hHHHH
Confidence            345555433322 3346788899998886  46666521  3335568899884311              011 11111


Q ss_pred             HHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcc
Q 012715          214 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK  293 (458)
Q Consensus       214 ~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  293 (458)
                      .=+..|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+....                .+..|.--   .....+.+
T Consensus       149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~----------------~~V~~vN~---~Y~~lT~~  208 (308)
T PF07387_consen  149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE----------------NQVNMVNI---EYESLTQE  208 (308)
T ss_pred             HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh----------------heeeEEee---eccccChH
Confidence            113566777744 67899999999999999999999999774321                11122221   12345777


Q ss_pred             cccHhHHHHHHHHHhCC
Q 012715          294 SDVYSYGVVLLEIVTAR  310 (458)
Q Consensus       294 ~Dvws~Gv~l~el~tg~  310 (458)
                      +.+-+|=.-++++....
T Consensus       209 aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  209 AEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             HHHHHHHHHHHHHHHHH
Confidence            88888777777776643

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=95.68  E-value=0.15  Score=57.48  Aligned_cols=139  Identities=17%  Similarity=0.193  Sum_probs=77.2

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC-------CCCeeeee-e----eeec-cC--ce
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-------HRHLVALR-G----FCIE-KR--ER  179 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-~----~~~~-~~--~~  179 (458)
                      .|+ |..-.+|+....+|..+++|..+...  .......|.++|..|.       -|.+++-. |    .... ++  ..
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            454 45678899888788899999886432  2233445566666552       22333221 1    1111 12  45


Q ss_pred             eeeeeecCCCCHHHHhc---------------------CC----CCCCCCHHH-----------------HHHHHHHHHH
Q 012715          180 FLMYEYMANGSLKDHLH---------------------SP----GRTPLSWQT-----------------RIQIAIDVAN  217 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~---------------------~~----~~~~l~~~~-----------------~~~i~~~ia~  217 (458)
                      +-+++|++|..|.+...                     ..    ....+.|..                 ...++.++..
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            67899999977765110                     00    011233321                 1122222222


Q ss_pred             HHH-----HHhhcCCCCeEeccCCCCCeeeCCCC--cEE-Eeeccccc
Q 012715          218 ALE-----YLHFYCDPPLCHRDIKSSNILLDENF--VAK-LADFGLAH  257 (458)
Q Consensus       218 gL~-----~LH~~~~~~iiHrDlk~~NIll~~~~--~~k-l~DfGla~  257 (458)
                      ..+     .+. ....++||+|+.+.|||++.++  .+. |+|||-+.
T Consensus       189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            221     122 1256799999999999999775  454 99999764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.63  E-value=0.063  Score=48.79  Aligned_cols=74  Identities=16%  Similarity=0.226  Sum_probs=52.2

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      .+.-|.--..|.... +...+-||.-   .......|..|+.-|..|.   --++.+++.+..+.++.|+|+||++-|.+
T Consensus        23 ~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          23 EVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            355555555555543 4567888853   2333456888888777774   46678888888899999999999998666


Q ss_pred             H
Q 012715          192 K  192 (458)
Q Consensus       192 ~  192 (458)
                      .
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            5

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=95.62  E-value=0.0026  Score=40.24  Aligned_cols=33  Identities=18%  Similarity=0.365  Sum_probs=20.0

Q ss_pred             CCceeeeehhhHHHHHHHHHHHHHHHHHHHHhh
Q 012715           29 HHPYHLTLIPGIGIAVTAVAVILLMVLIILIRR   61 (458)
Q Consensus        29 ~~~~~~~~i~~i~~~~~~~~~~~~~~~~~~~r~   61 (458)
                      +++...++..++++.++++++++++++++++||
T Consensus         6 ~~~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR   38 (40)
T PF08693_consen    6 SNSNTVAIAVGVVVPVGVIIIVLGAFLFFWYRR   38 (40)
T ss_pred             CCCceEEEEEEEEechHHHHHHHHHHhheEEec
Confidence            344566677777777776666666555544444

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PTZ00384 choline kinase; Provisional

Probab=95.57  E-value=0.13  Score=51.30  Aligned_cols=73  Identities=16%  Similarity=0.238  Sum_probs=44.1

Q ss_pred             eeeeecceEEEEEEEcCC--CE-----EEEEEecccchhhHhHHHHHHHHHHhcCCCCee-eeeeeeeccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSDG--SL-----IAVKRMDKISEQVEGDFCREIELLARLHHRHLV-ALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~  186 (458)
                      .|..|-...+|++...++  ..     |.+..... .....-+-.+|+++++.+...++- ++++.+.    -++|+||+
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~efI  131 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEWV  131 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEEe
Confidence            455688889999976533  22     33332211 111122345789999999755554 4555543    26999999


Q ss_pred             CCCCHH
Q 012715          187 ANGSLK  192 (458)
Q Consensus       187 ~~gsL~  192 (458)
                      +|.+|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            987664

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.44  E-value=0.042  Score=53.23  Aligned_cols=75  Identities=20%  Similarity=0.256  Sum_probs=55.8

Q ss_pred             ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..|++|++- |++|.- +.     .-.+.+...++.+.+..+.-+..  .-.+-|||+.-.||||+ +|++-|+||-++|
T Consensus       300 y~yl~~kdh-gt~is~-ik-----~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         300 YLYLHFKDH-GTPISI-IK-----ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             EEEEEEecC-Cceeee-ee-----cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeee
Confidence            456666654 444432 21     24678889999988887777763  45788999999999999 9999999999999


Q ss_pred             ccCCC
Q 012715          258 ASKDG  262 (458)
Q Consensus       258 ~~~~~  262 (458)
                      ....+
T Consensus       370 l~~~q  374 (488)
T COG5072         370 LSYSQ  374 (488)
T ss_pred             cccCC
Confidence            65443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	458
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-51
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-49
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-43
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-43
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-37
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-27
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-21
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-13
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		7e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		9e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		9e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  199 bits (505), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 113/295 (38%), Positives = 168/295 (56%), Gaps = 18/295 (6%)
Query: 97  FQKFSYKETKKATDNFST--IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQV-EGDFCR 153
            ++FS +E + A+DNFS   I+G+GGFG VYK + +DG+L+AVKR+ +   Q  E  F  
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQT 84
Query: 154 EIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--PGRTPLSWQTRIQI 211
           E+E              GFC+   ER L+Y YMANGS+   L      + PL W  R +I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS--KDGSICFEPV 269
           A+  A  L YLH +CDP + HRD+K++NILLDE F A + DFGLA     KD       V
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH-----V 199
Query: 270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRA------VQDGKNLVESA 323
              +RGT G++ PEY+ T + +EK+DV+ YGV+LLE++T +RA        D   ++   
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 259
Query: 324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
              +  E +L  LVD  ++ ++  E++  ++ +   CTQ     RP + +V+R+L
Sbjct: 260 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 110/295 (37%), Positives = 167/295 (56%), Gaps = 18/295 (6%)
Query: 97  FQKFSYKETKKATDNF--STIIGQGGFGTVYKAQFSDGSLIAVKRM-DKISEQVEGDFCR 153
            ++FS +E + A+DNF    I+G+GGFG VYK + +DG L+AVKR+ ++ ++  E  F  
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQT 76
Query: 154 EIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--PGRTPLSWQTRIQI 211
           E+E              GFC+   ER L+Y YMANGS+   L      + PL W  R +I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS--KDGSICFEPV 269
           A+  A  L YLH +CDP + HRD+K++NILLDE F A + DFGLA     KD       V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH-----V 191
Query: 270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRA------VQDGKNLVESA 323
              +RG  G++ PEY+ T + +EK+DV+ YGV+LLE++T +RA        D   ++   
Sbjct: 192 XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
              +  E +L  LVD  ++ ++  E++  ++ +   CTQ     RP + +V+R+L
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 111/281 (39%), Positives = 155/281 (55%), Gaps = 15/281 (5%)
Query: 104 ETKKATDNF--STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXX 161
           + ++AT+NF    +IG G FG VYK    DG+ +A+KR    S Q   +F  EIE     
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 162 XXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANAL 219
                    GFC E+ E  L+Y+YM NG+LK HL+        +SW+ R++I I  A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPG 278
            YLH      + HRD+KS NILLDENFV K+ DFG+   SK G+ +    +   ++GT G
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGI---SKKGTELGQTHLXXVVKGTLG 206
Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASES--RLA 334
           Y+DPEY +   LTEKSDVYS+GVVL E++ AR A+     + +V  A+  + S +  +L 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
           ++VDP + D    E LR        C     + RPS+  VL
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 111/281 (39%), Positives = 155/281 (55%), Gaps = 15/281 (5%)
Query: 104 ETKKATDNF--STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXX 161
           + ++AT+NF    +IG G FG VYK    DG+ +A+KR    S Q   +F  EIE     
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 162 XXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANAL 219
                    GFC E+ E  L+Y+YM NG+LK HL+        +SW+ R++I I  A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP-VNTDIRGTPG 278
            YLH      + HRD+KS NILLDENFV K+ DFG+   SK G+   +  +   ++GT G
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGI---SKKGTELDQTHLXXVVKGTLG 206
Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCMASES--RLA 334
           Y+DPEY +   LTEKSDVYS+GVVL E++ AR A+     + +V  A+  + S +  +L 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
           ++VDP + D    E LR        C     + RPS+  VL
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 107/300 (35%), Positives = 160/300 (53%), Gaps = 24/300 (8%)
Query: 97  FQKFSYKETKKATDNF--------STIIGQGGFGTVYKAQFSDGSLIAVKRM----DKIS 144
           F  FS+ E K  T+NF           +G+GGFG VYK  + + + +AVK++    D  +
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 70
Query: 145 EQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPL 203
           E+++  F +EI+              GF  +  +  L+Y YM NGSL D L    G  PL
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 263
           SW  R +IA   AN + +LH   +    HRDIKS+NILLDE F AK++DFGLA AS+   
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE--K 185
Query: 264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LV 320
                + + I GT  YM PE  +  E+T KSD+YS+GVVLLEI+T   AV + +    L+
Sbjct: 186 FAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
           +  +     E  + + +D ++ D+ D   +  + ++   C   +   RP IK+V ++L E
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 107/300 (35%), Positives = 159/300 (53%), Gaps = 24/300 (8%)
Query: 97  FQKFSYKETKKATDNF--------STIIGQGGFGTVYKAQFSDGSLIAVKRM----DKIS 144
           F  FS+ E K  T+NF           +G+GGFG VYK  + + + +AVK++    D  +
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 70
Query: 145 EQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPL 203
           E+++  F +EI+              GF  +  +  L+Y YM NGSL D L    G  PL
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 263
           SW  R +IA   AN + +LH   +    HRDIKS+NILLDE F AK++DFGLA AS+   
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE--K 185
Query: 264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LV 320
                +   I GT  YM PE  +  E+T KSD+YS+GVVLLEI+T   AV + +    L+
Sbjct: 186 FAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
           +  +     E  + + +D ++ D+ D   +  + ++   C   +   RP IK+V ++L E
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 107/300 (35%), Positives = 159/300 (53%), Gaps = 24/300 (8%)
Query: 97  FQKFSYKETKKATDNF--------STIIGQGGFGTVYKAQFSDGSLIAVKRM----DKIS 144
           F  FS+ E K  T+NF           +G+GGFG VYK  + + + +AVK++    D  +
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 64
Query: 145 EQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPL 203
           E+++  F +EI+              GF  +  +  L+Y YM NGSL D L    G  PL
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 124
Query: 204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 263
           SW  R +IA   AN + +LH   +    HRDIKS+NILLDE F AK++DFGLA AS+   
Sbjct: 125 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE--K 179
Query: 264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LV 320
                +   I GT  YM PE  +  E+T KSD+YS+GVVLLEI+T   AV + +    L+
Sbjct: 180 FAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 238
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
           +  +     E  + + +D ++ D+ D   +  + ++   C   +   RP IK+V ++L E
Sbjct: 239 DIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 106/302 (35%), Positives = 156/302 (51%), Gaps = 24/302 (7%)
Query: 97  FQKFSYKETKKATDNF--------STIIGQGGFGTVYKAQFSDGSLIAVKRM----DKIS 144
           F  FS+ E K  T+NF            G+GGFG VYK  + + + +AVK++    D  +
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 61
Query: 145 EQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPL 203
           E+++  F +EI+              GF  +  +  L+Y Y  NGSL D L    G  PL
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 263
           SW  R +IA   AN + +LH   +    HRDIKS+NILLDE F AK++DFGLA AS+   
Sbjct: 122 SWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE--K 176
Query: 264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LV 320
                  + I GT  Y  PE  +  E+T KSD+YS+GVVLLEI+T   AV + +    L+
Sbjct: 177 FAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 235
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
           +  +     E  + + +D +  D+ D   +    ++   C   +   RP IK+V ++L E
Sbjct: 236 DIKEEIEDEEKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294
Query: 381 SS 382
            +
Sbjct: 295 XT 296

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 94/281 (33%), Positives = 138/281 (49%), Gaps = 25/281 (8%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRM---DKISEQVEGDFCREIEXXXXXXXXXXX 167
           N    IG G FGTV++A++  GS +AVK +   D  +E+V  +F RE+            
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERV-NEFLREVAIMKRLRHPNIV 97
Query: 168 XXXGFCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYC 226
              G   +     ++ EY++ GSL   LH  G R  L  + R+ +A DVA  + YLH   
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR- 156
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           +PP+ HRD+KS N+L+D+ +  K+ DFGL+       +     +    GTP +M PE + 
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL----XSKXAAGTPEWMAPEVLR 212
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   EKSDVYS+GV+L E+ T +   Q   NL   AQV  A   +   L  PR  +   
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQ---QPWGNL-NPAQVVAAVGFKCKRLEIPRNLNP-- 266
Query: 347 MEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYESSDP 384
                 +  I+  C   E   RPS   I  +LR L +S+ P
Sbjct: 267 -----QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 93/281 (33%), Positives = 138/281 (49%), Gaps = 25/281 (8%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRM---DKISEQVEGDFCREIEXXXXXXXXXXX 167
           N    IG G FGTV++A++  GS +AVK +   D  +E+V  +F RE+            
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERV-NEFLREVAIMKRLRHPNIV 97
Query: 168 XXXGFCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYC 226
              G   +     ++ EY++ GSL   LH  G R  L  + R+ +A DVA  + YLH   
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR- 156
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           +PP+ HR++KS N+L+D+ +  K+ DFGL+       +     +    GTP +M PE + 
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS----SKSAAGTPEWMAPEVLR 212
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   EKSDVYS+GV+L E+ T +   Q   NL   AQV  A   +   L  PR  +   
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQ---QPWGNL-NPAQVVAAVGFKCKRLEIPRNLNP-- 266
Query: 347 MEQLRTIVTIVRWCTQREGQARPS---IKQVLRILYESSDP 384
                 +  I+  C   E   RPS   I  +LR L +S+ P
Sbjct: 267 -----QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 124/287 (43%), Gaps = 53/287 (18%)
Query: 116 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V+ A+        D  L+AVK + + SE    DF RE E             
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPG-------------RTPLSWQTRIQIAIDVA 216
            G C E R   +++EYM +G L   L S G               PL     + +A  VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 217 NALEY---LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH--ASKD----GSICFE 267
             + Y   LHF       HRD+ + N L+ +  V K+ DFG++    S D    G     
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 327
           P+         +M PE ++ ++ T +SDV+S+GVVL EI T  +  Q    L  +  +  
Sbjct: 223 PIR--------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK--QPWYQLSNTEAIDC 272
Query: 328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
            ++ R  EL  PR            +  I+R C QRE Q R SIK V
Sbjct: 273 ITQGR--ELERPRACPP-------EVYAIMRGCWQREPQQRHSIKDV 310

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 124/288 (43%), Gaps = 55/288 (19%)
Query: 116 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V+ A+        D  L+AVK + + SE    DF RE E             
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPG-------------RTPLSWQTRIQIAIDVA 216
            G C E R   +++EYM +G L   L S G               PL     + +A  VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 217 NALEY---LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 273
             + Y   LHF       HRD+ + N L+ +  V K+ DFG++          +  +TD 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR---------DIYSTDY 190
Query: 274 RGTPG-------YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 326
               G       +M PE ++ ++ T +SDV+S+GVVL EI T  +  Q    L  +  + 
Sbjct: 191 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK--QPWYQLSNTEAID 248
Query: 327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
             ++ R  EL  PR            +  I+R C QRE Q R SIK V
Sbjct: 249 CITQGR--ELERPRACPP-------EVYAIMRGCWQREPQQRHSIKDV 287

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 124/287 (43%), Gaps = 53/287 (18%)
Query: 116 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V+ A+        D  L+AVK + + SE    DF RE E             
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPG-------------RTPLSWQTRIQIAIDVA 216
            G C E R   +++EYM +G L   L S G               PL     + +A  VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 217 NALEY---LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH--ASKD----GSICFE 267
             + Y   LHF       HRD+ + N L+ +  V K+ DFG++    S D    G     
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 327
           P+         +M PE ++ ++ T +SDV+S+GVVL EI T  +  Q    L  +  +  
Sbjct: 194 PIR--------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK--QPWYQLSNTEAIDC 243
Query: 328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
            ++ R  EL  PR            +  I+R C QRE Q R SIK V
Sbjct: 244 ITQGR--ELERPRACPP-------EVYAIMRGCWQREPQQRHSIKDV 281

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 88/330 (26%), Positives = 136/330 (41%), Gaps = 67/330 (20%)
Query: 93  PSPMFQKF--------SYKETKKATDNFSTIIGQGGFGTVYKAQ------FSDGSLIAVK 138
           P+PM+Q+            E  +    +   IG+G FG V++A+      +   +++AVK
Sbjct: 24  PNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK 83
Query: 139 RM-DKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS 197
            + ++ S  ++ DF RE                G C   +   L++EYMA G L + L S
Sbjct: 84  MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143
Query: 198 ----------------------PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
                                 PG  PLS   ++ IA  VA  + YL    +    HRD+
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL 200
Query: 236 KSSNILLDENFVAKLADFGLA-------HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + N L+ EN V K+ADFGL+       +   DG+    P+         +M PE +   
Sbjct: 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI-PIR--------WMPPESIFYN 251
Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
             T +SDV++YGVVL EI +       G          MA E  +  + D  I    +  
Sbjct: 252 RYTTESDVWAYGVVLWEIFSYGLQPYYG----------MAHEEVIYYVRDGNILACPENC 301
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            L  +  ++R C  +    RPS   + RIL
Sbjct: 302 PLE-LYNLMRLCWSKLPADRPSFCSIHRIL 330

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 139/300 (46%), Gaps = 35/300 (11%)
Query: 92  GPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGD 150
           GPSP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +
Sbjct: 1   GPSPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 56
Query: 151 FCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 210
           F +E                G C  +   +++ E+M  G+L D+L    R  ++    + 
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY 116
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPV 269
           +A  +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D        
Sbjct: 117 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA 173
Query: 270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS 329
              I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L          
Sbjct: 174 KFPIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------- 219
Query: 330 ESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
            S++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 220 -SQVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 274

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 48/290 (16%)
Query: 116 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V+ A+        D  L+AVK +   +     DF RE E             
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDV 215
            G C +     +++EYM +G L   L + G              +  L     + IA  +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 216 ANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG-SICFEPVNT 271
           A+ + YL   HF       HRD+ + N L+  N + K+ DFG+   S+D  S  +  V  
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGM---SRDVYSTDYYRVGG 193
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
                  +M PE ++ ++ T +SDV+S+GV+L EI T  +  Q    L  +  +   ++ 
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK--QPWFQLSNTEVIECITQG 251
Query: 332 RLAELVDPRI--KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 379
           R+ E   PR+  K+ +D         ++  C QRE Q R +IK++ +IL+
Sbjct: 252 RVLE--RPRVCPKEVYD---------VMLGCWQREPQQRLNIKEIYKILH 290

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 41/284 (14%)
Query: 116 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V+ A+        D  L+AVK +   S+    DF RE E             
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPG-----------RTPLSWQTRIQIAIDVANA 218
            G C+E     +++EYM +G L   L + G            T L+    + IA  +A  
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 219 LEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG-SICFEPVNTDIR 274
           + YL   HF       HRD+ + N L+ EN + K+ DFG+   S+D  S  +  V     
Sbjct: 141 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGM---SRDVYSTDYYRVGGHTM 191
Query: 275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 334
               +M PE ++ ++ T +SDV+S GVVL EI T  +  Q    L  +  +   ++ R+ 
Sbjct: 192 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK--QPWYQLSNNEVIECITQGRV- 248
Query: 335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            L  PR          + +  ++  C QRE   R +IK +  +L
Sbjct: 249 -LQRPRTCP-------QEVYELMLGCWQREPHMRKNIKGIHTLL 284

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 143/312 (45%), Gaps = 35/312 (11%)
Query: 80  FPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVK 138
           +P P+  +    G SP + K+   E ++        +G G +G VY+  +   SL +AVK
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK 251
Query: 139 RMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSP 198
            + + + +VE +F +E                G C  +   +++ E+M  G+L D+L   
Sbjct: 252 TLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
Query: 199 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH- 257
            R  +S    + +A  +++A+EYL         HR++ + N L+ EN + K+ADFGL+  
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK 317
            + D           I+ T     PE +   + + KSDV+++GV+L EI T   +   G 
Sbjct: 368 MTGDTYTAHAGAKFPIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
Query: 318 NLVESAQVCMASESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS--- 370
           +L           S++ EL++   KD + ME+       +  ++R C Q     RPS   
Sbjct: 424 DL-----------SQVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 468
Query: 371 IKQVLRILYESS 382
           I Q    +++ S
Sbjct: 469 IHQAFETMFQES 480

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 143/312 (45%), Gaps = 35/312 (11%)
Query: 80  FPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVK 138
           +P P+  +    G SP + K+   E ++        +G G +G VY+  +   SL +AVK
Sbjct: 234 YPAPKRNKPTVYGVSPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK 290
Query: 139 RMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSP 198
            + + + +VE +F +E                G C  +   +++ E+M  G+L D+L   
Sbjct: 291 TLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 349
Query: 199 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH- 257
            R  ++    + +A  +++A+EYL         HR++ + N L+ EN + K+ADFGL+  
Sbjct: 350 NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRL 406
Query: 258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK 317
            + D           I+ T     PE +   + + KSDV+++GV+L EI T   +   G 
Sbjct: 407 MTGDTYTAHAGAKFPIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 462
Query: 318 NLVESAQVCMASESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS--- 370
           +L           S++ EL++   KD + ME+       +  ++R C Q     RPS   
Sbjct: 463 DL-----------SQVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 507
Query: 371 IKQVLRILYESS 382
           I Q    +++ S
Sbjct: 508 IHQAFETMFQES 519

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 138/299 (46%), Gaps = 35/299 (11%)
Query: 93  PSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDF 151
           PSP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F
Sbjct: 5   PSPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EF 60
Query: 152 CREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI 211
            +E                G C  +   +++ E+M  G+L D+L    R  ++    + +
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 120
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVN 270
           A  +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D         
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 330
             I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           
Sbjct: 178 FPIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------- 222
Query: 331 SRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           S++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 223 SQVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
            F   IG G FG V+   + +   +A+K + K     E DF  E E              
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLY 88
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G C+E+    L++E+M +G L D+L +  R   + +T + + +DV   + YL   C   +
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            HRD+ + N L+ EN V K++DFG+     D        +T  +    +  PE       
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRY 201
Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 350
           + KSDV+S+GV++ E+ +  +   + ++  E  +      S    L  PR+  +      
Sbjct: 202 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFRLYKPRLAST------ 251
Query: 351 RTIVTIVRWCTQREGQARPSIKQVLRILYESSD 383
             +  I+  C +   + RP+  ++LR L E ++
Sbjct: 252 -HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V    +  G+ +AVK +   ++     F  E                G  +E
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 176 -KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            K   +++ EYMA GSL D+L S GR+ L     ++ ++DV  A+EYL         HRD
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           + + N+L+ E+ VAK++DFGL   +K+ S   +     ++ T     PE +  ++ + KS
Sbjct: 143 LAARNVLVSEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTA----PEALREKKFSTKS 195
Query: 295 DVYSYGVVLLEIVTARRA 312
           DV+S+G++L EI +  R 
Sbjct: 196 DVWSFGILLWEIYSFGRV 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V    +  G+ +AVK +   ++     F  E                G  +E
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 176 -KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            K   +++ EYMA GSL D+L S GR+ L     ++ ++DV  A+EYL         HRD
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           + + N+L+ E+ VAK++DFGL   +K+ S   +     ++ T     PE +  ++ + KS
Sbjct: 128 LAARNVLVSEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTA----PEALREKKFSTKS 180
Query: 295 DVYSYGVVLLEIVTARRA 312
           DV+S+G++L EI +  R 
Sbjct: 181 DVWSFGILLWEIYSFGRV 198

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 116 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
           +GQG FG VY+    D       + +AVK +++   + E++E  F  E            
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
               G   + +   ++ E MA+G LK +L S        PGR P + Q  IQ+A ++A+ 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 272
           + YL+        HRD+ + N ++  +F  K+ DFG+          + G     PV   
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-- 197
Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
                 +M PE +     T  SD++S+GVVL EI +          L E     +++E  
Sbjct: 198 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQV 241
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGF 389
           L  ++D    D  D    R +  ++R C Q   + RP+  +++ +L    D +H  F
Sbjct: 242 LKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPKMRPTFLEIVNLL---KDDLHPSF 294

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 116 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
           +GQG FG VY+    D       + +AVK +++   + E++E  F  E            
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 79
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
               G   + +   ++ E MA+G LK +L S        PGR P + Q  IQ+A ++A+ 
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 272
           + YL+        HRD+ + N ++  +F  K+ DFG+          + G     PV   
Sbjct: 140 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-- 194
Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
                 +M PE +     T  SD++S+GVVL EI +          L E     +++E  
Sbjct: 195 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQV 238
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGF 389
           L  ++D    D  D    R +  ++R C Q   + RP+  +++ +L    D +H  F
Sbjct: 239 LKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPKMRPTFLEIVNLL---KDDLHPSF 291

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V    +  G+ +AVK +   ++     F  E                G  +E
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 176 -KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            K   +++ EYMA GSL D+L S GR+ L     ++ ++DV  A+EYL         HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           + + N+L+ E+ VAK++DFGL   +K+ S   +     ++ T     PE +  ++ + KS
Sbjct: 315 LAARNVLVSEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTA----PEALREKKFSTKS 367
Query: 295 DVYSYGVVLLEIVTARRA 312
           DV+S+G++L EI +  R 
Sbjct: 368 DVWSFGILLWEIYSFGRV 385

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 50/297 (16%)
Query: 116 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
           +GQG FG VY+    D       + +AVK +++   + E++E  F  E            
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
               G   + +   ++ E MA+G LK +L S        PGR P + Q  IQ+A ++A+ 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 272
           + YL+        HRD+ + N ++  +F  K+ DFG+          + G     PV   
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-- 197
Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
                 +M PE +     T  SD++S+GVVL EI +          L E     +++E  
Sbjct: 198 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQV 241
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGF 389
           L  ++D    D  D    R +  ++R C Q     RP+  +++ +L    D +H  F
Sbjct: 242 LKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPNMRPTFLEIVNLL---KDDLHPSF 294

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 102 YKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIEXXXX 160
           Y E + +    ST IG G FGTVYK ++  D ++  +K +D   EQ +  F  E+     
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQA-FRNEVAVLRK 88
Query: 161 XXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
                     G+ + K    ++ ++    SL  HLH    T       I IA   A  ++
Sbjct: 89  TRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMD 146
Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRGTPG 278
           YLH      + HRD+KS+NI L E    K+ DFGLA       GS   E       G+  
Sbjct: 147 YLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT----GSVL 199
Query: 279 YMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTA 309
           +M PE +  Q+    + +SDVYSYG+VL E++T 
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 116 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
           +GQG FG VY+    D       + +AVK +++   + E++E  F  E            
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 81
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
               G   + +   ++ E MA+G LK +L S        PGR P + Q  IQ+A ++A+ 
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 272
           + YL+        HRD+ + N ++  +F  K+ DFG+          + G     PV   
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 196
Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
                 +M PE +     T  SD++S+GVVL EI +          L E     +++E  
Sbjct: 197 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQV 240
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGF 389
           L  ++D    D  D    R +  ++R C Q   + RP+  +++ +L    D +H  F
Sbjct: 241 LKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPKMRPTFLEIVNLL---KDDLHPSF 293

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 23/275 (8%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
            F   IG G FG V+   + +   +A+K  R   +SE+   DF  E E            
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQ 64
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+E+    L++E+M +G L D+L +  R   + +T + + +DV   + YL   C  
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + HRD+ + N L+ EN V K++DFG+     D        +T  +    +  PE     
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFS 177
Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
             + KSDV+S+GV++ E+ +  +   + ++  E  +      S    L  PR+  +    
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFRLYKPRLAST---- 229
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 383
               +  I+  C +   + RP+  ++LR L E ++
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 23/275 (8%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
            F   IG G FG V+   + +   +A+K  R   +SE+   DF  E E            
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQ 66
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+E+    L++E+M +G L D+L +  R   + +T + + +DV   + YL   C  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC-- 123
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + HRD+ + N L+ EN V K++DFG+     D        +T  +    +  PE     
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFS 179
Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
             + KSDV+S+GV++ E+ +  +   + ++  E  +      S    L  PR+  +    
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFRLYKPRLAST---- 231
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 383
               +  I+  C +   + RP+  ++LR L E ++
Sbjct: 232 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 116 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
           +GQG FG VY+    D       + +AVK +++   + E++E  F  E            
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
               G   + +   ++ E MA+G LK +L S        PGR P + Q  IQ+A ++A+ 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 272
           + YL+        HRD+ + N ++  +F  K+ DFG+          + G     PV   
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 197
Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
                 +M PE +     T  SD++S+GVVL EI +          L E     +++E  
Sbjct: 198 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQV 241
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGF 389
           L  ++D    D  D    R +  ++R C Q   + RP+  +++ +L    D +H  F
Sbjct: 242 LKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPKMRPTFLEIVNLL---KDDLHPSF 294

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 52/298 (17%)
Query: 116 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
           +GQG FG VY+    D       + +AVK +++   + E++E  F  E            
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
               G   + +   ++ E MA+G LK +L S        PGR P + Q  IQ+A ++A+ 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL-------AHASKDGSICFEPVNT 271
           + YL+        HRD+ + N ++  +F  K+ DFG+       A+  K G     PV  
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLL-PVR- 197
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
                  +M PE +     T  SD++S+GVVL EI +          L E     +++E 
Sbjct: 198 -------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQ 240
Query: 332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGF 389
            L  ++D    D  D    R +  ++R C Q   + RP+  +++ +L    D +H  F
Sbjct: 241 VLKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPKMRPTFLEIVNLL---KDDLHPSF 294

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 116 IGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           +G G FG VY+  +   SL +AVK + + + +VE +F +E                G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            +   +++ E+M  G+L D+L    R  +S    + +A  +++A+EYL         HRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 235 IKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           + + N L+ EN + K+ADFGL+   + D           I+ T     PE +   + + K
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNKFSIK 190
Query: 294 SDVYSYGVVLLEIVT 308
           SDV+++GV+L EI T
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 148
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 23/275 (8%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
            F   IG G FG V+   + +   +A+K  R   +SE+   DF  E E            
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQ 69
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+E+    L++E+M +G L D+L +  R   + +T + + +DV   + YL   C  
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC-- 126
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + HRD+ + N L+ EN V K++DFG+     D        +T  +    +  PE     
Sbjct: 127 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFS 182
Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
             + KSDV+S+GV++ E+ +  +   + ++  E  +      S    L  PR+  +    
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFRLYKPRLAST---- 234
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 383
               +  I+  C +   + RP+  ++LR L E ++
Sbjct: 235 ---HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 2   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 57
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  +S    + +A
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 118 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 175 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 219
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 220 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           ++G+G FG   K    + G ++ +K + +  E+ +  F +E++              G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
            + +    + EY+  G+L+  + S   +   W  R+  A D+A+ + YLH      + HR
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT----------DIRGTPGYMDPE 283
           D+ S N L+ EN    +ADFGLA    D     E + +           + G P +M PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 284 YVVTQELTEKSDVYSYGVVLLEIV 307
            +  +   EK DV+S+G+VL EI+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 2   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 57
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  +S    + +A
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 118 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 175 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 219
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 220 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 2   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 57
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  +S    + +A
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 118 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 175 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 219
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 220 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 7   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 62
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  +S    + +A
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 122
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 123 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 180 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 224
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 225 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 147
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 14/198 (7%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V    +  G+ +AVK +   ++     F  E                G  +E
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 176 -KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            K   +++ EYMA GSL D+L S GR+ L     ++ ++DV  A+EYL         HRD
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           + + N+L+ E+ VAK++DFGL   +K+ S   +     ++ T     PE +     + KS
Sbjct: 134 LAARNVLVSEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTA----PEALREAAFSTKS 186
Query: 295 DVYSYGVVLLEIVTARRA 312
           DV+S+G++L EI +  R 
Sbjct: 187 DVWSFGILLWEIYSFGRV 204

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 148
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 2   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 57
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  +S    + +A
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 118 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 175 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 219
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 220 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 168
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 146
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 144
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 149
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 141
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 149
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 111/247 (44%), Gaps = 43/247 (17%)
Query: 87  RKFQEGPSP-MFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL---IAVKRMDK 142
           RK +  P P ++    + + K     F  +IG+G FG V KA+     L    A+KRM +
Sbjct: 5   RKVKNNPDPTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 59
Query: 143 ISEQVEG-DFCREIEXXXXXXXX-XXXXXXGFCIEKRERFLMYEYMANGSLKDHLH---- 196
            + + +  DF  E+E               G C  +   +L  EY  +G+L D L     
Sbjct: 60  YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 119
Query: 197 ----------SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 246
                     +   + LS Q  +  A DVA  ++YL         HR++ + NIL+ EN+
Sbjct: 120 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRNLAARNILVGENY 176
Query: 247 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-----TEKSDVYSYGV 301
           VAK+ADFGL+   +            ++ T G +   ++  + L     T  SDV+SYGV
Sbjct: 177 VAKIADFGLSRGQE----------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 226
Query: 302 VLLEIVT 308
           +L EIV+
Sbjct: 227 LLWEIVS 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  ++YL  
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL-- 167
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 285 VVTQELTEKSDVYSYGVVLLEIVT 308
           + TQ+ T KSDV+S+GV+L E++T
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 138/301 (45%), Gaps = 37/301 (12%)
Query: 92  GPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGD 150
           G SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +
Sbjct: 1   GMSPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 56
Query: 151 FCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 210
           F +E                G C  +   +++ E+M  G+L D+L    R  ++    + 
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 116
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 270
           +A  +++A+EYL         HRD+ + N L+ EN + K+ADFGL+     G     P  
Sbjct: 117 MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAG 172
Query: 271 TD--IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA 328
               I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L         
Sbjct: 173 AKFPIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------- 219
Query: 329 SESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYES 381
             S++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ 
Sbjct: 220 --SQVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 273
Query: 382 S 382
           S
Sbjct: 274 S 274

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 7   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 62
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  ++    + +A
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 123 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 179
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 180 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 224
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 225 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 7   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 62
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  ++    + +A
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 123 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 180 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 224
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQV 374
           ++ EL++   KD + ME+       +  ++R C Q     RPS  ++
Sbjct: 225 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 116 IGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           +G G +G VY+  +   SL +AVK + + + +VE +F +E                G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            +   +++ E+M  G+L D+L    R  +S    + +A  +++A+EYL         HRD
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 235 IKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           + + N L+ EN + K+ADFGL+   + D           I+ T     PE +   + + K
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNKFSIK 190
Query: 294 SDVYSYGVVLLEIVT 308
           SDV+++GV+L EI T
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 112 FSTIIGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQVEG-DFCREIEXXXXXXXX-XX 166
           F  +IG+G FG V KA+     L    A+KRM + + + +  DF  E+E           
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLH--------------SPGRTPLSWQTRIQIA 212
               G C  +   +L  EY  +G+L D L               +   + LS Q  +  A
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 272
            DVA  ++YL         HRD+ + NIL+ EN+VAK+ADFGL+   +            
Sbjct: 139 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE----------VY 185
Query: 273 IRGTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVT 308
           ++ T G +   ++  + L     T  SDV+SYGV+L EIV+
Sbjct: 186 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 7   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 62
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  ++    + +A
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 123 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 180 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 224
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQV 374
           ++ EL++   KD + ME+       +  ++R C Q     RPS  ++
Sbjct: 225 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 112 FSTIIGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQVEG-DFCREIEXXXXXXXX-XX 166
           F  +IG+G FG V KA+     L    A+KRM + + + +  DF  E+E           
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLH--------------SPGRTPLSWQTRIQIA 212
               G C  +   +L  EY  +G+L D L               +   + LS Q  +  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 272
            DVA  ++YL         HRD+ + NIL+ EN+VAK+ADFGL+   +            
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE----------VY 195
Query: 273 IRGTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVT 308
           ++ T G +   ++  + L     T  SDV+SYGV+L EIV+
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 4   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 59
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  ++    + +A
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 120 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 177 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 221
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 222 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 7   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 62
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  ++    + +A
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 123 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 180 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 224
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 225 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 278

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 2   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 57
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  ++    + +A
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 117
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 118 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 175 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 219
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 220 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 2   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 57
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  ++    + +A
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 117
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 118 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 175 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 219
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQV 374
           ++ EL++   KD + ME+       +  ++R C Q     RPS  ++
Sbjct: 220 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 115 IIGQGGFGTVYKAQFSDGSL----IAVKRMDKISE--QVEGDFCREIEXXXXXXXXXXXX 168
           +IG+G FG VY  ++ D +      A+K + +I+E  QVE  F RE              
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGLNHPNVLA 86
Query: 169 XXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             G  +       ++  YM +G L   + SP R P + +  I   + VA  +EYL    +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP-TVKDLISFGLQVARGMEYL---AE 142
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
               HRD+ + N +LDE+F  K+ADFGLA    D        +   R    +   E + T
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 288 QELTEKSDVYSYGVVLLEIVT 308
              T KSDV+S+GV+L E++T
Sbjct: 203 YRFTTKSDVWSFGVLLWELLT 223

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  +++L  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 147
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDP 282
                  HRD+ + N +LDE F  K+ADFGLA    D    F+ V+  T  +    +M  
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE--FDSVHNKTGAKLPVKWMAL 204
Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E + TQ+ T KSDV+S+GV+L E++T
Sbjct: 205 ESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 24/226 (10%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRM-----DKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           IIG GGFG VY+A F  G  +AVK       + IS+ +E +  +E +             
Sbjct: 14  IIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIE-NVRQEAKLFAMLKHPNIIAL 71
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            G C+++    L+ E+   G L   L      P      +  A+ +A  + YLH     P
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP---DILVNWAVQIARGMNYLHDEAIVP 128
Query: 230 LCHRDIKSSNILLDE--------NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 281
           + HRD+KSSNIL+ +        N + K+ DFGLA      +           G   +M 
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT------KMSAAGAYAWMA 182
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 327
           PE +     ++ SDV+SYGV+L E++T     +    L  +  V M
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 137/298 (45%), Gaps = 35/298 (11%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 15  SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 70
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  ++    + +A
Sbjct: 71  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 130
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNT 271
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+   + D          
Sbjct: 131 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 187
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
            I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 188 PIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 232
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           ++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 233 QVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 286

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  +++L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 149
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDP 282
                  HRD+ + N +LDE F  K+ADFGLA    D    F+ V+  T  +    +M  
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE--FDSVHNKTGAKLPVKWMAL 206
Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E + TQ+ T KSDV+S+GV+L E++T
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  +++L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 150
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDP 282
                  HRD+ + N +LDE F  K+ADFGLA    D    F+ V+  T  +    +M  
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKE--FDSVHNKTGAKLPVKWMAL 207
Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E + TQ+ T KSDV+S+GV+L E++T
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  +++L  
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 154
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDP 282
                  HRD+ + N +LDE F  K+ADFGLA    D    F+ V+  T  +    +M  
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE--FDSVHNKTGAKLPVKWMAL 211
Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E + TQ+ T KSDV+S+GV+L E++T
Sbjct: 212 ESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  +++L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 149
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDP 282
                  HRD+ + N +LDE F  K+ADFGLA    D    F+ V+  T  +    +M  
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE--FDSVHNKTGAKLPVKWMAL 206
Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E + TQ+ T KSDV+S+GV+L E++T
Sbjct: 207 ESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 128/297 (43%), Gaps = 50/297 (16%)
Query: 116 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
           +GQG FG VY+    D       + +AVK +++   + E++E  F  E            
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 82
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
               G   + +   ++ E MA+G LK +L S        PGR P + Q  IQ+A ++A+ 
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 272
           + YL+        HR++ + N ++  +F  K+ DFG+          + G     PV   
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 197
Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
                 +M PE +     T  SD++S+GVVL EI +          L E     +++E  
Sbjct: 198 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQV 241
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGF 389
           L  ++D    D  D    R +  ++R C Q     RP+  +++ +L    D +H  F
Sbjct: 242 LKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPNMRPTFLEIVNLL---KDDLHPSF 294

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 128/297 (43%), Gaps = 50/297 (16%)
Query: 116 IGQGGFGTVYKAQFSD------GSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
           +GQG FG VY+    D       + +AVK +++   + E++E  F  E            
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNEASVMKGFTCHHV 83
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANA 218
               G   + +   ++ E MA+G LK +L S        PGR P + Q  IQ+A ++A+ 
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKDGSICFEPVNTD 272
           + YL+        HR++ + N ++  +F  K+ DFG+          + G     PV   
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 198
Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
                 +M PE +     T  SD++S+GVVL EI +          L E     +++E  
Sbjct: 199 ------WMAPESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQPYQGLSNEQV 242
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGF 389
           L  ++D    D  D    R +  ++R C Q     RP+  +++ +L    D +H  F
Sbjct: 243 LKFVMDGGYLDQPDNCPER-VTDLMRMCWQFNPNMRPTFLEIVNLL---KDDLHPSF 295

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 23/275 (8%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
            F   IG G FG V+   + +   +A+K  R   +SE+   DF  E E            
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQ 67
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+E+    L+ E+M +G L D+L +  R   + +T + + +DV   + YL   C  
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC-- 124
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + HRD+ + N L+ EN V K++DFG+     D        +T  +    +  PE     
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFS 180
Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
             + KSDV+S+GV++ E+ +  +   + ++  E  +      S    L  PR+  +    
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFRLYKPRLASTH--- 233
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 383
               +  I+  C +   + RP+  ++LR L E ++
Sbjct: 234 ----VYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  +++L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 150
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDP 282
                  HRD+ + N +LDE F  K+ADFGLA    D    F+ V+  T  +    +M  
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE--FDSVHNKTGAKLPVKWMAL 207
Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E + TQ+ T KSDV+S+GV+L E++T
Sbjct: 208 ESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 111 NFSTIIGQGGFGTVYKAQF--SDGSLI--AVKRMDKISEQVE-GDFCREIEXXXXXXXXX 165
           +F+ +IG+G FG VY      +DG  I  AVK +++I++  E   F  E           
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 166 XXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                G C+       ++  YM +G L++ + +    P + +  I   + VA  +++L  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL-- 208
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDP 282
                  HRD+ + N +LDE F  K+ADFGLA    D    F+ V+  T  +    +M  
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE--FDSVHNKTGAKLPVKWMAL 265
Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E + TQ+ T KSDV+S+GV+L E++T
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 10/195 (5%)
Query: 116 IGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           +G G +G VY+  +   SL +AVK + + + +VE +F +E                G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            +   +++ E+M  G+L D+L    R  +S    + +A  +++A+EYL         HRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 235 IKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           + + N L+ EN + K+ADFGL+   + D           I+ T     PE +   + + K
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTA----PESLAYNKFSIK 190
Query: 294 SDVYSYGVVLLEIVT 308
           SDV+++GV+L EI T
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 32/276 (11%)
Query: 116 IGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           +G G +G VY+  +   SL +AVK + + + +VE +F +E                G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            +   +++ E+M  G+L D+L    R  ++    + +A  +++A+EYL         HRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 235 IKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           + + N L+ EN + K+ADFGL+   + D           I+ T     PE +   + + K
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKFSIK 194
Query: 294 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ---- 349
           SDV+++GV+L EI T   +   G +L           S++ EL++   KD + ME+    
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDL-----------SQVYELLE---KD-YRMERPEGC 239
Query: 350 LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
              +  ++R C Q     RPS   I Q    +++ S
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 121/270 (44%), Gaps = 23/270 (8%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
            F   IG G FG V+   + +   +A+K  R   +SE+   DF  E E            
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQ 66
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+E+    L++E+M +G L D+L +  R   + +T + + +DV   + YL    + 
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EA 122
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + HRD+ + N L+ EN V K++DFG+     D        +T  +    +  PE     
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFS 179
Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
             + KSDV+S+GV++ E+ +  +   + ++  E  +      S    L  PR+  +    
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFRLYKPRLAST---- 231
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
               +  I+  C +   + RP+  ++LR L
Sbjct: 232 ---HVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 137/299 (45%), Gaps = 37/299 (12%)
Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFC 152
           SP + K+   E ++        +G G +G VY+  +   SL +AVK + + + +VE +F 
Sbjct: 4   SPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFL 59
Query: 153 REIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA 212
           +E                G C  +   +++ E+M  G+L D+L    R  ++    + +A
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 272
             +++A+EYL         HRD+ + N L+ EN + K+ADFGL+     G     P    
Sbjct: 120 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAK 175
Query: 273 --IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 330
             I+ T     PE +   + + KSDV+++GV+L EI T   +   G +L           
Sbjct: 176 FPIKWTA----PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------- 220
Query: 331 SRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPS---IKQVLRILYESS 382
           S++ EL++   KD + ME+       +  ++R C Q     RPS   I Q    +++ S
Sbjct: 221 SQVYELLE---KD-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 275

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 10/214 (4%)
Query: 97  FQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREI 155
           FQ     E ++        +G G +G VY   +   SL +AVK + + + +VE +F +E 
Sbjct: 21  FQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEA 79
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 215
                          G C  +   +++ EYM  G+L D+L    R  ++    + +A  +
Sbjct: 80  AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQI 139
Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIR 274
           ++A+EYL         HRD+ + N L+ EN V K+ADFGL+   + D           I+
Sbjct: 140 SSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 196
Query: 275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            T     PE +     + KSDV+++GV+L EI T
Sbjct: 197 WTA----PESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 36/290 (12%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V+   +++ + +AVK +   +  V+  F  E                     
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYMA GSL D L S     +     I  +  +A  + Y+         HRD+
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 136
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +++N+L+ E+ + K+ADFGLA   +D      E     I+ T     PE +     T KS
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGCFTIKS 192
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+G++L EIVT  +    G+   +     ++   R+     PR+++  D      + 
Sbjct: 193 DVWSFGILLYEIVTYGKIPYPGRTNAD-VMTALSQGYRM-----PRVENCPD-----ELY 241
Query: 355 TIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGR 404
            I++ C + + + RP+                  ++Q+V D+ Y  T+G+
Sbjct: 242 DIMKMCWKEKAEERPTFD----------------YLQSVLDDFYTATEGQ 275

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRM-----DKISEQVEG--DFCREIEXXXXXXXXXXX 167
           IG+GGFG V+K +   D S++A+K +     +  +E +E   +F RE+            
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 168 XXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
              G  +    R +M E++  G L   L      P+ W  ++++ +D+A  +EY+    +
Sbjct: 87  KLYGL-MHNPPRMVM-EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 228 PPLCHRDIKSSNIL---LDEN--FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
           PP+ HRD++S NI    LDEN    AK+ADFGL+  S           + + G   +M P
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-------SGLLGNFQWMAP 195
Query: 283 EYVVTQE--LTEKSDVYSYGVVLLEIVTA 309
           E +  +E   TEK+D YS+ ++L  I+T 
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 88
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH+   T    +  I IA   A  ++YLH      + H
Sbjct: 89  ST-KPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143
Query: 233 RDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA   +   GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS----GSILWMAPEVIRMQDS 199
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 76
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH+   T    +  I IA   A  ++YLH      + H
Sbjct: 77  ST-KPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLH---AKSIIH 131
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA       GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLS----GSILWMAPEVIRMQDS 187
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 188 NPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           ++G+G FG V KA++     +A+K+++  SE+    F  E+               G C+
Sbjct: 16  VVGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR---IQIAIDVANALEYLHFYCDPPLC 231
                 L+ EY   GSL + LH  G  PL + T    +   +  +  + YLH      L 
Sbjct: 73  NPV--CLVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 232 HRDIKSSNILL-DENFVAKLADFGLAHASKDGSIC-FEPVNTDIRGTPGYMDPEYVVTQE 289
           HRD+K  N+LL     V K+ DFG A        C  +   T+ +G+  +M PE      
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTA--------CDIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 290 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 349
            +EK DV+S+G++L E++T R+   +           + + +R      P IK+      
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-----PPLIKN-----L 230
Query: 350 LRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            + I +++  C  ++   RPS++++++I+
Sbjct: 231 PKPIESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           ++G+G FG V KA++     +A+K+++  SE+    F  E+               G C+
Sbjct: 15  VVGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR---IQIAIDVANALEYLHFYCDPPLC 231
                 L+ EY   GSL + LH  G  PL + T    +   +  +  + YLH      L 
Sbjct: 72  NPV--CLVMEYAEGGSLYNVLH--GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 232 HRDIKSSNILLDEN-FVAKLADFGLAHASKDGSIC-FEPVNTDIRGTPGYMDPEYVVTQE 289
           HRD+K  N+LL     V K+ DFG A        C  +   T+ +G+  +M PE      
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTA--------CDIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 290 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 349
            +EK DV+S+G++L E++T R+   +           + + +R      P IK+      
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-----PPLIKN-----L 229
Query: 350 LRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            + I +++  C  ++   RPS++++++I+
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
            F   +G G FG V   ++     +A+K M K     E +F  E +              
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G C ++R  F++ EYMANG L ++L    R     Q  +++  DV  A+EYL        
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQF 126
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD+ + N L+++  V K++DFGL+ +   D           +R +P    PE ++  +
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSP----PEVLMYSK 182
Query: 290 LTEKSDVYSYGVVLLEIVT 308
            + KSD++++GV++ EI +
Sbjct: 183 FSSKSDIWAFGVLMWEIYS 201

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 21/274 (7%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
            F   +G G FG V   ++     +A+K M K     E +F  E +              
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G C ++R  F++ EYMANG L ++L    R     Q  +++  DV  A+EYL        
Sbjct: 86  GVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD+ + N L+++  V K++DFGL+ +   D           +R +P    PE ++  +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSP----PEVLMYSK 197
Query: 290 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 349
            + KSD++++GV++ EI +  +   +     E+A+  +A   RL     P +        
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIAQGLRLYR---PHLAS------ 247
Query: 350 LRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 383
              + TI+  C   +   RP+ K +L  + +  D
Sbjct: 248 -EKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V+ A ++  + +AVK M   S  VE  F  E                   + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 80
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K   +++ E+MA GSL D L S   +       I  +  +A  + ++         HRD+
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 137
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +++NIL+  + V K+ADFGLA   +D      E     I+ T     PE +     T KS
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFTIKS 193
Query: 295 DVYSYGVVLLEIVTARR 311
           DV+S+G++L+EIVT  R
Sbjct: 194 DVWSFGILLMEIVTYGR 210

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V   ++     +A+K M K     E +F  E +              G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +R  F++ EYMANG L ++L    R     Q  +++  DV  A+EYL         HRD+
Sbjct: 76  QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPEYVVTQELTEK 293
            + N L+++  V K++DFGL+    D       V +   +R +P    PE ++  + + K
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP----PEVLMYSKFSSK 186
Query: 294 SDVYSYGVVLLEIVT 308
           SD++++GV++ EI +
Sbjct: 187 SDIWAFGVLMWEIYS 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 23/270 (8%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V   ++     +A+K M K     E +F  E +              G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +R  F++ EYMANG L ++L    R     Q  +++  DV  A+EYL         HRD+
Sbjct: 91  QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPEYVVTQELTEK 293
            + N L+++  V K++DFGL+    D       V +   +R +P    PE ++  + + K
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP----PEVLMYSKFSSK 201
Query: 294 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTI 353
           SD++++GV++ EI +  +   +     E+A+  +A   RL     P +           +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIAQGLRLYR---PHLAS-------EKV 250
Query: 354 VTIVRWCTQREGQARPSIKQVLRILYESSD 383
            TI+  C   +   RP+ K +L  + +  D
Sbjct: 251 YTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V   ++     +A+K M K     E +F  E +              G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +R  F++ EYMANG L ++L    R     Q  +++  DV  A+EYL         HRD+
Sbjct: 71  QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 126
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPEYVVTQELTEK 293
            + N L+++  V K++DFGL+    D       V +   +R +P    PE ++  + + K
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP----PEVLMYSKFSSK 181
Query: 294 SDVYSYGVVLLEIVT 308
           SD++++GV++ EI +
Sbjct: 182 SDIWAFGVLMWEIYS 196

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 23/275 (8%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
            F   +G G FG V   ++     +A+K M K     E +F  E +              
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 76
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G C ++R  F++ EYMANG L ++L    R     Q  +++  DV  A+EYL        
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQF 132
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPEYVVTQ 288
            HRD+ + N L+++  V K++DFGL+    D       V +   +R +P    PE ++  
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP----PEVLMYS 187
Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
           + + KSD++++GV++ EI +  +   +     E+A+  +A   RL     P +       
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-HIAQGLRLYR---PHLAS----- 238
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 383
               + TI+  C   +   RP+ K +L  + +  D
Sbjct: 239 --EKVYTIMYSCWHEKADERPTFKILLSNILDVMD 271

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V   ++     +A+K M K     E +F  E +              G C +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +R  F++ EYMANG L ++L    R     Q  +++  DV  A+EYL         HRD+
Sbjct: 75  QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 130
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPEYVVTQELTEK 293
            + N L+++  V K++DFGL+    D       V +   +R +P    PE ++  + + K
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP----PEVLMYSKFSSK 185
Query: 294 SDVYSYGVVLLEIVT 308
           SD++++GV++ EI +
Sbjct: 186 SDIWAFGVLMWEIYS 200

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V+ A ++  + +AVK M   S  VE  F  E                   + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 253
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K   +++ E+MA GSL D L S   +       I  +  +A  + ++         HRD+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 310
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +++NIL+  + V K+ADFGLA   +D      E     I+ T     PE +     T KS
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFTIKS 366
Query: 295 DVYSYGVVLLEIVTARR 311
           DV+S+G++L+EIVT  R
Sbjct: 367 DVWSFGILLMEIVTYGR 383

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 88
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
                +  ++ ++    SL  HLH+   T    +  I IA   A  ++YLH      + H
Sbjct: 89  STAP-QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143
Query: 233 RDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA   +   GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS----GSILWMAPEVIRMQDS 199
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 99
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 100 S-TKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 154
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA       GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----GSILWMAPEVIRMQDK 210
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 211 NPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXX 158
           E  + T      +G G FG V+   ++  + +AVK + + S        E +  ++++  
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 78
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                          + +   +++ EYM NGSL D L +P    L+    + +A  +A  
Sbjct: 79  RLVRLYA-------VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 131
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTP 277
           + ++    +    HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T 
Sbjct: 132 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 188
Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
               PE +     T KSDV+S+G++L EIVT  R
Sbjct: 189 ----PEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 92
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 93  S-TKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 147
Query: 233 RDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA   +   GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS----GSILWMAPEVIRMQDK 203
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 204 NPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 100
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 155
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA       GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----GSILWMAPEVIRMQDK 211
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRM-----DKISEQVEG--DFCREIEXXXXXXXXXXX 167
           IG+GGFG V+K +   D S++A+K +     +  +E +E   +F RE+            
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 168 XXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
              G  +    R +M E++  G L   L      P+ W  ++++ +D+A  +EY+    +
Sbjct: 87  KLYGL-MHNPPRMVM-EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 228 PPLCHRDIKSSNIL---LDEN--FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
           PP+ HRD++S NI    LDEN    AK+ADFG +  S           + + G   +M P
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSV-------SGLLGNFQWMAP 195
Query: 283 EYVVTQE--LTEKSDVYSYGVVLLEIVTA 309
           E +  +E   TEK+D YS+ ++L  I+T 
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXX 158
           E  + T      +G G FG V+   ++  + +AVK + + S        E +  ++++  
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                          + +   +++ EYM NGSL D L +P    L+    + +A  +A  
Sbjct: 75  RLVRLYA-------VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTP 277
           + ++    +    HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T 
Sbjct: 128 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 184
Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
               PE +     T KSDV+S+G++L EIVT  R
Sbjct: 185 ----PEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXX 158
           E  + T      +G G FG V+   ++  + +AVK + + S        E +  ++++  
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 77
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                          + +   +++ EYM NGSL D L +P    L+    + +A  +A  
Sbjct: 78  RLVRLYA-------VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 130
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTP 277
           + ++    +    HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T 
Sbjct: 131 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 187
Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
               PE +     T KSDV+S+G++L EIVT  R
Sbjct: 188 ----PEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXX 158
           E  + T      +G G FG V+   ++  + +AVK + + S        E +  ++++  
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 76
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                          + +   +++ EYM NGSL D L +P    L+    + +A  +A  
Sbjct: 77  RLVRLYA-------VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 129
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTP 277
           + ++    +    HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T 
Sbjct: 130 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 186
Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
               PE +     T KSDV+S+G++L EIVT  R
Sbjct: 187 ----PEAINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXX 158
           E  + T      +G G FG V+   ++  + +AVK + + S        E +  ++++  
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                          + +   +++ EYM NGSL D L +P    L+    + +A  +A  
Sbjct: 69  RLVRLYA-------VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTP 277
           + ++    +    HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T 
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA 178
Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
               PE +     T KSDV+S+G++L EIVT  R
Sbjct: 179 ----PEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRM-----DKISEQVEG--DFCREIEXXXXXXXXXXX 167
           IG+GGFG V+K +   D S++A+K +     +  +E +E   +F RE+            
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 168 XXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
              G  +    R +M E++  G L   L      P+ W  ++++ +D+A  +EY+    +
Sbjct: 87  KLYGL-MHNPPRMVM-EFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 228 PPLCHRDIKSSNIL---LDEN--FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
           PP+ HRD++S NI    LDEN    AK+ADF L+  S           + + G   +M P
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSV-------SGLLGNFQWMAP 195
Query: 283 EYVVTQE--LTEKSDVYSYGVVLLEIVTA 309
           E +  +E   TEK+D YS+ ++L  I+T 
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 77
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 132
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA       GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----GSILWMAPEVIRMQDK 188
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 100
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 155
Query: 233 RDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA   +   GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS----GSILWMAPEVIRMQDK 211
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 74
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 75  S-TKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 129
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA       GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----GSILWMAPEVIRMQDK 185
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 186 NPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 72
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 127
Query: 233 RDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA   +   GS  FE     + G+  +M PE +  Q+ 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRMQDK 183
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 72
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 127
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA       GS  FE     + G+  +M PE +  Q+ 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDK 183
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXXXXXXXXXXXXXX 170
           +G G FG V+   ++  + +AVK + + S        E +  ++++              
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA----- 81
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              + +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++    +   
Sbjct: 82  --VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 136
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T     PE +    
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGT 192
Query: 290 LTEKSDVYSYGVVLLEIVTARR 311
            T KSDV+S+G++L EIVT  R
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGR 214

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 77
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              K +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 132
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA       GS  FE ++    G+  +M PE +  Q+ 
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS----GSILWMAPEVIRMQDK 188
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 189 NPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXXXXXXXXXXXXXX 170
           +G G FG V+   ++  + +AVK + + S        E +  ++++              
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA----- 80
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              + +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++    +   
Sbjct: 81  --VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 135
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T     PE +    
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGT 191
Query: 290 LTEKSDVYSYGVVLLEIVTARR 311
            T KSDV+S+G++L EIVT  R
Sbjct: 192 FTIKSDVWSFGILLTEIVTHGR 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXXXXXXXXXXXXXX 170
           +G G FG V+   ++  + +AVK + + S        E +  ++++              
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA----- 76
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              + +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++    +   
Sbjct: 77  --VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 131
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T     PE +    
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGT 187
Query: 290 LTEKSDVYSYGVVLLEIVTARR 311
            T KSDV+S+G++L EIVT  R
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGR 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXXXXXXXXXXXXXX 170
           +G G FG V+   ++  + +AVK + + S        E +  ++++              
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA----- 77
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              + +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++    +   
Sbjct: 78  --VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 132
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T     PE +    
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGT 188
Query: 290 LTEKSDVYSYGVVLLEIVTARR 311
            T KSDV+S+G++L EIVT  R
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGR 210

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXXXXXXXXXXXXXX 170
           +G G FG V+   ++  + +AVK + + S        E +  ++++              
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA----- 75
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              + +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++    +   
Sbjct: 76  --VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T     PE +    
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGT 186
Query: 290 LTEKSDVYSYGVVLLEIVTARR 311
            T KSDV+S+G++L EIVT  R
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXXXXXXXXXXXXXX 170
           +G G FG V+   ++  + +AVK + + S        E +  ++++              
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA----- 75
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              + +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++    +   
Sbjct: 76  --VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T     PE +    
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEAINYGT 186
Query: 290 LTEKSDVYSYGVVLLEIVTARR 311
            T KSDV+S+G++L EIVT  R
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXXXXXXXXXXXXXX 170
           +G G FG V+   ++  + +AVK + + S        E +  ++++              
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA----- 70
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              + +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++    +   
Sbjct: 71  --VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 125
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T     PE +    
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGT 181
Query: 290 LTEKSDVYSYGVVLLEIVTARR 311
            T KSDV+S+G++L EIVT  R
Sbjct: 182 FTIKSDVWSFGILLTEIVTHGR 203

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V+   +++ + +AVK +   +  V+  F  E                    +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ E+MA GSL D L S     +     I  +  +A  + Y+         HRD+
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 135
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICF-EPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +++N+L+ E+ + K+ADFGLA   +D      E     I+ T     PE +     T KS
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGCFTIKS 191
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           +V+S+G++L EIVT  +    G+    +A V M++ S+   +  PR+++  D      + 
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRT---NADV-MSALSQGYRM--PRMENCPD-----ELY 240
Query: 355 TIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDEEYEETDGR 404
            I++ C + + + RP+                  ++Q+V D+ Y  T+G+
Sbjct: 241 DIMKMCWKEKAEERPTFD----------------YLQSVLDDFYTATEGQ 274

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 23/233 (9%)
Query: 81  PPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAV 137
           PP R L+K  E             TK+  + F  +  +G+G +G+VYKA   + G ++A+
Sbjct: 10  PPRRQLKKLDEDSL----------TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAI 59
Query: 138 KRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS 197
           K++   S+  E    +EI               G   +  + +++ EY   GS+ D +  
Sbjct: 60  KQVPVESDLQE--IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL 117
Query: 198 PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 257
             +T L+      I       LEYLHF       HRDIK+ NILL+    AKLADFG+A 
Sbjct: 118 RNKT-LTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
              D           + GTP +M PE +        +D++S G+  +E+   +
Sbjct: 174 QLTDXM----AKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 18/196 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V+ A ++  + +AVK M   S  VE  F  E                   + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 247
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K   +++ E+MA GSL D L S   +       I  +  +A  + ++         HRD+
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDL 304
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+  + V K+ADFGLA       I              +  PE +     T KSD
Sbjct: 305 RAANILVSASLVCKIADFGLARVGAKFPI-------------KWTAPEAINFGSFTIKSD 351
Query: 296 VYSYGVVLLEIVTARR 311
           V+S+G++L+EIVT  R
Sbjct: 352 VWSFGILLMEIVTYGR 367

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKIS---EQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G FGTVYK ++     +AVK ++  +   +Q++  F  E+               G+
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGY 72
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
                +  ++ ++    SL  HLH    T       I IA   A  ++YLH      + H
Sbjct: 73  STAP-QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIH 127
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRGTPGYMDPEYVVTQE- 289
           RD+KS+NI L E+   K+ DFGLA       GS  FE     + G+  +M PE +  Q+ 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRMQDK 183
Query: 290 --LTEKSDVYSYGVVLLEIVTAR 310
              + +SDVY++G+VL E++T +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G FG V+  +  +D +L+AVK   + +   ++  F +E                G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
            +K+  +++ E +  G     L + G   L  +T +Q+  D A  +EYL   C     HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELTE 292
           D+ + N L+ E  V K++DFG++    DG       +  +R  P  +  PE +     + 
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADG---VXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 293 KSDVYSYGVVLLE 305
           +SDV+S+G++L E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXXXXXXXXXXXXXX 170
           +G G FG V+   ++  + +AVK + + S        E +  ++++              
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA----- 71
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              + +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++    +   
Sbjct: 72  --VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 126
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HR+++++NIL+ +    K+ADFGLA   +D      E     I+ T     PE +    
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGT 182
Query: 290 LTEKSDVYSYGVVLLEIVTARR 311
            T KSDV+S+G++L EIVT  R
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGR 204

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G FG V+  +  +D +L+AVK   + +   ++  F +E                G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
            +K+  +++ E +  G     L + G   L  +T +Q+  D A  +EYL   C     HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHR 237
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVTQELTE 292
           D+ + N L+ E  V K++DFG++    DG       +  +R  P  +  PE +     + 
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYA---ASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 293 KSDVYSYGVVLLE 305
           +SDV+S+G++L E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDF-CREIEXXXXXXXXXX-XXXXG 171
           ++G+G FG V+ A+F       A+K + K    ++ D  C  +E                
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 172 FCI--EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
           FC    K   F + EY+  G L  H+ S  +  LS  T    A ++   L++LH      
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLH---SKG 139
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + +RD+K  NILLD++   K+ADFG+   +  G    +    +  GTP Y+ PE ++ Q+
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNEFCGTPDYIAPEILLGQK 195
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQV 325
                D +S+GV+L E++  +     QD + L  S ++
Sbjct: 196 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 233

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 8/201 (3%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 76
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 77  EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 133
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 296 VYSYGVVLLEIVTARRAVQDG 316
           V+S+G++L E+ T  R    G
Sbjct: 191 VWSFGILLTELTTKGRVPYPG 211

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 8/196 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 332
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 296 VYSYGVVLLEIVTARR 311
           V+S+G++L E+ T  R
Sbjct: 447 VWSFGILLTELTTKGR 462

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 17  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 76
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 136
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 137 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 190
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 191 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 242
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 243 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 291
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 292 EYCTQDP 298

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 146 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASY 199
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 200 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 252 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 300
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 301 EYCTQDP 307

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXT---ARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 364 VWSFGILLTELTTKGRV 380

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 145 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 199 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 251 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 299
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 300 EYCTQDP 306

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 145 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 199 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 251 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 299
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 300 EYCTQDP 306

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 364 VWSFGILLTELTTKGRV 380

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 160 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 214 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 266 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 314
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 315 EYCTQDP 321

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 74
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 75  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 131
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 189 VWSFGILLTELTTKGRV 205

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 8/201 (3%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 72
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 129
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 296 VYSYGVVLLEIVTARRAVQDG 316
           V+S+G++L E+ T  R    G
Sbjct: 187 VWSFGILLTELTTKGRVPYPG 207

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 146 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 200 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 252 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 300
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 301 EYCTQDP 307

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAV-VS 83
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 146 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 200 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 252 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 300
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 301 EYCTQDP 307

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 160 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 214 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 266 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 314
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 315 EYCTQDP 321

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEA 99
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 160 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 214 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 266 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 314
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 315 EYCTQDP 321

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 84  EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 42  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 101
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 102 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 161
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 162 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 215
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 216 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 267
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 268 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 316
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 317 EYCTQDP 323

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-----VEGDFCREIEXX 158
           E  + T      +G G  G V+   ++  + +AVK + + S        E +  ++++  
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                          + +   +++ EYM NGSL D L +P    L+    + +A  +A  
Sbjct: 69  RLVRLYA-------VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTP 277
           + ++    +    HRD++++NIL+ +    K+ADFGLA   +D      E     I+ T 
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTA 178
Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
               PE +     T KSDV+S+G++L EIVT  R
Sbjct: 179 ----PEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 32  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 91
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 151
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 152 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 205
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 206 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 257
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 258 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 306
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 307 EYCTQDP 313

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 364 VWSFGILLTELTTKGRV 380

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 16/218 (7%)
Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDF-CREIEXXXXXXXXXX-XXXXG 171
           ++G+G FG V+ A+F       A+K + K    ++ D  C  +E                
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 172 FCI--EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
           FC    K   F + EY+  G L  H+ S  +  LS  T    A ++   L++LH      
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLH---SKG 138
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + +RD+K  NILLD++   K+ADFG+   +  G    +       GTP Y+ PE ++ Q+
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNXFCGTPDYIAPEILLGQK 194
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQV 325
                D +S+GV+L E++  +     QD + L  S ++
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 127/307 (41%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 52  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 111
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 112 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 171
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAH----AS- 259
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A     AS 
Sbjct: 172 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 225
Query: 260 -KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 226 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 277
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 278 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 326
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 327 EYCTQDP 333

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 125/307 (40%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 66  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 125
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH------A 258
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A        
Sbjct: 186 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239
Query: 259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 240 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 292 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 340
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 341 EYCTQDP 347

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 64
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 65  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 124
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 125 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 182 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 223
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      ++ ++R C Q   + RPS  +++  + E 
Sbjct: 224 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEE 282
Query: 382 SDP 384
            +P
Sbjct: 283 MEP 285

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 125/307 (40%), Gaps = 50/307 (16%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFS----DGS--LIAVKRMDKI-SEQVEGDFCREI 155
           KE  +        +G G FG VY+ Q S    D S   +AVK + ++ SEQ E DF  E 
Sbjct: 43  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 102
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP-----LSWQTRIQ 210
                          G  ++   RF++ E MA G LK  L      P     L+    + 
Sbjct: 103 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 162
Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH------A 258
           +A D+A   +YL   HF       HRDI + N LL       VAK+ DFG+A        
Sbjct: 163 VARDIACGCQYLEENHFI------HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 216
Query: 259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            + G     PV         +M PE  +    T K+D +S+GV+L EI +        K+
Sbjct: 217 YRKGGCAMLPVK--------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 268
Query: 319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL-RI 377
             E  +  + S  R+    DP             +  I+  C Q + + RP+   +L RI
Sbjct: 269 NQEVLEF-VTSGGRM----DPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERI 317
Query: 378 LYESSDP 384
            Y + DP
Sbjct: 318 EYCTQDP 324

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            ++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 73
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 134 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 191 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 232
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 233 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 291
Query: 382 SDP 384
            +P
Sbjct: 292 MEP 294

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 73
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +    ++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 74  EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 130
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXT---ARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 188 VWSFGILLTELTTKGRV 204

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ G L D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 84  EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L +     +     +Q    +   +EYL  
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER-IDHIKLLQYTSQICKGMEYL-- 133
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 188
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 134
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 189
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 190 PESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 140 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 197 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 238
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 239 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 382 SDP 384
            +P
Sbjct: 298 MEP 300

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ G L D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 84  EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 140
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM  GSL D L       L     + ++  +A+ + Y+         HRD+
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 195 VWSFGILLTELTTKGRV 211

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 80  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 139
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 140 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 197 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 238
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 239 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 382 SDP 384
            +P
Sbjct: 298 MEP 300

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 80
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM  GSL D L       L     + ++  +A+ + Y+         HRD+
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWT---ARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 195 VWSFGILLTELTTKGRV 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 188
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 129
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 184
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 185 PESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 128
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 183
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 185
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 136
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 191
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 192 PESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL-- 148
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 203
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDYYKKTT 217
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL-- 148
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 203
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 185
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDYYKKTT 217
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 135
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 190
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 191 PESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL-- 137
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 192
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 193 PESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 66
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 127 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 184 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 225
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 226 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 284
Query: 382 SDP 384
            +P
Sbjct: 285 MEP 287

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 216
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +                 + 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQLYA-VVS 250
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 307
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGL    +D            +    +  PE  +    T KSD
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 296 VYSYGVVLLEIVTARRA 312
           V+S+G++L E+ T  R 
Sbjct: 365 VWSFGILLTELTTKGRV 381

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 101
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 102 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 161
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 162 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 219 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 260
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 261 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 319
Query: 382 SDP 384
            +P
Sbjct: 320 MEP 322

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDYYKKTT 217
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 73
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 74  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 133
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 134 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 191 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 232
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 233 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 291
Query: 382 SDP 384
            +P
Sbjct: 292 MEP 294

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 70
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 71  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 130
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 131 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 188 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 229
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 230 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 288
Query: 382 SDP 384
            +P
Sbjct: 289 MEP 291

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDYYKNTT 217
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 69
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 70  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 129
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 130 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 187 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 228
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 229 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 287
Query: 382 SDP 384
            +P
Sbjct: 288 MEP 290

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 72
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 133 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 190 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 231
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 232 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 290
Query: 382 SDP 384
            +P
Sbjct: 291 MEP 293

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 8/203 (3%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V+   ++  + +A+K +   +   E  F  E +                 + 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYA-VVS 74
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM  GSL D L       L     + +A  VA  + Y+         HRD+
Sbjct: 75  EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDL 131
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +S+NIL+    + K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXT---ARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 296 VYSYGVVLLEIVTARRAVQDGKN 318
           V+S+G++L E+VT  R    G N
Sbjct: 189 VWSFGILLTELVTKGRVPYPGMN 211

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 110 DNFSTIIGQ---GGFGTVYKAQFSDGSLIAV-KRMDKISEQVEGDFCREIEXXXXXXXXX 165
           ++F  IIG+   G FG VYKAQ  + S++A  K +D  SE+   D+  EI+         
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHF 224
                     +   +++ E+ A G++ D +      PL+ +++IQ+      +AL YLH 
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLT-ESQIQVVCKQTLDALNYLH- 152
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
             D  + HRD+K+ NIL   +   KLADFG+   S   +   +  ++ I GTP +M PE 
Sbjct: 153 --DNKIIHRDLKAGNILFTLDGDIKLADFGV---SAKNTRTIQRRDSFI-GTPYWMAPEV 206
Query: 285 VVTQELTE-----KSDVYSYGVVLLEI 306
           V+ +   +     K+DV+S G+ L+E+
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 45/299 (15%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V++ ++  G  +AVK     S + E  + RE E                  +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
            ++       +L+ +Y  +GSL D+L+   R  ++ +  I++A+  A+ L +LH      
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDP 282
              P + HRD+KS NIL+ +N    +AD GLA  H S   +I   P N  + GT  YM P
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP-NHRV-GTKRYMAP 220
Query: 283 EYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV----CMASESR 332
           E +         E  +++D+Y+ G+V  EI  ARR    G  + E  Q+     + S+  
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG--IHEDYQLPYYDLVPSDPS 276
Query: 333 LAEL--------VDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
           + E+        + P I + +   E LR +  I+R C    G AR +  ++ + L + S
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 72
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 73  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 132
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N ++ E+F  K+ DFG+          + 
Sbjct: 133 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 190 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 231
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      +  ++R C Q   + RPS  +++  + E 
Sbjct: 232 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 290
Query: 382 SDP 384
            +P
Sbjct: 291 MEP 293

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDYYKKTT 263
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 125/303 (41%), Gaps = 45/303 (14%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-------IAVKRMDKISEQVEG-DFCREI 155
           E  +     S  +GQG FG VY+   + G +       +A+K +++ +   E  +F  E 
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 66
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQT 207
                          G   + +   ++ E M  G LK +L S        P   P S   
Sbjct: 67  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSK 126
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH------ASKD 261
            IQ+A ++A+ + YL+        HRD+ + N  + E+F  K+ DFG+          + 
Sbjct: 127 MIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           G     PV         +M PE +     T  SDV+S+GVVL EI T          L E
Sbjct: 184 GGKGLLPVR--------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------LAE 225
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
                +++E  L  +++  + D  D      ++ ++R C Q   + RPS  +++  + E 
Sbjct: 226 QPYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEE 284
Query: 382 SDP 384
            +P
Sbjct: 285 MEP 287

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 110 DNFSTIIGQ---GGFGTVYKAQFSDGSLIAV-KRMDKISEQVEGDFCREIEXXXXXXXXX 165
           ++F  IIG+   G FG VYKAQ  + S++A  K +D  SE+   D+  EI+         
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHF 224
                     +   +++ E+ A G++ D +      PL+ +++IQ+      +AL YLH 
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLT-ESQIQVVCKQTLDALNYLH- 152
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
             D  + HRD+K+ NIL   +   KLADFG+   S   +   +  ++ I GTP +M PE 
Sbjct: 153 --DNKIIHRDLKAGNILFTLDGDIKLADFGV---SAKNTRXIQRRDSFI-GTPYWMAPEV 206
Query: 285 VVTQELTE-----KSDVYSYGVVLLEI 306
           V+ +   +     K+DV+S G+ L+E+
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 45/299 (15%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V++ ++  G  +AVK     S + E  + RE E                  +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
            ++       +L+ +Y  +GSL D+L+   R  ++ +  I++A+  A+ L +LH      
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDP 282
              P + HRD+KS NIL+ +N    +AD GLA  H S   +I   P N  + GT  YM P
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP-NHRV-GTKRYMAP 207
Query: 283 EYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV----CMASESR 332
           E +         E  +++D+Y+ G+V  EI  ARR    G  + E  Q+     + S+  
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG--IHEDYQLPYYDLVPSDPS 263
Query: 333 LAEL--------VDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
           + E+        + P I + +   E LR +  I+R C    G AR +  ++ + L + S
Sbjct: 264 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 322

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V ++ADFGLA    +  I +    T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINN--IDYYKKTT 217
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 45/299 (15%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V++ ++  G  +AVK     S + E  + RE E                  +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
            ++       +L+ +Y  +GSL D+L+   R  ++ +  I++A+  A+ L +LH      
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDP 282
              P + HRD+KS NIL+ +N    +AD GLA  H S   +I   P N  + GT  YM P
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP-NHRV-GTKRYMAP 184
Query: 283 EYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV----CMASESR 332
           E +         E  +++D+Y+ G+V  EI  ARR    G  + E  Q+     + S+  
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG--IHEDYQLPYYDLVPSDPS 240
Query: 333 LAEL--------VDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
           + E+        + P I + +   E LR +  I+R C    G AR +  ++ + L + S
Sbjct: 241 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 299

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I      T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDXXKKTT 217
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 45/299 (15%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V++ ++  G  +AVK     S + E  + RE E                  +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
            ++       +L+ +Y  +GSL D+L+   R  ++ +  I++A+  A+ L +LH      
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDP 282
              P + HRD+KS NIL+ +N    +AD GLA  H S   +I   P N  + GT  YM P
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP-NHRV-GTKRYMAP 182
Query: 283 EYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV----CMASESR 332
           E +         E  +++D+Y+ G+V  EI  ARR    G  + E  Q+     + S+  
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG--IHEDYQLPYYDLVPSDPS 238
Query: 333 LAEL--------VDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
           + E+        + P I + +   E LR +  I+R C    G AR +  ++ + L + S
Sbjct: 239 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 297

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF---EPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL          F   EP  + I     +  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----FWYA 185
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 45/299 (15%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V++ ++  G  +AVK     S + E  + RE E                  +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
            ++       +L+ +Y  +GSL D+L+   R  ++ +  I++A+  A+ L +LH      
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDP 282
              P + HRD+KS NIL+ +N    +AD GLA  H S   +I   P N  + GT  YM P
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP-NHRV-GTKRYMAP 187
Query: 283 EYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV----CMASESR 332
           E +         E  +++D+Y+ G+V  EI  ARR    G  + E  Q+     + S+  
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG--IHEDYQLPYYDLVPSDPS 243
Query: 333 LAEL--------VDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
           + E+        + P I + +   E LR +  I+R C    G AR +  ++ + L + S
Sbjct: 244 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 302

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINN--IDYYKKTT 204
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I      T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDXXKKTT 217
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDYYKKTT 206
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 116 IGQGGFGTVYKAQFSDGSL-IAVKRM---DKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G GG  TVY A+ +  ++ +A+K +    +  E+    F RE+                
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
              E    +L+ EY+   +L +++ S G  PLS  T I     + + +++ H   D  + 
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIV 133
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRDIK  NIL+D N   K+ DFG+A A  + S+        + GT  Y  PE    +   
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT---QTNHVLGTVQYFSPEQAKGEATD 190
Query: 292 EKSDVYSYGVVLLEIVTA 309
           E +D+YS G+VL E++  
Sbjct: 191 ECTDIYSIGIVLYEMLVG 208

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +   PG        R P   ++++  +  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDYYKKTT 209
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 31/213 (14%)
Query: 110 DNFSTIIGQ---GGFGTVYKAQFSDGSLIAV-KRMDKISEQVEGDFCREIEXXXXXXXXX 165
           ++F  IIG+   G FG VYKAQ  + S++A  K +D  SE+   D+  EI+         
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHF 224
                     +   +++ E+ A G++ D +      PL+ +++IQ+      +AL YLH 
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLT-ESQIQVVCKQTLDALNYLH- 152
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS------KDGSICFEPVNTDIRGTPG 278
             D  + HRD+K+ NIL   +   KLADFG++  +      +D  I          GTP 
Sbjct: 153 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI----------GTPY 200
Query: 279 YMDPEYVVTQELTE-----KSDVYSYGVVLLEI 306
           +M PE V+ +   +     K+DV+S G+ L+E+
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 45/299 (15%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G FG V++ ++  G  +AVK     S + E  + RE E                  +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
            ++       +L+ +Y  +GSL D+L+   R  ++ +  I++A+  A+ L +LH      
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLA--HASKDGSICFEPVNTDIRGTPGYMDP 282
              P + HRD+KS NIL+ +N    +AD GLA  H S   +I   P N  + GT  YM P
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP-NHRV-GTKRYMAP 181
Query: 283 EYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV----CMASESR 332
           E +         E  +++D+Y+ G+V  EI  ARR    G  + E  Q+     + S+  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG--IHEDYQLPYYDLVPSDPS 237
Query: 333 LAEL--------VDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
           + E+        + P I + +   E LR +  I+R C    G AR +  ++ + L + S
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 31/268 (11%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMD---KISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           IG G FG VY A+   +  ++A+K+M    K S +   D  +E+               G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             + +   +L+ EY   GS  D L    + PL     ++IA     AL+ L +     + 
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQ---EVEIAAVTHGALQGLAYLHSHNMI 176
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K+ NILL E  + KL DFG A           P N  + GTP +M PE ++  +  
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSAS-------IMAPANXFV-GTPYWMAPEVILAMDEG 228
Query: 292 E---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
           +   K DV+S G+  +E+   +  + +           M++   +A+   P ++     E
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPALQSGHWSE 280
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLR 376
             R  V     C Q+  Q RP+ + +L+
Sbjct: 281 YFRNFVDS---CLQKIPQDRPTSEVLLK 305

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 21/240 (8%)
Query: 77  LKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-- 134
           L+ F  P +     E P+    +F+ KE      +   ++G G FG V   +    S   
Sbjct: 19  LRTFVDPHTF----EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 135 --IAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSL 191
             +A+K +    +E+   DF  E                G   + +   ++ EYM NGSL
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 251
              L    R   +  T IQ+   +      + +  D    HRD+ + NIL++ N V K++
Sbjct: 134 DSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVS 189
Query: 252 DFGLAHASKD---GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           DFGLA   +D    +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 190 DFGLARVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 31/268 (11%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMD---KISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           IG G FG VY A+   +  ++A+K+M    K S +   D  +E+               G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             + +   +L+ EY   GS  D L    + PL     ++IA     AL+ L +     + 
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQ---EVEIAAVTHGALQGLAYLHSHNMI 137
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K+ NILL E  + KL DFG A           P N  + GTP +M PE ++  +  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSAS-------IMAPANXFV-GTPYWMAPEVILAMDEG 189
Query: 292 E---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
           +   K DV+S G+  +E+   +  + +           M++   +A+   P ++     E
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPALQSGHWSE 241
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLR 376
             R  V     C Q+  Q RP+ + +L+
Sbjct: 242 YFRNFVDS---CLQKIPQDRPTSEVLLK 266

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++  Y + G+L+++L +   PG        R P   ++++  +  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDYYKKTT 217
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 21/240 (8%)
Query: 77  LKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-- 134
           L+ F  P +     E P+    +F+ KE      +   ++G G FG V   +    S   
Sbjct: 19  LRTFVDPHTF----EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 135 --IAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSL 191
             +A+K +    +E+   DF  E                G   + +   ++ EYM NGSL
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 251
              L    R   +  T IQ+   +      + +  D    HRD+ + NIL++ N V K++
Sbjct: 134 DSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVS 189
Query: 252 DFGLAHASKD---GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           DFGL+   +D    +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ EY+  GSL+D+L    +  +     +Q    +   +EYL  
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 131
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HR++ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----FWYA 186
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 187 PESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G FG V+K        ++A+K +D + +E    D  +EI               G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           ++  + +++ EY+  GS  D L  PG  PL       I  ++   L+YLH        HR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLE-PG--PLDETQIATILREILKGLDYLH---SEKKIHR 128
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           DIK++N+LL E+   KLADFG+A    D  I     NT + GTP +M PE +       K
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFV-GTPFWMAPEVIKQSAYDSK 184
Query: 294 SDVYSYGVVLLEI 306
           +D++S G+  +E+
Sbjct: 185 ADIWSLGITAIEL 197

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
           DNF  I G+G  G V  A   S G L+AVK+MD   +Q       E+             
Sbjct: 154 DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                +   E +++ E++  G+L D +     T ++ +    + + V  AL  LH     
Sbjct: 213 MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 267
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRDIKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M PE +  
Sbjct: 268 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----VPRRKXLVGTPYWMAPELISR 321
Query: 288 QELTEKSDVYSYGVVLLEIV 307
                + D++S G++++E+V
Sbjct: 322 LPYGPEVDIWSLGIMVIEMV 341

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 111 NFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXX 165
            + + +G+G FG+V   ++     + G+L+AVK++       + DF REI+         
Sbjct: 10  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 69
Query: 166 XXXXXG--FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
                G  +   + E  L+ EY+ +G L+D L    R  L     +  +  +   +EYL 
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLG 128
Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH---ASKDGSICFEPVNTDIRGTPGYM 280
                   HRD+ + NIL++     K+ADFGLA      KD  +  EP  + I     + 
Sbjct: 129 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPI----FWY 181
Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            PE +     + +SDV+S+GVVL E+ T
Sbjct: 182 APESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G+G +G V++  +  G  +AVK      EQ    + RE E                  +
Sbjct: 16  VGKGRYGEVWRGLWH-GESVAVKIFSSRDEQ---SWFRETEIYNTVLLRHDNILGFIASD 71
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
              R      +L+  Y  +GSL D L    R  L     +++A+  A  L +LH      
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQ---RQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
              P + HRD KS N+L+  N    +AD GLA     GS   +  N    GT  YM PE 
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 285 VVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           +  Q      E  + +D++++G+VL EI  ARR + +G
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTIVNG 224

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G FG V+K        ++A+K +D + +E    D  +EI               G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           ++  + +++ EY+  GS  D L  PG  PL       I  ++   L+YLH        HR
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLE-PG--PLDETQIATILREILKGLDYLH---SEKKIHR 143
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           DIK++N+LL E+   KLADFG+A    D  I          GTP +M PE +       K
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIK----RNXFVGTPFWMAPEVIKQSAYDSK 199
Query: 294 SDVYSYGVVLLEIV 307
           +D++S G+  +E+ 
Sbjct: 200 ADIWSLGITAIELA 213

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+          +   +AVK + D  +E+   D   E+E          
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS---PG--------RTP---LSWQTRIQI 211
                G C +    +++  Y + G+L+++L +   PG        R P   ++++  +  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
              +A  +EYL         HRD+ + N+L+ EN V K+ADFGLA    +  I +    T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN--IDYYKKTT 217
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G FG V+K        ++A+K +D + +E    D  +EI               G  
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           ++  + +++ EY+  GS  D L  PG  PL       I  ++   L+YLH        HR
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLE-PG--PLDETQIATILREILKGLDYLH---SEKKIHR 148
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           DIK++N+LL E+   KLADFG+A    D  I     NT + GTP +M PE +       K
Sbjct: 149 DIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTFV-GTPFWMAPEVIKQSAYDSK 204
Query: 294 SDVYSYGVVLLEI 306
           +D++S G+  +E+
Sbjct: 205 ADIWSLGITAIEL 217

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 13/194 (6%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IGQG  GTVY A   + G  +A+++M+   +  +     EI                  +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E +++ EY+A GSL D +        +     QIA      L+ L F     + HRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 235 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           IKS NILL  +   KL DFG  A  + + S       +++ GTP +M PE V  +    K
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 294 SDVYSYGVVLLEIV 307
            D++S G++ +E++
Sbjct: 197 VDIWSLGIMAIEMI 210

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ EY+   +L+D +H+ G  P++ +  I++   +A+A + L+F     + HRD+K +N
Sbjct: 92  YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEV---IADACQALNFSHQNGIIHRDVKPAN 146
Query: 240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSY 299
           IL+      K+ DFG+A A  D           I GT  Y+ PE      +  +SDVYS 
Sbjct: 147 ILISATNAVKVVDFGIARAIADSGNSVXQTAAVI-GTAQYLSPEQARGDSVDARSDVYSL 205
Query: 300 GVVLLEIVT 308
           G VL E++T
Sbjct: 206 GCVLYEVLT 214

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 21/240 (8%)
Query: 77  LKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-- 134
           L+ F  P +     E P+    +F+ KE      +   ++G G FG V   +    S   
Sbjct: 19  LRTFVDPHTF----EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 135 --IAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSL 191
             +A+K +    +E+   DF  E                G   + +   ++ EYM NGSL
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 251
              L    R   +  T IQ+   +      + +  D    HRD+ + NIL++ N V K++
Sbjct: 134 DSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVS 189
Query: 252 DFGLAHASKD---GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           DFGL+   +D    +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G FG V+K        ++A+K +D + +E    D  +EI               G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           ++  + +++ EY+  GS  D L  PG  PL       I  ++   L+YLH        HR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLE-PG--PLDETQIATILREILKGLDYLH---SEKKIHR 128
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           DIK++N+LL E+   KLADFG+A    D  I          GTP +M PE +       K
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIK----RNXFVGTPFWMAPEVIKQSAYDSK 184
Query: 294 SDVYSYGVVLLEI 306
           +D++S G+  +E+
Sbjct: 185 ADIWSLGITAIEL 197

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           F   +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE          
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 167 XXXXGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
               G C    +R   L+ E++  GSL+++L    +  +     +Q    +   +EYL  
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK-HKERIDHIKLLQYTSQICKGMEYL-- 133
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPVNTDIRGTPGYMD 281
                  HRD+ + NIL++     K+ DFGL       K+     EP  + I     +  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI----FWYA 188
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +   + +  SDV+S+GVVL E+ T
Sbjct: 189 PESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 21/240 (8%)
Query: 77  LKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-- 134
           L+ F  P +     E P+    +F+ KE      +   ++G G FG V   +    S   
Sbjct: 19  LRTFVDPHTF----EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 135 --IAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSL 191
             +A+K +    +E+   DF  E                G   + +   ++ EYM NGSL
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 251
              L    R   +  T IQ+   +      + +  D    HRD+ + NIL++ N V K++
Sbjct: 134 DSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVS 189
Query: 252 DFGLAHASKD---GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           DFGL    +D    +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
           DNF  I G+G  G V  A   S G L+AVK+MD   +Q       E+             
Sbjct: 77  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                +   E +++ E++  G+L D +     T ++ +    + + V  AL  LH     
Sbjct: 136 MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 190
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRDIKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M PE +  
Sbjct: 191 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----VPRRKXLVGTPYWMAPELISR 244
Query: 288 QELTEKSDVYSYGVVLLEIV 307
                + D++S G++++E+V
Sbjct: 245 LPYGPEVDIWSLGIMVIEMV 264

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           +G G FG VYKA+  + G+L A K ++  SE+   D+  EIE              G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              + ++M E+   G++   +    R      T  QI +     LE L+F     + HRD
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKRIIHRD 142
Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE-- 292
           +K+ N+L+      +LADFG+   S       +  ++ I GTP +M PE V+ + + +  
Sbjct: 143 LKAGNVLMTLEGDIRLADFGV---SAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTP 198
Query: 293 ---KSDVYSYGVVLLEI 306
              K+D++S G+ L+E+
Sbjct: 199 YDYKADIWSLGITLIEM 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
           DNF  I G+G  G V  A   S G L+AVK+MD   +Q       E+             
Sbjct: 34  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                +   E +++ E++  G+L D +     T ++ +    + + V  AL  LH     
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 147
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRDIKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M PE +  
Sbjct: 148 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----VPRRKXLVGTPYWMAPELISR 201
Query: 288 QELTEKSDVYSYGVVLLEIV 307
                + D++S G++++E+V
Sbjct: 202 LPYGPEVDIWSLGIMVIEMV 221

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E          
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L           ++P   P   LS +  +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I +    T
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 199
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 24/263 (9%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G FG VYK        ++A+K +D + +E    D  +EI               G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           ++  + +++ EY+  GS  D L  PG  PL       I  ++   L+YLH        HR
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLL-KPG--PLEETYIATILREILKGLDYLH---SERKIHR 140
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           DIK++N+LL E    KLADFG+A    D  I          GTP +M PE +       K
Sbjct: 141 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIK----RNXFVGTPFWMAPEVIKQSAYDFK 196
Query: 294 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTI 353
           +D++S G+  +E+        D   +            R+  L+      + + +  +  
Sbjct: 197 ADIWSLGITAIELAKGEPPNSDLHPM------------RVLFLIPKNSPPTLEGQHSKPF 244
Query: 354 VTIVRWCTQREGQARPSIKQVLR 376
              V  C  ++ + RP+ K++L+
Sbjct: 245 KEFVEACLNKDPRFRPTAKELLK 267

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
           DNF  I G+G  G V  A   S G L+AVK+MD   +Q       E+             
Sbjct: 32  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                +   E +++ E++  G+L D +     T ++ +    + + V  AL  LH     
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 145
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRDIKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M PE +  
Sbjct: 146 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----VPRRKXLVGTPYWMAPELISR 199
Query: 288 QELTEKSDVYSYGVVLLEIV 307
                + D++S G++++E+V
Sbjct: 200 LPYGPEVDIWSLGIMVIEMV 219

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E          
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L           ++P   P   LS +  +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I +    T
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 202
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E          
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L           ++P   P   LS +  +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I +    T
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 203
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 21/240 (8%)
Query: 77  LKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-- 134
           L+ F  P +     E P+    +F+ KE      +   ++G G FG V   +    S   
Sbjct: 19  LRTFVDPHTY----EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 135 --IAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSL 191
             +A+K +    +E+   DF  E                G   + +   ++ EYM NGSL
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 251
              L    R   +  T IQ+   +      + +  D    HRD+ + NIL++ N V K++
Sbjct: 134 DSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVS 189
Query: 252 DFGLAHASKD---GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           DFGL+   +D    +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 13/194 (6%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IGQG  GTVY A   + G  +A+++M+   +  +     EI                  +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E +++ EY+A GSL D +        +     QIA      L+ L F     + HRD
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 142
Query: 235 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           IKS NILL  +   KL DFG  A  + + S       + + GTP +M PE V  +    K
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 294 SDVYSYGVVLLEIV 307
            D++S G++ +E++
Sbjct: 198 VDIWSLGIMAIEMI 211

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           +G G FG VYKA+  + G+L A K ++  SE+   D+  EIE              G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              + ++M E+   G++   +    R      T  QI +     LE L+F     + HRD
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKRIIHRD 134
Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE-- 292
           +K+ N+L+      +LADFG+   S       +  ++ I GTP +M PE V+ + + +  
Sbjct: 135 LKAGNVLMTLEGDIRLADFGV---SAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTP 190
Query: 293 ---KSDVYSYGVVLLEI 306
              K+D++S G+ L+E+
Sbjct: 191 YDYKADIWSLGITLIEM 207

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E          
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L           ++P   P   LS +  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I +    T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 210
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 13/194 (6%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IGQG  GTVY A   + G  +A+++M+   +  +     EI                  +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E +++ EY+A GSL D +        +     QIA      L+ L F     + HRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 235 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           IKS NILL  +   KL DFG  A  + + S       + + GTP +M PE V  +    K
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 294 SDVYSYGVVLLEIV 307
            D++S G++ +E++
Sbjct: 197 VDIWSLGIMAIEMI 210

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E          
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L           ++P   P   LS +  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I +    T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 210
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E          
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L           ++P   P   LS +  +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I +    T
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 195
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 13/194 (6%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IGQG  GTVY A   + G  +A+++M+   +  +     EI                  +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E +++ EY+A GSL D +        +     QIA      L+ L F     + HRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 235 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           IKS NILL  +   KL DFG  A  + + S       + + GTP +M PE V  +    K
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 294 SDVYSYGVVLLEIV 307
            D++S G++ +E++
Sbjct: 197 VDIWSLGIMAIEMI 210

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 17/226 (7%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL----IAVKRMD-KISE 145
           E P+    +F+ KE      +   ++G G FG V   +    S     +A+K +    +E
Sbjct: 29  EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 146 QVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
           +   DF  E                G   + +   ++ EYM NGSL   L    R   + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQ 143
Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD---G 262
            T IQ+   +      + +  D    HRD+ + NIL++ N V K++DFGL+   +D    
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 204 AYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 17/226 (7%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL----IAVKRMD-KISE 145
           E P+    +F+ KE      +   ++G G FG V   +    S     +A+K +    +E
Sbjct: 27  EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 85
Query: 146 QVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
           +   DF  E                G   + +   ++ EYM NGSL   L    R   + 
Sbjct: 86  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQ 141
Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD---G 262
            T IQ+   +      + +  D    HRD+ + NIL++ N V K++DFGL+   +D    
Sbjct: 142 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 201
Query: 263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 202 AYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 17/226 (7%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL----IAVKRMD-KISE 145
           E P+    +F+ KE      +   ++G G FG V   +    S     +A+K +    +E
Sbjct: 29  EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 146 QVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
           +   DF  E                G   + +   ++ EYM NGSL   L    R   + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQ 143
Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD---G 262
            T IQ+   +      + +  D    HRD+ + NIL++ N V K++DFGL+   +D    
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 204 AYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ EY+   +L+D +H+ G  P++ +  I++   +A+A + L+F     + HRD+K +N
Sbjct: 92  YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEV---IADACQALNFSHQNGIIHRDVKPAN 146
Query: 240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSY 299
           I++      K+ DFG+A A  D           I GT  Y+ PE      +  +SDVYS 
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQARGDSVDARSDVYSL 205
Query: 300 GVVLLEIVT 308
           G VL E++T
Sbjct: 206 GCVLYEVLT 214

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
           DNF  I G+G  G V  A   S G L+AVK+MD   +Q       E+             
Sbjct: 23  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                +   E +++ E++  G+L D +     T ++ +    + + V  AL  LH     
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 136
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRDIKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M PE +  
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----VPRRKXLVGTPYWMAPELISR 190
Query: 288 QELTEKSDVYSYGVVLLEIV 307
                + D++S G++++E+V
Sbjct: 191 LPYGPEVDIWSLGIMVIEMV 210

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
           DNF  I G+G  G V  A   S G L+AVK+MD   +Q       E+             
Sbjct: 27  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                +   E +++ E++  G+L D +     T ++ +    + + V  AL  LH     
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQG-- 140
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            + HRDIKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M PE +  
Sbjct: 141 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-----VPRRKXLVGTPYWMAPELISR 194
Query: 288 QELTEKSDVYSYGVVLLEIV 307
                + D++S G++++E+V
Sbjct: 195 LPYGPEVDIWSLGIMVIEMV 214

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ EY+   +L+D +H+ G  P++ +  I++   +A+A + L+F     + HRD+K +N
Sbjct: 92  YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEV---IADACQALNFSHQNGIIHRDVKPAN 146
Query: 240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSY 299
           I++      K+ DFG+A A  D           I GT  Y+ PE      +  +SDVYS 
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQARGDSVDARSDVYSL 205
Query: 300 GVVLLEIVT 308
           G VL E++T
Sbjct: 206 GCVLYEVLT 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ EY+   +L+D +H+ G  P++ +  I++   +A+A + L+F     + HRD+K +N
Sbjct: 92  YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEV---IADACQALNFSHQNGIIHRDVKPAN 146
Query: 240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSY 299
           I++      K+ DFG+A A  D           I GT  Y+ PE      +  +SDVYS 
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQARGDSVDARSDVYSL 205
Query: 300 GVVLLEIVT 308
           G VL E++T
Sbjct: 206 GCVLYEVLT 214

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ EY+   +L+D +H+ G  P++ +  I++   +A+A + L+F     + HRD+K +N
Sbjct: 92  YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEV---IADACQALNFSHQNGIIHRDVKPAN 146
Query: 240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSY 299
           I++      K+ DFG+A A  D           I GT  Y+ PE      +  +SDVYS 
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQARGDSVDARSDVYSL 205
Query: 300 GVVLLEIVT 308
           G VL E++T
Sbjct: 206 GCVLYEVLT 214

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E          
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L           ++P   P   LS +  +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I +    T
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 251
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
           +G+G FG+V   ++     + G+L+AVK++       + DF REI+              
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 171 G--FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           G  +   ++   L+ EY+ +G L+D L    R  L     +  +  +   +EYL      
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLG---SR 133
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH---ASKDGSICFEPVNTDIRGTPGYMDPEYV 285
              HRD+ + NIL++     K+ADFGLA      KD  +  EP  + I     +  PE +
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAPESL 189
Query: 286 VTQELTEKSDVYSYGVVLLEIVT 308
                + +SDV+S+GVVL E+ T
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E          
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L           ++P   P   LS +  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I +    T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDYYKKTT 210
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
           +G+G FG+V   ++     + G+L+AVK++       + DF REI+              
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 171 G--FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           G  +   ++   L+ EY+ +G L+D L    R  L     +  +  +   +EYL      
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLG---SR 134
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH---ASKDGSICFEPVNTDIRGTPGYMDPEYV 285
              HRD+ + NIL++     K+ADFGLA      KD  +  EP  + I     +  PE +
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAPESL 190
Query: 286 VTQELTEKSDVYSYGVVLLEIVT 308
                + +SDV+S+GVVL E+ T
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 34/282 (12%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V    +       G ++AVK + +    Q+   + REIE             
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 170 XGFCIEKRERF--LMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
            G C ++ E+   L+ EY+  GSL+D+L  H  G   L     +  A  +   + YLH  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH-- 129
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
                 HR + + N+LLD + + K+ DFGLA A  +G   +  V  D      +  PE +
Sbjct: 130 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSPVFWYAPECL 187
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN----LVESAQVCMASESRLAELVD--- 338
              +    SDV+S+GV L E++T   + Q        L+   Q  M +  RL EL++   
Sbjct: 188 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQM-TVLRLTELLERGE 246
Query: 339 --PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             PR  D    E    I  +++ C + E   RP+ + ++ IL
Sbjct: 247 RLPR-PDRCPCE----IYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 6/129 (4%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ EY+   +L+D +H+ G  P++ +  I++   +A+A + L+F     + HRD+K +N
Sbjct: 109 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEV---IADACQALNFSHQNGIIHRDVKPAN 163
Query: 240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSY 299
           I++      K+ DFG+A A  D           I GT  Y+ PE      +  +SDVYS 
Sbjct: 164 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQARGDSVDARSDVYSL 222
Query: 300 GVVLLEIVT 308
           G VL E++T
Sbjct: 223 GCVLYEVLT 231

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
           +G+G FG+V   ++     + G+L+AVK++       + DF REI+              
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 171 G--FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           G  +   ++   L+ EY+ +G L+D L    R  L     +  +  +   +EYL      
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYLG---SR 146
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH---ASKDGSICFEPVNTDIRGTPGYMDPEYV 285
              HRD+ + NIL++     K+ADFGLA      KD  +  EP  + I     +  PE +
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAPESL 202
Query: 286 VTQELTEKSDVYSYGVVLLEIVT 308
                + +SDV+S+GVVL E+ T
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 34/282 (12%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V    +       G ++AVK + +    Q+   + REIE             
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 170 XGFCIEKRERF--LMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
            G C ++ E+   L+ EY+  GSL+D+L  H  G   L     +  A  +   + YLH  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH-- 128
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
                 HR + + N+LLD + + K+ DFGLA A  +G   +  V  D      +  PE +
Sbjct: 129 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSPVFWYAPECL 186
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN----LVESAQVCMASESRLAELVD--- 338
              +    SDV+S+GV L E++T   + Q        L+   Q  M +  RL EL++   
Sbjct: 187 KECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQM-TVLRLTELLERGE 245
Query: 339 --PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             PR  D    E    I  +++ C + E   RP+ + ++ IL
Sbjct: 246 RLPR-PDRCPCE----IYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 32/229 (13%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           IG+G +G V+  ++  G  +AVK      E     + RE E                  +
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 176 KR------ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
            +      + +L+ +Y  NGSL D+L S   T L  ++ +++A    + L +LH      
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPE 283
              P + HRD+KS NIL+ +N    +AD GLA     D +    P NT + GT  YM PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPPE 216
Query: 284 YVVTQELTEK-------SDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
            V+ + L          +D+YS+G++L E+  ARR V  G  +VE  Q+
Sbjct: 217 -VLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGG--IVEEYQL 260

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 114/251 (45%), Gaps = 40/251 (15%)
Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVKRM--------DKISEQVEGDFCREIEXXXXXX 162
           ++GQG FG V+  +   GS    L A+K +        D++  ++E D   E+       
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEY 221
                   G      + +L+ +++  G L   L    +  +  +  ++  + ++A AL++
Sbjct: 91  LHYAFQTEG------KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDH 141
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGT 276
           LH      + +RD+K  NILLDE    KL DFGL+     H  K  S C         GT
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---------GT 189
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 336
             YM PE V  +  T+ +D +S+GV++ E++T     Q GK+  E+  + + ++  + + 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKETMTMILKAKLGMPQF 248
Query: 337 VDPRIKDSFDM 347
           + P  +    M
Sbjct: 249 LSPEAQSLLRM 259

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 34/282 (12%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V    +       G ++AVK +      Q    + +EI+             
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 170 XGFCIEKRERFL--MYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
            G C ++ E+ L  + EY+  GSL+D+L  HS G   L     +  A  +   + YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH-- 134
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
                 HR++ + N+LLD + + K+ DFGLA A  +G   +  V  D      +  PE +
Sbjct: 135 -SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSPVFWYAPECL 192
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN----LVESAQVCMASESRLAELVD--- 338
              +    SDV+S+GV L E++T   + Q        L+  AQ  M +  RL EL++   
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-TVLRLTELLERGE 251
Query: 339 --PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             PR  D    E    +  +++ C + E   RP+ + ++ IL
Sbjct: 252 RLPR-PDKCPCE----VYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXX 165
           D+F  I  +G G  G V+K       L+  +++   +I   +     RE++         
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 125
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +  E  N +  GT  YM PE +
Sbjct: 126 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDEMAN-EFVGTRSYMSPERL 178
Query: 286 VTQELTEKSDVYSYGVVLLEIVTAR 310
                + +SD++S G+ L+E+   R
Sbjct: 179 QGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXX 165
           D+F  I  +G G  G V+K       L+  +++   +I   +     RE++         
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREK 185
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 237
Query: 286 VTQELTEKSDVYSYGVVLLEIVTAR 310
                + +SD++S G+ L+E+   R
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXX 165
           D+F  I  +G G  G V+K       L+  +++   +I   +     RE++         
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 141
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 142 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 194
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
                + +SD++S G+ L+E+   R  +  G
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPIGSG 225

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 13/194 (6%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IGQG  GTVY A   + G  +A+++M+   +  +     EI                  +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E +++ EY+A GSL D +        +     QIA      L+ L F     + HR+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRN 142
Query: 235 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           IKS NILL  +   KL DFG  A  + + S       + + GTP +M PE V  +    K
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQS-----KRSTMVGTPYWMAPEVVTRKAYGPK 197
Query: 294 SDVYSYGVVLLEIV 307
            D++S G++ +E++
Sbjct: 198 VDIWSLGIMAIEMI 211

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
           + ++ F++ +Y+  G L   L    R P         A +V  ALEYLH      + +RD
Sbjct: 77  DAQQIFMIMDYIEGGELFSLLRKSQRFPNP--VAKFYAAEVCLALEYLH---SKDIIYRD 131
Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           +K  NILLD+N   K+ DFG A    D       V   + GTP Y+ PE V T+   +  
Sbjct: 132 LKPENILLDKNGHIKITDFGFAKYVPD-------VTYXLCGTPDYIAPEVVSTKPYNKSI 184
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
           D +S+G+++ E++       D  N +++ +  + +E R     +  +KD
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDS-NTMKTYEKILNAELRFPPFFNEDVKD 232

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 115 IIGQGGFGTVYKAQFSDGSL-----IAVKRMDK-ISEQVEGDFCREIEXXXXXXXXXXXX 168
           +IG G FG VYK      S      +A+K +    +E+   DF  E              
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G   + +   ++ EYM NG+L   L        S    + +   +A  ++YL    + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKD---GSICFEPVNTDIRGTPGYMDPEYV 285
              HRD+ + NIL++ N V K++DFGL+   +D    +         IR T     PE +
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAI 222
Query: 286 VTQELTEKSDVYSYGVVLLEIVT 308
             ++ T  SDV+S+G+V+ E++T
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 116 IGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXX-XXXX 165
           +G+G FG V  A+         +  + +AVK +    +E+   D   E+E          
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHS-----------PGRTP---LSWQTRIQI 211
                G C +    +++ EY + G+L+++L +           P   P   LS +  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA       I      T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HIDXXKKTT 210
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + R    +M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 120/282 (42%), Gaps = 48/282 (17%)
Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +IG GGFG V+KA+   DG    +KR+   +E+ E    RE++              G C
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIVHYNG-C 72
Query: 174 IE-------------KRER----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 216
            +              R +    F+  E+   G+L+  +       L     +++   + 
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
             ++Y+H      L +RD+K SNI L +    K+ DFGL  + K+     +      +GT
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-----DGKRXRSKGT 184
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 336
             YM PE + +Q+  ++ D+Y+ G++L E             L+        +     +L
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAE-------------LLHVCDTAFETSKFFTDL 231
Query: 337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            D  I D FD ++     T+++    ++ + RP+  ++LR L
Sbjct: 232 RDGIISDIFDKKE----KTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 114/251 (45%), Gaps = 40/251 (15%)
Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVKRM--------DKISEQVEGDFCREIEXXXXXX 162
           ++GQG FG V+  +   GS    L A+K +        D++  ++E D   E+       
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEY 221
                   G      + +L+ +++  G L   L    +  +  +  ++  + ++A AL++
Sbjct: 91  LHYAFQTEG------KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDH 141
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGT 276
           LH      + +RD+K  NILLDE    KL DFGL+     H  K  S C         GT
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---------GT 189
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 336
             YM PE V  +  T+ +D +S+GV++ E++T     Q GK+  E+  + + ++  + + 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKETMTMILKAKLGMPQF 248
Query: 337 VDPRIKDSFDM 347
           + P  +    M
Sbjct: 249 LSPEAQSLLRM 259

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX-GF 172
           ++G G +G VYK +    G L A+K MD   ++ E +  +EI                G 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 173 CIEKR------ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
            I+K       + +L+ E+   GS+ D + +     L  +    I  ++   L +LH + 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 148
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRDIK  N+LL EN   KL DFG++ A  D ++     NT I GTP +M PE + 
Sbjct: 149 --KVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRR--NTFI-GTPYWMAPEVIA 202
Query: 287 TQELTE-----KSDVYSYGVVLLEIV 307
             E  +     KSD++S G+  +E+ 
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMA 228

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 114/251 (45%), Gaps = 40/251 (15%)
Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVKRM--------DKISEQVEGDFCREIEXXXXXX 162
           ++GQG FG V+  +   GS    L A+K +        D++  ++E D   E+       
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEY 221
                   G      + +L+ +++  G L   L    +  +  +  ++  + ++A AL++
Sbjct: 92  LHYAFQTEG------KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDH 142
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGT 276
           LH      + +RD+K  NILLDE    KL DFGL+     H  K  S C         GT
Sbjct: 143 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---------GT 190
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 336
             YM PE V  +  T+ +D +S+GV++ E++T     Q GK+  E+  + + ++  + + 
Sbjct: 191 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKETMTMILKAKLGMPQF 249
Query: 337 VDPRIKDSFDM 347
           + P  +    M
Sbjct: 250 LSPEAQSLLRM 260

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 34/282 (12%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V    +       G ++AVK +      Q    + +EI+             
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 170 XGFCIEKRERFL--MYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
            G C ++ E+ L  + EY+  GSL+D+L  HS G   L     +  A  +   + YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH-- 134
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
                 HR++ + N+LLD + + K+ DFGLA A  +G   +  V  D      +  PE +
Sbjct: 135 -AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSPVFWYAPECL 192
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN----LVESAQVCMASESRLAELVD--- 338
              +    SDV+S+GV L E++T   + Q        L+  AQ  M +  RL EL++   
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-TVLRLTELLERGE 251
Query: 339 --PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             PR  D    E    +  +++ C + E   RP+ + ++ IL
Sbjct: 252 RLPR-PDKCPCE----VYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXX 165
           D+F  I  +G G  G V+K       L+  +++   +I   +     RE++         
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 149
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 150 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 202
Query: 286 VTQELTEKSDVYSYGVVLLEIVTAR 310
                + +SD++S G+ L+E+   R
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 12/193 (6%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G FG V+K        ++A+K +D + +E    D  +EI               G  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           ++  + +++ EY+  GS  D L +         T ++   ++   L+YLH        HR
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLH---SEKKIHR 144
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           DIK++N+LL E    KLADFG+A    D  I     NT + GTP +M PE +       K
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTFV-GTPFWMAPEVIQQSAYDSK 200
Query: 294 SDVYSYGVVLLEI 306
           +D++S G+  +E+
Sbjct: 201 ADIWSLGITAIEL 213

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/229 (31%), Positives = 101/229 (44%), Gaps = 45/229 (19%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRM---DKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           I  +G FG V+KAQ  +   +AVK     DK S Q E    REI                
Sbjct: 22  IKARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQSE----REI--FSTPGMKHENLLQF 74
Query: 172 FCIEKR------ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF- 224
              EKR      E +L+  +   GSL D+L       ++W     +A  ++  L YLH  
Sbjct: 75  IAAEKRGSNLEVELWLITAFHDKGSLTDYLKG---NIITWNELCHVAETMSRGLSYLHED 131
Query: 225 --YC-----DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN--TDIRG 275
             +C      P + HRD KS N+LL  +  A LADFGLA       + FEP     D  G
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA-------VRFEPGKPPGDTHG 184
Query: 276 TPG---YMDPEYV-----VTQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
             G   YM PE +       ++   + D+Y+ G+VL E+V+  +A  DG
Sbjct: 185 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAA-DG 232

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 92  GPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL----IAVKRMD-KISEQ 146
           G +    +F+ KE      +   ++G G FG V   +    S     +A+K +    +E+
Sbjct: 18  GSTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 76
Query: 147 VEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHL--HSPGRTPLS 204
              DF  E                G   + +   ++ EYM NGSL   L  H    T + 
Sbjct: 77  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 136
Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD--- 261
               + +   +A+ ++YL    D    HRD+ + NIL++ N V K++DFGL+   +D   
Sbjct: 137 ---LVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 190
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 191 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 19/227 (8%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL----IAVKRMD-KISE 145
           E P+    +F+ KE + +      +IG G FG V   +          +A+K +    +E
Sbjct: 6   EDPNQAVHEFA-KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTE 64
Query: 146 QVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLH-SPGRTPLS 204
           +   DF  E                G   + +   ++ EYM NGSL   L  + G+    
Sbjct: 65  KQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF--- 121
Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD--- 261
             T IQ+   +      + +  D    HRD+ + NIL++ N V K++DFGL+   +D   
Sbjct: 122 --TVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            +         IR T     PE +  ++ T  SDV+SYG+V+ E+V+
Sbjct: 180 AAYTTRGGKIPIRWTA----PEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 114/260 (43%), Gaps = 19/260 (7%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G G FG V   ++     +AVK M K     E +F +E +              G C +
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EY++NG L ++L S G+  L     +++  DV   + +L         HRD+
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLE---SHQFIHRDL 130
Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            + N L+D +   K++DFG+     D        +   +    +  PE     + + KSD
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYV---SSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 296 VYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVT 355
           V+++G+++ E+ +  +   D   L  +++V +   S+   L  P +          TI  
Sbjct: 188 VWAFGILMWEVFSLGKMPYD---LYTNSEVVLKV-SQGHRLYRPHLASD-------TIYQ 236
Query: 356 IVRWCTQREGQARPSIKQVL 375
           I+  C     + RP+ +Q+L
Sbjct: 237 IMYSCWHELPEKRPTFQQLL 256

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXX 165
           D+F  I  +G G  G V+K       L+  +++   +I   +     RE++         
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 122
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 175
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAV 313
                + +SD++S G+ L+E+   R  +
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 92  GPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL----IAVKRMD-KISEQ 146
           G +    +F+ KE      +   ++G G FG V   +    S     +A+K +    +E+
Sbjct: 1   GSTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 59
Query: 147 VEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHL--HSPGRTPLS 204
              DF  E                G   + +   ++ EYM NGSL   L  H    T + 
Sbjct: 60  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ 119
Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD--- 261
               + +   +A+ ++YL    D    HRD+ + NIL++ N V K++DFGL+   +D   
Sbjct: 120 ---LVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 174 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 21/240 (8%)
Query: 77  LKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL-- 134
           L+ F  P +     E P+    +F+ KE      +   ++G G FG V   +    S   
Sbjct: 19  LRTFVDPHTF----EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE 73
Query: 135 --IAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSL 191
             +A+K +    +E+   DF  E                G   + +   ++ E M NGSL
Sbjct: 74  ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA 251
              L    R   +  T IQ+   +      + +  D    HRD+ + NIL++ N V K++
Sbjct: 134 DSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVS 189
Query: 252 DFGLAHASKD---GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           DFGL+   +D    +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 190 DFGLSRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXX 165
           D+F  I  +G G  G V+K       L+  +++   +I   +     RE++         
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 122
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 175
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAV 313
                + +SD++S G+ L+E+   R  +
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G+G +G V++  +  G  +AVK     S + E  + RE E                  +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
              R      +L+  Y   GSL D+L     T L   + ++I + +A+ L +LH      
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
              P + HRD+KS NIL+ +N    +AD GLA      +   +  N    GT  YM PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 285 ------VVTQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
                 V   +  ++ D++++G+VL E+  ARR V +G
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNG 224

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G+G +G V++  +  G  +AVK     S + E  + RE E                  +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
              R      +L+  Y   GSL D+L     T L   + ++I + +A+ L +LH      
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
              P + HRD+KS NIL+ +N    +AD GLA      +   +  N    GT  YM PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 285 ------VVTQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
                 V   +  ++ D++++G+VL E+  ARR V +G
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNG 224

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIE 175
           +G+G +G V++  +  G  +AVK     S + E  + RE E                  +
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 176 KRER------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--- 226
              R      +L+  Y   GSL D+L     T L   + ++I + +A+ L +LH      
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 227 --DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
              P + HRD+KS NIL+ +N    +AD GLA      +   +  N    GT  YM PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 285 ------VVTQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
                 V   +  ++ D++++G+VL E+  ARR V +G
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNG 253

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXX 165
           D+F  I  +G G  G V+K       L+  +++   +I   +     RE++         
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 122
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 175
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAV 313
                + +SD++S G+ L+E+   R  +
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXX 165
           D+F  I  +G G  G V+K       L+  +++   +I   +     RE++         
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 122
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 175
Query: 286 VTQELTEKSDVYSYGVVLLEIVTAR 310
                + +SD++S G+ L+E+   R
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXX 165
           D+F  I  +G G  G V+K       L+  +++   +I   +     RE++         
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 166 XXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                G      E  +  E+M  GSL   L   GR P     ++ IA  V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE- 122
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNIL++     KL DFG++     G +     N+ + GT  YM PE +
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFV-GTRSYMSPERL 175
Query: 286 VTQELTEKSDVYSYGVVLLEIVTAR 310
                + +SD++S G+ L+E+   R
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 38/291 (13%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRM---DKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           IG+G F  VY+A    DG  +A+K++   D +  +   D  +EI+               
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHS--------PGRTPLSWQTRIQIAIDVANALEYLH 223
             IE  E  ++ E    G L   +          P RT   W+  +Q+     +ALE++H
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT--VWKYFVQLC----SALEHMH 153
Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRDIK +N+ +    V KL D GL       +         + GTP YM PE
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPE 206
Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
            +       KSD++S G +L E+   +      K  + S  +C     ++ +   P +  
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--LC----KKIEQCDYPPLPS 260
Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVE 394
               E+LR +V +   C   + + RP +  V    Y+ +  MH+    ++E
Sbjct: 261 DHYSEELRQLVNM---CINPDPEKRPDVTYV----YDVAKRMHACTASSLE 304

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 61/295 (20%)
Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +IG GGFG V+KA+   DG    ++R+   +E+ E    RE++              G C
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIVHYNG-C 73
Query: 174 IE--------------------------KRER----FLMYEYMANGSLKDHLHSPGRTPL 203
            +                           R +    F+  E+   G+L+  +       L
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 263
                +++   +   ++Y+H      L HRD+K SNI L +    K+ DFGL  + K+  
Sbjct: 134 DKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-- 188
Query: 264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA 323
              +   T  +GT  YM PE + +Q+  ++ D+Y+ G++L E             L+   
Sbjct: 189 ---DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE-------------LLHVC 232
Query: 324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                +     +L D  I D FD ++     T+++    ++ + RP+  ++LR L
Sbjct: 233 DTAFETSKFFTDLRDGIISDIFDKKE----KTLLQKLLSKKPEDRPNTSEILRTL 283

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    R     Q       ++ANAL Y H      + 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITELANALSYCH---SKRVI 134
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL  N   K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 185
Query: 289 ELTEKSDVYSYGVVLLEIVTA 309
              EK D++S GV+  E +  
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVG 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    R     Q       ++ANAL Y H      + 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITELANALSYCH---SKRVI 134
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL  N   K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC---------GTLDYLPPEMIEGR 185
Query: 289 ELTEKSDVYSYGVVLLEIVTA 309
              EK D++S GV+  E +  
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVG 206

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 17/226 (7%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL----IAVKRMD-KISE 145
           E P+    +F+ KE      +   ++G G FG V   +    S     +A+K +    +E
Sbjct: 29  EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 146 QVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
           +   DF  E                G   + +   ++ E M NGSL   L    R   + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL----RKHDAQ 143
Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD---G 262
            T IQ+   +      + +  D    HRD+ + NIL++ N V K++DFGL+   +D    
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 204 AYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 15/226 (6%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDK-ISE 145
           E P+   ++F+ KE   +      +IG G FG V              +A+K +    +E
Sbjct: 17  EDPNEAVREFA-KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 75
Query: 146 QVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
           +   DF  E                G   +     ++ E+M NGSL   L    R     
Sbjct: 76  KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL----RQNDGQ 131
Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 265
            T IQ+   +      + +  D    HRD+ + NIL++ N V K++DFGL+   +D +  
Sbjct: 132 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT-- 189
Query: 266 FEPVNTDIRGTP---GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            +P  T   G      +  PE +  ++ T  SDV+SYG+V+ E+++
Sbjct: 190 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 106 KKATDNFSTI--IGQGGFGTVYKAQFSDGSLI-AVKRMDKI---SEQVEGDFCREIEXXX 159
           K   D+F  +  +G+G FG VY A+      I A+K + K     E VE    REIE   
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 160 XXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
                       +  +++  +LM E+   G L   L   GR     Q       ++A+AL
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADAL 127
Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-HAS--KDGSICFEPVNTDIRGT 276
            Y H   +  + HRDIK  N+L+      K+ADFG + HA   +   +C         GT
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---------GT 175
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
             Y+ PE +  +   EK D++  GV+  E +  
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 19/227 (8%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDK-ISE 145
           E P+   ++F+ KE   +      +IG G FG V   +          +A+K +    ++
Sbjct: 13  EDPNQAVREFA-KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD 71
Query: 146 QVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLH-SPGRTPLS 204
           +   DF  E                G   + +   ++ EYM NGSL   L  + GR    
Sbjct: 72  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF--- 128
Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD--- 261
             T IQ+   +      + +  D    HRD+ + NIL++ N V K++DFG++   +D   
Sbjct: 129 --TVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            +         IR T     PE +  ++ T  SDV+SYG+V+ E+++
Sbjct: 187 AAYTTRGGKIPIRWTA----PEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 13/194 (6%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IG+G  G V  A +   G  +AVK+MD   +Q       E+                  +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E +++ E++  G+L D +     T ++ +    + + V  AL YLH   +  + HRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRD 166
Query: 235 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           IKS +ILL  +   KL+DFG  A  SK+      P    + GTP +M PE +       +
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKE-----VPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 294 SDVYSYGVVLLEIV 307
            D++S G++++E++
Sbjct: 222 VDIWSLGIMVIEMI 235

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 15/225 (6%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMD-KISE 145
           E P+    +F+ KE   +      +IG G FG V   +          +A+K +    +E
Sbjct: 27  EDPNRAVHQFA-KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 146 QVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
           +   DF  E                G     +   ++ E+M NG+L   L    R     
Sbjct: 86  KQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL----RKHDGQ 141
Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 265
            T IQ+   +      + +  D    HRD+ + NIL++ N V K++DFGL+   +D    
Sbjct: 142 FTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDP-- 199
Query: 266 FEPVNTDIRGT--PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            E V T   G     +  PE +  ++ T  SDV+SYG+V+ E+++
Sbjct: 200 -EAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+  +   I A+K + K   +   VE    RE+E              G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKKVI 130
Query: 232 HRDIKSSNILLDENFVAKLADFGL---AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG    A +S+  ++C         GT  Y+ PE +  +
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---------GTLDYLPPEMIEGR 181
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 123/282 (43%), Gaps = 34/282 (12%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V    +       G ++AVK +      Q    + +EI+             
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 170 XGFCIEKRERFL--MYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
            G C +     L  + EY+  GSL+D+L  HS G   L     +  A  +   + YLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH-- 151
Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
                 HRD+ + N+LLD + + K+ DFGLA A  +G   +  V  D      +  PE +
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYR-VREDGDSPVFWYAPECL 209
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN----LVESAQVCMASESRLAELVD--- 338
              +    SDV+S+GV L E++T   + Q        L+  AQ  M +  RL EL++   
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-TVLRLTELLERGE 268
Query: 339 --PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             PR  D    E    +  +++ C + E   RP+ + ++ IL
Sbjct: 269 RLPR-PDKCPAE----VYHLMKNCWETEASFRPTFENLIPIL 305

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 18/273 (6%)
Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGD-FCREIEXXXXXXXXXXXXXXGF 172
           +IG G    V  A  +     +A+KR++    Q   D   +EI+                
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 173 CIEKRERFLMYEYMANGSLKD---HLHSPGRTP---LSWQTRIQIAIDVANALEYLHFYC 226
            + K E +L+ + ++ GS+ D   H+ + G      L   T   I  +V   LEYLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
                HRD+K+ NILL E+   ++ADFG+ A  +  G I    V     GTP +M PE +
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 286 -VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 344
              +    K+D++S+G+  +E+ T          +    +V M +       ++  ++D 
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM----KVLMLTLQNDPPSLETGVQDK 254
Query: 345 FDMEQL-RTIVTIVRWCTQREGQARPSIKQVLR 376
             +++  ++   ++  C Q++ + RP+  ++LR
Sbjct: 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 131
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDPEYVVTQE 289
           HRDIK  N+LL      K+ADFG +        C  P +  T + GT  Y+ PE +  + 
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS--------CHAPSSRRTTLSGTLDYLPPEMIEGRM 183
Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
             EK D++S GV+  E +  +
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGK 204

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 18/273 (6%)
Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGD-FCREIEXXXXXXXXXXXXXXGF 172
           +IG G    V  A  +     +A+KR++    Q   D   +EI+                
Sbjct: 17  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 173 CIEKRERFLMYEYMANGSLKD---HLHSPGRTP---LSWQTRIQIAIDVANALEYLHFYC 226
            + K E +L+ + ++ GS+ D   H+ + G      L   T   I  +V   LEYLH   
Sbjct: 77  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 133
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
                HRD+K+ NILL E+   ++ADFG+ A  +  G I    V     GTP +M PE +
Sbjct: 134 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 193
Query: 286 -VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 344
              +    K+D++S+G+  +E+ T          +    +V M +       ++  ++D 
Sbjct: 194 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM----KVLMLTLQNDPPSLETGVQDK 249
Query: 345 FDMEQL-RTIVTIVRWCTQREGQARPSIKQVLR 376
             +++  ++   ++  C Q++ + RP+  ++LR
Sbjct: 250 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 282

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 16/219 (7%)
Query: 96  MFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRMD--KISEQVEGDF 151
           + QK    E K   D+F  I  +G G  G V K Q     LI  +++   +I   +    
Sbjct: 4   LTQKAKVGELKD--DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQI 61
Query: 152 CREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI 211
            RE++              G      E  +  E+M  GSL   L    R P     ++ I
Sbjct: 62  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI 121
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  V   L YL       + HRD+K SNIL++     KL DFG++     G +     N+
Sbjct: 122 A--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANS 172
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
            + GT  YM PE +     + +SD++S G+ L+E+   R
Sbjct: 173 FV-GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 17/200 (8%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 130
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRDIK  N+LL      K+ADFG + HA            TD+ GT  Y+ PE +  +  
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR-------RTDLCGTLDYLPPEMIEGRMH 183
Query: 291 TEKSDVYSYGVVLLEIVTAR 310
            EK D++S GV+  E +  +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 17/200 (8%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 131
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRDIK  N+LL      K+ADFG + HA            TD+ GT  Y+ PE +  +  
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR-------RTDLCGTLDYLPPEMIEGRMH 184
Query: 291 TEKSDVYSYGVVLLEIVTAR 310
            EK D++S GV+  E +  +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 17/200 (8%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 135
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRDIK  N+LL      K+ADFG + HA            TD+ GT  Y+ PE +  +  
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR-------RTDLCGTLDYLPPEMIEGRMH 188
Query: 291 TEKSDVYSYGVVLLEIVTAR 310
            EK D++S GV+  E +  +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGK 208

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 117/293 (39%), Gaps = 39/293 (13%)
Query: 112 FSTIIGQGGFGTVYKA-QFSDGS-----LIAVKRMDKISEQVEGD-FCREIEXXXXX-XX 163
           F   +G G FG V +A  F  G       +AVK +   +   E +    E++        
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 164 XXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
                  G C       ++ EY   G L + L    R  L       IA   A+  + LH
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV-LETDPAFAIANSTASTRDLLH 168
Query: 224 F---------YCDPPLC-HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 273
           F         +     C HRD+ + N+LL    VAK+ DFGLA    + S     V  + 
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNA 226
Query: 274 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           R    +M PE +     T +SDV+SYG++L EI +       G N      V     S+ 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL------GLNPYPGILV----NSKF 276
Query: 334 AELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
            +LV    KD + M Q     + I +I++ C   E   RP+ +Q+   L E +
Sbjct: 277 YKLV----KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 17/200 (8%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 130
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRDIK  N+LL      K+ADFG + HA            TD+ GT  Y+ PE +  +  
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR-------RTDLCGTLDYLPPEMIEGRMH 183
Query: 291 TEKSDVYSYGVVLLEIVTAR 310
            EK D++S GV+  E +  +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGK 203

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 42/225 (18%)
Query: 114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
            ++GQG FG V KA+ + D    A+K++    E++      E+                 
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVVRYYAA 70
Query: 173 CIEKRE-------------RFLMYEYMANGSLKDHLHSPGRTPLS---WQTRIQIAIDVA 216
            +E+R               F+  EY  NG+L D +HS          W+   QI     
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL---- 126
Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
            AL Y+H      + HRD+K  NI +DE+   K+ DFGLA   K+     + +  D +  
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLA---KNVHRSLDILKLDSQNL 180
Query: 277 PGYMD--------PEYVVTQEL------TEKSDVYSYGVVLLEIV 307
           PG  D          YV T+ L       EK D+YS G++  E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 15/224 (6%)
Query: 93  PSPMFQKFSYKETKKATDNFSTIIGQGGFGTV----YKAQFSDGSLIAVKRMDK-ISEQV 147
           P+   ++F+ KE   +      +IG G FG V     KA     S +A+K +    +E+ 
Sbjct: 2   PNEAVREFA-KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ 60
Query: 148 EGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQT 207
             +F  E                G         ++ E+M NG+L   L    R      T
Sbjct: 61  RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL----RLNDGQFT 116
Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 267
            IQ+   +      + +  +    HRD+ + NIL++ N V K++DFGL+   ++ S   +
Sbjct: 117 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS--SD 174
Query: 268 PVNTDIRGTP---GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           P  T   G      +  PE +  ++ T  SD +SYG+V+ E+++
Sbjct: 175 PTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 119/297 (40%), Gaps = 45/297 (15%)
Query: 112 FSTIIGQGGFGTVYKA-QFSDGS-----LIAVKRMDKISEQVEGD-FCREIEXXXXX-XX 163
           F   +G G FG V +A  F  G       +AVK +   +   E +    E++        
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 164 XXXXXXXGFCIEKRERFLMYEYMANGSLKDHL-----------HSPGRTP---LSWQTRI 209
                  G C       ++ EY   G L + L           ++P   P   LS +  +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 210 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 269
             +  VA  + +L         HRD+ + N+LL    VAK+ DFGLA    + S     V
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--V 224
Query: 270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS 329
             + R    +M PE +     T +SDV+SYG++L EI +       G N      V    
Sbjct: 225 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL------GLNPYPGILV---- 274
Query: 330 ESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
            S+  +LV    KD + M Q     + I +I++ C   E   RP+ +Q+   L E +
Sbjct: 275 NSKFYKLV----KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 327

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 116 IGQGGFG-TVYKAQFSDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G FG  +      DG    +K ++  ++S +   +  RE+                 
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
             E    +++ +Y   G L   +++           +   + +  AL+++H   D  + H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILH 148
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RDIKS NI L ++   +L DFG+A          E     I GTP Y+ PE    +    
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNS---TVELARACI-GTPYYLSPEICENKPYNN 204
Query: 293 KSDVYSYGVVLLEIVTARRAVQDG--KNLV 320
           KSD+++ G VL E+ T + A + G  KNLV
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLV 234

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 21/227 (9%)
Query: 92  GPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSL----IAVKRMD-KISEQ 146
           G +    +F+ KE      +   ++G G FG V   +    S     +A+K +    +E+
Sbjct: 1   GSTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 59
Query: 147 VEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHL--HSPGRTPLS 204
              DF  E                G   + +   ++ E M NGSL   L  H    T + 
Sbjct: 60  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ 119
Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD--- 261
               + +   +A+ ++YL    D    HRD+ + NIL++ N V K++DFGL+   +D   
Sbjct: 120 ---LVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 173
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            +         IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 174 AAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 156
Query: 232 HRDIKSSNILLDENFVAKLADFGL---AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG    A +S+  ++C         GT  Y+ PE +  +
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 207
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 21/201 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKI---SEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K     E VE    REIE               
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +++  +LM E+   G L   L   GR     Q       ++A+AL Y H   +  + 
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCH---ERKVI 137
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HAS--KDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+L+      K+ADFG + HA   +   +C         GT  Y+ PE +  +
Sbjct: 138 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---------GTLDYLPPEMIEGK 188
Query: 289 ELTEKSDVYSYGVVLLEIVTA 309
              EK D++  GV+  E +  
Sbjct: 189 THDEKVDLWCAGVLCYEFLVG 209

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G +   L    +     Q       ++ANAL Y H      + 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 135
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 186
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 115/291 (39%), Gaps = 39/291 (13%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSL-IAVKRMDKISEQVEGD-FCREIEXXXXX-XX 163
           F   +G G FG V +A        D  L +AVK +   +   E +    E++        
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 164 XXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRT--------PLSWQTRIQIAIDV 215
                  G C       ++ EY   G L + L              PL  +  +  +  V
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 275
           A  + +L         HRD+ + N+LL    VAK+ DFGLA    + S     V  + R 
Sbjct: 162 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARL 216
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 335
              +M PE +     T +SDV+SYG++L EI +       G N      V     S+  +
Sbjct: 217 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL------GLNPYPGILV----NSKFYK 266
Query: 336 LVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
           LV    KD + M Q     + I +I++ C   E   RP+ +Q+   L E +
Sbjct: 267 LV----KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 313

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 115/291 (39%), Gaps = 39/291 (13%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSL-IAVKRMDKISEQVEGD-FCREIEXXXXX-XX 163
           F   +G G FG V +A        D  L +AVK +   +   E +    E++        
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 164 XXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRT--------PLSWQTRIQIAIDV 215
                  G C       ++ EY   G L + L              PL  +  +  +  V
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 275
           A  + +L         HRD+ + N+LL    VAK+ DFGLA    + S     V  + R 
Sbjct: 170 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARL 224
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 335
              +M PE +     T +SDV+SYG++L EI +       G N      V     S+  +
Sbjct: 225 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL------GLNPYPGILV----NSKFYK 274
Query: 336 LVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
           LV    KD + M Q     + I +I++ C   E   RP+ +Q+   L E +
Sbjct: 275 LV----KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 321

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 130
Query: 232 HRDIKSSNILLDENFVAKLADFGL---AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG    A +S+  ++C         GT  Y+ PE +  +
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---------GTLDYLPPEMIEGR 181
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 135
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEXIEGR 186
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 187 XHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 18/215 (8%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDK-ISEQVEGDFCREIEX 157
           KE   +      +IG G FG V   +          +A+K +    +++   DF  E   
Sbjct: 3   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 62
Query: 158 XXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLH-SPGRTPLSWQTRIQIAIDVA 216
                        G   + +   ++ EYM NGSL   L  + GR      T IQ+   + 
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLR 117
Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD---GSICFEPVNTDI 273
                + +  D    HRD+ + NIL++ N V K++DFG++   +D    +         I
Sbjct: 118 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 274 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           R T     PE +  ++ T  SDV+SYG+V+ E+++
Sbjct: 178 RWTA----PEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 147
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 148 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 198
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 199 MHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 18/215 (8%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDK-ISEQVEGDFCREIEX 157
           KE   +      +IG G FG V   +          +A+K +    +++   DF  E   
Sbjct: 9   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 68
Query: 158 XXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLH-SPGRTPLSWQTRIQIAIDVA 216
                        G   + +   ++ EYM NGSL   L  + GR      T IQ+   + 
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLR 123
Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD---GSICFEPVNTDI 273
                + +  D    HRD+ + NIL++ N V K++DFG++   +D    +         I
Sbjct: 124 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 274 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           R T     PE +  ++ T  SDV+SYG+V+ E+++
Sbjct: 184 RWTA----PEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 133
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---------GTLDYLPPEMIEGR 184
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 133
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 184
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 134/320 (41%), Gaps = 28/320 (8%)
Query: 65  GLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTV 124
           G  DPE +D T+ +P P   SL   Q    P   +    E  K    F  I+G+G F TV
Sbjct: 1   GAMDPEFMDGTAAEPRPGAGSL---QHAQPPPQPRKKRPEDFK----FGKILGEGSFSTV 53
Query: 125 YKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRER- 179
             A + +     A+K ++K   I E       RE +               FC +  E+ 
Sbjct: 54  VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FCFQDDEKL 112
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH      + HRD+K  N
Sbjct: 113 YFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH---GKGIIHRDLKPEN 167
Query: 240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSY 299
           ILL+E+   ++ DFG A      S   +       GT  Y+ PE +  +   + SD+++ 
Sbjct: 168 ILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLTEKSACKSSDLWAL 225
Query: 300 GVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRW 359
           G ++ ++V      + G   +   Q  +  E    E   P+ +D   +E+L  +    R 
Sbjct: 226 GCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL--VEKLLVLDATKRL 282
Query: 360 -CTQREG----QARPSIKQV 374
            C + EG    +A P  + V
Sbjct: 283 GCEEMEGYGPLKAHPFFESV 302

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 130
Query: 232 HRDIKSSNILLDENFVAKLADFGL---AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG    A +S+  ++C         GT  Y+ PE +  +
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 181
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 131
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC---------GTLDYLPPEMIEGR 182
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 133
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 184
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 135
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 186
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 129
Query: 232 HRDIKSSNILLDENFVAKLADFGL---AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG    A +S+  ++C         GT  Y+ PE +  +
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 180
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 88/194 (45%), Gaps = 13/194 (6%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IG+G  G V  A +   G  +AVK MD   +Q       E+                  +
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E +++ E++  G+L D +    +  L+ +    +   V  AL YLH      + HRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRD 166
Query: 235 IKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           IKS +ILL  +   KL+DFG  A  SKD      P    + GTP +M PE +       +
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKD-----VPKRKXLVGTPYWMAPEVISRSLYATE 221
Query: 294 SDVYSYGVVLLEIV 307
            D++S G++++E+V
Sbjct: 222 VDIWSLGIMVIEMV 235

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 156
Query: 232 HRDIKSSNILLDENFVAKLADFGL---AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG    A +S+   +C         GT  Y+ PE +  +
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC---------GTLDYLPPEMIEGR 207
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 134
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 185
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 117/295 (39%), Gaps = 43/295 (14%)
Query: 112 FSTIIGQGGFGTVYKAQF-----SDGSL-IAVKRMDKISEQVEGD-FCREIEXXXXX-XX 163
           F   +G G FG V +A        D  L +AVK +   +   E +    E++        
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 164 XXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGR------------TPLSWQTRIQI 211
                  G C       ++ EY   G L + L    R            + LS +  +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           +  VA  + +L         HRD+ + N+LL    VAK+ DFGLA    + S     V  
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI--VKG 224
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
           + R    +M PE +     T +SDV+SYG++L EI +       G N      V     S
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL------GLNPYPGILV----NS 274
Query: 332 RLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQVLRILYESS 382
           +  +LV    KD + M Q     + I +I++ C   E   RP+ +Q+   L E +
Sbjct: 275 KFYKLV----KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 17/200 (8%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 130
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRDIK  N+LL      K+ADFG + HA            T++ GT  Y+ PE +  +  
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR-------RTELCGTLDYLPPEMIEGRMH 183
Query: 291 TEKSDVYSYGVVLLEIVTAR 310
            EK D++S GV+  E +  +
Sbjct: 184 DEKVDLWSLGVLCYEFLVGK 203

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 29/237 (12%)
Query: 93  PSPMF--QKFSYKETKKATDNFS-----------TIIGQGGFGTVYKAQF----SDGSLI 135
           P P F  +  +Y+E  +A  +F+            IIG G  G V   +          +
Sbjct: 21  PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 136 AVKRMDK-ISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDH 194
           A+K +    +E+   DF  E                G     R   ++ EYM NGSL   
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 195 LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 254
           L    RT     T +Q+   +      + +  D    HRD+ + N+L+D N V K++DFG
Sbjct: 141 L----RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 255 LAHASK---DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           L+   +   D +         IR T     PE +  +  +  SDV+S+GVV+ E++ 
Sbjct: 197 LSRVLEDDPDAAXTTTGGKIPIRWTA----PEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 14/214 (6%)
Query: 103 KETKKATDNFSTIIGQGGFGTV----YKAQFSDGSLIAVKRMDK-ISEQVEGDFCREIEX 157
           KE   +      +IG G FG V     KA     S +A+K +    +E+   +F  E   
Sbjct: 9   KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 68
Query: 158 XXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
                        G         ++ E+M NG+L   L    R      T IQ+   +  
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL----RLNDGQFTVIQLVGMLRG 124
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
               + +  +    HRD+ + NIL++ N V K++DFGL+   ++ S   +P  T   G  
Sbjct: 125 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS--SDPTYTSSLGGK 182
Query: 278 ---GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
               +  PE +  ++ T  SD +SYG+V+ E+++
Sbjct: 183 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 29/237 (12%)
Query: 93  PSPMF--QKFSYKETKKATDNFS-----------TIIGQGGFGTVYKAQF----SDGSLI 135
           P P F  +  +Y+E  +A  +F+            IIG G  G V   +          +
Sbjct: 21  PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 136 AVKRMDK-ISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDH 194
           A+K +    +E+   DF  E                G     R   ++ EYM NGSL   
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 195 LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG 254
           L    RT     T +Q+   +      + +  D    HRD+ + N+L+D N V K++DFG
Sbjct: 141 L----RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 255 LAHASK---DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           L+   +   D +         IR T     PE +  +  +  SDV+S+GVV+ E++ 
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTA----PEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G G FG V   +    G  +AVK +++    S  V G   REI+               
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
                 + F++ EY++ G L D++   GR     + R ++   + +A++Y H +    + 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVE-EMEAR-RLFQQILSAVDYCHRHM---VV 133
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K  N+LLD +  AK+ADFGL++   DG         D  G+P Y  PE V++  L 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL-----RDSCGSPNYAAPE-VISGRLY 187
Query: 292 E--KSDVYSYGVVLLEIVTA 309
              + D++S GV+L  ++  
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG V  A   + G  +A+K ++K       ++G   REI                
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
               K E  ++ EY  N  L D++    R  +S Q   +    + +A+EY H +    + 
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIV 125
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K  N+LLDE+   K+ADFGL++   DG+           G+P Y  PE V++ +L 
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPE-VISGKLY 179
Query: 292 E--KSDVYSYGVVLLEIVTARRAVQD 315
              + DV+S GV+L  ++  R    D
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG V  A   + G  +A+K ++K       ++G   REI                
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
               K E  ++ EY  N  L D++    R  +S Q   +    + +A+EY H +    + 
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIV 135
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K  N+LLDE+   K+ADFGL++   DG+           G+P Y  PE V++ +L 
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPE-VISGKLY 189
Query: 292 E--KSDVYSYGVVLLEIVTARRAVQD 315
              + DV+S GV+L  ++  R    D
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 105 TKKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDK-ISEQVEGDFCREIEXXXX 160
            +   DNF  I  +G+G FG V  A+  + G L AVK + K +  Q +   C   E    
Sbjct: 18  NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRIL 77
Query: 161 XXXXXXXXXXGF--CIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVA 216
                         C +  +R F + E++  G L  H+    R     + R +  A ++ 
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYAAEII 134
Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
           +AL +LH   D  + +RD+K  N+LLD     KLADFG+    K+G IC         GT
Sbjct: 135 SALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC---KEG-ICNGVTTATFCGT 187
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           P Y+ PE +         D ++ GV+L E++  
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G G FG V   +    G  +AVK +++    S  V G   REI+               
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
                 + F++ EY++ G L D++   GR  L  +   ++   + + ++Y H +    + 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHM---VV 138
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K  N+LLD +  AK+ADFGL++   DG            G+P Y  PE V++  L 
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC-----GSPNYAAPE-VISGRLY 192
Query: 292 E--KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC 326
              + D++S GV+L  ++       D        ++C
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG V  A   + G  +A+K ++K       ++G   REI                
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
               K E  ++ EY  N  L D++    R  +S Q   +    + +A+EY H +    + 
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIV 134
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K  N+LLDE+   K+ADFGL++   DG+           G+P Y  PE V++ +L 
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPE-VISGKLY 188
Query: 292 E--KSDVYSYGVVLLEIVTARRAVQD 315
              + DV+S GV+L  ++  R    D
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 40/234 (17%)
Query: 115 IIGQGGFGTVYKAQF----SDGSLIAVKRM--------DKISEQVEGDFCREIEXXXXXX 162
           ++GQG FG V+  +       G L A+K +        D++  ++E D   ++       
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEY 221
                   G      + +L+ +++  G L   L    +  +  +  ++  + ++A  L++
Sbjct: 95  LHYAFQTEG------KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALGLDH 145
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGT 276
           LH      + +RD+K  NILLDE    KL DFGL+     H  K  S C         GT
Sbjct: 146 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC---------GT 193
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 330
             YM PE V  Q  +  +D +SYGV++ E++T     Q GK+  E+  + + ++
Sbjct: 194 VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQ-GKDRKETMTLILKAK 246

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 132
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+   +C         GT  Y+ PE +  +
Sbjct: 133 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---------GTLDYLPPEMIEGR 183
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG V  A   + G  +A+K ++K       ++G   REI                
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
               K E  ++ EY  N  L D++    R  +S Q   +    + +A+EY H +    + 
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIV 129
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K  N+LLDE+   K+ADFGL++   DG+           G+P Y  PE V++ +L 
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-----GSPNYAAPE-VISGKLY 183
Query: 292 E--KSDVYSYGVVLLEIVTARRAVQD 315
              + DV+S GV+L  ++  R    D
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRM---DKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +  +G FG V+KAQ  +   +AVK     DK S Q       E E               
Sbjct: 31  VKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQ------NEYEVYSLPGMKHENILQF 83
Query: 172 FCIEKR------ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
              EKR      + +L+  +   GSL D L +     +SW     IA  +A  L YLH  
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHED 140
Query: 226 C-------DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
                    P + HRDIKS N+LL  N  A +ADFGLA   + G    +       GT  
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ--VGTRR 198
Query: 279 YMDPEYV-----VTQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           YM PE +       ++   + D+Y+ G+VL E+ + R    DG
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS-RCTAADG 240

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 127
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 128 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 178
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 179 MHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 130
Query: 232 HRDIKSSNILLDENFVAKLADFGL---AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG    A +S+   +C         GT  Y+ PE +  +
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC---------GTLDYLPPEMIEGR 181
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 130
Query: 232 HRDIKSSNILLDENFVAKLADFGL---AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG    A +S+   +C         GT  Y+ PE +  +
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---------GTLDYLPPEMIEGR 181
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 133
Query: 232 HRDIKSSNILLDENFVAKLADFGL---AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG    A +S+   +C         GT  Y+ PE +  +
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC---------GTLDYLPPEMIEGR 184
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 133
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA  S+   +C         GT  Y+ PE +  +
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---------GTLDYLPPEMIEGR 184
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 132
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+A+FG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 133 HRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 183
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G G FG V   +    G  +AVK +++    S  V G   REI+               
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
                 + F++ EY++ G L D++   GR     + R ++   + +A++Y H +    + 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVE-EMEAR-RLFQQILSAVDYCHRHM---VV 133
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K  N+LLD +  AK+ADFGL++   DG    E + T   G+P Y  PE V++  L 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDG----EFLRTSC-GSPNYAAPE-VISGRLY 187
Query: 292 E--KSDVYSYGVVLLEIVTA 309
              + D++S GV+L  ++  
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     Q       ++ANAL Y H      + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 133
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HA--SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+A+FG + HA  S+  ++C         GT  Y+ PE +  +
Sbjct: 134 HRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC---------GTLDYLPPEMIEGR 184
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              EK D++S GV+  E +  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 14/214 (6%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDK-ISEQVEGDFCREIEX 157
           KE   +      +IG G FG V              +A+K +    +E+   DF  E   
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 61
Query: 158 XXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
                        G   +     ++ E+M NGSL   L    R      T IQ+   +  
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL----RQNDGQFTVIQLVGMLRG 117
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
               + +  D    HR + + NIL++ N V K++DFGL+   +D +   +P  T   G  
Sbjct: 118 IAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDT--SDPTYTSALGGK 175
Query: 278 ---GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
               +  PE +  ++ T  SDV+SYG+V+ E+++
Sbjct: 176 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 119/304 (39%), Gaps = 52/304 (17%)
Query: 112 FSTIIGQGGFGTVYKA-QFSDGS-----LIAVKRMDKISEQVEGD-FCREIEXXXXXXX- 163
           F   +G G FG V +A  F  G       +AVK +   +   E +    E++        
Sbjct: 35  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 164 XXXXXXXGFCIEKRERFLMYEYMANGSLKDHLH-----------SPGRTP---------- 202
                  G C       ++ EY   G L + L            +PG+ P          
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 262
           L  +  +  +  VA  + +L         HRD+ + N+LL    VAK+ DFGLA    + 
Sbjct: 155 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 322
           S     V  + R    +M PE +     T +SDV+SYG++L EI +       G N    
Sbjct: 212 SNYI--VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL------GLNPYPG 263
Query: 323 AQVCMASESRLAELVDPRIKDSFDMEQ----LRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             V     S+  +LV    KD + M Q     + I +I++ C   E   RP+ +Q+   L
Sbjct: 264 ILV----NSKFYKLV----KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 315
Query: 379 YESS 382
            E +
Sbjct: 316 QEQA 319

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 112 FSTIIGQGGFGTVYKAQFS--DGS--LIAVKRM--DKISEQVEGDFCREIEXXXXXXXXX 165
              I+G+G FG+V +      DG+   +AVK M  D  S++   +F  E           
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 166 XXXXXGFCIEKRER-----FLMYEYMANGSLKDHL------HSPGRTPLSWQTRIQIAID 214
                G CIE   +      ++  +M  G L  +L        P   PL  QT ++  +D
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QTLLKFMVD 155
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA------SKDGSICFEP 268
           +A  +EYL    +    HRD+ + N +L ++    +ADFGL+         + G I   P
Sbjct: 156 IALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           V         ++  E +  +  T KSDV+++GV + EI T
Sbjct: 213 VK--------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 15/209 (7%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKI-----SEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  DG  + +    K+     S +   +   E              
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L DH+    R  L  Q  +   + +A  + YL    D 
Sbjct: 84  LLGICLTSTVQ-LVTQLMPYGCLLDHVRE-NRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVT 287
            L HRD+ + N+L+      K+ DFGLA       I     + D    P  +M  E ++ 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLL---DIDETEYHADGGKVPIKWMALESILR 195
Query: 288 QELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           +  T +SDV+SYGV + E++T      DG
Sbjct: 196 RRFTHQSDVWSYGVTVWELMTFGAKPYDG 224

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 17/200 (8%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKISEQ---VEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K   +   VE    RE+E              G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G +   L    +     Q       ++ANAL Y H      + 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYITELANALSYCH---SKRVI 135
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRDIK  N+LL      K+ADFG + HA              + GT  Y+ PE +  +  
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR-------RXXLXGTLDYLPPEMIEGRMH 188
Query: 291 TEKSDVYSYGVVLLEIVTAR 310
            EK D++S GV+  E +  +
Sbjct: 189 DEKVDLWSLGVLCYEFLVGK 208

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGD-FCREIEXXXXXXXXXXXXXXGFC 173
           +G+GGFG V++A+   D    A+KR+   + ++  +   RE++                 
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 174 IEKRER------------FLMYEYMANGSLKDHLHSPGRTPLSWQTR---IQIAIDVANA 218
           +EK               ++  +     +LKD ++  GR  +  + R   + I + +A A
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN--GRCTIEERERSVCLHIFLQIAEA 130
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSICFEPV-----N 270
           +E+LH      L HRD+K SNI    + V K+ DFGL  A    ++      P+     +
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
           T   GT  YM PE +     + K D++S G++L E++
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
            ++GQG FG V KA+ + D    A+K++    E++      E+                 
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVVRYYAA 70
Query: 173 CIEKRE-------------RFLMYEYMANGSLKDHLHSPGRTPLS---WQTRIQIAIDVA 216
            +E+R               F+  EY  N +L D +HS          W+   QI     
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---- 126
Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
            AL Y+H      + HRD+K  NI +DE+   K+ DFGLA   K+     + +  D +  
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLA---KNVHRSLDILKLDSQNL 180
Query: 277 PGYMD--------PEYVVTQEL------TEKSDVYSYGVVLLEIV 307
           PG  D          YV T+ L       EK D+YS G++  E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEG-----DFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  + +    KI  +  G     +F  E              
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M +G L +++H   +  +  Q  +   + +A  + YL    + 
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLEYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 159
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVT 287
            L HRD+ + N+L+      K+ DFGLA   +      +  N D    P  +M  E +  
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE---KEYNADGGKMPIKWMALECIHY 216
Query: 288 QELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           ++ T +SDV+SYGV + E++T      DG
Sbjct: 217 RKFTHQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E+++   LKD + +   T +           +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 123 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 173
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 214

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 52/224 (23%)
Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G GGFG V +    D G  +A+K+   ++S +    +C EI+                 
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN-------V 74
Query: 174 IEKRER-------------FLMYEYMANGSLKDHLH----------SPGRTPLSWQTRIQ 210
           +  RE               L  EY   G L+ +L+           P RT LS      
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS------ 128
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFE 267
              D+++AL YLH   +  + HRD+K  NI+L    +  + K+ D G A     G +C E
Sbjct: 129 ---DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182
Query: 268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
            V     GT  Y+ PE +  ++ T   D +S+G +  E +T  R
Sbjct: 183 FV-----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 52/224 (23%)
Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G GGFG V +    D G  +A+K+   ++S +    +C EI+                 
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN-------V 75
Query: 174 IEKRER-------------FLMYEYMANGSLKDHLH----------SPGRTPLSWQTRIQ 210
           +  RE               L  EY   G L+ +L+           P RT LS      
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS------ 129
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFE 267
              D+++AL YLH   +  + HRD+K  NI+L    +  + K+ D G A     G +C E
Sbjct: 130 ---DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 183
Query: 268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR 311
            V     GT  Y+ PE +  ++ T   D +S+G +  E +T  R
Sbjct: 184 FV-----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E+++   LKD + +   T +           +   L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 122 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 172
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 213

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEG-----DFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  + +    KI  +  G     +F  E              
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M +G L +++H   +  +  Q  +   + +A  + YL    + 
Sbjct: 82  LLGVCLSPTIQ-LVTQLMPHGCLLEYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVVT 287
            L HRD+ + N+L+      K+ DFGLA   +      +  N D    P  +M  E +  
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE---KEYNADGGKMPIKWMALECIHY 193
Query: 288 QELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           ++ T +SDV+SYGV + E++T      DG
Sbjct: 194 RKFTHQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 22/206 (10%)
Query: 114 TIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCR---EIEXXXXXXXXXXXXX 169
            ++G+G F  VY+A+    G  +A+K +DK +    G   R   E++             
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             +  +    +L+ E   NG +  +L +  + P S          +   + YLH +    
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYLHSH---G 132
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHA-----SKDGSICFEPVNTDIRGTPGYMDPEY 284
           + HRD+  SN+LL  N   K+ADFGLA        K  ++C         GTP Y+ PE 
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---------GTPNYISPEI 183
Query: 285 VVTQELTEKSDVYSYGVVLLEIVTAR 310
                   +SDV+S G +   ++  R
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 30/230 (13%)
Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           ++ +GGF  VY+AQ    G   A+KR+  +S + E +     E               FC
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 174 ----IEKRE------RFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYL 222
               I K E       FL+   +  G L + L     R PLS  T ++I      A++++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA----------HASKDGSICFEPVNTD 272
           H    PP+ HRD+K  N+LL      KL DFG A           +++  ++  E +  +
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 273 IRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTARRAVQDGKNL 319
              TP Y  PE +       + EK D+++ G +L  +   +   +DG  L
Sbjct: 212 T--TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 23/226 (10%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +AVK +DK  ++        RE+                 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR     + R +    + +A++Y H      + H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 233 RDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++     +K  + C         G+P Y  PE    +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---------GSPPYAAPELFQGK 187
Query: 289 ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +    + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 23/226 (10%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +AVK +DK  ++        RE+                 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR     + R +    + +A++Y H      + H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 233 RDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++     +K  + C         G+P Y  PE    +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---------GSPPYAAPELFQGK 187
Query: 289 ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +    + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LKD + +   T +           +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 120 HSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 170
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 211

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 115 IIGQGGFGTVYKAQFS--DGSLIAVK----RMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G+G FG+V +AQ    DGS + V     + D I+     +F RE              
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 169 XXGFCIEKRER------FLMYEYMANGSLKDHLHSP--GRTP--LSWQTRIQIAIDVANA 218
             G  +  R +       ++  +M +G L   L +   G  P  L  QT ++  +D+A  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           +EYL         HRD+ + N +L E+    +ADFGL+     G    +   + +     
Sbjct: 150 MEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--PVK 204
Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           ++  E +     T  SDV+++GV + EI+T
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 34/227 (14%)
Query: 103 KETKKATDNFSTI--IGQGGFGTV---------YKAQFSDGSLIAVKR------MDKISE 145
           KE  K  +++  I  + QG F  +         Y  +  + SL+  KR       DKIS 
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 146 QVE-GDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDH------LHSP 198
           + +  DF  E++              G      E +++YEYM N S+         L   
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 199 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
               +  Q    I   V N+  Y+H   +  +CHRD+K SNIL+D+N   KL+DFG +  
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE--KSDVYSYGVVL 303
             D  I         RGT  +M PE+   +      K D++S G+ L
Sbjct: 202 MVDKKI------KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +AVK +DK  ++        RE+                 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR     + R +    + +A++Y H      + H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 233 RDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++     +K  + C         G P Y  PE    +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC---------GAPPYAAPELFQGK 187
Query: 289 ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +    + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREI--EXXXXXXXXXXXXXXG 171
           ++G+GGFG V+  Q  + G L A K+++K   +    +   +  +               
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 172 FCIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQT--RIQIAIDVANALEYLHFYCDP 228
           +  E K +  L+   M  G ++ H+++       +Q    I     + + LE+LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QR 308
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + +RD+K  N+LLD++   +++D GLA   K G    +       GTPG+M PE ++ +
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG----QTKTKGYAGTPGFMAPELLLGE 364
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
           E     D ++ GV L E++ AR
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREI--EXXXXXXXXXXXXXXG 171
           ++G+GGFG V+  Q  + G L A K+++K   +    +   +  +               
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 172 FCIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQT--RIQIAIDVANALEYLHFYCDP 228
           +  E K +  L+   M  G ++ H+++       +Q    I     + + LE+LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QR 308
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + +RD+K  N+LLD++   +++D GLA   K G    +       GTPG+M PE ++ +
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG----QTKTKGYAGTPGFMAPELLLGE 364
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
           E     D ++ GV L E++ AR
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREI--EXXXXXXXXXXXXXXG 171
           ++G+GGFG V+  Q  + G L A K+++K   +    +   +  +               
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 172 FCIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQT--RIQIAIDVANALEYLHFYCDP 228
           +  E K +  L+   M  G ++ H+++       +Q    I     + + LE+LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QR 308
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + +RD+K  N+LLD++   +++D GLA   K G    +       GTPG+M PE ++ +
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG----QTKTKGYAGTPGFMAPELLLGE 364
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
           E     D ++ GV L E++ AR
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 107 KATD-NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK-ISEQVEGDFCREIEXXXXXXX 163
           K TD NF  ++G+G FG V  A +     L A+K + K +  Q +   C  +E       
Sbjct: 17  KLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 164 XXXXXXXGF--CIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
                      C +  +R + + EY+  G L  H+   G+        +  A +++  L 
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISIGLF 134
Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 280
           +LH      + +RD+K  N++LD     K+ADFG+        +       +  GTP Y+
Sbjct: 135 FLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV----TTREFCGTPDYI 187
Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
            PE +  Q   +  D ++YGV+L E++  +
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 83/182 (45%), Gaps = 21/182 (11%)
Query: 200 RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 259
           + P++ +  I  +  VA  +E+L         HRD+ + NILL EN V K+ DFGLA   
Sbjct: 193 KEPITMEDLISYSFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLAR-- 247
Query: 260 KDGSICFEP---VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
               I   P      D R    +M PE +  +  + KSDV+SYGV+L EI +   +   G
Sbjct: 248 ---DIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG 304
Query: 317 KNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
             + E    C    SRL E +  R  +    E    I  I+  C  R+ + RP   +++ 
Sbjct: 305 VQMDE--DFC----SRLREGMRMRAPEYSTPE----IYQIMLDCWHRDPKERPRFAELVE 354
Query: 377 IL 378
            L
Sbjct: 355 KL 356

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 30  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 81
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 82  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 138
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 139 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 190
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREI--EXXXXXXXXXXXXXXG 171
           ++G+GGFG V+  Q  + G L A K+++K   +    +   +  +               
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 172 FCIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQT--RIQIAIDVANALEYLHFYCDP 228
           +  E K +  L+   M  G ++ H+++       +Q    I     + + LE+LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QR 308
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + +RD+K  N+LLD++   +++D GLA   K G    +       GTPG+M PE ++ +
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG----QTKTKGYAGTPGFMAPELLLGE 364
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
           E     D ++ GV L E++ AR
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 37  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 88
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 89  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 145
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 146 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 197
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 198 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 8/145 (5%)
Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 240
           L+   M  G LK H++  G+        +  A ++   LE LH      + +RD+K  NI
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENI 317
Query: 241 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYG 300
           LLD++   +++D GLA    +G      V     GT GYM PE V  +  T   D ++ G
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQTIKGRV-----GTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 301 VVLLEIVTARRAVQDGKNLVESAQV 325
            +L E++  +   Q  K  ++  +V
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEV 397

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 46  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 97
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 98  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 154
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 155 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 206
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 207 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 19  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 70
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 71  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 127
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 128 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 179
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 180 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 18  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 69
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 70  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 178
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 26  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 77
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 78  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 134
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 135 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 186
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 187 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 68/145 (46%), Gaps = 8/145 (5%)
Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 240
           L+   M  G LK H++  G+        +  A ++   LE LH      + +RD+K  NI
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENI 317
Query: 241 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYG 300
           LLD++   +++D GLA    +G      V     GT GYM PE V  +  T   D ++ G
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQTIKGRV-----GTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 301 VVLLEIVTARRAVQDGKNLVESAQV 325
            +L E++  +   Q  K  ++  +V
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEV 397

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 18  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 69
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 70  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 178
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 31  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 82
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 83  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 139
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 140 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 191
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 192 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 18  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 69
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 70  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 178
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 30  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 81
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 82  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 138
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 139 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 190
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 52  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 103
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 104 LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 161 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 212
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 23/226 (10%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +AV+ +DK  ++        RE+                 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR     + R +    + +A++Y H      + H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 233 RDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++     +K  + C         G+P Y  PE    +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---------GSPPYAAPELFQGK 187
Query: 289 ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +    + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 22  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 73
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 74  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 130
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 131 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 182
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 183 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 52  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 103
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 104 LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 161 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 212
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 213 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 54  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 105
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 106 LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 162
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 163 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 214
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 215 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 23  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 74
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 75  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 131
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 132 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 183
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 184 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 15/222 (6%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +AV+ +DK  ++        RE+                 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR     + R +    + +A++Y H      + H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RD+K+ N+LLD +   K+ADFG ++    G+   E       G+P Y  PE    ++   
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE-----FCGSPPYAAPELFQGKKYDG 191
Query: 293 -KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
            + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 56  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 107
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 108 LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 164
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 165 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 216
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 217 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 23/226 (10%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +AVK +DK  ++        RE+                 
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR     + R +    + +A++Y H      + H
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXK-EKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 233 RDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++     +K  + C         G P Y  PE    +
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC---------GAPPYAAPELFQGK 187
Query: 289 ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +    + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 232

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 97  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 148
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 149 LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 205
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 206 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 257
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 258 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++  DK  +  E    R+
Sbjct: 18  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRK 69
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 70  LDHCNIVRLRYFFYSSG---EKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 178
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVE-GDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V   ++     + G  +AVK +   S      D  +EIE             
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 170 XGFCIEKRERF--LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
            G C E       L+ E++ +GSLK++L    +  ++ + +++ A+ +   ++YL     
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG---S 132
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM-DPEYVV 286
               HRD+ + N+L++     K+ DFGL  A +           D R +P +   PE ++
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--XXTVKDDRDSPVFWYAPECLM 190
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
             +    SDV+S+GV L E++T
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 116 IGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVE-GDFCREIEXXXXXXXXXXXXX 169
           +G+G FG V   ++     + G  +AVK +   S      D  +EIE             
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 170 XGFCIEKRERF--LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
            G C E       L+ E++ +GSLK++L    +  ++ + +++ A+ +   ++YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG---S 144
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM-DPEYVV 286
               HRD+ + N+L++     K+ DFGL  A +           D R +P +   PE ++
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--EXXTVKDDRDSPVFWYAPECLM 202
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
             +    SDV+S+GV L E++T
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 23/226 (10%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +AVK +DK  ++        RE+                 
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR     + R +    + +A++Y H      + H
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR-QIVSAVQYCH---QKYIVH 137
Query: 233 RDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++     +K  + C         G+P Y  PE    +
Sbjct: 138 RDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC---------GSPPYAAPELFQGK 188
Query: 289 ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +    + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 233

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 42/225 (18%)
Query: 114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
            ++GQG FG V KA+ + D    A+K++    E++      E+                 
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVXLLASLNHQYVVRYYAA 70
Query: 173 CIEKRE-------------RFLMYEYMANGSLKDHLHSPGRTPLS---WQTRIQIAIDVA 216
            +E+R               F+  EY  N +L D +HS          W+   QI     
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---- 126
Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
            AL Y+H      + HR++K  NI +DE+   K+ DFGLA   K+     + +  D +  
Sbjct: 127 EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLA---KNVHRSLDILKLDSQNL 180
Query: 277 PGYMD--------PEYVVTQEL------TEKSDVYSYGVVLLEIV 307
           PG  D          YV T+ L       EK D YS G++  E +
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 179
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           E ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 218

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 103 KETKKATD-NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK-ISEQVEGDFCREIEXXX 159
           ++  K TD NF  ++G+G FG V  ++      L AVK + K +  Q +   C  +E   
Sbjct: 14  RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV 73
Query: 160 XXXXXXXXXXXGF--CIEKRER-FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAID 214
                          C +  +R + + EY+  G L  H+   GR   P +     +IAI 
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG 133
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD-I 273
                  L F     + +RD+K  N++LD     K+ADFG+   +      ++ V T   
Sbjct: 134 -------LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-----IWDGVTTKXF 181
Query: 274 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
            GTP Y+ PE +  Q   +  D +++GV+L E++  +
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +A+K +DK  ++        RE+                 
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR     + R +    + +A++Y H      + H
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFR-QIVSAVQYCH---QKRIVH 134
Query: 233 RDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++      K  + C         G+P Y  PE    +
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC---------GSPPYAAPELFQGK 185
Query: 289 ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +    + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 230

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 179
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           E ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 218

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 172
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 213

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 176
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           E ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  IG G FG V   +    G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EYM  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    K+ADFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  IG G FG V   +    G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EYM  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    K+ADFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E+++   LK  + +   T +           +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 123 HSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 173
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            PE ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 209

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 17/221 (7%)
Query: 97  FQKFSYKETKKATD-NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK-ISEQVEGDFCR 153
           F     ++  K TD NF  ++G+G FG V  ++      L AVK + K +  Q +   C 
Sbjct: 329 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388
Query: 154 EIEXXXXXXXXXXXXXXGF--CIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 210
            +E                  C +  +R + + EY+  G L  H+   GR        + 
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVF 446
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 270
            A ++A  L +L       + +RD+K  N++LD     K+ADFG+   +      ++ V 
Sbjct: 447 YAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-----IWDGVT 498
Query: 271 TD-IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           T    GTP Y+ PE +  Q   +  D +++GV+L E++  +
Sbjct: 499 TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 173
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 214

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 172
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 213

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E+++   LK  + +   T +           +   L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 121 HSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 171
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            PE ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 207

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 124 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 174
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 215

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 122 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 172
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 213

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 172
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVT-RRALFPG 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 123 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 173
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 214

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYR 171
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            PE ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 207

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 121 HSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 171
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 212

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 170
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            PE ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 206

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 42/230 (18%)
Query: 112 FSTIIGQGGFGTVYKAQFSDGS------LIAVKRMDKISEQVEGD-FCREIEXXXXX-XX 163
           F  ++G G FG V  A     S       +AVK + + ++  E +    E++        
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 164 XXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGR---------------------TP 202
                  G C      +L++EY   G L ++L S                          
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 262
           L+++  +  A  VA  +E+L F       HRD+ + N+L+    V K+ DFGLA      
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 263 SICFEPVNTDIRGTP----GYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           S      N  +RG       +M PE +     T KSDV+SYG++L EI +
Sbjct: 226 S------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 172
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 171
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 205

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 170
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            PE ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 206

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 172
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 206

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 171
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            PE ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 207

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 171
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 205

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 123 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 173
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 214

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 170
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            PE ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 206

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 172
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 206

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYRAP 171
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYRAP 171
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 205

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 170
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 211

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 123 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYRAP 173
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           E ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 212

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +A+K +DK  ++        RE+                 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR     + R +    + +A++Y H      + H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFR-QIVSAVQYCH---QKRIVH 137
Query: 233 RDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++      K  + C         G P Y  PE    +
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---------GAPPYAAPELFQGK 188
Query: 289 ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +    + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 233

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD-FCREIEXXXXXXXX-XXXXXXGF 172
           +G G  G V+K +F   G +IAVK+M +   + E      +++               G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
            I   + F+  E M  G+  + L    + P+  +   ++ + +  AL YL       + H
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIH 148
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RD+K SNILLDE    KL DFG++     G +  +       G   YM PE +   + T+
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 293 -----KSDVYSYGVVLLEIVTAR 310
                ++DV+S G+ L+E+ T +
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ 226

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++   K  +  E    R+
Sbjct: 18  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK 69
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 70  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 178
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 20/212 (9%)
Query: 102 YKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM-----DKISEQVEGDFCREI 155
           Y ++ +  +N   ++G+G +G V K +  D G ++A+K+      DK+ +++     REI
Sbjct: 20  YFQSMEKYENLG-LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA---MREI 75
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 215
           +                C +K+  +L++E++ +  L D    P    L +Q   +    +
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQI 133
Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 275
            N + + H +    + HRDIK  NIL+ ++ V KL DFG A            V  D   
Sbjct: 134 INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----EVYDDEVA 186
Query: 276 TPGYMDPEYVVTQELTEKS-DVYSYGVVLLEI 306
           T  Y  PE +V      K+ DV++ G ++ E+
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++   K  +  E    R+
Sbjct: 18  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK 69
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 70  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 178
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 23/226 (10%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G F  V  A+    G  +AVK +DK  ++        RE+                 
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + G      + R +    + +A++Y H      + H
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMK-EKEARAKFR-QIVSAVQYCH---QKFIVH 129
Query: 233 RDIKSSNILLDENFVAKLADFGLAH----ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++     +K  + C         G+P Y  PE    +
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---------GSPPYAAPELFQGK 180
Query: 289 ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           +    + DV+S GV+L  +V+      DG+NL E  +  +  + R+
Sbjct: 181 KYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRI 225

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRM--DKISEQVEGDFCRE 154
           Q+ SY +TK        +IG G FG VY+A+  D G L+A+K++   K  +  E    R+
Sbjct: 18  QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRK 69
Query: 155 IEXXXXXXXXXXXXXXGFCIEKRERF---LMYEYMANGSLKDHLH-SPGRTPLSWQTRIQ 210
           ++              G   EK++     L+ +Y+     +   H S  +  L       
Sbjct: 70  LDHCNIVRLRYFFYSSG---EKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL 126
Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPV 269
               +  +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A     G    EP 
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG----EP- 178
Query: 270 NTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIV 307
           N     +  Y  PE +    + T   DV+S G VL E++
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 18/229 (7%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG-----DFCREIEXXXXXXXXXXXX 168
           ++G G FGTV+K  +  +G  I +    K+ E   G          +             
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C     + L+ +Y+  GSL DH+    R  L  Q  +   + +A  + YL  +   
Sbjct: 98  LLGLCPGSSLQ-LVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHG-- 153
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            + HR++ + N+LL      ++ADFG+A      D  + +    T I+    +M  E + 
Sbjct: 154 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMALESIH 208
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 335
             + T +SDV+SYGV + E++T       G  L E   +    E RLA+
Sbjct: 209 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLAQ 256

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 92  GPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQV 147
           GPS      S    K +  +F  +IG+G FG V  A+  ++    AVK + K   + ++ 
Sbjct: 28  GPS------SNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE 81
Query: 148 EGDFCREIEXXXXXXXXXXXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQ 206
           E     E                 F  +  ++ + + +Y+  G L  HL    R  L  +
Sbjct: 82  EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPR 140
Query: 207 TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKD 261
            R   A ++A+AL YLH      + +RD+K  NILLD      L DFGL      H S  
Sbjct: 141 ARF-YAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
            + C         GTP Y+ PE +  Q      D +  G VL E++
Sbjct: 197 STFC---------GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXX 162
           + +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI       
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 163 XXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
                        + + +L++E++ +  LK  + +   T +           +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYM 280
           H +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y 
Sbjct: 123 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYXHEVVTLWYR 173
Query: 281 DPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
            PE ++  +  +   D++S G +  E+VT RRA+  G + ++
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEID 214

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 21/201 (10%)
Query: 116 IGQGGFGTVYKAQFSDGSLI-AVKRMDKI---SEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G+G FG VY A+      I A+K + K     E VE    REIE               
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  ++R  +L+ EY   G L   L          Q    I  ++A+AL Y H      + 
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKS--CTFDEQRTATIMEELADALMYCH---GKKVI 145
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HAS--KDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG + HA   +  ++C         GT  Y+ PE +  +
Sbjct: 146 HRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC---------GTLDYLPPEMIEGR 196
Query: 289 ELTEKSDVYSYGVVLLEIVTA 309
              EK D++  GV+  E++  
Sbjct: 197 MHNEKVDLWCIGVLCYELLVG 217

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 25/173 (14%)
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN-----TD 272
            L+Y+H      + HRD+K SN+L++EN   K+ DFG+A       +C  P       T+
Sbjct: 171 GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG-----LCTSPAEHQYFMTE 222
Query: 273 IRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
              T  Y  PE +++  E T+  D++S G +  E++ ARR +  GKN V   Q+ M    
Sbjct: 223 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML-ARRQLFPGKNYVHQLQLIMM--- 278
Query: 332 RLAELVDPRIKDSFDMEQLRTIVTI------VRWCTQREGQARPSIKQVLRIL 378
            +     P +  +   E++R  +        V W T   G  R ++  + R+L
Sbjct: 279 -VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRML 330

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 25/189 (13%)
Query: 202 PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 261
           PL+ +        +   L+Y+H      + HRD+K SN+L++EN   K+ DFG+A     
Sbjct: 154 PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG--- 207
Query: 262 GSICFEPVN-----TDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQD 315
             +C  P       T+   T  Y  PE +++  E T+  D++S G +  E++ ARR +  
Sbjct: 208 --LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML-ARRQLFP 264
Query: 316 GKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTI------VRWCTQREGQARP 369
           GKN V   Q+ M     +     P +  +   E++R  +        V W T   G  R 
Sbjct: 265 GKNYVHQLQLIMM----VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQ 320
Query: 370 SIKQVLRIL 378
           ++  + R+L
Sbjct: 321 ALSLLGRML 329

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 18/229 (7%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG-----DFCREIEXXXXXXXXXXXX 168
           ++G G FGTV+K  +  +G  I +    K+ E   G          +             
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C     + L+ +Y+  GSL DH+    R  L  Q  +   + +A  + YL  +   
Sbjct: 80  LLGLCPGSSLQ-LVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLEEHG-- 135
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            + HR++ + N+LL      ++ADFG+A      D  + +    T I+    +M  E + 
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----WMALESIH 190
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 335
             + T +SDV+SYGV + E++T       G  L E   +    E RLA+
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-RLAQ 238

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 180 FLMYEYMANGSLKDHLHS------PGRTP-------LSWQTRIQIAIDVANALEYLHFYC 226
            ++ E+   G+L  +L S      P +TP       L+ +  I  +  VA  +E+L    
Sbjct: 109 MVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---A 165
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYV 285
                HRD+ + NILL E  V K+ DFGLA    KD     +    D R    +M PE +
Sbjct: 166 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK---GDARLPLKWMAPETI 222
Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 345
             +  T +SDV+S+GV+L EI +   +   G  + E  + C     RL E    R  D  
Sbjct: 223 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYT 276
Query: 346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             E  +T++     C   E   RP+  +++  L
Sbjct: 277 TPEMYQTMLD----CWHGEPSQRPTFSELVEHL 305

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/294 (22%), Positives = 123/294 (41%), Gaps = 27/294 (9%)
Query: 116 IGQGGFGTVYK-AQFSDGSLIAVKRM-DKISEQVEGDFCREIEXXXXXXXX-XXXXXXGF 172
           IG+G +G+V K      G ++AVKR+   + E+ +     +++               G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 173 CIEKRERFLMYEYMANG--SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              + + ++  E M+        +++S     +  +   +I +    AL   H   +  +
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN--HLKENLKI 147
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV----V 286
            HRDIK SNILLD +   KL DFG++     G +      T   G   YM PE +     
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            Q    +SDV+S G+ L E+ T R       ++ +     +  +        P++ +S +
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP-------PQLSNSEE 255
Query: 347 MEQLRTIVTIVRWCTQREGQARPSIKQVLR----ILYESSDPMHSGFVQAVEDE 396
            E   + +  V  C  ++   RP  K++L+    ++YE      + +V  + D+
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQ 309

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 86  LLGICLTSTVQLIM-QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 140
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 196
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI         
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 171
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 205

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 149
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANSFVGTAQYVSPELLT 207
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +  ++ SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 208 EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 264
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 83  LLGICLTSTVQLIM-QLMPFGXLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 137
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 193
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  IG G FG V   +    G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    K+ADFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 83  LLGICLTSTVQLIM-QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 137
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 193
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 15/197 (7%)
Query: 111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIEXXXXXXXXXXXX 168
           +F  ++G G F  V  A+      L+A+K + K + E  EG    EI             
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                      +L+ + ++ G L D +   G       +R+     V +A++YLH   D 
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH---DL 135
Query: 229 PLCHRDIKSSNIL---LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
            + HRD+K  N+L   LDE+    ++DFGL+     GS+      +   GTPGY+ PE +
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-----STACGTPGYVAPEVL 190
Query: 286 VTQELTEKSDVYSYGVV 302
             +  ++  D +S GV+
Sbjct: 191 AQKPYSKAVDCWSIGVI 207

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 83
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 84  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 139
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+DE    ++ DFG A   K  +  +C         G
Sbjct: 140 TFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC---------G 187
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 82  LLGICLTSTVQLIM-QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 84  LLGICLTSTVQLIM-QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 138
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 194
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 108/260 (41%), Gaps = 15/260 (5%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 72
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 73  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 127
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 185
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 242
Query: 347 MEQLRTIVTIVRW-CTQREG 365
           +E+L  +    R  C + EG
Sbjct: 243 VEKLLVLDATKRLGCEEMEG 262

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 85  LLGICLTSTVQLIM-QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 139
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 195
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKR--MDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G VYKA+ S G ++A+KR  +D   E +     REI                  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
             +R   L++E+M    LK  L    +T L      QI I +   L  +       + HR
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDE-NKTGLQ---DSQIKIYLYQLLRGVAHCHQHRILHR 143
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELTE 292
           D+K  N+L++ +   KLADFGLA A     I       ++  T  Y  P+ ++ +++ + 
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVV-TLWYRAPDVLMGSKKYST 199
Query: 293 KSDVYSYGVVLLEIVTAR 310
             D++S G +  E++T +
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 117
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 173
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +         + GTP
Sbjct: 174 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-------LCGTP 223
Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
            Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 108/260 (41%), Gaps = 15/260 (5%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 72  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 126
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 184
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 241
Query: 347 MEQLRTIVTIVRW-CTQREG 365
           +E+L  +    R  C + EG
Sbjct: 242 VEKLLVLDATKRLGCEEMEG 261

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 20/217 (9%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVE 148
           EGP     ++   E  +   +F  ++G G F  V  A+      L+A+K + K + E  E
Sbjct: 6   EGP-----RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE 60
Query: 149 GDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 208
           G    EI                        +L+ + ++ G L D +   G       +R
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL---LDENFVAKLADFGLAHASKDGSIC 265
           +     V +A++YLH   D  + HRD+K  N+L   LDE+    ++DFGL+     GS+ 
Sbjct: 121 L--IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVV 302
                +   GTPGY+ PE +  +  ++  D +S GV+
Sbjct: 176 -----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+   R+D  +E V     REI         
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 172
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 206

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFS-DGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXX 164
           +NF  +  IG+G +G VYKA+    G ++A+   R+D  +E V     REI         
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 165 XXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG--TPGYMDP 282
           +    + HRD+K  N+L++     KLADFGLA A         PV T      T  Y  P
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHEVVTLWYRAP 171
Query: 283 EYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
           E ++  +  +   D++S G +  E+VT RRA+  G
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPG 205

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVKR--MDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G VYKA+ S G ++A+KR  +D   E +     REI                  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
             +R   L++E+M    LK  L    +T L      QI I +   L  +       + HR
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDE-NKTGLQ---DSQIKIYLYQLLRGVAHCHQHRILHR 143
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELTE 292
           D+K  N+L++ +   KLADFGLA A     I       ++  T  Y  P+ ++ +++ + 
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAF---GIPVRSYTHEVV-TLWYRAPDVLMGSKKYST 199
Query: 293 KSDVYSYGVVLLEIVTAR 310
             D++S G +  E++T +
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 20/217 (9%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVE 148
           EGP     ++   E  +   +F  ++G G F  V  A+      L+A+K + K + E  E
Sbjct: 6   EGP-----RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE 60
Query: 149 GDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 208
           G    EI                        +L+ + ++ G L D +   G       +R
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL---LDENFVAKLADFGLAHASKDGSIC 265
           +     V +A++YLH   D  + HRD+K  N+L   LDE+    ++DFGL+     GS+ 
Sbjct: 121 L--IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVV 302
                +   GTPGY+ PE +  +  ++  D +S GV+
Sbjct: 176 -----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 115/273 (42%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 149
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 207
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +  A++ +  E    E   P+ +D   
Sbjct: 208 EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI-IKLEYDFPEKFFPKARDL-- 264
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +         + GTP
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LXGTP 202
Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
            Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 115/273 (42%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 149
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 207
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +  A++ +  E    E   P+ +D   
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI-IKLEYDFPEKFFPKARDL-- 264
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 20/217 (9%)
Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVE 148
           EGP     ++   E  +   +F  ++G G F  V  A+      L+A+K + K + E  E
Sbjct: 6   EGP-----RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE 60
Query: 149 GDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 208
           G    EI                        +L+ + ++ G L D +   G       +R
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL---LDENFVAKLADFGLAHASKDGSIC 265
           +     V +A++YLH   D  + HRD+K  N+L   LDE+    ++DFGL+     GS+ 
Sbjct: 121 L--IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVV 302
                +   GTPGY+ PE +  +  ++  D +S GV+
Sbjct: 176 -----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 70  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 124
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 182
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 239
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 108/260 (41%), Gaps = 15/260 (5%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 125
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 183
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 240
Query: 347 MEQLRTIVTIVRW-CTQREG 365
           +E+L  +    R  C + EG
Sbjct: 241 VEKLLVLDATKRLGCEEMEG 260

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 59/114 (51%), Gaps = 13/114 (11%)
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
           A+EY H +    + HRD+K  N+LLD+N   K+ADFGL++   DG+           G+P
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-----GSP 171
Query: 278 GYMDPEYVVTQELTE--KSDVYSYGVVLLEIVTARRAVQDG--KNLVESAQVCM 327
            Y  PE V+  +L    + DV+S G+VL  ++  R    D    NL +    C+
Sbjct: 172 NYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV 224

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 146
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANSFVGTAQYVSPELLT 204
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 261
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 150
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANSFVGTAQYVSPELLT 208
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 265
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 13/200 (6%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G +G   K +  SDG ++  K +D   ++E  +     E+                 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 173 CIEKRER--FLMYEYMANGSLKDHLH--SPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
            I++     +++ EY   G L   +   +  R  L  +  +++   +  AL+  H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 229 --PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K +N+ LD     KL DFGLA          E    +  GTP YM PE + 
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD----EDFAKEFVGTPYYMSPEQMN 189
Query: 287 TQELTEKSDVYSYGVVLLEI 306
                EKSD++S G +L E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL 209

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 18/126 (14%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA---SKDGSIC 265
           + I I +A A+E+LH      L HRD+K SNI    + V K+ DFGL  A    ++    
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 266 FEPV-----NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA-------RRAV 313
             P+     +    GT  YM PE +     + K D++S G++L E++ +        R +
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII 283
Query: 314 QDGKNL 319
            D +NL
Sbjct: 284 TDVRNL 289

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +         + GTP
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX-------LAGTP 202
Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
            Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 115 IIGQGGFGTVYK-AQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF- 172
           +IG+G    V +    + G   AVK M+  +E++  +   E+               G  
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 173 ----CIEKRER----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                I+  E     FL+++ M  G L D+L    +  LS +    I   +  A+ +LH 
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLH- 217
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                + HRD+K  NILLD+N   +L+DFG +   + G    E     + GTPGY+ PE 
Sbjct: 218 --ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-----LCGTPGYLAPEI 270
Query: 285 V-VTQELT-----EKSDVYSYGVVLLEIVTA 309
           +  + + T     ++ D+++ GV+L  ++  
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 149
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 207
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 264
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 28/269 (10%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 85  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 139
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 195
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +  T +SDV+SYGV + E++T      DG    E + +    E     L  P I  + D
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPIC-TID 250
Query: 347 MEQLRTIVTIVRWCTQREGQARPSIKQVL 375
                 +  I+R C   +  +RP  ++++
Sbjct: 251 ------VYMIMRKCWMIDADSRPKFRELI 273

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 147
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 205
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 262
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 147
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 205
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 262
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 150
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 208
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 209 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 265
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 28/269 (10%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 92  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 146
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 202
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +  T +SDV+SYGV + E++T      DG    E + +    E     L  P I  + D
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPI-CTID 257
Query: 347 MEQLRTIVTIVRWCTQREGQARPSIKQVL 375
                 +  I+R C   +  +RP  ++++
Sbjct: 258 ------VYMIMRKCWMIDADSRPKFRELI 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRIQQ 97
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY   G +  HL   GR   P +     QI +    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 153
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    K+ADFG A   K  +  +C         G
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC---------G 201
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 149
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 207
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 264
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 149
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 207
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 264
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 146
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 204
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 261
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 77  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 131
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 189
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 246
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 247 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 279

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 44/227 (19%)
Query: 116 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVE-GDFCREIEXXXXXXXXXXXX 168
           +G+G FG V KA        +  + +AVK + + +   E  D   E              
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS----------------------PGRTPLSWQ 206
             G C +     L+ EY   GSL+  L                        P    L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 207 TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 266
             I  A  ++  ++YL    +  L HRD+ + NIL+ E    K++DFGL   S+D    +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL---SRD---VY 201
Query: 267 EPVNTDIRGTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVT 308
           E  ++ ++ + G +  +++  + L     T +SDV+S+GV+L EIVT
Sbjct: 202 EE-DSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G +G   K +  SDG ++  K +D   ++E  +     E+                 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 173 CIEKRER--FLMYEYMANGSLKDHLH--SPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
            I++     +++ EY   G L   +   +  R  L  +  +++   +  AL+  H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 229 --PLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYV 285
              + HRD+K +N+ LD     KL DFGLA   + D S     V     GTP YM PE +
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-----GTPYYMSPEQM 188
Query: 286 VTQELTEKSDVYSYGVVLLEI 306
                 EKSD++S G +L E+
Sbjct: 189 NRMSYNEKSDIWSLGCLLYEL 209

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 44/227 (19%)
Query: 116 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVE-GDFCREIEXXXXXXXXXXXX 168
           +G+G FG V KA        +  + +AVK + + +   E  D   E              
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS----------------------PGRTPLSWQ 206
             G C +     L+ EY   GSL+  L                        P    L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 207 TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 266
             I  A  ++  ++YL    +  L HRD+ + NIL+ E    K++DFGL   S+D    +
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGL---SRD---VY 201
Query: 267 EPVNTDIRGTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVT 308
           E  ++ ++ + G +  +++  + L     T +SDV+S+GV+L EIVT
Sbjct: 202 EE-DSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 97
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 153
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 201
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 147
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANAFVGTAQYVSPELLT 205
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 262
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKD 261
           L+ +  I  +  VA  +E+L         HRD+ + NILL E  V K+ DFGLA    KD
Sbjct: 145 LTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
                +    D R    +M PE +  +  T +SDV+S+GV+L EI +   +   G  + E
Sbjct: 202 PDXVRK---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             + C     RL E    R  D    E  +T++     C   E   RP+  +++  L
Sbjct: 259 --EFC----RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 305

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG G +G   K +  SDG ++  K +D   ++E  +     E+                 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 173 CIEKRER--FLMYEYMANGSLKDHLH--SPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
            I++     +++ EY   G L   +   +  R  L  +  +++   +  AL+  H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 229 --PLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYV 285
              + HRD+K +N+ LD     KL DFGLA   + D S     V     GTP YM PE +
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-----GTPYYMSPEQM 188
Query: 286 VTQELTEKSDVYSYGVVLLEI 306
                 EKSD++S G +L E+
Sbjct: 189 NRMSYNEKSDIWSLGCLLYEL 209

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 117
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL---- 173
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 174 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 221
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G +G VYKAQ + G   A+K  R++K  E +     REI                  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
             K+   L++E++     K  L       L   T     + + N + Y H   D  + HR
Sbjct: 70  HTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELTE 292
           D+K  N+L++     K+ADFGLA A     I       +I  T  Y  P+ ++ +++ + 
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180
Query: 293 KSDVYSYGVVLLEIVTA 309
             D++S G +  E+V  
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 91
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 92  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL---- 147
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 148 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 195
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR  F+ Y+       KD L        + +  I  +  VA  +E+L         HRD+
Sbjct: 117 KRNEFVPYKVAPEDLYKDFL--------TLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 236 KSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NILL E  V K+ DFGLA    KD     +    D R    +M PE +  +  T +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRK---GDARLPLKWMAPETIFDRVYTIQS 222
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+GV+L EI +   +   G  + E  + C     RL E    R  D    E  +T++
Sbjct: 223 DVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYTTPEMYQTML 276
Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
                C   E   RP+  +++  L
Sbjct: 277 D----CWHGEPSQRPTFSELVEHL 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR  F+ Y+       KD L        + +  I  +  VA  +E+L         HRD+
Sbjct: 126 KRNEFVPYKVAPEDLYKDFL--------TLEHLICYSFQVAKGMEFL---ASRKCIHRDL 174
Query: 236 KSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NILL E  V K+ DFGLA    KD     +    D R    +M PE +  +  T +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRK---GDARLPLKWMAPETIFDRVYTIQS 231
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+GV+L EI +   +   G  + E  + C     RL E    R  D    E  +T++
Sbjct: 232 DVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYTTPEMYQTML 285
Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
                C   E   RP+  +++  L
Sbjct: 286 D----CWHGEPSQRPTFSELVEHL 305

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+++D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +    G+  A+K +DK  + V+    +EIE          
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKEIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY   G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+++D+    K+ DFGLA   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR  F+ Y+       KD L        + +  I  +  VA  +E+L         HRD+
Sbjct: 117 KRNEFVPYKVAPEDLYKDFL--------TLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 236 KSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NILL E  V K+ DFGLA    KD     +    D R    +M PE +  +  T +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRK---GDARLPLKWMAPETIFDRVYTIQS 222
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+GV+L EI +   +   G  + E  + C     RL E    R  D    E  +T++
Sbjct: 223 DVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYTTPEMYQTML 276
Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
                C   E   RP+  +++  L
Sbjct: 277 D----CWHGEPSQRPTFSELVEHL 296

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 20/134 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +++ EY+A G +  HL   GR   P +     QI +      EYLH      L +RD+K 
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKP 169
Query: 238 SNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            N+L+D+    ++ DFG A   K  +  +C         GTP Y+ PE ++++   +  D
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------GTPEYLAPEIILSKGYNKAVD 220
Query: 296 VYSYGVVLLEIVTA 309
            ++ GV++ E+   
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 114/269 (42%), Gaps = 28/269 (10%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 84  LLGICLTSTVQLIM-QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 138
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFG A    +++     E     I+    +M  E ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK----WMALESIL 194
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +  T +SDV+SYGV + E++T      DG    E + +    E     L  P I  + D
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPIC-TID 249
Query: 347 MEQLRTIVTIVRWCTQREGQARPSIKQVL 375
                 +  I+R C   +  +RP  ++++
Sbjct: 250 ------VYMIMRKCWMIDADSRPKFRELI 272

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 84  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 138
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 194
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 88  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 142
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 198
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 228

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 25/204 (12%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR  F+ Y+       KD L        + +  I  +  VA  +E+L         HRD+
Sbjct: 117 KRNEFVPYKVAPEDLYKDFL--------TLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 236 KSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NILL E  V K+ DFGLA    KD          D R    +M PE +  +  T +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDARLPLKWMAPETIFDRVYTIQS 222
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+GV+L EI +   +   G  + E  + C     RL E    R  D    E  +T++
Sbjct: 223 DVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYTTPEMYQTML 276
Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
                C   E   RP+  +++  L
Sbjct: 277 D----CWHGEPSQRPTFSELVEHL 296

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 11/203 (5%)
Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F TV  A + +     A+K ++K   I E       RE +          
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 98  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 152
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 210
Query: 287 TQELTEKSDVYSYGVVLLEIVTA 309
            +   + SD+++ G ++ ++V  
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAG 233

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 107 LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 161
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 217
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 247

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR  F+ Y+       KD L        + +  I  +  VA  +E+L         HRD+
Sbjct: 163 KRNEFVPYKVAPEDLYKDFL--------TLEHLICYSFQVAKGMEFL---ASRKCIHRDL 211
Query: 236 KSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NILL E  V K+ DFGLA    KD     +    D R    +M PE +  +  T +S
Sbjct: 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRK---GDARLPLKWMAPETIFDRVYTIQS 268
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+GV+L EI +   +   G  + E  + C     RL E    R  D    E  +T++
Sbjct: 269 DVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYTTPEMYQTML 322
Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
                C   E   RP+  +++  L
Sbjct: 323 D----CWHGEPSQRPTFSELVEHL 342

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 25/204 (12%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR  F+ Y+       KD L        + +  I  +  VA  +E+L         HRD+
Sbjct: 117 KRNEFVPYKVAPEDLYKDFL--------TLEHLICYSFQVAKGMEFL---ASRKCIHRDL 165
Query: 236 KSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NILL E  V K+ DFGLA    KD          D R    +M PE +  +  T +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDARLPLKWMAPETIFDRVYTIQS 222
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+GV+L EI +   +   G  + E  + C     RL E    R  D    E  +T++
Sbjct: 223 DVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYTTPEMYQTML 276
Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
                C   E   RP+  +++  L
Sbjct: 277 D----CWHGEPSQRPTFSELVEHL 296

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXX 158
           E ++        IG+G FG V++  +    +    +A+K      S+ V   F +E    
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                       G  I +   +++ E    G L+  L    +  L   + I  A  ++ A
Sbjct: 66  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTA 123
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           L YL         HRDI + N+L+  N   KL DFGL+   +D        +T  + + G
Sbjct: 124 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STXXKASKG 172
Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                +M PE +  +  T  SDV+ +GV + EI+
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 89  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 143
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 199
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR  F+ Y+       KD L        + +  I  +  VA  +E+L         HRD+
Sbjct: 126 KRNEFVPYKVAPEDLYKDFL--------TLEHLICYSFQVAKGMEFL---ASRKCIHRDL 174
Query: 236 KSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NILL E  V K+ DFGLA    KD     +    D R    +M PE +  +  T +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDXVRK---GDARLPLKWMAPETIFDRVYTIQS 231
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+GV+L EI +   +   G  + E  + C     RL E    R  D    E  +T++
Sbjct: 232 DVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYTTPEMYQTML 285
Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
                C   E   RP+  +++  L
Sbjct: 286 D----CWHGEPSQRPTFSELVEHL 305

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 85  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 139
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 195
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 25/204 (12%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR  F+ Y+       KD L        + +  I  +  VA  +E+L         HRD+
Sbjct: 126 KRNEFVPYKVAPEDLYKDFL--------TLEHLICYSFQVAKGMEFL---ASRKCIHRDL 174
Query: 236 KSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NILL E  V K+ DFGLA    KD          D R    +M PE +  +  T +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDARLPLKWMAPETIFDRVYTIQS 231
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+GV+L EI +   +   G  + E  + C     RL E    R  D    E  +T++
Sbjct: 232 DVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYTTPEMYQTML 285
Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
                C   E   RP+  +++  L
Sbjct: 286 D----CWHGEPSQRPTFSELVEHL 305

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G +G VYKAQ + G   A+K  R++K  E +     REI                  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
             K+   L++E++     K  L       L   T     + + N + Y H   D  + HR
Sbjct: 70  HTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELTE 292
           D+K  N+L++     K+ADFGLA A     I       ++  T  Y  P+ ++ +++ + 
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 293 KSDVYSYGVVLLEIVTA 309
             D++S G +  E+V  
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 116 IGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           IG+G +G VYKAQ + G   A+K  R++K  E +     REI                  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
             K+   L++E++     K  L       L   T     + + N + Y H   D  + HR
Sbjct: 70  HTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELTE 292
           D+K  N+L++     K+ADFGLA A     I       ++  T  Y  P+ ++ +++ + 
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAF---GIPVRKYTHEVV-TLWYRAPDVLMGSKKYST 180
Query: 293 KSDVYSYGVVLLEIVTA 309
             D++S G +  E+V  
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGXLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFYCDPPLCHRDIKSS 238
           F+M EY   G L  HL    R  +  + R +    ++ +AL+YLH   +  + +RD+K  
Sbjct: 228 FVM-EYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLE 281
Query: 239 NILLDENFVAKLADFGLAHAS-KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVY 297
           N++LD++   K+ DFGL     KDG+           GTP Y+ PE +   +     D +
Sbjct: 282 NLMLDKDGHIKITDFGLCKEGIKDGATM-----KTFCGTPEYLAPEVLEDNDYGRAVDWW 336
Query: 298 SYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
             GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 337 GLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEIRFPRTLGPEAK 380

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 85  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 139
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 195
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 44/227 (19%)
Query: 116 IGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVE-GDFCREIEXXXXXXXXXXXX 168
           +G+G FG V KA        +  + +AVK + + +   E  D   E              
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS----------------------PGRTPLSWQ 206
             G C +     L+ EY   GSL+  L                        P    L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 207 TRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 266
             I  A  ++  ++YL    +  L HRD+ + NIL+ E    K++DFGL   S+D    +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL---SRD---VY 201
Query: 267 EPVNTDIRGTPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVT 308
           E  ++ ++ + G +  +++  + L     T +SDV+S+GV+L EIVT
Sbjct: 202 EE-DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 18/175 (10%)
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFYCDPPL 230
           F    R  F+M EY   G L  HL    R  +  + R +    ++ +AL+YLH   +  +
Sbjct: 79  FQTHDRLCFVM-EYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNV 132
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RD+K  N++LD++   K+ DFGL     KDG+           GTP Y+ PE +   +
Sbjct: 133 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-----KXFCGTPEYLAPEVLEDND 187
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEIRFPRTLGPEAK 239

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 18/175 (10%)
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFYCDPPL 230
           F    R  F+M EY   G L  HL    R  +  + R +    ++ +AL+YLH   +  +
Sbjct: 217 FQTHDRLCFVM-EYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNV 270
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHAS-KDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RD+K  N++LD++   K+ DFGL     KDG+           GTP Y+ PE +   +
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-----KTFCGTPEYLAPEVLEDND 325
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEIRFPRTLGPEAK 377

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 28/269 (10%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +  T +SDV+SYGV + E++T      DG    E + +    E     L  P I  + D
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPI-CTID 247
Query: 347 MEQLRTIVTIVRWCTQREGQARPSIKQVL 375
                 +  I+R C   +  +RP  ++++
Sbjct: 248 ------VYMIMRKCWMIDADSRPKFRELI 270

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 25/204 (12%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR  F+ Y+       KD L        + +  I  +  VA  +E+L         HRD+
Sbjct: 128 KRNEFVPYKEAPEDLYKDFL--------TLEHLICYSFQVAKGMEFL---ASRKCIHRDL 176
Query: 236 KSSNILLDENFVAKLADFGLAH-ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            + NILL E  V K+ DFGLA    KD          D R    +M PE +  +  T +S
Sbjct: 177 AARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDARLPLKWMAPETIFDRVYTIQS 233
Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIV 354
           DV+S+GV+L EI +   +   G  + E  + C     RL E    R  D    E  +T++
Sbjct: 234 DVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEGTRMRAPDYTTPEMYQTML 287
Query: 355 TIVRWCTQREGQARPSIKQVLRIL 378
                C   E   RP+  +++  L
Sbjct: 288 D----CWHGEPSQRPTFSELVEHL 307

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 18/175 (10%)
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFYCDPPL 230
           F    R  F+M EY   G L  HL    R  +  + R +    ++ +AL+YLH   +  +
Sbjct: 77  FQTHDRLCFVM-EYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNV 130
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHAS-KDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RD+K  N++LD++   K+ DFGL     KDG+           GTP Y+ PE +   +
Sbjct: 131 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-----KXFCGTPEYLAPEVLEDND 185
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEIRFPRTLGPEAK 237

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            F    R  F+M EY   G L  HL S  R     + R   A ++ +ALEYLH      +
Sbjct: 73  AFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYLH---SRDV 126
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RDIK  N++LD++   K+ DFGL      DG+           GTP Y+ PE +   +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-----KTFCGTPEYLAPEVLEDND 181
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIRFPRTLSPEAK 233

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 79  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAEGMNYLE---DR 133
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 189
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 190 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 219

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 76  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 130
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 186
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            F    R  F+M EY   G L  HL S  R     + R   A ++ +ALEYLH      +
Sbjct: 73  AFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYLH---SRDV 126
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RDIK  N++LD++   K+ DFGL      DG+           GTP Y+ PE +   +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-----KXFCGTPEYLAPEVLEDND 181
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIRFPRTLSPEAK 233

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 18/175 (10%)
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI-AIDVANALEYLHFYCDPPL 230
           F    R  F+M EY   G L  HL    R  +  + R +    ++ +AL+YLH   +  +
Sbjct: 78  FQTHDRLCFVM-EYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNV 131
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RD+K  N++LD++   K+ DFGL     KDG+           GTP Y+ PE +   +
Sbjct: 132 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-----KXFCGTPEYLAPEVLEDND 186
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEIRFPRTLGPEAK 238

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            F    R  F+M EY   G L  HL S  R     + R   A ++ +ALEYLH      +
Sbjct: 76  AFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYLH---SRDV 129
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RDIK  N++LD++   K+ DFGL      DG+           GTP Y+ PE +   +
Sbjct: 130 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-----KTFCGTPEYLAPEVLEDND 184
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIRFPRTLSPEAK 236

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ ++   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 136 AVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERF-LMYEYMANGSLKDH 194
           AVK ++K    +     RE+E                  E+ +RF L++E M  GS+  H
Sbjct: 42  AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH 101
Query: 195 LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVA--KLA 251
           +H   R   +      +  DVA+AL++LH   +  + HRD+K  NIL +  N V+  K+ 
Sbjct: 102 IHK--RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKIC 156
Query: 252 DFGLAHASKDGSICFEPVNTDIRGTPG----YMDPEYV--VTQELT---EKSDVYSYGVV 302
           DFGL    K    C  P++T    TP     YM PE V   ++E +   ++ D++S GV+
Sbjct: 157 DFGLGSGIKLNGDC-SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
Query: 303 LLEIVTA 309
           L  +++ 
Sbjct: 216 LYILLSG 222

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            F    R  F+M EY   G L  HL S  R     + R   A ++ +ALEYLH      +
Sbjct: 73  AFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYLH---SRDV 126
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RDIK  N++LD++   K+ DFGL      DG+           GTP Y+ PE +   +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-----KXFCGTPEYLAPEVLEDND 181
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIRFPRTLSPEAK 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 112/273 (41%), Gaps = 19/273 (6%)
Query: 111 NFSTIIGQGGFGT-VYKAQFSDGSLIAVKRMDK---ISEQVEGDFCREIEXXXXXXXXXX 166
            F  I+G+G F T V   + +     A+K ++K   I E       RE +          
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                   +  + +    Y  NG L  ++   G    +  TR   A ++ +ALEYLH   
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIVSALEYLH--- 147
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y+ PE + 
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANXFVGTAQYVSPELLT 205
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +   + SD+++ G ++ ++V      + G   +   Q  +  E    E   P+ +D   
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKLEYDFPEKFFPKARDL-- 262
Query: 347 MEQLRTIVTIVRW-CTQREG----QARPSIKQV 374
           +E+L  +    R  C + EG    +A P  + V
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            F    R  F+M EY   G L  HL S  R     + R   A ++ +ALEYLH      +
Sbjct: 78  AFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYLH---SRDV 131
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RDIK  N++LD++   K+ DFGL      DG+           GTP Y+ PE +   +
Sbjct: 132 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-----KXFCGTPEYLAPEVLEDND 186
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIRFPRTLSPEAK 238

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            F    R  F+M EY   G L  HL S  R     + R   A ++ +ALEYLH      +
Sbjct: 73  AFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYLH---SRDV 126
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RDIK  N++LD++   K+ DFGL      DG+           GTP Y+ PE +   +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-----KXFCGTPEYLAPEVLEDND 181
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIRFPRTLSPEAK 233

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 84  LLGICLTSTVQLIM-QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 138
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFG A    +++     E     I+    +M  E ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK----WMALESIL 194
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 17/177 (9%)
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKD 261
           L+ +  I  +  VA  +E+L         HRD+ + NILL E  V K+ DFGLA    KD
Sbjct: 141 LTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKD 197
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
                +    D R    +M PE +  +  T +SDV+S+GV+L EI +   +   G  + E
Sbjct: 198 PDYVRK---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 254
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                     RL E    R  D    E  +T++     C   E   RP+  +++  L
Sbjct: 255 EFX------RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 301

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            F    R  F+M EY   G L  HL S  R     + R   A ++ +ALEYLH      +
Sbjct: 73  AFQTHDRLCFVM-EYANGGELFFHL-SRERVFTEERARFYGA-EIVSALEYLH---SRDV 126
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            +RDIK  N++LD++   K+ DFGL      DG+           GTP Y+ PE +   +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-----KTFCGTPEYLAPEVLEDND 181
Query: 290 LTEKSDVYSYGVVLLEIVTARRAV--QDGKNLVESAQVCMASESRLAELVDPRIK 342
                D +  GVV+ E++  R     QD + L E   + +  E R    + P  K
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIRFPRTLSPEAK 233

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 22/152 (14%)
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRD+ + NILL    + K+ DFGLA H   D +     V  + R    +M PE +     
Sbjct: 191 HRDLAARNILLTHGRITKICDFGLARHIKNDSNYV---VKGNARLPVKWMAPESIFNCVY 247
Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM--- 347
           T +SDV+SYG+ L E+ +   +   G          M  +S+  ++    IK+ F M   
Sbjct: 248 TFESDVWSYGIFLWELFSLGSSPYPG----------MPVDSKFYKM----IKEGFRMLSP 293
Query: 348 -EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                 +  I++ C   +   RP+ KQ+++++
Sbjct: 294 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++  G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 89  LLGICLTSTVQLIM-QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 143
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 199
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXX 158
           E ++        IG+G FG V++  +    +    +A+K      S+ V   F +E    
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                       G  I +   +++ E    G L+  L    +  L   + I  A  ++ A
Sbjct: 66  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTA 123
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           L YL         HRDI + N+L+  N   KL DFGL+   +D        +T  + + G
Sbjct: 124 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STYYKASKG 172
Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                +M PE +  +  T  SDV+ +GV + EI+
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKD 261
           L+ +  I  +  VA  +E+L         HRD+ + NILL E  V K+ DFGLA    KD
Sbjct: 141 LTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKD 197
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
                +    D R    +M PE +  +  T +SDV+S+GV+L EI +   +   G  + E
Sbjct: 198 PDYVRK---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 254
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             + C     RL E    R  D    E  +T++     C   E   RP+  +++  L
Sbjct: 255 --EFC----RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 301

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 17/177 (9%)
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKD 261
           L+ +  I  +  VA  +E+L         HRD+ + NILL E  V K+ DFGLA    KD
Sbjct: 197 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
                     D R    +M PE +  +  T +SDV+S+GV+L EI +   +   G  + E
Sbjct: 254 PDYV---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 310
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             + C     RL E    R  D    E  +T++     C   E   RP+  +++  L
Sbjct: 311 --EFC----RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 357

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 17/177 (9%)
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKD 261
           L+ +  I  +  VA  +E+L         HRD+ + NILL E  V K+ DFGLA    KD
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
                     D R    +M PE +  +  T +SDV+S+GV+L EI +   +   G  + E
Sbjct: 247 PDYV---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             + C     RL E    R  D    E  +T++     C   E   RP+  +++  L
Sbjct: 304 --EFC----RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 350

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCIEKRERF-------LMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F ++    F       ++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCIEKRERF-------LMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F ++    F       ++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + +M + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 86  LLGICLTSTVQLIM-QLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 140
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFG A    +++     E     I+    +M  E ++
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK----WMALESIL 196
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 17/177 (9%)
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKD 261
           L+ +  I  +  VA  +E+L         HRD+ + NILL E  V K+ DFGLA    KD
Sbjct: 195 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
                     D R    +M PE +  +  T +SDV+S+GV+L EI +   +   G  + E
Sbjct: 252 PDYV---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 308
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             + C     RL E    R  D    E  +T++     C   E   RP+  +++  L
Sbjct: 309 --EFC----RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 355

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 41/200 (20%)
Query: 210 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 269
           +IA+ +  ALE+LH      + HRD+K SN+L++     K+ DFG++     G +     
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDSVA 209
Query: 270 NTDIRGTPGYMDPEYVVTQELTE-----KSDVYSYGVVLLEIVTAR-------RAVQDGK 317
            T   G   YM PE  +  EL +     KSD++S G+ ++E+   R          Q  K
Sbjct: 210 KTIDAGCKPYMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK 268
Query: 318 NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR- 376
            +VE     + ++   AE VD                     C ++  + RP+  ++++ 
Sbjct: 269 QVVEEPSPQLPADKFSAEFVD-----------------FTSQCLKKNSKERPTYPELMQH 311
Query: 377 ---ILYESSDPMHSGFVQAV 393
               L+ES     + FV+ +
Sbjct: 312 PFFTLHESKGTDVASFVKLI 331

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXX 158
           E ++        IG+G FG V++  +    +    +A+K      S+ V   F +E    
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                       G  I +   +++ E    G L+  L    +  L   + I  A  ++ A
Sbjct: 66  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTA 123
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           L YL         HRDI + N+L+  N   KL DFGL+   +D        +T  + + G
Sbjct: 124 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STYYKASKG 172
Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                +M PE +  +  T  SDV+ +GV + EI+
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF---SDGSLIAVKRMD---KISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +    +   I V  M+     S +   +   E              
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 116 LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 170
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 171 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 226
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 227 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 256

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCIEKRERF-------LMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F ++    F       ++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXX 158
           E ++        IG+G FG V++  +    +    +A+K      S+ V   F +E    
Sbjct: 34  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                       G  I +   +++ E    G L+  L    +  L   + I  A  ++ A
Sbjct: 94  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTA 151
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           L YL         HRDI + N+L+  N   KL DFGL+   +D        +T  + + G
Sbjct: 152 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STYYKASKG 200
Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                +M PE +  +  T  SDV+ +GV + EI+
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 17/177 (9%)
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH-ASKD 261
           L+ +  I  +  VA  +E+L         HRD+ + NILL E  V K+ DFGLA    KD
Sbjct: 188 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
                     D R    +M PE +  +  T +SDV+S+GV+L EI +   +   G  + E
Sbjct: 245 PDYV---RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 301
Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             + C     RL E    R  D    E  +T++     C   E   RP+  +++  L
Sbjct: 302 --EFC----RRLKEGTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHL 348

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXX 158
           E ++        IG+G FG V++  +    +    +A+K      S+ V   F +E    
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                       G  I +   +++ E    G L+  L    +  L   + I  A  ++ A
Sbjct: 68  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTA 125
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           L YL         HRDI + N+L+  N   KL DFGL+   +D        +T  + + G
Sbjct: 126 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STYYKASKG 174
Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                +M PE +  +  T  SDV+ +GV + EI+
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    +EIE          
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKEIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY   G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+++D+    ++ DFGLA   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXX 158
           E ++        IG+G FG V++  +    +    +A+K      S+ V   F +E    
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                       G  I +   +++ E    G L+  L    +  L   + I  A  ++ A
Sbjct: 71  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTA 128
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           L YL         HRDI + N+L+  N   KL DFGL+   +D        +T  + + G
Sbjct: 129 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STYYKASKG 177
Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                +M PE +  +  T  SDV+ +GV + EI+
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 14/126 (11%)
Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 240
           L+ E ++ G L D L    +  LS +        + + + YLH      + H D+K  NI
Sbjct: 92  LILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENI 146
Query: 241 -LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
            LLD+N      KL DFGLAH  +DG + F+    +I GTP ++ PE V  + L  ++D+
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDG-VEFK----NIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 297 YSYGVV 302
           +S GV+
Sbjct: 202 WSIGVI 207

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 69/139 (49%), Gaps = 10/139 (7%)
Query: 173 CIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           C +   R F + EY+  G L  H+    + P     R   A +++ AL YLH   +  + 
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNYLH---ERGII 175
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           +RD+K  N+LLD     KL D+G+    K+G    +  +T   GTP Y+ PE +  ++  
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTST-FCGTPNYIAPEILRGEDYG 231
Query: 292 EKSDVYSYGVVLLEIVTAR 310
              D ++ GV++ E++  R
Sbjct: 232 FSVDWWALGVLMFEMMAGR 250

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+ + NILL    + K+ DFGLA   K+ S     V  + R    +M PE +     T
Sbjct: 191 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--VKGNARLPVKWMAPESIFNCVYT 248
Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM---- 347
            +SDV+SYG+ L E+ +   +   G          M  +S+  ++    IK+ F M    
Sbjct: 249 FESDVWSYGIFLWELFSLGSSPYPG----------MPVDSKFYKM----IKEGFRMLSPE 294
Query: 348 EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                +  I++ C   +   RP+ KQ+++++
Sbjct: 295 HAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXX 158
           E ++        IG+G FG V++  +    +    +A+K      S+ V   F +E    
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                       G  I +   +++ E    G L+  L    +  L   + I  A  ++ A
Sbjct: 69  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTA 126
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           L YL         HRDI + N+L+  N   KL DFGL+   +D        +T  + + G
Sbjct: 127 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STYYKASKG 175
Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                +M PE +  +  T  SDV+ +GV + EI+
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXX 158
           E ++        IG+G FG V++  +    +    +A+K      S+ V   F +E    
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                       G  I +   +++ E    G L+  L    +  L   + I  A  ++ A
Sbjct: 63  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTA 120
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           L YL         HRDI + N+L+  N   KL DFGL+   +D        +T  + + G
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STYYKASKG 169
Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                +M PE +  +  T  SDV+ +GV + EI+
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 14/141 (9%)
Query: 173 CIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           C +   R F + EY+  G L  H+    + P     R   A +++ AL YLH   +  + 
Sbjct: 89  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNYLH---ERGII 143
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT--DIRGTPGYMDPEYVVTQE 289
           +RD+K  N+LLD     KL D+G+    K+G     P +T     GTP Y+ PE +  ++
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGMC---KEG---LRPGDTTSXFCGTPNYIAPEILRGED 197
Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
                D ++ GV++ E++  R
Sbjct: 198 YGFSVDWWALGVLMFEMMAGR 218

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +    G+  A+K +DK  + V+    ++IE          
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 97
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 153
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K    ++C         G
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---------G 201
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 14/126 (11%)
Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 240
           L+ E ++ G L D L    +  LS +        + + + YLH      + H D+K  NI
Sbjct: 92  LILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENI 146
Query: 241 -LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
            LLD+N      KL DFGLAH  +DG + F+    +I GTP ++ PE V  + L  ++D+
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDG-VEFK----NIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 297 YSYGVV 302
           +S GV+
Sbjct: 202 WSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 14/126 (11%)
Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 240
           L+ E ++ G L D L    +  LS +        + + + YLH      + H D+K  NI
Sbjct: 92  LILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENI 146
Query: 241 -LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
            LLD+N      KL DFGLAH  +DG + F+    +I GTP ++ PE V  + L  ++D+
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDG-VEFK----NIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 297 YSYGVV 302
           +S GV+
Sbjct: 202 WSIGVI 207

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 14/126 (11%)
Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 240
           L+ E ++ G L D L    +  LS +        + + + YLH      + H D+K  NI
Sbjct: 92  LILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENI 146
Query: 241 -LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
            LLD+N      KL DFGLAH  +DG + F+    +I GTP ++ PE V  + L  ++D+
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDG-VEFK----NIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 297 YSYGVV 302
           +S GV+
Sbjct: 202 WSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 14/126 (11%)
Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 240
           L+ E ++ G L D L    +  LS +        + + + YLH      + H D+K  NI
Sbjct: 92  LILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENI 146
Query: 241 -LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
            LLD+N      KL DFGLAH  +DG + F+    +I GTP ++ PE V  + L  ++D+
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDG-VEFK----NIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 297 YSYGVV 302
           +S GV+
Sbjct: 202 WSIGVI 207

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 14/126 (11%)
Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 240
           L+ E ++ G L D L    +  LS +        + + + YLH      + H D+K  NI
Sbjct: 92  LILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENI 146
Query: 241 -LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
            LLD+N      KL DFGLAH  +DG + F+    +I GTP ++ PE V  + L  ++D+
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHEIEDG-VEFK----NIFGTPEFVAPEIVNYEPLGLEADM 201
Query: 297 YSYGVV 302
           +S GV+
Sbjct: 202 WSIGVI 207

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +    G+  A+K +DK  + V+    ++IE          
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 82
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 83  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 138
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK--DGSICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K    ++C         G
Sbjct: 139 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC---------G 186
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 187 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+ + NILL    + K+ DFGLA   K+ S     V  + R    +M PE +     T
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDS--NYVVKGNARLPVKWMAPESIFNCVYT 225
Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM---- 347
            +SDV+SYG+ L E+ +   +   G          M  +S+  ++    IK+ F M    
Sbjct: 226 FESDVWSYGIFLWELFSLGSSPYPG----------MPVDSKFYKM----IKEGFRMLSPE 271
Query: 348 EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                +  I++ C   +   RP+ KQ+++++
Sbjct: 272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 20/151 (13%)
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+ + NILL    + K+ DFGLA   K+ S     V  + R    +M PE +     T
Sbjct: 186 HRDLAARNILLTHGRITKICDFGLARDIKNDS--NYVVKGNARLPVKWMAPESIFNCVYT 243
Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM---- 347
            +SDV+SYG+ L E+ +   +   G          M  +S+  ++    IK+ F M    
Sbjct: 244 FESDVWSYGIFLWELFSLGSSPYPG----------MPVDSKFYKM----IKEGFRMLSPE 289
Query: 348 EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                +  I++ C   +   RP+ KQ+++++
Sbjct: 290 HAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 320

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ P  ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 97
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 153
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 201
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 14/141 (9%)
Query: 173 CIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           C +   R F + EY+  G L  H+    + P     R   A +++ AL YLH   +  + 
Sbjct: 74  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNYLH---ERGII 128
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT--DIRGTPGYMDPEYVVTQE 289
           +RD+K  N+LLD     KL D+G+    K+G     P +T     GTP Y+ PE +  ++
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGMC---KEG---LRPGDTTSXFCGTPNYIAPEILRGED 182
Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
                D ++ GV++ E++  R
Sbjct: 183 YGFSVDWWALGVLMFEMMAGR 203

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 20/161 (12%)
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 281
           + F       HRD+ + NILL    + K+ DFGLA   K+ S     V  + R    +M 
Sbjct: 174 MAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--VKGNARLPVKWMA 231
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 341
           PE +     T +SDV+SYG+ L E+ +   +   G          M  +S+  ++    I
Sbjct: 232 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG----------MPVDSKFYKM----I 277
Query: 342 KDSFDM----EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           K+ F M         +  I++ C   +   RP+ KQ+++++
Sbjct: 278 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 318

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  ++V     ++IE          
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK--QKVVK--LKQIEHTLNEKRILQ 89
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL---- 145
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 146 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 193
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  ++V     ++IE          
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK--QKVVK--LKQIEHTLNEKRILQ 89
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 145
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 146 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 193
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 97
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 153
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 201
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 14/141 (9%)
Query: 173 CIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           C +   R F + EY+  G L  H+    + P     R   A +++ AL YLH   +  + 
Sbjct: 78  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNYLH---ERGII 132
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT--DIRGTPGYMDPEYVVTQE 289
           +RD+K  N+LLD     KL D+G+    K+G     P +T     GTP Y+ PE +  ++
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMC---KEG---LRPGDTTSXFCGTPNYIAPEILRGED 186
Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
                D ++ GV++ E++  R
Sbjct: 187 YGFSVDWWALGVLMFEMMAGR 207

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 23/202 (11%)
Query: 116 IGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXXXXXXXXXXXXXX 170
           IG+G FG V++  +    +    +A+K      S+ V   F +E                
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G  I +   +++ E    G L+  L    +  L   + I  A  ++ AL YL        
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLE---SKRF 512
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----YMDPEYV 285
            HRDI + N+L+  N   KL DFGL+   +D        +T  + + G     +M PE +
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------STYYKASKGKLPIKWMAPESI 564
Query: 286 VTQELTEKSDVYSYGVVLLEIV 307
             +  T  SDV+ +GV + EI+
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 97
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 153
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 201
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 117
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 173
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 174 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 221
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 114/269 (42%), Gaps = 28/269 (10%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 84  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 138
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFG A    +++     E     I+    +M  E ++
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK----WMALESIL 194
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
            +  T +SDV+SYGV + E++T      DG    E + +    E     L  P I  + D
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----RLPQPPIC-TID 249
Query: 347 MEQLRTIVTIVRWCTQREGQARPSIKQVL 375
                 +  I+R C   +  +RP  ++++
Sbjct: 250 ------VYMIMRKCWMIDADSRPKFRELI 272

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 97
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY   G +  HL   GR   P +     QI +    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 153
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+++D+    K+ DFG A   K  +  +C         G
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---------G 201
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 97
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 153
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 201
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 97
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL---- 153
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 201
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +    G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +    G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +    G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +    G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+  G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP Y+ PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 64/134 (47%), Gaps = 20/134 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +++ EY+  G +  HL   GR   P +     QI +      EYLH      L +RD+K 
Sbjct: 117 YMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKP 169
Query: 238 SNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            N+L+D+    ++ DFG A   K  +  +C         GTP Y+ PE ++++   +  D
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------GTPEYLAPEIILSKGYNKAVD 220
Query: 296 VYSYGVVLLEIVTA 309
            ++ GV++ E+   
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +++ EY   G +  HL   GR   P +     QI +      EYLH      L +RD+K 
Sbjct: 118 YMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKP 170
Query: 238 SNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            N+++D+    K+ DFG A   K  +  +C         GTP Y+ PE ++++   +  D
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---------GTPEYLAPEIILSKGYNKAVD 221
Query: 296 VYSYGVVLLEIVTA 309
            ++ GV++ E+   
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +++ EY   G +  HL   GR   P +     QI +      EYLH      L +RD+K 
Sbjct: 117 YMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKP 169
Query: 238 SNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            N+++D+    K+ DFG A   K  +  +C         GTP Y+ PE ++++   +  D
Sbjct: 170 ENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---------GTPEYLAPEIILSKGYNKAVD 220
Query: 296 VYSYGVVLLEIVTA 309
            ++ GV++ E+   
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +++ EY   G +  HL   GR   P +     QI +      EYLH      L +RD+K 
Sbjct: 117 YMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKP 169
Query: 238 SNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            N+++D+    K+ DFG A   K  +  +C         GTP Y+ PE ++++   +  D
Sbjct: 170 ENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---------GTPEYLAPEIILSKGYNKAVD 220
Query: 296 VYSYGVVLLEIVTA 309
            ++ GV++ E+   
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 113 STIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           S ++G+G +  V  A    +G   AVK ++K +        RE+E               
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 172 FCIEKRERF-LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              E   RF L++E +  GS+  H+    +   + +   ++  DVA AL++LH      +
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQK--QKHFNEREASRVVRDVAAALDFLH---TKGI 132
Query: 231 CHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG----YMDPE 283
            HRD+K  NIL    ++    K+ DF L    K  + C  P+ T    TP     YM PE
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSC-TPITTPELTTPCGSAEYMAPE 191
Query: 284 Y--VVTQELT---EKSDVYSYGVVLLEIVTA 309
              V T + T   ++ D++S GVVL  +++ 
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +++ EY   G +  HL   GR   P +     QI +      EYLH      L +RD+K 
Sbjct: 118 YMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKP 170
Query: 238 SNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            N+++D+    K+ DFG A   K  +  +C         GTP Y+ PE ++++   +  D
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---------GTPEYLAPEIILSKGYNKAVD 221
Query: 296 VYSYGVVLLEIVTA 309
            ++ GV++ E+   
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +++ EY   G +  HL   GR   P +     QI +      EYLH      L +RD+K 
Sbjct: 118 YMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKP 170
Query: 238 SNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            N+++D+    K+ DFG A   K  +  +C         GTP Y+ PE ++++   +  D
Sbjct: 171 ENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---------GTPEYLAPEIILSKGYNKAVD 221
Query: 296 VYSYGVVLLEIVTA 309
            ++ GV++ E+   
Sbjct: 222 WWALGVLIYEMAAG 235

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++  G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 89  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 143
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 199
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFG A    +++     E     I+    +M  E ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++  G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 136
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFGLA    +++     E     I+    +M  E ++
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESIL 192
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/276 (22%), Positives = 110/276 (39%), Gaps = 29/276 (10%)
Query: 73  DKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDG 132
           D+ +  P    +++ ++ E   P   K       +       +IG+G FG V   +  + 
Sbjct: 39  DECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA 98
Query: 133 -SLIAVKRMDK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRER-FLMYEYMAN 188
             + A+K ++K  + ++ E    RE                 +  +     +L+ +Y   
Sbjct: 99  DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158
Query: 189 GSLKDHLHS-----PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD 243
           G L   L       P      +   + IAID  + L Y+H         RDIK  NIL+D
Sbjct: 159 GDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNILMD 209
Query: 244 ENFVAKLADFG-LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE-----KSDVY 297
            N   +LADFG      +DG++     ++   GTP Y+ PE +   E  +     + D +
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTV----QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 298 SYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL 333
           S GV + E++         ++LVE+    M  + R 
Sbjct: 266 SLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERF 300

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           +IG+G +G VYK    D   +AVK     + Q   +F  E                    
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVG 75
Query: 175 EKR-------ERFLMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHF- 224
           ++R       E  L+ EY  NGSL  +L  H+       W +  ++A  V   L YLH  
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHTE 130
Query: 225 -----YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC--FEPVNTDIR--G 275
                +  P + HRD+ S N+L+  +    ++DFGL+       +    E  N  I   G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 276 TPGYMDPEYVV-------TQELTEKSDVYSYGVVLLEI 306
           T  YM PE +         +   ++ D+Y+ G++  EI
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 115 IIGQGGFGTVYKAQF-SDGSLI----AVKRM-DKISEQVEGDFCREIEXXXXXXXXXXXX 168
           ++G G FGTVYK  +  +G  +    A+K + +  S +   +   E              
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
             G C+    + L+ + M  G L D++    +  +  Q  +   + +A  + YL    D 
Sbjct: 89  LLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DR 143
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--ASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            L HRD+ + N+L+      K+ DFG A    +++     E     I+    +M  E ++
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK----WMALESIL 199
Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDG 316
            +  T +SDV+SYGV + E++T      DG
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXX 166
           D F  I  +G G FG V   +  + G+  A+K +DK  + V+    ++IE          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVK---LKQIEHTLNEKRILQ 96
Query: 167 XXXXGFCI-------EKRERFLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVAN 217
                F +       +    +++ EY+A G +  HL   GR   P +     QI +    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL---- 152
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRG 275
             EYLH      L +RD+K  N+L+D+    ++ DFG A   K  +  +C         G
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC---------G 200
Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           TP  + PE ++++   +  D ++ GV++ E+   
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 17/196 (8%)
Query: 112 FSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
           F  ++G G F  V+   Q   G L A+K + K     +     EI               
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
                    +L+ + ++ G L D +   G  T       IQ    V +A++YLH   +  
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ---QVLSAVKYLH---ENG 126
Query: 230 LCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           + HRD+K  N+L    +EN    + DFGL+   ++G      + +   GTPGY+ PE + 
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG------IMSTACGTPGYVAPEVLA 180
Query: 287 TQELTEKSDVYSYGVV 302
            +  ++  D +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVI 196

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 115 IIGQGGFGTV----YKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
           +IG+G FG V    +K+     ++  + + + I       F  E +              
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
               + R  +++ EYM  G L  +L S    P  W  R   A +V  AL+ +H       
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKW-ARFYTA-EVVLALDAIH---SMGF 194
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSI-CFEPVNTDIRGTPGYMDPEYVVTQ 288
            HRD+K  N+LLD++   KLADFG     +K+G + C   V     GTP Y+ PE + +Q
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQ 249
Query: 289 ----ELTEKSDVYSYGVVLLEIVTA 309
                   + D +S GV L E++  
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 115 IIGQGGFGTV----YKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
           +IG+G FG V    +K+     ++  + + + I       F  E +              
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
               + R  +++ EYM  G L  +L S    P  W  R   A +V  AL+ +H       
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKW-ARFYTA-EVVLALDAIH---SMGF 189
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSI-CFEPVNTDIRGTPGYMDPEYVVTQ 288
            HRD+K  N+LLD++   KLADFG     +K+G + C   V     GTP Y+ PE + +Q
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQ 244
Query: 289 ----ELTEKSDVYSYGVVLLEIVTA 309
                   + D +S GV L E++  
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPAFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 65/134 (48%), Gaps = 18/134 (13%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR   ++ E M  G L   +   G    + +   +I  D+  A+++LH +    + HRD+
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDV 154
Query: 236 KSSNILL---DENFVAKLADFGLAHASKDGSI---CFEPVNTDIRGTPGYMDPEYVVTQE 289
           K  N+L    +++ V KL DFG A  +   ++   C+         TP Y+ PE +  ++
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---------TPYYVAPEVLGPEK 205
Query: 290 LTEKSDVYSYGVVL 303
             +  D++S GV++
Sbjct: 206 YDKSCDMWSLGVIM 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 43/201 (21%)
Query: 210 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 269
           +IA+ +  ALE+LH      + HRD+K SN+L++     K+ DFG++    D       V
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD------V 164
Query: 270 NTDI-RGTPGYMDPEYVVTQELTE-----KSDVYSYGVVLLEIVTAR-------RAVQDG 316
             DI  G   YM PE  +  EL +     KSD++S G+ ++E+   R          Q  
Sbjct: 165 AKDIDAGCKPYMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223
Query: 317 KNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
           K +VE     + ++   AE VD                     C ++  + RP+  ++++
Sbjct: 224 KQVVEEPSPQLPADKFSAEFVD-----------------FTSQCLKKNSKERPTYPELMQ 266
Query: 377 ----ILYESSDPMHSGFVQAV 393
                L+ES     + FV+ +
Sbjct: 267 HPFFTLHESKGTDVASFVKLI 287

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 65/134 (48%), Gaps = 18/134 (13%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           KR   ++ E M  G L   +   G    + +   +I  D+  A+++LH +    + HRD+
Sbjct: 79  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDV 135
Query: 236 KSSNILL---DENFVAKLADFGLAHASKDGSI---CFEPVNTDIRGTPGYMDPEYVVTQE 289
           K  N+L    +++ V KL DFG A  +   ++   C+         TP Y+ PE +  ++
Sbjct: 136 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---------TPYYVAPEVLGPEK 186
Query: 290 LTEKSDVYSYGVVL 303
             +  D++S GV++
Sbjct: 187 YDKSCDMWSLGVIM 200

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 115 IIGQGGFGTV----YKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
           +IG+G FG V    +KA     ++  + + + I       F  E +              
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 140
Query: 171 GFCIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
            FC  + +++L  + EYM  G L  +L S    P  W  +   A +V  AL+ +H     
Sbjct: 141 -FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKW-AKFYTA-EVVLALDAIH---SM 193
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR-GTPGYMDPEYVVT 287
            L HRD+K  N+LLD++   KLADFG      +  +    V+ D   GTP Y+ PE + +
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM----VHCDTAVGTPDYISPEVLKS 249
Query: 288 QE----LTEKSDVYSYGVVLLEIVTA 309
           Q        + D +S GV L E++  
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 115 IIGQGGFGTV----YKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
           +IG+G FG V    +K+     ++  + + + I       F  E +              
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
               + R  +++ EYM  G L  +L S    P  W  R   A +V  AL+ +H       
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKW-ARFYTA-EVVLALDAIH---SMGF 194
Query: 231 CHRDIKSSNILLDENFVAKLADFGLA-HASKDGSI-CFEPVNTDIRGTPGYMDPEYVVTQ 288
            HRD+K  N+LLD++   KLADFG     +K+G + C   V     GTP Y+ PE + +Q
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQ 249
Query: 289 ----ELTEKSDVYSYGVVLLEIVTA 309
                   + D +S GV L E++  
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 18/189 (9%)
Query: 118 QGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKR 177
           Q G G  Y A+F     ++  R     E++E    RE+                    K 
Sbjct: 33  QKGTGKEYAAKFIKKRRLSSSRRGVSREEIE----REVNILREIRHPNIITLHDIFENKT 88
Query: 178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +  L+ E ++ G L D L    +  L+     Q    + + + YLH      + H D+K 
Sbjct: 89  DVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKP 143
Query: 238 SNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
            NI LLD+N      KL DFG+AH  + G+        +I GTP ++ PE V  + L  +
Sbjct: 144 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-----KNIFGTPEFVAPEIVNYEPLGLE 198
Query: 294 SDVYSYGVV 302
           +D++S GV+
Sbjct: 199 ADMWSIGVI 207

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 82/189 (43%), Gaps = 18/189 (9%)
Query: 118 QGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKR 177
           Q G G  Y A+F     ++  R     E++E    RE+                    K 
Sbjct: 26  QKGTGKEYAAKFIKKRRLSSSRRGVSREEIE----REVNILREIRHPNIITLHDIFENKT 81
Query: 178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +  L+ E ++ G L D L    +  L+     Q    + + + YLH      + H D+K 
Sbjct: 82  DVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKP 136
Query: 238 SNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
            NI LLD+N      KL DFG+AH  + G+        +I GTP ++ PE V  + L  +
Sbjct: 137 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-----KNIFGTPEFVAPEIVNYEPLGLE 191
Query: 294 SDVYSYGVV 302
           +D++S GV+
Sbjct: 192 ADMWSIGVI 200

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 23/214 (10%)
Query: 104 ETKKATDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXX 158
           E ++        IG+G FG V++  +    +    +A+K      S+ V   F +E    
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 159 XXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
                       G  I +   +++ E    G L+  L    +  L   + I  A  ++ A
Sbjct: 66  RQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTA 123
Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           L YL         HRDI + N+L+      KL DFGL+   +D        +T  + + G
Sbjct: 124 LAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED--------STYYKASKG 172
Query: 279 -----YMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                +M PE +  +  T  SDV+ +GV + EI+
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQ-VEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G G + TVYK    + G  +A+K +   SE+       REI                  
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 174 IEKRERFLMYEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             + +  L++E+M N  LK ++ S   G TP   +  + +       L+ L F  +  + 
Sbjct: 73  HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL-VKYFQWQLLQGLAFCHENKIL 130
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT--DIRGTPGYMDPEYVV-TQ 288
           HRD+K  N+L+++    KL DFGLA A         PVNT      T  Y  P+ ++ ++
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGI------PVNTFSSEVVTLWYRAPDVLMGSR 184
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
             +   D++S G +L E++T +
Sbjct: 185 TYSTSIDIWSCGCILAEMITGK 206

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 18/142 (12%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +L++E M  GS+  H+H   R   +      +  DVA+AL++LH   +  + HRD+K  N
Sbjct: 87  YLVFEKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPEN 141
Query: 240 ILLDE-NFVA--KLADFGLAHASKDGSICFEPVNTDIRGTPG----YMDPEYV--VTQEL 290
           IL +  N V+  K+ DF L    K    C  P++T    TP     YM PE V   ++E 
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDC-SPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 291 T---EKSDVYSYGVVLLEIVTA 309
           +   ++ D++S GV+L  +++ 
Sbjct: 201 SIYDKRCDLWSLGVILYILLSG 222

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 19/211 (9%)
Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGS-LIAVKRMDK---ISEQVEGDFCREIEXXXXXXX 163
           D+F  +  IG+G FG V   Q +D   + A+K M+K   +      +  +E++       
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 164 XXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
                      ++ + F++ + +  G L+ HL          +T      ++  AL+YL 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQ 132
Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
              +  + HRD+K  NILLDE+    + DF +A       +  E   T + GT  YM PE
Sbjct: 133 ---NQRIIHRDMKPDNILLDEHGHVHITDFNIA-----AMLPRETQITTMAGTKPYMAPE 184
Query: 284 YVVTQELTEKS---DVYSYGVVLLEIVTARR 311
              +++    S   D +S GV   E++  RR
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +++ EY   G +  HL   GR   P +     QI +      EYLH      L +RD+K 
Sbjct: 117 YMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKP 169
Query: 238 SNILLDENFVAKLADFGLAHASKDGS--ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
            N+++D+    ++ DFG A   K  +  +C         GTP Y+ PE ++++   +  D
Sbjct: 170 ENLMIDQQGYIQVTDFGFAKRVKGRTWXLC---------GTPEYLAPEIILSKGYNKAVD 220
Query: 296 VYSYGVVLLEIVTA 309
            ++ GV++ E+   
Sbjct: 221 WWALGVLIYEMAAG 234

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 72/128 (56%), Gaps = 15/128 (11%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSW-QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS 238
           ++++E +  G +   +  P   PLS  Q R     D+   +EYLH+     + HRDIK S
Sbjct: 114 YMVFELVNQGPV---MEVPTLKPLSEDQARFYFQ-DLIKGIEYLHY---QKIIHRDIKPS 166
Query: 239 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQEL--TEKSD 295
           N+L+ E+   K+ADFG+++  K GS   + + ++  GTP +M PE +  T+++   +  D
Sbjct: 167 NLLVGEDGHIKIADFGVSNEFK-GS---DALLSNTVGTPAFMAPESLSETRKIFSGKALD 222
Query: 296 VYSYGVVL 303
           V++ GV L
Sbjct: 223 VWAMGVTL 230

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 85  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 139
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 140 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 194
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 195 LEADMWSIGVI 205

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 13/208 (6%)
Query: 116 IGQGGFGTVYKAQFSDG-SLIAVKR--MDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G +GTV+KA+  +   ++A+KR  +D   E V     REI                 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
               ++  L++E+  +  LK +  S     L  +        +   L + H      + H
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RD+K  N+L++ N   KLADFGLA A      C+         T  Y  P+ +   +L  
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYS 180
Query: 293 KS-DVYSYGVVLLEIVTARRAVQDGKNL 319
            S D++S G +  E+  A R +  G ++
Sbjct: 181 TSIDMWSAGCIFAELANAARPLFPGNDV 208

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 85  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 139
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 140 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 194
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 195 LEADMWSIGVI 205

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 85/200 (42%), Gaps = 29/200 (14%)
Query: 181 LMYEYMANGSLKDHLH----SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 236
           L+ E   +G+LK +L        +   SW  +I         L++LH    PP+ HRD+K
Sbjct: 106 LVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFLHTRT-PPIIHRDLK 158
Query: 237 SSNILLDE-NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
             NI +       K+ D GLA   +            + GTP +  PE    ++  E  D
Sbjct: 159 CDNIFITGPTGSVKIGDLGLATLKR------ASFAKAVIGTPEFXAPE-XYEEKYDESVD 211
Query: 296 VYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVT 355
           VY++G   LE  T+     + +N   +AQ+      R+   V P    SFD   +  +  
Sbjct: 212 VYAFGXCXLEXATSEYPYSECQN---AAQI----YRRVTSGVKPA---SFDKVAIPEVKE 261
Query: 356 IVRWCTQREGQARPSIKQVL 375
           I+  C ++    R SIK +L
Sbjct: 262 IIEGCIRQNKDERYSIKDLL 281

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 23/202 (11%)
Query: 116 IGQGGFGTVYKAQF----SDGSLIAVKRMDKI-SEQVEGDFCREIEXXXXXXXXXXXXXX 170
           IG+G FG V++  +    +    +A+K      S+ V   F +E                
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G  I +   +++ E    G L+  L    +  L   + I  A  ++ AL YL        
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLE---SKRF 512
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----YMDPEYV 285
            HRDI + N+L+      KL DFGL+   +D        +T  + + G     +M PE +
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMED--------STYYKASKGKLPIKWMAPESI 564
Query: 286 VTQELTEKSDVYSYGVVLLEIV 307
             +  T  SDV+ +GV + EI+
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL 586

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 116 IGQGGFGTVYKAQFSDGS-LIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IG G FG     +    + L+AVK +++  E++  +  REI                  +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIER-GEKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
                 ++ EY + G L + + + GR   S          + + + Y H      +CHRD
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM---QVCHRD 140
Query: 235 IKSSNILLDENFV--AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           +K  N LLD +     K+ DFG    SK   +  +P +T   GTP Y+ PE ++ +E   
Sbjct: 141 LKLENTLLDGSPAPRLKICDFGY---SKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDG 195
Query: 293 K-SDVYSYGVVLLEIVTARRAVQD 315
           K +DV+S GV L  ++      +D
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 86/212 (40%), Gaps = 22/212 (10%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVKRMD--------KISEQVEGDFCREIE 156
           AT  +  +  IG G +GTVYKA+    G  +A+K +          IS   E    R +E
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 157 XXXXXXXXXXXXXXGFCIEKRE--RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAID 214
                               RE    L++E++ +  L+ +L       L  +T   +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
               L++LH  C   + HRD+K  NIL+      KLADFGLA       +  +PV     
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALDPVVV--- 173
Query: 275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
            T  Y  PE ++        D++S G +  E+
Sbjct: 174 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 81/189 (42%), Gaps = 18/189 (9%)
Query: 118 QGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKR 177
           Q G G  Y A+F     +   R     E++E    RE+                    K 
Sbjct: 47  QKGTGKEYAAKFIKKRRLXSSRRGVSREEIE----REVNILREIRHPNIITLHDIFENKT 102
Query: 178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           +  L+ E ++ G L D L    +  L+     Q    + + + YLH      + H D+K 
Sbjct: 103 DVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKP 157
Query: 238 SNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
            NI LLD+N      KL DFG+AH  + G+        +I GTP ++ PE V  + L  +
Sbjct: 158 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-----KNIFGTPEFVAPEIVNYEPLGLE 212
Query: 294 SDVYSYGVV 302
           +D++S GV+
Sbjct: 213 ADMWSIGVI 221

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 116 IGQGGFGTVYKAQFSDGS----LIAVKRM--DKISE-QVEGDFCREIEXXXXXXXXXXXX 168
           +G G FG V + ++   S     +AVK +  D +S+ +   DF RE+             
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             G  +    + ++ E    GSL D L    G   L   T  + A+ VA  + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE---S 129
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVV 286
               HRD+ + N+LL    + K+ DFGL  A       +  V  + R  P  +  PE + 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLK 187
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
           T+  +  SD + +GV L E+ T
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 116 IGQGGFGTVYKAQFSDGS----LIAVKRM--DKISE-QVEGDFCREIEXXXXXXXXXXXX 168
           +G G FG V + ++   S     +AVK +  D +S+ +   DF RE+             
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             G  +    + ++ E    GSL D L    G   L   T  + A+ VA  + YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE---S 133
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVV 286
               HRD+ + N+LL    + K+ DFGL  A       +  V  + R  P  +  PE + 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLK 191
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
           T+  +  SD + +GV L E+ T
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFT 213

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 26/204 (12%)
Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRM-----DKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           +G+G F TVYKA+  +   ++A+K++      +  + +     REI+             
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 170 XGFCIEKRERFLMYEYMANG---SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                 K    L++++M       +KD+  S   TP   +  + + +     LEYLH + 
Sbjct: 78  LDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTL---QGLEYLHQHW 132
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHA--SKDGSICFEPVNTDIRGTPGYMDPEY 284
              + HRD+K +N+LLDEN V KLADFGLA +  S + +   + V      T  Y  PE 
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV------TRWYRAPEL 183
Query: 285 VVTQELTEKS-DVYSYGVVLLEIV 307
           +    +     D+++ G +L E++
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELL 207

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 116 IGQGGFGTVYKAQFSDGS----LIAVKRM--DKISE-QVEGDFCREIEXXXXXXXXXXXX 168
           +G G FG V + ++   S     +AVK +  D +S+ +   DF RE+             
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             G  +    + ++ E    GSL D L    G   L   T  + A+ VA  + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE---S 129
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVV 286
               HRD+ + N+LL    + K+ DFGL  A       +  V  + R  P  +  PE + 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLK 187
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
           T+  +  SD + +GV L E+ T
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 116 IGQGGFGTVYKAQFSDGS----LIAVKRM--DKISE-QVEGDFCREIEXXXXXXXXXXXX 168
           +G G FG V + ++   S     +AVK +  D +S+ +   DF RE+             
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             G  +    + ++ E    GSL D L    G   L   T  + A+ VA  + YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE---S 139
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVV 286
               HRD+ + N+LL    + K+ DFGL  A       +  V  + R  P  +  PE + 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLK 197
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
           T+  +  SD + +GV L E+ T
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 82/205 (40%), Gaps = 23/205 (11%)
Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMD-----------KISEQVEGDFCREIEXXXXXXX 163
           IG G +GTVYKA+    G  +A+K +             IS   E    R +E       
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 164 XXXXXXXGFCIEKRE--RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
                        RE    L++E++ +  L+ +L       L  +T   +       L++
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 281
           LH  C   + HRD+K  NIL+      KLADFGLA         ++   T +  T  Y  
Sbjct: 136 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-----YQMALTPVVVTLWYRA 187
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEI 306
           PE ++        D++S G +  E+
Sbjct: 188 PEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEG-DFCREIEXXXXXXXXXXXXX 169
             +++G+G +G V  A     G ++A+K+++   + +      REI+             
Sbjct: 15  LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 170 XGFCIEKRERFLMYE--YMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYC 226
             F I++ + F  +   Y+    ++  LH    T +     IQ  I     A++ LH   
Sbjct: 75  --FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH--- 129
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLA----HASKDGSICFEPVN-----TDIRGTP 277
              + HRD+K SN+L++ N   K+ DFGLA     ++ D S   EP       T+   T 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS---EPTGQQSGMTEXVATR 186
Query: 278 GYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            Y  PE ++T  + +   DV+S G +L E+   RR +  G++
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD 227

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 24/222 (10%)
Query: 112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEG-DFCREIEXXXXXXXXXXXXX 169
             +++G+G +G V  A     G ++A+K+++   + +      REI+             
Sbjct: 15  LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 170 XGFCIEKRERFLMYE--YMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYC 226
             F I++ + F  +   Y+    ++  LH    T +     IQ  I     A++ LH   
Sbjct: 75  --FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH--- 129
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLA----HASKDGSICFEPVN-----TDIRGTP 277
              + HRD+K SN+L++ N   K+ DFGLA     ++ D S   EP       T+   T 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS---EPTGQQSGMTEYVATR 186
Query: 278 GYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            Y  PE ++T  + +   DV+S G +L E+   RR +  G++
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD 227

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 17/202 (8%)
Query: 116 IGQGGFGTVYKAQFSDGS----LIAVKRM--DKISE-QVEGDFCREIEXXXXXXXXXXXX 168
           +G G FG V + ++   S     +AVK +  D +S+ +   DF RE+             
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             G  +    + ++ E    GSL D L    G   L   T  + A+ VA  + YL     
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE---S 133
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVV 286
               HRD+ + N+LL    + K+ DFGL  A       +  V  + R  P  +  PE + 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLK 191
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
           T+  +  SD + +GV L E+ T
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFT 213

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 110 DNFST--IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQV-EGDFCREIEXXXXXXXXX 165
           ++FS   IIG+GGFG VY  + +D G + A+K +DK   ++ +G+     E         
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 166 XXXXXGFCIE------KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
                  C+        +  F++ + M  G L  HL   G    S       A ++   L
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGL 305
Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNT 271
           E++H   +  + +RD+K +NILLDE+   +++D GLA        HAS            
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----------- 351
Query: 272 DIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTA----RRAVQDGKNLVESAQVC 326
              GT GYM PE +      + S D +S G +L +++      R+     K+ ++   + 
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408
Query: 327 MASE 330
           MA E
Sbjct: 409 MAVE 412

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 14/131 (10%)
Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           K +  L+ E +A G L D L    +  L+ +   +    + N + YLH      + H D+
Sbjct: 86  KTDVILIGELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDL 140
Query: 236 KSSNI-LLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           K  NI LLD N      K+ DFGLAH      I F     +I GTP ++ PE V  + L 
Sbjct: 141 KPENIMLLDRNVPKPRIKIIDFGLAH-----KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 292 EKSDVYSYGVV 302
            ++D++S GV+
Sbjct: 196 LEADMWSIGVI 206

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 110 DNFST--IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQV-EGDFCREIEXXXXXXXXX 165
           ++FS   IIG+GGFG VY  + +D G + A+K +DK   ++ +G+     E         
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 166 XXXXXGFCIE------KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
                  C+        +  F++ + M  G L  HL   G    S       A ++   L
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGL 304
Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNT 271
           E++H   +  + +RD+K +NILLDE+   +++D GLA        HAS            
Sbjct: 305 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----------- 350
Query: 272 DIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTA----RRAVQDGKNLVESAQVC 326
              GT GYM PE +      + S D +S G +L +++      R+     K+ ++   + 
Sbjct: 351 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 407
Query: 327 MASE 330
           MA E
Sbjct: 408 MAVE 411

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 116 IGQGGFGTVYKAQFSDGS-LIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IG G FG     +    + L+AVK +++  E+++ +  REI                  +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
                 ++ EY + G L + + + GR   S          + + + Y H      +CHRD
Sbjct: 85  TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM---QVCHRD 139
Query: 235 IKSSNILLDENFV--AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           +K  N LLD +     K+ DFG    SK   +  +P +T   GTP Y+ PE ++ +E   
Sbjct: 140 LKLENTLLDGSPAPRLKICDFGY---SKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDG 194
Query: 293 K-SDVYSYGVVLLEIVTARRAVQD 315
           K +DV+S GV L  ++      +D
Sbjct: 195 KVADVWSCGVTLYVMLVGAYPFED 218

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/285 (20%), Positives = 112/285 (39%), Gaps = 39/285 (13%)
Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIA-VKRMDKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           NF T + +   G ++K ++    ++  V ++   S +   DF  E               
Sbjct: 13  NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 170 XGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
            G C         L+  +M  GSL + LH      +     ++ A+D+A  + +LH   +
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM-DPEYVV 286
           P +    + S ++++DE+  A++       +  D    F+        +PG M  P +V 
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARI-------SMADVKFSFQ--------SPGRMYAPAWVA 176
Query: 287 TQELTEK--------SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 338
            + L +K        +D++S+ V+L E+VT      D  N+    +V +     L   + 
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG---LRPTIP 233
Query: 339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD 383
           P I           +  +++ C   +   RP    ++ IL +  D
Sbjct: 234 PGISPH--------VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 85/212 (40%), Gaps = 22/212 (10%)
Query: 108 ATDNFSTI--IGQGGFGTVYKAQFS-DGSLIAVKRMD--------KISEQVEGDFCREIE 156
           AT  +  +  IG G +GTVYKA+    G  +A+K +          IS   E    R +E
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 157 XXXXXXXXXXXXXXGFCIEKRE--RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAID 214
                               RE    L++E++ +  L+ +L       L  +T   +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
               L++LH  C   + HRD+K  NIL+      KLADFGLA       +   PV     
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALAPVVV--- 173
Query: 275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
            T  Y  PE ++        D++S G +  E+
Sbjct: 174 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 80/202 (39%), Gaps = 20/202 (9%)
Query: 116 IGQGGFGTVYKAQFS-DGSLIAVKRMD--------KISEQVEGDFCREIEXXXXXXXXXX 166
           IG G +GTVYKA+    G  +A+K +          IS   E    R +E          
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 167 XXXXGFCIEKRE--RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                     RE    L++E++ +  L+ +L       L  +T   +       L++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
            C   + HRD+K  NIL+      KLADFGLA         F  V T       Y  PE 
Sbjct: 131 NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTL-----WYRAPEV 182
Query: 285 VVTQELTEKSDVYSYGVVLLEI 306
           ++        D++S G +  E+
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEM 204

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 31/210 (14%)
Query: 115 IIGQGGFGTVYKAQ----FSDGSLIAVKRM----------DKISEQVEGDFCREIEXXXX 160
           ++G+GG+G V++ +     + G + A+K +          D    + E +   E++    
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 161 XXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
                     G      + +L+ EY++ G L   L   G       T      +++ AL 
Sbjct: 84  VDLIYAFQTGG------KLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALG 135
Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS-KDGSICFEPVNTDIRGTPGY 279
           +LH      + +RD+K  NI+L+     KL DFGL   S  DG+     V     GT  Y
Sbjct: 136 HLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-----VTHTFCGTIEY 187
Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           M PE ++        D +S G ++ +++T 
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 31/210 (14%)
Query: 115 IIGQGGFGTVYKAQ----FSDGSLIAVKRM----------DKISEQVEGDFCREIEXXXX 160
           ++G+GG+G V++ +     + G + A+K +          D    + E +   E++    
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 161 XXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
                     G      + +L+ EY++ G L   L   G       T      +++ AL 
Sbjct: 84  VDLIYAFQTGG------KLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALG 135
Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS-KDGSICFEPVNTDIRGTPGY 279
           +LH      + +RD+K  NI+L+     KL DFGL   S  DG+     V     GT  Y
Sbjct: 136 HLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-----VTHXFCGTIEY 187
Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           M PE ++        D +S G ++ +++T 
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 110 DNFST--IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQV-EGDFCREIEXXXXXXXXX 165
           ++FS   IIG+GGFG VY  + +D G + A+K +DK   ++ +G+     E         
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 166 XXXXXGFCIE------KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
                  C+        +  F++ + M  G L  HL   G    S       A ++   L
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGL 305
Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNT 271
           E++H   +  + +RD+K +NILLDE+   +++D GLA        HAS            
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----------- 351
Query: 272 DIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTA----RRAVQDGKNLVESAQVC 326
              GT GYM PE +      + S D +S G +L +++      R+     K+ ++   + 
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408
Query: 327 MASE 330
           MA E
Sbjct: 409 MAVE 412

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 110 DNFST--IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQV-EGDFCREIEXXXXXXXXX 165
           ++FS   IIG+GGFG VY  + +D G + A+K +DK   ++ +G+     E         
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 166 XXXXXGFCIE------KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
                  C+        +  F++ + M  G L  HL   G    S       A ++   L
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGL 305
Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNT 271
           E++H   +  + +RD+K +NILLDE+   +++D GLA        HAS            
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----------- 351
Query: 272 DIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTA----RRAVQDGKNLVESAQVC 326
              GT GYM PE +      + S D +S G +L +++      R+     K+ ++   + 
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 408
Query: 327 MASE 330
           MA E
Sbjct: 409 MAVE 412

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 17/202 (8%)
Query: 116 IGQGGFGTVYKAQFSDGS----LIAVKRM--DKISE-QVEGDFCREIEXXXXXXXXXXXX 168
           +G G FG V + ++   S     +AVK +  D +S+ +   DF RE+             
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             G  +    + ++ E    GSL D L    G   L   T  + A+ VA  + YL     
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE---S 129
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVV 286
               HRD+ + N+LL    + K+ DFGL  A          V  + R  P  +  PE + 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--HXVMQEHRKVPFAWCAPESLK 187
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
           T+  +  SD + +GV L E+ T
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT 209

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 106/254 (41%), Gaps = 36/254 (14%)
Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRM-----DKISEQVEGDFCREIEXXXXXXXXXXXXX 169
           IG+G +G V+K +  D G ++A+K+      D + +++     REI              
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA---LREIRMLKQLKHPNLVNL 67
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP------LSWQTRIQIAIDVANALEYLH 223
                 KR   L++EY  +  L +        P      ++WQT           L+ ++
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT-----------LQAVN 116
Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
           F       HRD+K  NIL+ ++ V KL DFG A      S  ++    D   T  Y  PE
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD----DEVATRWYRSPE 172
Query: 284 YVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 342
            +V   +     DV++ G V  E+++    +  GK+ V+   +   +   L +L+ PR +
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKT---LGDLI-PRHQ 227
Query: 343 DSFDMEQLRTIVTI 356
             F   Q  + V I
Sbjct: 228 QVFSTNQYFSGVKI 241

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMXGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 115/272 (42%), Gaps = 28/272 (10%)
Query: 112 FSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCR-EIEXXXXXXXXXXXXX 169
           F   +G G FG V+  +  S G    +K ++K   QV  +    EIE             
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSP---GRTPLSWQTRIQIAIDVANALEYLHFYC 226
                +    +++ E    G L + + S    G+  LS     ++   + NAL Y H   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEGYVAELMKQMMNALAYFH--- 141
Query: 227 DPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
              + H+D+K  NIL  +   +   K+ DFGLA   K      +  +T+  GT  YM PE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-----DEHSTNAAGTALYMAPE 196
Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
            V  +++T K D++S GVV+  ++T       G +L E  Q     E   A    P    
Sbjct: 197 -VFKRDVTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEVQQKATYKEPNYAVECRPLTPQ 254
Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
           + D+  L+ ++T       ++ + RPS  QVL
Sbjct: 255 AVDL--LKQMLT-------KDPERRPSAAQVL 277

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 85/202 (42%), Gaps = 17/202 (8%)
Query: 116 IGQGGFGTVYKAQFSDGS----LIAVKRM--DKISE-QVEGDFCREIEXXXXXXXXXXXX 168
           +G G FG V + ++   S     +AVK +  D +S+ +   DF RE+             
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             G  +    + ++ E    GSL D L    G   L   T  + A+ VA  + YL     
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE---S 139
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP-GYMDPEYVV 286
               HRD+ + N+LL    + K+ DFGL  A          V  + R  P  +  PE + 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--HXVMQEHRKVPFAWCAPESLK 197
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
           T+  +  SD + +GV L E+ T
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMXGTLPYVAPELLKRREFH 185
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 12/202 (5%)
Query: 114 TIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
            ++G+G +G VY  +  S+   IA+K + +   +       EI               G 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSP-GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             E     +  E +  GSL   L S  G    + QT       +   L+YLH   D  + 
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 144
Query: 232 HRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--Q 288
           HRDIK  N+L++  + V K++DFG +      + C E       GT  YM PE +    +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT----GTLQYMAPEIIDKGPR 200
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              + +D++S G  ++E+ T +
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK 222

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 111 NFSTIIGQGGFGT--VYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXX 168
           +F   IG G FG   + + + +   L+AVK +++    ++ +  REI             
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVR 80
Query: 169 XXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                +      ++ EY + G L + + + GR   S          + + + Y H     
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCH---SM 135
Query: 229 PLCHRDIKSSNILLDENFV--AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            +CHRD+K  N LLD +     K+ DFG    SK   +  +P +T   GTP Y+ PE ++
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGY---SKSSVLHSQPKST--VGTPAYIAPEVLL 190
Query: 287 TQELTEK-SDVYSYGVVLLEIVTARRAVQD 315
            QE   K +DV+S GV L  ++      +D
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 104/266 (39%), Gaps = 31/266 (11%)
Query: 84  RSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDGSLI-AVKRM 140
           + + +F E   P  Q    KE +   ++F  I  IG+G FG V   +  +   I A+K +
Sbjct: 50  KYVAEFLEWAKPFTQLV--KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL 107
Query: 141 DK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRER-FLMYEYMANGSLKDHLHS 197
           +K  + ++ E    RE                 +  +     +L+ +Y   G L   L  
Sbjct: 108 NKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSK 167
Query: 198 -----PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD 252
                P      +   + +AID  + L Y+H         RDIK  N+LLD N   +LAD
Sbjct: 168 FEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLAD 218
Query: 253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE-----LTEKSDVYSYGVVLLEIV 307
           FG      D       V     GTP Y+ PE +   E        + D +S GV + E++
Sbjct: 219 FGSCLKMNDDGTVQSSVAV---GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 275
Query: 308 TARRAVQDGKNLVESAQVCMASESRL 333
                    ++LVE+    M  E R 
Sbjct: 276 YGETPFY-AESLVETYGKIMNHEERF 300

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRM--DKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           +IG G FG V++A+  +   +A+K++  DK  +  E    R ++              G 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNG- 105
Query: 173 CIEKRERFL--MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYCDPP 229
             +K E FL  + EY+     +   H            I++ +  +  +L Y+H      
Sbjct: 106 -DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--- 161
Query: 230 LCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-T 287
           +CHRDIK  N+LLD  + V KL DFG A     G    EP N     +  Y  PE +   
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG----EP-NVSXICSRYYRAPELIFGA 216
Query: 288 QELTEKSDVYSYGVVLLEIVTAR 310
              T   D++S G V+ E++  +
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 37/220 (16%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFC----REIEXXXXXXXXXXXXXX 170
           I+G G  GTV       G  +AVKRM         DFC     EI+              
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 92
Query: 171 GFCIEKRERFLMYEY-MANGSLKDHLHSPGRTPLSWQTR-----IQIAIDVANALEYLHF 224
            +C E  +RFL     + N +L+D + S   +  + + +     I +   +A+ + +LH 
Sbjct: 93  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 150
Query: 225 YCDPPLCHRDIKSSNILLD-------------ENFVAKLADFGLAHASKDGSICFEPVNT 271
                + HRD+K  NIL+              EN    ++DFGL      G   F     
Sbjct: 151 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 272 DIRGTPGYMDPEYV---VTQELTEKSDVYSYGVVLLEIVT 308
           +  GT G+  PE +     + LT   D++S G V   I++
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 37/220 (16%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFC----REIEXXXXXXXXXXXXXX 170
           I+G G  GTV       G  +AVKRM         DFC     EI+              
Sbjct: 40  ILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 92
Query: 171 GFCIEKRERFLMYEY-MANGSLKDHLHSPGRTPLSWQTR-----IQIAIDVANALEYLHF 224
            +C E  +RFL     + N +L+D + S   +  + + +     I +   +A+ + +LH 
Sbjct: 93  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 150
Query: 225 YCDPPLCHRDIKSSNILLD-------------ENFVAKLADFGLAHASKDGSICFEPVNT 271
                + HRD+K  NIL+              EN    ++DFGL      G   F     
Sbjct: 151 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 272 DIRGTPGYMDPEYV---VTQELTEKSDVYSYGVVLLEIVT 308
           +  GT G+  PE +     + LT   D++S G V   I++
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 104/266 (39%), Gaps = 31/266 (11%)
Query: 84  RSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDGSLI-AVKRM 140
           + + +F E   P  Q    KE +   ++F  I  IG+G FG V   +  +   I A+K +
Sbjct: 66  KYVAEFLEWAKPFTQLV--KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL 123
Query: 141 DK--ISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRER-FLMYEYMANGSLKDHLHS 197
           +K  + ++ E    RE                 +  +     +L+ +Y   G L   L  
Sbjct: 124 NKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSK 183
Query: 198 -----PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD 252
                P      +   + +AID  + L Y+H         RDIK  N+LLD N   +LAD
Sbjct: 184 FEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLAD 234
Query: 253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE-----LTEKSDVYSYGVVLLEIV 307
           FG      D       V     GTP Y+ PE +   E        + D +S GV + E++
Sbjct: 235 FGSCLKMNDDGTVQSSVAV---GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 291
Query: 308 TARRAVQDGKNLVESAQVCMASESRL 333
                    ++LVE+    M  E R 
Sbjct: 292 YGETPFY-AESLVETYGKIMNHEERF 316

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 116 IGQGGFGTVYK--AQFSDGSLIAVKRMDKISEQVEGDFC---REIEXXXXXXXXXXXXXX 170
           +G+G + TVYK  ++ +D +L+A+K +    E  EG  C   RE+               
Sbjct: 10  LGEGTYATVYKGKSKLTD-NLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
                ++   L++EY+ +  LK +L   G        ++     +   L Y H      +
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCH---RQKV 121
Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQE 289
            HRD+K  N+L++E    KLADFGLA A    SI  +  + ++  T  Y  P+ ++ + +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAK---SIPTKTYDNEVV-TLWYRPPDILLGSTD 177
Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
            + + D++  G +  E+ T R
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVE--GDFCREIEXXXXXXXXXXX 167
           N   ++G+G FG V K +        AVK ++K S + +      RE+E           
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 168 XXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
                  +    +++ E    G L D +    R   S     +I   V + + Y+H +  
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 228 PPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIR---GTPGYMD 281
             + HRD+K  NILL   +++   K+ DFGL       S CF+  NT ++   GT  Y+ 
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGL-------STCFQQ-NTKMKDRIGTAYYIA 191
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           PE V+     EK DV+S GV+L  +++ 
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVE--GDFCREIEXXXXXXXXXXX 167
           N   ++G+G FG V K +        AVK ++K S + +      RE+E           
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 168 XXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
                  +    +++ E    G L D +    R   S     +I   V + + Y+H +  
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 228 PPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIR---GTPGYMD 281
             + HRD+K  NILL   +++   K+ DFGL       S CF+  NT ++   GT  Y+ 
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGL-------STCFQQ-NTKMKDRIGTAYYIA 191
Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVTA 309
           PE V+     EK DV+S GV+L  +++ 
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEG-DFCREIEXXXXXXXXXXXXX 169
             +++G+G +G V  A     G ++A+K+++   + +      REI+             
Sbjct: 15  LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI 74
Query: 170 XGFCIEKRERFLMYE--YMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYC 226
             F I++ + F  +   Y+    ++  LH    T +     IQ  I     A++ LH   
Sbjct: 75  --FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH--- 129
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLA----HASKDGSICFEPVN-----TDIRGTP 277
              + HRD+K SN+L++ N   K+ DFGLA     ++ D S   EP        +   T 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS---EPTGQQSGMVEFVATR 186
Query: 278 GYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            Y  PE ++T  + +   DV+S G +L E+   RR +  G++
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRD 227

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 13/208 (6%)
Query: 116 IGQGGFGTVYKAQFSDG-SLIAVKR--MDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IG+G +GTV+KA+  +   ++A+KR  +D   E V     REI                 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
               ++  L++E+  +  LK +  S     L  +        +   L + H      + H
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RD+K  N+L++ N   KLA+FGLA A      C+         T  Y  P+ +   +L  
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYS 180
Query: 293 KS-DVYSYGVVLLEIVTARRAVQDGKNL 319
            S D++S G +  E+  A R +  G ++
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDV 208

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 12/202 (5%)
Query: 114 TIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
            ++G+G +G VY  +  S+   IA+K + +   +       EI               G 
Sbjct: 14  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 173 CIEKRERFLMYEYMANGSLKDHLHSP-GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             E     +  E +  GSL   L S  G    + QT       +   L+YLH   D  + 
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 130
Query: 232 HRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--Q 288
           HRDIK  N+L++  + V K++DFG +      + C E       GT  YM PE +    +
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT----GTLQYMAPEIIDKGPR 186
Query: 289 ELTEKSDVYSYGVVLLEIVTAR 310
              + +D++S G  ++E+ T +
Sbjct: 187 GYGKAADIWSLGCTIIEMATGK 208

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 23/202 (11%)
Query: 111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVE--GDFCREIEXXXXXXXXXXX 167
           N   ++G+G FG V K +        AVK ++K S + +      RE+E           
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 168 XXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
                  +    +++ E    G L D +    R   S     +I   V + + Y+H +  
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKH-- 140
Query: 228 PPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIR---GTPGYMD 281
             + HRD+K  NILL   +++   K+ DFGL       S CF+  NT ++   GT  Y+ 
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGL-------STCFQQ-NTKMKDRIGTAYYIA 191
Query: 282 PEYVVTQELTEKSDVYSYGVVL 303
           PE V+     EK DV+S GV+L
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVIL 212

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 32  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 91
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 147
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 148 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 190
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 191 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 250
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 251 -GGQVFF------------RQRVSXECQHL------IRWCLALRPSDRPTFEEI 285

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 123/307 (40%), Gaps = 64/307 (20%)
Query: 92  GPSPMFQKFSYKETKKATDNFST--IIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQ 146
           G   +FQ    KE +     +    ++G GGFG+VY   + SD   +A+K +  D+IS+ 
Sbjct: 13  GLEVLFQGPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 72
Query: 147 VEGDFCREIEXXXXXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-G 189
            E      +               G        E+ + F++           ++++   G
Sbjct: 73  GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG 132
Query: 190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVA 248
           +L++ L         WQ        V  A+ + H   +  + HRDIK  NIL+D N    
Sbjct: 133 ALQEEL----ARSFFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL 177
Query: 249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIV 307
           KL DFG       G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V
Sbjct: 178 KLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231
Query: 308 TARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQA 367
                 +  + ++   QV              R + S + + L      +RWC       
Sbjct: 232 CGDIPFEHDEEIIR-GQVFF------------RQRVSXECQHL------IRWCLALRPSD 272
Query: 368 RPSIKQV 374
           RP+ +++
Sbjct: 273 RPTFEEI 279

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 43/227 (18%)
Query: 116 IGQGGFGTVYKA----QFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           IG+G F +VY A    Q      IA+K +   S  +      E++               
Sbjct: 29  IGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIR--IAAELQCLTVAGGQDNVMGVK 86
Query: 172 FCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           +C  K +  ++   Y+ + S  D L+S     LS+Q   +  +++  AL+ +H +    +
Sbjct: 87  YCFRKNDHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQF---GI 138
Query: 231 CHRDIKSSNILLDENFVA-KLADFGLAHASKDGSI-CFEPVNTDIR-------------- 274
            HRD+K SN L +       L DFGLA  + D  I   + V ++ +              
Sbjct: 139 VHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLS 198
Query: 275 ---------GTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTAR 310
                    GTPG+  PE V+T+    T   D++S GV+ L +++ R
Sbjct: 199 RRQQVAPRAGTPGFRAPE-VLTKCPNQTTAIDMWSAGVIFLSLLSGR 244

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 32  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 91
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 147
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 148 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 190
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 191 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 250
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 251 -GGQVFF------------RQRVSXECQHL------IRWCLALRPSDRPTFEEI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 31  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 90
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 146
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 147 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 189
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 190 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 249
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 250 -GGQVFF------------RQRVSXECQHL------IRWCLALRPSDRPTFEEI 284

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRM-DKISEQVEGDFC-REIEXXXXXXXXXXXXXXGF 172
           +G+G +G V+K+     G ++AVK++ D      +     REI                 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 173 CI---EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYCDP 228
            +     R+ +L+++YM        LH+  R  +      Q  +  +   ++YLH     
Sbjct: 77  VLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLH---SG 128
Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAH--------------ASKDGSICF---EPVNT 271
            L HRD+K SNILL+     K+ADFGL+               +  + +  F   +P+ T
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 272 DIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTAR 310
           D   T  Y  PE ++ + + T+  D++S G +L EI+  +
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 11/202 (5%)
Query: 116 IGQGGFGTVYKAQFSDGS-LIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IG G FG     +    + L+AVK +++  E+++ +  REI                  +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
                 ++ EY + G L + + + GR   S          + + + Y H      +CHRD
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM---QVCHRD 140
Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK- 293
           +K  N LLD +   +L      + SK   +  +P   D  GTP Y+ PE ++ +E   K 
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGY-SKSSVLHSQP--KDTVGTPAYIAPEVLLKKEYDGKV 197
Query: 294 SDVYSYGVVLLEIVTARRAVQD 315
           +DV+S GV L  ++      +D
Sbjct: 198 ADVWSCGVTLYVMLVGAYPFED 219

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 13/202 (6%)
Query: 112 FSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDK-ISEQVEGDFCREIEXXXXXXXXXX 166
            + I+G+G FG VY+  +++       +AVK   K  +   +  F  E            
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
               G  IE+   +++ E    G L  +L    +  L   T +  ++ +  A+ YL    
Sbjct: 88  VKLIGI-IEEEPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLE--- 142
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
                HRDI   NIL+      KL DFGL+   +D       V    R    +M PE + 
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT---RLPIKWMSPESIN 199
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
            +  T  SDV+ + V + EI++
Sbjct: 200 FRRFTTASDVWMFAVCMWEILS 221

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 51  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 110
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L       
Sbjct: 111 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARS 166
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 167 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 209
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 210 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 269
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 270 R-GQVFF------------RQRVSXECQHL------IRWCLALRPSDRPTFEEI 304

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMXGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 46  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 105
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 106 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 161
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 162 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 204
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 205 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 264
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 265 R-GQVFF------------RQRVSXECQHL------IRWCLALRPSDRPTFEEI 299

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMXGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 13/202 (6%)
Query: 112 FSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDK-ISEQVEGDFCREIEXXXXXXXXXX 166
            + I+G+G FG VY+  +++       +AVK   K  +   +  F  E            
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
               G  IE+   +++ E    G L  +L    +  L   T +  ++ +  A+ YL    
Sbjct: 72  VKLIGI-IEEEPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLE--- 126
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
                HRDI   NIL+      KL DFGL+   +D       V    R    +M PE + 
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT---RLPIKWMSPESIN 183
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
            +  T  SDV+ + V + EI++
Sbjct: 184 FRRFTTASDVWMFAVCMWEILS 205

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 19  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 78
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 134
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 135 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 177
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 178 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 237
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 238 R-GQVFF------------RQRVSXECQHL------IRWCLALRPSDRPTFEEI 272

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 18  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 77
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 78  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 133
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 134 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 176
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 177 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 236
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 237 R-GQVFF------------RQRVSXECQHL------IRWCLALRPSDRPTFEEI 271

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 31  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 90
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 146
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 147 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 189
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 190 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 249
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 250 -GGQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 284

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 32  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 91
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 147
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 148 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 190
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 191 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 250
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 251 -GGQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 285

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK-DGSICFEPVNTDIRGT 276
            ++YLH   +  + HRD+K  N+ L+++   K+ DFGLA   + DG         D+ GT
Sbjct: 138 GVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-----RKKDLCGT 189
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           P Y+ PE +  +  + + D++S G +L  ++  +
Sbjct: 190 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 13/202 (6%)
Query: 112 FSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDK-ISEQVEGDFCREIEXXXXXXXXXX 166
            + I+G+G FG VY+  +++       +AVK   K  +   +  F  E            
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 167 XXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
               G  IE+   +++ E    G L  +L    +  L   T +  ++ +  A+ YL    
Sbjct: 76  VKLIGI-IEEEPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLE--- 130
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
                HRDI   NIL+      KL DFGL+   +D       V    R    +M PE + 
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT---RLPIKWMSPESIN 187
Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
            +  T  SDV+ + V + EI++
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 31  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 90
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 146
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 147 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 189
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 190 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 249
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 250 -GGQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 284

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK-DGSICFEPVNTDIRGT 276
            ++YLH   +  + HRD+K  N+ L+++   K+ DFGLA   + DG         D+ GT
Sbjct: 154 GVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-----RKKDLCGT 205
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           P Y+ PE +  +  + + D++S G +L  ++  +
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 11/202 (5%)
Query: 116 IGQGGFGTVYKAQFSDGS-LIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IG G FG     +    + L+AVK +++  E+++ +  REI                  +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
                 ++ EY + G L + + + GR   S          + + + Y H      +CHRD
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM---QVCHRD 140
Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK- 293
           +K  N LLD +   +L      + SK   +  +P +T   GTP Y+ PE ++ +E   K 
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGY-SKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKV 197
Query: 294 SDVYSYGVVLLEIVTARRAVQD 315
           +DV+S GV L  ++      +D
Sbjct: 198 ADVWSCGVTLYVMLVGAYPFED 219

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 32  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 91
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 92  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 147
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 148 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 190
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 191 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 250
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 251 -GGQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 285

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 46  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 105
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L       
Sbjct: 106 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARS 161
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 162 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 204
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 205 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 264
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 265 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 299

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 19  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 78
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 134
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 135 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 177
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 178 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 237
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 238 R-GQVFF------------RQRVSXECQHL------IRWCLALRPXDRPTFEEI 272

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 116 IGQGGFGTVYKAQFSDGS-LIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCI 174
           IG G FG     +    + L+AVK +++  E+++ +  REI                  +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGR-----TPLSWQTRIQIAIDVANALEYLHFYCDPP 229
                 ++ EY + G L + + + GR         +Q  I   +  A+A++         
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-GVSYAHAMQ--------- 135
Query: 230 LCHRDIKSSNILLDENFV--AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
           + HRD+K  N LLD +     K+ADFG + AS   S     V     GTP Y+ PE ++ 
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV-----GTPAYIAPEVLLK 190
Query: 288 QELTEK-SDVYSYGVVLLEIVTARRAVQD 315
           +E   K +DV+S GV L  ++      +D
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 18  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 77
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 78  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 133
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 134 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 176
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 177 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 236
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 237 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 271

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 63
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L       
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARS 119
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 120 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 162
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 163 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 222
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 223 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 257

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 38  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L       
Sbjct: 98  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARS 153
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 154 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 196
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 197 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 256
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 257 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 291

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 28/142 (19%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTR--IQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           FL+++ M  G L D+L +   T    +TR  ++  ++V  AL  L+      + HRD+K 
Sbjct: 100 FLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKP 152
Query: 238 SNILLDENFVAKLADFGLAHASKDG----SICFEPVNTDIRGTPGYMDPEYVVTQE---- 289
            NILLD++   KL DFG +     G    S+C         GTP Y+ PE +        
Sbjct: 153 ENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC---------GTPSYLAPEIIECSMNDNH 203
Query: 290 --LTEKSDVYSYGVVLLEIVTA 309
               ++ D++S GV++  ++  
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 58/127 (45%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 145
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +   EP       TP Y+ PE +  ++  +  D+
Sbjct: 146 LLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCY-----TPYYVAPEVLGPEKYDKSCDM 200
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 201 WSLGVIM 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMXGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 31  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 90
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 91  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 146
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 147 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 189
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 190 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 249
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 250 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 284

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 19  KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 78
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 79  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 134
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 135 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 177
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 178 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 237
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 238 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 272

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 125
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 183
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 184 AEPVDVWSCGIVLTAMLAG 202

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 116 IGQGGFGTVYKAQF---SDGSLIAVKRMDKISEQVEGD-FCREIEXXXXXXXXXXXXXXG 171
           +G G FG+V +  +        +A+K + + +E+ + +   RE +              G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
            C  + E  ++   MA G          R  +      ++   V+  ++YL    +    
Sbjct: 78  VC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRD+ + N+LL     AK++DFGL+ A   D S  +    +  +    +  PE +  ++ 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINFRKF 190
Query: 291 TEKSDVYSYGVVLLEIVT 308
           + +SDV+SYGV + E ++
Sbjct: 191 SSRSDVWSYGVTMWEALS 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 185
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 20/138 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTR--IQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           FL+++ M  G L D+L +   T    +TR  ++  ++V  AL  L+      + HRD+K 
Sbjct: 87  FLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKP 139
Query: 238 SNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE------LT 291
            NILLD++   KL DFG +     G    E     + GTP Y+ PE +            
Sbjct: 140 ENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCGTPSYLAPEIIECSMNDNHPGYG 194
Query: 292 EKSDVYSYGVVLLEIVTA 309
           ++ D++S GV++  ++  
Sbjct: 195 KEVDMWSTGVIMYTLLAG 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 20/138 (14%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTR--IQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           FL+++ M  G L D+L +   T    +TR  ++  ++V  AL  L+      + HRD+K 
Sbjct: 100 FLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKP 152
Query: 238 SNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE------LT 291
            NILLD++   KL DFG +     G    E     + GTP Y+ PE +            
Sbjct: 153 ENILLDDDMNIKLTDFGFSCQLDPGEKLRE-----VCGTPSYLAPEIIECSMNDNHPGYG 207
Query: 292 EKSDVYSYGVVLLEIVTA 309
           ++ D++S GV++  ++  
Sbjct: 208 KEVDMWSTGVIMYTLLAG 225

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 41/224 (18%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFC----REIEXXXXXXXXXXXXXX 170
           I+G G  GTV       G  +AVKRM         DFC     EI+              
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 171 GFCIEKRERFLMYEY-MANGSLKDHLHSPGRTPLSWQTR-----IQIAIDVANALEYLHF 224
            +C E  +RFL     + N +L+D + S   +  + + +     I +   +A+ + +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132
Query: 225 YCDPPLCHRDIKSSNILLD-------------ENFVAKLADFGLAHASKDGSICFEPVNT 271
                + HRD+K  NIL+              EN    ++DFGL      G   F     
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 272 DIRGTPGYMDPEYV-------VTQELTEKSDVYSYGVVLLEIVT 308
           +  GT G+  PE +         + LT   D++S G V   I++
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 185
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 185
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 185
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 63
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 119
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 120 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 162
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 163 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 222
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 223 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 257

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 185
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 4/100 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 472 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 527
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             T  +    +  PE +   + + KSDV+S+GV++ E  +
Sbjct: 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 62
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 118
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 119 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 161
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 162 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 221
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 222 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 256

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 4   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 63
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L    R+ 
Sbjct: 64  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---ARS- 119
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 120 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 162
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 163 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 222
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 223 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 257

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI---GIT 127
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 185
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 4/100 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 473 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 528
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             T  +    +  PE +   + + KSDV+S+GV++ E  +
Sbjct: 529 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYCDPPLCHRDIKSSN 239
           L+ +Y+  G L  HL    R     +  +QI + ++  ALE+LH      + +RDIK  N
Sbjct: 136 LILDYINGGELFTHLSQRERFT---EHEVQIYVGEIVLALEHLH---KLGIIYRDIKLEN 189
Query: 240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL--TEKSDVY 297
           ILLD N    L DFGL   SK+          D  GT  YM P+ V   +    +  D +
Sbjct: 190 ILLDSNGHVVLTDFGL---SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWW 246
Query: 298 SYGVVLLEIVTA 309
           S GV++ E++T 
Sbjct: 247 SLGVLMYELLTG 258

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 41/224 (18%)
Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFC----REIEXXXXXXXXXXXXXX 170
           I+G G  GTV       G  +AVKRM         DFC     EI+              
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 171 GFCIEKRERFLMYEY-MANGSLKDHLHSPGRTPLSWQTR-----IQIAIDVANALEYLHF 224
            +C E  +RFL     + N +L+D + S   +  + + +     I +   +A+ + +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132
Query: 225 YCDPPLCHRDIKSSNILLD-------------ENFVAKLADFGLAHASKDGSICFEPVNT 271
                + HRD+K  NIL+              EN    ++DFGL      G   F     
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 272 DIRGTPGYMDPEYV-------VTQELTEKSDVYSYGVVLLEIVT 308
           +  GT G+  PE +         + LT   D++S G V   I++
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 62
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L       
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEEL----ARS 118
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 119 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 161
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 162 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 221
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 222 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 256

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI---GIT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI---GIT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI---GIT 127
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 185
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 186 AEPVDVWSCGIVLTAMLAG 204

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/151 (22%), Positives = 69/151 (45%), Gaps = 27/151 (17%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPEY 284
           + HRD+K  N+ L+E+   K+ DFGLA        +  ++C         GTP Y+ PE 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---------GTPNYIAPEV 188
Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 344
           +  +  + + DV+S G ++  ++  +   +    L E+      +E  + + ++P     
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEYSIPKHINP----- 242
Query: 345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
                     ++++   Q +  ARP+I ++L
Sbjct: 243 -------VAASLIQKMLQTDPTARPTINELL 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI---GIT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 14/199 (7%)
Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMD-KISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           +G+G +G V  A        +AVK +D K +     +  +EI               G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLC 231
            E   ++L  EY + G L D +      P     R   Q+   V     YLH      + 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI---GIT 126
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFH 184
Query: 291 TEKSDVYSYGVVLLEIVTA 309
            E  DV+S G+VL  ++  
Sbjct: 185 AEPVDVWSCGIVLTAMLAG 203

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 70/151 (46%), Gaps = 27/151 (17%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLA-HASKDG----SICFEPVNTDIRGTPGYMDPEY 284
           + HRD+K  N+ L+E+   K+ DFGLA     DG    ++C         GTP Y+ PE 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---------GTPNYIAPEV 188
Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 344
           +  +  + + DV+S G ++  ++  +   +    L E+      +E  + + ++P     
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEYSIPKHINP----- 242
Query: 345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
                     ++++   Q +  ARP+I ++L
Sbjct: 243 -------VAASLIQKMLQTDPTARPTINELL 266

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 115 IIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEG--DFCREIEXXXXXXXXXXXXXXG 171
           +IG+G +G VY A   +    +A+K+++++ E +       REI                
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 172 FCI-----EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
             I     +  E +++ E +A+  LK    +P      + T   I   + N L   +F  
Sbjct: 93  LIIPDDLLKFDELYIVLE-IADSDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH 146
Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLA---HASKDGSICFE--------PVNTDIRG 275
           +  + HRD+K +N LL+++   K+ DFGLA   ++ KD +I  +        P N +++ 
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 276 -------TPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRA 312
                  T  Y  PE ++ QE   KS D++S G +  E++   ++
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/151 (22%), Positives = 69/151 (45%), Gaps = 27/151 (17%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPEY 284
           + HRD+K  N+ L+E+   K+ DFGLA        +  ++C         GTP Y+ PE 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---------GTPNYIAPEV 192
Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 344
           +  +  + + DV+S G ++  ++  +   +    L E+      +E  + + ++P     
Sbjct: 193 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEYSIPKHINP----- 246
Query: 345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
                     ++++   Q +  ARP+I ++L
Sbjct: 247 -------VAASLIQKMLQTDPTARPTINELL 270

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 62/282 (21%)
Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +               G
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 172 FC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAID 214
                   E+ + F++           ++++   G+L++ L         WQ        
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-------- 118
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDI 273
           V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       G++  + V TD 
Sbjct: 119 VLEAVRHCH---NXGVLHRDIKDENILIDLNRGELKLIDFG------SGALLKDTVYTDF 169
Query: 274 RGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
            GT  Y  PE++       +S  V+S G++L ++V      +  + ++   QV       
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFF----- 223
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
                  R + S + + L      +RWC       RP+ +++
Sbjct: 224 -------RQRVSXECQHL------IRWCLALRPSDRPTFEEI 252

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/198 (22%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 116 IGQGGFGTVYKAQF---SDGSLIAVKRMDKISEQVEGD-FCREIEXXXXXXXXXXXXXXG 171
           +G G FG+V +  +        +A+K + + +E+ + +   RE +              G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
            C  + E  ++   MA G          R  +      ++   V+  ++YL    +    
Sbjct: 404 VC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HR++ + N+LL     AK++DFGL+ A   D S  +    +  +    +  PE +  ++ 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGKWPLKWYAPECINFRKF 516
Query: 291 TEKSDVYSYGVVLLEIVT 308
           + +SDV+SYGV + E ++
Sbjct: 517 SSRSDVWSYGVTMWEALS 534

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 62/294 (21%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXX 159
           KE  ++      ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +    
Sbjct: 2   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 61
Query: 160 XXXXXXXXXXXGFC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTP 202
                      G        E+ + F++           ++++   G+L++ L       
Sbjct: 62  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARS 117
Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKD 261
             WQ        V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       
Sbjct: 118 FFWQ--------VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------S 160
Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLV 320
           G++  + V TD  GT  Y  PE++       +S  V+S G++L ++V      +  + ++
Sbjct: 161 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII 220
Query: 321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
              QV              R + S + + L      +RWC       RP+ +++
Sbjct: 221 R-GQVFF------------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 255

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 14/141 (9%)
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           F  +KR  +L+ E    G L D +    R   +      I   V + + YLH +    + 
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIV 158
Query: 232 HRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRD+K  N+LL   +++ + K+ DFGL+   ++     E +     GT  Y+ PE V+ +
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-----GTAYYIAPE-VLRK 212
Query: 289 ELTEKSDVYSYGVVLLEIVTA 309
           +  EK DV+S GV+L  ++  
Sbjct: 213 KYDEKCDVWSIGVILFILLAG 233

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 114 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK- 169
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
             T  +    +  PE +   + + KSDV+S+GV++ E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 19/147 (12%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           + HRD+K  N+ L+E+   K+ DFGLA     DG          + GTP Y+ PE +  +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPNYIAPEVLSKK 216
Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
             + + DV+S G ++  ++  +   +    L E+      +E  + + ++P         
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEYSIPKHINP--------- 266
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVL 375
                 ++++   Q +  ARP+I ++L
Sbjct: 267 ---VAASLIQKMLQTDPTARPTINELL 290

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 128 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 183
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
             T  +    +  PE +   + + KSDV+S+GV++ E
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 17/197 (8%)
Query: 112 FSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKIS-EQVEGDFCREIEXXXXXXXXXXXXX 169
           F   +G G F  V  A+  + G L AVK + K + +  E     EI              
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                     +L+ + ++ G L D +   G  T     T I+  +D   A+ YLH     
Sbjct: 86  EDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD---AVYYLH---RM 139
Query: 229 PLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
            + HRD+K  N+L    DE     ++DFGL+     G      V +   GTPGY+ PE +
Sbjct: 140 GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD-----VMSTACGTPGYVAPEVL 194
Query: 286 VTQELTEKSDVYSYGVV 302
             +  ++  D +S GV+
Sbjct: 195 AQKPYSKAVDCWSIGVI 211

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 63/134 (47%), Gaps = 12/134 (8%)
Query: 179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLCHRDIK 236
           ++L  EY + G L D +      P     R   Q+   V     YLH      + HRDIK
Sbjct: 79  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---ITHRDIK 131
Query: 237 SSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-TEKSD 295
             N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +  +E   E  D
Sbjct: 132 PENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 296 VYSYGVVLLEIVTA 309
           V+S G+VL  ++  
Sbjct: 190 VWSCGIVLTAMLAG 203

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 114 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 169
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
             T  +    +  PE +   + + KSDV+S+GV++ E
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 38/238 (15%)
Query: 107 KATDNFST--IIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEG--DFCREIEXXXXX 161
           K  DN+    +IG+G +G VY A   + +  +A+K+++++ E +       REI      
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 162 XXXXXXXXXGFCIEKR-----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 216
                       I +      E +++ E +A+  LK    +P      + T   +   + 
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTP-----IFLTEQHVKTILY 138
Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA---HASKDGSICFE------ 267
           N L    F  +  + HRD+K +N LL+++   K+ DFGLA   ++ KD  I  +      
Sbjct: 139 NLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEE 198
Query: 268 -----PVNTDIRG-------TPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRA 312
                P N +++        T  Y  PE ++ QE  T   D++S G +  E++   ++
Sbjct: 199 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 108 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 163
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
             T  +    +  PE +   + + KSDV+S+GV++ E
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 200

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 120 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 175
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
             T  +    +  PE +   + + KSDV+S+GV++ E
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 22/142 (15%)
Query: 210 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV 269
           +IA+ +  ALE+LH      + HRD+K SN+L++     K  DFG++    D       V
Sbjct: 140 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD------V 191
Query: 270 NTDI-RGTPGYMDPEYVVTQELTE-----KSDVYSYGVVLLEIVTAR-------RAVQDG 316
             DI  G   Y  PE  +  EL +     KSD++S G+  +E+   R          Q  
Sbjct: 192 AKDIDAGCKPYXAPER-INPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQL 250
Query: 317 KNLVESAQVCMASESRLAELVD 338
           K +VE     + ++   AE VD
Sbjct: 251 KQVVEEPSPQLPADKFSAEFVD 272

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 110 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 165
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
             T  +    +  PE +   + + KSDV+S+GV++ E
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 46/288 (15%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVK-----RMDKISEQVEGDFCREIE 156
           +E  +A      ++G+GGFGTV+   + +D   +A+K     R+   S   +   C  +E
Sbjct: 26  REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC-PLE 84
Query: 157 XXXXXXXXXXXXXXGFC-----IEKRERFLMY--EYMANGSLKDHLHSPGRTPLSWQTRI 209
                         G        E +E F++     +    L D++   G  PL      
Sbjct: 85  VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSR 142
Query: 210 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEP 268
                V  A+++ H      + HRDIK  NIL+D     AKL DFG       G++  + 
Sbjct: 143 CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFG------SGALLHDE 193
Query: 269 VNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 327
             TD  GT  Y  PE++   +     + V+S G++L ++V        G    E  Q  +
Sbjct: 194 PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC-------GDIPFERDQEIL 246
Query: 328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVL 375
            +E      V P                ++R C   +  +RPS++++L
Sbjct: 247 EAELHFPAHVSP------------DCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 83/196 (42%), Gaps = 20/196 (10%)
Query: 116 IGQGGFGTVY----KAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           +G G +G V     K   ++ ++  +K+    +    G    E+                
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           F  +KR  +L+ E    G L D +    R   S      I   V +   YLH +    + 
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIIL--RQKFSEVDAAVIMKQVLSGTTYLHKH---NIV 143
Query: 232 HRDIKSSNILLDE---NFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
           HRD+K  N+LL+    + + K+ DFGL AH    G +       +  GT  Y+ PE V+ 
Sbjct: 144 HRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM------KERLGTAYYIAPE-VLR 196
Query: 288 QELTEKSDVYSYGVVL 303
           ++  EK DV+S GV+L
Sbjct: 197 KKYDEKCDVWSCGVIL 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 130 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 185
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
             T  +    +  PE +   + + KSDV+S+GV++ E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           I++   V+  ++YL    +    HRD+ + N+LL     AK++DFGL+ A +     ++ 
Sbjct: 130 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 185
Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
             T  +    +  PE +   + + KSDV+S+GV++ E
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 19/147 (12%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           + HRD+K  N+ L+E+   K+ DFGLA     DG          + GTP Y+ PE +  +
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPNYIAPEVLSKK 214
Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
             + + DV+S G ++  ++  +   +    L E+      +E  + + ++P         
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEYSIPKHINP--------- 264
Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVL 375
                 ++++   Q +  ARP+I ++L
Sbjct: 265 ---VAASLIQKMLQTDPTARPTINELL 288

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 126/303 (41%), Gaps = 36/303 (11%)
Query: 115 IIGQGGFGT-VYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFC 173
           ++G G  GT VY+  F D   +AVKR   I  +      RE++               FC
Sbjct: 31  VLGHGAEGTIVYRGMF-DNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVIRY-FC 85
Query: 174 IEKRERFLMYEYMA----NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            EK  +F   +Y+A      +L++++       L  +  I +     + L +LH      
Sbjct: 86  TEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLH---SLN 138
Query: 230 LCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
           + HRD+K  NIL+          A ++DFGL      G   F    + + GT G++ PE 
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR-RSGVPGTEGWIAPEM 197
Query: 285 V---VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 341
           +     +  T   D++S G V   +++   +   GK+L   A + + + S L  L   + 
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVIS-EGSHPFGKSLQRQANILLGACS-LDCLHPEKH 255
Query: 342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQAVEDE-EYEE 400
           +D    E +  ++ +       + Q RPS K VL+  +  S      F Q V D  E E 
Sbjct: 256 EDVIARELIEKMIAM-------DPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKES 308
Query: 401 TDG 403
            DG
Sbjct: 309 LDG 311

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 62/282 (21%)
Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +               G
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 172 FC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAID 214
                   E+ + F++           ++++   G+L++ L         WQ        
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-------- 118
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDI 273
           V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       G++  + V TD 
Sbjct: 119 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------SGALLKDTVYTDF 169
Query: 274 RGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
            GT  Y  PE++       +S  V+S G++L ++V      +  + ++   QV       
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-GGQVFF----- 223
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
                  R + S + + L      +RWC       RP+ +++
Sbjct: 224 -------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 252

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 161
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 162 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 216
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 217 WSLGVIM 223

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 50/98 (51%), Gaps = 17/98 (17%)
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTD 272
            ++YLH   +  + HRD+K  N+ L+++   K+ DFGLA        +  ++C       
Sbjct: 154 GVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC------- 203
Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
             GTP Y+ PE +  +  + + D++S G +L  ++  +
Sbjct: 204 --GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 191
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 246
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 247 WSLGVIM 253

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 62/282 (21%)
Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRM--DKISEQVEGDFCREIEXXXXXXXXXXXXXXG 171
           ++G GGFG+VY   + SD   +A+K +  D+IS+  E      +               G
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 172 FC-----IEKRERFLM-----------YEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAID 214
                   E+ + F++           ++++   G+L++ L         WQ        
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQ-------- 118
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDI 273
           V  A+ + H   +  + HRDIK  NIL+D N    KL DFG       G++  + V TD 
Sbjct: 119 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG------SGALLKDTVYTDF 169
Query: 274 RGTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR 332
            GT  Y  PE++       +S  V+S G++L ++V      +  + ++   QV       
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFF----- 223
Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
                  R + S + + L      +RWC       RP+ +++
Sbjct: 224 -------RQRVSSECQHL------IRWCLALRPSDRPTFEEI 252

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 67/145 (46%), Gaps = 19/145 (13%)
Query: 232 HRDIKSSNILLDENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           HRD+K  N+ L+E+   K+ DFGLA     DG          + GTP Y+ PE +  +  
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPNYIAPEVLSKKGH 192
Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 350
           + + DV+S G ++  ++  +   +    L E+      +E  + + ++P           
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEYSIPKHINP----------- 240
Query: 351 RTIVTIVRWCTQREGQARPSIKQVL 375
               ++++   Q +  ARP+I ++L
Sbjct: 241 -VAASLIQKMLQTDPTARPTINELL 264

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 151
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 152 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 206
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 207 WSLGVIM 213

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 77/193 (39%), Gaps = 25/193 (12%)
Query: 103 KETKKATDNFST--IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC--REIEX 157
           KE +   D+F    +IG+G F  V   +    G + A+K M+K      G+    RE   
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 158 XXXXXXXXXXXXXGFCIEKRER-FLMYEYMANGSLKDHLHSPG-RTPLS----WQTRIQI 211
                         F  +     +L+ EY   G L   L   G R P      +   I +
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM 173
Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG-LAHASKDGSICFEPVN 270
           AID  + L Y+H         RDIK  NILLD     +LADFG       DG++     +
Sbjct: 174 AIDSVHRLGYVH---------RDIKPDNILLDRCGHIRLADFGSCLKLRADGTV----RS 220
Query: 271 TDIRGTPGYMDPE 283
               GTP Y+ PE
Sbjct: 221 LVAVGTPDYLSPE 233

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 65/135 (48%), Gaps = 14/135 (10%)
Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           F  +KR  +L+ E    G L D +    R   S      I   V +   YLH +    + 
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEI--ILRQKFSEVDAAVIMKQVLSGTTYLHKH---NIV 126
Query: 232 HRDIKSSNILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRD+K  N+LL+    + + K+ DFGL+   + G    E +     GT  Y+ PE V+ +
Sbjct: 127 HRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-----GTAYYIAPE-VLRK 180
Query: 289 ELTEKSDVYSYGVVL 303
           +  EK DV+S GV+L
Sbjct: 181 KYDEKCDVWSCGVIL 195

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 153
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 154 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 208
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 209 WSLGVIM 215

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 197
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 198 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 252
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 253 WSLGVIM 259

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 147
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 148 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 202
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 203 WSLGVIM 209

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 152
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 153 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 207
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 208 WSLGVIM 214

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 147
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 148 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 202
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 203 WSLGVIM 209

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 146
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 147 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 201
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 202 WSLGVIM 208

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 57/127 (44%), Gaps = 11/127 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 145
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P  T     P Y+ PE +  ++  +  D+
Sbjct: 146 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVLGPEKYDKSCDM 200
Query: 297 YSYGVVL 303
           +S GV++
Sbjct: 201 WSLGVIM 207

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 21/203 (10%)
Query: 116 IGQGGFGTVYKAQ--FSDGSLIAVKRMD--------KISEQVEGDFCREIEXXXXXXXXX 165
           IG+G +G V+KA+   + G  +A+KR+          +S   E    R +E         
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 166 XXXXXGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
                      RE    L++E++ +  L  +L       +  +T   +   +   L++LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
            +    + HRD+K  NIL+  +   KLADFGLA         F+   T +  T  Y  PE
Sbjct: 138 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWYRAPE 189
Query: 284 YVVTQELTEKSDVYSYGVVLLEI 306
            ++        D++S G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 92/229 (40%), Gaps = 30/229 (13%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRM-DKISEQVEGDFCREI 155
           KE   +   F   +G+  FG VYK              +A+K + DK    +  +F  E 
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 80
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHL--HSPG------------RT 201
                          G   + +   +++ Y ++G L + L   SP             ++
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 202 PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--S 259
            L     + +   +A  +EYL  +    + H+D+ + N+L+ +    K++D GL     +
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            D           IR    +M PE ++  + +  SD++SYGVVL E+ +
Sbjct: 198 ADYYKLLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK-DGSICFEPVNTDIRGT 276
            ++YLH   +  + HRD+K  N+ L+++   K+ DFGLA   + DG          + GT
Sbjct: 154 GVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-----RKKXLCGT 205
Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
           P Y+ PE +  +  + + D++S G +L  ++  +
Sbjct: 206 PNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 92/229 (40%), Gaps = 30/229 (13%)
Query: 103 KETKKATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRM-DKISEQVEGDFCREI 155
           KE   +   F   +G+  FG VYK              +A+K + DK    +  +F  E 
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 156 EXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHL--HSPG------------RT 201
                          G   + +   +++ Y ++G L + L   SP             ++
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 202 PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA--S 259
            L     + +   +A  +EYL  +    + H+D+ + N+L+ +    K++D GL     +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            D           IR    +M PE ++  + +  SD++SYGVVL E+ +
Sbjct: 181 ADYYKLLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 21/203 (10%)
Query: 116 IGQGGFGTVYKAQ--FSDGSLIAVKRMD--------KISEQVEGDFCREIEXXXXXXXXX 165
           IG+G +G V+KA+   + G  +A+KR+          +S   E    R +E         
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 166 XXXXXGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
                      RE    L++E++ +  L  +L       +  +T   +   +   L++LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
            +    + HRD+K  NIL+  +   KLADFGLA         F+   T +  T  Y  PE
Sbjct: 138 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWYRAPE 189
Query: 284 YVVTQELTEKSDVYSYGVVLLEI 306
            ++        D++S G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 21/203 (10%)
Query: 116 IGQGGFGTVYKAQ--FSDGSLIAVKRMD--------KISEQVEGDFCREIEXXXXXXXXX 165
           IG+G +G V+KA+   + G  +A+KR+          +S   E    R +E         
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 166 XXXXXGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
                      RE    L++E++ +  L  +L       +  +T   +   +   L++LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
            +    + HRD+K  NIL+  +   KLADFGLA         F+   T +  T  Y  PE
Sbjct: 138 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS-----FQMALTSVVVTLWYRAPE 189
Query: 284 YVVTQELTEKSDVYSYGVVLLEI 306
            ++        D++S G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 3/97 (3%)
Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K  NIL+  +  A L DFG+A A+ D  +  +  NT   GT  Y  PE       T
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNT--VGTLYYXAPERFSESHAT 213
Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA 328
            ++D+Y+   VL E +T     Q  +  V  A +  A
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQA 250

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 98/238 (41%), Gaps = 34/238 (14%)
Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGD---FCREIEXXXXXXXXXXXXXX 170
           ++G+G FG V   +    G   AVK + K   + + D     RE++              
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            F  +K   +L+ E    G L D + S  R   S     +I   V + + Y+H      +
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMH---KNKI 153
Query: 231 CHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDPEYV 285
            HRD+K  N+LL+   ++   ++ DFGL       S  FE      D  GT  Y+ PE V
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGL-------STHFEASKKMKDKIGTAYYIAPE-V 205
Query: 286 VTQELTEKSDVYSYGVVLLEIVTA------------RRAVQDGKNLVESAQVCMASES 331
           +     EK DV+S GV+L  +++              + V+ GK   E  Q    SES
Sbjct: 206 LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 263

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 16/133 (12%)
Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
           +K+  +L+ E+   G L + +    R          I   + + + YLH      + HRD
Sbjct: 117 DKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQILSGICYLH---KHNIVHRD 171
Query: 235 IKSSNILLDEN---FVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           IK  NILL+        K+ DFGL +  SKD  +       D  GT  Y+ PE V+ ++ 
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL------RDRLGTAYYIAPE-VLKKKY 224
Query: 291 TEKSDVYSYGVVL 303
            EK DV+S GV++
Sbjct: 225 NEKCDVWSCGVIM 237

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 11/126 (8%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
            ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD+K  N
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH---SINIAHRDVKPEN 191
Query: 240 ILLDE---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDV 296
           +L      N + KL DFG A  +   +    P       TP Y+ PE +  ++  +  D 
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPEVLGPEKYDKSCDX 246
Query: 297 YSYGVV 302
           +S GV+
Sbjct: 247 WSLGVI 252

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 49/105 (46%), Gaps = 21/105 (20%)
Query: 210 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN--FVAKLADFGLAHASKDGSICFE 267
            I   + +AL YLH   +  +CHRDIK  N L   N  F  KL DFGL+         F 
Sbjct: 172 NIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE-------FY 221
Query: 268 PVN-------TDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVL 303
            +N       T   GTP ++ PE + T  +    K D +S GV+L
Sbjct: 222 KLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 28/258 (10%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKR--MDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IGQG FG V+KA+    G  +A+K+  M+   E       REI+                
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 173 CIEKRE--------RFLMYEYMAN---GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           C  K           +L++++  +   G L + L    +  LS   R+   +   N L Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQML--LNGLYY 140
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 281
           +H      + HRD+K++N+L+  + V KLADFGLA A             +   T  Y  
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 282 PEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 340
           PE ++ + +     D++  G ++ E+ T R  +  G     + Q  +A  S+L   + P 
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQG----NTEQHQLALISQLCGSITPE 252
Query: 341 IKDSFDMEQLRTIVTIVR 358
           +  + D  +L   + +V+
Sbjct: 253 VWPNVDNYELYEKLELVK 270

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNT 271
           +   LE + +     + HR++K  N+LL    +    KLADFGLA    D          
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----- 188
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
              GTPGY+ PE +     ++  D+++ GV+L
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D    F        
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF-------V 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D    F        
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF-------V 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 24/135 (17%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ E M  G L D +   G   L   T       +  A++YLH   +  + HRD+K  N
Sbjct: 90  YIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPEN 144
Query: 240 ILL---DENFVAKLADFG----LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV---TQE 289
           +LL   +E+ + K+ DFG    L   S   ++C         GTP Y+ PE +V   T  
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---------GTPTYLAPEVLVSVGTAG 195
Query: 290 LTEKSDVYSYGVVLL 304
                D +S GV+L 
Sbjct: 196 YNRAVDCWSLGVILF 210

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 24/135 (17%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ E M  G L D +   G   L   T       +  A++YLH   +  + HRD+K  N
Sbjct: 89  YIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPEN 143
Query: 240 ILL---DENFVAKLADFG----LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV---TQE 289
           +LL   +E+ + K+ DFG    L   S   ++C         GTP Y+ PE +V   T  
Sbjct: 144 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---------GTPTYLAPEVLVSVGTAG 194
Query: 290 LTEKSDVYSYGVVLL 304
                D +S GV+L 
Sbjct: 195 YNRAVDCWSLGVILF 209

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 24/135 (17%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ E M  G L D +   G   L   T       +  A++YLH   +  + HRD+K  N
Sbjct: 90  YIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPEN 144
Query: 240 ILL---DENFVAKLADFG----LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV---TQE 289
           +LL   +E+ + K+ DFG    L   S   ++C         GTP Y+ PE +V   T  
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---------GTPTYLAPEVLVSVGTAG 195
Query: 290 LTEKSDVYSYGVVLL 304
                D +S GV+L 
Sbjct: 196 YNRAVDCWSLGVILF 210

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/137 (24%), Positives = 66/137 (48%), Gaps = 18/137 (13%)
Query: 206 QTRIQIAI-DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 264
           + RIQ  +  +   L Y+H      + HRD+K  N+ ++E+   K+ DFGLA  +     
Sbjct: 127 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----- 178
Query: 265 CFEPVNTDIRG---TPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
                ++++ G   T  Y  PE ++     T+  D++S G ++ E++T +   +   +L 
Sbjct: 179 -----DSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
Query: 321 ESAQVCMASESRLAELV 337
           +  ++   + +  AE V
Sbjct: 234 QLKEIMKVTGTPPAEFV 250

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D    F        
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV------- 179
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 115 IIGQGGFGTVY--KAQFSDGSLIAVKRMDKISEQVEGD---FCREIEXXXXXXXXXXXXX 169
           ++G+G FG V   K + + G   AVK + K   + + D     RE++             
Sbjct: 56  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             F  +K   +L+ E    G L D + S  R   S     +I   V + + Y+H      
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMH---KNK 169
Query: 230 LCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDPEY 284
           + HRD+K  N+LL+   ++   ++ DFGL       S  FE      D  GT  Y+ PE 
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGL-------STHFEASKKMKDKIGTAYYIAPE- 221
Query: 285 VVTQELTEKSDVYSYGVVLLEIVTA 309
           V+     EK DV+S GV+L  +++ 
Sbjct: 222 VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 24/135 (17%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ E M  G L D +   G   L   T       +  A++YLH   +  + HRD+K  N
Sbjct: 90  YIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPEN 144
Query: 240 ILL---DENFVAKLADFG----LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV---TQE 289
           +LL   +E+ + K+ DFG    L   S   ++C         GTP Y+ PE +V   T  
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---------GTPTYLAPEVLVSVGTAG 195
Query: 290 LTEKSDVYSYGVVLL 304
                D +S GV+L 
Sbjct: 196 YNRAVDCWSLGVILF 210

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 22/204 (10%)
Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGD---FCREIEXXXXXXXXXXXXXX 170
           ++G+G FG V   +    G   AVK + K   + + D     RE++              
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
            F  +K   +L+ E    G L D + S  R   S     +I   V + + Y+H      +
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMH---KNKI 171
Query: 231 CHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDPEYV 285
            HRD+K  N+LL+   ++   ++ DFGL       S  FE      D  GT  Y+ PE V
Sbjct: 172 VHRDLKPENLLLESKSKDANIRIIDFGL-------STHFEASKKMKDKIGTAYYIAPE-V 223
Query: 286 VTQELTEKSDVYSYGVVLLEIVTA 309
           +     EK DV+S GV+L  +++ 
Sbjct: 224 LHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 115 IIGQGGFGTVY--KAQFSDGSLIAVKRMDKISEQVEGD---FCREIEXXXXXXXXXXXXX 169
           ++G+G FG V   K + + G   AVK + K   + + D     RE++             
Sbjct: 33  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             F  +K   +L+ E    G L D + S  R   S     +I   V + + Y+H      
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMH---KNK 146
Query: 230 LCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDPEY 284
           + HRD+K  N+LL+   ++   ++ DFGL       S  FE      D  GT  Y+ PE 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGL-------STHFEASKKMKDKIGTAYYIAPE- 198
Query: 285 VVTQELTEKSDVYSYGVVLLEIVTA 309
           V+     EK DV+S GV+L  +++ 
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-------TGYV 194
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 24/135 (17%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ E M  G L D +   G   L   T       +  A++YLH   +  + HRD+K  N
Sbjct: 96  YIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPEN 150
Query: 240 ILL---DENFVAKLADFG----LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV---TQE 289
           +LL   +E+ + K+ DFG    L   S   ++C         GTP Y+ PE +V   T  
Sbjct: 151 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---------GTPTYLAPEVLVSVGTAG 201
Query: 290 LTEKSDVYSYGVVLL 304
                D +S GV+L 
Sbjct: 202 YNRAVDCWSLGVILF 216

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 28/258 (10%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKR--MDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IGQG FG V+KA+    G  +A+K+  M+   E       REI+                
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 173 CIEKRE--------RFLMYEYMAN---GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           C  K           +L++++  +   G L + L    +  LS   R+   +   N L Y
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQML--LNGLYY 139
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 281
           +H      + HRD+K++N+L+  + V KLADFGLA A             +   T  Y  
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 282 PEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 340
           PE ++ + +     D++  G ++ E+ T R  +  G     + Q  +A  S+L   + P 
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQG----NTEQHQLALISQLCGSITPE 251
Query: 341 IKDSFDMEQLRTIVTIVR 358
           +  + D  +L   + +V+
Sbjct: 252 VWPNVDNYELYEKLELVK 269

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-------TGYV 188
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 10/98 (10%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILL--DENFV-AKLADFGLAHASKDGSICFEPVNT 271
           +  AL Y H   D  + HRD+K  N+LL   EN    KL DFG+A    +  +    V  
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL----VAG 191
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
              GTP +M PE V  +   +  DV+  GV+L  +++ 
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM-------TGYV 188
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-------TGYV 190
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 39/76 (51%), Gaps = 9/76 (11%)
Query: 232 HRDIKSSNILLD---ENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
           HRD+K  N+LL    +    KLADFGLA     D    F        GTPGY+ PE +  
Sbjct: 126 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF-----GFAGTPGYLSPEVLRK 180
Query: 288 QELTEKSDVYSYGVVL 303
           +   +  D+++ GV+L
Sbjct: 181 EAYGKPVDIWACGVIL 196

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-------TGYV 190
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 194
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-------TGYV 190
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 195
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 203
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 195
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 195
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 203
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 24/135 (17%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ E M  G L D +   G   L   T       +  A++YLH   +  + HRD+K  N
Sbjct: 215 YIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPEN 269
Query: 240 ILL---DENFVAKLADFG----LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV---TQE 289
           +LL   +E+ + K+ DFG    L   S   ++C         GTP Y+ PE +V   T  
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---------GTPTYLAPEVLVSVGTAG 320
Query: 290 LTEKSDVYSYGVVLL 304
                D +S GV+L 
Sbjct: 321 YNRAVDCWSLGVILF 335

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 185
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 202
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 206
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 188
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 133 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 182
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 183 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 190
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 185
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 185
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 24/135 (17%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ E M  G L D +   G   L   T       +  A++YLH   +  + HRD+K  N
Sbjct: 229 YIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPEN 283
Query: 240 ILL---DENFVAKLADFG----LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV---TQE 289
           +LL   +E+ + K+ DFG    L   S   ++C         GTP Y+ PE +V   T  
Sbjct: 284 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---------GTPTYLAPEVLVSVGTAG 334
Query: 290 LTEKSDVYSYGVVLL 304
                D +S GV+L 
Sbjct: 335 YNRAVDCWSLGVILF 349

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 202
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 144 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 193
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 194 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 28/258 (10%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKR--MDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IGQG FG V+KA+    G  +A+K+  M+   E       REI+                
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 173 CIEKRE--------RFLMYEYMAN---GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           C  K           +L++++  +   G L + L    +  LS   R+   +   N L Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQML--LNGLYY 140
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 281
           +H      + HRD+K++N+L+  + V KLADFGLA A             +   T  Y  
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 282 PEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 340
           PE ++ + +     D++  G ++ E+ T R  +  G     + Q  +A  S+L   + P 
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQG----NTEQHQLALISQLCGSITPE 252
Query: 341 IKDSFDMEQLRTIVTIVR 358
           +  + D  +L   + +V+
Sbjct: 253 VWPNVDNYELYEKLELVK 270

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 189
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 189
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 189
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGXV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 28/258 (10%)
Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKR--MDKISEQVEGDFCREIEXXXXXXXXXXXXXXGF 172
           IGQG FG V+KA+    G  +A+K+  M+   E       REI+                
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 173 CIEKRE--------RFLMYEYMAN---GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           C  K           +L++++  +   G L + L    +  LS   R+   +   N L Y
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQML--LNGLYY 140
Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 281
           +H      + HRD+K++N+L+  + V KLADFGLA A             +   T  Y  
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 282 PEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 340
           PE ++ + +     D++  G ++ E+ T R  +  G     + Q  +A  S+L   + P 
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQG----NTEQHQLALISQLCGSITPE 252
Query: 341 IKDSFDMEQLRTIVTIVR 358
           +  + D  +L   + +V+
Sbjct: 253 VWPNVDNYELYEKLELVK 270

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 132 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 181
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 188
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 180
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 179
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 179
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 180
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM-------TGYV 185
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 65/147 (44%), Gaps = 27/147 (18%)
Query: 230 LCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           + HRDIK  NIL+D N    KL DFG       G++  + V TD  GT  Y  PE++   
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFG------SGALLKDTVYTDFDGTRVYSPPEWIRYH 231
Query: 289 ELTEKS-DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 347
               +S  V+S G++L ++V      +  + ++   QV              R + S + 
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQVFF------------RQRVSSEC 278
Query: 348 EQLRTIVTIVRWCTQREGQARPSIKQV 374
           + L      +RWC       RP+ +++
Sbjct: 279 QHL------IRWCLALRPSDRPTFEEI 299

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM-------TGYV 189
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 179
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNT 271
           +   LE + +     + HR++K  N+LL    +    KLADFGLA    D          
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----- 165
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
              GTPGY+ PE +     ++  D+++ GV+L
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-DPDHDHTGFLTEYV 192
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-DPDHDHTGFLTEYV 208
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-DPDHDHTGFLTEYV 192
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-DPDHDHTGFLTEYV 188
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNT 271
           +   LE + +     + HR++K  N+LL    +    KLADFGLA    D          
Sbjct: 110 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----- 164
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
              GTPGY+ PE +     ++  D+++ GV+L
Sbjct: 165 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNT 271
           +   LE + +     + HR++K  N+LL    +    KLADFGLA    D          
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----- 165
Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
              GTPGY+ PE +     ++  D+++ GV+L
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVA-DPDHDHTGFLTEYV 188
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 208
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 192
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 193
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 139 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 194
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 130 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 185
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 192
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 192
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D    +        
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY-------V 206
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 190
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 186
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 141 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 196
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 188
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 186
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVA-DPDHDHTGFLTEYV 188
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 188
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 39/78 (50%), Gaps = 9/78 (11%)
Query: 230 LCHRDIKSSNILL---DENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYV 285
           + HRD+K  N+LL    +    KLADFGLA     D    F        GTPGY+ PE +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF-----GFAGTPGYLSPEVL 178
Query: 286 VTQELTEKSDVYSYGVVL 303
                 +  D+++ GV+L
Sbjct: 179 RKDPYGKPVDMWACGVIL 196

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLTEYV 190
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 39/78 (50%), Gaps = 9/78 (11%)
Query: 230 LCHRDIKSSNILL---DENFVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYV 285
           + HRD+K  N+LL    +    KLADFGLA     D    F        GTPGY+ PE +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF-----GFAGTPGYLSPEVL 178
Query: 286 VTQELTEKSDVYSYGVVL 303
                 +  D+++ GV+L
Sbjct: 179 RKDPYGKPVDMWACGVIL 196

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D         T+  
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVA-DPDHDHTGFLTEYV 190
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 115 IIGQGGFGTVY--KAQFSDGSLIAVKRMDKISEQVEGD---FCREIEXXXXXXXXXXXXX 169
           ++G+G FG V   K + + G   AVK + K   + + D     RE++             
Sbjct: 33  VLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 170 XGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             F  +K   +L+ E    G L D + S  R   S     +I   V + + Y H      
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYXH---KNK 146
Query: 230 LCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVN--TDIRGTPGYMDPEY 284
           + HRD+K  N+LL+   ++   ++ DFGL       S  FE      D  GT  Y+ PE 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGL-------STHFEASKKXKDKIGTAYYIAPE- 198
Query: 285 VVTQELTEKSDVYSYGVVLLEIVTA 309
           V+     EK DV+S GV+L  +++ 
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D         T   
Sbjct: 163 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------TGYV 212
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++         D++S G ++ E++T R
Sbjct: 213 ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 115 IIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEG--DFCREIEXXXXXXXXXXXXXXG 171
           +IG G +G V +A    +  ++A+K++ ++ E +       REI                
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 172 FCI----EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
             I    EK +   +   +A+   K       RTP+ + T + I   + N L  + +   
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSDFKKLF----RTPV-YLTELHIKTLLYNLLVGVKYVHS 174
Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHA----------------SKDGSICFEPVNT 271
             + HRD+K +N L++++   K+ DFGLA                    D ++   P   
Sbjct: 175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234
Query: 272 DIRG-------TPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVT 308
           +++        T  Y  PE ++ QE  TE  DV+S G +  E++ 
Sbjct: 235 NLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+L++     K+ DFGLA  + D         T+  
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIA-DPEHDHTGFLTEXV 208
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ D+GLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S GV++ E++
Sbjct: 202 YKENVDIWSVGVIMGEMI 219

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 26/215 (12%)
Query: 112 FSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEXXXXXXXXXXXXXX 170
           F   +G+GGF  V   +   DG   A+KR+    +Q   +  RE +              
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 171 GFCIEKR----ERFLMYEYMANGSLKDH---LHSPGRTPLSWQTRIQIAIDVANALEYLH 223
            +C+ +R    E +L+  +   G+L +    L   G   L+    + + + +   LE +H
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIH 151
Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI--------RG 275
                   HRD+K +NILL +     L D G   +     I  E     +        R 
Sbjct: 152 ---AKGYAHRDLKPTNILLGDEGQPVLMDLG---SMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 276 TPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIV 307
           T  Y  PE    Q    + E++DV+S G VL  ++
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 40/78 (51%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S GV++ E++
Sbjct: 202 YKENVDIWSVGVIMGEMI 219

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 11/134 (8%)
Query: 178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           E  L+ EY A G +           +S    I++   +   + YLH      + H D+K 
Sbjct: 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKP 159
Query: 238 SNILLDENFV---AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            NILL   +     K+ DFG++   K G  C      +I GTP Y+ PE +    +T  +
Sbjct: 160 QNILLSSIYPLGDIKIVDFGMSR--KIGHAC---ELREIMGTPEYLAPEILNYDPITTAT 214
Query: 295 DVYSYGVVLLEIVT 308
           D+++ G++   ++T
Sbjct: 215 DMWNIGIIAYMLLT 228

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 17/100 (17%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD---GSICFEPVNT 271
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA  + D   G +       
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV------- 203
Query: 272 DIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
               T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 204 ---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S   EP       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMEPEVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
             E  D++S G ++ E+V  +
Sbjct: 202 YKENVDIWSVGCIMGEMVCHK 222

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 16/104 (15%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFV-AKLADFGLAHASKDGSICFEP----- 268
           +  ALE L +     + H D+K+ N+LL  +   A L DFG A       +C +P     
Sbjct: 191 LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHA-------VCLQPDGLGK 243
Query: 269 ---VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
                  I GT  +M PE V+ +    K DV+S   ++L ++  
Sbjct: 244 SLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 47/104 (45%), Gaps = 16/104 (15%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFV-AKLADFGLAHASKDGSICFEP----- 268
           +  ALE L +     + H D+K+ N+LL  +   A L DFG A       +C +P     
Sbjct: 172 LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHA-------VCLQPDGLGK 224
Query: 269 ---VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
                  I GT  +M PE V+ +    K DV+S   ++L ++  
Sbjct: 225 DLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGL   + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/249 (23%), Positives = 90/249 (36%), Gaps = 57/249 (22%)
Query: 100 FSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDGS-LIAVKRMDKI-----SEQVEGDF 151
           FS+K+     + F  I  +G G FG V   Q  D     AVK +  I     S ++E D 
Sbjct: 25  FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADI 84
Query: 152 CREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMA------NGSLKDHLHSPGRTPLSW 205
            ++I+                 ++   +F+ Y++M         SL + +          
Sbjct: 85  LKKIQNDDINNNNI--------VKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHI 136
Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV------------------ 247
           +      I++  AL YL       L H D+K  NILLD+ +                   
Sbjct: 137 EDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 248 -------AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYG 300
                   KL DFG A    D        +  I  T  Y  PE ++       SD++S+G
Sbjct: 194 YRTKSTGIKLIDFGCATFKSD-------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 301 VVLLEIVTA 309
            VL E+ T 
Sbjct: 247 CVLAELYTG 255

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 39/77 (50%), Gaps = 7/77 (9%)
Query: 230 LCHRDIKSSNILLDENF---VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           + HRD+K  N+LL         KLADFGLA    +G    +       GTPGY+ PE + 
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGE---QQAWFGFAGTPGYLSPEVLR 197
Query: 287 TQELTEKSDVYSYGVVL 303
                +  D+++ GV+L
Sbjct: 198 KDPYGKPVDLWACGVIL 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 7/77 (9%)
Query: 230 LCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           + HRD+K  N+LL    +    KLADFGLA   +     +        GTPGY+ PE + 
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW----FGFAGTPGYLSPEVLR 206
Query: 287 TQELTEKSDVYSYGVVL 303
                +  D+++ GV+L
Sbjct: 207 KDPYGKPVDIWACGVIL 223

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 5/81 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S   EP       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMEPEVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
             E  D++S G ++ E+V  +
Sbjct: 202 YKENVDLWSVGCIMGEMVCHK 222

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +     C   + T    T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-----CTNFMMTPYVVTRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
                D++S G ++ E+V
Sbjct: 202 YAANVDIWSVGCIMGELV 219

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 109/284 (38%), Gaps = 42/284 (14%)
Query: 112 FSTIIGQGGFGTVYKA---QFSD-GSL----IAVKRMDKISEQVEGDFCREIEXXXXXXX 163
           F+  +GQG F  ++K    +  D G L    + +K +DK        F            
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 164 XXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
                  G C+   E  L+ E++  GSL  +L    +  ++   ++++A  +A A   +H
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAA---MH 127
Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG-SICFEPVNTDIRGTPGYMDP 282
           F  +  L H ++ + NILL      K  +      S  G SI   P +      P ++ P
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-WVPP 186
Query: 283 EYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 341
           E +   + L   +D +S+G  L EI                   C   +  L+ L D + 
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEI-------------------CSGGDKPLSAL-DSQR 226
Query: 342 KDSF--DMEQL-----RTIVTIVRWCTQREGQARPSIKQVLRIL 378
           K  F  D  QL       +  ++  C   E   RPS + ++R L
Sbjct: 227 KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D          +  
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLXEXV 192
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+LL+     K+ DFGLA  + D          +  
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-DPDHDHTGFLXEXV 193
Query: 275 GTPGYMDPEYVVTQELTEKS-DVYSYGVVLLEIVTAR 310
            T  Y  PE ++  +   KS D++S G +L E+++ R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+  FGLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 73/185 (39%), Gaps = 20/185 (10%)
Query: 85  SLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKA-QFSDGSLIAVK--R 139
           +L    +GP  M    S   +  + D +  I  +G+G +G VYKA        +A+K  R
Sbjct: 11  TLEAQTQGPGSM--SVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR 68
Query: 140 MDKISEQVEGDFCREIEXXXXXXXXXXXXXXGFCIEKRERFLMYEYMANGSLKDHLHSPG 199
           ++   E V G   RE+                         L++EY  N   K    +P 
Sbjct: 69  LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD 128
Query: 200 RTPLSWQTRIQIAIDVANALEYLHFYCDPPLC-HRDIKSSNILL-----DENFVAKLADF 253
            +    ++ +   I+  N       +C    C HRD+K  N+LL      E  V K+ DF
Sbjct: 129 VSMRVIKSFLYQLINGVN-------FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181
Query: 254 GLAHA 258
           GLA A
Sbjct: 182 GLARA 186

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRDIK  NI++ E+F  KL DFG A   + G + +        GT  Y  PE ++   
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY-----TFCGTIEYCAPEVLMGNP 205
Query: 290 L-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA-----QVCMASESRLAELVDPRIKD 343
               + +++S GV L  +V       + +  VE+A      V     S ++ L+ P  + 
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPVPER 265
Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 377
              +E+L T      W TQ    A  + ++V R+
Sbjct: 266 RTTLEKLVTD----PWVTQPVNLADYTWEEVFRV 295

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +    +      T    T  Y  PE ++   
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM-----TPYVVTRYYRAPEVILGMG 199
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 200 YKENVDIWSVGCIMGELV 217

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 202 YKENVDIWSVGCIMGEMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 202 YKENVDIWSVGCIMGEMV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 202 YKENVDIWSVGCIMGEMV 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +    +      T    T  Y  PE ++   
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM-----TPYVVTRYYRAPEVILGMG 194
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 195 YKENVDIWSVGCIMGEMV 212

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 44/94 (46%), Gaps = 9/94 (9%)
Query: 214 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 273
           D   AL +LH      L H D+K +NI L      KL DFGL    + G+     V    
Sbjct: 165 DTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQ--- 216
Query: 274 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
            G P YM PE ++       +DV+S G+ +LE+ 
Sbjct: 217 EGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVA 249

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 202 YKENVDIWSVGCIMGEMV 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ D GLA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/78 (29%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +    +    V T       Y  PE ++   
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRY-----YRAPEVILGMG 203
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E++
Sbjct: 204 YKENVDIWSVGCIMGEMI 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/127 (24%), Positives = 60/127 (47%), Gaps = 14/127 (11%)
Query: 206 QTRIQ-IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGS 263
           + +IQ +   +   L+Y+H      + HRD+K  N+ ++E+   K+ DFGLA HA  +  
Sbjct: 143 EEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 197
Query: 264 ICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 322
                  T    T  Y  PE +++     +  D++S G ++ E++T +   +    L + 
Sbjct: 198 ------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 251
Query: 323 AQVCMAS 329
            Q+   +
Sbjct: 252 TQILKVT 258

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR 274
           +   L+Y+H      + HRD+K SN+ ++E+   K+ DF LA  + D         T   
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM-------TGYV 183
Query: 275 GTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTAR 310
            T  Y  PE ++      +  D++S G ++ E++T R
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/78 (29%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +    +    V T       Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRY-----YRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E++
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 194
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 195 YKENVDIWSVGCIMGEMV 212

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 16/104 (15%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFV-AKLADFGLAHASKDGSICFEP----- 268
           +  ALE L +     + H D+K+ N+LL  +   A L DFG A       +C +P     
Sbjct: 156 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA-------LCLQPDGLGK 208
Query: 269 ---VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
                  I GT  +M PE V+ +    K D++S   ++L ++  
Sbjct: 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +    +      T    T  Y  PE ++   
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-----TPYVVTRYYRAPEVILGMG 195
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 196 YKENVDIWSVGCIMGEMV 213

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 202 YKENVDIWSVGCIMGEMV 219

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/124 (32%), Positives = 59/124 (47%), Gaps = 17/124 (13%)
Query: 180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN 239
           +++ EY+   SLK    S G+  L     I   +++  AL YLH      L + D+K  N
Sbjct: 160 YIVMEYVGGQSLK---RSKGQK-LPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPEN 212
Query: 240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSY 299
           I+L E  + KL D G    S+  S  +      + GTPG+  PE V T   T  +D+Y+ 
Sbjct: 213 IMLTEEQL-KLIDLG--AVSRINSFGY------LYGTPGFQAPEIVRTGP-TVATDIYTV 262
Query: 300 GVVL 303
           G  L
Sbjct: 263 GRTL 266

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 200
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 201 YKENVDIWSVGCIMGEMV 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 202
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 203 YKENVDIWSVGCIMGEMV 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 195
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 196 YKENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 202
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 203 YKENVDIWSVGCIMGEMV 220

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 47/104 (45%), Gaps = 16/104 (15%)
Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILLDENFV-AKLADFGLAHASKDGSICFEP----- 268
           +  ALE L +     + H D+K+ N+LL  +   A L DFG A       +C +P     
Sbjct: 170 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA-------LCLQPDGLGK 222
Query: 269 ---VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTA 309
                  I GT  +M PE V+ +    K D++S   ++L ++  
Sbjct: 223 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E++
Sbjct: 202 YKENVDIWSVGCIMGEMI 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 5/78 (6%)
Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +   S    P       T  Y  PE ++   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV----TRYYRAPEVILGMG 201
Query: 290 LTEKSDVYSYGVVLLEIV 307
             E  D++S G ++ E+V
Sbjct: 202 YKENVDIWSVGCIMGEMV 219

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	458
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-130
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-128
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-121
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-81
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-67
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-67
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-66
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-65
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-65
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-62
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-60
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-57
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-54
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-46
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-44
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-44
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-40
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-38
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-37
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-37
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-36
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-36
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-35
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-33
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-33
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-27
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-18
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  378 bits (974), Expect = e-130
 Identities = 120/291 (41%), Positives = 164/291 (56%), Gaps = 17/291 (5%)

Query: 98  QKFSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREI 155
            +    + ++AT+NF    +IG G FG VYK    DG+ +A+KR    S Q   +F  EI
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 156 ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH--SPGRTPLSWQTRIQIAI 213
           E L+   H HLV+L GFC E+ E  L+Y+YM NG+LK HL+        +SW+ R++I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 214 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP-VNTD 272
             A  L YLH      + HRD+KS NILLDENFV K+ DFG+   SK G+   +  ++T 
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI---SKKGTELDQTHLSTV 200

Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-----NLVESAQVCM 327
           ++GT GY+DPEY +   LTEKSDVYS+GVVL E++ AR A+         NL E A    
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260

Query: 328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            +  +L ++VDP + D    E LR        C     + RPS+  VL  L
Sbjct: 261 NNG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  374 bits (963), Expect = e-128
 Identities = 119/293 (40%), Positives = 180/293 (61%), Gaps = 16/293 (5%)

Query: 98  QKFSYKETKKATDNFST--IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQ-VEGDFCRE 154
           ++FS +E + A+DNFS   I+G+GGFG VYK + +DG+L+AVKR+ +   Q  E  F  E
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 155 IELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLH--SPGRTPLSWQTRIQIA 212
           +E+++   HR+L+ LRGFC+   ER L+Y YMANGS+   L      + PL W  R +IA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 213 IDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 272
           +  A  L YLH +CDP + HRD+K++NILLDE F A + DFGLA   K        V T 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---KLMDYKDTHVTTA 194

Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV-------QDGKNLVESAQV 325
           +RGT G++ PEY+ T + +EK+DV+ YGV+LLE++T +RA         D   L++  + 
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 326 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            +  E +L  LVD  ++ ++  E++  ++ +   CTQ     RP + +V+R+L
Sbjct: 255 -LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  354 bits (910), Expect = e-121
 Identities = 112/304 (36%), Positives = 169/304 (55%), Gaps = 24/304 (7%)

Query: 91  EGPSPMFQKFSYKETKKATDNFST--------IIGQGGFGTVYKAQFSDGSLIAVKRM-- 140
           E     F  FS+ E K  T+NF           +G+GGFG VYK    + + +AVK++  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64

Query: 141 --DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSP 198
             D  +E+++  F +EI+++A+  H +LV L GF  +  +  L+Y YM NGSL D L   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124

Query: 199 -GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 257
            G  PLSW  R +IA   AN + +LH   +    HRDIKS+NILLDE F AK++DFGLA 
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV---Q 314
           AS+  +     + + I GT  YM PE  +  E+T KSD+YS+GVVLLEI+T   AV   +
Sbjct: 182 ASEKFAQ--TVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

Query: 315 DGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQV 374
           + + L++  +     E  + + +D ++ D  D   +  + ++   C   +   RP IK+V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

Query: 375 LRIL 378
            ++L
Sbjct: 298 QQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  252 bits (645), Expect = 8e-81
 Identities = 74/307 (24%), Positives = 117/307 (38%), Gaps = 35/307 (11%)

Query: 100 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL 157
              +     +       +  +G FG V+KAQ      +AVK      +Q       E+  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ-SWQNEYEVYS 71

Query: 158 LARLHHRHLVALRGFCIE----KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI 213
           L  + H +++   G          + +L+  +   GSL D L       +SW     IA 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHIAE 128

Query: 214 DVANALEYLH-------FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF 266
            +A  L YLH           P + HRDIKS N+LL  N  A +ADFGLA   + G    
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS-- 186

Query: 267 EPVNTDIRGTPGYMDPEYV-----VTQELTEKSDVYSYGVVLLEIVTARRA----VQDGK 317
                   GT  YM PE +       ++   + D+Y+ G+VL E+ +   A    V +  
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 318 NLVESAQVCMASESRLAELV-----DPRIKDSFD-MEQLRTIVTIVRWCTQREGQARPSI 371
              E       S   + E+V      P ++D +     +  +   +  C   + +AR S 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 372 KQVLRIL 378
             V   +
Sbjct: 307 GCVGERI 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  216 bits (552), Expect = 4e-67
 Identities = 69/269 (25%), Positives = 127/269 (47%), Gaps = 24/269 (8%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
              ++G+G FG V KA++     +A+K+++  SE     F  E+  L+R++H ++V L G
Sbjct: 12  VEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYG 68

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTP-LSWQTRIQIAIDVANALEYLHFYCDPPL 230
            C+      L+ EY   GSL + LH     P  +    +   +  +  + YLH      L
Sbjct: 69  ACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 231 CHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
            HRD+K  N+LL     V K+ DFG A   +          T+ +G+  +M PE      
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-------TNNKGSAAWMAPEVFEGSN 179

Query: 290 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ 349
            +EK DV+S+G++L E++T R+   +           + + +R      P +  +     
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR------PPLIKNLPKP- 232

Query: 350 LRTIVTIVRWCTQREGQARPSIKQVLRIL 378
              I +++  C  ++   RPS++++++I+
Sbjct: 233 ---IESLMTRCWSKDPSQRPSMEEIVKIM 258

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  216 bits (551), Expect = 5e-67
 Identities = 81/270 (30%), Positives = 133/270 (49%), Gaps = 20/270 (7%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVAL 169
               IG G FGTV++A++  GS +AVK +       +   +F RE+ ++ RL H ++V  
Sbjct: 41  IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDP 228
            G   +     ++ EY++ GSL   LH  G R  L  + R+ +A DVA  + YLH   +P
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           P+ HR++KS N+L+D+ +  K+ DFGL+       +     +    GTP +M PE +  +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL----SSKSAAGTPEWMAPEVLRDE 214

Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
              EKSDVYS+GV+L E+ T ++   +       A V    +          I  + + +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------LEIPRNLNPQ 267

Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
               +  I+  C   E   RPS   ++ +L
Sbjct: 268 ----VAAIIEGCWTNEPWKRPSFATIMDLL 293

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  214 bits (547), Expect = 4e-66
 Identities = 67/319 (21%), Positives = 122/319 (38%), Gaps = 48/319 (15%)

Query: 100 FSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIE- 156
            +  E     DN     +IG+G +G VYK    D   +AVK     + Q   +F  E   
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 157 -LLARLHHRHLVALRGFCIE-----KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 210
             +  + H ++              + E  L+ EY  NGSL  +L         W +  +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115

Query: 211 IAIDVANALEYLH------FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA----HASK 260
           +A  V   L YLH       +  P + HRD+ S N+L+  +    ++DFGL+        
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 261 DGSICFEPVNTDIRGTPGYMDPEY-------VVTQELTEKSDVYSYGVVLLEIVTARRAV 313
                 +       GT  YM PE           +   ++ D+Y+ G++  EI      +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 314 QDGKNLVESAQVCMASE-------SRLAELVD-----PRIKDSF--DMEQLRTIVTIVRW 359
             G++ V   Q+   +E         +  LV      P+  +++  +   +R++   +  
Sbjct: 236 FPGES-VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 360 CTQREGQARPSIKQVLRIL 378
           C  ++ +AR + +     +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  210 bits (537), Expect = 2e-65
 Identities = 55/276 (19%), Positives = 111/276 (40%), Gaps = 31/276 (11%)

Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVA 168
           NF T + +   G ++K ++  G+ I VK +     S +   DF  E   L    H +++ 
Sbjct: 13  NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 169 LRGFCIEKRERFLMY--EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
           + G C             +M  GSL + LH      +     ++ A+D+A  + +LH   
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           +P +    + S ++++DE+  A+++   +          F   +      P ++ PE  +
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVK---------FSFQSPGRMYAPAWVAPE-AL 180

Query: 287 TQE----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 342
            ++        +D++S+ V+L E+VT      D  N+    +V +    R      P I 
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-R------PTIP 233

Query: 343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                     +  +++ C   +   RP    ++ IL
Sbjct: 234 PGISPH----VSKLMKICMNEDPAKRPKFDMIVPIL 265

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  209 bits (535), Expect = 6e-65
 Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 35/282 (12%)

Query: 112 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG-------DFCREIELLARLHH 163
           +   IG+GGFG V+K +   D S++A+K +     + E        +F RE+ +++ L+H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
            ++V L G         ++ E++  G L   L      P+ W  ++++ +D+A  +EY+ 
Sbjct: 83  PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQ 139

Query: 224 FYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
              +PP+ HRD++S NI L          AK+ADFGL+  S           + + G   
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-------SGLLGNFQ 191

Query: 279 YMDPEYVVTQEL--TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 336
           +M PE +  +E   TEK+D YS+ ++L  I+T      D  +  +   + M  E  L   
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGKIKFINMIREEGLR-- 248

Query: 337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             P I +         +  ++  C   + + RP    +++ L
Sbjct: 249 --PTIPEDCPPR----LRNVIELCWSGDPKKRPHFSYIVKEL 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  201 bits (513), Expect = 7e-62
 Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 33/279 (11%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRM----DKISEQVEGDFCREIELLARLHHRHLV 167
              IIG GGFG VY+A +  G  +AVK      D+   Q   +  +E +L A L H +++
Sbjct: 11  LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
           ALRG C+++    L+ E+   G L   L       +     +  A+ +A  + YLH    
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 228 PPLCHRDIKSSNILLDE--------NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGY 279
            P+ HRD+KSSNIL+ +        N + K+ DFGLA      +           G   +
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK------MSAAGAYAW 180

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 339
           M PE +     ++ SDV+SYGV+L E++T       G + +  A     ++         
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLAVAYGVAMNKLA------L 233

Query: 340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            I  +           ++  C   +  +RPS   +L  L
Sbjct: 234 PIPSTCPEP----FAKLMEDCWNPDPHSRPSFTNILDQL 268

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  199 bits (508), Expect = 9e-61
 Identities = 66/293 (22%), Positives = 127/293 (43%), Gaps = 33/293 (11%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL--LARLHHRHLVAL 169
               +G+G +G V++  +  G  +AVK     S + E  + RE EL     L H +++  
Sbjct: 12  LLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGF 67

Query: 170 RGFCIEKR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH-- 223
               +  R    + +L+  Y   GSL D+L     T L   + ++I + +A+ L +LH  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 224 ---FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 280
                  P + HRD+KS NIL+ +N    +AD GLA      +   +  N    GT  YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 281 DPE------YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 334
            PE       V   +  ++ D++++G+VL E+     +    ++        + ++    
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 335 ELVD--------PRIKDSFDMEQ-LRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           ++          P I + +  +  L ++  +++ C  +   AR +  ++ + L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  199 bits (507), Expect = 2e-60
 Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 29/276 (10%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G+G FG   K      G ++ +K + +  E+ +  F +E++++  L H +++   G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
           + +    + EY+  G+L+  + S       W  R+  A D+A+ + YLH      + HRD
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133

Query: 235 IKSSNILLDENFVAKLADFGLA----------HASKDGSICFEPVNTDIRGTPGYMDPEY 284
           + S N L+ EN    +ADFGLA             +            + G P +M PE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--ELVDPRIK 342
           +  +   EK DV+S+G+VL EI+    A  D         + +             P   
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFF 253

Query: 343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                        I   C   + + RPS  ++   L
Sbjct: 254 P------------ITVRCCDLDPEKRPSFVKLEHWL 277

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  199 bits (509), Expect = 2e-60
 Identities = 76/333 (22%), Positives = 132/333 (39%), Gaps = 37/333 (11%)

Query: 76  SLKPFPPPRSLRKFQEG----PSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD 131
           S+   PP  SLR   E      S        + T          IG+G +G V+  ++  
Sbjct: 1   SMTYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-R 59

Query: 132 GSLIAVKRMDKISEQVEGDFCREIE--LLARLHHRHLVALRGFCIEKRER----FLMYEY 185
           G  +AVK         E  + RE E      + H +++      I+        +L+ +Y
Sbjct: 60  GEKVAVK---VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116

Query: 186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH-----FYCDPPLCHRDIKSSNI 240
             NGSL D+L     T L  ++ +++A    + L +LH         P + HRD+KS NI
Sbjct: 117 HENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173

Query: 241 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE------YVVTQELTEKS 294
           L+ +N    +AD GLA      +   +       GT  YM PE           +    +
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233

Query: 295 DVYSYGVVLLEIVT---ARRAVQDGKNLVESAQVCMASESRLAELVD-----PRIKDSFD 346
           D+YS+G++L E+     +   V++ +           S   + E+V      P   + + 
Sbjct: 234 DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS 293

Query: 347 MEQ-LRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            ++ LR +  ++  C      +R +  +V + L
Sbjct: 294 SDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  190 bits (486), Expect = 1e-57
 Identities = 68/271 (25%), Positives = 121/271 (44%), Gaps = 27/271 (9%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           IG G FGTVYK ++     +AVK +     + Q    F  E+ +L +  H +++   G+ 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 174 IEKRERFLMY---EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
              +    +    ++    SL  HLH+   T    +  I IA   A  ++YLH      +
Sbjct: 90  TAPQ----LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSI 141

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            HRD+KS+NI L E+   K+ DFGLA      S         + G+  +M PE +  Q+ 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG--SHQFEQLSGSILWMAPEVIRMQDS 199

Query: 291 ---TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 347
              + +SDVY++G+VL E++T +    +  N     Q+              +++ +   
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLSPDLSKVRSNCPK 256

Query: 348 EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                +  ++  C +++   RPS  ++L  +
Sbjct: 257 R----MKRLMAECLKKKRDERPSFPRILAEI 283

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  191 bits (487), Expect = 3e-57
 Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 33/293 (11%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIE--LLARLHHRHLVAL 169
               IG+G FG V++ ++  G  +AVK     S + E  + RE E      L H +++  
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGF 101

Query: 170 RGFCIEKR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH-- 223
                +      + +L+ +Y  +GSL D+L+   R  ++ +  I++A+  A+ L +LH  
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHME 158

Query: 224 ---FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 280
                  P + HRD+KS NIL+ +N    +AD GLA      +   +       GT  YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 281 DPE------YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA 334
            PE       +   E  +++D+Y+ G+V  EI          ++        + S+  + 
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 335 ELVD--------PRIKDSFDM-EQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           E+          P I + +   E LR +  I+R C    G AR +  ++ + L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (476), Expect = 7e-56
 Identities = 53/279 (18%), Positives = 104/279 (37%), Gaps = 30/279 (10%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVAL 169
              +IG+G FG VY  ++     +A++   +++ +E     F RE+    +  H ++V  
Sbjct: 37  IGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            G C+      ++       +L   +    +  L      QIA ++   + YLH      
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKG 150

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN-TDIRGTPGYMDPEYVVTQ 288
           + H+D+KS N+  D   V  + DFGL   S                G   ++ PE +   
Sbjct: 151 ILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 289 EL---------TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 339
                      ++ SDV++ G +  E+       +         Q+   +  +       
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--GTGMKP-----N 262

Query: 340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             +     E    I  I+ +C   E + RP+  +++ +L
Sbjct: 263 LSQIGMGKE----ISDILLFCWAFEQEERPTFTKLMDML 297

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  160 bits (408), Expect = 3e-46
 Identities = 63/273 (23%), Positives = 113/273 (41%), Gaps = 34/273 (12%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRG 171
            IG+G F TVYK         +A   +   K+++     F  E E+L  L H ++V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 172 FCIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                 +       +  E M +G+LK +L       +  +        +   L++LH   
Sbjct: 93  SWESTVKGKKCIVLVT-ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 227 DPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
            PP+ HRD+K  NI +       K+ D GLA      ++        + GTP +M PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA------TLKRASFAKAVIGTPEFMAPE-M 201

Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE--SRLAELVDPRIKD 343
             ++  E  DVY++G+ +LE+ T+     + +N  +  +   +    +   ++  P +K+
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                       I+  C ++    R SIK +L 
Sbjct: 262 ------------IIEGCIRQNKDERYSIKDLLN 282

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  156 bits (396), Expect = 2e-44
 Identities = 71/298 (23%), Positives = 127/298 (42%), Gaps = 48/298 (16%)

Query: 101 SYKETKKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIEL 157
           ++   K+   +F  I  IG GGFG V+KA+   DG    +KR+   +E+ E    RE++ 
Sbjct: 2   AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKA 57

Query: 158 LARLHHRHLVALRGFCIEKRERFLMY----------------EYMANGSLKDHLHSPGRT 201
           LA+L H ++V   G                            E+   G+L+  +      
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 202 PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD 261
            L     +++   +   ++Y+H      L +RD+K SNI L +    K+ DFGL  + K+
Sbjct: 118 KLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
                    T  +GT  YM PE + +Q+  ++ D+Y+ G++L E++       +      
Sbjct: 175 DG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT 229

Query: 322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY 379
                        +L D  I D FD +      T+++    ++ + RP+  ++LR L 
Sbjct: 230 -------------DLRDGIISDIFDKK----EKTLLQKLLSKKPEDRPNTSEILRTLT 270

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  155 bits (393), Expect = 9e-44
 Identities = 62/276 (22%), Positives = 109/276 (39%), Gaps = 28/276 (10%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G+GGF  V   +   DG   A+KR+    +Q   +  RE ++    +H +++ L  +C+
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96

Query: 175 EKRER----FLMYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
            +R      +L+  +   G+L + +         L+    + + + +   LE +H     
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPE 283
              HRD+K +NILL +     L D G       H                R T  Y  PE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213

Query: 284 YVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 340
               Q    + E++DV+S G VL  ++             +S  V +A +++L+    PR
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VALAVQNQLSIPQSPR 271

Query: 341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
              S  + QL      +      +   RP I  +L 
Sbjct: 272 H--SSALWQL------LNSMMTVDPHQRPHIPLLLS 299

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  149 bits (378), Expect = 5e-42
 Identities = 67/273 (24%), Positives = 111/273 (40%), Gaps = 29/273 (10%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRG 171
            IG G +G   K +  SDG ++  K +D   ++E  +     E+ LL  L H ++V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 172 FCIEKRERFL---MYEYMANGSLKDHL--HSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
             I++    L   M EY   G L   +   +  R  L  +  +++   +  AL+  H   
Sbjct: 73  RIIDRTNTTLYIVM-EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 227 DPPLC--HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
           D      HRD+K +N+ LD     KL DFGLA      +       T + GTP YM PE 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKTFV-GTPYYMSPEQ 187

Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE-SAQVCMASESRLAELVDPRIKD 343
           +      EKSD++S G +L E+           +  E + ++      R+       + +
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRYSDELNE 246

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                       I+      +   RPS++++L 
Sbjct: 247 ------------IITRMLNLKDYHRPSVEEILE 267

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (380), Expect = 3e-41
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 22/202 (10%)

Query: 116 IGQGGFGTVYKAQFSDGSL-IAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           IG+G FG V+  +    +  +AVK   + +   ++  F +E  +L +  H ++V L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
            +K+  +++ E +  G     L + G   L  +T +Q+  D A  +EYL         HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237

Query: 234 DIKSSNILLDENFVAKLADFGLA-------HASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           D+ + N L+ E  V K++DFG++       +A+  G     P    ++ T     PE + 
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV-P----VKWTA----PEALN 288

Query: 287 TQELTEKSDVYSYGVVLLEIVT 308
               + +SDV+S+G++L E  +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (377), Expect = 3e-41
 Identities = 62/266 (23%), Positives = 115/266 (43%), Gaps = 24/266 (9%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRG 171
            IG+G FG     +   DG    +K ++  ++S +   +  RE+ +LA + H ++V  R 
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
              E    +++ +Y   G L   +++           +   + +  AL+++H   D  + 
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRDIKS NI L ++   +L DFG+A          E     I GTP Y+ PE    +   
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV---ELARACI-GTPYYLSPEICENKPYN 203

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVE-SAQVCMASESRLAELVDPRIKDSFDMEQL 350
            KSD+++ G VL E+ T + A  +  ++     ++   S   ++      ++        
Sbjct: 204 NKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISGSFPPVSLHYSYDLRS------- 255

Query: 351 RTIVTIVRWCTQREGQARPSIKQVLR 376
                +V    +R  + RPS+  +L 
Sbjct: 256 -----LVSQLFKRNPRDRPSVNSILE 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  146 bits (371), Expect = 1e-40
 Identities = 74/324 (22%), Positives = 133/324 (41%), Gaps = 48/324 (14%)

Query: 67  EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYK 126
           E  + +    +  F P ++LR    G + +     ++  KK        IG+G F  VY+
Sbjct: 3   EQSQGMQGPPVPQFQPQKALRP-DMGYNTLAN---FRIEKK--------IGRGQFSEVYR 50

Query: 127 AQ-FSDGSLIAVKRMD---KISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM 182
           A    DG  +A+K++     +  +   D  +EI+LL +L+H +++      IE  E  ++
Sbjct: 51  AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110

Query: 183 YEYMANGSLKDHLHSPGR--TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI 240
            E    G L   +    +    +  +T  +  + + +ALE++H      + HRDIK +N+
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANV 167

Query: 241 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYG 300
            +    V KL D GL    +  S      ++ + GTP YM PE +       KSD++S G
Sbjct: 168 FITATGVVKLGDLGLG---RFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLG 223

Query: 301 VVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM-------EQLRTI 353
            +L E+   +                   +  L  L     +  +         E+LR  
Sbjct: 224 CLLYEMAALQSPFY-------------GDKMNLYSLCKKIEQCDYPPLPSDHYSEELR-- 268

Query: 354 VTIVRWCTQREGQARPSIKQVLRI 377
             +V  C   + + RP +  V  +
Sbjct: 269 -QLVNMCINPDPEKRPDVTYVYDV 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (367), Expect = 3e-40
 Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 42/285 (14%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           +G+GGFG V++A+   D    A+KR+     E       RE++ LA+L H  +V      
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72

Query: 174 IEKRERF-------------LMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANAL 219
           +EK                  M +     +LKD ++             + I + +A A+
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQM-QLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNT 271
           E+LH      L HRD+K SNI    + V K+ DFGL           +    +     +T
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
              GT  YM PE +     + K D++S G++L E++       +                
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRT------------ 236

Query: 332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
            L ++ + +    F  ++      +V+         RP    ++ 
Sbjct: 237 -LTDVRNLKFPPLFT-QKYPCEYVMVQDMLSPSPMERPEAINIIE 279

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  145 bits (368), Expect = 6e-40
 Identities = 70/288 (24%), Positives = 112/288 (38%), Gaps = 41/288 (14%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFC 173
           + +GGF  VY+AQ    G   A+KR+    E+      +E+  + +L  H ++V      
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 174 IEKRER-------FLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
              +E        FL+   +  G L + L     R PLS  T ++I      A++++H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLA---------HASKDGSICFEPVNTDIRGT 276
             PP+ HRD+K  N+LL      KL DFG A           S       E   T    T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT-RNTT 213

Query: 277 PGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-VESAQVCMASESR 332
           P Y  PE +       + EK D+++ G +L  +   +   +DG  L + + +  +     
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDT 273

Query: 333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE 380
                            L      +R   Q   + R SI +V+  L E
Sbjct: 274 Q----------YTVFHSL------IRAMLQVNPEERLSIAEVVHQLQE 305

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  145 bits (367), Expect = 8e-40
 Identities = 65/341 (19%), Positives = 132/341 (38%), Gaps = 40/341 (11%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDK--ISEQVEGDFCREIELLARL--HHRHLVALRG 171
           IG GG   V++       + A+K ++      Q    +  EI  L +L  H   ++ L  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           + I  +  +++ E   N  L   L       +    R     ++  A+  +H      + 
Sbjct: 77  YEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH---QHGIV 130

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-------- 283
           H D+K +N L+ +  + KL DFG+A+  +  +     V     GT  YM PE        
Sbjct: 131 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSS 187

Query: 284 ---YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--ELVD 338
                   +++ KSDV+S G +L  +   +   Q   N +      +     +   ++ +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247

Query: 339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR--ILYESSDPMHSGFVQAVEDE 396
             ++D            +++ C +R+ + R SI ++L    +   + P++       E+ 
Sbjct: 248 KDLQD------------VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEM 295

Query: 397 EYEETDGRPRTSQRKAHRSDPTFYSGDGRYLASSSSTSRSY 437
           +Y         S     ++  T Y       + +SS+S+++
Sbjct: 296 KYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 336

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  142 bits (361), Expect = 3e-39
 Identities = 74/324 (22%), Positives = 114/324 (35%), Gaps = 46/324 (14%)

Query: 67  EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKAT---DNFSTI--IGQGGF 121
              ENL   S+    P R    F+   S   Q   Y  ++  +    +F  +  +G G +
Sbjct: 13  LGTENLYFQSMHQLQPRR--VSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSY 70

Query: 122 GTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKR 177
           G V+K +   DG L AVKR        +       E+    ++  H   V L     E  
Sbjct: 71  GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130

Query: 178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
             +L  E     SL+ H  + G   L          D   AL +LH      L H D+K 
Sbjct: 131 ILYLQTEL-CGPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKP 185

Query: 238 SNILLDENFVAKLADFGLA----HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           +NI L      KL DFGL      A                G P YM PE ++       
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---------GDPRYMAPE-LLQGSYGTA 235

Query: 294 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD-PRIKDSFDMEQLRT 352
           +DV+S G+ +LE+         G+              +L +    P        E LR 
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGW-----------QQLRQGYLPPEFTAGLSSE-LR- 282

Query: 353 IVTIVRWCTQREGQARPSIKQVLR 376
             +++    + + + R + + +L 
Sbjct: 283 --SVLVMMLEPDPKLRATAEALLA 304

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  142 bits (360), Expect = 4e-39
 Identities = 74/316 (23%), Positives = 120/316 (37%), Gaps = 58/316 (18%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           ++GQG FG V KA+   D    A+K++    E++      E+ LLA L+H+++V      
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVVRYYAAW 71

Query: 174 IEKRERFLMY-------------EYMANGSLKDHLHSPGRTP---LSWQTRIQIAIDVAN 217
           +E+R                   EY  NG+L D +HS          W+   QI      
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL----E 127

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR--- 274
           AL Y+H      + HRD+K  NI +DE+   K+ DFGLA          +  + ++    
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 275 -------GTPGYMDPEYVVTQELT--EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
                  GT  Y+  E V+       EK D+YS G++  E++        G   V   + 
Sbjct: 185 DNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPF---STGMERVNILKK 240

Query: 326 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM 385
             +          P   D+    + +    I+R     +   RP  + +L          
Sbjct: 241 LRSVSIEF----PPDFDDNKMKVEKK----IIRLLIDHDPNKRPGARTLLN--------- 283

Query: 386 HSGFVQAVEDEEYEET 401
                   +DE  +E 
Sbjct: 284 SGWLPVKHQDEVIKEA 299

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  143 bits (363), Expect = 9e-39
 Identities = 67/385 (17%), Positives = 140/385 (36%), Gaps = 50/385 (12%)

Query: 82  PPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI----------IGQGGFGTVYKAQFSD 131
              +  + Q   SP        +   + +   ++          IG GG   V++     
Sbjct: 20  TAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEK 79

Query: 132 GSLIAVKRMDK--ISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEYMA 187
             + A+K ++      Q    +  EI  L +L      ++ L  + I  +  +++ E   
Sbjct: 80  KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 138

Query: 188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV 247
           N  L   L       +    R     ++  A+  +H      + H D+K +N L+ +  +
Sbjct: 139 NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML 193

Query: 248 AKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-----------YVVTQELTEKSDV 296
            KL DFG+A+  +  +     V     G   YM PE                +++ KSDV
Sbjct: 194 -KLIDFGIANQMQPDTTSV--VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250

Query: 297 YSYGVVLLEIVTARRAVQDGKNLVESAQVCMAS--ESRLAELVDPRIKDSFDMEQLRTIV 354
           +S G +L  +   +   Q   N +      +    E    ++ +  ++D           
Sbjct: 251 WSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD----------- 299

Query: 355 TIVRWCTQREGQARPSIKQVLR--ILYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKA 412
            +++ C +R+ + R SI ++L    +   + P++       E+ +Y         S    
Sbjct: 300 -VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSI 358

Query: 413 HRSDPTFYSGDGRYLASSSSTSRSY 437
            ++  T Y       + +SS+S+++
Sbjct: 359 LKAAKTLYEHYSGGESHNSSSSKTF 383

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  140 bits (356), Expect = 1e-38
 Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 35/217 (16%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSL--------IAVKRMDKISEQVEGDFCREIELLARLHH 163
           F+  +GQG F  ++K    +           + +K +DK        F     ++++L H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL- 222
           +HLV   G C+   E  L+ E++  GSL  +L    +  ++   ++++A  +A A+ +L 
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLE 130

Query: 223 --HFYCDPPLCHRDIKSSNILLD--------ENFVAKLADFGLAHASKDGSICFEPVNTD 272
                      H ++ + NILL              KL+D G++       I  E     
Sbjct: 131 ENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER---- 180

Query: 273 IRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVT 308
           I   P    PE +   + L   +D +S+G  L EI +
Sbjct: 181 IPWVP----PECIENPKNLNLATDKWSFGTTLWEICS 213

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  141 bits (357), Expect = 2e-38
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 51/225 (22%)

Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVA 168
           ++G+G FG+V +AQ          +AVK  + D I+     +F RE   +    H H+  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 169 LRGFCIEKRERFLMY------EYMANGSLKDHL--HSPGRTP--LSWQTRIQIAIDVANA 218
           L G  +  R +  +        +M +G L   L     G  P  L  QT ++  +D+A  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 219 LEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 275
           +EYL   +F       HRD+ + N +L E+    +ADFGL+                I  
Sbjct: 150 MEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSR--------------KIYS 189

Query: 276 TPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
              Y            +  E +     T  SDV+++GV + EI+T
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  140 bits (354), Expect = 2e-38
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 38/218 (17%)

Query: 111 NFSTIIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRH 165
           +F+ +IG+G FG VY     D        AVK +           F  E  ++    H +
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 166 LVALRGFCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL-- 222
           +++L G C+      L+   YM +G L++ + +      + +  I   + VA  ++YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYLAS 146

Query: 223 -HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----------HASKDGSICFEPVN 270
             F       HRD+ + N +LDE F  K+ADFGLA           H      +   PV 
Sbjct: 147 KKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL---PVK 197

Query: 271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                   +M  E + TQ+ T KSDV+S+GV+L E++T
Sbjct: 198 --------WMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  140 bits (354), Expect = 4e-38
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 50/227 (22%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGS------LIAVKRM-DKISEQVEGDFCREIELLARLHHR 164
            S  +GQG FG VY+              +A+K + +  S +   +F  E  ++   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHL--------HSPGRTPLSWQTRIQIAIDVA 216
           H+V L G   + +   ++ E M  G LK +L        ++P   P S    IQ+A ++A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 217 NALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 273
           + + YL    F       HRD+ + N ++ E+F  K+ DFG+                DI
Sbjct: 149 DGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTR--------------DI 188

Query: 274 RGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             T  Y            M PE +     T  SDV+S+GVVL EI T
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  138 bits (351), Expect = 4e-38
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 28/205 (13%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
               IG+G FG V    +  G+ +AVK + K     +  F  E  ++ +L H +LV L G
Sbjct: 25  LLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLG 81

Query: 172 FCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCD 227
             +E++    +  EYMA GSL D+L S GR+ L     ++ ++DV  A+EYL   +F   
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 138

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLA----HASKDGSICFEPVNTDIRGTPGYMDPE 283
               HRD+ + N+L+ E+ VAK++DFGL          G +   P    ++ T     PE
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---P----VKWTA----PE 184

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
            +  ++ + KSDV+S+G++L EI +
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYS 209

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  140 bits (354), Expect = 4e-38
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 50/224 (22%)

Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVA 168
           I+G+G FG+V +            +AVK  ++D  S++   +F  E   +    H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 169 LRGFCIEKRERFLMY-----EYMANGSLKDHL----HSPGRTPLSWQTRIQIAIDVANAL 219
           L G CIE   + +        +M  G L  +L       G   +  QT ++  +D+A  +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 220 EYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
           EYL   +F       HRD+ + N +L ++    +ADFGL+                I   
Sbjct: 161 EYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSK--------------KIYSG 200

Query: 277 PGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             Y            +  E +  +  T KSDV+++GV + EI T
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  139 bits (352), Expect = 4e-38
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 55/228 (24%)

Query: 116 IGQGGFGTVYKAQ------FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 169
           +G+G FG V+ A+        D  L+AVK +   +     DF RE ELL  L H H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQIAIDV 215
            G C +     +++EYM +G L   L +                +  L     + IA  +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 216 ANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD 272
           A+ + YL   HF       HRD+ + N L+  N + K+ DFG++               D
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSR--------------D 182

Query: 273 IRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +  T  Y            M PE ++ ++ T +SDV+S+GV+L EI T
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (352), Expect = 5e-38
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 24/210 (11%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHL 166
              +IG+G FG VY  ++ D +      A+K +      Q    F RE  L+  L+H ++
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 167 VALRGFCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL--- 222
           +AL G  +       +   YM +G L   + SP R   + +  I   + VA  +EYL   
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYLAEQ 143

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPG 278
            F       HRD+ + N +LDE+F  K+ADFGLA    D        +      ++ T  
Sbjct: 144 KF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA- 196

Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
               E + T   T KSDV+S+GV+L E++T
Sbjct: 197 ---LESLQTYRFTTKSDVWSFGVLLWELLT 223

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  141 bits (356), Expect = 5e-38
 Identities = 69/315 (21%), Positives = 118/315 (37%), Gaps = 41/315 (13%)

Query: 11  LVAVSPSQHMLAVPQNENHHPYHLTLIPGIGIAVTAVAVILLMVLIILIRRKSRGLEDPE 70
           +  + P  H                L+P     +  +  I  +   +  +  S  L    
Sbjct: 1   MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60

Query: 71  NLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFS 130
                       P  ++  Q                    +F+ +IG+G FG VY     
Sbjct: 61  ANTVHIDLSALNPELVQAVQH---------VVIGPSSLIVHFNEVIGRGHFGCVYHGTLL 111

Query: 131 DGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM-YE 184
           D        AVK +           F  E  ++    H ++++L G C+      L+   
Sbjct: 112 DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171

Query: 185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNIL 241
           YM +G L++ + +      + +  I   + VA  +++L    F       HRD+ + N +
Sbjct: 172 YMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCM 224

Query: 242 LDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           LDE F  K+ADFGLA         +  + +    PV         +M  E + TQ+ T K
Sbjct: 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK--------WMALESLQTQKFTTK 276

Query: 294 SDVYSYGVVLLEIVT 308
           SDV+S+GV+L E++T
Sbjct: 277 SDVWSFGVLLWELMT 291

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  139 bits (352), Expect = 6e-38
 Identities = 60/238 (25%), Positives = 92/238 (38%), Gaps = 64/238 (26%)

Query: 115 IIGQGGFGTVYKAQFSDG------SLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLV 167
            +G+G FG V KA           + +AVK + +  S     D   E  +L +++H H++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHL----------------------HSPGRTPLSW 205
            L G C +     L+ EY   GSL+  L                        P    L+ 
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 206 QTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 262
              I  A  ++  ++YL            HRD+ + NIL+ E    K++DFGL+      
Sbjct: 150 GDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSR----- 198

Query: 263 SICFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                    D+     Y            M  E +     T +SDV+S+GV+L EIVT
Sbjct: 199 ---------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (349), Expect = 7e-38
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 30/205 (14%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
            IG G FG V+   + +   +A+K + +     E DF  E E++ +L H  LV L G C+
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 231
           E+    L+ E+M +G L D+L +  R   + +T + + +DV   + YL            
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126

Query: 232 HRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPE 283
           HRD+ + N L+ EN V K++DFG+          +S        P    ++       PE
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF---P----VKWAS----PE 175

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
                  + KSDV+S+GV++ E+ +
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFS 200

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  142 bits (360), Expect = 7e-38
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 28/205 (13%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
               IG+G FG V    +  G+ +AVK + K     +  F  E  ++ +L H +LV L G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLG 253

Query: 172 FCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCD 227
             +E++    +  EYMA GSL D+L S GR+ L     ++ ++DV  A+EYL   +F   
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 310

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLA----HASKDGSICFEPVNTDIRGTPGYMDPE 283
               HRD+ + N+L+ E+ VAK++DFGL          G +   P    ++ T     PE
Sbjct: 311 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---P----VKWTA----PE 356

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
            +  ++ + KSDV+S+G++L EI +
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYS 381

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  138 bits (350), Expect = 9e-38
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 30/206 (14%)

Query: 115 IIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
            +G G +G VY+  +   SL +AVK + + + +VE +F +E  ++  + H +LV L G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPL 230
             +   +++ E+M  G+L D+L    R  +S    + +A  +++A+EYL   +F      
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF------ 132

Query: 231 CHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDP 282
            HRD+ + N L+ EN + K+ADFGL+         A         P+         +  P
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIK--------WTAP 181

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E +   + + KSDV+++GV+L EI T
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (359), Expect = 1e-37
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 16/201 (7%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
               +GQG FG V+   ++  + +A+K +   +   E  F +E +++ +L H  LV L  
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 246

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 228
              E+   +++ EYM+ GSL D L       L     + +A  +A+ + Y+   ++    
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 301

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVT 287
              HRD++++NIL+ EN V K+ADFGLA   +D      +     I+ T     PE  + 
Sbjct: 302 --VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALY 355

Query: 288 QELTEKSDVYSYGVVLLEIVT 308
              T KSDV+S+G++L E+ T
Sbjct: 356 GRFTIKSDVWSFGILLTELTT 376

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (347), Expect = 1e-37
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 30/205 (14%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
            +G G FG V   ++     +AVK + + S   + +F +E + + +L H  LV   G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 231
           ++   +++ EY++NG L ++L S G+  L     +++  DV   + +L    F       
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESHQF------I 126

Query: 232 HRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPE 283
           HRD+ + N L+D +   K++DFG+          +S        P    ++ +     PE
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF---P----VKWSA----PE 175

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
                + + KSDV+++G+++ E+ +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFS 200

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  142 bits (360), Expect = 1e-37
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 24/206 (11%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSL-IAVKRMDKISEQVEGDFCREIELLARLHHRHLVALR 170
               +G G +G VY+  +   SL +AVK + + + +VE +F +E  ++  + H +LV L 
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 282

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G C  +   +++ E+M  G+L D+L    R  +S    + +A  +++A+EYL        
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339

Query: 231 CHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDP 282
            HR++ + N L+ EN + K+ADFGL+         A         P+         +  P
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF---PIK--------WTAP 388

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E +   + + KSDV+++GV+L EI T
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIAT 414

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  138 bits (350), Expect = 1e-37
 Identities = 58/278 (20%), Positives = 110/278 (39%), Gaps = 38/278 (13%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDK--ISEQVEGDFCREIELLARL--HHRHLVALRG 171
           IG GG   V++       + A+K ++      Q    +  EI  L +L  H   ++ L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           + I  +  +++ E   N  L   L       +    R     ++  A+  +H      + 
Sbjct: 96  YEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIH---QHGIV 149

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE-------- 283
           H D+K +N L+ +  + KL DFG+A+  +  +     V     GT  YM PE        
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSS 206

Query: 284 ---YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES--AQVCMASESRLAELVD 338
                   +++ KSDV+S G +L  +   +   Q   N +    A +    E    ++ +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266

Query: 339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
             ++D            +++ C +R+ + R SI ++L 
Sbjct: 267 KDLQD------------VLKCCLKRDPKQRISIPELLA 292

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  137 bits (348), Expect = 1e-37
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 30/205 (14%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
            +G G FG V+   ++  + +AVK   K        F  E  L+ +L H+ LV L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 231
            +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++   ++       
Sbjct: 79  -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY------I 131

Query: 232 HRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPE 283
           HRD++++NIL+ +    K+ADFGLA         A +       P    I+ T     PE
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF---P----IKWTA----PE 180

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
            +     T KSDV+S+G++L EIVT
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (348), Expect = 1e-37
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 30/205 (14%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
            +G G FG V   ++     +A+K + + S   + +F  E +++  L H  LV L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLC 231
           ++R  F++ EYMANG L ++L    R     Q  +++  DV  A+EYL    F       
Sbjct: 90  KQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQF------L 142

Query: 232 HRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYMDPE 283
           HRD+ + N L+++  V K++DFGL+         +S        P    +R +P    PE
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF---P----VRWSP----PE 191

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
            ++  + + KSD++++GV++ EI +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS 216

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  137 bits (346), Expect = 3e-37
 Identities = 68/282 (24%), Positives = 117/282 (41%), Gaps = 30/282 (10%)

Query: 115 IIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 169
            +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE+L  L H ++V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 170 RGFCIEKRERFLMY--EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HF 224
           +G C     R L    EY+  GSL+D+L    +  +     +Q    +   +EYL    +
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKRY 135

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPGYM 280
                  HRD+ + NIL++     K+ DFGL          F+ V       I       
Sbjct: 136 ------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK-VKEPGESPIFWYA--- 185

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR 340
            PE +   + +  SDV+S+GVVL E+ T     +                  +   +   
Sbjct: 186 -PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

Query: 341 IKDSFDMEQLRT----IVTIVRWCTQREGQARPSIKQVLRIL 378
           +K++  + +       I  I+  C       RPS + +   +
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  140 bits (355), Expect = 3e-37
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 30/208 (14%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
               +G G FG V+ A ++  + +AVK   K        F  E  ++  L H  LV L  
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVK-TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 228
              ++    +  E+MA GSL D L S   +       I  +  +A  + ++   ++    
Sbjct: 251 VVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---- 305

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRGTPGYM 280
              HRD++++NIL+  + V K+ADFGLA         A +            I+ T    
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-------IKWTA--- 353

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            PE +     T KSDV+S+G++L+EIVT
Sbjct: 354 -PEAINFGSFTIKSDVWSFGILLMEIVT 380

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  138 bits (349), Expect = 6e-37
 Identities = 65/298 (21%), Positives = 117/298 (39%), Gaps = 68/298 (22%)

Query: 58  LIRRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATD------- 110
           +  R+   +    +    S  P     +        +PM    S  E  +          
Sbjct: 24  IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTA-DTPMLAGVSEYELPEDPKWEFPRDK 82

Query: 111 -NFSTIIGQGGFGTVYKA--------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLAR 160
                 +G+G FG V  A        +  +   +AVK + D  +E+   D   E+E++  
Sbjct: 83  LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 142

Query: 161 L-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL--------------HSPGRTPLSW 205
           +  H++++ L G C +    +++ EY + G+L+++L              +      +++
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 206 QTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 262
           +  +     +A  +EYL            HRD+ + N+L+ EN V K+ADFGLA      
Sbjct: 203 KDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLAR----- 251

Query: 263 SICFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                    DI     Y            M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 252 ---------DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  136 bits (345), Expect = 8e-37
 Identities = 73/226 (32%), Positives = 105/226 (46%), Gaps = 44/226 (19%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGS------LIAVKRMDKISEQVEGDFCREIELLARLHHRH 165
               +G+G FG V+ A+  +        L+AVK + + SE    DF RE ELL  L H+H
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHL--HSP-----------GRTPLSWQTRIQIA 212
           +V   G C E R   +++EYM +G L   L  H P              PL     + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 213 IDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA-------SKDG 262
             VA  + YL   HF       HRD+ + N L+ +  V K+ DFG++            G
Sbjct: 165 SQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 218

Query: 263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                P    IR    +M PE ++ ++ T +SDV+S+GVVL EI T
Sbjct: 219 RTML-P----IR----WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (355), Expect = 1e-36
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 16/201 (7%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRG 171
               +GQG FG V+   ++  + +A+K +   +   E  F +E +++ +L H  LV L  
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYA 329

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 228
              E+   +++ EYM+ GSL D L       L     + +A  +A+ + Y+   ++    
Sbjct: 330 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---- 384

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS-ICFEPVNTDIRGTPGYMDPEYVVT 287
              HRD++++NIL+ EN V K+ADFGLA   +D      +     I+ T     PE  + 
Sbjct: 385 --VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALY 438

Query: 288 QELTEKSDVYSYGVVLLEIVT 308
              T KSDV+S+G++L E+ T
Sbjct: 439 GRFTIKSDVWSFGILLTELTT 459

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  136 bits (345), Expect = 1e-36
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 59/232 (25%)

Query: 116 IGQGGFGTVYKA--------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 165
           +G+G FG V  A        +  +   +AVK + D  +E+   D   E+E++  +  H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHL--------------HSPGRTPLSWQTRIQI 211
           ++ L G C +    +++ EY + G+L+++L              +      ++++  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 212 AIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
              +A  +EYL            HRD+ + N+L+ EN V K+ADFGLA            
Sbjct: 163 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLAR----------- 205

Query: 269 VNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
              DI     Y            M PE +  +  T +SDV+S+GV++ EI T
Sbjct: 206 ---DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  136 bits (344), Expect = 1e-36
 Identities = 67/283 (23%), Positives = 117/283 (41%), Gaps = 32/283 (11%)

Query: 115 IIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 169
            +G+G FG+V   ++     + G ++AVK++   +E+   DF REIE+L  L H ++V  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 170 RGFCIEKRERFLM--YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HF 224
           +G C     R L    EY+  GSL+D+L       +     +Q    +   +EYL    +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKRY 166

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----Y 279
                  HRD+ + NIL++     K+ DFGL          ++         PG     +
Sbjct: 167 ------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV------KEPGESPIFW 214

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 339
             PE +   + +  SDV+S+GVVL E+ T     +                  +   +  
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 340 RIKDSFDMEQLRT----IVTIVRWCTQREGQARPSIKQVLRIL 378
            +K++  + +       I  I+  C       RPS + +   +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  135 bits (343), Expect = 2e-36
 Identities = 76/225 (33%), Positives = 108/225 (48%), Gaps = 45/225 (20%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSL---IAVKRM-DKISEQVEGDFCREIELLARL-HHRHL 166
           F  +IG+G FG V KA+     L    A+KRM +  S+    DF  E+E+L +L HH ++
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQIA 212
           + L G C  +   +L  EY  +G+L D L                   + LS Q  +  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 213 IDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA------HASKDGS 263
            DVA  ++YL    F       HRD+ + NIL+ EN+VAK+ADFGL+           G 
Sbjct: 149 ADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 202

Query: 264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +   PV         +M  E +     T  SDV+SYGV+L EIV+
Sbjct: 203 L---PVR--------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  136 bits (344), Expect = 2e-36
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 72/289 (24%)

Query: 72  LDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATD--------NFSTIIGQGGFGT 123
           ++  ++     P  L   +  P+PM+Q+       K            +   IG+G FG 
Sbjct: 3   MESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGR 62

Query: 124 VYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK 176
           V++A+      +   +++AVK + ++ S  ++ DF RE  L+A   + ++V L G C   
Sbjct: 63  VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122

Query: 177 RERFLMYEYMANGSLKDHLHS----------------------PGRTPLSWQTRIQIAID 214
           +   L++EYMA G L + L S                      PG  PLS   ++ IA  
Sbjct: 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182

Query: 215 VANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           VA  + YL    F       HRD+ + N L+ EN V K+ADFGL+               
Sbjct: 183 VAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSR-------------- 222

Query: 272 DIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +I     Y            M PE +     T +SDV++YGVVL EI +
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  135 bits (342), Expect = 2e-36
 Identities = 54/203 (26%), Positives = 81/203 (39%), Gaps = 21/203 (10%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G+G FG V++ +    G   AVK++      +E     E+   A L    +V L G   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR-----LEVFRVEELVACAGLSSPRIVPLYGAVR 120

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 231
           E     +  E +  GSL   +   G  P       +           LEYLH      + 
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPED-----RALYYLGQALEGLEYLH---TRRIL 172

Query: 232 HRDIKSSNILLDEN-FVAKLADFGLA-HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           H D+K+ N+LL  +   A L DFG A     DG          I GT  +M PE VV  +
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGK 231

Query: 290 -LTEKSDVYSYGVVLLEIVTARR 311
               K D++S   ++L ++    
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCH 254

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  134 bits (339), Expect = 3e-36
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 21/206 (10%)

Query: 115 IIGQGGFGTVYKAQF-----SDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
            +G+G FG V   ++     + G  +AVK +  +       D  +EIE+L  L+H ++V 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 169 LRGFCIEKRERFLM--YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
            +G C E     +    E++ +GSLK++L       ++ + +++ A+ +   ++YL    
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLG--- 143

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPGYMDP 282
                HRD+ + N+L++     K+ DFGL  A +     +  V  D    +        P
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT-VKDDRDSPVFWYA----P 198

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVT 308
           E ++  +    SDV+S+GV L E++T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (341), Expect = 4e-36
 Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 36/292 (12%)

Query: 115 IIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 169
            +G+G FG+V   ++     + G+L+AVK++       + DF REI++L  LH   +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 170 RGFCIEKRERFLMY--EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HF 224
           RG       + L    EY+ +G L+D L       L     +  +  +   +EYL     
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRC 148

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----Y 279
                  HRD+ + NIL++     K+ADFGLA         +          PG     +
Sbjct: 149 ------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV------REPGQSPIFW 196

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 339
             PE +     + +SDV+S+GVVL E+ T                 C      L+ L++ 
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE- 255

Query: 340 RIKDSFDMEQLRT----IVTIVRWCTQREGQARPS---IKQVLRILYESSDP 384
            +++   +         +  +++ C     Q RPS   +   L +L+  S  
Sbjct: 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  133 bits (337), Expect = 5e-36
 Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 56/233 (24%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGS------LIAVKRM-DKISEQVEGDFCREIELLARLHHR 164
           F   +G+  FG VYK      +       +A+K + DK    +  +F  E  L ARL H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQ 210
           ++V L G   + +   +++ Y ++G L + L                  ++ L     + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 211 IAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 267
           +   +A  +EYL   H        H+D+ + N+L+ +    K++D GL            
Sbjct: 133 LVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFR---------- 176

Query: 268 PVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
               ++     Y            M PE ++  + +  SD++SYGVVL E+ +
Sbjct: 177 ----EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  134 bits (339), Expect = 6e-36
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 23/205 (11%)

Query: 115 IIGQGGFGTVYKAQFSDGSL-----IAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
           ++G G FGTVYK  +          +A+K + +  S +   +   E  ++A + + H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFY 225
           L G C+      L+ + M  G L D++       +  Q  +   + +A  + YL      
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRL- 138

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPE 283
                 HRD+ + N+L+      K+ DFGLA         +        I+    +M  E
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALE 189

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
            ++ +  T +SDV+SYGV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  134 bits (340), Expect = 6e-36
 Identities = 56/232 (24%), Positives = 89/232 (38%), Gaps = 55/232 (23%)

Query: 112 FSTIIGQGGFGTVYKA------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 163
           F   +G G FG V +A      +      +AVK +        +     E+++++ L  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS------------PGRTPLSWQTRIQI 211
            ++V L G C       ++ EY   G L + L                 +  S +  +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 212 AIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           +  VA  + +L   +        HRD+ + N+LL    VAK+ DFGLA            
Sbjct: 170 SSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLAR----------- 212

Query: 269 VNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
              DI     Y            M PE +     T +SDV+SYG++L EI +
Sbjct: 213 ---DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  134 bits (338), Expect = 8e-36
 Identities = 54/212 (25%), Positives = 85/212 (40%), Gaps = 27/212 (12%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGF 172
           I+GQG    V++ +    G L A+K  + IS  +      RE E+L +L+H+++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 173 CIEKRERFLMY---EYMANGSLKDHLHSPGRT-PLSWQTRIQIAIDVANALEYLHFYCDP 228
             E+          E+   GSL   L  P     L     + +  DV   + +L    + 
Sbjct: 76  -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131

Query: 229 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
            + HR+IK  NI+     D   V KL DFG A   +D           + GT  Y+ P+ 
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-----VSLYGTEEYLHPDM 186

Query: 285 V--------VTQELTEKSDVYSYGVVLLEIVT 308
                      ++     D++S GV      T
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  133 bits (337), Expect = 9e-36
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 29/209 (13%)

Query: 115 IIGQGGFGTVYKAQF-----SDGSLIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
            +G+G FG V    +       G ++AVK +      Q    + +EI++L  L+H H++ 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 169 LRGFCIEKRERFLM--YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---H 223
            +G C +     L    EY+  GSL+D+L    R  +     +  A  +   + YL   H
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQH 154

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD----IRGTPGY 279
           +       HRD+ + N+LLD + + K+ DFGLA A  +G   +  V  D    +     +
Sbjct: 155 Y------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDSPVF----W 203

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             PE +   +    SDV+S+GV L E++T
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLT 232

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (337), Expect = 1e-35
 Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 36/220 (16%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGS------LIAVKRM-DKISEQVEGDFCREIELLARLHHR 164
               +G G FG VY+ Q S          +AVK + +  SEQ E DF  E  ++++ +H+
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHL-----HSPGRTPLSWQTRIQIAIDVANAL 219
           ++V   G  ++   RF++ E MA G LK  L          + L+    + +A D+A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 220 EYL---HFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDI 273
           +YL   HF       HRDI + N LL       VAK+ DFG+A      S          
Sbjct: 154 QYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-------R 200

Query: 274 RGTPGY-----MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +G         M PE  +    T K+D +S+GV+L EI +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  133 bits (337), Expect = 2e-35
 Identities = 64/249 (25%), Positives = 109/249 (43%), Gaps = 34/249 (13%)

Query: 75  TSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGS- 133
           T+   +            P+    KF   E   +      +IG G FG VYK      S 
Sbjct: 16  TTENLYFQGAM----GSDPNQAVLKF-TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG 70

Query: 134 ----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN 188
                +A+K +    +E+   DF  E  ++ +  H +++ L G   + +   ++ EYM N
Sbjct: 71  KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMEN 130

Query: 189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDEN 245
           G+L   L        S    + +   +A  ++YL   ++       HRD+ + NIL++ N
Sbjct: 131 GALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNY------VHRDLAARNILVNSN 183

Query: 246 FVAKLADFGLAHASKDGSICFEPVNTD------IRGTPGYMDPEYVVTQELTEKSDVYSY 299
            V K++DFGL+   +D     E   T       IR T     PE +  ++ T  SDV+S+
Sbjct: 184 LVCKVSDFGLSRVLEDDP---EATYTTSGGKIPIRWTA----PEAISYRKFTSASDVWSF 236

Query: 300 GVVLLEIVT 308
           G+V+ E++T
Sbjct: 237 GIVMWEVMT 245

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (335), Expect = 2e-35
 Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 58/235 (24%)

Query: 112 FSTIIGQGGFGTVYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 163
               +G+G FG V +A        +    +AVK + +  +         E+++L  + HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 164 RHLVALRGFCIEKRE-RFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTR 208
            ++V L G C +      ++ E+   G+L  +L S                +  L+ +  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 209 IQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 265
           I  +  VA  +E+L            HRD+ + NILL E  V K+ DFGLA         
Sbjct: 151 ICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLAR-------- 196

Query: 266 FEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                 DI   P Y            M PE +  +  T +SDV+S+GV+L EI +
Sbjct: 197 ------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (336), Expect = 2e-35
 Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 23/241 (9%)

Query: 80  FPPPRSLRKFQEGPSPMFQKFSY-KETKKATDNFSTIIGQGGFGTVYKAQFSDGS----L 134
            P P+   +      P     S+ +E + +  +   IIG G  G V   +          
Sbjct: 20  LPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVP 79

Query: 135 IAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKD 193
           +A+K +    +E+   DF  E  ++ +  H +++ L G     R   ++ EYM NGSL  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139

Query: 194 HLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKL 250
            L +      +    + +   V   + YL    +       HRD+ + N+L+D N V K+
Sbjct: 140 FLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKV 192

Query: 251 ADFGLAHASKDGSICFEPVNTD---IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIV 307
           +DFGL+   +D              IR T     PE +  +  +  SDV+S+GVV+ E++
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEAIAFRTFSSASDVWSFGVVMWEVL 248

Query: 308 T 308
            
Sbjct: 249 A 249

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  134 bits (338), Expect = 2e-35
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 59/232 (25%)

Query: 116 IGQGGFGTVYKA--------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HHRH 165
           +G+G FG V  A        + +  + +AVK +    +E+   D   E+E++  +  H++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHS--------------PGRTPLSWQTRIQI 211
           ++ L G C +    +++ EY + G+L+++L +                   LS +  +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 212 AIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
           A  VA  +EYL            HRD+ + N+L+ E+ V K+ADFGLA            
Sbjct: 197 AYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLAR----------- 239

Query: 269 VNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
              DI     Y            M PE +  +  T +SDV+S+GV+L EI T
Sbjct: 240 ---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  131 bits (333), Expect = 3e-35
 Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 41/297 (13%)

Query: 116 IGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQVEGD------FCREIELLARLHHRHL 166
           +G GG  TVY A+  D  L   +A+K +                F RE+   ++L H+++
Sbjct: 19  LGGGGMSTVYLAE--DTILNIKVAIKAIF---IPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
           V++     E    +L+ EY+   +L +++ S G  PLS  T I     + + +++ H   
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH--- 128

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD-IRGTPGYMDPEYV 285
           D  + HRDIK  NIL+D N   K+ DFG+A A  + S+      T+ + GT  Y  PE  
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL----TQTNHVLGTVQYFSPEQA 184

Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA----QVCMASESRLAELVDPRI 341
             +   E +D+YS G+VL E++       +G+  V  A    Q  + + +     V   I
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPF-NGETAVSIAIKHIQDSVPNVTT---DVRKDI 240

Query: 342 KDSFDMEQLRTIVTIVRWCTQREGQARP-SIKQVLRILYESSDPMHSGFVQAVEDEE 397
             S           ++   T+++   R  +I+++   L        +       D+ 
Sbjct: 241 PQSLS--------NVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKM 289

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  131 bits (333), Expect = 3e-35
 Identities = 55/236 (23%), Positives = 86/236 (36%), Gaps = 59/236 (25%)

Query: 112 FSTIIGQGGFGTVYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 163
           F   +G G FG V +A             +AVK +              E+++L+ L +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHL----------------HSPGRTPLSWQT 207
            ++V L G C       ++ EY   G L + L                       L  + 
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 208 RIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 264
            +  +  VA  + +L   +        HRD+ + NILL    + K+ DFGLA        
Sbjct: 147 LLSFSYQVAKGMAFLASKNC------IHRDLAARNILLTHGRITKICDFGLAR------- 193

Query: 265 CFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                  DI+    Y            M PE +     T +SDV+SYG+ L E+ +
Sbjct: 194 -------DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  131 bits (331), Expect = 5e-35
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 14/203 (6%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           ++G+G +G VY  +       IA+K + +   +       EI L   L H+++V   G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 174 IEKRERFLMYEYMANGSLKDHL-HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
            E     +  E +  GSL   L    G    + QT       +   L+YLH   D  + H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 233 RDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL- 290
           RDIK  N+L++  + V K++DFG +      +    P      GT  YM PE ++ +   
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGIN----PCTETFTGTLQYMAPE-IIDKGPR 200

Query: 291 --TEKSDVYSYGVVLLEIVTARR 311
              + +D++S G  ++E+ T + 
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKP 223

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  132 bits (334), Expect = 7e-35
 Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 29/232 (12%)

Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISE 145
           E P+    +F+ KE      +   ++G G FG V   +    S     +A+K +    +E
Sbjct: 29  EDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87

Query: 146 QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
           +   DF  E  ++ +  H +++ L G   + +   ++ EYM NGSL   L        + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTV 146

Query: 206 QTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG 262
              + +   +A+ ++YL    +       HRD+ + NIL++ N V K++DFGL    +D 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200

Query: 263 SICFEPVNTD------IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
               E   T       IR T     PE +  ++ T  SDV+SYG+VL E+++
Sbjct: 201 P---EAAYTTRGGKIPIRWTS----PEAIAYRKFTSASDVWSYGIVLWEVMS 245

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (333), Expect = 8e-35
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 36/217 (16%)

Query: 115 IIGQGGFGTVYKAQFSDGS------LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLV 167
            +G G FG VY+ Q S          +AVK + +  SEQ E DF  E  ++++ +H+++V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHL-----HSPGRTPLSWQTRIQIAIDVANALEYL 222
              G  ++   RF++ E MA G LK  L          + L+    + +A D+A   +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 223 ---HFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
              HF       HRDI + N LL       VAK+ DFG+A                 +G 
Sbjct: 198 EENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-------RKGG 244

Query: 277 PGY-----MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                   M PE  +    T K+D +S+GV+L EI +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  130 bits (330), Expect = 9e-35
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 28/208 (13%)

Query: 116 IGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQVEGD------FCREIELLARLHHRHL 166
           +G+GG G VY+A+  D      +A+K M   SE +  D        RE     RL   H+
Sbjct: 42  VGRGGMGDVYEAE--DTVRERIVALKLM---SETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
           V +  F     + ++    +    L   L   G  PL+    + I   + +AL+  H   
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH--- 151

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT---DIRGTPGYMDPE 283
                HRD+K  NIL+  +  A L DFG+A A+ D  +      T   +  GT  YM PE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL------TQLGNTVGTLYYMAPE 205

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARR 311
                  T ++D+Y+   VL E +T   
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSP 233

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (329), Expect = 2e-34
 Identities = 60/241 (24%), Positives = 93/241 (38%), Gaps = 64/241 (26%)

Query: 112 FSTIIGQGGFGTVYKAQ------FSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 163
           F  ++G G FG V  A             +AVK + +K           E++++ +L  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS---------------------PGRTP 202
            ++V L G C      +L++EY   G L ++L S                          
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 203 LSWQTRIQIAIDVANALEYL---HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 259
           L+++  +  A  VA  +E+L            HRD+ + N+L+    V K+ DFGLA   
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSC------VHRDLAARNVLVTHGKVVKICDFGLAR-- 220

Query: 260 KDGSICFEPVNTDIRGTPGY------------MDPEYVVTQELTEKSDVYSYGVVLLEIV 307
                       DI     Y            M PE +     T KSDV+SYG++L EI 
Sbjct: 221 ------------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

Query: 308 T 308
           +
Sbjct: 269 S 269

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (331), Expect = 2e-34
 Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 27/212 (12%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGD-FCREIELLARLHHRHLVALRGF 172
           I+GQG    V++ +    G L A+K  + IS     D   RE E+L +L+H+++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 173 CIEKRERFLMY---EYMANGSLKDHLHSPGRT-PLSWQTRIQIAIDVANALEYLHFYCDP 228
             E+          E+   GSL   L  P     L     + +  DV   + +L    + 
Sbjct: 76  -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131

Query: 229 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
            + HR+IK  NI+     D   V KL DFG A   +D             GT  Y+ P+ 
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-----GTEEYLHPDM 186

Query: 285 V--------VTQELTEKSDVYSYGVVLLEIVT 308
                      ++     D++S GV      T
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  128 bits (323), Expect = 4e-34
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 29/210 (13%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSL----IAVKRM-DKISEQVEGDFCREIELLARLHHRHL 166
            + I+G+G FG VY+  +++       +AVK      +   +  F  E  ++  L H H+
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---H 223
           V L G   E+   +++ E    G L  +L     + L   T +  ++ +  A+ YL   +
Sbjct: 76  VKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESIN 133

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG----- 278
                   HRDI   NIL+      KL DFGL+   +D            + +       
Sbjct: 134 C------VHRDIAVRNILVASPECVKLGDFGLSRYIED--------EDYYKASVTRLPIK 179

Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           +M PE +  +  T  SDV+ + V + EI++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS 209

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (327), Expect = 6e-34
 Identities = 75/335 (22%), Positives = 126/335 (37%), Gaps = 55/335 (16%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLARLHHRHLVALRG-F 172
           +G G  G V+K      G ++A K +  +I   +     RE+++L   +  ++V   G F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
             +      M E+M  GSL   L   GR P     ++  +I V   L YL       + H
Sbjct: 101 YSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKV--SIAVIKGLTYLR--EKHKIMH 155

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RD+K SNIL++     KL DFG++      S+     N+ + GT  YM PE +     + 
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVS-GQLIDSMA----NSFV-GTRSYMSPERLQGTHYSV 209

Query: 293 KSDVYSYGVVLLEIVTAR----------RAVQDGKNLVESAQVCMASESRLAELVDPRIK 342
           +SD++S G+ L+E+   R            +  G  +   A             ++    
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269

Query: 343 DSFDM----EQLRTIVT-----------------IVRWCTQREGQARPSIKQVLR----I 377
           DS       E L  IV                   V  C  +    R  +KQ++      
Sbjct: 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329

Query: 378 LYESSDPMHSGFVQAVEDEEYEETDGRPRTSQRKA 412
             ++ +   +G++ +           +P T    A
Sbjct: 330 RSDAEEVDFAGWLCSTIGLN------QPSTPTHAA 358

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  129 bits (326), Expect = 6e-34
 Identities = 57/258 (22%), Positives = 101/258 (39%), Gaps = 43/258 (16%)

Query: 82  PPRSLRKFQEGPSPMFQKFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQFSDGSLIAVK 138
           P  S++      S +     Y + K    +++  I  + QG F  +   +  D    A+K
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60

Query: 139 RMDK-----------------ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 181
           + +K                   +    DF  E++++  + + + +   G      E ++
Sbjct: 61  KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120

Query: 182 MYEYMANGSLKDHLHSPGRTPLSWQTRI------QIAIDVANALEYLHFYCDPPLCHRDI 235
           +YEYM N S+            ++   I       I   V N+  Y+H   +  +CHRD+
Sbjct: 121 IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDV 178

Query: 236 KSSNILLDENFVAKLADFGLAHASKDG---SICFEPVNTDIRGTPGYMDPEYVVTQELT- 291
           K SNIL+D+N   KL+DFG +    D                GT  +M PE+   +    
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR---------GTYEFMPPEFFSNESSYN 229

Query: 292 -EKSDVYSYGVVLLEIVT 308
             K D++S G+ L  +  
Sbjct: 230 GAKVDIWSLGICLYVMFY 247

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  127 bits (322), Expect = 7e-34
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVAL 169
            IG+G FG V++  +         +A+K   +  S+ V   F +E   + +  H H+V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYC 226
            G   E    +++ E    G L+  L     + L   + I  A  ++ AL YL    F  
Sbjct: 82  IGVITENP-VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRF-- 137

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----YMD 281
                HRDI + N+L+  N   KL DFGL+   +D +          + + G     +M 
Sbjct: 138 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--------YKASKGKLPIKWMA 185

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +  +  T  SDV+ +GV + EI+ 
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  127 bits (322), Expect = 8e-34
 Identities = 57/289 (19%), Positives = 100/289 (34%), Gaps = 56/289 (19%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK--ISEQVEGDFCREIELLARL-HHRHLVALRG 171
           IG G FG+V+K     DG + A+KR  K       E +  RE+   A L  H H+V    
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78

Query: 172 FCIEKRERFLMY-EYMANGSLKDHLHSPGRT--PLSWQTRIQIAIDVANALEYLHFYCDP 228
               + +  L+  EY   GSL D +    R            + + V   L Y+H     
Sbjct: 79  -AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134

Query: 229 PLCHRDIKSSNILLDEN-------------------FVAKLADFGLAHASKDGSICFEPV 269
            L H DIK SNI +                       + K+ D G         +     
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE---- 190

Query: 270 NTDIRGTPGYMDPEYVVTQEL--TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 327
                G   ++  E V+ +      K+D+++  + ++    A    ++G           
Sbjct: 191 ----EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-------- 237

Query: 328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                + +   PRI      ++      +++     + + RPS   +++
Sbjct: 238 ---HEIRQGRLPRIPQVLS-QEFT---ELLKVMIHPDPERRPSAMALVK 279

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  126 bits (320), Expect = 1e-33
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 24/205 (11%)

Query: 115 IIGQGGFGTVYKAQFSDGSL---IAVK--RMDKISEQVEGDFCREIELLARLHHRHLVAL 169
            +G G FGTV K  +    +   +AVK  + +     ++ +   E  ++ +L + ++V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYC 226
            G C E     L+ E    G L  +L             I++   V+  ++YL   +F  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYLEESNF-- 138

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD---IRGTPGYMDPE 283
                HRD+ + N+LL     AK++DFGL+ A +     ++        ++       PE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PE 190

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
            +   + + KSDV+S+GV++ E  +
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  127 bits (322), Expect = 2e-33
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 23/205 (11%)

Query: 115 IIGQGGFGTVYKAQFSDGS-----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVA 168
           ++G G FGTVYK  +          +A+K + +  S +   +   E  ++A + + H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFY 225
           L G C+      L+ + M  G L D++       +  Q  +   + +A  + YL      
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRL- 138

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD--IRGTPGYMDPE 283
                 HRD+ + N+L+      K+ DFGLA         +        I+    +M  E
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALE 189

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
            ++ +  T +SDV+SYGV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  126 bits (319), Expect = 2e-33
 Identities = 54/201 (26%), Positives = 86/201 (42%), Gaps = 30/201 (14%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G+G F  VY+A+    G  +A+K +DK       +      E+++  +L H  ++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 172 FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRI---QIAIDVANALEYLHFYCD 227
              E     +L+ E   NG +  +L +  +     + R    QI       + YLH +  
Sbjct: 79  -YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII----TGMLYLHSHG- 132

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGS----ICFEPVNTDIRGTPGYMDP 282
             + HRD+  SN+LL  N   K+ADFGLA            +C         GTP Y+ P
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---------GTPNYISP 181

Query: 283 EYVVTQELTEKSDVYSYGVVL 303
           E         +SDV+S G + 
Sbjct: 182 EIATRSAHGLESDVWSLGCMF 202

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  125 bits (317), Expect = 3e-33
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 21/200 (10%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G+G FG VY A+      ++A+K + K       VE    RE+E+ + L H +++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +    +L+ EY   G++   L    +     +T   I  ++ANAL Y H      + 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATYIT-ELANALSYCHSKR---VI 131

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDG---SICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+LL      K+ADFG +  +       +C         GT  Y+ PE +  +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---------GTLDYLPPEMIEGR 182

Query: 289 ELTEKSDVYSYGVVLLEIVT 308
              EK D++S GV+  E + 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLV 202

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  125 bits (315), Expect = 7e-33
 Identities = 47/207 (22%), Positives = 90/207 (43%), Gaps = 30/207 (14%)

Query: 116 IGQGGFGTVYKAQFSDGS---LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G G FG+V +  +        +A+K +     +    +  RE +++ +L + ++V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 228
            C +     L+ E    G L   L       +      ++   V+  ++YL   +F    
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF---- 131

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-------PVNTDIRGTPGYMD 281
              HRD+ + N+LL     AK++DFGL+ A       +        P    ++       
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP----LKWYA---- 181

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +  ++ + +SDV+SYGV + E ++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  130 bits (328), Expect = 7e-33
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 20/219 (9%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVAL--- 169
            +G GGFG V +      G  +A+K+  + +S +    +C EI+++ +L+H ++V+    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 170 ---RGFCIEKRERFLMYEYMANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFY 225
                         L  EY   G L+ +L+       L       +  D+++AL YLH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-- 138

Query: 226 CDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
            +  + HRD+K  NI+L    +  + K+ D G A     G +C     T+  GT  Y+ P
Sbjct: 139 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-----TEFVGTLQYLAP 192

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE 321
           E +  ++ T   D +S+G +  E +T  R        V+
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  127 bits (321), Expect = 1e-32
 Identities = 61/275 (22%), Positives = 107/275 (38%), Gaps = 35/275 (12%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGF 172
           ++G G  GT+      D   +AVKR+        +    RE++LL     H +++    F
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPNVIRY--F 84

Query: 173 CIEKRERFLMY---EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
           C EK  +F  Y   E  A  +L++++       L  +    +     + L +LH      
Sbjct: 85  CTEKDRQFQ-YIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLH---SLN 138

Query: 230 LCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
           + HRD+K  NIL+          A ++DFGL      G   F   +    GT G++ PE 
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEM 197

Query: 285 V---VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI 341
           +     +  T   D++S G V   +++            ++  +  A      + + P  
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS---LDCLHPEK 254

Query: 342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
            +     +L      +      + Q RPS K VL+
Sbjct: 255 HEDVIAREL------IEKMIAMDPQKRPSAKHVLK 283

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  124 bits (314), Expect = 1e-32
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 20/199 (10%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G G FG VYKA+    G+L A K ++  SE+   D+  EIE+LA   H ++V L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 231
              + ++M E+   G++   +       L   T  QI +    +  AL +LH      + 
Sbjct: 87  HDGKLWIMIEFCPGGAVDA-IMLELDRGL---TEPQIQVVCRQMLEALNFLH---SKRII 139

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           HRD+K+ N+L+      +LADFG++  +       +  ++ I GTP +M PE V+ + + 
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---LQKRDSFI-GTPYWMAPEVVMCETMK 195

Query: 292 E-----KSDVYSYGVVLLE 305
           +     K+D++S G+ L+E
Sbjct: 196 DTPYDYKADIWSLGITLIE 214

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  125 bits (315), Expect = 1e-32
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 37/215 (17%)

Query: 112 FSTIIGQGGFGTVYKAQFSDGSL-----IAVKRM-DKISEQVEGDFCREIELLARLHHRH 165
              ++G G FGTV+K  +          + +K + DK   Q        +  +  L H H
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL--- 222
           +V L G C       L+ +Y+  GSL DH+    R  L  Q  +   + +A  + YL   
Sbjct: 77  IVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA---------HASKDGSICFEPVNTDI 273
                    HR++ + N+LL      ++ADFG+A             +      P+    
Sbjct: 135 GM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT---PIK--- 182

Query: 274 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                +M  E +   + T +SDV+SYGV + E++T
Sbjct: 183 -----WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  123 bits (311), Expect = 2e-32
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 39/214 (18%)

Query: 115 IIGQGGFGTVYKAQF--SDGSLI--AVK--RMDKISEQ-VEGDFCREIELLARLHHRHLV 167
            +G G FG V + ++    G  +  AVK  + D +S+     DF RE+  +  L HR+L+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 168 ALRGFCIEKRERFLMY---EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL-- 222
            L G  +       M    E    GSL D L           T  + A+ VA  + YL  
Sbjct: 85  RLYGVVLTPP----MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLES 139

Query: 223 -HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-------PVNTDIR 274
             F       HRD+ + N+LL    + K+ DFGL  A       +        P      
Sbjct: 140 KRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP----FA 189

Query: 275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                  PE + T+  +  SD + +GV L E+ T
Sbjct: 190 WCA----PESLKTRTFSHASDTWMFGVTLWEMFT 219

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  126 bits (318), Expect = 3e-32
 Identities = 71/312 (22%), Positives = 119/312 (38%), Gaps = 60/312 (19%)

Query: 101 SYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLAR 160
           +++++ K       I+G G  GTV       G  +AVKRM             EI+LL  
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTE 64

Query: 161 L-HHRHLVALRGFCIEKRERFLMYEYMA----NGSLKDHLHSPGRTPLSWQTR-----IQ 210
              H +++    +C E  +RFL   Y+A    N +L+D + S   +  + + +     I 
Sbjct: 65  SDDHPNVIRY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-------------ENFVAKLADFGLAH 257
           +   +A+ + +LH      + HRD+K  NIL+              EN    ++DFGL  
Sbjct: 120 LLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176

Query: 258 ASKDGSICFEPVNTDIRGTPGYMDPE-------YVVTQELTEKSDVYSYGVVLLEIVTAR 310
               G   F     +  GT G+  PE           + LT   D++S G V   I++  
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 311 RAVQDGKNLVESAQVCMA--SESRLAELVDPRI----KDSFDMEQLRTIVTIVRWCTQRE 364
           +     K   E + +     S   +  L D  +     D            ++      +
Sbjct: 237 KHPFGDKYSRE-SNIIRGIFSLDEMKCLHDRSLIAEATD------------LISQMIDHD 283

Query: 365 GQARPSIKQVLR 376
              RP+  +VLR
Sbjct: 284 PLKRPTAMKVLR 295

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (323), Expect = 4e-32
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 115 IIGQGGFGTVYKAQFSDGS----LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVAL 169
            IG+G FG V++  +         +A+K   +  S+ V   F +E   + +  H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYC 226
            G   E    +++ E    G L+  L    +  L   + I  A  ++ AL YL    F  
Sbjct: 457 IGVITENP-VWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRF-- 512

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG-----YMD 281
                HRDI + N+L+  N   KL DFGL+   +D +          + + G     +M 
Sbjct: 513 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--------YKASKGKLPIKWMA 560

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +  +  T  SDV+ +GV + EI+ 
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILM 587

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  125 bits (315), Expect = 4e-32
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 25/209 (11%)

Query: 116 IGQG--GFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALR 170
           IG+G     TV  A++   G  + V+R++    S ++      E+ +    +H ++V  R
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCD 227
              I   E +++  +MA GS KD + +     ++    + IA     V  AL+Y+H    
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLKALDYIH---H 146

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDP 282
               HR +K+S+IL+  +    L+          H  +   +   P          ++ P
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP--KYSVKVLPWLSP 204

Query: 283 EYVVTQEL---TEKSDVYSYGVVLLEIVT 308
           E V+ Q L     KSD+YS G+   E+  
Sbjct: 205 E-VLQQNLQGYDAKSDIYSVGITACELAN 232

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (311), Expect = 4e-32
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 116 IGQGGFGTVYKAQFSDGSL---IAVKRMDKISEQVEGD------FCREIELLARLHHRHL 166
           +G GG   V+ A+  D      +AVK +      +  D      F RE +  A L+H  +
Sbjct: 20  LGFGGMSEVHLAR--DLRDHRDVAVKVLR---ADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 167 VALRGFCIEKRERFLMY----EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
           VA+      +     +     EY+   +L+D +H+ G  P++ +  I++  D   AL + 
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFS 132

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
           H      + HRD+K +NI++      K+ DFG+A A  D           + GT  Y+ P
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSP 188

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTARR 311
           E      +  +SDVYS G VL E++T   
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  122 bits (308), Expect = 5e-32
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 21/200 (10%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G+G FG VY A+   +  ++A+K + K     E VE    REIE+ + L H +++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
           +  +++  +LM E+   G L   L   GR     ++   +  ++A+AL Y H      + 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFME-ELADALHYCHERK---VI 136

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDG---SICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HRDIK  N+L+      K+ADFG +  +      ++C         GT  Y+ PE +  +
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---------GTLDYLPPEMIEGK 187

Query: 289 ELTEKSDVYSYGVVLLEIVT 308
              EK D++  GV+  E + 
Sbjct: 188 THDEKVDLWCAGVLCYEFLV 207

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  121 bits (306), Expect = 2e-31
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 22/230 (9%)

Query: 85  SLRKFQEGPSPMFQKFSYKETKKATD---NFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK 138
           SL   Q    P  Q     E          F  +  +G+G +G+VYKA     G ++A+K
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 139 RMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSP 198
           ++  +   ++ +  +EI ++ +    H+V   G   +  + +++ EY   GS+ D +   
Sbjct: 61  QVP-VESDLQ-EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118

Query: 199 GRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 255
            +  L   T  +IA         LEYLH        HRDIK+ NILL+    AKLADFG+
Sbjct: 119 NK-TL---TEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171

Query: 256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLE 305
           A      ++     NT I GTP +M PE +        +D++S G+  +E
Sbjct: 172 A-GQLTDTMA--KRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  121 bits (305), Expect = 2e-31
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 21/198 (10%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           IGQG  GTVY A   + G  +A+++M+   +  +     EI ++    + ++V      +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 231
              E +++ EY+A GSL D +     T +      QIA    +   ALE+LH      + 
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE---TCM---DEGQIAAVCRECLQALEFLH---SNQVI 138

Query: 232 HRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV--NTDIRGTPGYMDPEYVVTQE 289
           HRDIKS NILL  +   KL DFG         I  E    +T + GTP +M PE V  + 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192

Query: 290 LTEKSDVYSYGVVLLEIV 307
              K D++S G++ +E++
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (306), Expect = 4e-31
 Identities = 41/251 (16%), Positives = 78/251 (31%), Gaps = 29/251 (11%)

Query: 81  PPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSD------G 132
            P  S     E    +       E +  +        +G+G F  VY+A   D       
Sbjct: 36  KPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNK 95

Query: 133 SLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK 192
               +K     +        + +E L        +      + +    L+ E  + G+L 
Sbjct: 96  QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155

Query: 193 DHLHSPGRT---PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL------- 242
           + ++    T    +     I  A+ +   +E +H   D  + H DIK  N +L       
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQ 212

Query: 243 ----DENFVAKLADFGLAHASKDGSICFEPVN-TDIRGTPGYMDPEYVVTQELTEKSDVY 297
               D +    L D G    S D  +  +    T    T G+   E +  +    + D +
Sbjct: 213 DDEDDLSAGLALIDLGQ---SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269

Query: 298 SYGVVLLEIVT 308
                +  ++ 
Sbjct: 270 GVAATVYCMLF 280

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (315), Expect = 5e-31
 Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 27/205 (13%)

Query: 116 IGQGGFGTVYKA--QFSDGSLIAVKRMDKISEQVEGD-FCREIELLARLHHRHLVALRGF 172
           I  GG G +Y A  +  +G  + +K +    +         E + LA + H  +V +  F
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 173 CIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
                       +++ EY+   SLK          L     I   +++  AL YLH    
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH---S 200

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHA-SKDGSICFEPVNTDIRGTPGYMDPEYVV 286
             L + D+K  NI+L E  + KL D G     +  G +          GTPG+  PE +V
Sbjct: 201 IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYLY---------GTPGFQAPE-IV 249

Query: 287 TQELTEKSDVYSYGVVLLEIVTARR 311
               T  +D+Y+ G  L  +     
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLP 274

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  120 bits (302), Expect = 8e-31
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 27/201 (13%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           IG+G  G V  A+    G  +AVK MD   +Q       E+ ++    H ++V +    +
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLC 231
              E +++ E++  G+L D +       L      QIA     V  AL YLH      + 
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQ---VRL---NEEQIATVCEAVLQALAYLH---AQGVI 163

Query: 232 HRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           HRDIKS +ILL  +   KL+DFG          K          + + GTP +M PE + 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--------KSLV-GTPYWMAPEVIS 214

Query: 287 TQELTEKSDVYSYGVVLLEIV 307
                 + D++S G++++E+V
Sbjct: 215 RSLYATEVDIWSLGIMVIEMV 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  119 bits (301), Expect = 8e-31
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 17/205 (8%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG G    V  A        +A+KR++  K    ++ +  +EI+ +++ HH ++V+    
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYYTS 81

Query: 173 CIEKRERFLMYEYMANGSLKD---HLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYC 226
            + K E +L+ + ++ GS+ D   H+ + G           IA    +V   LEYLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
                HRD+K+ NILL E+   ++ADFG+ A  +  G I    V     GTP +M PE V
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-V 197

Query: 286 VTQELT--EKSDVYSYGVVLLEIVT 308
           + Q      K+D++S+G+  +E+ T
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELAT 222

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  124 bits (312), Expect = 1e-30
 Identities = 45/203 (22%), Positives = 90/203 (44%), Gaps = 22/203 (10%)

Query: 116 IGQGGFGTVYKAQFSDGS---LIAVKRM-DKISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G G FG+V +  +        +A+K +     +    +  RE +++ +L + ++V L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL---HFYCDP 228
            C +     L+ E    G L   L       +      ++   V+  ++YL   +F    
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF---- 457

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTD---IRGTPGYMDPEYV 285
              HR++ + N+LL     AK++DFGL+ A       +   +     ++       PE +
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECI 511

Query: 286 VTQELTEKSDVYSYGVVLLEIVT 308
             ++ + +SDV+SYGV + E ++
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  122 bits (307), Expect = 2e-30
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 27/228 (11%)

Query: 92  GPSPMFQKFSYKET---KKATDNFST------IIGQGGFGTVYKAQF-SDGSLIAVKRMD 141
           GP  M            + +T  FS       ++G+G FG V   +    G   AVK + 
Sbjct: 1   GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60

Query: 142 K---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSP 198
           K     +  +    RE++LL +L H +++ L  F  +K   +L+ E    G L D + S 
Sbjct: 61  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120

Query: 199 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGL 255
            R   S     +I   V + + Y+H      + HRD+K  N+LL    ++   ++ DFGL
Sbjct: 121 KR--FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175

Query: 256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
           +   +           D  GT  Y+ PE V+     EK DV+S GV+L
Sbjct: 176 STHFEASKKM-----KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  121 bits (305), Expect = 4e-30
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 17/198 (8%)

Query: 112 FSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVA 168
               +G G +G V   +        A+K + K  +S         E+ +L  L H +++ 
Sbjct: 41  RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L  F  +KR  +L+ E    G L D +    +   +      I   V + + YLH +   
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHN-- 156

Query: 229 PLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
            + HRD+K  N+LL   +++ + K+ DFGL+   ++          +  GT  Y+ PE V
Sbjct: 157 -IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-----KERLGTAYYIAPE-V 209

Query: 286 VTQELTEKSDVYSYGVVL 303
           + ++  EK DV+S GV+L
Sbjct: 210 LRKKYDEKCDVWSIGVIL 227

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  118 bits (298), Expect = 4e-30
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 29/208 (13%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVA----- 168
           +G G +G VYK +    G L A+K MD   ++ E +  +EI +L +  HHR++       
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIATYYGAF 90

Query: 169 LRGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLH 223
           ++       ++   +M E+   GS+ D + +     L       IA    ++   L +LH
Sbjct: 91  IKKNPPGMDDQLWLVM-EFCGAGSVTDLIKNTKGNTL---KEEWIAYICREILRGLSHLH 146

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRDIK  N+LL EN   KL DFG++ A  D ++     NT I GTP +M PE
Sbjct: 147 ---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVG--RRNTFI-GTPYWMAPE 199

Query: 284 YVVTQELTE-----KSDVYSYGVVLLEI 306
            +   E  +     KSD++S G+  +E+
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEM 227

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (296), Expect = 4e-30
 Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 20/199 (10%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD--KISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G FG V+K        ++A+K +D  +  +++E D  +EI +L++    ++    G 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYGS 88

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPP 229
            ++  + +++ EY+  GS  D L      PL      QIA    ++   L+YLH      
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEP---GPL---DETQIATILREILKGLDYLH---SEK 139

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
             HRDIK++N+LL E+   KLADFG+A      +      NT + GTP +M PE +    
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQI--KRNTFV-GTPFWMAPEVIKQSA 195

Query: 290 LTEKSDVYSYGVVLLEIVT 308
              K+D++S G+  +E+  
Sbjct: 196 YDSKADIWSLGITAIELAR 214

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (294), Expect = 8e-30
 Identities = 52/202 (25%), Positives = 84/202 (41%), Gaps = 33/202 (16%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G+GGF   ++        + A K + K   +          EI +   L H+H+V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 172 FCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLS-WQTR---IQIAIDVANALEYLHFYC 226
              E  +  F++ E     SL +         L+  + R    QI        +YLH   
Sbjct: 83  -FFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIV----LGCQYLHRNR 135

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLA-HASKDGS----ICFEPVNTDIRGTPGYMD 281
              + HRD+K  N+ L+E+   K+ DFGLA     DG     +C         GTP Y+ 
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---------GTPNYIA 183

Query: 282 PEYVVTQELTEKSDVYSYGVVL 303
           PE +  +  + + DV+S G ++
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIM 205

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (294), Expect = 9e-30
 Identities = 70/322 (21%), Positives = 121/322 (37%), Gaps = 67/322 (20%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLARLH-HRHLVALRGF 172
           +G G  G V+K +F   G +IAVK+M    +++       +++++ + H   ++V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
            I   + F+  E M   + K      G  P     ++   + +  AL YL       + H
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM--TVAIVKALYYLK--EKHGVIH 148

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RD+K SNILLDE    KL DFG++             +    G   YM PE +   + T+
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGIS-GRLVDDK---AKDRSA-GCAAYMAPERIDPPDPTK 203

Query: 293 -----KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 347
                ++DV+S G+ L+E                           LA    P      D 
Sbjct: 204 PDYDIRADVWSLGISLVE---------------------------LATGQFPYKNCKTDF 236

Query: 348 EQLRTIVT------------------IVRWCTQREGQARPSIKQVLR----ILYESSDPM 385
           E L  ++                    V+ C  ++ + RP   ++L       YE+ +  
Sbjct: 237 EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

Query: 386 HSGFVQAVEDEEYEETDGRPRT 407
            + + + V   + E     P +
Sbjct: 297 VASWFKDVMA-KTESPRSGPSS 317

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  116 bits (293), Expect = 9e-30
 Identities = 65/294 (22%), Positives = 124/294 (42%), Gaps = 37/294 (12%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIE-LLARLHHRHLVALRGF 172
           +G+G +G V K +    G ++AVKR+   ++ Q +     +++  +  +     V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 173 CIEKRERFLMYEYMANGSL----KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
              + + ++  E M + SL    K  +      P     +I  A+ +  ALE+LH     
Sbjct: 75  LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI--AVSIVKALEHLH--SKL 129

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + HRD+K SN+L++     K+ DFG++       +     + D  G   YM PE  +  
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGIS-GYLVDDV---AKDIDA-GCKPYMAPE-RINP 183

Query: 289 ELTE-----KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
           EL +     KSD++S G+ ++E+   R          +  Q+    E    +L   +   
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLKQVVEEPSPQLPADKFSA 241

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR----ILYESSDPMHSGFVQAV 393
            F        V     C ++  + RP+  ++++     L+ES     + FV+ +
Sbjct: 242 EF--------VDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKLI 287

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (295), Expect = 2e-29
 Identities = 32/359 (8%), Positives = 66/359 (18%), Gaps = 73/359 (20%)

Query: 60  RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQG 119
            R+    E    ++  +   +P                 +   K            +  G
Sbjct: 25  CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQG---ERKLK--------LVEPLRVG 73

Query: 120 GFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFC-- 173
               V+           A+K        S              ARL        R     
Sbjct: 74  DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133

Query: 174 ------------------------IEKRERFLMYEYMANGSLKD-----HLHSPGRTPLS 204
                                          L+    +   L+            R    
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEG 192

Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 264
                 +   +      L       L H      N+ +  +    L D            
Sbjct: 193 ILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249

Query: 265 CFEPVNTDIRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTAR----RAVQDGK 317
                       P    P   +       T   + +  G+ +  +              K
Sbjct: 250 AS--------SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

Query: 318 NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
              +   + +     LA      + D         + T++      + + R    + + 
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDF--------VKTLIGRFLNFDRRRRLLPLEAME 352

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  116 bits (293), Expect = 2e-29
 Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 39/251 (15%)

Query: 69  PENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFST--IIGQGGFGTVYK 126
           P +  K  +     P +                     ++   +     +G+GGF   ++
Sbjct: 4   PADPGKAGVPGVAAPGAPAAAPPAKEIP----EVLVDPRSRRRYVRGRFLGKGGFAKCFE 59

Query: 127 AQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER-FL 181
                   + A K + K   +          EI +   L H+H+V   G   E  +  F+
Sbjct: 60  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFV 118

Query: 182 MYEYMANGSLKDHLHSPGRTPLS-WQTR---IQIAIDVANALEYLHFYCDPPLCHRDIKS 237
           + E     SL +         L+  + R    QI        +YLH      + HRD+K 
Sbjct: 119 VLELCRRRSLLELHKRRKA--LTEPEARYYLRQIV----LGCQYLHRNR---VIHRDLKL 169

Query: 238 SNILLDENFVAKLADFGLA-HASKDGS----ICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
            N+ L+E+   K+ DFGLA     DG     +C         GTP Y+ PE +  +  + 
Sbjct: 170 GNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---------GTPNYIAPEVLSKKGHSF 220

Query: 293 KSDVYSYGVVL 303
           + DV+S G ++
Sbjct: 221 EVDVWSIGCIM 231

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  115 bits (291), Expect = 2e-29
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 15/193 (7%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
           ++G G F  V+   Q   G L A+K + K     +     EI +L ++ H ++V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
                 +L+ + ++ G L D +   G    + +    +   V +A++YLH   +  + HR
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLH---ENGIVHR 130

Query: 234 DIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
           D+K  N+L    +EN    + DFGL+   ++G +      +   GTPGY+ PE +  +  
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM------STACGTPGYVAPEVLAQKPY 184

Query: 291 TEKSDVYSYGVVL 303
           ++  D +S GV+ 
Sbjct: 185 SKAVDCWSIGVIT 197

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  118 bits (298), Expect = 3e-29
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 19/221 (8%)

Query: 90  QEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISE 145
               S   +   ++ T     N   ++G+G FG V K +        AVK ++K    ++
Sbjct: 4   HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63

Query: 146 QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
                  RE+ELL +L H +++ L     +    +++ E    G L D +    R   S 
Sbjct: 64  DTS-TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSE 120

Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDG 262
               +I   V + + Y+H +    + HRD+K  NILL   +++   K+ DFGL+   +  
Sbjct: 121 HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
           +        D  GT  Y+ PE V+     EK DV+S GV+L
Sbjct: 178 TKM-----KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  118 bits (298), Expect = 4e-29
 Identities = 56/249 (22%), Positives = 96/249 (38%), Gaps = 34/249 (13%)

Query: 74  KTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDN--FSTIIGQGGFGTVYKAQF-S 130
                        +     P      +  K+  K  ++      +G G +G V   +  +
Sbjct: 4   HHHHSSGRENLYFQGIAINPGM----YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKN 59

Query: 131 DGSLIAVKRMDK-------------ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR 177
             S  A+K + K               E+   +   EI LL  L H +++ L     +K+
Sbjct: 60  GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK 119

Query: 178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKS 237
             +L+ E+   G L + + +  +          I   + + + YLH +    + HRDIK 
Sbjct: 120 YFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHN---IVHRDIKP 174

Query: 238 SNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
            NILL   +     K+ DFGL+               D  GT  Y+ PE V+ ++  EK 
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKL-----RDRLGTAYYIAPE-VLKKKYNEKC 228

Query: 295 DVYSYGVVL 303
           DV+S GV++
Sbjct: 229 DVWSCGVIM 237

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  113 bits (286), Expect = 8e-29
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 18/201 (8%)

Query: 111 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLV 167
            F   +G G FG V+  +  S G    +K ++K      +E     EIE+L  L H +++
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLKSLDHPNII 83

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR--IQIAIDVANALEYLHFY 225
            +     +    +++ E    G L + + S      +       ++   + NAL Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141

Query: 226 CDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
               + H+D+K  NIL      +   K+ DFGLA   K              GT  YM P
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-----GTALYMAP 195

Query: 283 EYVVTQELTEKSDVYSYGVVL 303
           E V  +++T K D++S GVV+
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVM 215

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  113 bits (286), Expect = 1e-28
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 27/206 (13%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK---------ISEQVEGDFCREIELLARL-HH 163
           I+G+G    V +          AVK +D            +++     +E+++L ++  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
            +++ L+         FL+++ M  G L D+L       LS +   +I   +   +  LH
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALH 141

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRD+K  NILLD++   KL DFG +     G    E       GTP Y+ PE
Sbjct: 142 KLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC-----GTPSYLAPE 193

Query: 284 ------YVVTQELTEKSDVYSYGVVL 303
                         ++ D++S GV++
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIM 219

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  114 bits (288), Expect = 1e-28
 Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 28/248 (11%)

Query: 74  KTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFST--IIGQGGFGTVYKAQF-S 130
              L    P  +   + +   P  +   +   K+    +    +IG+G    V +    +
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117

Query: 131 DGSLIAVKRMDK--------ISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFL 181
            G   AVK M+           E+V     RE  +L ++  H H++ L          FL
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177

Query: 182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 241
           +++ M  G L D+L       LS +    I   +  A+ +LH      + HRD+K  NIL
Sbjct: 178 VFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENIL 232

Query: 242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE------YVVTQELTEKSD 295
           LD+N   +L+DFG +   + G    E       GTPGY+ PE              ++ D
Sbjct: 233 LDDNMQIRLSDFGFSCHLEPGEKLRELC-----GTPGYLAPEILKCSMDETHPGYGKEVD 287

Query: 296 VYSYGVVL 303
           +++ GV+L
Sbjct: 288 LWACGVIL 295

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  113 bits (284), Expect = 2e-28
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 19/218 (8%)

Query: 93  PSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVE 148
            S   +   ++ T     N   ++G+G FG V K +        AVK ++K    ++   
Sbjct: 7   HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66

Query: 149 GDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 208
               RE+ELL +L H +++ L     +    +++ E    G L D +    R   S    
Sbjct: 67  -TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDA 123

Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSIC 265
            +I   V + + Y+H      + HRD+K  NILL   +++   K+ DFGL+   +  +  
Sbjct: 124 ARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180

Query: 266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
                 D  GT  Y+ PE V+     EK DV+S GV+L
Sbjct: 181 -----KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  114 bits (286), Expect = 2e-28
 Identities = 66/251 (26%), Positives = 110/251 (43%), Gaps = 32/251 (12%)

Query: 69  PENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYK 126
           P   +        P  +  +      P   +  +K+       FS +  IG G FG VY 
Sbjct: 15  PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD--DPEKLFSDLREIGHGSFGAVYF 72

Query: 127 AQ-FSDGSLIAVKRMDKISEQVEGDF---CREIELLARLHHRHLVALRGFCIEKRERFLM 182
           A+   +  ++A+K+M    +Q    +    +E+  L +L H + +  RG  + +   +L+
Sbjct: 73  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132

Query: 183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPPLCHRDIKSSN 239
            EY   GS  D L    + PL     ++IA         L YLH      + HRD+K+ N
Sbjct: 133 MEYCL-GSASDLLEVHKK-PL---QEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGN 184

Query: 240 ILLDENFVAKLADFGL-AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE---KSD 295
           ILL E  + KL DFG  +  +          N+ + GTP +M PE ++  +  +   K D
Sbjct: 185 ILLSEPGLVKLGDFGSASIMAPA--------NSFV-GTPYWMAPEVILAMDEGQYDGKVD 235

Query: 296 VYSYGVVLLEI 306
           V+S G+  +E+
Sbjct: 236 VWSLGITCIEL 246

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  112 bits (283), Expect = 4e-28
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 18/202 (8%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 172
           ++G+G    V            AVK ++K    +     RE+E+L +   HR+++ L  F
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
             E+   +L++E M  GS+  H+H       +      +  DVA+AL++LH   +  + H
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLH---NKGIAH 134

Query: 233 RDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIR---GTPGYMDPEYVV 286
           RD+K  NIL    ++    K+ DF L    K    C      ++    G+  YM PE V 
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

Query: 287 TQELTEKS-----DVYSYGVVL 303
                        D++S GV+L
Sbjct: 195 AFSEEASIYDKRCDLWSLGVIL 216

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (284), Expect = 5e-28
 Identities = 45/308 (14%), Positives = 87/308 (28%), Gaps = 74/308 (24%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGD----------------------- 150
           ++GQ       +A     G    V                                    
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 151 -----FCREIELLARLHHRHLVALRGFC--IEKRERFLMYEYMA--NGSLKDHLHSPGRT 201
                F    +L+     + ++ +R     +    RF +Y  M     +  + L S   T
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 202 --PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 259
              L    R+Q+ + V   L  LH Y    L H  ++  +I+LD+     L  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-----------TEKSDVYSYGVVLLEIVT 308
           +DG+            + G+  PE    +             T   D ++ G+V+  I  
Sbjct: 255 RDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 309 ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR 368
           A   +      +  ++    S   + + V    +             ++    +   + R
Sbjct: 309 ADLPI-TKDAALGGSEWIFRSCKNIPQPV----RA------------LLEGFLRYPKEDR 351

Query: 369 PSIKQVLR 376
               Q + 
Sbjct: 352 LLPLQAME 359

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  111 bits (279), Expect = 6e-28
 Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 15/197 (7%)

Query: 111 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVAL 169
                IG+G +G V  A         A K++ K   +    F +EIE++  L H +++ L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
                +  + +L+ E    G L + +              +I  DV +A+ Y H      
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL---N 126

Query: 230 LCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
           + HRD+K  N L      +   KL DFGLA   K G +          GTP Y+ P+ V+
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-----RTKVGTPYYVSPQ-VL 180

Query: 287 TQELTEKSDVYSYGVVL 303
                 + D +S GV++
Sbjct: 181 EGLYGPECDEWSAGVMM 197

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (281), Expect = 9e-28
 Identities = 70/314 (22%), Positives = 124/314 (39%), Gaps = 34/314 (10%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMD-KISEQVEGDFCREIELLARL-HHRHLVALRGF 172
           IG+G +G+V K      G ++AVKR+   + E+ +     +++++ R     ++V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI---DVANALEYLHFYCDPP 229
              + + ++  E M+  S                    +         AL +L    +  
Sbjct: 90  LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRDIK SNILLD +   KL DFG++      SI      T   G   YM PE  +   
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGIS-GQLVDSI----AKTRDAGCRPYMAPE-RIDPS 200

Query: 290 LTE-----KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD- 343
            +      +SDV+S G+ L E+ T R       ++ +  Q+    +    +L +   ++ 
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQVVKGDPPQLSNSEEREF 258

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR----ILYESSDPMHSGFVQAVEDEEYE 399
           S            V  C  ++   RP  K++L+    ++YE      + +V  + D +  
Sbjct: 259 SPSFINF------VNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD-QMP 311

Query: 400 ETDGRPRTSQRKAH 413
            T   P       H
Sbjct: 312 ATPSSPMYVDHHHH 325

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  112 bits (282), Expect = 1e-27
 Identities = 49/249 (19%), Positives = 98/249 (39%), Gaps = 19/249 (7%)

Query: 64  RGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI------IG 117
           RG     +        +  P+    + +    +++K+  +  +    +          +G
Sbjct: 2   RGSHHHHHHGSKVRGKYDGPKI-NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60

Query: 118 QGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK 176
            G FG V++  + + G +   K ++      +     EI ++ +LHH  L+ L     +K
Sbjct: 61  SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120

Query: 177 RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 236
            E  L+ E+++ G L D + +     +S    I         L+++H   +  + H DIK
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EHSIVHLDIK 176

Query: 237 SSNILL--DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
             NI+    +    K+ DFGLA       I           T  +  PE V  + +   +
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIV-----KVTTATAEFAAPEIVDREPVGFYT 231

Query: 295 DVYSYGVVL 303
           D+++ GV+ 
Sbjct: 232 DMWAIGVLG 240

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  111 bits (280), Expect = 2e-27
 Identities = 54/245 (22%), Positives = 89/245 (36%), Gaps = 22/245 (8%)

Query: 69  PENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFST------IIGQGGFG 122
              +D  +   +    S       P        Y       D  S        +G+G   
Sbjct: 8   SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67

Query: 123 TVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 181
            VY+ +        A+K + K     +     EI +L RL H +++ L+       E  L
Sbjct: 68  IVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125

Query: 182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 241
           + E +  G L D +   G    S +        +  A+ YLH      + HRD+K  N+L
Sbjct: 126 VLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLL 180

Query: 242 L---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYS 298
                 +   K+ADFGL+   +   +          GTPGY  PE +       + D++S
Sbjct: 181 YATPAPDAPLKIADFGLSKIVEHQVLMKTVC-----GTPGYCAPEILRGCAYGPEVDMWS 235

Query: 299 YGVVL 303
            G++ 
Sbjct: 236 VGIIT 240

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  112 bits (282), Expect = 2e-27
 Identities = 52/230 (22%), Positives = 93/230 (40%), Gaps = 34/230 (14%)

Query: 96  MFQKFSYKETKKATDNFST------IIGQGGFGTVYKA-QFSDGSLIAVKRMDK------ 142
           +F   +  +                 +G G  G V  A +      +A++ + K      
Sbjct: 117 VFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176

Query: 143 --ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGR 200
                    +   EIE+L +L+H  ++ ++ F  +  + +++ E M  G L D +    R
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR 235

Query: 201 TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAH 257
             L   T       +  A++YLH   +  + HRD+K  N+LL   +E+ + K+ DFG + 
Sbjct: 236 --LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290

Query: 258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL----TEKSDVYSYGVVL 303
              + S+          GTP Y+ PE V+            D +S GV+L
Sbjct: 291 ILGETSLMRTLC-----GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVIL 334

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  108 bits (273), Expect = 5e-27
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 18/207 (8%)

Query: 105 TKKATDNFST--IIGQGGFGTVYKA-QFSDGSLIAVKRMDK--ISEQVEGDFCREIELLA 159
           + K +DN+     +G+G F  V +    + G   A K ++   +S +      RE  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 160 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
           +L H ++V L     E+   +L+++ +  G L + + +      S          +  ++
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESI 118

Query: 220 EYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
            Y H      + HR++K  N+LL    +    KLADFGLA    D             GT
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-----GT 170

Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVL 303
           PGY+ PE +     ++  D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  110 bits (277), Expect = 8e-27
 Identities = 54/252 (21%), Positives = 95/252 (37%), Gaps = 25/252 (9%)

Query: 61  RKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGG 120
                   P      +  P PPP+   +F        +K +  +  K     S ++G G 
Sbjct: 18  APPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV---TSQVLGLGI 74

Query: 121 FGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFC----I 174
            G V +          A+K +            RE+EL  R     H+V +         
Sbjct: 75  NGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYA 129

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            ++   ++ E +  G L   +   G    + +   +I   +  A++YLH      + HRD
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRD 186

Query: 235 IKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           +K  N+L      N + KL DFG A  +   +    P       TP Y+ PE +  ++  
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-----YTPYYVAPEVLGPEKYD 241

Query: 292 EKSDVYSYGVVL 303
           +  D++S GV++
Sbjct: 242 KSCDMWSLGVIM 253

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  109 bits (274), Expect = 9e-27
 Identities = 57/236 (24%), Positives = 90/236 (38%), Gaps = 51/236 (21%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVAL 169
           IGQG +G V  A +    ++ A+K M+K     I+ +       E+ L+ +LHH ++  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ------------------- 210
                +++   L+ E    G L D L+                                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 211 -------------------IAIDVANALEYLHFYCDPPLCHRDIKSSNILL--DENFVAK 249
                              I   + +AL YLH   +  +CHRDIK  N L   +++F  K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 250 LADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV--VTQELTEKSDVYSYGVVL 303
           L DFGL+      +       T   GTP ++ PE +    +    K D +S GV+L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (273), Expect = 2e-26
 Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 25/257 (9%)

Query: 60  RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFS------ 113
              +   E   N D T   P    R+     + P+P    F ++         +      
Sbjct: 34  SGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP-APFDHRIVTAKQGAVNSFYTVS 92

Query: 114 --TIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALR 170
              I+G G FG V+K  + + G  +A K +     + + +   EI ++ +L H +L+ L 
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
                K +  L+ EY+  G L D +       L+    I     +   + ++H      +
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMH---QMYI 208

Query: 231 CHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT 287
            H D+K  NIL    D   + K+ DFGLA   K              GTP ++ PE VV 
Sbjct: 209 LHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKL-----KVNFGTPEFLAPE-VVN 261

Query: 288 QE-LTEKSDVYSYGVVL 303
            + ++  +D++S GV+ 
Sbjct: 262 YDFVSFPTDMWSVGVIA 278

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (278), Expect = 2e-26
 Identities = 52/250 (20%), Positives = 95/250 (38%), Gaps = 16/250 (6%)

Query: 60  RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFST--IIG 117
           R++ RG +  E       K            +     + +    +     D++     +G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166

Query: 118 QGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK 176
            G FG V++    + G+  A K +    E  +    +EI+ ++ L H  LV L     + 
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226

Query: 177 RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 236
            E  ++YE+M+ G L + +       +S    ++    V   L ++H   +    H D+K
Sbjct: 227 NEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLK 282

Query: 237 SSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
             NI+      N + KL DFGL                   GT  +  PE    + +   
Sbjct: 283 PENIMFTTKRSNEL-KLIDFGLTAHLDPKQSV-----KVTTGTAEFAAPEVAEGKPVGYY 336

Query: 294 SDVYSYGVVL 303
           +D++S GV+ 
Sbjct: 337 TDMWSVGVLS 346

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  108 bits (271), Expect = 3e-26
 Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 18/229 (7%)

Query: 83  PRSLRKFQEGPSPMFQKFSYKETKKATDNFST--IIGQGGFGTVYKA-QFSDGSLIAVKR 139
           P               +F    + K +DN+     +G+G F  V +    + G   A K 
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 140 MDK--ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS 197
           ++   +S +      RE  +  +L H ++V L     E+   +L+++ +  G L + + +
Sbjct: 62  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121

Query: 198 PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFG 254
             R   S          +  ++ Y H      + HR++K  N+LL    +    KLADFG
Sbjct: 122 --REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFG 176

Query: 255 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
           LA    D             GTPGY+ PE +     ++  D+++ GV+L
Sbjct: 177 LAIEVNDSEAWHGFA-----GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (270), Expect = 3e-26
 Identities = 49/200 (24%), Positives = 77/200 (38%), Gaps = 18/200 (9%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVA 168
           +IG+G F  V +      G   AVK +D             D  RE  +   L H H+V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYC 226
           L          ++++E+M    L   +         +   +       +  AL Y H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--- 147

Query: 227 DPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
           D  + HRD+K   +LL   + +   KL  FG+A    +  +          GTP +M PE
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA----GGRVGTPHFMAPE 203

Query: 284 YVVTQELTEKSDVYSYGVVL 303
            V  +   +  DV+  GV+L
Sbjct: 204 VVKREPYGKPVDVWGCGVIL 223

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  106 bits (266), Expect = 4e-26
 Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 21/199 (10%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEG------DFCREIELLARLHHRHLVA 168
           +G G F  V K  Q   G   A K + K             +  RE+ +L  + H +++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L      K +  L+ E ++ G L D L       L+     Q    + + + YLH     
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLH---SK 127

Query: 229 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
            + H D+K  NI+L      N   KL DFG+AH  + G+        +I GTP ++ PE 
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-----KNIFGTPEFVAPEI 182

Query: 285 VVTQELTEKSDVYSYGVVL 303
           V  + L  ++D++S GV+ 
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  107 bits (268), Expect = 4e-26
 Identities = 45/246 (18%), Positives = 87/246 (35%), Gaps = 26/246 (10%)

Query: 140 MDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS-P 198
               S         +I  +     ++ V        K   ++  +     +LKD ++   
Sbjct: 97  WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156

Query: 199 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-- 256
                     + I I +A A+E+LH      L HRD+K SNI    + V K+ DFGL   
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

Query: 257 ------HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
                   +    +     +T   GT  YM PE +     + K D++S G++L E++ + 
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF 273

Query: 311 RAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPS 370
               +   +             + ++ + +    F  ++      +V+         RP 
Sbjct: 274 STQMERVRI-------------ITDVRNLKFPLLFT-QKYPQEHMMVQDMLSPSPTERPE 319

Query: 371 IKQVLR 376
              ++ 
Sbjct: 320 ATDIIE 325

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  106 bits (268), Expect = 5e-26
 Identities = 45/196 (22%), Positives = 78/196 (39%), Gaps = 17/196 (8%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDK--ISEQVEGDFCREIELLARL-HHRHLVALRG 171
           +G+G F  V +    S G   A K + K    +    +   EI +L        ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
                 E  L+ EY A G +           +S    I++   +   + YLH      + 
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IV 153

Query: 232 HRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           H D+K  NILL         K+ DFG++               +I GTP Y+ PE ++  
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL-----REIMGTPEYLAPE-ILNY 207

Query: 289 E-LTEKSDVYSYGVVL 303
           + +T  +D+++ G++ 
Sbjct: 208 DPITTATDMWNIGIIA 223

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (266), Expect = 8e-26
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 28/209 (13%)

Query: 111 NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDK--------ISEQVEGDFCREIELLARL 161
             S  +G G  G V  A +      +A+K + K               +   EIE+L +L
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 162 HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           +H  ++ ++ F  +  + +++ E M  G L D +    R  L   T       +  A++Y
Sbjct: 73  NHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQY 129

Query: 222 LHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           LH      + HRD+K  N+LL   +E+ + K+ DFG +    + S+          GTP 
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-----GTPT 181

Query: 279 YMDPEYVVTQEL----TEKSDVYSYGVVL 303
           Y+ PE V+            D +S GV+L
Sbjct: 182 YLAPE-VLVSVGTAGYNRAVDCWSLGVIL 209

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (265), Expect = 1e-25
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 21/200 (10%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEG------DFCREIELLARLHHRHLV 167
            +G G F  V K  + S G   A K + K   +         +  RE+ +L ++ H +++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD 227
            L      + +  L+ E ++ G L D L       LS +        + + + YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH---T 133

Query: 228 PPLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
             + H D+K  NI+L          KL DFGLAH  +DG         +I GTP ++ PE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-----KNIFGTPEFVAPE 188

Query: 284 YVVTQELTEKSDVYSYGVVL 303
            V  + L  ++D++S GV+ 
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  105 bits (265), Expect = 2e-25
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 21/199 (10%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEG------DFCREIELLARLHHRHLVA 168
           +G G F  V K  + S G   A K + K   +         +  RE+ +L ++ H +++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L      + +  L+ E ++ G L D L       LS +        + + + YLH     
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH---TK 134

Query: 229 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
            + H D+K  NI+L          KL DFGLAH  +DG         +I GTP ++ PE 
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-----KNIFGTPEFVAPEI 189

Query: 285 VVTQELTEKSDVYSYGVVL 303
           V  + L  ++D++S GV+ 
Sbjct: 190 VNYEPLGLEADMWSIGVIT 208

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  105 bits (264), Expect = 2e-25
 Identities = 49/222 (22%), Positives = 86/222 (38%), Gaps = 21/222 (9%)

Query: 90  QEGPSPMFQKFSYKETKKATD--NFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQ 146
           Q        +  ++ + + TD       IG G +    +    +     AVK +DK    
Sbjct: 2   QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61

Query: 147 VEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
                  EIE+L R   H +++ L+    + +  +++ E M  G L D +    +   S 
Sbjct: 62  PT----EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSE 115

Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASKD 261
           +    +   +   +EYLH      + HRD+K SNIL           ++ DFG A   + 
Sbjct: 116 REASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172

Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
            +            T  ++ PE +  Q      D++S GV+L
Sbjct: 173 ENGLL----MTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  106 bits (266), Expect = 2e-25
 Identities = 44/307 (14%), Positives = 80/307 (26%), Gaps = 73/307 (23%)

Query: 115 IIGQGGFGTVYKA-QFSDGSLIAVKRMDK---ISEQVEGDFCREIELLARL--------- 161
           ++GQ       +A     G    V                   E+  L  L         
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 162 --HHRHLVALRGFCIEKR----------------ERFLMYEYMA--NGSLKDHLHSPGRT 201
             H R +         ++                 RF +Y  M     +  + L S   T
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 202 --PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS 259
              L    R+Q+ + V   L  LH Y    L H  ++  +I+LD+     L  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 260 KDGSICFEPVNTDIRGTPGYMDPEYV----------VTQELTEKSDVYSYGVVLLEIVTA 309
              ++             G+  PE                +T   D ++ G+ +  I  A
Sbjct: 262 GASAVS--------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

Query: 310 RRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP 369
                     +  ++    S   + + V                  ++    +   + R 
Sbjct: 314 DLPN-TDDAALGGSEWIFRSCKNIPQPVRA----------------LLEGFLRYPKEDRL 356

Query: 370 SIKQVLR 376
              Q + 
Sbjct: 357 LPLQAME 363

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  105 bits (263), Expect = 2e-25
 Identities = 40/192 (20%), Positives = 83/192 (43%), Gaps = 15/192 (7%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G+G FG V++  + S       K +            +EI +L    HR+++ L     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESFE 71

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E  +++E+++   + + +++     L+ +  +     V  AL++LH +    + H D
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH---NIGHFD 127

Query: 235 IKSSNILL--DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE-LT 291
           I+  NI+     +   K+ +FG A   K G          +   P Y  PE V   + ++
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-----RLLFTAPEYYAPE-VHQHDVVS 181

Query: 292 EKSDVYSYGVVL 303
             +D++S G ++
Sbjct: 182 TATDMWSLGTLV 193

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  105 bits (263), Expect = 2e-25
 Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 24/215 (11%)

Query: 94  SPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKA-QFSDGSLIAVKRMDKISEQVEGDFC 152
           SP +Q +      K        +G+G F    K          AVK + K   ++E +  
Sbjct: 4   SPFYQHYDLDLKDK-------PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQ 53

Query: 153 REIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI 211
           +EI  L     H ++V L     ++   FL+ E +  G L + +        S      I
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYI 111

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEP 268
              + +A+ ++H      + HRD+K  N+L    ++N   K+ DFG A      +     
Sbjct: 112 MRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL-- 166

Query: 269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
                  T  Y  PE +      E  D++S GV+L
Sbjct: 167 --KTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  107 bits (270), Expect = 2e-25
 Identities = 64/249 (25%), Positives = 115/249 (46%), Gaps = 22/249 (8%)

Query: 70  ENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKAT-DNFS--TIIGQGGFGTVYK 126
              +  S+ PF        F       F ++ + E +  T + F    ++G+GGFG V  
Sbjct: 148 LTHEYLSVAPFADYLDSIYFNR-----FLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCA 202

Query: 127 AQFSD-GSLIAVKRMDK--ISEQVEGDFCR-EIELLARLHHRHLVALRGFCIEKRER-FL 181
            Q    G + A K+++K  I ++        E ++L +++ R +V+L  +  E ++   L
Sbjct: 203 CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCL 261

Query: 182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 241
           +   M  G LK H++  G+        +  A ++   LE LH      + +RD+K  NIL
Sbjct: 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENIL 318

Query: 242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGV 301
           LD++   +++D GLA    +G    + +     GT GYM PE V  +  T   D ++ G 
Sbjct: 319 LDDHGHIRISDLGLAVHVPEG----QTIKG-RVGTVGYMAPEVVKNERYTFSPDWWALGC 373

Query: 302 VLLEIVTAR 310
           +L E++  +
Sbjct: 374 LLYEMIAGQ 382

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  105 bits (263), Expect = 2e-25
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 24/202 (11%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G F  V  A+    G  +A+K +DK  ++        RE+ ++  L+H ++V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
              ++  +L+ EY + G + D+L + GR  +  +        + +A++Y H      + H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR---IVH 137

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPEYVVTQ 288
           RD+K+ N+LLD +   K+ADFG ++    G      C         G P Y  PE +   
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---------GAPPYAAPE-LFQG 187

Query: 289 ELTE--KSDVYSYGVVLLEIVT 308
           +  +  + DV+S GV+L  +V+
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVS 209

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  104 bits (262), Expect = 3e-25
 Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 28/224 (12%)

Query: 94  SPMFQKFSYKETKKA--TDNF---STIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQV 147
           S +   F   E KK   TD++     ++G G  G V +      G   A+K +       
Sbjct: 10  SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--- 66

Query: 148 EGDFCREIELLARL-HHRHLVALRGFC----IEKRERFLMYEYMANGSLKDHLHSPGRTP 202
                +E++   +     H+V +          KR   ++ E M  G L   +   G   
Sbjct: 67  --KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124

Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHAS 259
            + +   +I  D+  A+++LH +    + HRD+K  N+L    +++ V KL DFG A  +
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181

Query: 260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVL 303
              ++           TP Y+ PE +  ++  +  D++S GV++
Sbjct: 182 TQNAL------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (258), Expect = 5e-25
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 36/204 (17%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVAL 169
           +G+G +G V  A        +AVK +D        E ++    +EI +   L+H ++V  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKMLNHENVVKF 70

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCD 227
            G   E   ++L  EY + G L D +      P     R   Q+       + YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGIG- 125

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-------CFEPVNTDIRGTPGYM 280
             + HRDIK  N+LLDE    K++DFGLA   +  +        C         GT  Y+
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---------GTLPYV 174

Query: 281 DPEYVVTQELT-EKSDVYSYGVVL 303
            PE +  +E   E  DV+S G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (260), Expect = 5e-25
 Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 21/199 (10%)

Query: 116 IGQGGFGTVYKA-QFSDGSLIAVKRMDK------ISEQVEGDFCREIELLARLHHRHLVA 168
           +G G F  V K  + S G   A K + K             D  RE+ +L  + H +++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L      K +  L+ E +A G L D L       L+ +   +    + N + YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQ-- 134

Query: 229 PLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
            + H D+K  NI+L          K+ DFGLAH    G+        +I GTP ++ PE 
Sbjct: 135 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-----KNIFGTPEFVAPEI 188

Query: 285 VVTQELTEKSDVYSYGVVL 303
           V  + L  ++D++S GV+ 
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  104 bits (260), Expect = 5e-25
 Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 45/246 (18%)

Query: 76  SLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSL 134
           +L+  P    L           QK+S              +G G FG V+ A        
Sbjct: 2   ALEEPPKAVELEGLAACEGEYSQKYSTMSP----------LGSGAFGFVWTAVDKEKNKE 51

Query: 135 IAVKRMDK--------ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 186
           + VK + K        I +   G    EI +L+R+ H +++ +      +    L+ E  
Sbjct: 52  VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKH 111

Query: 187 ANGS-LKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD 243
            +G  L   +    R      + I  Q+     +A+ YL       + HRDIK  NI++ 
Sbjct: 112 GSGLDLFAFIDRHPRLDEPLASYIFRQLV----SAVGYLRLKD---IIHRDIKDENIVIA 164

Query: 244 ENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPEYVVTQELTE--KSDVY 297
           E+F  KL DFG A   + G +    C         GT  Y  PE V+        + +++
Sbjct: 165 EDFTIKLIDFGSAAYLERGKLFYTFC---------GTIEYCAPE-VLMGNPYRGPELEMW 214

Query: 298 SYGVVL 303
           S GV L
Sbjct: 215 SLGVTL 220

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  102 bits (256), Expect = 8e-25
 Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 29/200 (14%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G G FG V   +    G  +AVK +++    S  V G   REI+ L    H H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPP 229
                 + F++ EY++ G L D++   GR       R+  QI     +A++Y H +    
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCHRHM--- 131

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPEYV 285
           + HRD+K  N+LLD +  AK+ADFGL++   DG      C         G+P Y  PE V
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---------GSPNYAAPE-V 181

Query: 286 VTQELTE--KSDVYSYGVVL 303
           ++  L    + D++S GV+L
Sbjct: 182 ISGRLYAGPEVDIWSCGVIL 201

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (262), Expect = 1e-24
 Identities = 46/195 (23%), Positives = 82/195 (42%), Gaps = 15/195 (7%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRG 171
            +G+G F  V +      G   A   ++   +S +      RE  +   L H ++V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
              E+   +L+++ +  G L + + +  R   S          +  A+ + H      + 
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMG---VV 132

Query: 232 HRDIKSSNILL---DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
           HR++K  N+LL    +    KLADFGLA   +     +        GTPGY+ PE +   
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW----FGFAGTPGYLSPEVLRKD 188

Query: 289 ELTEKSDVYSYGVVL 303
              +  D+++ GV+L
Sbjct: 189 PYGKPVDLWACGVIL 203

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (255), Expect = 2e-24
 Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 36/204 (17%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVAL 169
           +G+G +G V  A        +AVK +D        E ++    +EI +   L+H ++V  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKMLNHENVVKF 70

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCD 227
            G   E   ++L  EY + G L D +      P     R   Q+       + YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGIG- 125

Query: 228 PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI-------CFEPVNTDIRGTPGYM 280
             + HRDIK  N+LLDE    K++DFGLA   +  +        C         GT  Y+
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---------GTLPYV 174

Query: 281 DPEYVVTQELT-EKSDVYSYGVVL 303
            PE +  +E   E  DV+S G+VL
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVL 198

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  102 bits (256), Expect = 3e-24
 Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 35/202 (17%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           IG G FG     +      L+AVK +++   I E V+    REI     L H ++V  + 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINHRSLRHPNIVRFKE 83

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPP 229
             +      ++ EY + G L + + + GR           Q+     + + Y H      
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----SGVSYCHSMQ--- 136

Query: 230 LCHRDIKSSNILLDENFVA--KLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPE 283
           +CHRD+K  N LLD +     K+ DFG + +S   S               GTP Y+ PE
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---------GTPAYIAPE 187

Query: 284 YVVTQELTE--KSDVYSYGVVL 303
            V+ ++  +   +DV+S GV L
Sbjct: 188 -VLLRQEYDGKIADVWSCGVTL 208

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (256), Expect = 1e-23
 Identities = 62/244 (25%), Positives = 113/244 (46%), Gaps = 25/244 (10%)

Query: 78  KPFPPPRSLRKFQEGPSPMFQKFSYKETKKAT-DNFS--TIIGQGGFGTVYKAQFSD-GS 133
            PF        F       F ++ + E +    D F    ++G+GGFG V+  Q    G 
Sbjct: 157 APFQEFLDSLYFLR-----FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGK 211

Query: 134 LIAVKRMDK--ISEQVEGDFCR-EIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANG 189
           L A K+++K  + ++        E ++LA++H R +V+L  +  E +    L+   M  G
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGG 270

Query: 190 SLKDHLHSPGRTPLSW---QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 246
            ++ H+++       +   +     A  + + LE+LH      + +RD+K  N+LLD++ 
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIFYTA-QIVSGLEHLH---QRNIIYRDLKPENVLLDDDG 326

Query: 247 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEI 306
             +++D GLA    +             GTPG+M PE ++ +E     D ++ GV L E+
Sbjct: 327 NVRISDLGLA---VELKAGQTKTKG-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEM 382

Query: 307 VTAR 310
           + AR
Sbjct: 383 IAAR 386

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 58/240 (24%), Positives = 87/240 (36%), Gaps = 31/240 (12%)

Query: 81  PPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAV 137
             PR             +    KE +     +     +G GGFG+VY     SD   +A+
Sbjct: 14  LVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAI 73

Query: 138 KRMDK--ISEQVEGDFC----REIELLARLHHR--HLVALRGFCIEKRERFLMYEYMAN- 188
           K ++K  IS+  E         E+ LL ++      ++ L  +        L+ E     
Sbjct: 74  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 133

Query: 189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV- 247
             L D +   G   L  +        V  A+ + H      + HRDIK  NIL+D N   
Sbjct: 134 QDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 188

Query: 248 AKLADFGLAHASKDGSI---CFEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVL 303
            KL DFG     KD                GT  Y  PE++         + V+S G++L
Sbjct: 189 LKLIDFGSGALLKDTVYTDFD---------GTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 38/204 (18%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK-------ISEQVEGDFCREIELLARLHHRHLV 167
           +G+G FG V  A  +     +A+K + +       +  +VE    REI  L  L H H++
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE----REISYLKLLRHPHII 72

Query: 168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFY 225
            L        +  ++ EY A G L D++    R       R   QI      A+EY H +
Sbjct: 73  KLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRH 127

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMD 281
               + HRD+K  N+LLD+N   K+ADFGL++   DG+     C         G+P Y  
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---------GSPNYAA 175

Query: 282 PEYVVTQELTE--KSDVYSYGVVL 303
           PE V+  +L    + DV+S G+VL
Sbjct: 176 PE-VINGKLYAGPEVDVWSCGIVL 198

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 97.3 bits (243), Expect = 9e-23
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 39/214 (18%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDK--------ISEQVEGDFCREIELLARLHHRHL 166
           +G+G +G V +   S+     AVK + K            V+    +EI+LL RL H+++
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHKNV 68

Query: 167 VALRG--FCIEKRERFLMYEYMANGS--LKDHLHSPGRTPLSWQTR---IQIAIDVANAL 219
           + L    +  EK++ +++ EY   G   + D +    R P+  Q      Q+ ID    L
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPV-CQAHGYFCQL-ID---GL 122

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA---HASKDGSICFEPVNTDIRGT 276
           EYLH      + H+DIK  N+LL      K++  G+A   H       C     T  +G+
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC----RT-SQGS 174

Query: 277 PGYMDPEYVVTQELTE--KSDVYSYGVVLLEIVT 308
           P +  PE     +     K D++S GV L  I T
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 99.5 bits (248), Expect = 1e-22
 Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 29/200 (14%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRG 171
           +G G FG V   +    G  +AVK +++    S  V G   REI+ L    H H++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 172 FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRI--QIAIDVANALEYLHFYCDPP 229
                 + F++ EY++ G L D++   GR       R+  QI     + ++Y H +    
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCHRHM--- 136

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI----CFEPVNTDIRGTPGYMDPEYV 285
           + HRD+K  N+LLD +  AK+ADFGL++   DG      C         G+P Y  PE V
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---------GSPNYAAPE-V 186

Query: 286 VTQELTE--KSDVYSYGVVL 303
           ++  L    + D++S GV+L
Sbjct: 187 ISGRLYAGPEVDIWSSGVIL 206

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 24/244 (9%)

Query: 72  LDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATD-NFSTIIGQGGFGTVYKAQF- 129
           +D T+ +P P   SL+  Q  P P          K+  D  F  I+G+G F TV  A+  
Sbjct: 1   MDGTAAEPRPGAGSLQHAQPPPQP--------RKKRPEDFKFGKILGEGSFSTVVLAREL 52

Query: 130 SDGSLIAVKRMDK---ISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY 185
           +     A+K ++K   I E +V     RE ++++RL H   V L     +  + +    Y
Sbjct: 53  ATSREYAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111

Query: 186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN 245
             NG L  ++   G    +  TR   A ++ +ALEYLH      + HRD+K  NILL+E+
Sbjct: 112 AKNGELLKYIRKIGSFDET-CTRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNED 166

Query: 246 FVAKLADFGLAHASKDGSICFEPVNTD-IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL 304
              ++ DFG A   K  S   +    +   GT  Y+ PE +  +   + SD+++ G ++ 
Sbjct: 167 MHIQITDFGTA---KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 223

Query: 305 EIVT 308
           ++V 
Sbjct: 224 QLVA 227

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 11/173 (6%)

Query: 90  QEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSDGSLIAVK--RMDKISE 145
                   ++  Y   +   + +  +  +G+G +G VYKA+ S G ++A+K  R+D   E
Sbjct: 3   HHHHHSSGRENLY--FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60

Query: 146 QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSW 205
            +     REI LL  LHH ++V+L      +R   L++E+M    LK  L    +T L  
Sbjct: 61  GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN-KTGLQD 118

Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
                    +   + + H      + HRD+K  N+L++ +   KLADFGLA A
Sbjct: 119 SQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARA 168

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 68/233 (29%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK------------------------------IS 144
           IG+G +G V  A   +D +  A+K + K                                
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 145 EQVEGDFCREIELLARLHHRHLVALRGFCIE------KRERFLMYEYMANGSLKDHLHSP 198
           EQV     +EI +L +L H ++V L    +E      +   ++++E +  G + +    P
Sbjct: 81  EQVY----QEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVME---VP 129

Query: 199 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
              PLS         D+   +EYLH+     + HRDIK SN+L+ E+   K+ADFG+++ 
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 259 SKDG-----SICFEPVNTDIRGTPGYMDPEYVVTQELT---EKSDVYSYGVVL 303
            K       +           GTP +M PE +         +  DV++ GV L
Sbjct: 187 FKGSDALLSNTV---------GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 12/153 (7%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC---REIELLARLHH 163
           + +  I  IG+G +G V+K +  D G ++A+K+    SE          REI +L +L H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
            +LV L      KR   L++EY  + ++   L    R  +       I      A+ + H
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH 119

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
            +      HRD+K  NIL+ ++ V KL DFG A
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFA 149

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 49/205 (23%), Positives = 79/205 (38%), Gaps = 31/205 (15%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDK------ISEQVEGDFCREIELLARLH----HR 164
           +G+GGFGTV+     +D   +A+K + +                 E+ LL ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 165 HLVALRGFCIEKRERFLMYEYMANGS-LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
            ++ L  +   +    L+ E       L D++   G   L           V  A+++ H
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCH 156

Query: 224 FYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSI---CFEPVNTDIRGTPGY 279
                 + HRDIK  NIL+D     AKL DFG      D                GT  Y
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---------GTRVY 204

Query: 280 MDPEYVVTQELT-EKSDVYSYGVVL 303
             PE++   +     + V+S G++L
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILL 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 46/169 (27%), Positives = 85/169 (50%), Gaps = 12/169 (7%)

Query: 94  SPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGD 150
           S      +     ++ + +  +  +G+G +G V K +  D G ++A+K+    S+  +  
Sbjct: 9   SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMV 67

Query: 151 FC---REIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQT 207
                REI+LL +L H +LV L   C +K+  +L++E++ + ++ D L       L +Q 
Sbjct: 68  KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPN-GLDYQV 125

Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
             +    + N + + H +    + HRDIK  NIL+ ++ V KL DFG A
Sbjct: 126 VQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 13/161 (8%)

Query: 104 ETKKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFC---REI 155
           + K     +  +  +G+G F TVYKA+  +   ++A+K  ++   SE  +G      REI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 156 ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 215
           +LL  L H +++ L      K    L++++M    L+  +       L+        +  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNS-LVLTPSHIKAYMLMT 121

Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
              LEYLH +    + HRD+K +N+LLDEN V KLADFGLA
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 94.9 bits (237), Expect = 5e-22
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 9/152 (5%)

Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI LL  L+H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           ++V L      + + +L++E++ +  LK  + +   T +           +   L + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
           +    + HRD+K  N+L++     KLADFGLA
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLA 150

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.5 bits (236), Expect = 6e-22
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 9/153 (5%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRH 165
           + +  +  IG+G +G VYKAQ + G   A+K  R++K  E +     REI +L  L H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           +V L      K+   L++E++ +  LK  L       L   T     + + N + Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
               + HRD+K  N+L++     K+ADFGLA A
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARA 149

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.0 bits (244), Expect = 6e-22
 Identities = 62/258 (24%), Positives = 107/258 (41%), Gaps = 35/258 (13%)

Query: 67  EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFS--TIIGQGGFGTV 124
           E  +NL     + F       +F +       K          ++FS   IIG+GGFG V
Sbjct: 152 EICQNLRGDVFQKFIESDKFTRFCQ------WKNVELNIHLTMNDFSVHRIIGRGGFGEV 205

Query: 125 YKAQFSD-GSLIAVKRMDKIS----EQVEGDFC-REI-ELLARLHHRHLVALRGFCIEKR 177
           Y  + +D G + A+K +DK      +        R +  L++      +V +  +     
Sbjct: 206 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTP 264

Query: 178 ER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK 236
           ++   + + M  G L  HL   G    +   R   A ++   LE++H   +  + +RD+K
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAA-EIILGLEHMH---NRFVVYRDLK 319

Query: 237 SSNILLDENFVAKLADFGLAHASKDG---SICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
            +NILLDE+   +++D GLA         +           GT GYM PE +      + 
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVLQKGVAYDS 370

Query: 294 S-DVYSYGVVLLEIVTAR 310
           S D +S G +L +++   
Sbjct: 371 SADWFSLGCMLFKLLRGH 388

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 31/217 (14%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDKI----SEQVEGDFCREIELLARLH 162
           D+F  +  IG+G FG V   Q +D   + A+K M+K       +V   F +E++++  L 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF-KELQIMQGLE 73

Query: 163 HRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           H  LV L  +  +  E  F++ + +  G L+ HL            ++ I  ++  AL+Y
Sbjct: 74  HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-TVKLFIC-ELVMALDY 130

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG----SICFEPVNTDIRGTP 277
           L       + HRD+K  NILLDE+    + DF +A          ++          GT 
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---------GTK 178

Query: 278 GYMDPEYVVTQELTEKS---DVYSYGVVLLEIVTARR 311
            YM PE   +++    S   D +S GV   E++  RR
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.8 bits (229), Expect = 5e-21
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 10/154 (6%)

Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR 164
             +  +  IG+G +GTV+KA+      ++A+K  R+D   E V     REI LL  L H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           ++V L       ++  L++E+  +  LK +  S     L  +        +   L + H 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
                + HRD+K  N+L++ N   KLA+FGLA A
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARA 150

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 18/160 (11%)

Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR 164
             +  +  IGQG FG V+KA+    G  +A+K   M+   E       REI++L  L H 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 165 HLVALRGFCIEKRER--------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 216
           ++V L   C  K           +L++++  +  L   L +      +     ++   + 
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLL 134

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA 256
           N L Y+H      + HRD+K++N+L+  + V KLADFGLA
Sbjct: 135 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 18/250 (7%)

Query: 67  EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTV 124
              + L K +               G   M    +  + +   + F  +  +G+G FG V
Sbjct: 105 TVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV 164

Query: 125 YKAQFSD-GSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRER 179
              +    G   A+K + K      ++V      E  +L    H  L AL+ +  +  +R
Sbjct: 165 ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-ENRVLQNSRHPFLTALK-YSFQTHDR 222

Query: 180 -FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS 238
              + EY   G L  HL          + R   A ++ +AL+YLH   +  + +RD+K  
Sbjct: 223 LCFVMEYANGGELFFHLSRERVFSED-RARFYGA-EIVSALDYLHSEKN--VVYRDLKLE 278

Query: 239 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYS 298
           N++LD++   K+ DFGL    K+G      + T   GTP Y+ PE +   +     D + 
Sbjct: 279 NLMLDKDGHIKITDFGL---CKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWG 334

Query: 299 YGVVLLEIVT 308
            GVV+ E++ 
Sbjct: 335 LGVVMYEMMC 344

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 46/200 (23%), Positives = 78/200 (39%), Gaps = 29/200 (14%)

Query: 67  EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTV 124
               ++     +   P           + +             D +  I  +G+G +G V
Sbjct: 4   HHHHHMGTLEAQTQGPGSMSVSAAPSATSI-------------DRYRRITKLGEGTYGEV 50

Query: 125 YKAQ-FSDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL 181
           YKA        +A+K  R++   E V G   RE+ LL  L HR+++ L+          L
Sbjct: 51  YKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110

Query: 182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL 241
           ++EY  N  LK ++       +S +        + N + + H        HRD+K  N+L
Sbjct: 111 IFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLL 164

Query: 242 LDENFVA-----KLADFGLA 256
           L  +  +     K+ DFGLA
Sbjct: 165 LSVSDASETPVLKIGDFGLA 184

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 15/156 (9%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS-EQVEGDFC---REIELLARLH 162
           + +  +  +G+G + TVYK +     +L+A+K   +I  E  EG  C   RE+ LL  L 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCTAIREVSLLKDLK 58

Query: 163 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
           H ++V L      ++   L++EY+ +  LK +L   G   ++          +   L Y 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYC 116

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
           H      + HRD+K  N+L++E    KLADFGLA A
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARA 149

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 53/271 (19%), Positives = 104/271 (38%), Gaps = 67/271 (24%)

Query: 69  PENLDKTSLKPFPPPRSLRK--FQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYK 126
              L+   L P   P  + K    +G +   ++ +Y   K         IG G FG V++
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKV--------IGNGSFGVVFQ 58

Query: 127 AQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER------F 180
           A+  +   +A+K++    ++ +    RE++++  + H ++V L+ F     ++       
Sbjct: 59  AKLVESDEVAIKKV-LQDKRFKN---RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114

Query: 181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAID--------VANALEYLHFYCDPPLCH 232
           L+ EY+   ++              + +  + +         +  +L Y+H      +CH
Sbjct: 115 LVLEYV-PETVYRASRH------YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICH 164

Query: 233 RDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT---- 287
           RDIK  N+LLD    V KL DFG A               ++          Y+ +    
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKI-------LIAGEPNV---------SYICSRYYR 208

Query: 288 --------QELTEKSDVYSYGVVLLEIVTAR 310
                      T   D++S G V+ E++  +
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 30/242 (12%)

Query: 84  RSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRM 140
           + +  F +   P+  +   KE +   D+F  +  IG+G F  V   +    G + A+K M
Sbjct: 37  KYVADFLQWAEPIVVRL--KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM 94

Query: 141 DK--ISEQVEGDFCR-EIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLH 196
           +K  + ++ E    R E ++L     R +  L  F  +     +L+ EY   G L   L 
Sbjct: 95  NKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS 153

Query: 197 SPGRT-PLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 255
             G   P     R  +A ++  A++ +H        HRDIK  NILLD     +LADFG 
Sbjct: 154 KFGERIPAEM-ARFYLA-EIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 256 A-HASKDGSI-CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVY-------SYGVVLLEI 306
                 DG++     V     GTP Y+ PE +        +  Y       + GV   E+
Sbjct: 209 CLKLRADGTVRSLVAV-----GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263

Query: 307 VT 308
             
Sbjct: 264 FY 265

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 35/263 (13%), Positives = 75/263 (28%), Gaps = 56/263 (21%)

Query: 116 IGQGGFGTVYKAQFSDGSL---IAVKRMD---KISEQVEGDFCREIELLARLHHRHLVAL 169
            G       ++A   D +L   +A+  +D    + + V  +       L+R+    +  +
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
                 +    ++ E++  GSL++       T  S    I+    +A A +  H      
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           +       S + +  +    LA                         P  M         
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAY------------------------PATMPDA------ 179

Query: 290 LTEKSDVYSYGVVLLEIVTARR--AVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 347
              + D+   G  L  ++  R        ++ +  A+   A +      +D  I      
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS- 237

Query: 348 EQLRTIVTIVRWCTQREGQARPS 370
                   +     Q +G  R +
Sbjct: 238 -------AVAARSVQGDGGIRSA 253

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 16/161 (9%)

Query: 108 ATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKIS-EQVEGDFC---REIELLAR 160
           ++  F  +  +G G + TVYK    + G  +A+K   ++  +  EG      REI L+  
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK---EVKLDSEEGTPSTAIREISLMKE 59

Query: 161 LHHRHLVALRGFCIEKRERFLMYEYMAN---GSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
           L H ++V L      + +  L++E+M N     +           L           +  
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
            L + H      + HRD+K  N+L+++    KL DFGLA A
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA 157

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 72/259 (27%), Positives = 111/259 (42%), Gaps = 40/259 (15%)

Query: 65  GLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATD-NFSTIIGQGGFGT 123
           G+  P+  +  +  P PPP   ++   GPS            K +D +F  +IG+G FG 
Sbjct: 1   GISQPQEPELMNANPAPPPAPSQQINLGPSS-------NPHAKPSDFHFLKVIGKGSFGK 53

Query: 124 VYKAQF-SDGSLIAVKRMDKIS----EQVEGDFCREIE---LLARLHHRHLVALRGFCIE 175
           V  A+  ++    AVK + K +    ++ +       E   LL  + H  LV L  F  +
Sbjct: 54  VLLARHKAEEVFYAVKVLQKKAILKKKEEK---HIMSERNVLLKNVKHPFLVGLH-FSFQ 109

Query: 176 KRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
             ++ + + +Y+  G L  HL          + R   A ++A+AL YLH      + +RD
Sbjct: 110 TADKLYFVLDYINGGELFYHLQRERCFLEP-RARFYAA-EIASALGYLH---SLNIVYRD 164

Query: 235 IKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           +K  NILLD      L DFGL      H S   + C         GTP Y+ PE +  Q 
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---------GTPEYLAPEVLHKQP 215

Query: 290 LTEKSDVYSYGVVLLEIVT 308
                D +  G VL E++ 
Sbjct: 216 YDRTVDWWCLGAVLYEMLY 234

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.4 bits (220), Expect = 9e-20
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)

Query: 106 KKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC------REIE 156
             AT  +  +  IG G +GTVYKA+    G  +A+K + ++     G         RE+ 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVA 63

Query: 157 LLARLH---HRHLVALRGFCIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTR 208
           LL RL    H ++V L   C   R        L++E++    L+ +L       L  +T 
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122

Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
             +       L++LH  C   + HRD+K  NIL+      KLADFGLA  
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 28/184 (15%)

Query: 95  PM---FQKFSYKETKKATDNFSTI---IGQGGFGTVYKAQFSD---GSLIAVKRMDKISE 145
            M   F+     E ++  D F      +G+G +G VYKA+  D       A+K+++    
Sbjct: 2   KMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--T 59

Query: 146 QVEGDFCREIELLARLHHRHLVALRGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPL 203
            +    CREI LL  L H ++++L+   +   +R  +L+++Y  +  L   +     +  
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKA 118

Query: 204 SWQTRIQIAIDVA-------NALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLAD 252
           + +        V        + + YLH      + HRD+K +NIL+     E    K+AD
Sbjct: 119 NKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD 175

Query: 253 FGLA 256
            G A
Sbjct: 176 MGFA 179

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 26/244 (10%)

Query: 76  SLKPFPPPRSLRKFQEGPSPMF-QKFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQFSD 131
           + K      S+++F       F +K+       A  D F  I  +G G FG V   +  +
Sbjct: 5   AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64

Query: 132 GSLI-AVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM 186
                A+K +DK      +Q+E     E  +L  ++   LV L     +    +++ EY+
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123

Query: 187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF 246
           A G +  HL   GR       R   A  +    EYLH   D  L +RD+K  N+L+D+  
Sbjct: 124 AGGEMFSHLRRIGRFSEP-HARFYAA-QIVLTFEYLH-SLD--LIYRDLKPENLLIDQQG 178

Query: 247 VAKLADFGLAHASKDG--SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLL 304
             ++ DFG A   K    ++C         GTP  + PE ++++   +  D ++ GV++ 
Sbjct: 179 YIQVTDFGFAKRVKGRTWTLC---------GTPEALAPEIILSKGYNKAVDWWALGVLIY 229

Query: 305 EIVT 308
           E+  
Sbjct: 230 EMAA 233

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 70/243 (28%)

Query: 98  QKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC-REI 155
           Q+ SY +TK         IG G FG VY+A+  D G L+A+K++       +  F  RE+
Sbjct: 52  QEVSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNREL 98

Query: 156 ELLARLHHRHLVALRGFCIEKRERF------LMYEYMA---NGSLKDHLHSPGRTPLS-- 204
           +++ +L H ++V LR F     E+       L+ +Y+        + +  +    P+   
Sbjct: 99  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158

Query: 205 ----WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHAS 259
               +Q           +L Y+H +    +CHRDIK  N+LLD +  V KL DFG A   
Sbjct: 159 KLYMYQL--------FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query: 260 KDGSICFEPVNTDIRGTPGYMDPEYVVT------------QELTEKSDVYSYGVVLLEIV 307
             G    EP N             Y+ +             + T   DV+S G VL E++
Sbjct: 208 VRG----EP-NV-----------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

Query: 308 TAR 310
             +
Sbjct: 252 LGQ 254

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 18/167 (10%)

Query: 106 KKATDNFSTI--IGQGGFGTVYKAQ--FSDGSLIAVK--RMDKISEQVEGDFCREIELLA 159
            +A   +  +  IG+G +G V+KA+   + G  +A+K  R+    E +     RE+ +L 
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66

Query: 160 RLH---HRHLVALRGFCIEKRER-----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI 211
            L    H ++V L   C   R        L++E++ +  L  +L       +  +T   +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDM 125

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
              +   L++LH +    + HRD+K  NIL+  +   KLADFGLA  
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 33/212 (15%)

Query: 111 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK----ISEQVEGDFCREIELLARLHHRH 165
           ++  ++G+G FG V   +  + G   A+K + K      ++V      E  +L    H  
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPF 66

Query: 166 LVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           L AL+ +  +  +R   + EY   G L  HL          + R   A ++ +ALEYLH 
Sbjct: 67  LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGA-EIVSALEYLH- 122

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--------SICFEPVNTDIRGT 276
                + +RDIK  N++LD++   K+ DFGL    K+G        + C         GT
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGL---CKEGISDGATMKTFC---------GT 168

Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           P Y+ PE +   +     D +  GVV+ E++ 
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 19/224 (8%)

Query: 93  PSPMFQKFSYKETKKATD-NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK----ISEQ 146
           P    ++ S +   K  D     ++G+G FG V+ A+F       A+K + K    + + 
Sbjct: 1   PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD 60

Query: 147 VEGDFC-REIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLS 204
           VE     + + L     H  L  +     + +E  F + EY+  G L  H+ S  +  LS
Sbjct: 61  VECTMVEKRV-LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS 118

Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 264
            +     A ++   L++LH      + +RD+K  NILLD++   K+ADFG+    K+  +
Sbjct: 119 -RATFYAA-EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM---CKEN-M 169

Query: 265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             +       GTP Y+ PE ++ Q+     D +S+GV+L E++ 
Sbjct: 170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.0 bits (215), Expect = 2e-18
 Identities = 58/256 (22%), Positives = 105/256 (41%), Gaps = 21/256 (8%)

Query: 63  SRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKAT-DNFSTI--IGQG 119
             G E  E L +   +      +    ++  + + +  +     +    +F+ +  +G+G
Sbjct: 293 PEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKG 352

Query: 120 GFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFC-REIELLARLHHRHLVALRGFC 173
            FG V  ++      L AVK + K      + VE     + + L        L  L   C
Sbjct: 353 SFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQLH-SC 410

Query: 174 IEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
            +  +R + + EY+  G L  H+   GR           A ++A  L +L       + +
Sbjct: 411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAA-EIAIGLFFLQ---SKGIIY 465

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           RD+K  N++LD     K+ADFG+    K+  I          GTP Y+ PE +  Q   +
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGM---CKEN-IWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521

Query: 293 KSDVYSYGVVLLEIVT 308
             D +++GV+L E++ 
Sbjct: 522 SVDWWAFGVLLYEMLA 537

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 40/183 (21%), Positives = 67/183 (36%), Gaps = 26/183 (14%)

Query: 83  PRSLRKFQEGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMD 141
           P      Q   + +     YK T +       ++G G  G V +          A+K + 
Sbjct: 2   PHVKSGLQIKKNAIIDD--YKVTSQ-------VLGLGINGKVLQIFNKRTQEKFALKMLQ 52

Query: 142 KISEQVEGDFCREIELLARL-HHRHLVALRGFC----IEKRERFLMYEYMANGSLKDHLH 196
                      RE+EL  R     H+V +          ++   ++ E +  G L   + 
Sbjct: 53  DCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 107

Query: 197 SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADF 253
             G    + +   +I   +  A++YLH      + HRD+K  N+L      N + KL DF
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 164

Query: 254 GLA 256
           G A
Sbjct: 165 GFA 167

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.6 bits (209), Expect = 4e-18
 Identities = 50/276 (18%), Positives = 89/276 (32%), Gaps = 90/276 (32%)

Query: 112 FSTIIGQGGFGTVYKA------QFSDGSLIAVKRM-DKISEQVEGDFCREIELLARL-HH 163
               +G+G FG V +A      + +    +AVK + +  +         E+++L  + HH
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 164 RHLVALRGFCIEKRERFLM-YEYMANGSLKDHLHSPGRTPLSWQTRIQIA---------- 212
            ++V L G C +     ++  E+   G+L  +L S     + ++T+              
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 213 ---------------------------IDVANALEYLHFYCDPPLCHRD----------- 234
                                      +      E         L               
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 235 ---IKSSNIL----------LDENFVAKLADFGLA---------HASKDGSICFEPVNTD 272
              + S   +          L E  V K+ DFGLA             D  +   P+   
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLK-- 260

Query: 273 IRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                 +M PE +  +  T +SDV+S+GV+L EI +
Sbjct: 261 ------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 61/240 (25%), Positives = 106/240 (44%), Gaps = 28/240 (11%)

Query: 84  RSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRM 140
           +++ ++ E   P   K   K+ +   ++F  +  IG+G FG V   +  +   + A+K +
Sbjct: 50  KNILEYLEWAKPFTSKV--KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL 107

Query: 141 DK--ISEQVEGDFCR-EIELLARLHHRHLVALRG-FCIEKRERFLMYEYMANGSLKDHLH 196
           +K  + ++ E    R E ++L     + +  L   F  +     +M +Y   G L   L 
Sbjct: 108 NKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM-DYYVGGDLLTLLS 166

Query: 197 -SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 255
               R P     R  +A ++  A++ +H        HRDIK  NIL+D N   +LADFG 
Sbjct: 167 KFEDRLPEEM-ARFYLA-EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS 221

Query: 256 A-HASKDGSI-CFEPVNTDIRGTPGYMDPEYVVTQELTEKS-----DVYSYGVVLLEIVT 308
                +DG++     V     GTP Y+ PE +   E  +       D +S GV + E++ 
Sbjct: 222 CLKLMEDGTVQSSVAV-----GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 18/205 (8%)

Query: 111 NFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDK----ISEQVEGDFC-REIELLARLHHR 164
           NF  ++G+G FG V  ++      L AVK + K      + VE     + + L       
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPP 81

Query: 165 HLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
            L  L   C +  +R + + EY+  G L  H+   GR           A ++A  L +L 
Sbjct: 82  FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-HAVFYAA-EIAIGLFFLQ 138

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + +RD+K  N++LD     K+ADFG+    K+  I          GTP Y+ PE
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGM---CKEN-IWDGVTTKTFCGTPDYIAPE 191

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVT 308
            +  Q   +  D +++GV+L E++ 
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLA 216

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 111 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK----ISEQVEGDFCREIE---LLARLH 162
           +   +IG+G +  V   +      + A+K + K      E ++     + E        +
Sbjct: 12  DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID---WVQTEKHVFEQASN 68

Query: 163 HRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           H  LV L   C +   R F + EY+  G L  H+    + P     R   A +++ AL Y
Sbjct: 69  HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNY 125

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMD 281
           LH   +  + +RD+K  N+LLD     KL D+G+    K+G +      +   GTP Y+ 
Sbjct: 126 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM---CKEG-LRPGDTTSTFCGTPNYIA 178

Query: 282 PEYVVTQELTEKSDVYSYGVVLLEIVT 308
           PE +  ++     D ++ GV++ E++ 
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMA 205

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 25/231 (10%)

Query: 90  QEGPSPMFQKFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDK--- 142
           +E    M  + S K +      +F  +  IG+G +  V   +      + A++ + K   
Sbjct: 31  EEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV 90

Query: 143 -ISEQVEGDFCREIE---LLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHS 197
              E ++     + E        +H  LV L   C +   R F + EY+  G L  H+  
Sbjct: 91  NDDEDID---WVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQR 146

Query: 198 PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH 257
             + P     R   A +++ AL YLH   +  + +RD+K  N+LLD     KL D+G+  
Sbjct: 147 QRKLPEE-HARFYSA-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM-- 199

Query: 258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
             K+G +      +   GTP Y+ PE +  ++     D ++ GV++ E++ 
Sbjct: 200 -CKEG-LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 68/230 (29%), Positives = 103/230 (44%), Gaps = 24/230 (10%)

Query: 92  GPSPMFQ---KFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK-- 142
           GP    +         + +   DNF  I  +G+G FG V  A+    G L AVK + K  
Sbjct: 1   GPKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV 60

Query: 143 --ISEQVEGDFC-REIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSP 198
               + VE     + I L    +H  L  L   C +  +R F + E++  G L  H+   
Sbjct: 61  ILQDDDVECTMTEKRI-LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS 118

Query: 199 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
            R   + + R   A ++ +AL +LH   D  + +RD+K  N+LLD     KLADFG+   
Sbjct: 119 RRFDEA-RARFYAA-EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM--- 170

Query: 259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            K+G IC         GTP Y+ PE +         D ++ GV+L E++ 
Sbjct: 171 CKEG-ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 65/250 (26%), Positives = 112/250 (44%), Gaps = 26/250 (10%)

Query: 70  ENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKA 127
            +LD  +L+     +++  F         K   ++ +   +++  +  IG+G FG V   
Sbjct: 34  YDLDFPALRK---NKNIDNFLSRYKDTINKI--RDLRMKAEDYEVVKVIGRGAFGEVQLV 88

Query: 128 QF-SDGSLIAVKRMDK--ISEQVEGDFCR-EIELLARLHHRHLVALRG-FCIEKRERFLM 182
           +  S   + A+K + K  + ++ +  F   E +++A  +   +V L   F  ++    +M
Sbjct: 89  RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148

Query: 183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL 242
            EYM  G L + + S    P  W  R   A +V  AL+ +H        HRD+K  N+LL
Sbjct: 149 -EYMPGGDLVNLM-SNYDVPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLL 201

Query: 243 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK----SDVYS 298
           D++   KLADFG     K         +T + GTP Y+ PE + +Q          D +S
Sbjct: 202 DKSGHLKLADFGT--CMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 258

Query: 299 YGVVLLEIVT 308
            GV L E++ 
Sbjct: 259 VGVFLYEMLV 268

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 34/223 (15%)

Query: 103 KETKKAT-DNFSTI--IGQGGFGTVY----KAQFSDGSLIAVKRMDKIS----EQVEGDF 151
           +  +KA    F  +  +GQG FG V+     +      L A+K + K +    ++V    
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM 75

Query: 152 CREIELLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ 210
            R+I  L  ++H  +V L  +  +   + +L+ +++  G L   L            +  
Sbjct: 76  ERDI--LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-DVKFY 131

Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSIC 265
           +A ++A AL++LH      + +RD+K  NILLDE    KL DFGL+     H  K  S C
Sbjct: 132 LA-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 187

Query: 266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                    GT  YM PE V  +  T+ +D +S+GV++ E++T
Sbjct: 188 ---------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.0 bits (201), Expect = 4e-17
 Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 43/233 (18%)

Query: 98  QKFSYKETKKATDNFSTI--IGQGGFGTVYKAQF----SDGSLIAVKRMDKIS-----EQ 146
              +    K   + F  +  +G+GG+G V++ +     + G + A+K + K       + 
Sbjct: 5   TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD 64

Query: 147 VEGDFCREIE--LLARLHHRHLVALRGFCIEKRER-FLMYEYMANGSLKDHLHSPGRTPL 203
                  + E  +L  + H  +V L  +  +   + +L+ EY++ G L   L   G    
Sbjct: 65  TA---HTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120

Query: 204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG- 262
                  +A +++ AL +LH      + +RD+K  NI+L+     KL DFGL    K+  
Sbjct: 121 D-TACFYLA-EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL---CKESI 172

Query: 263 -------SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                  + C         GT  YM PE ++        D +S G ++ +++T
Sbjct: 173 HDGTVTHTFC---------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 55/257 (21%), Positives = 93/257 (36%), Gaps = 66/257 (25%)

Query: 92  GPSPMFQKF----SYKETKKATDNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKR----- 139
           GP  M        + + ++K  D F      GQG FGTV   +    G  +A+K+     
Sbjct: 1   GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP 60

Query: 140 MDKISEQVEGDFCREIELLARLHHRHLVALR-GFCIEKRERF------LMYEYMANGSLK 192
             +  E       + ++ LA LHH ++V L+  F              ++ EY+   +L 
Sbjct: 61  RFRNRE------LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLH 113

Query: 193 DHL--HSPGRTPLSW---QTRI-QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-EN 245
                +   +        +  + Q+      ++  LH      +CHRDIK  N+L++  +
Sbjct: 114 RCCRNYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEAD 168

Query: 246 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT------------QELTEK 293
              KL DFG A          EP N             Y+ +            Q  T  
Sbjct: 169 GTLKLCDFGSAKKLSPS----EP-NV-----------AYICSRYYRAPELIFGNQHYTTA 212

Query: 294 SDVYSYGVVLLEIVTAR 310
            D++S G +  E++   
Sbjct: 213 VDIWSVGCIFAEMMLGE 229

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 26/209 (12%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLH 162
            +F  +  +G G FG V+  +   +G   A+K + K      +QVE     E  +L+ + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND-ERLMLSIVT 64

Query: 163 HRHLVALRG-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEY 221
           H  ++ + G F   ++   +M +Y+  G L   L    R P     +   A +V  ALEY
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIM-DYIEGGELFSLLRKSQRFPNP-VAKFYAA-EVCLALEY 121

Query: 222 LHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG--SICFEPVNTDIRGTPGY 279
           LH      + +RD+K  NILLD+N   K+ DFG A    D   ++C         GTP Y
Sbjct: 122 LH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC---------GTPDY 169

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           + PE V T+   +  D +S+G+++ E++ 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 65/345 (18%), Positives = 128/345 (37%), Gaps = 63/345 (18%)

Query: 60  RRKSRGLEDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IG 117
             ++   +   +  + ++         RK      P           +  D +     IG
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 118 QGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALRG- 171
            G +G V +A    +  ++A+K++ ++ E +    C    REI +L RL+H H+V +   
Sbjct: 63  TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI--DCKRILREIAILNRLNHDHVVKVLDI 120

Query: 172 FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLHFYC 226
              +  E+F    ++ E   +   K    +P    L+ +  I+ +  ++   ++Y+H   
Sbjct: 121 VIPKDVEKFDELYVVLEIA-DSDFKKLFRTP--VYLT-ELHIKTLLYNLLVGVKYVH--- 173

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLA-----HASKDGSICFEPVNTDIRGTPGYMD 281
              + HRD+K +N L++++   K+ DFGLA       + +  +   P   D+        
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 282 P-------EYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQD------- 315
                    +VVT+     EL       TE  DV+S G +  E++   +           
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293

Query: 316 ---GKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIV 357
              G +       C           D +     + +QL  I  I+
Sbjct: 294 LFPGSS-------CFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL 331

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 55/235 (23%), Positives = 81/235 (34%), Gaps = 52/235 (22%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGD-------FC----REIELLARLHH 163
            I  G +G V     S+G  +A+KR+                  C    REI LL   HH
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 164 RHLVALRG-FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVAN 217
            +++ LR  F   +        L+ E M    L   +H   R  +S    IQ     +  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD-QRIVIS-PQHIQYFMYHILL 145

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
            L  LH   +  + HRD+   NILL +N    + DF LA                     
Sbjct: 146 GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARED---------------TAD 187

Query: 278 GYMDPEYVVT------------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
                 YV              +  T+  D++S G V+ E+   R+A+  G    
Sbjct: 188 ANK-THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKALFRGSTFY 240

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 62/265 (23%), Positives = 98/265 (36%), Gaps = 41/265 (15%)

Query: 67  EDPENLDKTSLKPFPPPRSLRKFQEGPSPMFQKFSYKETKKATDNFSTI--IGQGGFGTV 124
           E   +               +             +    K   +NF  +  +G G +G V
Sbjct: 11  EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV 70

Query: 125 Y---KAQFSD-GSLIAVKRMDKIS-----EQVEGDFCREIE---LLARLHHRHLVALRGF 172
           +   K    D G L A+K + K +     +  E       E   L        LV L  +
Sbjct: 71  FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE---HTRTERQVLEHIRQSPFLVTLH-Y 126

Query: 173 CIEKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLC 231
             +   +  L+ +Y+  G L  HL    R     + +I +  ++  ALE+LH      + 
Sbjct: 127 AFQTETKLHLILDYINGGELFTHLSQRERFTEH-EVQIYVG-EIVLALEHLH---KLGII 181

Query: 232 HRDIKSSNILLDENFVAKLADFGLA------HASKDGSICFEPVNTDIRGTPGYMDPEYV 285
           +RDIK  NILLD N    L DFGL+         +    C         GT  YM P+ V
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC---------GTIEYMAPDIV 232

Query: 286 VTQEL--TEKSDVYSYGVVLLEIVT 308
              +    +  D +S GV++ E++T
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLT 257

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 51/225 (22%), Positives = 99/225 (44%), Gaps = 41/225 (18%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 169
           +IG+G +G VY A   +    +A+K+++++ E +    C    REI +L RL   +++ L
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI--DCKRILREITILNRLKSDYIIRL 90

Query: 170 RG-FCIEKRERF----LMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLH 223
                 +   +F    ++ E   +  LK    +P    L+ +  I+ I  ++     ++H
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP--IFLT-EEHIKTILYNLLLGENFIH 146

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLA--------HASKDGSICFEPVNTDIRG 275
              +  + HRD+K +N LL+++   K+ DFGLA            +     E      + 
Sbjct: 147 ---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203

Query: 276 TPGYMDPEYVVTQ-----EL-------TEKSDVYSYGVVLLEIVT 308
               +   +VVT+     EL       T+  D++S G +  E++ 
Sbjct: 204 LKKQL-TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 169
           ++G+G +G V  A     G ++A+K+++   + +   F     REI++L    H +++ +
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKILKHFKHENIITI 74

Query: 170 RG-FCIEKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAIDVANALEYL 222
                 +  E F    ++ E M      D LH    T  LS    IQ        A++ L
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQ----TD-LHRVISTQMLS-DDHIQYFIYQTLRAVKVL 128

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
           H      + HRD+K SN+L++ N   K+ DFGLA    +        N++  G    M  
Sbjct: 129 H---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES----AADNSEPTGQQSGM-V 180

Query: 283 EYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
           E+V T+     E+       +   DV+S G +L E+   RR +  G++  
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYR 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 45/218 (20%), Positives = 92/218 (42%), Gaps = 29/218 (13%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 169
            IG G  G V  A  +     +A+K++ +  +           RE+ L+  ++H++++ L
Sbjct: 32  PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVNHKNIIGL 89

Query: 170 R------GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYL 222
                      E ++ +++ E M      + L    +  L    R+  +   +   +++L
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDA----N-LCQVIQMELD-HERMSYLLYQMLCGIKHL 143

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
           H      + HRD+K SNI++  +   K+ DFGLA  +         + T    T  Y  P
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAP 195

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
           E ++     E  D++S G ++ E++     +  G + +
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHI 232

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 44/201 (21%), Positives = 87/201 (43%), Gaps = 16/201 (7%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 170
           IG G  G V  A  +     +A+K++ +  +           RE+ L+  ++H+++++L 
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVNHKNIISLL 127

Query: 171 G-FCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
             F  +K        Y+    +  +L    +  L  +    +   +   +++LH      
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAG 184

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
           + HRD+K SNI++  +   K+ DFGLA  +         + T    T  Y  PE ++   
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMG 239

Query: 290 LTEKSDVYSYGVVLLEIVTAR 310
             E  D++S G ++ E+V  +
Sbjct: 240 YKENVDIWSVGCIMGEMVRHK 260

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 54/229 (23%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 170
           +G G +G+V  A     G  +A+K++ +  +     F     RE+ LL  + H +++ L 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI--FAKRAYRELLLLKHMQHENVIGLL 89

Query: 171 ------GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQ-IAIDVANALEYLH 223
                        + +L+  +M      D L        S + +IQ +   +   L+Y+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFS-EEKIQYLVYQMLKGLKYIH 143

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRD+K  N+ ++E+   K+ DFGLA                 R     M   
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLA-----------------RHADAEM-TG 182

Query: 284 YVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
           YVVT+     E+        +  D++S G ++ E++T  + +  GK+ +
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYL 230

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 71.5 bits (176), Expect = 8e-14
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 49/229 (21%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 170
           IG+G +G V  A  +     +A+K++     Q    +C    REI++L R  H +++ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT---YCQRTLREIKILLRFRHENIIGIN 91

Query: 171 G-FCIEKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAIDVANALEYLH 223
                   E+     ++ + M      D L+   +T  LS    I      +   L+Y+H
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLS-NDHICYFLYQILRGLKYIH 145

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRD+K SN+LL+     K+ DFGLA  +                  G++  E
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-----------DHTGFL-TE 190

Query: 284 YVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
           YV T+     E+       T+  D++S G +L E+++  R +  GK+ +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYL 238

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 45/247 (18%), Positives = 80/247 (32%), Gaps = 72/247 (29%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC-REIELLARLHHRHLVALRGF 172
            +G G FG V +    + G   A+K   K+ +     +  RE++++  L H +++ L  +
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALK---KVLQDPR--YKNRELDIMKVLDHVNIIKLVDY 68

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIA--IDVANALEY----LHFYC 226
                +         +   K    + G         +  +    +   +EY    LH   
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 227 D---------PPL---------------------CHRDIKSSNILLD-ENFVAKLADFGL 255
                     P                       CHRDIK  N+L++ ++   KL DFG 
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT------------QELTEKSDVYSYGVVL 303
           A          EP +             Y+ +             E T   D++S G V 
Sbjct: 189 AKKLIPS----EP-SV-----------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 304 LEIVTAR 310
            E++  +
Sbjct: 233 GELILGK 239

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 38/192 (19%), Positives = 72/192 (37%), Gaps = 33/192 (17%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVE---GDFCREIELLARLHHRHLVA--- 168
             +   G +Y+A   S  +  +  +  K S +++   G    E     R      V    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 169 ----LRGFCI---------EKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAID 214
                    I         + + RFL+   +  G SL+  L    +  LS ++ +Q+A  
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGS--ICF-EP 268
           + +ALE+LH        H ++ + NI +   D++ V  LA +G A         + + E 
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKHVAYVEG 223

Query: 269 VNTDIRGTPGYM 280
             +   G   ++
Sbjct: 224 SRSPHEGDLEFI 235

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 42/233 (18%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLH-HRHLVA 168
            +G+G +G V+K+     G ++AVK++    +           REI +L  L  H ++V 
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST--DAQRTFREIMILTELSGHENIVN 73

Query: 169 LRGFCI--EKRERFLMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAIDVANALEYLHF 224
           L         R+ +L+++YM      D LH+  R   L      Q +   +   ++YLH 
Sbjct: 74  LLNVLRADNDRDVYLVFDYME----TD-LHAVIRANILE-PVHKQYVVYQLIKVIKYLH- 126

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLA-------HASKDGSICFEPVNTDIRGTP 277
                L HRD+K SNILL+     K+ADFGL+         + +  +       +     
Sbjct: 127 --SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 278 GYMDPEYVVT------------QELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
             +  +YV T             + T+  D++S G +L EI+   + +  G +
Sbjct: 185 PIL-TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPGSS 235

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 51/229 (22%), Positives = 92/229 (40%), Gaps = 53/229 (23%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 170
           +G G +G V  A     G+ +A+K++ +  +     F     RE+ LL  + H +++ L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL--FAKRAYRELRLLKHMRHENVIGLL 90

Query: 171 GFCI--EKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQIAIDVANALEYLH 223
                 E  + F    L+  +M      D L    +   L       +   +   L Y+H
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMG----TD-LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRD+K  N+ ++E+   K+ DFGLA                 R     M   
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLA-----------------RQADSEM-TG 184

Query: 284 YVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
           YVVT+     E+       T+  D++S G ++ E++T  + +  G + +
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHL 232

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 55/228 (24%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVALR 170
           +G G +G+V  A  +  G  +AVK++ +  + +         RE+ LL  + H +++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 94

Query: 171 GFCI--EKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAIDVANALEYL 222
                    E F    L+   M      D L++  +   L+    +Q +   +   L+Y+
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMG----AD-LNNIVKCQKLT-DDHVQFLIYQILRGLKYI 148

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
           H      + HRD+K SN+ ++E+   K+ DFGLA                 R T   M  
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLA-----------------RHTADEM-T 187

Query: 283 EYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKN 318
            YV T+     E+        +  D++S G ++ E++T  R +  G +
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTD 234

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.4 bits (161), Expect = 3e-12
 Identities = 43/270 (15%), Positives = 78/270 (28%), Gaps = 74/270 (27%)

Query: 90  QEGPSPM---FQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVK-------- 138
           Q+GP P          +  +K        IG+G FG V++   +D + +A+K        
Sbjct: 7   QKGPVPFSHCLPTEKLQRCEK--------IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPD 57

Query: 139 RMDKISEQVEGDFCREIELLARLH---------HRHLVALRGFCI--------------- 174
            ++   ++   +   EI +   L              + L                    
Sbjct: 58  LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117

Query: 175 ---------------EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
                          +  + F++ E+   G     L        S  T   I   +  +L
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASL 174

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR----- 274
                       HRD+   N+LL +  + KL       +S   S   +    D       
Sbjct: 175 AVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232

Query: 275 --GTPGYMD---PEYVVTQELTEKSDVYSY 299
             G   + D    E + T +   + D+Y  
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 29/190 (15%)

Query: 102 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLAR 160
           Y+  +K        IG G FG +Y     + G  +A+K     ++        E ++   
Sbjct: 11  YRLGRK--------IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKM 60

Query: 161 LHH-RHLVALRGFCIEKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
           +     +  +R    E     ++ E +  G SL+D  +   R   S +T + +A  + + 
Sbjct: 61  MQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRK-FSLKTVLLLADQMISR 117

Query: 219 LEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGS----ICFEPVN 270
           +EY+H        HRD+K  N L+      N V  + DFGLA   +D      I +   N
Sbjct: 118 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRDARTHQHIPYRE-N 172

Query: 271 TDIRGTPGYM 280
            ++ GT  Y 
Sbjct: 173 KNLTGTARYA 182

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 41/193 (21%), Positives = 74/193 (38%), Gaps = 35/193 (18%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKR--MDKISEQVEGDFCREIELLARLHHRHLVA----- 168
           IGQGGFG +Y A  +    +      + K+     G    E++   R      +      
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 169 ----------LRGFCIEKRE----RFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAI 213
                       G  +  +     RF++ +    G  L+    +  +   S +T +Q+++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKR-FSRKTVLQLSL 159

Query: 214 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAK--LADFGLAHASKDGS----ICFE 267
            + + LEY+H +      H DIK+SN+LL+     +  L D+GLA+             +
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 268 PVNTDIRGTPGYM 280
           P      GT  + 
Sbjct: 217 P-KRCHDGTIEFT 228

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 44/193 (22%), Positives = 72/193 (37%), Gaps = 38/193 (19%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA------ 168
           IG GGFG +Y A   +     A   + K+  Q  G    E++   R+  +  +       
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 169 ---------LRGF----CIEKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAID 214
                      G        +  RF++ E +  G  L+      G       T +Q+ I 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT--FKKSTVLQLGIR 159

Query: 215 VANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGS----ICFE 267
           + + LEY+H        H DIK++N+LL   + + V  LAD+GL++              
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV-YLADYGLSYRYCPNGNHKQYQEN 215

Query: 268 PVNTDIRGTPGYM 280
           P      GT  + 
Sbjct: 216 P-RKGHNGTIEFT 227

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 31/192 (16%)

Query: 102 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLAR 160
           YK  ++        IG+G FG +++     +   +A+K   + S+        E      
Sbjct: 12  YKVGRR--------IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKL 61

Query: 161 LHH-RHLVALRGFCIEKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
           L     +  +  F  E     L+ + +  G SL+D L   GR   S +T    A  +   
Sbjct: 62  LAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRK-FSVKTVAMAAKQMLAR 118

Query: 219 LEYLHFYCDPPLCHRDIKSSNILL------DENFVAKLADFGLAHASKDGS----ICFEP 268
           ++ +H      L +RDIK  N L+      + N +  + DFG+    +D      I +  
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIY-VVDFGMVKFYRDPVTKQHIPYRE 174

Query: 269 VNTDIRGTPGYM 280
              ++ GT  YM
Sbjct: 175 -KKNLSGTARYM 185

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 53/241 (21%), Positives = 96/241 (39%), Gaps = 60/241 (24%)

Query: 115 IIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFC----REIELLARLHHRHLVAL 169
            +G GG G V+ A  +D    +A+K   KI             REI+++ RL H ++V +
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQS-VKHALREIKIIRRLDHDNIVKV 73

Query: 170 R----------GFCIEKRERF----LMYEYMANGSLKDHLHSPGRT-PLSWQTRIQ-IAI 213
                         +          ++ EYM      D L +     PL  +   +    
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LANVLEQGPLL-EEHARLFMY 127

Query: 214 DVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTD 272
            +   L+Y+H      + HRD+K +N+ ++ E+ V K+ DFGLA                
Sbjct: 128 QLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY--------- 175

Query: 273 IRGTPGYMDPEYVVTQ-----EL-------TEKSDVYSYGVVLLEIVTARRAVQDGKNLV 320
                G++  E +VT+      L       T+  D+++ G +  E++T  + +  G + +
Sbjct: 176 --SHKGHL-SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKTLFAGAHEL 231

Query: 321 E 321
           E
Sbjct: 232 E 232

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 27/189 (14%)

Query: 102 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLAR 160
           ++  +K        IG G FG +Y          +A+K  +  ++        E ++   
Sbjct: 9   FRLGRK--------IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRI 58

Query: 161 LH-HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
           L     +  +R F +E     L+ + +   SL+D  +   R  LS +T + +A  + N +
Sbjct: 59  LQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRV 116

Query: 220 EYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASKDGS----ICFEPVNT 271
           E++H        HRDIK  N L+      N V  + DFGLA   +D S    I +   N 
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYRE-NK 171

Query: 272 DIRGTPGYM 280
           ++ GT  Y 
Sbjct: 172 NLTGTARYA 180

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 44/192 (22%), Positives = 73/192 (38%), Gaps = 31/192 (16%)

Query: 102 YKETKKATDNFSTIIGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLAR 160
           ++  KK        IG G FG +   +       +A+K     S         E     +
Sbjct: 11  FRVGKK--------IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQ 60

Query: 161 LHH-RHLVALRGFCIEKRERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
           L     +  +  F    +   ++ E +  G SL+D      RT  S +T + IAI + + 
Sbjct: 61  LGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRT-FSLKTVLMIAIQLISR 117

Query: 219 LEYLHFYCDPPLCHRDIKSSNILL------DENFVAKLADFGLAHASKDGS----ICFEP 268
           +EY+H      L +RD+K  N L+       +  +  + DF LA    D      I +  
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAKEYIDPETKKHIPYRE 173

Query: 269 VNTDIRGTPGYM 280
            +  + GT  YM
Sbjct: 174 -HKSLTGTARYM 184

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 45/224 (20%), Positives = 86/224 (38%), Gaps = 52/224 (23%)

Query: 116 IGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFC 173
           +G+G +  V++A        + VK +  + ++      REI++L  L    +++ L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITL--AD 98

Query: 174 I----EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAI-DVANALEYLHFYCDP 228
           I      R   L++E++ N   K          L+    I+  + ++  AL+Y H     
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLT-DYDIRFYMYEILKALDYCH---SM 149

Query: 229 PLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGT-PGYMDPEYVV 286
            + HRD+K  N+++D E+   +L D+GLA                     PG      V 
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLA-----------------EFYHPGQEYNVRVA 192

Query: 287 T------------QELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
           +            Q      D++S G +L  ++  +     G +
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 46/221 (20%), Positives = 88/221 (39%), Gaps = 43/221 (19%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARL----HHRHL 166
            +G G F TV+ A+   + + +A+K        +E  E     EI+LL R+    + +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE----DEIKLLQRVNDADNTKED 81

Query: 167 VALRGFCIEKRERF-----------LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 215
                  ++  + F           +++E +   +L   +       +      QI+  +
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILLDE------NFVAKLADFGLAHASKDGSICF--E 267
              L+Y+H  C   + H DIK  N+L++           K+AD G A        C+  E
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--------CWYDE 190

Query: 268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
                I+ T  Y  PE ++       +D++S   ++ E++T
Sbjct: 191 HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 48/208 (23%), Positives = 86/208 (41%), Gaps = 31/208 (14%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVKRM---DKISEQVEGDFCREIELLARLHHR------ 164
           +IG+G FG V KA        +A+K +    +   Q       EI +L  L  +      
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTM 159

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           +++ +      +    + +E ++  +L + +        S     + A  +   L+ LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH- 217

Query: 225 YCDPPLCHRDIKSSNILLDENFVA--KLADFGLAHASKDGSICFE--PVNTDIRGTPGYM 280
                + H D+K  NILL +   +  K+ DF        GS C+E   V T I+ +  Y 
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDF--------GSSCYEHQRVYTYIQ-SRFYR 266

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            PE ++        D++S G +L E++T
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLT 294

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARLHHR------ 164
           +IG+G FG V KA    +   +A+K          Q +     E+ LL  ++        
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKY 116

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           ++V L+   + +    L++E ++  +L D L +     +S     + A  +  AL +L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA- 174

Query: 225 YCDPPLCHRDIKSSNILL--DENFVAKLADFGLAHASKDGSICF--EPVNTDIRGTPGYM 280
             +  + H D+K  NILL   +    K+ DF        GS C   + +   I+ +  Y 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDF--------GSSCQLGQRIYQYIQ-SRFYR 225

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVT 308
            PE ++        D++S G +L+E+ T
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 45/223 (20%), Positives = 79/223 (35%), Gaps = 39/223 (17%)

Query: 115 IIGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARLHHRHLVALR 170
            +G G FG V   Q   +    AVK    + K +   +     E ++L ++ +       
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK----IEADILKKIQNDD--INN 95

Query: 171 GFCIEKRERF-------LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
              ++   +F       L++E +   SL + +          +      I++  AL YL 
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR----GTPGY 279
                 L H D+K  NILLD+ +  K                +   +T I+    G   +
Sbjct: 155 ---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211

Query: 280 MD---PEYVVTQ---------EL--TEKSDVYSYGVVLLEIVT 308
                   + T+          L     SD++S+G VL E+ T
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 47/265 (17%), Positives = 79/265 (29%), Gaps = 87/265 (32%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVK---RMDKISEQVEGDFCREIELLARL-----HHRHL 166
           +G G F TV+ +        +A+K     +  +E        EI LL  +     +  + 
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL----DEIRLLKSVRNSDPNDPN- 99

Query: 167 VALRGFCIEKRERF-----------LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 215
              R   ++  + F           +++E + +  L   +       L      +I   V
Sbjct: 100 ---REMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILL--------------------------------- 242
              L+YLH  C   + H DIK  NILL                                 
Sbjct: 156 LQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 243 ----------------DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
                            E    K+AD G A          +    DI+ T  Y   E ++
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH------KHFTEDIQ-TRQYRSLEVLI 266

Query: 287 TQELTEKSDVYSYGVVLLEIVTARR 311
                  +D++S   +  E+ T   
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDY 291

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 46/218 (21%), Positives = 78/218 (35%), Gaps = 33/218 (15%)

Query: 115 IIGQGGFGTVYKA--QFSDGSLIAVK---RMDKISEQVEGDFCREIELLARLHHR----- 164
            +G+G FG V +        S +A+K    + K  E        EI +L ++  +     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR----LEINVLKKIKEKDKENK 81

Query: 165 -HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
              V +  +        + +E +   +  + L      P        +A  + +AL +LH
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD-----------GSICF--EPVN 270
              +  L H D+K  NIL   +    L +   +   K            GS  F  E   
Sbjct: 141 ---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT 197

Query: 271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT 308
           T +  T  Y  PE ++     +  DV+S G +L E   
Sbjct: 198 TIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	458
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.74
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.62
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.48
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.25
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.14
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.01
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.88
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.66
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.53
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.52
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.45
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.33
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.3
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.21
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.13
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.07
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.63
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.54
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.33
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.41
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	93.86
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	93.85
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	93.8
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.82
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.84
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.1
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.67

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-59  Score=452.72  Aligned_cols=261  Identities=21%  Similarity=0.341  Sum_probs=212.3

Q ss_pred             HHHHHhhcccceeeeecceEEEEEEEc------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc
Q 012715          104 ETKKATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEK  176 (458)
Q Consensus       104 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  176 (458)
                      ++..++..|.+.||+|+||+||+|.+.      +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            344455678889999999999999873      4678999999643 333456899999999999999999999999999


Q ss_pred             CceeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 012715          177 RERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL  242 (458)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll  242 (458)
                      +..+||||||++|+|.++|....              ...++|..+++|+.|||.||+|||   +++|+||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEE
Confidence            99999999999999999996432              235899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHH
Q 012715          243 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVE  321 (458)
Q Consensus       243 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~  321 (458)
                      ++++++||+|||+++.......  ........||++|||||++.++.|+.++|||||||+||||+| |+.||.+... .+
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-~~  255 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADY--YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QD  255 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGC--BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-HH
T ss_pred             CCCCCEEECCcccceeccCCCc--eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-HH
Confidence            9999999999999986543221  123345679999999999999999999999999999999999 8889875433 33


Q ss_pred             HHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       322 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....+.. ...      +..    +..++..+.+++.+||+.||++||||.||+++|...
T Consensus       256 ~~~~i~~-~~~------~~~----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 VVEMIRN-RQV------LPC----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHT-TCC------CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHc-CCC------CCC----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            3332221 111      111    223346789999999999999999999999999643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.9e-58  Score=444.63  Aligned_cols=255  Identities=33%  Similarity=0.488  Sum_probs=205.2

Q ss_pred             hcccceeeeecceEEEEEEEc------CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ..+.++||+|+||+||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..||||
T Consensus        43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~  122 (329)
T 4aoj_A           43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF  122 (329)
T ss_dssp             EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            345678999999999999874      47899999998777777788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 012715          184 EYMANGSLKDHLHSPG-------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL  250 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  250 (458)
                      |||++|+|.++|+...             ..+++|.+++.|+.||+.||+|||   +++|+||||||+||||++++.+||
T Consensus       123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki  199 (329)
T 4aoj_A          123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKI  199 (329)
T ss_dssp             ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEE
T ss_pred             EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEE
Confidence            9999999999997542             236999999999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhh
Q 012715          251 ADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMAS  329 (458)
Q Consensus       251 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  329 (458)
                      +|||+++.......  ........||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.... +....+.. 
T Consensus       200 ~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~~~i~~-  275 (329)
T 4aoj_A          200 GDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-EAIDCITQ-  275 (329)
T ss_dssp             CCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-HHHHHHHH-
T ss_pred             cccccceeccCCCc--ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-HHHHHHHc-
Confidence            99999986644321  112345679999999999999999999999999999999999 89999755433 33222221 


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          330 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       330 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..+      +.....+    +..+.+++.+||+.||++|||++||+++|...
T Consensus       276 g~~------~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          276 GRE------LERPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             TCC------CCCCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCC------CCCcccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            111      1122223    35689999999999999999999999998653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-58  Score=443.48  Aligned_cols=254  Identities=30%  Similarity=0.487  Sum_probs=209.5

Q ss_pred             hcccceeeeecceEEEEEEEc------CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+.||+|+||+||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|||
T Consensus        15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~   94 (299)
T 4asz_A           15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   94 (299)
T ss_dssp             EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            456789999999999999864      47789999998777777788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          184 EYMANGSLKDHLHSPG-----------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                      |||++|+|.++|+..+           ...++|..++.|+.||+.||+|||   +++|+||||||+||||++++.+||+|
T Consensus        95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~D  171 (299)
T 4asz_A           95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGD  171 (299)
T ss_dssp             ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECC
Confidence            9999999999996532           346999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      ||+|+........  .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+... .+....+... .
T Consensus       172 FGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-~~~~~~i~~~-~  247 (299)
T 4asz_A          172 FGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQG-R  247 (299)
T ss_dssp             CSCHHHHTGGGCE--EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHHT-C
T ss_pred             cccceecCCCCce--eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcC-C
Confidence            9999865433211  12234568999999999999999999999999999999999 8999975443 3333322221 1


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .      +.....    ++..+.+++.+||+.||++|||+++|++.|..
T Consensus       248 ~------~~~p~~----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          248 V------LQRPRT----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             C------CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C------CCCCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1      111222    33568999999999999999999999988864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.4e-57  Score=440.75  Aligned_cols=257  Identities=23%  Similarity=0.359  Sum_probs=214.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||+||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||+|
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            445578999999999999886 6999999999765555567789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++..   ..+++..+..++.||+.||+|||   +++|+||||||+||||+.+|.+||+|||+|+.......    
T Consensus       156 g~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~----  225 (346)
T 4fih_A          156 GALTDIVTH---TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP----  225 (346)
T ss_dssp             EEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC----
T ss_pred             CcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC----
Confidence            999999975   24999999999999999999999   89999999999999999999999999999987654321    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.... +....+....       .+.+..  ...
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~-------~~~~~~--~~~  295 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDNL-------PPRLKN--LHK  295 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSS-------CCCCSC--GGG
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCC-------CCCCCc--ccc
Confidence            235678999999999999999999999999999999999999999765433 3333222111       111110  111


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                      ....+.+++.+||+.||++|||+.|+++|.|+.....+
T Consensus       296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            22568899999999999999999999999988654433

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-57  Score=436.91  Aligned_cols=256  Identities=28%  Similarity=0.417  Sum_probs=201.8

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      ..+.+.||+|+||+||+|+++  ..||||.++..  .....+.|.+|+++|++++|||||+++|+|.+ +..+||||||+
T Consensus        38 l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~  114 (307)
T 3omv_A           38 VMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE  114 (307)
T ss_dssp             CCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred             eEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence            356789999999999999874  36999998643  34455789999999999999999999999865 56899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      ||+|.++|+... ..+++..++.|+.|||.||+|||   +++|+||||||+||||++++.+||+|||+|+.......  .
T Consensus       115 gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~--~  188 (307)
T 3omv_A          115 GSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG--S  188 (307)
T ss_dssp             SCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred             CCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc--c
Confidence            999999997643 35999999999999999999999   88999999999999999999999999999986543221  1


Q ss_pred             cccccccCCCcccccccccc---CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      .......||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+..+......... ....     .|.+. .
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~-~~~~-----~p~~~-~  261 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG-RGYA-----SPDLS-K  261 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH-TTCC-----CCCST-T
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh-cCCC-----CCCcc-c
Confidence            12345679999999999864   4689999999999999999999999976554433333222 1111     11111 1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....++..+.+++.+||+.||++|||+.||+++|+..
T Consensus       262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1223346789999999999999999999999988653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.2e-57  Score=440.59  Aligned_cols=254  Identities=24%  Similarity=0.407  Sum_probs=207.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      |.+.+.||+|+||+||+|+.. +|+.||||++...  .....+.+.+|+++|++|+|||||++++++.+++..|||||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~  105 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC  105 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            456678999999999999875 6999999998643  3344567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +||+|.++|...+...+++..++.|+.||+.||+|||   +++|+||||||+||||+.+|.+||+|||+|+......   
T Consensus       106 ~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~---  179 (350)
T 4b9d_A          106 EGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV---  179 (350)
T ss_dssp             TTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH---
T ss_pred             CCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc---
Confidence            9999999997655566899999999999999999999   8999999999999999999999999999998764321   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                       ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.... ..+....+....  .     +.+...++
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~--~-----~~~~~~~s  250 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKIISGS--F-----PPVSLHYS  250 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHTC--C-----CCCCTTSC
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-HHHHHHHHHcCC--C-----CCCCccCC
Confidence             12345679999999999999999999999999999999999999997544 333333332221  1     11222233


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                          ..+.+++.+||+.||++|||++|+++|.|...
T Consensus       251 ----~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          251 ----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ----HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ----HHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                46889999999999999999999999988753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-56  Score=423.47  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=204.5

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec----cCceeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMY  183 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  183 (458)
                      .|.++||+|+||+||+|.+. ++..||+|++...  .....+.|.+|+++|++++|||||++++++.+    ++..||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            35668999999999999875 5889999998643  33445679999999999999999999999865    34689999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeccCCCCCeeeCC-CCcEEEeecccccccC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDE-NFVAKLADFGLAHASK  260 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~  260 (458)
                      |||+||+|.+++...  ..+++..+..++.||+.||+|||   +++  |+||||||+||||+. +|.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999764  35999999999999999999999   776  999999999999984 8999999999998644


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ..      .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+..+.............  +    +.
T Consensus       184 ~~------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~----~~  250 (290)
T 3fpq_A          184 AS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--P----AS  250 (290)
T ss_dssp             TT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--C----GG
T ss_pred             CC------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--C----CC
Confidence            32      2345689999999998864 6999999999999999999999999876665554443322111  1    11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .....+    ..+.+++.+||+.||++|||++|+++|.|..
T Consensus       251 ~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~  287 (290)
T 3fpq_A          251 FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  287 (290)
T ss_dssp             GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCccCC----HHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence            111122    4588999999999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.3e-56  Score=442.35  Aligned_cols=258  Identities=22%  Similarity=0.345  Sum_probs=215.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||+|
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            445678999999999999875 6999999999765555567799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...   .+++..+..++.||+.||+|||   +++|+||||||+||||+.+|.+||+|||+|+.......    
T Consensus       233 G~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~----  302 (423)
T 4fie_A          233 GALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP----  302 (423)
T ss_dssp             EEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC----
T ss_pred             CcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc----
Confidence            9999999743   4999999999999999999999   89999999999999999999999999999987654321    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... +....+.....  ..+   .....++  
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-~~~~~i~~~~~--~~~---~~~~~~s--  374 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMKMIRDNLP--PRL---KNLHKVS--  374 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCC--CCC---SCTTSSC--
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHcCCC--CCC---cccccCC--
Confidence            235678999999999999999999999999999999999999999765443 33222221110  000   1111222  


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCc
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS  387 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~  387 (458)
                        ..+.+|+.+||+.||++|||+.|+++|.|......++
T Consensus       375 --~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~  411 (423)
T 4fie_A          375 --PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPA  411 (423)
T ss_dssp             --HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             --HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCCc
Confidence              5688999999999999999999999999886544433

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.5e-56  Score=426.32  Aligned_cols=247  Identities=24%  Similarity=0.345  Sum_probs=207.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||.+.+.   .....+.+.+|+++|++++|||||++++++.+.+..||||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            567789999999999999875 6899999998643   233456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |+||+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....... 
T Consensus       114 ~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~-  187 (311)
T 4aw0_A          114 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-  187 (311)
T ss_dssp             CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT-
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC-
Confidence            99999999997643  4999999999999999999999   89999999999999999999999999999987643321 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                       .......+||+.|||||++.+..|+.++|||||||+||||+||+.||... +..+....+......        +...+
T Consensus       188 -~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~--------~p~~~  257 (311)
T 4aw0_A          188 -QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYD--------FPEKF  257 (311)
T ss_dssp             -CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC--------CCTTC
T ss_pred             -cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCC--------CCccc
Confidence             11234578999999999999999999999999999999999999999754 333444443333222        22233


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLR  376 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~  376 (458)
                      +    ..+.+++.+||+.||++|||++|++.
T Consensus       258 s----~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          258 F----PKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             C----HHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             C----HHHHHHHHHHccCCHhHCcChHHHcC
Confidence            3    45889999999999999999998533

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.4e-55  Score=413.75  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=196.8

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .|.+.+.||+|+||+||+|... +|+.||||.+...   .......+.+|+++|++++|||||++++++.+.+..|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3567789999999999999875 6999999998643   22334578999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      || +|+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        94 y~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           94 YA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             CC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             CC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            99 689999997643  5999999999999999999999   8999999999999999999999999999998765432 


Q ss_pred             ccccccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                          .....+||+.|||||++.+..| +.++|||||||++|||+||+.||.+. +..+....+......        +..
T Consensus       167 ----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-~~~~~~~~i~~~~~~--------~p~  233 (275)
T 3hyh_A          167 ----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-SIPVLFKNISNGVYT--------LPK  233 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC--------CCT
T ss_pred             ----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCCCC--------CCC
Confidence                2345689999999999998876 57999999999999999999999653 344444433332222        122


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .++    ..+.+++.+||+.||++|||++|+++|.|...
T Consensus       234 ~~s----~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          234 FLS----PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             TSC----HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             CCC----HHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            233    45889999999999999999999999998753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.5e-55  Score=425.35  Aligned_cols=251  Identities=22%  Similarity=0.234  Sum_probs=201.5

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      .+.++||+|+||+||+|++. +|+.||||+++...     ...+|+.+|++++|||||++++++.+++..|||||||+||
T Consensus        61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            34568999999999999875 68999999986432     2347999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-cEEEeecccccccCCCCcccc-
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSICFE-  267 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~~-  267 (458)
                      +|.++|+..+  .+++..+..++.||+.||+|||   +++|+||||||+||||+.+| .+||+|||+|+.......... 
T Consensus       136 ~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          136 SLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             BHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence            9999997643  5999999999999999999999   99999999999999999987 699999999987654332111 


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+..... ....+......+.     .+...++ 
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~~~~-----~~~~~~s-  283 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASEPPPIR-----EIPPSCA-  283 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHSCCGGG-----GSCTTSC-
T ss_pred             ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcCCCCch-----hcCccCC-
Confidence            12234679999999999999999999999999999999999999997543321 1222222211111     1222233 


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                         ..+.+++.+||+.||++|||+.|++++|...
T Consensus       284 ---~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          284 ---PLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence               5688999999999999999999999998653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.4e-55  Score=420.87  Aligned_cols=261  Identities=27%  Similarity=0.391  Sum_probs=197.3

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC----ceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR----ERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++|+|.+.+    ..||||||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            44668999999999999998 6899999998643322 222344566667889999999999998764    57999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-----CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      |++|+|.++|+..   +++|..+++++.|++.||+|||..     +.++|+||||||+||||+.++++||+|||+|+...
T Consensus        83 ~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           83 HEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            9999999999753   499999999999999999999932     13499999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCCccccccccccC------CCCcccccHhHHHHHHHHHhCCCccCCCcc-------------hHH
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKN-------------LVE  321 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~-------------~~~  321 (458)
                      ..............||+.|||||++.+.      .++.++|||||||+||||+||..|+.....             ..+
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            4432222233456799999999998754      478899999999999999999876632111             111


Q ss_pred             HHHHHHhhccccccccCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          322 SAQVCMASESRLAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       322 ~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ......     .....+|.+.... +.+.+..+.+++.+||+.||++||||.||++.|..
T Consensus       240 ~~~~~~-----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          240 EMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             HHHHHH-----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHH-----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            111111     1112233332221 23566789999999999999999999999999865

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-55  Score=431.98  Aligned_cols=260  Identities=26%  Similarity=0.348  Sum_probs=209.3

Q ss_pred             HHHHhhcccceeeeecceEEEEEEEcC------CCEEEEEEecccc-hhhHhHHHHHHHHHHhcCC-CCeeeeeeeeecc
Q 012715          105 TKKATDNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKIS-EQVEGDFCREIELLARLHH-RHLVALRGFCIEK  176 (458)
Q Consensus       105 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~  176 (458)
                      +....+.+.+.||+|+||+||+|.+..      ++.||||++.... ....+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            334556677899999999999998642      3589999997543 3345679999999999965 8999999999764


Q ss_pred             -CceeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 012715          177 -RERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL  241 (458)
Q Consensus       177 -~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIl  241 (458)
                       +..+||||||++|+|.++|+...              ...+++..++.++.|||.||+|||   +++||||||||+|||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL  217 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcccee
Confidence             56899999999999999996421              245899999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchH
Q 012715          242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLV  320 (458)
Q Consensus       242 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~  320 (458)
                      +++++.+||+|||+|+........  .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.....
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCCCEEECcchhhhhcccCCCc--eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999876443211  12345678999999999999999999999999999999998 899997654333


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ....... ...+      +.....+    ...+.+++.+||+.||++|||+.||+++|..
T Consensus       296 ~~~~~i~-~g~~------~~~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          296 EFCRRLK-EGTR------MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             HHHHHHH-HTCC------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHH-cCCC------CCCCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            3333222 1111      1122222    3568899999999999999999999999854

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-55  Score=421.62  Aligned_cols=251  Identities=25%  Similarity=0.347  Sum_probs=202.4

Q ss_pred             hcccceeeeecceEEEEEEEc----CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+.||+|+||+||+|+..    .++.||||.+....  ......+.+|+++|++++|||||++++++.+.+..||||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            567789999999999999762    47899999986432  223346889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      |||+||+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus       106 Ey~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          106 DFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             CCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999999997643  5999999999999999999999   8999999999999999999999999999998654332


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                          ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+. +..+....+......        +..
T Consensus       181 ----~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~--------~p~  247 (304)
T 3ubd_A          181 ----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILKAKLG--------MPQ  247 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCC--------CCT
T ss_pred             ----ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-CHHHHHHHHHcCCCC--------CCC
Confidence                1234568999999999999999999999999999999999999999754 333443333322211        122


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  382 (458)
                      .++    ..+.+++.+||+.||++|||     ++|+++|.|+..
T Consensus       248 ~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          248 FLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             TSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             cCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            233    45889999999999999998     589999998753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.8e-53  Score=407.29  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=191.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC----------
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKR----------  177 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------  177 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            456689999999999999875 68999999986433 334567999999999999999999999987654          


Q ss_pred             --ceeeeeeecCCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 012715          178 --ERFLMYEYMANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG  254 (458)
Q Consensus       178 --~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  254 (458)
                        ..|+|||||++|+|.+++..... ...++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCc
Confidence              36899999999999999986543 23566778999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCccc--------ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHH
Q 012715          255 LAHASKDGSICF--------EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC  326 (458)
Q Consensus       255 la~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  326 (458)
                      +|+.........        ....+..+||+.|||||.+.+..|+.++|||||||+||||++   ||....+........
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~  240 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV  240 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence            998765432111        012234679999999999999999999999999999999996   665322221111111


Q ss_pred             HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       327 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .  ....+.         ........+.+++.+||+.||++|||+.|+++|.|+.
T Consensus       241 ~--~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~  284 (299)
T 4g31_A          241 R--NLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE  284 (299)
T ss_dssp             H--TTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred             h--cCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence            1  111110         0112234567899999999999999999999998764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=409.35  Aligned_cols=267  Identities=22%  Similarity=0.350  Sum_probs=206.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeec------cCcee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIE------KRERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~  180 (458)
                      |.+.+.||+|+||+||+|+.. +|+.||||++....  ....+.+.+|+++|+.++|||||++++++..      .+..|
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            456689999999999999875 69999999996432  3344678899999999999999999998764      35789


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      ||||||+ |+|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       136 ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            9999996 6899999764  35999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      .............+||+.|||||++.+. .++.++||||+||++|||++|+.||.+...... ...+....+........
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGGGTC
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChHHhh
Confidence            4332222334567899999999998875 569999999999999999999999975544333 33322222111110000


Q ss_pred             c------------C--CCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          340 R------------I--KDSFDME-----QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       340 ~------------~--~~~~~~~-----~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .            +  ....+..     ....+.+++.+||..||++|||+.|+|+|.|+..-
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            0            0  0001111     12467899999999999999999999999998653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.9e-50  Score=397.74  Aligned_cols=263  Identities=21%  Similarity=0.288  Sum_probs=202.3

Q ss_pred             hcccceeeeecceEEEEEEEc----CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      |.+.+.||+|+||+||+|+.+    .++.||||.+....  ....+.+|+++|..+ +||||+++++++.+.+..|+|||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            556789999999999999753    46789999886543  234688999999998 69999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC-CcEEEeecccccccCCCC
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGS  263 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~  263 (458)
                      ||++|+|.+++.     .+++..+..++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+...+..
T Consensus       101 ~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A          101 YLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             CCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             CCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            999999999995     3899999999999999999999   9999999999999999876 899999999998654332


Q ss_pred             ccc------------------------ccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcc
Q 012715          264 ICF------------------------EPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKN  318 (458)
Q Consensus       264 ~~~------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~  318 (458)
                      ...                        .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||..+.+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence            110                        0112345799999999999875 589999999999999999999999987665


Q ss_pred             hHHHHHHHHhhcccc------------------------c---------cccCCcCCCC---------CCHHHHHHHHHH
Q 012715          319 LVESAQVCMASESRL------------------------A---------ELVDPRIKDS---------FDMEQLRTIVTI  356 (458)
Q Consensus       319 ~~~~~~~~~~~~~~~------------------------~---------~~~d~~~~~~---------~~~~~~~~l~~l  356 (458)
                      ..+....+....+..                        .         +...+.....         ........+.++
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            444332221110000                        0         0000000000         000112457899


Q ss_pred             HHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          357 VRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       357 ~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      +.+||+.||++|||++|+++|.|+..
T Consensus       333 l~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          333 LDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHCcCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999998753

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.8e-50  Score=415.52  Aligned_cols=256  Identities=20%  Similarity=0.281  Sum_probs=214.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      |.+.+.||+|+||.||+|..+ +|+.||+|.+........+.+.+|+++|+.++|||||++++++.+.+..|||||||+|
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g  238 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            456789999999999999875 6999999999766666667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC--CcEEEeecccccccCCCCccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN--FVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~--~~~kl~DfGla~~~~~~~~~~  266 (458)
                      |+|.++|.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+......   
T Consensus       239 g~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---  311 (573)
T 3uto_A          239 GELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---  311 (573)
T ss_dssp             CBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---
Confidence            99999996543 35999999999999999999999   8999999999999999854  899999999999775543   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.... +....+......+..    .....++
T Consensus       312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~~~~~i~~~~~~~~~----~~~~~~s  384 (573)
T 3uto_A          312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNMDD----SAFSGIS  384 (573)
T ss_dssp             --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCCCCS----GGGTTSC
T ss_pred             --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHHHhCCCCCCc----ccccCCC
Confidence              234467999999999999999999999999999999999999999755433 333333322222211    1112223


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                          ..+.+|+.+||+.||.+||++.|+++|.|+...
T Consensus       385 ----~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          385 ----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             ----HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             ----HHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence                457899999999999999999999999997653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.7e-49  Score=409.77  Aligned_cols=249  Identities=26%  Similarity=0.362  Sum_probs=202.4

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHH---HHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCRE---IELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.++||+|+||+||+|+.. +|+.||||.+.+..   ......+.+|   +.+++.++|||||++++++.+.+..||||
T Consensus       192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm  271 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL  271 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence            34578999999999999876 69999999986422   1222233344   56666778999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      |||+||+|.++|...+  .+++..+..++.||+.||+|||   +++||||||||+||||+.+|.+||+|||+|+......
T Consensus       272 Ey~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          272 DLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             CCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            9999999999997643  4999999999999999999999   9999999999999999999999999999998765432


Q ss_pred             cccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCc--chHHHHHHHHhhccccccccCCc
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGK--NLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                            ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||.+..  +..+.........        ..
T Consensus       347 ------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--------~~  412 (689)
T 3v5w_A          347 ------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------VE  412 (689)
T ss_dssp             ------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--------CC
T ss_pred             ------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--------CC
Confidence                  245689999999999974 579999999999999999999999996432  2223222222221        11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS  382 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  382 (458)
                      +...++    ..+.+++.+||+.||.+|++     ++||++|.|+..
T Consensus       413 ~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          413 LPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             CCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             CCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            222333    45889999999999999998     799999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-47  Score=374.32  Aligned_cols=282  Identities=41%  Similarity=0.733  Sum_probs=232.3

Q ss_pred             ccccCHHHHHHHhhccc--ceeeeecceEEEEEEEcCCCEEEEEEecccch-hhHhHHHHHHHHHHhcCCCCeeeeeeee
Q 012715           97 FQKFSYKETKKATDNFS--TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFC  173 (458)
Q Consensus        97 ~~~~~~~~~~~~~~~~~--~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~  173 (458)
                      ...|++.++...+.+|.  +.||+|+||.||+|...+|+.||||++..... .....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            35688888888777764  78999999999999988899999999865332 2234689999999999999999999999


Q ss_pred             eccCceeeeeeecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 012715          174 IEKRERFLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA  251 (458)
Q Consensus       174 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  251 (458)
                      .+.+..++||||+++|+|.+++....  ...+++..+..++.|++.||+|||..+..+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997643  3359999999999999999999994333399999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCC-------CcchHHHHH
Q 012715          252 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD-------GKNLVESAQ  324 (458)
Q Consensus       252 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~-------~~~~~~~~~  324 (458)
                      |||+++.......   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..       .....++..
T Consensus       177 Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          177 DFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             CCSSCEECCSSSS---CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             cCccccccCcccc---cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            9999986643321   123445699999999999999999999999999999999999999951       111222221


Q ss_pred             HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          325 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       325 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      . ......+....+..+...+.......+.+++.+||+.||.+|||+.+++++|+...
T Consensus       254 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          254 G-LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             T-TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             H-HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            1 12334455666777777888889999999999999999999999999999998643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.3e-47  Score=364.29  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=212.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||+||+|... +|+.||||.+........+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  101 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence            445678999999999999864 6899999998765555567789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........    
T Consensus       102 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----  171 (297)
T 3fxz_A          102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----  171 (297)
T ss_dssp             CBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred             CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc----
Confidence            9999999753   4899999999999999999999   88999999999999999999999999999986654321    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..................   ....       +..
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~~-------~~~  241 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP---ELQN-------PEK  241 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---CCSC-------GGG
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCC-------ccc
Confidence            234467999999999999999999999999999999999999999765544333222211111   1111       112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      ....+.+++.+||+.||++|||+.|+++|.|.....
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            235688999999999999999999999999886544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.3e-47  Score=369.39  Aligned_cols=264  Identities=42%  Similarity=0.683  Sum_probs=223.9

Q ss_pred             ccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      +.+.||+|+||+||+|.+.+|..||||++........+.+.+|+++++.++||||+++++++.+.+..++||||+++|+|
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  122 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL  122 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred             ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence            35689999999999999888999999998766666677899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          192 KDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       192 ~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      .+++....  ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......  ...
T Consensus       123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  197 (321)
T 2qkw_B          123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ--THL  197 (321)
T ss_dssp             GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC--CCC
T ss_pred             HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccc--ccc
Confidence            99997543  235899999999999999999999   89999999999999999999999999999986543221  112


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc-----hHHHHHHHHhhccccccccCCcCCCC
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-----LVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ...+... ......+...+++.+...
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  276 (321)
T 2qkw_B          198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE-SHNNGQLEQIVDPNLADK  276 (321)
T ss_dssp             BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHH-HHTTTCCCSSSSSSCTTC
T ss_pred             ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhh-ccccccHHHhcChhhccc
Confidence            2345689999999999999999999999999999999999999864322     2222221 223345566777777777


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ...+....+.+++.+||+.||++||++.|++++|+..
T Consensus       277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            8888999999999999999999999999999999754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.8e-46  Score=365.21  Aligned_cols=269  Identities=23%  Similarity=0.326  Sum_probs=220.1

Q ss_pred             ccCHHHHHHHhhc------------ccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCC
Q 012715           99 KFSYKETKKATDN------------FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH  165 (458)
Q Consensus        99 ~~~~~~~~~~~~~------------~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  165 (458)
                      .|+.++++.++..            +.+.||+|+||.||+|... +|+.||||.+........+.+.+|+.++++++|+|
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4778888877753            3357999999999999886 69999999987655555677999999999999999


Q ss_pred             eeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC
Q 012715          166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN  245 (458)
Q Consensus       166 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~  245 (458)
                      |+++++++...+..++||||+++|+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.+
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            999999999999999999999999999999753   4999999999999999999999   8899999999999999999


Q ss_pred             CcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHH
Q 012715          246 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV  325 (458)
Q Consensus       246 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  325 (458)
                      +.+||+|||++........    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-~~~  252 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-MKR  252 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHH
T ss_pred             CcEEEeeeeeeeecccCcc----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH
Confidence            9999999999986644321    22446799999999999999999999999999999999999999975543322 221


Q ss_pred             HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCc
Q 012715          326 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS  387 (458)
Q Consensus       326 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~  387 (458)
                      ....       ..+.+..  .......+.+++.+||+.||++||++.+++++.|......+.
T Consensus       253 ~~~~-------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          253 LRDS-------PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             HHHS-------SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             HhcC-------CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence            1111       1111110  111225688999999999999999999999999886554433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-46  Score=366.86  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=209.0

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++.+.+..|+||||+
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~   96 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA   96 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence            44567899999999999987 47999999998643  3344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++|+|.+++...+  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....+.   
T Consensus        97 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  168 (328)
T 3fe3_A           97 SGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---  168 (328)
T ss_dssp             TTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence            9999999997543  4899999999999999999999   8999999999999999999999999999998665433   


Q ss_pred             ccccccccCCCccccccccccCCCC-cccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        ......||+.|+|||.+.+..+. .++|||||||++|||++|+.||.+. +..+...........+        ....
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~--------p~~~  237 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLRGKYRI--------PFYM  237 (328)
T ss_dssp             --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCC--------CTTS
T ss_pred             --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCC--------CCCC
Confidence              23456799999999999888775 7999999999999999999999654 3333333333222111        1112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      +    ..+.+++.+||+.||.+|||++|+++|.|...
T Consensus       238 s----~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          238 S----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             C----HHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             C----HHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence            2    45789999999999999999999999998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.4e-45  Score=353.37  Aligned_cols=277  Identities=39%  Similarity=0.681  Sum_probs=227.4

Q ss_pred             ccccCHHHHHHHhhccc--------ceeeeecceEEEEEEEcCCCEEEEEEeccc----chhhHhHHHHHHHHHHhcCCC
Q 012715           97 FQKFSYKETKKATDNFS--------TIIGQGGFGTVYKAQFSDGSLIAVKRMDKI----SEQVEGDFCREIELLARLHHR  164 (458)
Q Consensus        97 ~~~~~~~~~~~~~~~~~--------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~  164 (458)
                      ...|++.++.+++.+|.        +.||+|+||.||+|.. ++..||||++...    .....+.+.+|++++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            45799999999999886        4699999999999987 6889999998642    233456799999999999999


Q ss_pred             CeeeeeeeeeccCceeeeeeecCCCCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC
Q 012715          165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD  243 (458)
Q Consensus       165 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~  243 (458)
                      ||+++++++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+++||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            99999999999999999999999999999997432 346999999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc---hH
Q 012715          244 ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LV  320 (458)
Q Consensus       244 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~---~~  320 (458)
                      .++.+||+|||+++........  .......||+.|+|||.+.+ .++.++||||||+++|||++|..||.....   ..
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQT--VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSC--EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             CCCcEEEeeccccccccccccc--ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            9999999999999865432211  12234578999999998765 589999999999999999999999975432   22


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+..........+.+.+++.+. .........+.+++.+||+.||.+||++.+++++|...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            3333323333344445555443 35567778899999999999999999999999999753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.9e-46  Score=365.24  Aligned_cols=254  Identities=24%  Similarity=0.359  Sum_probs=209.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchh------hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQ------VEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|... +|..||+|.+......      ..+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            456789999999999999876 6899999998643221      246789999999999999999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC----cEEEeecccccc
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLAHA  258 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~~  258 (458)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++    .+||+|||+++.
T Consensus        94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           94 LELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             EECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            9999999999999764  35999999999999999999999   89999999999999998876    799999999987


Q ss_pred             cCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                      ...+.     ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +....+......+.    
T Consensus       169 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~----  238 (361)
T 2yab_A          169 IEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITAVSYDFD----  238 (361)
T ss_dssp             CCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCCCC----
T ss_pred             cCCCC-----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCCCC----
Confidence            65432     224467999999999999999999999999999999999999999754332 33322222211111    


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      +......    ...+.+++.+||..||.+|||+.|+++|.|...
T Consensus       239 ~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          239 EEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             HHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             chhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            1111112    246889999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=362.92  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=206.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||+||+|.+. ++..||+|.+........+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus        12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   91 (310)
T 3s95_A           12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG   91 (310)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence            445678999999999999875 6899999998776667778899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc-
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE-  267 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-  267 (458)
                      |+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......... 
T Consensus        92 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           92 GTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             CBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred             CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence            99999997643 35999999999999999999999   89999999999999999999999999999986643322110 


Q ss_pred             ---------cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          268 ---------PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       268 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                               .......||+.|+|||.+.+..++.++||||||+++|||++|..|+..........      ........+
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------~~~~~~~~~  241 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------GLNVRGFLD  241 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------SBCHHHHHH
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------hhhhhcccc
Confidence                     01124579999999999999999999999999999999999999886422110000      000000000


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ......+    +..+.+++.+||+.||++|||+.++++.|...
T Consensus       242 ~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          242 RYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             HTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111111    23588999999999999999999999988653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-45  Score=360.59  Aligned_cols=251  Identities=23%  Similarity=0.339  Sum_probs=208.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||+|.+...   .......+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~   86 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence            445679999999999999876 6899999998643   233445788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+++......  
T Consensus        87 ~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  159 (337)
T 1o6l_A           87 ANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             CTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence            9999999999753  35899999999999999999999   8999999999999999999999999999998643221  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .......+......        +...+
T Consensus       160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~--------~p~~~  228 (337)
T 1o6l_A          160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIR--------FPRTL  228 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--------CCTTS
T ss_pred             --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC--------CCCCC
Confidence              12345679999999999999999999999999999999999999997543 23333332222111        11222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      +    ..+.+++.+||+.||++||     +++|+++|.|+..
T Consensus       229 s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          229 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             C----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             C----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            2    4688999999999999999     9999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.9e-46  Score=359.06  Aligned_cols=254  Identities=30%  Similarity=0.506  Sum_probs=199.2

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.+.||+|+||+||+|++ +|..||||.+....  ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL  116 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred             HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence            345667999999999999987 68899999986432  344567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          187 ANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       187 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ++|+|.+++...+. ..+++..++.++.|++.||+|||   +.+  |+||||||+|||++.++.+||+|||+++......
T Consensus       117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence            99999999976432 23899999999999999999999   888  9999999999999999999999999997544322


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      .    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..........      ...+..
T Consensus       194 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-~~~~~~~~~~------~~~~~~  262 (309)
T 3p86_A          194 L----SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-VVAAVGFKCK------RLEIPR  262 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-HHHHHHHSCC------CCCCCT
T ss_pred             c----ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCC------CCCCCc
Confidence            1    2234579999999999999999999999999999999999999997544322 2221111110      111222


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .++    ..+.+++.+||+.||.+|||+.++++.|...
T Consensus       263 ~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          263 NLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            223    5688999999999999999999999988654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-45  Score=359.88  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=205.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|... +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   88 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence            345678999999999999876 78999999985432 2334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        89 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~  161 (323)
T 3tki_A           89 GGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--E  161 (323)
T ss_dssp             TEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--E
T ss_pred             CCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc--c
Confidence            999999997643  4999999999999999999999   89999999999999999999999999999986543221  1


Q ss_pred             cccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      .......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....................    .+  ..   
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----~~--~~---  232 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----NP--WK---  232 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS----TT--GG---
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC----Cc--cc---
Confidence            12345679999999999988775 7799999999999999999999975444322222211111110    00  01   


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       .....+.+++.+||+.||++|||+.|++++.|...
T Consensus       233 -~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          233 -KIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             -GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence             12256789999999999999999999999988754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=358.32  Aligned_cols=254  Identities=18%  Similarity=0.262  Sum_probs=209.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||+||+|... ++..||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g   85 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence            456678999999999999876 5889999988643 33445788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC--CCcEEEeecccccccCCCCccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE--NFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      |+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++....+.   
T Consensus        86 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---  158 (321)
T 1tki_A           86 LDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---  158 (321)
T ss_dssp             CBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred             CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---
Confidence            99999997643 35999999999999999999999   899999999999999987  7899999999998765443   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......||+.|+|||.+.+..++.++|||||||++|||++|..||...... +..............    ...... 
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~----~~~~~~-  230 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDE----EAFKEI-  230 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCCCH----HHHTTS-
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-HHHHHHHcCCCCCCh----hhhccC-
Confidence              123456899999999999988999999999999999999999999754432 333322222211111    001111 


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                         ...+.+++.+||..||.+|||+.|+++|.|...
T Consensus       231 ---s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          231 ---SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---CHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence               256889999999999999999999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=357.84  Aligned_cols=256  Identities=23%  Similarity=0.334  Sum_probs=209.4

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccch------hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||.||+|... +|..||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4567789999999999999876 589999999864322      134678999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC----cEEEeeccccc
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLAH  257 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~  257 (458)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||+++
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            99999999999999764  35999999999999999999999   89999999999999999877    89999999998


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ......     ......||+.|+|||.+.+..++.++|||||||++|||++|..||...... +..............  
T Consensus       167 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~--  238 (326)
T 2y0a_A          167 KIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNYEFED--  238 (326)
T ss_dssp             ECCTTS-----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHTCCCCCH--
T ss_pred             ECCCCC-----ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHhcCCCcCc--
Confidence            765432     223457999999999999999999999999999999999999999754432 222222111111110  


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                        ......    ...+.+++.+||+.||++|||+.|+++|.|....
T Consensus       239 --~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          239 --EYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             --HHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             --cccccC----CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence              001111    2568899999999999999999999999987643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.1e-45  Score=364.63  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=206.2

Q ss_pred             hhcccceeeeecceEEEEEEEc--------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCc
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE  178 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  178 (458)
                      .+.+.+.||+|+||.||+|.+.        ++..||||.+... .......+.+|+++++++ +||||++++++|.+.+.
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  161 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  161 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence            3456688999999999999762        3567999998653 334456799999999999 89999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC
Q 012715          179 RFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE  244 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~  244 (458)
                      .|+||||+++|+|.+++....              ...+++..++.++.||+.||+|||   +++|+||||||+|||++.
T Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTE  238 (370)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred             EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECC
Confidence            999999999999999997532              235899999999999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHH
Q 012715          245 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESA  323 (458)
Q Consensus       245 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~  323 (458)
                      ++.+||+|||+++........  .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.... ..+..
T Consensus       239 ~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-~~~~~  315 (370)
T 2psq_A          239 NNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF  315 (370)
T ss_dssp             TCCEEECCCSSCEETTCCCTT--CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHH
T ss_pred             CCCEEEccccCCcccCcccce--ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHH
Confidence            999999999999865443211  12234567889999999999999999999999999999999 888886543 22222


Q ss_pred             HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...... .      .+....    .....+.+++.+||+.||.+||++.|++++|..
T Consensus       316 ~~~~~~-~------~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          316 KLLKEG-H------RMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             HHHHTT-C------CCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhcC-C------CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            221111 0      111112    223568999999999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=358.66  Aligned_cols=258  Identities=23%  Similarity=0.386  Sum_probs=206.1

Q ss_pred             HHhhcccceeeeecceEEEEEEEc----CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      ...+.+.+.||+|+||+||+|.+.    .+..||||.+... .....+.+.+|++++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            344556789999999999999884    3456999998753 34445679999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999997543 35999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      .... ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... +........ .      ...
T Consensus       204 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~~-~------~~~  274 (325)
T 3kul_A          204 DPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-DVISSVEEG-Y------RLP  274 (325)
T ss_dssp             ---C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHHTT-C------CCC
T ss_pred             Cccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHcC-C------CCC
Confidence            3211 112233456889999999999999999999999999999999 99999654433 222221111 0      111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ...    .....+.+++.+||+.||.+||++.++++.|...
T Consensus       275 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          275 APM----GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            112    2235689999999999999999999999998653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.9e-45  Score=356.37  Aligned_cols=264  Identities=23%  Similarity=0.284  Sum_probs=204.5

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|...+|+.||+|++...  .......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  102 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME  102 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred             hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence            3456789999999999999988999999998643  22334678899999999999999999999999999999999998


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      + +|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......   
T Consensus       103 ~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---  174 (311)
T 3niz_A          103 K-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR---  174 (311)
T ss_dssp             E-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             C-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc---
Confidence            5 8888887643 35999999999999999999999   89999999999999999999999999999986643321   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc----ccc-----
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA----ELV-----  337 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~-----  337 (458)
                       ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....................    ...     
T Consensus       175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence             2234568999999999876 56899999999999999999999999755443332222111110000    000     


Q ss_pred             -CCc--CCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 -DPR--IKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 -d~~--~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       +..  .......     .....+.+++.+||+.||++|||++|+++|.|+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence             000  0000000     11246889999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-45  Score=353.21  Aligned_cols=265  Identities=23%  Similarity=0.310  Sum_probs=210.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC--ceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKR--ERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~  185 (458)
                      +.+.++||+|+||+||+|... +|+.||||.+.... ....+.+.+|++++++++||||+++++++.+..  ..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (319)
T 4euu_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (319)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence            456679999999999999886 48999999987533 233567889999999999999999999988765  77999999


Q ss_pred             cCCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee----CCCCcEEEeecccccccC
Q 012715          186 MANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASK  260 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DfGla~~~~  260 (458)
                      +++|+|.+++..... ..+++..++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++...
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            999999999976432 34999999999999999999999   8899999999999999    788899999999998765


Q ss_pred             CCCcccccccccccCCCccccccccc--------cCCCCcccccHhHHHHHHHHHhCCCccCCCc---chHHHHHHHHhh
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVV--------TQELTEKSDVYSYGVVLLEIVTARRAVQDGK---NLVESAQVCMAS  329 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~---~~~~~~~~~~~~  329 (458)
                      ...     ......||..|+|||.+.        +..++.++|||||||++|||++|+.||....   ...+........
T Consensus       168 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          168 DDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             TTC-----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             CCC-----ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            433     223456999999999886        5788999999999999999999999996432   222222222221


Q ss_pred             cc--ccccc---c--------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          330 ES--RLAEL---V--------DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       330 ~~--~~~~~---~--------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..  .+...   .        +......+.......+.+++.+||+.||++|||++|+++++.+..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            11  00000   0        011122445677788999999999999999999999999997643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.6e-45  Score=348.66  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=209.0

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.+.||+|+||.||+|.+.++..||+|.+..... ...++.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN   87 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence            4556789999999999999998888999999865332 346789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++...+ ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.........   
T Consensus        88 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~---  160 (268)
T 3sxs_A           88 GCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV---  160 (268)
T ss_dssp             CBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE---
T ss_pred             CcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh---
Confidence            99999997542 34899999999999999999999   889999999999999999999999999999866544321   


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ........    ....+   ...  
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~----~~~~~---~~~--  230 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-VLKVSQGH----RLYRP---HLA--  230 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTC----CCCCC---TTS--
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-HHHHHcCC----CCCCC---CcC--
Confidence            2234456788999999999999999999999999999999 8989865443322 22211111    01111   111  


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                        ...+.+++.+||+.||.+|||+.+++++|....+
T Consensus       231 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          231 --SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             --hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence              2468899999999999999999999999976544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.8e-45  Score=359.77  Aligned_cols=255  Identities=21%  Similarity=0.334  Sum_probs=209.1

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      ..+.+.+.||+|+||.||+|... +|..||+|.+...  .....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            45667789999999999999875 6899999998643  33445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC---CcEEEeecccccccCC
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN---FVAKLADFGLAHASKD  261 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla~~~~~  261 (458)
                      |+++|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.+   +.+||+|||++.....
T Consensus       109 ~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          109 LVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             CCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            99999999999764  35899999999999999999999   8899999999999999764   4699999999987654


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ..     ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +....+.........   + .
T Consensus       184 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~~---~-~  253 (362)
T 2bdw_A          184 SE-----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYDYPS---P-E  253 (362)
T ss_dssp             CC-----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCCT---T-G
T ss_pred             Cc-----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCCCCc---c-c
Confidence            32     223467999999999999999999999999999999999999999765432 222222222111111   0 0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....    ...+.+++.+||+.||++||++.++++|.|..
T Consensus       254 ~~~~----~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  289 (362)
T 2bdw_A          254 WDTV----TPEAKSLIDSMLTVNPKKRITADQALKVPWIC  289 (362)
T ss_dssp             GGGS----CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred             ccCC----CHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence            1112    25688999999999999999999999998874

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=363.40  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=205.5

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.+.||+|+||+||+|+.. +|+.||||.+...   .......+.+|.+++..+ +||||+++++++.+.+..|+||
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            3456789999999999999876 5899999998643   233445688999999998 6999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       104 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          104 EFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            999999999999764  34999999999999999999999   8899999999999999999999999999998543222


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                          ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....+......+        ..
T Consensus       179 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~~~~--------p~  245 (353)
T 3txo_A          179 ----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEVVY--------PT  245 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCCC--------CT
T ss_pred             ----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCCC--------CC
Confidence                123456799999999999999999999999999999999999999975433 33333333222111        11


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSI------KQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~------~evl~~l~~~~  382 (458)
                      .++    ..+.+++.+||+.||.+||++      +++++|.|+..
T Consensus       246 ~~~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          246 WLH----EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             TSC----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             CCC----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            222    458899999999999999998      99999998854

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-45  Score=364.68  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=211.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|... +|+.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g  132 (387)
T 1kob_A           53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence            556788999999999999876 6899999998765555556799999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC--CCcEEEeecccccccCCCCccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE--NFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      |+|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++......   
T Consensus       133 g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---  205 (387)
T 1kob_A          133 GELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---  205 (387)
T ss_dssp             CBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred             CcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc---
Confidence            99999997643 35899999999999999999999   899999999999999974  5789999999998765433   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......||+.|+|||++.+..++.++|||||||++|||++|..||...... +...........    .++......+
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~i~~~~~~----~~~~~~~~~s  278 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWE----FDEDAFSSVS  278 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCC----CCSSTTTTSC
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC----CCccccccCC
Confidence              123346999999999999999999999999999999999999999765433 222222211111    1111112222


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                          ..+.+++.+||+.||.+||++.|+++|.|....
T Consensus       279 ----~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          279 ----PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             ----HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ----HHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                568899999999999999999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.9e-45  Score=351.54  Aligned_cols=264  Identities=24%  Similarity=0.271  Sum_probs=207.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||+||+|... +|+.||||++...  .......+.+|++++++++||||+++++++.+++..++||||+
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   83 (292)
T 3o0g_A            4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence            445678999999999999886 6899999998643  2334467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++ +|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus        84 ~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  156 (292)
T 3o0g_A           84 DQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             SE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--
T ss_pred             CC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--
Confidence            76 6666554322 35999999999999999999999   88999999999999999999999999999986643321  


Q ss_pred             ccccccccCCCccccccccccCC-CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc--------c
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL--------V  337 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~  337 (458)
                        ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+..+.+..+...............        .
T Consensus       157 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence              234457899999999998765 89999999999999999999999876666555444433211111000        0


Q ss_pred             CC---------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 DP---------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 d~---------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      +.         .............+.+++.+||+.||++|||++|+++|.|+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  288 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence            00         0000011122356889999999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-45  Score=346.46  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=206.9

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   90 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             ceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence            456679999999999999998889999999875332 3457999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.......   ..
T Consensus        91 ~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~  163 (269)
T 4hcu_A           91 CLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TS  163 (269)
T ss_dssp             BHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH---HS
T ss_pred             cHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccccc---cc
Confidence            9999997643 35899999999999999999999   89999999999999999999999999999986543321   12


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+........       .........   
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-~~~~~~~~~~-------~~~~~~~~~---  232 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG-------FRLYKPRLA---  232 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTT-------CCCCCCTTS---
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHhcC-------ccCCCCCcC---
Confidence            234457888999999999999999999999999999999 8888865433 2222222111       011111112   


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ...+.+++.+||+.||++||++.+++++|.+
T Consensus       233 -~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          233 -STHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence             2568899999999999999999999999965

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8e-45  Score=352.84  Aligned_cols=248  Identities=24%  Similarity=0.372  Sum_probs=208.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|+.. +|+.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~   87 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   87 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence            445679999999999999876 68999999986432   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++....  .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+++.....   
T Consensus        88 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           88 IEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             CCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            99999999997643  4899999999999999999999   999999999999999999999999999999865432   


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                          .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.... .....+......        +...+
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~--------~p~~~  226 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-KTYEKILNAELR--------FPPFF  226 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHCCCC--------CCTTS
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCC--------CCCCC
Confidence                23457999999999999999999999999999999999999999765433 333322222211        11222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      +    ..+.+++.+||+.||++||     +++++++|.|+..
T Consensus       227 ~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          227 N----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             C----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             C----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            2    4688999999999999999     9999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.8e-45  Score=350.04  Aligned_cols=258  Identities=25%  Similarity=0.392  Sum_probs=203.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecc---cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... ++..||+|.+..   ......+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   92 (294)
T 4eqm_A           13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY   92 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence            456679999999999999875 689999998843   2334456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...+  ++++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        93 ~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  166 (294)
T 4eqm_A           93 IEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-  166 (294)
T ss_dssp             CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc-
Confidence            99999999997643  5999999999999999999999   88999999999999999999999999999986644321 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................    ......
T Consensus       167 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~  240 (294)
T 4eqm_A          167 --TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT----DVRKDI  240 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHH----HSCTTS
T ss_pred             --cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcch----hcccCC
Confidence              12234569999999999999999999999999999999999999997654433322221111111111    111222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhhCCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-SIKQVLRILYESSD  383 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~l~~~~~  383 (458)
                          +..+.+++.+||+.||.+|| +++++.+.|.....
T Consensus       241 ----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          241 ----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             ----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             ----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                35689999999999999999 88888888876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.8e-45  Score=359.19  Aligned_cols=256  Identities=22%  Similarity=0.294  Sum_probs=195.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|... +++.||||.+....  ..+.+.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            455678999999999999886 57899999986533  335688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCCCCcc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |+|.+++...+  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++......  
T Consensus       133 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--  205 (349)
T 2w4o_A          133 GELFDRIVEKG--YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--  205 (349)
T ss_dssp             CBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--
Confidence            99999997643  4899999999999999999999   889999999999999975   8899999999998654332  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+...................    .......
T Consensus       206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~----~~~~~~~  278 (349)
T 2w4o_A          206 ---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI----SPWWDEV  278 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC----TTTTTTS
T ss_pred             ---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC----CchhhhC
Confidence               223456899999999999999999999999999999999999999765544333333322211111    1111122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                          ...+.+++.+||+.||++||++.|+++|.|......
T Consensus       279 ----~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          279 ----SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             ----CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             ----CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence                256889999999999999999999999998875543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.6e-45  Score=362.90  Aligned_cols=252  Identities=20%  Similarity=0.323  Sum_probs=204.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.++||+|+||+||+|+.. +++.||+|++.+..   ......+.+|..++.++ +||||+++++++.+.+..|+|||
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E  133 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE  133 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence            456689999999999999886 57899999986532   23345688999999987 89999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++|+|..++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+++...... 
T Consensus       134 ~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-  207 (396)
T 4dc2_A          134 YVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  207 (396)
T ss_dssp             CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence            99999999999753  34999999999999999999999   8999999999999999999999999999998533221 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc--------hHHHHHHHHhhccccccc
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--------LVESAQVCMASESRLAEL  336 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  336 (458)
                         ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .............     
T Consensus       208 ---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----  279 (396)
T 4dc2_A          208 ---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----  279 (396)
T ss_dssp             ---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-----
T ss_pred             ---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-----
Confidence               123456799999999999999999999999999999999999999953211        1112222222111     


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHhhhCC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSI------KQVLRILYESS  382 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~------~evl~~l~~~~  382 (458)
                         .+...++    ..+.+++.+||+.||.+||++      .|+++|.|+..
T Consensus       280 ---~~p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          280 ---RIPRSLS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             ---CCCTTSC----HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             ---CCCCcCC----HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence               1122223    458899999999999999984      89999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=366.53  Aligned_cols=256  Identities=21%  Similarity=0.285  Sum_probs=207.9

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      ..+.+.+.||+|+||+||+|... +|+.||+|.+...  .....+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            34566789999999999999875 6899999998643  23445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC---CCCcEEEeecccccccCC
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKD  261 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~~  261 (458)
                      |+++|+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++   .++.+||+|||+++....
T Consensus        91 ~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           91 LVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             CCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            999999999997643  5999999999999999999999   89999999999999998   568899999999986654


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ...    ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.... +...........+..   + .
T Consensus       166 ~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~-~~~~~i~~~~~~~~~---~-~  236 (444)
T 3soa_A          166 EQQ----AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH-RLYQQIKAGAYDFPS---P-E  236 (444)
T ss_dssp             TCC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCCCCT---T-T
T ss_pred             CCc----eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhCCCCCCc---c-c
Confidence            321    224567999999999999999999999999999999999999999755433 333332222211111   1 1


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....+    ..+.+++.+||+.||.+|||+.|+++|.|..
T Consensus       237 ~~~~s----~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~  272 (444)
T 3soa_A          237 WDTVT----PEAKDLINKMLTINPSKRITAAEALKHPWIS  272 (444)
T ss_dssp             TTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred             cccCC----HHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence            11222    5688999999999999999999999998763

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=8.2e-45  Score=357.83  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=207.9

Q ss_pred             HHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-----hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      ...+.+.+.||+|+||+||+|... +|+.||||.+....     ....+.+.+|+++++.++||||+++++++.+.+..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            345677889999999999999875 68999999985321     123567999999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc---EEEeeccc
Q 012715          181 LMYEYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV---AKLADFGL  255 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGl  255 (458)
                      +|||||++|+|.+++...  ....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999887532  2335899999999999999999999   899999999999999986554   99999999


Q ss_pred             ccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc
Q 012715          256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE  335 (458)
Q Consensus       256 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  335 (458)
                      ++.......    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  +............  
T Consensus       180 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~~--  251 (351)
T 3c0i_A          180 AIQLGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYKM--  251 (351)
T ss_dssp             CEECCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCCC--
T ss_pred             eeEecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCCC--
Confidence            987654321    23345799999999999999999999999999999999999999975421  2222222111111  


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                        ++......    ...+.+++.+||+.||++||++.|+++|.|...
T Consensus       252 --~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          252 --NPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             --CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             --CccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence              11111112    256889999999999999999999999988753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.2e-45  Score=364.90  Aligned_cols=267  Identities=22%  Similarity=0.274  Sum_probs=207.8

Q ss_pred             hcccceeeee--cceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQG--GFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|  +||+||+|+.. +|+.||||++...  .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  106 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS  106 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence            4567899999  99999999886 6899999998643  23445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      ||++|+|.+++.......+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++........
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred             ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence            999999999997654556999999999999999999999   89999999999999999999999999999865432211


Q ss_pred             c---cccccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          265 C---FEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       265 ~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      .   .........||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.+.............   ....+.+.
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~  260 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG---TVPCLLDT  260 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC---CCCccccc
Confidence            1   0112233478999999999987  67999999999999999999999999754433222211100   00000000


Q ss_pred             c------------------------------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          340 R------------------------------------IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       340 ~------------------------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .                                    ............+.+++.+||+.||++|||+.|+++|.|+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence            0                                    000011122356899999999999999999999999988754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-45  Score=366.31  Aligned_cols=254  Identities=25%  Similarity=0.432  Sum_probs=205.5

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.+.||+|+||.||+|.+. +++.||||.+... .......|.+|++++++++||||++++++|.+.+..++||||+
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  194 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV  194 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence            3456689999999999999986 6899999998643 2334467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++|+|.+++...+ ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....+... 
T Consensus       195 ~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~-  269 (377)
T 3cbl_A          195 QGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-  269 (377)
T ss_dssp             TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE-
T ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee-
Confidence            9999999997532 34899999999999999999999   899999999999999999999999999999865443211 


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                       .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.... ......+      ....  
T Consensus       270 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-~~~~~-~~~~~~~------~~~~--  338 (377)
T 3cbl_A          270 -ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-QTREF-VEKGGRL------PCPE--  338 (377)
T ss_dssp             -CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-HHHHH-HHTTCCC------CCCT--
T ss_pred             -ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH-HHcCCCC------CCCC--
Confidence             11122335778999999999999999999999999999998 88888654332 22221 1111111      1111  


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                        .++..+.+++.+||+.||++|||+.++++.|..
T Consensus       339 --~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          339 --LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence              223568899999999999999999999999865

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=355.89  Aligned_cols=253  Identities=23%  Similarity=0.292  Sum_probs=200.0

Q ss_pred             HHHHHhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCce
Q 012715          104 ETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRER  179 (458)
Q Consensus       104 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  179 (458)
                      ++....+...++||+|+||+||+|.+. +|+.||||++...  .......+..|+..+.++ +|+||++++++|.+++..
T Consensus        53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            344456677789999999999999886 7999999987542  223344566677666666 899999999999999999


Q ss_pred             eeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      ++||||+ +++|.+++...+ ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            9999999 679999887543 35999999999999999999999   889999999999999999999999999999866


Q ss_pred             CCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      ....     ......||+.|+|||++.+ .++.++|||||||++|||++|..++.........     .. ..    ..+
T Consensus       208 ~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-----~~-~~----~~~  271 (311)
T 3p1a_A          208 GTAG-----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-----RQ-GY----LPP  271 (311)
T ss_dssp             C-----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH-----TT-TC----CCH
T ss_pred             ccCC-----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-----hc-cC----CCc
Confidence            4432     2334569999999998876 7999999999999999999998777543222111     00 00    111


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+....    ...+.+++.+||+.||++|||+.|++++.|..
T Consensus       272 ~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (311)
T 3p1a_A          272 EFTAGL----SSELRSVLVMMLEPDPKLRATAEALLALPVLR  309 (311)
T ss_dssp             HHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred             ccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence            111112    25689999999999999999999999998864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=363.83  Aligned_cols=252  Identities=22%  Similarity=0.290  Sum_probs=203.2

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      .+.||+|+||.||+|... +|..||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            357999999999999875 6899999999766555667899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee--CCCCcEEEeecccccccCCCCcccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL--DENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll--~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      .+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++......     .
T Consensus       174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-----~  244 (373)
T 2x4f_A          174 FDRIIDES-YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-----K  244 (373)
T ss_dssp             HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----B
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----c
Confidence            99886432 35899999999999999999999   8899999999999999  567899999999998765432     1


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+......+.    ......++   
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~----~~~~~~~~---  316 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWDLE----DEEFQDIS---  316 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCSC----SGGGTTSC---
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCC----hhhhccCC---
Confidence            234569999999999999999999999999999999999999997654432 2222222211111    11111222   


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          350 LRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       ..+.+++.+||+.||.+||++.|+++|.|...
T Consensus       317 -~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          317 -EEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             -HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             -HHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence             56889999999999999999999999998753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.9e-45  Score=355.82  Aligned_cols=255  Identities=27%  Similarity=0.393  Sum_probs=200.7

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc----eeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE----RFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|++. ++.||||++..... ....+.+|+.++.+++||||+++++++.+...    .++||||
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~  103 (322)
T 3soc_A           26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF  103 (322)
T ss_dssp             EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             chhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence            345678999999999999874 89999999865432 33456679999999999999999999987553    6999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------CeEeccCCCCCeeeCCCCcEEEeeccc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP----------PLCHRDIKSSNILLDENFVAKLADFGL  255 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~----------~iiHrDlk~~NIll~~~~~~kl~DfGl  255 (458)
                      +++|+|.+++...   .+++..++.++.|++.||+|||   +.          +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          104 HEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             CTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            9999999999753   4999999999999999999999   77          999999999999999999999999999


Q ss_pred             ccccCCCCcccccccccccCCCcccccccccc-----CCCCcccccHhHHHHHHHHHhCCCccCCCcch-----------
Q 012715          256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-----------  319 (458)
Q Consensus       256 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~-----------  319 (458)
                      ++........  .......||+.|+|||.+.+     ..++.++|||||||++|||+||+.||....+.           
T Consensus       178 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          178 ALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             CEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             ccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            9865543211  12334579999999999976     35677899999999999999999998643211           


Q ss_pred             ----HHHHHHHHhhccccccccCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          320 ----VESAQVCMASESRLAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       320 ----~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                          ..+.... .     .....+.+...+ ....+..+.+++.+||+.||++|||+.|+++.|..
T Consensus       256 ~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          256 HPSLEDMQEVV-V-----HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             SCCHHHHHHHH-T-----TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCchhhhhhhh-h-----cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                1111110 0     011111111111 12455779999999999999999999999999865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3e-45  Score=373.29  Aligned_cols=256  Identities=27%  Similarity=0.425  Sum_probs=209.3

Q ss_pred             HhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      ..+.+.+.||+|+||+||+|.+.++..||||.+.... ...+.|.+|+++|++++||||+++++++. .+..++||||++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            3455678999999999999999888999999987543 34578999999999999999999999986 667899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---  339 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---  339 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH---
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce---
Confidence            999999998654445899999999999999999999   88999999999999999999999999999987643221   


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      .......+|..|+|||.+....++.++|||||||+||||+| |+.||.+.... +...... ...++      ....   
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~-~~~~~------~~~~---  408 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALE-RGYRM------PRPE---  408 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHH-HTCCC------CCCT---
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCCC------CCCC---
Confidence            11233456889999999999999999999999999999999 99999754332 2222221 11111      1111   


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                       ..+..+.+++.+||+.||++|||+++|++.|.....
T Consensus       409 -~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          409 -NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence             223568999999999999999999999999977544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7e-45  Score=349.97  Aligned_cols=260  Identities=25%  Similarity=0.416  Sum_probs=201.5

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHh--cCCCCeeeeeeeeecc----Cceeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLAR--LHHRHLVALRGFCIEK----RERFLM  182 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~lv  182 (458)
                      .+.+.+.||+|+||+||+|.+ +|+.||||++...   ....+.+|.+++..  ++||||+++++++.+.    ...++|
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv   84 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI   84 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence            345678999999999999988 7899999998643   23456778888877  7899999999987653    457999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-----CDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      |||+++|+|.++++.   ..+++..++.++.|++.||+|||..     ++++|+||||||+|||++.++.+||+|||+++
T Consensus        85 ~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  161 (301)
T 3q4u_A           85 THYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV  161 (301)
T ss_dssp             ECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             hhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence            999999999999964   3599999999999999999999932     26789999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCCCccccccccccC------CCCcccccHhHHHHHHHHHhC----------CCccCCCcc---
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTA----------RRAVQDGKN---  318 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg----------~~p~~~~~~---  318 (458)
                      .................||+.|+|||.+.+.      .++.++|||||||++|||++|          +.||.....   
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~  241 (301)
T 3q4u_A          162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP  241 (301)
T ss_dssp             EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence            6554432222223445799999999999876      566799999999999999999          778754221   


Q ss_pred             hHHHHHHHHhhccccccccCCcCCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          319 LVESAQVCMASESRLAELVDPRIKD-SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..............     .+.+.. .++......+.+++.+||+.||++|||+.++++.|..
T Consensus       242 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          242 SFEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CHHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             chhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            11211111111111     111111 1223566789999999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.9e-45  Score=350.04  Aligned_cols=263  Identities=25%  Similarity=0.310  Sum_probs=203.0

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|+..+|+.||+|++....  ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (288)
T 1ob3_A            4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD   83 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence            44567899999999999998889999999986432  2234678899999999999999999999999999999999997


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      + +|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus        84 ~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---  155 (288)
T 1ob3_A           84 Q-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---  155 (288)
T ss_dssp             E-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             C-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc---
Confidence            5 9999987643 35899999999999999999999   88999999999999999999999999999976543221   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc----ccc-----cc
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----LAE-----LV  337 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~-----~~  337 (458)
                       ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...................    ...     ..
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence             1234568999999999876 458999999999999999999999997654433332221111000    000     01


Q ss_pred             CCcCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 DPRIK-------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 d~~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ++...       ..+.......+.+++.+||+.||++|||+.|+++|.|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  285 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence            11110       000011235688999999999999999999999998864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.3e-46  Score=381.15  Aligned_cols=260  Identities=23%  Similarity=0.379  Sum_probs=213.1

Q ss_pred             HHHHhhcccceeeeecceEEEEEEEcC-CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          105 TKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       105 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +....+.+.+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+++|++++||||++++++|.+.+..++||
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            344456677899999999999999874 8899999987543 23568999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999999999998655567999999999999999999999   8999999999999999999999999999998765432


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ..   ......++..|+|||.+.+..++.++|||||||+||||+| |..||..... .+...... ...      ..   
T Consensus       373 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-~~~~~~~~-~~~------~~---  438 (495)
T 1opk_A          373 YT---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE-KDY------RM---  438 (495)
T ss_dssp             EE---CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHHHHH-TTC------CC---
T ss_pred             ee---ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH-cCC------CC---
Confidence            11   2234456789999999999999999999999999999999 8888865432 22222211 111      11   


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                       ..+...+..+.+++.+||+.||++||++.++++.|.....
T Consensus       439 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          439 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence             1112233568999999999999999999999999977543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-44  Score=353.27  Aligned_cols=267  Identities=19%  Similarity=0.262  Sum_probs=210.9

Q ss_pred             cCHHHHHHHhhccc-ceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcC-CCCeeeeeeeee
Q 012715          100 FSYKETKKATDNFS-TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLH-HRHLVALRGFCI  174 (458)
Q Consensus       100 ~~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  174 (458)
                      |...+.....+.+. +.||+|+||.||+|... +|+.||+|.+....  ......+.+|+.++..+. ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33444444555555 78999999999999876 68999999986432  233567899999999995 699999999999


Q ss_pred             ccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEe
Q 012715          175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLA  251 (458)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~  251 (458)
                      +.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence            9999999999999999999997655567999999999999999999999   889999999999999987   7899999


Q ss_pred             ecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc
Q 012715          252 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       252 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      |||+++......     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .....
T Consensus       177 Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-~~~~~  250 (327)
T 3lm5_A          177 DFGMSRKIGHAC-----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI-SQVNV  250 (327)
T ss_dssp             CGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHTCC
T ss_pred             eCccccccCCcc-----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH-Hhccc
Confidence            999998765432     123457999999999999999999999999999999999999999765443222222 11111


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ...    .....    .....+.+++.+||+.||.+|||++++++|.|....
T Consensus       251 ~~~----~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          251 DYS----EETFS----SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             CCC----TTTTT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             ccC----chhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            111    11111    123568899999999999999999999999987543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-45  Score=366.87  Aligned_cols=256  Identities=25%  Similarity=0.441  Sum_probs=195.5

Q ss_pred             hhcccceeeeecceEEEEEEEc----CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.+.||+|+||.||+|++.    ++..||||.+... .....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT  125 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence            4556689999999999999875    5778999998643 3444567999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++...+ ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       126 e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          126 EYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             ECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             eCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            9999999999998643 35999999999999999999999   8899999999999999999999999999998664432


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +....... ....         
T Consensus       202 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-~~~~~i~~-~~~~---------  269 (373)
T 2qol_A          202 EAA-YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-DVIKAVDE-GYRL---------  269 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-HHHHHHHT-TEEC---------
T ss_pred             ccc-eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc-CCCC---------
Confidence            110 11222345788999999999999999999999999999998 99999754332 22222111 1110         


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                       ..+...+..+.+++.+||+.||++||++.++++.|...
T Consensus       270 -~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          270 -PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             -CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence             11112335689999999999999999999999998654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.7e-45  Score=358.92  Aligned_cols=251  Identities=23%  Similarity=0.347  Sum_probs=207.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|+.. +|+.||||.+....   ......+..|..++..+ +||||+++++++.+.+..|+|||
T Consensus        19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E   98 (345)
T 1xjd_A           19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   98 (345)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            455689999999999999886 58999999986532   23345678899999987 89999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++|+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+++.......
T Consensus        99 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           99 YLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence            999999999997533  4899999999999999999999   88999999999999999999999999999986432221


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                          ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+....+.....        .+...
T Consensus       174 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~--------~~p~~  240 (345)
T 1xjd_A          174 ----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMDNP--------FYPRW  240 (345)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC--------CCCTT
T ss_pred             ----cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHhCCC--------CCCcc
Confidence                23456799999999999999999999999999999999999999975433 333333222211        11222


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHhhhCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIK-QVLRILYESS  382 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl~~l~~~~  382 (458)
                      ++    ..+.+++.+||+.||++||++. ++++|.|+..
T Consensus       241 ~s----~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          241 LE----KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             SC----HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             cC----HHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence            22    4688999999999999999998 9999988754

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=358.58  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=206.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +++.||+|.+....   ......+.+|+++|+.++||||+++++++.+.+..|+||||
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   96 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL   96 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence            456679999999999999876 58899999986432   23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +.+|+|.+++....  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+++......  
T Consensus        97 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  169 (384)
T 4fr4_A           97 LLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--  169 (384)
T ss_dssp             CTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence            99999999998643  5999999999999999999999   8999999999999999999999999999998765432  


Q ss_pred             cccccccccCCCcccccccccc---CCCCcccccHhHHHHHHHHHhCCCccCCCc--chHHHHHHHHhhccccccccCCc
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGK--NLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                         ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||....  ..............        .
T Consensus       170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------~  238 (384)
T 4fr4_A          170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV--------T  238 (384)
T ss_dssp             ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC--------C
T ss_pred             ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc--------C
Confidence               2345679999999999864   458999999999999999999999996432  22222222211111        1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhhhCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPS-IKQVLRILYESS  382 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-~~evl~~l~~~~  382 (458)
                      ....+    ...+.+++.+||+.||.+||+ ++++++|.|+..
T Consensus       239 ~p~~~----s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          239 YPSAW----SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             CCTTS----CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             CCCcC----CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            11222    256889999999999999998 999999988753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.3e-45  Score=352.69  Aligned_cols=266  Identities=26%  Similarity=0.403  Sum_probs=202.3

Q ss_pred             hhcccceeeeecceEEEEEEE-----cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  181 (458)
                      .+.+.+.||+|+||+||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...  ...++
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   90 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL   90 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence            455678999999999999985     25889999999876666677899999999999999999999998654  56899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        91 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           91 IMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             EEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             EEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            999999999999997643 24899999999999999999999   89999999999999999999999999999987644


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc------cccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES------RLAE  335 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------~~~~  335 (458)
                      .... ........++..|+|||.+.+..++.++||||||+++|||+||..|+.....  +..........      ...+
T Consensus       167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          167 DKEF-FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHHHHHCTTCCTHHHHHHHHH
T ss_pred             Ccce-eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH--HHHhhhcCccccchhHHHHHH
Confidence            3211 1122334578889999999999999999999999999999999988753211  11000000000      0000


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+........+...+..+.+++.+||+.||++|||+.|+++.|...
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0000111111222336799999999999999999999999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.8e-45  Score=365.14  Aligned_cols=255  Identities=23%  Similarity=0.329  Sum_probs=207.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|+.. +++.||+|++.+..   ......+.+|+.++..++||||+++++++.+.+..|+||||
T Consensus        71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~  150 (410)
T 3v8s_A           71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY  150 (410)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            344578999999999999886 58999999986422   22234588999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |+||+|.+++...   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+++........
T Consensus       151 ~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          151 MPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             CTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             CCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            9999999999753   4899999999999999999999   899999999999999999999999999999876543321


Q ss_pred             cccccccccCCCccccccccccCC----CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQE----LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                         .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||..... .+....+......+.   .+. 
T Consensus       225 ---~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~~---~p~-  296 (410)
T 3v8s_A          225 ---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKNSLT---FPD-  296 (410)
T ss_dssp             ---ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTHHHHCC---CCT-
T ss_pred             ---cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-hhHHHHHHhcccccc---CCC-
Confidence               233567999999999998765    88999999999999999999999975443 333333322111110   010 


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhhCC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESS  382 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~  382 (458)
                      ...++    ..+.+++.+||..+|.+  ||+++|+++|.|+..
T Consensus       297 ~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          297 DNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             TCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             ccccc----HHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            11222    46889999999999988  999999999999865

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-44  Score=352.52  Aligned_cols=251  Identities=21%  Similarity=0.330  Sum_probs=198.6

Q ss_pred             hhcccceeeeecceEEEEEEE----cCCCEEEEEEecccc----hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||.||+|+.    .+|+.||+|.+....    ......+.+|++++++++||||+++++++.+.+..|
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   97 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY   97 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence            355678999999999999987    478999999986532    233456889999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++|+|.+++...+  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           98 LILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             EEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            9999999999999997533  4899999999999999999999   8899999999999999999999999999997543


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ....    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +....+......        
T Consensus       173 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~--------  239 (327)
T 3a62_A          173 HDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KTIDKILKCKLN--------  239 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHTCCC--------
T ss_pred             cCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCC--------
Confidence            2211    223457999999999999999999999999999999999999999754432 322222222111        


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~  381 (458)
                      +...++    ..+.+++.+||+.||++||     ++.++++|.|+.
T Consensus       240 ~p~~~~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~  281 (327)
T 3a62_A          240 LPPYLT----QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR  281 (327)
T ss_dssp             CCTTSC----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred             CCCCCC----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence            111222    5688999999999999999     899999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=350.07  Aligned_cols=250  Identities=23%  Similarity=0.342  Sum_probs=197.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccch--------------------------hhHhHHHHHHHHHHhcC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--------------------------QVEGDFCREIELLARLH  162 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~  162 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+.....                          ...+.+.+|++++++++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   94 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD   94 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred             eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence            456678999999999999875 688999999854321                          12356899999999999


Q ss_pred             CCCeeeeeeeeec--cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCe
Q 012715          163 HRHLVALRGFCIE--KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI  240 (458)
Q Consensus       163 h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NI  240 (458)
                      ||||+++++++.+  .+..++||||+++++|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+||
T Consensus        95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNL  168 (298)
T ss_dssp             CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred             CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHE
Confidence            9999999999987  5678999999999999887643   35999999999999999999999   88999999999999


Q ss_pred             eeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCC---CCcccccHhHHHHHHHHHhCCCccCCCc
Q 012715          241 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTARRAVQDGK  317 (458)
Q Consensus       241 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tg~~p~~~~~  317 (458)
                      |++.++.+||+|||+++.......    ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||.+..
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EECCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999987654321    223457999999999997765   4788999999999999999999997543


Q ss_pred             chHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          318 NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .. .............     + .....+    ..+.+++.+||+.||++||++.|+++|.|.
T Consensus       245 ~~-~~~~~~~~~~~~~-----~-~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~hp~~  296 (298)
T 2zv2_A          245 IM-CLHSKIKSQALEF-----P-DQPDIA----EDLKDLITRMLDKNPESRIVVPEIKLHPWV  296 (298)
T ss_dssp             HH-HHHHHHHHCCCCC-----C-SSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred             HH-HHHHHHhcccCCC-----C-CccccC----HHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence            32 2222221111111     1 111222    468899999999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.9e-44  Score=354.15  Aligned_cols=252  Identities=21%  Similarity=0.324  Sum_probs=205.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|+.. +|+.||+|.+...   .......+.+|..++.++ +||||+++++++.+.+..|+|||
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e   90 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE   90 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence            445678999999999999886 5889999998643   233445688999999998 89999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++|+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        91 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-  164 (345)
T 3a8x_A           91 YVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  164 (345)
T ss_dssp             CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence            999999999997533  4999999999999999999999   8899999999999999999999999999998543221 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc--------chHHHHHHHHhhccccccc
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK--------NLVESAQVCMASESRLAEL  336 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~--------~~~~~~~~~~~~~~~~~~~  336 (458)
                         .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....        .............      
T Consensus       165 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------  235 (345)
T 3a8x_A          165 ---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------  235 (345)
T ss_dssp             ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred             ---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence               12345679999999999999999999999999999999999999996421        1111112211111      


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHhhhCC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSI------KQVLRILYESS  382 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~------~evl~~l~~~~  382 (458)
                        ..+...++    ..+.+++.+||+.||.+||++      .++++|.|+..
T Consensus       236 --~~~p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          236 --IRIPRSLS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             --CCCCTTSC----HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             --CCCCCCCC----HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence              11122222    468899999999999999995      89999998753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-44  Score=345.83  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=204.3

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.+.||+|+||.||+|.+.++..||+|.+..... ..+++.+|++++.+++|+||+++++++.+.+..++||||+++
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  103 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN  103 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred             HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence            4456689999999999999998888999999875432 346789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.... ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   .
T Consensus       104 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~  176 (283)
T 3gen_A          104 GCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---T  176 (283)
T ss_dssp             CBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH---H
T ss_pred             CcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc---c
Confidence            99999997633 34999999999999999999999   89999999999999999999999999999986543321   1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... +........       .........  
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~~-------~~~~~~~~~--  246 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQG-------LRLYRPHLA--  246 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTT-------CCCCCCTTC--
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-HHHHHHhcc-------cCCCCCCcC--
Confidence            2234457888999999999999999999999999999998 99998654432 222221111       111111112  


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                        ...+.+++.+||+.||.+||++++++++|..
T Consensus       247 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          247 --SEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence              2568899999999999999999999999965

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-44  Score=365.91  Aligned_cols=257  Identities=21%  Similarity=0.302  Sum_probs=207.2

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.++||+|+||+||+|++. +++.||+|++....   ......+.+|..++..++||||++++++|.+.+..|+|||||
T Consensus        77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~  156 (437)
T 4aw2_A           77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY  156 (437)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence            34578999999999999986 47899999986422   222345889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........ 
T Consensus       157 ~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-  231 (437)
T 4aw2_A          157 VGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-  231 (437)
T ss_dssp             TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-
Confidence            9999999997643 35999999999999999999999   899999999999999999999999999999766443221 


Q ss_pred             ccccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          267 EPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                        .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...... +....+......   ..-|..
T Consensus       232 --~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~~~~~---~~~p~~  305 (437)
T 4aw2_A          232 --QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIMNHKER---FQFPTQ  305 (437)
T ss_dssp             --ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHH---CCCCSS
T ss_pred             --ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhhhcccc---ccCCcc
Confidence              223467999999999987     567999999999999999999999999754433 333333221111   111111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHhhhCC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQA--RPSIKQVLRILYESS  382 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~--RPs~~evl~~l~~~~  382 (458)
                      ....+    ..+.+++.+||..+|++  ||+++|+++|.|+..
T Consensus       306 ~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          306 VTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             CCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             cccCC----HHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            12233    45889999999888888  999999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5e-45  Score=371.14  Aligned_cols=246  Identities=28%  Similarity=0.456  Sum_probs=201.8

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC-ceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR-ERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|.+ .|+.||||.++...  ..+.|.+|+++|++++||||+++++++.+.+ ..++||||+++
T Consensus       195 ~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          195 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             eEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            44567899999999999988 47899999987543  4567999999999999999999999987765 78999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...+...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....      
T Consensus       272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------  342 (450)
T 1k9a_A          272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------  342 (450)
T ss_dssp             CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc------
Confidence            99999998665556899999999999999999999   899999999999999999999999999999854322      


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                       .....++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +...... ...      ......    
T Consensus       343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~-~~~------~~~~p~----  409 (450)
T 1k9a_A          343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVE-KGY------KMDAPD----  409 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHHHH-TTC------CCCCCT----
T ss_pred             -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCC------CCCCCC----
Confidence             122357889999999999999999999999999999998 99998654322 2222211 111      111112    


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .++..+.+++.+||+.||++|||+.++++.|..
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            233678999999999999999999999998864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=347.90  Aligned_cols=268  Identities=23%  Similarity=0.269  Sum_probs=205.0

Q ss_pred             HHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-----hhhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccC
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-----EQVEGDFCREIELLARLH---HRHLVALRGFCIEKR  177 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  177 (458)
                      ...+.+.+.||+|+||+||+|+.. +|+.||||.+....     ......+.+|++++++++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            344567789999999999999864 68999999986322     122345778888877775   999999999998765


Q ss_pred             -----ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          178 -----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       178 -----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                           ..++||||+. |+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEee
Confidence                 4799999997 59999998766666999999999999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      ||+++......     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...................
T Consensus       164 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          164 FGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             CSCTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             CccccccCCCc-----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99998654332     2344678999999999999999999999999999999999999997655443332222111100


Q ss_pred             cccccC-------CcCCC--CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          333 LAELVD-------PRIKD--SFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       333 ~~~~~d-------~~~~~--~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ......       ..+..  ...     .+....+.+++.+||+.||++|||+.|+++|.|....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            000000       00000  000     0122568899999999999999999999999887543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.7e-44  Score=355.11  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=208.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|+.. +|+.||+|.+....   ....+.+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus        43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  122 (350)
T 1rdq_E           43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence            345678999999999999876 68999999986432   23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+++.....   
T Consensus       123 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          123 VAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             CTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence            99999999997643  4899999999999999999999   899999999999999999999999999999866432   


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                          .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+....+......        +...+
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~--------~p~~~  261 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSGKVR--------FPSHF  261 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC--------CCTTC
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-HHHHHHHHcCCCC--------CCCCC
Confidence                2345799999999999999999999999999999999999999975433 3333332222111        11222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  382 (458)
                      +    ..+.+++.+||+.||.+||+     ++++++|.|+..
T Consensus       262 ~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          262 S----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             C----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             C----HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            3    56889999999999999998     999999998753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.1e-45  Score=370.56  Aligned_cols=259  Identities=19%  Similarity=0.260  Sum_probs=199.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC------cee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  180 (458)
                      +.+.+.||+|+||+||+|... +|+.||||++...  .......+.+|+.+++.++||||+++++++...+      ..|
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            445678999999999999875 6899999998643  3344567899999999999999999999986553      569


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++ +|.+.+..    .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       144 lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          144 LVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             EEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             EEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence            99999976 57777753    3899999999999999999999   8899999999999999999999999999998665


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc---
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV---  337 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  337 (458)
                      ...     ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......+............+..   
T Consensus       216 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          216 TSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             -CC-----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             CCc-----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            432     234567999999999999999999999999999999999999999765544433333221111111000   


Q ss_pred             -----------------------CCcCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 -----------------------DPRIKDSF---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 -----------------------d~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                             ...+....   .......+.+++.+||+.||++|||++|+++|.|..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence                                   00000000   011246789999999999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.5e-44  Score=347.46  Aligned_cols=256  Identities=24%  Similarity=0.353  Sum_probs=209.5

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccch------hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      ..+.+.+.||+|+||.||+|... +|..||+|.+.....      ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34667789999999999999876 689999999864322      13567999999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC----cEEEeecccc
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLA  256 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla  256 (458)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999999764  35899999999999999999999   88999999999999999887    7999999999


Q ss_pred             cccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          257 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      .......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +............   
T Consensus       167 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~---  237 (321)
T 2a2a_A          167 HEIEDGV-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANITSVSYDF---  237 (321)
T ss_dssp             EECCTTC-----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHTTCCCC---
T ss_pred             eecCccc-----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhccccc---
Confidence            8765432     223456999999999999999999999999999999999999999754332 2222222111111   


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       ++......    ...+.+++.+||+.||++|||+.|+++|.|...
T Consensus       238 -~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          238 -DEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             -CHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             -Chhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence             11111112    246889999999999999999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=357.63  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCC--CCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|...+++.||||++...  .......+.+|+++|.+++|  +||+++++++.+.+..++||| 
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-   89 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-   89 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence            4566799999999999999888999999998632  34445678999999999976  999999999999999999999 


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +.+|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++........
T Consensus        90 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           90 CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            5688999999764  35899999999999999999999   88999999999999997 578999999999866443211


Q ss_pred             cccccccccCCCcccccccccc-----------CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT-----------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA  334 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  334 (458)
                        .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||....+..........      
T Consensus       164 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~------  235 (343)
T 3dbq_A          164 --VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID------  235 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC------
T ss_pred             --ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc------
Confidence              12334579999999999865           67899999999999999999999999765443332222211      


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       335 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                          +.....++......+.+++.+||+.||.+|||+.|+++|+|.....
T Consensus       236 ----~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          236 ----PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             ----TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             ----CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence                1111111111224688999999999999999999999999986543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.4e-45  Score=360.47  Aligned_cols=257  Identities=26%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             HhhcccceeeeecceEEEEEEEc------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCc-
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE-  178 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~-  178 (458)
                      ..+.+.+.||+|+||.||+|.+.      +++.||||++... .....+.+.+|++++.++ +||||+++++++.+.+. 
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            34556689999999999999742      4579999999753 334456799999999999 78999999999987654 


Q ss_pred             eeeeeeecCCCCHHHHhcCCCC----------------------------------------------------------
Q 012715          179 RFLMYEYMANGSLKDHLHSPGR----------------------------------------------------------  200 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  200 (458)
                      .++||||+++|+|.+++.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8999999999999999976432                                                          


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccccccc
Q 012715          201 ------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIR  274 (458)
Q Consensus       201 ------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~  274 (458)
                            ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........  .......
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~  256 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDAR  256 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC--EEC--CE
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc--hhccccC
Confidence                  12899999999999999999999   889999999999999999999999999999865433211  1233456


Q ss_pred             CCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHH
Q 012715          275 GTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTI  353 (458)
Q Consensus       275 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  353 (458)
                      ||+.|+|||.+.+..++.++|||||||++|||+| |+.||............... ..      ........+    ..+
T Consensus       257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~------~~~~~~~~~----~~l  325 (359)
T 3vhe_A          257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GT------RMRAPDYTT----PEM  325 (359)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-TC------CCCCCTTCC----HHH
T ss_pred             CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc-CC------CCCCCCCCC----HHH
Confidence            8899999999999999999999999999999998 99999755433333222211 11      111112222    468


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          354 VTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       354 ~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+++..||+.||.+||++.|++++|..
T Consensus       326 ~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          326 YQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            899999999999999999999999965

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.2e-44  Score=360.84  Aligned_cols=248  Identities=21%  Similarity=0.322  Sum_probs=193.0

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeec----cCceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE----KRERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~  187 (458)
                      ++||+|+||+||+|... +|+.||||++...     ..+.+|++++.++ +|+||+++++++..    .+..|+|||||+
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~  142 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD  142 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence            58999999999999876 6899999998632     3567889987554 89999999998875    567899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~~  264 (458)
                      +|+|.+++...+...+++..+..++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++...... 
T Consensus       143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-  218 (400)
T 1nxk_A          143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-  218 (400)
T ss_dssp             SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence            999999998766567999999999999999999999   889999999999999987   7899999999998654322 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchH---HHHHHHHhhccccccccCCcC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV---ESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~d~~~  341 (458)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....+......+.   .+ .
T Consensus       219 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~---~~-~  290 (400)
T 1nxk_A          219 ----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP---NP-E  290 (400)
T ss_dssp             ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC---TT-T
T ss_pred             ----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC---Cc-c
Confidence                2245678999999999999999999999999999999999999997543211   01111111111111   00 0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ...+    ...+.+++.+||+.||++|||+.|+++|.|...
T Consensus       291 ~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          291 WSEV----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccC----CHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            1122    256889999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=362.02  Aligned_cols=257  Identities=28%  Similarity=0.398  Sum_probs=205.2

Q ss_pred             HhhcccceeeeecceEEEEEEEc------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      ..+.+.+.||+|+||.||+|.+.      ++..||||++... .......+.+|+.++++++||||+++++++.+....+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            34566789999999999999853      4668999998643 3444567999999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC---cEEEee
Q 012715          181 LMYEYMANGSLKDHLHSPG-----RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLAD  252 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl~D  252 (458)
                      +||||+++|+|.+++....     ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997432     235899999999999999999999   89999999999999998554   599999


Q ss_pred             cccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      ||+++.......  ........||+.|+|||.+.+..++.++|||||||++|||++ |..||..... .+......... 
T Consensus       228 FG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-~~~~~~i~~~~-  303 (367)
T 3l9p_A          228 FGMARDIYRAGY--YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGG-  303 (367)
T ss_dssp             CHHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTC-
T ss_pred             Cccccccccccc--cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCC-
Confidence            999975422111  012234567899999999999999999999999999999998 8888865433 23322222111 


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .      ......+    ...+.+++.+||+.||.+||++.+++++|+..
T Consensus       304 ~------~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          304 R------MDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             C------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C------CCCCccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            0      1111122    35688999999999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-44  Score=353.57  Aligned_cols=263  Identities=24%  Similarity=0.271  Sum_probs=202.6

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-----chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-----SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      ..+.+.+.||+|+||.||+|... ++..||+|.+...     .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            34667789999999999999875 6889999988643     23445679999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHh
Q 012715          182 MYEYMANGSLKDHLHSPG--------------------------------------RTPLSWQTRIQIAIDVANALEYLH  223 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~gL~~LH  223 (458)
                      ||||+++|+|.+++....                                      ...+++..+..++.|++.||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            999999999999995210                                      112356778899999999999999


Q ss_pred             hcCCCCeEeccCCCCCeeeCCCC--cEEEeecccccccCCCCcccccccccccCCCcccccccccc--CCCCcccccHhH
Q 012715          224 FYCDPPLCHRDIKSSNILLDENF--VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSY  299 (458)
Q Consensus       224 ~~~~~~iiHrDlk~~NIll~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~  299 (458)
                         +.+|+||||||+|||++.++  .+||+|||+++.................||+.|+|||.+.+  ..++.++|||||
T Consensus       186 ---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          186 ---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             ---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             ---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence               88999999999999998766  89999999998653322111112345579999999999875  678999999999


Q ss_pred             HHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          300 GVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       300 Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ||++|||++|+.||......... ...........   .+. ...+    ...+.+++.+||+.||.+||++.++++|.|
T Consensus       263 G~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~---~~~-~~~~----~~~~~~li~~~l~~~p~~Rps~~~~l~hp~  333 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADTI-SQVLNKKLCFE---NPN-YNVL----SPLARDLLSNLLNRNVDERFDAMRALQHPW  333 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHH-HHHHHCCCCTT---SGG-GGGS----CHHHHHHHHHHSCSCTTTSCCHHHHHHSHH
T ss_pred             HHHHHHHHHCCCCCCCCChHHHH-HHHHhcccccC---Ccc-cccC----CHHHHHHHHHHcCCChhHCCCHHHHhcChh
Confidence            99999999999999765443322 22222111111   111 0011    256889999999999999999999999988


Q ss_pred             hCC
Q 012715          380 ESS  382 (458)
Q Consensus       380 ~~~  382 (458)
                      ...
T Consensus       334 ~~~  336 (345)
T 3hko_A          334 ISQ  336 (345)
T ss_dssp             HHT
T ss_pred             hcc
Confidence            743

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-44  Score=354.51  Aligned_cols=248  Identities=24%  Similarity=0.358  Sum_probs=203.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+....   ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY   90 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence            456679999999999999874 78999999986422   22235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      + +|+|.+++...+  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....+.  
T Consensus        91 ~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           91 A-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             C-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred             C-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence            9 789999986533  4999999999999999999999   8899999999999999999999999999998765443  


Q ss_pred             cccccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC--CcCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD--PRIK  342 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~  342 (458)
                         ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.+.....           ....+..  ..+.
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----------~~~~i~~~~~~~p  228 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----------LFKKVNSCVYVMP  228 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----------CBCCCCSSCCCCC
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----------HHHHHHcCCCCCc
Confidence               2344579999999999988776 689999999999999999999997532110           0000000  1111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ...    ...+.+++.+||+.||.+|||++|+++|.|+...
T Consensus       229 ~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          229 DFL----SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             ccC----CHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            222    3568899999999999999999999999998643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-44  Score=355.29  Aligned_cols=252  Identities=23%  Similarity=0.317  Sum_probs=207.9

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.+.||+|+||.||+|+.. +|+.||||.+...   .....+.+..|..++..+ +||||+++++++.+.+..|+||
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~  100 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  100 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence            3456789999999999999886 4789999998643   223345688999999988 7999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||++||+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+++......
T Consensus       101 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A          101 EYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            9999999999997533  4999999999999999999999   8899999999999999999999999999998643221


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                          .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ..+....+......        +..
T Consensus       176 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~--------~p~  242 (353)
T 2i0e_A          176 ----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNVA--------YPK  242 (353)
T ss_dssp             ----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--------CCT
T ss_pred             ----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCCCC--------CCC
Confidence                12345679999999999999999999999999999999999999997543 33333333322211        112


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  382 (458)
                      .++    ..+.+++.+||+.||.+||+     ++++++|.|+..
T Consensus       243 ~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          243 SMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             TSC----HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             CCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            222    56889999999999999994     699999998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.3e-45  Score=358.72  Aligned_cols=252  Identities=23%  Similarity=0.359  Sum_probs=195.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||+||+++.. +++.||||.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  100 (361)
T 3uc3_A           22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG  100 (361)
T ss_dssp             EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence            456789999999999999886 68999999986533 2335688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc--EEEeecccccccCCCCccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--AKLADFGLAHASKDGSICF  266 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~--~kl~DfGla~~~~~~~~~~  266 (458)
                      |+|.+++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.  +||+|||+++......   
T Consensus       101 ~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---  172 (361)
T 3uc3_A          101 GELYERICNAG--RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  172 (361)
T ss_dssp             CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---
Confidence            99999996533  4999999999999999999999   899999999999999987665  9999999997433221   


Q ss_pred             ccccccccCCCccccccccccCCCCcc-cccHhHHHHHHHHHhCCCccCCCcch---HHHHHHHHhhccccccccCCcCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEK-SDVYSYGVVLLEIVTARRAVQDGKNL---VESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dvws~Gv~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                        ......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||......   ..............+.      .
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~  244 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD------D  244 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT------T
T ss_pred             --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC------c
Confidence              2234569999999999988887665 89999999999999999999754332   2222222211111110      0


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ...+    ..+.+++.+||+.||++|||+.|+++|.|+..
T Consensus       245 ~~~s----~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          245 IRIS----PECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             SCCC----HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             CCCC----HHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            1122    56889999999999999999999999998743

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.4e-44  Score=339.85  Aligned_cols=253  Identities=22%  Similarity=0.272  Sum_probs=207.0

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT   89 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence            4556789999999999999876 477999999876555556789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee---CCCCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      +++|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||++....... 
T Consensus        90 ~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-  163 (277)
T 3f3z_A           90 GGELFERVVHK--RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-  163 (277)
T ss_dssp             SCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence            99999998753  34899999999999999999999   8999999999999999   788999999999998665432 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                          ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||...... +................    ...
T Consensus       164 ----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~----~~~  233 (277)
T 3f3z_A          164 ----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-EVMLKIREGTFTFPEKD----WLN  233 (277)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCCHHH----HTT
T ss_pred             ----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCCCCchh----hhc
Confidence                22345699999999988654 899999999999999999999999764433 22222221111111100    001


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                          ....+.+++.+||+.||.+||++.++++|.|..
T Consensus       234 ----~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  266 (277)
T 3f3z_A          234 ----VSPQAESLIRRLLTKSPKQRITSLQALEHEWFE  266 (277)
T ss_dssp             ----SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             ----CCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence                125688999999999999999999999988763

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.3e-45  Score=353.70  Aligned_cols=255  Identities=24%  Similarity=0.331  Sum_probs=199.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC----------
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR----------  177 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------  177 (458)
                      +.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|++++++++||||+++++++.+..          
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~   87 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE   87 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence            456689999999999999986 7999999998643 3344567999999999999999999999986543          


Q ss_pred             -----------------------------------------------ceeeeeeecCCCCHHHHhcCCCC-CCCCHHHHH
Q 012715          178 -----------------------------------------------ERFLMYEYMANGSLKDHLHSPGR-TPLSWQTRI  209 (458)
Q Consensus       178 -----------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~  209 (458)
                                                                     ..++|||||++|+|.+++..... ...++..++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~  167 (332)
T 3qd2_B           88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL  167 (332)
T ss_dssp             --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred             hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence                                                           27999999999999999976432 235677789


Q ss_pred             HHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc--------ccccccccCCCcccc
Q 012715          210 QIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF--------EPVNTDIRGTPGYMD  281 (458)
Q Consensus       210 ~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~~~~gt~~y~a  281 (458)
                      .++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.........        ........||+.|+|
T Consensus       168 ~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          168 HIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            99999999999999   8999999999999999999999999999998765432110        012344579999999


Q ss_pred             ccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHcc
Q 012715          282 PEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCT  361 (458)
Q Consensus       282 PE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl  361 (458)
                      ||.+.+..++.++|||||||++|||++|..|+....   .......  ....+         .........+.+++.+||
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---~~~~~~~--~~~~~---------~~~~~~~~~~~~li~~~l  310 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---RIITDVR--NLKFP---------LLFTQKYPQEHMMVQDML  310 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---HHHHHHH--TTCCC---------HHHHHHCHHHHHHHHHHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---HHHHHhh--ccCCC---------cccccCChhHHHHHHHHc
Confidence            999999999999999999999999999876653211   1111100  00000         001223356789999999


Q ss_pred             ccCCCCCCCHHHHHHHhhhC
Q 012715          362 QREGQARPSIKQVLRILYES  381 (458)
Q Consensus       362 ~~dp~~RPs~~evl~~l~~~  381 (458)
                      +.||++||++.|+++|.|+.
T Consensus       311 ~~~p~~Rps~~~~l~~~~f~  330 (332)
T 3qd2_B          311 SPSPTERPEATDIIENAIFE  330 (332)
T ss_dssp             CSSGGGSCCHHHHHHSTTCC
T ss_pred             cCCCCcCCCHHHHhhchhhh
Confidence            99999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=357.09  Aligned_cols=258  Identities=26%  Similarity=0.394  Sum_probs=208.6

Q ss_pred             HHhhcccceeeeecceEEEEEEEc--------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeecc
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEK  176 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  176 (458)
                      ...+.+.+.||+|+||+||+|.+.        ++..||||++... .......+.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            345566789999999999999862        2357999998653 334456799999999999 899999999999999


Q ss_pred             CceeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 012715          177 RERFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL  242 (458)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll  242 (458)
                      +..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||   +.+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999997543              235999999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHH
Q 012715          243 DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVE  321 (458)
Q Consensus       243 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~  321 (458)
                      +.++.+||+|||+++........  .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.... ..+
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-~~~  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTT--CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHH
T ss_pred             cCCCcEEEcccCccccccccccc--ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHH
Confidence            99999999999999866543211  12334567889999999999999999999999999999999 888886443 333


Q ss_pred             HHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       322 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .........       .......+    ...+.+++.+||+.||++||+++|++++|...
T Consensus       302 ~~~~~~~~~-------~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          302 LFKLLKEGH-------RMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             HHHHHHTTC-------CCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCC-------CCCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            333222111       11111222    25688999999999999999999999998654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.7e-45  Score=370.42  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=203.1

Q ss_pred             HhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      ..+.+.+.||+|+||.||+|.+.++..||||.+.... ...+.|.+|+++|++++||||+++++++.+ +..++||||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            3455678999999999999999888889999987533 234679999999999999999999999876 67899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++.......+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++........  
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--  336 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--  336 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee--
Confidence            999999997543345899999999999999999999   899999999999999999999999999999866443211  


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                       ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.... +...... ...+      ..    .+
T Consensus       337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~i~-~~~~------~~----~~  403 (452)
T 1fmk_A          337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVE-RGYR------MP----CP  403 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHH-TTCC------CC----CC
T ss_pred             -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCC------CC----CC
Confidence             1233457889999999999999999999999999999999 88888654332 2222211 1111      11    11


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ...+..+.+++.+||+.||++|||++++++.|.....
T Consensus       404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            2233568999999999999999999999999976543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.9e-44  Score=371.83  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=210.3

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.||+|+||.||+|+.. +|+.||||.+....   ......+.+|+++|+.++||||+++++++.+.+..|+||||+
T Consensus       187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~  266 (576)
T 2acx_A          187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM  266 (576)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence            34568999999999999886 69999999986432   233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      +||+|.+++...+...+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+++....+.   
T Consensus       267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---  340 (576)
T 2acx_A          267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---  340 (576)
T ss_dssp             CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCc---
Confidence            9999999998766566999999999999999999999   8899999999999999999999999999998765433   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc---hHHHHHHHHhhccccccccCCcCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN---LVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ............        ..+..
T Consensus       341 --~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--------~~~p~  410 (576)
T 2acx_A          341 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--------EEYSE  410 (576)
T ss_dssp             --CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--------CCCCT
T ss_pred             --cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--------ccCCc
Confidence              12345799999999999999999999999999999999999999975432   222222222111        11112


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      .++    ..+.+++.+||+.||.+||     +++|+++|.|+..
T Consensus       411 ~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          411 RFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             TSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             cCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            223    5688999999999999999     8999999998864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-44  Score=351.03  Aligned_cols=259  Identities=23%  Similarity=0.310  Sum_probs=195.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|... +|+.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (317)
T 2pmi_A            7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD   86 (317)
T ss_dssp             ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred             eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence            345578999999999999875 68999999986433 2334678899999999999999999999999999999999998


Q ss_pred             CCCHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          188 NGSLKDHLHSP----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       188 ~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                       |+|.+++...    ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence             5999988532    1235899999999999999999999   8899999999999999999999999999998654322


Q ss_pred             cccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc-------
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE-------  335 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  335 (458)
                      .    ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............ ....+...+       
T Consensus       163 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          163 N----TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI-FDIMGTPNESLWPSVT  237 (317)
T ss_dssp             C----CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCSCCTTTCGGGG
T ss_pred             c----cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCChhHhhhhh
Confidence            1    2234568999999999876 46899999999999999999999999765443322222 111110000       


Q ss_pred             -------------------ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          336 -------------------LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       336 -------------------~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                         .+.+......    ...+.+++.+||+.||++|||+.|+++|.|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  298 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA  298 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence                               0001111112    24689999999999999999999999998764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.7e-45  Score=369.14  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=199.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+...   .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  229 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY  229 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence            455689999999999999875 6899999998642   233345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      +++|+|.+++...  ..+++..+..++.||+.||+|||   + ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       230 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          230 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             CSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            9999999999753  35899999999999999999999   7 8999999999999999999999999999986433221


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .............+        ...
T Consensus       305 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~~--------p~~  371 (446)
T 4ejn_A          305 ----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEIRF--------PRT  371 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCCC--------CTT
T ss_pred             ----ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCCC--------Ccc
Confidence                23456799999999999999999999999999999999999999975443 23333322222111        122


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      ++    ..+.+++.+||+.||.+||     +++|+++|.|+..
T Consensus       372 ~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          372 LG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             SC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            22    4688999999999999999     9999999998864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=362.07  Aligned_cols=257  Identities=21%  Similarity=0.269  Sum_probs=205.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||++.+..   ......+.+|.+++..++|+||+++++++.+.+..|+||||
T Consensus        63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~  142 (412)
T 2vd5_A           63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY  142 (412)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence            344578999999999999885 68999999986432   22334688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...+ ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       143 ~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          143 YVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence            99999999997533 25999999999999999999999   899999999999999999999999999999876543211


Q ss_pred             cccccccccCCCccccccccc-------cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVV-------TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                         .....+||+.|+|||++.       ...++.++|||||||++|||++|+.||...... +....+......   ...
T Consensus       219 ---~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~---~~~  291 (412)
T 2vd5_A          219 ---RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKIVHYKEH---LSL  291 (412)
T ss_dssp             ---ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTHHHH---CCC
T ss_pred             ---ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccC---cCC
Confidence               123457999999999987       457899999999999999999999999754433 332222221111   111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHhhhCC
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQAR---PSIKQVLRILYESS  382 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Ps~~evl~~l~~~~  382 (458)
                      +.....++    ..+.+++.+||. +|.+|   |+++|+++|.|+..
T Consensus       292 p~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          292 PLVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             C----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             CccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            11112233    568899999999 99998   69999999998854

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=355.08  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=206.6

Q ss_pred             HhhcccceeeeecceEEEEEEE------cCCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCce
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRER  179 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  179 (458)
                      ..+.+.+.||+|+||.||+|.+      .++..||||.+... .....+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            4456678999999999999986      24568999998643 233456799999999999 899999999999999999


Q ss_pred             eeeeeecCCCCHHHHhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCC
Q 012715          180 FLMYEYMANGSLKDHLHSPGR---------------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSS  238 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~  238 (458)
                      ++||||+++|+|.+++.....                     ..+++..++.++.|++.||+|||   +.+|+||||||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~  201 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  201 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChh
Confidence            999999999999999976432                     23899999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCc
Q 012715          239 NILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGK  317 (458)
Q Consensus       239 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~  317 (458)
                      |||++.++.+||+|||++.........  .......||+.|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccc--eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999865433211  12234457889999999999999999999999999999998 999997654


Q ss_pred             chHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          318 NLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .......... ..      ..+.....    ....+.+++.+||+.||.+||++.+++++|.....
T Consensus       280 ~~~~~~~~~~-~~------~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          280 VDANFYKLIQ-NG------FKMDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CSHHHHHHHH-TT------CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cHHHHHHHHh-cC------CCCCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            3333222211 11      11111112    23568999999999999999999999999976544

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.5e-44  Score=340.45  Aligned_cols=248  Identities=21%  Similarity=0.376  Sum_probs=204.0

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|.+ +|..||||.+...  .....+.+.+|+.++++++||||+++++++.+.  +..++||||
T Consensus        12 y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (271)
T 3kmu_A           12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW   90 (271)
T ss_dssp             CEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred             hHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence            45667999999999999998 5889999998643  334456799999999999999999999999887  788999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      +++|+|.+++.......+++..++.++.|++.||+|||   +.+  ++||||||+|||++.++.++|+|||++.....  
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--  165 (271)
T 3kmu_A           91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--  165 (271)
T ss_dssp             CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred             cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence            99999999998766557999999999999999999999   778  99999999999999999999999998764322  


Q ss_pred             cccccccccccCCCccccccccccCCCCc---ccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTE---KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                             ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||............ ....      ..+.
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~------~~~~  231 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-ALEG------LRPT  231 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH-HHSC------CCCC
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH-HhcC------CCCC
Confidence                   2346899999999998765554   799999999999999999999755443222222 1111      1122


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....++    ..+.+++..||+.||++|||++++++.|...
T Consensus       232 ~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          232 IPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            222233    5689999999999999999999999998654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5e-45  Score=349.05  Aligned_cols=251  Identities=23%  Similarity=0.380  Sum_probs=204.7

Q ss_pred             hhcccceeeeecceEEEEEEEcC-C-------CEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD-G-------SLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||+||+|.... +       ..||+|.+........+.+.+|++++++++||||+++++++.+.+..+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI   88 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence            35567899999999999997653 3       479999997766666778999999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc--------EEEee
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--------AKLAD  252 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~--------~kl~D  252 (458)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.        +||+|
T Consensus        89 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           89 LVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             EEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence            9999999999999997643 24899999999999999999999   899999999999999998887        99999


Q ss_pred             cccccccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      ||++......        ....||..|+|||.+.+ ..++.++|||||||++|||++|..++.............. ...
T Consensus       165 fg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-~~~  235 (289)
T 4fvq_A          165 PGISITVLPK--------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DRH  235 (289)
T ss_dssp             CCSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTC
T ss_pred             CcccccccCc--------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-ccC
Confidence            9998754332        22357889999999987 7799999999999999999997766655544433332221 111


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      .+..        ..    ...+.+++.+||+.||++|||+.+++++|.....+
T Consensus       236 ~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          236 QLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             CCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             CCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1111        11    13477899999999999999999999999876554

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-44  Score=353.64  Aligned_cols=258  Identities=29%  Similarity=0.468  Sum_probs=207.3

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||.||+|...      ++..||||.+... .......+.+|++++++++||||+++++++.+.+..++
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  127 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL  127 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence            3455678999999999999874      3478999998753 33445679999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCC
Q 012715          182 MYEYMANGSLKDHLHSPG----------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN  239 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~N  239 (458)
                      ||||+++|+|.+++....                      ...+++..++.++.||+.||+|||   +++|+||||||+|
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~N  204 (343)
T 1luf_A          128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRN  204 (343)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred             EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcce
Confidence            999999999999997532                      146999999999999999999999   8899999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcc
Q 012715          240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKN  318 (458)
Q Consensus       240 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~  318 (458)
                      ||++.++.+||+|||+++.......  ........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus       205 Il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          205 CLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             EEECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            9999999999999999976533221  112234568899999999999999999999999999999999 8889865433


Q ss_pred             hHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                       .+........  ..     +.....+    ...+.+++.+||+.||++||++.+++++|.....
T Consensus       283 -~~~~~~~~~~--~~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          283 -EEVIYYVRDG--NI-----LACPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             -HHHHHHHHTT--CC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -HHHHHHHhCC--Cc-----CCCCCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence             2222221111  11     1111222    3568999999999999999999999999987654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.4e-44  Score=353.89  Aligned_cols=254  Identities=27%  Similarity=0.421  Sum_probs=206.3

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +...+.||+|+||+||+|.. .+|+.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  135 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY  135 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence            45567899999999999987 47899999998643   233346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +. |+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       136 ~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          136 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             CS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             CC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            97 68888885332 35999999999999999999999   889999999999999999999999999999765432   


Q ss_pred             cccccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                           ....||+.|+|||.+.   ...++.++|||||||++|||++|+.||.+........... ...  ....    ..
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~-~~~--~~~~----~~  275 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNE--SPAL----QS  275 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSC--CCCC----CC
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hcC--CCCC----CC
Confidence                 2456999999999984   5678999999999999999999999997655433322221 111  1111    11


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCc
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS  387 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~  387 (458)
                      ..+    ...+.+++.+||+.||++|||+++++++.|......+.
T Consensus       276 ~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~  316 (348)
T 1u5q_A          276 GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  316 (348)
T ss_dssp             TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             CCC----CHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence            122    25688999999999999999999999999987655443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.6e-44  Score=364.99  Aligned_cols=250  Identities=24%  Similarity=0.399  Sum_probs=208.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+....   ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~   97 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY   97 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            456678999999999999886 79999999986432   22345789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...+  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....+.  
T Consensus        98 ~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--  170 (476)
T 2y94_A           98 VSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  170 (476)
T ss_dssp             CSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence            99999999997643  5999999999999999999999   9999999999999999999999999999998765433  


Q ss_pred             cccccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.+... ......+......        ....
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~--------~p~~  238 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-PTLFKKICDGIFY--------TPQY  238 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-HHHHHHHHTTCCC--------CCTT
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-HHHHHHHhcCCcC--------CCcc
Confidence               2234579999999999988766 6899999999999999999999975433 2333322221111        1112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .+    ..+.+++.+||+.||.+|||++|+++|.|...
T Consensus       239 ~s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          239 LN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             CC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             CC----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            22    45889999999999999999999999988754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.8e-44  Score=356.51  Aligned_cols=259  Identities=23%  Similarity=0.315  Sum_probs=205.8

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-----CCCeeeeeeeeeccCceeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-----HRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv  182 (458)
                      .+.+.+.||+|+||+||+|+.. +++.||||.+... ......+..|+++++.++     |+||+++++++...+..++|
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv  114 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI  114 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence            4556689999999999999874 6899999998643 334456788999999996     99999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC------------------
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE------------------  244 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~------------------  244 (458)
                      |||+ +++|.+++.......+++..+..++.||+.||+|||   +.+|+||||||+|||++.                  
T Consensus       115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~  190 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK  190 (360)
T ss_dssp             ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred             EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence            9999 899999998765556999999999999999999999   899999999999999975                  


Q ss_pred             -------CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc
Q 012715          245 -------NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK  317 (458)
Q Consensus       245 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~  317 (458)
                             ++.+||+|||+++.....       .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       191 ~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          191 IQIYRTKSTGIKLIDFGCATFKSDY-------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             EEEEEESCCCEEECCCTTCEETTSC-------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccCCCCEEEEeccCceecCCC-------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                   789999999999864432       234578999999999999999999999999999999999999997654


Q ss_pred             chHHHHHHHHhhcccccc-------------ccC-CcC----CCCC-CHH---------------HHHHHHHHHHHcccc
Q 012715          318 NLVESAQVCMASESRLAE-------------LVD-PRI----KDSF-DME---------------QLRTIVTIVRWCTQR  363 (458)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~-------------~~d-~~~----~~~~-~~~---------------~~~~l~~l~~~cl~~  363 (458)
                      ........ .......+.             ..+ ...    .... ...               ....+.+++.+||+.
T Consensus       264 ~~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          264 HMEHLAMM-ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             HHHHHHHH-HHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHH-HHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence            43222221 111110000             000 000    0000 000               015678999999999


Q ss_pred             CCCCCCCHHHHHHHhhh
Q 012715          364 EGQARPSIKQVLRILYE  380 (458)
Q Consensus       364 dp~~RPs~~evl~~l~~  380 (458)
                      ||++|||+.|+++|.|.
T Consensus       343 dP~~Rpta~elL~hp~f  359 (360)
T 3llt_A          343 DPTLRPSPAELLKHKFL  359 (360)
T ss_dssp             SGGGSCCHHHHTTSGGG
T ss_pred             ChhhCCCHHHHhcCccc
Confidence            99999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.8e-44  Score=360.35  Aligned_cols=255  Identities=22%  Similarity=0.338  Sum_probs=202.1

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcC--CCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLH--HRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|...+++.||||.+...  .......+.+|+++|.+++  |+||+++++++...+..|+||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            5566899999999999999888999999998532  3445577999999999996  5999999999999999999999 


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +.+++|.+++....  .+++..+..++.||+.||+|||   +.+|+||||||+|||++ ++.+||+|||+++........
T Consensus       137 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          137 CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            56889999997643  5899999999999999999999   99999999999999995 579999999999876433211


Q ss_pred             cccccccccCCCcccccccccc-----------CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT-----------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA  334 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  334 (458)
                        .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||................     
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~-----  283 (390)
T 2zmd_A          211 --VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-----  283 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT-----
T ss_pred             --ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc-----
Confidence              12334679999999999865           468899999999999999999999997654433332222211     


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       335 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                           .....++......+.+++.+||+.||.+||++.|+++|.|....
T Consensus       284 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          284 -----NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             -----TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             -----cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence                 11111111112568899999999999999999999999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.9e-44  Score=339.86  Aligned_cols=255  Identities=21%  Similarity=0.330  Sum_probs=207.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||.||+|... +|..||+|.+...  .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   87 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   87 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence            445678999999999999875 5899999998643  3344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc---EEEeecccccccCCCC
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV---AKLADFGLAHASKDGS  263 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGla~~~~~~~  263 (458)
                      ++++|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++.......
T Consensus        88 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           88 TGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             CSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            999999988753  35899999999999999999999   889999999999999976554   9999999997665432


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                           ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+..... .............   .+ ...
T Consensus       163 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~---~~-~~~  232 (284)
T 3kk8_A          163 -----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYDYP---SP-EWD  232 (284)
T ss_dssp             -----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCC---TT-TTT
T ss_pred             -----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHhccccCC---ch-hhc
Confidence                 2234679999999999999999999999999999999999999997654332 2222221111111   01 111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ..    ...+.+++.+||+.||++||++.|+++|.|....
T Consensus       233 ~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          233 TV----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             TS----CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             cc----CHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            22    2568899999999999999999999999887544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3e-44  Score=340.34  Aligned_cols=247  Identities=30%  Similarity=0.502  Sum_probs=192.4

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccc----hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|.+ .|..||||.+....    ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (271)
T 3dtc_A            9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF   87 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred             eeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence            45667999999999999997 58899999886432    22346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC---eEeccCCCCCeeeCC--------CCcEEEeecc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP---LCHRDIKSSNILLDE--------NFVAKLADFG  254 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~---iiHrDlk~~NIll~~--------~~~~kl~DfG  254 (458)
                      +++++|.+++..   ..+++..++.++.|++.||+|||   +.+   ++||||||+|||++.        ++.+||+|||
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           88 ARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             CTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             CCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999964   35999999999999999999999   666   999999999999986        7789999999


Q ss_pred             cccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc
Q 012715          255 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA  334 (458)
Q Consensus       255 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  334 (458)
                      +++......      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||............. ...    
T Consensus       162 ~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~----  230 (271)
T 3dtc_A          162 LAREWHRTT------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA-MNK----  230 (271)
T ss_dssp             C-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-TSC----
T ss_pred             ccccccccc------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh-cCC----
Confidence            997654322      224568999999999999999999999999999999999999997654332222211 110    


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       335 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                        ........    ....+.+++.+||+.||.+|||+.|++++|..
T Consensus       231 --~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          231 --LALPIPST----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             --CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             --CCCCCCcc----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence              11111222    23568999999999999999999999999853

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8.8e-44  Score=350.35  Aligned_cols=274  Identities=24%  Similarity=0.306  Sum_probs=209.6

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--------C
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEK--------R  177 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  177 (458)
                      .+.+.+.||+|+||+||+|... +|+.||||++....  ......+.+|+++++.++|+||+++++++.+.        +
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            3456689999999999999884 78999999885432  23345788999999999999999999998873        4


Q ss_pred             ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        98 ~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            68999999975 8888776543 34999999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      .................||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............. .........
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~  251 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS-QLCGSITPE  251 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCCCChh
Confidence            665332222223345678999999998876 568999999999999999999999997654433322221 111111110


Q ss_pred             cCCcC-------------CCCCCH-HH------HHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCcc
Q 012715          337 VDPRI-------------KDSFDM-EQ------LRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSG  388 (458)
Q Consensus       337 ~d~~~-------------~~~~~~-~~------~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~~  388 (458)
                      ..+..             ...... +.      ...+.+++.+||+.||++|||++|+++|.|+...+.+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  323 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  323 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence            00000             000000 11      245889999999999999999999999999987766544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.4e-44  Score=349.62  Aligned_cols=250  Identities=20%  Similarity=0.265  Sum_probs=184.6

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      +.||+|+||+||+|... +|+.||||.+...   ....+.+|+.++..+. ||||+++++++.+.+..|+||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            57999999999999885 6899999998543   3456789999999997 99999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC---cEEEeecccccccCCCCccccc
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      .+++...  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++   .+||+|||+++.......    
T Consensus        94 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~----  164 (325)
T 3kn6_A           94 FERIKKK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ----  164 (325)
T ss_dssp             HHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC----
Confidence            9999764  35999999999999999999999   89999999999999997665   899999999986544321    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc------hHHHHHHHHhhccccccccCCcCC
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN------LVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....      ..+...........        ..
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--------~~  236 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--------FE  236 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--------CC
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--------CC
Confidence            22345689999999999999999999999999999999999999974322      11222221111100        00


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ..........+.+++.+||+.||.+||++.|+++|.|....
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            00001123568999999999999999999999999987653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-44  Score=342.54  Aligned_cols=255  Identities=26%  Similarity=0.414  Sum_probs=204.8

Q ss_pred             ccceeeeecceEEEEEEEcC-C---CEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCce-eeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFSD-G---SLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRER-FLMYEY  185 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~  185 (458)
                      ..++||+|+||+||+|.+.+ +   ..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+.. ++||||
T Consensus        25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  104 (298)
T 3pls_A           25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred             cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence            34789999999999998642 2   379999987533 34456799999999999999999999999876655 999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +.+|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++........
T Consensus       105 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          105 MCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             CTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             ccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            99999999997643 45899999999999999999999   889999999999999999999999999999865443322


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      .........+|..|+|||.+.+..++.++||||||+++|||++|+.|+....+..+..........       .......
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~  253 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-------LPQPEYC  253 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-------CCCCTTC
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-------CCCCccc
Confidence            222334556889999999999999999999999999999999977776555444443333222110       1111122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                          ...+.+++.+||+.||.+|||++++++.|...
T Consensus       254 ----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          254 ----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----hHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                25688999999999999999999999998653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.8e-44  Score=342.39  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=201.0

Q ss_pred             hcccceeeeecceEEEEEEEcC----CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec-cCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  183 (458)
                      +.+.+.||+|+||+||+|.+.+    +..||+|.+... .....+.+.+|+.++++++||||++++++|.+ ++..++||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            4456789999999999998642    236899988753 33445679999999999999999999998654 56789999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......
T Consensus       107 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          107 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             ECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             eCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999997643 35899999999999999999999   8899999999999999999999999999998765443


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ...........+|+.|+|||.+.+..++.++||||||+++|||++|..|+..+.+..+..........       .....
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~  255 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------LLQPE  255 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-------CCCCT
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-------CCCCc
Confidence            22222334556788999999999999999999999999999999965554444333333222222111       01111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..    ...+.+++.+||+.||.+||++.++++.|...
T Consensus       256 ~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          256 YC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            12    25689999999999999999999999998653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-44  Score=353.56  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=196.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCC----EEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+.||+|+||+||+|.+. ++.    .||+|.+... .......+.+|+.++++++||||++++++|.+.+ .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~   95 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence            456679999999999999864 344    3688877532 3344567999999999999999999999998754 78999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+.+|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        96 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           96 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             ECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred             EecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence            9999999999997643 35999999999999999999999   8899999999999999999999999999998664433


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ..  .......+|..|+|||.+.+..++.++|||||||++|||++ |+.||...... +....... ...          
T Consensus       172 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~-~~~----------  237 (327)
T 3poz_A          172 KE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEK-GER----------  237 (327)
T ss_dssp             C---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHT-TCC----------
T ss_pred             cc--ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHHHHHc-CCC----------
Confidence            21  12233457889999999999999999999999999999999 99998654332 22222111 111          


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ...+......+.+++.+||+.||.+||++.+++++|...
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            011112235688999999999999999999999998654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-44  Score=363.89  Aligned_cols=258  Identities=22%  Similarity=0.341  Sum_probs=196.0

Q ss_pred             HHHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc
Q 012715          106 KKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--------EQVEGDFCREIELLARLHHRHLVALRGFCIEK  176 (458)
Q Consensus       106 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  176 (458)
                      ....+.+.+.||+|+||+||+|... +++.||||.+....        ......+.+|+++|++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3445666789999999999999875 58999999986422        122235889999999999999999999975 4


Q ss_pred             CceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC---CcEEEeec
Q 012715          177 RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN---FVAKLADF  253 (458)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~---~~~kl~Df  253 (458)
                      +..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence            5689999999999999998764  35999999999999999999999   8899999999999999754   45999999


Q ss_pred             ccccccCCCCcccccccccccCCCcccccccccc---CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE  330 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~  330 (458)
                      |+++......     ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.................
T Consensus       287 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~  361 (419)
T 3i6u_A          287 GHSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  361 (419)
T ss_dssp             STTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred             ccceecCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence            9998765432     2344679999999999863   6788999999999999999999999975443322222211111


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          331 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       331 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ...    .+......    ...+.+++.+||+.||++||++.|+++|.|...
T Consensus       362 ~~~----~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          362 YNF----IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CCC----CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCC----Cchhhccc----CHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            110    00111111    256889999999999999999999999998854

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.8e-44  Score=346.23  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=206.2

Q ss_pred             hhcccceeeeecceEEEEEEE------cCCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||.||+|..      .++..||||.+... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  103 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL  103 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence            345667899999999999976      24578999998643 33445679999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCC
Q 012715          182 MYEYMANGSLKDHLHSPGR----------------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN  239 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~N  239 (458)
                      ||||+++|+|.+++.....                      ..+++..++.++.|++.||+|||   +++|+||||||+|
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~N  180 (314)
T 2ivs_A          104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARN  180 (314)
T ss_dssp             EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGG
T ss_pred             EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchhe
Confidence            9999999999999975332                      34899999999999999999999   8899999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcc
Q 012715          240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKN  318 (458)
Q Consensus       240 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~  318 (458)
                      ||++.++.+||+|||+++........  .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       181 Ili~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          181 ILVAEGRKMKISDFGLSRDVYEEDSY--VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             EEEETTTEEEECCCTTCEECTTTSCE--ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EEEcCCCCEEEccccccccccccccc--eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999866443221  12234457889999999999999999999999999999999 9999865433


Q ss_pred             hHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      . ......... .      .+.....+    ...+.+++.+||+.||++||++.+++++|..
T Consensus       259 ~-~~~~~~~~~-~------~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          259 E-RLFNLLKTG-H------RMERPDNC----SEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             G-GHHHHHHTT-C------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H-HHHHHhhcC-C------cCCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            2 222211111 0      11111222    3568999999999999999999999999865

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=359.74  Aligned_cols=256  Identities=26%  Similarity=0.454  Sum_probs=191.3

Q ss_pred             hcccceeeeecceEEEEEEEc--CC--CEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec-cCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS--DG--SLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  183 (458)
                      +.+.+.||+|+||+||+|.+.  ++  ..||||.+... .....+.|.+|+.++++++||||++++++|.+ .+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            345678999999999999864  22  46899988643 33445789999999999999999999998765 45789999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       171 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             ECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             ECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999997643 35899999999999999999999   8899999999999999999999999999998654432


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ...........+|+.|+|||.+.+..++.++|||||||++|||+| |..||...... +......... .   ..   ..
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~~~~~~~~~~-~---~~---~p  318 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGR-R---LL---QP  318 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-CHHHHHHTTC-C---CC---CC
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-HHHHHHHcCC-C---CC---CC
Confidence            211122334567889999999999999999999999999999999 55566433222 2222211111 1   01   11


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..+    +..+.+++.+||+.||++||++.+++++|...
T Consensus       319 ~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          319 EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            122    25689999999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.4e-44  Score=346.24  Aligned_cols=265  Identities=23%  Similarity=0.295  Sum_probs=202.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||+||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (311)
T 4agu_A            5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC   84 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence            445678999999999999886 58999999885432  333567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++++|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++........  
T Consensus        85 ~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  157 (311)
T 4agu_A           85 DHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--  157 (311)
T ss_dssp             SEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--
Confidence            999999998764  34899999999999999999999   88999999999999999999999999999986653321  


Q ss_pred             ccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-------------c
Q 012715          267 EPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-------------R  332 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------~  332 (458)
                        ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||..................             .
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          158 --YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             --ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence              2234568999999999876 67899999999999999999999999765443332221111000             0


Q ss_pred             cccccCCcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          333 LAELVDPRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       333 ~~~~~d~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ......+.......     ......+.+++.+||+.||.+|||++|+++|.|+..-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence            00000000000000     0123568899999999999999999999999987653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.9e-44  Score=344.54  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=207.6

Q ss_pred             hhcccceeeeecceEEEEEEE------cCCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||.||+|.+      .++..||||.+.... ....+.+.+|++++.++ +||||+++++++.+.+..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  103 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence            455678999999999999975      246799999987443 23456799999999999 8999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC
Q 012715          181 LMYEYMANGSLKDHLHSPGR----------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE  244 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~  244 (458)
                      +||||+++|+|.+++.....                ..+++..++.++.|++.||+|||   +++|+||||||+|||++.
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH  180 (313)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcC
Confidence            99999999999999975432                24899999999999999999999   889999999999999999


Q ss_pred             CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHH
Q 012715          245 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESA  323 (458)
Q Consensus       245 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~  323 (458)
                      ++.+||+|||+++........  .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..........
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             CCCEEEccccccccccccccc--eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            999999999999866543211  12234457889999999999999999999999999999999 888986544333322


Q ss_pred             HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..... .      .........    ...+.+++.+||+.||.+||++.+++++|..
T Consensus       259 ~~~~~-~------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          259 KMIKE-G------FRMLSPEHA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             HHHHH-T------CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhcc-C------CCCCCcccC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            22111 1      111111122    2568999999999999999999999999865

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-44  Score=341.02  Aligned_cols=254  Identities=26%  Similarity=0.345  Sum_probs=200.1

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.+.||+|+||+||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            4566789999999999999875 68899999986533 334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee---CCCCcEEEeecccccccCC
Q 012715          187 ANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKD  261 (458)
Q Consensus       187 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~  261 (458)
                      ++|+|.+++...  ....+++..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||++.....
T Consensus       103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            999999998532  1245999999999999999999999   8999999999999999   4568899999999976544


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ..     ......||+.|+|||.+. ..++.++||||||+++|||++|+.||.... ..+..............     .
T Consensus       180 ~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~-----~  247 (285)
T 3is5_A          180 DE-----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-LEEVQQKATYKEPNYAV-----E  247 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCC------
T ss_pred             cc-----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-HHHHHhhhccCCccccc-----c
Confidence            32     223456899999999875 568999999999999999999999997543 22222222111111110     0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....+    ..+.+++.+||+.||++||++.|++++.|+.
T Consensus       248 ~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~  283 (285)
T 3is5_A          248 CRPLT----PQAVDLLKQMLTKDPERRPSAAQVLHHEWFK  283 (285)
T ss_dssp             -CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred             cCcCC----HHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence            11122    4688999999999999999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.7e-44  Score=337.08  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=206.0

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG   88 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred             eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence            456678999999999999998889999999875432 3467899999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........   ..
T Consensus        89 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~---~~  161 (267)
T 3t9t_A           89 CLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TS  161 (267)
T ss_dssp             BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH---HS
T ss_pred             cHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccccc---cc
Confidence            9999997543 35899999999999999999999   89999999999999999999999999999986543211   12


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.........       ........   
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~i~~~~-------~~~~~~~~---  230 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGF-------RLYKPRLA---  230 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC-------CCCCCTTS---
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-HHHHHHHhcCC-------cCCCCccC---
Confidence            234457889999999998999999999999999999999 8888865432 22222221110       01111112   


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ...+.+++.+||+.||++||++.+++++|..
T Consensus       231 -~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          231 -STHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -cHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             2568899999999999999999999999865

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.2e-44  Score=338.73  Aligned_cols=248  Identities=26%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|... ++..||+|.+....   ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   90 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence            345678999999999999876 57799999985422   22345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......  
T Consensus        91 ~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--  163 (279)
T 3fdn_A           91 APLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  163 (279)
T ss_dssp             CTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence            9999999999754  34899999999999999999999   9999999999999999999999999999986543322  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                          .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...........        .....
T Consensus       164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~--------~~~~~  230 (279)
T 3fdn_A          164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-QETYKRISRVEFT--------FPDFV  230 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC--------CCTTS
T ss_pred             ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-HHHHHHHHhCCCC--------CCCcC
Confidence                2345689999999999999999999999999999999999999975433 2222222211111        11122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                          ...+.+++.+||+.||.+||+++|+++|.|..
T Consensus       231 ----~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          231 ----TEGARDLISRLLKHNPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             ----CHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred             ----CHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence                24688999999999999999999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.4e-44  Score=349.56  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=202.9

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeec
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.+.||+|+||.||+|... +|+.||||.+.....    ...+|++++.++ +||||+++++++.+++..|+||||+
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            4566789999999999999876 588999999865432    345789999888 7999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC----CcEEEeecccccccCCC
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN----FVAKLADFGLAHASKDG  262 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~----~~~kl~DfGla~~~~~~  262 (458)
                      ++|+|.+++...+  .+++..+..++.||+.||+|||   +.+|+||||||+|||+.++    +.+||+|||+++.....
T Consensus        99 ~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           99 KGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            9999999997643  5999999999999999999999   8899999999999998542    35999999999865443


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc--chHHHHHHHHhhccccccccCCc
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK--NLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ..    ......||+.|+|||.+.+..++.++|||||||++|||++|..||....  ...+....+......+    ...
T Consensus       174 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~----~~~  245 (342)
T 2qr7_A          174 NG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL----SGG  245 (342)
T ss_dssp             TC----CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC----CST
T ss_pred             CC----ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc----Ccc
Confidence            21    2234578999999999998889999999999999999999999997532  2333333222211111    111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .....+    ..+.+++.+||..||++||++.++++|.|..
T Consensus       246 ~~~~~s----~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          246 YWNSVS----DTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             TTTTSC----HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             ccccCC----HHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            112222    5688999999999999999999999999873

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.8e-44  Score=340.08  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=192.5

Q ss_pred             hhcccceeeeecceEEEEEEEcC----CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.+.||+|+||.||+|.+..    +..||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   94 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   94 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence            45567899999999999998743    457999988643 3344567999999999999999999999974 56789999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......
T Consensus        95 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           95 ELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             ECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            9999999999997543 35899999999999999999999   8899999999999999999999999999998664432


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ..   ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........ ....... .      .....
T Consensus       171 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-~~~i~~~-~------~~~~~  239 (281)
T 1mp8_A          171 YY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-IGRIENG-E------RLPMP  239 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTT-C------CCCCC
T ss_pred             cc---ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-HHHHHcC-C------CCCCC
Confidence            11   1233456789999999999999999999999999999997 8889875443322 2211111 0      01111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..    ....+.+++.+||+.||++||++.+++++|..
T Consensus       240 ~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          240 PN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            22    23568899999999999999999999999865

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.8e-44  Score=348.69  Aligned_cols=257  Identities=19%  Similarity=0.222  Sum_probs=203.8

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|.. .+|+.||||.+....  ....+.+|+++++++ +|+||+++++++.+.+..++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A           11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            34567899999999999986 478999999886432  234688999999999 8999999999999999999999999 


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc-----EEEeecccccccCCC
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-----AKLADFGLAHASKDG  262 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~DfGla~~~~~~  262 (458)
                      +++|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++.....
T Consensus        88 ~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           88 GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            99999999754 235999999999999999999999   889999999999999998887     999999999865443


Q ss_pred             Ccccc---cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc--chHHHHHHHHhhcccccccc
Q 012715          263 SICFE---PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK--NLVESAQVCMASESRLAELV  337 (458)
Q Consensus       263 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~  337 (458)
                      .....   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....  ...+..............  
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~--  241 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI--  241 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH--
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH--
Confidence            21110   11245679999999999999999999999999999999999999997532  222222222111100000  


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                       ..+...    .+ .+.+++..||+.||.+||++++|++.|...
T Consensus       242 -~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          242 -EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             -HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             -HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence             000111    12 689999999999999999999999988654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.8e-43  Score=337.32  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=202.9

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec----cCceeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMY  183 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  183 (458)
                      .+.+.||+|+||+||+|... ++..||+|.+...  .......+.+|+.++++++||||+++++++..    ....++||
T Consensus        29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  108 (290)
T 1t4h_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence            45568999999999999875 5789999988643  34445678999999999999999999998875    35689999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeccCCCCCeeeC-CCCcEEEeecccccccC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLD-ENFVAKLADFGLAHASK  260 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~  260 (458)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+  ++||||||+|||++ .++.+||+|||++....
T Consensus       109 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            999999999999753  34899999999999999999999   777  99999999999998 78999999999997554


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ...      .....||+.|+|||.+. ..++.++||||||+++|||++|+.||..................  .    ..
T Consensus       184 ~~~------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~----~~  250 (290)
T 1t4h_A          184 ASF------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--P----AS  250 (290)
T ss_dssp             TTS------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--C----GG
T ss_pred             ccc------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--c----cc
Confidence            332      23456899999999876 45899999999999999999999999876655444433222111  1    11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .....    ...+.+++.+||+.||.+|||+.++++|.|+..
T Consensus       251 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          251 FDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             GGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             cCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            11111    245889999999999999999999999998754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-43  Score=341.30  Aligned_cols=256  Identities=21%  Similarity=0.378  Sum_probs=206.9

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      ..+.+.+.||+|+||+||+|... +|+.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            34566789999999999999876 68999999987654444567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee---CCCCcEEEeecccccccCCCC
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ++++|.+++...+  .+++..+..++.|++.||+|||   +.+++||||||+||++   +.++.+||+|||++.......
T Consensus        89 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           89 SGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             CSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             CCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            9999999986533  4899999999999999999999   8899999999999999   788999999999987544321


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                            .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .............    ......
T Consensus       164 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~----~~~~~~  232 (304)
T 2jam_A          164 ------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYEF----ESPFWD  232 (304)
T ss_dssp             ------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHCCCCC----CTTTTT
T ss_pred             ------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCC----Cccccc
Confidence                  22346899999999999999999999999999999999999999754432 2222222111111    111112


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ..    ...+.+++.+||+.||++||++.++++|.|....
T Consensus       233 ~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          233 DI----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TS----CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             cC----CHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            22    2568899999999999999999999999987543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4e-44  Score=354.65  Aligned_cols=264  Identities=19%  Similarity=0.237  Sum_probs=201.1

Q ss_pred             hhcccceeeeecceEEEEEEEcC------CCEEEEEEecccchhh-----------HhHHHHHHHHHHhcCCCCeeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD------GSLIAVKRMDKISEQV-----------EGDFCREIELLARLHHRHLVALRG  171 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  171 (458)
                      .+.+.+.||+|+||.||+|.+.+      ++.||||.+.......           ...+..|+..+..++|+||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            34567899999999999998764      4789999986433211           122445666677778999999999


Q ss_pred             eeecc----CceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC--CC
Q 012715          172 FCIEK----RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--EN  245 (458)
Q Consensus       172 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~--~~  245 (458)
                      ++...    ...+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++  .+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCT
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCC
Confidence            98875    4589999999 999999997642 45999999999999999999999   88999999999999998  88


Q ss_pred             CcEEEeecccccccCCCCccc---ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHH
Q 012715          246 FVAKLADFGLAHASKDGSICF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES  322 (458)
Q Consensus       246 ~~~kl~DfGla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~  322 (458)
                      +.+||+|||+++.........   ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.+.......
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999998654322111   11123456999999999999999999999999999999999999999753322222


Q ss_pred             HHH-HHhhccccccccCCcCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          323 AQV-CMASESRLAELVDPRIK-DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       323 ~~~-~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ... .......+.+++++.+. ..+    +..+.+++..||+.||.+||++.++++.|...
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          271 VRDSKIRYRENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             HHHHHHHHHHCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHhhhhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            211 11112233333333322 112    25689999999999999999999999988653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-44  Score=374.46  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=205.9

Q ss_pred             cccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .+.+.||+|+||.||+|.+.++..||||.+.... ...+.|.+|+++|++++|+||+++++++.+ +..+|||||+++|+
T Consensus       270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs  347 (535)
T 2h8h_A          270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS  347 (535)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred             hhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence            3456799999999999999888889999987543 234679999999999999999999999876 67899999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |.+++.......+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   ...
T Consensus       348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~  421 (535)
T 2h8h_A          348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TAR  421 (535)
T ss_dssp             HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH---HTT
T ss_pred             HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce---ecc
Confidence            999997543345899999999999999999999   89999999999999999999999999999986643221   112


Q ss_pred             ccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      ....++..|+|||.+.+..++.++|||||||+||||++ |+.||.+.... +...... ...+      .....    .+
T Consensus       422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-~~~~~i~-~~~~------~~~~~----~~  489 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVE-RGYR------MPCPP----EC  489 (535)
T ss_dssp             CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-HHHHHHH-TTCC------CCCCT----TC
T ss_pred             cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCC------CCCCC----CC
Confidence            33457889999999999999999999999999999999 88888654332 2222211 1111      11111    23


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          350 LRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ...+.+++.+||+.||++||++++|++.|.....
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            3568999999999999999999999999976544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-43  Score=337.62  Aligned_cols=252  Identities=27%  Similarity=0.448  Sum_probs=205.2

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.+.||+|+||+||+|...++..||||.+.... ...+.+.+|++++++++||||+++++++. .+..++||||+++
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   91 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN   91 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred             hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCC
Confidence            455678999999999999998888899999986533 23567999999999999999999999986 4568999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.......+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.........   
T Consensus        92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---  165 (279)
T 1qpc_A           92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT---  165 (279)
T ss_dssp             CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE---
T ss_pred             CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc---
Confidence            99999997643335999999999999999999999   899999999999999999999999999999876543321   


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +........       ........+  
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~-------~~~~~~~~~--  235 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG-------YRMVRPDNC--  235 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTT-------CCCCCCTTC--
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-HHHHHHhcc-------cCCCCcccc--
Confidence            2234457889999999998899999999999999999999 88888654332 222222111       011111222  


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                        ...+.+++.+||+.||++||++.++++.|..
T Consensus       236 --~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          236 --PEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --cHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence              3568999999999999999999999998864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.6e-44  Score=348.72  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=198.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCE----EEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSL----IAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+.||+|+||+||+|.+. ++..    ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++||
T Consensus        15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~   93 (325)
T 3kex_A           15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT   93 (325)
T ss_dssp             EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred             ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence            345678999999999999875 3443    7888775332 333456789999999999999999999986 56789999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+.+|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           94 QYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             ECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             EeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            9999999999997642 35899999999999999999999   8899999999999999999999999999998765433


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ..  .......||..|+|||.+.+..++.++|||||||++|||++ |+.||...... +........ ...   ..+   
T Consensus       170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~-~~~---~~~---  239 (325)
T 3kex_A          170 KQ--LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVPDLLEKG-ERL---AQP---  239 (325)
T ss_dssp             TC--CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HHHHHHHTT-CBC---CCC---
T ss_pred             cc--ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HHHHHHHcC-CCC---CCC---
Confidence            21  12344567889999999999999999999999999999999 99999754332 222221111 110   001   


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..    ....+.+++.+||+.||.+||++.+++++|....
T Consensus       240 ~~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          240 QI----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             TT----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             Cc----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            01    1124678999999999999999999999997654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=352.28  Aligned_cols=247  Identities=21%  Similarity=0.297  Sum_probs=204.8

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRE  178 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  178 (458)
                      ..+.+.+.||+|+||+||+|... +|+.||||.+....        ......+.+|++++++++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            34556689999999999999864 68899999986432        1233467889999999999999999999999999


Q ss_pred             eeeeeeecCCC-CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          179 RFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       179 ~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      .++||||+.+| +|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            99999999777 9999998643  4999999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      ......     ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......             ....
T Consensus       179 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~~  240 (335)
T 3dls_A          179 YLERGK-----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEAA  240 (335)
T ss_dssp             ECCTTC-----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------TTTC
T ss_pred             ECCCCC-----ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------Hhhc
Confidence            765443     2234569999999999988877 78999999999999999999999652211             0000


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ..  ....++    ..+.+++.+||+.||++||++.+++++.|....
T Consensus       241 ~~--~~~~~~----~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          241 IH--PPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             CC--CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             cC--CCcccC----HHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            10  011122    568899999999999999999999999987653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.8e-44  Score=355.26  Aligned_cols=268  Identities=24%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccC--ceee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLH-HRHLVALRGFCIEKR--ERFL  181 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l  181 (458)
                      ..+.+.+.||+|+||.||+|... +|+.||||++...  .......+.+|+.++..+. |+||+++++++...+  ..|+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            34556789999999999999875 6899999998542  3344567889999999997 999999999997544  6899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      |||||+ |+|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        89 v~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             EEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             EecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence            999997 599999975   25899999999999999999999   89999999999999999999999999999986532


Q ss_pred             CCcc-----------------cccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHH
Q 012715          262 GSIC-----------------FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA  323 (458)
Q Consensus       262 ~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~  323 (458)
                      ....                 .....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            1100                 0112344679999999999976 679999999999999999999999997655443333


Q ss_pred             HHHHhhcccccccc----------------------CCcCCCCCC------------HHHHHHHHHHHHHccccCCCCCC
Q 012715          324 QVCMASESRLAELV----------------------DPRIKDSFD------------MEQLRTIVTIVRWCTQREGQARP  369 (458)
Q Consensus       324 ~~~~~~~~~~~~~~----------------------d~~~~~~~~------------~~~~~~l~~l~~~cl~~dp~~RP  369 (458)
                      ...........+.+                      .......++            ......+.+++.+||+.||++||
T Consensus       242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence            32211110000000                      000000000            01124688999999999999999


Q ss_pred             CHHHHHHHhhhCC
Q 012715          370 SIKQVLRILYESS  382 (458)
Q Consensus       370 s~~evl~~l~~~~  382 (458)
                      |++|+++|.|...
T Consensus       322 t~~e~l~Hp~~~~  334 (388)
T 3oz6_A          322 SANDALKHPFVSI  334 (388)
T ss_dssp             CHHHHTTSTTTTT
T ss_pred             CHHHHhCCHHHHH
Confidence            9999999988653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-43  Score=346.60  Aligned_cols=268  Identities=24%  Similarity=0.305  Sum_probs=205.5

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccch-----hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-----QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      .+.+.+.||+|+||.||+|... +|+.||||.+.....     .....+.+|++++++++||||+++++++.+.+..++|
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   90 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   90 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence            3456689999999999999875 589999999864221     1234688999999999999999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+++ +|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           91 FDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            999986 8999987643 35889999999999999999999   889999999999999999999999999999866433


Q ss_pred             CcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc----ccc-
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL----AEL-  336 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~-  336 (458)
                      ..    ......||+.|+|||.+.+. .++.++|||||||++|||++|..||....................    .+. 
T Consensus       166 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          166 NR----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             CC----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             cc----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            21    23446789999999998754 589999999999999999999998876554433333222111110    000 


Q ss_pred             --cCC---cCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          337 --VDP---RIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       337 --~d~---~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                        .+.   ......+     ......+.+++.+||+.||++|||+.|+++|.|+...+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence              000   0000011     112257899999999999999999999999999876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.8e-43  Score=337.93  Aligned_cols=249  Identities=27%  Similarity=0.478  Sum_probs=198.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchh-------hHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQ-------VEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      +.+.+.||+|+||+||+|.+. +++.||+|.+......       ..+.+.+|++++++++||||+++++++.+..  ++
T Consensus        21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l   98 (287)
T 4f0f_A           21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM   98 (287)
T ss_dssp             EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred             ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence            456678999999999999875 7899999998542221       1157899999999999999999999986654  79


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeccCCCCCeeeCCCCc-----EEEeecc
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFV-----AKLADFG  254 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlk~~NIll~~~~~-----~kl~DfG  254 (458)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+  |+||||||+|||++.++.     +||+|||
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           99 VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             EEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            999999999999987643 35999999999999999999999   888  999999999999988776     9999999


Q ss_pred             cccccCCCCcccccccccccCCCcccccccc--ccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc
Q 012715          255 LAHASKDGSICFEPVNTDIRGTPGYMDPEYV--VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       255 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      +++.....       .....||+.|+|||.+  ....++.++|||||||++|||++|+.||.................  
T Consensus       175 ~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--  245 (287)
T 4f0f_A          175 LSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--  245 (287)
T ss_dssp             TCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--
T ss_pred             cccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--
Confidence            99754332       2345799999999998  455678999999999999999999999975433222111111111  


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                         ...+.+...+    ...+.+++.+||+.||.+||+++++++.|..
T Consensus       246 ---~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          246 ---GLRPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             ---CCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---CCCCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence               1112222222    3568999999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.6e-43  Score=344.66  Aligned_cols=257  Identities=25%  Similarity=0.408  Sum_probs=206.6

Q ss_pred             HhhcccceeeeecceEEEEEEEc--------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccC
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS--------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKR  177 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  177 (458)
                      ..+.+.+.||+|+||.||+|.+.        ++..||||.+... .......+.+|+++++++ +||||+++++++.+.+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            34556789999999999999863        4678999998643 334456799999999999 8999999999999999


Q ss_pred             ceeeeeeecCCCCHHHHhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC
Q 012715          178 ERFLMYEYMANGSLKDHLHSPGR--------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD  243 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~  243 (458)
                      ..++||||+++|+|.+++.....              ..+++..++.++.|++.||+|||   +.+|+||||||+|||++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEc
Confidence            99999999999999999976432              24899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHH
Q 012715          244 ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVES  322 (458)
Q Consensus       244 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~  322 (458)
                      .++.+||+|||+++........  .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+.
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~  268 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEEL  268 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSE--ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHH
T ss_pred             CCCCEEEccccccccccccccc--cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-HHHH
Confidence            9999999999999866543211  12234457889999999999999999999999999999999 888886543 3233


Q ss_pred             HHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          323 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       323 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ........       .......+    ...+.+++.+||+.||.+||++.+++++|...
T Consensus       269 ~~~~~~~~-------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          269 FKLLKEGH-------RMDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHHHHHTC-------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCC-------CCCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            22221111       11111222    25688999999999999999999999998653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.9e-44  Score=345.25  Aligned_cols=256  Identities=24%  Similarity=0.334  Sum_probs=197.1

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      ++||+|+||+||+|... +++.||||.+..........+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            57999999999999864 6899999999765555567899999999995 799999999999999999999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc---EEEeecccccccCCCCcc---
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV---AKLADFGLAHASKDGSIC---  265 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGla~~~~~~~~~---  265 (458)
                      .+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||++.........   
T Consensus        99 ~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (316)
T 2ac3_A           99 LSHIHKR--RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI  173 (316)
T ss_dssp             HHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred             HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence            9999753  35899999999999999999999   889999999999999988765   999999999765322110   


Q ss_pred             cccccccccCCCcccccccccc-----CCCCcccccHhHHHHHHHHHhCCCccCCCcch--------------HHHHHHH
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT-----QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--------------VESAQVC  326 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--------------~~~~~~~  326 (458)
                      .........||+.|+|||.+.+     ..++.++|||||||++|||++|+.||......              .......
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  253 (316)
T 2ac3_A          174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI  253 (316)
T ss_dssp             --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred             cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence            0111233569999999999875     56889999999999999999999999653211              1111111


Q ss_pred             HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       327 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ......+...    ....    ....+.+++.+||+.||++|||+.|+++|.|...
T Consensus       254 ~~~~~~~~~~----~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  301 (316)
T 2ac3_A          254 QEGKYEFPDK----DWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG  301 (316)
T ss_dssp             HHCCCCCCHH----HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred             hccCcccCch----hccc----CCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence            1111110000    0011    1256889999999999999999999999988754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.1e-43  Score=364.44  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=207.5

Q ss_pred             cceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          113 STIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .++||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++.+.+..|+||||++|
T Consensus       190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g  269 (543)
T 3c4z_A          190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG  269 (543)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence            467999999999999886 69999999986432   23345788999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          189 GSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       189 gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      |+|.+++....  ...+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+++.......  
T Consensus       270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--  344 (543)
T 3c4z_A          270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--  344 (543)
T ss_dssp             CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--
T ss_pred             CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--
Confidence            99999997643  346999999999999999999999   89999999999999999999999999999987654321  


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc---chHHHHHHHHhhccccccccCCcCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK---NLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+..........        ....
T Consensus       345 --~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--------~~p~  414 (543)
T 3c4z_A          345 --KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--------TYPD  414 (543)
T ss_dssp             --CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--------CCCT
T ss_pred             --ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--------CCCc
Confidence              2234579999999999999999999999999999999999999997543   22233332222111        1112


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  382 (458)
                      .++    ..+.+++.+||+.||.+||+     ++++++|.|+..
T Consensus       415 ~~s----~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          415 KFS----PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             TSC----HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             ccC----HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            222    56889999999999999996     489999988754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.1e-44  Score=341.89  Aligned_cols=259  Identities=26%  Similarity=0.440  Sum_probs=195.7

Q ss_pred             HhhcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      ..+.+.+.||+|+||+||+|.+.  ..||||.+...  .....+.+.+|++++++++|+||+++++++ .....++||||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~  100 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW  100 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence            34556789999999999999863  46999998643  334456799999999999999999999975 45678999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  175 (289)
T 3og7_A          101 CEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-  175 (289)
T ss_dssp             CCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             cCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc-
Confidence            99999999997543 45999999999999999999999   88999999999999999999999999999975543211 


Q ss_pred             cccccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                       ........||+.|+|||.+.   +..++.++||||||+++|||++|+.||.................  ..... ..+.
T Consensus       176 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~-~~~~  251 (289)
T 3og7_A          176 -SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS--LSPDL-SKVR  251 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS--CCCCT-TSSC
T ss_pred             -cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc--cCcch-hhcc
Confidence             11223456899999999986   56788899999999999999999999976655444333322111  11000 1111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .    ..+..+.+++.+||+.||.+||++.++++.|....
T Consensus       252 ~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          252 S----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             c----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            2    22357899999999999999999999999997654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.5e-44  Score=342.03  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=206.0

Q ss_pred             HHHHHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeec-------
Q 012715          104 ETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE-------  175 (458)
Q Consensus       104 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  175 (458)
                      ......+...+.||+|+||.||+|... +|+.||+|.+....    ..+.+|++++++++||||+++++++..       
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            344455667789999999999999886 79999999986543    356789999999999999999998864       


Q ss_pred             ---------cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC
Q 012715          176 ---------KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF  246 (458)
Q Consensus       176 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~  246 (458)
                               ....++||||+++|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCC
Confidence                     445799999999999999997544456999999999999999999999   88999999999999999999


Q ss_pred             cEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHH
Q 012715          247 VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC  326 (458)
Q Consensus       247 ~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~  326 (458)
                      .+||+|||++.......     ......||+.|+|||.+.+..++.++||||||+++|||++|..|+.....   .....
T Consensus       160 ~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~  231 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDL  231 (284)
T ss_dssp             EEEECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---HHHHH
T ss_pred             CEEECcchhheeccccc-----cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---HHHHh
Confidence            99999999998765432     12345689999999999999999999999999999999999988753211   11111


Q ss_pred             HhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          327 MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       327 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                                .+..+...++    ..+.+++.+||+.||.+||++.|++++|+....
T Consensus       232 ----------~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          232 ----------RDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             ----------HTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ----------hcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence                      1111222233    457899999999999999999999999987543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=344.38  Aligned_cols=264  Identities=25%  Similarity=0.372  Sum_probs=200.0

Q ss_pred             HHHHHHhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhc--CCCCeeeeeeeeecc----
Q 012715          103 KETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL--HHRHLVALRGFCIEK----  176 (458)
Q Consensus       103 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----  176 (458)
                      .+.....+.+.+.||+|+||.||+|.+. |+.||||++....   ...+.+|.+++..+  +|+||+++++++.+.    
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            3344456677889999999999999884 8999999985432   23455666666655  899999999999887    


Q ss_pred             CceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC--------CeEeccCCCCCeeeCCCCcE
Q 012715          177 RERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP--------PLCHRDIKSSNILLDENFVA  248 (458)
Q Consensus       177 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~--------~iiHrDlk~~NIll~~~~~~  248 (458)
                      ...++||||+++|+|.+++...   .+++..++.++.|++.||+|||   +.        +|+||||||+|||++.++.+
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCE
Confidence            6789999999999999999753   4999999999999999999999   77        99999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccCCCccccccccccCCCCcc------cccHhHHHHHHHHHhC----------CCc
Q 012715          249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK------SDVYSYGVVLLEIVTA----------RRA  312 (458)
Q Consensus       249 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~Dvws~Gv~l~el~tg----------~~p  312 (458)
                      ||+|||+++.................||+.|+|||.+.+..+..+      +|||||||++|||+||          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999997654433221112234579999999999987766665      9999999999999999          666


Q ss_pred             cCCCcc---hHHHHHHHHhhccccccccCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          313 VQDGKN---LVESAQVCMASESRLAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       313 ~~~~~~---~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      |.....   ...........     ....+...... ...+...+.+++.+||+.||++||++.+++++|...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          262 YHDLVPSDPSYEDMREIVCI-----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             TTTTSCSSCCHHHHHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhhcCCCCchhhhHHHHhh-----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            643211   11111111111     11111111111 125678899999999999999999999999999653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.7e-44  Score=349.58  Aligned_cols=256  Identities=24%  Similarity=0.359  Sum_probs=196.4

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCce----ee
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER----FL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~l  181 (458)
                      +.+.+.||+|+||.||+|.. .+++.||||.+...   .......+.+|++++.+++||||+++++++......    |+
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l   93 (311)
T 3ork_A           14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   93 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence            45667999999999999987 47899999998643   233345789999999999999999999998876543    99


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++|+|.+++...+  .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           94 VMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            999999999999997533  5899999999999999999999   88999999999999999999999999999986544


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ ..........    .
T Consensus       169 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~----~  242 (311)
T 3ork_A          169 SGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-VREDPIPPSA----R  242 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHCCCCCHHH----H
T ss_pred             ccccc-ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcCCCCCccc----c
Confidence            32111 1223456899999999999999999999999999999999999999765443222222 1111111110    0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...+    ...+.+++.+||+.||.+||++.+++.+.+.
T Consensus       243 ~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          243 HEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             STTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             cCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence            1112    2568899999999999999998888877654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-44  Score=346.25  Aligned_cols=255  Identities=24%  Similarity=0.396  Sum_probs=209.4

Q ss_pred             HHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      ...+.+.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            344556789999999999999886 48899999986533 3456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.........
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  167 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  167 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence            99999999998766667999999999999999999999   889999999999999999999999999999866543321


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .........       ........
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~~~~~~-------~~~~~~~~  236 (288)
T 3kfa_A          168 ---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKD-------YRMERPEG  236 (288)
T ss_dssp             ---EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTT-------CCCCCCTT
T ss_pred             ---cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhcc-------CCCCCCCC
Confidence               2234457889999999999999999999999999999999 88888643322 222211111       11111122


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +    +..+.+++.+||+.||.+||++.++++.|..
T Consensus       237 ~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          237 C----PEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence            2    3568999999999999999999999998854

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.3e-43  Score=334.01  Aligned_cols=257  Identities=23%  Similarity=0.332  Sum_probs=207.4

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence            3556789999999999999876 68999999986432 334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........  
T Consensus        88 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--  160 (276)
T 2yex_A           88 SGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--  160 (276)
T ss_dssp             TTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred             CCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc--
Confidence            999999999763  35899999999999999999999   89999999999999999999999999999976543221  


Q ss_pred             ccccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                      ........||..|+|||.+.+..+ +.++||||||+++|||++|+.||....................    .+  ....
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~--~~~~  234 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----NP--WKKI  234 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS----TT--GGGS
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc----Cc--hhhc
Confidence            112344678999999999987765 7799999999999999999999975443322222211111100    00  0112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                          ...+.+++.+||+.||.+|||+.|++++.|...
T Consensus       235 ----~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (276)
T 2yex_A          235 ----DSAPLALLHKILVENPSARITIPDIKKDRWYNK  267 (276)
T ss_dssp             ----CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ----CHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence                246889999999999999999999999987654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-43  Score=340.35  Aligned_cols=260  Identities=25%  Similarity=0.420  Sum_probs=212.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  103 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG  103 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence            445678999999999999875 68999999986432 3345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +++|.+++..   ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........   
T Consensus       104 ~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---  174 (303)
T 3a7i_A          104 GGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---  174 (303)
T ss_dssp             TEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC---
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc---
Confidence            9999999975   35999999999999999999999   88999999999999999999999999999986654321   


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......       ..+.+...++ 
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-------~~~~~~~~~~-  244 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV-LFLIPKN-------NPPTLEGNYS-  244 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS-------CCCCCCSSCC-
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH-HHHhhcC-------CCCCCccccC-
Confidence             22345689999999999999999999999999999999999999975443322 1111111       1122222333 


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCcchhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHSGFVQ  391 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~~~~~  391 (458)
                         ..+.+++.+||+.||.+||++.++++++|.........+..
T Consensus       245 ---~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~  285 (303)
T 3a7i_A          245 ---KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLT  285 (303)
T ss_dssp             ---HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGGGGH
T ss_pred             ---HHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCccHHHH
Confidence               45889999999999999999999999998765544444443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.4e-43  Score=341.49  Aligned_cols=257  Identities=19%  Similarity=0.298  Sum_probs=203.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeec--cCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIE--KRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|... +++.||||.+....   .+.+.+|++++++++ |+||+++++++.+  ....++||||
T Consensus        38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~  114 (330)
T 3nsz_A           38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  114 (330)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence            456679999999999999864 68999999986433   357889999999997 9999999999987  6678999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-cEEEeecccccccCCCCc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASKDGSI  264 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~  264 (458)
                      +.+++|.+++..     +++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++...... 
T Consensus       115 ~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-  185 (330)
T 3nsz_A          115 VNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-  185 (330)
T ss_dssp             CCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred             cCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence            999999999863     889999999999999999999   89999999999999999766 89999999998665432 


Q ss_pred             ccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc--ccccc-----
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES--RLAEL-----  336 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~-----  336 (458)
                          ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..+....+.........+  .+.+.     
T Consensus       186 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          186 ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             ----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             ----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence                2234568999999999877 67899999999999999999999999765543333222111000  00000     


Q ss_pred             --cCC----------------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          337 --VDP----------------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       337 --~d~----------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                        .++                .............+.+++.+||+.||++|||++|+++|.|+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  325 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  325 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence              000                0000001112356899999999999999999999999998754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=340.23  Aligned_cols=250  Identities=26%  Similarity=0.472  Sum_probs=194.7

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +.+.+.||+|+||+||+|.+ .++.||||.+...  ...+.|.+|++++++++||||+++++++.  +..++||||+++|
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~   84 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGG   84 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTC
T ss_pred             eeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCC
Confidence            44567899999999999988 5789999998643  34567999999999999999999999887  4589999999999


Q ss_pred             CHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc-EEEeecccccccCCCCcccc
Q 012715          190 SLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-AKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       190 sL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~-~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|.+++..... ..+++..++.++.|++.||+|||..+.++|+||||||+|||++.++. +||+|||++......     
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----  159 (307)
T 2eva_A           85 SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----  159 (307)
T ss_dssp             BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred             CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----
Confidence            99999986443 24789999999999999999999432389999999999999988876 799999999754332     


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                        .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.................      ..+.....++ 
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~-  230 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG------TRPPLIKNLP-  230 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT------CCCCCBTTCC-
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC------CCCCcccccC-
Confidence              1234689999999999999999999999999999999999999975332211111111111      1111222223 


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                         ..+.+++.+||+.||++|||+.+++++|...
T Consensus       231 ---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          231 ---KPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence               5688999999999999999999999998754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.8e-43  Score=337.22  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=203.9

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccch------hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      ..+.+.+.||+|+||.||+|... +|+.||+|.+.....      ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            34667789999999999999886 689999998864321      13567999999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC----cEEEeecccc
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLA  256 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla  256 (458)
                      +||||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999753  35899999999999999999999   88999999999999998877    8999999999


Q ss_pred             cccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          257 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      .......     ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +............   
T Consensus       160 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~---  230 (283)
T 3bhy_A          160 HKIEAGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-ETLTNISAVNYDF---  230 (283)
T ss_dssp             EECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCCCC---
T ss_pred             eeccCCC-----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-HHHHHhHhcccCC---
Confidence            8664432     123456899999999999999999999999999999999999999754432 2222211111111   


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ++......    ...+.+++.+||+.||++||++.++++|.|.
T Consensus       231 -~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  269 (283)
T 3bhy_A          231 -DEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEHSWI  269 (283)
T ss_dssp             -CHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred             -cchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence             00111111    2568899999999999999999999998765

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=351.55  Aligned_cols=258  Identities=22%  Similarity=0.334  Sum_probs=198.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC------cee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  180 (458)
                      +.+.+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+++++.++||||+++++++...+      ..|
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  106 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY  106 (367)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence            445678999999999999875 6899999998542  3334567899999999999999999999987653      459


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+ +++|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       107 lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          107 LVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             EEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            999999 8899999975   34899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc----
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE----  335 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----  335 (458)
                      ..       .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+...................+    
T Consensus       180 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          180 SE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             SS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            32       234578999999999887 789999999999999999999999997654433332221111110000    


Q ss_pred             ---------------ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          336 ---------------LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       336 ---------------~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                     .....+. .........+.+++.+||+.||.+|||++|+++|.|+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~  313 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  313 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence                           0000000 001112356889999999999999999999999998864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=347.95  Aligned_cols=264  Identities=23%  Similarity=0.298  Sum_probs=198.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccch-hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (324)
T 3mtl_A            4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   83 (324)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence            445678999999999999886 689999999864332 222346689999999999999999999999999999999997


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                       |+|.+++...+ ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......   
T Consensus        84 -~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---  155 (324)
T 3mtl_A           84 -KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---  155 (324)
T ss_dssp             -EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             -cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---
Confidence             59999987543 35899999999999999999999   89999999999999999999999999999976543221   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC--------
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD--------  338 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d--------  338 (458)
                       ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....................+...        
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence             2234568999999999876 578999999999999999999999997654433222221111111110000        


Q ss_pred             -----CcCCCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 -----PRIKDSF----DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 -----~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                           +......    .......+.+++.+||+.||++|||++|+++|.|+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  287 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS  287 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence                 0000000    0011256889999999999999999999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-43  Score=345.71  Aligned_cols=253  Identities=22%  Similarity=0.338  Sum_probs=208.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||++... +++.||+|.+...   .....+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus        43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  122 (335)
T 2owb_A           43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL  122 (335)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence            445678999999999999886 5789999988643   234456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++...  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus       123 ~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-  196 (335)
T 2owb_A          123 CRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-  196 (335)
T ss_dssp             CTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence            9999999998753  35899999999999999999999   88999999999999999999999999999986543221 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......||..|+|||.+.+..++.++||||||+++|||++|+.||...... +..........        .+...+
T Consensus       197 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~--------~~~~~~  264 (335)
T 2owb_A          197 ---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEY--------SIPKHI  264 (335)
T ss_dssp             ---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCC--------CCCTTS
T ss_pred             ---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHhcCCC--------CCCccC
Confidence               223456899999999999999999999999999999999999999754332 22222221111        111222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      +    ..+.+++.+||+.||++||++.|++++.|.....
T Consensus       265 ~----~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          265 N----PVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             C----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             C----HHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            2    4588999999999999999999999998876543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2e-44  Score=351.39  Aligned_cols=269  Identities=26%  Similarity=0.372  Sum_probs=207.9

Q ss_pred             hhcccceeeeecceEEEEEEE-----cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeee--ccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI--EKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  181 (458)
                      .+.+.+.||+|+||.||+|++     .++..||||++........+.+.+|++++++++|+||+++++++.  +.+..++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  103 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL  103 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence            345677999999999999985     368899999998766666678999999999999999999999887  4556899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          104 VMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999997532 24899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc---cccccccC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE---SRLAELVD  338 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~d  338 (458)
                      .... ........||..|+|||.+.+..++.++||||||+++|||++|+.||.................   ..+.+.+.
T Consensus       180 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          180 DKDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TCSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             CCcc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            3321 1123345688899999999999999999999999999999999999864321100000000000   00000111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .......+......+.+++.+||+.||++||++.+++++|....
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111122223366899999999999999999999999997653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.9e-43  Score=336.03  Aligned_cols=258  Identities=18%  Similarity=0.214  Sum_probs=204.6

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||.||+|.. .+|+.||||.+....  ....+.+|+.++..+ +|+|++++++++.+....++||||+ 
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            45567899999999999986 478999999885432  234688999999999 7999999999999999999999999 


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc-----EEEeecccccccCCC
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV-----AKLADFGLAHASKDG  262 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~DfGla~~~~~~  262 (458)
                      +++|.+++...+ ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.     +||+|||+++.....
T Consensus        89 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            999999997543 35999999999999999999999   999999999999999987765     999999999866543


Q ss_pred             Ccccc---cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc--hHHHHHHHHhhcccccccc
Q 012715          263 SICFE---PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--LVESAQVCMASESRLAELV  337 (458)
Q Consensus       263 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~  337 (458)
                      .....   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....  ................   
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---  241 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP---  241 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC---
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc---
Confidence            22110   123456799999999999999999999999999999999999999976432  2222111111110000   


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+.+...+    +..+.+++.+||+.||++||++++|++.|...
T Consensus       242 ~~~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          242 LRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            00111122    25689999999999999999999999998754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.7e-43  Score=356.14  Aligned_cols=262  Identities=19%  Similarity=0.228  Sum_probs=205.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc------CCCCeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL------HHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.+.||+|+||+||+|... +++.||||++... ......+.+|++++..+      +|+||+++++++...+..++|
T Consensus        99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  177 (429)
T 3kvw_A           99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT  177 (429)
T ss_dssp             EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence            556789999999999999875 5899999998653 33345788899999888      467999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc--EEEeecccccccC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV--AKLADFGLAHASK  260 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~--~kl~DfGla~~~~  260 (458)
                      |||+. ++|.+++.......+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.  +||+|||+++...
T Consensus       178 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~  253 (429)
T 3kvw_A          178 FELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH  253 (429)
T ss_dssp             ECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             EeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence            99996 69999998766566999999999999999999999   889999999999999999887  9999999997654


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc-------
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL-------  333 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  333 (458)
                      ..       .....||+.|+|||++.+..++.++|||||||++|||++|..||....................       
T Consensus       254 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~  326 (429)
T 3kvw_A          254 QR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS  326 (429)
T ss_dssp             CC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred             Cc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            32       2345789999999999999999999999999999999999999976544332222211100000       


Q ss_pred             ---ccccCCc---------------------------C---CCCCCH------HHHHHHHHHHHHccccCCCCCCCHHHH
Q 012715          334 ---AELVDPR---------------------------I---KDSFDM------EQLRTIVTIVRWCTQREGQARPSIKQV  374 (458)
Q Consensus       334 ---~~~~d~~---------------------------~---~~~~~~------~~~~~l~~l~~~cl~~dp~~RPs~~ev  374 (458)
                         ...++..                           .   ......      .....+.+++.+||+.||++|||+.|+
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~  406 (429)
T 3kvw_A          327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA  406 (429)
T ss_dssp             TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence               0000000                           0   000000      012568899999999999999999999


Q ss_pred             HHHhhhCCC
Q 012715          375 LRILYESSD  383 (458)
Q Consensus       375 l~~l~~~~~  383 (458)
                      ++|.|....
T Consensus       407 L~Hpw~~~~  415 (429)
T 3kvw_A          407 LRHPWLRRR  415 (429)
T ss_dssp             HTSTTTC--
T ss_pred             hCChhhccC
Confidence            999987643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.8e-43  Score=337.97  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=208.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +++.||+|.+...   .....+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   96 (294)
T 2rku_A           17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL   96 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence            445678999999999999886 5789999988543   233456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++........ 
T Consensus        97 ~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  170 (294)
T 2rku_A           97 CRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-  170 (294)
T ss_dssp             CTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence            9999999998753  35899999999999999999999   88999999999999999999999999999986543221 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +..........        .+....
T Consensus       171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--------~~~~~~  238 (294)
T 2rku_A          171 ---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEY--------SIPKHI  238 (294)
T ss_dssp             ---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCC--------CCCTTS
T ss_pred             ---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhccC--------CCcccc
Confidence               223456899999999999999999999999999999999999999754432 22222211111        111222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      +    ..+.+++.+||+.||++||++++++++.|......
T Consensus       239 ~----~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          239 N----PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             C----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             C----HHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence            2    46889999999999999999999999998765433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.4e-43  Score=348.09  Aligned_cols=254  Identities=26%  Similarity=0.412  Sum_probs=204.6

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--------hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCc
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--------EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE  178 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  178 (458)
                      .+.+.+.||+|+||.||+|.+. +|+.||||.+....        ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            3445579999999999999986 69999999885432        12245688999999999 79999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      .++||||+++++|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence            99999999999999999753  35999999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCCCcccccccccc------CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVT------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      .....     ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||...... ............
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~  323 (365)
T 2y7j_A          250 LEPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-LMLRMIMEGQYQ  323 (365)
T ss_dssp             CCTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC
T ss_pred             cCCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCC
Confidence            65432     2234679999999998863      35889999999999999999999999764433 222222211111


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ...   +. ....    ...+.+++.+||+.||++||++.++++|.|+.
T Consensus       324 ~~~---~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          324 FSS---PE-WDDR----SSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             CCH---HH-HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CCC---cc-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            000   00 0111    24688999999999999999999999998863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.8e-44  Score=346.13  Aligned_cols=256  Identities=23%  Similarity=0.381  Sum_probs=190.9

Q ss_pred             hhcccceeeeecceEEEEEEEcCC----CEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCce---
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDG----SLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER---  179 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  179 (458)
                      .+.+.+.||+|+||+||+|.+...    ..||||.+...  .....+.+.+|++++++++||||+++++++.+.+..   
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            345678999999999999987532    27999998643  344467899999999999999999999999887655   


Q ss_pred             ---eeeeeecCCCCHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          180 ---FLMYEYMANGSLKDHLHSP----GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       180 ---~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                         ++||||+++|+|.+++...    ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~D  180 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVAD  180 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEee
Confidence               9999999999999998532    1225899999999999999999999   88999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      ||+++........  .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......... ....... 
T Consensus       181 fg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~~~~-  256 (323)
T 3qup_A          181 FGLSRKIYSGDYY--RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-NYLIGGN-  256 (323)
T ss_dssp             CCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTC-
T ss_pred             ccccccccccccc--cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-HHHhcCC-
Confidence            9999865443211  12234457889999999999999999999999999999999 88888754433222 2211111 


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .      .....    .....+.+++.+||+.||++|||+.++++.|.+.
T Consensus       257 ~------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          257 R------LKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             C------CCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C------CCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0      11111    2235689999999999999999999998888654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-43  Score=335.74  Aligned_cols=249  Identities=20%  Similarity=0.347  Sum_probs=202.6

Q ss_pred             eeeeecceEEEEEEEc---CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          115 IIGQGGFGTVYKAQFS---DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .||+|+||.||+|.+.   ++..||||.+... .....+.+.+|++++++++||||+++++++ ..+..++||||+++++
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~   95 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP   95 (287)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred             cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence            8999999999999764   5788999998753 334556799999999999999999999999 5567899999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......... ...
T Consensus        96 L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~-~~~  170 (287)
T 1u59_A           96 LHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TAR  170 (287)
T ss_dssp             HHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE-CCC
T ss_pred             HHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee-ecc
Confidence            999997543 35999999999999999999999   8899999999999999999999999999998765433211 122


Q ss_pred             ccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... +....... ..      .+.....    .
T Consensus       171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~i~~-~~------~~~~~~~----~  238 (287)
T 1u59_A          171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQ-GK------RMECPPE----C  238 (287)
T ss_dssp             CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHHT-TC------CCCCCTT----C
T ss_pred             ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHhc-CC------cCCCCCC----c
Confidence            33457899999999998899999999999999999998 99999754432 22222111 10      1111222    2


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          350 LRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ...+.+++..||+.||++||++.+++++|+..
T Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            35689999999999999999999999999753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.7e-44  Score=353.12  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=197.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHH-HHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIEL-LARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|+.. ++..||||.+....   ......+.+|..+ ++.++||||+++++++.+.+..|+|||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E  119 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD  119 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence            456789999999999999886 58899999986432   2233456677776 467899999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |++||+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+++...... 
T Consensus       120 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-  193 (373)
T 2r5t_A          120 YINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-  193 (373)
T ss_dssp             CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence            999999999997533  4899999999999999999999   8999999999999999999999999999998643221 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         ......+||+.|+|||++.+..++.++|||||||++|||++|..||.... ..+....+......        +...
T Consensus       194 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~--------~~~~  261 (373)
T 2r5t_A          194 ---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNILNKPLQ--------LKPN  261 (373)
T ss_dssp             ---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-HHHHHHHHHHSCCC--------CCSS
T ss_pred             ---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcccC--------CCCC
Confidence               12345679999999999999999999999999999999999999997543 33333333322111        1122


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSI----KQVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~----~evl~~l~~~  381 (458)
                      ++    ..+.+++.+||+.||.+||++    .++++|.|+.
T Consensus       262 ~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~  298 (373)
T 2r5t_A          262 IT----NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS  298 (373)
T ss_dssp             SC----HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred             CC----HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence            22    458899999999999999986    6888888764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=354.11  Aligned_cols=266  Identities=23%  Similarity=0.309  Sum_probs=209.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC--ceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKR--ERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~  185 (458)
                      +.+.++||+|+||+||+|.+. +|+.||||.+.... ....+.+.+|++++++++||||+++++++.+.+  ..++||||
T Consensus        11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~   90 (396)
T 4eut_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred             eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence            456679999999999999886 48999999987533 233567889999999999999999999998765  67999999


Q ss_pred             cCCCCHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee----CCCCcEEEeecccccccC
Q 012715          186 MANGSLKDHLHSPGR-TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLAHASK  260 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DfGla~~~~  260 (458)
                      +++|+|.+++..... ..+++..++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++...
T Consensus        91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            999999999976432 23999999999999999999999   8899999999999999    778889999999998765


Q ss_pred             CCCcccccccccccCCCcccccccccc--------CCCCcccccHhHHHHHHHHHhCCCccCCCc---chHHHHHHHHhh
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT--------QELTEKSDVYSYGVVLLEIVTARRAVQDGK---NLVESAQVCMAS  329 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~---~~~~~~~~~~~~  329 (458)
                      ...     ......||..|+|||.+.+        ..++.++|||||||++|||++|+.||....   ...+........
T Consensus       168 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          168 DDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             CCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            432     2234579999999999865        567889999999999999999999996422   222222222221


Q ss_pred             ccc--cccc---c--------CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          330 ESR--LAEL---V--------DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       330 ~~~--~~~~---~--------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ...  +...   .        +......+.......+.+++.+||+.||++||++.++++.+.....
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            110  0000   0        0111223456777889999999999999999999999998876543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.2e-44  Score=338.45  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=184.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+....   ......+.+|++++.+++||||+++++++.+.+..++||||
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM   92 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence            445678999999999999874 78999999986432   22246789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........ 
T Consensus        93 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  167 (278)
T 3cok_A           93 CHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-  167 (278)
T ss_dssp             CTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             CCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence            99999999998643 35899999999999999999999   88999999999999999999999999999986543221 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ....        ..+.......
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~--------~~~~~~~~~~  235 (278)
T 3cok_A          168 ---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-NKVV--------LADYEMPSFL  235 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CC--------SSCCCCCTTS
T ss_pred             ---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-HHHh--------hcccCCcccc
Confidence               122356899999999999989999999999999999999999999754322111 1000        0011111222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                          ...+.+++.+||+.||++||+++++++|.|...
T Consensus       236 ----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  268 (278)
T 3cok_A          236 ----SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR  268 (278)
T ss_dssp             ----CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred             ----CHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence                256889999999999999999999999988754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.2e-44  Score=346.72  Aligned_cols=265  Identities=23%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             hhcccceeeeecceEEEEEEE-----cCCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Ccee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  180 (458)
                      .+.+.+.||+|+||.||+|++     .+++.||||.+... .......+.+|++++++++|+||+++++++.+.  +..+
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  101 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK  101 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence            345667899999999999984     36889999998643 233456789999999999999999999999876  6689


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       102 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          102 LIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999995432 34999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc-----ccccc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-----SRLAE  335 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~  335 (458)
                      ...... .......||..|+|||.+.+..++.++||||||+++|||++|..|+......  .........     ..+..
T Consensus       178 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          178 TDKEYY-TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL--FLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             TTCCEE-ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--HHHHHCSCCGGGHHHHHHH
T ss_pred             CCCcce-eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH--HhhccCCcccccCHHHHHH
Confidence            443211 1233456888999999999999999999999999999999999886432110  000000000     00000


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+........+......+.+++.+||+.||.+|||+.++++.|..
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            000000111122233568999999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.8e-44  Score=349.88  Aligned_cols=265  Identities=23%  Similarity=0.275  Sum_probs=197.5

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      .+.+.+.||+|+||+||+|... +|+.||||++....  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            3455689999999999999865 68999999986432  22345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee-----CCCCcEEEeecccccccC
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL-----DENFVAKLADFGLAHASK  260 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll-----~~~~~~kl~DfGla~~~~  260 (458)
                      ++ |+|.+++....  .+++..+..++.||+.||+|||   +.+|+||||||+|||+     +.++.+||+|||+++...
T Consensus       115 ~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          115 AE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             CS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             CC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            97 59999997643  4899999999999999999999   8899999999999999     455669999999998654


Q ss_pred             CCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc--
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV--  337 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  337 (458)
                      ....    ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........................  
T Consensus       189 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          189 IPIR----QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             Cccc----ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            3221    22345689999999999874 5899999999999999999999999766554333332211110000000  


Q ss_pred             ----------CCcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          338 ----------DPRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       338 ----------d~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                                .+........     .....+.+++.+||+.||++|||++|+++|.|+...
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                      0000000000     012568899999999999999999999999988643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=338.26  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=202.2

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      .+||+|+||.||+|... ++..||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            48999999999999874 68899999987665555678999999999999999999999999999999999999999999


Q ss_pred             HHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccccCCCCccccccc
Q 012715          193 DHLHSP-GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       193 ~~l~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      +++... +...+++..+..++.|++.||+|||   +.+++||||||+||+++. ++.+||+|||++........    ..
T Consensus       108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~----~~  180 (295)
T 2clq_A          108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP----CT  180 (295)
T ss_dssp             HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---------
T ss_pred             HHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC----cc
Confidence            999754 2335778999999999999999999   889999999999999987 89999999999986543221    22


Q ss_pred             ccccCCCccccccccccCC--CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          271 TDIRGTPGYMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ....||+.|+|||.+.+..  ++.++||||||+++|||++|+.||...............      ....+.+...++  
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~--  252 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM------FKVHPEIPESMS--  252 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH------HCCCCCCCTTSC--
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc------ccccccccccCC--
Confidence            3456899999999987643  889999999999999999999999653332221111100      011122222333  


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                        ..+.+++.+||+.||++||++.+++++.|....
T Consensus       253 --~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          253 --AEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             --HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             --HHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence              568899999999999999999999999887543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.7e-44  Score=350.20  Aligned_cols=264  Identities=25%  Similarity=0.405  Sum_probs=204.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||.||+|... +|+.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  106 (331)
T 4aaa_A           27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV  106 (331)
T ss_dssp             EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence            445678999999999999886 58999999885432  333456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++++|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......  
T Consensus       107 ~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  179 (331)
T 4aaa_A          107 DHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  179 (331)
T ss_dssp             SEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             CcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence            9999999876533  4999999999999999999999   88999999999999999999999999999976543221  


Q ss_pred             ccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc-------------cc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE-------------SR  332 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------------~~  332 (458)
                        ......||..|+|||.+.+. .++.++|||||||++|||++|+.||.................             ..
T Consensus       180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence              22345689999999999875 789999999999999999999999976655443333221111             11


Q ss_pred             cccccCCcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          333 LAELVDPRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ......+.+......     .....+.+++.+||+.||++|||+.|+++|.|+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            111111222211111     12367999999999999999999999999988754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-43  Score=344.69  Aligned_cols=263  Identities=26%  Similarity=0.415  Sum_probs=203.2

Q ss_pred             cccceeeeecceEEEEEEEc-----CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc--Cceeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-----DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK--RERFLM  182 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  182 (458)
                      .+.+.||+|+||+||++.+.     +|+.||||++.... ......+.+|++++++++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            45678999999999998653     57899999987533 34456799999999999999999999999874  578999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+++|+|.+++...   .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++......
T Consensus       114 ~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             ECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            9999999999999753   3899999999999999999999   889999999999999999999999999999876544


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHH---HhhccccccccCC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC---MASESRLAELVDP  339 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~d~  339 (458)
                      .... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||.............   ......+.+.+..
T Consensus       188 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          188 HEYY-RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             CSEE-EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             cccc-ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence            3211 12334568889999999999999999999999999999999999986432110000000   0000001111111


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ......+......+.+++.+||+.||.+||++.++++.|..
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            11111222233679999999999999999999999998854

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-43  Score=361.41  Aligned_cols=267  Identities=21%  Similarity=0.322  Sum_probs=186.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-----Cceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  181 (458)
                      +.+.+.||+|+||+||+|... +|+.||||++...  .....+.+.+|+++|++++|+||+++++++...     +..|+
T Consensus        55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  134 (458)
T 3rp9_A           55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV  134 (458)
T ss_dssp             EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence            456789999999999999875 6899999998642  334456789999999999999999999998543     56899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+ +|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++....
T Consensus       135 v~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          135 VLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             EECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             EEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            99998 57999999764  35999999999999999999999   88999999999999999999999999999986542


Q ss_pred             CCcc-----------------------cccccccccCCCcccccccc-ccCCCCcccccHhHHHHHHHHHh---------
Q 012715          262 GSIC-----------------------FEPVNTDIRGTPGYMDPEYV-VTQELTEKSDVYSYGVVLLEIVT---------  308 (458)
Q Consensus       262 ~~~~-----------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~t---------  308 (458)
                      ....                       .....+..+||+.|+|||++ ....++.++|||||||+||||++         
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            2110                       00123456789999999976 46679999999999999999999         


Q ss_pred             --CCCccCCCcch-------------------HHHHHHHHhhcccc-c---------------cccCC----cCCCCCCH
Q 012715          309 --ARRAVQDGKNL-------------------VESAQVCMASESRL-A---------------ELVDP----RIKDSFDM  347 (458)
Q Consensus       309 --g~~p~~~~~~~-------------------~~~~~~~~~~~~~~-~---------------~~~d~----~~~~~~~~  347 (458)
                        |+++|.+....                   .+....+....+.. .               ..+..    .+...+ .
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  367 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF-P  367 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS-T
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC-C
Confidence              44444322100                   01111111000000 0               00000    000000 1


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .....+.+++.+||..||++|||++|+++|.|+..-
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            113568899999999999999999999999998653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.3e-43  Score=334.97  Aligned_cols=248  Identities=24%  Similarity=0.378  Sum_probs=205.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... ++..||+|.+....   ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   95 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF   95 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence            455678999999999999876 57899999985432   22345789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++|+|.+++...+  .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  
T Consensus        96 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  168 (284)
T 2vgo_A           96 APRGELYKELQKHG--RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--  168 (284)
T ss_dssp             CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence            99999999997543  4899999999999999999999   9999999999999999999999999999987554321  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                          .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +.........        ..+....
T Consensus       169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~--------~~~~~~~  235 (284)
T 2vgo_A          169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-ETHRRIVNVD--------LKFPPFL  235 (284)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTC--------CCCCTTS
T ss_pred             ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-HHHHHHhccc--------cCCCCcC
Confidence                23456899999999999999999999999999999999999999754432 2222222111        1112222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      +    ..+.+++.+||+.||.+||+++++++|.|..
T Consensus       236 ~----~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          236 S----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             C----HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             C----HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence            2    4688999999999999999999999998764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-43  Score=348.64  Aligned_cols=264  Identities=22%  Similarity=0.314  Sum_probs=210.5

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhh-----------------HhHHHHHHHHHHhcCCCCeeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQV-----------------EGDFCREIELLARLHHRHLVALRGF  172 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~~~  172 (458)
                      +.+.+.||+|+||.||+|.. +|+.||||.+.......                 ...+.+|++++.+++||||++++++
T Consensus        33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  111 (348)
T 2pml_X           33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI  111 (348)
T ss_dssp             EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred             eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            45667899999999999998 89999999986432111                 1679999999999999999999999


Q ss_pred             eeccCceeeeeeecCCCCHHHH------hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCC
Q 012715          173 CIEKRERFLMYEYMANGSLKDH------LHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDEN  245 (458)
Q Consensus       173 ~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~  245 (458)
                      +.+.+..++||||+++|+|.++      +.......+++..++.++.|++.||+|||   + .+++||||||+|||++.+
T Consensus       112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECTT
T ss_pred             EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcCC
Confidence            9999999999999999999999      66544567999999999999999999999   7 899999999999999999


Q ss_pred             CcEEEeecccccccCCCCcccccccccccCCCccccccccccC-CCCc-ccccHhHHHHHHHHHhCCCccCCCcchHHHH
Q 012715          246 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTE-KSDVYSYGVVLLEIVTARRAVQDGKNLVESA  323 (458)
Q Consensus       246 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~  323 (458)
                      +.+||+|||++......      ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||.......+..
T Consensus       189 ~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             SCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             CcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            99999999999865443      22345689999999999877 6666 9999999999999999999997665534444


Q ss_pred             HHHHhhccccccccCCcC----C---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          324 QVCMASESRLAELVDPRI----K---DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~----~---~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ..................    .   ..........+.+++.+||+.||.+||++.|+++|.|+...
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            333222111111000000    0   00001223578999999999999999999999999987653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=349.37  Aligned_cols=254  Identities=23%  Similarity=0.323  Sum_probs=203.7

Q ss_pred             hhcccceeeeecceEEEEEEE----cCCCEEEEEEecccc----hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCce
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF----SDGSLIAVKRMDKIS----EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRER  179 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  179 (458)
                      .+.+.+.||+|+||.||+|+.    .+|+.||||.+....    ....+.+.+|++++.++ +|+||+++++++...+..
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  134 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  134 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence            355678999999999999987    368999999986432    23345678899999999 699999999999999999


Q ss_pred             eeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      ++||||+++|+|.+++....  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       135 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            99999999999999997533  5899999999999999999999   889999999999999999999999999999865


Q ss_pred             CCCCcccccccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCccCCCc---chHHHHHHHHhhccccc
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAVQDGK---NLVESAQVCMASESRLA  334 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~  334 (458)
                      .....   .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||....   .............    
T Consensus       210 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----  282 (355)
T 1vzo_A          210 VADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----  282 (355)
T ss_dssp             CGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----
T ss_pred             ccCCC---CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC----
Confidence            43221   12234579999999999985  457899999999999999999999996432   2222222222111    


Q ss_pred             cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          335 ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       335 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                          +.....++    ..+.+++.+||+.||.+||     +++|+++|+|+..
T Consensus       283 ----~~~~~~~~----~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          283 ----PPYPQEMS----ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             ----CCCCTTSC----HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             ----CCCCcccC----HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence                11222222    4688999999999999999     9999999998753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.6e-43  Score=360.34  Aligned_cols=254  Identities=23%  Similarity=0.330  Sum_probs=202.4

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      ..+.+.+.||+|+||+||+|+.. ++..||+|.+....  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            34667789999999999999886 68899999986432  3335678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCC
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKD  261 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~  261 (458)
                      ||++|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       117 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          117 CYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            99999999988653  34899999999999999999999   889999999999999976   45699999999987654


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ..     ......||+.|+|||++. ..++.++|||||||++|+|++|..||..... .+...........+.    ...
T Consensus       192 ~~-----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~----~~~  260 (494)
T 3lij_A          192 QK-----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKYTFD----SPE  260 (494)
T ss_dssp             TB-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCCC----SGG
T ss_pred             Cc-----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCC----chh
Confidence            32     234467999999999876 5699999999999999999999999975443 233333222221111    111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....+    ..+.+++.+||+.||.+|||+.|+++|.|..
T Consensus       261 ~~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  296 (494)
T 3lij_A          261 WKNVS----EGAKDLIKQMLQFDSQRRISAQQALEHPWIK  296 (494)
T ss_dssp             GTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             cccCC----HHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence            11222    4688999999999999999999999998763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.8e-43  Score=334.14  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=198.5

Q ss_pred             hcccceeeeecceEEEEEEEcC----CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||+||+|.+.+    +..||+|.+... .....+.+.+|++++++++||||+++++++.+ +..++|||
T Consensus        14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   92 (281)
T 3cc6_A           14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME   92 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence            4456799999999999998643    236999998653 33445679999999999999999999999765 46789999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++........
T Consensus        93 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           93 LYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             CCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred             cCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence            999999999997532 35899999999999999999999   89999999999999999999999999999986644321


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      .   ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......... ..... ...      .....
T Consensus       169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-~~~~~-~~~------~~~~~  237 (281)
T 3cc6_A          169 Y---KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-GVLEK-GDR------LPKPD  237 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-HHHHH-TCC------CCCCT
T ss_pred             c---ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-HHHhc-CCC------CCCCC
Confidence            1   1233457889999999998999999999999999999998 99999654333222 11111 111      11111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+    ...+.+++.+||+.||++||++.+++++|..
T Consensus       238 ~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          238 LC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence            22    2568899999999999999999999999865

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=373.55  Aligned_cols=248  Identities=21%  Similarity=0.359  Sum_probs=197.4

Q ss_pred             eeeeecceEEEEEEEc---CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          115 IIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .||+|+||.||+|.+.   ++..||||.++... ....+.|.+|+++|++++||||++++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999774   45679999987542 3356789999999999999999999999976 56899999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |.+++... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......... ...
T Consensus       422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~  496 (613)
T 2ozo_A          422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TAR  496 (613)
T ss_dssp             HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee-eec
Confidence            99999754 345999999999999999999999   8899999999999999999999999999998764332111 112


Q ss_pred             ccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      ....+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... +....+.. ..+      .    ..+..+
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i~~-~~~------~----~~p~~~  564 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQ-GKR------M----ECPPEC  564 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-HHHHHHHT-TCC------C----CCCTTC
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHc-CCC------C----CCCCcC
Confidence            23346789999999999999999999999999999998 99999755433 22222111 111      1    112223


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          350 LRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +..+.+++..||+.||++||++.++++.|..
T Consensus       565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            3679999999999999999999999998854

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.1e-43  Score=335.75  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=201.6

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ..+.+.+.||+|+||+||+|... +++.||||.+...  .......+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            34556789999999999999886 7999999998642  334456788999999999 8999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-----------------
Q 012715          184 EYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----------------  244 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-----------------  244 (458)
                      ||+++|+|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+|||++.                 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            9999999999997532  145899999999999999999999   889999999999999984                 


Q ss_pred             --CCcEEEeecccccccCCCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHH
Q 012715          245 --NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE  321 (458)
Q Consensus       245 --~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~  321 (458)
                        .+.+||+|||++.......        ...||..|+|||.+.+. .++.++|||||||++|||++|..++........
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~  239 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE  239 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH
T ss_pred             CCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH
Confidence              4489999999998665432        23589999999999765 667899999999999999999887754432211


Q ss_pred             HHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          322 SAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       322 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .    .  ....     +.+...++    ..+.+++.+||+.||++||++.++++|.|...
T Consensus       240 ~----~--~~~~-----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          240 I----R--QGRL-----PRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             H----H--TTCC-----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             H----H--cCCC-----CCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence            1    1  1111     12222233    56889999999999999999999999988754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-43  Score=344.06  Aligned_cols=258  Identities=26%  Similarity=0.405  Sum_probs=206.7

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||.||+|.+.      ++..||||.+.... ......+.+|++++++++|+||+++++++.+.+..++
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  105 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV  105 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence            4556789999999999999764      36789999986432 3344578999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 012715          182 MYEYMANGSLKDHLHSPG--------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF  253 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  253 (458)
                      ||||+++|+|.+++....        ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus       106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Df  182 (322)
T 1p4o_A          106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF  182 (322)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcC
Confidence            999999999999986421        235799999999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccc
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      |+++........  .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.... ..+........  .
T Consensus       183 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~--~  257 (322)
T 1p4o_A          183 GMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLRFVMEG--G  257 (322)
T ss_dssp             TCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-HHHHHHHHHTT--C
T ss_pred             cccccccccccc--ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-HHHHHHHHHcC--C
Confidence            999765432211  12233457889999999999999999999999999999999 778876433 22222222111  1


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .     ......    ....+.+++.+||+.||.+||++.+++++|.....
T Consensus       258 ~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          258 L-----LDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             C-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             c-----CCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1     111112    23568899999999999999999999999987654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.5e-43  Score=358.75  Aligned_cols=256  Identities=23%  Similarity=0.340  Sum_probs=206.2

Q ss_pred             HHhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ...+.+.+.||+|+||+||+|... +|+.||||.+...  .......+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            345677889999999999999876 6899999998542  2234567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC---CCCcEEEeecccccccC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASK  260 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~  260 (458)
                      |||.+|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++   .++.+||+|||+++...
T Consensus       101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999998653  35999999999999999999999   89999999999999995   46689999999998665


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ...     ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... +.............   .+ 
T Consensus       176 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~---~~-  244 (486)
T 3mwu_A          176 QNT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYAFD---LP-  244 (486)
T ss_dssp             CC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCSC---SG-
T ss_pred             CCC-----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC---Cc-
Confidence            432     2234579999999999875 5999999999999999999999999754432 33322222111110   00 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .....    ...+.+++.+||+.||.+|||+.++++|.|...
T Consensus       245 ~~~~~----s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          245 QWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             GGGGS----CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             ccCCC----CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence            01112    246889999999999999999999999988753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.1e-43  Score=351.61  Aligned_cols=262  Identities=20%  Similarity=0.226  Sum_probs=204.7

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC--------CCCeeeeeeeee----
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH--------HRHLVALRGFCI----  174 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~----  174 (458)
                      ..+.+.+.||+|+||+||+|... +++.||||++... ....+.+.+|+++++.++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            44667789999999999999865 6889999998643 334567899999999995        788999999987    


Q ss_pred             ccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeccCCCCCeeeCCCC-------
Q 012715          175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENF-------  246 (458)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlk~~NIll~~~~-------  246 (458)
                      +....++||||+ +++|.+++.......+++..++.++.||+.||+|||   ++ +|+||||||+|||++.++       
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence            566889999999 567777765544456999999999999999999999   77 999999999999999775       


Q ss_pred             ------------------------------------------cEEEeecccccccCCCCcccccccccccCCCccccccc
Q 012715          247 ------------------------------------------VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY  284 (458)
Q Consensus       247 ------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~  284 (458)
                                                                .+||+|||+++.....       .....||+.|+|||.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------SCSCCSCGGGCCHHH
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------CccCCCCCcccCChh
Confidence                                                      8999999999865432       234578999999999


Q ss_pred             cccCCCCcccccHhHHHHHHHHHhCCCccCCCcc-----hHHHHHHHHhhccccc-----------cccCCc-----C--
Q 012715          285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-----LVESAQVCMASESRLA-----------ELVDPR-----I--  341 (458)
Q Consensus       285 ~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~-----------~~~d~~-----~--  341 (458)
                      +.+..++.++|||||||++|||++|+.||.....     ............+..+           +.+...     +  
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            9999999999999999999999999999964321     1111111111111000           000000     0  


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          342 ------------KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       342 ------------~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                  ....+......+.+++.+||+.||++|||+.|+++|.|+.
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                        0123456677899999999999999999999999998864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.5e-43  Score=348.79  Aligned_cols=259  Identities=19%  Similarity=0.278  Sum_probs=195.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC------cee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  180 (458)
                      +.+.+.||+|+||.||+|... +|+.||||++...  .......+.+|+.+++.++||||+++++++...+      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  106 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  106 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred             eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence            445678999999999999875 6889999998642  3344567889999999999999999999987665      679


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+++ +|.+++..    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       107 lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          107 IVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             EEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            99999974 88888863    4899999999999999999999   8899999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc---
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV---  337 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  337 (458)
                      ...     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+......+............+..   
T Consensus       179 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          179 TSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccc-----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            322     223457899999999999999999999999999999999999999765544333322111110000000   


Q ss_pred             ----------CCcC-------------CCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 ----------DPRI-------------KDS---FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 ----------d~~~-------------~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                .+..             ...   ........+.+++.+||+.||++|||++|+++|.|..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                      0000             000   0112356799999999999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-43  Score=341.89  Aligned_cols=255  Identities=26%  Similarity=0.427  Sum_probs=197.8

Q ss_pred             hcccceeeeecceEEEEEEEcC-----CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+.||+|+||+||+|.+..     +..||||.+... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus        46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  125 (333)
T 1mqb_A           46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT  125 (333)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence            3445789999999999998653     235999998643 3344557999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       126 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          126 EYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             ECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             eCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence            9999999999997543 35999999999999999999999   8899999999999999999999999999998654332


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      .. ........+|..|+|||.+.+..++.++|||||||++|||++ |+.||...... +....... ...      ....
T Consensus       202 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-~~~~~~~~-~~~------~~~~  272 (333)
T 1mqb_A          202 EA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAIND-GFR------LPTP  272 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHT-TCC------CCCC
T ss_pred             cc-ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHC-CCc------CCCc
Confidence            11 011223456889999999999999999999999999999999 99999654332 22222111 111      1111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                          ......+.+++.+||+.||++||++.+++++|...
T Consensus       273 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          273 ----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             ----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                12235689999999999999999999999998653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-43  Score=342.34  Aligned_cols=257  Identities=26%  Similarity=0.365  Sum_probs=205.2

Q ss_pred             HhhcccceeeeecceEEEEEEE------cCCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccC-c
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKR-E  178 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~  178 (458)
                      ..+.+.+.||+|+||+||+|.+      .+++.||||.+.... ......+.+|++++.++ +||||+++++++...+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            3455678999999999999975      246899999986533 33456799999999999 6999999999987754 5


Q ss_pred             eeeeeeecCCCCHHHHhcCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC
Q 012715          179 RFLMYEYMANGSLKDHLHSPGR--------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE  244 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~  244 (458)
                      .++||||+++|+|.+++.....              ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE  183 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECC
Confidence            8999999999999999976442              12889999999999999999999   889999999999999999


Q ss_pred             CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHH
Q 012715          245 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESA  323 (458)
Q Consensus       245 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~  323 (458)
                      ++.+||+|||+++........  .......||+.|+|||.+.+..++.++||||||+++|||+| |..||..........
T Consensus       184 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          184 KNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             GGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCEEECCCccccccccCccc--eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            999999999999865433211  12234557889999999999999999999999999999998 999987544333332


Q ss_pred             HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...... ..      .......    ...+.+++.+||+.||.+||++.+++++|..
T Consensus       262 ~~~~~~-~~------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          262 RRLKEG-TR------MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             HHHHHT-CC------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhccC-cc------CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            222211 11      1111122    2568899999999999999999999999865

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5e-43  Score=332.88  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=198.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+....   ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY   92 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence            445678999999999999886 68999999986432   23345789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++....  .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  
T Consensus        93 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  165 (276)
T 2h6d_A           93 VSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  165 (276)
T ss_dssp             CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             cCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence            99999999997543  4899999999999999999999   8899999999999999999999999999998765432  


Q ss_pred             cccccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ............        .+...
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~--------~~~~~  233 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-PTLFKKIRGGVF--------YIPEY  233 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC--------CCCTT
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhcCcc--------cCchh
Confidence               1234568999999999987765 6899999999999999999999965432 222222221111        11112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .+    ..+.+++.+||+.||.+||++.++++|.|....
T Consensus       234 ~~----~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          234 LN----RSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             SC----HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cC----HHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            22    468899999999999999999999999887543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=347.22  Aligned_cols=266  Identities=20%  Similarity=0.211  Sum_probs=197.9

Q ss_pred             hhcccceeeeecceEEEEEEEc----CCCEEEEEEecccchh-----------hHhHHHHHHHHHHhcCCCCeeeeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKISEQ-----------VEGDFCREIELLARLHHRHLVALRGFC  173 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~  173 (458)
                      .+.+.+.||+|+||.||+|...    ++..||||.+......           ....+.+|+..+..++|+||+++++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~  117 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG  117 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence            4556789999999999999885    5788999988643221           123467888999999999999999999


Q ss_pred             ec----cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC--c
Q 012715          174 IE----KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF--V  247 (458)
Q Consensus       174 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~--~  247 (458)
                      .+    ....++||||+ +++|.+++...+  .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++  .
T Consensus       118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          118 LTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred             ccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence            88    67889999999 999999998644  6999999999999999999999   88999999999999998877  9


Q ss_pred             EEEeecccccccCCCCcc---cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc-chHHHH
Q 012715          248 AKLADFGLAHASKDGSIC---FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-NLVESA  323 (458)
Q Consensus       248 ~kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~-~~~~~~  323 (458)
                      +||+|||+++........   .........||+.|+|||.+.+..++.++|||||||++|||++|+.||.... +.....
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            999999999865432111   0112245579999999999999999999999999999999999999995422 221111


Q ss_pred             HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .........+..........   ...+..+.+++.+||+.||++||+++++++.|.....
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          272 TAKTNLLDELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHTTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHhhcccccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            11111111111111100000   0122568999999999999999999999999976543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.4e-43  Score=341.20  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=200.9

Q ss_pred             HHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--------EQVEGDFCREIELLARLHHRHLVALRGFCIEKR  177 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  177 (458)
                      ...+.+.+.||+|+||.||+|... +++.||||.+....        ......+.+|++++++++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            445677889999999999999875 58899999986422        122345889999999999999999999987654


Q ss_pred             ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC---cEEEeecc
Q 012715          178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLADFG  254 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfG  254 (458)
                       .++||||+++|+|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++   .+||+|||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence             89999999999999999764  35999999999999999999999   88999999999999998765   49999999


Q ss_pred             cccccCCCCcccccccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc
Q 012715          255 LAHASKDGSICFEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       255 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      +++......     ......||+.|+|||.+.   ...++.++|||||||++|||++|..||..................
T Consensus       163 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          163 HSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             TCEECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             cceeccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            998765432     123356899999999874   567899999999999999999999999754332222221111111


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..    .+......    ...+.+++.+||+.||++||++.++++|.|...
T Consensus       238 ~~----~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          238 NF----IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             CC----CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             cc----Cchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            00    01111112    256889999999999999999999999998764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-43  Score=356.84  Aligned_cols=259  Identities=24%  Similarity=0.355  Sum_probs=197.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Cceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|.+. +|+.||||++....    ..+.+|+++|++++|+||+++++++...      ...++|
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            445678999999999999886 58999999886432    2234799999999999999999998542      236799


Q ss_pred             eeecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC-CcEEEeeccccccc
Q 012715          183 YEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHAS  259 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~  259 (458)
                      |||+++ +|.+.+..  .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.+ +.+||+|||+++..
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999975 67666542  12346999999999999999999999   9999999999999999954 67899999999866


Q ss_pred             CCCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-------
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-------  331 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------  331 (458)
                      ..+.     ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+................       
T Consensus       208 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          208 VRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CTTC-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCC-----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4432     22345789999999998764 7999999999999999999999999765544333332211110       


Q ss_pred             ----ccccccCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          332 ----RLAELVDPRIKDS-----FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       332 ----~~~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                          ...+...+.+...     +.......+.+++.+||+.||.+||++.|+++|.|+.
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~  341 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  341 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence                1111111111110     1112235689999999999999999999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.3e-43  Score=344.64  Aligned_cols=256  Identities=26%  Similarity=0.388  Sum_probs=204.4

Q ss_pred             hhcccceeeeecceEEEEEEEcC-C-----CEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD-G-----SLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||.||+|.... +     ..||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  126 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL  126 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence            34567899999999999998742 2     479999986543 33456799999999999 8999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcE
Q 012715          181 LMYEYMANGSLKDHLHSPG------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVA  248 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~  248 (458)
                      +||||+++|+|.+++....            ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus       127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~  203 (333)
T 2i1m_A          127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVA  203 (333)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeE
Confidence            9999999999999986421            235899999999999999999999   8899999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHH
Q 012715          249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCM  327 (458)
Q Consensus       249 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~  327 (458)
                      ||+|||+++........  .......+|+.|+|||.+.+..++.++|||||||++|||+| |..||..............
T Consensus       204 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  281 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK  281 (333)
T ss_dssp             EBCCCGGGCCGGGCTTS--EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred             EECccccccccccccce--eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence            99999999865432211  12234457889999999999999999999999999999999 8888865443322222211


Q ss_pred             hhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       328 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ....      .......    ...+.+++.+||+.||.+||++.+++++|..
T Consensus       282 -~~~~------~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          282 -DGYQ------MAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             -HTCC------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -cCCC------CCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence             1111      1111112    2568899999999999999999999999865

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.9e-43  Score=360.73  Aligned_cols=254  Identities=24%  Similarity=0.330  Sum_probs=207.6

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      ..+.+.+.||+|+||.||+|... +|+.||||.+...   .......+.+|++++++++||||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            45667789999999999999886 7899999998542   2334567999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee---CCCCcEEEeecccccccC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASK  260 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~  260 (458)
                      ||+.+|+|.+++....  .+++..+..++.|++.||+|||   +++|+||||||+|||+   +.++.+||+|||+++...
T Consensus       106 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             CCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            9999999999997643  5999999999999999999999   8899999999999999   567899999999998665


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ...     ......||+.|+|||.+.+ .++.++|||||||++|||++|..||...... +.............   .+ 
T Consensus       181 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~---~~-  249 (484)
T 3nyv_A          181 ASK-----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKYTFE---LP-  249 (484)
T ss_dssp             CCC-----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCCC---SG-
T ss_pred             ccc-----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHcCCCCCC---Cc-
Confidence            433     1234569999999998866 6999999999999999999999999754433 32222222111110   00 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .....    ...+.+++.+||+.||.+|||+.|+++|.|..
T Consensus       250 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~  286 (484)
T 3nyv_A          250 QWKKV----SESAKDLIRKMLTYVPSMRISARDALDHEWIQ  286 (484)
T ss_dssp             GGGGS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             ccccC----CHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence            01112    25688999999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=352.66  Aligned_cols=267  Identities=20%  Similarity=0.300  Sum_probs=186.9

Q ss_pred             cceeeeecceEEEEEEEc---CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeec--cCceeeeeeecC
Q 012715          113 STIIGQGGFGTVYKAQFS---DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYEYMA  187 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  187 (458)
                      .++||+|+||+||+|++.   ++..||||++....  ....+.+|+++|++++||||+++++++..  ....++||||+.
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            357999999999999875   47899999986432  23468899999999999999999999954  678899999996


Q ss_pred             CCCHHHHhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee----CCCCcEEEeecccc
Q 012715          188 NGSLKDHLHS-------PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL----DENFVAKLADFGLA  256 (458)
Q Consensus       188 ~gsL~~~l~~-------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DfGla  256 (458)
                       |+|.+++..       .....+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus       104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence             588888752       11234899999999999999999999   8899999999999999    67889999999999


Q ss_pred             cccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcch--------HHHHHHHH
Q 012715          257 HASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--------VESAQVCM  327 (458)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--------~~~~~~~~  327 (458)
                      +........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......        .+....+.
T Consensus       180 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          180 RLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             C-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             eecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            866432211 112344678999999999987 45899999999999999999999999643221        11111111


Q ss_pred             hhcccc-----ccc------------cCCcCCCCCCHH---------HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          328 ASESRL-----AEL------------VDPRIKDSFDME---------QLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       328 ~~~~~~-----~~~------------~d~~~~~~~~~~---------~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ...+..     ..+            +...........         ....+.+++.+||+.||.+|||++|+++|.|+.
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~  338 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL  338 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence            100000     000            000000000000         024578999999999999999999999999998


Q ss_pred             CCCCC
Q 012715          382 SDPMH  386 (458)
Q Consensus       382 ~~~~~  386 (458)
                      ..+.+
T Consensus       339 ~~~~~  343 (405)
T 3rgf_A          339 EDPLP  343 (405)
T ss_dssp             SSSCC
T ss_pred             cCCCC
Confidence            76543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=342.15  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=202.4

Q ss_pred             hhcccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeee----ccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI----EKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~  183 (458)
                      .+.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++++.++||||+++++++.    .....++||
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            355678999999999999987 478999999987666666778999999999999999999999987    345789999


Q ss_pred             eecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          184 EYMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       184 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||+++|+|.+++...  ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            999999999998642  2346999999999999999999999   88999999999999999999999999999875432


Q ss_pred             CCccc-----ccccccccCCCccccccccccCC---CCcccccHhHHHHHHHHHhCCCccCCC----cchHHHHHHHHhh
Q 012715          262 GSICF-----EPVNTDIRGTPGYMDPEYVVTQE---LTEKSDVYSYGVVLLEIVTARRAVQDG----KNLVESAQVCMAS  329 (458)
Q Consensus       262 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tg~~p~~~~----~~~~~~~~~~~~~  329 (458)
                      .....     ........||+.|+|||.+.+..   ++.++||||||+++|||++|+.||...    ......    ...
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~  262 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA----VQN  262 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----HHC
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----hhc
Confidence            11000     00112345799999999987554   789999999999999999999998521    111110    111


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          330 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       330 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      ...      ......+    ...+.+++.+||+.||.+||++.+++++|.....+.
T Consensus       263 ~~~------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          263 QLS------IPQSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             C--------CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             cCC------CCccccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            000      0001112    256899999999999999999999999998766544

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.8e-43  Score=336.86  Aligned_cols=256  Identities=22%  Similarity=0.308  Sum_probs=197.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL  115 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence            456689999999999999875 68899999986432   23346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +++++|.+++...  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.........
T Consensus       116 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          116 INGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             CCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            9999999999753  35899999999999999999999   889999999999999999999999999999765443211


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...........    ...+
T Consensus       191 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~-~~~~~~~~~~~----~~~~  261 (309)
T 2h34_A          191 ---QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAH-INQAIPRPSTV----RPGI  261 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHH-HHSCCCCGGGT----STTC
T ss_pred             ---cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHH-hccCCCCcccc----CCCC
Confidence               223456899999999999999999999999999999999999999754322 21111 11111111111    1122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhhCCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-SIKQVLRILYESSD  383 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~l~~~~~  383 (458)
                      +    ..+.+++.+||+.||++|| +++++++.|.....
T Consensus       262 ~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          262 P----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             C----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             C----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            2    4688999999999999999 99999999977654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-43  Score=353.20  Aligned_cols=260  Identities=19%  Similarity=0.287  Sum_probs=198.1

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-----------
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----------  176 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----------  176 (458)
                      .+.+.+.||+|+||+||+|... +|+.||||++.....    ...+|+++++.++|+||+++++++...           
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            3456789999999999999874 789999998864322    234799999999999999999998543           


Q ss_pred             ---------------------------CceeeeeeecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 012715          177 ---------------------------RERFLMYEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCD  227 (458)
Q Consensus       177 ---------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~  227 (458)
                                                 ...++||||++ |+|.+.+..  .....+++..+..++.||+.||+|||   +
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~  159 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---S  159 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---T
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---H
Confidence                                       34789999998 588777652  12346999999999999999999999   9


Q ss_pred             CCeEeccCCCCCeeeC-CCCcEEEeecccccccCCCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHH
Q 012715          228 PPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLE  305 (458)
Q Consensus       228 ~~iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~e  305 (458)
                      .+|+||||||+|||++ .++.+||+|||+++......     ......||+.|+|||.+.+. .++.++|||||||++||
T Consensus       160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            9999999999999997 68999999999998664432     22345689999999998764 58999999999999999


Q ss_pred             HHhCCCccCCCcchHHHHHHHHhhccc-----------cccccCCcCCCC-----CCHHHHHHHHHHHHHccccCCCCCC
Q 012715          306 IVTARRAVQDGKNLVESAQVCMASESR-----------LAELVDPRIKDS-----FDMEQLRTIVTIVRWCTQREGQARP  369 (458)
Q Consensus       306 l~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~d~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RP  369 (458)
                      |++|+.||.+.................           ..+..-+.....     ++......+.+++.+||+.||.+||
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  314 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI  314 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence            999999997665544433332211110           001001111100     1112235689999999999999999


Q ss_pred             CHHHHHHHhhhC
Q 012715          370 SIKQVLRILYES  381 (458)
Q Consensus       370 s~~evl~~l~~~  381 (458)
                      |+.|+++|.|+.
T Consensus       315 t~~e~l~hp~f~  326 (383)
T 3eb0_A          315 NPYEAMAHPFFD  326 (383)
T ss_dssp             CHHHHHTSGGGH
T ss_pred             CHHHHhcCHHHH
Confidence            999999998763

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-43  Score=340.38  Aligned_cols=259  Identities=25%  Similarity=0.372  Sum_probs=203.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||.||+|... +|..||+|.+........+.+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus        21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (302)
T 2j7t_A           21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG  100 (302)
T ss_dssp             EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred             eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence            455678999999999999886 5899999998766555667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      ++|.+++.... ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.......    .
T Consensus       101 ~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~  172 (302)
T 2j7t_A          101 GAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL----Q  172 (302)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH----H
T ss_pred             CcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc----c
Confidence            99999986432 34999999999999999999999   8899999999999999999999999999875321110    1


Q ss_pred             ccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          269 VNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ......||..|+|||.+.     +..++.++||||||+++|||++|+.||............ ....  ......     
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~-----  244 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSD--PPTLLT-----  244 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSC--CCCCSS-----
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-hccC--CcccCC-----
Confidence            123356899999999983     667899999999999999999999999755433222221 1111  111111     


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                        +......+.+++.+||+.||++|||+.++++|.|.......
T Consensus       245 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          245 --PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             --GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             --ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence              11122568899999999999999999999999988765443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.2e-43  Score=341.14  Aligned_cols=260  Identities=19%  Similarity=0.280  Sum_probs=206.3

Q ss_pred             hhcccceeeeecceEEEEEEE-c-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCC------CeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF-S-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHR------HLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||+||+|.. . +|+.||||.+.... ...+.+.+|+++++.++|+      +++++++++.+.+..+
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            455678999999999999987 3 68899999986533 3456788999999999765      4999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC----------------
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE----------------  244 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~----------------  244 (458)
                      +||||+ +++|.+++...+..++++..+..++.|++.||+|||   +++|+||||||+|||++.                
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence            999999 889999998766567999999999999999999999   889999999999999987                


Q ss_pred             ---CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHH
Q 012715          245 ---NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE  321 (458)
Q Consensus       245 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~  321 (458)
                         ++.+||+|||+++.....       .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDEH-------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EESCCCEEECCCSSCEETTSC-------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccCCCceEeeCcccccCccc-------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence               678999999999865432       2345789999999999999999999999999999999999999975443322


Q ss_pred             HHHHHHhhccccccc-------------------------------cCCc-CCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 012715          322 SAQVCMASESRLAEL-------------------------------VDPR-IKDSFDMEQLRTIVTIVRWCTQREGQARP  369 (458)
Q Consensus       322 ~~~~~~~~~~~~~~~-------------------------------~d~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RP  369 (458)
                      ... .......++..                               ..+. -...........+.+++.+||+.||.+||
T Consensus       243 ~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          243 LAM-MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHH-HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHH-HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            111 11111100000                               0000 00011234457899999999999999999


Q ss_pred             CHHHHHHHhhhC
Q 012715          370 SIKQVLRILYES  381 (458)
Q Consensus       370 s~~evl~~l~~~  381 (458)
                      |+.|+++|.|+.
T Consensus       322 t~~ell~hp~f~  333 (339)
T 1z57_A          322 TLREALKHPFFD  333 (339)
T ss_dssp             CHHHHTTSGGGG
T ss_pred             CHHHHhcCHHHH
Confidence            999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-43  Score=350.32  Aligned_cols=261  Identities=24%  Similarity=0.325  Sum_probs=203.1

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      .+.+.+.||+|+||+||+|... +|..||+|.+... .......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  113 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM  113 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence            3445678999999999999886 6899999998643 3444567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      ++|+|.+++...+  .+++..+..++.|++.||+|||   +. +|+||||||+|||++.++.+||+|||++......   
T Consensus       114 ~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  185 (360)
T 3eqc_A          114 DGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  185 (360)
T ss_dssp             TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence            9999999997643  4899999999999999999999   64 8999999999999999999999999998654221   


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHh-hccc------------
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMA-SESR------------  332 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-~~~~------------  332 (458)
                         ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....... ....            
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE-LELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH-HHHHHC------------------
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccCCCCCCCcccCC
Confidence               2234578999999999999999999999999999999999999997543221 1110000 0000            


Q ss_pred             -------------------cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          333 -------------------LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       333 -------------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                         ....................+.+++.+||+.||++|||++|+++|.|..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  329 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  329 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence                               0000000000000011124688999999999999999999999998864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-42  Score=340.49  Aligned_cols=269  Identities=28%  Similarity=0.414  Sum_probs=210.2

Q ss_pred             cCHHHHHHHhhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHh--cCCCCeeeeeeeeeccC
Q 012715          100 FSYKETKKATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLAR--LHHRHLVALRGFCIEKR  177 (458)
Q Consensus       100 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~  177 (458)
                      +...+.....+.+.+.||+|+||.||+|.+ +|+.||||.+...   ....+.+|++++..  ++||||+++++++....
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            444555666778889999999999999988 6899999998643   24567889999988  68999999999998876


Q ss_pred             ----ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEeccCCCCCeeeCCCCcE
Q 012715          178 ----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-----CDPPLCHRDIKSSNILLDENFVA  248 (458)
Q Consensus       178 ----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~iiHrDlk~~NIll~~~~~~  248 (458)
                          ..++||||+++|+|.+++...   .+++..++.++.|++.||+|||..     ++.+|+||||||+|||++.++.+
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence                789999999999999999753   489999999999999999999932     15689999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccccCCCccccccccccC------CCCcccccHhHHHHHHHHHhC----------CCc
Q 012715          249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTA----------RRA  312 (458)
Q Consensus       249 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg----------~~p  312 (458)
                      ||+|||++..................||+.|+|||.+.+.      .++.++|||||||++|||+||          ..|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            9999999986654332211123455799999999998765      344789999999999999999          677


Q ss_pred             cCCCc----chHHHHHHHHhhccccccccCCcCCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          313 VQDGK----NLVESAQVCMASESRLAELVDPRIKDS-FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       313 ~~~~~----~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      |....    ....+.....      .....+.+... .+.+....+.+++.+||+.||++||++.+++++|...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          267 YYDLVPSDPSVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             TTTTSCSSCCHHHHHHHHT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCcCcccHHHHHHHHH------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            75432    1222222111      11112222211 1235667899999999999999999999999999653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.5e-42  Score=343.97  Aligned_cols=263  Identities=19%  Similarity=0.246  Sum_probs=205.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CC-----CeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HR-----HLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.+.||+|+||+||+|... +++.||||++... ......+.+|+.++..++ |+     +|+++++++...+..++|
T Consensus        56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv  134 (382)
T 2vx3_A           56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV  134 (382)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence            455679999999999999876 6889999998643 334567888999999885 55     499999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC--CCCcEEEeecccccccC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENFVAKLADFGLAHASK  260 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~--~~~~~kl~DfGla~~~~  260 (458)
                      |||+. |+|.+++.......+++..+..++.|++.||+|||.+ ..+|+||||||+|||++  .++.+||+|||+++...
T Consensus       135 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~  212 (382)
T 2vx3_A          135 FEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG  212 (382)
T ss_dssp             EECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred             EecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence            99996 5999999866555699999999999999999999932 47899999999999995  47889999999998764


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc-----
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE-----  335 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  335 (458)
                      ..       .....||+.|+|||++.+..++.++|||||||++|||++|+.||......................     
T Consensus       213 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  285 (382)
T 2vx3_A          213 QR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA  285 (382)
T ss_dssp             CC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            32       234578999999999999999999999999999999999999997654433322221111100000     


Q ss_pred             ---------ccCCc------------C-------------------------CCCCCHHHHHHHHHHHHHccccCCCCCC
Q 012715          336 ---------LVDPR------------I-------------------------KDSFDMEQLRTIVTIVRWCTQREGQARP  369 (458)
Q Consensus       336 ---------~~d~~------------~-------------------------~~~~~~~~~~~l~~l~~~cl~~dp~~RP  369 (458)
                               +.+..            .                         .......+...+.+++.+||+.||++||
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp  365 (382)
T 2vx3_A          286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI  365 (382)
T ss_dssp             TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence                     00000            0                         0011223445789999999999999999


Q ss_pred             CHHHHHHHhhhCC
Q 012715          370 SIKQVLRILYESS  382 (458)
Q Consensus       370 s~~evl~~l~~~~  382 (458)
                      |+.|+++|.|+..
T Consensus       366 ta~e~L~hp~f~~  378 (382)
T 2vx3_A          366 QPYYALQHSFFKK  378 (382)
T ss_dssp             CHHHHTTSGGGCC
T ss_pred             CHHHHhcCccccc
Confidence            9999999998754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=345.52  Aligned_cols=265  Identities=26%  Similarity=0.407  Sum_probs=205.0

Q ss_pred             hhcccceeeeecceEEEEEEE-----cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC--ceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF-----SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKR--ERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  181 (458)
                      .+.+.+.||+|+||.||+|++     .+|+.||||++........+.+.+|++++++++|+||+++++++...+  ..++
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  121 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL  121 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence            355678999999999999984     368899999998766666678999999999999999999999987654  7899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       122 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          122 IMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             EEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            999999999999997643 35899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc------ccccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE------SRLAE  335 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~------~~~~~  335 (458)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||+||..|+.....  ..........      ..+.+
T Consensus       198 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          198 DKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             SCSEE-ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccc-ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHHHhhccccchhhhHHHHHH
Confidence            33211 112334578889999999998999999999999999999999988753211  0000000000      00001


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+........+...+..+.+++.+||+.||++||++.++++.|..
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111000111112233568999999999999999999999998865

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-43  Score=337.06  Aligned_cols=254  Identities=25%  Similarity=0.368  Sum_probs=202.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec--cCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|... +|+.||+|.+...  .....+.+.+|++++++++||||+++++++.+  ....++|||
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   87 (279)
T 2w5a_A            8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   87 (279)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred             eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence            445678999999999999886 6899999998643  33445679999999999999999999998754  567899999


Q ss_pred             ecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          185 YMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYCDPP-----LCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       185 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-----iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      |+++|+|.+++...  ....+++..++.++.|++.||+|||   +.+     ++||||||+|||++.++.+||+|||+++
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999642  2345999999999999999999999   666     9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      .......    ......||..|+|||.+.+..++.++||||||+++|||++|+.||..... .+........  ..    
T Consensus       165 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~i~~~--~~----  233 (279)
T 2w5a_A          165 ILNHDTS----FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREG--KF----  233 (279)
T ss_dssp             HC---CH----HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHT--CC----
T ss_pred             eeccccc----cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-HHHHHHHhhc--cc----
Confidence            6544321    12234689999999999999999999999999999999999999975432 2222221111  11    


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       +.+...+    ...+.+++.+||+.||.+||++.|++++++...
T Consensus       234 -~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          234 -RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -ccCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence             1112222    256889999999999999999999999987654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=346.83  Aligned_cols=260  Identities=18%  Similarity=0.209  Sum_probs=201.9

Q ss_pred             hhcccceeeeecceEEEEEEEcC---------CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeee-----------
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD---------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVA-----------  168 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------  168 (458)
                      .+.+.+.||+|+||.||+|....         ++.||||.+...     ..+.+|++++++++||||++           
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            34567899999999999998763         789999988643     46889999999999999988           


Q ss_pred             ----eeeeeec-cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC
Q 012715          169 ----LRGFCIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD  243 (458)
Q Consensus       169 ----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~  243 (458)
                          +++++.. ++..++||||+ +++|.+++.......+++..++.++.||+.||+|||   +.+|+||||||+|||++
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEc
Confidence                5677765 67889999999 999999998653456999999999999999999999   88999999999999999


Q ss_pred             CCC--cEEEeecccccccCCCCcc---cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCc-
Q 012715          244 ENF--VAKLADFGLAHASKDGSIC---FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGK-  317 (458)
Q Consensus       244 ~~~--~~kl~DfGla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~-  317 (458)
                      .++  .+||+|||+++........   .........||+.|+|||.+.+..++.++|||||||++|||++|+.||.... 
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            988  9999999999865432211   0112234579999999999999999999999999999999999999997543 


Q ss_pred             chHHHHHHHHhhccccccccCCcCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          318 NLVESAQVCMASESRLAELVDPRIK-DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..................+.+.... ..++    ..+.+++.+||+.||++||+++++++.|...
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             CHHHHHHHHHHHHHSCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHhccCChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            2222222111111111222211110 1122    5689999999999999999999999998654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.6e-43  Score=370.26  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=196.8

Q ss_pred             ceeeeecceEEEEEEEc---CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.||+|+||.||+|.+.   .++.||||+++...  ....+.+.+|+++|++++||||++++++|.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999663   46789999987532  2345689999999999999999999999864 568999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......... .
T Consensus       454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~  527 (635)
T 4fl3_A          454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-K  527 (635)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc-c
Confidence            9999999753  35999999999999999999999   8899999999999999999999999999998765433211 1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.... +....... ..      ......    
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~~~~i~~-~~------~~~~p~----  595 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEK-GE------RMGCPA----  595 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHT-TC------CCCCCT----
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHc-CC------CCCCCC----
Confidence            2233457889999999999999999999999999999998 99999754432 22222211 11      111112    


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..+..+.+++..||+.||++||++.+|++.|..
T Consensus       596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            233678999999999999999999999998854

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.5e-43  Score=372.08  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=209.5

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+.+.++||+|+||.||+|+.. +++.||||++...   .....+.+..|..++..+ +|+||+++++++.+.+..||||
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~  421 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  421 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence            3455678999999999999876 5889999998642   233445688999999988 6999999999999999999999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++...+  .+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++......
T Consensus       422 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          422 EYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             eCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            9999999999997643  4999999999999999999999   8999999999999999999999999999998643322


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      .    ......||+.|+|||++.+..|+.++|||||||+||||++|+.||.... ..+....+......+        ..
T Consensus       497 ~----~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~~--------p~  563 (674)
T 3pfq_A          497 V----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNVAY--------PK  563 (674)
T ss_dssp             C----CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHSSCCCC--------CT
T ss_pred             c----ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCCCCC--------Cc
Confidence            1    2345679999999999999999999999999999999999999997543 334444433322111        12


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHhhhCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSI-----KQVLRILYESS  382 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~-----~evl~~l~~~~  382 (458)
                      .++    ..+.+++.+||+.||++||++     +||++|.|+..
T Consensus       564 ~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          564 SMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             TSC----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             cCC----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            222    568899999999999999997     99999998753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=336.50  Aligned_cols=258  Identities=25%  Similarity=0.368  Sum_probs=205.8

Q ss_pred             HhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      ..+.+.+.||+|+||.||+|... +|+.||+|.+....  ....+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            34556688999999999999886 58999999986432  3457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ++|+|.+++... ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++........  
T Consensus       107 ~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--  180 (314)
T 3com_A          107 GAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--  180 (314)
T ss_dssp             TTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--
Confidence            999999998632 235899999999999999999999   89999999999999999999999999999976544321  


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......||..|+|||.+.+..++.++||||||+++|||++|+.||............ ...  .......+       
T Consensus       181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~--~~~~~~~~-------  248 (314)
T 3com_A          181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-PTN--PPPTFRKP-------  248 (314)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHS--CCCCCSSG-------
T ss_pred             --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-hcC--CCcccCCc-------
Confidence              223456899999999999999999999999999999999999999765443222211 111  10111111       


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      ......+.+++.+||+.||.+||++.+++++.|......
T Consensus       249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            111256889999999999999999999999998876543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.3e-43  Score=347.68  Aligned_cols=265  Identities=22%  Similarity=0.295  Sum_probs=196.5

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccc-----------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeec---
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS-----------EQVEGDFCREIELLARLHHRHLVALRGFCIE---  175 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  175 (458)
                      +.+.+.||+|+||.||+|...+|..||||++....           ....+.+.+|++++++++||||+++++++..   
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (362)
T 3pg1_A           24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE  103 (362)
T ss_dssp             CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred             eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence            34457999999999999998889999999885422           1123678999999999999999999999854   


Q ss_pred             --cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 012715          176 --KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF  253 (458)
Q Consensus       176 --~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  253 (458)
                        ....++||||+. |+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          104 PAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             CCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCEEEEec
Confidence              335799999997 68988887543 35999999999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-  331 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-  331 (458)
                      |+++......     ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.................. 
T Consensus       179 g~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          179 NLAREDTADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             TC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             Cccccccccc-----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9997543322     2234568999999999876 67899999999999999999999999765433322222111000 


Q ss_pred             c-----------cccccCCcCCCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          332 R-----------LAELVDPRIKDS-------FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       332 ~-----------~~~~~d~~~~~~-------~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                      .           ..+.........       ........+.+++.+||+.||.+|||+.|+++|.|+..-.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            0           000000000000       0011125688999999999999999999999999886543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-42  Score=358.53  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=202.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccch-------------hhHhHHHHHHHHHHhcCCCCeeeeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-------------QVEGDFCREIELLARLHHRHLVALRGFCIE  175 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  175 (458)
                      +.+.+.||+|+||+||+|... ++..||||.+.....             ...+.+.+|+.++++++||||+++++++.+
T Consensus        38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  117 (504)
T 3q5i_A           38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED  117 (504)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            456689999999999999876 578999999864321             234678999999999999999999999999


Q ss_pred             cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC---cEEEee
Q 012715          176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF---VAKLAD  252 (458)
Q Consensus       176 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~---~~kl~D  252 (458)
                      .+..++|||||++|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       118 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          118 KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            99999999999999999998653  34999999999999999999999   88999999999999998765   699999


Q ss_pred             cccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      ||++.......     ......||+.|+|||.+. ..++.++|||||||++|+|++|..||..... .+...........
T Consensus       193 fg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~  265 (504)
T 3q5i_A          193 FGLSSFFSKDY-----KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-QDIIKKVEKGKYY  265 (504)
T ss_dssp             CTTCEECCTTS-----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC
T ss_pred             CCCCEEcCCCC-----ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC
Confidence            99998765432     234457999999999876 5699999999999999999999999975433 2333322221111


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..    .......    ...+.+++.+||+.||.+|||++|+++|.|...
T Consensus       266 ~~----~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          266 FD----FNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             CC----HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CC----ccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            10    0000111    256889999999999999999999999998743

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-42  Score=335.80  Aligned_cols=257  Identities=23%  Similarity=0.373  Sum_probs=193.9

Q ss_pred             HhhcccceeeeecceEEEEEEEc----CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC----
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR----  177 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  177 (458)
                      ..+.+.+.||+|+||.||+|.+.    ++..||+|.+...  .....+.+.+|+.++++++||||+++++++.+.+    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            34556678999999999999764    2458999998643  3344567999999999999999999999998765    


Q ss_pred             -ceeeeeeecCCCCHHHHhcC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          178 -ERFLMYEYMANGSLKDHLHS----PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       178 -~~~lv~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                       ..++||||+++|+|.+++..    .....+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEee
Confidence             35999999999999999842    23356999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhcc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      ||+++........  .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ......... 
T Consensus       191 fg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~-  266 (313)
T 3brb_A          191 FGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-MYDYLLHGH-  266 (313)
T ss_dssp             CSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHTTC-
T ss_pred             cCcceeccccccc--CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-HHHHHHcCC-
Confidence            9999865443211  12233457889999999999999999999999999999999 778886544332 222211111 


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                            .+.....+    ...+.+++.+||+.||.+||++.+++++|...
T Consensus       267 ------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          267 ------RLKQPEDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             ------CCCCBTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  11111222    25689999999999999999999999998653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=342.44  Aligned_cols=257  Identities=24%  Similarity=0.413  Sum_probs=192.6

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHH--HHhcCCCCeeeeeeeeec-----cCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIEL--LARLHHRHLVALRGFCIE-----KRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|++ +++.||||++....   ...+..|.++  +..++|+||+++++++..     ....++|
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            34567899999999999987 78999999986433   2344445554  445899999999985542     2356899


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC---------CeEeccCCCCCeeeCCCCcEEEeec
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP---------PLCHRDIKSSNILLDENFVAKLADF  253 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~---------~iiHrDlk~~NIll~~~~~~kl~Df  253 (458)
                      |||+++|+|.+++...   ..++..++.++.|++.||+|||   +.         +|+||||||+|||++.++.+||+||
T Consensus        91 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF  164 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF  164 (336)
T ss_dssp             ECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred             EecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence            9999999999999753   3689999999999999999999   77         9999999999999999999999999


Q ss_pred             ccccccCCCCccc----ccccccccCCCcccccccccc-------CCCCcccccHhHHHHHHHHHhCCCccCCCcchH--
Q 012715          254 GLAHASKDGSICF----EPVNTDIRGTPGYMDPEYVVT-------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV--  320 (458)
Q Consensus       254 Gla~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~--  320 (458)
                      |+++.........    ........||+.|+|||.+.+       ..++.++|||||||++|||++|..|+..+....  
T Consensus       165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            9998664332110    112234569999999999976       466789999999999999999988875433211  


Q ss_pred             --------------HHHHHHHhhccccccccCCcCCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          321 --------------ESAQVCMASESRLAELVDPRIKDSF--DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       321 --------------~~~~~~~~~~~~~~~~~d~~~~~~~--~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                    ..........     ...+.+....  .......+.+++.+||+.||++|||++|+++.|...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSRE-----KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTS-----CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhhhcccCCCchHHHHHhhhccc-----ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence                          1111111111     1111111111  224566799999999999999999999999998653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.8e-43  Score=339.28  Aligned_cols=264  Identities=22%  Similarity=0.298  Sum_probs=204.6

Q ss_pred             hcccceeeeecceEEEEEEE--cCCCEEEEEEecccc--hhhHhHHHHHHHHHHhc---CCCCeeeeeeeee-----ccC
Q 012715          110 DNFSTIIGQGGFGTVYKAQF--SDGSLIAVKRMDKIS--EQVEGDFCREIELLARL---HHRHLVALRGFCI-----EKR  177 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~~  177 (458)
                      +.+.+.||+|+||.||+|..  .+|+.||+|.+....  ......+.+|+.+++.+   +||||+++++++.     ...
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   92 (326)
T 1blx_A           13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   92 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence            44567999999999999987  368899999886432  22234577888888777   8999999999987     556


Q ss_pred             ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..++||||+. |+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            7899999997 69999997655556999999999999999999999   8899999999999999999999999999997


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc----cc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES----RL  333 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~  333 (458)
                      ......     ......||..|+|||.+.+..++.++|||||||++|||++|+.||..................    ..
T Consensus       169 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          169 IYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             cccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            654321     234467899999999999999999999999999999999999999765544333222211000    00


Q ss_pred             ccc-------cCC---cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          334 AEL-------VDP---RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       334 ~~~-------~d~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ...       +..   .....+.......+.+++.+||+.||.+||++.++++|.|...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  302 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  302 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence            000       000   0000011122356889999999999999999999999988754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-42  Score=351.38  Aligned_cols=267  Identities=20%  Similarity=0.298  Sum_probs=196.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-----Cceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  181 (458)
                      +.+.+.||+|+||.||+|... +|+.||||++...  .......+.+|+++|++++|+||+++++++...     +..|+
T Consensus        28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l  107 (432)
T 3n9x_A           28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI  107 (432)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred             EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence            456789999999999999875 5889999998643  334456789999999999999999999999776     57899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+. |+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       108 v~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          108 VLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             EEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             EEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            999986 5999999764  35999999999999999999999   88999999999999999999999999999987643


Q ss_pred             CCccc------------------ccccccccCCCcccccccc-ccCCCCcccccHhHHHHHHHHHhCCCcc---------
Q 012715          262 GSICF------------------EPVNTDIRGTPGYMDPEYV-VTQELTEKSDVYSYGVVLLEIVTARRAV---------  313 (458)
Q Consensus       262 ~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tg~~p~---------  313 (458)
                      .....                  ........||+.|+|||.+ ....++.++|||||||++|||++|..|+         
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            22110                  0123567899999999986 5667999999999999999999854333         


Q ss_pred             -CCCcch-----------------HHHHHHHHhhcccc-cc------------ccC-CcCCCCCC-----HHHHHHHHHH
Q 012715          314 -QDGKNL-----------------VESAQVCMASESRL-AE------------LVD-PRIKDSFD-----MEQLRTIVTI  356 (458)
Q Consensus       314 -~~~~~~-----------------~~~~~~~~~~~~~~-~~------------~~d-~~~~~~~~-----~~~~~~l~~l  356 (458)
                       ..+.+.                 .+....+....+.. .+            .+. .......+     ......+.++
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence             222210                 11111111100000 00            000 00000000     0122568899


Q ss_pred             HHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          357 VRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       357 ~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      +.+||+.||++|||++|+++|.|...
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~  367 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKD  367 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhh
Confidence            99999999999999999999999865

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.9e-43  Score=341.59  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=201.9

Q ss_pred             HHhhcccceeeeecceEEEEEEE------cCCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCce
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER  179 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  179 (458)
                      ...+.+.+.||+|+||.||+|.+      .++..||||.+... .......+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            34456778999999999999974      25778999998643 344556799999999999999999999999999999


Q ss_pred             eeeeeecCCCCHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEe
Q 012715          180 FLMYEYMANGSLKDHLHSPGR-----TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLA  251 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~  251 (458)
                      ++||||+++|+|.+++.....     ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432     34899999999999999999999   889999999999999984   4569999


Q ss_pred             ecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhc
Q 012715          252 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASE  330 (458)
Q Consensus       252 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~  330 (458)
                      |||+++........  .......||+.|+|||.+.+..++.++||||||+++|||+| |..||..... .+........ 
T Consensus       186 Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~-  261 (327)
T 2yfx_A          186 DFGMARDIYRASYY--RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSG-  261 (327)
T ss_dssp             CCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTT-
T ss_pred             cccccccccccccc--ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-HHHHHHHhcC-
Confidence            99999754332211  12234467899999999999999999999999999999998 8888865432 2222221111 


Q ss_pred             cccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          331 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       331 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .      .+.....+    ...+.+++.+||+.||.+||++.+++++|+..
T Consensus       262 ~------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          262 G------RMDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             C------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C------CCCCCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1      01111222    25688999999999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-42  Score=336.63  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=194.2

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecc---cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .+.+.+.||+|+||.||+|... +|..||||++..   ........+.+|++++++++|+||+++++++.+.+..++|||
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            3556789999999999999874 789999999864   233445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          185 YMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       185 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |+++|+|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            9999999999863  12345899999999999999999999   889999999999999999999999999999765432


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc-hHHHHHHHHhhccccccccCCcC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-LVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ..    ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ..........  .....    ..
T Consensus       190 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~----~~  259 (310)
T 2wqm_A          190 TT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPP----LP  259 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT--TCSCC----CC
T ss_pred             Cc----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc--ccCCC----Cc
Confidence            21    12345689999999999999999999999999999999999999965432 2222222111  11111    11


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...+    ...+.+++.+||+.||.+||++.+++++|..
T Consensus       260 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~  294 (310)
T 2wqm_A          260 SDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKR  294 (310)
T ss_dssp             TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            1122    2568899999999999999999999998865

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-42  Score=333.29  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=199.9

Q ss_pred             hcccc-eeeeecceEEEEEEEc---CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFST-IIGQGGFGTVYKAQFS---DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+ .||+|+||+||+|.+.   ++..||||.+....  ....+.+.+|+++++.++||||+++++++ +.+..++||
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   96 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM   96 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence            34455 8999999999999653   46789999986432  23356799999999999999999999998 667889999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++++|.+++...  ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.......
T Consensus        97 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (291)
T 1xbb_A           97 EMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  171 (291)
T ss_dssp             ECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence            999999999999764  34899999999999999999999   8899999999999999999999999999998765433


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +....... ..      .+...
T Consensus       172 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~-~~------~~~~~  242 (291)
T 1xbb_A          172 NYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEK-GE------RMGCP  242 (291)
T ss_dssp             SEE-EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHT-TC------CCCCC
T ss_pred             Ccc-cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHHc-CC------CCCCC
Confidence            211 11233456789999999998899999999999999999999 99999754432 22222111 11      11111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..    ....+.+++.+||+.||.+||++.++++.|..
T Consensus       243 ~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          243 AG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             TT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            22    23568999999999999999999999998854

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-43  Score=340.21  Aligned_cols=257  Identities=25%  Similarity=0.425  Sum_probs=200.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeec------cCceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE------KRERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~l  181 (458)
                      +.+.+.||+|+||.||+|.+. +|+.||||.+.... .....+.+|+.++.++ +||||+++++++..      .+..++
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            345678999999999999874 68999999986433 3346789999999999 79999999999987      467899


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++|+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred             EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence            999999999999997654456999999999999999999999   88999999999999999999999999999876543


Q ss_pred             CCcccccccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      ...    ......||+.|+|||.+.     +..++.++|||||||++|||++|+.||.+............   ......
T Consensus       182 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~  254 (326)
T 2x7f_A          182 TVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPAPRL  254 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCC
T ss_pred             Ccc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc---CccccC
Confidence            211    123456899999999987     56789999999999999999999999976544322222111   111111


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPM  385 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~  385 (458)
                      .    ...+    ...+.+++.+||..||.+||++.++++|.|....+.
T Consensus       255 ~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          255 K----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             S----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             C----cccc----CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            1    1112    256889999999999999999999999998866543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.2e-42  Score=332.12  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=205.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---------hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCc
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---------EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRE  178 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  178 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+....         ....+.+.+|+++++++. ||||+++++++.+.+.
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (298)
T 1phk_A           19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   98 (298)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence            445678999999999999886 68999999986432         123456889999999996 9999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus        99 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           99 FFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            99999999999999999753  35899999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCCCccccccccc------cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVV------TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      .....     ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||...... ............
T Consensus       174 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~  247 (298)
T 1phk_A          174 LDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-LMLRMIMSGNYQ  247 (298)
T ss_dssp             CCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC
T ss_pred             cCCCc-----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-HHHHHHhcCCcc
Confidence            65432     223456899999999885      456889999999999999999999999754432 222222221111


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ..   .+.     .......+.+++.+||+.||.+||++.++++|.|...
T Consensus       248 ~~---~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (298)
T 1phk_A          248 FG---SPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  289 (298)
T ss_dssp             CC---TTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cC---ccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence            10   000     0122356899999999999999999999999988753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.9e-43  Score=352.16  Aligned_cols=261  Identities=22%  Similarity=0.339  Sum_probs=197.3

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc------eeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE------RFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~lv~  183 (458)
                      |.+.++||+|+||+||+|++.++..||+|++.....    ...+|+++++.++||||+++++++...+.      .++||
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            456789999999999999997777799998854322    22379999999999999999999965443      78999


Q ss_pred             eecCCCCHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC-CCCcEEEeecccccccCC
Q 012715          184 EYMANGSLKDHLH-SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKD  261 (458)
Q Consensus       184 e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~~  261 (458)
                      ||++++.+..... ......+++..+..++.||+.||+|||   +.+|+||||||+|||++ .++.+||+|||+++....
T Consensus       118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            9998754333321 111345999999999999999999999   89999999999999999 799999999999987644


Q ss_pred             CCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc---------
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES---------  331 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------  331 (458)
                      +.     ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+................         
T Consensus       195 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          195 GE-----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             TC-----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CC-----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            32     22345789999999998764 5899999999999999999999999765544333332211100         


Q ss_pred             --ccccccCCcCCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          332 --RLAELVDPRIKD-----SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       332 --~~~~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                        ...+..-+....     .+.......+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE  327 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence              000000011110     011112357899999999999999999999999998864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3e-43  Score=343.11  Aligned_cols=252  Identities=33%  Similarity=0.471  Sum_probs=199.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCE--EEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSL--IAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||.||+|+.. +|..  +|+|.+... .......+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  106 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE  106 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence            456789999999999999875 4554  499988642 334456789999999999 89999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEE
Q 012715          185 YMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKL  250 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl  250 (458)
                      |+++|+|.+++....              ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEE
Confidence            999999999997643              246999999999999999999999   899999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhh
Q 012715          251 ADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMAS  329 (458)
Q Consensus       251 ~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~  329 (458)
                      +|||+++.....     .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+...... .
T Consensus       184 ~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-~~~~~~~~-~  256 (327)
T 1fvr_A          184 ADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLP-Q  256 (327)
T ss_dssp             CCTTCEESSCEE-----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHGG-G
T ss_pred             cccCcCcccccc-----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-HHHHHHhh-c
Confidence            999998743221     11233457889999999998899999999999999999998 9999965432 22222111 1


Q ss_pred             ccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          330 ESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       330 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .      ........    ....+.+++.+||+.||.+||++.+++++|...
T Consensus       257 ~------~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          257 G------YRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             T------CCCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C------CCCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1      11111122    235689999999999999999999999998654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.1e-43  Score=338.04  Aligned_cols=246  Identities=28%  Similarity=0.451  Sum_probs=194.1

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-CceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK-RERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||+||+|.. +|+.||||.+....  ..+.+.+|++++++++|+||+++++++.+. +..++||||+++
T Consensus        23 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   99 (278)
T 1byg_A           23 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   99 (278)
T ss_dssp             EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             ceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence            45667899999999999987 58899999986433  346789999999999999999999997654 478999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......     
T Consensus       100 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----  171 (278)
T 1byg_A          100 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----  171 (278)
T ss_dssp             EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-----
Confidence            99999997543334889999999999999999999   8899999999999999999999999999987544321     


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                        ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +....... .      ..+.....   
T Consensus       172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~-~------~~~~~~~~---  238 (278)
T 1byg_A          172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPRVEK-G------YKMDAPDG---  238 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-GHHHHHTT-T------CCCCCCTT---
T ss_pred             --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHhc-C------CCCCCccc---
Confidence              23357889999999999999999999999999999998 99988654322 22211111 0      11112222   


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ....+.+++.+||+.||++||++.++++.|..
T Consensus       239 -~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          239 -CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence             23568999999999999999999999998864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=332.42  Aligned_cols=255  Identities=23%  Similarity=0.321  Sum_probs=201.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc----hhhHhHHHHHHHHHHhcCCCCeeeeeeeee--ccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS----EQVEGDFCREIELLARLHHRHLVALRGFCI--EKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|... ++..||+|.+....    ......+.+|++++++++|+||+++++++.  +.+..++|
T Consensus         7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV   86 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred             eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence            456679999999999999875 68899999986432    234567999999999999999999999984  45688999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||++++ |.+++.......+++..+..++.|++.||+|||   +++++||||||+|||++.++.+||+|||++......
T Consensus        87 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           87 MEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             ehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999876 777776555557999999999999999999999   889999999999999999999999999999865432


Q ss_pred             CcccccccccccCCCccccccccccCC--CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ..  ........||..|+|||.+.+..  ++.++||||||+++|||++|+.||.... ..+.........        ..
T Consensus       163 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i~~~~--------~~  231 (305)
T 2wtk_C          163 AA--DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGS--------YA  231 (305)
T ss_dssp             CS--SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCC--------CC
T ss_pred             cc--ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHHHhcCC--------CC
Confidence            11  11223456899999999987644  4789999999999999999999997543 223222222111        11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      +...++    ..+.+++.+||+.||.+||++.|+++|.|....
T Consensus       232 ~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          232 IPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             CCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             CCCccC----HHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            122222    568899999999999999999999999887543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.2e-43  Score=345.82  Aligned_cols=260  Identities=22%  Similarity=0.324  Sum_probs=186.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Ccee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  180 (458)
                      +.+.+.||+|+||.||+|... +|+.||||++...  .......+.+|+++++.++||||+++++++...      ...|
T Consensus        31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~  110 (367)
T 2fst_X           31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY  110 (367)
T ss_dssp             EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence            445678999999999999864 6899999998642  333456788999999999999999999998654      5679


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +|+||+ +++|.+++..   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       111 lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          111 LVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             EEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             EEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            999999 7899999875   35999999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      ..       .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+...................+....
T Consensus       184 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          184 DE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            32       234578999999999877 6899999999999999999999999976554333222211111100000000


Q ss_pred             -----------cC--CCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          340 -----------RI--KDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       340 -----------~~--~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                                 .+  ......     .....+.+++.+||+.||.+|||+.|+++|.|+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence                       00  000111     112568899999999999999999999999988653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.8e-43  Score=340.33  Aligned_cols=254  Identities=23%  Similarity=0.364  Sum_probs=194.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCE----EEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSL----IAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.+.||+|+||+||+|.+. ++..    ||+|.+... .......+.+|+.++++++||||+++++++.... .++|+
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~   95 (327)
T 3lzb_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT   95 (327)
T ss_dssp             EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred             ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence            445678999999999999874 4443    577776532 3345568999999999999999999999998754 78999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      +|+.+|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        96 ~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           96 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             CCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred             EecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence            9999999999997643 35999999999999999999999   8899999999999999999999999999998664332


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ..  .......+|..|+|||.+.+..++.++|||||||++|||++ |..||...... +....... ...      ....
T Consensus       172 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~-~~~------~~~~  241 (327)
T 3lzb_A          172 KE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEK-GER------LPQP  241 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHT-TCC------CCCC
T ss_pred             cc--ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHc-CCC------CCCC
Confidence            11  12233457889999999999999999999999999999999 99998654332 22222111 110      1111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .    .....+.+++.+||+.||.+||++.|+++.|....
T Consensus       242 ~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          242 P----ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             T----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1    12346889999999999999999999999987643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.1e-43  Score=339.87  Aligned_cols=266  Identities=24%  Similarity=0.387  Sum_probs=188.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++||||+++++++...+..++||||++
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   96 (303)
T 2vwi_A           17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS   96 (303)
T ss_dssp             CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred             hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence            445678999999999999764 68999999886432 3345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          188 NGSLKDHLHS------PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       188 ~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      +++|.+++..      .....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  173 (303)
T 2vwi_A           97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT  173 (303)
T ss_dssp             TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred             CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence            9999999863      12345899999999999999999999   88999999999999999999999999999976543


Q ss_pred             CCcc-cccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc-ccC
Q 012715          262 GSIC-FEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE-LVD  338 (458)
Q Consensus       262 ~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~d  338 (458)
                      .... .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...................... ..+
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (303)
T 2vwi_A          174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD  253 (303)
T ss_dssp             --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC----
T ss_pred             CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccccc
Confidence            2211 1112234568999999999876 568999999999999999999999997654433322221111111110 111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      +.....++    ..+.+++.+||+.||.+||++.++++|.|+..
T Consensus       254 ~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  293 (303)
T 2vwi_A          254 KEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRHKFFQK  293 (303)
T ss_dssp             -CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred             chhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence            22222233    46889999999999999999999999987754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.1e-42  Score=341.09  Aligned_cols=265  Identities=21%  Similarity=0.305  Sum_probs=203.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-----Cceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|... ++..||||++.... ......+.+|++++.+++||||+++++++...     ...++|
T Consensus        29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv  108 (364)
T 3qyz_A           29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV  108 (364)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence            455679999999999999875 68899999986433 33446789999999999999999999998765     368999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+. |+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       109 ~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          109 QDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             EECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            99997 5999999753   4999999999999999999999   899999999999999999999999999999865432


Q ss_pred             CcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC---
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD---  338 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d---  338 (458)
                      ... ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....................+...   
T Consensus       182 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          182 HDH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GCB-CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCc-cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            211 112244579999999998754 458999999999999999999999997655443332221111110000000   


Q ss_pred             ----------CcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 ----------PRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 ----------~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                .......+.     .....+.+++.+||+.||.+|||+.|+++|.|...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  319 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  319 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence                      000000110     11256889999999999999999999999998764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-43  Score=353.40  Aligned_cols=241  Identities=17%  Similarity=0.164  Sum_probs=188.0

Q ss_pred             cccceeeeecceEEEEEEE-cCCCEEEEEEecc---cchhhHhHHHHHHH---HHHhcCCCCeeeee-------eeeecc
Q 012715          111 NFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIE---LLARLHHRHLVALR-------GFCIEK  176 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~~~~~  176 (458)
                      .+.+.||+|+||+||+|.+ .+|+.||||.+..   ......+.+.+|++   ++++++||||++++       +++.+.
T Consensus        76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~  155 (377)
T 3byv_A           76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  155 (377)
T ss_dssp             EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred             EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence            3457899999999999986 4699999999863   23345577899994   55555799999998       555544


Q ss_pred             C-----------------ceeeeeeecCCCCHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecc
Q 012715          177 R-----------------ERFLMYEYMANGSLKDHLHSPGR-----TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD  234 (458)
Q Consensus       177 ~-----------------~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrD  234 (458)
                      +                 ..|+||||+ +|+|.+++...+.     ..+++..++.++.||+.||+|||   +.+|+|||
T Consensus       156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrD  231 (377)
T 3byv_A          156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTY  231 (377)
T ss_dssp             TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred             CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            3                 278999999 6899999974321     12445888899999999999999   88999999


Q ss_pred             CCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccC-----------CCCcccccHhHHHHH
Q 012715          235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-----------ELTEKSDVYSYGVVL  303 (458)
Q Consensus       235 lk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvws~Gv~l  303 (458)
                      |||+|||++.++.+||+|||+++....       ......| +.|+|||.+.+.           .++.++|||||||++
T Consensus       232 ikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          232 LRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            999999999999999999999986432       1234567 999999999887           899999999999999


Q ss_pred             HHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          304 LEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       304 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      |||++|+.||.......           ........  ...++    ..+.+++.+||+.||++||++.|+++|.|+
T Consensus       304 ~elltg~~Pf~~~~~~~-----------~~~~~~~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  363 (377)
T 3byv_A          304 YWIWCADLPITKDAALG-----------GSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEY  363 (377)
T ss_dssp             HHHHHSSCCC------C-----------CSGGGGSS--CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred             HHHHHCCCCCccccccc-----------chhhhhhh--ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence            99999999996432110           01111110  11222    568899999999999999999999998875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-42  Score=333.09  Aligned_cols=254  Identities=21%  Similarity=0.326  Sum_probs=188.6

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-h-hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-E-QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      .+.+.+.||+|+||+||+|... +|+.||||++.... . .....+.++...++.++||||+++++++.+.+..++||||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~   87 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL   87 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence            3456679999999999999874 78999999986432 2 2223344555567788999999999999999999999999


Q ss_pred             cCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          186 MANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       186 ~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      ++ |+|.+++..  .....+++..+..++.|++.||+|||   ++ +++||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence            97 588887753  12346999999999999999999999   76 9999999999999999999999999999765443


Q ss_pred             CcccccccccccCCCcccccccc----ccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYV----VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD  338 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d  338 (458)
                      .     ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||.................  ....  
T Consensus       164 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~--  234 (290)
T 3fme_A          164 V-----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP--SPQL--  234 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC--CCCC--
T ss_pred             c-----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC--CCCc--
Confidence            2     12334689999999996    566789999999999999999999999976443333322222111  1111  


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                        ....+    ...+.+++.+||+.||++|||+.|+++|.|+.
T Consensus       235 --~~~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~  271 (290)
T 3fme_A          235 --PADKF----SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT  271 (290)
T ss_dssp             --CTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             --ccccC----CHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence              01122    25688999999999999999999999998874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-42  Score=332.66  Aligned_cols=259  Identities=27%  Similarity=0.394  Sum_probs=197.7

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeec------------
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE------------  175 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------------  175 (458)
                      .+.+.+.||+|+||.||+|... +|+.||||.+... ......+.+|++++++++||||+++++++.+            
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            3556789999999999999875 7899999998643 3445678999999999999999999998865            


Q ss_pred             -cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 012715          176 -KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFG  254 (458)
Q Consensus       176 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  254 (458)
                       .+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence             456799999999999999997533 35788999999999999999999   8899999999999999999999999999


Q ss_pred             cccccCCCCcc----------cccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHH
Q 012715          255 LAHASKDGSIC----------FEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA  323 (458)
Q Consensus       255 la~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~  323 (458)
                      ++.........          .........||..|+|||.+.+. .++.++|||||||++|||++   |+..+.+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            99865432100          01122345689999999999764 78999999999999999998   554333322222


Q ss_pred             HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .......        ..+...++......+.+++.+||+.||.+|||+.++++|.|....
T Consensus       239 ~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          239 KKLRSVS--------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHSTT--------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             Hhccccc--------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            2222111        111222333334568899999999999999999999999987543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.2e-42  Score=343.07  Aligned_cols=258  Identities=21%  Similarity=0.321  Sum_probs=199.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCce------e
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRER------F  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------~  180 (458)
                      +.+.+.||+|+||+||+|... +|+.||||++...  .......+.+|+.+++.++||||+++++++...+..      +
T Consensus        44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  123 (371)
T 4exu_A           44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  123 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred             EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence            445678999999999999875 6899999998643  333456789999999999999999999999877654      9


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+. ++|.+++..    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       124 lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          124 LVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             EEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             EEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence            9999997 699998843    3999999999999999999999   8899999999999999999999999999997654


Q ss_pred             CCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC-
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD-  338 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d-  338 (458)
                      ..       .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....................+... 
T Consensus       196 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          196 AE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            32       234568999999999887 789999999999999999999999997654433332221111110000000 


Q ss_pred             --------------CcCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 --------------PRIKDSF---DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 --------------~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                    ......+   .......+.+++.+||+.||++|||+.|+++|.|+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  329 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  329 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence                          0000000   0011356899999999999999999999999998754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.6e-43  Score=341.33  Aligned_cols=254  Identities=26%  Similarity=0.358  Sum_probs=184.4

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeee--------ccCc
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCI--------EKRE  178 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~~  178 (458)
                      .+.+.+.||+|+||.||+|.+. +|+.||||++..........+.+|+.++.++. ||||+++++++.        ....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            3456789999999999999875 68999999987666666678999999999996 999999999984        3345


Q ss_pred             eeeeeeecCCCCHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeccCCCCCeeeCCCCcEEEeeccc
Q 012715          179 RFLMYEYMANGSLKDHLHS-PGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLDENFVAKLADFGL  255 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlk~~NIll~~~~~~kl~DfGl  255 (458)
                      .++||||+. |+|.+++.. .....+++..++.++.||+.||+|||   +.+  |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            799999996 799998864 12335999999999999999999999   888  99999999999999999999999999


Q ss_pred             ccccCCCCccc--------ccccccccCCCcccccccc---ccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHH
Q 012715          256 AHASKDGSICF--------EPVNTDIRGTPGYMDPEYV---VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ  324 (458)
Q Consensus       256 a~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~  324 (458)
                      ++.........        ........||+.|+|||.+   .+..++.++|||||||++|||++|+.||.+...... ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~  263 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-VN  263 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-hc
Confidence            98665432110        0011234589999999998   567789999999999999999999999965432211 00


Q ss_pred             HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          325 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       325 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                          ..      .........    ...+.+++.+||+.||.+||++.|++++|+..
T Consensus       264 ----~~------~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          264 ----GK------YSIPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             ------------CCCCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----Cc------ccCCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                00      000001111    13478899999999999999999999999764

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.7e-43  Score=351.16  Aligned_cols=255  Identities=9%  Similarity=-0.013  Sum_probs=182.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhc--CCCCeeeee-------eeeecc
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARL--HHRHLVALR-------GFCIEK  176 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~~  176 (458)
                      +.+.+.||+|+||.||+|.+. +|+.||||++....   ....+.+.+|++++..+  +||||++++       +++...
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            345678999999999999875 78999999987533   23445678886655555  599988755       333322


Q ss_pred             -----------------CceeeeeeecCCCCHHHHhcCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCCeEec
Q 012715          177 -----------------RERFLMYEYMANGSLKDHLHSPGRTPLSWQTR------IQIAIDVANALEYLHFYCDPPLCHR  233 (458)
Q Consensus       177 -----------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~~LH~~~~~~iiHr  233 (458)
                                       ...|+||||++ |+|.+++...+. .+.+..+      +.++.||+.||+|||   +++|+||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHr  218 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHG  218 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccC
Confidence                             33799999998 899999975322 2455566      788899999999999   8999999


Q ss_pred             cCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCC
Q 012715          234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARR  311 (458)
Q Consensus       234 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~  311 (458)
                      ||||+|||++.++.+||+|||+++.....       .....+|+.|+|||.+.+  ..++.++|||||||++|||++|+.
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999865432       113457799999999987  789999999999999999999999


Q ss_pred             ccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          312 AVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       312 p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ||.........    ..........................+.+++.+||+.||++||++.++++|.|+
T Consensus       292 Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          292 PFGLVTPGIKG----SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             STTBCCTTCTT----CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             CCCCcCccccc----chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            99754221000    000000000000111111111223578999999999999999999999998876

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.3e-42  Score=341.09  Aligned_cols=266  Identities=20%  Similarity=0.271  Sum_probs=190.8

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc-------ee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE-------RF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------~~  180 (458)
                      .+.+.+.||+|+||+||+|... +|..||||++.... .....+.+|++.+..++||||+++++++...+.       .+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  102 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN  102 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence            3445689999999999999885 68999999885432 233467788999999999999999999976443       78


Q ss_pred             eeeeecCCCCHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeeccccc
Q 012715          181 LMYEYMANGSLKDHLHS--PGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAH  257 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~  257 (458)
                      +||||+++ +|...+..  .....+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.+||+|||+++
T Consensus       103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            99999986 55544431  1234589999999999999999999943 679999999999999996 8999999999998


Q ss_pred             ccCCCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc-
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE-  335 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-  335 (458)
                      ......     ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....................+ 
T Consensus       181 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          181 KLSPSE-----PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             CCCTTS-----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ecCCCC-----CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            765433     22345689999999998664 48999999999999999999999997655443332222111100000 


Q ss_pred             --ccCCc----------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          336 --LVDPR----------------IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       336 --~~d~~----------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                        ..++.                ............+.+++.+||+.||.+|||+.|+++|.|+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  320 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE  320 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence              00000                000111123467999999999999999999999999998754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=342.84  Aligned_cols=247  Identities=16%  Similarity=0.182  Sum_probs=196.9

Q ss_pred             hhcccceeeeecceEEEEEE------EcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccCce
Q 012715          109 TDNFSTIIGQGGFGTVYKAQ------FSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRER  179 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~  179 (458)
                      .+.+.+.||+|+||+||+|.      ..+++.||||.+....   ..++.+|++++..++   |+||+++++++...+..
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            34556789999999999993      3468999999986543   446788899988887   99999999999999999


Q ss_pred             eeeeeecCCCCHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-----------C
Q 012715          180 FLMYEYMANGSLKDHLHSP---GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----------N  245 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-----------~  245 (458)
                      ++||||+++|+|.+++...   ....+++..++.++.||+.||+|||   +.+|+||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccccccc
Confidence            9999999999999999631   2346999999999999999999999   899999999999999998           8


Q ss_pred             CcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHH
Q 012715          246 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV  325 (458)
Q Consensus       246 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~  325 (458)
                      +.+||+|||+++.......  ........||+.|+|||++.+..++.++|||||||++|||+||+.||......      
T Consensus       220 ~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------  291 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG------  291 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT------
T ss_pred             CCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC------
Confidence            9999999999975431110  11234567999999999999999999999999999999999999998532210      


Q ss_pred             HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhhh
Q 012715          326 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQAR-PSIKQVLRILYE  380 (458)
Q Consensus       326 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-Ps~~evl~~l~~  380 (458)
                          ...    ....++...   ....+.+++..|++.+|.+| |+++++.+.|..
T Consensus       292 ----~~~----~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          292 ----ECK----PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             ----EEE----ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             ----cee----echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                001    111111111   13467889999999999999 567777776654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-42  Score=336.57  Aligned_cols=256  Identities=22%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecc--cchhhHhHHHHHHHHHHhcC--CCCeeeeeeeeeccCceeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDK--ISEQVEGDFCREIELLARLH--HRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .+.+.+.||+|+||.||+|...+++.||||.+..  ........+.+|++++.+++  |+||+++++++.+.+..++|||
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e  108 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  108 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence            3456679999999999999988899999999853  23445577999999999997  5999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                       +.+++|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++ +.+||+|||+++.......
T Consensus       109 -~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~  181 (313)
T 3cek_A          109 -CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT  181 (313)
T ss_dssp             -CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred             -cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence             56889999997643  5899999999999999999999   889999999999999964 8999999999986543321


Q ss_pred             ccccccccccCCCcccccccccc-----------CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVT-----------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL  333 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  333 (458)
                      .  .......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||...............     
T Consensus       182 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-----  254 (313)
T 3cek_A          182 S--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----  254 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-----
T ss_pred             c--ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh-----
Confidence            1  11234568999999999875           46888999999999999999999999765443332222211     


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          334 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       334 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                           +.....++......+.+++.+||+.||.+||++.|++++.|....
T Consensus       255 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          255 -----PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             -----TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             -----cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence                 111111111112568899999999999999999999999987654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1e-41  Score=327.04  Aligned_cols=258  Identities=19%  Similarity=0.278  Sum_probs=198.5

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeee-eccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC-IEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||.||+|.. .+|+.||||.+.....  ...+.+|++++..++|+|++..++++ .+.+..++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            44567899999999999987 4789999998764332  34688999999999988766666655 5567789999999 


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC---CCCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~~~  264 (458)
                      +++|.+++.... ..+++..++.++.|++.||+|||   +++|+||||||+|||++   .++.+||+|||+++.......
T Consensus        88 ~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           88 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            899999997432 35999999999999999999999   89999999999999994   788999999999987654332


Q ss_pred             ccc---cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch--HHHHHHHHhhccccccccCC
Q 012715          265 CFE---PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESRLAELVDP  339 (458)
Q Consensus       265 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~d~  339 (458)
                      ...   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......  .+.............   .+
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~  240 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---IE  240 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---HH
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---hH
Confidence            110   1124567999999999999999999999999999999999999999753211  111111111000000   00


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+...++    ..+.+++.+||+.||.+||++.++++.|...
T Consensus       241 ~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          241 VLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             HHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            0111222    5688999999999999999999999988653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.2e-42  Score=337.41  Aligned_cols=260  Identities=20%  Similarity=0.273  Sum_probs=204.0

Q ss_pred             hhcccceeeeecceEEEEEEEc-CC-CEEEEEEecccchhhHhHHHHHHHHHHhcCCCC------eeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DG-SLIAVKRMDKISEQVEGDFCREIELLARLHHRH------LVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||+||+|... ++ ..||+|.+... ....+.+.+|++++++++|+|      ++.+++++...+..+
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            4556789999999999999875 34 68999998643 334567889999999997665      899999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee------------------
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL------------------  242 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll------------------  242 (458)
                      +||||+ +++|.+++.......+++..+..++.||+.||+|||   +.+|+||||||+|||+                  
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccccc
Confidence            999999 678888876655556999999999999999999999   9999999999999999                  


Q ss_pred             -CCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHH
Q 012715          243 -DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE  321 (458)
Q Consensus       243 -~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~  321 (458)
                       +.++.+||+|||+++.....       .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEH-------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccCCCcEEEeecCcccccccc-------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence             56789999999999864432       2345799999999999999999999999999999999999999976544322


Q ss_pred             HHHHHHhhcccccc-c----------cCCc---------------------CCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 012715          322 SAQVCMASESRLAE-L----------VDPR---------------------IKDSFDMEQLRTIVTIVRWCTQREGQARP  369 (458)
Q Consensus       322 ~~~~~~~~~~~~~~-~----------~d~~---------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RP  369 (458)
                      ....... .+..+. +          ....                     .....+......+.+++.+||+.||++||
T Consensus       248 ~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          248 LVMMEKI-LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHH-HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHH-cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            2211111 111000 0          0000                     00011223456789999999999999999


Q ss_pred             CHHHHHHHhhhC
Q 012715          370 SIKQVLRILYES  381 (458)
Q Consensus       370 s~~evl~~l~~~  381 (458)
                      |+.|+++|.|+.
T Consensus       327 t~~e~l~hp~f~  338 (355)
T 2eu9_A          327 TLAEALLHPFFA  338 (355)
T ss_dssp             CHHHHTTSGGGG
T ss_pred             CHHHHhcChhhc
Confidence            999999988764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-42  Score=350.34  Aligned_cols=256  Identities=23%  Similarity=0.288  Sum_probs=191.9

Q ss_pred             cceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          113 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      .++||+|+||+||.+...+|+.||||++...   ..+.+.+|++++.++ +||||+++++++.+.+..++|||||. |+|
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL   95 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL   95 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence            4689999999998776668999999988542   234678999999987 89999999999999999999999995 699


Q ss_pred             HHHhcCCCCCC-----CCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC-------------CcEEEeec
Q 012715          192 KDHLHSPGRTP-----LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-------------FVAKLADF  253 (458)
Q Consensus       192 ~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~-------------~~~kl~Df  253 (458)
                      .+++.......     .++..++.++.||+.||+|||   +.+|+||||||+|||++.+             +.+||+||
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             HHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            99997643211     133456789999999999999   8899999999999999654             48999999


Q ss_pred             ccccccCCCCcccccccccccCCCcccccccccc-------CCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHH
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-------QELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQV  325 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~  325 (458)
                      |+++.................||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.+......   .
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~  249 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES---N  249 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH---H
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH---H
Confidence            9998765543221112334579999999999865       678999999999999999999 8889865432211   1


Q ss_pred             HHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          326 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       326 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ........     +......+......+.+++.+||+.||.+||++.++++|.|+...
T Consensus       250 i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          250 IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             HHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             HhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            11111111     111222244566789999999999999999999999999988643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.3e-42  Score=327.18  Aligned_cols=259  Identities=19%  Similarity=0.270  Sum_probs=198.2

Q ss_pred             hhcccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeee-eccCceeeeeeec
Q 012715          109 TDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC-IEKRERFLMYEYM  186 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~  186 (458)
                      .+.+.+.||+|+||.||+|.. .+++.||||.+....  ....+.+|++++..++|+|++..++++ .+.+..++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            355678999999999999987 478999999865332  224688999999999988777766665 5667789999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee---CCCCcEEEeecccccccCCCC
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~  263 (458)
                       +++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++......
T Consensus        88 -~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           88 -GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             -CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             -CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence             999999997432 35999999999999999999999   8899999999999999   788999999999998765432


Q ss_pred             ccc---ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch--HHHHHHHHhhccccccccC
Q 012715          264 ICF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESRLAELVD  338 (458)
Q Consensus       264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~d  338 (458)
                      ...   ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......  ...............   .
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~  239 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---I  239 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---H
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---h
Confidence            211   01223567999999999999999999999999999999999999999753221  111111110000000   0


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       339 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      +.+...++    ..+.+++..||+.||++||++.++++.|...
T Consensus       240 ~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          240 EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            00111122    5689999999999999999999999988653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.5e-42  Score=341.39  Aligned_cols=262  Identities=19%  Similarity=0.242  Sum_probs=204.3

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-----------CCCeeeeeeeeecc
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-----------HRHLVALRGFCIEK  176 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~  176 (458)
                      .+.+.+.||+|+||+||+|... +++.||||.+... ......+.+|++++++++           |+||+++++++...
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            4566789999999999999874 6899999998643 334467889999999886           89999999998865


Q ss_pred             C----ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeccCCCCCeeeC------CC
Q 012715          177 R----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLD------EN  245 (458)
Q Consensus       177 ~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlk~~NIll~------~~  245 (458)
                      +    ..++||||+ +++|.+++.......+++..+..++.||+.||+|||   ++ +|+||||||+|||++      ..
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCc
Confidence            4    789999999 899999998655556999999999999999999999   77 999999999999994      44


Q ss_pred             CcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcc-----hH
Q 012715          246 FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN-----LV  320 (458)
Q Consensus       246 ~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~-----~~  320 (458)
                      +.+||+|||+++.....       .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ..
T Consensus       175 ~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             EEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             ceEEEcccccccccCCC-------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            58999999999765432       2345689999999999999999999999999999999999999974321     11


Q ss_pred             HHHHHHHhhcccccc-----------ccCC-------------------cCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 012715          321 ESAQVCMASESRLAE-----------LVDP-------------------RIKDSFDMEQLRTIVTIVRWCTQREGQARPS  370 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~-----------~~d~-------------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs  370 (458)
                      ..........+.++.           .++.                   .-...++......+.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            111111111111000           0000                   0011244566788999999999999999999


Q ss_pred             HHHHHHHhhhCC
Q 012715          371 IKQVLRILYESS  382 (458)
Q Consensus       371 ~~evl~~l~~~~  382 (458)
                      +.|+++|.|+..
T Consensus       328 ~~ell~hp~f~~  339 (373)
T 1q8y_A          328 AGGLVNHPWLKD  339 (373)
T ss_dssp             HHHHHTCGGGTT
T ss_pred             HHHHhhChhhhc
Confidence            999999998764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=332.19  Aligned_cols=265  Identities=22%  Similarity=0.296  Sum_probs=197.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeee--------------
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI--------------  174 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------------  174 (458)
                      +...+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++||||+++++++.              
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   92 (320)
T 2i6l_A           13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT   92 (320)
T ss_dssp             EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred             eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence            345678999999999999886 48999999987666666778999999999999999999999874              


Q ss_pred             ccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC-CCCcEEEeec
Q 012715          175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADF  253 (458)
Q Consensus       175 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~-~~~~~kl~Df  253 (458)
                      +.+..++||||++ |+|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++ +++.+||+||
T Consensus        93 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           93 ELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             SCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence            3467899999997 699999965   35899999999999999999999   88999999999999997 5779999999


Q ss_pred             ccccccCCCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      |+++........ ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus       166 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~  243 (320)
T 2i6l_A          166 GLARIMDPHYSH-KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-QLILESIPV  243 (320)
T ss_dssp             TTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHSCC
T ss_pred             ccccccCCCccc-ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCC
Confidence            999865432111 112234467999999998865 67899999999999999999999999765543222 221111100


Q ss_pred             c-----ccc-------cCCcCC-CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          333 L-----AEL-------VDPRIK-DSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       333 ~-----~~~-------~d~~~~-~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      .     .++       +..... ...+     ......+.+++.+||+.||++||++.|+++|.|....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            0     000       000000 0000     0123568999999999999999999999999987643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-41  Score=325.26  Aligned_cols=257  Identities=24%  Similarity=0.332  Sum_probs=205.5

Q ss_pred             HHHHHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCcee
Q 012715          104 ETKKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       104 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  180 (458)
                      ......+.+.+.||+|+||.||+|... +++.||+|.+....  ......+.+|++++++++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            444556777889999999999999886 68999999986432  234567899999999999999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC---CcEEEeeccccc
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN---FVAKLADFGLAH  257 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla~  257 (458)
                      +||||+++++|.+++....  .+++..++.++.|++.||+|||   +.+++||||||+||+++.+   +.+||+|||++.
T Consensus        98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999999886533  4899999999999999999999   8899999999999999754   479999999998


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ......     ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... +............    
T Consensus       173 ~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~----  241 (287)
T 2wei_A          173 CFQQNT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKYAF----  241 (287)
T ss_dssp             TBCCCS-----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCC----
T ss_pred             eecCCC-----ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCCCCC----
Confidence            654432     1223458899999998865 4899999999999999999999999754332 2222222111110    


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +......+    ...+.+++.+||+.||++|||+.+++++.|.
T Consensus       242 ~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~hp~~  280 (287)
T 2wei_A          242 DLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEHPWI  280 (287)
T ss_dssp             CSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred             Cchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcCHHH
Confidence            00001122    2568899999999999999999999998865

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.6e-41  Score=334.18  Aligned_cols=264  Identities=20%  Similarity=0.302  Sum_probs=201.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-----Cceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  182 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+... .......+.+|++++++++||||+++++++...     ...++|
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   92 (353)
T 2b9h_A           13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII   92 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred             eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence            345678999999999999876 6899999998643 233456788999999999999999999988764     678999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+. |+|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        93 ~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           93 QELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             ECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            99997 699999875   35999999999999999999999   889999999999999999999999999999866432


Q ss_pred             Ccccc------cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc-
Q 012715          263 SICFE------PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-  334 (458)
Q Consensus       263 ~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-  334 (458)
                      .....      .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............. ...+... 
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~  244 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF-GIIGTPHS  244 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HHHCCCCS
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-HHhCCCch
Confidence            21100      11233578999999998764 778999999999999999999999997654332222211 1100000 


Q ss_pred             -------------cccC--CcCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          335 -------------ELVD--PRIKDSFD-----MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       335 -------------~~~d--~~~~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                   +...  +... ...     ......+.+++.+||+.||++|||+.|+++|.|...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYP-AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCC-CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccccccccchhhHHhhcccCCC-CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                         0000  0000 000     012356889999999999999999999999998764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=336.84  Aligned_cols=257  Identities=20%  Similarity=0.309  Sum_probs=198.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc------ee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE------RF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~  180 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+...  .......+.+|+.+++.++||||+++++++...+.      .+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  105 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  105 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence            445678999999999999875 6899999998643  33345678999999999999999999999987654      49


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+. |+|.+++..    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       106 lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          106 LVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             EEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             EEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            9999997 588888743    4899999999999999999999   8899999999999999999999999999997643


Q ss_pred             CCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc-------
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-------  332 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------  332 (458)
                      ..       .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...................       
T Consensus       178 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          178 AE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             CC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            32       234568999999999877 678999999999999999999999997654332222211110000       


Q ss_pred             ------------cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          333 ------------LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       333 ------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                  +.....+.+. .........+.+++.+||+.||++||++.++++|.|+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  311 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP  311 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                        0000000000 011122357899999999999999999999999998754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-42  Score=331.48  Aligned_cols=257  Identities=23%  Similarity=0.361  Sum_probs=195.4

Q ss_pred             hhcccceeeeecceEEEEEEEc--CCC--EEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS--DGS--LIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||+||+|.+.  ++.  .||||.+...   .....+.+.+|++++++++||||+++++++.+.+ .++
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   97 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM   97 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence            3456788999999999999864  233  6899988643   2344567999999999999999999999988765 889


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      ||||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        98 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999997532 34899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ..... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+...........      ..
T Consensus       174 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~------~~  245 (291)
T 1u46_A          174 NDDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGER------LP  245 (291)
T ss_dssp             -CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTSCCC------CC
T ss_pred             cccch-hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-HHHHHHHHccCCC------CC
Confidence            33211 12233457889999999999899999999999999999999 9999865433 2222222211111      11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ....    ....+.+++.+||+.||.+||++.+++++|.+..
T Consensus       246 ~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          246 RPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            1112    2356899999999999999999999999997654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.8e-42  Score=350.08  Aligned_cols=258  Identities=21%  Similarity=0.304  Sum_probs=201.1

Q ss_pred             hcccceeeeecceEEEEEEE-cCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC-CCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.++||+|+||.||+|.+ .+++.||||.+.....  ..++.+|++++..++| +++..+..++.+.+..+|||||+ 
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            44567899999999999987 4689999998754322  3468899999999986 66667777777888899999999 


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee---CCCCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL---DENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      +++|.+++.... ..+++..++.|+.||+.||+|||   +++|+||||||+||||   +.++.+||+|||+++.......
T Consensus        86 g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           86 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            999999997433 35999999999999999999999   8899999999999999   5889999999999987654332


Q ss_pred             cc---ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch--HHHHHHHHhhccccccccCC
Q 012715          265 CF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESRLAELVDP  339 (458)
Q Consensus       265 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~d~  339 (458)
                      ..   ........||..|+|||.+.+..++.++|||||||+||||++|+.||......  .+.......  ..+..... 
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~--~~~~~~~~-  238 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--KKVATSIE-  238 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH--HHHHSCHH-
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh--ccccccHH-
Confidence            11   01223567999999999999999999999999999999999999999754331  111111111  01110000 


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+...+    +..+.+++..||+.+|++||++.+|++.|...
T Consensus       239 ~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          239 ALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            011122    25689999999999999999999999987654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.9e-42  Score=335.38  Aligned_cols=247  Identities=20%  Similarity=0.299  Sum_probs=173.7

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHH-HHHHhcCCCCeeeeeeeeec----cCceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREI-ELLARLHHRHLVALRGFCIE----KRERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~  187 (458)
                      ++||+|+||+||+|... +|+.||||++....     ...+|+ ..+..++|+||+++++++..    +...++||||++
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            46999999999999886 68999999986422     122333 34566789999999999876    455899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~~  264 (458)
                      +|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++...... 
T Consensus       110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-  185 (336)
T 3fhr_A          110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-  185 (336)
T ss_dssp             TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence            999999998776667999999999999999999999   889999999999999976   4569999999998654322 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHH---HHHHHhhccccccccCCcC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES---AQVCMASESRLAELVDPRI  341 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~d~~~  341 (458)
                           .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.........   ..........   . ....
T Consensus       186 -----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~-~~~~  256 (336)
T 3fhr_A          186 -----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG---F-PNPE  256 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C---C-CTTT
T ss_pred             -----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc---c-Cchh
Confidence                 23456899999999999999999999999999999999999999643321110   0000000000   0 0001


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ...    ....+.+++.+||+.||.+|||+.|+++|.|...
T Consensus       257 ~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          257 WSE----VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             STT----CCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hcc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            112    2356889999999999999999999999998754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.7e-42  Score=334.59  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=178.7

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHH-HHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIE-LLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+.+.||+|+||.||+|... +|+.||||.+... .......+..|+. +++.++||||+++++++.+.+..++||||++
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~  104 (327)
T 3aln_A           25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS  104 (327)
T ss_dssp             EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence            34578999999999999885 6899999998653 2333445666666 6667799999999999999999999999998


Q ss_pred             CCCHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          188 NGSLKDHLHS---PGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       188 ~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      + +|.+++..   .....+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  180 (327)
T 3aln_A          105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI  180 (327)
T ss_dssp             E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred             C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence            5 88877752   22346899999999999999999999   77 99999999999999999999999999998654332


Q ss_pred             cccccccccccCCCcccccccc----ccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYV----VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                           ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||.......+....       ......+
T Consensus       181 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------~~~~~~~  248 (327)
T 3aln_A          181 -----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ-------VVKGDPP  248 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC-------CCCSCCC
T ss_pred             -----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH-------HhcCCCC
Confidence                 12334689999999998    4567899999999999999999999999754322111110       0000111


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .+...........+.+++.+||+.||++||++.+++++.|..
T Consensus       249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            111111112235689999999999999999999999988764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.8e-41  Score=357.92  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=200.4

Q ss_pred             HhhcccceeeeecceEEEEEEEcC----CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      ..+.+.+.||+|+||.||+|.+..    +..||||.+... .....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            445567889999999999998742    457999988643 3344567999999999999999999999985 4678999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||+++|+|.+++.... ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       469 ~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999997543 35899999999999999999999   889999999999999999999999999999876543


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ...   ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+.... +........ ..      ...
T Consensus       545 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~~~~~i~~~-~~------~~~  613 (656)
T 2j0j_A          545 TYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG-ER------LPM  613 (656)
T ss_dssp             ------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHHT-CC------CCC
T ss_pred             cce---eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcC-CC------CCC
Confidence            211   1233457889999999999999999999999999999997 88888654432 222222111 11      111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...+    +..+.+++.+||+.||++||++.++++.|..
T Consensus       614 ~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          614 PPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Cccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2222    3568899999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=331.87  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=195.4

Q ss_pred             HHHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccch------hhHhHHHHHHHHHHhc----CCCCeeeeeeeee
Q 012715          106 KKATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARL----HHRHLVALRGFCI  174 (458)
Q Consensus       106 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~~~~  174 (458)
                      ....+.+.+.||+|+||.||+|... +|+.||||.+.....      .....+.+|+.++.++    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            3445667789999999999999874 688999999864322      1234567899999999    8999999999999


Q ss_pred             ccCceeeeeee-cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC-CCCcEEEee
Q 012715          175 EKRERFLMYEY-MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLAD  252 (458)
Q Consensus       175 ~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~-~~~~~kl~D  252 (458)
                      +.+..++|||| +.+++|.+++...+  .+++..++.++.|++.||+|||   +.+|+||||||+||+++ .++.+||+|
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEE
Confidence            99999999999 78999999997633  5899999999999999999999   88999999999999999 899999999


Q ss_pred             cccccccCCCCcccccccccccCCCccccccccccCCCC-cccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT-EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      ||+++......      .....||..|+|||.+.+..+. .++||||||+++|||++|+.||......       .... 
T Consensus       184 fg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~-  249 (312)
T 2iwi_A          184 FGSGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------LEAE-  249 (312)
T ss_dssp             CSSCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHTC-
T ss_pred             cchhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-------hhhc-
Confidence            99998765432      2345689999999999877664 5899999999999999999999642211       1111 


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                             ..+....+    ..+.+++.+||+.||++||++.|++++.|....
T Consensus       250 -------~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          250 -------LHFPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             -------CCCCTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             -------cCCcccCC----HHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence                   11112222    468899999999999999999999999887543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=330.35  Aligned_cols=256  Identities=21%  Similarity=0.317  Sum_probs=195.6

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||.||+|.+.+  .||+|.+...  .....+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            4456789999999999998753  4999988642  22334567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc-c
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC-F  266 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~  266 (458)
                      +++|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||++ ++.+||+|||+++........ .
T Consensus       113 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~  187 (319)
T 2y4i_B          113 GRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR  187 (319)
T ss_dssp             SEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence            999999997643 35899999999999999999999   88999999999999998 679999999998754321111 1


Q ss_pred             ccccccccCCCcccccccccc---------CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVT---------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ........||+.|+|||.+..         ..++.++||||||+++|||++|+.||...... .........  ......
T Consensus       188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~--~~~~~~  264 (319)
T 2y4i_B          188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-AIIWQMGTG--MKPNLS  264 (319)
T ss_dssp             CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-HHHHHHHTT--CCCCCC
T ss_pred             ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhccC--CCCCCC
Confidence            112234568999999999864         45788999999999999999999999754432 222211111  111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ..    .++    ..+.+++.+||..||.+||++.++++.|.....
T Consensus       265 ~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          265 QI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             CS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             cC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            11    111    358899999999999999999999999976543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.6e-42  Score=334.57  Aligned_cols=245  Identities=23%  Similarity=0.356  Sum_probs=201.1

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccch------hhHhHHHHHHHHHHhcC--CCCeeeeeeeeeccCce
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLH--HRHLVALRGFCIEKRER  179 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~  179 (458)
                      .+.+.+.||+|+||.||+|... +|+.||||.+.....      .....+.+|+.++++++  |+||+++++++.+.+..
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~  123 (320)
T 3a99_A           44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF  123 (320)
T ss_dssp             TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence            3556789999999999999864 689999999864321      12245778999999996  59999999999999999


Q ss_pred             eeeeeecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC-CCCcEEEeeccccc
Q 012715          180 FLMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAH  257 (458)
Q Consensus       180 ~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGla~  257 (458)
                      ++|||++.+ ++|.+++...  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++ +++.+||+|||+++
T Consensus       124 ~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          124 VLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             EEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            999999986 8999999753  35899999999999999999999   89999999999999999 78999999999998


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL  336 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  336 (458)
                      ......      .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......       ....      
T Consensus       199 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~------  259 (320)
T 3a99_A          199 LLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQ------  259 (320)
T ss_dssp             ECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHCC------
T ss_pred             cccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------hccc------
Confidence            765432      234569999999999987766 68899999999999999999999643211       1110      


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       337 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                        ......++    ..+.+++.+||+.||++||++++++++.|....
T Consensus       260 --~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  300 (320)
T 3a99_A          260 --VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  300 (320)
T ss_dssp             --CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             --ccccccCC----HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence              01112222    468899999999999999999999999987654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=327.04  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=182.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccch--hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE--QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +.+.+.||+|+||.||+|... +|+.||||.+.....  .....+.++..+++.++||||+++++++.+.+..++||||+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~  106 (318)
T 2dyl_A           27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM  106 (318)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence            345678999999999999886 689999999864322  22233445556778889999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP-PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                       ++.+..+.... ...+++..+..++.|++.||+|||   +. +++||||||+|||++.++.+||+|||++.......  
T Consensus       107 -~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (318)
T 2dyl_A          107 -GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--  179 (318)
T ss_dssp             -SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             -CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--
Confidence             55665555432 235899999999999999999999   74 99999999999999999999999999997654332  


Q ss_pred             cccccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          266 FEPVNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                         ......||+.|+|||.+.     ...++.++||||||+++|||++|+.||.......+...........  ..  + 
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~--~-  251 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP--LL--P-  251 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC--CC--C-
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC--CC--C-
Confidence               123456899999999984     5678899999999999999999999997654443333332222111  00  0 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....++    ..+.+++.+||+.||.+||++.++++|.|..
T Consensus       252 ~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          252 GHMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             SSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             ccCCCC----HHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence            001122    4688999999999999999999999988753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=340.00  Aligned_cols=254  Identities=22%  Similarity=0.292  Sum_probs=189.5

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +...++||+|+||+||.....+|+.||||++....   ...+.+|+++|+++ +||||+++++++.+.+..|+|||||. 
T Consensus        26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            34457899999999766555689999999986432   23466899999999 79999999999999999999999996 


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-----CCcEEEeecccccccCCCC
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-----~~~~kl~DfGla~~~~~~~  263 (458)
                      |+|.+++..... .+.+..++.++.||+.||+|||   +.+|+||||||+|||++.     ...+||+|||+++......
T Consensus       102 g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          102 ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            599999976543 3555567899999999999999   889999999999999953     3368899999998765432


Q ss_pred             cccccccccccCCCccccccccc---cCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVV---TQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      ... .......||+.|+|||.+.   ...++.++|||||||++|||++ |..||......  ...... ...... .   
T Consensus       178 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~~~~~~-~~~~~~-~---  249 (432)
T 3p23_A          178 HSF-SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANILL-GACSLD-C---  249 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--HHHHHT-TCCCCT-T---
T ss_pred             cce-eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--HHHHHh-ccCCcc-c---
Confidence            111 1234467999999999997   4667889999999999999999 88888543221  111111 111100 0   


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       .  .........+.+++.+||+.||.+||++.++++|.|+..
T Consensus       250 -~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          250 -L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             -S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             -c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence             0  011233456789999999999999999999999998754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.8e-41  Score=354.56  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=203.9

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec------cCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIE------KRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~  180 (458)
                      .+.+.+.||+|+||+||+|... +|..||||.+... .....+.+.+|++++++++||||+++++++..      ++..+
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            3556789999999999999874 6899999988643 34445679999999999999999999998765      67789


Q ss_pred             eeeeecCCCCHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCc---EEEeecccc
Q 012715          181 LMYEYMANGSLKDHLHSPG-RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFV---AKLADFGLA  256 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGla  256 (458)
                      +||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||++
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            9999999999999997643 235899999999999999999999   889999999999999987664   999999999


Q ss_pred             cccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc---cc
Q 012715          257 HASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES---RL  333 (458)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~  333 (458)
                      .......     ......||..|+|||.+.+..++.++|||||||++|||++|..||........+.........   ..
T Consensus       172 ~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          172 KELDQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CBTTSCC-----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccc-----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            8765443     224467999999999999999999999999999999999999999765433322111000000   00


Q ss_pred             ccccCC--------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          334 AELVDP--------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       334 ~~~~d~--------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+....        .............+.+++.+||..||++||++.++++|.|+
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F  301 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF  301 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTH
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHH
Confidence            000000        01122334456789999999999999999999998776653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-39  Score=311.85  Aligned_cols=226  Identities=20%  Similarity=0.322  Sum_probs=179.5

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHH-HhcCCCCeeeeeeeeec----cCceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELL-ARLHHRHLVALRGFCIE----KRERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~  187 (458)
                      +.||+|+||.||+|... +++.||+|.+..     ...+.+|++++ +.++||||+++++++..    ....++||||++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            67999999999999874 689999999864     23567899988 55589999999999877    678899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~~  264 (458)
                      +|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||++....    
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----  171 (299)
T 3m2w_A           99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----  171 (299)
T ss_dssp             SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence            999999998766567999999999999999999999   899999999999999998   7899999999986432    


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                                            +..++.++|||||||++|||++|+.||.........       ...........  ..
T Consensus       172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~~~~~~~~--~~  220 (299)
T 3m2w_A          172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRIRMGQ--YE  220 (299)
T ss_dssp             ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCCSSCTTC--CS
T ss_pred             ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHHHHHhhcc--cc
Confidence                                  234678999999999999999999999653321100       00000000000  01


Q ss_pred             CCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          345 FDM----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       345 ~~~----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      ++.    .....+.+++.+||+.||.+||++.|+++|.|...
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence            111    12357899999999999999999999999998754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.7e-39  Score=344.28  Aligned_cols=234  Identities=23%  Similarity=0.328  Sum_probs=187.4

Q ss_pred             HhhcccceeeeecceEEEEEEEc--CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCc-----e
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS--DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRE-----R  179 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  179 (458)
                      ..+.+.+.||+|+||.||+|.+.  +|+.||||.+... .......+.+|++++.+++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            34566789999999999999885  5899999988643 33445678999999999999999999999988766     7


Q ss_pred             eeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccccc
Q 012715          180 FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       180 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      ||||||++|++|.+++..    .+++..++.++.||+.||+|||   +++|+||||||+|||++.+ .+||+|||+++..
T Consensus       160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            999999999999998754    5999999999999999999999   8899999999999999886 8999999999865


Q ss_pred             CCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC
Q 012715          260 KDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP  339 (458)
Q Consensus       260 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~  339 (458)
                      ...        ....||+.|+|||.+.+.. +.++|||||||++|||++|..|+.....               ..+   
T Consensus       232 ~~~--------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------------~~~---  284 (681)
T 2pzi_A          232 NSF--------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------------DGL---  284 (681)
T ss_dssp             TCC--------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------------SSC---
T ss_pred             ccC--------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------------ccc---
Confidence            432        3456999999999887654 8899999999999999999888753110               000   


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI  377 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~  377 (458)
                       ............+.+++.+||+.||.+||+..+.+.+
T Consensus       285 -~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  321 (681)
T 2pzi_A          285 -PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA  321 (681)
T ss_dssp             -CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence             0000011223568899999999999999975555443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-39  Score=326.39  Aligned_cols=240  Identities=18%  Similarity=0.168  Sum_probs=180.5

Q ss_pred             ccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCC-CCeeeee----------------
Q 012715          112 FSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHH-RHLVALR----------------  170 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~----------------  170 (458)
                      +.++||+|+||+||+|.+. +|+.||||++....   ....+.+.+|+.++..++| +|...+.                
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence            3568999999999999864 69999999987322   2235679999999999987 3221111                


Q ss_pred             -----eeeec-----cCceeeeeeecCCCCHHHHhc-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccC
Q 012715          171 -----GFCIE-----KRERFLMYEYMANGSLKDHLH-----SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI  235 (458)
Q Consensus       171 -----~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDl  235 (458)
                           .++..     ....+++|+++ +++|.+++.     ......+++..++.++.|++.||+|||   +++|+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDi  237 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYL  237 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCc
Confidence                 11111     12356677755 689999984     223345888899999999999999999   899999999


Q ss_pred             CCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCcccccccc----------ccCCCCcccccHhHHHHHHH
Q 012715          236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV----------VTQELTEKSDVYSYGVVLLE  305 (458)
Q Consensus       236 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvws~Gv~l~e  305 (458)
                      ||+|||++.++.+||+|||+++.....       .....| +.|+|||.+          .+..++.++|||||||++||
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            999999999999999999998765432       234567 999999999          55668899999999999999


Q ss_pred             HHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          306 IVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       306 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      |++|+.||.......           .....+..  ...++    ..+.+++.+||+.||++||++.+++++.|+
T Consensus       310 lltg~~Pf~~~~~~~-----------~~~~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~  367 (413)
T 3dzo_A          310 IWCADLPNTDDAALG-----------GSEWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEY  367 (413)
T ss_dssp             HHHSSCCCCTTGGGS-----------CSGGGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             HHHCCCCCCCcchhh-----------hHHHHHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence            999999996543210           01111110  11222    568999999999999999999999987765

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-38  Score=304.72  Aligned_cols=225  Identities=14%  Similarity=0.107  Sum_probs=178.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      |.+.+.||+|+||.||+|... +|+.||||.+....   ....+.+.+|+.++.+++|+||+++++++.+.+..|+||||
T Consensus        33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  112 (286)
T 3uqc_A           33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence            556679999999999999886 48999999986432   33346799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      ++|++|.+++...    ....++.+++.|++.||+|||   +++|+||||||+|||++.+|.+||+++|           
T Consensus       113 ~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          113 IRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             CCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             cCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            9999999999642    455678999999999999999   8999999999999999999999998554           


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC--C
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK--D  343 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~--~  343 (458)
                                   |++       .++.++|||||||++|||+||+.||..........        ...........  .
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~  226 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------PAERDTAGQPIEPA  226 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------ECCBCTTSCBCCHH
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------HHHHHhccCCCChh
Confidence                         333       26889999999999999999999997543211000        00000000000  0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .........+.+++.+||+.||++| |+.|+++.|...
T Consensus       227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            0001123568999999999999999 999999999764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.4e-39  Score=315.69  Aligned_cols=247  Identities=16%  Similarity=0.147  Sum_probs=185.9

Q ss_pred             HhhcccceeeeecceEEEEEEEcCCCEEEEEEecccc--------hhhHhHHHHHHHHHHhcC---------CCCeeeee
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--------EQVEGDFCREIELLARLH---------HRHLVALR  170 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l~  170 (458)
                      ..+.+.+.||+|+||+||+|+. +|+.||||++....        ....+.+.+|+.+++.++         |+||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            3456678999999999999988 78999999986432        223367899999999986         66666666


Q ss_pred             eee-----------------ec-------------cCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 012715          171 GFC-----------------IE-------------KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE  220 (458)
Q Consensus       171 ~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~  220 (458)
                      +.+                 .+             .+..|+||||+++|++.+.+..   ..+++..+..++.||+.||+
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHH
Confidence            553                 32             6789999999999987777643   35899999999999999999


Q ss_pred             HHhhcCCCCeEeccCCCCCeeeCCCC--------------------cEEEeecccccccCCCCcccccccccccCCCccc
Q 012715          221 YLHFYCDPPLCHRDIKSSNILLDENF--------------------VAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM  280 (458)
Q Consensus       221 ~LH~~~~~~iiHrDlk~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~  280 (458)
                      |||+  +++|+||||||+|||++.++                    .+||+|||+|+.....         ...||+.|+
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt~~y~  244 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFCDVSM  244 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECCCCTT
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEeeccc
Confidence            9992  36899999999999999887                    9999999999865432         246999999


Q ss_pred             cccccccCCCCcccccHhHHHH-HHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHH
Q 012715          281 DPEYVVTQELTEKSDVYSYGVV-LLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRW  359 (458)
Q Consensus       281 aPE~~~~~~~~~~~Dvws~Gv~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~  359 (458)
                      |||.+.+.. +.++||||||++ .+++++|..||.+.............. ..    ................+.+++.+
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~s~~~~dli~~  318 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ-MT----FKTKCNTPAMKQIKRKIQEFHRT  318 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT-CC----CSSCCCSHHHHHHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh-hc----cCcccchhhhhhcCHHHHHHHHH
Confidence            999998766 889999998777 778888998884311101111111100 00    00111111123456789999999


Q ss_pred             ccccCCCCCCCHHHHH-HHhhh
Q 012715          360 CTQREGQARPSIKQVL-RILYE  380 (458)
Q Consensus       360 cl~~dp~~RPs~~evl-~~l~~  380 (458)
                      ||+.|     |++|++ +|.|+
T Consensus       319 ~L~~d-----sa~e~l~~Hp~f  335 (336)
T 2vuw_A          319 MLNFS-----SATDLLCQHSLF  335 (336)
T ss_dssp             GGGSS-----SHHHHHHHCGGG
T ss_pred             HhccC-----CHHHHHhcCCCc
Confidence            99976     999999 99875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=6.8e-33  Score=288.60  Aligned_cols=185  Identities=16%  Similarity=0.100  Sum_probs=130.9

Q ss_pred             eeeeecceEEEEEE-EcCCCEEEEEEeccc----------chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeee
Q 012715          115 IIGQGGFGTVYKAQ-FSDGSLIAVKRMDKI----------SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  182 (458)
                      ..+.|+.|.+..++ +-.|+.||+|.+...          .+...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            46778888777664 335899999998532          123345799999999999 699999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      |||++|++|.++|...+  +++..   +|+.||+.||+|+|   ++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999998754  46554   58899999999999   999999999999999999999999999999876543


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCc
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRA  312 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p  312 (458)
                      ..    .....+||+.|||||.+.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~~----~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CS----WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -C----CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Cc----cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            21    2344679999999998875 467789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=4.5e-29  Score=258.35  Aligned_cols=185  Identities=19%  Similarity=0.208  Sum_probs=146.7

Q ss_pred             cceeeeecceEEEEEEEcCCCEEEEEEecccc--------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          113 STIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       113 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .++||+|+||.||+|.. .+..+++|+.....        ....+.+.+|++++++++||||+++..++...+..|||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            35899999999999955 67889999764211        1123458999999999999999977777778888899999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      |+++++|.+++..          +..++.|++.||+|||   +++|+||||||+|||++.  .+||+|||+++.......
T Consensus       420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            9999999999975          4689999999999999   899999999999999998  999999999987754321


Q ss_pred             ccc---cccccccCCCcccccccccc--CCCCcccccHhHHHHHHHHHhCCCcc
Q 012715          265 CFE---PVNTDIRGTPGYMDPEYVVT--QELTEKSDVYSYGVVLLEIVTARRAV  313 (458)
Q Consensus       265 ~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~p~  313 (458)
                      ...   .......||+.|||||++..  ..|+...|+|+..+-..+-+.++.+|
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            100   01235679999999999987  67888999999999888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.2e-25  Score=213.73  Aligned_cols=153  Identities=13%  Similarity=0.099  Sum_probs=121.7

Q ss_pred             ccceeeeecceEEEEEEEcCCCEEEEEEecccch------------------hhHhHHHHHHHHHHhcCCCCeeeeeeee
Q 012715          112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISE------------------QVEGDFCREIELLARLHHRHLVALRGFC  173 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~~  173 (458)
                      +.+.||+|+||.||+|.+.+|+.||||.+.....                  .....+.+|++++++++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            3478999999999999987799999999853221                  13456899999999999  5 6666654


Q ss_pred             eccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 012715          174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF  253 (458)
Q Consensus       174 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  253 (458)
                      . .+..++||||++||+|.+ +..        .....++.|++.||+|||   +.+|+||||||+|||++ ++.+||+||
T Consensus       171 ~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          171 A-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             E-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred             e-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence            3 456799999999999998 532        234579999999999999   89999999999999999 999999999


Q ss_pred             ccccccCCCCcccccccccccCCCcccccccccc----------CCCCcccccHh
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVT----------QELTEKSDVYS  298 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws  298 (458)
                      |+++.                 +..|+|||++..          ..|...+|+|.
T Consensus       237 G~a~~-----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          237 PQSVE-----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             TTCEE-----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCCeE-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99863                 345788998753          34455556654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=9.8e-21  Score=177.62  Aligned_cols=136  Identities=21%  Similarity=0.195  Sum_probs=105.8

Q ss_pred             cccceeeeecceEEEEEEE-cCCCE--EEEEEecccch------------------------hhHhHHHHHHHHHHhcCC
Q 012715          111 NFSTIIGQGGFGTVYKAQF-SDGSL--IAVKRMDKISE------------------------QVEGDFCREIELLARLHH  163 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~h  163 (458)
                      .+.+.||+|+||.||+|.. .+|+.  ||||.+.....                        .....+.+|+.+|.+++|
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            3557899999999999988 68888  99998643211                        111357899999999988


Q ss_pred             CCe--eeeeeeeeccCceeeeeeecCC-C----CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCC
Q 012715          164 RHL--VALRGFCIEKRERFLMYEYMAN-G----SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIK  236 (458)
Q Consensus       164 ~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk  236 (458)
                      +|+  ..++++    +..+|||||+.+ |    +|.++...     .++..+..++.|++.||.|||.  ..+|+|||||
T Consensus       130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            764  334432    467899999942 4    78777542     2345678999999999999994  4689999999


Q ss_pred             CCCeeeCCCCcEEEeeccccccc
Q 012715          237 SSNILLDENFVAKLADFGLAHAS  259 (458)
Q Consensus       237 ~~NIll~~~~~~kl~DfGla~~~  259 (458)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.4e-18  Score=169.85  Aligned_cols=138  Identities=13%  Similarity=0.141  Sum_probs=98.0

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccc--------------hhhHhHH--------HHHHHHHHhcCCCCee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS--------------EQVEGDF--------CREIELLARLHHRHLV  167 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~--------~~E~~~l~~l~h~niv  167 (458)
                      +.+...||.|+||.||+|...+|+.||||.++...              ......+        ..|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            45667899999999999998899999999864210              0001112        3455566666444332


Q ss_pred             eeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-
Q 012715          168 ALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-  246 (458)
Q Consensus       168 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-  246 (458)
                      ...-+  .....+|||||++|++|..+...        .....++.|++.+|.|||   ..|||||||||.|||+++++ 
T Consensus       177 vp~p~--~~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 VPEPI--AQSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CCCEE--EEETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred             CCeee--eccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence            11111  11234799999999988765432        234578899999999999   88999999999999998776 


Q ss_pred             ---------cEEEeecccccccC
Q 012715          247 ---------VAKLADFGLAHASK  260 (458)
Q Consensus       247 ---------~~kl~DfGla~~~~  260 (458)
                               .+.|+||+-+....
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccccceEEEEeCCcccCC
Confidence                     38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=5.3e-13  Score=124.92  Aligned_cols=138  Identities=17%  Similarity=0.108  Sum_probs=109.0

Q ss_pred             ccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          112 FSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      +...+|.|+.+.||++.. ++..+++|............+.+|+++++.+. +.++.++++++.+.+..|+||||++|.+
T Consensus        18 ~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             eEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence            456788888999999975 47899999876432223346889999999995 6778899999988889999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC--------------------------------------------  226 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------------------  226 (458)
                      |.+.+..       ......++.+++++|+.||...                                            
T Consensus        97 l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (263)
T 3tm0_A           97 CSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE  169 (263)
T ss_dssp             HHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred             hhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence            9887421       1234578889999999999610                                            


Q ss_pred             ------------CCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          227 ------------DPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       227 ------------~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                                  ...++|+|+++.||++++++.+.|+||+.+.
T Consensus       170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                        1458999999999999877667899998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=4.3e-12  Score=118.16  Aligned_cols=128  Identities=17%  Similarity=0.129  Sum_probs=97.8

Q ss_pred             eeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCC--eeeeeeeeeccCceeeeeeecCCCCHHHH
Q 012715          117 GQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH--LVALRGFCIEKRERFLMYEYMANGSLKDH  194 (458)
Q Consensus       117 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~  194 (458)
                      +.|..+.||++...+|..+++|.....   ....+.+|+.+++.+.+.+  +.++++++..++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            355569999998777888999986543   2356789999999996544  556888888888899999999998884  


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------------
Q 012715          195 LHSPGRTPLSWQTRIQIAIDVANALEYLHFYC------------------------------------------------  226 (458)
Q Consensus       195 l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------------  226 (458)
                      ...     .+   ...++.+++..|..||...                                                
T Consensus       104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence            221     12   2367788888888888431                                                


Q ss_pred             -------CCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          227 -------DPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       227 -------~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                             ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                   1129999999999999887777899999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=5.3e-11  Score=116.64  Aligned_cols=140  Identities=15%  Similarity=0.209  Sum_probs=105.5

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEec--ccc-hhhHhHHHHHHHHHHhcC--CCCeeeeeeeeecc---Cceeeeeee
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMD--KIS-EQVEGDFCREIELLARLH--HRHLVALRGFCIEK---RERFLMYEY  185 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~  185 (458)
                      +.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +.++.++++++.+.   +..|+||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            46899999999999875 4678888764  221 122356889999999997  45688899988776   458999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC---------------------------------------  226 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~---------------------------------------  226 (458)
                      ++|..+.+..    ...++...+..++.+++..|+.||...                                       
T Consensus       123 v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          123 VSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             cCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            9998775422    123778888899999999999999621                                       


Q ss_pred             ----------------CCCeEeccCCCCCeeeCCCCc--EEEeecccccc
Q 012715          227 ----------------DPPLCHRDIKSSNILLDENFV--AKLADFGLAHA  258 (458)
Q Consensus       227 ----------------~~~iiHrDlk~~NIll~~~~~--~kl~DfGla~~  258 (458)
                                      ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            257999999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=3.7e-10  Score=107.97  Aligned_cols=187  Identities=22%  Similarity=0.225  Sum_probs=121.1

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCC--eeeeeeeeeccC---ceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRH--LVALRGFCIEKR---ERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~  187 (458)
                      +.++.|....||+..    ..+++|.....  .....+.+|+++|+.+. +..  +.+++.++...+   ..|+||++++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            358999999999863    45788875432  33467889999999984 332  445555544433   3488999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC-----------------------------------------  226 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----------------------------------------  226 (458)
                      |.+|.+...    ..++..++..++.+++..|+.||...                                         
T Consensus       100 G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A          100 GVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            988875432    13677778888888998888888511                                         


Q ss_pred             --------------CCCeEeccCCCCCeeeCC--CCcEEEeecccccccCCCCcccccccccc--cC---------CCcc
Q 012715          227 --------------DPPLCHRDIKSSNILLDE--NFVAKLADFGLAHASKDGSICFEPVNTDI--RG---------TPGY  279 (458)
Q Consensus       227 --------------~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~~--~g---------t~~y  279 (458)
                                    ...++|+|+++.||++++  +..+.|+||+.+..... ...........  .+         ..+.
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                          135899999999999998  56788999998864321 11100000000  00         0001


Q ss_pred             cc-ccccccCCCCcccccHhHHHHHHHHHhCCCcc
Q 012715          280 MD-PEYVVTQELTEKSDVYSYGVVLLEIVTARRAV  313 (458)
Q Consensus       280 ~a-PE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~  313 (458)
                      .. |+....  .....+.|++|.++|++.+|..++
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11 111111  112258999999999999998766

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.62  E-value=2.2e-07  Score=86.71  Aligned_cols=134  Identities=20%  Similarity=0.201  Sum_probs=97.4

Q ss_pred             eeeeecce-EEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          115 IIGQGGFG-TVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       115 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      .+..|..| .||+.... ++..+.+|+-..   .....+.+|..+|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 68987665 456788886532   23456889999999885 44467888999998999999999999888


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 012715          192 KDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC---------------------------------------------  226 (458)
Q Consensus       192 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~---------------------------------------------  226 (458)
                      .+....      .......++.+++..|+-||...                                             
T Consensus       108 ~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            776532      11233456667777777777321                                             


Q ss_pred             ----------CCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          227 ----------DPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       227 ----------~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                                ...++|+|+.+.||++++++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      1137999999999999988777899999764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=2.8e-07  Score=87.98  Aligned_cols=135  Identities=19%  Similarity=0.205  Sum_probs=95.6

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCC---Ceeeeeeeee-ccCceeeeeeecCCC
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHR---HLVALRGFCI-EKRERFLMYEYMANG  189 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g  189 (458)
                      +.++.|....||+.    |..+++|...  .......+.+|+++|..+.+.   .+.+++.++. ..+..++||||++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            35788888999987    5667888743  223346788999999999752   3566777764 455678999999998


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY--------------------------------------------  225 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~--------------------------------------------  225 (458)
                      +|.+..-.    .++......++.+++..|+.||..                                            
T Consensus        99 ~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           99 ILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             ECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             ECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            88763221    144555566666666666666632                                            


Q ss_pred             -------------CCCCeEeccCCCCCeeeCC---CCc-EEEeecccccc
Q 012715          226 -------------CDPPLCHRDIKSSNILLDE---NFV-AKLADFGLAHA  258 (458)
Q Consensus       226 -------------~~~~iiHrDlk~~NIll~~---~~~-~kl~DfGla~~  258 (458)
                                   ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1335799999999999987   355 58999997753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.48  E-value=2.6e-07  Score=90.09  Aligned_cols=79  Identities=6%  Similarity=-0.021  Sum_probs=55.6

Q ss_pred             cee-eeecceEEEEEEEc-------CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcC-C--CCeeeeeeeeecc---
Q 012715          114 TII-GQGGFGTVYKAQFS-------DGSLIAVKRMDKIS---EQVEGDFCREIELLARLH-H--RHLVALRGFCIEK---  176 (458)
Q Consensus       114 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  176 (458)
                      +.| +.|....+|+....       ++..+++|......   ......+.+|+.+++.+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            356 78888999998764       26678888754322   111246788999999885 3  3577888887665   


Q ss_pred             CceeeeeeecCCCCHH
Q 012715          177 RERFLMYEYMANGSLK  192 (458)
Q Consensus       177 ~~~~lv~e~~~~gsL~  192 (458)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.25  E-value=4.7e-06  Score=82.39  Aligned_cols=74  Identities=14%  Similarity=0.084  Sum_probs=49.2

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccch-------hhHhHHHHHHHHHHhcCC--CC-eeeeeeeeeccCceeee
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-------QVEGDFCREIELLARLHH--RH-LVALRGFCIEKRERFLM  182 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~lv  182 (458)
                      +.||.|.++.||++... ++..++||.......       .....+..|.++|+.+..  +. +.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            46899999999999754 468899997542111       123456789999998842  33 3455544  34556899


Q ss_pred             eeecCCC
Q 012715          183 YEYMANG  189 (458)
Q Consensus       183 ~e~~~~g  189 (458)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.14  E-value=1e-05  Score=77.82  Aligned_cols=138  Identities=19%  Similarity=0.264  Sum_probs=79.1

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC--CCCeeeeee------eeeccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH--HRHLVALRG------FCIEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~~  186 (458)
                      .|+.|..+.||+....+| .+++|+....    ...+..|+.++..|.  .-.+.+++.      +....+..++||+|+
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            466678899999987554 5889987642    123445666666553  123344443      122456678999999


Q ss_pred             CCCCHH--------------HHhcC----CC-C-------CCCCHHHHH-------------------------------
Q 012715          187 ANGSLK--------------DHLHS----PG-R-------TPLSWQTRI-------------------------------  209 (458)
Q Consensus       187 ~~gsL~--------------~~l~~----~~-~-------~~l~~~~~~-------------------------------  209 (458)
                      +|..+.              ..++.    .. .       ..-.|....                               
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542              11111    10 0       011232110                               


Q ss_pred             HHHHHHHHHHHHHhh----------cCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          210 QIAIDVANALEYLHF----------YCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       210 ~i~~~ia~gL~~LH~----------~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      .+...+..++++|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            111123345566652          125789999999999999888899999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=2.2e-05  Score=74.73  Aligned_cols=136  Identities=16%  Similarity=0.192  Sum_probs=90.9

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC---CCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH---HRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      +.|+.|....+|+... ++..+++|.....   ....+..|+..|+.|.   ...+.++++++...+..++||||+++..
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            3589999999999876 5678888876432   2456889999999884   3678889998888888999999999876


Q ss_pred             HH--------H---HhcCCCC-C-------------------CCCHHHHH---HHHH----------------HHHHH-H
Q 012715          191 LK--------D---HLHSPGR-T-------------------PLSWQTRI---QIAI----------------DVANA-L  219 (458)
Q Consensus       191 L~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~~----------------~ia~g-L  219 (458)
                      +.        .   .|+.... .                   .-+|....   ++..                .+..- .
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            42        1   1222111 0                   01454322   1111                11111 1


Q ss_pred             HHHhh-cCCCCeEeccCCCCCeeeCCCCcEEEeecc
Q 012715          220 EYLHF-YCDPPLCHRDIKSSNILLDENFVAKLADFG  254 (458)
Q Consensus       220 ~~LH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DfG  254 (458)
                      ..|.. .....++|+|+.+.|++++.++ +.|.||+
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            23321 2256799999999999999887 8899984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.01  E-value=2.4e-05  Score=73.63  Aligned_cols=74  Identities=20%  Similarity=0.283  Sum_probs=54.9

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC---CCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH---RHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      +.+|.|..+.||+..+.||+.|.+|+...........|..|+..|+.|.-   --+.+++++.    ..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            46899999999999999999999997654333334568899999999852   2344555542    3478999998765


Q ss_pred             H
Q 012715          191 L  191 (458)
Q Consensus       191 L  191 (458)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.88  E-value=5.4e-05  Score=75.32  Aligned_cols=79  Identities=10%  Similarity=0.080  Sum_probs=47.3

Q ss_pred             CCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccC---CCCcccccHhHHHHH
Q 012715          227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVL  303 (458)
Q Consensus       227 ~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l  303 (458)
                      ...++|+|+++.|||++.++ ++|+||+.+...... ........  .-...|.+|+.....   .-....++......+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLG--NLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHH--HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHH--HHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            67899999999999998876 999999988643210 00000000  001345666544311   112234556777788


Q ss_pred             HHHHhC
Q 012715          304 LEIVTA  309 (458)
Q Consensus       304 ~el~tg  309 (458)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            887765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.66  E-value=0.00019  Score=68.89  Aligned_cols=139  Identities=13%  Similarity=0.105  Sum_probs=73.1

Q ss_pred             eeeeecceE-EEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC--CCeeeeeeeeeccCceeeeeeecCCCCH
Q 012715          115 IIGQGGFGT-VYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       115 ~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      .|+.|+... +|+....+|..+++|......   ...+..|+.++..+..  -.+.+++.+..+.+  +++||++.+..+
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l   99 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF   99 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence            355554444 667765446777777543221   1345567777777742  33556776643333  789999977666


Q ss_pred             HHHhcC---------------------CCC---CCCCHHHHH-------HH-------------HHHHHHHHHHHh---h
Q 012715          192 KDHLHS---------------------PGR---TPLSWQTRI-------QI-------------AIDVANALEYLH---F  224 (458)
Q Consensus       192 ~~~l~~---------------------~~~---~~l~~~~~~-------~i-------------~~~ia~gL~~LH---~  224 (458)
                      .+++..                     ...   ..++.....       .+             ...+...++.+.   .
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~  179 (333)
T 3csv_A          100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL  179 (333)
T ss_dssp             HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence            544321                     100   012211110       00             001111222221   1


Q ss_pred             cCCCCeEeccCCCCCeeeCCC----CcEEEeecccccc
Q 012715          225 YCDPPLCHRDIKSSNILLDEN----FVAKLADFGLAHA  258 (458)
Q Consensus       225 ~~~~~iiHrDlk~~NIll~~~----~~~kl~DfGla~~  258 (458)
                      .....++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            125679999999999999874    6899999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.53  E-value=0.00031  Score=66.41  Aligned_cols=70  Identities=10%  Similarity=0.017  Sum_probs=44.1

Q ss_pred             ceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCe-eeeeeeeeccCceeeeeeec-CCCCH
Q 012715          114 TIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYM-ANGSL  191 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL  191 (458)
                      +.|+.|....+|+.     ..+++|........ .....+|+.+++.+...++ .++++++  .+.-++++||+ +|.+|
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            46888999999998     45778876532211 1234578888888753233 4555543  33457899999 65444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.52  E-value=0.00063  Score=64.71  Aligned_cols=140  Identities=14%  Similarity=0.147  Sum_probs=78.7

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCC--eeeeeee------eeccCceeeeeeec
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRH--LVALRGF------CIEKRERFLMYEYM  186 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~  186 (458)
                      .|+.|....+|+....+| .+++|.....  .....+..|+.++..+...+  +.+++..      ....+..+++|+|+
T Consensus        29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            467788899999987655 6778877542  12235667888888874222  3333321      11235578999999


Q ss_pred             CCCCHHH--------------Hhc----CCCCC---CC---CHHHHHH------------HHHHHHHHHHHHhhc----C
Q 012715          187 ANGSLKD--------------HLH----SPGRT---PL---SWQTRIQ------------IAIDVANALEYLHFY----C  226 (458)
Q Consensus       187 ~~gsL~~--------------~l~----~~~~~---~l---~~~~~~~------------i~~~ia~gL~~LH~~----~  226 (458)
                      +|..+..              .++    .....   ..   .|.....            +...+...+++++..    .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            8865310              011    10100   01   1222110            001134445555421    1


Q ss_pred             CCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          227 DPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       227 ~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..+++|+|+++.|||+++++.+.|+||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3579999999999999987667899998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.45  E-value=0.00021  Score=71.21  Aligned_cols=72  Identities=19%  Similarity=0.255  Sum_probs=49.1

Q ss_pred             ceeeeecceEEEEEEEcC--------CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCe-eeeeeeeeccCceeeeee
Q 012715          114 TIIGQGGFGTVYKAQFSD--------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYE  184 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  184 (458)
                      +.|+.|....||++...+        +..+++|+....  .....+.+|+.++..+...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            357888899999998753        478888877431  111456689999998853333 566766543    38999


Q ss_pred             ecCCCCH
Q 012715          185 YMANGSL  191 (458)
Q Consensus       185 ~~~~gsL  191 (458)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.33  E-value=0.00075  Score=67.67  Aligned_cols=73  Identities=15%  Similarity=0.108  Sum_probs=47.2

Q ss_pred             ceeeeecceEEEEEEEcC-CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCe-eeeeeeeeccCceeeeeeecCCCCH
Q 012715          114 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYEYMANGSL  191 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL  191 (458)
                      +.|+.|-...+|+....+ +..+++|+....... ..+..+|..++..|...++ .++++++.  +  .+||||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            358888889999998764 477888876432211 1123589999999975445 46777663  2  359999987444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.30  E-value=0.0022  Score=61.07  Aligned_cols=139  Identities=14%  Similarity=0.105  Sum_probs=80.0

Q ss_pred             eeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC--CCeeeeeee-----eeccCceeeeeeecC
Q 012715          115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH--RHLVALRGF-----CIEKRERFLMYEYMA  187 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~-----~~~~~~~~lv~e~~~  187 (458)
                      .|+ |....||+....+|+.+++|...... .....+..|..++..+..  -.+.+++..     ....+..++||+|++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            366 88889999877677789999875221 123466778888888852  224445443     112345678999998


Q ss_pred             CCCHH-----H------H---hc----CCC---CCCCCHHHH----HHH---------------HHHHHHHHHHHhhc--
Q 012715          188 NGSLK-----D------H---LH----SPG---RTPLSWQTR----IQI---------------AIDVANALEYLHFY--  225 (458)
Q Consensus       188 ~gsL~-----~------~---l~----~~~---~~~l~~~~~----~~i---------------~~~ia~gL~~LH~~--  225 (458)
                      |..+.     .      .   ++    ...   ...+++...    ..+               ...+...++.+...  
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            75431     1      1   11    110   111222211    001               01111122233211  


Q ss_pred             --CCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          226 --CDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       226 --~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                        ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence              245689999999999999 4 89999998764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.21  E-value=0.0011  Score=64.83  Aligned_cols=138  Identities=19%  Similarity=0.212  Sum_probs=81.9

Q ss_pred             eeeeecceEEEEEEEc--------CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeee
Q 012715          115 IIGQGGFGTVYKAQFS--------DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      .|..|-...+|++...        ++..+.+|+.... ........+|..+++.|. +.-..++++++.+    .+||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            4677888889998764        2478888875332 123456678999999885 3223566666644    289999


Q ss_pred             cCCCCHHH--------------H---hcCCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHHh-
Q 012715          186 MANGSLKD--------------H---LHSPG---RTPLS--WQTRIQIAIDVAN-------------------ALEYLH-  223 (458)
Q Consensus       186 ~~~gsL~~--------------~---l~~~~---~~~l~--~~~~~~i~~~ia~-------------------gL~~LH-  223 (458)
                      ++|.+|..              .   |+...   .....  |.++.++..++..                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            99855431              1   12211   11122  4455555544322                   233332 


Q ss_pred             ---h-cCCCCeEeccCCCCCeeeCCC----CcEEEeeccccc
Q 012715          224 ---F-YCDPPLCHRDIKSSNILLDEN----FVAKLADFGLAH  257 (458)
Q Consensus       224 ---~-~~~~~iiHrDlk~~NIll~~~----~~~kl~DfGla~  257 (458)
                         . .....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               1 123468999999999999876    789999998774

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.13  E-value=0.00066  Score=66.07  Aligned_cols=72  Identities=11%  Similarity=0.078  Sum_probs=43.7

Q ss_pred             eeeeecceEEEEEEEcC---------CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCC-eeeeeeeeeccCceeeeee
Q 012715          115 IIGQGGFGTVYKAQFSD---------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRH-LVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       115 ~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  184 (458)
                      .|+.|....+|+....+         +..+++|....... ...+...|.++++.+...+ ..++++..    .-++|||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e  114 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE  114 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence            57788889999998754         26788887643222 1123467888888885333 34666543    2378999


Q ss_pred             ecCCCCH
Q 012715          185 YMANGSL  191 (458)
Q Consensus       185 ~~~~gsL  191 (458)
                      |++|.++
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.07  E-value=0.0019  Score=62.12  Aligned_cols=68  Identities=12%  Similarity=0.115  Sum_probs=43.8

Q ss_pred             eeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC---CCeeeeeee------eeccCceeeeeeecC
Q 012715          117 GQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH---RHLVALRGF------CIEKRERFLMYEYMA  187 (458)
Q Consensus       117 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~------~~~~~~~~lv~e~~~  187 (458)
                      |.|....||+....+| .+++|+......      ..|+.++..|..   +++.+.+..      +...+..++||+|++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3444689999987666 899997654321      356667766631   224555432      233466789999999


Q ss_pred             CCCH
Q 012715          188 NGSL  191 (458)
Q Consensus       188 ~gsL  191 (458)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.54  E-value=0.0062  Score=53.88  Aligned_cols=104  Identities=14%  Similarity=0.113  Sum_probs=66.2

Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      -+|.+.|...+ .++++.+++.++.|.+.+|.-+-.  ...-..+=+-|..|++..+|.+...+ +.+.           
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            37889887654 479999999999999999877621  11111223446889999999888764 1110           


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCcc
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAV  313 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~  313 (458)
                           .....+.+||... ...+.+.=|||||+++|.-+--..+-
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence                 1223466888653 34567889999999999988654443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.33  E-value=0.056  Score=53.38  Aligned_cols=138  Identities=14%  Similarity=0.161  Sum_probs=83.1

Q ss_pred             ceeeeecceEEEEEEEcC--------CCEEEEEEecccchhhHhHHHHHHHHHHhcCCCC-eeeeeeeeeccCceeeeee
Q 012715          114 TIIGQGGFGTVYKAQFSD--------GSLIAVKRMDKISEQVEGDFCREIELLARLHHRH-LVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e  184 (458)
                      +.|..|-...+|+....+        +..+++++..... ....+..+|..+++.+...+ ..++++.+.    -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            357778889999998753        5788888754322 11223468899988885323 345555332    378999


Q ss_pred             ecCCCCHHH--------------H---hcC--------C---CCCCCCHHHHHHHHHHH-------------------HH
Q 012715          185 YMANGSLKD--------------H---LHS--------P---GRTPLSWQTRIQIAIDV-------------------AN  217 (458)
Q Consensus       185 ~~~~gsL~~--------------~---l~~--------~---~~~~l~~~~~~~i~~~i-------------------a~  217 (458)
                      |++|.+|..              .   |+.        .   ...+.-|.++.++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            999865421              0   111        0   11122244444443322                   12


Q ss_pred             HHHHHhh---------------------cCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          218 ALEYLHF---------------------YCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       218 gL~~LH~---------------------~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      .+..|..                     .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            2333321                     11346899999999999 778899999999875

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.41  E-value=0.085  Score=33.54  Aligned_cols=22  Identities=18%  Similarity=0.214  Sum_probs=9.1

Q ss_pred             ehhhHHHHHHHHHHHHHHHHHH
Q 012715           36 LIPGIGIAVTAVAVILLMVLII   57 (458)
Q Consensus        36 ~i~~i~~~~~~~~~~~~~~~~~   57 (458)
                      ++.++..+++++++++++++++
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~   34 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLF   34 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeehhHHHHHHHHHHHHHHHH
Confidence            4444444444444444333333

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=93.86  E-value=0.1  Score=33.08  Aligned_cols=6  Identities=50%  Similarity=1.043  Sum_probs=2.3

Q ss_pred             HHHhhc
Q 012715           57 ILIRRK   62 (458)
Q Consensus        57 ~~~r~~   62 (458)
                      +++|||
T Consensus        32 ~~~RRR   37 (44)
T 2l2t_A           32 VYVRRK   37 (44)
T ss_dssp             HHHHTT
T ss_pred             HHhhhh
Confidence            333433

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=93.85  E-value=0.087  Score=33.36  Aligned_cols=26  Identities=31%  Similarity=0.461  Sum_probs=10.7

Q ss_pred             hhhHHHHHHHHHHHHHHHHHHHHhhcc
Q 012715           37 IPGIGIAVTAVAVILLMVLIILIRRKS   63 (458)
Q Consensus        37 i~~i~~~~~~~~~~~~~~~~~~~r~~~   63 (458)
                      |.++.+++. +++++++++.+|.|||+
T Consensus        14 Ia~~vVGvl-l~vi~~l~~~~~~RRR~   39 (44)
T 2jwa_A           14 IISAVVGIL-LVVVLGVVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHH-HHHHHHHHHHhheehhh
Confidence            444444433 33333333344444443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=93.80  E-value=0.068  Score=32.90  Aligned_cols=29  Identities=24%  Similarity=0.193  Sum_probs=14.0

Q ss_pred             eeeehhhHHHHHHHHHHHHHHHHHHHHhh
Q 012715           33 HLTLIPGIGIAVTAVAVILLMVLIILIRR   61 (458)
Q Consensus        33 ~~~~i~~i~~~~~~~~~~~~~~~~~~~r~   61 (458)
                      .-..|.+|.+++.+.+++++.+.++++||
T Consensus         9 s~GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A            9 TGGEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence            34455666665554444444444444443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.82  E-value=0.31  Score=47.57  Aligned_cols=30  Identities=37%  Similarity=0.560  Sum_probs=25.2

Q ss_pred             CeEeccCCCCCeee------CCCCcEEEeecccccc
Q 012715          229 PLCHRDIKSSNILL------DENFVAKLADFGLAHA  258 (458)
Q Consensus       229 ~iiHrDlk~~NIll------~~~~~~kl~DfGla~~  258 (458)
                      .++|+|+.+.|||+      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567899999998753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.84  E-value=0.07  Score=53.39  Aligned_cols=61  Identities=11%  Similarity=0.113  Sum_probs=18.4

Q ss_pred             ccceeeeecceEEEEEEEcC-CCEEEE------EEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec
Q 012715          112 FSTIIGQGGFGTVYKAQFSD-GSLIAV------KRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE  175 (458)
Q Consensus       112 ~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  175 (458)
                      +.+.||   ||.||+|.+.. ...|||      |.....  .......|.+|..++..++|+|+++.++|...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            345676   99999998854 467888      665431  22333468899999999999999999887653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.10  E-value=1.5  Score=38.63  Aligned_cols=83  Identities=10%  Similarity=0.082  Sum_probs=58.9

Q ss_pred             CCCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEeccCCCCCe
Q 012715          162 HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE-YLHFYCDPPLCHRDIKSSNI  240 (458)
Q Consensus       162 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~-~LH~~~~~~iiHrDlk~~NI  240 (458)
                      .||++  -..+-.+.+...+.|+.-+++.=...++.     ++...+++++..|+.... +++     .-+|--|.|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence            57777  33344566677777765544333334433     788899999988887666 554     457888999999


Q ss_pred             eeCCCCcEEEeecccc
Q 012715          241 LLDENFVAKLADFGLA  256 (458)
Q Consensus       241 ll~~~~~~kl~DfGla  256 (458)
                      +++.++.++|.-.|+-
T Consensus       116 ~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          116 MFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EECTTCCEEESCCEET
T ss_pred             EEeCCCcEEEEEcCCc
Confidence            9999999999877753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.67  E-value=1.1  Score=39.50  Aligned_cols=116  Identities=10%  Similarity=0.177  Sum_probs=76.3

Q ss_pred             CCCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCee
Q 012715          162 HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNIL  241 (458)
Q Consensus       162 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIl  241 (458)
                      .||+.+.. .+-.+.+...+.|+.-+++.=...++     .++...+++++..|+....+++     .-+|--|.|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence            57888866 45555666666666443222122233     3788899999999988876665     2378889999999


Q ss_pred             eCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccC
Q 012715          242 LDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQ  314 (458)
Q Consensus       242 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~  314 (458)
                      ++.++.+++.=.|+-...                     +|.     ..+...=.-.+=+++..+++++..|.
T Consensus       112 f~~~~~p~i~~RGik~~l---------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV---------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTB---------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCC---------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999877763221                     221     11222223356778889999887774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	458
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-71
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-69
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-67
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-66
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-65
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-63
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-63
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-60
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-55
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-51
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-48
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-48
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-47
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-45
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-39
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 4e-71
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 17/266 (6%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           IG G FGTVYK ++     + +  +   + Q    F  E+ +L +  H +++   G+   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
            +   ++ ++    SL  HLH    T       I IA   A  ++YLH      + HRD+
Sbjct: 76  PQ-LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDL 130

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE---LTE 292
           KS+NI L E+   K+ DFGLA      S         + G+  +M PE +  Q+    + 
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWS--GSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188

Query: 293 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 352
           +SDVY++G+VL E++T +       N  +     +       +L   R      M++L  
Sbjct: 189 QSDVYAFGIVLYELMTGQLPY-SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL-- 245

Query: 353 IVTIVRWCTQREGQARPSIKQVLRIL 378
               +  C +++   RP   Q+L  +
Sbjct: 246 ----MAECLKKKRDERPLFPQILASI 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 5e-69
 Identities = 70/263 (26%), Positives = 120/263 (45%), Gaps = 19/263 (7%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +G G FG V+   ++  + +AVK + + S   +  F  E  L+ +L H+ LV L     +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM NGSL D L +P    L+    + +A  +A  + ++    +    HRD+
Sbjct: 80  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ +    K+ADFGLA   +D            +    +  PE +     T KSD
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYT---AREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 296 VYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVT 355
           V+S+G++L EIVT  R    G    E  Q        L         D+   E    +  
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQ-------NLERGYRMVRPDNCPEE----LYQ 241

Query: 356 IVRWCTQREGQARPSIKQVLRIL 378
           ++R C +   + RP+   +  +L
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 3e-67
 Identities = 66/269 (24%), Positives = 122/269 (45%), Gaps = 21/269 (7%)

Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALR 170
            F   IG G FG V+   + +   +A+K + +     E DF  E E++ +L H  LV L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLY 66

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G C+E+    L++E+M +G L D+L +  R   + +T + + +DV      + +  +  +
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEG---MAYLEEACV 122

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            HRD+ + N L+ EN V K++DFG+     D        +T  +    +  PE       
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---STGTKFPVKWASPEVFSFSRY 179

Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ-VCMASESRLAELVDPRIKDSFDMEQ 349
           + KSDV+S+GV++ E+ +  +   + ++  E  + +          L    +        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ------ 233

Query: 350 LRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                 I+  C +   + RP+  ++LR L
Sbjct: 234 ------IMNHCWKERPEDRPAFSRLLRQL 256

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 4e-67
 Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 25/265 (9%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
            IG+G FG V    +  G+ +AVK +    +     F  E  ++ +L H +LV L G  +
Sbjct: 14  TIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 175 EKRER-FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
           E++   +++ EYMA GSL D+L S GR+ L     ++ ++DV  A+EYL         HR
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127

Query: 234 DIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEK 293
           D+ + N+L+ E+ VAK++DFGL                  +    +  PE +  ++ + K
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 180

Query: 294 SDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTI 353
           SDV+S+G++L EI +  R       L +          R+ +       D         +
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEKGYKMDAPDGCPPA----V 229

Query: 354 VTIVRWCTQREGQARPSIKQVLRIL 378
             +++ C   +   RPS  Q+   L
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQL 254

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (541), Expect = 3e-66
 Identities = 60/296 (20%), Positives = 122/296 (41%), Gaps = 32/296 (10%)

Query: 100 FSYKETKKATDNFST-----------IIGQGGFGTVYKAQF----SDGSLIAVKRMDK-I 143
           F++++  +A   F+            +IG G FG V              +A+K +    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 144 SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPL 203
           +E+   DF  E  ++ +  H +++ L G   +     ++ E+M NGSL D          
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125

Query: 204 SWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS 263
           +    + +   +A  ++YL         HRD+ + NIL++ N V K++DFGL+   +D +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 264 ICFEPVNT-DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVES 322
                 +    +    +  PE +  ++ T  SDV+SYG+V+ E+++            + 
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD- 241

Query: 323 AQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                     +   ++   +    M+    +  ++  C Q++   RP   Q++  L
Sbjct: 242 ----------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 5e-66
 Identities = 67/270 (24%), Positives = 122/270 (45%), Gaps = 19/270 (7%)

Query: 111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALR 170
            F   +G G FG V   ++     +A+K + +     E +F  E +++  L H  LV L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLY 65

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G C ++R  F++ EYMANG L ++L    R     Q  +++  DV  A+EYL        
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            HRD+ + N L+++  V K++DFGL+    D        +   +    +  PE ++  + 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT---SSVGSKFPVRWSPPEVLMYSKF 178

Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 350
           + KSD++++GV++ EI +  +   +               S  AE +   ++        
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFT-----------NSETAEHIAQGLRLYRPHLAS 227

Query: 351 RTIVTIVRWCTQREGQARPSIKQVLRILYE 380
             + TI+  C   +   RP+ K +L  + +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (532), Expect = 5e-65
 Identities = 71/287 (24%), Positives = 134/287 (46%), Gaps = 22/287 (7%)

Query: 93  PSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDKISEQVEGDF 151
            SP + K+   E ++        +G G +G VY+  +      +AVK + + + +VE +F
Sbjct: 5   SSPNYDKW---EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EF 60

Query: 152 CREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQI 211
            +E  ++  + H +LV L G C  +   +++ E+M  G+L D+L    R  +S    + +
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A  +++A+EYL         HRD+ + N L+ EN + K+ADFGL+      +      + 
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT---AHA 174

Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
             +    +  PE +   + + KSDV+++GV+L EI T   +   G +L           S
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------S 223

Query: 332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           ++ EL++   +          +  ++R C Q     RPS  ++ +  
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 7e-65
 Identities = 69/272 (25%), Positives = 126/272 (46%), Gaps = 22/272 (8%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           +GQG FG V+   ++  + +A+K +   +   E  F +E +++ +L H  LV L      
Sbjct: 25  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV-S 82

Query: 176 KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDI 235
           +   +++ EYM+ GSL D L       L     + +A  +A+ + Y+         HRD+
Sbjct: 83  EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 139

Query: 236 KSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSD 295
           +++NIL+ EN V K+ADFGLA   +D            +    +  PE  +    T KSD
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSD 196

Query: 296 VYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVT 355
           V+S+G++L E+ T  R    G    E           + + V+   +     E   ++  
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNRE-----------VLDQVERGYRMPCPPECPESLHD 245

Query: 356 IVRWCTQREGQARPSIKQVLRIL---YESSDP 384
           ++  C ++E + RP+ + +   L   + S++P
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-63
 Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 23/275 (8%)

Query: 111 NFSTIIGQGGFGTVYKAQFSDGS----LIAVKRMDKISEQVE-GDFCREIELLARLHHRH 165
           +F+ +IG+G FG VY     D        AVK +++I++  E   F  E  ++    H +
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 166 LVALRGFCIE-KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           +++L G C+  +    ++  YM +G L++ + +    P + +  I   + VA  +    F
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGM---KF 145

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                  HRD+ + N +LDE F  K+ADFGLA    D         T  +    +M  E 
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA-ELVDPRIKD 343
           + TQ+ T KSDV+S+GV+L E++T         N  +     +     L  E     + +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                       ++  C   + + RPS  +++  +
Sbjct: 266 ------------VMLKCWHPKAEMRPSFSELVSRI 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 1e-63
 Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 29/287 (10%)

Query: 116 IGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIE 175
           IG+G FG V++ ++  G  +AVK      E+       EI     L H +++       +
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 176 KR----ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC----- 226
                 + +L+ +Y  +GSL D+L+   R  ++ +  I++A+  A+ L +LH        
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
            P + HRD+KS NIL+ +N    +AD GLA      +   +       GT  YM PE + 
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185

Query: 287 TQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL---- 336
                   E  +++D+Y+ G+V  EI          ++        + S+  + E+    
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245

Query: 337 ----VDPRIKDSFD-MEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
               + P I + +   E LR +  I+R C    G AR +  ++ + L
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 2e-63
 Identities = 70/304 (23%), Positives = 111/304 (36%), Gaps = 45/304 (14%)

Query: 108 ATDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK-ISEQVEGDFCREIELLARLHH 163
             D+F  I  +G G  G V+K      G ++A K +   I   +     RE+++L   + 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
            ++V   G      E  +  E+M  GSL   L   GR  +  Q   +++I V   L YL 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRD+K SNIL++     KL DFG++    D       +     GT  YM PE
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPE 173

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN--------------LVESAQVCMAS 329
            +     + +SD++S G+ L+E+   R  +                     E+       
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 330 ESRLAELVDPRIKDSFDMEQLRTIVT-----------------IVRWCTQREGQARPSIK 372
              L+             E L  IV                   V  C  +    R  +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

Query: 373 QVLR 376
           Q++ 
Sbjct: 294 QLMV 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-63
 Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 27/278 (9%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHR 164
           +++  +  IG G +G   K +  SDG ++  K +D   ++E  +     E+ LL  L H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 165 HLVALRGFCIEKRER--FLMYEYMANGSLKDHLHSPG--RTPLSWQTRIQIAIDVANALE 220
           ++V      I++     +++ EY   G L   +      R  L  +  +++   +  AL+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 221 YLH--FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
             H        + HRD+K +N+ LD     KL DFGLA      +           GTP 
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT----SFAKAFVGTPY 179

Query: 279 YMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD 338
           YM PE +      EKSD++S G +L E+               + ++      R+     
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239

Query: 339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
             + +            I+      +   RPS++++L 
Sbjct: 240 DELNE------------IITRMLNLKDYHRPSVEEILE 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 3e-62
 Identities = 65/273 (23%), Positives = 113/273 (41%), Gaps = 30/273 (10%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHH 163
           ++F     +G+G FG VY A+      ++A+K + K       VE    RE+E+ + L H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
            +++ L G+  +    +L+ EY   G++   L          Q       ++ANAL Y H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH 123

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
                 + HRDIK  N+LL      K+ADFG +  +             + GT  Y+ PE
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT------TLCGTLDYLPPE 174

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
            +  +   EK D++S GV+  E +  +    +     E+ +     E    + V    +D
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARD 233

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                       ++    +     RP +++VL 
Sbjct: 234 ------------LISRLLKHNPSQRPMLREVLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 9e-61
 Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 28/273 (10%)

Query: 112 FSTIIGQGGFGTVYKAQFSD-GSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVA 168
           F   IG+G F TVYK   ++    +A   +    +++     F  E E+L  L H ++V 
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 169 LRGFCIE----KRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
                      K+   L+ E M +G+LK +L       +  +        +   L++LH 
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH- 129

Query: 225 YCDPPLCHRDIKSSNILL-DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
              PP+ HRD+K  NI +       K+ D GLA   +            + GTP +M PE
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------FAKAVIGTPEFMAPE 183

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
            +  ++  E  DVY++G+ +LE+ T+     + +N  +  +       R+   V P   D
Sbjct: 184 -MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-------RVTSGVKPASFD 235

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
              + +++    I+  C ++    R SIK +L 
Sbjct: 236 KVAIPEVK---EIIEGCIRQNKDERYSIKDLLN 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (500), Expect = 3e-60
 Identities = 82/301 (27%), Positives = 129/301 (42%), Gaps = 49/301 (16%)

Query: 110 DNFSTI--IGQGGFGTVYKAQ------FSDGSLIAVKRMDK-ISEQVEGDFCREIELLAR 160
           +N   +  IG+G FG V++A+      +   +++AVK + +  S  ++ DF RE  L+A 
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 161 LHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS----------------------P 198
             + ++V L G C   +   L++EYMA G L + L S                      P
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 199 GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA 258
           G  PLS   ++ IA  VA  + YL    +    HRD+ + N L+ EN V K+ADFGL+  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKN 318
                  +   + +      +M PE +     T +SDV++YGVVL EI +       G  
Sbjct: 190 IYSAD--YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 319 LVESAQ-VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRI 377
             E    V   +     E     + +            ++R C  +    RPS   + RI
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYN------------LMRLCWSKLPADRPSFCSIHRI 295

Query: 378 L 378
           L
Sbjct: 296 L 296

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 4e-60
 Identities = 57/268 (21%), Positives = 108/268 (40%), Gaps = 23/268 (8%)

Query: 116 IGQGGFGTVYKAQFSD---GSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALR 170
           +G G FGTV K  +        +AVK +        ++ +   E  ++ +L + ++V + 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 171 GFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPL 230
           G C E     L+ E    G L  +L       +  +  I++   V+  ++YL        
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNF 128

Query: 231 CHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL 290
            HRD+ + N+LL     AK++DFGL+ A       +    T  +    +  PE +   + 
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 291 TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQL 350
           + KSDV+S+GV++ E  +  +    G    E           +  +++   +        
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------VTAMLEKGERMGCPAGCP 236

Query: 351 RTIVTIVRWCTQREGQARPSIKQVLRIL 378
           R +  ++  C   + + RP    V   L
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 7e-60
 Identities = 56/283 (19%), Positives = 115/283 (40%), Gaps = 24/283 (8%)

Query: 103 KETKKATDNFSTI---IGQGGFGTVYKAQF---SDGSLIAVKRMDKISEQVE-GDFCREI 155
           K+     DN       +G G FG+V +  +        +A+K + + +E+ +  +  RE 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 156 ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 215
           +++ +L + ++V L G C +     L+ E    G L   L    R  +      ++   V
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 118

Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 275
           +  ++YL         HRD+ + N+LL     AK++DFGL+ A       +    +  + 
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKW 174

Query: 276 TPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE 335
              +  PE +  ++ + +SDV+SYGV + E ++  +         E           +  
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----------VMA 223

Query: 336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            ++   +     E    +  ++  C   + + RP    V + +
Sbjct: 224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 7e-60
 Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 22/270 (8%)

Query: 115 IIGQGGFGTVYKAQFSDGS-----LIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVA 168
           +IG G FG VYK      S      +A+K +    +E+   DF  E  ++ +  H +++ 
Sbjct: 14  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L G   + +   ++ EYM NG+L   L        S    + +   +A  ++YL    + 
Sbjct: 74  LEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NM 129

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
              HRD+ + NIL++ N V K++DFGL+   +D         +  +    +  PE +  +
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY-TTSGGKIPIRWTAPEAISYR 188

Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
           + T  SDV+S+G+V+ E++T         +  E           + + ++   +    M+
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----------VMKAINDGFRLPTPMD 237

Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
               I  ++  C Q+E   RP    ++ IL
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (498), Expect = 1e-59
 Identities = 69/291 (23%), Positives = 117/291 (40%), Gaps = 35/291 (12%)

Query: 95  PMFQKFSYKETKKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVE 148
           P   +  +K+       FS +  IG G FG VY A+   +  ++A+K+M      S +  
Sbjct: 2   PDVAELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59

Query: 149 GDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTR 208
            D  +E+  L +L H + +  RG  + +   +L+ EY    +         + PL     
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEI 117

Query: 209 IQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP 268
             +       L YLH      + HRD+K+ NILL E  + KL DFG A            
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------ 168

Query: 269 VNTDIRGTPGYMDPEYVVTQ---ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
                 GTP +M PE ++     +   K DV+S G+  +E+   +  + +   +     +
Sbjct: 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

Query: 326 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                    +   P ++     E  R     V  C Q+  Q RP+ + +L+
Sbjct: 227 A--------QNESPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLK 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-59
 Identities = 86/287 (29%), Positives = 128/287 (44%), Gaps = 38/287 (13%)

Query: 111 NFSTIIGQGGFGTVYKAQFSDGSL---IAVKRMDKI-SEQVEGDFCREIELLARL-HHRH 165
            F  +IG+G FG V KA+     L    A+KRM +  S+    DF  E+E+L +L HH +
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLH--------------SPGRTPLSWQTRIQI 211
           ++ L G C  +   +L  EY  +G+L D L               +   + LS Q  +  
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           A DVA  ++YL         HRD+ + NIL+ EN+VAK+ADFGL+   +          T
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-----KKT 184

Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
             R    +M  E +     T  SDV+SYGV+L EIV+       G    E          
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------- 234

Query: 332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
            L E +    +    +     +  ++R C + +   RPS  Q+L  L
Sbjct: 235 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 6e-59
 Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 33/288 (11%)

Query: 102 YKETKK---ATDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREI 155
           Y+   +     D +  I  +G G FG VYKAQ      L A K +D  SE+   D+  EI
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 156 ELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDV 215
           ++LA   H ++V L      +   +++ E+ A G++   +    R PL+      +    
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQT 119

Query: 216 ANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRG 275
            +AL YLH   D  + HRD+K+ NIL   +   KLADFG++  +               G
Sbjct: 120 LDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----IQRRDSFIG 172

Query: 276 TPGYMDPEYVVTQEL-----TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 330
           TP +M PE V+ +         K+DV+S G+ L+E+        +   +    ++  +  
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP 232

Query: 331 SRLA--ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
             LA         KD             ++ C ++   AR +  Q+L+
Sbjct: 233 PTLAQPSRWSSNFKD------------FLKKCLEKNVDARWTTSQLLQ 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 1e-58
 Identities = 65/291 (22%), Positives = 116/291 (39%), Gaps = 39/291 (13%)

Query: 112 FSTIIGQGGFGTVYKAQF------SDGSLIAVKRMDKISEQVE-GDFCREIELLARL-HH 163
           F   +G G FG V +A             +AVK +   +   E      E+++L+ L +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLH----------------SPGRTPLSWQT 207
            ++V L G C       ++ EY   G L + L                       L  + 
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 208 RIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE 267
            +  +  VA  + +L         HRD+ + NILL    + K+ DFGLA   K+ S    
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS--NY 201

Query: 268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCM 327
            V  + R    +M PE +     T +SDV+SYG+ L E+ +   +   G  +        
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-------- 253

Query: 328 ASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             +S+  +++    +          +  I++ C   +   RP+ KQ+++++
Sbjct: 254 --DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 4e-58
 Identities = 69/293 (23%), Positives = 115/293 (39%), Gaps = 44/293 (15%)

Query: 115 IIGQGGFGTVYKA------QFSDGSLIAVKRMDKISEQVE-GDFCREIELLARL-HHRHL 166
           ++G G FG V  A      +      +AVK + + ++  E      E++++ +L  H ++
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 167 VALRGFCIEKRERFLMYEYMANGSLKDHLHSPGR---------------------TPLSW 205
           V L G C      +L++EY   G L ++L S                          L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 206 QTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC 265
           +  +  A  VA  +E+L         HRD+ + N+L+    V K+ DFGLA      S  
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN- 219

Query: 266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQV 325
              V  + R    +M PE +     T KSDV+SYG++L EI +       G  +      
Sbjct: 220 -YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 274

Query: 326 CMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                    +L+    K          I  I++ C   + + RPS   +   L
Sbjct: 275 ------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 6e-58
 Identities = 60/274 (21%), Positives = 109/274 (39%), Gaps = 26/274 (9%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK-ISEQVEGDFCREIELLARLHHRH 165
           +++  +  +G+G +G V  A        +AVK +D   +     +  +EI +   L+H +
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           +V   G   E   ++L  EY + G L D +       +      +    +   + YLH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH-- 120

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRDIK  N+LLDE    K++DFGLA   +  +   E +   + GT  Y+ PE +
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELL 177

Query: 286 VTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL--VDPRIK 342
             +E   E  DV+S G+VL  ++          +  +        ++ L     +D    
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237

Query: 343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                        ++         AR +I  + +
Sbjct: 238 A------------LLHKILVENPSARITIPDIKK 259

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 4e-56
 Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 29/283 (10%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF----SDGSLIAVKRMDK---ISEQVEGDFCREIELLAR 160
            +   +  +G G FG V + ++         +AVK +        +   DF RE+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 161 LHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
           L HR+L+ L G  +    + +  E    GSL D L    +      T  + A+ VA  + 
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMG 125

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 280
           YL         HRD+ + N+LL    + K+ DFGL  A       +  +    +    + 
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV-MQEHRKVPFAWC 181

Query: 281 DPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--ELVD 338
            PE + T+  +  SD + +GV L E+ T  +    G N  +          RL   E   
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 339 PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES 381
             I +            ++  C   + + RP+   +   L E+
Sbjct: 242 QDIYN------------VMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 9e-56
 Identities = 65/264 (24%), Positives = 112/264 (42%), Gaps = 25/264 (9%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           IGQG  GTVY A   + G  +A+++M+   +  +     EI ++    + ++V      +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E +++ EY+A GSL D +     T +       +  +   ALE+LH      + HRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141

Query: 235 IKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKS 294
           IKS NILL  +   KL DFG            +   + + GTP +M PE V  +    K 
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQIT----PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 295 DVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA--ELVDPRIKDSFDMEQLRT 352
           D++S G++ +E++       +   L     +       L   E +    +D         
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD--------- 248

Query: 353 IVTIVRWCTQREGQARPSIKQVLR 376
               +  C   + + R S K++L+
Sbjct: 249 ---FLNRCLDMDVEKRGSAKELLQ 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-55
 Identities = 66/319 (20%), Positives = 124/319 (38%), Gaps = 43/319 (13%)

Query: 107 KATD-NFSTIIGQGGFGTVYKAQFSD-----GSLIAVKRMDKI-SEQVEGDFCREIELLA 159
           K T+     ++G G FGTVYK  +          +A+K + +  S +   +   E  ++A
Sbjct: 7   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66

Query: 160 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
            + + H+  L G C+    + +  + M  G L D++          Q  +   + +A  +
Sbjct: 67  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGM 124

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGY 279
            YL       L HRD+ + N+L+      K+ DFGLA          E      +    +
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKW 179

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 339
           M  E ++ +  T +SDV+SYGV + E++T      DG              S ++ +++ 
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----------ASEISSILEK 228

Query: 340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE------------------S 381
             +          +  I+  C   +  +RP  ++++    +                   
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288

Query: 382 SDPMHSGFVQAVEDEEYEE 400
             P  S F +A+ DEE  +
Sbjct: 289 PSPTDSNFYRALMDEEDMD 307

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 8e-55
 Identities = 64/285 (22%), Positives = 113/285 (39%), Gaps = 26/285 (9%)

Query: 106 KKATDNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDK---ISEQVEGDFCREIELLA 159
           KK  ++F     +G+G F TV  A+  +     A+K ++K   I E       RE ++++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 160 RLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANAL 219
           RL H   V L     +  + +    Y  NG L  ++   G              ++ +AL
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSAL 121

Query: 220 EYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGY 279
           EYLH      + HRD+K  NILL+E+   ++ DFG A      S   +       GT  Y
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQY 176

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP 339
           + PE +  +   + SD+++ G ++ ++V      +   N     Q  +  E    E   P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKLEYDFPEKFFP 235

Query: 340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 384
           + +D            +V      +   R   +++       + P
Sbjct: 236 KARD------------LVEKLLVLDATKRLGCEEMEGYGPLKAHP 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 2e-53
 Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 26/270 (9%)

Query: 115 IIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVAL 169
            IG+G FG V++  +         +A+K      S+ V   F +E   + +  H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 170 RGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP 229
            G   E    +++ E    G L+  L       L   + I  A  ++ AL YL       
Sbjct: 74  IGVITENP-VWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLE---SKR 128

Query: 230 LCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQE 289
             HRDI + N+L+  N   KL DFGL+   +D +       +  +    +M PE +  + 
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFRR 185

Query: 290 LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVE-SAQVCMASESRLAELVDPRIKDSFDME 348
            T  SDV+ +GV + EI+        G    +   ++       +     P +       
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS----- 240

Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                  ++  C   +   RP   ++   L
Sbjct: 241 -------LMTKCWAYDPSRRPRFTELKAQL 263

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 6e-53
 Identities = 67/288 (23%), Positives = 118/288 (40%), Gaps = 31/288 (10%)

Query: 112 FSTIIGQGGFGTVYKA------QFSDGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHR 164
            S  +GQG FG VY+       +    + +A+K +++  S +   +F  E  ++   +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLH--------SPGRTPLSWQTRIQIAIDVA 216
           H+V L G   + +   ++ E M  G LK +L         +P   P S    IQ+A ++A
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
           + + YL         HRD+ + N ++ E+F  K+ DFG+     +    +          
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--YYRKGGKGLLP 198

Query: 277 PGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAEL 336
             +M PE +     T  SDV+S+GVVL EI T       G +             ++   
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----------NEQVLRF 247

Query: 337 VDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP 384
           V               +  ++R C Q   + RPS  +++  + E  +P
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (449), Expect = 1e-52
 Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 20/279 (7%)

Query: 102 YKETKKATDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKIS-EQVEGDFCREIEL 157
           +K+ +   D +     +G G F  V  A+      L+A+K + K + E  EG    EI +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 158 LARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVAN 217
           L ++ H ++VAL          +L+ + ++ G L D +   G    + +   ++   V +
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118

Query: 218 ALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTP 277
           A++YLH         +        LDE+    ++DFGL+     GS+      +   GTP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-----STACGTP 173

Query: 278 GYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV 337
           GY+ PE +  +  ++  D +S GV+   ++         +N  +  +  + +E       
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEFDSPY 232

Query: 338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
              I DS            +R   +++ + R + +Q L+
Sbjct: 233 WDDISDSA--------KDFIRHLMEKDPEKRFTCEQALQ 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  178 bits (452), Expect = 1e-52
 Identities = 54/265 (20%), Positives = 102/265 (38%), Gaps = 21/265 (7%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFC 173
            +G G FG V++    + G+  A K +    E  +    +EI+ ++ L H  LV L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
            +  E  ++YE+M+ G L + +       +S    ++    V   L ++H   +    H 
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHL 148

Query: 234 DIKSSNILL--DENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELT 291
           D+K  NI+     +   KL DFGL                   GT  +  PE    + + 
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-----VTTGTAEFAAPEVAEGKPVG 203

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 351
             +D++S GV+   +++       G+N  E+ +   + +  + +     I +        
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDG------ 256

Query: 352 TIVTIVRWCTQREGQARPSIKQVLR 376
                +R     +   R +I Q L 
Sbjct: 257 --KDFIRKLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  177 bits (449), Expect = 5e-52
 Identities = 53/264 (20%), Positives = 105/264 (39%), Gaps = 21/264 (7%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G G FG V++    + G +   K ++      +     EI ++ +LHH  L+ L     
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
           +K E  L+ E+++ G L D + +     +S    I         L+++H   +  + H D
Sbjct: 97  DKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 235 IKSSNILLD--ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           IK  NI+ +  +    K+ DFGLA       I           T  +  PE V  + +  
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-----ATAEFAAPEIVDREPVGF 207

Query: 293 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 352
            +D+++ GV+   +++       G++ +E+ Q     +    E     +           
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCDWEFDEDAFSSVSPEA------- 259

Query: 353 IVTIVRWCTQREGQARPSIKQVLR 376
               ++   Q+E + R ++   L 
Sbjct: 260 -KDFIKNLLQKEPRKRLTVHDALE 282

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 3e-51
 Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 40/288 (13%)

Query: 115 IIGQGGFGTVYKAQF--------SDGSLIAVKRMDK-ISEQVEGDFCREIELLARL-HHR 164
            +G+G FG V  A+         +  + +AVK +    +E+   D   E+E++  +  H+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTP--------------LSWQTRIQ 210
           +++ L G C +    +++ EY + G+L+++L +                   LS +  + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 211 IAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN 270
            A  VA  +EYL         HRD+ + N+L+ E+ V K+ADFGLA              
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK--KT 194

Query: 271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 330
           T+ R    +M PE +  +  T +SDV+S+GV+L EI T   +   G  + E         
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 245

Query: 331 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             L +L+    +          +  ++R C       RP+ KQ++  L
Sbjct: 246 --LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  169 bits (429), Expect = 5e-50
 Identities = 55/286 (19%), Positives = 111/286 (38%), Gaps = 38/286 (13%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK---------ISEQVEGDFCREIEL 157
           +N+     +G+G    V +          AVK +D            +++     +E+++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 158 LARLH-HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVA 216
           L ++  H +++ L+         FL+++ M  G L D+L       LS +   +I   + 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALL 120

Query: 217 NALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGT 276
             +  LH      + HRD+K  NILLD++   KL DFG +     G         ++ GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-----REVCGT 172

Query: 277 PGYMDPEYVVTQEL------TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE 330
           P Y+ PE +            ++ D++S GV++  ++         +  +   ++ M+  
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLMLRMIMSGN 231

Query: 331 SRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
            +          D+           +V      + Q R + ++ L 
Sbjct: 232 YQFGSPEWDDYSDTV--------KDLVSRFLVVQPQKRYTAEEALA 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 6e-50
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 38/287 (13%)

Query: 115 IIGQGGFGTVYKA------QFSDGSLIAVKRMDKISEQVEG-DFCREIELLAR-LHHRHL 166
            +G+G FG V +A      + +    +AVK + + +   E      E+++L    HH ++
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 167 VALRGFCIEKRER-FLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQI 211
           V L G C +      ++ E+   G+L  +L S                +  L+ +  I  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 212 AIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNT 271
           +  VA  +E+L         HRD+ + NILL E  V K+ DFGLA               
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR--KG 194

Query: 272 DIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES 331
           D R    +M PE +  +  T +SDV+S+GV+L EI +   +   G  + E          
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------R 248

Query: 332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
           RL E    R  D    E    +   +  C   E   RP+  +++  L
Sbjct: 249 RLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 1e-49
 Identities = 47/264 (17%), Positives = 101/264 (38%), Gaps = 22/264 (8%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G+G FG V++    S       K +            +EI +L    HR+++ L     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESFE 71

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
              E  +++E+++   + + +++     L+ +  +     V  AL++LH      + H D
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 235 IKSSNILLD--ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTE 292
           I+  NI+     +   K+ +FG A   K G          +   P Y  PE      ++ 
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-----RLLFTAPEYYAPEVHQHDVVST 182

Query: 293 KSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRT 352
            +D++S G ++  +++        +   +  +  M +E    E     I           
Sbjct: 183 ATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEA------- 234

Query: 353 IVTIVRWCTQREGQARPSIKQVLR 376
            +  V     +E ++R +  + L+
Sbjct: 235 -MDFVDRLLVKERKSRMTASEALQ 257

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 23/270 (8%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHHRHLVALR 170
           I+G GG   V+ A+       +AVK +             F RE +  A L+H  +VA+ 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 171 GFCIEKRER----FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYC 226
                +       +++ EY+   +L+D +H+ G  P++ +  I++  D   AL +     
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFS---H 128

Query: 227 DPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV 286
              + HRD+K +NI++      K+ DFG+A A  D           + GT  Y+ PE   
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQAR 187

Query: 287 TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD 346
              +  +SDVYS G VL E++T       G + V  A   +  +          +    D
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 347 MEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                    +V     +  + R      +R
Sbjct: 247 --------AVVLKALAKNPENRYQTAAEMR 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 4e-48
 Identities = 62/274 (22%), Positives = 112/274 (40%), Gaps = 29/274 (10%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD---FCREIELLAR-LH 162
           ++F     +G+G FG V+ A+F       A+K + K    ++ D      E  +L+    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 163 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYL 222
           H  L  +      K   F + EY+  G L  H+ S  +           A ++   L++L
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119

Query: 223 HFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
                  + +RD+K  NILLD++   K+ADFG+   +  G    +       GTP Y+ P
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTNTFCGTPDYIAP 172

Query: 283 EYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK 342
           E ++ Q+     D +S+GV+L E++  +     G++  E               ++   K
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAK 231

Query: 343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
           D            ++     RE + R  ++  +R
Sbjct: 232 D------------LLVKLFVREPEKRLGVRGDIR 253

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (411), Expect = 6e-47
 Identities = 59/278 (21%), Positives = 113/278 (40%), Gaps = 36/278 (12%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHH 163
            +F  +  +G G FG V+  +   +G   A+K + K   +  +       E  +L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
             ++ + G   + ++ F++ +Y+  G L   L    R P          +        L 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
           +     + +RD+K  NILLD+N   K+ DFG A    D       V   + GTP Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-------VTYTLCGTPDYIAPE 171

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
            V T+   +  D +S+G+++ E++          N +++ +  + +E R     +  +KD
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELRFPPFFNEDVKD 230

Query: 344 SFDMEQLRTIVTIVRWC-----TQREGQARPSIKQVLR 376
                       ++        +QR G  +   + V  
Sbjct: 231 ------------LLSRLITRDLSQRLGNLQNGTEDVKN 256

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-45
 Identities = 56/271 (20%), Positives = 107/271 (39%), Gaps = 27/271 (9%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGF 172
           ++G G  G V +          A+K +    +       RE+EL  R     H+V +   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 173 C----IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                  ++   ++ E +  G L   +   G    + +   +I   +  A++YLH     
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 229 PLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
            + HRD+K  N+L      N + KL DFG A  +   +    P       TP Y+ PE +
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-----TPYYVAPEVL 185

Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 345
             ++  +  D++S GV++  ++           L  S    M +  R+ +   P  + S 
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMGQYEFPNPEWSE 243

Query: 346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
             E+++    ++R   + E   R +I + + 
Sbjct: 244 VSEEVK---MLIRNLLKTEPTQRMTITEFMN 271

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 6e-45
 Identities = 52/270 (19%), Positives = 101/270 (37%), Gaps = 18/270 (6%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           IG G FG +Y     + G  +A+K     ++  +     E ++   +     +    +C 
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWCG 72

Query: 175 EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRD 234
            + +  +M   +   SL+D  +   R   S +T + +A  + + +EY+H        HRD
Sbjct: 73  AEGDYNVMVMELLGPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 235 IKSSNIL---LDENFVAKLADFGLAHASKDGS---ICFEPVNTDIRGTPGYMDPEYVVTQ 288
           +K  N L     +  +  + DFGLA   +D           N ++ GT  Y      +  
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 289 ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME 348
           E + + D+ S G VL+         Q  K   +  +    SE ++       +   +  E
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEVLCKGYPSE 247

Query: 349 QLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
                 T + +C       +P    + ++ 
Sbjct: 248 ----FATYLNFCRSLRFDDKPDYSYLRQLF 273

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (391), Expect = 5e-44
 Identities = 66/302 (21%), Positives = 117/302 (38%), Gaps = 38/302 (12%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IGQG FG V+KA+    G  +A+K++      E       REI++L  L H ++V L   
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 173 CIEKRER--------FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           C  K           +L++++  +       +   +  LS   R+   +     L  L++
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGLYY 132

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                + HRD+K++N+L+  + V KLADFGLA A            T+   T  Y  PE 
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 285 VVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
           ++  ++     D++  G ++ E+ T R  +  G        +       +   V P + +
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 344 SFDMEQLRTI--------------------VTIVRWCTQREGQARPSIKQVLRILYESSD 383
               E+L  +                    + ++      +   R      L   +  SD
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311

Query: 384 PM 385
           PM
Sbjct: 312 PM 313

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  155 bits (393), Expect = 8e-44
 Identities = 62/276 (22%), Positives = 110/276 (39%), Gaps = 35/276 (12%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSD-GSLIAVKRMDK---ISEQVEGDFCRE---IELLAR 160
           ++FS    IG+GGFG VY  + +D G + A+K +DK     +Q E     E   + L++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 161 LHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALE 220
                +V +        +   + + M  G L  HL   G            A ++   LE
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAAEIILGLE 121

Query: 221 YLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYM 280
           ++H   +  + +RD+K +NILLDE+   +++D GLA                  GT GYM
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA------SVGTHGYM 172

Query: 281 DPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQ--DGKNLVESAQVCMASESRLAELV 337
            PE +         +D +S G +L +++      +    K+  E  ++ +     L +  
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232

Query: 338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQ 373
            P ++             ++    QR+   R     
Sbjct: 233 SPELRS------------LLEGLLQRDVNRRLGCLG 256

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-43
 Identities = 58/297 (19%), Positives = 108/297 (36%), Gaps = 35/297 (11%)

Query: 107 KATDNFSTI--IGQGGFGTVYKAQF--SDGSLIAVKRMDK--ISEQVEGDFCREIELLAR 160
           +A   +  +  IG+G +G V+KA+   + G  +A+KR+      E +     RE+ +L  
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 161 L---HHRHLVALRGFCIEKRERFLMYEYM----ANGSLKDHLHSPGRTPLSWQTRIQIAI 213
           L    H ++V L   C   R        +     +  L  +L       +  +T   +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 214 DVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDI 273
            +   L++LH      + HRD+K  NIL+  +   KLADFGLA              T +
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-----TSV 175

Query: 274 RGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC------- 326
             T  Y  PE ++        D++S G +  E+   +   +   ++ +  ++        
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235

Query: 327 -------MASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                  +A   +       +  + F  +       ++  C       R S    L 
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-43
 Identities = 68/293 (23%), Positives = 115/293 (39%), Gaps = 33/293 (11%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK-----ISEQVEGDFCREIELLARLHHRHLVA 168
            +G+G F TVYKA+  +   ++A+K++         + +     REI+LL  L H +++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L      K    L++++M                L+        +     LEYLH     
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + HRD+K +N+LLDEN V KLADFGLA +            T    T  Y  PE +   
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP----NRAYTHQVVTRWYRAPELLFGA 175

Query: 289 EL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM 347
            +     D+++ G +L E++  R     G + ++       +     E   P +    D 
Sbjct: 176 RMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 348 EQLRTIVTI----------------VRWCTQREGQARPSIKQVLRILYESSDP 384
              ++   I                ++        AR +  Q L++ Y S+ P
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (382), Expect = 5e-43
 Identities = 45/273 (16%), Positives = 90/273 (32%), Gaps = 22/273 (8%)

Query: 116 IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFC 173
           IG+G FG +++     +   +A+K   + S+  +     E      L     +  +  F 
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 174 IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHR 233
            E     L+ + +  G   + L        S +T    A  +   ++ +H   +  L +R
Sbjct: 71  QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125

Query: 234 DIKSSNILLDENFV-----AKLADFGLAHASKDGS---ICFEPVNTDIRGTPGYMDPEYV 285
           DIK  N L+            + DFG+    +D             ++ GT  YM     
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 286 VTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF 345
           + +E + + D+ + G V +  +      Q  K      +     E + +  +       F
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG-F 244

Query: 346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL 378
             E        + +       A P    +  + 
Sbjct: 245 PEE----FYKYMHYARNLAFDATPDYDYLQGLF 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 7e-43
 Identities = 60/272 (22%), Positives = 103/272 (37%), Gaps = 30/272 (11%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD------FCREIELLARLHHRHLVA 168
           +G G F  V K +  S G   A K + K   +            RE+ +L  + H +++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 169 LRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
           L      K +  L+ E +A G L D L           T     I     L  +++    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHSL 132

Query: 229 PLCHRDIKSSNILLDENFVA----KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
            + H D+K  NI+L +  V     K+ DFGLAH    G+        +I GTP ++ PE 
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-----KNIFGTPEFVAPEI 187

Query: 285 VVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS 344
           V  + L  ++D++S GV+   +++       G    E+     A      +         
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDEYFSNTSAL 246

Query: 345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                       +R    ++ + R +I+  L+
Sbjct: 247 A--------KDFIRRLLVKDPKKRMTIQDSLQ 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 7e-43
 Identities = 59/273 (21%), Positives = 102/273 (37%), Gaps = 40/273 (14%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD------FCREIELLARLHHRH-- 165
           ++G GGFG+VY     SD   +A+K ++K      G+         E+ LL ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           ++ L  +        L+ E            +  R  L  +        V  A+ +    
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHC--- 126

Query: 226 CDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
            +  + HRDIK  NIL+D N    KL DFG     KD       V TD  GT  Y  PE+
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD------TVYTDFDGTRVYSPPEW 180

Query: 285 VVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
           +         + V+S G++L ++V      +  + ++         +    + V    + 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-------GQVFFRQRVSSECQH 233

Query: 344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                       ++RWC       RP+ +++  
Sbjct: 234 ------------LIRWCLALRPSDRPTFEEIQN 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (373), Expect = 7e-42
 Identities = 62/288 (21%), Positives = 116/288 (40%), Gaps = 30/288 (10%)

Query: 110 DNFSTI--IGQGGFGTVYKAQFSDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRH 165
           + +  +  IG+G +G VYKAQ + G   A+K++  +K  E +     REI +L  L H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 166 LVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
           +V L      K+   L++E++     K      G   L   T     + + N + Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH-- 117

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
            D  + HRD+K  N+L++     K+ADFGLA A       +         T  Y  P+ +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE----IVTLWYRAPDVL 172

Query: 286 V-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVC----------------MA 328
           + +++ +   D++S G +  E+V             +  ++                 + 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 329 SESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLR 376
                  + +P   +SF      + + ++    + +   R + KQ L 
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-41
 Identities = 59/278 (21%), Positives = 103/278 (37%), Gaps = 33/278 (11%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDK---ISEQVEGDFCREIELLARLHH 163
           ++F  +  +G+G FG V   +  + G   A+K + K   I++        E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 164 RHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
             L AL+           + EY   G L  HL        + +       ++ +AL    
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSAL---E 119

Query: 224 FYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE 283
           +     + +RDIK  N++LD++   K+ DFGL        I          GTP Y+ PE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGATMKTFCGTPEYLAPE 175

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
            +   +     D +  GVV+ E++  R      ++     ++ +  E R    + P  K 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILMEEIRFPRTLSPEAKS 234

Query: 344 SFDMEQLRTIVTIVRWC-----TQREGQARPSIKQVLR 376
                       ++         QR G      K+V+ 
Sbjct: 235 ------------LLAGLLKKDPKQRLGGGPSDAKEVME 260

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-41
 Identities = 72/311 (23%), Positives = 117/311 (37%), Gaps = 45/311 (14%)

Query: 91  EGPSPMFQKFSYKETKKATDNFSTIIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG 149
           +GP    Q+ SY +TK        +IG G FG VY+A+    G L+A+K++ +       
Sbjct: 12  QGPDRP-QEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN- 61

Query: 150 DFCREIELLARLHHRHLVALRGFCIEKRER------FLMYEYMANGSLKDHLH-SPGRTP 202
              RE++++ +L H ++V LR F     E+       L+ +Y+     +   H S  +  
Sbjct: 62  ---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118

Query: 203 LSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKD 261
           L           +  +L Y+H      +CHRDIK  N+LLD +  V KL DFG A     
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175

Query: 262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL-- 319
           G    EP  + I               + T   DV+S G VL E++  +        +  
Sbjct: 176 G----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

Query: 320 ---------VESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVT-----IVRWCTQREG 365
                      + +          E   P+IK     +  R         +     +   
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291

Query: 366 QARPSIKQVLR 376
            AR +  +   
Sbjct: 292 TARLTPLEACA 302

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-41
 Identities = 68/290 (23%), Positives = 118/290 (40%), Gaps = 32/290 (11%)

Query: 110 DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVK--RMDKISEQVEGDFCREIELLARLHHR 164
           +NF  +  IG+G +G VYKA+    G ++A+K  R+D  +E V     REI LL  L+H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
           ++V L      + + +L++E++ +  LK  + +   T +           +   L +   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC-- 118

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPE- 283
                + HRD+K  N+L++     KLADFGLA A       +    T    T  Y  PE 
Sbjct: 119 -HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----THEVVTLWYRAPEI 173

Query: 284 YVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD 343
            +  +  +   D++S G +  E+VT R     G + ++       +     E+V P +  
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVTS 232

Query: 344 SFDMEQL-----------------RTIVTIVRWCTQREGQARPSIKQVLR 376
             D +                       +++      +   R S K  L 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 3e-40
 Identities = 55/287 (19%), Positives = 105/287 (36%), Gaps = 32/287 (11%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGD-FCREIELLARLHHRHLVALRGF 172
            IG+G +G V  A    +   +A+K++     Q       REI++L R  H +++ +   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 173 C----IEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDP 228
                IE+ +   +  ++    L   L       LS          +   L+Y+H     
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGLKYIH---SA 128

Query: 229 PLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQ 288
            + HRD+K SN+LL+     K+ DFGLA  +         +   +  T  Y  PE ++  
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLNS 187

Query: 289 EL-TEKSDVYSYGVVLLEIVTAR-----RAVQDGKNLVESAQVCMASESRLAELVDPRIK 342
           +  T+  D++S G +L E+++ R     +   D  N +       + E     +      
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247

Query: 343 DSFDMEQLRTI-------------VTIVRWCTQREGQARPSIKQVLR 376
               +     +             + ++          R  ++Q L 
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-40
 Identities = 62/282 (21%), Positives = 110/282 (39%), Gaps = 30/282 (10%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRM--DKISEQVEGDFCREIELLARLHHRHLVALRGF 172
           IG+G +GTV+KA+      ++A+KR+  D   E V     REI LL  L H+++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCH 232
               ++  L++E+      K      G               +   L+ L F     + H
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNVLH 124

Query: 233 RDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVV-TQELT 291
           RD+K  N+L++ N   KLA+FGLA A      C+    +    T  Y  P+ +   +  +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCY----SAEVVTLWYRPPDVLFGAKLYS 180

Query: 292 EKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLR 351
              D++S G +  E+  A R +  G ++ +  +          E   P +    D +   
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 352 TIVT-----------------IVRWCTQREGQARPSIKQVLR 376
                                +++   +     R S ++ L+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (360), Expect = 3e-39
 Identities = 63/306 (20%), Positives = 119/306 (38%), Gaps = 38/306 (12%)

Query: 84  RSLRKF-QEGPSPMFQKFSYKETKKAT-DNFSTI--IGQGGFGTVYKAQF-SDGSLIAVK 138
            S+++F  +      +K+       A  D F  I  +G G FG V   +    G+  A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 139 RMDK---ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGSLKDHL 195
            +DK   +  +       E  +L  ++   LV L     +    +++ EY+A G +  HL
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 196 HSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGL 255
              GR   S       A  +    EYLH      L +RD+K  N+L+D+    ++ DFG 
Sbjct: 133 RRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

Query: 256 AHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQD 315
           A          +     + GTP  + PE ++++   +  D ++ GV++ E+         
Sbjct: 188 AK-------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF- 239

Query: 316 GKNLVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWC-----TQREGQARPS 370
               ++  +  ++ + R        +KD            ++R       T+R G  +  
Sbjct: 240 ADQPIQIYEKIVSGKVRFPSHFSSDLKD------------LLRNLLQVDLTKRFGNLKNG 287

Query: 371 IKQVLR 376
           +  +  
Sbjct: 288 VNDIKN 293

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  133 bits (335), Expect = 5e-36
 Identities = 51/300 (17%), Positives = 113/300 (37%), Gaps = 49/300 (16%)

Query: 110 DNFSTI--IGQGGFGTVYKAQ-FSDGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRH 165
           D++  +  +G+G +  V++A   ++   + VK +  + ++      REI++L  L    +
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 166 LVALRGFCIEKRER--FLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLH 223
           ++ L     +   R   L++E++ N   K          L+         ++  AL+Y H
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH 146

Query: 224 FYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDP 282
                 + HRD+K  N+++D E+   +L D+GLA     G      V      +  +  P
Sbjct: 147 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-----ASRYFKGP 198

Query: 283 EYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVE---------SAQVCMASESR 332
           E +V  ++     D++S G +L  ++  +     G +  +           +       +
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258

Query: 333 LAELVDPRIKDSFDMEQLRTIVTI----------------VRWCTQREGQARPSIKQVLR 376
               +DPR  D       +                     +    + + Q+R + ++ + 
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 1e-35
 Identities = 59/311 (18%), Positives = 116/311 (37%), Gaps = 48/311 (15%)

Query: 100 FSYKETKKATDNFS------TIIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGD 150
           F  +E  K              +G G +G V  A     G+ +A+K++ +   SE     
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 151 FCREIELLARLHHRHLVALRGFCIEKR------ERFLMYEYMANGSLKDHLHSPGRTPLS 204
             RE+ LL  + H +++ L              + +L+  +M  G+    L       L 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK--HEKLG 119

Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 264
                 +   +   L Y+H      + HRD+K  N+ ++E+   K+ DFGLA        
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR------- 169

Query: 265 CFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA 323
             +   T    T  Y  PE ++     T+  D++S G ++ E++T +   +   +L +  
Sbjct: 170 QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229

Query: 324 QVCMASESRLAELVDPRIKD----------SFDMEQLRTIVT--------IVRWCTQREG 365
           ++   + +  AE V     D            + +   +I+T        ++      + 
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289

Query: 366 QARPSIKQVLR 376
           + R +  + L 
Sbjct: 290 EQRVTAGEALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 8e-34
 Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 36/280 (12%)

Query: 110 DNFSTI--IGQGGFGTVYKAQ----FSDGSLIAVKRMDKIS----EQVEGDFCREIELLA 159
           +NF  +  +G G +G V+  +       G L A+K + K +     +       E ++L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 160 RL-HHRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANA 218
            +     LV L      + +  L+ +Y+  G L  HL    R          + I V   
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138

Query: 219 LEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPG 278
           +  L       + +RDIK  NILLD N    L DFGL+               D  GT  
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA---DETERAYDFCGTIE 195

Query: 279 YMDPEYVVTQE--LTEKSDVYSYGVVLLEIVTARR---AVQDGKNLVESAQVCMASESRL 333
           YM P+ V   +    +  D +S GV++ E++T         +  +  E ++  + SE   
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

Query: 334 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQ 373
            + +    KD            +++    ++ + R     
Sbjct: 256 PQEMSALAKD------------LIQRLLMKDPKKRLGCGP 283

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 4e-31
 Identities = 43/205 (20%), Positives = 86/205 (41%), Gaps = 22/205 (10%)

Query: 115 IIGQGGFGTVYKAQF-SDGSLIAVKRMDK--ISEQVEGDFCREIELLARLHHRHLVALRG 171
            IG G  G V  A        +A+K++ +   ++       RE+ L+  ++H+++++L  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 172 FCI------EKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY 225
                    E ++ +L+ E M     +             +    +   +   +++LH  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSA 138

Query: 226 CDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYV 285
               + HRD+K SNI++  +   K+ DFGLA  +         + T    T  Y  PE +
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVI 190

Query: 286 VTQELTEKSDVYSYGVVLLEIVTAR 310
           +     E  D++S G ++ E+V  +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-30
 Identities = 53/312 (16%), Positives = 115/312 (36%), Gaps = 48/312 (15%)

Query: 99  KFSYKETKKA----TDNFSTI--IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEG-- 149
            F  +E  K      + +  +  +G G +G+V  A     G  +AVK++ +  + +    
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 150 DFCREIELLARLHHRHLVALRGFCIEKR-----ERFLMYEYMANGSLKDHLHSPGRTPLS 204
              RE+ LL  + H +++ L       R         +  ++    L + +       L+
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLT 119

Query: 205 WQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI 264
                 +   +   L+Y+H      + HRD+K SN+ ++E+   K+ DFGLA        
Sbjct: 120 DDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR------- 169

Query: 265 CFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESA 323
             +   T    T  Y  PE ++      +  D++S G ++ E++T  R +  G + ++  
Sbjct: 170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQL 228

Query: 324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTI-------------------VRWCTQRE 364
           ++ +         +  +I        ++++  +                   +      +
Sbjct: 229 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

Query: 365 GQARPSIKQVLR 376
              R +  Q L 
Sbjct: 289 SDKRITAAQALA 300

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (271), Expect = 7e-27
 Identities = 36/211 (17%), Positives = 73/211 (34%), Gaps = 21/211 (9%)

Query: 116 IGQGGFGTVYKAQF-SDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCI 174
           +G G F TV+ A+   + + +A+K +    +        EI+LL R++            
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 175 EKRERFLMYEYMANGSLK--------------DHLHSPGRTPLSWQTRIQIAIDVANALE 220
               + L +      +                  +       +      QI+  +   L+
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 221 YLHFYCDPPLCHRDIKSSNILLD-ENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGY 279
           Y+H      + H DIK  N+L++  +    L    +A             N+    T  Y
Sbjct: 140 YMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQTREY 195

Query: 280 MDPEYVVTQELTEKSDVYSYGVVLLEIVTAR 310
             PE ++       +D++S   ++ E++T  
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 93.3 bits (231), Expect = 8e-23
 Identities = 31/201 (15%), Positives = 67/201 (33%), Gaps = 26/201 (12%)

Query: 115 IIGQGGFGTVYKAQFSDGSLIAVK----------RMDKISEQVEGDFCREIELLARLHHR 164
           ++G+G    V+           VK          ++ +  +  +  F       AR   R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 165 HLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHF 224
            L  L+G  + K     +Y +  N  L + + +     +  +   ++   +   +   + 
Sbjct: 67  ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120

Query: 225 YCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEY 284
                + H D+   N+L+ E  +  + DF  +          E +  D+R    Y    Y
Sbjct: 121 --HRGIVHGDLSQYNVLVSEEGI-WIIDFPQS-VEVGEEGWREILERDVRNIITYFSRTY 176

Query: 285 VVTQELTEKSDVYSYGVVLLE 305
                   + D+ S    +L+
Sbjct: 177 ------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	458
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.63
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.25
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.8
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.25
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.8
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.57

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-56  Score=415.98  Aligned_cols=252  Identities=28%  Similarity=0.463  Sum_probs=201.1

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANG  189 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  189 (458)
                      +++.+.||+|+||+||+|.+.++..||||++.... ...++|.+|++++++++||||++++|+|.+.+..++|||||++|
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g   85 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   85 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence            35677899999999999999888999999987533 33567999999999999999999999999999999999999999


Q ss_pred             CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 012715          190 SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPV  269 (458)
Q Consensus       190 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  269 (458)
                      +|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........   .
T Consensus        86 ~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---~  158 (263)
T d1sm2a_          86 CLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT---S  158 (263)
T ss_dssp             BHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             cHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCce---e
Confidence            9999987643 45899999999999999999999   899999999999999999999999999999876543321   2


Q ss_pred             cccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          270 NTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       270 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      .....||+.|+|||.+.+..++.++|||||||++|||+|++.|+....+..+......... +   ...|   ..+    
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~---~~~p---~~~----  227 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-R---LYKP---RLA----  227 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-C---CCCC---TTS----
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-C---CCCc---ccc----
Confidence            2345689999999999999999999999999999999997666665555544444332211 1   1111   122    


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          350 LRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ...+.+++.+||+.||++|||++||+++|..
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            2568899999999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=417.24  Aligned_cols=253  Identities=27%  Similarity=0.447  Sum_probs=210.6

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.+.||+|+||+||+|.++++..||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++|||||++
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~   91 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence            355678899999999999999888899999997533 334679999999999999999999998855 567999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.......+++..+++++.||+.||+|||   +++|+||||||+||||++++.+||+|||+|+........   
T Consensus        92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~---  165 (272)
T d1qpca_          92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT---  165 (272)
T ss_dssp             CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE---
T ss_pred             CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccc---
Confidence            99999987655556999999999999999999999   899999999999999999999999999999977654321   


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|||||++.+..++.++|||||||++|||+||+.|+.......+........       ..+.....++  
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-------~~~~~p~~~~--  236 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------YRMVRPDNCP--  236 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------CCCCCCTTCC--
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------CCCCCcccCh--
Confidence            2345678999999999999999999999999999999999877776665554444433221       1111222233  


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                        ..+.+++.+||+.||++|||+++|++.|..
T Consensus       237 --~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         237 --EELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence              568999999999999999999999998753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-55  Score=412.04  Aligned_cols=255  Identities=23%  Similarity=0.319  Sum_probs=206.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+++..|+|||||+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence            445689999999999999875 68999999986432 2334578999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+.......  .
T Consensus        87 gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--~  159 (271)
T d1nvra_          87 GGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--E  159 (271)
T ss_dssp             TEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE--E
T ss_pred             CCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc--c
Confidence            99999999764  35999999999999999999999   89999999999999999999999999999987643321  1


Q ss_pred             cccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||....+...............      ...... 
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~------~~~~~~-  232 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------NPWKKI-  232 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS------TTGGGS-
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------CccccC-
Confidence            23445689999999999988876 5789999999999999999999976544333332222111100      001112 


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                         ...+.+++.+||+.||++|||++|+++|.|+.
T Consensus       233 ---s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~  264 (271)
T d1nvra_         233 ---DSAPLALLHKILVENPSARITIPDIKKDRWYN  264 (271)
T ss_dssp             ---CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             ---CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence               24678999999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-55  Score=409.98  Aligned_cols=248  Identities=26%  Similarity=0.401  Sum_probs=209.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||+|.+...   .......+.+|++++++++||||+++++++.+++..|+||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            556789999999999999885 6899999998642   233456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |++|+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......  
T Consensus        88 ~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--  160 (263)
T d2j4za1          88 APLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  160 (263)
T ss_dssp             CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred             cCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence            99999999997533  5999999999999999999999   8999999999999999999999999999998665432  


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                          .....||+.|||||++.+..++.++|||||||+||||++|+.||... +..+...........        +...+
T Consensus       161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~--------~p~~~  227 (263)
T d2j4za1         161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRISRVEFT--------FPDFV  227 (263)
T ss_dssp             ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCCC--------CCTTS
T ss_pred             ----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC--------CCccC
Confidence                23457999999999999999999999999999999999999999644 333333333222211        12222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      +    ..+.+++.+||+.||++|||++|+++|.|..
T Consensus       228 s----~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         228 T----EGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             C----HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             C----HHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence            2    5688999999999999999999999998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-55  Score=414.18  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=211.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      |.+.+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++||||+++++++.+.+..|+|||||+|
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            445678999999999999874 6999999998765555567899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.......    
T Consensus       102 g~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~----  171 (293)
T d1yhwa1         102 GSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----  171 (293)
T ss_dssp             CBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred             CcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc----
Confidence            9999988653   4999999999999999999999   89999999999999999999999999999987654321    


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|||||++.+..++.++|||||||++|||+||+.||.+.................   .   .....+   
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~---~---~~~~~~---  242 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE---L---QNPEKL---  242 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC---C---SSGGGS---
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC---C---CCcccC---
Confidence            2345679999999999999999999999999999999999999997655443332222111111   1   111122   


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       ...+.+++.+||+.||++|||++|+++|.|...
T Consensus       243 -s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         243 -SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             -CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             -CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence             256889999999999999999999999998754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-55  Score=418.51  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=216.0

Q ss_pred             HHhhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          107 KATDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       107 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      ...+.+.+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            334566789999999999999886 58899999986543 3356799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |++|+|.+++.......+++..++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+........
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence            99999999997665667999999999999999999999   889999999999999999999999999999876544321


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         ......||+.|+|||++.+..|+.++|||||||++|||++|+.|+..+.+..+........       ..+.....+
T Consensus       172 ---~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-------~~~~~~~~~  241 (287)
T d1opja_         172 ---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------YRMERPEGC  241 (287)
T ss_dssp             ---EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-------CCCCCCTTC
T ss_pred             ---eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-------CCCCCCccc
Confidence               2334568999999999999999999999999999999999888887766655544432211       111222223


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                          +..+.+++.+||+.||++|||+.||++.|....
T Consensus       242 ----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         242 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                356899999999999999999999999886543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-55  Score=417.72  Aligned_cols=266  Identities=25%  Similarity=0.443  Sum_probs=201.4

Q ss_pred             ccCHHHHHHHhhcc-----------cceeeeecceEEEEEEEcC-C---CEEEEEEeccc-chhhHhHHHHHHHHHHhcC
Q 012715           99 KFSYKETKKATDNF-----------STIIGQGGFGTVYKAQFSD-G---SLIAVKRMDKI-SEQVEGDFCREIELLARLH  162 (458)
Q Consensus        99 ~~~~~~~~~~~~~~-----------~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~  162 (458)
                      .++++++..++.+|           .++||+|+||+||+|.++. |   ..||||.+... .....+.|.+|+++|++++
T Consensus         6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~   85 (299)
T d1jpaa_           6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD   85 (299)
T ss_dssp             GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence            44555555555544           3579999999999998752 3   36899988643 4445568999999999999


Q ss_pred             CCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeee
Q 012715          163 HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILL  242 (458)
Q Consensus       163 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll  242 (458)
                      |||||+++|+|.+++..++|||||++|+|.+++..... .+++.+++.++.||+.||+|||   +++|+||||||+||||
T Consensus        86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl  161 (299)
T d1jpaa_          86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILV  161 (299)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEE
Confidence            99999999999999999999999999999999876433 5999999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcccc-cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchH
Q 012715          243 DENFVAKLADFGLAHASKDGSICFE-PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLV  320 (458)
Q Consensus       243 ~~~~~~kl~DfGla~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~  320 (458)
                      +.++++||+|||+++.......... .......||+.|||||.+.+..++.++|||||||+||||+| |+.||.+.... 
T Consensus       162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-  240 (299)
T d1jpaa_         162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-  240 (299)
T ss_dssp             CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred             CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999987654322111 11223468999999999999999999999999999999998 88888754432 


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +....... ..+      +    ..+...+..+.+++.+||+.||++|||+.||++.|..
T Consensus       241 ~~~~~i~~-~~~------~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         241 DVINAIEQ-DYR------L----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             HHHHHHHT-TCC------C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHc-CCC------C----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            32222211 111      1    1122234678999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-55  Score=411.73  Aligned_cols=256  Identities=26%  Similarity=0.416  Sum_probs=200.9

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|+++|++++|||||+++|++.+ +..++|||||+
T Consensus        10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~   86 (276)
T d1uwha_          10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE   86 (276)
T ss_dssp             CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred             EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence            345678999999999999864  36999998632  34456789999999999999999999999755 56899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+........  
T Consensus        87 ~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~--  160 (276)
T d1uwha_          87 GSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS--  160 (276)
T ss_dssp             EEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred             CCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc--
Confidence            999999997643 35999999999999999999999   899999999999999999999999999999866433211  


Q ss_pred             cccccccCCCcccccccccc---CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      .......||+.|||||++.+   ..|+.++|||||||+||||+||+.||.+............. ....+..  ......
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~p~~--~~~~~~  237 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-GYLSPDL--SKVRSN  237 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH-TSCCCCG--GGSCTT
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc-CCCCCcc--hhcccc
Confidence            12345679999999999864   35899999999999999999999999765554333332221 1111111  111222


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                          .+..+.+++.+||+.||++|||++||+++|+..
T Consensus       238 ----~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         238 ----CPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                235689999999999999999999999998653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=412.31  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=210.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||+||+|++. +|..||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence            445678999999999999875 6899999999766666677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++.... .++++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......    .
T Consensus        94 g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~----~  165 (288)
T d2jfla1          94 GAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----Q  165 (288)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----H
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----c
Confidence            99999986432 35999999999999999999999   8999999999999999999999999999997543211    1


Q ss_pred             ccccccCCCccccccccc-----cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          269 VNTDIRGTPGYMDPEYVV-----TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ......||+.|||||++.     ...|+.++|||||||++|||+||+.||.+........... ....  ..+..     
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~-~~~~--~~~~~-----  237 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEP--PTLAQ-----  237 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-HSCC--CCCSS-----
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCC--CCCCc-----
Confidence            234567999999999984     4568999999999999999999999997655443333222 1111  11111     


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                        +......+.+++.+||+.||++|||++|+++|.|...+
T Consensus       238 --~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         238 --PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             --cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence              11223568899999999999999999999999987644

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-54  Score=402.60  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=203.0

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec----cCceeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE----KRERFLMY  183 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  183 (458)
                      .|.++||+|+||+||+|.+. ++..||+|.+...  .....+.|.+|+++|++++|||||++++++.+    ....|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45668999999999999875 6889999998643  33445679999999999999999999999865    34579999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEeccCCCCCeeeC-CCCcEEEeecccccccC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPP--LCHRDIKSSNILLD-ENFVAKLADFGLAHASK  260 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~  260 (458)
                      |||++|+|.+++...  ..+++..+..++.||+.||+|||   +++  |+||||||+|||++ +++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            999999999999763  35999999999999999999999   777  99999999999996 58899999999998654


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ..      ......||+.|||||++.+ .++.++|||||||++|||++|+.||.+..+.............  +    +.
T Consensus       167 ~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~----~~  233 (270)
T d1t4ha_         167 AS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--P----AS  233 (270)
T ss_dssp             TT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--C----GG
T ss_pred             CC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--C----cc
Confidence            32      2245679999999998865 6999999999999999999999999766655544443322111  1    11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +....+    ..+.+++.+||+.||++|||++|+++|.|+
T Consensus       234 ~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~Hp~f  269 (270)
T d1t4ha_         234 FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNHAFF  269 (270)
T ss_dssp             GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             cCccCC----HHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence            111122    458899999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=398.02  Aligned_cols=250  Identities=28%  Similarity=0.458  Sum_probs=208.5

Q ss_pred             cccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCCCC
Q 012715          111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMANGS  190 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  190 (458)
                      .|.+.||+|+||+||+|+++++..||||.++.... ..++|.+|++++++++||||++++|+|.+++..++||||+++|+
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~   85 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC   85 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence            46789999999999999998888999999875433 34689999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 012715          191 LKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEPVN  270 (458)
Q Consensus       191 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  270 (458)
                      |.+++.... ..+++..+++++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+++........   ..
T Consensus        86 l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~---~~  158 (258)
T d1k2pa_          86 LLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT---SS  158 (258)
T ss_dssp             HHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC---CC
T ss_pred             HHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce---ee
Confidence            999986543 35899999999999999999999   899999999999999999999999999999866543321   23


Q ss_pred             ccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHHH
Q 012715          271 TDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDMEQ  349 (458)
Q Consensus       271 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  349 (458)
                      ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+....... ..+   ...|   ..    .
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~i~~-~~~---~~~p---~~----~  226 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQ-GLR---LYRP---HL----A  226 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHHT-TCC---CCCC---TT----C
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHHHHHHHh-CCC---CCCc---cc----c
Confidence            34678999999999999999999999999999999998 788886543 3333332221 111   1111   12    2


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          350 LRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       350 ~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      +..+.+++.+||+.||++|||+++++++|.+
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            2578999999999999999999999999854

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=406.03  Aligned_cols=254  Identities=25%  Similarity=0.368  Sum_probs=194.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec--cCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE--KRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  184 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||.+...  .....+.+.+|++++++++|||||++++++.+  .+..|+|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            456689999999999999875 6899999998643  33445678999999999999999999999865  456899999


Q ss_pred             ecCCCCHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          185 YMANGSLKDHLHSP--GRTPLSWQTRIQIAIDVANALEYLHFYC--DPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       185 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      ||++|+|.+++...  ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  165 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  165 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence            99999999998632  2346999999999999999999999432  2359999999999999999999999999998765


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPR  340 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~  340 (458)
                      ....    ......||+.|||||++.+..|+.++|||||||++|||+||+.||.... ..+....+...  ..     +.
T Consensus       166 ~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-~~~~~~~i~~~--~~-----~~  233 (269)
T d2java1         166 HDTS----FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREG--KF-----RR  233 (269)
T ss_dssp             --------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHT--CC-----CC
T ss_pred             cCCC----ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-HHHHHHHHHcC--CC-----CC
Confidence            4321    2345679999999999999999999999999999999999999997543 33333322211  11     11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          341 IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       341 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      +...++    ..+.+++.+||+.||.+|||+.|+++|+|
T Consensus       234 ~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         234 IPYRYS----DELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence            222233    46889999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=404.37  Aligned_cols=254  Identities=25%  Similarity=0.401  Sum_probs=200.6

Q ss_pred             cccceeeeecceEEEEEEEcCC-----CEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFSDG-----SLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      .+.++||+|+||+||+|.++++     ..||||++... ......+|.+|++++++++|||||+++|+|.+.+..++|||
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e   89 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE   89 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence            4567899999999999987642     37999998643 33445679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      ||.+|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+++.......
T Consensus        90 ~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          90 YMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             CCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             ecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            999999999886543 35999999999999999999999   89999999999999999999999999999987644321


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                      . ........||+.|||||++.+..++.++|||||||++|||++|+.|+..+.+..+........ .      .+.    
T Consensus       166 ~-~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~------~~~----  233 (283)
T d1mqba_         166 A-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-F------RLP----  233 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-C------CCC----
T ss_pred             c-ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-C------CCC----
Confidence            1 112334568999999999999999999999999999999999877776665554444332211 1      111    


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .+...+..+.+++.+||+.||++|||+.||++.|..
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence            122234678999999999999999999999998854

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-53  Score=407.78  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=195.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||.+.... ......+.+|+++|++++||||+++++++.+++..|+|||||+
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            567789999999999999875 68999999986432 2334568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC---CCCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~~~  264 (458)
                      ||+|.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||+.   +++.+||+|||+|+....+. 
T Consensus        91 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          91 GGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             SCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             CCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            99999999764  35999999999999999999999   89999999999999994   57899999999998665433 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                          .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... +....+........    ......
T Consensus       165 ----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~~~~  235 (307)
T d1a06a_         165 ----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEYEFD----SPYWDD  235 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHTTCCCCC----TTTTTT
T ss_pred             ----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHhccCCCCC----CccccC
Confidence                223467999999999999999999999999999999999999999765433 33232222221111    111122


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ++    ..+.+++.+||+.||++|||++|+++|.|....
T Consensus       236 ~s----~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         236 IS----DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             SC----HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             CC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            22    568899999999999999999999999988654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.4e-53  Score=411.38  Aligned_cols=256  Identities=20%  Similarity=0.277  Sum_probs=213.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      |.+.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|||||||+|
T Consensus        28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  107 (350)
T d1koaa2          28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  107 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            566789999999999999875 6899999999776666667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC--CCCcEEEeecccccccCCCCccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~--~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      |+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+++......   
T Consensus       108 g~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---  180 (350)
T d1koaa2         108 GELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---  180 (350)
T ss_dssp             CBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---
T ss_pred             CCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---
Confidence            99999996543 35999999999999999999999   89999999999999996  46899999999998765443   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......||+.|||||++.+..++.++|||||||++|||++|+.||.+. +..+....+...........    ....+
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~----~~~~s  253 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMDDSA----FSGIS  253 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCSCCGG----GGGCC
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCccc----ccCCC
Confidence              234467999999999999999999999999999999999999999754 33343333333222221111    11122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                          ..+.+++.+||+.||++|||++|+++|.|....
T Consensus       254 ----~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         254 ----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             ----HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             ----HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                468899999999999999999999999987643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-53  Score=400.34  Aligned_cols=249  Identities=21%  Similarity=0.342  Sum_probs=202.6

Q ss_pred             cc-eeeeecceEEEEEEEc---CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          113 ST-IIGQGGFGTVYKAQFS---DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       113 ~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      .+ +||+|+||+||+|.++   ++..||||.++.. .....+.|.+|+++|++++|||||+++|+|.+ +..|+|||||+
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~   91 (285)
T d1u59a_          13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG   91 (285)
T ss_dssp             EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCC
Confidence            44 4999999999999764   3557999998643 34445789999999999999999999999865 56899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      +|+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........ .
T Consensus        92 ~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~  166 (285)
T d1u59a_          92 GGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-Y  166 (285)
T ss_dssp             TEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE-E
T ss_pred             CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccccc-c
Confidence            999999986543 35999999999999999999999   899999999999999999999999999999876544322 1


Q ss_pred             cccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                      .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.... +....+.. ..+      +.....+ 
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~i~~-~~~------~~~p~~~-  237 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQ-GKR------MECPPEC-  237 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHHHT-TCC------CCCCTTC-
T ss_pred             ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHHc-CCC------CCCCCcC-
Confidence            22334568999999999999999999999999999999998 89999754432 33222221 111      1122223 


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                         +..+.+++.+||+.||++|||+.+|++.|.
T Consensus       238 ---~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         238 ---PPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             ---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence               356889999999999999999999988774

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=403.42  Aligned_cols=247  Identities=23%  Similarity=0.367  Sum_probs=197.9

Q ss_pred             ceeeeecceEEEEEEEcC---CCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          114 TIIGQGGFGTVYKAQFSD---GSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      ++||+|+||+||+|.+++   ++.||||++...  +....+.|.+|+++|++++|||||+++|+|.+ +..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            369999999999998753   468999998642  33345679999999999999999999999864 567899999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.+++...  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus        92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~  165 (277)
T d1xbba_          92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YK  165 (277)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-EE
T ss_pred             CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc-cc
Confidence            9999999764  35999999999999999999999   899999999999999999999999999999876543321 11


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                      ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.+... .+....+.. ..+      +.....   
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-~~~~~~i~~-~~~------~~~p~~---  234 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLEK-GER------MGCPAG---  234 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHT-TCC------CCCCTT---
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-HHHHHHHHc-CCC------CCCCcc---
Confidence            2334578999999999999999999999999999999998 8999975433 232222221 111      112222   


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                       .+..+.+++.+||+.||++|||+.+|++.|.
T Consensus       235 -~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         235 -CPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             -CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             -cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence             2356889999999999999999999988774

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=403.78  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=205.8

Q ss_pred             hhcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      .+.+.+.||+|+||+||+|.++++..||||++.... ...+.|.+|+.++++++|+|||+++|+|.+ +..++|||||++
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~   95 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   95 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence            456778999999999999999888899999986433 335679999999999999999999999854 568999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|..++.......++|..++.++.||+.||+|||   +++|+||||||+||||+.++++||+|||+++.......   .
T Consensus        96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~---~  169 (285)
T d1fmka3          96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---T  169 (285)
T ss_dssp             CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCc---e
Confidence            99999987654456999999999999999999999   88999999999999999999999999999987654332   1


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCHH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDME  348 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  348 (458)
                      ......||+.|+|||++.++.++.++|||||||++|||+||+.|+.......+........       ..+.....+   
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-------~~~~~~~~~---  239 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-------YRMPCPPEC---  239 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------CCCCCCTTS---
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------CCCCCCccc---
Confidence            2344568999999999999999999999999999999999888877666655544433221       111122222   


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          349 QLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       349 ~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                       ...+.+++.+||+.||++||++++|++.|...
T Consensus       240 -~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         240 -PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             -CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence             35689999999999999999999999988654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=418.34  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=203.8

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||+|+++.. .......+.+|+++|++++|||||+++++|.+.+..|+|||||+
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~   87 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   87 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            445678999999999999875 6899999998643 33445679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCD-PPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~-~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      ||+|.+++.+.+  .+++..+..++.|++.||+|||   + ++|+||||||+|||++.+|.+||+|||+|+...+.    
T Consensus        88 gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----  158 (322)
T d1s9ja_          88 GGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  158 (322)
T ss_dssp             TEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred             CCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----
Confidence            999999997643  4999999999999999999999   6 48999999999999999999999999999865321    


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccc------------
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLA------------  334 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------  334 (458)
                        .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.................+...            
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              234568999999999999999999999999999999999999999754332111110000000000            


Q ss_pred             ----------------------cccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          335 ----------------------ELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       335 ----------------------~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                                            ....+.+..   ......+.+++.+||+.||++|||++|+++|.|..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~  302 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  302 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence                                  000000000   00124688999999999999999999999998763

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=410.41  Aligned_cols=255  Identities=26%  Similarity=0.388  Sum_probs=204.2

Q ss_pred             hhcccceeeeecceEEEEEEEcC-C-----CEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD-G-----SLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||+||+|++.. +     ..||||.+... .......+.+|+.+|.++ +|||||+++++|.+.+..+
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  117 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence            45677899999999999998743 2     36999988643 334456799999999998 8999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCC
Q 012715          181 LMYEYMANGSLKDHLHSPGR---------------------TPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSN  239 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~N  239 (458)
                      +|||||++|+|.++|+....                     ..+++..++.++.||+.||+|||   +++|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGG
T ss_pred             EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhc
Confidence            99999999999999975421                     35899999999999999999999   8999999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcc
Q 012715          240 ILLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKN  318 (458)
Q Consensus       240 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~  318 (458)
                      ||++.++.+||+|||+|+........  .......||+.|||||.+.+..++.++|||||||+||||+| |+.||.+...
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cccccCCeEEEeeccccccccCCCce--eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999865433211  12234568999999999999999999999999999999998 8899875444


Q ss_pred             hHHHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          319 LVESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ....... .....+      +.....    .+..+.+++.+||+.||++|||++||+++|.
T Consensus       273 ~~~~~~~-~~~~~~------~~~p~~----~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFYKL-IQNGFK------MDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHHHH-HHTTCC------CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHH-HhcCCC------CCCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3333322 221111      111222    2356899999999999999999999999984

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-53  Score=405.69  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=207.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +...+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            455678999999999999875 68899999986432   33446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |.+|+|..++...  .++++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....   
T Consensus        97 ~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          97 CLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             CSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            9999998776543  35999999999999999999999   899999999999999999999999999999865432   


Q ss_pred             cccccccccCCCcccccccccc---CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVT---QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                           ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+............ ..  .....    .
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~-~~--~~~~~----~  236 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NE--SPALQ----S  236 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SC--CCCCS----C
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-CC--CCCCC----C
Confidence                 34579999999999864   4689999999999999999999999976554433322221 11  11111    1


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                      ..++    ..+.+++.+||+.||++|||++|+++|.|......+
T Consensus       237 ~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~  276 (309)
T d1u5ra_         237 GHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (309)
T ss_dssp             TTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             CCCC----HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence            1222    568899999999999999999999999887654433

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.5e-52  Score=409.15  Aligned_cols=256  Identities=21%  Similarity=0.309  Sum_probs=213.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||++..........+.+|+++|++++|||||++++++.+++..|||||||+|
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            566789999999999999875 6999999998765555566789999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC--CCCcEEEeecccccccCCCCccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD--ENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~--~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      |+|.+++...+ ..+++..+..++.||+.||+|||   +++|+||||||+||||+  .++.+||+|||+|+......   
T Consensus       111 g~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---  183 (352)
T d1koba_         111 GELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---  183 (352)
T ss_dssp             CBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred             ChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC---
Confidence            99999886543 35999999999999999999999   89999999999999997  57899999999998776543   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......||+.|||||++.+..++.++|||||||++|||+||+.||.+.... +....+......+..    ......+
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~~~----~~~~~~s  256 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVKRCDWEFDE----DAFSSVS  256 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHHHHHHHCCCCCCS----STTTTSC
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCCc----ccccCCC
Confidence              234467999999999999999999999999999999999999999755443 333332222221111    1112222


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                          ..+.+++.+||+.||.+|||+.|+++|.|....
T Consensus       257 ----~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         257 ----PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             ----HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ----HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                568899999999999999999999999887543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-53  Score=401.95  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=203.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||.+...   .....+.+.+|+++|++++||||+++++++.+++..|+||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            557789999999999999875 6899999998642   233446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |+||+|.+++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus        90 ~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          90 AKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999987643  5999999999999999999999   899999999999999999999999999999876433211


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                        .......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+....+......        +...+
T Consensus       165 --~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-~~~~~~~i~~~~~~--------~p~~~  233 (288)
T d1uu3a_         165 --ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKIIKLEYD--------FPEKF  233 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHTTCCC--------CCTTC
T ss_pred             --cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-HHHHHHHHHcCCCC--------CCccC
Confidence              12344679999999999999999999999999999999999999997543 33333333322211        22223


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPSIKQVLRIL  378 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l  378 (458)
                      +    ..+.+++.+||+.||++|||++|++++.
T Consensus       234 s----~~~~~li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         234 F----PKARDLVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             C----HHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             C----HHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence            3    4588999999999999999999975544

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=399.24  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=209.4

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccc------hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS------EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||+||+|+.. +|+.||||.+....      ....+.+.+|+++|++++|||||++++++.+.+..||
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3566789999999999999885 68999999985422      1234679999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC----cEEEeeccccc
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF----VAKLADFGLAH  257 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~  257 (458)
                      |||||++|+|.+++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++    .+||+|||+++
T Consensus        91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          91 ILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            999999999999997643  5999999999999999999999   89999999999999998776    59999999998


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ....+.     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.... +....+...........
T Consensus       166 ~~~~~~-----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~  239 (293)
T d1jksa_         166 KIDFGN-----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNYEFEDEY  239 (293)
T ss_dssp             ECTTSC-----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHTTCCCCCHHH
T ss_pred             hcCCCc-----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-HHHHHHHhcCCCCCchh
Confidence            765443     234567899999999999999999999999999999999999999754332 33232222221111111


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                      .    ...    ...+.+++.+||+.||++|||++|+++|.|...
T Consensus       240 ~----~~~----s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         240 F----SNT----SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             H----TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             c----CCC----CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            1    111    246889999999999999999999999987743

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=401.65  Aligned_cols=257  Identities=25%  Similarity=0.415  Sum_probs=207.1

Q ss_pred             hcccceeeeecceEEEEEEEcCC----CEEEEEEecc-cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeec-cCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDG----SLIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIE-KRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  183 (458)
                      .+|.++||+|+||+||+|.+.++    ..||||+++. .+....++|.+|+++|++++||||++++|+|.+ ++..++||
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            35677899999999999987532    3689999874 344556789999999999999999999999876 45789999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      |||++|+|.+++.... ..+++..+++++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++......
T Consensus       109 E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             ECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999999997654 35788999999999999999999   8999999999999999999999999999998765544


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKD  343 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  343 (458)
                      ...........||..|+|||.+.+..++.++||||||+++|||+||+.||....+..+......... +      +....
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~------~~~p~  257 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-R------LLQPE  257 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-C------CCCCT
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-C------CCCcc
Confidence            3322334456789999999999999999999999999999999999988876554444433332211 1      11111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          344 SFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       344 ~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ..    ...+.+++.+||+.||++||++.||+++|...
T Consensus       258 ~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         258 YC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            22    25689999999999999999999999998654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=400.44  Aligned_cols=251  Identities=23%  Similarity=0.336  Sum_probs=211.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.++||+|+||.||+|+.. +|+.||||++.+.   .....+.+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            456789999999999999875 7999999998643   223456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |+||+|.+++...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+....... 
T Consensus        87 ~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-  160 (337)
T d1o6la_          87 ANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             CTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred             cCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence            99999999998643  4899999999999999999999   99999999999999999999999999999986543221 


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                         .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.. ..+...........        +...+
T Consensus       161 ---~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-~~~~~~~i~~~~~~--------~p~~~  228 (337)
T d1o6la_         161 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIR--------FPRTL  228 (337)
T ss_dssp             ---CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--------CCTTS
T ss_pred             ---ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-HHHHHHHHhcCCCC--------CCccC
Confidence               2345679999999999999999999999999999999999999997543 33444433332222        22233


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  382 (458)
                      +    ..+.+++.+||+.||.+||+     ++|+++|.|+..
T Consensus       229 s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         229 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             C----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             C----HHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            3    45789999999999999994     999999998754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-51  Score=394.37  Aligned_cols=248  Identities=24%  Similarity=0.374  Sum_probs=209.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            456789999999999999875 6999999998642   233356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      |+||+|..++....  .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....   
T Consensus        86 ~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          86 IEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             cCCccccccccccc--cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            99999999997643  4888999999999999999999   999999999999999999999999999999876543   


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                          .....||+.|||||++.+..|+.++|||||||++|||+||+.||.+... .+....+......+        ...+
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~~~~--------p~~~  224 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAELRF--------PPFF  224 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCCCCC--------CTTS
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-HHHHHHHHcCCCCC--------CCCC
Confidence                2356799999999999999999999999999999999999999975433 33333333222211        1222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      +    ..+.+++.+||..||.+|+     +++++++|.|+..
T Consensus       225 s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         225 N----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             C----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             C----HHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence            2    4588999999999999996     9999999998753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=391.51  Aligned_cols=246  Identities=29%  Similarity=0.463  Sum_probs=195.3

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-CceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK-RERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~  188 (458)
                      +.|.+.||+|+||.||+|++ .|..||||+++..  ...+.|.+|++++++++||||++++|+|.+. +..++||||+++
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~   85 (262)
T d1byga_           9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   85 (262)
T ss_dssp             EEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             eEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence            34678899999999999998 5789999999653  3346799999999999999999999998654 568999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFEP  268 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  268 (458)
                      |+|.++|.......+++..+++++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....      
T Consensus        86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~------  156 (262)
T d1byga_          86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------  156 (262)
T ss_dssp             EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC------
Confidence            99999997654446899999999999999999999   899999999999999999999999999999865432      


Q ss_pred             ccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCCH
Q 012715          269 VNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFDM  347 (458)
Q Consensus       269 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  347 (458)
                       .....+|..|+|||++.+..++.++|||||||++|||+| |+.|+.. .+..+....+.. .      ..+.+...   
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~-~------~~~~~~~~---  224 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEK-G------YKMDAPDG---  224 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTT-T------CCCCCCTT---
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHc-C------CCCCCCcc---
Confidence             233468899999999999999999999999999999999 5666543 333333332211 1      11222222   


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          348 EQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       348 ~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                       ...++.+++.+||+.||.+|||+.+++++|..
T Consensus       225 -~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         225 -CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence             23578999999999999999999999999854

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-51  Score=395.03  Aligned_cols=256  Identities=30%  Similarity=0.468  Sum_probs=206.3

Q ss_pred             hcccceeeeecceEEEEEEEc------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.+.||+|+||+||+|++.      +++.||||++... .....++|.+|+++|++++||||++++++|.+.+..++|
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v   94 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL   94 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence            456789999999999999874      3578999998643 333456799999999999999999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCe
Q 012715          183 YEYMANGSLKDHLHSPG----------------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNI  240 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NI  240 (458)
                      |||+++|+|.+++....                      ...+++..++.++.|++.||+|||   +++++||||||+||
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NI  171 (301)
T d1lufa_          95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNC  171 (301)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccce
Confidence            99999999999986321                      235899999999999999999999   89999999999999


Q ss_pred             eeCCCCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchH
Q 012715          241 LLDENFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV  320 (458)
Q Consensus       241 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~  320 (458)
                      |++.++.+||+|||+|+........  .......||+.|+|||.+.+..|+.++|||||||++|||++|..|+..+.+..
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             EECCCCcEEEccchhheeccCCccc--cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            9999999999999999865433211  12344568999999999999999999999999999999999976544444444


Q ss_pred             HHHHHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          321 ESAQVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       321 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      +........  ..     +.....++    ..+.+++.+||+.||++||||.||++.|...
T Consensus       250 e~~~~v~~~--~~-----~~~p~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         250 EVIYYVRDG--NI-----LACPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             HHHHHHHTT--CC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             HHHHHHHcC--CC-----CCCCccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            444332221  11     11222233    5689999999999999999999999998753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1e-50  Score=383.39  Aligned_cols=253  Identities=23%  Similarity=0.353  Sum_probs=207.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---------hhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCc
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---------EQVEGDFCREIELLARLH-HRHLVALRGFCIEKRE  178 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  178 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||++....         ....+.+.+|+.++++++ ||||+++++++.+++.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence            456789999999999999874 68999999985422         122346889999999997 9999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      .|||||||++|+|.++|...+  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            999999999999999997643  5999999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCCCcccccccccc------CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVT------QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR  332 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  332 (458)
                      ...+.     ......||..|+|||.+.+      ..++.++||||+||+||||++|+.||.+..... ....+......
T Consensus       160 ~~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~  233 (277)
T d1phka_         160 LDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQ  233 (277)
T ss_dssp             CCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC
T ss_pred             ccCCC-----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCC
Confidence            65433     2345679999999999863      357889999999999999999999997654433 33322222211


Q ss_pred             cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          333 LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       333 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ....    ....+    ...+.+++.+||+.||++|||++|+++|.|..
T Consensus       234 ~~~~----~~~~~----s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~  274 (277)
T d1phka_         234 FGSP----EWDDY----SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  274 (277)
T ss_dssp             CCTT----TGGGS----CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             CCCc----ccccC----CHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence            1110    11112    25688999999999999999999999998763

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=390.44  Aligned_cols=264  Identities=24%  Similarity=0.295  Sum_probs=203.2

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccch-----hhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE-----QVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      ++||+|+||+||+|+.. +|+.||||++.....     .....+.+|+++|++++|||||++++++.+++..|+||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            57999999999999875 689999999864321     223568999999999999999999999999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      ++++..+...  ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus        84 ~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~---  155 (299)
T d1ua2a_          84 TDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---  155 (299)
T ss_dssp             EEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC---
T ss_pred             chHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc---
Confidence            8877777654  335889999999999999999999   89999999999999999999999999999986654321   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc----cccccC---C
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR----LAELVD---P  339 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~d---~  339 (458)
                       ......||+.|+|||++.. ..|+.++|||||||++|||+||..||....+..............    ......   .
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence             2334579999999999865 467999999999999999999999987655443332221111000    000000   0


Q ss_pred             c---CCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCC
Q 012715          340 R---IKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMH  386 (458)
Q Consensus       340 ~---~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~  386 (458)
                      .   .....+.     .....+.+++.+||+.||++|||++|+++|.|+...+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            0   0000111     112568999999999999999999999999998766543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-51  Score=393.65  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=197.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCC----EEEEEEecc-cchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGS----LIAVKRMDK-ISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      +.+.++||+|+||+||+|.+. +|+    .||+|++.. ......++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            456689999999999999875 343    589998864 3344567899999999999999999999999865 567889


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+.+|+|.+++.... ..+++..+++++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        90 e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          90 QLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             ECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            9999999999887543 45999999999999999999999   8899999999999999999999999999998765433


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      ..  .......||+.|||||.+.++.++.++|||||||++|||+| |..||.+ .+..+....... ..+      +...
T Consensus       166 ~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~-~~~------~~~p  235 (317)
T d1xkka_         166 KE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEK-GER------LPQP  235 (317)
T ss_dssp             C----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHH-TCC------CCCC
T ss_pred             cc--ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHc-CCC------CCCC
Confidence            21  12234568999999999999999999999999999999999 6666653 333333322221 111      1111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .    ..+..+.+++.+||+.||.+|||+.|++++|..
T Consensus       236 ~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         236 P----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             T----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence            1    223568999999999999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=389.68  Aligned_cols=253  Identities=18%  Similarity=0.258  Sum_probs=208.6

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecCC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMAN  188 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  188 (458)
                      |.+.+.||+|+||+||+|... +|+.||||.+..... ....+.+|+++|+.++||||+++++++.+.+..|||||||+|
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            456789999999999999875 688999999875432 345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC--CCcEEEeecccccccCCCCccc
Q 012715          189 GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE--NFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       189 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      |+|.+++...+ ..+++.++..++.||+.||+|||   +++|+||||||+|||++.  .+.+||+|||+++......   
T Consensus        86 g~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---  158 (321)
T d1tkia_          86 LDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---  158 (321)
T ss_dssp             CBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC---
Confidence            99999997643 35999999999999999999999   899999999999999985  4589999999998765443   


Q ss_pred             ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCCC
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSFD  346 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  346 (458)
                        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... +....+......+.....+    .+ 
T Consensus       159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~----~~-  230 (321)
T d1tkia_         159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDEEAFK----EI-  230 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCCCHHHHT----TS-
T ss_pred             --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCChhhcc----CC-
Confidence              223456899999999999999999999999999999999999999755433 3333333222222111111    12 


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          347 MEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       347 ~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                         ...+.+++.+||..||.+|||++|+++|.|..
T Consensus       231 ---s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  262 (321)
T d1tkia_         231 ---SIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             ---CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ---CHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence               24588999999999999999999999998874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=387.48  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=193.4

Q ss_pred             hhcccceeeeecceEEEEEEEcC----CCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD----GSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMY  183 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  183 (458)
                      .+++.+.||+|+||.||+|.+..    +..||||.+... .....+.|.+|++++++++||||++++|++. .+..++||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence            45677899999999999998742    356899988643 3444567999999999999999999999986 46789999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      ||+++|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+......
T Consensus        87 E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          87 ELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             ECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999876533 35899999999999999999999   8999999999999999999999999999998765432


Q ss_pred             cccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcCC
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRIK  342 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  342 (458)
                      .   .......||+.|+|||.+.+..++.++|||||||++|||+| |..||.+.... +........ ..      +...
T Consensus       163 ~---~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-~~~~~i~~~-~~------~~~~  231 (273)
T d1mp8a_         163 Y---YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENG-ER------LPMP  231 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTT-CC------CCCC
T ss_pred             c---eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-HHHHHHHcC-CC------CCCC
Confidence            1   12344568999999999999999999999999999999998 77777654432 222222211 11      1122


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          343 DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       343 ~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..+    +..+.+++.+||+.||++|||++||+++|..
T Consensus       232 ~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         232 PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            223    3568999999999999999999999999854

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-50  Score=394.81  Aligned_cols=248  Identities=22%  Similarity=0.333  Sum_probs=208.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+++|+.++||||+++++++.+.+..++||||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            445678999999999999875 6999999998642   223345789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 012715          186 MANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSIC  265 (458)
Q Consensus       186 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  265 (458)
                      +.+|+|..++...+  .+++..+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+.....   
T Consensus       123 ~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         123 VAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             CTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             ccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence            99999999997643  5999999999999999999999   899999999999999999999999999999876542   


Q ss_pred             cccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCCC
Q 012715          266 FEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDSF  345 (458)
Q Consensus       266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  345 (458)
                          .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.. .......+......        ....+
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~~--------~p~~~  261 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVR--------FPSHF  261 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC--------CCTTC
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-HHHHHHHHhcCCCC--------CCccC
Confidence                234679999999999999999999999999999999999999997543 33333332222211        11223


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhCC
Q 012715          346 DMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYESS  382 (458)
Q Consensus       346 ~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~~  382 (458)
                      +    ..+.+++.+||+.||.+|+     +++++++|.|+..
T Consensus       262 s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         262 S----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             C----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             C----HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence            3    4588999999999999994     9999999998754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-51  Score=392.25  Aligned_cols=251  Identities=33%  Similarity=0.477  Sum_probs=201.4

Q ss_pred             cccceeeeecceEEEEEEEcC-CC--EEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCceeeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFSD-GS--LIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERFLMYEY  185 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  185 (458)
                      .+.+.||+|+||+||+|.+.+ |.  .||||++... .....+.|.+|+++|.++ +|||||+++|+|.+++..++||||
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey   92 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence            456799999999999998763 43  5788887543 344556899999999999 799999999999999999999999


Q ss_pred             cCCCCHHHHhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEe
Q 012715          186 MANGSLKDHLHSP--------------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLA  251 (458)
Q Consensus       186 ~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~  251 (458)
                      +++|+|.++|+..              ....+++..+++++.||+.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEc
Confidence            9999999999753              2346999999999999999999999   8999999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc
Q 012715          252 DFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES  331 (458)
Q Consensus       252 DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  331 (458)
                      |||+++......     ......||..|+|||.+.+..++.++|||||||++|||++|..|+..+.+..+....+.. . 
T Consensus       170 DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~-~-  242 (309)
T d1fvra_         170 DFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G-  242 (309)
T ss_dssp             CTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-T-
T ss_pred             cccccccccccc-----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-c-
Confidence            999997554321     223456899999999999999999999999999999999987655445555444433221 1 


Q ss_pred             ccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          332 RLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       332 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                           ..+.....    .+..+.+++.+||+.||++||||+||+++|..
T Consensus       243 -----~~~~~~~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         243 -----YRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             -----CCCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                 11222222    23579999999999999999999999999854

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=393.34  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=199.1

Q ss_pred             ceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhc-CCCCeeeeeeeeec----cCceeeeeeecC
Q 012715          114 TIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARL-HHRHLVALRGFCIE----KRERFLMYEYMA  187 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~  187 (458)
                      ++||+|+||+||+|+.. +|+.||||+++..     ..+.+|++++.++ +|||||++++++.+    +...|+|||||+
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~   92 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   92 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence            46999999999999874 6899999998642     3567899987665 79999999999865    467899999999


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC---CCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE---NFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~~  264 (458)
                      ||+|.+++...+...+++..+..++.||+.||+|||   +++|+||||||+|||++.   ++.+||+|||+|+...... 
T Consensus        93 gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~-  168 (335)
T d2ozaa1          93 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-  168 (335)
T ss_dssp             SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-
T ss_pred             CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCC-
Confidence            999999998766667999999999999999999999   899999999999999975   5679999999998765443 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                          ......||+.|||||++.+..|+.++|||||||+||||+||+.||.+.......... ... ..   .....+...
T Consensus       169 ----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-~~~-i~---~~~~~~~~~  239 (335)
T d2ozaa1         169 ----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTR-IR---MGQYEFPNP  239 (335)
T ss_dssp             ----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------C-CC---SCSSSCCTT
T ss_pred             ----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-HHH-Hh---cCCCCCCCc
Confidence                234567999999999999999999999999999999999999999654322111110 000 00   000001110


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ........+.+++.+||+.||++|||+.|+++|.|..
T Consensus       240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence            1112346789999999999999999999999998764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=390.35  Aligned_cols=257  Identities=26%  Similarity=0.367  Sum_probs=195.8

Q ss_pred             HhhcccceeeeecceEEEEEEEc------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeecc-Cc
Q 012715          108 ATDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEK-RE  178 (458)
Q Consensus       108 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  178 (458)
                      ..+.+.+.||+|+||.||+|.+.      +++.||||++... .....+.+.+|..++.++ +|+||+.+++++.+. +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            34567789999999999999863      2468999998643 334456788899988888 689999999998765 46


Q ss_pred             eeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC
Q 012715          179 RFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE  244 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~  244 (458)
                      .++|||||++|+|.+++....              ...+++..++.++.||+.||+|||   +++|+||||||+||||+.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence            899999999999999996422              235899999999999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCC-ccCCCcchHHHH
Q 012715          245 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARR-AVQDGKNLVESA  323 (458)
Q Consensus       245 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~-p~~~~~~~~~~~  323 (458)
                      ++.+||+|||+|+........  .......||+.|||||.+.+..++.++|||||||++|||+||.. ||..........
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             GGCEEECC------CCSCTTS--CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCcEEEccCcchhhccccccc--cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999865433211  12345679999999999999999999999999999999999765 554433333322


Q ss_pred             HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .. ......      +......+    ..+.+++.+||+.||++|||++|++++|..
T Consensus       248 ~~-~~~~~~------~~~~~~~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         248 RR-LKEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             HH-HHHTCC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH-HhcCCC------CCCCccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            22 222111      12222222    568899999999999999999999999964

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=393.44  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=196.7

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEecccchhhHhHHHH--HHHHHHhcCCCCeeeeeeeeeccC----ceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCR--EIELLARLHHRHLVALRGFCIEKR----ERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  183 (458)
                      +.+.+.||+|+||.||+|++ +|+.||||++....   ...+.+  |+..+.+++||||++++++|.+.+    ..++||
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            44667899999999999997 68999999986432   233444  445556789999999999998754    579999


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-----CDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      |||++|+|.++|++.   .++|..+++++.|++.||+|||..     ..++|+||||||+||||+.++.+||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999999853   499999999999999999999942     247999999999999999999999999999987


Q ss_pred             cCCCCcccccccccccCCCccccccccccC------CCCcccccHhHHHHHHHHHhCCCccCCCcc-------------h
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ------ELTEKSDVYSYGVVLLEIVTARRAVQDGKN-------------L  319 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~-------------~  319 (458)
                      ................||+.|||||++.+.      .++.++|||||||+||||+||..|+.....             .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            654433222234456799999999998764      367799999999999999999877642110             1


Q ss_pred             HHHHHHHHhhccccccccCCcCCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          320 VESAQVCMASESRLAELVDPRIKDSF-DMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ........     ..+..+|.+.... +.+.+..+.+++.+||+.||++|||+.||+++|.+
T Consensus       238 ~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         238 VEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             HHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            11111111     1111222222221 23456779999999999999999999999999865

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=385.27  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=195.7

Q ss_pred             hcccceeeeecceEEEEEEEcC--C--CEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSD--G--SLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.+.||+|+||+||+|++..  +  ..||||++...   .....+.|.+|+++|++++||||++++|+|.+ +..++|
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv   88 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV   88 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence            4566789999999999998642  2  37899988642   33445689999999999999999999999976 467899


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      ||||++|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          89 TELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            99999999999886543 35999999999999999999999   899999999999999999999999999999976544


Q ss_pred             CcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      .... .......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.+. +..+..........+      +..
T Consensus       165 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-~~~~~~~~i~~~~~~------~~~  236 (273)
T d1u46a_         165 DDHY-VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGER------LPR  236 (273)
T ss_dssp             CCEE-EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCCC------CCC
T ss_pred             CCcc-eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-CHHHHHHHHHhCCCC------CCC
Confidence            3211 12334568899999999999999999999999999999998 88888644 333333333222211      111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      ...+    +..+.+++.+||+.||++|||+.+|++.|.+.
T Consensus       237 ~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         237 PEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1222    25688999999999999999999999988653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=389.13  Aligned_cols=250  Identities=23%  Similarity=0.357  Sum_probs=206.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHH-hcCCCCeeeeeeeeeccCceeeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLA-RLHHRHLVALRGFCIEKRERFLMYE  184 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e  184 (458)
                      +.+.+.||+|+||+||+|... +|+.||||++.+.   .....+.+..|..++. .++||||+++++++.+++..|||||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            456789999999999999876 6899999998642   2233456777777765 6899999999999999999999999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~  264 (458)
                      ||++|+|.+++....  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 y~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-  157 (320)
T d1xjda_          84 YLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  157 (320)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             ecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence            999999999997643  4899999999999999999999   8899999999999999999999999999998654332 


Q ss_pred             ccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcCCCC
Q 012715          265 CFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRIKDS  344 (458)
Q Consensus       265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  344 (458)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+....+....        +.+...
T Consensus       158 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~--------~~~p~~  225 (320)
T d1xjda_         158 ---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDN--------PFYPRW  225 (320)
T ss_dssp             ---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCC--------CCCCTT
T ss_pred             ---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCC--------CCCCcc
Confidence               12345679999999999999999999999999999999999999997543 333333322221        112222


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHhhhC
Q 012715          345 FDMEQLRTIVTIVRWCTQREGQARPSIK-QVLRILYES  381 (458)
Q Consensus       345 ~~~~~~~~l~~l~~~cl~~dp~~RPs~~-evl~~l~~~  381 (458)
                      ++    ..+.+++.+||+.||++||++. ++++|.|+.
T Consensus       226 ~s----~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~  259 (320)
T d1xjda_         226 LE----KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR  259 (320)
T ss_dssp             SC----HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred             CC----HHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence            33    4588999999999999999996 899988764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.6e-50  Score=391.84  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=201.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc---hhhHhHHHHH---HHHHHhcCCCCeeeeeeeeeccCceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS---EQVEGDFCRE---IELLARLHHRHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~lv  182 (458)
                      +.+.++||+|+||.||+|+.. +|+.||||.+....   ......+.+|   +++++.++|||||++++++.+.+..|+|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            446689999999999999875 69999999985321   1222334444   5666667899999999999999999999


Q ss_pred             eeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCC
Q 012715          183 YEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDG  262 (458)
Q Consensus       183 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~  262 (458)
                      ||||+||+|.++|....  .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        86 mE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             ECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            99999999999997643  4889999999999999999999   999999999999999999999999999999876543


Q ss_pred             CcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcch--HHHHHHHHhhccccccccCC
Q 012715          263 SICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMASESRLAELVDP  339 (458)
Q Consensus       263 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~d~  339 (458)
                      .      .....||+.|||||++.. ..|+.++|||||||+||||+||+.||......  .........        ...
T Consensus       161 ~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--------~~~  226 (364)
T d1omwa3         161 K------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------MAV  226 (364)
T ss_dssp             C------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--------CCC
T ss_pred             c------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--------CCC
Confidence            2      234579999999999975 56899999999999999999999999754322  111111100        111


Q ss_pred             cCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHhhhCC
Q 012715          340 RIKDSFDMEQLRTIVTIVRWCTQREGQARPS-----IKQVLRILYESS  382 (458)
Q Consensus       340 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs-----~~evl~~l~~~~  382 (458)
                      .....++    ..+.+++.+||+.||++||+     ++|+++|.|+..
T Consensus       227 ~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         227 ELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             CCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             CCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            1222333    45889999999999999999     799999998854

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=386.46  Aligned_cols=260  Identities=26%  Similarity=0.405  Sum_probs=210.8

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEeccc-chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKI-SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFL  181 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  181 (458)
                      .+.+.+.||+|+||+||+|.+.      ++..||||+++.. .......|.+|++++++++||||++++|+|...+..++
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  100 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV  100 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence            3456788999999999999763      3578999999643 33444579999999999999999999999999999999


Q ss_pred             eeeecCCCCHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeec
Q 012715          182 MYEYMANGSLKDHLHSP--------GRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADF  253 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  253 (458)
                      |||||++|+|.+++...        ....+++..+.+++.|+++||.|||   +++|+||||||+|||++.++++||+||
T Consensus       101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DF  177 (308)
T d1p4oa_         101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDF  177 (308)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeec
Confidence            99999999999998531        2235799999999999999999999   889999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc
Q 012715          254 GLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL  333 (458)
Q Consensus       254 Gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  333 (458)
                      |+++........  .......||+.|+|||.+.+..++.++|||||||++|||+||..++..+.+..+....+... .. 
T Consensus       178 Gla~~~~~~~~~--~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~-~~-  253 (308)
T d1p4oa_         178 GMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GL-  253 (308)
T ss_dssp             TCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-CC-
T ss_pred             ccceeccCCcce--eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-CC-
Confidence            999866443221  12344568999999999999999999999999999999999975544555555554433321 11 


Q ss_pred             ccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCC
Q 012715          334 AELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSDP  384 (458)
Q Consensus       334 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~  384 (458)
                           +.....+    +..+.+++.+||+.+|++|||+++|+++|....++
T Consensus       254 -----~~~p~~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         254 -----LDKPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             -----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -----CCCcccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                 1112222    25699999999999999999999999999775443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-49  Score=377.45  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=198.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc---chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC----ceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI---SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR----ERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  181 (458)
                      |.+.+.||+|+||+||+|... +|+.||||.+...   +......|.+|+++++.++||||+++++++...+    ..|+
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            456789999999999999874 7999999998643   2334567999999999999999999999988654    3789


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      |||||+||+|.+++...+  .+++.+++.++.||+.||+|||   +++|+||||||+|||++.++..+|+|||++.....
T Consensus        89 vmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence            999999999999987643  5999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      .... ........||+.|||||++.+..++.++|||||||++|||+||+.||...... +.................   
T Consensus       164 ~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~---  238 (277)
T d1o6ya_         164 SGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPIPPSARH---  238 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHCCCCCGGGTS---
T ss_pred             cccc-ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-HHHHHHHhcCCCCCchhc---
Confidence            3211 12334567999999999999999999999999999999999999999754433 333322322222221111   


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARP-SIKQVLRILY  379 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-s~~evl~~l~  379 (458)
                       ...+    ..+.+++.+||+.||++|| |++++++.|.
T Consensus       239 -~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         239 -EGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             -SSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -cCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence             2222    5688999999999999999 8999987764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-50  Score=385.42  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=208.5

Q ss_pred             hhcccceeeeecceEEEEEEEc------CCCEEEEEEecccc-hhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCcee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS------DGSLIAVKRMDKIS-EQVEGDFCREIELLARL-HHRHLVALRGFCIEKRERF  180 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  180 (458)
                      .+.+.+.||+|+||.||+|.+.      +++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+.+..+
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~  103 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEE
Confidence            4567889999999999999762      45789999997533 34455799999999999 6999999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC
Q 012715          181 LMYEYMANGSLKDHLHSPG----------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE  244 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~  244 (458)
                      +|||||++|+|.++++...                ...+++..+..++.||+.||+|||   +++++||||||+|||++.
T Consensus       104 lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH  180 (311)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEET
T ss_pred             EEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccc
Confidence            9999999999999996432                235899999999999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHH
Q 012715          245 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQ  324 (458)
Q Consensus       245 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~  324 (458)
                      ++.+||+|||+++........  .......||+.|+|||.+.+..++.++|||||||++|||+|++.|+....+..+...
T Consensus       181 ~~~~ki~DfG~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         181 GRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             TTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cCcccccccchheeccCCCcc--eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999876543321  233456789999999999999999999999999999999996666554444433333


Q ss_pred             HHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          325 VCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       325 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      .......      .+.....    .+..+.+++.+||+.||.+|||+.||++.|..
T Consensus       259 ~~i~~~~------~~~~~~~----~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         259 KMIKEGF------RMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHHHHTC------CCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhcCC------CCCCccc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2222211      1111122    23568999999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-50  Score=382.26  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=201.7

Q ss_pred             hhcccceeeeecceEEEEEEEcC--------CCEEEEEEeccc-chhhHhHHHHHHHHHHhc-CCCCeeeeeeeeeccCc
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFSD--------GSLIAVKRMDKI-SEQVEGDFCREIELLARL-HHRHLVALRGFCIEKRE  178 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  178 (458)
                      .+.+.+.||+|+||.||+|+...        +..||||+++.. ......++.+|+..+.++ +|||||+++++|.+++.
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            35567899999999999997632        347999998653 334457899999999998 79999999999999999


Q ss_pred             eeeeeeecCCCCHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC
Q 012715          179 RFLMYEYMANGSLKDHLHSPG--------------RTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE  244 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~  244 (458)
                      .++|||||++|+|.++|....              ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.
T Consensus        94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECT
T ss_pred             EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecC
Confidence            999999999999999997543              235899999999999999999999   899999999999999999


Q ss_pred             CCcEEEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHh-CCCccCCCcchHHHH
Q 012715          245 NFVAKLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVT-ARRAVQDGKNLVESA  323 (458)
Q Consensus       245 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~p~~~~~~~~~~~  323 (458)
                      ++.+||+|||+++........  .......||+.|+|||.+.++.|+.++|||||||++|||++ |..||.+ .+..+..
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~~  247 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELF  247 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTT--CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHH
T ss_pred             CCCeEeccchhhccccccccc--cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CCHHHHH
Confidence            999999999999866543321  12345678999999999999999999999999999999998 5666654 3333333


Q ss_pred             HHHHhhccccccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          324 QVCMASESRLAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       324 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                      ..... ..      .+.....++    ..+.+++.+||+.||++|||+.||++.|..
T Consensus       248 ~~i~~-~~------~~~~p~~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         248 KLLKE-GH------RMDKPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             HHHHT-TC------CCCCCSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHc-CC------CCCCCccch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            32221 11      112222233    568999999999999999999999999854

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=378.52  Aligned_cols=264  Identities=25%  Similarity=0.333  Sum_probs=203.7

Q ss_pred             cccceeeeecceEEEEEEEc-CCCEEEEEEecccc--hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          111 NFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS--EQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      ...+.||+|+||+||+|... +|+.||||++....  ......+.+|+++|++++||||+++++++.+++..|+||||+.
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~   84 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   84 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence            44578999999999999874 69999999986432  2335679999999999999999999999999999999999997


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      + ++.+++.......+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+......    
T Consensus        85 ~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~----  156 (298)
T d1gz8a_          85 Q-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----  156 (298)
T ss_dssp             E-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS----
T ss_pred             C-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc----
Confidence            5 5555554444456999999999999999999999   8999999999999999999999999999998664432    


Q ss_pred             cccccccCCCccccccccccCC-CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCC------c
Q 012715          268 PVNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDP------R  340 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~------~  340 (458)
                      .......||+.|+|||.+.... ++.++|||||||++|||++|+.||.+............. .+...+...+      .
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT-LGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCTTTSTTGGGSTT
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHh-cCCCchhhccccccccc
Confidence            1234557999999999887665 578999999999999999999999765544333332211 1111111000      0


Q ss_pred             CCCC------CCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCC
Q 012715          341 IKDS------FDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESSD  383 (458)
Q Consensus       341 ~~~~------~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~  383 (458)
                      ....      .+.     .....+.+++.+||+.||++|||++|+++|.|+..-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            0000      000     112568899999999999999999999999887543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=375.53  Aligned_cols=272  Identities=24%  Similarity=0.287  Sum_probs=204.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec--------cCc
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE--------KRE  178 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~  178 (458)
                      +.+.+.||+|+||+||+|+.. +|+.||||++...  .......+.+|+++|++++|+||+++++++..        .+.
T Consensus        12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~   91 (318)
T d3blha1          12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS   91 (318)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred             EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence            455678999999999999875 7999999988532  33344678999999999999999999998865        346


Q ss_pred             eeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccc
Q 012715          179 RFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHA  258 (458)
Q Consensus       179 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~  258 (458)
                      .++||||+.++.+..+...  ...++...+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          92 IYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             EEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeee
Confidence            7999999988776655544  335899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ................||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+..+....... ....+......
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i-~~~~~~~~~~~  245 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI-SQLCGSITPEV  245 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCCCCTTT
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH-HHhcCCCChhh
Confidence            654332222233446799999999998765 6899999999999999999999999755443332222 21111111111


Q ss_pred             CCcC-------------CCCCCH-HH------HHHHHHHHHHccccCCCCCCCHHHHHHHhhhCCCCCCc
Q 012715          338 DPRI-------------KDSFDM-EQ------LRTIVTIVRWCTQREGQARPSIKQVLRILYESSDPMHS  387 (458)
Q Consensus       338 d~~~-------------~~~~~~-~~------~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~~~~~~  387 (458)
                      ....             ...... +.      ...+.+++.+||+.||++|||++|+++|.|+..++.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~  315 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  315 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence            0000             000011 11      23567899999999999999999999999998776643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=378.13  Aligned_cols=243  Identities=23%  Similarity=0.364  Sum_probs=199.4

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccch------hhHhHHHHHHHHHHhcC--CCCeeeeeeeeeccCcee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISE------QVEGDFCREIELLARLH--HRHLVALRGFCIEKRERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~  180 (458)
                      +.+.++||+|+||+||+|+.. +|+.||||++.....      .....+.+|+.+|++++  ||||+++++++.+.+..+
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            556789999999999999875 689999999864221      12234678999999996  899999999999999999


Q ss_pred             eeeeecCC-CCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-CCcEEEeecccccc
Q 012715          181 LMYEYMAN-GSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-NFVAKLADFGLAHA  258 (458)
Q Consensus       181 lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~  258 (458)
                      +||||+.+ +++.+++...  ..+++..+..++.||+.||+|||   +++|+||||||+|||++. ++.+||+|||+|+.
T Consensus        86 lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccccee
Confidence            99999976 6888888653  35999999999999999999999   899999999999999985 57999999999986


Q ss_pred             cCCCCcccccccccccCCCccccccccccCCC-CcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          259 SKDGSICFEPVNTDIRGTPGYMDPEYVVTQEL-TEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       259 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ....      ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||......       ....       
T Consensus       161 ~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-------~~~~-------  220 (273)
T d1xwsa_         161 LKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQ-------  220 (273)
T ss_dssp             CCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHCC-------
T ss_pred             cccc------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-------hhcc-------
Confidence            5433      2345679999999999987765 57799999999999999999999643211       1111       


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          338 DPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       338 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                       ..+...++    ..+.+++.+||+.||++|||++|+++|.|...
T Consensus       221 -~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         221 -VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             -CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             -cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence             11222333    46889999999999999999999999988754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.8e-49  Score=373.22  Aligned_cols=263  Identities=25%  Similarity=0.302  Sum_probs=202.6

Q ss_pred             hcccceeeeecceEEEEEEEcCCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +...+.||+|+||+||+|++++|+.||||++...  .....+.+.+|+++|++++||||+++++++.+.+..+++|||+.
T Consensus         4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~   83 (286)
T d1ob3a_           4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD   83 (286)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence            3456789999999999999989999999998643  23335679999999999999999999999999999999999998


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICFE  267 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  267 (458)
                      ++.+..+....  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++........   
T Consensus        84 ~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---  155 (286)
T d1ob3a_          84 QDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---  155 (286)
T ss_dssp             EEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             hhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc---
Confidence            87777776543  35999999999999999999999   88999999999999999999999999999987644321   


Q ss_pred             cccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc-------cccccc--
Q 012715          268 PVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES-------RLAELV--  337 (458)
Q Consensus       268 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~--  337 (458)
                       ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+........+.......       ......  
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence             1234468999999999875 45689999999999999999999999765443333322211100       000000  


Q ss_pred             CCcCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 DPRIK-------DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 d~~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      +....       ..+.......+.+++.+||+.||++|||++|+++|.|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            00000       000111225688999999999999999999999998763

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=374.60  Aligned_cols=263  Identities=22%  Similarity=0.278  Sum_probs=199.7

Q ss_pred             hcccceeeeecceEEEEEEEc-C-CCEEEEEEeccc--chhhHhHHHHHHHHHHhc---CCCCeeeeeeeeec-----cC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-D-GSLIAVKRMDKI--SEQVEGDFCREIELLARL---HHRHLVALRGFCIE-----KR  177 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  177 (458)
                      |.+.+.||+|+||+||+|+.. + ++.||||++...  .......+.+|+++|+.|   +||||++++++|..     ..
T Consensus         9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~   88 (305)
T d1blxa_           9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   88 (305)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred             EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence            455678999999999999874 4 667999998542  222234577888887776   79999999999863     34


Q ss_pred             ceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          178 ERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       178 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..+++|||+.++++....... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          89 KLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             EEEEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             eEEEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            679999999987766554433 345899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccccc
Q 012715          258 ASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELV  337 (458)
Q Consensus       258 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  337 (458)
                      ......     ......||+.|+|||++.+..|+.++|||||||++|||++|+.||........................
T Consensus       165 ~~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         165 IYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            654322     335567999999999999999999999999999999999999999765444333322211110000000


Q ss_pred             C--------------CcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 D--------------PRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 d--------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      .              ......+.......+.+++.+||+.||++|||++|+++|.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~  297 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  297 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence            0              0000001111224688999999999999999999999998864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=374.52  Aligned_cols=260  Identities=25%  Similarity=0.362  Sum_probs=195.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc------Cceeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLVALRGFCIEK------RERFLM  182 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv  182 (458)
                      |+..++||+|+||+||+|++. +|+.||||++.....    .+.+|+++|++++|+||+++++++...      ...+||
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            445678999999999999885 699999999865332    234799999999999999999998543      246899


Q ss_pred             eeecCCCCHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC-cEEEeecccccccC
Q 012715          183 YEYMANGSLKDHLH-SPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF-VAKLADFGLAHASK  260 (458)
Q Consensus       183 ~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~  260 (458)
                      ||||+++.+..+.. ......+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+++...
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            99998764443332 112346999999999999999999999   99999999999999999765 89999999998765


Q ss_pred             CCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcc--------
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASES--------  331 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------  331 (458)
                      ...     ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..................        
T Consensus       175 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         175 RGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             TTS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             CCc-----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            443     2344679999999998765 57899999999999999999999999765543333222111000        


Q ss_pred             ---ccccccCCcCC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          332 ---RLAELVDPRIK-----DSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       332 ---~~~~~~d~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                         ...+..-+...     ..........+.+++.+||+.||++|||+.|+++|.|+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  307 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  307 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence               00000000000     001111234688999999999999999999999998763

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=369.55  Aligned_cols=258  Identities=22%  Similarity=0.340  Sum_probs=195.9

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC------cee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKR------ERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  180 (458)
                      +...+.||+|+||+||+|... +|+.||||++...  .....+.+.+|+++|++++|||||+++++|...+      ..|
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence            445678999999999999875 6999999998642  3344567899999999999999999999998654      569


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||| +++|..+++.   ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|+...
T Consensus       100 lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             EEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccC
Confidence            999999 6688887764   24999999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCcccccccccccCCCcccccccccc-CCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccc-------
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVT-QELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESR-------  332 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------  332 (458)
                      ..       .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.................       
T Consensus       173 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         173 SE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             SS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             Cc-------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            32       245679999999999876 457899999999999999999999997655433322221111000       


Q ss_pred             ------------cccccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          333 ------------LAELVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       333 ------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                  +.+.....+. .........+.+++.+||..||++|||++|+++|.|+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence                        0000000000 000111245789999999999999999999999988754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=359.00  Aligned_cols=263  Identities=24%  Similarity=0.268  Sum_probs=210.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccCceeeeeeec
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEKRERFLMYEYM  186 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  186 (458)
                      +...+.||+|+||+||+|+.. +|+.||||+++..  .......+.+|+.+|+.++||||+++++++.+.+..++|++++
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~   83 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence            345678999999999999875 7899999998532  3344578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 012715          187 ANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGSICF  266 (458)
Q Consensus       187 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  266 (458)
                      .+++|..++...+  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.++.......  
T Consensus        84 ~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--  156 (292)
T d1unla_          84 DQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             SEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred             ccccccccccccc--ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence            9999998887643  5889999999999999999999   89999999999999999999999999999987654331  


Q ss_pred             ccccccccCCCccccccccccCC-CCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc--------cc
Q 012715          267 EPVNTDIRGTPGYMDPEYVVTQE-LTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE--------LV  337 (458)
Q Consensus       267 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~  337 (458)
                        ......++..|+|||.+.... ++.++|||||||++|||++|+.||..+.+..+.............+        ..
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence              223445788999999887665 6899999999999999999999988777766555443322111100        00


Q ss_pred             CC----cC-----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhC
Q 012715          338 DP----RI-----KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYES  381 (458)
Q Consensus       338 d~----~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~  381 (458)
                      +.    ..     ...........+.+++.+||+.||.+|||++|+++|.|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~  287 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence            00    00     0001112225688999999999999999999999999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-46  Score=362.51  Aligned_cols=258  Identities=18%  Similarity=0.283  Sum_probs=200.6

Q ss_pred             hhcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeec--cCceeeeee
Q 012715          109 TDNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIE--KRERFLMYE  184 (458)
Q Consensus       109 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e  184 (458)
                      .+.+.++||+|+||+||+|+.. +|+.||||+++...   .+.+.+|+++|++++ ||||+++++++..  ....++|||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            3556789999999999999874 68999999986533   356889999999995 9999999999874  456899999


Q ss_pred             ecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCC-CcEEEeecccccccCCCC
Q 012715          185 YMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDEN-FVAKLADFGLAHASKDGS  263 (458)
Q Consensus       185 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~  263 (458)
                      ||.+++|..+.+     .+++..+..++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+......
T Consensus       113 ~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         113 HVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             CCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             ecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999987653     4999999999999999999999   9999999999999999865 469999999998765433


Q ss_pred             cccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhc------------
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASE------------  330 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~------------  330 (458)
                           ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||..+.+............            
T Consensus       185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         185 -----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             -----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             -----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence                 23456789999999998765 579999999999999999999999986655433222111000            


Q ss_pred             -----cccccccCCc--------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          331 -----SRLAELVDPR--------IKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       331 -----~~~~~~~d~~--------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                           ..........        ............+.+++.+||+.||++|||++|+|+|.|+..
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                 0000000000        000000112246889999999999999999999999998854

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=366.02  Aligned_cols=266  Identities=21%  Similarity=0.295  Sum_probs=198.0

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccc-hhhHhHHHHHHHHHHhcCCCCeeeeeeeeeccC----ceeeee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKIS-EQVEGDFCREIELLARLHHRHLVALRGFCIEKR----ERFLMY  183 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  183 (458)
                      +.+.++||+|+||+||+|... +|+.||||++.... ....+.+.+|+++|++++||||+++++++....    ..++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence            445679999999999999864 79999999986533 344567899999999999999999999987653    234555


Q ss_pred             eecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCCCC
Q 012715          184 EYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKDGS  263 (458)
Q Consensus       184 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~  263 (458)
                      +|+.+|+|.+++...   .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        90 ~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          90 THLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            667799999999753   4999999999999999999999   8999999999999999999999999999998654332


Q ss_pred             cccccccccccCCCccccccccc-cCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccccc-------
Q 012715          264 ICFEPVNTDIRGTPGYMDPEYVV-TQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAE-------  335 (458)
Q Consensus       264 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  335 (458)
                      .. ........||+.|+|||.+. ...++.++||||+||++|||++|+.||......................       
T Consensus       164 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         164 DH-TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             CB-CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             cc-ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            11 11234567999999999985 4567899999999999999999999997554332222211110000000       


Q ss_pred             ------ccCCcCCCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          336 ------LVDPRIKDSFDME-----QLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       336 ------~~d~~~~~~~~~~-----~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                            ..........+..     ....+.+++.+||+.||.+|||++|+++|.|...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~  300 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  300 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                  0000000011111     1145889999999999999999999999987653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=362.96  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=202.1

Q ss_pred             hcccceeeeecceEEEEEEEc----CCCEEEEEEeccc----chhhHhHHHHHHHHHHhcCC-CCeeeeeeeeeccCcee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS----DGSLIAVKRMDKI----SEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~  180 (458)
                      +.+.+.||+|+||+||+|...    +|+.||||.+...    .....+.+.+|++++++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            556789999999999999752    4789999998642    22345678899999999976 89999999999999999


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +||||+.+|+|.+++...+  .++...+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       106 ~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999999997644  4778899999999999999999   8999999999999999999999999999998664


Q ss_pred             CCCcccccccccccCCCccccccccccC--CCCcccccHhHHHHHHHHHhCCCccCCCcchH---HHHHHHHhhcccccc
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQ--ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLV---ESAQVCMASESRLAE  335 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~  335 (458)
                      .....   ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.......   .........      
T Consensus       181 ~~~~~---~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~------  251 (322)
T d1vzoa_         181 ADETE---RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------  251 (322)
T ss_dssp             GGGGG---GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC------
T ss_pred             ccccc---cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC------
Confidence            43221   23445799999999999754  46889999999999999999999997543221   111111111      


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHhhhC
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARP-----SIKQVLRILYES  381 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----s~~evl~~l~~~  381 (458)
                        .+.+....    ...+.+++.+||+.||++||     +++|+++|.|+.
T Consensus       252 --~~~~~~~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~  296 (322)
T d1vzoa_         252 --EPPYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  296 (322)
T ss_dssp             --CCCCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             --CCCCcccC----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence              11111222    35688999999999999999     589999998874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-45  Score=351.40  Aligned_cols=258  Identities=20%  Similarity=0.273  Sum_probs=192.3

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCee-eeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHLV-ALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|++. +|+.||||.+....  ...++.+|+++++.++|+|++ .+.+++.+.+..++||||+ 
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            557789999999999999874 68999999876432  234688999999999876654 5555567778889999999 


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeC---CCCcEEEeecccccccCCCCc
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLD---ENFVAKLADFGLAHASKDGSI  264 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~~~  264 (458)
                      +++|.+.+.... ..+++..+..++.|++.||+|||   +++|+||||||+|||++   .+..+||+|||+|+.......
T Consensus        86 ~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          86 GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            557776665433 35999999999999999999999   89999999999999985   456799999999987654332


Q ss_pred             cc---ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccCCcC
Q 012715          265 CF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVDPRI  341 (458)
Q Consensus       265 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  341 (458)
                      ..   ........||+.|||||.+.+..++.++|||||||++|||+||+.||...................+.. ..+.+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  240 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIEVL  240 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CHHHH
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-ChhHh
Confidence            11   112345679999999999999999999999999999999999999997543322211111110100000 00111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 012715          342 KDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILY  379 (458)
Q Consensus       342 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~  379 (458)
                      ...++    ..+.+++..||+.+|++||++.++.+.|.
T Consensus       241 ~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         241 CKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             TTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             ccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            12222    56889999999999999999998766554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.7e-45  Score=346.82  Aligned_cols=255  Identities=19%  Similarity=0.241  Sum_probs=201.5

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcCC-CCeeeeeeeeeccCceeeeeeecC
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLHH-RHLVALRGFCIEKRERFLMYEYMA  187 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~  187 (458)
                      +.+.+.||+|+||+||+|++. +|+.||||.+....  ....+.+|++++..++| +|++.+++++.++...++||||+ 
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            456789999999999999875 68999999875432  23467899999999975 89999999999999999999999 


Q ss_pred             CCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCC-----CCcEEEeecccccccCCC
Q 012715          188 NGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDE-----NFVAKLADFGLAHASKDG  262 (458)
Q Consensus       188 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~-----~~~~kl~DfGla~~~~~~  262 (458)
                      +++|.+++...+ ..+++.++..++.|++.||+|||   +++|+||||||+|||++.     ++.+||+|||+|+.....
T Consensus        84 ~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          84 GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            689999987544 35999999999999999999999   999999999999999964     578999999999876543


Q ss_pred             Cccc---ccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch--HHHHHHHHhh-c-ccccc
Q 012715          263 SICF---EPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL--VESAQVCMAS-E-SRLAE  335 (458)
Q Consensus       263 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~--~~~~~~~~~~-~-~~~~~  335 (458)
                      ....   ........||+.|||||.+.+..++.++|||||||++|||+||+.||......  .......... . ....+
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence            2111   11234567999999999999999999999999999999999999999743322  1211111111 0 01111


Q ss_pred             ccCCcCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhh
Q 012715          336 LVDPRIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYE  380 (458)
Q Consensus       336 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~  380 (458)
                           +...++    .++.+++..|+..+|++||+++.+.+.+.+
T Consensus       240 -----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         240 -----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             -----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             -----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                 112222    568899999999999999999988877654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=361.37  Aligned_cols=260  Identities=19%  Similarity=0.253  Sum_probs=192.1

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeec------cCcee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIE------KRERF  180 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~  180 (458)
                      +...++||+|+||+||+|++. +|+.||||++...  .......+.+|+.+|++++||||+++++++..      ....|
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence            344578999999999999876 6999999998643  33444578899999999999999999999864      36789


Q ss_pred             eeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccC
Q 012715          181 LMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASK  260 (458)
Q Consensus       181 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~  260 (458)
                      +|||||.++ +.+.+..    .+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+|++|||+++...
T Consensus        99 iv~Ey~~~~-l~~~~~~----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          99 LVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEeccchH-HHHhhhc----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhccc
Confidence            999999765 4455532    4899999999999999999999   8999999999999999999999999999988665


Q ss_pred             CCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhcccc-------
Q 012715          261 DGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRL-------  333 (458)
Q Consensus       261 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  333 (458)
                      ...     ......||+.|+|||.+.+..++.++||||+||++|||++|+.||....................       
T Consensus       171 ~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         171 TSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             ccc-----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            432     23456789999999999999999999999999999999999999975544333222211111000       


Q ss_pred             -------------------ccccCCcCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          334 -------------------AELVDPRIKDS---FDMEQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       334 -------------------~~~~d~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                         ...........   ........+.+++.+||..||++|||++|+|+|.|...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                               00010010011   11233467899999999999999999999999987753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-45  Score=355.23  Aligned_cols=259  Identities=21%  Similarity=0.311  Sum_probs=197.2

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEeccc--chhhHhHHHHHHHHHHhcCCCCeeeeeeeeecc-----Cceee
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKI--SEQVEGDFCREIELLARLHHRHLVALRGFCIEK-----RERFL  181 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  181 (458)
                      |...+.||+|+||+||+|+.. +|+.||||++...  +....+.+.+|+++|++++|+||+++++++...     ...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            445678999999999999864 7999999998643  233445788999999999999999999998643     34577


Q ss_pred             eeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEeecccccccCC
Q 012715          182 MYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLADFGLAHASKD  261 (458)
Q Consensus       182 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~  261 (458)
                      +++|+.+|+|.+++...   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||++.....
T Consensus       100 i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             EEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccCc
Confidence            78888899999999653   4999999999999999999999   89999999999999999999999999999875432


Q ss_pred             CCcccccccccccCCCccccccccccC-CCCcccccHhHHHHHHHHHhCCCccCCCcchHHHHHHHHhhccccccccC--
Q 012715          262 GSICFEPVNTDIRGTPGYMDPEYVVTQ-ELTEKSDVYSYGVVLLEIVTARRAVQDGKNLVESAQVCMASESRLAELVD--  338 (458)
Q Consensus       262 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~d--  338 (458)
                             ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+...................+...  
T Consensus       174 -------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         174 -------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             -------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             -------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence                   23446789999999987765 46889999999999999999999997654433322221111110000000  


Q ss_pred             ------------CcCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhhCC
Q 012715          339 ------------PRIKDSFDM-----EQLRTIVTIVRWCTQREGQARPSIKQVLRILYESS  382 (458)
Q Consensus       339 ------------~~~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPs~~evl~~l~~~~  382 (458)
                                  +.. .....     .....+.+++.+||+.||++|||++|+++|.|+..
T Consensus       247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         247 SSESARNYIQSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             CCHHHHHHHTTSCCC-CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cchhhhhhhhhcccC-CCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                        000 00000     11245789999999999999999999999998864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.2e-40  Score=321.10  Aligned_cols=262  Identities=19%  Similarity=0.210  Sum_probs=192.7

Q ss_pred             hcccceeeeecceEEEEEEEc-CCCEEEEEEecccchhhHhHHHHHHHHHHhcC-----------CCCeeeeeeeeecc-
Q 012715          110 DNFSTIIGQGGFGTVYKAQFS-DGSLIAVKRMDKISEQVEGDFCREIELLARLH-----------HRHLVALRGFCIEK-  176 (458)
Q Consensus       110 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~-  176 (458)
                      |.+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++           |+||+++++++... 
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            567789999999999999874 79999999997543 23457788999998885           57899999887654 


Q ss_pred             -CceeeeeeecCCC-CHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCC------cE
Q 012715          177 -RERFLMYEYMANG-SLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENF------VA  248 (458)
Q Consensus       177 -~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~------~~  248 (458)
                       ...+++|+++..+ +............+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++      .+
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence             4556666665544 33333443444568999999999999999999993  38999999999999997654      49


Q ss_pred             EEeecccccccCCCCcccccccccccCCCccccccccccCCCCcccccHhHHHHHHHHHhCCCccCCCcch------HHH
Q 012715          249 KLADFGLAHASKDGSICFEPVNTDIRGTPGYMDPEYVVTQELTEKSDVYSYGVVLLEIVTARRAVQDGKNL------VES  322 (458)
Q Consensus       249 kl~DfGla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~p~~~~~~~------~~~  322 (458)
                      |++|||.+......       .....||+.|+|||.+....++.++||||+||+++||++|+.||......      ...
T Consensus       172 kl~dfg~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         172 KIADLGNACWYDEH-------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EECCCTTCEETTBC-------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eEeecccccccccc-------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            99999998755432       23467999999999999999999999999999999999999998633211      111


Q ss_pred             HHHHHhhc----------cccccccCC-------------------cCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 012715          323 AQVCMASE----------SRLAELVDP-------------------RIKDSFDMEQLRTIVTIVRWCTQREGQARPSIKQ  373 (458)
Q Consensus       323 ~~~~~~~~----------~~~~~~~d~-------------------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPs~~e  373 (458)
                      ........          .......+.                   .............+.+++.+||..||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            11100000          000000000                   0012234556778999999999999999999999


Q ss_pred             HHHHhhhC
Q 012715          374 VLRILYES  381 (458)
Q Consensus       374 vl~~l~~~  381 (458)
                      +|+|.|+.
T Consensus       325 ~L~Hp~f~  332 (362)
T d1q8ya_         325 LVNHPWLK  332 (362)
T ss_dssp             HHTCGGGT
T ss_pred             HhcCcccC
Confidence            99999876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.1e-25  Score=199.50  Aligned_cols=163  Identities=12%  Similarity=0.098  Sum_probs=121.3

Q ss_pred             cccceeeeecceEEEEEEEcCCCEEEEEEecccc------------------hhhHhHHHHHHHHHHhcCCCCeeeeeee
Q 012715          111 NFSTIIGQGGFGTVYKAQFSDGSLIAVKRMDKIS------------------EQVEGDFCREIELLARLHHRHLVALRGF  172 (458)
Q Consensus       111 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~~  172 (458)
                      .+.++||+|+||+||+|...+|+.||||.++...                  .........|+..+.++.|.|++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4567999999999999998899999999764210                  0112235578899999999999988765


Q ss_pred             eeccCceeeeeeecCCCCHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEeccCCCCCeeeCCCCcEEEee
Q 012715          173 CIEKRERFLMYEYMANGSLKDHLHSPGRTPLSWQTRIQIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLAD  252 (458)
Q Consensus       173 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  252 (458)
                      .    ..+++|||++++.+.+         ++......++.|++.+|+|||   +.+|+||||||+|||++++ .++|+|
T Consensus        83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence            3    3479999998865433         334556789999999999999   8999999999999999965 489999


Q ss_pred             cccccccCCCCcccccccccccCCCcccc------ccccccCCCCcccccHhHHHHH
Q 012715          253 FGLAHASKDGSICFEPVNTDIRGTPGYMD------PEYVVTQELTEKSDVYSYGVVL  303 (458)
Q Consensus       253 fGla~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Dvws~Gv~l  303 (458)
                      ||+|+....+...            .|..      .+ +....|+.++|+||..--+
T Consensus       146 FG~a~~~~~~~~~------------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWR------------EILERDVRNIIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHH------------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcH------------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHH
Confidence            9999765433211            1111      01 1235788999999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.63  E-value=8.5e-08  Score=86.90  Aligned_cols=131  Identities=18%  Similarity=0.143  Sum_probs=93.7

Q ss_pred             ecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcC-CCCeeeeeeeeeccCceeeeeeecCCCCHHHHhcC
Q 012715          119 GGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLH-HRHLVALRGFCIEKRERFLMYEYMANGSLKDHLHS  197 (458)
Q Consensus       119 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  197 (458)
                      ++.+.||+... ++..+.+|+...........+.+|...+..+. +--+.+++.++.+++..++||++++|.++.+....
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            33468998865 56677888876544444556788999998885 44467788888888889999999999888766532


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------------------
Q 012715          198 PGRTPLSWQTRIQIAIDVANALEYLHFYC---------------------------------------------------  226 (458)
Q Consensus       198 ~~~~~l~~~~~~~i~~~ia~gL~~LH~~~---------------------------------------------------  226 (458)
                      .       .....++.+++..++.||...                                                   
T Consensus       104 ~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  176 (263)
T d1j7la_         104 E-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT  176 (263)
T ss_dssp             C-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred             c-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence            1       122344556666666666321                                                   


Q ss_pred             -----CCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          227 -----DPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       227 -----~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                           ...++|+|+.+.|||+++++.+-|.||+.+.
T Consensus       177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                 1137999999999999987777799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.25  E-value=8.4e-07  Score=79.65  Aligned_cols=129  Identities=18%  Similarity=0.141  Sum_probs=85.2

Q ss_pred             eeeecc-eEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCC--CCeeeeeeeeeccCceeeeeeecCCCCHH
Q 012715          116 IGQGGF-GTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHH--RHLVALRGFCIEKRERFLMYEYMANGSLK  192 (458)
Q Consensus       116 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~  192 (458)
                      +..|.. +.||+...+++..+.+|......   ...+..|+..++.+..  -.+.++++++.+.+..++||++++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444543 67999988778788888754322   3357788888888853  34567888888888999999999886653


Q ss_pred             HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----------------------------------------------
Q 012715          193 DHLHSPGRTPLSWQTRIQIAIDVANALEYLHFY-----------------------------------------------  225 (458)
Q Consensus       193 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~-----------------------------------------------  225 (458)
                      +..       ...   ...+.+++..|+-||..                                               
T Consensus        95 ~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          95 SSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             ccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            211       111   11122333333333310                                               


Q ss_pred             --------CCCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          226 --------CDPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       226 --------~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                              ....++|+|+.+.|||++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                    12238999999999999988778899998653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.80  E-value=4e-05  Score=73.22  Aligned_cols=75  Identities=13%  Similarity=0.096  Sum_probs=48.2

Q ss_pred             ceeeeecceEEEEEEEcC-CCEEEEEEecc----cc---hhhHhHHHHHHHHHHhcC-C--CCeeeeeeeeeccCceeee
Q 012715          114 TIIGQGGFGTVYKAQFSD-GSLIAVKRMDK----IS---EQVEGDFCREIELLARLH-H--RHLVALRGFCIEKRERFLM  182 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  182 (458)
                      +.||.|....||+....+ ++.++||.-..    ..   .........|.+.|..+. +  ..+.+++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            368999999999998654 67899996421    11   112234567888888773 3  345556554  44566899


Q ss_pred             eeecCCCC
Q 012715          183 YEYMANGS  190 (458)
Q Consensus       183 ~e~~~~gs  190 (458)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.25  E-value=0.00095  Score=61.51  Aligned_cols=92  Identities=14%  Similarity=0.066  Sum_probs=54.8

Q ss_pred             ccccCHHHHHHHhhccc-----ceeee-ecceEEEEEEEcCCCEEEEEEecccchhhHhHHHHHHHHHHhcCCCCe--ee
Q 012715           97 FQKFSYKETKKATDNFS-----TIIGQ-GGFGTVYKAQFSDGSLIAVKRMDKISEQVEGDFCREIELLARLHHRHL--VA  168 (458)
Q Consensus        97 ~~~~~~~~~~~~~~~~~-----~~lG~-G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~  168 (458)
                      +..++.+.+..+...+.     +++-= +.--.||++..++|..|++|..... ....+++..|...+..|...++  +.
T Consensus         5 f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~   83 (325)
T d1zyla1           5 FQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAA   83 (325)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             ccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCC
Confidence            34455566655554332     12111 2235899999989999999976532 2234668889999988853322  11


Q ss_pred             eee-----eeeccCceeeeeeecCCC
Q 012715          169 LRG-----FCIEKRERFLMYEYMANG  189 (458)
Q Consensus       169 l~~-----~~~~~~~~~lv~e~~~~g  189 (458)
                      .+.     .....+..+.++++++|.
T Consensus        84 p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          84 PVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceecCCCeeeeeeeEEEEEEeecCCc
Confidence            111     122345678889998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.80  E-value=0.0018  Score=61.29  Aligned_cols=72  Identities=19%  Similarity=0.247  Sum_probs=48.5

Q ss_pred             ceeeeecceEEEEEEEcCC--------CEEEEEEecccchhhHhHHHHHHHHHHhcCCCCe-eeeeeeeeccCceeeeee
Q 012715          114 TIIGQGGFGTVYKAQFSDG--------SLIAVKRMDKISEQVEGDFCREIELLARLHHRHL-VALRGFCIEKRERFLMYE  184 (458)
Q Consensus       114 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  184 (458)
                      +.|+.|-.-.+|++...++        ..|.++.....  .......+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4688899999999987543        45666655422  223456689999998853344 477777643    68899


Q ss_pred             ecCCCCH
Q 012715          185 YMANGSL  191 (458)
Q Consensus       185 ~~~~gsL  191 (458)
                      |++|.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.57  E-value=0.0029  Score=57.61  Aligned_cols=31  Identities=23%  Similarity=0.315  Sum_probs=27.6

Q ss_pred             CCCeEeccCCCCCeeeCCCCcEEEeeccccc
Q 012715          227 DPPLCHRDIKSSNILLDENFVAKLADFGLAH  257 (458)
Q Consensus       227 ~~~iiHrDlk~~NIll~~~~~~kl~DfGla~  257 (458)
                      ..++||+|+.+.||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5689999999999999998878899999764